Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.8517944936845898,-2.083965643681833,0.0,0.1283836261663511,0.07,3/29,1.87%,DUSP4;DUSP6;FOS
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,-0.8719865496848883,-2.012244356690363,0.0,0.16689871401625642,0.16,2/21,1.13%,DUSP4;DUSP6
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,-0.8632269721317424,-2.003604911548437,0.0,0.11982471775526102,0.17,3/22,3.71%,DUSP4;DUSP6;DUSP2
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.7381602333056848,-1.9831024656641443,0.0,0.11233567289555721,0.19,2/68,0.03%,CYP1A2;UGT2B15
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.7894318305454785,-1.917205766499937,0.0,0.29528234018260757,0.4,1/33,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.7104636825427971,-1.8583770910666553,0.047619047619047616,0.5584687738236273,0.64,8/34,9.12%,NPAS4;DRD4;GABRE;NLGN3;GRID2;MPP2;GABRA5;INSYN2A
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,-0.7056153641357198,-1.85784036000063,0.0,0.4805215722226284,0.65,16/49,11.84%,NDST3;ST3GAL3;CHPF2;XYLT1;UST;EXTL1;HS6ST2;B4GALT2;CHST11;ST3GAL2;CHST12;CHSY1;CSGALNACT1;CHST6;B3GAT3;B4GALT4
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.8029950360853435,-1.8566195407857768,0.0,0.4316899429843556,0.68,7/34,3.71%,DUSP4;DUSP6;UBASH3B;PTPN9;PTPRO;PTPRB;DUSP2
prerank,KEGG_2021_Human__Porphyrin and chlorophyll metabolism,-0.8805671297000442,-1.8521956408929348,0.0,0.4094011189971418,0.69,1/23,0.03%,UGT2B15
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,-0.7175385677572584,-1.8409036831317698,0.0,0.42623363887228566,0.76,5/70,2.22%,CYP1A2;UGT2B15;GLYATL1;PODXL2;GSTT2B
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.7406395441617168,-1.8336023571682172,0.0,0.4283344618459169,0.81,4/31,4.30%,ARC;MFSD2A;CLDN4;BCL9L
prerank,KEGG_2021_Human__Tryptophan metabolism,-0.7775633171496655,-1.8326910475345308,0.0,0.3979892411156884,0.81,2/39,0.97%,CYP1A2;TPH1
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.6818188839332214,-1.8325115945928567,0.0,0.3673746841067893,0.81,7/58,3.22%,DUSP4;ARC;TPH1;DUSP6;FOS;CHD4;EGR1
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.7749809688475324,-1.8035242331287065,0.0,0.48602372762975776,0.9,4/39,4.07%,DUSP4;DUSP6;DUSP2;PPP5C
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.9297327295556248,-1.7996066477753427,0.0,0.469028180927736,0.91,1/10,0.24%,EIF2S3B
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.7328874554808468,-1.7984717028637838,0.0,0.4421211126103716,0.91,6/35,5.95%,PER2;FBP2;G6PC3;ENO3;PC;CRY1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.9023127859216329,-1.7944764704798886,0.0,0.4380147245675508,0.92,4/20,4.07%,DUSP4;DUSP6;DUSP2;PPP5C
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,-0.6075797017428253,-1.7863689990704352,0.0,0.44720296447945634,0.94,21/124,10.50%,DUSP4;ARC;NGF;TPH1;DUSP6;FOS;SHC3;CHD4;EGR1;ADCYAP1;RALB;PPP2R5D;NTRK1;VGF;ASCL1;RAPGEF1;FOSL1;RALGDS;TRIB1;NAB2;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.8140236644367613,-1.782871928842202,0.0,0.4425856586261051,0.94,4/16,6.35%,SPRED3;SPRED2;SPRED1;PARD3
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.8915221133552398,-1.7756597925251563,0.0,0.45126844597472415,0.94,2/17,0.03%,CYP1A2;UGT2B15
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,-0.6236387109777074,-1.7712913390301033,0.0,0.45729024939252677,0.94,20/108,10.20%,DUSP4;ARC;NGF;TPH1;DUSP6;FOS;SHC3;CHD4;EGR1;ADCYAP1;RALB;PPP2R5D;NTRK1;VGF;ASCL1;RAPGEF1;FOSL1;RALGDS;TRIB1;NAB2
prerank,Reactome_2022__ERKs Are Inactivated R-HSA-202670,-0.9060195913058445,-1.7654953050393,0.0,0.47443585487837936,0.96,2/12,1.13%,DUSP4;DUSP6
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.7968600120608722,-1.7589039177796855,0.0,0.5023707110857217,0.97,10/33,10.13%,ARC;NGF;NLGN3;GRID2;GRIK4;CX3CR1;BCR;GRIK1;NLGN2;CEL
prerank,KEGG_2021_Human__Pentose and glucuronate interconversions,-0.9181924345935231,-1.7580677354462055,0.0,0.48625298410505474,0.97,1/16,0.03%,UGT2B15
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.8474728475722003,-1.757086584978938,0.0,0.46937053726417965,0.97,4/15,7.73%,ARC;WNT7A;SHANK1;EPHB2
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.7233627496693813,-1.7537311247238763,0.0,0.4646499700866784,0.97,6/38,5.95%,PER2;FBP2;G6PC3;ENO3;PC;CRY1
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.7970756289047948,-1.748974526873033,0.0,0.46788699313959076,0.97,1/24,0.01%,CYP1A2
prerank,Reactome_2022__Retrograde Neurotrophin Signaling R-HSA-177504,-0.8630365435462822,-1.7390829071899234,0.0,0.5029887068017398,0.98,2/13,7.28%,NGF;NTRK1
prerank,Reactome_2022__Sulfur Amino Acid Metabolism R-HSA-1614635,0.841522749277103,1.7375082611535118,0.017543859649122806,1.0,0.52,3/22,3.05%,SQOR;BHMT;VSIG2
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.8982882898728474,-1.7366125956835847,0.02564102564102564,0.49715452477521477,0.98,2/10,0.67%,CYP1A2;EPHX2
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.8010071795885033,-1.7304744229549471,0.0,0.5169580680298405,1.0,1/18,0.24%,EIF2S3B
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.8987509535207558,1.7281063790415347,0.0,0.8058184585698338,0.59,1/22,0.01%,GPR62
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,-0.6477017504587825,-1.7266860897093148,0.0,0.5176759119610931,1.0,3/62,1.87%,DUSP4;DUSP6;FOS
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),-0.8546626084976379,-1.7247091543244175,0.0,0.5111273116747854,1.0,1/14,0.13%,PER2
prerank,Reactome_2022__Arachidonic Acid Metabolism R-HSA-2142753,-0.6878802067647729,-1.711979257297403,0.045454545454545456,0.5703345332117294,1.0,2/50,0.67%,CYP1A2;EPHX2
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.7519168969994775,-1.7110877432846012,0.0,0.5614895650275414,1.0,9/44,8.31%,CDH4;ZNF703;CDH20;CDH5;CSK;CDH19;CDH13;PVR;CDH9
prerank,KEGG_2021_Human__Drug metabolism,-0.707494739334192,-1.7103479004348485,0.0,0.5494819199919827,1.0,6/67,3.56%,CYP1A2;UGT2B15;NME1-NME2;GSTT2B;CES2;UPB1
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,-0.6585886627558317,-1.708871693273431,0.0,0.5424208205528335,1.0,3/59,1.87%,DUSP4;DUSP6;FOS
prerank,KEGG_2021_Human__Steroid hormone biosynthesis,-0.8220488722499679,-1.708196601190272,0.0,0.5315776088833781,1.0,2/30,0.03%,CYP1A2;UGT2B15
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),-0.7656220163241038,-1.708067399469097,0.038461538461538464,0.5179265760868847,1.0,5/25,10.09%,ARC;WNT7A;SHANK1;EPHB2;ITGA3
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.9236807953263005,-1.7076462174255884,0.0,0.5072799177496078,1.0,1/12,0.13%,RFX6
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.9857982606767558,-1.7049348221496263,0.0,0.5112877912074933,1.0,1/6,0.13%,PER2
prerank,Reactome_2022__Degradation Of Cysteine And Homocysteine R-HSA-1614558,0.9127517125956439,1.704343571998979,0.015151515151515152,0.8462537934084633,0.75,2/12,3.05%,SQOR;VSIG2
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.9792892375851479,-1.7040945790121047,0.0,0.5032011884129908,1.0,3/8,1.26%,SPRED3;SPRED2;SPRED1
prerank,KEGG_2021_Human__Metabolism of xenobiotics by cytochrome P450,-0.7904480151016973,-1.7000737922644495,0.0,0.5135345046654044,1.0,2/39,0.03%,CYP1A2;UGT2B15
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.8432613136786333,-1.69807485629039,0.0,0.5004043610802095,1.0,2/12,5.09%,PER2;GYS1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.8432613136786333,-1.69807485629039,0.0,0.5004043610802095,1.0,2/12,5.09%,PER2;GYS1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.8456035613663558,-1.6933110179387247,0.0,0.5166727710828041,1.0,2/13,0.50%,NPAS4;ADRA1A
prerank,Reactome_2022__Biosynthesis Of DHA-derived SPMs R-HSA-9018677,-0.8476412859916833,-1.687327997567726,0.0,0.5369784711827381,1.0,2/14,0.67%,CYP1A2;EPHX2
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.8102825524598991,-1.6866608066405064,0.0,0.518081424758796,1.0,1/12,0.64%,SPRY4
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.8102825524598991,-1.6866608066405064,0.0,0.518081424758796,1.0,1/12,0.64%,SPRY4
prerank,Reactome_2022__Methylation R-HSA-156581,-0.925979151454039,-1.6859009107933383,0.0,0.5135345046654044,1.0,1/11,0.01%,CYP1A2
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,0.8698730148778089,1.6851601448709235,0.0,0.8751361754360562,0.86,1/24,0.07%,NLRP4
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.8270015801875146,-1.6830852540227879,0.05128205128205128,0.5212375222353854,1.0,2/11,1.74%,PHLDB2;OSR1
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.7973606581576217,-1.6795764295821354,0.0,0.5293936584859537,1.0,3/27,2.59%,CYP1A2;EPHX2;ELOVL6
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.631272679503595,-1.6791969608434607,0.0,0.5219288186839736,1.0,18/80,10.94%,DUSP4;SPRED3;SPRY4;SPRED2;DUSP6;SPRED1;PRKCD;FOXO1;APOE;IGBP1;PTPRJ;PRDM15;EPHB2;WNK2;PTPRR;CAMK2N1;EMILIN1;SPRY1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex1:Brain,-0.7975267406750361,-1.6782798805770116,0.0,0.5176524700330044,1.0,7/14,15.15%,PDGFD;MDGA1;SERPINE2;CDH9;JAG1;HPCAL1;MN1
prerank,Reactome_2022__RAS Signaling Downstream Of NF1 Loss-Of-Function Variants R-HSA-6802953,-0.9505594611408146,-1.6707351668886334,0.025,0.543966179015947,1.0,3/6,1.26%,SPRED3;SPRED2;SPRED1
prerank,KEGG_2021_Human__Retinol metabolism,-0.7570133627210782,-1.6692168030912469,0.0,0.5422457519716974,1.0,2/34,0.03%,CYP1A2;UGT2B15
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.8797126302729619,-1.6684808147316559,0.0,0.5346261003927335,1.0,2/9,1.49%,DRD4;CBARP
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.6987337337744338,-1.6640494621518,0.0,0.5520495925153096,1.0,5/43,1.26%,DUSP4;SPRED3;SPRED2;DUSP6;SPRED1
prerank,KEGG_2021_Human__Ascorbate and aldarate metabolism,-0.9110438055852493,-1.6639153140526661,0.0,0.5440809536498121,1.0,2/12,4.09%,UGT2B15;RGN
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.7470673498065972,-1.6632903050131045,0.03333333333333333,0.5392112298986746,1.0,5/21,5.00%,DRD4;CSK;RHBDF1;APOE;WWP2
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.80989606895368,-1.6630640004622215,0.038461538461538464,0.5315082123286936,1.0,3/22,1.26%,SPRED3;SPRED2;SPRED1
prerank,Reactome_2022__Aflatoxin Activation And Detoxification R-HSA-5423646,-0.7954295522549759,-1.65884517885566,0.0,0.5476298283358124,1.0,1/13,0.01%,CYP1A2
prerank,KEGG_2021_Human__Linoleic acid metabolism,-0.7839983398662003,-1.6580775708869289,0.0,0.5441809186535012,1.0,1/18,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.6306521414509734,-1.6540427342785904,0.05263157894736842,0.5583668820568287,1.0,11/67,9.74%,ARC;ADRA1A;NMU;CRHR2;NLGN3;CACNG4;SLC8A3;MPP2;EPHB2;NLGN2;SHISA7
prerank,CellMarker_Augmented_2021__Follicular Dendritic cell:Spleen,0.7778030838509111,1.6510044043533274,0.0,1.0,0.97,27/53,15.35%,RASGRP4;CYTIP;ARHGAP9;ITGAX;GMFG;SASH3;PTPRC;ITGAM;NFAM1;SCIMP;CLEC12A;WAS;NAPSB;HCK;CSF3R;IKZF1;TAGAP;HK3;CD37;IGSF6;PSTPIP1;MYO1F;P2RX1;PARVG;ADGRE3;CD300LF;PIK3R6
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),-0.931927056835064,-1.6508293215442842,0.0,0.5688999434496433,1.0,3/5,1.26%,SPRED3;SPRED2;SPRED1
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Embryonic Prefrontal Cortex,-0.5896523826516701,-1.6454662968609988,0.0,0.5883920343839383,1.0,26/109,12.47%,ARC;ETV5;SPRY4;TRIB2;FIBIN;DUSP6;BCHE;ETV1;PSAT1;MMP2;S100B;GRID2;RND3;SERPINE2;SEZ6L;OCIAD2;SLITRK2;NEUROD6;TTYH1;BCL11A;SPRY1;PTPRZ1;ALCAM;RAMP1;NOVA1;NEUROD2
prerank,"Reactome_2022__Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",0.8466332851380924,1.637644377333911,0.0,1.0,0.98,3/18,3.20%,GATA4;C1QTNF1;GNAT3
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.6874676449897581,-1.6342666871108025,0.047619047619047616,0.6442523785802348,1.0,8/24,12.91%,NPAS4;DRD4;NLGN3;GRID2;MPP2;INSYN2A;GRIN1;ARRB2
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.8295857646566944,-1.6321340749430742,0.0,0.6505409116936747,1.0,4/9,13.42%,APOE;CEL;CYP46A1;ADH4
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,-0.7684556334342949,-1.6304793534733826,0.0,0.6547564934483906,1.0,9/26,14.73%,CDH4;CDH5;CDH19;CDH13;PVR;CDH9;NECTIN3;CDH12;CDH11
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.6234266037613752,-1.6265727117223172,0.0,0.6707579309126025,1.0,5/51,2.80%,PER2;FBP2;G6PC3;ENO3;PC
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.8868826140480217,-1.6240691063890675,0.0,0.676214899536195,1.0,3/11,4.76%,NOX4;TST;MTHFR
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.814347230321827,-1.62371858578525,0.02857142857142857,0.6712112962387258,1.0,3/20,1.87%,DNMT1;GATAD2A;FOS
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.8825737002036614,-1.6174450168188115,0.030303030303030304,0.7039702168121585,1.0,3/8,8.84%,NGF;NTRK1;RAPGEF1
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.7786488743579097,-1.6125175821611826,0.0,0.7196517784557654,1.0,6/15,17.96%,ADAMTS12;FBXO27;NEU4;NGLY1;FBXO44;ADAMTS9
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.6564350622314241,-1.6105581487824359,0.05,0.7220711514923693,1.0,7/54,5.34%,PER2;RFX6;GRP;GCK;ITPR2;CELA2A;ABCC8
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.8922141707980639,-1.6091168892238643,0.0,0.7220295135595586,1.0,1/12,0.01%,CYP1A2
prerank,Reactome_2022__Biosynthesis Of Specialized Proresolving Mediators (SPMs) R-HSA-9018678,-0.8145696935511526,-1.6082596379495275,0.0,0.7196240098271786,1.0,2/16,0.67%,CYP1A2;EPHX2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.7298631372184377,-1.6050507603630266,0.030303030303030304,0.7347878448248173,1.0,2/31,1.02%,ARC;LZTS3
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.6208346227244649,-1.6048310919763413,0.0,0.7273426205501353,1.0,3/35,1.26%,SPRED3;SPRED2;SPRED1
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,-0.6433253442987622,-1.604314478502438,0.030303030303030304,0.7213859703195349,1.0,10/35,19.68%,DYNLT5;IFT88;KIF17;CLUAP1;TRAF3IP1;DYNC2I1;IFT52;IFT43;IFT81;DYNLRB1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.8558352355986769,-1.6039474363927413,0.0,0.7162201544755313,1.0,2/10,7.45%,ADAM8;CLPTM1
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Undefined,-0.7834567859719221,-1.6036632268053412,0.02702702702702703,0.7088044150813855,1.0,4/13,4.78%,IL7R;CD38;SELE;APOE
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),-0.6913405024880209,-1.6035352161881904,0.045454545454545456,0.7006301549931966,1.0,12/44,16.84%,PER2;PRDM5;HDAC10;HDAC3;MIER2;BAZ2A;SIRT7;RCOR2;MIDEAS;PER1;ZNF541;HDAC5
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.9556282329094532,-1.6015156156850463,0.0,0.7044084741705579,1.0,1/7,1.47%,PRKCD
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.8667975270781512,1.6003955849822284,0.0,1.0,1.0,1/16,0.01%,GPR62
prerank,Reactome_2022__Synthesis Of Epoxy (EET) And Dihydroxyeicosatrienoic Acids (DHET) R-HSA-2142670,-0.94479808913814,-1.5989883054890095,0.021739130434782608,0.7114592616718624,1.0,2/5,0.67%,CYP1A2;EPHX2
prerank,Reactome_2022__Chylomicron Assembly R-HSA-8963888,-0.9407979835067053,-1.5979504001413523,0.0,0.7101880120402152,1.0,2/6,4.78%,APOB;APOE
prerank,Reactome_2022__Activation Of TRKA Receptors R-HSA-187015,-0.9055918107386594,-1.5966944477278926,0.030303030303030304,0.7105884425021294,1.0,3/5,7.28%,NGF;ADCYAP1;NTRK1
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.9135651765460342,-1.5965323129525921,0.0,0.7041915678917557,1.0,2/9,4.21%,GCK;NR4A3
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.8217982139920434,-1.596473038118943,0.0,0.6970647338895746,1.0,1/12,0.53%,NIPAL1
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.8625501264937785,-1.5961985040328917,0.02702702702702703,0.6905308072565425,1.0,1/10,0.33%,MT1G
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.7309844835287197,-1.5953521358327238,0.03333333333333333,0.687422993884051,1.0,12/22,23.09%,SMARCB1;ERBB2;DDX11;PIH1D1;SMARCA4;EIF2AK3;MARS1;WDR75;DHX33;BNC1;UBTF;WDR43
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.8316736523489734,-1.5947866448610455,0.0,0.6824083513919125,1.0,4/12,1.74%,SPRED3;SPRED2;SPRED1;OSR1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.7350562212953715,-1.5943817838858256,0.04,0.6775027228669942,1.0,4/26,7.73%,ARC;NLGN3;TGFA;EPHB2
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.8413518530210786,-1.5942174023623843,0.0,0.6636340846194682,1.0,5/18,12.51%,DNMT1;GATAD2A;FOS;DNMT3A;BAZ2A
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.8413518530210786,-1.5942174023623843,0.0,0.6636340846194682,1.0,5/18,12.51%,DNMT1;GATAD2A;FOS;DNMT3A;BAZ2A
prerank,Reactome_2022__AKT Phosphorylates Targets In Nucleus R-HSA-198693,-0.8730320888952068,-1.5928793284562621,0.025,0.6640811989278413,1.0,2/10,3.43%,NR4A1;FOXO1
prerank,CellMarker_Augmented_2021__Ectoderm cell:Germ,-0.603327673059035,-1.5914643327113713,0.0,0.6666587254575628,1.0,25/96,13.81%,RASSF2;DTX1;HRH2;MYO9B;LRRN2;GFRA2;NLGN3;S100B;VASH1;TMEM132C;NLRP1;SEZ6L;TBKBP1;PREX1;TMEM132E;KCNIP1;ADAMTS10;SDK2;CMTM5;TTYH1;NHSL2;RNF175;NRXN2;TNRC6C;PLXNA4
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.8789462077826632,-1.5913672960657015,0.05128205128205128,0.6537084638470327,1.0,2/11,4.61%,ACER2;ACER3
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.8789462077826632,-1.5913672960657015,0.05128205128205128,0.6537084638470327,1.0,2/11,4.61%,ACER2;ACER3
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.9254406920284536,-1.5912926524477318,0.0,0.6412762127009237,1.0,3/5,7.05%,CD14;SARM1;TICAM2
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.9254406920284536,-1.5912926524477318,0.0,0.6412762127009237,1.0,3/5,7.05%,CD14;SARM1;TICAM2
prerank,CellMarker_Augmented_2021__Endothelial cell:Plasma,0.7600880037018445,1.5886966329247578,0.0,1.0,1.0,25/56,16.42%,RASGRP4;ARHGAP9;GP1BA;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;ITGAM;NFAM1;CLEC12A;WAS;HCK;CSF3R;HK3;CD37;IGSF6;MYO1F;P2RX1;PARVG;CD300LF;PIK3R6;FERMT3;PIK3CG;CD244
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.7758124423184574,-1.587607841680213,0.04,0.6571716309703319,1.0,4/20,8.84%,NGF;RAB35;NTRK1;RAPGEF1
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.8330636836213279,-1.5859238913967395,0.07894736842105263,0.6600428780552404,1.0,5/7,14.65%,TESMIN;LETM2;CLDN16;SLC4A11;LETM1
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),-0.8594943469650906,-1.5853897306360007,0.0,0.6565015136098751,1.0,3/7,3.35%,NPAS4;DRD4;NLGN3
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.6830341806262922,-1.5840189788856933,0.0,0.6584598672801123,1.0,14/30,17.70%,GLYATL1;DDAH2;GLUD2;FPGS;KYAT1;ALDH4A1;PYCR3;AADAT;ALDH18A1;RIMKLB;DDAH1;GLUD1;SLC39A8;GOT2
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.7817738537132561,-1.5834413941595469,0.0,0.6563460050104503,1.0,2/11,3.29%,MT1G;IFI16
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.9274010217433994,-1.5825193114074796,0.027777777777777776,0.6533030939068848,1.0,2/9,2.81%,DRD4;HRH1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.622783845048987,-1.5814065969896662,0.0,0.6542765546589837,1.0,18/101,12.57%,ARC;NPAS4;NGF;NPTX2;NMU;NLGN3;GRID2;GRIK4;DLGAP4;SLC8A3;CX3CR1;BCR;GRIK1;NLGN2;CEL;SNCAIP;DLGAP1;GRM2
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),0.977479891608926,1.5800096685091065,0.0,1.0,1.0,1/5,0.08%,SQOR
prerank,CellMarker_Augmented_2021__Monocyte:Undefined,0.7525001209197397,1.5772921497882273,0.0,1.0,1.0,24/43,15.08%,CLEC5A;OSCAR;C3AR1;TLR2;ITGAX;LILRB3;PTAFR;ITGAM;TFEC;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;NLRC4;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;FPR1;ADGRE3;CD300LF
prerank,Reactome_2022__RUNX3 Regulates YAP1-mediated Transcription R-HSA-8951671,-0.8210615340007656,-1.5753524625122093,0.05128205128205128,0.6876845160855011,1.0,3/7,7.57%,TEAD2;CCN2;TEAD4
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.8544354592226516,-1.5722238714459202,0.025,0.7049321124822122,1.0,1/13,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.6930923645618323,-1.5705881779298059,0.03225806451612903,0.7104283022496174,1.0,2/36,1.23%,IL7R;H1-4
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.7492248416444922,-1.5692685956653156,0.02857142857142857,0.7117773292141664,1.0,9/26,9.67%,NLGN3;GRID2;WNT7A;DLG5;SYNDIG1;AGRN;EPHB2;SLITRK2;NLGN2
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.9098600121589449,-1.5683443902510368,0.0,0.711726727559709,1.0,2/8,0.67%,CYP1A2;EPHX2
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.8427161442355797,-1.5673744707395412,0.05,0.7116770215097551,1.0,3/11,1.26%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.7122648510802887,-1.566836680162372,0.0,0.7082496710177035,1.0,6/21,12.08%,GRIN3A;APOE;SHANK1;DLG5;PTPRS;NEURL1
prerank,Reactome_2022__Xenobiotics R-HSA-211981,-0.8103957504898717,-1.5663211750773736,0.05714285714285714,0.7045470128137756,1.0,1/13,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.6903834757759066,-1.5658797225769445,0.041666666666666664,0.700354815845405,1.0,12/43,16.84%,PRDM5;HDAC7;HDAC10;FLNA;HDAC3;MIER2;BAZ2A;SIRT7;RCOR2;MIDEAS;ZNF541;HDAC5
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.9275674296663559,-1.5629446650266519,0.045454545454545456,0.7119256124506718,1.0,1/8,1.39%,PHLDB2
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,0.828914406086352,1.5623421979719816,0.0,1.0,1.0,1/17,0.07%,NLRP4
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.68102774950018,-1.562293539019416,0.023255813953488372,0.7103531315594122,1.0,8/19,16.35%,SPRY4;EPHB2;STAMBP;SPRY1;DAB2IP;SLIT2;TGFB2;SPRY2
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.8248405798093636,-1.5620712639637393,0.0,0.705138975313673,1.0,1/15,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.8900919650239207,1.561631724114889,0.0,1.0,1.0,3/10,8.05%,IYD;DIO1;DUOX1
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.6638927326078273,1.5608445773485993,0.0,1.0,1.0,53/87,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPL13;RPS12;RPS4X;RPL27A;RPS19;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL24;RPL23;EIF4A2;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS18;RPS24;RPL10;RPS29;RPLP1;RPS28;RPL34
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.9244323129830261,-1.5608286424964017,0.030303030303030304,0.7073937801765947,1.0,2/6,4.78%,MFSD2A;APOE
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.6205762049240183,-1.560726981281916,0.06060606060606061,0.7020780614402854,1.0,15/65,13.53%,NPAS4;SLITRK6;WNT3A;KIRREL3;NLGN3;GRID2;WNT7A;PCDHB6;SDK2;NLGN2;CBLN4;PCDHB9;NRXN2;LRRTM3;DBNL
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.5684103218677865,-1.5592001429669395,0.0,0.7061099439149311,1.0,28/142,12.27%,DUSP4;EPHX2;DUSP6;PPEF1;PTPN9;DUSP15;PPM1M;PTPRO;PTPRB;DUSP2;THNSL2;PPP5C;PNKP;PTPRA;PTPRF;PPP2R5D;PTPRJ;PTPRE;NT5C;CTDSP1;PTPRR;PTPRS;PTPRZ1;PPM1H;CTDSP2;PGP;PLPPR3;PLPP2
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.8636182906351237,-1.5515523439330696,0.0,0.7420366522050309,1.0,3/9,7.81%,PRKCD;SMPD3;NSMAF
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.8636182906351237,-1.5515523439330696,0.0,0.7420366522050309,1.0,3/9,7.81%,PRKCD;SMPD3;NSMAF
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.877065122967234,1.5512390412603698,0.029850746268656716,1.0,1.0,2/13,2.51%,PKP2;GJC3
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.562806222756127,-1.5507086173401663,0.0,0.7426736006471079,1.0,23/103,14.57%,ARC;PACSIN2;CFAP410;MAST2;RND3;KLHL20;APOE;PLD2;SH3KBP1;PAK6;FGD1;FGD5;WASF3;RHOBTB2;SYNE3;PACSIN3;CAPZB;SIPA1L3;ZNF135;MICAL1;BIN1;MICAL3;CSPG5
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.6959705617111998,1.5488457564909652,0.0,1.0,1.0,23/62,13.47%,ITGB2;CLEC5A;C3AR1;TLR2;TNFRSF1B;ITGAX;LILRB3;PTAFR;ITGAM;TFEC;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;TRIM25;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;FPR1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),-0.8096586085055744,-1.5485291573575874,0.02857142857142857,0.7448272107036811,1.0,7/18,11.80%,WNT3A;GPC6;MDGA1;WNT7A;GPC4;SLITRK2;LRFN4
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),-0.8096586085055744,-1.5485291573575874,0.02857142857142857,0.7448272107036811,1.0,7/18,11.80%,WNT3A;GPC6;MDGA1;WNT7A;GPC4;SLITRK2;LRFN4
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.7311426516961903,-1.5474968750194595,0.04,0.7463301267998583,1.0,5/21,9.80%,DRD4;CBARP;CACNB1;HPCA;GNB5
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.7022811094223339,-1.547167364156622,0.0625,0.742336021375824,1.0,5/18,11.31%,NLGN3;WNT7A;SHANK1;NLGN2;GRIN1
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.8051773531700975,-1.5471012919545624,0.0,0.7373170407369056,1.0,4/13,12.78%,TEFM;EARS2;TFB1M;SLC25A33
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.6645297562300397,-1.5468584131473309,0.05555555555555555,0.7331587079011241,1.0,9/38,15.56%,DTX1;MLF1;PPP5C;BAZ2A;TERT;POLR2F;TAF1B;POLR3A;POLR2C
prerank,Reactome_2022__Myogenesis R-HSA-525793,-0.6933993429402404,-1.5459250025006976,0.05405405405405406,0.7337318756052673,1.0,3/22,7.84%,CDH4;BOC;BNIP2
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.8899198997307517,-1.5459113542415914,0.02564102564102564,0.7283116236279091,1.0,1/12,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6845119456264322,1.54526961158314,0.0,1.0,1.0,55/85,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPL13;RPS12;RPS4X;RPL27A;RPS19;SRP19;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL24;RPL23;RPS15;SRP14;RPS27;RPL8;RPS3;RPS23;RPS20;RPS18;RPS24;RPL10;RPS29;RPLP1;RPS28;RPL34
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.7273003589605523,1.5449878284230896,0.013513513513513514,1.0,1.0,9/43,11.00%,PCLAF;SYCP1;DTL;UBE2L6;TRIM25;FAAP20;POLD4;RPA3;RPS27A
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.8602638042621089,-1.5442172548326014,0.024390243902439025,0.7351399728167254,1.0,1/8,1.80%,CDH5
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.7244179617060976,1.543361725930659,0.014084507042253521,1.0,1.0,27/51,15.08%,ITGB2;CYTIP;TNFRSF1B;ITGAX;LILRB3;SASH3;PTPRC;PTAFR;ITGAM;NFAM1;FCGR3A;ADGRE1;CLEC12A;CD80;CEACAM8;HCK;CSF3R;TAGAP;HK3;IGSF6;ALOX5AP;PSTPIP1;MYO1F;FPR1;PARVG;ADGRE3;CD300LF
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.7044679715187874,1.5432873178208866,0.011494252873563218,1.0,1.0,28/66,15.35%,RASGRP4;ITGB2;C3AR1;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;CCL5;SASH3;PTPRC;ITGAM;NFAM1;CLEC12A;WAS;HCK;CSF3R;IL5;TAGAP;HK3;ALOX5AP;PSTPIP1;MYO1F;FPR1;PARVG;ADGRE3;CD300LF;PIK3R6
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.8987303215216772,1.542645733096877,0.0,1.0,1.0,3/11,6.38%,MYRF;SOX10;PLP1
prerank,Reactome_2022__Dopamine Receptors R-HSA-390651,-0.9632594119703448,-1.5420376015177386,0.0,0.7446250317648364,1.0,1/5,0.34%,DRD4
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.7557403997090848,-1.5410347853731932,0.038461538461538464,0.7443418325894694,1.0,8/17,17.96%,AOAH;FBXO27;NEU4;NGLY1;SAMHD1;FBXO44;FUCA1;ADAMTS9
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),-0.897716225572742,-1.5400384127643998,0.0,0.7453747171731071,1.0,1/8,0.13%,RFX6
prerank,CellMarker_Augmented_2021__Regulatory B cell:Peripheral Blood,0.7566888897308099,1.5387217591718267,0.0,1.0,1.0,21/42,16.42%,C19ORF38;ARHGAP9;SASH3;NFAM1;CLEC12A;WAS;NAPSB;HCK;CSF3R;IKZF1;TAGAP;HK3;CD37;PNOC;MYO1F;P2RX1;PARVG;ADGRE3;CD300LF;PIK3R6;CD244
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Pluripotent Stem Cell,0.6712576470404945,1.5377759588822832,0.0,1.0,1.0,17/78,10.83%,C1QB;CLEC5A;OSCAR;LPAR1;TLR2;ARHGEF40;ARHGAP24;ARHGAP31;NID1;LMO2;TFEC;VSIG4;ANPEP;HCK;PSAP;KIAA0930;HK3
prerank,KEGG_2021_Human__Complement and coagulation cascades,0.6881936994044859,1.537649112881572,0.0,1.0,1.0,26/55,17.55%,C1QB;ITGB2;C3AR1;ITGAX;C3;ITGAM;VSIG4;SERPIND1;F8;CPB2;C4BPA;C4BPB;KNG1;PLAUR;F7;PLAU;CFD;VWF;VTN;PLAT;PLG;MASP2;MASP1;PROCR;A2M;TFPI
prerank,Reactome_2022__NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.7358871277298495,-1.537041931888491,0.09523809523809523,0.7614637537475246,1.0,1/13,0.34%,NGF
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),-0.9136661269489001,-1.5355529059181714,0.047619047619047616,0.7641134814922466,1.0,2/7,0.54%,TACR3;GRK5
prerank,Reactome_2022__Amine Ligand-Binding Receptors R-HSA-375280,-0.6990475854182843,-1.5354025364354273,0.06896551724137931,0.759755959134442,1.0,4/31,2.07%,DRD4;ADRA1A;ADRA1B;HRH2
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.5866937544130135,-1.5345449392145571,0.0,0.7600128564613706,1.0,7/116,3.55%,CYP1A2;PER2;AOAH;PC;THEM4;PDZD11;MECR
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),-0.9260780264763464,-1.5342668686167413,0.043478260869565216,0.7559264073076489,1.0,1/5,0.72%,GABRE
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.8158030612743324,-1.5339014094890013,0.0,0.7422344401051871,1.0,1/10,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.8158030612743324,-1.5339014094890013,0.0,0.7422344401051871,1.0,1/10,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.8158030612743324,-1.5339014094890013,0.0,0.7422344401051871,1.0,1/10,0.01%,CYP1A2
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,0.7322704266955816,1.5333271438742224,0.01282051282051282,1.0,1.0,5/23,8.69%,GML;HSPA1L;HSPA8;DNAJB1;COL4A6
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.7487156631028988,-1.532868798048132,0.05555555555555555,0.7431301539259131,1.0,3/13,7.81%,PRKCD;SMPD3;NSMAF
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.8158454759616387,-1.5324579359057529,0.07692307692307693,0.7399962343588387,1.0,3/9,3.82%,SLC38A5;SLC6A20;SLC6A17
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.8549786237139207,1.5309133189324813,0.04411764705882353,1.0,1.0,2/13,5.77%,ESR1;GPER1
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.6815905517715574,-1.530779158844576,0.037037037037037035,0.7454924886983929,1.0,8/24,12.44%,ARC;NLGN3;CACNG4;SHANK1;NLGN2;SHISA7;CACNG2;CNIH3
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.5668538806012131,-1.5306716327171292,0.0,0.7410923279575744,1.0,23/131,11.92%,DUSP4;EYA4;DUSP6;UBASH3B;PPEF1;PTPN9;PPM1M;PTPRO;PTPRB;DUSP2;PPP5C;PTPRA;PTPRF;PPP2R5D;PTPRJ;PTPRE;CTDSP1;PTPRR;PTPRS;PTPRZ1;PPM1H;CTDSP2;PGP
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.6758613688614489,1.5297055353920497,0.0,1.0,1.0,56/88,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPL13;RPS12;RPS4X;RPL27A;RPS19;SRP19;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL24;RPL23;RPS15;SRP14;RPS27;RPL8;RPS3;RPS23;RPS20;RPS18;RPS24;RPL10;SEC62;RPS29;RPLP1;RPS28;RPL34
prerank,Reactome_2022__PI3K/AKT Activation R-HSA-198203,-0.8304666769180654,-1.5291250094208304,0.05555555555555555,0.745823278942389,1.0,2/8,7.28%,NGF;NTRK1
prerank,CellMarker_Augmented_2021__Megakaryocyte:Blood,0.7287752157958165,1.528565711358862,0.0410958904109589,1.0,1.0,26/47,15.08%,RASGRP4;ITGB2;CLEC5A;TMEM150B;OSCAR;C3AR1;TLR2;TNFRSF1B;ITGAX;LILRB3;ITGAM;TFEC;NFAM1;FCGR3A;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;FPR1;P2RX1;PARVG;CD300LF
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.8776914235918488,1.5280497428312587,0.014705882352941176,1.0,1.0,1/9,1.06%,BLK
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.8288419497583867,-1.5261212231920411,0.11538461538461539,0.7622246414445945,1.0,1/11,0.59%,MFSD2A
prerank,Reactome_2022__Biosynthesis Of Maresins R-HSA-9018682,-0.9269810267997706,-1.5261167433810687,0.02631578947368421,0.7572100056456168,1.0,2/6,0.67%,CYP1A2;EPHX2
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.778241846374439,1.525672739026667,0.04918032786885246,1.0,1.0,5/21,11.61%,ENDOG;H1-0;GPER1;DNASE2;ERN2
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),0.9517757854417935,1.5253285883708196,0.0,1.0,1.0,1/6,0.01%,GPR62
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucose-dependent Insulinotropic Polypeptide (GIP) R-HSA-400511",0.8982041680595101,1.5252983449495785,0.0,1.0,1.0,2/10,1.14%,GATA4;C1QTNF1
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.7784783869624341,1.5237188607247807,0.0547945205479452,1.0,1.0,3/18,5.05%,GATA4;SMAD6;HEY2
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.8675923019285088,-1.5231683004820658,0.025,0.7708891330655343,1.0,1/10,1.42%,DGKD
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.8546898348766351,1.5229064424167462,0.015151515151515152,1.0,1.0,6/11,14.41%,ITGB2;ITGAM;HLA-F;SYK;F2RL1;IL4
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.8296485898186325,-1.521308765348285,0.11428571428571428,0.7797221139830403,1.0,3/8,14.81%,KLHL41;MYOCD;GPC1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.7606581138526735,1.5208220842048363,0.0,1.0,1.0,4/20,4.08%,ESR1;CCL5;FGF2;FLT1
prerank,Reactome_2022__ARMS-mediated Activation R-HSA-170984,-0.8416454025891782,-1.5205468379505025,0.10810810810810811,0.7788330560272255,1.0,2/7,7.28%,NGF;NTRK1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.72440353620228,-1.5201453056850853,0.07142857142857142,0.7763917495213822,1.0,5/20,10.66%,LIN28B;TRIM71;KHSRP;DGCR8;AGO2
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.6737713286793495,1.5198700858326937,0.013157894736842105,1.0,1.0,33/76,15.73%,RASGRP4;IL21R;ITGB2;ARHGAP9;GP1BA;TNFRSF1B;ITGAX;GMFG;LILRB3;SASH3;ALOX12;TGFB1;ITGAM;NFAM1;FCGR3A;CLEC12A;FLI1;WAS;HCK;CSF3R;TAGAP;VWF;HK3;PSTPIP1;MYO1F;FPR1;ITGA2B;P2RX1;PARVG;ADGRE3;CD300LF;PIK3R6;FERMT3
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),-0.8104471885116793,-1.5197416348123918,0.06451612903225806,0.7731638123585031,1.0,4/17,6.06%,ARC;NPAS4;APOE;SHANK1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.6893641258599063,-1.5183192310816709,0.02631578947368421,0.7776147483620127,1.0,3/20,0.57%,PER2;ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),-0.8498109843859842,-1.5181256423431815,0.06818181818181818,0.7738545114328987,1.0,1/8,0.34%,DRD4
prerank,GO_Biological_Process_2021__cytidine to uridine editing (GO:0016554),-0.8821832763318092,-1.5179343442181958,0.05405405405405406,0.7700610376990448,1.0,1/6,4.60%,APOBEC3H
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.7765802516615509,-1.517903922333084,0.07894736842105263,0.7655172740353854,1.0,2/11,8.67%,NAA40;METAP2
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.7385187152271081,-1.51738880550432,0.10526315789473684,0.7640410739936981,1.0,7/16,17.41%,WWC1;NEK8;DLG5;MOB3B;WWC2;VGLL4;MARK3
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.7626750584523317,1.5164589595632325,0.04225352112676056,1.0,1.0,6/31,4.37%,SMOC1;MAB21L1;C3;FREM2;HIPK1;ITGAM
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),-0.8236078502403917,-1.5155830081789317,0.07317073170731707,0.7703017569981067,1.0,5/6,15.01%,SLC38A5;SLC25A29;SLC3A2;SLC16A10;SLC36A4
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.836288369744516,-1.5150612356369033,0.07142857142857142,0.768892668418232,1.0,2/9,8.49%,OSR1;COMMD1
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.7289279662019381,-1.5142649830238852,0.030303030303030304,0.7689012083490192,1.0,7/24,9.07%,SPRED3;SPRED2;SPRED1;TWIST1;SMYD2;ATR;SNAI2
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.7874771853651867,-1.5138891681389175,0.0,0.7663574407725139,1.0,4/11,15.79%,DNMT1;MPHOSPH8;MORC2;SETDB1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.6315001600720996,1.5138357508945748,0.012658227848101266,1.0,1.0,18/112,7.63%,NLRP4;EOLA1;S100A13;NOX5;TRIL;LRRC19;TNFRSF1B;ACE2;ANXA1;PTPRC;NFAM1;NLRP12;RNF26;SFTPD;PLD4;IGF2BP2;AFAP1L2;IL26
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.7878012403358393,-1.5134532067434003,0.08571428571428572,0.7648435309754653,1.0,1/10,0.59%,MFSD2A
prerank,Reactome_2022__GAB1 Signalosome R-HSA-180292,-0.7328258518907659,-1.5132460819665954,0.02564102564102564,0.7619721050623136,1.0,2/13,6.89%,CSK;TGFA
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.929901843613453,1.5121561653304882,0.0,1.0,1.0,3/7,6.38%,MYRF;SOX10;PLP1
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.8082518727899825,-1.5117934953319472,0.0,0.7671111580046234,1.0,3/10,12.78%,TEFM;TFB1M;SLC25A33
prerank,CellMarker_Augmented_2021__Purkinje cell:Brain,-0.5656242950499979,-1.5116069904332128,0.058823529411764705,0.763429457009202,1.0,46/92,28.09%,MAST2;MAP3K10;DLG5;PRRC2A;NLGN2;KLHL29;KIF1C;TAOK2;LLGL1;RAB11FIP3;PLEC;ZC3H7B;ANKRD52;TNRC18;MICAL3;SCRIB;GPC1;CSNK1E;RAI1;EP400;ANO8;PRR12;ZNF512B;ABL1;ATN1;ARHGAP35;TOM1L2;CDC42BPB;PIP4K2B;ADD1;CTIF;LARP1;EVI5L;SKI;NUMA1;PCBP4;AGAP1;PACS2;SMG6;HERC2;ZHX3;PLXNA1;MACF1;NEURL4;PAFAH1B1;GOLGA3
prerank,CellMarker_Augmented_2021__Macrophage:Eye,0.6886463094156179,1.511060650330829,0.0,1.0,1.0,22/58,13.47%,ITGB2;TMEM150B;OSCAR;C3AR1;TLR2;TNFRSF1B;ITGAX;LILRB3;TAPBPL;SLC7A7;PTAFR;ITGAM;TFEC;FCGR3A;CLEC12A;ANPEP;HCK;PLAUR;HK3;IGSF6;CSF1R;FPR1
prerank,CellMarker_Augmented_2021__Macrophage:Retinal Pigment Epithelium,0.6886463094156179,1.511060650330829,0.0,1.0,1.0,22/58,13.47%,ITGB2;TMEM150B;OSCAR;C3AR1;TLR2;TNFRSF1B;ITGAX;LILRB3;TAPBPL;SLC7A7;PTAFR;ITGAM;TFEC;FCGR3A;CLEC12A;ANPEP;HCK;PLAUR;HK3;IGSF6;CSF1R;FPR1
prerank,CellMarker_Augmented_2021__Macrophage:Artery,0.6886463094156179,1.511060650330829,0.0,1.0,1.0,22/58,13.47%,ITGB2;TMEM150B;OSCAR;C3AR1;TLR2;TNFRSF1B;ITGAX;LILRB3;TAPBPL;SLC7A7;PTAFR;ITGAM;TFEC;FCGR3A;CLEC12A;ANPEP;HCK;PLAUR;HK3;IGSF6;CSF1R;FPR1
prerank,CellMarker_Augmented_2021__Macrophage:Visceral Adipose Tissue,0.6886463094156179,1.511060650330829,0.0,1.0,1.0,22/58,13.47%,ITGB2;TMEM150B;OSCAR;C3AR1;TLR2;TNFRSF1B;ITGAX;LILRB3;TAPBPL;SLC7A7;PTAFR;ITGAM;TFEC;FCGR3A;CLEC12A;ANPEP;HCK;PLAUR;HK3;IGSF6;CSF1R;FPR1
prerank,CellMarker_Augmented_2021__Macrophage:Lymph Node,0.6886463094156179,1.511060650330829,0.0,1.0,1.0,22/58,13.47%,ITGB2;TMEM150B;OSCAR;C3AR1;TLR2;TNFRSF1B;ITGAX;LILRB3;TAPBPL;SLC7A7;PTAFR;ITGAM;TFEC;FCGR3A;CLEC12A;ANPEP;HCK;PLAUR;HK3;IGSF6;CSF1R;FPR1
prerank,CellMarker_Augmented_2021__Monocyte:Kidney,0.6886463094156179,1.511060650330829,0.0,1.0,1.0,22/58,13.47%,ITGB2;TMEM150B;OSCAR;C3AR1;TLR2;TNFRSF1B;ITGAX;LILRB3;TAPBPL;SLC7A7;PTAFR;ITGAM;TFEC;FCGR3A;CLEC12A;ANPEP;HCK;PLAUR;HK3;IGSF6;CSF1R;FPR1
prerank,GO_Biological_Process_2021__omega-hydroxylase P450 pathway (GO:0097267),-0.9643848404832376,-1.5090391683089144,0.0,0.7765332429465318,1.0,1/6,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.7088773503024484,-1.5085657366337888,0.06666666666666667,0.7758252385889847,1.0,2/15,11.02%,IWS1;NXF5
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.6200117724434562,-1.5084113962036516,0.0,0.7677193277361398,1.0,12/51,17.40%,NUP210;TRIM71;NUP42;POM121C;NUP214;AAAS;AGO2;POLR2F;NUP37;POLR2C;NUP98;TNRC6A
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.6200117724434562,-1.5084113962036516,0.0,0.7677193277361398,1.0,12/51,17.40%,NUP210;TRIM71;NUP42;POM121C;NUP214;AAAS;AGO2;POLR2F;NUP37;POLR2C;NUP98;TNRC6A
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.8479692439644617,-1.5082908053057147,0.02564102564102564,0.7600164778563706,1.0,1/8,3.27%,PDZD11
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.8479692439644617,-1.5082908053057147,0.02564102564102564,0.7600164778563706,1.0,1/8,3.27%,PDZD11
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.700359465350915,-1.5081435220314028,0.08,0.7564479306716813,1.0,2/44,0.67%,CYP1A2;EPHX2
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.8576009991726923,-1.5080332101873015,0.023809523809523808,0.7534243589515188,1.0,2/10,4.00%,SMPD3;SMPD4
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.8538568122995255,1.5079400081975356,0.03278688524590164,1.0,1.0,3/9,11.68%,ITGB2;ITGAM;F2RL1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.6380039493081798,-1.5078930062201228,0.0,0.7498607885861457,1.0,11/31,15.93%,CDH20;CDH5;CDH19;CDH13;SELL;CDH9;PCDHB6;PCDHB9;CDH12;CDH11;SELP
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.7513755766922863,-1.5076909148634114,0.08108108108108109,0.7466934346308499,1.0,4/13,15.79%,DNMT1;MPHOSPH8;MORC2;SETDB1
prerank,Reactome_2022__Glucuronidation R-HSA-156588,-0.883615846935833,-1.5074202704288158,0.06666666666666667,0.7437029394222052,1.0,1/8,0.03%,UGT2B15
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),0.941484249008692,1.5073734400201788,0.0,1.0,1.0,1/6,1.06%,BLK
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.8933935746661792,-1.5073276811078702,0.02564102564102564,0.740251523620708,1.0,2/7,4.32%,PUM3;PNKP
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.6687632003346574,-1.5053218125195196,0.0,0.7484835560485246,1.0,5/27,11.55%,ARC;APOE;EPHB2;SHISA7;CYP46A1
prerank,PanglaoDB_Augmented_2021__Macrophages,0.6406409323763398,1.505204777218952,0.0,1.0,1.0,43/120,13.47%,ITGB2;CLEC5A;C3AR1;CYTIP;TLR2;TNFRSF1B;ITGAX;LYVE1;CCL5;SASH3;SLC37A2;AHR;SLC7A7;PTPRC;PTAFR;CPM;ITGAM;TFEC;NFAM1;FCGR3A;SCIMP;ADGRE1;VSIG4;CLEC12A;FGL2;SYK;MMP9;CD80;P2RY6;CHIT1;HCK;CSF3R;HPGDS;TAGAP;HK3;DAB2;IGSF6;CD5L;ALOX5AP;SELENOP;MYO1F;CSF1R;FPR1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.7228248737883592,1.5048017406281589,0.013888888888888888,1.0,1.0,9/42,11.00%,PCLAF;POLE2;DTL;UBE2L6;TRIM25;FAAP20;POLD4;RPA3;RPS27A
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.7243334107226623,1.5042403084637481,0.05194805194805195,1.0,1.0,10/28,15.82%,NRAP;TBX1;TMEM204;HEY2;DUSP29;POPDC2;CHRNB1;SGCZ;WNT5B;FBXO40
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Heart,0.8113069527171893,1.5030105160759193,0.015151515151515152,1.0,1.0,1/13,0.23%,GATA4
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.7779881879892551,-1.5020288760138831,0.0,0.7670223926340748,1.0,4/13,15.79%,DNMT1;MPHOSPH8;MORC2;SETDB1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.868052563493474,-1.501926940299363,0.0,0.7635702911937088,1.0,1/9,0.54%,APOB
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.7546192019760817,1.5017597259422937,0.014285714285714285,1.0,1.0,6/28,7.89%,GATA4;CCDC39;MESP1;DAND5;TBX6;MMP21
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.7016117704372165,-1.5017589010792898,0.038461538461538464,0.7607074967630943,1.0,1/25,0.13%,RFX6
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,0.8429221122464999,1.501345672767321,0.027777777777777776,1.0,1.0,2/15,3.49%,MCUB;STOML2
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.7159515501335568,1.5008164319314765,0.028985507246376812,1.0,1.0,8/34,9.24%,CIDEB;GPER1;MMP9;IGF1;HGF;PLAUR;PINK1;MOAP1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.6192610949211046,-1.5005692134973418,0.08,0.7648094093546264,1.0,8/62,4.30%,SPRED3;SPRED2;ZNF703;SPRED1;BAMBI;PHLDB2;TWIST1;BCL9L
prerank,CellMarker_Augmented_2021__Monocyte:Lung,0.6969761794340282,1.4994332243667476,0.02564102564102564,1.0,1.0,20/47,13.47%,ITGB2;CLEC5A;C3AR1;TLR2;ITGAX;LILRB3;PTAFR;ITGAM;TFEC;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;CSF1R;FPR1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.738575413874281,-1.498869448963306,0.02631578947368421,0.7660223027925617,1.0,1/13,0.07%,IL7R
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.738575413874281,-1.498869448963306,0.02631578947368421,0.7660223027925617,1.0,1/13,0.07%,IL7R
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.8883329963989193,1.4986441758062414,0.05263157894736842,1.0,1.0,1/12,0.35%,TBX1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Undefined,0.6457825133103402,1.4964010765477533,0.02666666666666667,1.0,1.0,21/76,14.15%,C3AR1;SLFN14;ITGAX;SP100;PTPRC;APOL6;TFEC;FCGR3A;VSIG4;CLEC12A;FLI1;HEMGN;FGL2;CPED1;CA1;SOD2;IGSF6;TM6SF1;CSF1R;FPR1;MAP3K7CL
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.8418857629232219,-1.4962085421692193,0.0,0.7758135147706934,1.0,3/8,11.55%,APOE;CEL;CYP46A1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.8418857629232219,-1.4962085421692193,0.0,0.7758135147706934,1.0,3/8,11.55%,APOE;CEL;CYP46A1
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.7770969960380336,-1.4961922138616466,0.07142857142857142,0.7717728193812627,1.0,5/14,8.96%,GLA;ACER2;ACER3;NEU4;NEU3
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,-0.6144756060812935,-1.4952379105868976,0.037037037037037035,0.7732951576082029,1.0,13/37,21.46%,ST3GAL3;MGAT4C;MAN1A1;B4GALT2;ALG12;RPN1;ALG11;CHST8;ALG1;B4GALT3;ALG3;DAD1;MAN1A2
prerank,CellMarker_Augmented_2021__T Helper cell:Eye,0.7135525041435301,1.4932779798318656,0.013513513513513514,1.0,1.0,29/58,15.35%,ITGB2;C3AR1;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;ITGAM;NFAM1;FCGR3A;CLEC12A;FGL2;HCK;CSF3R;IKZF1;TAGAP;HLA-DPB1;HK3;CD4;GPR183;ALOX5AP;PSTPIP1;MYO1F;CSF1R;PARVG;CD300LF;PIK3R6
prerank,CellMarker_Augmented_2021__T Helper cell:Salivary Gland,0.7135525041435301,1.4932779798318656,0.013513513513513514,1.0,1.0,29/58,15.35%,ITGB2;C3AR1;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;ITGAM;NFAM1;FCGR3A;CLEC12A;FGL2;HCK;CSF3R;IKZF1;TAGAP;HLA-DPB1;HK3;CD4;GPR183;ALOX5AP;PSTPIP1;MYO1F;CSF1R;PARVG;CD300LF;PIK3R6
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.8102411118242505,-1.4930487727683903,0.08108108108108109,0.7830077653609621,1.0,1/7,2.03%,KMT2B
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.8016551837152629,-1.492952771237814,0.08333333333333333,0.7793215297082554,1.0,2/10,5.64%,SKAP1;ASS1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.8417005075070723,-1.4922835353908541,0.1,0.7798650271104981,1.0,1/9,1.74%,OSR1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),-0.797707038502354,-1.4922747699579324,0.06382978723404255,0.775906321389125,1.0,5/10,18.74%,OSR1;PKD2;FGFR2;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),-0.8361147201115594,-1.4921061269973626,0.058823529411764705,0.7728305253922925,1.0,3/9,5.18%,TSKU;IFT88;PDZD7
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.8468902710884706,1.491837943163197,0.03389830508474576,1.0,1.0,3/14,7.78%,ENDOG;H1-0;DNASE2
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.8009631586812307,1.4913051549963043,0.0,1.0,1.0,2/19,0.72%,SMAD6;LRP4
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.6411035199416301,1.4912709441091032,0.0,1.0,1.0,13/90,7.68%,AQP3;SMAD6;ESR1;MICB;MAPKAPK3;WNT8B;ANXA1;TGFB1;IL12A;SOCS2;GGT5;WNT8A;HSD17B2
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.6905877084001748,-1.4909164546172764,0.09090909090909091,0.7764951379588955,1.0,6/30,14.62%,MFSD2A;APOE;PLIN5;SCARB1;CHP1;NR1H2
prerank,Reactome_2022__Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,-0.7877120291223133,-1.4907149551216583,0.08823529411764706,0.7739606903438476,1.0,5/20,10.50%,SLITRK6;PTPRF;PPFIBP2;SLITRK2;PTPRS
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.748995530561392,-1.4906629453615985,0.03125,0.7704295018997647,1.0,3/27,1.07%,ARC;LZTS3;ABHD17A
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,0.7047903190869694,1.4896461859400902,0.02531645569620253,1.0,1.0,5/32,8.69%,GML;HSPA1L;HSPA8;DNAJB1;COL4A6
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.8013855359912326,1.4896386292741501,0.014925373134328358,1.0,1.0,1/15,1.47%,CASQ2
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,-0.7350211363443393,-1.4887848969943847,0.02564102564102564,0.778754738324901,1.0,1/16,0.03%,UGT2B15
prerank,Reactome_2022__Kinesins R-HSA-983189,-0.5896001074230073,-1.4887537598051446,0.05555555555555555,0.7750449944180456,1.0,6/40,11.71%,KIFC1;KIF2B;KIF15;KIF4B;KIFC2;KIF1C
prerank,Reactome_2022__Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.6666211949388923,-1.4880538342190799,0.03333333333333333,0.7754622753047933,1.0,1/41,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.7038896674484443,-1.487963932727669,0.08,0.7721805417712727,1.0,6/29,7.68%,GLA;DDAH2;KHSRP;ASS1;PKD2;CX3CR1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.9020175660785215,1.4877933405131711,0.0,1.0,1.0,2/9,5.31%,CCL5;WNT5A
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.6828584120144023,-1.4877217687933089,0.05714285714285714,0.7699901462549845,1.0,2/19,5.08%,GANC;MAN1A1
prerank,CellMarker_Augmented_2021__Activated B cell:Undefined,0.7110724766191671,1.487365267638539,0.0379746835443038,1.0,1.0,17/49,15.35%,ITGB2;CYTIP;ARHGAP9;SASH3;PTPRC;ITGAM;WAS;NAPSB;HCK;IKZF1;TAGAP;CD37;TMC8;ALOX5AP;MYO1F;PARVG;PIK3R6
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.6289050162305989,-1.486332658585735,0.03125,0.7750773798071932,1.0,5/29,9.74%,ARC;APOE;EPHB2;RAB5A;SHISA7
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.818167372202268,-1.4854628847998907,0.07142857142857142,0.7772147214839871,1.0,1/10,0.54%,APOB
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.842819327522516,1.4849494477814846,0.029850746268656716,1.0,1.0,3/16,5.00%,AQP3;ANXA1;GPR151
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.880443344370318,1.4839150426096495,0.0,1.0,1.0,1/9,0.23%,GATA4
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),-0.923847541256047,-1.4839079155920967,0.0,0.7826486990361147,1.0,1/5,0.01%,CYP1A2
prerank,CellMarker_Augmented_2021__M2 macrophage:Peripheral Blood,-0.9410664477502128,-1.4838338829098228,0.04878048780487805,0.7793497458898304,1.0,1/5,1.93%,CD14
prerank,Reactome_2022__Synthesis Of (16-20)-Hydroxyeicosatetraenoic Acids (HETE) R-HSA-2142816,-0.9660328521606951,-1.483628343733006,0.0,0.7768122062871112,1.0,1/5,0.01%,CYP1A2
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",-0.8374388802758955,-1.4827355193605432,0.02631578947368421,0.7782954544763889,1.0,2/11,8.38%,GABRE;GABRA5
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Bone Marrow,-0.9486707675590209,-1.4814082151647832,0.0,0.7825373795857916,1.0,2/7,3.46%,CDH5;KIT
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,-0.6960295987551863,-1.4807289210609427,0.06666666666666667,0.7833200966607693,1.0,2/19,2.33%,SIGIRR;PTPN9
prerank,Reactome_2022__Phosphate Bond Hydrolysis By NTPDase Proteins R-HSA-8850843,-0.9119786924796034,-1.4795944324423709,0.022222222222222223,0.7854689388800848,1.0,1/7,0.81%,ENTPD2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.8245714015292349,-1.4792837721506287,0.05128205128205128,0.7835561776625031,1.0,1/7,0.50%,TSKU
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.8619148121536617,1.4792693647063835,0.0,1.0,1.0,2/9,6.35%,BLK;SYK
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.8745458623234884,1.4788590179302994,0.046875,1.0,1.0,2/10,5.08%,MICB;RNF26
prerank,"Reactome_2022__GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",0.7744035117968344,1.4787402125019014,0.045454545454545456,1.0,1.0,2/18,2.45%,GAD1;HSPA8
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.7446208447056465,1.4784589234821908,0.04054054054054054,1.0,1.0,6/29,5.72%,GATA4;PKP2;MYBPC3;TGFB1;HEY2;MESP1
prerank,Reactome_2022__Maturation Of Protein 3A R-HSA-9683673,-0.7458941511322518,-1.4783908626054236,0.058823529411764705,0.7840867269966134,1.0,4/9,17.26%,ST3GAL3;ST3GAL2;ST3GAL4;ST6GALNAC3
prerank,CellMarker_Augmented_2021__Basal Progenitor cell:Breast,-0.5633308844175604,-1.4783250628504851,0.04,0.7807255651776681,1.0,9/60,8.67%,ADGRF4;EHF;CLDN4;ESRP1;ERBB2;TMEM125;PERP;CDCP1;ITGB4
prerank,CellMarker_Augmented_2021__Monocyte:Synovium,0.7074717578247157,1.4776495154902818,0.01282051282051282,1.0,1.0,23/44,15.08%,C1QB;ITGB2;CLEC5A;C3AR1;TLR2;ITGAX;LILRB3;PTAFR;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;CD4;CSF1R;FPR1;ADGRE3;CD300LF
prerank,CellMarker_Augmented_2021__Monocyte:Plasma,0.7074717578247157,1.4776495154902818,0.01282051282051282,1.0,1.0,23/44,15.08%,C1QB;ITGB2;CLEC5A;C3AR1;TLR2;ITGAX;LILRB3;PTAFR;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;CD4;CSF1R;FPR1;ADGRE3;CD300LF
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.696666999106887,1.4768189013683708,0.029850746268656716,1.0,1.0,6/28,14.41%,MICB;AIM2;TRAF3IP2;ZDHHC11;STAT1;IL4
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.6411039912179323,1.4762808716569011,0.0,1.0,1.0,58/97,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPL13;RPS12;RPS4X;RPL27A;RPS19;SRP19;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RPLP2;RPL7;RPL38;ZFAND2A;RPS15A;SPCS2;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL24;RPL23;RPS15;SRP14;RPS27;RPL8;RPS3;RPS23;RPS20;RPS18;RPS24;RPL10;SEC62;RPS29;RPLP1;RPS28;RPL34
prerank,CellMarker_Augmented_2021__Natural Killer cell:Splenic Red Pulp,0.683383593154863,1.4761188599426904,0.03529411764705882,1.0,1.0,16/45,18.03%,RASGRP4;ARHGAP9;CCL5;NLRP12;FCAR;SH2D1B;NLRC3;CD37;PSTPIP1;MYO1F;KLRB1;ITK;ADGRE3;CD244;TIGIT;CD8B
prerank,CellMarker_Augmented_2021__Natural Killer cell:Gut,0.683383593154863,1.4761188599426904,0.03529411764705882,1.0,1.0,16/45,18.03%,RASGRP4;ARHGAP9;CCL5;NLRP12;FCAR;SH2D1B;NLRC3;CD37;PSTPIP1;MYO1F;KLRB1;ITK;ADGRE3;CD244;TIGIT;CD8B
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lung,0.683383593154863,1.4761188599426904,0.03529411764705882,1.0,1.0,16/45,18.03%,RASGRP4;ARHGAP9;CCL5;NLRP12;FCAR;SH2D1B;NLRC3;CD37;PSTPIP1;MYO1F;KLRB1;ITK;ADGRE3;CD244;TIGIT;CD8B
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.7653528644600474,1.4757780063560129,0.015384615384615385,1.0,1.0,6/21,9.24%,CIDEB;GPER1;MMP9;PLAUR;PINK1;MOAP1
prerank,Reactome_2022__Surfactant Metabolism R-HSA-5683826,0.7914339783777308,1.4751390636277604,0.056338028169014086,1.0,1.0,3/20,5.42%,CSF2RA;SFTPA1;SFTPD
prerank,CellMarker_Augmented_2021__Neutrophil:Lung,0.7153957406875804,1.4740835203373426,0.04,1.0,1.0,25/55,15.08%,RASGRP4;ITGB2;ARHGAP9;ITGAX;GMFG;SASH3;PTPRC;PTAFR;ITGAM;NFAM1;NLRP12;FCAR;CLEC12A;CEACAM8;HCK;CSF3R;TAGAP;HK3;IGSF6;PSTPIP1;MYO1F;FPR1;PARVG;ADGRE3;CD300LF
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.5624354890317145,-1.4736555755459935,0.09090909090909091,0.8041856546803673,1.0,10/88,8.48%,DUSP4;DUSP6;FOS;NKIRAS2;S100B;ECSIT;PPP2R5D;NOD1;ALPK1;RIPK2
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.7454189841245601,-1.4735896333040055,0.08108108108108109,0.800763690115759,1.0,3/14,5.74%,MFSD2A;TWIST1;PLIN5
prerank,CellMarker_Augmented_2021__Dendritic cell:Synovium,0.7111977783439719,1.4728737288802156,0.025974025974025976,1.0,1.0,24/55,15.08%,RASGRP4;CYTIP;ARHGAP9;ITGAX;LILRB3;SASH3;PTPRC;ITGAM;NFAM1;FCGR3A;SCIMP;CLEC12A;FGL2;HCK;CSF3R;IKZF1;TAGAP;HK3;IGSF6;MYO1F;FPR1;PARVG;ADGRE3;CD300LF
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.8530756268553166,-1.4728732782855698,0.0,0.8020200646392052,1.0,1/8,0.34%,NGF
prerank,CellMarker_Augmented_2021__Proerythroblast:Germ,0.6776847770471971,1.4725624475394359,0.01282051282051282,1.0,1.0,23/64,16.35%,ITGB2;C3AR1;TNFRSF1B;ITGAX;SH3TC1;ADAMDEC1;ITGAM;TFEC;VSIG4;STAT5A;ANPEP;HCK;HLA-DMA;EHBP1L1;HK3;CSF1R;P2RX1;ADCY7;PARVG;CD300LF;PIK3R6;FERMT3;ENG
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.6245138466074953,-1.472160995690079,0.04,0.8028024767753541,1.0,5/32,7.68%,PER2;FOXO1;HES1;ASCL1;CX3CR1
prerank,Reactome_2022__Tachykinin Receptors Bind Tachykinins R-HSA-380095,-0.923766534246137,-1.471338267111375,0.08333333333333333,0.80380815629354,1.0,2/5,5.69%,TACR3;TAC3
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,-0.6080322537194359,-1.471065614472758,0.038461538461538464,0.8019964647079246,1.0,9/73,3.96%,SPRED3;SPRED2;DUSP6;SPRED1;CSK;AGTRAP;TENT4A;KIAA1549;ESRP1
prerank,KEGG_2021_Human__Coronavirus disease,0.5984229359163452,1.4701055083629806,0.0,1.0,1.0,71/169,24.63%,C1QB;C3AR1;TLR2;ACE2;PIK3R3;C3;RPL37A;RPL21;IL12A;SYK;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;CFD;RPS16;VWF;RPL15;RPS5;RPS27A;RPS3A;STAT1;RPL41;RPL13;OAS2;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;MASP2;MASP1;MAPK3;ISG15;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;C6;RPL38;NFKBIA;RPS15A;RPSA;RPLP0;RPS6;RPL35;IFIH1;RPL27;RPS14;RPL7A;RPL24;RPL23;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS18;RPS24;IRAK1;PIK3CB
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,-0.5701608765433924,-1.4699154910120618,0.0,0.8069338849975721,1.0,21/45,15.86%,CHPF2;XYLT1;GPC6;UST;GPC2;SDC3;GPC4;ARSB;AGRN;CHST11;CHST12;CHSY1;CSGALNACT1;SPAM1;VCAN;IDUA;B3GAT3;CHST3;CSPG5;GPC1;SDC4
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.7926626761981576,1.4689697050903685,0.014492753623188406,1.0,1.0,4/22,6.37%,MYBPH;MYBPC3;CAV3;C12ORF57
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,-0.688445190860832,-1.4687717046404256,0.09090909090909091,0.8102938246180673,1.0,3/21,8.01%,NIPAL1;LRRC8B;AZGP1
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.7666166631213571,1.4686099487678912,0.05172413793103448,1.0,1.0,3/14,4.08%,ESR1;FGF2;FLT1
prerank,CellMarker_Augmented_2021__T Helper cell:Blood,0.6689194126625235,1.4685420607488335,0.036585365853658534,1.0,1.0,27/59,16.42%,RASGRP4;ITGB2;CYTIP;ARHGAP9;GP1BA;ITGAX;GMFG;SASH3;PTPRC;ITGAM;NFAM1;CLEC12A;WAS;HCK;IKZF1;TAGAP;HK3;CD37;TMC8;CD4;PSTPIP1;MYO1F;PARVG;CD300LF;PIK3R6;FERMT3;CD244
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Intestine,-0.54738015540972,-1.4680968594891668,0.0,0.8115315646964634,1.0,19/82,9.15%,DUSP4;ETV5;SPRY4;MYO10;EMP1;SPRED1;HRH1;RAI14;FRMD6;ARSJ;RND3;SERPINE2;RHBDF1;PARVA;PHLDA2;NCS1;SERPINE1;FOSL1;DCBLD2
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.7324823297863929,-1.468022345281033,0.06976744186046512,0.8084789932002057,1.0,4/17,15.74%,APOE;FGF1;ABCG1;SEC14L2
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.7645493206975005,-1.467604350063703,0.08108108108108109,0.8075274023144635,1.0,2/7,9.84%,CRLS1;PGS1
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),-0.8304536924071719,-1.4671287320977675,0.08333333333333333,0.8062491723246851,1.0,1/6,3.40%,ANO7
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.5627463865717255,-1.4670617650388476,0.041666666666666664,0.8031479574588484,1.0,14/59,17.79%,TBC1D10A;TBC1D16;IFT88;DCDC2;TBC1D2;TBC1D22B;CROCC;TBC1D8;RABEP2;ENTR1;SDCCAG8;MARK4;CCDC88A;ARHGAP35
prerank,CellMarker_Augmented_2021__Macrophage:Synovium,0.7025681316839675,1.4667489918987686,0.0136986301369863,1.0,1.0,24/53,13.47%,C1QB;ITGB2;CLEC5A;C3AR1;TLR2;TNFRSF1B;ITGAX;LILRB3;SLC7A7;ITGAM;TFEC;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;CD4;MYO1F;CSF1R;FPR1
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,0.6497258919003666,1.4658495176683697,0.04477611940298507,1.0,1.0,9/60,14.04%,CDC25A;PSMB9;CDKN2A;CCNE2;RPS27A;CDKN1B;CDKN1A;CCNA2;PSMC5
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.9095311895553402,-1.4658093825921312,0.0,0.803747620123847,1.0,2/5,6.44%,PEX7;DHRS7B
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.9095311895553402,-1.4658093825921312,0.0,0.803747620123847,1.0,2/5,6.44%,PEX7;DHRS7B
prerank,CellMarker_Augmented_2021__Myotube:Muscle,0.6400342628405883,1.4657515451667282,0.024691358024691357,1.0,1.0,14/61,9.58%,MYBPH;MYH1;MYH8;LMOD3;TECRL;CASQ2;KCNA7;ASB5;ART1;SMTNL1;CAV3;LRRC39;ASB15;CSRP3
prerank,CellMarker_Augmented_2021__Neutrophil:Pluripotent Stem Cell,0.7118276938971247,1.4653359008735816,0.041666666666666664,1.0,1.0,24/48,15.08%,ITGB2;C3AR1;ARHGAP9;TNFRSF1B;ITGAX;LILRB3;SASH3;PTPRC;ITGAM;NFAM1;FCGR3A;CLEC12A;FGL2;ANPEP;HCK;CSF3R;TAGAP;HK3;IGSF6;ALOX5AP;MYO1F;FPR1;ADGRE3;CD300LF
prerank,Reactome_2022__Frs2-mediated Activation R-HSA-170968,-0.7256737937956773,-1.4650086226370589,0.05405405405405406,0.8050860386175368,1.0,3/12,8.84%,NGF;NTRK1;RAPGEF1
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),-0.8585267710238296,-1.4648628249678797,0.05405405405405406,0.8028620298471046,1.0,2/6,12.23%,NLGN2;NRXN2
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Liver,0.7051631677195185,1.4648496999459837,0.02702702702702703,1.0,1.0,21/52,15.35%,RASGRP4;ITGB2;C3AR1;ARHGAP9;ITGAX;GMFG;SASH3;PTPRC;ITGAM;NFAM1;FCGR3A;CLEC12A;WAS;HCK;CSF3R;HK3;IGSF6;MYO1F;PARVG;CD300LF;PIK3R6
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Blood,0.7051631677195185,1.4648496999459837,0.02702702702702703,1.0,1.0,21/52,15.35%,RASGRP4;ITGB2;C3AR1;ARHGAP9;ITGAX;GMFG;SASH3;PTPRC;ITGAM;NFAM1;FCGR3A;CLEC12A;WAS;HCK;CSF3R;HK3;IGSF6;MYO1F;PARVG;CD300LF;PIK3R6
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,-0.5750399019621918,-1.464668556577695,0.0,0.8006568686086253,1.0,14/142,6.19%,CYP1A2;UGT2B15;GLYATL1;PODXL2;GSTT2B;CES2;BPHL;CYP4V2;AKR7L;PAPSS2;GSTM5;CYP7B1;AOC3;GSTZ1
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),0.8724468917729398,1.4646413616954663,0.0,1.0,1.0,4/10,7.69%,MCM2;DONSON;MCMDC2;MCM3
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.8061832671504968,-1.4642761178231212,0.05714285714285714,0.7998787442921267,1.0,1/10,0.35%,GRP
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.6385554234935518,-1.4639452540973035,0.045454545454545456,0.797974362133963,1.0,12/49,11.42%,SPRED3;SPRED2;EYA4;SPRED1;PRKCD;RNF168;BRCC3;ATR;ERCC8;WRAP53;ANKLE1;FXR2
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,0.6961818796650492,1.4637529165241407,0.0547945205479452,1.0,1.0,7/35,11.19%,IL21R;CSF2RA;PIK3R3;STAT5A;SYK;IL5;STAT1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.5911010626605873,-1.463440545215307,0.045454545454545456,0.7976437091816516,1.0,15/64,14.99%,TBC1D10A;MYO10;TBC1D16;IFT88;DCDC2;TBC1D2;FSCN1;RAB5A;TBC1D22B;FXR2;TRPM2;TBC1D8;CAPZB;RABEP2;SDCCAG8
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.7118582745337327,1.4632203388392795,0.04054054054054054,1.0,1.0,6/29,8.11%,HSPA1L;HSPA8;CHCHD4;DNAJB1;SDF2L1;HSPA5
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.5776827015474876,-1.463218032079361,0.0,0.7951760845678372,1.0,10/94,8.48%,DUSP4;DUSP6;FOS;NKIRAS2;S100B;SARM1;PPP2R5D;NOD1;ALPK1;RIPK2
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Embryonic Stem Cell,0.652301837069798,1.462916304767913,0.013333333333333334,1.0,1.0,19/66,11.27%,C1QB;CLEC5A;TLR2;ITGAX;CSF2RA;SP100;C3;APOL6;CPM;ADAMDEC1;TFEC;FCGR3A;VSIG4;FGL2;SDS;SOD2;CD302;ZNF366;IGSF6
prerank,CellMarker_Augmented_2021__Anterior Foregut Endoderm cell:Lung,0.652301837069798,1.462916304767913,0.013333333333333334,1.0,1.0,19/66,11.27%,C1QB;CLEC5A;TLR2;ITGAX;CSF2RA;SP100;C3;APOL6;CPM;ADAMDEC1;TFEC;FCGR3A;VSIG4;FGL2;SDS;SOD2;CD302;ZNF366;IGSF6
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),-0.8086522833534662,-1.4620624526626385,0.05263157894736842,0.7982691444409841,1.0,6/14,11.80%,GPC6;GPC4;PTPRF;SLITRK2;PTPRS;LRFN4
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Heart,-0.536583284284203,-1.46187490593489,0.045454545454545456,0.7962437376573405,1.0,12/85,7.00%,RFX6;SLITRK6;WWC1;RAI14;CKMT1B;KIAA1549;RND3;KITLG;HS6ST2;DLG5;PTPRF;MID1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.7127564269471719,-1.4611889145681585,0.10256410256410256,0.7963483116071647,1.0,4/17,5.21%,MFSD2A;LCN12;APOE;SLC25A17
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.7128710433370877,-1.460983784466192,0.125,0.7940316813427888,1.0,4/12,17.80%,TTC21A;CILK1;DYNC2I1;IFT43
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.5766499987172365,-1.459147181090919,0.05263157894736842,0.8029478790804073,1.0,5/46,6.87%,PER2;LIMK1;CRY1;MINAR1;USP4
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.800866179557908,-1.459129985849647,0.03225806451612903,0.7999969941073155,1.0,1/15,1.80%,CDH5
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),-0.8018261369621912,-1.4585815689770385,0.09090909090909091,0.8003965422411501,1.0,3/8,13.45%,COMMD1;WNK2;WNK3
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.7130093653003778,1.458359654231444,0.029411764705882353,1.0,1.0,10/28,8.12%,ESR1;WNT8B;ANXA1;SSTR1;TGFB1;GPER1;SOCS2;GGT5;RAMP3;H2AZ1
prerank,CellMarker_Augmented_2021__Dendritic cell:Spleen,0.7061461614322992,1.458329462043112,0.02702702702702703,1.0,1.0,24/54,15.35%,RASGRP4;ITGB2;ARHGAP9;TNFRSF1B;ITGAX;CSF2RA;LILRB3;SASH3;PTPRC;ITGAM;NFAM1;FCGR3A;CLEC12A;HCK;CSF3R;TAGAP;HK3;IGSF6;PSTPIP1;MYO1F;FPR1;PARVG;CD300LF;PIK3R6
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Thymus,0.7061461614322992,1.458329462043112,0.02702702702702703,1.0,1.0,24/54,15.35%,RASGRP4;ITGB2;ARHGAP9;TNFRSF1B;ITGAX;CSF2RA;LILRB3;SASH3;PTPRC;ITGAM;NFAM1;FCGR3A;CLEC12A;HCK;CSF3R;TAGAP;HK3;IGSF6;PSTPIP1;MYO1F;FPR1;PARVG;CD300LF;PIK3R6
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),-0.8955927535291803,-1.4580472976053596,0.04878048780487805,0.8000681219358694,1.0,1/5,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.7133400532371578,1.4572061608505116,0.05405405405405406,1.0,1.0,8/28,14.30%,SLC9A2;SLC26A6;SLC4A1;ATP1A4;SLC9C1;ATP6AP1;LACC1;SLC9B1
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.8494672068709257,-1.4568283055659283,0.1111111111111111,0.8042795921963497,1.0,3/8,7.72%,NR4A1;CORO1B;CCN3
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),-0.8091179237584927,-1.4567698711549681,0.07142857142857142,0.8014733014312967,1.0,2/7,8.71%,PRKCD;SLC30A10
prerank,CellMarker_Augmented_2021__Microglial cell:Optic Nerve,0.6980962962600086,1.4567121256071738,0.0379746835443038,1.0,1.0,24/54,15.35%,ITGB2;CYTIP;ARHGAP9;ITGAX;GMFG;SASH3;PTPRC;ITGAM;FCGR3A;CLEC12A;WAS;HCK;CSF3R;IKZF1;TAGAP;HK3;CD4;ALOX5AP;PSTPIP1;MYO1F;P2RX1;PARVG;CD300LF;PIK3R6
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.9441775464958564,1.4556973193770737,0.0,1.0,1.0,1/5,1.54%,GAD1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.686609536880189,1.455196680423576,0.028169014084507043,1.0,1.0,9/40,14.49%,LMOD3;LMOD1;C15ORF62;SCIN;VASP;BAIAP2L1;HCK;ALOX15;CARMIL1
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,-0.6150437935005629,-1.4550615686408752,0.0,0.808100760877363,1.0,4/68,3.65%,CYP1A2;CES2;BPHL;CYP4V2
prerank,CellMarker_Augmented_2021__PP cell:Pancreas,-0.6526064877853586,-1.4545633251961974,0.06666666666666667,0.8081036024804212,1.0,9/33,9.67%,RFX6;GCK;ADCYAP1;CELA2A;CFC1;ABCC8;VGF;CRH;KIRREL2
prerank,CellMarker_Augmented_2021__Macrophage:Alveolus,0.6922852555309222,1.4544956506407642,0.0375,1.0,1.0,25/56,16.42%,ITGB2;CYTIP;ARHGAP9;ITGAX;GMFG;SASH3;PTPRC;ITGAM;NFAM1;FCGR3A;CLEC12A;WAS;HCK;IKZF1;TAGAP;HK3;TMC8;ALOX5AP;PSTPIP1;MYO1F;PARVG;CD300LF;PIK3R6;FERMT3;CD244
prerank,Reactome_2022__Hormone Ligand-Binding Receptors R-HSA-375281,0.8799112954631508,1.4540934337976965,0.046875,1.0,1.0,4/7,10.20%,GNRHR;GPHB5;TSHR;GNRH1
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,0.6207088206905453,1.454065664509266,0.0,1.0,1.0,52/82,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL23;RPS15;RPS27;GNL3;RPL8;RPS3;RPS23;RPS20;RPS24;RPS29;RPLP1;RPS28;RPL34
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,-0.6451841057528299,-1.4538683613318006,0.10344827586206896,0.8086646112991982,1.0,15/41,23.43%,CPSF1;NUP210;NUP42;POM121C;NUP214;AAAS;SYMPK;NUP37;NUP98;CPSF4;SEH1L;CPSF3;NUP50;TPR;ALYREF
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.873831600553295,1.4538240490787375,0.016666666666666666,1.0,1.0,2/7,6.03%,NFAM1;CD81
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.5548209937300449,-1.4536445948540893,0.05555555555555555,0.8066434212554321,1.0,12/98,7.10%,PER2;RFX6;DRD4;GCK;ITPR2;RHBDF1;APOE;CELA2A;ABCC8;MYO18A;ADAM8;APBB3
prerank,CellMarker_Augmented_2021__Lymphocyte:Peripheral Blood,0.721069059798129,1.4535396332929933,0.027777777777777776,1.0,1.0,25/49,16.42%,RASGRP4;ITGB2;TMEM150B;C3AR1;ARHGAP9;ITGAX;GMFG;SASH3;ITGAM;NFAM1;CLEC12A;WAS;HCK;CSF3R;IKZF1;HK3;CD4;MYO1F;P2RX1;PARVG;CD300LF;PIK3R6;KCNE3;FERMT3;CD244
prerank,CellMarker_Augmented_2021__Muller cell:Retina,0.6481133723818303,1.4531826016410219,0.024691358024691357,1.0,1.0,22/69,17.77%,C1QB;CLEC5A;TLR2;FAXDC2;LMO2;FCGR3A;VSIG4;FGL2;HCK;CSF3R;VWF;HK3;RHOU;TM6SF1;CD4;CSF1R;CD300LF;KCNE3;GLUL;GAS7;FPR3;PADI2
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Blood,0.7154790864159201,1.4529088501799472,0.014084507042253521,1.0,1.0,22/52,15.97%,ADAM28;CYTIP;SLFN14;SASH3;PTPRC;ITGAM;FCGR3A;CLEC12A;HEMGN;SYK;SLC4A1;CA1;HCK;CSF3R;IKZF1;TAGAP;IGSF6;MYO1F;KLRB1;ADGRE3;KCNE3;PIK3CG
prerank,Reactome_2022__FGFRL1 Modulation Of FGFR1 Signaling R-HSA-5658623,-0.8501383792403122,-1.4523505241917027,0.04878048780487805,0.8107300126104909,1.0,3/10,4.49%,SPRED2;SPRED1;FGF18
prerank,GO_Biological_Process_2021__lymphocyte apoptotic process (GO:0070227),-0.8755424877208007,-1.452200852497402,0.10256410256410256,0.8082651964543284,1.0,1/5,3.68%,CLC
prerank,Reactome_2022__Scavenging Of Heme From Plasma R-HSA-2168880,0.8392809447244532,1.4520877942303965,0.015384615384615385,1.0,1.0,4/10,10.25%,AMBP;APOL1;JCHAIN;HPR
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.5793688562133129,-1.4520005013926214,0.0,0.8060193806202627,1.0,14/95,12.09%,ARC;CPSF1;NUP210;NUP42;MAGOHB;POM121C;NUP214;SRRM1;SRSF4;AAAS;NXF5;UPF2;SYMPK;U2AF2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.9113393177545243,-1.4512666804194927,0.0,0.8069756843177194,1.0,1/6,1.23%,UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),-0.7890095496575333,-1.451238201476465,0.1951219512195122,0.8041077929229913,1.0,3/7,18.95%,CPEB1;UNK;RBM24
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.9421325538297356,1.4508891092452476,0.0,1.0,1.0,1/6,2.83%,LRP2
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.6183729037679273,1.4508596457897742,0.0,1.0,1.0,20/105,11.07%,ESR1;C1QB;CLEC5A;OSCAR;C3AR1;TLR2;MMP19;SLC7A7;CASR;FCGR3A;ITGA2;VSIG4;ANPEP;MMP9;P2RY6;HCK;PSAP;VWF;HK3;DAB2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),-0.8484070707648577,-1.4505074039408232,0.025,0.8060022807359034,1.0,2/9,3.72%,ARC;GRID2
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.6241983268814021,-1.4503632187687554,0.1111111111111111,0.8037011754528776,1.0,7/25,20.49%,PRKCD;PID1;PTPRE;SLC27A4;AHSG;PTPN2;PIP4K2B
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),0.9248671134610371,1.4490631268825735,0.015625,1.0,1.0,1/6,1.06%,BLK
prerank,Reactome_2022__Regulation Of Innate Immune Responses To Cytosolic DNA R-HSA-3134975,0.8262747199937827,1.448680413978037,0.015625,1.0,1.0,1/12,0.07%,NLRP4
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.8433808239612279,1.448302749367991,0.01639344262295082,1.0,1.0,2/9,10.36%,NEK2;ECT2
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.6302725128070888,-1.4482796813343444,0.06666666666666667,0.8134229749471101,1.0,10/41,16.86%,NUP210;PIAS3;NUP42;POM121C;NUP214;AAAS;NUP37;PIAS4;NUP98;SUMO2
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.9234796206805918,-1.4482368256457478,0.022727272727272728,0.8105253721924311,1.0,1/6,0.17%,PKD1L1
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,0.6321981257570225,1.4480591596007277,0.02666666666666667,1.0,1.0,53/80,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;EEF1A1;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;EEF2;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL23;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24;RPS29;RPLP1;RPS28;RPL34
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.7783392829893331,1.4477638555661874,0.05970149253731343,1.0,1.0,1/14,0.46%,ESR1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.6035295191739793,-1.4477524616579327,0.05714285714285714,0.8103243798522382,1.0,7/64,4.62%,CYP1A2;EPHX2;LIPC;HACD1;ELOVL6;MLYCD;LTC4S
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.9033847270148009,1.4475277498556272,0.0,1.0,1.0,2/8,5.31%,CCL5;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.9033847270148009,1.4475277498556272,0.0,1.0,1.0,2/8,5.31%,CCL5;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.8047019638363448,1.447418360559567,0.04838709677419355,1.0,1.0,6/18,15.72%,ITGAX;SIX4;FGF2;AGT;SOX9;WNT5B
prerank,KEGG_2021_Human__Legionellosis,0.6808868026968642,1.4469787700226635,0.04,1.0,1.0,9/41,7.41%,ITGB2;HSPA1L;TLR2;HSPA8;C3;CASP7;ITGAM;IL12A;NLRC4
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.814962700171987,-1.4469283879643338,0.06521739130434782,0.8124018970503931,1.0,2/6,12.71%,ASS1;MAPK7
prerank,KEGG_2021_Human__Staphylococcus aureus infection,0.6935114504430604,1.4466291199791963,0.08695652173913043,1.0,1.0,15/34,14.97%,C1QB;ITGB2;C3AR1;C3;PTAFR;ITGAM;FCGR3A;FCAR;HLA-DMA;CFD;HLA-DPB1;FPR1;PLG;MASP2;MASP1
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.6341584875200563,-1.4460401069552844,0.04,0.8144155292973716,1.0,5/18,12.91%,NPAS4;GRID2;MPP2;GRIN1;ARRB2
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),0.885284093070772,1.4459869286427705,0.01639344262295082,1.0,1.0,3/6,10.06%,PLEKHH2;SCIN;VIL1
prerank,Reactome_2022__Digestion And Absorption R-HSA-8963743,0.800884325511861,1.4459680976750033,0.0,1.0,1.0,6/14,12.89%,PNLIPRP3;LCT;NPC1L1;CHIT1;TREH;SLC5A1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.8117514853553651,1.4459041109162938,0.0625,1.0,1.0,2/14,4.27%,ESR1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.8135778291974068,-1.445366114487429,0.02857142857142857,0.8152119842787703,1.0,5/10,16.12%,SMARCB1;DDX11;PIH1D1;SMARCA4;MARS1
prerank,CellMarker_Augmented_2021__Dendritic cell:Thymus,0.6600551177182943,1.4447943579895608,0.05194805194805195,1.0,1.0,22/58,15.97%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;ITGAM;WAS;CD80;HCK;IKZF1;TAGAP;CD37;IGSF6;GPR183;ALOX5AP;MYO1F;PARVG;PIK3R6;PIK3CG
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.6188987926891927,1.4447360720271105,0.0,1.0,1.0,27/78,10.37%,OIT3;SLC28A1;LECT2;IYD;RORC;ABCC6;BHMT;ITIH2;CYP3A4;CYP4F12;CYP3A5;SLC10A1;TSHR;FMO5;TMEM45B;DIO1;SLC6A4;SLC22A7;NR1H4;SMLR1;HSD17B2;KLB;ALDOB;C4BPB;KNG1;SLC15A1;SLC5A9
prerank,CellMarker_Augmented_2021__Progenitor cell:Stomach,0.6153035266990688,1.444554792579555,0.013513513513513514,1.0,1.0,26/85,17.33%,NEK2;CDC25A;SGO1;KIF14;BUB1;CEP55;CENPU;DTL;POLQ;TICRR;ASPM;ERCC6L;NDC80;FOXM1;RAD54L;ECT2;KIF18A;TTK;CCNA2;DEPDC1;ANLN;NUF2;BUB1B;GINS1;BRCA1;NCAPG
prerank,CellMarker_Augmented_2021__Oxyntic Progenitor cell:Stomach,0.6153035266990688,1.444554792579555,0.013513513513513514,1.0,1.0,26/85,17.33%,NEK2;CDC25A;SGO1;KIF14;BUB1;CEP55;CENPU;DTL;POLQ;TICRR;ASPM;ERCC6L;NDC80;FOXM1;RAD54L;ECT2;KIF18A;TTK;CCNA2;DEPDC1;ANLN;NUF2;BUB1B;GINS1;BRCA1;NCAPG
prerank,CellMarker_Augmented_2021__Oxyntic Stem cell:Stomach,0.6153035266990688,1.444554792579555,0.013513513513513514,1.0,1.0,26/85,17.33%,NEK2;CDC25A;SGO1;KIF14;BUB1;CEP55;CENPU;DTL;POLQ;TICRR;ASPM;ERCC6L;NDC80;FOXM1;RAD54L;ECT2;KIF18A;TTK;CCNA2;DEPDC1;ANLN;NUF2;BUB1B;GINS1;BRCA1;NCAPG
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.7904704100777805,-1.4444253963057971,0.1,0.8179665734292706,1.0,3/8,11.92%,GCK;CRY1;PGP
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.8682366192086872,1.4443767376479777,0.016666666666666666,1.0,1.0,2/8,6.35%,BLK;SYK
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.886779243483368,1.4443044810597523,0.034482758620689655,1.0,1.0,3/10,6.91%,BLK;ANXA1;CDKN2A
prerank,CellMarker_Augmented_2021__M2 macrophage:Lung,0.6770239589585482,1.4439742113159681,0.04,1.0,1.0,20/51,11.98%,C1QB;ITGB2;CLEC5A;C3AR1;TLR2;ITGAX;SLC7A7;ADAMDEC1;ITGAM;TFEC;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;HLA-DMA;HLA-DPB1;HK3;IGSF6;CD4
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.7308431168486547,-1.4436600101286634,0.12121212121212122,0.8195075259860278,1.0,4/16,12.16%,RNF168;PCGF1;KDM2B;RING1
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,0.7456259721341253,1.443292630591932,0.045454545454545456,1.0,1.0,1/18,0.40%,CDC25A
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.7452408073511547,-1.443063831090961,0.07317073170731707,0.8197532278177381,1.0,5/11,18.74%,OSR1;PKD2;FGFR2;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.9126983888420406,1.4424568793036567,0.03225806451612903,1.0,1.0,2/7,4.37%,ITGB2;ITGAM
prerank,Reactome_2022__Plasma Lipoprotein Assembly R-HSA-8963898,-0.8199227197210375,-1.4424302042040413,0.05263157894736842,0.8203761086061631,1.0,2/11,4.78%,APOB;APOE
prerank,CellMarker_Augmented_2021__Macrophage:Subcutaneous Adipose Tissue,0.6950804570990876,1.4419371635763312,0.025974025974025976,1.0,1.0,24/52,15.08%,ITGB2;C3AR1;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;SASH3;PTPRC;ITGAM;NFAM1;FCGR3A;CLEC12A;FGL2;HCK;CSF3R;TAGAP;HK3;IGSF6;ALOX5AP;MYO1F;CSF1R;FPR1;PARVG;CD300LF
prerank,CellMarker_Augmented_2021__Monocyte:Subcutaneous Adipose Tissue,0.6950804570990876,1.4419371635763312,0.025974025974025976,1.0,1.0,24/52,15.08%,ITGB2;C3AR1;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;SASH3;PTPRC;ITGAM;NFAM1;FCGR3A;CLEC12A;FGL2;HCK;CSF3R;TAGAP;HK3;IGSF6;ALOX5AP;MYO1F;CSF1R;FPR1;PARVG;CD300LF
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),-0.8960610812111177,-1.4417015864138858,0.020833333333333332,0.8216552074646469,1.0,2/8,6.49%,OSR1;FGF1
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.5154699698168532,-1.4415300680402432,0.045454545454545456,0.8200092635394375,1.0,14/89,7.63%,RFX6;NPAS4;CAMK1G;SPRED2;WWC1;DUSP15;CFC1;SPTBN4;ABCC8;GPC4;TTBK1;PRR36;DNAJB5;KCNIP1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.724192291075352,-1.441410439622352,0.09375,0.8177662144092431,1.0,2/22,0.92%,CYP1A2;LIPC
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.8604016640936105,1.4410379921013692,0.03333333333333333,1.0,1.0,3/8,7.69%,MCM2;MCMDC2;MCM3
prerank,CellMarker_Augmented_2021__Oral Keratinocyte Stem cell:Oral Mucosa,-0.5465280148693735,-1.4410301297132913,0.0,0.8162397526881757,1.0,13/78,8.67%,ADGRF4;EHF;CLDN4;DSG2;LAMA3;ESRP1;RHBDF1;ADGRG6;PTPRF;PERP;GPRC5A;CDCP1;ITGB4
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7526496834730122,1.4402959760899028,0.06060606060606061,1.0,1.0,3/20,6.03%,PTPRC;NFAM1;CD81
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.8937906190418217,1.440292747599904,0.03508771929824561,1.0,1.0,2/8,2.54%,RRAS;TMEM100
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.8584901526564512,-1.4402797048040106,0.05555555555555555,0.8152128522165885,1.0,2/5,5.10%,DPM3;DPY19L3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.8584901526564512,-1.4402797048040106,0.05555555555555555,0.8152128522165885,1.0,2/5,5.10%,DPM3;DPY19L3
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.8292977642566803,1.440234647574945,0.03278688524590164,1.0,1.0,2/10,3.75%,SLC12A7;SLC12A3
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.8292977642566803,1.440234647574945,0.03278688524590164,1.0,1.0,2/10,3.75%,SLC12A7;SLC12A3
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.6039681389221113,-1.4401483585515806,0.03333333333333333,0.8131578739342122,1.0,4/31,7.73%,ARC;NLGN3;PKD2;EPHB2
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.8839730310988182,1.4389584622856306,0.046153846153846156,1.0,1.0,2/7,5.97%,TGFB1;ACMSD
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.8313910773659955,-1.4385217397514658,0.125,0.81894028490414,1.0,2/6,7.61%,PDZD7;JAG2
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.9375613377611494,1.4380745881971813,0.0425531914893617,1.0,1.0,1/6,0.23%,GATA4
prerank,KEGG_2021_Human__Amphetamine addiction,-0.5298204057897155,-1.4367651368888052,0.05263157894736842,0.8262861882656477,1.0,5/57,3.92%,ARC;FOS;CREB3L4;CREB3L1;GRIN3A
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.812755467542974,-1.4367190894458854,0.045454545454545456,0.8236197967618546,1.0,3/10,5.18%,TSKU;IFT88;PDZD7
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.5771513904522438,-1.4364037686218685,0.047619047619047616,0.822747834070318,1.0,8/61,5.44%,CYP1A2;APOB;GPC6;GPC2;SDC3;CYP4V2;APOE;GPC4
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,-0.6836075469590837,-1.4361318128050944,0.0625,0.8214283812700068,1.0,3/15,5.70%,KIT;SH2B2;KITLG
prerank,CellMarker_Augmented_2021__Macrophage:Intervertebral Disc,0.6676116298747804,1.4360267606699635,0.03896103896103896,1.0,1.0,23/55,15.08%,C1QB;ITGB2;CLEC5A;C3AR1;TNFRSF1B;ITGAX;SASH3;PTPRC;ITGAM;TFEC;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;HLA-DPB1;HK3;IGSF6;CD4;MYO1F;CSF1R;PARVG;CD300LF
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.8965008916388624,-1.4358745097504826,0.07142857142857142,0.8198921928799682,1.0,2/7,7.82%,DNAJC30;SLC30A5
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.7199259078122059,1.4354833175794788,0.0625,1.0,1.0,7/18,19.63%,DAB2;CHMP3;MAPK3;DENND10;MSN;RAB21;MAP2K1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex5:Brain,-0.7540755780333329,-1.4353246924335161,0.07142857142857142,0.8194028631459391,1.0,3/9,12.01%,ARSJ;IFITM10;RNF182
prerank,Reactome_2022__DNA Replication Initiation R-HSA-68952,0.8047503412193868,1.4352149816916153,0.03076923076923077,1.0,1.0,1/7,2.76%,POLE2
prerank,CellMarker_Augmented_2021__Vaginal cell:Vagina,-0.5986284635493188,-1.4347825650992694,0.16129032258064516,0.8195902959948387,1.0,4/53,1.40%,ADGRF4;EHF;CLDN4;ANXA8
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.8259364816771677,1.4343296258213414,0.0196078431372549,1.0,1.0,1/10,0.46%,ESR1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.7170523837689327,-1.4340892837005228,0.047619047619047616,0.8214315426106987,1.0,4/15,12.71%,IL11;CDH5;SERPINE1;MAPK7
prerank,Reactome_2022__Prolonged ERK Activation Events R-HSA-169893,-0.7103775785601536,-1.434015980491732,0.08823529411764706,0.8188913932902326,1.0,5/14,14.83%,NGF;NTRK1;RAPGEF1;CRK;CRKL
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.8335861426396554,1.433826463854611,0.03333333333333333,1.0,1.0,2/10,9.64%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.47344465669634556,-1.4335012255137456,0.0,0.8189898034611934,1.0,25/182,12.27%,DUSP4;GCK;FBP2;EPHX2;G6PC3;DUSP15;BCKDK;PTPRB;THNSL2;ACYP2;PNKP;PLA2G2C;PPIP5K1;PLA2G5;EPHB2;PLA2G4C;NT5C;ITPKA;PFKP;PFKFB3;GK5;PGP;G6PD;PLPPR3;PLPP2
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,0.626675254068135,1.4334045637698218,0.02702702702702703,1.0,1.0,53/83,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;EEF1A1;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;EEF2;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL23;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24;RPS29;RPLP1;RPS28;RPL34
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.7336851835635585,-1.4333682942886035,0.06666666666666667,0.8166084028498319,1.0,4/13,9.69%,PPP1R9B;SRGAP2;FGD1;FGD5
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.8328691640275665,1.4331956335699663,0.06666666666666667,1.0,1.0,3/12,7.90%,HLA-F;IL12A;AXL
prerank,Reactome_2022__Synthesis Of PIPs At Late Endosome Membrane R-HSA-1660517,-0.7832076119360403,-1.4331666775802403,0.15151515151515152,0.8151257309448464,1.0,1/11,4.56%,VAC14
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7854534503084455,1.4331521942615693,0.06779661016949153,1.0,1.0,3/19,2.83%,TBX1;SMAD6;LRP2
prerank,Reactome_2022__TNFR1-mediated Ceramide Production R-HSA-5626978,-0.8472047901438701,-1.4325179138386956,0.17391304347826086,0.8154998281279042,1.0,2/5,7.81%,SMPD3;NSMAF
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.7136108691431051,-1.4324201652680661,0.09523809523809523,0.8134176232601167,1.0,1/14,0.81%,ENTPD2
prerank,CellMarker_Augmented_2021__Neutrophil:Undefined,0.8177408631007277,1.4317873161601606,0.029850746268656716,1.0,1.0,10/17,14.71%,ITGB2;TLR2;CSF2RA;ITGAM;FCGR3A;FCAR;CEACAM8;CSF3R;MME;CD44
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.6415202531722314,-1.43164186707702,0.037037037037037035,0.8153233619564426,1.0,6/27,11.31%,NLGN3;WNT7A;SHANK1;SLC8A3;NLGN2;GRIN1
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.6550270900151265,1.4315664934397985,0.05194805194805195,1.0,1.0,20/60,13.33%,ITGB2;CLEC5A;C3AR1;TLR2;TNFRSF1B;ITGAX;CSF2RA;SP100;PTPRC;PTAFR;APOL6;ITGAM;TFEC;FGL2;IRF1;HCK;IGSF6;GPR183;NFKB2;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.7505448471489927,-1.4313742630777473,0.12121212121212122,0.8136910706550056,1.0,3/18,1.26%,SPRED3;SPRED2;SPRED1
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,0.609204949187239,1.4313653013860446,0.0,1.0,1.0,53/91,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;EIF1AX;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;EIF3G;RPL27;RPS14;RPL7A;RPL23;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24;RPS29;RPLP1;RPS28;RPL34
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.8407779924472045,-1.43122939566025,0.05555555555555555,0.811983062655493,1.0,3/12,9.47%,CDH5;CLIP3;MAPRE1
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,0.6041808522035161,1.430765959170869,0.0,1.0,1.0,54/100,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;EIF1AX;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;EIF3G;RPL27;RPS14;RPL7A;RPL23;EIF4A2;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24;RPS29;RPLP1;RPS28;RPL34
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.5862306574145715,-1.4307545978883849,0.09090909090909091,0.8124478969012017,1.0,14/38,26.43%,PRKCD;PID1;PTPRE;SNX5;SLC27A4;AHSG;SIK2;PTPN2;PIP4K2B;C1QTNF12;GKAP1;NCK1;SORL1;INPP5K
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),-0.9183786866427525,-1.430665180802988,0.0,0.8073140264815163,1.0,2/5,5.01%,OSR1;WNT7A
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),-0.9183786866427525,-1.430665180802988,0.0,0.8073140264815163,1.0,2/5,5.01%,OSR1;WNT7A
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,-0.6185866214593081,-1.4303238354563839,0.03571428571428571,0.8065915286611285,1.0,11/27,23.48%,HDAC7;HDAC10;MAML1;HDAC3;MAMLD1;HDAC5;HDAC11;CREBBP;HDAC4;NOTCH1;NCOR2
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,0.6039660446991231,1.4300033430435193,0.0,1.0,1.0,54/101,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;EIF1AX;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;EIF3G;RPL27;RPS14;RPL7A;RPL23;EIF4A2;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24;RPS29;RPLP1;RPS28;RPL34
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.7277333540897438,1.4289502191346284,0.02857142857142857,1.0,1.0,4/25,7.84%,GATA4;CCDC39;MESP1;TBX6
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.8123037805730763,1.428873893804264,0.046153846153846156,1.0,1.0,7/14,13.99%,TMEM100;FGF2;MESP1;VEZF1;BTG1;SFRP4;SOX9
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,0.6186611840744601,1.4281823452912752,0.012987012987012988,1.0,1.0,51/83,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL23;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24;RPS29;RPLP1;RPS28;RPL34
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.6677904967085486,1.428151910602284,0.0684931506849315,1.0,1.0,9/43,14.62%,TULP1;TLR2;PTPRC;SFTPD;SYK;HCK;TGM2;SIRPG;CYBA
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.5759535899581413,-1.4277718842421845,0.0,0.8192240225173109,1.0,10/26,14.57%,CHPF2;XYLT1;CHST11;CHST12;CHSY1;CSGALNACT1;VCAN;B3GAT3;CHST3;CSPG5
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Kidney,-0.8519439286618421,-1.4268992852215554,0.14,0.8205499179678507,1.0,1/5,0.07%,IL7R
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,0.6015372408855341,1.4268952902557637,0.0,1.0,1.0,53/91,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL23;RPS15;DDIT3;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24;RPS29;CEBPB;RPLP1;RPS28;RPL34
prerank,CellMarker_Augmented_2021__Enterocyte:Large Intestine,0.6973160197681737,1.4264204652743178,0.047619047619047616,1.0,1.0,10/37,12.40%,CDHR5;CYP3A5;RARRES1;TMEM45B;IGF2BP2;ANPEP;NR1H4;STEAP1;SLC15A1;GPANK1
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.6251136062776229,1.426367125005048,0.01282051282051282,1.0,1.0,18/70,9.59%,ST6GALNAC1;PLEKHS1;STEAP4;CAPN13;SCGB3A2;SFTPA1;VSIG2;AHR;CYP4F12;SYT2;SFTPD;ITGB6;SMIM22;MUC4;FOXM1;DUOX1;TMC4;TRIM29
prerank,CellMarker_Augmented_2021__B cell:Blood,-0.8940847474553169,-1.4261810904073864,0.09090909090909091,0.8226721074738855,1.0,1/5,0.22%,CD38
prerank,Reactome_2022__Scavenging By Class F Receptors R-HSA-3000484,-0.8658983691631543,-1.4258178559840309,0.0,0.8221619849363564,1.0,1/6,0.54%,APOB
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.6841715659809711,1.4251737270178468,0.05714285714285714,1.0,1.0,8/44,11.00%,PCLAF;DTL;UBE2L6;TRIM25;FAAP20;POLD4;RPA3;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),0.9143135190903271,1.4245835211674351,0.03571428571428571,1.0,1.0,1/6,1.06%,BLK
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.6834522414839596,1.4242438963927022,0.057971014492753624,1.0,1.0,23/49,15.08%,CLEC5A;C3AR1;TLR2;ITGAX;LILRB3;SLC7A7;ITGAM;TFEC;NFAM1;FCGR3A;ADGRE1;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;FPR1;ADGRE3;CD300LF
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,0.6588261104957679,1.4239585828868868,0.056338028169014086,1.0,1.0,2/45,0.92%,CDC25A;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.8629120004025815,-1.4237892827524006,0.02564102564102564,0.8271513692384352,1.0,2/8,4.65%,GLA;KHSRP
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.8629120004025815,-1.4237892827524006,0.02564102564102564,0.8271513692384352,1.0,2/8,4.65%,GLA;KHSRP
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),-0.7583795311323075,-1.4236642362652367,0.05714285714285714,0.8252098029773962,1.0,2/10,5.74%,MFSD2A;PLIN5
prerank,Reactome_2022__RAS Processing R-HSA-9648002,-0.6658307450397952,-1.4229820353725582,0.1388888888888889,0.8263237029616054,1.0,2/18,6.56%,ABHD17A;FNTA
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.8340458694193504,-1.4229683124626595,0.03225806451612903,0.8237741605178782,1.0,1/8,4.99%,SP7
prerank,Reactome_2022__HDL Remodeling R-HSA-8964058,-0.7621137541393576,-1.4229345703947254,0.08888888888888889,0.8214067230269058,1.0,3/7,15.55%,APOE;ALB;ABCG1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.8347394700422268,1.4228678757125541,0.041666666666666664,1.0,1.0,1/10,0.35%,TBX1
prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.5206274472756295,-1.4225704021383005,0.0,0.8205406229287977,1.0,12/171,4.49%,CYP1A2;UGT2B15;EPHX2;BCL2;BCL6;FOS;GSTT2B;CREB3L4;PAQR7;CREB3L1;EIF4EBP1;FGF18
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.7228959836897593,-1.4222849156273554,0.13793103448275862,0.819597777558135,1.0,2/9,5.70%,KIT;KITLG
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),0.902174548999465,1.4216833145218928,0.07547169811320754,1.0,1.0,2/6,4.18%,SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),-0.8073804734799621,-1.4215880423184224,0.029411764705882353,0.8206707962735951,1.0,1/8,3.39%,HDAC10
prerank,Reactome_2022__Thyroxine Biosynthesis R-HSA-209968,0.8981297696295544,1.421555808400147,0.046153846153846156,1.0,1.0,2/7,8.05%,IYD;DUOX1
prerank,CellMarker_Augmented_2021__Preadipocyte:Adipose Tissue,0.6683896949681976,1.4214468633717765,0.05333333333333334,1.0,1.0,20/52,15.08%,C3AR1;TNFRSF1B;ITGAX;GMFG;PTPRC;ITGAM;TFEC;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;PARVG;CD300LF
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.6476094706917069,-1.4202871483891002,0.058823529411764705,0.8253758794331624,1.0,8/27,18.09%,BOC;MEGF10;BNIP2;MYOCD;FGFR2;PTBP1;ABL1;MAPK12
prerank,Reactome_2022__Cation-coupled Chloride Cotransporters R-HSA-426117,0.9290815058950714,1.4202480967953106,0.0,1.0,1.0,2/7,3.75%,SLC12A7;SLC12A3
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.7505872026968806,1.4198012065371948,0.06756756756756757,1.0,1.0,5/24,5.79%,KIF14;TNFRSF1B;MYRF;ITGAX;JAM2
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,-0.6096570426529329,-1.419601518817153,0.09090909090909091,0.8269943360448984,1.0,9/27,20.23%,POLR3D;BDP1;POLR3E;POLR3K;POLR2F;POLR3A;POLR3B;BRF1;POLR3F
prerank,CellMarker_Augmented_2021__Responder T cell:Blood,0.6450906205895536,1.4194573896754192,0.05555555555555555,1.0,1.0,22/61,13.09%,ITGB2;C3AR1;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;FCGR3A;FLI1;FGL2;HCK;IKZF1;TAGAP;HLA-DPB1;CD37;CD4;GPR183;ALOX5AP;PSTPIP1;MYO1F
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.8308829039348781,-1.418864856635249,0.13513513513513514,0.8285212938007589,1.0,1/9,1.08%,ZNF703
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.6771519798792873,1.4187061719320984,0.07352941176470588,1.0,1.0,7/33,16.34%,TBX1;SOX10;SEMA3A;ERBB4;SEMA3F;SEMA3B;HTR2B
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.7588804139490084,-1.4185240290349366,0.05,0.8280946385562715,1.0,4/12,5.74%,TWIST1;MLYCD;NR4A3;PLIN5
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),-0.8371858359252177,-1.4179443538263259,0.08333333333333333,0.8285588552868,1.0,2/5,4.78%,LIPC;APOE
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.6876629313518153,1.4176090781782833,0.058823529411764705,1.0,1.0,1/24,2.53%,PLEKHH2
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.6257044704015073,-1.4174274907200524,0.09375,0.828255494201726,1.0,5/24,13.86%,GCK;CRY1;PGP;ZNF692;SIRT7
prerank,CellMarker_Augmented_2021__Oocyte:Ovary,0.6770628340534941,1.417106537704621,0.0375,1.0,1.0,15/39,15.83%,NLRP4;SLFN14;GP1BA;TOPAZ1;CCDC73;DCAF4L1;NLRP5;CCDC38;ZAN;TEX14;PP2D1;TULP2;WDR87;CATSPERD;PKD1L3
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.8736754882427064,1.4170204807232605,0.014285714285714285,1.0,1.0,1/9,2.12%,ACE2
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.8736754882427064,1.4170204807232605,0.014285714285714285,1.0,1.0,1/9,2.12%,ACE2
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,-0.6055129923243256,-1.4160455020340597,0.058823529411764705,0.8340121314831584,1.0,10/44,16.66%,NUP210;NUP42;POM121C;NUP214;AAAS;POLR2F;PBRM1;NUP37;POLR2C;NUP98
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.8304800497544228,-1.415664064765896,0.09302325581395349,0.8334137078051167,1.0,1/5,4.78%,APOE
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.7418085487102632,-1.4155167207615964,0.1794871794871795,0.8312241733900894,1.0,5/12,17.41%,WWC1;DLG5;WWC2;VGLL4;MARK3
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,0.6001730769248226,1.415250892535163,0.013157894736842105,1.0,1.0,10/74,14.04%,CDC25A;PSMB9;CCND1;CKS1B;CCNE2;RPS27A;CDKN1B;CDKN1A;CCNA2;PSMC5
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.6269166089056315,1.4148918999702764,0.04411764705882353,1.0,1.0,11/45,15.99%,ANXA1;CCL5;PTPRC;SYK;CD80;IGF1;PDCD1LG2;HLA-DPB1;TNFSF4;IL4;AGER
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.6788168783828932,-1.414759887425634,0.10344827586206896,0.832426712941762,1.0,9/32,16.86%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;PIAS4;NUP98;SUMO2
prerank,KEGG_2021_Human__Salivary secretion,-0.5479368762041904,-1.4145203551965146,0.0,0.8310858565472371,1.0,4/63,2.63%,CD38;ADRA1A;ADRA1B;ITPR2
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,-0.6134308514157872,-1.4145067057626102,0.11363636363636363,0.8286076746047325,1.0,9/26,20.23%,POLR3D;BDP1;POLR3E;POLR3K;POLR2F;POLR3A;POLR3B;BRF1;POLR3F
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.7505198303276116,-1.4141452904166363,0.0,0.8280350072925454,1.0,1/11,0.13%,PER2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.7910044280742243,1.4139433397634178,0.07936507936507936,1.0,1.0,2/12,5.45%,CASQ2;CAV3
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,0.5786330944404143,1.4137185406364934,0.039473684210526314,1.0,1.0,22/107,15.99%,SLC25A31;ITGB2;TLR2;GP1BA;PIK3R3;C3;ITGAM;FCGR3A;HAT1;ACTG1;SYK;H2BC4;H4C8;H2AZ1;VWF;FPR1;ITGA2B;ELANE;H2BC18;CYBA;MAPK3;AGER
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,-0.6763210612579066,-1.4135588075321857,0.11764705882352941,0.8293896338728339,1.0,3/18,6.60%,NOX4;MYO18A;STAT5B
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.7288517600727809,1.413104948696006,0.07936507936507936,1.0,1.0,3/18,13.70%,GPER1;RAMP3;CALCR
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,0.6740563357458134,1.4129839656212033,0.08955223880597014,1.0,1.0,2/26,6.35%,CLEC5A;SYK
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.875067140217152,1.4127922750942778,0.017857142857142856,1.0,1.0,2/9,4.27%,ESR1;TGFB1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.7655525487332902,-1.4125115075511805,0.10344827586206896,0.832614785308116,1.0,2/17,0.57%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.7122659182031678,1.4122383678581443,0.08064516129032258,1.0,1.0,4/18,11.61%,CCL5;DAZL;DDX3X;BOLL
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.8503516093325308,1.4120645988831588,0.06153846153846154,1.0,1.0,4/10,9.22%,GATA4;STK26;REST;PINK1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.6128984336354026,-1.4111107458854308,0.11538461538461539,0.838395807958679,1.0,7/26,20.49%,PRKCD;PID1;PTPRE;SLC27A4;AHSG;PTPN2;PIP4K2B
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.8126063953779394,1.4110837646439855,0.07692307692307693,1.0,1.0,2/11,5.77%,AMBP;GPER1
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.7066958166830508,-1.4107554988918551,0.12121212121212122,0.8379949417040009,1.0,6/16,20.08%,CPSF1;ERN1;CSTF2;CPSF4;TSEN2;FAM98B
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.6968265654881032,-1.4107044538595097,0.06976744186046512,0.8356571679015211,1.0,4/11,12.71%,ASS1;PKD2;HDAC3;MAPK7
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),-0.7555295468051537,-1.4103735003705322,0.07317073170731707,0.8354989840211392,1.0,2/12,1.82%,GCK;PPP1R3E
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),-0.8294177903797921,-1.4103022038710484,0.11904761904761904,0.8334911754025058,1.0,4/6,16.75%,DDAH2;ASS1;ALDH18A1;DDAH1
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.8488767710275537,1.4101021197710668,0.05084745762711865,1.0,1.0,1/10,0.35%,TBX1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.7956066812959954,-1.4096676520974118,0.07142857142857142,0.8346473229269904,1.0,1/11,0.07%,IL7R
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.801403962812876,-1.4096571628349128,0.11904761904761904,0.8321558383809396,1.0,3/9,5.95%,PER2;PIWIL2;CRY1
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.7875485595417739,-1.4091059122474225,0.17777777777777778,0.8328123559291037,1.0,5/9,18.42%,KDM8;KDM7A;KDM2B;KDM4B;KDM2A
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Intestine,0.7894817995813802,1.4090489196987175,0.047619047619047616,1.0,1.0,6/11,11.98%,ITGAX;ITGAM;ADGRE1;CD80;PDCD1LG2;CD4
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Blood,0.7894817995813802,1.4090489196987175,0.047619047619047616,1.0,1.0,6/11,11.98%,ITGAX;ITGAM;ADGRE1;CD80;PDCD1LG2;CD4
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Lung,0.7894817995813802,1.4090489196987175,0.047619047619047616,1.0,1.0,6/11,11.98%,ITGAX;ITGAM;ADGRE1;CD80;PDCD1LG2;CD4
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Skin,0.7894817995813802,1.4090489196987175,0.047619047619047616,1.0,1.0,6/11,11.98%,ITGAX;ITGAM;ADGRE1;CD80;PDCD1LG2;CD4
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Stomach,0.7894817995813802,1.4090489196987175,0.047619047619047616,1.0,1.0,6/11,11.98%,ITGAX;ITGAM;ADGRE1;CD80;PDCD1LG2;CD4
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),-0.8173299148731586,-1.4090268226486116,0.0625,0.8308744470884623,1.0,2/7,11.11%,EGR1;AKR1C3
prerank,CellMarker_Augmented_2021__Trophoblast Stem cell:Undefined,-0.6051593574755904,-1.408477077222644,0.12121212121212122,0.8310750711596929,1.0,8/48,7.95%,ADGRF4;CLDN4;WNT3A;ESRP1;F11R;CRABP2;PERP;LYPD6B
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),0.9109953788947289,1.4081083250017694,0.05172413793103448,1.0,1.0,2/7,2.57%,ITGB2;ANXA1
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,0.6122030716000424,1.4079660860599508,0.012987012987012988,1.0,1.0,52/86,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL23;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24;NCBP1;RPS29;RPLP1;RPS28;RPL34
prerank,CellMarker_Augmented_2021__Endothelial cell:Muscle,-0.8890290680357359,-1.406620491474848,0.02040816326530612,0.8391896083245352,1.0,1/5,1.80%,CDH5
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.8732427428788095,1.4064518722636308,0.031746031746031744,1.0,1.0,2/8,5.05%,GATA4;HEY2
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.8145830215827102,-1.406289525228034,0.075,0.8381185195259792,1.0,2/7,6.88%,PRKCD;DDX11
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),-0.6830086699329694,-1.4058209008808715,0.07692307692307693,0.8375055026599649,1.0,8/17,23.22%,NEU4;B4GALNT1;NEU3;ST3GAL5;ST6GALNAC3;ST6GALNAC5;CLN6;ST8SIA3
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.816693515599781,-1.4054721750920367,0.05263157894736842,0.8367083753280117,1.0,1/6,4.21%,NR4A3
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.6752467927475274,-1.4051943052807325,0.09090909090909091,0.8358784663402196,1.0,7/30,16.66%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;NUP98
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Heart,-0.7798689460893031,-1.4051258972638507,0.07142857142857142,0.8338217952932024,1.0,4/7,4.76%,CALD1;CDH5;HRH2;CNN1
prerank,Reactome_2022__Presynaptic Depolarization And Calcium Channel Opening R-HSA-112308,-0.763636446202663,-1.4050019340244988,0.10810810810810811,0.8319258975579552,1.0,4/12,16.32%,CACNG4;CACNB1;CACNG2;CACNA1A
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Blood,-0.8738206675227375,-1.4045655926451381,0.1,0.8319333185768087,1.0,1/5,0.07%,IL7R
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),-0.8677472077195886,-1.4040697108374525,0.043478260869565216,0.832125687639021,1.0,2/6,4.38%,IL11;RAB11FIP1
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.7209898768382081,1.4040301819716863,0.078125,1.0,1.0,5/21,14.52%,FGF2;TGFB1;PRR5L;THBS1;DDR2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.7283010497482849,1.4040076278968066,0.08,1.0,1.0,6/22,8.61%,GATA4;C3;TGFB1;NODAL;FLT4;CYP1B1
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,0.5991209803937427,1.403958786750204,0.012987012987012988,1.0,1.0,10/76,14.04%,CDC25A;PSMB9;CCND1;CKS1B;CCNE2;RPS27A;CDKN1B;CDKN1A;CCNA2;PSMC5
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.8303199997450432,1.4038942921955475,0.07575757575757576,1.0,1.0,5/9,14.33%,CCL5;SFTPD;TAFA4;P2RY12;EDNRB
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone Marrow,0.6618146463293211,1.4037456946801368,0.05063291139240506,1.0,1.0,23/53,13.47%,C1QB;ITGB2;C3AR1;TLR2;ITGAX;SASH3;PTPRC;PTAFR;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;SYK;HCK;CSF3R;HK3;IGSF6;EPCAM;MYO1F;CSF1R;FPR1
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),0.8938960324763648,1.4035424005055142,0.017241379310344827,1.0,1.0,2/6,2.06%,MICB;TCF7
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.5615167654473796,-1.40298877708146,0.047619047619047616,0.8353789743996708,1.0,6/48,13.53%,NGF;SRGAP2;NYAP2;DAB2IP;TAOK2;DBNL
prerank,CellMarker_Augmented_2021__FGFR1LowNME5- Epithelial cell:Esophagus,0.6675386091531892,1.4029611803241133,0.025,1.0,1.0,3/45,2.06%,CLCA2;CYTIP;TCF7
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,0.6391573669913745,1.4026019091824096,0.0379746835443038,1.0,1.0,28/52,25.85%,RPS9;RPS16;RPS5;RPS27A;RPS3A;RPS12;RPS4X;RPS19;FAU;RPS21;RPS11;RPS13;RPS7;EIF1AX;RPS15A;RPSA;RPS6;EIF3G;RPS14;EIF4A2;RPS15;RPS27;RPS3;RPS23;RPS20;RPS24;RPS29;RPS28
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.5863683158664913,-1.4025818395055207,0.07692307692307693,0.834751073056401,1.0,9/39,12.99%,MYO10;PRKCD;AGRN;FSCN1;RAB5A;FXR2;NEURL1;TRPM2;CAPZB
prerank,CellMarker_Augmented_2021__Monocyte:Liver,0.6825610085657445,1.4025589130035951,0.09722222222222222,1.0,1.0,21/41,15.08%,ITGB2;C3AR1;TLR2;ITGAX;LILRB3;PTAFR;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;FPR1;ADGRE3;CD300LF
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.7185788569762758,-1.4021856472209593,0.11764705882352941,0.8350071045859476,1.0,9/14,19.31%,PNKP;KMT5C;WRAP53;KDM4D;SHLD2;SMCHD1;MAD2L2;SHLD1;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.7309172585992153,1.4013774736431377,0.0821917808219178,1.0,1.0,6/21,8.61%,GATA4;C3;TGFB1;NODAL;FLT4;CYP1B1
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Peripheral Blood,-0.6179950948225957,-1.4012116312004823,0.1276595744680851,0.8375659987416735,1.0,3/30,1.33%,IL7R;P2RY10;IL16
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.6838252314268662,1.401082424052269,0.0273972602739726,1.0,1.0,10/37,15.58%,C3AR1;ACE2;SGCG;COL4A3;TRDN;STAT1;SGCZ;PLN;CXCL12;ELN
prerank,KEGG_2021_Human__Malaria,0.7230340860620386,1.4008916647836098,0.041666666666666664,1.0,1.0,10/31,13.27%,ITGB2;TLR2;SDC2;TGFB1;CD81;IL12A;HGF;TGFB3;THBS1;KLRB1
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.9311769834116935,1.4005433689548294,0.030303030303030304,1.0,1.0,1/6,1.75%,SLFN14
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.8083376166601194,1.4004798878611155,0.08771929824561403,1.0,1.0,3/12,5.05%,RRAS;TMEM100;HEY2
prerank,GO_Biological_Process_2021__metanephric nephron tubule development (GO:0072234),-0.9007503768117157,-1.4004222271163391,0.12244897959183673,0.8397091548942903,1.0,2/5,7.60%,OSR1;PKD2
prerank,Reactome_2022__Physiological Factors R-HSA-5578768,0.8428945504130109,1.4001784592245805,0.06666666666666667,1.0,1.0,2/8,3.98%,GATA4;HIPK1
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),0.9537551053855023,1.4000580551545003,0.01818181818181818,1.0,1.0,2/5,3.28%,TBX1;SIX4
prerank,CellMarker_Augmented_2021__Hepatoblast:Liver,0.6121146892812471,1.3999917401386905,0.05333333333333334,1.0,1.0,24/83,15.58%,OLFML1;ENPP2;PRRX1;ADAM33;FAM20A;PTPRC;FLT1;COL6A6;CPED1;JAM2;OGN;ANGPTL2;IGF1;ANGPTL1;HGF;DCN;ASPN;COLEC12;PLN;FILIP1L;MASP1;SLCO2B1;CXCL12;ELN
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,-0.4792041450667168,-1.399973125203443,0.0,0.839221578976927,1.0,5/123,2.05%,IL7R;SYT12;APOB;SYNJ2;PACSIN2
prerank,Reactome_2022__Transcriptional Regulation Of Testis Differentiation R-HSA-9690406,0.8846100434790694,1.3998813943171047,0.06451612903225806,1.0,1.0,1/7,0.23%,GATA4
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.5937357660375828,-1.3996338900281209,0.12903225806451613,0.8388818239700191,1.0,6/33,11.43%,PLK3;MRRF;GBF1;CDK1;ATG2A;STX5
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.8373203615488392,1.399571458193064,0.058823529411764705,1.0,1.0,1/10,0.97%,MCUB
prerank,Reactome_2022__Activation Of Ca-permeable Kainate Receptor R-HSA-451308,-0.8154420170078029,-1.3995508083145736,0.09523809523809523,0.8372782290150312,1.0,4/9,13.12%,GRIK4;NCALD;GRIK1;LLGL1
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.92013726734232,1.3994514306819972,0.0,1.0,1.0,2/7,6.63%,SLC22A3;SLC6A4
prerank,Reactome_2022__Aspirin ADME R-HSA-9749641,-0.6604991852553355,-1.3991643665875666,0.10526315789473684,0.8370540300413414,1.0,4/22,2.70%,UGT2B15;GLYATL1;BCHE;CES2
prerank,GO_Biological_Process_2021__positive regulation of epithelial tube formation (GO:1905278),0.9328279435842238,1.3990471949464938,0.019230769230769232,1.0,1.0,2/5,3.51%,SIX4;FGF2
prerank,KEGG_2021_Human__Starch and sucrose metabolism,-0.657144161606179,-1.3989392402895255,0.12903225806451613,0.8358960802830995,1.0,4/27,5.09%,GCK;GANC;G6PC3;GYS1
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,-0.6051928731133033,-1.3989334403453548,0.0967741935483871,0.8335970363790032,1.0,10/40,22.24%,APOB;CARM1;HDAC3;NR1D1;MAFK;SMARCD3;CRTC1;NPAS2;RORA;CREBBP
prerank,Reactome_2022__RUNX3 Regulates NOTCH Signaling R-HSA-8941856,-0.6946926724886109,-1.3986274006304207,0.1111111111111111,0.8327412587492066,1.0,4/13,11.37%,MAML1;GATD3;MAMLD1;JAG1
prerank,CellMarker_Augmented_2021__PROM1High Progenitor cell:Large Intestine,-0.4698653238310925,-1.3977873814320196,0.0,0.834814529146698,1.0,18/94,9.15%,NGF;ADAMTS12;MYO10;COL12A1;RAI14;FRMD6;ARSJ;COL8A1;RND3;CCBE1;KIAA1549L;PARVA;ZFHX4;EML1;RASSF8;RPGRIP1L;GPR161;DCBLD2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.8504083681459134,1.397750394222038,0.06557377049180328,1.0,1.0,1/7,0.98%,PLA2G10
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.5947756404220588,-1.3975935392250058,0.10344827586206896,0.8333555434781454,1.0,9/44,10.13%,SPRED3;SPRED2;SPRED1;CDH5;PUM3;HSPB1;ASPSCR1;FKTN;KDM4D
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.6816744374896537,1.3973102367843764,0.07246376811594203,1.0,1.0,5/24,9.13%,BLK;VSIG4;SFTPD;CD80;PDCD1LG2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.6536901510241411,-1.397114197712771,0.11764705882352941,0.8337488031891569,1.0,5/23,12.71%,IL11;CDH5;SERPINE1;NUPR1;MAPK7
prerank,Reactome_2022__Signaling To P38 Via RIT And RIN R-HSA-187706,-0.819767050932811,-1.3969988533537019,0.15151515151515152,0.8319471179920324,1.0,2/5,7.28%,NGF;NTRK1
prerank,Reactome_2022__p75NTR Recruits Signaling Complexes R-HSA-209543,-0.7323559199463641,-1.396725659379453,0.05128205128205128,0.8311076282922796,1.0,2/11,8.48%,NGF;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),-0.7567632192471342,-1.3967237123163143,0.07142857142857142,0.8288306210914788,1.0,2/11,1.82%,GCK;PPP1R3E
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.7717675100050145,1.396072878216529,0.07462686567164178,1.0,1.0,6/16,16.38%,CCL5;P2RY12;THBS1;CSF1R;MAPK3;CSF1
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.5912989729894781,-1.3959881067606175,0.034482758620689655,0.8306350457975942,1.0,6/33,7.72%,DRD4;MIDN;RAB11FIP1;RHBDF1;APOE;CCN3
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.8512319928190641,1.3957667204383404,0.06896551724137931,1.0,1.0,2/6,0.88%,RAB34;MAPKAPK3
prerank,PanglaoDB_Augmented_2021__Microglia,0.6000082960267147,1.3954579103008888,0.05952380952380952,1.0,1.0,33/94,15.20%,IL21R;C1QB;ITGB2;C3AR1;TNFRSF1B;ITGAX;SASH3;PTPRC;PTAFR;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;P2RY6;HCK;CSF3R;P2RY12;HPGDS;TAGAP;HK3;IGSF6;COLEC12;CD4;GPR183;ALOX5AP;MYO1F;CSF1R;FPR1;PARVG;CD300LF;SLCO2B1
prerank,CellMarker_Augmented_2021__Clara cell:Lung,0.6694328349336909,1.3950773768933222,0.041666666666666664,1.0,1.0,15/44,15.47%,CCDC60;FAM81B;CFAP126;C11ORF16;MAP3K19;VWA3B;AKAP14;BPIFB1;OR7E122P;MROH9;MORN5;PLEKHG7;DNAI1;CATSPERD;DNAH3
prerank,Reactome_2022__Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,-0.6839999196320963,-1.3946223843929972,0.11764705882352941,0.8347734253971761,1.0,2/15,6.60%,NOX4;STAT5B
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.68962497694148,-1.3943396854399468,0.1,0.8343191358065997,1.0,2/13,5.57%,STX6;MYO18A
prerank,KEGG_2021_Human__Morphine addiction,-0.5190110412501945,-1.3938747504159363,0.041666666666666664,0.8348414931874241,1.0,20/82,17.00%,GRK5;GABRE;PDE10A;PDE7B;GABRA5;GNAS;KCNJ6;GNB5;GNB3;ADCY3;ADCY2;PDE3A;ARRB2;GABBR2;PDE3B;GRK4;CACNA1A;PRKCA;GABRP;ADCY6
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.7058401827463481,-1.3938610164450849,0.0967741935483871,0.8327586562141693,1.0,4/20,7.23%,ARC;CRHR2;SLC8A3;MPP2
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.7213119767752,-1.3932388044965538,0.14705882352941177,0.8339398940654703,1.0,3/17,12.27%,ACER2;ACER3;PLPP2
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.7975637468131407,-1.393037620983482,0.10810810810810811,0.8328024954355425,1.0,2/9,3.27%,PC;PDZD11
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.7219441799968964,-1.3929246453281294,0.17142857142857143,0.8312237458223536,1.0,2/16,2.63%,PRKCD;ITPR2
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.6492305805189366,-1.3924942499884956,0.10344827586206896,0.8312668158407376,1.0,4/19,11.92%,GCK;CRY1;NUPR1;PGP
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.6239353554845113,1.3923628202714375,0.08450704225352113,1.0,1.0,8/56,7.86%,AQP3;TBX1;MICB;WNT8B;WNT5A;WNT8A;HSD17B2;STRA8
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.5879789332939204,-1.3923531110933998,0.09090909090909091,0.8297348170047161,1.0,13/45,9.67%,WNT3A;GPC6;NLGN3;GRID2;MDGA1;WNT7A;GPC4;LHFPL4;DLG5;SYNDIG1;EPHB2;SLITRK2;NLGN2
prerank,CellMarker_Augmented_2021__Monocyte:Spleen,0.6663276834748479,1.391979753711729,0.0684931506849315,1.0,1.0,20/49,13.47%,ITGB2;CLEC5A;C3AR1;TLR2;ITGAX;LILRB3;PTAFR;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;FPR1
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",0.6467171611599899,1.3917589734499995,0.02702702702702703,1.0,1.0,27/46,25.85%,RPS9;RPS16;RPS5;RPS27A;RPS3A;RPS12;RPS4X;RPS19;FAU;RPS21;RPS11;RPS13;RPS7;EIF1AX;RPS15A;RPSA;RPS6;EIF3G;RPS14;RPS15;RPS27;RPS3;RPS23;RPS20;RPS24;RPS29;RPS28
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.869400188359859,-1.3913529982393171,0.06818181818181818,0.8326497626842122,1.0,1/8,0.81%,ENTPD2
prerank,CellMarker_Augmented_2021__Late Transit-Amplifying Prostate Epithelial cell:Prostate,-0.5491226744507874,-1.3913081829688827,0.12,0.8286517754514905,1.0,4/46,0.96%,ADGRF4;EHF;MLPH;CLDN4
prerank,CellMarker_Augmented_2021__Early Transit-Amplifying Prostate Epithelial cell:Prostate,-0.5491226744507874,-1.3913081829688827,0.12,0.8286517754514905,1.0,4/46,0.96%,ADGRF4;EHF;MLPH;CLDN4
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),-0.836865130088587,-1.3910584586021542,0.15,0.82795582869603,1.0,1/6,3.72%,GRID2
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.563881776330703,-1.3909582945041137,0.08333333333333333,0.8264189156987143,1.0,8/35,17.59%,PHLDB2;MAP10;ERBB2;IGBP1;MARK2;TRAF3IP1;MARK4;CAMSAP3
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.8606125196780656,-1.3909577875627044,0.022222222222222223,0.819945660484364,1.0,1/5,4.78%,APOE
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.8606125196780656,-1.3909577875627044,0.022222222222222223,0.819945660484364,1.0,1/5,4.78%,APOE
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.8606125196780656,-1.3909577875627044,0.022222222222222223,0.819945660484364,1.0,1/5,4.78%,APOE
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),-0.835222271157694,-1.390948096883912,0.08333333333333333,0.8178438185628335,1.0,1/6,8.45%,AQP1
prerank,CellMarker_Augmented_2021__Periodontal Ligament Stem cell:Periodontal Ligament,0.6386924282772812,1.3909258415203483,0.08333333333333333,1.0,1.0,19/66,10.69%,ITGB2;C3AR1;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;ITGAM;TFEC;FCGR3A;VSIG4;FLI1;FGL2;HCK;IKZF1;TAGAP;HLA-DPB1
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),0.8454095316268362,1.3906354555684708,0.13114754098360656,1.0,1.0,2/6,7.67%,TCF7;LEF1
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,-0.6459353229318963,-1.390019782043666,0.12,0.8203546980047802,1.0,15/40,23.43%,CPSF1;NUP210;NUP42;POM121C;NUP214;AAAS;SYMPK;NUP37;NUP98;CPSF4;SEH1L;CPSF3;NUP50;TPR;ALYREF
prerank,CellMarker_Augmented_2021__Fibroblast:Undefined,0.7645665254664071,1.3893028128871112,0.06060606060606061,1.0,1.0,8/19,19.80%,PTPRC;ITGAM;CD81;NT5E;MME;CD44;ENG;IL1R1
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.933571523960118,1.3891959961031408,0.016129032258064516,1.0,1.0,2/6,3.68%,SLC22A3;SLC18A2
prerank,Reactome_2022__Phenylalanine Metabolism R-HSA-8964208,-0.7952250212659296,-1.3891510460870862,0.16666666666666666,0.8202287227294655,1.0,2/6,10.57%,PAH;KYAT1
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),-0.7952250212659296,-1.3891510460870862,0.16666666666666666,0.8202287227294655,1.0,2/6,10.57%,PAH;KYAT1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.5584844075945338,-1.388901716845834,0.15789473684210525,0.8193059194600566,1.0,5/46,6.87%,PER2;PIAS3;CRY1;MINAR1;USP4
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.7902364168014456,1.3887877152150554,0.031746031746031744,1.0,1.0,4/11,13.99%,TBX1;WNT5A;STAT1;SOX9
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.8452199154244059,1.3885394079188196,0.04081632653061224,1.0,1.0,1/6,3.51%,FGF2
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.6720233882325034,-1.388528684627619,0.10810810810810811,0.8191799447493575,1.0,8/18,22.81%,MAML1;CCN3;HDAC3;FBXO22;HDAC5;RBM24;HDAC4;NOTCH1
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.7563947937614768,1.3884826683010396,0.04838709677419355,1.0,1.0,4/16,12.52%,MYRF;SOX10;PLP1;PRDM8
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),0.8602073794173247,1.3880787703840891,0.03571428571428571,1.0,1.0,2/5,9.91%,CYP26B1;PRAME
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,0.6517190957137948,1.3872303165289526,0.06578947368421052,1.0,1.0,3/45,3.68%,GAD1;HSPA8;SLC18A2
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,0.638049150702528,1.3862008160623744,0.02531645569620253,1.0,1.0,28/52,25.85%,RPS9;RPS16;RPS5;RPS27A;RPS3A;RPS12;RPS4X;RPS19;FAU;RPS21;RPS11;RPS13;RPS7;EIF1AX;RPS15A;RPSA;RPS6;EIF3G;RPS14;EIF4A2;RPS15;RPS27;RPS3;RPS23;RPS20;RPS24;RPS29;RPS28
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.8481712505561958,1.3861849600904774,0.09090909090909091,1.0,1.0,1/7,2.11%,TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.7731857142368083,1.3858628639965227,0.06349206349206349,1.0,1.0,3/12,14.41%,BLK;SYK;IL4
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.8167157015907841,-1.3856039003912484,0.08333333333333333,0.8325842751280391,1.0,1/6,2.03%,KMT2B
prerank,Reactome_2022__Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,-0.7512145640532676,-1.3855604984161354,0.125,0.8307504157633886,1.0,4/13,12.50%,GALE;DPM3;PMM2;DHDDS
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.7546356973597855,-1.3853615911914425,0.1388888888888889,0.8295481803998743,1.0,4/10,18.01%,HSF1;TFCP2;C5AR1;MED1
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.7608471128056912,1.385119246459243,0.04477611940298507,1.0,1.0,5/19,7.90%,IL21R;NFIL3;PTPRC;IFNK;AXL
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),-0.7885871547274317,-1.3849779493693963,0.1388888888888889,0.8294627613205651,1.0,4/8,12.47%,ANAPC2;DAB2IP;NEURL1;NEUROD2
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),-0.882798829077122,-1.3835478248109192,0.13513513513513514,0.8345587394346661,1.0,1/6,2.81%,HRH1
prerank,Reactome_2022__p75NTR Negatively Regulates Cell Cycle Via SC1 R-HSA-193670,-0.8498085166917606,-1.3833380891597573,0.12195121951219512,0.8334209980145759,1.0,1/5,0.34%,NGF
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,0.6230839957738298,1.3831919840704079,0.0410958904109589,1.0,1.0,12/53,20.47%,PSMB9;CCND1;CKS1B;CCNE2;RPS27A;CDKN1B;CDKN1A;CCNA2;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.5795413186870478,-1.3829686276148252,0.0,0.8335209668527492,1.0,1/34,0.18%,NOX4
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.6148432977079857,-1.382840387992421,0.08823529411764706,0.8319388329359064,1.0,6/27,14.31%,SMYD5;DNMT1;MACROH2A2;DNMT3A;MPHOSPH8;MORC2
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.6920023993845537,-1.382812334843421,0.027777777777777776,0.8301065919007234,1.0,4/18,7.60%,TMEM106A;DDAH2;ASS1;PKD2
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.8214685584371452,1.3826050726557508,0.06666666666666667,1.0,1.0,2/8,3.49%,GLRX;STOML2
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.6190396617499966,1.3818872817485663,0.057971014492753624,1.0,1.0,4/56,6.69%,GPR62;NMUR2;CXCR5;ACKR4
prerank,KEGG_2021_Human__Sulfur metabolism,0.8314270453585874,1.3818065638198296,0.06153846153846154,1.0,1.0,1/10,0.08%,SQOR
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.9318809466038895,1.3816744078641334,0.01639344262295082,1.0,1.0,2/5,6.63%,SLC22A3;SLC6A4
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.9318809466038895,1.3816744078641334,0.01639344262295082,1.0,1.0,2/5,6.63%,SLC22A3;SLC6A4
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.8713995278121218,-1.3813840839633538,0.08888888888888889,0.8358128003250969,1.0,3/5,12.67%,ADAMTS12;FGF1;RNF207
prerank,Reactome_2022__Scavenging By Class B Receptors R-HSA-3000471,-0.8689489782152344,-1.3813423527511641,0.0784313725490196,0.8339800355766168,1.0,2/5,10.60%,APOB;SCARB1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.8523801521414495,1.381269282631092,0.08196721311475409,1.0,1.0,1/7,1.47%,CASQ2
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.8523801521414495,1.381269282631092,0.08196721311475409,1.0,1.0,1/7,1.47%,CASQ2
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,0.6033624773781232,1.3812385314952742,0.013333333333333334,1.0,1.0,55/102,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;SSR4;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;SRP19;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;SPCS2;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL23;RPS15;SRP14;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24;RPS29;RPLP1;RPS28;RPL34
prerank,Reactome_2022__FLT3 Signaling Thru SRC Family Kinases R-HSA-9706374,0.8086391421964383,1.381216308902439,0.07407407407407407,1.0,1.0,2/5,8.80%,SYK;HCK
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,0.6561101163297196,1.3807334087923424,0.0625,1.0,1.0,8/47,11.00%,PCLAF;POLE2;DTL;UBE2L6;TRIM25;POLD4;RPA3;RPS27A
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.5290979607741099,-1.38060938629746,0.04,0.8362544427593743,1.0,4/45,7.73%,EFNB1;MMP2;EPHA6;EPHB2
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.6954683487140363,1.3805746144533269,0.06451612903225806,1.0,1.0,5/26,13.13%,MGST1;ABCG2;SLC26A6;SLC13A4;SLC25A19
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.7512328299668951,1.3803013699702174,0.08771929824561403,1.0,1.0,3/9,15.83%,GNAT3;ASIC1;PKD1L3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.7953334119557118,-1.3802669692206788,0.10526315789473684,0.8355474655199612,1.0,3/8,10.50%,RAB7B;SLC15A4;PTPRS
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),-0.7796359166794274,-1.3802389120996956,0.05714285714285714,0.8336015746637492,1.0,4/9,12.47%,ANAPC2;DAB2IP;NEURL1;NEUROD2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),-0.7345478415451441,-1.3800425273828563,0.12121212121212122,0.8327139950651149,1.0,1/13,1.36%,NAA40
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.8391463078227789,1.3794495463252228,0.057692307692307696,1.0,1.0,4/9,11.68%,GPER1;ADRB1;SOD2;F2RL1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Umbilical Cord Blood,0.6171231140745977,1.3792198365736144,0.02531645569620253,1.0,1.0,18/64,13.85%,PLEKHS1;CAPN13;ACE2;CMAHP;AHR;CLCA4;RARRES1;MAP3K19;ITGA2;ITGB6;FUT2;MUC4;LAMC2;CP;BPIFB1;ERN2;SLC5A1;MROH9
prerank,Reactome_2022__Digestion R-HSA-8935690,0.8267482661646505,1.3787009985915963,0.0,1.0,1.0,4/10,9.72%,PNLIPRP3;LCT;CHIT1;TREH
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.6618679880451002,1.3785816507364916,0.05,1.0,1.0,12/42,13.20%,TBX1;LOX;FLT1;TGFB1;HEY2;SYK;FLT4;CYP1B1;AGGF1;ID1;ANGPTL3;RASA1
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,0.6908453781704454,1.3782735076838977,0.09090909090909091,1.0,1.0,6/26,11.19%,STAT5A;SYK;HCK;CSF3R;RPS27A;STAT1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.5517091661097141,-1.3781909837953434,0.045454545454545456,0.8402312086827907,1.0,11/39,17.74%,SLC38A5;SLC25A29;SLC6A20;ABCC8;PKD2;SLC3A2;SLC7A5;TRPM2;SLC36A4;SLC6A9;PKD2L1
prerank,CellMarker_Augmented_2021__M2 macrophage:Serum,0.6371877209304133,1.3780261841794723,0.0821917808219178,1.0,1.0,20/53,13.47%,C1QB;CLEC5A;C3AR1;TLR2;ITGAX;PTPRC;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;CD4;MYO1F;CSF1R;FPR1
prerank,CellMarker_Augmented_2021__M2 macrophage:Brain,0.6371877209304133,1.3780261841794723,0.0821917808219178,1.0,1.0,20/53,13.47%,C1QB;CLEC5A;C3AR1;TLR2;ITGAX;PTPRC;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;CD4;MYO1F;CSF1R;FPR1
prerank,CellMarker_Augmented_2021__Kupffer cell:Fetal Liver,0.6371877209304133,1.3780261841794723,0.0821917808219178,1.0,1.0,20/53,13.47%,C1QB;CLEC5A;C3AR1;TLR2;ITGAX;PTPRC;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;CD4;MYO1F;CSF1R;FPR1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.57890246253072,-1.3780139843133394,0.15151515151515152,0.8389522132560249,1.0,7/32,13.32%,CPSF1;LSM10;TTF2;SNRPB;SYMPK;CSTF2;CPSF7
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Dental Pulp,0.8211790562415958,1.377947409184521,0.13559322033898305,1.0,1.0,4/8,16.35%,PTPRC;NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.7548961994380319,1.377566480968941,0.0967741935483871,1.0,1.0,3/14,6.49%,GATA4;HEY2;DAND5
prerank,CellMarker_Augmented_2021__Bone Marrow Stromal cell:Bone Marrow,-0.5567238678477143,-1.3770537893588128,0.05263157894736842,0.8416224888806914,1.0,13/68,8.67%,ADGRF4;EHF;CLDN4;ARSJ;DSG2;LAMA3;ESRP1;RND3;PARVA;PERP;GPRC5A;CDCP1;ITGB4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.9031216184930435,-1.3770517008700245,0.07142857142857142,0.8395596886628465,1.0,3/5,9.66%,FOXO1;TRPC3;MLIP
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.819557817248076,1.376946260398288,0.029850746268656716,1.0,1.0,3/10,11.68%,PLEKHH2;VIL1;F2RL1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.7943784884016516,-1.376244200174355,0.13513513513513514,0.8425607074711972,1.0,1/7,3.27%,PDZD11
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.6347818408895227,-1.3761929396427912,0.10714285714285714,0.8406622467531777,1.0,9/24,15.25%,WWP2;NIBAN2;BEND6;CHAC1;ZBTB7A;DLK2;NEURL1;TCIM;DLL1
prerank,Reactome_2022__Interleukin-10 Signaling R-HSA-6783783,0.7207565583416871,1.3760802269673225,0.12698412698412698,1.0,1.0,5/20,6.90%,TNFRSF1B;CCL5;PTAFR;IL12A;CD80
prerank,CellMarker_Augmented_2021__IL-17Ralpha T cell:Peripheral Blood,-0.6796843436760265,-1.3758385313232384,0.12903225806451613,0.8402723951033686,1.0,2/28,0.17%,IL7R;P2RY10
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.6970740255382797,1.375220072694017,0.07462686567164178,1.0,1.0,4/25,6.35%,ITGB2;ANXA1;CCL5;SYK
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.8110806346558547,1.3751214090505879,0.05454545454545454,1.0,1.0,1/9,0.44%,SMAD6
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.7647120473623907,-1.375043420964465,0.18181818181818182,0.8427200936997086,1.0,5/11,17.62%,MFSD2A;PLIN5;SCARB1;NR1H2;CTDNEP1
prerank,CellMarker_Augmented_2021__Responder T cell:Peripheral Blood,0.6326785681986751,1.3750348534349535,0.0821917808219178,1.0,1.0,22/55,15.08%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;ITGAM;WAS;HCK;IKZF1;TAGAP;CD37;CD4;GPR183;ALOX5AP;PSTPIP1;MYO1F;SIRPG;PARVG;CD300LF
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.7214347579623562,-1.3747289608870068,0.10526315789473684,0.8426380035087844,1.0,2/12,8.74%,GMNC;ATR
prerank,"Reactome_2022__WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",0.812985173781191,1.3746855265345002,0.15,1.0,1.0,1/10,5.31%,WNT5A
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.8611980562786486,1.3743621796796028,0.03225806451612903,1.0,1.0,1/7,0.23%,GATA4
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.6954253302904376,-1.3742329308613839,0.06451612903225806,0.843207531180979,1.0,5/15,20.08%,CPSF1;CSTF2;CPSF4;TSEN2;FAM98B
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.6242581292907905,-1.3738164882510921,0.06060606060606061,0.8432484053114212,1.0,10/28,22.22%,LIN28B;TRIM71;DGCR8;AGO2;ZC3H7B;PUS10;SNIP1;TUT7;ADAR;TARBP2
prerank,KEGG_2021_Human__Galactose metabolism,-0.6485732442101501,-1.3738066811014267,0.08571428571428572,0.8412830887727719,1.0,5/26,1.95%,GCK;GANC;G6PC3;GLA;GALE
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),0.7464949039285481,1.3737832703828012,0.11594202898550725,1.0,1.0,6/15,10.08%,TBX1;MESP1;TBX6;HCK;GDF11;IKZF1
prerank,Reactome_2022__NADE Modulates Death Signaling R-HSA-205025,-0.8684710799167853,-1.3736189306666868,0.05,0.8404047586241933,1.0,1/5,0.34%,NGF
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.5377504424538284,-1.3734183847061698,0.10526315789473684,0.8398377688738529,1.0,19/67,15.83%,DTX1;PRAG1;POFUT1;MAML1;WWP2;JAG2;CCN3;NIBAN2;BEND6;CHAC1;ZMIZ1;ZBTB7A;DLK2;JAG1;NEURL1;LLGL1;TCIM;DLL1;TGFB2
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,0.7754068649056042,1.3731937159825722,0.07142857142857142,1.0,1.0,4/12,13.25%,CCNE2;CDKN1B;CDKN1A;CCNA2
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.6246769484649417,-1.372860339797131,0.16129032258064516,0.8406523072792385,1.0,3/18,8.84%,NGF;NTRK1;RAPGEF1
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,0.6804138475770095,1.3728168417119888,0.06493506493506493,1.0,1.0,7/31,11.00%,PCLAF;POLE2;UBE2L6;TRIM25;POLD4;RPA3;RPS27A
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,0.7024283023025992,1.3726858416813223,0.10294117647058823,1.0,1.0,6/21,11.19%,STAT5A;SYK;HCK;CSF3R;RPS27A;STAT1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.7538900048243015,1.3720376070859814,0.056338028169014086,1.0,1.0,4/16,8.90%,SIX4;JAM2;IGF1;ERVW-1
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.8670839310503018,-1.372014798978907,0.15625,0.8437249641532436,1.0,1/5,0.13%,PER2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.9107061927451578,1.3718171935501369,0.017857142857142856,1.0,1.0,2/5,6.03%,LRP2;CD81
prerank,Reactome_2022__Defective CSF2RA Causes SMDP4 R-HSA-5688890,0.895692407416212,1.37179967891666,0.06779661016949153,1.0,1.0,3/6,5.42%,CSF2RA;SFTPA1;SFTPD
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.8941948649842362,1.3717270133948052,0.08333333333333333,1.0,1.0,1/5,5.31%,WNT5A
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.7919357599919205,1.370833727071773,0.10526315789473684,1.0,1.0,4/11,11.67%,CCL5;POU2F3;REST;HMGA2
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.7251078737873441,1.3707614135986776,0.13114754098360656,1.0,1.0,6/19,16.38%,CCL5;THBS1;CSF1R;MTUS1;MAPK3;CSF1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),-0.8678984966760954,-1.370135759669859,0.1276595744680851,0.8504424148520664,1.0,1/5,4.76%,MTHFR
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.837036601612834,-1.3698463701734513,0.07317073170731707,0.8500395494582976,1.0,2/6,3.82%,SLC6A20;SLC6A17
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.6414917261236622,-1.3697951182254648,0.14705882352941177,0.8482424548693098,1.0,8/29,5.83%,DUSP4;COL4A2;COL12A1;MMP2;DUSP2;LAMA3;COL8A1;ITGA4
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,0.7358547612552172,1.3697215146297137,0.05555555555555555,1.0,1.0,1/22,0.44%,SMAD6
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.6787595470457836,1.3696194412956006,0.09722222222222222,1.0,1.0,10/31,9.25%,SLC22A3;ABCG2;SLCO1A2;SLC17A8;SLC4A1;SLC13A4;ABCC11;SLC22A25;SLC22A6;SLC22A24
prerank,Reactome_2022__Lipophagy R-HSA-9613354,0.8151524228132208,1.3695858882288623,0.07407407407407407,1.0,1.0,1/7,2.45%,HSPA8
prerank,CellMarker_Augmented_2021__Colorectal Stem cell:Colorectum,-0.8561006092919121,-1.3695280239082372,0.14285714285714285,0.8476650034261791,1.0,2/5,11.08%,LGR5;MSI1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.8094933088751978,1.3692099342178796,0.10294117647058823,1.0,1.0,1/9,3.45%,C3
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.783803370110681,-1.3690507380506955,0.08,0.8478454672025827,1.0,2/14,0.57%,ADRA1A;ADRA1B
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,-0.5599007054381901,-1.3689341726507889,0.05263157894736842,0.8464880966573873,1.0,10/37,10.20%,ARC;TPH1;FOS;CHD4;EGR1;VGF;ASCL1;FOSL1;TRIB1;NAB2
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),0.9407720370216941,1.3684952290352488,0.017241379310344827,1.0,1.0,1/5,1.34%,SLC22A3
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),-0.8915067427233343,-1.3684376227921635,0.041666666666666664,0.8475724640818355,1.0,4/6,10.86%,NR4A1;NR4A3;NR1D1;NUPR1
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Brain,0.6283445949382594,1.368403990628035,0.0945945945945946,1.0,1.0,18/54,13.09%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;FGL2;WAS;IKZF1;TAGAP;CD37;CD4;GPR183;ALOX5AP;PSTPIP1;MYO1F
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,-0.5344346295742681,-1.3675467218894761,0.037037037037037035,0.8504815310034001,1.0,11/56,14.48%,NR4A1;CREB3L4;ITPR2;CREB3L1;GNAS;GNA11;SCARB1;ADCY3;ADCY2;CREB3L2;HSD3B2
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.7694915125645718,-1.3674340232753037,0.17142857142857143,0.8487983191040133,1.0,1/8,1.03%,GLYATL1
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.5184146666816801,-1.367008216463339,0.058823529411764705,0.8488247655603167,1.0,3/88,0.54%,IL7R;SYT12;APOB
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.8048592623105084,-1.3667553708774594,0.1,0.8481659794572346,1.0,2/5,16.49%,CRY1;PER1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.6741595496085011,-1.3665326441131633,0.08571428571428572,0.8474805248578321,1.0,10/26,17.94%,PER2;CRY1;ATOH7;OPN5;PER3;FBXL6;PPP1CA;BHLHE40;PER1;CRTC1
prerank,CellMarker_Augmented_2021__Dendritic cell:Bone Marrow,0.6567155201350835,1.3664844815263177,0.056338028169014086,1.0,1.0,18/53,12.45%,ITGB2;CYTIP;ITGAX;GMFG;SASH3;PTPRC;PTAFR;ITGAM;TFEC;CD80;NAPSB;HCK;HLA-DMA;IKZF1;TAGAP;HLA-DPB1;GPR183;ALOX5AP
prerank,CellMarker_Augmented_2021__Vascular Progenitor cell:Blood,0.5972135308284251,1.36640240754974,0.0136986301369863,1.0,1.0,14/84,8.69%,NEK2;CDC25A;KIF14;BUB1;CEP55;CENPU;DTL;POLQ;TICRR;ASPM;NDC80;FOXM1;MCM3;RAD54L
prerank,CellMarker_Augmented_2021__Vascular Stem cell:Blood,0.5972135308284251,1.36640240754974,0.0136986301369863,1.0,1.0,14/84,8.69%,NEK2;CDC25A;KIF14;BUB1;CEP55;CENPU;DTL;POLQ;TICRR;ASPM;NDC80;FOXM1;MCM3;RAD54L
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.6739076731529522,-1.3657584141359989,0.09090909090909091,0.8493777687730855,1.0,10/27,17.94%,PER2;CRY1;ATOH7;OPN5;PER3;FBXL6;PPP1CA;BHLHE40;PER1;CRTC1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.873651729149,1.365743608514007,0.09090909090909091,1.0,1.0,1/7,0.31%,AQP3
prerank,CellMarker_Augmented_2021__Endothelial cell:Antecubital Vein,0.8381714782106774,1.3657125295344887,0.08333333333333333,1.0,1.0,2/5,4.37%,PTPRC;ITGAM
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.8098761493122708,-1.365664569780452,0.09523809523809523,0.848160214157055,1.0,1/6,0.51%,BUD23
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),-0.8384822601283982,-1.3654388291577375,0.1111111111111111,0.8471253383569599,1.0,1/5,1.57%,MIDN
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),-0.8363505331725221,-1.3647032892093374,0.05,0.8483330894157284,1.0,1/5,5.83%,ITGA4
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.7695051471330219,-1.3635136815272326,0.15625,0.852590667042031,1.0,2/12,4.04%,NRDE2;IWS1
prerank,KEGG_2021_Human__Ribosome,0.5753916245119173,1.363423300868848,0.036585365853658534,1.0,1.0,64/122,26.93%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPL13;MRPL20;RPS12;RPS4X;RPL27A;MRPL34;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;MRPS2;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL24;RPL23;MRPL19;RPS15;MRPL28;MRPL10;RPS27;RPL8;RPS3;RPS23;RPS20;RPS18;RPS24;RPL10;RPS29;RPLP1;RPS28;RPL34;RPL36A-HNRNPH2;MRPS12;RPL18
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,-0.6505581545784213,-1.36333959573323,0.0967741935483871,0.8515820755732874,1.0,13/37,23.25%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;PIAS4;NUP98;VHL;SEH1L;PML;NUP50;TPR
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.8837775566791204,1.3629834579152653,0.07462686567164178,1.0,1.0,1/5,3.81%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.7445945591406664,-1.3627189100990589,0.20588235294117646,0.8527421766252008,1.0,3/6,24.99%,HSPA1A;PRKN;LAPTM5
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.8656289846849331,1.3623525918591388,0.09302325581395349,1.0,1.0,1/6,2.21%,ARHGAP24
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.686118536717314,1.3623087724952694,0.06060606060606061,1.0,1.0,5/21,14.41%,AIM2;TRAF3IP2;ZDHHC11;STAT1;IL4
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,-0.44386998530546257,-1.3621631483581418,0.0,0.853342620650251,1.0,24/237,7.23%,DUSP4;SPRED3;SPRED2;ABHD17A;DUSP6;SPRED1;SHC3;CSK;GFRA2;KIT;DUSP2;PPP5C;GPRIN1;FGF18;SPTBN4;ERBB2;KITLG;PTPRA;FGF1;FNTA;TGFA;SPTB;PPP2R5D;MPP2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.7379429245039092,-1.3621309666568837,0.125,0.8515531630367204,1.0,5/15,17.62%,MFSD2A;PLIN5;SCARB1;NR1H2;CTDNEP1
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,0.5893420182458428,1.3616699060457145,0.05128205128205128,1.0,1.0,52/84,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;SEPHS2;RPL23;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24;RPS29;RPLP1;RPS28;RPL34
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.5780104570427665,1.3615139854596279,0.06578947368421052,1.0,1.0,29/150,11.36%,OLFML1;TBX1;CAVIN1;C1QTNF1;STEAP4;TIMP3;TLR2;LMOD1;ACOX2;ADAM33;LOX;AOX1;ECM2;C3;APOL6;ANGPTL2;ADRB1;ACTA2;NQO1;CYP1B1;ADGRL4;CFD;COL6A2;PLAC9;DCN;UCP1;COL1A1;DAB2;ASPN
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.7471347726915895,1.3612335828550686,0.1,1.0,1.0,2/14,5.05%,TBX1;HEY2
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.5499935817027507,-1.3611657682036649,0.21052631578947367,0.8538092061447716,1.0,10/95,8.48%,DUSP4;DUSP6;FOS;NKIRAS2;S100B;ECSIT;PPP2R5D;NOD1;ALPK1;RIPK2
prerank,Reactome_2022__N-Glycan Antennae Elongation R-HSA-975577,-0.6799365242517151,-1.3611164222797842,0.10810810810810811,0.8522586181264229,1.0,4/15,13.20%,MGAT4C;B4GALT2;B4GALT4;ST3GAL4
prerank,Reactome_2022__Chylomicron Clearance R-HSA-8964026,-0.8550445063639458,-1.3610873655182238,0.075,0.8504547776587205,1.0,3/5,4.78%,APOB;LIPC;APOE
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),0.9169201452137262,1.3608317153950116,0.05970149253731343,1.0,1.0,3/5,6.63%,SLC22A3;SLC18A2;SLC6A4
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.8527509632667767,1.3607165794712406,0.019230769230769232,1.0,1.0,1/7,0.46%,ESR1
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),0.9220020412694816,1.3606265108841318,0.03773584905660377,1.0,1.0,2/5,4.18%,SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),0.9220020412694816,1.3606265108841318,0.03773584905660377,1.0,1.0,2/5,4.18%,SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),0.9220020412694816,1.3606265108841318,0.03773584905660377,1.0,1.0,2/5,4.18%,SLC28A1;SLC28A3
prerank,Reactome_2022__CHL1 Interactions R-HSA-447041,0.8724501970387952,1.3606183046178342,0.045454545454545456,1.0,1.0,2/9,5.00%,HSPA8;ITGA2
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),-0.7926810624138192,-1.3605360264710684,0.15384615384615385,0.8516306204055097,1.0,3/6,1.26%,SPRED3;SPRED2;SPRED1
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.5539266183134827,-1.3602207046181491,0.2,0.8472173044602688,1.0,10/91,8.48%,DUSP4;DUSP6;FOS;NKIRAS2;S100B;ECSIT;PPP2R5D;NOD1;ALPK1;RIPK2
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.5539266183134827,-1.3602207046181491,0.2,0.8472173044602688,1.0,10/91,8.48%,DUSP4;DUSP6;FOS;NKIRAS2;S100B;ECSIT;PPP2R5D;NOD1;ALPK1;RIPK2
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.5539266183134827,-1.3602207046181491,0.2,0.8472173044602688,1.0,10/91,8.48%,DUSP4;DUSP6;FOS;NKIRAS2;S100B;ECSIT;PPP2R5D;NOD1;ALPK1;RIPK2
prerank,KEGG_2021_Human__Sulfur relay system,-0.757098859694102,-1.3599932560965935,0.13513513513513514,0.8463597627002211,1.0,3/8,17.73%,TST;NFS1;CTU1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.6708025372444328,1.3598713896654244,0.08333333333333333,1.0,1.0,5/41,3.98%,SMOC1;MAB21L1;SIX4;FREM2;HIPK1
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.7917332621069129,1.3592708679959087,0.05714285714285714,1.0,1.0,1/12,1.29%,RORC
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.8884738790731521,1.3586767485305398,0.13333333333333333,1.0,1.0,3/5,4.37%,C1QB;C3;ITGAM
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreas,-0.7367131963404494,-1.3584339375045493,0.06666666666666667,0.8521534511028314,1.0,2/11,2.11%,RFX6;KLHL41
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.5507471287383805,-1.357913114430035,0.07142857142857142,0.8533098842489003,1.0,15/60,16.44%,NGF;DTX1;VWC2;HES1;ASCL1;PCP4;BEND6;MMD2;CDK5RAP2;NEUROD2;BRINP1;BIN1;IMPACT;DLL1;RHOA
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.7705466925992854,1.3579110967473182,0.046153846153846156,1.0,1.0,3/15,5.05%,SMAD6;TNFRSF1B;HEY2
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.5707941450258777,-1.357714533784861,0.0625,0.8525581688073439,1.0,11/36,21.62%,IFT88;PCM1;KIF17;CLUAP1;TRAF3IP1;DYNC2I1;IFT52;IFT43;IFT81;DYNLRB1;IFT22
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.6713842122383286,1.3576346055850605,0.08571428571428572,1.0,1.0,4/32,5.31%,SMAD6;LRP4;NOTUM;WNT5A
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.8744587249793081,-1.3576289048845664,0.19444444444444445,0.8491134675984635,1.0,2/5,8.94%,SMYD5;KMT5C
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.8744587249793081,-1.3576289048845664,0.19444444444444445,0.8491134675984635,1.0,2/5,8.94%,SMYD5;KMT5C
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.40994134868172116,-1.3575840958403693,0.0,0.8475576621505174,1.0,57/446,10.99%,DUSP4;ARC;NGF;SPRED2;TPH1;DUSP6;SPRED1;PRKCD;CDH5;FOS;SHC3;CSK;PDGFD;CHD4;COL6A3;COL4A2;ITPR2;THEM4;HGFAC;EGR1;KIT;S100B;ADCYAP1;SH2B2;ATP6V0D2;ESRP1;FGF18;APOE;ERBB2;KITLG;RALB;SH3KBP1;ATP6V1E2;FGF1;STAT5B;NANOS3;TGFA;PPP2R5D;NTRK1;VGF;PTPRJ;HSPB1;ASCL1;ANOS1;RAPGEF1;FOSL1;HDAC3;RALGDS;WASF3;ITGA3;TRIB1;ATP6V0A2;NAB2;PTPRS;HNRNPF;SPRY1;PTPRZ1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),0.7733186967681012,1.3575268458406047,0.1076923076923077,1.0,1.0,3/10,10.00%,ENPP2;CYP1B1;PPT1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.7112402578687742,1.3572428048509015,0.015384615384615385,1.0,1.0,2/21,9.64%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.810626901048009,1.3570631118794532,0.07575757575757576,1.0,1.0,3/10,13.99%,SIX4;AGT;SOX9
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.641235847572948,-1.3569986050295606,0.09375,0.8487959565050773,1.0,5/16,14.41%,PNP;PRPSAP1;RRM2B;RRM2;GART
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.8189500097812784,1.3568478057967865,0.03225806451612903,1.0,1.0,4/9,12.41%,APOLD1;TMEM100;VEZF1;BTG1
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.8195932535601781,1.3564227656060845,0.04918032786885246,1.0,1.0,1/9,0.37%,NEK2
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.7951980754140665,1.356245262645471,0.11538461538461539,1.0,1.0,1/11,0.35%,TBX1
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),0.9363375114735952,1.356199222140237,0.06896551724137931,1.0,1.0,2/5,2.83%,TBX1;LRP2
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,0.7660113405565068,1.3561429900538675,0.109375,1.0,1.0,1/14,0.07%,NLRP4
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Stem Cell,0.640087234668257,1.3560760928966435,0.08,1.0,1.0,22/57,15.97%,ITGB2;C3AR1;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;ITGAM;TFEC;FCGR3A;CLEC12A;FLI1;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;PARVG;CD300LF;PIK3CG
prerank,CellMarker_Augmented_2021__Platelet:Bone Marrow,0.640087234668257,1.3560760928966435,0.08,1.0,1.0,22/57,15.97%,ITGB2;C3AR1;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;ITGAM;TFEC;FCGR3A;CLEC12A;FLI1;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;PARVG;CD300LF;PIK3CG
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Umbilical Cord Blood,0.640087234668257,1.3560760928966435,0.08,1.0,1.0,22/57,15.97%,ITGB2;C3AR1;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;ITGAM;TFEC;FCGR3A;CLEC12A;FLI1;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;PARVG;CD300LF;PIK3CG
prerank,CellMarker_Augmented_2021__Endothelial cell:Eye,0.640087234668257,1.3560760928966435,0.08,1.0,1.0,22/57,15.97%,ITGB2;C3AR1;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;ITGAM;TFEC;FCGR3A;CLEC12A;FLI1;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;PARVG;CD300LF;PIK3CG
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),0.76255208897759,1.355983990490929,0.125,1.0,1.0,3/11,16.07%,BUB1;WEE2;BUB1B
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.7778493825353449,1.3556214586820916,0.09523809523809523,1.0,1.0,3/10,13.99%,TBX1;STAT1;SOX9
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.6957888254718486,1.355573992621585,0.1323529411764706,1.0,1.0,6/24,13.07%,FGF2;FLT1;TGFB1;CD81;P2RY12;TNFAIP8L3
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,0.6334051644435897,1.355512953497128,0.06944444444444445,1.0,1.0,1/53,0.07%,NLRP4
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.7885511637551227,-1.3555090854992378,0.13636363636363635,0.8545798485733919,1.0,1/7,3.47%,LIN28B
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.7714345304366871,-1.3552192008373738,0.08571428571428572,0.8543958352730092,1.0,2/5,20.45%,RAB7B;GCC2
prerank,Reactome_2022__Diseases Associated With Surfactant Metabolism R-HSA-5687613,0.8662164485565942,1.3546648415803373,0.06557377049180328,1.0,1.0,3/8,5.42%,CSF2RA;SFTPA1;SFTPD
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.8204877605278502,1.354573773206235,0.09523809523809523,1.0,1.0,3/9,13.99%,SIX4;AGT;SOX9
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.6467172906390599,1.3543015222497885,0.057971014492753624,1.0,1.0,13/34,25.69%,HSPA1L;HSPA8;DNAJB1;DNAJA1;FKBP5;FKBP4;DYNLL1;HSPA2;DCTN3;DCTN1;DYNLL2;HSP90AB1;ACTR10
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Dorsolateral Prefrontal Cortex,-0.503077465402795,-1.3541925544349311,0.08,0.8575410881555902,1.0,19/98,15.20%,SPHKAP;EFR3B;SHC3;CELF5;SLC6A17;ELAVL3;KIAA1549L;FGF1;SRRM4;HPCA;BEND6;NEUROD6;MMD2;GRIA4;ADGRA1;LRRTM3;CELF4;TCEAL6;GABBR2
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.8627658866900628,1.354111004439767,0.05172413793103448,1.0,1.0,3/8,7.90%,NFIL3;PTPRC;AXL
prerank,Reactome_2022__Transport Of RCbl Within Body R-HSA-9758890,0.8232760296620512,1.3537863377829618,0.05970149253731343,1.0,1.0,3/8,10.77%,TCN1;LRP2;LDLRAP1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.8315678330064596,-1.3535788652755372,0.13333333333333333,0.8582445409220572,1.0,2/8,4.21%,ADAMTS1;NR4A3
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.7396360717372794,-1.353314536133342,0.13513513513513514,0.8578031351791643,1.0,4/11,11.43%,PLK3;GBF1;CDK1;STX5
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.7649615855666805,1.3532539081036348,0.0625,1.0,1.0,2/10,11.00%,TLR2;RPS27A
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),-0.7974573345993494,-1.3531037071245922,0.18181818181818182,0.8571691196379365,1.0,2/6,4.78%,APOB;APOE
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.7559430918014698,1.3529809252530145,0.037037037037037035,1.0,1.0,3/15,7.29%,FGF2;FLT1;COL4A3
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,0.7256747969120253,1.352862796145238,0.08333333333333333,1.0,1.0,4/17,8.80%,BLNK;PIK3R3;SYK;HCK
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7237890833584523,1.3528595752528372,0.08196721311475409,1.0,1.0,1/18,1.47%,CASQ2
prerank,CellMarker_Augmented_2021__Immune cell:Undefined,0.7750434309444075,1.3526558980096064,0.06557377049180328,1.0,1.0,6/15,13.63%,ITGB2;LILRB3;PTPRC;ITGAM;CD4;SIRPG
prerank,GO_Biological_Process_2021__pronephros development (GO:0048793),-0.7941779330028695,-1.3524306378390916,0.1956521739130435,0.8591997927409407,1.0,1/6,1.74%,OSR1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.6890883856672143,1.3524262678881729,0.14084507042253522,1.0,1.0,5/24,8.11%,HSPA1L;HSPA8;DNAJB1;SDF2L1;HSPA5
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Placenta,0.810047182566294,1.3520380718005813,0.08928571428571429,1.0,1.0,5/9,16.35%,PTPRC;NT5E;ACTA2;CD44;ENG
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.6150489328511755,-1.3518641757178624,0.1724137931034483,0.8600596197747539,1.0,6/19,14.00%,BUD23;NSUN4;TFB1M;METTL15;ZCCHC4;MRM1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.7155052672373625,-1.3518351352336377,0.10256410256410256,0.8582376385765643,1.0,4/15,17.40%,TENT4A;AGO2;TNRC6C;TNRC6A
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.8494564790227761,1.3517710886633587,0.09523809523809523,1.0,1.0,2/9,4.27%,RORC;TGFB1
prerank,CellMarker_Augmented_2021__Neutrophil:Brain,0.6550621845749461,1.3513911978051811,0.07692307692307693,1.0,1.0,17/44,15.35%,RASGRP4;C19ORF38;CLEC5A;OSCAR;ARHGAP9;ITGAM;NFAM1;CLEC12A;HCK;CSF3R;HK3;MYO1F;ELANE;P2RX1;PARVG;CD300LF;PIK3R6
prerank,CellMarker_Augmented_2021__Neutrophil:Spleen,0.6550621845749461,1.3513911978051811,0.07692307692307693,1.0,1.0,17/44,15.35%,RASGRP4;C19ORF38;CLEC5A;OSCAR;ARHGAP9;ITGAM;NFAM1;CLEC12A;HCK;CSF3R;HK3;MYO1F;ELANE;P2RX1;PARVG;CD300LF;PIK3R6
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.7397686743121855,-1.3513549900130204,0.09090909090909091,0.8591509403428454,1.0,4/15,12.06%,NLGN3;CACNG4;NLGN2;CACNG2
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.5264548001818714,-1.351209742222956,0.10526315789473684,0.8579435129335086,1.0,9/113,5.34%,RFX6;CNGA3;SLC38A5;ARX;KLHL41;GPC6;ADCYAP1;CFC1;ABCC8
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,-0.6287625419169465,-1.3510964746388834,0.12903225806451613,0.8567686778691191,1.0,1/18,0.07%,IL7R
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.7103582183905326,1.3510556376754201,0.0967741935483871,1.0,1.0,1/14,0.25%,NRAP
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.7029436546025918,1.3510154202494136,0.09230769230769231,1.0,1.0,3/20,7.73%,SLC12A7;SLC12A3;ATP1A4
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.7994518750954649,1.3507281341572508,0.05970149253731343,1.0,1.0,2/14,4.93%,ACAA2;BOK
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.6607218491576653,1.350593411213862,0.09210526315789473,1.0,1.0,4/25,9.22%,GATA4;REST;SOD2;PINK1
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,-0.5579260717243647,-1.3505083837711014,0.047619047619047616,0.8580077566221981,1.0,21/87,13.53%,SYT12;SLITRK6;NLGN3;GPRIN1;SHANK1;DLGAP4;PTPRF;PPFIBP2;MPP2;SLITRK2;NLGN2;EPB41L5;PTPRS;GRIA4;SHARPIN;LRFN4;DLGAP1;NRXN2;LLGL1;LRRTM3;DBNL
prerank,Reactome_2022__NOTCH2 Intracellular Domain Regulates Transcription R-HSA-2197563,-0.7057588241395921,-1.3504458983068044,0.08571428571428572,0.8565919431809796,1.0,3/11,10.63%,MAML1;GATD3;MAMLD1
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,0.5729546147299327,1.3498413937509486,0.024691358024691357,1.0,1.0,56/108,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;EIF1AX;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;EIF3G;RPL27;RPS14;RPL7A;RPL23;EIF4A2;RPS15;EIF2B2;RPS27;RPL8;EIF2B5;RPS3;RPS23;RPS20;RPS24;RPS29;RPLP1;RPS28;RPL34
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,-0.6331308636880261,-1.3493503408784566,0.19230769230769232,0.8600612646341563,1.0,11/34,23.43%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;NUP98;SEH1L;NUP50;TPR;ALYREF
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.5783240425483293,1.3492898240232203,0.03614457831325301,1.0,1.0,27/105,15.08%,AMBP;MICB;ITGB2;OSCAR;CD160;AHR;C3;C17ORF99;FCGR3A;GPR151;SFTPD;HLA-F;SH2D1B;CD81;SYK;CD99;LAIR2;IRF1;HLA-A;COL1A1;TNFSF4;COLEC12;KLRB1;ADCY7;IL4;CRTAM;CD300LF
prerank,Reactome_2022__Phase 1 - Inactivation Of Fast Na+ Channels R-HSA-5576894,-0.7667324129227071,-1.3491514357025727,0.1875,0.8590278986410382,1.0,2/7,7.63%,KCNIP3;KCNIP1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.7190217651861875,-1.3490664529786935,0.15625,0.8577003354876733,1.0,2/14,0.57%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.684424573732066,-1.3488875197880132,0.1702127659574468,0.8568388214709951,1.0,3/11,5.74%,PAH;RGN;FADS1
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,0.6590154220428249,1.3486665342488962,0.10666666666666667,1.0,1.0,8/26,17.66%,GML;HSPA1L;DNAJB1;COL4A6;RPA3;EEF1A1;FKBP4;HSPH1
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.8176901614873036,1.3486129596888399,0.13559322033898305,1.0,1.0,2/5,17.12%,OTUD4;STPG4
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.8176901614873036,1.3486129596888399,0.13559322033898305,1.0,1.0,2/5,17.12%,OTUD4;STPG4
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),-0.7389058264853432,-1.3485278289156817,0.16216216216216217,0.856926919495613,1.0,3/7,4.78%,APOB;LIPC;APOE
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.6306630785092471,1.3484906651902078,0.10526315789473684,1.0,1.0,6/49,10.77%,ITGB2;TGFB1;CD81;SYK;RAMP3;LDLRAP1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5824034587009604,1.348347686106485,0.06172839506172839,1.0,1.0,54/104,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPL13;RPS12;RPS4X;RPL27A;RPS19;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL24;RPL23;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS18;RPS24;NCBP1;RPL10;RPS29;RPLP1;RPS28;RPL34
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.5355614067173672,-1.348326569555843,0.09090909090909091,0.8561245928093102,1.0,2/33,0.51%,RFX6;GCK
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.607175851870838,-1.3478624064165714,0.11538461538461539,0.8565367964607877,1.0,1/41,0.07%,IL7R
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,-0.5675767617630683,-1.3478488450537713,0.0625,0.854852312473352,1.0,10/98,8.48%,DUSP4;DUSP6;FOS;NKIRAS2;S100B;SARM1;PPP2R5D;NOD1;ALPK1;RIPK2
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.7660493385273668,1.347777833366122,0.06153846153846154,1.0,1.0,4/15,6.66%,TNFRSF1B;AHR;IL12A;IL27
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.6173567098087389,1.3466584504063237,0.04054054054054054,1.0,1.0,21/55,21.71%,ACE2;BCO1;FOXA3;FLI1;MISP;CLCA1;HSD11B2;NR1H4;CD99;VIL1;HNF4G;PIEZO2;EPCAM;KRT8;MOGAT2;AGR2;NOS2;SLC44A3;CBLC;B3GNT3;LGALS4
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),-0.7361850492296698,-1.3464407091040318,0.2,0.859580641916711,1.0,2/7,15.25%,CDK6;DLL1
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),0.778205790241811,1.3462475183253177,0.0625,1.0,1.0,1/14,1.06%,BLK
prerank,Reactome_2022__Abacavir Transmembrane Transport R-HSA-2161517,0.9173313071733564,1.3462369606446627,0.06557377049180328,1.0,1.0,2/5,4.64%,SLC22A3;ABCG2
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.8181919875046075,1.3462212171840624,0.06779661016949153,1.0,1.0,3/7,15.53%,BLK;AXL;CXCL12
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex2:Brain,-0.7526523156500082,-1.3461628195335542,0.14705882352941177,0.8589934454080276,1.0,2/10,2.14%,PCED1B;PAH
prerank,CellMarker_Augmented_2021__Thymic Emigrant cell:Blood,0.6133887598561362,1.345904454477106,0.1038961038961039,1.0,1.0,20/55,16.42%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;ITGAM;FCGR3A;IKZF1;TAGAP;CD37;GPR183;ALOX5AP;PSTPIP1;MYO1F;PARVG;PIK3CG;CD244
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.7982800949431917,1.3458887015899066,0.06349206349206349,1.0,1.0,3/12,5.72%,GATA4;HEY2;MESP1
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.8340521346645043,-1.3457418210577174,0.06666666666666667,0.8592894928897106,1.0,4/7,11.43%,PLK3;GBF1;CDK1;STX5
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.6654206103539206,-1.3457331428066623,0.10256410256410256,0.8575333702127955,1.0,1/14,1.42%,SEC24C
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.868203463061166,1.3455255952636251,0.034482758620689655,1.0,1.0,1/6,2.57%,PTX3
prerank,CellMarker_Augmented_2021__Hemangioblast:Germ,-0.7991604142151056,-1.3451930059073167,0.10810810810810811,0.8590539159565842,1.0,1/9,1.80%,CDH5
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.8262092765669768,1.3448149121222792,0.08064516129032258,1.0,1.0,4/7,14.33%,CCL5;SFTPD;TAFA4;EDNRB
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.7797229654652604,-1.344774500203386,0.12195121951219512,0.8589501203551202,1.0,2/8,10.78%,ZNF703;GPX1
prerank,CellMarker_Augmented_2021__Dendritic cell:Blood,0.6546638226642373,1.3444427282836289,0.05555555555555555,1.0,1.0,20/53,15.35%,ITGB2;C3AR1;CYTIP;ARHGAP9;ITGAX;GMFG;SASH3;PTPRC;ITGAM;TFEC;NFAM1;CLEC12A;HCK;TAGAP;IGSF6;GPR183;ALOX5AP;PARVG;CD300LF;PIK3R6
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.7083157182369131,-1.3443418003622358,0.20588235294117646,0.8575286569160678,1.0,3/10,21.09%,ASCC2;ALKBH3;MGMT
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.7083157182369131,-1.3443418003622358,0.20588235294117646,0.8575286569160678,1.0,3/10,21.09%,ASCC2;ALKBH3;MGMT
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.7863604140204744,1.3437459250781012,0.06060606060606061,1.0,1.0,2/8,2.81%,BACE2;ITM2A
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.710369612264634,1.3437028149440078,0.07575757575757576,1.0,1.0,5/18,7.24%,ITGB2;TRIL;ITGAM;SCIMP;NR1H4
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7515956127984282,1.3436897107385812,0.1044776119402985,1.0,1.0,2/11,8.95%,BOK;TP53BP2
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.5407939646701723,-1.3436697788944392,0.10714285714285714,0.8591421718195857,1.0,9/65,12.09%,ARC;TST;MAGOHB;POM121C;NUP214;SRRM1;SRSF4;NXF5;U2AF2
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.659478838522432,-1.3435457015509982,0.16279069767441862,0.8582498025460804,1.0,3/16,12.55%,NRDE2;AGO2;TERT
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.7515902781484676,-1.3423565941406668,0.19444444444444445,0.8620606063746705,1.0,6/13,18.80%,SMPD3;RAB7A;SNF8;SDCBP;SDC4;TSG101
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.7972363181486019,1.3422902894713333,0.12121212121212122,1.0,1.0,3/12,11.48%,TBX1;ROGDI;WNT6
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),-0.7907892481880909,-1.3419888620450218,0.14634146341463414,0.861978146376895,1.0,1/6,2.39%,TIE1
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.7465183622190984,1.3417441969286692,0.1038961038961039,1.0,1.0,5/18,11.70%,SGO1;SYCP1;IHO1;MEIOB;RNF212B
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,-0.5868167566778744,-1.3417109953725717,0.17073170731707318,0.8614776642164501,1.0,3/31,4.78%,APOB;LIPC;APOE
prerank,CellMarker_Augmented_2021__Adventitial cell:Skeletal Muscle,0.6136562406944454,1.3416745205135396,0.05333333333333334,1.0,1.0,23/68,14.40%,C1QB;C3AR1;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;TFEC;FCGR3A;VSIG4;FLI1;FGL2;HCK;CSF3R;IKZF1;TAGAP;HLA-DPB1;CD4;MYO1F;CSF1R;EVI2A;PARVG
prerank,CellMarker_Augmented_2021__Dendritic cell:Peripheral Blood,0.8384258226667599,1.3415632549170071,0.045454545454545456,1.0,1.0,3/7,6.90%,ITGAX;CLEC4C;CD80
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),0.8413483437263325,1.34146199364448,0.03333333333333333,1.0,1.0,2/7,1.93%,SGO1;BUB1
prerank,KEGG_2021_Human__Cellular senescence,0.5530313597792963,1.3413596204363243,0.04,1.0,1.0,18/139,10.71%,GATA4;CDC25A;SLC25A31;RRAS;PIK3R3;HIPK4;HIPK1;TGFB1;TRAF3IP2;HLA-F;RAD1;CDKN2A;FOXM1;CCND2;CCND1;HLA-A;TGFB3;CCNE2
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.7180582753746664,1.341143095076298,0.1527777777777778,1.0,1.0,4/26,7.52%,GATA4;TBX1;HEY2;WNT8A
prerank,Reactome_2022__Platelet Adhesion To Exposed Collagen R-HSA-75892,0.7971922199658863,1.3411082337860063,0.1,1.0,1.0,3/9,10.33%,GP1BA;ITGA2;VWF
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),-0.769623121458562,-1.341067042301126,0.1111111111111111,0.8629362840083803,1.0,2/9,5.62%,CRLS1;CPNE6
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.7423453944722898,-1.3409230767884566,0.06060606060606061,0.8618890213443656,1.0,5/18,11.59%,NDST3;XYLT1;HS6ST2;CSGALNACT1;B3GAT3
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.8220216369995957,1.3407869610949907,0.09375,1.0,1.0,1/6,3.00%,OLAH
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.6079081987493732,-1.3406717730683477,0.15625,0.8613397817877276,1.0,9/30,10.13%,SYNJ2;WNT3A;NLGN3;WNT7A;PLD2;SNCB;RAB5A;NLGN2;CEL
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.762905074375711,1.3404263032568695,0.11940298507462686,1.0,1.0,4/14,14.41%,GPR55;LILRB3;GPR137B;IL4
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.796948942423316,1.340066427757686,0.11940298507462686,1.0,1.0,3/10,2.25%,TNFRSF1B;MYRF;ITGAX
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Blood,0.6124413918574532,1.3395900475509361,0.10810810810810811,1.0,1.0,21/54,16.42%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;GMFG;SASH3;PTPRC;ITGAM;FCGR3A;WAS;IKZF1;TAGAP;CD37;CD4;GPR183;ALOX5AP;PSTPIP1;MYO1F;PARVG;PIK3CG;CD244
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.8548002992064674,1.3394443707943944,0.06153846153846154,1.0,1.0,3/6,13.61%,C1QB;CD81;IGLL1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.7397611245832116,1.3394187346811408,0.09836065573770492,1.0,1.0,5/17,16.38%,CCL5;THBS1;CSF1R;MAPK3;CSF1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.7237868344614438,-1.339354001221262,0.10344827586206896,0.8657984259969964,1.0,7/18,18.96%,NPTX2;DLGAP4;SLC8A3;HTR2C;DLGAP1;DLGAP3;AKAP9
prerank,CellMarker_Augmented_2021__CD14++CD16- monocyte:Blood,0.6624422644241472,1.3393088031251514,0.136986301369863,1.0,1.0,20/40,15.08%,C3AR1;TLR2;ITGAX;LILRB3;PTAFR;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;FPR1;ADGRE3;CD300LF
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Blood,0.6624422644241472,1.3393088031251514,0.136986301369863,1.0,1.0,20/40,15.08%,C3AR1;TLR2;ITGAX;LILRB3;PTAFR;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;FPR1;ADGRE3;CD300LF
prerank,CellMarker_Augmented_2021__Classical monocyte:Blood,0.6624422644241472,1.3393088031251514,0.136986301369863,1.0,1.0,20/40,15.08%,C3AR1;TLR2;ITGAX;LILRB3;PTAFR;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;FPR1;ADGRE3;CD300LF
prerank,CellMarker_Augmented_2021__Intermediate monocyte:Blood,0.6624422644241472,1.3393088031251514,0.136986301369863,1.0,1.0,20/40,15.08%,C3AR1;TLR2;ITGAX;LILRB3;PTAFR;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;FPR1;ADGRE3;CD300LF
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.6614382975571361,1.3392938410298325,0.09523809523809523,1.0,1.0,4/27,9.22%,ACAA2;IGF1;HGF;PINK1
prerank,Reactome_2022__Abacavir ADME R-HSA-2161522,0.9015979739209845,1.3391047961407698,0.046153846153846156,1.0,1.0,2/7,4.64%,SLC22A3;ABCG2
prerank,GO_Biological_Process_2021__regulation of myoblast proliferation (GO:2000291),-0.8077716728102153,-1.3390923396653545,0.15555555555555556,0.8651917516605749,1.0,2/5,6.35%,KLHL41;MEGF10
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.7166091837977997,1.3390097354801882,0.06349206349206349,1.0,1.0,2/25,0.80%,LRP4;ITGB2
prerank,Reactome_2022__IRF3-mediated Induction Of Type I IFN R-HSA-3270619,0.7676261065489496,1.3389276392095237,0.12121212121212122,1.0,1.0,1/12,0.07%,NLRP4
prerank,CellMarker_Augmented_2021__Stem cell:Bone,0.81988143927216,1.338632385441493,0.09803921568627451,1.0,1.0,3/7,16.35%,PTPRC;NT5E;ENG
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.7035486232330019,1.3383877459066764,0.12307692307692308,1.0,1.0,7/17,23.72%,BORA;GPSM2;ANKRD53;RAE1;TACC3;DCTN1;PSRC1
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Endometrium,0.621146210435333,1.338242040232137,0.11267605633802817,1.0,1.0,12/44,8.44%,APOL1;TCN1;ACSL5;TAPBPL;CYP4F12;CIDEB;APOL6;TMEM45B;HLA-F;HSH2D;C4BPA;IRF1
prerank,CellMarker_Augmented_2021__Trophoblast cell:Endometrium,0.621146210435333,1.338242040232137,0.11267605633802817,1.0,1.0,12/44,8.44%,APOL1;TCN1;ACSL5;TAPBPL;CYP4F12;CIDEB;APOL6;TMEM45B;HLA-F;HSH2D;C4BPA;IRF1
prerank,CellMarker_Augmented_2021__Monocyte:Bone Marrow,0.671520825281727,1.3382304486392516,0.1111111111111111,1.0,1.0,20/43,15.08%,ITGB2;C3AR1;TLR2;ITGAX;LILRB3;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;FPR1;ADGRE3;CD300LF
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.7181956447746463,-1.3380501795566324,0.18181818181818182,0.8692113957488025,1.0,1/7,1.25%,EMP1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.7075740308052163,1.337749300461145,0.20833333333333334,1.0,1.0,2/19,3.49%,MCUB;STOML2
prerank,Reactome_2022__Activation Of SMO R-HSA-5635838,-0.7568483233681536,-1.3368954062641711,0.075,0.8724672811943415,1.0,2/15,2.59%,BOC;PTCH1
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Placenta,0.5701145390241004,1.3368166205519196,0.10975609756097561,1.0,1.0,25/76,15.72%,OLFML1;CASQ2;LMOD1;ADAM33;LYVE1;ABI3BP;MYH11;INMT;JAM2;DAAM2;OGN;GGT5;PGM5;RAMP3;ACTA2;ADGRL4;DCN;ASPN;PLN;NEXN;FILIP1L;MASP1;CXCL12;ELN;MYL9
prerank,CellMarker_Augmented_2021__Dendritic cell:Placenta,0.6325387756683989,1.3367666808887324,0.136986301369863,1.0,1.0,21/56,15.08%,ITGB2;C3AR1;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;ITGAM;FCGR3A;WAS;HCK;IKZF1;TAGAP;HK3;GPR183;ALOX5AP;MYO1F;PARVG;CD300LF
prerank,Reactome_2022__TNF Signaling R-HSA-75893,-0.5297314778339065,-1.3367554648500524,0.10810810810810811,0.8714906952169961,1.0,6/41,10.58%,SMPD3;CFLAR;CLIP3;USP4;NSMAF;SHARPIN
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.6749645406265321,1.3363289454877212,0.03896103896103896,1.0,1.0,8/27,12.65%,NRAP;ALPK2;HEY2;MYH11;CAV3;IGF1;CHRNB1;SGCZ
prerank,CellMarker_Augmented_2021__Epithelial cell:Endometrium,0.6370386021809114,1.3362610100247037,0.1232876712328767,1.0,1.0,20/61,17.14%,RASGRP4;TMEM150B;OSCAR;TNFRSF1B;SLC7A7;TFEC;CLEC12A;TLDC2;PLAUR;CASP10;MYO1F;P2RX1;ADCY7;CYBA;CD300LF;KCNE3;FERMT3;PIK3CG;CD244;SERPINB1
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),0.8208634646249806,1.3361286735940978,0.07547169811320754,1.0,1.0,2/7,5.77%,TBX1;MYO3B
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.6320958868318526,1.335999381412189,0.08333333333333333,1.0,1.0,6/40,10.77%,ITGB2;CAV3;CD81;SYK;RAMP3;LDLRAP1
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,-0.634331660022946,-1.3359817261685603,0.19230769230769232,0.874112757116218,1.0,11/33,23.43%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;NUP98;SEH1L;NUP50;TPR;ALYREF
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.6372848510067076,-1.3355016219922713,0.13333333333333333,0.8750586958739635,1.0,4/26,4.61%,PM20D1;ACER2;DDAH2;ACER3
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.5319468625791242,-1.3351938141740674,0.05263157894736842,0.87479886785781,1.0,10/70,8.62%,ADGRF4;NIPAL1;CLDN4;ANXA8;HOPX;PHLDA2;PERP;GPRC5A;CDCP1;SERPINE1
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.5027455312193759,-1.3351204521705953,0.1111111111111111,0.8736212239407288,1.0,7/73,11.71%,KIFC1;KIF2B;KDELR1;KIF15;KIF4B;KIFC2;KIF1C
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.8446918597180276,-1.334858518533153,0.16326530612244897,0.873441697940082,1.0,2/6,9.59%,BNIP2;BNIPL
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.6182290738066986,1.3343005179161724,0.07042253521126761,1.0,1.0,14/33,20.30%,SLC16A8;SLC10A1;SLCO1A2;ABCC2;SLC51A;NR1H4;ABCC11;SLCO2B1;GHRL;ABCG5;SLC16A1;SLC10A5;CEACAM1;STARD5
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.6106740061818919,1.3339203461483757,0.11940298507462686,1.0,1.0,20/59,19.51%,MICB;ADA;PTPRC;IFNK;LCP1;NLRC3;TNFSF4;F2RL1;CD4;ITK;IL4;CD44;CRTAM;PIK3CG;ZAP70;MSN;RASGRP1;CD8B;IRF4;RAB29
prerank,CellMarker_Augmented_2021__Urothelium cell:Undefined,0.6497968545572992,1.3335066541397922,0.11688311688311688,1.0,1.0,18/38,15.08%,DENND1C;C19ORF38;TMEM150B;OSCAR;FRAT1;NFAM1;CLEC12A;HSH2D;NAPSB;HCK;CSF3R;CFD;HK3;ASGR2;FPR1;UPK3A;ADGRE3;CD300LF
prerank,Reactome_2022__Metabolism Of Angiotensinogen To Angiotensins R-HSA-2022377,0.7878849910256657,1.3334636914178808,0.15,1.0,1.0,5/10,19.58%,ACE2;ANPEP;CPB2;ATP6AP2;CTSZ
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.809890267345263,1.3334596900972318,0.14925373134328357,1.0,1.0,2/6,2.81%,BACE2;ITM2A
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.6825748297479555,-1.333433255225941,0.07692307692307693,0.8780931579773796,1.0,9/17,23.09%,ERBB2;FLNA;SIRT7;EIF2AK3;WDR75;DHX33;BNC1;UBTF;WDR43
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.7748163794244769,1.3333741215014054,0.0967741935483871,1.0,1.0,2/13,3.49%,TULP1;RP1
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.6563431897668427,1.3333691000998262,0.08433734939759036,1.0,1.0,8/33,10.68%,C1QB;C3AR1;C3;CD81;CPB2;C4BPA;C4BPB;VTN
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.7567039681081239,-1.3331603146614206,0.14705882352941177,0.877448803104925,1.0,5/10,18.96%,NPTX2;DLGAP4;DLGAP1;DLGAP3;AKAP9
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Bone Marrow,-0.5494501547082044,-1.3330896498863272,0.16129032258064516,0.8760473236392669,1.0,6/39,8.19%,IL7R;CD38;KIT;KITLG;STAT5B;CDCP1
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Undefined,0.7682166446085626,1.3330706030402015,0.1,1.0,1.0,8/13,19.80%,STAT5A;IL5;CD4;IL4;IL17RB;MAF;IRF4;IL1R1
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),0.8188803540465188,1.3326610461026762,0.05714285714285714,1.0,1.0,1/9,3.49%,STOML2
prerank,"Reactome_2022__Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",0.7085202879017044,1.3321872512846789,0.10256410256410256,1.0,1.0,5/18,13.35%,TCN1;LRP2;LDLRAP1;AMN;CBLIF
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.8071895259935336,-1.3321782505110213,0.15789473684210525,0.8785685787494154,1.0,3/7,13.82%,SMYD5;PRDM15;ESRRB
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),0.8315130971610739,1.3321331397765734,0.12307692307692308,1.0,1.0,3/7,15.14%,NPR2;NPPA;GUCY2F
prerank,CellMarker_Augmented_2021__Osteogenic Precursor-Like cell:Dermis,-0.5015490356974475,-1.3321094939586213,0.19230769230769232,0.8770695152617932,1.0,22/99,18.10%,PDE10A;MYO10;MLF1;KIAA1549;ZFHX4;CAP2;EML1;RASSF8;RNF150;RPGRIP1L;NFIB;NOVA1;NEUROD2;KCTD1;NME5;DNAH5;OSBPL6;TGFB2;ARNT2;DDAH1;IFT81;PCDH7
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.661150991455529,1.3313489328123034,0.04938271604938271,1.0,1.0,8/31,10.68%,C1QB;C3AR1;C3;CD81;CPB2;C4BPA;C4BPB;VTN
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.718108537502552,-1.331219687241176,0.09090909090909091,0.880485116160875,1.0,10/21,21.69%,NDST3;XYLT1;HS6ST2;B3GAT3;SULF2;GPC1;EXT1;EXT2;HS6ST3;SGSH
prerank,Reactome_2022__Wax And Plasmalogen Biosynthesis R-HSA-8848584,-0.7802620430801788,-1.3310303800861436,0.11764705882352941,0.8796665172137871,1.0,2/7,15.64%,DHRS7B;AWAT2
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.6807932242442188,1.3310006197184054,0.058823529411764705,1.0,1.0,2/26,4.24%,MCUB;CASR
prerank,CellMarker_Augmented_2021__Pyramidal cell:Undefined,-0.7378147511818087,-1.3309727322470744,0.125,0.8781740928902243,1.0,1/12,0.23%,POU3F1
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.6020915913820679,-1.3308679562312231,0.15384615384615385,0.8767875911770197,1.0,10/53,8.67%,ADGRF4;CLDN4;WWC1;DSG2;LAMA3;ESRP1;ADGRG6;PERP;GPRC5A;ITGB4
prerank,Reactome_2022__Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.672508881839476,-1.3308375307683062,0.21875,0.8752066655387047,1.0,2/15,6.66%,DDAH2;NANOS3
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.7597871555940213,1.3303840926816297,0.07936507936507936,1.0,1.0,3/11,7.69%,MCM2;MCMDC2;MCM3
prerank,Reactome_2022__Passive Transport By Aquaporins R-HSA-432047,0.8235562720318512,1.3299437878807083,0.1875,1.0,1.0,1/6,0.31%,AQP3
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.6364812012355359,-1.3299431708804785,0.2,0.8781190741183917,1.0,2/18,4.83%,BCL2;NLRP1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.685516887036944,1.329867017323521,0.08571428571428572,1.0,1.0,6/24,7.33%,ITGB2;PKP2;ITGAX;RNASE10;IZUMO1;ITGA5
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.7445600032259679,1.3296824899120994,0.11764705882352941,1.0,1.0,1/11,1.34%,SLC22A3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.7834660833088902,-1.3296135490606835,0.12,0.8776862009000391,1.0,2/11,4.21%,ADAMTS1;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.7602314722634101,1.3295974536701598,0.1111111111111111,1.0,1.0,5/13,16.38%,CCL5;THBS1;CSF1R;MAPK3;CSF1
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Peripheral Blood,-0.5730820516995538,-1.3285561242517514,0.10714285714285714,0.8807812062851658,1.0,1/27,0.07%,IL7R
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.8553212031665213,1.3280611471785715,0.06557377049180328,1.0,1.0,3/9,6.49%,GATA4;HEY2;DAND5
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.6305589452608599,1.3280211169883198,0.09523809523809523,1.0,1.0,7/23,11.37%,SLC25A31;SGO1;SYCP3;MEIOB;TDRD9;MEIOC;BRDT
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.5803405750372667,1.3277713251105807,0.09333333333333334,1.0,1.0,10/76,7.24%,ITGB2;MAPKAPK3;TLR2;TRIL;SFTPA1;ITGAM;SCIMP;SFTPD;SCARA3;NR1H4
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.6833841095566785,-1.3276705708748027,0.11627906976744186,0.8832942187147851,1.0,6/14,23.22%,B4GALNT1;ST3GAL2;ST3GAL5;ST6GALNAC3;ST6GALNAC5;ST8SIA3
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.5805961006361411,-1.3276261686537614,0.12903225806451613,0.881790196907884,1.0,2/24,5.09%,PER2;GYS1
prerank,Reactome_2022__p75NTR Regulates Axonogenesis R-HSA-193697,-0.7844296299030482,-1.327482547019715,0.09090909090909091,0.8812548369964877,1.0,1/8,0.34%,NGF
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.7942315801739506,-1.3274002265497193,0.15,0.8799083537712217,1.0,2/8,3.46%,IL11;KIT
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.5049410271632497,-1.3272352414039623,0.0625,0.8790589207735097,1.0,22/74,18.94%,SLITRK6;S100B;WNT7A;SPTBN4;DHFR;PARD3;RTN4RL2;EPHB2;SLITRK2;FGFR2;TAOK2;LLGL1;MARK2;DSCAML1;PARD6B;CDK5;PAK3;MTR;ARHGAP35;BRSK1;AFG3L2;RAB10
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.677811950798292,1.327110691158385,0.09722222222222222,1.0,1.0,2/24,1.82%,LRP4;SMOC1
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,-0.4398923100196328,-1.3268845992893903,0.0,0.8791455425471697,1.0,24/242,7.23%,DUSP4;SPRED3;SPRED2;ABHD17A;DUSP6;SPRED1;SHC3;CSK;GFRA2;KIT;DUSP2;PPP5C;GPRIN1;FGF18;SPTBN4;ERBB2;KITLG;PTPRA;FGF1;FNTA;TGFA;SPTB;PPP2R5D;MPP2
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),0.8782378660834737,1.3263319208002506,0.07272727272727272,1.0,1.0,1/7,0.31%,AQP3
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.7697764770104973,1.3262623466995804,0.11428571428571428,1.0,1.0,4/16,12.89%,SLC9A2;SLC5A2;SLC9C1;SLC5A1
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.6371380689613955,-1.3260724499089092,0.15384615384615385,0.8808243786844445,1.0,2/13,7.28%,NGF;NTRK1
prerank,Reactome_2022__Downregulation Of ERBB4 Signaling R-HSA-1253288,0.7726343275966314,1.3255104203820174,0.0967741935483871,1.0,1.0,2/9,11.00%,ERBB4;RPS27A
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.753713359858423,-1.3254183582842953,0.1935483870967742,0.8824479112074184,1.0,3/14,5.01%,OSR1;TWIST1;WNT7A
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.7360582034882791,-1.3254056797473472,0.13157894736842105,0.8808922912490073,1.0,3/13,9.26%,PTCD2;IWS1;SAFB2
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,-0.6331136536591768,-1.3253300634670873,0.20689655172413793,0.8796836320430624,1.0,13/34,23.91%,NUP210;NUP42;POM121C;NUP214;CDK1;AAAS;NUP37;NUP98;NEK9;SEH1L;NUP50;TPR;NEK6
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),0.7295551234635268,1.3250509671530077,0.15873015873015872,1.0,1.0,2/9,6.12%,AQP3;SLC26A6
prerank,Reactome_2022__NF-kB Is Activated And Signals Survival R-HSA-209560,-0.7358545323577265,-1.3249413897828959,0.14285714285714285,0.8798168805309183,1.0,1/12,0.34%,NGF
prerank,CellMarker_Augmented_2021__Delta cell:Pancreas,-0.6738329957864128,-1.3248675162140877,0.18181818181818182,0.8785177473715962,1.0,3/16,1.74%,POU3F1;EHF;ETV1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.5262473641115231,-1.3248605608934525,0.0967741935483871,0.8769328366932533,1.0,13/54,15.25%,PACSIN2;CDH13;CD151;APOE;CLIP3;LRSAM1;RAB5A;PACSIN3;HIP1;SNX33;RUBCN;RUFY1;DLL1
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),0.7398558155390706,1.32482355825248,0.16129032258064516,1.0,1.0,2/12,14.79%,NDC80;NUF2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.6763679474007268,1.3247552846193735,0.14084507042253522,1.0,1.0,3/21,5.56%,TULP1;JCHAIN;ACTG1
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.8014414719874948,1.3246583297653711,0.11864406779661017,1.0,1.0,2/7,11.00%,TLR2;RPS27A
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.8014414719874948,1.3246583297653711,0.11864406779661017,1.0,1.0,2/7,11.00%,TLR2;RPS27A
prerank,Reactome_2022__Modulation By Mtb Of Host Immune System R-HSA-9637628,0.8014414719874948,1.3246583297653711,0.11864406779661017,1.0,1.0,2/7,11.00%,TLR2;RPS27A
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Retina,-0.5211211354087012,-1.3242821135289067,0.11538461538461539,0.8780134433580115,1.0,23/94,14.81%,CBARP;TBC1D16;P3H4;GPRIN1;RHBDF1;KIAA1549L;B4GALT2;MPP2;AGRN;VGF;B4GALNT1;NCS1;GPR161;FGD1;FSCN1;NLGN2;SRRM3;AMOTL2;NAT14;CHST3;RCOR2;GTF2IRD1;GPC1
prerank,GO_Biological_Process_2021__regulation of T-helper 1 cell differentiation (GO:0045625),0.8775874699711008,1.324152265736517,0.0967741935483871,1.0,1.0,4/5,11.63%,ANXA1;IL27;CD80;TNFSF4
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.5484469200739366,-1.3240778599285878,0.07692307692307693,0.877400729352668,1.0,14/50,23.41%,GLUD2;CARM1;TFB1M;PPARGC1B;HDAC3;NR1D1;IDH2;GLUD1;SMARCD3;CRTC1;ALAS1;ATP5F1B;CREBBP;ACSS2
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,0.5936749606741296,1.323881447135055,0.13793103448275862,1.0,1.0,15/54,15.08%,MICB;ITGB2;OSCAR;CD160;C3;HLA-F;SH2D1B;CD81;CD99;LAIR2;HLA-A;COLEC12;KLRB1;CRTAM;CD300LF
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.769722753785441,1.3238144552470377,0.12121212121212122,1.0,1.0,4/12,11.63%,CD81;SYK;HLA-A;TNFSF4
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,0.6466345112070396,1.3237351026362543,0.058823529411764705,1.0,1.0,7/29,17.38%,PIK3R3;SYK;RHOB;RHOG;PIK3R6;PIK3CG;VAV3
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.7525603026133216,1.3237076986960152,0.06896551724137931,1.0,1.0,4/16,15.08%,MCM2;MCMDC2;RECQL4;HMGA1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.8056580177885732,-1.3236745892180308,0.13157894736842105,0.8776333589112887,1.0,1/8,3.43%,FOXO1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8173754971009848,-1.3235069217547755,0.13636363636363635,0.8768794002182254,1.0,1/6,0.96%,CLDN4
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.8362308661747447,1.3234180363816495,0.03278688524590164,1.0,1.0,2/6,11.19%,IL21R;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.8362308661747447,1.3234180363816495,0.03278688524590164,1.0,1.0,2/6,11.19%,IL21R;STAT1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.8154237819923107,1.3233424223211943,0.08064516129032258,1.0,1.0,2/10,12.40%,TGFB1;TAF7
prerank,Reactome_2022__O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,-0.5957618359087006,-1.3233335979404468,0.1,0.8759842784255105,1.0,11/34,14.31%,ADAMTS1;ADAMTS12;POFUT2;ADAMTS8;THSD7A;ADAMTS3;ADAMTS10;ADAMTS16;ADAMTS6;SPON2;ADAMTS13
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,0.5852805195541997,1.323194124940066,0.09090909090909091,1.0,1.0,12/73,21.53%,PSMB9;TLR2;SNAP23;HLA-F;HLA-A;RPS27A;PSMC5;NDUFA2;PSMA3;PSMB6;PSMD6;B2M
prerank,GO_Biological_Process_2021__regulation of t-circle formation (GO:1904429),-0.813496186044814,-1.3229025274599784,0.12195121951219512,0.8766972919665641,1.0,3/5,17.38%,SLX4;RTEL1;ERCC1
prerank,KEGG_2021_Human__PPAR signaling pathway,0.572920878382079,1.3228178707634108,0.12857142857142856,1.0,1.0,9/60,13.95%,PLIN4;ACSL5;ACOX2;ANGPTL4;SLC27A6;ACSL3;UCP1;SCD;RXRG
prerank,Reactome_2022__MyD88 Deficiency (TLR2/4) R-HSA-5602498,0.7972319220103476,1.3227880327971724,0.140625,1.0,1.0,1/9,1.83%,TLR2
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),0.8543503955418801,1.322765101938691,0.1206896551724138,1.0,1.0,2/5,7.67%,TCF7;LEF1
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.814631459836625,-1.322707567522452,0.15,0.8759253809092684,1.0,2/6,10.39%,NMU;MYOCD
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.746847158755424,1.322680829672303,0.09230769230769231,1.0,1.0,3/17,2.25%,TNFRSF1B;MYRF;ITGAX
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.7203817381609134,-1.322631607986637,0.16216216216216217,0.8747029399865427,1.0,1/13,0.81%,ENTPD2
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.6549698962115135,-1.321807863018556,0.12903225806451613,0.8764862106993299,1.0,8/32,16.66%,NUP210;NUP42;POM121C;NUP214;AAAS;PBRM1;NUP37;NUP98
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.5302185661337876,-1.3213438312662558,0.16666666666666666,0.8771454636632143,1.0,11/97,8.48%,DUSP4;DUSP6;FOS;SIGIRR;NKIRAS2;S100B;ECSIT;PPP2R5D;NOD1;ALPK1;RIPK2
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,-0.6484984051434286,-1.3211183407857183,0.12903225806451613,0.8764021622827195,1.0,12/33,23.25%,NUP210;NUP42;POM121C;NUP214;AAAS;PBRM1;NUP37;NUP98;SEH1L;HSPA1A;NUP50;TPR
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),0.6765910100261701,1.3210834220411984,0.14814814814814814,1.0,1.0,5/15,11.37%,SLC25A31;SYCP3;TDRD9;MEIOC;BRDT
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:White Adipose Tissue,0.6054524583873182,1.3210477645233518,0.09722222222222222,1.0,1.0,10/49,9.92%,PLIN4;GSDMA;STEAP4;KCNA7;CPM;FCAR;INMT;IGF1;ATP1A4;CFD
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.8402938046618501,1.3210089884245515,0.10714285714285714,1.0,1.0,1/8,1.83%,TLR2
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,0.6571560446351914,1.3207249298636028,0.1111111111111111,1.0,1.0,7/38,11.00%,PCLAF;POLE2;UBE2L6;TRIM25;POLD4;RPA3;RPS27A
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),0.9083205922701487,1.3205543614117832,0.08333333333333333,1.0,1.0,1/5,1.99%,IHO1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.6404654690300674,1.3202869696604749,0.11538461538461539,1.0,1.0,7/37,8.98%,LPAR1;ANXA1;SIX4;ROGDI;MESP1;PRDM12;NDUFS2
prerank,CellMarker_Augmented_2021__Basophil:Umbilical Cord Blood,0.6182195984108438,1.3199844557169138,0.08974358974358974,1.0,1.0,19/54,16.42%,ITGB2;CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;FCGR3A;FGL2;LCP1;NLRC3;IKZF1;TAGAP;TMC8;GPR183;MYO1F;KLRB1;PARVG;PIK3CG;CD244
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.5747763395425014,1.319839261600908,0.08860759493670886,1.0,1.0,38/115,19.73%,C2ORF78;NEK2;TEX101;SLC25A31;GALNTL5;BANF2;SYCP1;LRRC46;TOPAZ1;DAZL;STRA8;PDCL2;IQCF1;ASB17;MEIOC;EFCAB10;BCL2L14;SMC1B;TULP2;TNP1;MORN5;WDR87;CATSPERD;DNAH3;GTSF1;MS4A5;TAF7L;PGAM2;BRCA1;GGNBP1;POTEA;PHF13;DKKL1;DEPDC4;GSG1;FKBP6;TSACC;TSSK3
prerank,Reactome_2022__RNA Polymerase III Chain Elongation R-HSA-73780,-0.6296732065385939,-1.3197420276830747,0.10416666666666667,0.8804937549549082,1.0,7/17,20.23%,POLR3D;POLR3E;POLR3K;POLR2F;POLR3A;POLR3B;POLR3F
prerank,Reactome_2022__Beta Oxidation Of decanoyl-CoA To octanoyl-CoA-CoA R-HSA-77346,-0.8364990418070074,-1.31953930949786,0.05,0.879605164690011,1.0,2/6,8.91%,MECR;ECHS1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.7612755295494298,1.3194990184410178,0.09859154929577464,1.0,1.0,3/11,9.71%,TGFB1;HLA-F;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.6696117186884255,1.3193324636457764,0.09859154929577464,1.0,1.0,5/22,13.07%,FGF2;FLT1;TGFB1;P2RY12;TNFAIP8L3
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.744729484662654,-1.3193237685762578,0.13333333333333333,0.8790738402702962,1.0,3/10,11.50%,PACSIN2;RAB35;WASHC2C
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.7319305978627376,-1.3191419084385776,0.16216216216216217,0.8748862978019935,1.0,5/10,17.38%,EXO1;SMARCAL1;SLX4;NBN;ERCC1
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.7319305978627376,-1.3191419084385776,0.16216216216216217,0.8748862978019935,1.0,5/10,17.38%,EXO1;SMARCAL1;SLX4;NBN;ERCC1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.7319305978627376,-1.3191419084385776,0.16216216216216217,0.8748862978019935,1.0,5/10,17.38%,EXO1;SMARCAL1;SLX4;NBN;ERCC1
prerank,Reactome_2022__CaM Pathway R-HSA-111997,-0.5414937364634811,-1.3187725693855687,0.07407407407407407,0.8749297267898811,1.0,5/31,18.11%,PRKCD;ADCY2;PRKCA;ADCY6;PRKAR2A
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.6934816817737142,-1.3186270827164595,0.2,0.8740142127445124,1.0,1/11,0.31%,NPAS4
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.9155117648183468,1.3184818792806317,0.03508771929824561,1.0,1.0,1/6,1.34%,SLC22A3
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.43261000090699187,-1.3178697452781263,0.0,0.8763232897340278,1.0,22/131,15.10%,ARC;NGF;SLITRK6;DCDC2;S100B;WNT7A;SPTBN4;SHANK1;PARD3;EPHB2;SLITRK2;SRGAP2;NYAP2;ALCAM;DAB2IP;FGFR2;TAOK2;LLGL1;DBNL;DSCAML1;IMPACT;PARD6B
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),0.7458018714774922,1.3178524987209164,0.1111111111111111,1.0,1.0,3/11,11.77%,SCIMP;SCARA3;COLEC12
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.5939959033584715,1.3176929510593356,0.07352941176470588,1.0,1.0,13/51,15.70%,TNFRSF1B;ANXA1;CCL5;PTPRC;VSIG4;SFTPD;IL27;CD80;PDCD1LG2;HLA-DPB1;TNFSF4;IL4;IDO1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.5641192256703939,-1.3175821295729067,0.15789473684210525,0.8761774733864732,1.0,8/74,5.82%,CYP1A2;EPHX2;ELOVL6;PNPLA3;LTC4S;SLC27A2;FADS1;FAAH2
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.6110584571165117,1.317421801641932,0.07792207792207792,1.0,1.0,26/70,15.08%,RASGRP4;ITGB2;TLR2;ITGAX;LILRB3;NR1I3;PTAFR;ITGAM;NFAM1;FCGR3A;CLEC12A;MMP9;CEACAM8;HCK;CSF3R;TAGAP;HK3;IGSF6;ALOX5AP;PSTPIP1;MYO1F;FPR1;MME;ELANE;ADGRE3;CD300LF
prerank,KEGG_2021_Human__Viral myocarditis,0.6177496642436479,1.3171663861205625,0.14102564102564102,1.0,1.0,9/46,10.69%,ITGB2;SGCG;HLA-F;ACTG1;CD80;CCND1;HLA-A;HLA-DMA;HLA-DPB1
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.6800014490135562,-1.3165695912540558,0.12121212121212122,0.8794045813362141,1.0,3/15,5.74%,PRKCD;TWIST1;PLIN5
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,-0.46541446801980885,-1.3164464761826185,0.0,0.878417949955918,1.0,16/157,7.34%,CYP1A2;ACAD10;EPHX2;HACD1;ELOVL6;THEM4;MECR;MLYCD;LTC4S;ACBD4;SLC25A17;SLC27A2;FAAH2;HSD17B12;ACOX3;PTGS1
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Bone Marrow,0.6370668768005612,1.3161343567577017,0.18309859154929578,1.0,1.0,20/51,15.08%,C3AR1;ITGAX;SASH3;PTPRC;ITGAM;NFAM1;FCGR3A;CLEC12A;FGL2;HCK;CSF3R;TAGAP;HK3;IGSF6;MYO1F;CSF1R;FPR1;PARVG;ADGRE3;CD300LF
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,0.5982782223495587,1.3159118914858339,0.13333333333333333,1.0,1.0,4/45,10.19%,ESR1;ATP1A4;CALB1;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),-0.7830302879128967,-1.3155678038545762,0.18181818181818182,0.8806328841060486,1.0,3/6,10.05%,CCBE1;ADAMTS3;JCAD
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.8246449016562385,-1.3155118136366775,0.17142857142857143,0.8794162731470576,1.0,2/5,6.65%,AGBL1;AGBL3
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.7725613521915158,-1.3152242877902556,0.15555555555555556,0.8790814805358188,1.0,2/6,16.91%,FRRS1L;FYN
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.6508115883776363,-1.3146634435036806,0.18181818181818182,0.8799464445516672,1.0,3/20,4.60%,SMYD5;PIWIL2;APOBEC3H
prerank,KEGG_2021_Human__DNA replication,0.6597520466711537,1.314589977546732,0.06944444444444445,1.0,1.0,5/31,9.53%,MCM2;POLE2;MCM3;POLD4;RPA3
prerank,CellMarker_Augmented_2021__Memory B cell:Undefined,0.8936931424313171,1.31442902909877,0.05357142857142857,1.0,1.0,1/5,1.83%,TLR2
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.8135936567341937,-1.3143959263537737,0.1282051282051282,0.8795658861493614,1.0,3/8,14.94%,MID1;MAPRE1;CHAMP1
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Jejunum,-0.5140992630875235,-1.3140913547381965,0.11764705882352941,0.8780752260352525,1.0,4/59,1.40%,ADGRF4;EHF;CLDN4;ANXA8
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Breast,-0.5140992630875235,-1.3140913547381965,0.11764705882352941,0.8780752260352525,1.0,4/59,1.40%,ADGRF4;EHF;CLDN4;ANXA8
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.7574949698294249,-1.3140707333491892,0.17391304347826086,0.8765786838994497,1.0,2/6,10.10%,SIGIRR;TRIB1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.6604183256046722,1.3140592423506563,0.16923076923076924,1.0,1.0,2/32,0.91%,TULP1;ROPN1B
prerank,Reactome_2022__Initial Triggering Of Complement R-HSA-166663,0.79561812776902,1.3140248898120885,0.10294117647058823,1.0,1.0,4/11,14.97%,C1QB;C3;MASP2;MASP1
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,0.5944259994727717,1.313850394125708,0.06666666666666667,1.0,1.0,2/70,0.92%,RASGRP4;PSMB9
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.5297465117077276,-1.3136454580874635,0.06896551724137931,0.8773490296343204,1.0,13/68,14.99%,TBC1D10A;TBC1D16;IFT88;DCDC2;TBC1D2;TRAPPC12;RAB5A;TBC1D22B;ALMS1;TBC1D8;NPRL2;RABEP2;SDCCAG8
prerank,KEGG_2021_Human__Folate biosynthesis,-0.6510040363256175,-1.3135778821792172,0.1794871794871795,0.8760871285408601,1.0,5/21,11.11%,TPH1;PAH;DHFR;FPGS;AKR1C3
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,0.5695631990442475,1.3134901406990325,0.11475409836065574,1.0,1.0,2/56,1.73%,NLRP4;AIM2
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.8654433119758637,1.3134660451042368,0.07142857142857142,1.0,1.0,2/6,4.92%,TLR2;PRDX4
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.4923127450787801,-1.3134358038249543,0.1111111111111111,0.87514838503396,1.0,5/60,0.97%,UGT2B15;RFX6;APOB;LIPC;TPH1
prerank,Reactome_2022__Caspase Activation Via Dependence Receptors In Absence Of Ligand R-HSA-418889,-0.6849817446777641,-1.313406985341758,0.24390243902439024,0.8737585091990616,1.0,4/10,28.14%,CASP9;CASP3;DAPK3;DAPK2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.6976647367473057,-1.313172606589375,0.1590909090909091,0.8732128015063636,1.0,2/7,13.45%,WNK2;WNK3
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryo,0.5885430666987298,1.31314978102231,0.11842105263157894,1.0,1.0,17/55,11.38%,C1QB;C3AR1;TNFRSF1B;ITGAX;LYVE1;ITGAM;TFEC;FCGR3A;VSIG4;FGL2;RAMP3;HCK;CSF3R;ZNF366;VWF;HK3;CLDN5
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.8779325308884955,1.312980705517503,0.07272727272727272,1.0,1.0,2/6,6.91%,ANXA1;CDKN2A
prerank,CellMarker_Augmented_2021__M1 macrophage:Undefined,0.7954616936278593,1.312922618641537,0.14545454545454545,1.0,1.0,4/7,11.19%,ROS1;FCGR3A;CD80;STAT1
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,-0.6017435041789317,-1.3127215530864071,0.07407407407407407,0.8739822903694862,1.0,10/32,14.77%,ENTPD2;UPB1;ADPRM;NT5C1A;UPP1;NT5C;UPP2;DNPH1;SAMHD1;NUDT18
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,0.6720775815055997,1.3126057056783234,0.1044776119402985,1.0,1.0,4/22,13.93%,CDC25A;FOXM1;CCNA2;PKMYT1
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.7687717330956351,1.3123662530715912,0.15873015873015872,1.0,1.0,3/12,11.67%,GATA4;MESP1;HMGA2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.8426624694954967,1.3122503075344232,0.1346153846153846,1.0,1.0,1/5,1.83%,TLR2
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Peripheral Blood,0.6470534442406396,1.312050326145634,0.14473684210526316,1.0,1.0,23/48,16.47%,ITGB2;CYTIP;ARHGAP9;ITGAX;SASH3;PTPRC;ITGAM;FCGR3A;CLEC12A;WAS;HCK;TAGAP;HK3;TMC8;ALOX5AP;PSTPIP1;MYO1F;KLRB1;SIRPG;PARVG;CD300LF;CD244;ZAP70
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Blood,0.6470534442406396,1.312050326145634,0.14473684210526316,1.0,1.0,23/48,16.47%,ITGB2;CYTIP;ARHGAP9;ITGAX;SASH3;PTPRC;ITGAM;FCGR3A;CLEC12A;WAS;HCK;TAGAP;HK3;TMC8;ALOX5AP;PSTPIP1;MYO1F;KLRB1;SIRPG;PARVG;CD300LF;CD244;ZAP70
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.8041289241828113,1.3118108973752316,0.11475409836065574,1.0,1.0,1/6,9.06%,SOD2
prerank,GO_Biological_Process_2021__lipid hydroxylation (GO:0002933),0.905202050296354,1.3113169293311608,0.06557377049180328,1.0,1.0,2/5,3.43%,CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.7201322819704742,1.311133000401464,0.10810810810810811,1.0,1.0,3/20,8.73%,BUB1;SHCBP1L;PIF1
prerank,Reactome_2022__Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.6780515093977821,1.311028491420076,0.08823529411764706,1.0,1.0,1/17,0.88%,MAPKAPK3
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.5375371902188212,-1.3110247782789617,0.12,0.8804675657894437,1.0,5/26,9.33%,SLC38A5;SLC25A29;SLC6A20;SLC3A2;SLC7A5
prerank,Reactome_2022__Interleukin-27 Signaling R-HSA-9020956,0.7806460784225525,1.3103933823770775,0.11267605633802817,1.0,1.0,3/11,11.19%,CRLF1;IL27;STAT1
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,0.7126282902908253,1.3102767967895006,0.15384615384615385,1.0,1.0,5/18,12.98%,C3AR1;C3;NT5E;PSTPIP1;NFKB2
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.7353924605071505,1.3102343327648809,0.19047619047619047,1.0,1.0,1/12,0.23%,GATA4
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.45265677788949094,-1.3099566347053517,0.0,0.8841547934893911,1.0,18/157,9.46%,ARC;TSKU;MFSD2A;LZTS3;WNT3A;PTPN9;PTPRO;PRAG1;GPC2;APOE;STYXL1;ARSB;MINAR1;RTN4RL2;NTRK1;NCS1;RAPGEF1;P3H1
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,-0.5571150942083998,-1.309751897331558,0.10344827586206896,0.8837072934450502,1.0,14/42,18.95%,EARS2;LARS2;VARS1;QRSL1;WARS2;MTFMT;PARS2;PSTK;CARS1;MARS1;FARSA;GATB;HARS2;YARS1
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.6912416580083,-1.3097118776632843,0.125,0.8823395169257647,1.0,3/11,10.30%,PEX7;PEX13;PEX14
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.851403982452606,1.3091888875105708,0.08695652173913043,1.0,1.0,2/7,3.64%,ADAD2;ADARB2
prerank,Reactome_2022__Complement Cascade R-HSA-166658,0.6261084187220141,1.3091664875673557,0.10666666666666667,1.0,1.0,11/35,14.97%,C1QB;C3AR1;C3;CD81;CPB2;C4BPA;C4BPB;VTN;ELANE;MASP2;MASP1
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.7721207221610585,-1.3089428986473826,0.1935483870967742,0.8843432263252449,1.0,4/5,22.81%,HES1;RNF10;SKI;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.830267167609753,1.3088348739875904,0.14545454545454545,1.0,1.0,2/6,15.53%,AXL;CXCL12
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.6003284548301008,-1.3088136791669045,0.125,0.8833600078943383,1.0,5/21,14.02%,IBA57;NDOR1;HSCB;CIAO2A;NFS1
prerank,Reactome_2022__Arachidonate Production From DAG R-HSA-426048,-0.8180092499777997,-1.3085082343829948,0.2682926829268293,0.8833419741836012,1.0,2/5,13.89%,DAGLA;ABHD12
prerank,CellMarker_Augmented_2021__Macrophage:Undefined,0.6960728301192494,1.308108888908758,0.15625,1.0,1.0,9/19,13.33%,TLR2;ITGAX;ITGAM;FCGR3A;ADGRE1;CD80;CD63;LAMP2;CSF1R
prerank,KEGG_2021_Human__Proteoglycans in cancer,0.5410343118904006,1.3080457530786862,0.03529411764705882,1.0,1.0,32/177,13.21%,ESR1;TIMP3;WNT8B;TLR2;RRAS;SDC2;PIK3R3;FGF2;TGFB1;ITGA2;WNT5A;CAV3;ACTG1;ERBB4;MMP9;ITGA5;WNT8A;IGF1;CCND1;HGF;HPSE2;PLAUR;PLAU;FZD8;DCN;VTN;COL1A1;WNT6;NUDT16L1;CDKN1A;CD63;THBS1
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,-0.6517628929984345,-1.3078213865666033,0.15625,0.8849985722357667,1.0,8/32,16.66%,NUP210;NUP42;POM121C;NUP214;AAAS;PBRM1;NUP37;NUP98
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.6829106326412603,1.3077628474544858,0.0945945945945946,1.0,1.0,8/25,11.69%,SASH3;CLCF1;PTPRC;SCIMP;WNT5A;TNFSF4;F2RL1;LACC1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.7227176860520378,-1.3076512545541408,0.10714285714285714,0.8841530699247944,1.0,4/11,8.48%,NLRP1;NOD1;IRF5;RIPK2
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.7160254434686351,1.3074933529247368,0.1518987341772152,1.0,1.0,3/18,5.93%,LMOD3;LMOD1;SCIN
prerank,Reactome_2022__Polo-like Kinase Mediated Events R-HSA-156711,0.7274351424044685,1.307294919427566,0.13636363636363635,1.0,1.0,2/14,7.26%,CDC25A;FOXM1
prerank,Reactome_2022__Digestion Of Dietary Carbohydrate R-HSA-189085,0.8837589011922841,1.3071642145808626,0.0,1.0,1.0,3/6,9.72%,LCT;CHIT1;TREH
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,-0.6134347313833302,-1.306084187548291,0.14814814814814814,0.889918806265057,1.0,3/26,6.60%,NOX4;MYO18A;STAT5B
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.7924964843690867,-1.305996732281518,0.25,0.8872661141703868,1.0,1/5,2.75%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.7924964843690867,-1.305996732281518,0.25,0.8872661141703868,1.0,1/5,2.75%,NRDE2
prerank,CellMarker_Augmented_2021__Dendritic cell:Undefined,0.7329670639296821,1.3058289635769296,0.14035087719298245,1.0,1.0,7/17,9.60%,ITGAX;PTPRC;CLEC4C;ITGAM;ANPEP;CD80;CD302
prerank,Reactome_2022__eNOS Activation R-HSA-203615,-0.7421823179044573,-1.30574805174065,0.1891891891891892,0.8871087217015263,1.0,2/11,6.66%,DDAH2;NANOS3
prerank,KEGG_2021_Human__Glucagon signaling pathway,-0.5178041972635121,-1.305615522219406,0.11538461538461539,0.8862005727024976,1.0,14/83,13.59%,GCK;FBP2;G6PC3;CREB3L4;ITPR2;FOXO1;CREB3L1;GYS1;GNAS;PFKP;CPT1A;ADCY2;LDHC;CREB3L2
prerank,KEGG_2021_Human__Propanoate metabolism,-0.5393614850062649,-1.3054644011523346,0.11538461538461539,0.8852514264058138,1.0,11/32,23.41%,MLYCD;ACOX3;ACADS;ECHS1;LDHC;EHHADH;SUCLA2;ACACB;PCCB;PCCA;ACSS2
prerank,Reactome_2022__Glycogen Breakdown (Glycogenolysis) R-HSA-70221,0.7374772503104914,1.3053522744301744,0.18840579710144928,1.0,1.0,3/13,12.94%,PHKA1;PHKG1;PYGL
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.5324656901725349,1.30528749046342,0.02564102564102564,1.0,1.0,39/175,17.85%,APOL1;CLEC5A;BLK;TRIM58;TLR2;PTX3;SP100;C3;TRIM62;JCHAIN;SFTPD;TRIM25;SYK;IFIT1;ZDHHC11;DDX3X;RNF187;HCK;TRIM68;CFD;TIFA;TRIM77;BPIFB1;COLEC12;IGLL1;IL4;CYBA;MASP2;MASP1;CYLD;ISG15;IFI6;PIK3CG;AGER;ZAP70;PGLYRP2;NOS2;PGLYRP1;WFDC11
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.583281402390715,1.3052218038213108,0.10666666666666667,1.0,1.0,12/52,15.38%,CDC25A;CCNG2;CCND2;CCND1;CCNE2;CDKN1B;CDKN1A;CCNA2;CCNI;PKMYT1;CDKN2C;CDK5R1
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,0.6332907340766303,1.3043951744031066,0.10294117647058823,1.0,1.0,28/42,25.85%,DDX20;RPS9;RPS16;GEMIN4;RPS5;RPS27A;RPS3A;RPS12;RPS4X;SNRPD2;RPS19;FAU;RPS21;RPS11;RPS13;RPS7;RPS15A;RPSA;RPS6;RPS14;RPS15;RPS27;RPS3;RPS23;RPS20;RPS24;RPS29;RPS28
prerank,CellMarker_Augmented_2021__Monocyte:Blood,-0.7530166615859535,-1.3042965381176714,0.25,0.8897447738636791,1.0,3/5,10.54%,CD14;SELPLG;MPO
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.8214784182803861,1.3042885442413894,0.11666666666666667,1.0,1.0,4/8,16.00%,CASQ2;CAV3;KCNE3;KCNAB1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6934211507777338,1.3036645861322633,0.1323529411764706,1.0,1.0,4/23,4.27%,PKP2;MYBPC3;LRP2;TGFB1
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,-0.5645736053468726,-1.3036421200951893,0.08333333333333333,0.8910351259887915,1.0,6/37,18.11%,PRKCD;ITPR2;ADCY2;PRKCA;ADCY6;PRKAR2A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Dental Pulp,0.7877561764900706,1.3035668007048018,0.203125,1.0,1.0,4/9,16.35%,PTPRC;NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.717719048925048,1.3034652967554141,0.23333333333333334,1.0,1.0,3/13,12.94%,PHKA1;PHKG1;PYGL
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.8422244540901712,1.3032937550510306,0.03389830508474576,1.0,1.0,2/7,11.63%,ANXA1;TNFSF4
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.6466618587318568,-1.303047446491265,0.15789473684210525,0.8925185799246723,1.0,5/18,16.42%,TRIM71;AGO2;TERT;ZC3H7B;SNIP1
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.6918160481631639,1.3030072417381529,0.1388888888888889,1.0,1.0,3/15,13.69%,ANXA1;CD81;RHOG
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.634341322445622,-1.30273377282982,0.14285714285714285,0.8923319272620274,1.0,5/16,25.54%,PTPRJ;CORO1A;SCRIB;ANGPT1;LGALS3
prerank,CellMarker_Augmented_2021__Endothelial cell:Adipose Tissue,0.8226778227249749,1.3027137089365208,0.14035087719298245,1.0,1.0,4/8,16.35%,PTPRC;ABCG2;VWF;ENG
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.7014571343886681,1.302407220576054,0.13513513513513514,1.0,1.0,6/18,15.71%,SLC22A3;ABCG2;ABCC2;ABCC11;SLC47A1;SLC22A4
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,0.5399640101620401,1.3022175726446128,0.12345679012345678,1.0,1.0,8/111,7.94%,GATA4;ESR1;PIK3R3;ACTG1;DIO1;PFKFB2;ATP1A4;CCND1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.6628212063500522,1.3020180342441456,0.1527777777777778,1.0,1.0,7/27,12.87%,NOTUM;PTPRC;CYP26B1;RANBP3L;TGM2;RPL13;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.8295940532734627,1.3019979942038251,0.15517241379310345,1.0,1.0,3/7,9.06%,IL12A;CDKN2A;SOD2
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.7521153077159353,1.3016777687479006,0.1,1.0,1.0,2/12,3.64%,ADAD2;ADARB2
prerank,GO_Biological_Process_2021__centromeric sister chromatid cohesion (GO:0070601),0.8928725871786181,1.3016617652682698,0.1111111111111111,1.0,1.0,2/5,1.93%,SGO1;BUB1
prerank,Reactome_2022__Defective Factor IX Causes Hemophilia B R-HSA-9668250,0.8518537693660776,1.3016017297541858,0.05454545454545454,1.0,1.0,4/5,14.52%,GP1BA;F8;FAM110A;GGCX
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.7218074158016456,1.3015475744513771,0.13043478260869565,1.0,1.0,4/17,12.49%,C3AR1;C3;NT5E;PSTPIP1
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,0.6397443435408598,1.3015435101527197,0.1506849315068493,1.0,1.0,8/29,10.68%,C1QB;C3AR1;C3;CD81;CPB2;C4BPA;C4BPB;VTN
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.74426284080521,1.3015300656588573,0.2,1.0,1.0,4/10,7.54%,LMOD3;TMOD4;LMOD1;PGM5
prerank,PanglaoDB_Augmented_2021__Monocytes,0.5799062083282941,1.301435708402483,0.08536585365853659,1.0,1.0,31/99,15.70%,ITGB2;C3AR1;TLR2;TNFRSF1B;ITGAX;SASH3;PTPRC;PTAFR;ITGAM;NFAM1;FCGR3A;ADGRE1;CLEC12A;FGL2;IFIT1;HCK;CSF3R;PSAP;PLAU;TAGAP;HK3;IGSF6;ALOX5AP;MYO1F;CSF1R;FPR1;PARVG;CD44;ADGRE3;CD300LF;IDO1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.7051966078124021,1.301364134122429,0.2222222222222222,1.0,1.0,3/14,9.55%,PTPRC;ITGA2;P2RY12
prerank,CellMarker_Augmented_2021__Epithelial Hair Follicle Stem cell:Hair Follicle,-0.5627472893867149,-1.3010185997619241,0.13636363636363635,0.898357315976639,1.0,8/64,8.67%,ADGRF4;EHF;CLDN4;ESRP1;ERBB2;TMEM125;PERP;ITGB4
prerank,Reactome_2022__Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,-0.7005379629235563,-1.3008818004429406,0.1388888888888889,0.8975063498629299,1.0,6/12,24.76%,NDOR1;ERCC2;RTEL1;CIAO3;CIAO2B;BRIP1
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.7370975223516024,-1.3008388560999131,0.17073170731707318,0.8961787419065408,1.0,5/8,22.43%,KYAT1;AADAT;KYAT3;ACSM1;ACAA1
prerank,GO_Biological_Process_2021__fat-soluble vitamin catabolic process (GO:0042363),0.8388165673791812,1.3005356430042128,0.08064516129032258,1.0,1.0,3/7,6.20%,CYP3A4;CYP4F12;CYP26B1
prerank,Reactome_2022__Acetylcholine Binding And Downstream Events R-HSA-181431,0.7524364410698707,1.3004701970266905,0.18181818181818182,1.0,1.0,2/12,8.59%,CHRNA9;CHRNA5
prerank,CellMarker_Augmented_2021__Theca Interna cell:Ovarian Follicle,0.5737239704084285,1.300058009882453,0.1111111111111111,1.0,1.0,27/79,16.91%,OLFML1;PRRX1;LMOD1;ADAM33;LYVE1;ECM2;ABI3BP;MYH11;JAM2;DAAM2;OGN;ANGPTL2;IGF1;RAMP3;ANGPTL1;ACTA2;ADGRL4;OMD;DCN;ASPN;SFRP4;PLN;MASP1;CXCL12;ELN;A2M;GALNT15
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.5476767304676949,-1.2996724561676531,0.08695652173913043,0.9002738585390583,1.0,8/47,3.75%,GALR3;GRP;NMU;HCRTR2;NXPH4;SORCS2;ADCYAP1;GPR149
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,-0.6211119151215319,-1.2994373023154449,0.11764705882352941,0.8997498159363955,1.0,5/24,13.51%,MFSD2A;BCHE;CHKA;PEMT;SLC44A5
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",0.6419817661525835,1.2992613751481357,0.15789473684210525,1.0,1.0,7/38,9.57%,BLNK;CSF2RA;PIK3R3;STAT5A;SYK;HCK;IL5
prerank,Reactome_2022__Adrenoceptors R-HSA-390696,-0.8262142231889861,-1.2989641328480572,0.17142857142857143,0.9004853563015873,1.0,2/6,0.57%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.7704431455415102,1.298683714626688,0.16666666666666666,1.0,1.0,2/9,6.92%,CASQ2;P2RY6
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.7330416320123213,1.2985943802829674,0.17391304347826086,1.0,1.0,1/11,0.23%,GATA4
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5622366074279561,1.2983879932149254,0.0963855421686747,1.0,1.0,10/77,7.20%,RASGRP4;RRAS;ARIH2;PTPRC;HIPK1;FLT1;TGFB1;WNT5A;PLD4;FLT4
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.5505541730349854,1.298332227048224,0.07317073170731707,1.0,1.0,18/123,12.76%,AMBP;ITGB2;APOL1;SCGB3A2;LRP2;ITGAM;JCHAIN;SFTPD;CD81;STAB2;SYK;RAMP3;PPT1;HPR;LDLRAP1;DAB2;COLEC12;AMN
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.607047306377082,-1.2982465240351695,0.125,0.9026040064926382,1.0,9/21,27.49%,NAB2;CHD8;ICE1;POLR3F;BRF2;DHX36;ZNF345;CEBPA;RPTOR
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),0.8349488430412111,1.2981124936196757,0.14285714285714285,1.0,1.0,3/6,13.35%,TCN1;AMN;CBLIF
prerank,Reactome_2022__Organic Cation/Anion/Zwitterion Transport R-HSA-549132,0.7583130293243576,1.2979934380476206,0.14925373134328357,1.0,1.0,4/10,9.13%,SLC22A3;SLC22A8;SLC22A7;SLC22A6
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Subcutaneous Adipose Tissue,0.8207828672337116,1.2979918278662819,0.13559322033898305,1.0,1.0,4/9,16.35%,ANPEP;MME;CD44;ENG
prerank,Reactome_2022__Signaling By MAPK Mutants R-HSA-9652817,-0.7796987322106823,-1.2977301192566384,0.16216216216216217,0.9030729043953954,1.0,1/7,1.13%,DUSP6
prerank,PanglaoDB_Augmented_2021__Platelets,0.5545808944684371,1.297547259593174,0.033707865168539325,1.0,1.0,37/136,15.73%,ITGB2;C3AR1;NOX5;GP1BA;TNFRSF1B;ITGAX;GMFG;CCL5;SASH3;ALOX12;ITGAM;NFAM1;FCGR3A;ITGA2;CLEC12A;FGL2;HCK;HLA-A;F7;CSF3R;P2RY12;VWF;MFSD2B;HK3;DAB2;ALOX5AP;MYO1F;THBS1;FPR1;ITGA2B;MAP3K7CL;P2RX1;ADGRE3;CD300LF;PIK3R6;MYL9;FERMT3
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7414975057396205,1.297415917436724,0.13636363636363635,1.0,1.0,2/14,9.44%,STK26;RAPGEF6
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.6415610489349616,-1.2973612242864483,0.25806451612903225,0.9033891866105527,1.0,6/13,14.23%,P3H4;JMJD4;P3H1;P3H3;EGLN3;PLOD3
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.6558501455085433,1.29725010177056,0.08823529411764706,1.0,1.0,5/28,11.48%,AQP3;TBX1;ROGDI;TGFB3;WNT6
prerank,Reactome_2022__Atorvastatin ADME R-HSA-9754706,0.8203641037419122,1.2967498968023032,0.10526315789473684,1.0,1.0,5/6,15.20%,CYP3A4;ABCC2;PON1;PON3;SLCO2B1
prerank,CellMarker_Augmented_2021__Transitional B cell:Blood,0.6145159329799762,1.2959568020753893,0.10666666666666667,1.0,1.0,9/35,8.80%,DENND1C;MACC1;ADAM28;BLNK;PTAFR;JCHAIN;SYK;HSH2D;HCK
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),0.8492709273772022,1.2959053495700095,0.06060606060606061,1.0,1.0,3/6,13.24%,IRF1;TNFSF4;GLI3
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.6562813032196158,-1.2958212348106872,0.16216216216216217,0.9088095952950258,1.0,1/11,0.81%,SKAP1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7727535648827076,1.2957996742634095,0.18032786885245902,1.0,1.0,2/10,3.81%,BLK;PTPRC
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.6531317107523714,-1.2957916477871951,0.21428571428571427,0.9074378347305725,1.0,7/14,16.12%,SMARCB1;DDX11;MACROH2A2;SIRT7;PIH1D1;SMARCA4;MARS1
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),-0.8169365491472566,-1.2957641699840703,0.11904761904761904,0.9060277243264798,1.0,2/6,8.71%,PRKCD;SLC30A10
prerank,CellMarker_Augmented_2021__Basophil:Lung,0.6192262673659704,1.2957526167906936,0.06944444444444445,1.0,1.0,27/53,18.98%,C1QB;CLEC5A;C3AR1;FRMD4B;TLR2;ADAMDEC1;TFEC;FCGR3A;VSIG4;FGL2;HCK;HPGDS;ZNF366;HLA-DPB1;LPAR6;HK3;PLA2G7;IGSF6;CD4;CSF1R;IDO1;MAF;MSR1;FPR3;GBP1;HLA-DPA1;GPR34
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.5220796931793039,1.2956556658041536,0.024691358024691357,1.0,1.0,25/173,13.70%,GATA4;ESR1;RRAS;FGF20;LRP2;FGF2;GFRAL;TGFB1;GPER1;ERBB4;CD80;IL26;RAMP3;AXL;HGF;KLB;F7;PINK1;P2RY12;MYDGF;TNFAIP8L3;THBS1;NOP53;RHOG;CALCR
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7459807372888562,1.2955533426018897,0.16393442622950818,1.0,1.0,2/11,2.81%,BACE2;ITM2A
prerank,Reactome_2022__Inactivation Of CDC42 And RAC1 R-HSA-428543,-0.7489122866069715,-1.2952928193705517,0.17647058823529413,0.9069370853471032,1.0,2/7,13.63%,SRGAP2;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.6699016966440287,1.2949773676813972,0.11688311688311688,1.0,1.0,4/22,10.19%,CDC25A;DTL;CCND1;RAB11A
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.646523397808069,1.294737815845301,0.14492753623188406,1.0,1.0,4/29,7.84%,GATA4;CCDC39;MESP1;TBX6
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.795872421929962,1.2945500465708468,0.12121212121212122,1.0,1.0,2/7,2.92%,LRAT;BCO1
prerank,Reactome_2022__ChREBP Activates Metabolic Gene Expression R-HSA-163765,0.7801501183687736,1.2944862843459048,0.11320754716981132,1.0,1.0,1/7,2.97%,PKLR
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.8637964566349108,1.2944035445773645,0.15384615384615385,1.0,1.0,3/5,10.33%,FLI1;P2RY12;VWF
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.7955944538857823,1.294393218076249,0.1875,1.0,1.0,3/8,14.52%,TGFB1;THBS1;DDR2
prerank,CellMarker_Augmented_2021__Side-population cell:Undefined,-0.47830418508660344,-1.2943280789263414,0.13333333333333333,0.9099189504540136,1.0,5/62,1.51%,ADGRF4;EHF;EMP1;ANXA8;ZNF860
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.636692801353647,-1.293929466098296,0.16,0.9102847690227487,1.0,2/17,13.12%,CDH5;LLGL1
prerank,GO_Biological_Process_2021__glycerol transport (GO:0015793),0.8322582913791916,1.2938813963248077,0.19607843137254902,1.0,1.0,1/5,0.31%,AQP3
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.6319668253471885,1.293855918339215,0.1267605633802817,1.0,1.0,8/34,9.55%,RASGRP4;ESR1;LPAR1;GPR55;FGF2;FLT1;P2RY6;P2RY12
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.7585357308765842,-1.2936876050985298,0.30303030303030304,0.9085217405921284,1.0,1/6,4.04%,IWS1
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.7585357308765842,-1.2936876050985298,0.30303030303030304,0.9085217405921284,1.0,1/6,4.04%,IWS1
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.8488142558164222,1.2935700915812847,0.10606060606060606,1.0,1.0,2/6,9.24%,GATA4;NPY
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,0.6388971269722833,1.2934984329072414,0.17105263157894737,1.0,1.0,3/27,6.35%,BLK;BLNK;SYK
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.8454666273752645,-1.2934960308038381,0.14285714285714285,0.9064096211685158,1.0,1/5,1.39%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.8454666273752645,-1.2934960308038381,0.14285714285714285,0.9064096211685158,1.0,1/5,1.39%,PHLDB2
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),-0.7111074990847328,-1.293373515235874,0.18604651162790697,0.9055070873930988,1.0,5/9,24.53%,PTCH1;GRAMD1B;OSBPL7;GPLD1;LRP6
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),0.8790372867772921,1.2931746486943378,0.1016949152542373,1.0,1.0,2/5,8.50%,DDX3X;EIF6
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.6815982885912542,-1.2931266690050023,0.16216216216216217,0.9051785912753423,1.0,3/15,4.60%,SMYD5;PIWIL2;APOBEC3H
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.7824274182351616,1.293045595904377,0.125,1.0,1.0,1/11,2.12%,MYRF
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.6019060119112725,-1.2928891786758319,0.17647058823529413,0.9047244813689933,1.0,3/16,5.95%,GCK;BCKDK;CRY1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.5750821060765594,1.2928747486131713,0.05555555555555555,1.0,1.0,17/85,16.91%,ENPP2;RRAS;FGF2;WNT5A;MMP9;FLT4;RHOB;VIL1;RAB11A;DOCK5;AGT;THBS1;SOX9;ZNF580;PIK3CG;BCAR1;HYAL1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.8306795158417727,1.2927625371868627,0.15254237288135594,1.0,1.0,1/6,4.27%,TGFB1
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.7971168103524603,1.2927604800636268,0.18333333333333332,1.0,1.0,1/8,2.12%,ACE2
prerank,GO_Biological_Process_2021__metanephric collecting duct development (GO:0072205),-0.8976102688788498,-1.2927342220979126,0.07692307692307693,0.9026421244299124,1.0,1/5,2.59%,PTCH1
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),-0.8976102688788498,-1.2927342220979126,0.07692307692307693,0.9026421244299124,1.0,1/5,2.59%,PTCH1
prerank,Reactome_2022__p75NTR Signals Via NF-kB R-HSA-193639,-0.6687582863335885,-1.292580530552084,0.16666666666666666,0.9019422509313618,1.0,1/14,0.34%,NGF
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,-0.5143230892824034,-1.2925495954469035,0.0,0.9006992439670671,1.0,14/83,14.48%,CAMK1G;NR4A1;CREB3L4;ITPR2;CREB3L1;GNAS;GNA11;SCARB1;ADCY3;ADCY2;DAGLA;ATF1;CREB3L2;HSD3B2
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.7897495930065672,1.2925374938251986,0.16923076923076924,1.0,1.0,3/7,16.85%,CKMT2;CKB;CKM
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,0.5758028449530184,1.2924409126871117,0.058823529411764705,1.0,1.0,11/58,20.47%,PSMB9;CDKN2A;CCNE2;RPS27A;CDKN1B;CDKN1A;CCNA2;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.7567684053734292,1.2923076475753732,0.12857142857142856,1.0,1.0,3/10,14.71%,ENPP2;VIL1;CD44
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),-0.7542535816872205,-1.292168180514142,0.17391304347826086,0.9014080375529775,1.0,4/5,22.87%,TENT4A;RBM24;LARP4B;ELAVL4
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.8355462237478846,1.292132230481341,0.13114754098360656,1.0,1.0,1/8,0.35%,TBX1
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,0.6943376884011747,1.2920036440963423,0.18055555555555555,1.0,1.0,2/21,3.49%,MCUB;STOML2
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),-0.7640336117558729,-1.291938499760347,0.20512820512820512,0.9010481437111676,1.0,2/7,10.68%,SLC27A2;SLC27A4
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.597545038149438,-1.291843176964275,0.15,0.9001257848238852,1.0,5/22,14.02%,IBA57;NDOR1;HSCB;CIAO2A;NFS1
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.7930022482698502,1.2917461348110082,0.14814814814814814,1.0,1.0,1/7,7.03%,SOCS2
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.6990593053899156,-1.2916795056618107,0.18181818181818182,0.8996232505634003,1.0,2/11,4.89%,GFI1B;CBFB
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),-0.7567331938480478,-1.2915068724022947,0.1590909090909091,0.8988310371973857,1.0,2/6,9.67%,NLGN3;NLGN2
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.7578133899673116,1.291441413661167,0.27419354838709675,1.0,1.0,3/8,18.31%,LY6H;CHRNB2;CHRNA3
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6755805809032096,1.2911189889105654,0.1527777777777778,1.0,1.0,3/18,6.03%,BLK;NFAM1;CD81
prerank,Reactome_2022__Fatty Acids R-HSA-211935,0.8053239022214718,1.290951552843678,0.13636363636363635,1.0,1.0,2/7,7.88%,CYP4F12;CYP2J2
prerank,Reactome_2022__STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,-0.703550615384271,-1.2908279445295707,0.16216216216216217,0.9008874324158547,1.0,2/10,6.60%,NOX4;STAT5B
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.8160965645690641,-1.2907487269127924,0.1951219512195122,0.8996601861418113,1.0,1/6,3.39%,HDAC10
prerank,CellMarker_Augmented_2021__Exhausted CD8+ T cell:Liver,-0.4291220665725481,-1.290680993783447,0.0,0.8983954846537596,1.0,20/221,7.00%,DUSP4;P2RY10;CD38;UBASH3B;SEL1L3;ETV1;LIMK1;GBP2;PPM1M;IFI16;PMF1-BGLAP;JMJD4;GOLIM4;PDE7B;HLA-DRA;TTYH3;GTF2I;SARDH;OSBPL3;GBP4
prerank,Reactome_2022__TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,-0.6612897385978479,-1.2906758564711611,0.18421052631578946,0.8969694667438769,1.0,3/11,14.49%,MAP3K14;LTB;TRAF3
prerank,Reactome_2022__MECP2 Regulates Transcription Factors R-HSA-9022707,-0.7463550260069653,-1.2901175098452546,0.19047619047619047,0.898231293168371,1.0,1/5,9.11%,MECP2
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,-0.6048141479934784,-1.2899127330621774,0.1388888888888889,0.8977374462778362,1.0,11/33,23.25%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;NUP98;SEH1L;SGIP1;NUP50;TPR
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),-0.7442963755972565,-1.2897248056072428,0.14634146341463414,0.8974714995196156,1.0,2/9,0.57%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__hexose import across plasma membrane (GO:0140271),0.8569884815663282,1.2894776523277647,0.09090909090909091,1.0,1.0,2/5,12.89%,SLC5A2;SLC5A1
prerank,GO_Biological_Process_2021__regulation of nephron tubule epithelial cell differentiation (GO:0072182),-0.8119892426202854,-1.28926650070275,0.20512820512820512,0.8984799693625916,1.0,1/6,1.74%,OSR1
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Embryonic Prefrontal Cortex,0.5602184316200726,1.2890598310371304,0.05952380952380952,1.0,1.0,17/146,9.53%,CLIC1;CDCA3;SGO1;PCLAF;APOLD1;MCM2;BUB1;CENPU;HAT1;ASPM;NDC80;MCM3;H2AZ1;CKS1B;OIP5;EMX1;RPA3
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.5654088783743124,-1.2889228187253028,0.17391304347826086,0.8982547032683725,1.0,8/46,10.86%,GCK;NUP210;NUP42;POM121C;NUP214;NOA1;AAAS;ZBTB7A
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.6724279758746644,1.288854348790641,0.1388888888888889,1.0,1.0,10/26,14.73%,TEX101;SLC25A31;BANF2;SYCP1;SYCP3;CRISP1;ASB17;LYZL2;TNP1;WDR87
prerank,CellMarker_Augmented_2021__CD4+ T cell:Undefined,-0.7229569019041143,-1.288841530330902,0.20512820512820512,0.8971906455711333,1.0,2/12,3.16%,IL7R;SELE
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.7538275798835057,1.2888210669370386,0.13559322033898305,1.0,1.0,2/11,5.31%,ARIH2;WNT5A
prerank,GO_Biological_Process_2021__apoptotic chromosome condensation (GO:0030263),0.8095745062354565,1.288798330854953,0.19672131147540983,1.0,1.0,2/5,11.61%,GPER1;ERN2
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.7734657435369863,1.288742474872374,0.175,1.0,1.0,1/11,0.43%,TULP1
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Lung,0.5765976669326888,1.2887351901410338,0.06944444444444445,1.0,1.0,12/59,6.02%,ST6GALNAC1;PLEKHS1;CAPN13;TCN1;LIPH;CYP4F12;CLCA4;TMEM45B;ITGB6;MISP;SMIM22;FUT2
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryo,0.5753192683020126,1.2886873809893802,0.09210526315789473,1.0,1.0,16/58,16.98%,CLDN6;SCGB3A2;ARHGEF40;COL18A1;CYYR1;SYT2;FOXA3;SALL4;NODAL;L1TD1;UGT3A2;TCF7L1;CHST4;SLC7A3;FBN3;NSUN7
prerank,GO_Biological_Process_2021__negative regulation of striated muscle tissue development (GO:0045843),0.8286805104044135,1.2886546620671264,0.13793103448275862,1.0,1.0,1/5,4.27%,TGFB1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.6817246895005954,1.2884945853317344,0.12307692307692308,1.0,1.0,1/12,1.47%,CASQ2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.5740782748403763,1.2882810280878811,0.16666666666666666,1.0,1.0,27/75,13.47%,C1QB;ITGB2;CLEC5A;C3AR1;TLR2;TNFRSF1B;ITGAX;LILRB3;SASH3;PTAFR;ITGAM;NFAM1;FCGR3A;ADGRE1;VSIG4;GPIHBP1;CLEC12A;FGL2;CHIT1;HCK;CSF3R;HK3;IGSF6;CD4;MYO1F;CSF1R;FPR1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.688976594584966,1.288181470703076,0.1111111111111111,1.0,1.0,3/15,18.99%,CCL5;CXCL12;CCL25
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.5771366811308735,-1.2881691217236704,0.15384615384615385,0.8989715887004973,1.0,7/41,10.86%,GCK;NUP210;NUP42;POM121C;NUP214;AAAS;ZBTB7A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periodontal Ligament,0.7608573417886969,1.288026789116512,0.1896551724137931,1.0,1.0,3/8,16.35%,PTPRC;CD44;ENG
prerank,GO_Biological_Process_2021__regulation of natural killer cell cytokine production (GO:0002727),0.8481053942678409,1.2877631824559943,0.17647058823529413,1.0,1.0,2/5,5.53%,CD160;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell cytokine production (GO:0002729),0.8481053942678409,1.2877631824559943,0.17647058823529413,1.0,1.0,2/5,5.53%,CD160;HLA-F
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.8473274543109535,1.2876532729754278,0.23076923076923078,1.0,1.0,2/5,13.08%,ACE2;AGT
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.7533398913650743,1.2875711536766308,0.16129032258064516,1.0,1.0,1/13,1.12%,CAVIN1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),-0.6805554280012371,-1.2875661657344726,0.23076923076923078,0.9002161895177926,1.0,4/9,24.42%,GALNT13;POGLUT3;GALNT2;GALNT1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.5270933274562178,-1.2875628483454464,0.14814814814814814,0.8987872749312564,1.0,7/44,12.23%,GMNC;ESCO2;DSCC1;CTC1;ATR;BRPF3;STN1
prerank,GO_Biological_Process_2021__proline transmembrane transport (GO:0035524),-0.7927014807419764,-1.2874804096979868,0.16279069767441862,0.8977698105531288,1.0,1/5,1.89%,SLC6A20
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.5670765718611394,1.287465955820944,0.12195121951219512,1.0,1.0,16/79,15.38%,CDC25A;SPDYA;CCNG2;CDKN2A;CCND2;CCND1;CCNE2;INCA1;CDKN1B;CDKN1A;CCNA2;CCNI;PKMYT1;CDKN2C;LATS2;CDK5R1
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.7710295539281748,1.2873936859436965,0.11428571428571428,1.0,1.0,2/10,4.27%,TNFRSF1B;TGFB1
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation R-HSA-76046,-0.5286140383576958,-1.2870413068404964,0.13636363636363635,0.8983603613260618,1.0,11/35,22.32%,POLR3D;BDP1;POLR3E;POLR3K;POLR2F;POLR3A;POLR3B;BRF1;POLR3F;SNAPC3;BRF2
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.5090205758731673,-1.286989926127828,0.12,0.897225095473466,1.0,13/47,15.77%,NGF;LIMK1;CPNE6;AGRN;ISLR2;SYT3;SYT17;GOLGA4;DBNL;DLL1;RNF157;PPIB;MAP3K13
prerank,Reactome_2022__Sema4D Mediated Inhibition Of Cell Attachment And Migration R-HSA-416550,0.7802383978610725,1.2869561207378382,0.1111111111111111,1.0,1.0,1/8,1.85%,RRAS
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),0.8441326244966941,1.286920693441547,0.16363636363636364,1.0,1.0,1/6,1.12%,LMOD3
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.8409542252145735,1.2865261164029824,0.1111111111111111,1.0,1.0,1/7,0.44%,SMAD6
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7145633431460667,1.2865165393863616,0.19444444444444445,1.0,1.0,3/12,6.35%,ITGB2;CD81;SYK
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.8301244569741356,-1.286320482365675,0.1282051282051282,0.8985233848980018,1.0,2/6,10.31%,RPF2;NOL8
prerank,Reactome_2022__Linoleic Acid (LA) Metabolism R-HSA-2046105,0.8077304851286723,1.286153167852409,0.14754098360655737,1.0,1.0,1/7,1.04%,ELOVL2
prerank,Reactome_2022__Nef Mediated CD4 Down-regulation R-HSA-167590,0.8132910116950013,1.2860087241466227,0.11538461538461539,1.0,1.0,1/8,11.98%,CD4
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),-0.8159199372363617,-1.2847446690122044,0.1,0.9026822319035989,1.0,2/5,9.61%,MAPRE1;GAS2L2
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),-0.8159199372363617,-1.2847446690122044,0.1,0.9026822319035989,1.0,2/5,9.61%,MAPRE1;GAS2L2
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.6644862712870002,-1.2841774034923668,0.18181818181818182,0.9043084650640516,1.0,4/11,14.90%,MT1G;AQP1;HSF1;MT1E
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.8452754209430854,-1.2840992672355804,0.17647058823529413,0.9031727732326547,1.0,2/5,9.59%,BNIP2;BNIPL
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.5759806551302753,-1.283936734771179,0.19230769230769232,0.9023219146724561,1.0,5/19,18.93%,TRIM71;KDM2B;PTPRZ1;INSM1;PROX1
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.658585316155245,1.2838988694094113,0.09859154929577464,1.0,1.0,3/23,4.60%,TLR2;MYRF;SOX10
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),0.7527961726291138,1.2836116378148303,0.15942028985507245,1.0,1.0,2/8,6.06%,ENPP2;PON1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.5294691179203775,-1.283610979962856,0.16666666666666666,0.9027374913653333,1.0,18/47,21.24%,HNRNPL;CELF5;SRRM4;ZBTB7A;FXR2;SMU1;NOVA1;PTBP1;CELF4;THRAP3;RBM11;RBMX;RBFOX2;RBM24;RBM8A;KHDRBS1;CELF2;RBM25
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),0.7796545784579677,1.2834374750997994,0.10344827586206896,1.0,1.0,5/8,20.48%,PDE6A;CNGA1;PDE6B;PDE6G;GNGT1
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.7737208192136117,1.2833637307456582,0.10294117647058823,1.0,1.0,1/6,10.73%,GLRA1
prerank,CellMarker_Augmented_2021__Eosinophil:Undefined,0.6835669561093759,1.283320233054082,0.23529411764705882,1.0,1.0,4/19,5.07%,C3AR1;CSF2RA;PTPRC;ADGRE1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",-0.7961146974726706,-1.2831731561606847,0.15151515151515152,0.9034722297563076,1.0,2/6,9.67%,ADRA1A;NLGN2
prerank,CellMarker_Augmented_2021__Eosinophil:Blood,0.7747491912654747,1.283163872912627,0.15789473684210525,1.0,1.0,6/11,15.41%,CSF2RA;ITGAM;CD81;CSF3R;CD44;IL3RA
prerank,CellMarker_Augmented_2021__Neuron:Adipose Tissue,-0.46689625540193075,-1.2830812712471271,0.16666666666666666,0.9024848985805958,1.0,17/99,13.61%,EFR3B;TYRO3;SHC3;CELF5;CASKIN1;ELAVL3;KIAA1549L;LHFPL4;INA;SNCB;GABRA5;HPCA;SRRM3;TAGLN3;ADGRA1;BRINP1;JPH3
prerank,CellMarker_Augmented_2021__Mesodermal Embryonic Stem cell:Germ,0.5627973263840532,1.2829857868395784,0.11428571428571428,1.0,1.0,16/70,11.38%,ENPP2;C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;GPIHBP1;GGT5;RAMP3;HGF;ADGRL4;ZNF366;VWF;DCN;CLDN5
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.7319903470583933,1.2829376162459478,0.18181818181818182,1.0,1.0,2/13,5.05%,TBX1;HEY2
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),-0.7935847967146186,-1.2826778539960872,0.14634146341463414,0.9026986193789891,1.0,3/6,9.74%,APOE;LHFPL4;SHISA7
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.6922401982247358,-1.2824732224904842,0.13513513513513514,0.9022338746951426,1.0,3/15,6.27%,ACER2;ACER3;DHFR
prerank,GO_Biological_Process_2021__columnar/cuboidal epithelial cell differentiation (GO:0002065),0.8966750913547302,1.2822909989550486,0.13793103448275862,1.0,1.0,3/5,9.24%,GATA4;ROS1;NPY
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.8841579655745051,-1.2822330689280366,0.11904761904761904,0.9016511444510913,1.0,2/5,10.68%,MFSD2A;SLC27A4
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),0.8585222769140798,1.282123961277931,0.11764705882352941,1.0,1.0,1/5,4.27%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),0.8585222769140798,1.282123961277931,0.11764705882352941,1.0,1.0,1/5,4.27%,TGFB1
prerank,GO_Biological_Process_2021__cardiolipin biosynthetic process (GO:0032049),-0.8137721051641913,-1.2819553293607897,0.14634146341463414,0.901487564478615,1.0,2/5,9.84%,CRLS1;PGS1
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,-0.5391044766431073,-1.2816212860861071,0.08,0.901562605080087,1.0,7/29,15.25%,MAML1;GATD3;JAG2;MAMLD1;JAG1;NEURL1;DLL1
prerank,CellMarker_Augmented_2021__Epithelial cell:Placenta,-0.5267433340737906,-1.2815696310975737,0.06666666666666667,0.9003892399314803,1.0,13/62,10.09%,ADGRF4;CLDN4;ANXA8;ARSJ;LAMA3;RND3;PHLDA2;PERP;GPRC5A;NTN4;ITGB4;EFEMP1;ITGA3
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.5440122255869017,-1.281450875948923,0.12903225806451613,0.8994568718270907,1.0,4/36,8.76%,DCPS;TRIM71;KHSRP;ZC3H12D
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.7624470701355978,-1.28117937085052,0.1951219512195122,0.8992581716504306,1.0,2/5,19.25%,LIG3;XRCC4
prerank,CellMarker_Augmented_2021__Neuron:Undefined,-0.5806431668002289,-1.280960353305837,0.125,0.8986064992159684,1.0,6/32,13.00%,IL11;BCL2;FOS;CX3CR1;ALCAM;EPOR
prerank,CellMarker_Augmented_2021__Plasmablast:Peripheral Blood,0.6057608811336471,1.2804949065881073,0.16216216216216217,1.0,1.0,10/31,12.21%,DENND1C;BLNK;SASH3;JCHAIN;SYK;HSH2D;NAPSB;HCK;IKZF1;PNOC
prerank,CellMarker_Augmented_2021__Immature Transitional B cell:Blood,0.6057608811336471,1.2804949065881073,0.16216216216216217,1.0,1.0,10/31,12.21%,DENND1C;BLNK;SASH3;JCHAIN;SYK;HSH2D;NAPSB;HCK;IKZF1;PNOC
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.6611400031329676,1.280494530627006,0.16923076923076924,1.0,1.0,5/23,14.32%,AQP3;CYP4F12;RAB11A;AQP4;ADCY7
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.5628324445354673,-1.2804503901131574,0.13793103448275862,0.8995714664738881,1.0,8/38,17.45%,EPHX2;SYNJ2;PLPPR3;PLPP2;MTMR8;MTMR1;PLPPR1;TPTE2
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.6145186957020576,1.2803989566561034,0.13513513513513514,1.0,1.0,9/43,13.47%,SMAD6;KIF14;HSPA5;DDX3X;RPL13A;NLRC3;TMC8;NOP53;TFIP11
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.5684622187244567,-1.2803826171267136,0.16666666666666666,0.8986460619925843,1.0,10/24,18.42%,KDM8;KDM7A;KDM3B;KDM2B;PHF2;KDM4D;KDM1B;HR;KDM4B;KDM2A
prerank,Reactome_2022__Recycling Of Bile Acids And Salts R-HSA-159418,0.7204092021089711,1.279935143147811,0.06666666666666667,1.0,1.0,4/14,7.24%,SLC10A1;SLCO1A2;SLC51A;NR1H4
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),0.8404165214766872,1.2799152744845073,0.11627906976744186,1.0,1.0,1/5,3.49%,RP1
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),0.8404165214766872,1.2799152744845073,0.11627906976744186,1.0,1.0,1/5,3.49%,RP1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.6080684690554267,1.2798373391850744,0.1232876712328767,1.0,1.0,9/42,8.61%,AQP3;ESR1;WNT8B;ANXA1;CCL5;TGFB1;SOCS2;GGT5;CYP1B1
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7533121866628203,1.279637923685703,0.16923076923076924,1.0,1.0,2/13,9.44%,STK26;RAPGEF6
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.7897421407481373,-1.279443591731526,0.1724137931034483,0.9016299617462548,1.0,3/8,18.26%,SLC25A37;SLC39A8;ABCC5
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),0.799568407298511,1.2793085810104876,0.2,1.0,1.0,3/6,7.69%,MCM2;MCMDC2;MCM3
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),0.799568407298511,1.2793085810104876,0.2,1.0,1.0,3/6,7.69%,MCM2;MCMDC2;MCM3
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.7758204238049571,1.2790465296544684,0.16417910447761194,1.0,1.0,4/8,14.41%,RORC;LEF1;GPR183;IL4
prerank,KEGG_2021_Human__Mannose type O-glycan biosynthesis,-0.6106380501850223,-1.2790430449316765,0.1,0.9017822706353407,1.0,4/21,9.89%,ST3GAL3;RXYLT1;B4GALT2;FKTN
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Placenta,0.5576387741504889,1.2789652826956617,0.11688311688311688,1.0,1.0,20/71,10.69%,ENPP2;C1QB;ARHGAP31;ADAM33;LYVE1;TMEM204;PTPRC;FLT1;VSIG4;MYH11;FLI1;FGL2;GGT5;RAMP3;HGF;ACTA2;ADGRL4;VWF;DCN;HLA-DPB1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.6650216881495873,1.2783267972409358,0.16393442622950818,1.0,1.0,7/20,13.33%,CAVIN1;TGFB1;DUOX1;P2RY12;F2RL1;THBS1;CSF1R
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),0.8905023485714573,1.277946779760569,0.1509433962264151,1.0,1.0,1/5,8.36%,ALDOB
prerank,Reactome_2022__G0 And Early G1 R-HSA-1538133,0.6096198368705106,1.2779345433180465,0.14925373134328357,1.0,1.0,3/25,13.25%,CDC25A;CCNE2;CCNA2
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.5820255809602884,-1.2778187143331754,0.14705882352941177,0.9065723650768113,1.0,4/24,8.43%,ABHD17A;WNT3A;MDGA1;SLITRK2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.6665683247941885,-1.2775860435517417,0.24242424242424243,0.9059545930478492,1.0,4/14,22.68%,CPEB1;UNK;RBM24;DHX36
prerank,KEGG_2021_Human__Cell cycle,0.5366669189941164,1.2774279986829744,0.0875,1.0,1.0,19/114,14.01%,CDC25A;MCM2;BUB1;TGFB1;CDKN2A;CCND2;MCM3;CCND1;WEE2;TGFB3;CCNE2;CDKN1B;CDC14A;SMC1B;CDKN1A;TTK;CCNA2;PKMYT1;CDKN2C
prerank,GO_Biological_Process_2021__ADP transport (GO:0015866),-0.8204877191434576,-1.2773550553504602,0.15789473684210525,0.9056899001543849,1.0,3/5,14.29%,SLC17A9;SLC25A42;SLC25A41
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),-0.7298416464767076,-1.277100969209941,0.24390243902439024,0.9038596323402531,1.0,2/5,19.04%,PDE3A;HCN2
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),-0.7298416464767076,-1.277100969209941,0.24390243902439024,0.9038596323402531,1.0,2/5,19.04%,PDE3A;HCN2
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,0.5263231296105254,1.276977336597684,0.0375,1.0,1.0,62/139,25.85%,ATP6V1G2;RPL37A;RPL21;DEPDC5;RPL9;RPL18A;RRAGA;ATP6V0E2;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;WDR24;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;ATP6V0B;RSL24D1;RPLP2;LAMTOR3;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;SESN1;RPL27;RPS14;RPL7A;RPL23;ATP6V1D;RPS15;DDIT3;RPS27;RPL8;RPS3;RPS23;ATP6V0D1;RPS20;RPS24;RPS29;CEBPB;RPLP1;RPS28
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),-0.6094025415595324,-1.2767729328886455,0.16666666666666666,0.9041819892469203,1.0,8/13,30.48%,ALKBH8;CTU1;TRMT9B;MTO1;ELP1;ELP4;ELP3;URM1
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),-0.852713574504492,-1.2763668861199147,0.14705882352941177,0.9048718449087275,1.0,2/6,0.57%,ADRA1A;ADRA1B
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.6390594677621066,-1.2762992176370391,0.18181818181818182,0.9038749475404129,1.0,2/13,11.54%,RNF168;EAPP
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),0.7673045452132404,1.2762754743590952,0.11864406779661017,1.0,1.0,1/8,1.47%,CDHR5
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),0.8228124343258857,1.2761173007960125,0.10526315789473684,1.0,1.0,2/5,14.62%,DUOX1;CYBA
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.7668546098669102,-1.2759945035079219,0.17391304347826086,0.9037511226306602,1.0,3/7,20.07%,GTF2H2;ARRB2;ARRB1
prerank,CellMarker_Augmented_2021__Microglial cell:Undefined,0.7751211804894211,1.2758814651924715,0.14285714285714285,1.0,1.0,4/8,9.55%,PTPRC;ITGAM;ADGRE1;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.7088464574494431,-1.2758774748439223,0.25,0.9029326610225926,1.0,5/8,22.84%,PDE3A;RNF157;CDC34;PDE3B;UBE2B
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.6651277482046203,1.2758433571849723,0.22033898305084745,1.0,1.0,9/23,21.51%,DAO;ABHD14B;LIAS;GRHPR;SULT2A1;BPNT2;SULT4A1;GNMT;SULT6B1
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.7430282726338917,-1.2753768952683784,0.175,0.9039672320487792,1.0,2/8,7.68%,TMEM106A;CX3CR1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),-0.7754537247697193,-1.2751591291264506,0.20454545454545456,0.9035166110756653,1.0,1/5,16.33%,MTMR1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.6365282578650235,1.2750018411947546,0.11940298507462686,1.0,1.0,7/28,16.48%,PIK3R3;FGF2;FLT1;TGFB1;P2RY12;TNFAIP8L3;WASHC1
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.7433033161816782,1.274870493167805,0.13846153846153847,1.0,1.0,2/8,14.31%,SCIN;TMSB10
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.6894020646793935,1.2744847123383956,0.12987012987012986,1.0,1.0,4/19,10.19%,CDC25A;DTL;CCND1;RAB11A
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),0.83784921894022,1.2743778011807483,0.1323529411764706,1.0,1.0,1/6,7.33%,ITGA5
prerank,CellMarker_Augmented_2021__Circulating Precursor cell:Peripheral Blood,0.5844605099638361,1.2739567373002365,0.0958904109589041,1.0,1.0,18/62,14.40%,C1QB;ADAM28;LYVE1;ITM2A;SASH3;PTPRC;FCGR3A;VSIG4;MYH11;FGL2;HPGDS;IKZF1;VWF;HLA-DPB1;LPAR6;CD4;CSF1R;PARVG
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,-0.6198473390891862,-1.2738889103317796,0.2413793103448276,0.9082564978097936,1.0,7/32,16.66%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;NUP98
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.5440216323339515,-1.273865924637793,0.16666666666666666,0.9069564359114978,1.0,3/23,3.29%,TYRO3;SIGIRR;IFI16
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),-0.6981137880168442,-1.2738587008744469,0.21621621621621623,0.9056219313244904,1.0,5/9,26.10%,PGAP1;STX18;RINT1;SORL1;TBC1D20
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),-0.7937193660854467,-1.2738317507288235,0.23076923076923078,0.9044444698225906,1.0,3/6,17.08%,SERPINB9;CARD9;IRAK4
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.7859110076323429,1.273689063070661,0.0967741935483871,1.0,1.0,3/8,14.41%,ANXA1;TNFSF4;IL4
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta1 production (GO:0032908),-0.7795075951032632,-1.2736646728382321,0.23684210526315788,0.9036908162084434,1.0,1/5,0.50%,TSKU
prerank,CellMarker_Augmented_2021__GABAergic neuron:Undefined,0.9019608668252769,1.2736590443141886,0.09090909090909091,1.0,1.0,1/5,1.54%,GAD1
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.7713978193885418,1.273631927042054,0.2,1.0,1.0,1/13,1.05%,BACE2
prerank,CellMarker_Augmented_2021__T cell:Ascites,0.6110116794477144,1.2734452926082735,0.14102564102564102,1.0,1.0,24/46,19.79%,ITGB2;CYTIP;ARHGAP9;SASH3;PTPRC;FCGR3A;FGL2;HCK;IKZF1;TAGAP;HK3;THEMIS;CD4;PSTPIP1;MYO1F;KLRB1;SIRPG;PARVG;CD244;ZAP70;TIGIT;CD8B;TNFSF8;CD5
prerank,Reactome_2022__Dectin-2 Family R-HSA-5621480,0.6870336111405375,1.2732416442666072,0.1746031746031746,1.0,1.0,5/17,10.13%,CLEC4C;MUC17;SYK;MUC4;MUCL1
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.7150075199324835,-1.273151901175728,0.1891891891891892,0.9041221340496598,1.0,1/9,4.78%,APOE
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.6743494706564007,1.2731397877763326,0.15492957746478872,1.0,1.0,6/30,16.21%,VSIR;NR1H4;IGF1;NLRC3;IL4;GHRL
prerank,CellMarker_Augmented_2021__Macrophage:Serum,0.8639408469721827,1.2728891889650813,0.09259259259259259,1.0,1.0,4/5,13.33%,ITGAX;ITGAM;ADGRE1;CSF1R
prerank,Reactome_2022__SUMO Is Proteolytically Processed R-HSA-3065679,-0.75775836302057,-1.2728696033268925,0.21739130434782608,0.9039235874961709,1.0,3/5,17.28%,SENP1;SUMO2;SENP5
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5037141730969827,-1.2727824868192315,0.05263157894736842,0.9029077779805954,1.0,12/57,13.76%,BUD23;NSUN4;TRDMT1;METTL1;TFB1M;METTL8;PCIF1;METTL6;TRMT61B;TRMT61A;ZCCHC4;ALKBH8
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.8308922003413769,1.2726748872675584,0.20634920634920634,1.0,1.0,1/5,6.68%,NODAL
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.7810037351244954,1.2725432199456186,0.13114754098360656,1.0,1.0,3/9,5.60%,AMBP;ABCG2;ABCC2
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.7810037351244954,1.2725432199456186,0.13114754098360656,1.0,1.0,3/9,5.60%,AMBP;ABCG2;ABCC2
prerank,CellMarker_Augmented_2021__Mesoderm cell:Undefined,-0.48141685583230265,-1.2724291589422931,0.08695652173913043,0.9027685902096894,1.0,28/92,18.22%,CBARP;P3H4;KHSRP;TTYH3;SOX12;B4GALT2;AGRN;NACC1;FGD1;FAM234A;FSCN1;NLGN2;P3H3;LRFN4;ERCC2;LLGL1;ZC3H7B;NAT14;PLOD3;SCRIB;GPC1;CSNK1E;ZNF512B;SERPINH1;ABL1;GALNT2;TMEM201;NRSN2
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.7466310798450763,1.2723208125248284,0.12121212121212122,1.0,1.0,1/10,0.80%,ITGB2
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,-0.5022820459877412,-1.2722091352709903,0.12,0.9023453595086388,1.0,17/48,16.59%,NDST3;XYLT1;GLB1L;GPC6;GPC2;SDC3;GPC4;HS6ST2;AGRN;VCAN;IDUA;B3GAT3;GUSB;CSPG5;GPC1;SDC4;EXT1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.6293012634846824,1.2721524221892744,0.15942028985507245,1.0,1.0,5/30,5.05%,GATA4;SMAD6;TNFRSF1B;TGFB1;HEY2
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.5917168348661808,-1.2721108020186125,0.14705882352941177,0.901506793238025,1.0,9/21,24.40%,APOE;SHANK1;DLG5;NEURL1;DBNL;LRP8;CUX2;DHX36;NLGN1
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6695442634669738,1.2720379204777594,0.15151515151515152,1.0,1.0,3/22,3.75%,SLC12A7;CYP4F12;SLC12A3
prerank,Reactome_2022__MECP2 Regulates Transcription Of Neuronal Ligands R-HSA-9022702,-0.7577414993352682,-1.271979606354659,0.17073170731707318,0.9007274202227737,1.0,3/7,15.25%,CRH;MECP2;DLL1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.6399976482298038,1.2718573356769403,0.21739130434782608,1.0,1.0,7/28,19.16%,CCL5;VAPB;IFIT1;DDX3X;NR5A2;PPID;FKBP6
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.7042037867702462,1.271825794597484,0.13636363636363635,1.0,1.0,1/12,4.32%,LMO2
prerank,PanglaoDB_Augmented_2021__Basophils,0.553020110778777,1.2717723610458465,0.10256410256410256,1.0,1.0,35/99,15.41%,CLEC5A;C3AR1;TLR2;ITGAX;LILRB3;NFIL3;PTAFR;ITGAM;TFEC;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HGF;HCK;CSF3R;ID1;MBOAT1;HK3;GRM6;CD4;GPR183;HTR1B;MYO1F;CSF1R;FPR1;PLG;P2RX1;IL4;CD44;ADGRE3;CD300LF;PIK3R6;IL3RA
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.6320467799365177,-1.27163423910911,0.2571428571428571,0.9008754567872956,1.0,2/20,8.87%,PLK3;CNOT9
prerank,CellMarker_Augmented_2021__Endothelial cell:Ovary,-0.7013542658961784,-1.2714856771978054,0.225,0.9000804475310231,1.0,1/7,0.96%,CLDN4
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Skin,0.8878173050159219,1.271414292394268,0.05454545454545454,1.0,1.0,2/5,7.30%,ITGA2;NT5E
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,0.6845511142351218,1.2711383380009171,0.18571428571428572,1.0,1.0,9/21,27.15%,CSF2RA;PIK3R3;IL5;IL3RA;IL2RA;INPP5D;PIK3CB;INPPL1;IL5RA
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,-0.5075600963793313,-1.2710751440215495,0.07407407407407407,0.9006619639192184,1.0,8/45,18.11%,PRKCD;ITPR2;GNA14;GNA11;ADCY2;PRKCA;ADCY6;PRKAR2A
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.6613707473388469,1.2710086685262476,0.14285714285714285,1.0,1.0,4/26,4.19%,SASH3;CLCF1;PTPRC;C17ORF99
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.666021812464412,-1.2707115016857897,0.1891891891891892,0.901035010290489,1.0,3/15,9.91%,KLHL20;GBF1;DOP1B
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.800739366263508,1.2706590861978,0.17142857142857143,1.0,1.0,3/8,13.21%,C3;F2RL1;ALOX15
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.6594348848554352,1.270540862295577,0.19696969696969696,1.0,1.0,3/17,6.35%,BLK;C1QTNF1;SYK
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),0.8835521078786654,1.27050970008404,0.1320754716981132,1.0,1.0,1/5,2.00%,NOX5
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.7226370872797225,1.2704922493930557,0.14754098360655737,1.0,1.0,3/10,5.77%,GATA4;TGFB1;GPER1
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.582221974471165,-1.2703534334332662,0.17391304347826086,0.9010315751631118,1.0,9/32,15.64%,APOH;DGKD;PNPLA3;APOE;PGS1;GK5;LPL;ABHD12;AWAT2
prerank,GO_Biological_Process_2021__positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),0.816746839756668,1.2702570779045732,0.1935483870967742,1.0,1.0,1/5,2.57%,ANXA1
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.6275814145413146,1.2702477181470642,0.10526315789473684,1.0,1.0,5/37,5.72%,TBX1;MYBPC3;ALPK2;HEY2;MESP1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.7248227600001294,1.269968109509341,0.140625,1.0,1.0,2/12,5.05%,SMAD6;HEY2
prerank,CellMarker_Augmented_2021__Stem cell:Adipose Tissue,0.8134154593381935,1.2699409985455423,0.15517241379310345,1.0,1.0,5/10,16.35%,PTPRC;ABCG2;NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.5911738775184171,1.2694891249599118,0.11688311688311688,1.0,1.0,6/65,6.63%,SLC22A3;GAD1;HSPA8;SLC18A2;SLC17A8;SLC6A4
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.8064568482282003,1.2694313690031434,0.19672131147540983,1.0,1.0,1/6,3.38%,AHR
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.6264561644023663,-1.2693864142071472,0.16216216216216217,0.9037645018054916,1.0,4/24,17.45%,SYNJ2;MTMR8;MTMR1;TPTE2
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,0.6553367945499826,1.2693767421634472,0.08450704225352113,1.0,1.0,1/23,0.37%,NEK2
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,-0.4520749312368761,-1.2692287930139137,0.0625,0.9031395089702292,1.0,32/106,14.81%,NDST3;ST3GAL3;CHPF2;XYLT1;GLB1L;GPC6;UST;GPC2;SDC3;PAPSS2;GPC4;HS6ST2;ARSB;B4GALT2;AGRN;CHST11;ST3GAL2;CHST12;CHSY1;CSGALNACT1;SPAM1;VCAN;CHST6;PRELP;IDUA;B3GAT3;B4GALT4;ST3GAL4;CHST3;GUSB;CSPG5;GPC1
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.6301687141080827,1.269133101240386,0.18840579710144928,1.0,1.0,6/26,12.64%,TNFRSF1B;CCL5;C3;NR1H4;EIF6;PDK4
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.6391735145719178,-1.269003494099337,0.15151515151515152,0.9029274622241028,1.0,2/12,11.54%,RNF168;EAPP
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.674504157384889,1.2688122820329233,0.18840579710144928,1.0,1.0,7/20,15.99%,CCL5;JAM2;IL12A;PLA2G7;IL4;CXCL12;AGER
prerank,KEGG_2021_Human__Type I diabetes mellitus,0.641921648387672,1.2684752543449704,0.1791044776119403,1.0,1.0,7/23,10.69%,GAD1;HLA-F;IL12A;CD80;HLA-A;HLA-DMA;HLA-DPB1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.5058138392154341,-1.268322963458002,0.08571428571428572,0.9041715439337756,1.0,8/36,12.57%,GRID2;GRIN3A;GRIK4;GRIK1;GRIA4;GRIN1;DAGLA;GRM2
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,0.6371425174565399,1.2682681678207548,0.11594202898550725,1.0,1.0,11/41,20.57%,SYCP1;SYNE2;SYCP3;H2BC4;H2AZ1;STAG3;SMC1B;BRCA1;HSPA2;FKBP6;H2AZ2
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),-0.736300567772846,-1.2681393633962323,0.25,0.9037163815773627,1.0,2/6,15.25%,CDK6;DLL1
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.781330973623773,1.2680633140707904,0.19298245614035087,1.0,1.0,6/9,13.91%,GP1BA;CPB2;PLAUR;PLAU;PLAT;PLG
prerank,Reactome_2022__Release Of Hh-Np From Secreting Cell R-HSA-5362798,0.8247575276158672,1.2679804418525638,0.16393442622950818,1.0,1.0,2/6,11.40%,NOTUM;SCUBE2
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.4572900548192726,-1.2679784553756077,0.1,0.9031136879510652,1.0,23/96,17.28%,NUP210;P3H4;RNF113A;LOXL1;HDAC10;PIAS3;NUP42;POM121C;NUP214;SENP1;P3H3;AAAS;BCL11A;NNAT;SIRT7;PLOD3;RNF212;EEF1AKMT1;NUP37;PIAS4;NUP98;SUMO2;SENP5
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.5005407113114039,-1.267962120656316,0.09090909090909091,0.9018996186676095,1.0,14/96,12.09%,CPSF1;NUP210;IWS1;NUP42;MAGOHB;POM121C;NUP214;SRRM1;SRSF4;AAAS;NXF5;UPF2;SYMPK;U2AF2
prerank,Reactome_2022__Choline Catabolism R-HSA-6798163,0.8379857150257213,1.267929398042949,0.13559322033898305,1.0,1.0,2/6,2.47%,BHMT;CHDH
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.8379857150257213,1.267929398042949,0.13559322033898305,1.0,1.0,2/6,2.47%,BHMT;CHDH
prerank,CellMarker_Augmented_2021__Stem cell:Dental Pulp,0.7235349842003813,1.2678459562107107,0.1724137931034483,1.0,1.0,4/11,16.35%,PTPRC;NT5E;CD44;ENG
prerank,CellMarker_Augmented_2021__Marginal Zone B cell:Undefined,0.8299560863228421,1.267805639625349,0.12121212121212122,1.0,1.0,3/7,6.03%,PTPRC;EBF1;CD81
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),0.8254234295987775,1.2677210088983126,0.14516129032258066,1.0,1.0,2/5,9.92%,PKP2;NEFM
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.6775241659049931,1.2676382610664036,0.18571428571428572,1.0,1.0,6/17,22.42%,OSCAR;GPR183;CSF1R;CSF1;ANXA2;DCSTAMP
prerank,CellMarker_Augmented_2021__Granulosa cell:Ovary,-0.46514378815374546,-1.267542998893742,0.08695652173913043,0.9029710215523807,1.0,16/67,9.38%,IL11;CBARP;P3H4;TWIST1;COL4A2;RAI14;TWIST2;FADS1;MTHFD1L;PHLDA2;TEAD4;DLX1;NCS1;FOSL1;FSCN1;FIBCD1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.6452230820546698,1.2674001809910322,0.16129032258064516,1.0,1.0,7/29,17.01%,ESR1;TRIM25;ZNF366;CRHBP;WBP2;GHRL;BRCA1
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Embryonic Stem Cell,0.5982634207351116,1.2671510106423796,0.1232876712328767,1.0,1.0,19/45,16.24%,AMBP;OIT3;SLC28A1;ITIH2;CYP3A4;PON1;SLC22A7;NR1H4;SMLR1;CPB2;ALDOB;KNG1;MTTP;C3P1;ANGPTL3;GBA3;MOGAT2;HNF1A;ABCG5
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Embryo,0.5982634207351116,1.2671510106423796,0.1232876712328767,1.0,1.0,19/45,16.24%,AMBP;OIT3;SLC28A1;ITIH2;CYP3A4;PON1;SLC22A7;NR1H4;SMLR1;CPB2;ALDOB;KNG1;MTTP;C3P1;ANGPTL3;GBA3;MOGAT2;HNF1A;ABCG5
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Liver,0.5543444935814875,1.2670039658317265,0.1506849315068493,1.0,1.0,21/77,15.53%,ENPP2;C1QB;ARHGAP31;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;DAAM2;RAMP3;ADGRL4;ZNF366;VWF;DCN;COLEC12;PLN;EDNRB;SLCO2B1;CXCL12
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.743278099540079,1.2669031853012624,0.15714285714285714,1.0,1.0,3/12,7.79%,ANXA1;GPER1;REST
prerank,CellMarker_Augmented_2021__Cancer cell:Peripheral Blood,0.8010364765585175,1.2666608478667425,0.2,1.0,1.0,2/5,12.25%,SALL4;EPCAM
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.696336782833857,-1.2666014043630138,0.175,0.9052805593427004,1.0,2/14,6.76%,ENTPD2;ADPRM
prerank,Reactome_2022__LDL Clearance R-HSA-8964038,-0.6741862055244543,-1.2664512645749948,0.1935483870967742,0.9044755956990497,1.0,1/16,0.54%,APOB
prerank,CellMarker_Augmented_2021__Fibroblast:Lung,0.7296288811926931,1.2662859434447047,0.24193548387096775,1.0,1.0,1/8,8.34%,ACTA2
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.6673001106961205,1.2662381070364666,0.1774193548387097,1.0,1.0,4/16,14.66%,TBX1;MYO3B;SOX9;ZIC1
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),-0.789162950112922,-1.2661177053662165,0.3333333333333333,0.9043010122802233,1.0,3/6,18.01%,TFCP2;C5AR1;MED1
prerank,Reactome_2022__Interleukin-21 Signaling R-HSA-9020958,0.7640670349515056,1.2661075928099246,0.08620689655172414,1.0,1.0,3/8,11.19%,IL21R;STAT5A;STAT1
prerank,Reactome_2022__Neurotoxicity Of Clostridium Toxins R-HSA-168799,0.7420933817774107,1.2659599811404303,0.2153846153846154,1.0,1.0,2/9,6.81%,SYT2;VAMP1
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),-0.7630096563069948,-1.265864255185547,0.25,0.9040531468446887,1.0,3/6,21.00%,NR4A3;ADCY6;GNG2
prerank,CellMarker_Augmented_2021__Myeloid Conventional Dendritic cell:Bone Marrow,0.7825973717948831,1.2657820097098227,0.1935483870967742,1.0,1.0,3/8,12.35%,ITGAX;ITGAM;XCR1
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.751326044400072,-1.265707645985137,0.20512820512820512,0.9021432802589096,1.0,2/7,11.35%,EEFSEC;SECISBP2
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.751326044400072,-1.265707645985137,0.20512820512820512,0.9021432802589096,1.0,2/7,11.35%,EEFSEC;SECISBP2
prerank,Reactome_2022__Transport Of Nucleosides And Free Purine And Pyrimidine Bases Across Plasma Membrane R-HSA-83936,0.7347435767804943,1.2656240817421074,0.18461538461538463,1.0,1.0,2/11,4.18%,SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.7961165069081572,1.265304274295026,0.13333333333333333,1.0,1.0,1/6,1.34%,TIMP3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.7323120289334892,-1.26522956216385,0.1388888888888889,0.9033321724949422,1.0,4/7,24.34%,EMILIN1;SLIT2;CD200R1;ADTRP
prerank,GO_Biological_Process_2021__meiotic sister chromatid segregation (GO:0045144),0.8521653881666008,1.2651980251962955,0.14814814814814814,1.0,1.0,1/5,0.84%,SGO1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.5448108953564659,-1.26512575079677,0.15625,0.9026836160936385,1.0,14/39,22.83%,SH3KBP1;TGFA;RAB7A;PTPRJ;GPRC5A;SPRY1;DAB2IP;SPRY2;TSG101;BTC;PTPN2;DUSP3;PTPN3;ZFYVE28
prerank,CellMarker_Augmented_2021__Hepatocyte:Embryoid Body,0.591949847983883,1.2649778143803918,0.1095890410958904,1.0,1.0,16/51,10.68%,AMBP;OIT3;ITIH2;NPC1L1;SERPIND1;FTCD;PON1;SLC22A7;NR1H4;SMLR1;CPB2;KNG1;F7;HPR;MTTP;VTN
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.7180520395051438,1.2647333363454887,0.2222222222222222,1.0,1.0,3/13,12.94%,PHKA1;PHKG1;PYGL
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),-0.8094024078536779,-1.2644868408409429,0.2558139534883721,0.9047840632662258,1.0,2/5,14.10%,SMARCB1;PIH1D1
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.5657192683446698,1.2643978848091455,0.12987012987012986,1.0,1.0,22/71,15.47%,CCDC60;CCDC187;LRRC46;ECT2L;FAM81B;CFAP126;C11ORF16;MAP3K19;CCDC39;VWA3B;DYDC2;RSPH10B;ANKUB1;DCDC2B;AKAP14;BPIFB1;ZMYND10;DRC3;MORN5;DNAI1;CATSPERD;DNAH3
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.5096633693902617,-1.264396225795723,0.15384615384615385,0.9038426741301147,1.0,18/61,20.13%,CPSF1;TRDMT1;METTL1;POP1;ADAT2;TRMT61A;CSTF2;THG1L;QTRT2;WDR4;ADAT1;CTU1;QTRT1;CPSF4;TSEN2;FAM98B;TRMT9B;DTWD1
prerank,GO_Biological_Process_2021__negative regulation of T cell apoptotic process (GO:0070233),0.8411037877374582,1.2643472339246213,0.140625,1.0,1.0,1/5,2.77%,CCL5
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.7832591785812175,1.2643386287410514,0.171875,1.0,1.0,1/9,1.34%,SLC22A3
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.6982544694099452,1.2642316255984158,0.18571428571428572,1.0,1.0,7/15,19.59%,CD160;HLA-F;SH2D1B;IL12A;CRTAM;RASGRP1;RAET1G
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.6121064778891747,1.2638749839029326,0.16049382716049382,1.0,1.0,8/34,10.68%,C1QB;C3AR1;C3;CD81;CPB2;C4BPA;C4BPB;VTN
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.7275272888942683,1.2634801022611808,0.13432835820895522,1.0,1.0,2/12,5.72%,WNT8B;MESP1
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.694404293899568,-1.2633440619721505,0.20454545454545456,0.9071773299876944,1.0,6/9,25.86%,CCN3;HDAC3;HDAC5;HDAC4;NOTCH1;HDAC1
prerank,CellMarker_Augmented_2021__Osteoblast:Bone,0.6640923030210961,1.263114018398172,0.21875,1.0,1.0,7/19,16.35%,OSCAR;NFIL3;PTPRC;NT5E;CALCR;CD44;ENG
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.5923994866431276,-1.2630137742484706,0.1794871794871795,0.9071652675632296,1.0,5/17,14.75%,PARD3;FSCN1;PATJ;MARK2;SCRIB
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),0.8413256593582575,1.2627540778431494,0.15789473684210525,1.0,1.0,2/5,13.08%,ACE2;AGT
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.7741829738949888,-1.2626875762451573,0.22727272727272727,0.9072989229058315,1.0,4/7,19.01%,NDST3;CSGALNACT1;EXT1;EXT2
prerank,Reactome_2022__Reversal Of Alkylation Damage By DNA Dioxygenases R-HSA-73943,-0.7699496779328379,-1.2624558898794525,0.21951219512195122,0.9069775833814345,1.0,1/7,3.34%,ASCC2
prerank,CellMarker_Augmented_2021__Platelet:Liver,0.5602818127169354,1.2624422427177966,0.1643835616438356,1.0,1.0,15/61,14.25%,RASGRP4;C19ORF38;SLFN14;GP1BA;LILRB3;ALOX12;TGFB1;RGL4;WAS;NLRC4;CD37;MYO1F;ITGA2B;ARHGAP45;P2RX1
prerank,CellMarker_Augmented_2021__T Helper cell:Lung,0.5602818127169354,1.2624422427177966,0.1643835616438356,1.0,1.0,15/61,14.25%,RASGRP4;C19ORF38;SLFN14;GP1BA;LILRB3;ALOX12;TGFB1;RGL4;WAS;NLRC4;CD37;MYO1F;ITGA2B;ARHGAP45;P2RX1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.6787471716154794,1.26231315126399,0.15151515151515152,1.0,1.0,3/21,11.00%,POLE2;RPA3;RPS27A
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.650844726742969,1.2618718603745527,0.1388888888888889,1.0,1.0,3/22,6.35%,ITGB2;CCL5;SYK
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Amniotic Membrane,0.8366117342893322,1.2618342868672232,0.15217391304347827,1.0,1.0,4/5,16.35%,PTPRC;NT5E;CD44;ENG
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.6178555849946958,-1.261820313347105,0.14814814814814814,0.9085456814683233,1.0,7/33,16.66%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;NUP98
prerank,Reactome_2022__Tandem Pore Domain Potassium Channels R-HSA-1296346,-0.6891089540475237,-1.2615687614088449,0.23076923076923078,0.9082778885658702,1.0,1/8,0.63%,KCNK6
prerank,CellMarker_Augmented_2021__Progenitor cell:Prostate,-0.48857452512848665,-1.2615354553971152,0.1,0.9071235735443618,1.0,6/57,3.96%,ADGRF4;EHF;CLDN4;DSG2;LAMA3;ESRP1
prerank,Reactome_2022__Binding Of TCF/LEF:CTNNB1 To Target Gene Promoters R-HSA-4411364,0.8165765206988196,1.261486929695155,0.140625,1.0,1.0,3/7,13.42%,TCF7;LEF1;TCF7L1
prerank,Reactome_2022__APEX1-Independent Resolution Of AP Sites Via Single Nucleotide Replacement Pathway R-HSA-5649702,-0.6641256511378426,-1.2613861440022904,0.20588235294117646,0.9064968939396498,1.0,1/7,4.32%,PNKP
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.7259972339462665,-1.2613476537603086,0.17073170731707318,0.9054566714643708,1.0,3/9,17.44%,ECSIT;ABL1;SZT2
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.6160863283785233,-1.2611992900200937,0.17391304347826086,0.9036190596819305,1.0,11/33,23.25%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;NUP98;SEH1L;XPOT;NUP50;TPR
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.6160863283785233,-1.2611992900200937,0.17391304347826086,0.9036190596819305,1.0,11/33,23.25%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;NUP98;SEH1L;XPOT;NUP50;TPR
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.6870383046855606,1.261081673676802,0.19402985074626866,1.0,1.0,1/18,0.46%,ESR1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.5875053657572102,1.261066668585073,0.20270270270270271,1.0,1.0,10/48,16.91%,ENPP2;MARVELD3;VIL1;RAB11A;MCC;DOCK5;SOX9;IL4;GLUL;HYAL1
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),0.7482718913691266,1.2609850507620362,0.21818181818181817,1.0,1.0,1/6,1.87%,BHMT
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.6309529234497455,1.260825775537557,0.08064516129032258,1.0,1.0,13/49,16.47%,ANXA1;CCL5;PTPRC;CD81;CD80;HLA-A;PDCD1LG2;HLA-DPB1;TNFSF4;IL7;SIRPG;IL4;ZAP70
prerank,Reactome_2022__Defective B3GALTL Causes PpS R-HSA-5083635,-0.5788700348941037,-1.2607666505837793,0.16666666666666666,0.9041875385715871,1.0,10/33,14.31%,ADAMTS1;ADAMTS12;ADAMTS8;THSD7A;ADAMTS3;ADAMTS10;ADAMTS16;ADAMTS6;SPON2;ADAMTS13
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.5843142881118323,-1.2606224686105234,0.18421052631578946,0.9033359229095046,1.0,2/25,3.43%,NR4A1;FOXO1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.5861611862764087,-1.2605777493112515,0.10344827586206896,0.9022535872995281,1.0,6/29,10.68%,MFSD2A;LCN12;APOE;SLC27A2;CPT1A;SLC27A4
prerank,CellMarker_Augmented_2021__Pericyte:Skeletal Muscle,0.5326457680632175,1.2604740722295418,0.11842105263157894,1.0,1.0,23/86,17.26%,ENPP2;C1QB;LYVE1;CYYR1;PTPRC;PREX2;FLT1;MYH11;GPIHBP1;JAM2;DAAM2;RAMP3;ADGRL4;VWF;DCN;CLDN5;RFTN2;PLN;EDNRB;ELN;A2M;GALNT15;GAS7
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.6161689689183698,-1.2603576537668943,0.14814814814814814,0.9020337427311393,1.0,7/35,16.66%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;NUP98
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.764465830154512,1.2601894450736628,0.18181818181818182,1.0,1.0,4/9,18.60%,BOK;HSPA5;AGR2;TMEM33
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.7469450563969731,-1.2599614360785067,0.16666666666666666,0.9027264276649584,1.0,4/5,22.81%,MYOCD;SRF;GREM1;NOTCH1
prerank,CellMarker_Augmented_2021__Neural Crest cell:Germ,-0.4922153252582089,-1.2599253935671788,0.2,0.9016851674754378,1.0,28/95,14.19%,RASSF2;TRIB2;DTX1;HRH2;XYLT1;MYO9B;GFRA2;NLGN3;WDR86;S100B;VASH1;NLRP1;SEZ6L;ITGA4;PREX1;BACH2;LZTS1;ADAMTS10;SDK2;CROCC;GLT1D1;NHSL2;RNF175;CORO1A;TNRC6C;BCL11B;MICAL1;SIK3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.655347076514275,1.2597980278982985,0.125,1.0,1.0,5/21,11.98%,ANXA1;STOML2;PTPRC;CD80;CD4
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),-0.7590175109400019,-1.2595519917680267,0.18867924528301888,0.9019662980553756,1.0,1/6,2.74%,PIWIL2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.6839839136717379,1.2594537959982985,0.18333333333333332,1.0,1.0,7/18,19.00%,SYK;TNFSF4;F2RL1;IL4;ISG15;TIGIT;IRF4
prerank,GO_Biological_Process_2021__water transport (GO:0006833),0.714362218335225,1.2593210768390803,0.19642857142857142,1.0,1.0,4/11,14.80%,AQP3;SLC5A1;AQP4;UPK3A
prerank,CellMarker_Augmented_2021__Follicular B cell:Undefined,0.6711089480142792,1.2593202769301817,0.16666666666666666,1.0,1.0,6/17,10.08%,IL21R;PTPRC;EBF1;CD81;CD80;IKZF1
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.7469494053229951,1.2589165097714545,0.18181818181818182,1.0,1.0,2/9,0.88%,RAB34;MAPKAPK3
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),-0.7573452738132922,-1.2588658112525737,0.09090909090909091,0.9038492183361971,1.0,4/8,16.44%,PLIN5;PLA2G5;FGFR2;RHOA
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.8547803906195719,1.258757428948952,0.09433962264150944,1.0,1.0,1/6,0.44%,SMAD6
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6573123667970835,1.2587132306558786,0.15151515151515152,1.0,1.0,1/22,0.46%,ESR1
prerank,CellMarker_Augmented_2021__Epithelial cell:Ovary,-0.7014201936019178,-1.258628225671722,0.25,0.9039309745382905,1.0,1/6,0.96%,CLDN4
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.5687566672673029,-1.2585203968124432,0.21875,0.903035865655572,1.0,3/26,6.66%,CDH5;THEM4;NANOS3
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.7407401043337382,-1.2583340473941198,0.25,0.9023382874448815,1.0,4/8,24.40%,NLGN2;NRXN2;TMEM108;NLGN1
prerank,Reactome_2022__Mucopolysaccharidoses R-HSA-2206281,-0.7276032643333891,-1.2583283967926024,0.20930232558139536,0.9011999314286815,1.0,8/9,24.58%,ARSB;SPAM1;IDUA;HGSNAT;GUSB;GLB1;SGSH;GALNS
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.6289568852582842,1.2580898783400152,0.18055555555555555,1.0,1.0,10/35,19.28%,TNFRSF1B;CCL5;IL27;HLA-DPB1;CD4;SIRPG;CRTAM;TIGIT;HLA-DPA1;TNFSF8
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.7003641941317448,-1.2580660503869612,0.11764705882352941,0.9008604776573589,1.0,1/8,2.42%,TEFM
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.7020676175353906,1.2579251981621211,0.1875,1.0,1.0,2/11,4.50%,CARD14;TNFRSF10A
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,-0.4836687545474353,-1.2579039658942621,0.1,0.900239407800309,1.0,25/106,20.46%,NGF;PRKCD;BCL2;SHC3;SH2B2;SHC4;NTRK1;RIPK2;RAPGEF1;MAPKAPK2;MAPK7;CRK;CRKL;RPS6KA3;MATK;RHOA;IRAK4;ABL1;MAPK12;AKT2;MAP2K7;HRAS;ARHGDIB;PRDM4;YWHAE
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),-0.7397660942558602,-1.2578075519409626,0.17647058823529413,0.8995847739521616,1.0,2/8,5.74%,MFSD2A;PLIN5
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.6379050302938097,-1.257792548378127,0.27586206896551724,0.8984388302472659,1.0,6/14,8.43%,PODXL2;SELE;ITGA4;SELL;CX3CR1;SELPLG
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell apoptotic process (GO:0034392),-0.7786765509856248,-1.2576501542039198,0.2647058823529412,0.8979291508459437,1.0,2/5,1.19%,APOH;DNMT1
prerank,CellMarker_Augmented_2021__Effector Memory T cell:Undefined,-0.7970540323393762,-1.2576272591501556,0.23404255319148937,0.8967886072922326,1.0,1/5,0.07%,IL7R
prerank,CellMarker_Augmented_2021__Megakaryocyte:Umbilical Cord Blood,0.5756418368802092,1.2573916991833005,0.1388888888888889,1.0,1.0,17/47,14.92%,TRIM58;SLFN14;LMO2;CLEC12A;FLI1;HEMGN;CSF3R;P2RY12;VWF;HK3;CLDN5;TM6SF1;FPR1;ITGA2B;TRPC2;P2RX1;PTP4A2P2
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.7019877912279898,1.2573013064443472,0.21666666666666667,1.0,1.0,2/12,6.12%,AQP3;SLC26A6
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),-0.6505890118150977,-1.257163692630103,0.20512820512820512,0.8974225933988871,1.0,2/12,10.66%,METRNL;TFE3
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.4352605637611544,-1.257084128993328,0.06666666666666667,0.89640845664309,1.0,15/121,8.79%,GPR3;GPR78;GALR3;ADGRG3;GRK5;ADRA1B;CRHR2;ADCYAP1;LGR5;ADGRG6;VIPR1;S1PR5;GNAS;GPR161;GNA14
prerank,CellMarker_Augmented_2021__Natural Killer cell:Kidney,0.8313313855215552,1.2570654400382242,0.2,1.0,1.0,3/5,13.27%,CD160;FCGR3A;KLRB1
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,0.5712324711134131,1.2570142553375523,0.1282051282051282,1.0,1.0,14/57,12.89%,ST6GALNAC1;PLEKHS1;CAPN13;CYP4F12;CLCA4;MAP3K19;FUT2;MUC4;DUOX1;TMC4;TRIM29;CP;BPIFB1;SLC5A1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.7972578962244825,1.2569407748117774,0.21052631578947367,1.0,1.0,2/7,8.95%,BOK;TP53BP2
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.6956829830813543,1.256801733731171,0.2028985507246377,1.0,1.0,2/12,9.22%,ACOX2;PINK1
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),-0.737521562330087,-1.2567353846500706,0.20454545454545456,0.896866323611147,1.0,3/6,12.47%,EPHB2;ANAPC2;NEUROD2
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),-0.644276225841325,-1.2565663532378473,0.25806451612903225,0.8963447837214249,1.0,8/13,30.48%,ADAT2;ALKBH8;CTU1;TRMT9B;MTO1;ELP4;ELP3;URM1
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.7508275913429813,-1.256493482969114,0.21052631578947367,0.895336245090553,1.0,1/7,3.33%,NOP9
prerank,Reactome_2022__Transport And Synthesis Of PAPS R-HSA-174362,-0.8247555157154142,-1.256474250032928,0.14705882352941177,0.891823200169098,1.0,1/5,4.48%,PAPSS2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.8247555157154142,-1.256474250032928,0.14705882352941177,0.891823200169098,1.0,1/5,4.48%,PAPSS2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.8247555157154142,-1.256474250032928,0.14705882352941177,0.891823200169098,1.0,1/5,4.48%,PAPSS2
prerank,KEGG_2021_Human__African trypanosomiasis,0.6239242677743786,1.2563530043006954,0.17647058823529413,1.0,1.0,7/23,15.70%,APOL1;IL12A;KNG1;HPR;F2RL1;NPPA;IDO1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.5552799720239634,-1.2562860157983076,0.23809523809523808,0.8912773009518858,1.0,13/40,21.74%,NGF;LIMK1;ISLR2;GOLGA4;DBNL;SLIT2;PLXNA4;MAP3K13;RHOA;ROBO2;MAPT;PLXNA2;NTRK2
prerank,CellMarker_Augmented_2021__Stem cell:Blood Vessel,-0.8190703476057061,-1.2562150427052485,0.16666666666666666,0.8903690349107669,1.0,1/8,3.46%,KIT
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.7250774102603726,1.2560605824787847,0.16393442622950818,1.0,1.0,3/12,10.01%,CYP26B1;PRAME;DHRS3
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.5232602568353368,-1.2559876877348526,0.17391304347826086,0.890034195417399,1.0,13/51,22.21%,ADAMTS12;CAPN2;RAB7A;AFG1L;DAB2IP;MALT1;HTRA2;RSPRY1;CTSO;TCIRG1;CTSC;MYLIP;CTSV
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.78122649045107,1.2559183186020464,0.2545454545454545,1.0,1.0,3/8,18.48%,MYBPC3;PLN;SCN5A
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.6897940758006933,-1.2557620644395893,0.15625,0.8898903272130886,1.0,5/16,17.47%,FOXO1;DDX11;AQP1;SPIDR;MTR
prerank,PanglaoDB_Augmented_2021__Myocytes,0.5626696827127727,1.2556965667930315,0.10465116279069768,1.0,1.0,21/115,10.44%,MYH1;GATA4;NRAP;MYH8;TMOD4;PRRX1;CASQ2;MYH4;LMOD1;ASB5;SIX4;NID1;SGCG;CAV3;MMP9;ANGPTL2;KLHL38;CSRP3;TRDN;CKMT2;POPDC2
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),-0.72415960880154,-1.2556698938368025,0.2,0.8890911229294455,1.0,4/6,22.91%,SNX33;RHOA;SNX9;SNX18
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.7921004426373832,1.2556226426185517,0.125,1.0,1.0,4/8,15.53%,RAMP3;GRM6;CALCR;CXCL12
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.697802597695691,-1.2555391707210894,0.24489795918367346,0.8883629949666532,1.0,3/8,14.36%,CRYM;SLC7A5;SLC16A10
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.49935582447240934,-1.2555108758704867,0.13793103448275862,0.887309836663659,1.0,20/53,23.88%,NSUN4;TRDMT1;METTL1;TFB1M;ADAT2;TRMT61A;THG1L;QTRT2;PUS7;WDR4;CTU1;QTRT1;PUS7L;TRMT9B;DTWD1;ADAR;TRMT1;ANKRD16;FTSJ3;PARN
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.7552433214847707,1.2552871260805174,0.22580645161290322,1.0,1.0,2/10,5.45%,CASQ2;CAV3
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.6913790260736071,1.255273509607866,0.2,1.0,1.0,3/19,7.73%,CYP4F12;SLC12A3;ATP1A4
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,0.6263077314014986,1.2549691702389851,0.10810810810810811,1.0,1.0,15/36,25.73%,CENPU;H2BC4;H2AZ1;OIP5;CENPX;ITGB3BP;CENPN;CENPL;H2AZ2;CENPS-CORT;RBBP7;CENPM;H2AC6;CENPO;CENPK
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.7379524781256226,-1.2548247080780484,0.24390243902439024,0.8889577884643033,1.0,1/7,2.22%,TWIST1
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.7017283369997213,1.2548215892885621,0.14516129032258066,1.0,1.0,5/19,14.41%,SASH3;CLCF1;PTPRC;TNFSF4;IL4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.7961545112857746,1.2547689199967216,0.15151515151515152,1.0,1.0,3/7,11.63%,VSIR;IL12A;TNFSF4
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.5994049340317282,1.254755790260007,0.12658227848101267,1.0,1.0,13/43,16.59%,ST6GALNAC1;ACSL5;CYP4F12;ADAMDEC1;TMEM45B;MUC17;CLCA1;KLF15;CFD;SLC5A1;TM4SF20;MOGAT2;AGR2
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.559775774478798,1.2544542561469145,0.15789473684210525,1.0,1.0,10/64,12.89%,CLIC1;APOL1;SLC12A7;SLC12A3;SLC26A6;SLC4A1;GLRA2;GLRA1;ANO2;SLC5A1
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Peripheral Blood,0.5787085821523844,1.2543017274769548,0.20270270270270271,1.0,1.0,17/47,16.42%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;WAS;TAGAP;CD37;ALOX5AP;PSTPIP1;MYO1F;PARVG;IL3RA;CD244
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.7984358818841629,1.25419893266743,0.16666666666666666,1.0,1.0,1/6,2.45%,HSPA8
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.7636064329193845,-1.2539898926623618,0.13636363636363635,0.8909960964635855,1.0,3/6,9.33%,SLC6A17;SLC3A2;SLC7A5
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.660295579486582,-1.2539530911693564,0.21052631578947367,0.8899436409288317,1.0,2/12,1.42%,ADRA1A;DGKD
prerank,Reactome_2022__Circadian Clock R-HSA-400253,-0.47654650551775835,-1.2539236132135303,0.06666666666666667,0.888928227575815,1.0,10/65,11.26%,PER2;CARM1;CRY1;SERPINE1;HDAC3;NR1D1;CPT1A;CREM;NAMPT;BMAL2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.6744054344479639,1.253916188747094,0.2112676056338028,1.0,1.0,6/29,16.21%,VSIR;NR1H4;IGF1;NLRC3;IL4;GHRL
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Cartilage,-0.4423635021056497,-1.2537963473590956,0.0,0.8882061337849674,1.0,35/91,18.36%,CALD1;COL4A2;COL12A1;RAI14;FRMD6;ARSJ;RND3;KITLG;PARVA;MID1;FSTL1;CAP2;RASSF8;NTN4;SNAI2;DCBLD2;EFEMP1;ALCAM;ANTXR1;NAV2;AMOTL2;CHST3;FKBP9;GPC1;COL5A2;COL4A1;ADGRL2;TGFB2;DDAH1;SH3D19;SH3BP4;RBFOX2;CTTNBP2NL;COL16A1;PTPN21
prerank,CellMarker_Augmented_2021__T cell:Skin,-0.5056262430244217,-1.2536016241702321,0.12195121951219512,0.8877079002356062,1.0,4/34,3.05%,IL7R;P2RY10;GBP2;BCL2A1
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,-0.564304726401947,-1.2534469273171676,0.16666666666666666,0.8871427915423302,1.0,6/23,17.72%,ESRP1;HNRNPF;PTBP1;POLR2F;POLR2C;RBFOX2
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.5175846115448808,-1.253373653292515,0.12903225806451613,0.8862216146825256,1.0,4/47,1.40%,ADGRF4;EHF;ENTPD2;ANXA8
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.7544252834493554,-1.2533637316248847,0.25,0.8850988245807605,1.0,3/7,14.23%,P3H4;P3H3;PLOD3
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.7462186063233275,1.253301700623625,0.1896551724137931,1.0,1.0,4/8,20.84%,SLFN14;THBS1;FBP1;RYR3
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.7726664451201334,1.2532809852904374,0.14754098360655737,1.0,1.0,1/9,0.44%,SMAD6
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,0.5579022447747765,1.2531163131310636,0.1388888888888889,1.0,1.0,13/83,21.53%,PSMB9;TLR2;SNAP23;HLA-F;HLA-A;RPS27A;PSMC5;CYBA;NDUFA2;PSMA3;PSMB6;PSMD6;B2M
prerank,Reactome_2022__Repression Of WNT Target Genes R-HSA-4641265,0.7277065883344402,1.2528526755058287,0.15492957746478872,1.0,1.0,3/14,13.42%,TCF7;LEF1;TCF7L1
prerank,Reactome_2022__IRAK1 Recruits IKK Complex R-HSA-937039,0.7759723390505636,1.2528192335041144,0.14545454545454545,1.0,1.0,1/9,5.36%,PELI3
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),-0.7866125419016099,-1.252635100923972,0.2222222222222222,0.8867131005656115,1.0,1/8,0.50%,TSKU
prerank,KEGG_2021_Human__Pertussis,0.6117704489581155,1.2525629370885056,0.11842105263157894,1.0,1.0,11/54,8.62%,C1QB;ITGB2;SFTPA1;C3;CASP7;ITGAM;IL12A;ITGA5;C4BPA;IRF1;C4BPB
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.781461071027898,-1.2523246240967003,0.2222222222222222,0.8866610778867903,1.0,2/6,14.20%,TST;CBS
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),0.7591291784463853,1.2521330248519984,0.16176470588235295,1.0,1.0,5/8,16.42%,IFNK;LCP1;F2RL1;GPR183;CD244
prerank,KEGG_2021_Human__Phagosome,0.5239081340136786,1.2518658488252274,0.0875,1.0,1.0,30/117,18.84%,ITGB2;TLR2;ATP6V1G2;SFTPA1;C3;ITGAM;FCGR3A;ITGA2;FCAR;SFTPD;HLA-F;ACTG1;ITGA5;HLA-A;ATP6V0E2;HLA-DMA;HLA-DPB1;ATP6AP1;COLEC12;THBS1;LAMP2;CYBA;TUBA4A;TUBA3D;TUBB6;ATP6V0B;MSR1;TUBA1C;THBS2;HLA-DPA1
prerank,KEGG_2021_Human__Phototransduction,0.6756577985671331,1.251773094448138,0.2,1.0,1.0,10/19,20.48%,PDE6A;GRK7;SLC24A1;GNAT2;CNGA1;GUCY2F;RCVRN;PDE6B;PDE6G;GNGT1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.7275378541339865,-1.2515578774776135,0.19047619047619047,0.8886077766250147,1.0,2/9,5.18%,KIT;PDZD7
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.5137496985766259,-1.2513740175115704,0.09090909090909091,0.8884857353939295,1.0,8/35,15.77%,FOXO1;HHAT;ZDHHC23;ZDHHC5;ZDHHC16;ZDHHC14;ZDHHC18;ZDHHC3
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,0.6703562496734059,1.2513033081271485,0.19402985074626866,1.0,1.0,6/19,15.72%,KIF14;MYH11;MYL6;RHOB;CDKN1B;MYL9
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.6966011508388772,1.251014161227583,0.17647058823529413,1.0,1.0,4/21,3.42%,CYP3A4;LRAT;LRP2;CYP4F12
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.6159668152037135,-1.2509608123474962,0.14705882352941177,0.8889045779604686,1.0,3/20,6.92%,GCK;G6PC3;PGLS
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.6136768096703329,1.2506178247105353,0.18840579710144928,1.0,1.0,8/38,15.08%,TULP1;C3;PTPRC;SFTPD;F2RL1;SIRPG;CYBA;CD300LF
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.6383545399455428,1.250602777491523,0.203125,1.0,1.0,6/25,14.15%,TGFB1;P2RY12;F2RL1;GPR183;THBS1;ELANE
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,0.534704383087052,1.2505996959028114,0.1111111111111111,1.0,1.0,52/104,26.25%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL23;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24;NCBP1;RPS29;RPLP1;RPS28;RPL34
prerank,Reactome_2022__Processing And Activation Of SUMO R-HSA-3215018,-0.69570458069407,-1.2503787594394322,0.2619047619047619,0.8904020243671281,1.0,3/8,17.28%,SENP1;SUMO2;SENP5
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.6555755177053645,1.2501824494455829,0.21212121212121213,1.0,1.0,3/22,5.86%,MYBPH;MYBPC3;NMUR2
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.5261424442925884,1.2501398002713262,0.08235294117647059,1.0,1.0,66/145,25.85%,RPL37A;RPL21;RPL9;GGT5;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPL13;RPS12;CARNS1;RPS4X;RPL27A;MRPL34;EEF1A1;RPS19;YARS2;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;COPS5;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;ASMT;RPS15A;RPSA;RPLP0;RPS6;RPL35;RHD;IGF2BP3;RPL27;RPS14;RPL7A;RPL24;RPL23;RPS15;MRPL28;MRPL10;RPS27;PCSK5;RPL8;RPS3;RPS23;RPS20;RPS18;RPS24;MRPL37;RPL10;RPS29;RPLP1;RPS28
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.699727644612654,1.2501060279244696,0.21428571428571427,1.0,1.0,3/13,15.85%,CEP55;CHMP3;MITD1
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.7086928163873862,-1.2500936667262983,0.2,0.8905308326310569,1.0,6/9,24.18%,PID1;SELPLG;SBNO2;PTGIS;NFKB1;CHI3L1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.5877892180811329,-1.2497891037041329,0.17857142857142858,0.8905415201153734,1.0,8/32,8.39%,NR4A1;CDH5;CDH13;LPXN;FSTL1;CORO1B;CCN3;PRSS3
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),0.7978947762146582,1.2496681851643736,0.17857142857142858,1.0,1.0,1/7,0.35%,TBX1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.6298456813879918,-1.2493625556899306,0.23076923076923078,0.8909386748316452,1.0,3/10,11.59%,XYLT1;CSGALNACT1;B3GAT3
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.6522234650521122,-1.249015720051204,0.11428571428571428,0.8909991477678317,1.0,4/11,10.60%,LIPC;APOE;ALB;SCARB1
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.5904350053367083,1.2490050564455466,0.17142857142857143,1.0,1.0,27/63,15.35%,ITGB2;CYTIP;TLR2;ITGAX;SASH3;AHR;PTPRC;PTAFR;ITGAM;NFAM1;FCGR3A;HLA-F;FGL2;CD80;NAPSB;HCK;HLA-DMA;TAGAP;HLA-DPB1;HK3;IGSF6;EPCAM;MYO1F;CSF1R;PARVG;CD300LF;PIK3R6
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Embryonic Stem Cell,0.8318693078685473,1.248985032505812,0.16981132075471697,1.0,1.0,3/5,16.35%,NT5E;CD44;ENG
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Foreskin,0.8318693078685473,1.248985032505812,0.16981132075471697,1.0,1.0,3/5,16.35%,NT5E;CD44;ENG
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Embryo,-0.479770780221273,-1.2488599476335944,0.0,0.8904225727597566,1.0,7/78,4.25%,DUSP4;PHLDB2;KCNJ16;COL4A2;FRMD6;KIT;SERPINE2
prerank,CellMarker_Augmented_2021__Suppressor T cell:Peripheral Blood,0.6075051706240375,1.2487222207594448,0.17567567567567569,1.0,1.0,20/49,15.08%,ITGB2;CYTIP;ARHGAP9;ITGAX;GMFG;SASH3;PTPRC;ITGAM;FCGR3A;WAS;HCK;IKZF1;TAGAP;HK3;CD4;ALOX5AP;PSTPIP1;MYO1F;PARVG;CD300LF
prerank,Reactome_2022__Mitochondrial Uncoupling R-HSA-166187,-0.8549462570820725,-1.2484904553580325,0.225,0.8907178986722565,1.0,1/5,0.22%,PM20D1
prerank,Reactome_2022__Josephin Domain DUBs R-HSA-5689877,0.7136491871537192,1.2484406833427966,0.22950819672131148,1.0,1.0,2/11,11.00%,JOSD2;RPS27A
prerank,Reactome_2022__rRNA Modification In Mitochondrion R-HSA-6793080,-0.8194583250475111,-1.2483614198937487,0.23076923076923078,0.8900763248993964,1.0,3/5,14.00%,NSUN4;TFB1M;MRM1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.48166144590074456,-1.2482004991933495,0.15,0.8896367582773105,1.0,4/36,6.76%,SPRY4;ACER2;PTPRO;FZD7
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),0.6761879715991346,1.2480573331457936,0.16666666666666666,1.0,1.0,4/11,7.91%,GSDMA;AIM2;NLRC4;GSDME
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.7732073774162176,1.2480083478707182,0.18840579710144928,1.0,1.0,6/9,19.67%,PLA2G10;IQCF1;GLRA1;SERPINA10;POMZP3;SPINK13
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),-0.687471155400867,-1.2479878190619649,0.19047619047619047,0.8892650261795243,1.0,2/9,3.71%,DUSP4;DUSP2
prerank,Reactome_2022__rRNA Processing In Mitochondrion R-HSA-8868766,-0.7540404984992403,-1.2478824407081235,0.22857142857142856,0.8884113627565928,1.0,3/8,14.00%,NSUN4;TFB1M;MRM1
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,-0.638681206817643,-1.247043832963533,0.18181818181818182,0.8906697215307556,1.0,2/15,7.17%,APOB;PPP2R5D
prerank,Reactome_2022__Release Of Apoptotic Factors From Mitochondria R-HSA-111457,0.8324270281732662,1.2470367490724696,0.20967741935483872,1.0,1.0,1/5,7.91%,GSDME
prerank,CellMarker_Augmented_2021__Keratinocyte Progenitor cell:Skin,0.5561594024695702,1.2466112672217755,0.10588235294117647,1.0,1.0,19/73,11.36%,CLCA2;C1QB;TIMP3;SLC22A3;LYVE1;ECM2;C3;ABI3BP;ABCG2;MYH11;GPIHBP1;ITGB6;RAMP3;ADGRL4;HPGDS;OMD;VWF;DCN;ASPN
prerank,CellMarker_Augmented_2021__Lymphatic Endothelial cell:Ovary,0.8783522557056076,1.2464487141491836,0.13333333333333333,1.0,1.0,2/5,7.20%,LYVE1;FLT4
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.7843343883301521,-1.2463391638904175,0.275,0.8922412891214379,1.0,1/5,7.68%,CX3CR1
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.8156885990038937,1.2463038845470458,0.16981132075471697,1.0,1.0,1/5,9.06%,SOD2
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.6841825105617297,1.246084891416216,0.23529411764705882,1.0,1.0,5/16,17.10%,NEK2;BORA;PKMYT1;RCC1;FBXO5
prerank,CellMarker_Augmented_2021__Stromal cell:Bone Marrow,0.7548542335534245,1.246028101586504,0.17543859649122806,1.0,1.0,6/12,16.35%,PTPRC;ANPEP;NT5E;MME;CD44;ENG
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.7160838484980689,-1.2460167176966168,0.2903225806451613,0.8921666796653136,1.0,4/6,20.54%,SLC25A37;LDB1;SLC6A9;ABCB10
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.6901068425928457,-1.2459120183615309,0.1875,0.8913965063240455,1.0,3/7,22.22%,SLC4A11;CNNM4;SLC7A8
prerank,Reactome_2022__Alpha-Linolenic (Omega3) And Linoleic (Omega6) Acid Metabolism R-HSA-2046104,0.7284034079833251,1.2457112115650433,0.19696969696969696,1.0,1.0,1/12,1.04%,ELOVL2
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.7250286639169977,1.2457073766698539,0.22727272727272727,1.0,1.0,4/12,14.41%,TNFRSF1B;PTPRC;IGF1;IL4
prerank,Reactome_2022__Highly Calcium Permeable Postsynaptic Nicotinic Acetylcholine Receptors R-HSA-629594,0.7566132017198435,1.2456422652839787,0.1774193548387097,1.0,1.0,2/10,8.59%,CHRNA9;CHRNA5
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.7346158714390231,1.2456301988541094,0.22950819672131148,1.0,1.0,2/10,4.57%,ANXA1;NLRP12
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.5818728096277498,-1.2454637997990068,0.2,0.892150391884083,1.0,11/36,23.25%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;NUP98;SEH1L;SGIP1;NUP50;TPR
prerank,Reactome_2022__BH3-only Proteins Associate With And Inactivate Anti-Apoptotic BCL-2 Members R-HSA-111453,-0.7052591493556564,-1.2447937721619038,0.18421052631578946,0.8941415611315431,1.0,1/7,1.53%,BCL2
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,0.6585052677163349,1.2447620922173002,0.18461538461538463,1.0,1.0,4/18,9.55%,GNAT3;GNG12;GNG4;P2RY12
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.7130821638916751,1.2447132499681675,0.11594202898550725,1.0,1.0,1/11,4.32%,LMO2
prerank,CellMarker_Augmented_2021__Ito Cell (Hepatic Stellate cell):Liver,0.8169946733753493,1.244704493651086,0.265625,1.0,1.0,2/5,8.34%,LRAT;ACTA2
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.6597804405641853,-1.244499841825385,0.2,0.8942134085255012,1.0,6/12,24.45%,PCM1;PEX14;CAMSAP3;GCC2;BCCIP;DAG1
prerank,Reactome_2022__Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,-0.6324759667833925,-1.244426442103492,0.21428571428571427,0.8934610430496011,1.0,4/16,17.45%,VAC14;PI4KB;PI4KA;TPTE2
prerank,Reactome_2022__Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.5314909766425832,-1.2442728678001764,0.22580645161290322,0.892908119986972,1.0,1/25,0.18%,NOX4
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.8357174397029173,1.244118461291365,0.18181818181818182,1.0,1.0,1/6,8.98%,NDUFS2
prerank,CellMarker_Augmented_2021__Langerhans cell:Skin,0.611973876604134,1.2440845285133622,0.16216216216216217,1.0,1.0,16/38,15.35%,C1QB;CLEC5A;ITGAX;PTAFR;NFAM1;FGL2;NAPSB;HCK;HLA-DPB1;HK3;IGSF6;CD4;XCR1;CSF1R;CD300LF;PIK3R6
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),-0.6386270929526447,-1.2439590468389576,0.23076923076923078,0.8930470241663708,1.0,2/15,10.66%,METRNL;TFE3
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),-0.6332261740271241,-1.243956745805626,0.18181818181818182,0.8919050202991504,1.0,4/12,19.37%,PLIN5;LPL;OSBPL8;OSBPL11
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Embryo,0.8331260689483063,1.2439163620043878,0.18,1.0,1.0,3/5,16.35%,ANPEP;NT5E;ENG
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),-0.8372304315258512,-1.2437533997479138,0.15384615384615385,0.8916021486173487,1.0,2/5,8.96%,NEU4;NEU3
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.7515812384719704,1.243609047254636,0.18181818181818182,1.0,1.0,2/9,7.26%,SP100;FOXM1
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.4604140970477719,-1.243606448497992,0.125,0.891201796792261,1.0,10/116,5.34%,RFX6;POU3F1;EHF;NPTX2;BCHE;ETV1;ADCYAP1;SLC17A6;CFC1;ABCC8
prerank,CellMarker_Augmented_2021__Central Nervous System Stem cell:Fetal Brain,0.5907828623803164,1.243426327789483,0.12857142857142856,1.0,1.0,15/59,10.69%,C1QB;MYO15B;ADAM28;LYVE1;ITM2A;CYYR1;PTPRC;FCGR3A;VSIG4;MYH11;RAMP3;HPGDS;VWF;CP;HLA-DPB1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.798972645587392,-1.2433289410334953,0.29411764705882354,0.8887670547388997,1.0,3/5,9.56%,NOP9;NOP14;TBL3
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.798972645587392,-1.2433289410334953,0.29411764705882354,0.8887670547388997,1.0,3/5,9.56%,NOP9;NOP14;TBL3
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.798972645587392,-1.2433289410334953,0.29411764705882354,0.8887670547388997,1.0,3/5,9.56%,NOP9;NOP14;TBL3
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Undefined,0.5544795780328571,1.242960347425909,0.15789473684210525,1.0,1.0,14/83,10.66%,ENPP2;C1QB;LYVE1;NID1;CYYR1;PREX2;FLT1;CASR;DAAM2;KCNA5;RAMP3;ADGRL4;VWF;DCN
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.5966607016101854,1.2427564944299514,0.12987012987012986,1.0,1.0,11/34,27.27%,CENPU;OIP5;CENPX;ITGB3BP;CENPN;CENPL;RBBP7;CENPM;CENPO;CENPK;CENPP
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.8023596665811222,1.2427157162821467,0.21212121212121213,1.0,1.0,2/7,11.68%,C3;F2RL1
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),0.7584218084410386,1.2423188767191558,0.17857142857142858,1.0,1.0,4/9,16.91%,IL12A;CDKN1A;MME;HYAL1
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.6308902704929573,-1.2423168359993,0.2571428571428571,0.8918914780741826,1.0,3/12,9.84%,CRLS1;PLA2G5;PGS1
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.7064364439554874,-1.2422917143422454,0.175,0.8907936140021407,1.0,3/11,6.27%,MTHFR;MTHFD1L;DHFR
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.6028855447240393,1.2422728558836484,0.12698412698412698,1.0,1.0,6/33,14.32%,AQP3;GNG12;GNG4;RAB11A;AQP4;ADCY7
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),-0.6874235445904189,-1.2421824154856125,0.17777777777777778,0.8902998197338454,1.0,2/9,5.74%,TWIST1;PLIN5
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,-0.5518731943838835,-1.2419684023245734,0.11764705882352941,0.8901968071233703,1.0,7/33,10.97%,CD38;PNP;NMRK1;NT5C1A;ASPDH;NT5C;NAMPT
prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),-0.5150579200092792,-1.2418817279296286,0.15384615384615385,0.8893646022243502,1.0,8/26,20.42%,PC;ACO1;OGDH;IDH2;SUCLA2;ACO2;SDHB;CS
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),0.7939669313302015,1.2417951948574528,0.3076923076923077,1.0,1.0,1/5,2.82%,AOX1
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Stomach,0.6125247095986703,1.2417907215208202,0.13513513513513514,1.0,1.0,1/41,0.19%,ZFP41
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),0.6612079882268587,1.2416665324641287,0.15384615384615385,1.0,1.0,4/20,6.13%,LYVE1;FGF2;TGFB1;STAB2
prerank,KEGG_2021_Human__Taurine and hypotaurine metabolism,0.7392218374859343,1.2416302632089302,0.22033898305084745,1.0,1.0,2/9,7.31%,GAD1;GGT5
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.6350315312276221,1.2413572190662203,0.17567567567567569,1.0,1.0,11/27,27.27%,CENPU;OIP5;CENPX;ITGB3BP;CENPN;CENPL;RBBP7;CENPM;CENPO;CENPK;CENPP
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.6350315312276221,1.2413572190662203,0.17567567567567569,1.0,1.0,11/27,27.27%,CENPU;OIP5;CENPX;ITGB3BP;CENPN;CENPL;RBBP7;CENPM;CENPO;CENPK;CENPP
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.7605185899028365,1.2411678255550154,0.2,1.0,1.0,2/10,2.83%,CYP3A4;LRP2
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,0.5507485204386021,1.2411327100623584,0.11842105263157894,1.0,1.0,12/77,20.47%,PSMB9;TCF7;FRAT1;LEF1;RPS27A;PPP2R5A;TCF7L1;PSMC5;RBX1;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.8108586707123487,-1.2405733289117773,0.23809523809523808,0.8932132941803183,1.0,1/5,3.12%,TST
prerank,CellMarker_Augmented_2021__Granulocyte:Blood,0.5907359520297184,1.2405500609900766,0.189873417721519,1.0,1.0,15/54,14.99%,RASGRP4;KCNJ15;CLEC4C;NLRP12;SCIMP;FCAR;CLEC12A;SLC4A1;CA1;CEACAM8;CSF3R;IGSF6;MYO1F;FPR1;ADGRE3
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.7694426031245503,1.2405261312979663,0.23529411764705882,1.0,1.0,1/5,5.77%,GPER1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.6789790353986467,-1.240392233149267,0.18604651162790697,0.8927351093068737,1.0,2/8,13.45%,WNK2;WNK3
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.4734248229062703,-1.2403038933296109,0.10344827586206896,0.8919835963897363,1.0,5/83,0.57%,GPR3;GPR78;ADRA1A;ADGRG3;ADRA1B
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Peripheral Blood,0.617777230665018,1.2402287406187578,0.17333333333333334,1.0,1.0,14/36,14.99%,TRIM58;SLFN14;FCGR3A;CLEC12A;HEMGN;SH2D1B;SLC4A1;CA1;P2RY12;FPR1;ITGA2B;MAP3K7CL;PTP4A2P2;ADGRE3
prerank,CellMarker_Augmented_2021__Secretory cell:Lung,0.620308994769188,1.2402165243606529,0.18666666666666668,1.0,1.0,13/47,10.84%,STEAP4;CAPN13;C3;RARRES1;SERPINB7;ANPEP;PRR5L;HLA-A;HLA-DMA;CP;TGM2;HLA-DPB1;CA13
prerank,CellMarker_Augmented_2021__Premeiotic Germ cell:Gonad,0.7187805484080334,1.2400938987928818,0.2413793103448276,1.0,1.0,4/8,21.87%,OR8A1;PRAME;PASD1;CCDC144NL
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Testis,0.7187805484080334,1.2400938987928818,0.2413793103448276,1.0,1.0,4/8,21.87%,OR8A1;PRAME;PASD1;CCDC144NL
prerank,CellMarker_Augmented_2021__Premeiotic Germ cell:Testis,0.7187805484080334,1.2400938987928818,0.2413793103448276,1.0,1.0,4/8,21.87%,OR8A1;PRAME;PASD1;CCDC144NL
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.7358436082688089,1.2397954643240994,0.2,1.0,1.0,3/9,7.69%,MCM2;MCMDC2;MCM3
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.567604871509972,1.2396441188081264,0.21428571428571427,1.0,1.0,13/49,15.06%,PSMB9;TIMP3;A2ML1;VSIR;SERPIND1;SERPINB7;SERPINE3;KNG1;VTN;SPOCK3;AGT;SERPINA10;SERPINB5
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.6661609411099901,-1.239593027770135,0.22727272727272727,0.8936210039413127,1.0,6/10,27.18%,ASCL1;DLL1;POU3F2;EPOP;TGFBR1;ID2
prerank,CellMarker_Augmented_2021__T Helper cell:Undefined,-0.5550898584390096,-1.2395122971209538,0.14285714285714285,0.8928058319033889,1.0,4/28,4.78%,IL7R;CD38;SELE;APOE
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.761913354135259,1.2394610245740243,0.2,1.0,1.0,4/10,21.53%,CDKN2A;HMGA2;HMGA1;B2M
prerank,Reactome_2022__Creation Of C4 And C2 Activators R-HSA-166786,0.8074791514591388,1.2394279396359573,0.1791044776119403,1.0,1.0,3/7,14.97%,C1QB;MASP2;MASP1
prerank,Reactome_2022__Sodium/Proton Exchangers R-HSA-425986,0.8455847573498533,1.2393423874980456,0.10204081632653061,1.0,1.0,1/6,1.90%,SLC9A2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.6095508152132647,1.239328568847659,0.19736842105263158,1.0,1.0,9/31,23.72%,BORA;CHMP3;GPSM2;ANKRD53;RAE1;TACC3;DCTN1;CHMP1A;PSRC1
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.79460697796749,1.2390004545785003,0.1935483870967742,1.0,1.0,2/7,11.21%,WAS;RHOU
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),-0.7569313673685871,-1.2389881429915337,0.15,0.8939554600951711,1.0,3/6,15.59%,EIF5AL1;USP16;EIF5A
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,-0.5063175012072276,-1.2388930291544185,0.16666666666666666,0.8932704542510584,1.0,16/56,15.79%,SYT12;NLGN3;GPRIN1;SHANK1;DLGAP4;MPP2;NLGN2;EPB41L5;SHARPIN;DLGAP1;NRXN2;LLGL1;LRRTM3;DBNL;APBA3;DLGAP3
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",0.5745242964556936,1.2388887217972286,0.14666666666666667,1.0,1.0,28/53,25.85%,RPS9;RPS16;RPS5;RPS27A;RPS3A;RPS12;RPS4X;RPS19;FAU;RPS21;RPS11;RPS13;RPS7;EIF1AX;RPS15A;RPSA;RPS6;EIF3G;RPS14;EIF4A2;RPS15;RPS27;RPS3;RPS23;RPS20;RPS24;RPS29;RPS28
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.567106004251663,-1.2387495227669476,0.16666666666666666,0.8926353047813684,1.0,7/23,19.08%,MGAT4C;B4GALT2;B4GALT4;ST3GAL4;CHST8;FUCA1;B4GALT3
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.6915250529537498,1.2386649712644848,0.15151515151515152,1.0,1.0,1/16,0.37%,NEK2
prerank,CellMarker_Augmented_2021__Multipotent Mesenchymal Stroma cell:Adipose Tissue,0.833716626431456,1.2385768845698484,0.15217391304347827,1.0,1.0,3/5,16.35%,PTPRC;NT5E;ENG
prerank,CellMarker_Augmented_2021__Eosinophil:Bronchoalveolar System,0.5889352716331255,1.2385038720744326,0.18840579710144928,1.0,1.0,15/47,10.68%,AMBP;SLC28A1;NOTUM;ITIH2;PKLR;NPC1L1;FTCD;SLC22A7;NR1H4;SMLR1;PROZ;HPD;CPB2;F7;VTN
prerank,Reactome_2022__MET Activates RAP1 And RAC1 R-HSA-8875555,-0.6323519830305502,-1.2383199095647233,0.25925925925925924,0.8932839746728147,1.0,3/11,14.83%,RAPGEF1;CRK;CRKL
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,0.583394232072536,1.2382993547899672,0.13513513513513514,1.0,1.0,8/48,20.47%,PSMB9;FBXL7;RPS27A;PSMC5;RBX1;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.6900170744270083,-1.238258254138904,0.2571428571428571,0.8911710239741483,1.0,1/8,1.07%,ABHD17A
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.6900170744270083,-1.238258254138904,0.2571428571428571,0.8911710239741483,1.0,1/8,1.07%,ABHD17A
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant R-HSA-2660826,-0.7367247346646704,-1.2380596185954704,0.2,0.890765199261658,1.0,4/7,22.81%,JAG2;JAG1;DLL1;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.7862186606143613,1.2379473429396988,0.25396825396825395,1.0,1.0,1/5,1.34%,TIMP3
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.7110375371182184,1.2378028683133604,0.16923076923076924,1.0,1.0,5/15,15.26%,SLFN14;EXOSC8;EXOSC2;ERN2;EXOSC4
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.7334280664599522,-1.237762991470119,0.16216216216216217,0.8911418483599006,1.0,3/6,16.62%,PRKCD;DLL1;PRKCA
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),0.7790189940341132,1.2377289919927412,0.20588235294117646,1.0,1.0,4/8,14.48%,ALOX12;ALOX12B;ALOX15;ALOX15B
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),0.7790189940341132,1.2377289919927412,0.20588235294117646,1.0,1.0,4/8,14.48%,ALOX12;ALOX12B;ALOX15;ALOX15B
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),-0.6092091168647005,-1.237725483550087,0.16666666666666666,0.8901317842499006,1.0,4/16,12.23%,NLGN3;NLGN2;CEL;NRXN2
prerank,CellMarker_Augmented_2021__T cell:Peripheral Blood,-0.7145654956839127,-1.237621503748504,0.2,0.8895537596924026,1.0,1/11,0.07%,IL7R
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.6273733404655593,1.2375024022090255,0.16901408450704225,1.0,1.0,4/29,17.79%,RAB6D;TRAPPC3L;RAB6B;GABARAPL2
prerank,CellMarker_Augmented_2021__Retinal Progenitor cell:Retina,0.5484849402690487,1.2373456846343311,0.1518987341772152,1.0,1.0,9/89,7.42%,ENPP2;ITM2A;CYYR1;PREX2;FLT1;SHISA6;TMEM35A;PLP1;CCND2
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Periodontal Ligament,0.5484849402690487,1.2373456846343311,0.1518987341772152,1.0,1.0,9/89,7.42%,ENPP2;ITM2A;CYYR1;PREX2;FLT1;SHISA6;TMEM35A;PLP1;CCND2
prerank,GO_Biological_Process_2021__maintenance of protein location in extracellular region (GO:0071694),0.8448089056842761,1.2373238922706666,0.16923076923076924,1.0,1.0,2/5,11.77%,DAND5;FBN2
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Undefined,-0.5003925338447215,-1.2373085732424756,0.17391304347826086,0.8894856158933788,1.0,30/93,30.27%,BOD1L1;PCM1;BDP1;ALMS1;BPTF;MGA;MTR;CEP290;CEP295;AKAP9;ERCC6L2;HOOK3;GOLGB1;ANKRD26;GCC2;NEMF;TPR;SREK1;ZNF518A;MACF1;NEK1;NIPBL;UBN2;CSPP1;MDN1;SCAF11;ASH1L;CEP192;MYO9A;NHLRC2
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6675824142190883,-1.2370115318282162,0.21212121212121213,0.8895604653590619,1.0,4/16,11.37%,BTN3A2;BACH2;CD8A;JAG1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.5997978336899816,1.236964123538166,0.18309859154929578,1.0,1.0,6/33,17.87%,SLC9A2;SLC26A6;SLC4A1;SLC9C1;SLC9B1;NOX1
prerank,Reactome_2022__tRNA Processing R-HSA-72306,-0.49639506178504006,-1.2367368490624284,0.15,0.889365682894604,1.0,27/99,20.11%,CPSF1;NUP210;TRDMT1;METTL1;NUP42;POM121C;NUP214;TRMT61B;AAAS;ADAT2;TRMT61A;CSTF2;ALKBH8;THG1L;QTRT2;PUS7;NUP37;NLRP2B;NUP98;WDR4;ADAT1;CTU1;QTRT1;CPSF4;TSEN2;FAM98B;TRMT9B
prerank,CellMarker_Augmented_2021__M2 macrophage:Undefined,0.7868987740866861,1.2366817186730108,0.13333333333333333,1.0,1.0,4/7,19.00%,VSIG4;CSF1R;MSR1;IRF4
prerank,Reactome_2022__Biotin Transport And Metabolism R-HSA-196780,-0.6508892792384006,-1.2363263338817732,0.23076923076923078,0.8898362528282074,1.0,4/10,21.73%,PDZD11;ACACB;PCCB;PCCA
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.5603919351884311,-1.2362589539750666,0.14285714285714285,0.8889933680363822,1.0,10/27,22.32%,POLR3D;BDP1;POLR3E;POLR3K;POLR2F;POLR3A;POLR3B;POLR3F;SNAPC3;BRF2
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.7282479448129592,1.2357699799376687,0.2033898305084746,1.0,1.0,1/10,1.99%,RENBP
prerank,CellMarker_Augmented_2021__Germ cell:Embryo,0.7815908077333936,1.2356864285006837,0.18181818181818182,1.0,1.0,3/6,14.65%,DAZL;NLRP5;GDF9
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.7602445489210393,1.2352037735916008,0.18333333333333332,1.0,1.0,4/8,19.77%,TGFB1;HEY2;SOX9;HEY1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.5966239993535545,1.235037006669396,0.20588235294117646,1.0,1.0,1/32,0.37%,NEK2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.7236178069030703,-1.2349228703497237,0.3076923076923077,0.8927952118778588,1.0,2/8,3.42%,PTPRO;PTPRB
prerank,Reactome_2022__Olfactory Signaling Pathway R-HSA-381753,0.5509804621051237,1.2349217035572115,0.14084507042253522,1.0,1.0,22/60,15.17%,OR52N2;OR2H2;OR51I2;OR52I2;OR7C1;OR52A5;EBF1;OR2AJ1;OR5V1;OR56A3;OR10A2;OR8A1;OR2G6;OR52E5;OR2AG1;OR3A3;ANO2;OR2T10;OR6N1;OR3A2;OR2T12;OR51M1
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),-0.6489407763577548,-1.2348912555868294,0.17647058823529413,0.8918561313057317,1.0,3/13,12.51%,CFC1;ACVR1;GDF7
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.5885614041874786,-1.2348249344806594,0.0975609756097561,0.8911083863318179,1.0,7/18,28.17%,MSTO1;ALB;MARK2;TRAK2;MARK1;MTM1;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.5497583879097537,-1.2345692729051918,0.17073170731707318,0.891196338304754,1.0,6/22,16.62%,EIF4EBP1;HES1;HSF1;KLHL18;CCDC57;PRKCA
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.5389570540568077,-1.2344628549395102,0.2222222222222222,0.8904983734664567,1.0,2/36,0.17%,IL7R;P2RY10
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.682412509516812,1.2343902509719922,0.22727272727272727,1.0,1.0,4/13,14.71%,WAS;VIL1;CARMIL1;CD44
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),-0.7558825981682518,-1.234361180438113,0.21428571428571427,0.8900218426212029,1.0,2/5,12.23%,NLGN2;NRXN2
prerank,Reactome_2022__Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,0.6727577337514573,1.2343460310977703,0.2028985507246377,1.0,1.0,1/15,0.33%,ENPP2
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.5800312857155001,1.2341540490178398,0.18055555555555555,1.0,1.0,7/40,16.34%,TBX1;SOX10;SEMA3A;ERBB4;SEMA3F;SEMA3B;HTR2B
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.7740263874079525,-1.234103941762794,0.3225806451612903,0.8901264747533677,1.0,4/5,22.24%,SIRT7;FBL;FBLL1;CREBBP
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.636738609803997,1.233851334224478,0.18461538461538463,1.0,1.0,3/21,7.78%,ENDOG;H1-0;DNASE2
prerank,Reactome_2022__G1/S Transition R-HSA-69206,0.508455173820672,1.233709108062235,0.08860759493670886,1.0,1.0,22/114,21.18%,CDC25A;PSMB9;POLE2;TK1;MCM3;CCND1;CKS1B;RPA3;CCNE2;RPS27A;CDKN1B;CDKN1A;CCNA2;PSMC5;ORC4;FBXO5;PSMA3;PSMB6;PSMD6;POLE3;GMNN;CCNB1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.6574681240798518,1.2336948889091381,0.16923076923076924,1.0,1.0,5/16,8.12%,ESR1;SSTR1;GPER1;RAMP3;H2AZ1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.5751577896452037,1.2336629826270373,0.16901408450704225,1.0,1.0,10/56,20.86%,PSMB9;MCM2;MCM3;RPS27A;PSMC5;ORC4;PSMA3;PSMB6;PSMD6;GMNN
prerank,Reactome_2022__RUNX1 Regulates Estrogen Receptor Mediated Transcription R-HSA-8931987,0.808460312320741,1.233570147751848,0.1935483870967742,1.0,1.0,1/6,0.46%,ESR1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.6221042086946218,1.2335536075110562,0.2361111111111111,1.0,1.0,3/27,6.35%,ITGB2;CCL5;SYK
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.7487591648930285,-1.2334346027774585,0.22727272727272727,0.8916869098844139,1.0,2/9,0.59%,APOB;MFSD2A
prerank,CellMarker_Augmented_2021__Thecal cell:Ovary,0.5577517613056159,1.2333772726540373,0.14285714285714285,1.0,1.0,15/64,16.35%,TMEM150B;OSCAR;C3AR1;TLR2;SLC7A7;ANPEP;ITGA5;PLAUR;HK3;DAB2;ASGR2;CD300LF;TGFBI;KCNE3;ENG
prerank,CellMarker_Augmented_2021__Zymogenic Chief cell:Gastric Epithelium,0.5577517613056159,1.2333772726540373,0.14285714285714285,1.0,1.0,15/64,16.35%,TMEM150B;OSCAR;C3AR1;TLR2;SLC7A7;ANPEP;ITGA5;PLAUR;HK3;DAB2;ASGR2;CD300LF;TGFBI;KCNE3;ENG
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.7662266294334968,1.2333631238655662,0.1875,1.0,1.0,2/8,4.27%,ESR1;TGFB1
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.6331621910988487,-1.2333159724697498,0.2222222222222222,0.8909135607278346,1.0,1/12,0.63%,KCNK6
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.7912701578047274,-1.2333155777436113,0.24390243902439024,0.8898297242792605,1.0,2/5,6.88%,PRKCD;DDX11
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.7683417418710033,1.2332909925856643,0.23333333333333334,1.0,1.0,4/9,16.38%,IL12A;CSF1R;MAPK3;CSF1
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),0.7822305945576564,1.2331637739259982,0.2542372881355932,1.0,1.0,1/6,1.12%,LMOD3
prerank,KEGG_2021_Human__Inflammatory bowel disease,0.6460938574883837,1.233095055143612,0.14285714285714285,1.0,1.0,10/39,11.19%,IL21R;RORC;TLR2;TGFB1;IL12A;IL5;HLA-DMA;TGFB3;HLA-DPB1;STAT1
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreas,-0.44045840330421704,-1.233051763259192,0.07407407407407407,0.8897312882167681,1.0,32/99,21.35%,CBARP;VWA5B2;TYRO3;CKMT1B;KIAA1549;CASKIN1;PTPRF;MID1;CAP2;VGF;EPB41L4B;B4GALNT1;NCS1;HPCA;SRRM3;ATP9A;DISP2;GTF2IRD1;CSPG5;ARNT2;DDAH1;SLC30A8;RBFOX2;PTPN21;SYT7;SRCIN1;SEZ6L2;APLP1;HS6ST3;EPB41L1;STXBP1;ZNRF3
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.6964975341487357,1.2330169066613141,0.17391304347826086,1.0,1.0,4/15,12.45%,CRLF1;IL27;STAT1;OAS2
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.5997594457486424,1.2330095477194318,0.14285714285714285,1.0,1.0,3/25,8.11%,HSPA1L;HSPA8;HSPA5
prerank,Reactome_2022__Expression And Translocation Of Olfactory Receptors R-HSA-9752946,0.5660481980676284,1.2328401312931816,0.1044776119402985,1.0,1.0,21/53,15.17%,OR52N2;OR2H2;OR51I2;OR52I2;OR7C1;OR52A5;EBF1;OR2AJ1;OR5V1;OR56A3;OR10A2;OR8A1;OR2G6;OR52E5;OR2AG1;OR3A3;OR2T10;OR6N1;OR3A2;OR2T12;OR51M1
prerank,Reactome_2022__Highly Sodium Permeable Postsynaptic Acetylcholine Nicotinic Receptors R-HSA-629587,0.7252022422249114,1.2327046931358754,0.2923076923076923,1.0,1.0,2/6,18.31%,CHRNB2;CHRNA3
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.6259292521586302,1.2326988161958412,0.14705882352941177,1.0,1.0,3/21,7.89%,TBX1;DNAH11;MMP21
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.6682523619268761,1.2326472343514816,0.11940298507462686,1.0,1.0,7/18,21.53%,CD81;HLA-A;TNFSF4;IL4;IL1R1;IL18R1;B2M
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),-0.7252271270484393,-1.2326234062429975,0.19444444444444445,0.8903653763230948,1.0,1/5,0.98%,ADAMTS12
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In2:Brain,-0.4524601396172317,-1.2322876809977759,0.09090909090909091,0.8907800641229419,1.0,7/102,4.80%,TACR3;SPHKAP;EFR3B;MGAT4C;GRID2;GPR149;SLC17A6
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),0.757077388613833,1.2322330254296041,0.171875,1.0,1.0,4/9,14.88%,CYP3A4;CYP4F12;LDHD;CYP24A1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.7899713064642887,1.232105970907876,0.17647058823529413,1.0,1.0,1/6,2.11%,TNFRSF1B
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.7119345504001378,1.2320263569520187,0.22033898305084745,1.0,1.0,2/10,7.26%,SP100;FOXM1
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.727220614476863,1.2320030977893168,0.23728813559322035,1.0,1.0,4/12,17.08%,ANXA1;CD80;TNFSF4;MYB
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.6906442594003303,1.2317201055111182,0.20588235294117646,1.0,1.0,6/14,11.69%,TRIL;TNFRSF1B;SCIMP;WNT5A;F2RL1;LACC1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Undefined,0.6231314560412022,1.2315979071006409,0.1323529411764706,1.0,1.0,12/39,16.35%,ITGB2;PTPRC;ITGA2;ANPEP;NT5E;ITGA5;CD99;ACTA2;CD63;MME;CD44;ENG
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.6969192330523484,1.231484328869636,0.21428571428571427,1.0,1.0,6/10,21.86%,CD99;GPR183;PIK3CG;ZAP70;MSN;CXCL16
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.6110357867173724,-1.2314393119679274,0.225,0.8930588852622521,1.0,6/14,25.50%,LIN28B;AGO2;TUT7;ADAR;TARBP2;DROSHA
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.6291289127805767,1.2311431380804234,0.2,1.0,1.0,1/32,0.46%,ESR1
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.7947874015501053,1.231042352935961,0.203125,1.0,1.0,1/6,2.83%,LRP2
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.6337533242421531,1.2309274082037978,0.2222222222222222,1.0,1.0,8/24,21.72%,TCN1;ABCG2;AMN;CBLIF;SLC46A1;SLC23A1;SLC52A1;TTPA
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.8013149293994437,1.2307667368498754,0.16417910447761194,1.0,1.0,2/7,10.06%,ENPP2;VIL1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.5703168418407887,1.2303792236533289,0.13513513513513514,1.0,1.0,4/82,2.20%,FBXO48;PSMB9;KIF14;FBXL7
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.718995531454771,-1.2303133686190493,0.2777777777777778,0.8961704923012233,1.0,4/5,20.54%,SLC25A37;LDB1;SLC6A9;ABCB10
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),0.818429935258103,1.2302305693316222,0.2,1.0,1.0,2/5,16.58%,EDNRB;BCAR1
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,0.6011178736075173,1.230171789012016,0.14084507042253522,1.0,1.0,3/32,3.67%,PLA2G10;LIPH;LIPI
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.5381690000700203,1.2300580705756041,0.1267605633802817,1.0,1.0,12/60,6.98%,AQP3;PLA2G10;BACE2;CAPN13;ACE2;MANF;MISP;MUC17;SMIM22;MUC4;CLCA1;HSD11B2
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),-0.7450190365817011,-1.2300073155831475,0.17073170731707318,0.8960804979958651,1.0,3/7,9.04%,SLC25A17;SLC27A2;PEX13
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.6325195223544173,-1.2298794014849812,0.2702702702702703,0.89544869102106,1.0,2/10,9.37%,EMC4;EMC8
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),0.7984453157044866,1.229793754101692,0.21153846153846154,1.0,1.0,2/6,14.41%,CD81;IL4
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),0.7984453157044866,1.229793754101692,0.21153846153846154,1.0,1.0,2/6,14.41%,CD81;IL4
prerank,Reactome_2022__Regulation Of PTEN mRNA Translation R-HSA-8943723,-0.6379121496593345,-1.2297731538304755,0.2571428571428571,0.8948184064727002,1.0,3/11,17.40%,AGO2;TNRC6C;TNRC6A
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.7615199096175561,1.2295235542581153,0.14516129032258066,1.0,1.0,1/7,7.90%,AXL
prerank,KEGG_2021_Human__N-Glycan biosynthesis,-0.5321903850376712,-1.2294679715512862,0.10714285714285714,0.8947767119947722,1.0,16/48,21.46%,MGAT4C;DPM3;MAN1A1;ST6GAL2;B4GALT2;ALG12;RPN1;ALG11;MOGS;DOLPP1;ALG1;B4GALT3;ALG3;DAD1;ALG8;MAN1A2
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.7287943162947645,1.2293528560351659,0.23728813559322035,1.0,1.0,2/11,3.28%,TBX1;SIX4
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.7862356600127709,1.22925063596961,0.23809523809523808,1.0,1.0,3/6,9.00%,ANXA1;STOML2;HLA-A
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),-0.7076866984662957,-1.2288536643919283,0.18181818181818182,0.8948015087594252,1.0,3/7,17.47%,FOXO1;AQP1;MTR
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),-0.7076866984662957,-1.2288536643919283,0.18181818181818182,0.8948015087594252,1.0,3/7,17.47%,FOXO1;AQP1;MTR
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),0.8712219840628737,1.2288369545556697,0.10714285714285714,1.0,1.0,1/5,8.50%,EIF6
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.6288079083004687,-1.2286690286490904,0.18181818181818182,0.8944982912798957,1.0,9/17,29.19%,PCM1;CEP83;HOOK3;GOLGB1;C2CD3;CSNK1D;PIBF1;BBS4;CEP192
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.46927599309288187,-1.2286140373613432,0.10526315789473684,0.8936730403943702,1.0,7/82,8.87%,NGF;RASSF2;IL11;WNT3A;SPTBN4;RIPK2;CNOT9
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.7623144331276901,1.2285880874496777,0.21666666666666667,1.0,1.0,4/9,21.53%,CDKN2A;HMGA2;HMGA1;B2M
prerank,Reactome_2022__Alpha-oxidation Of Phytanate R-HSA-389599,-0.7470667968742388,-1.2285349370781913,0.2222222222222222,0.8928958344725063,1.0,2/5,5.53%,SLC25A17;SLC27A2
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,0.550274368875926,1.2284927676870208,0.16666666666666666,1.0,1.0,2/64,0.92%,NEK2;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),0.8226763650662132,1.2284255195650753,0.15,1.0,1.0,1/5,11.68%,F2RL1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.6219646899113196,1.2282341013635167,0.14285714285714285,1.0,1.0,13/38,20.13%,CCL5;IL12A;F7;PLA2G7;F2RL1;THBS1;CSF1R;MAPK3;CXCL12;ZNF580;CSF1;VEGFC;CREB3
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.6353984060394448,1.2281642810279492,0.28169014084507044,1.0,1.0,1/25,0.47%,RAB34
prerank,CellMarker_Augmented_2021__Stem cell:Eye,0.7927494645600057,1.2279084030328031,0.22388059701492538,1.0,1.0,2/7,14.71%,CSF2RA;CD44
prerank,KEGG_2021_Human__Oxidative phosphorylation,0.5731818412365283,1.2278307894947518,0.16049382716049382,1.0,1.0,29/94,24.43%,COX6A1;ATP6V1G2;ATP5PF;NDUFB11;NDUFS2;ATP6V0E2;COX7A2;ATP6AP1;COX17;ATP5F1E;NDUFB10;NDUFA2;ATP5MC3;ATP6V0B;COX4I1;COX7B;NDUFB9;COX6C;COX6B1;NDUFB4;UQCRFS1;ATP6V1D;NDUFA1;COX7A1;NDUFB2;COX5A;ATP6V0D1;COX7C;ATP5ME
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.6948505992866427,1.2275393414261921,0.17647058823529413,1.0,1.0,4/12,6.29%,ANXA1;CCL5;FLT1;MSMP
prerank,CellMarker_Augmented_2021__Neural Stem cell:Hippocampus,0.5263040313820581,1.2272784164675556,0.1625,1.0,1.0,14/89,13.25%,NEK2;SGO1;MCM2;BUB1;CENPU;DTL;BORA;NDC80;MCM3;OIP5;WDR76;KIF18A;TTK;CCNA2
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.6110292932562864,1.2272562205344637,0.22388059701492538,1.0,1.0,6/28,13.52%,GALNTL5;TOPAZ1;SYCP3;JAM2;MEIOC;TNP1
prerank,KEGG_2021_Human__Osteoclast differentiation,0.514759412526267,1.227065199635957,0.1518987341772152,1.0,1.0,22/92,20.41%,BLNK;OSCAR;PIK3R3;LILRB3;TGFB1;FCGR3A;SYK;STAT1;FOSL2;NFKB2;CSF1R;SIRPG;CALCR;CYBA;MAPK3;CYLD;CSF1;NOX1;NFKBIA;MAP2K1;IL1R1;NFATC2
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.5158678613546649,1.2270515980578403,0.08433734939759036,1.0,1.0,22/154,12.92%,TBX1;ESR1;RORC;MGST1;WNT8B;TNFRSF1B;AHR;SSTR1;WNT5A;GPER1;CD80;NR1H4;RAMP3;STRA8;AXL;H2AZ1;PDCD1LG2;UCP1;WNT6;TNFSF4;PDK4;CRHBP
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.534446635167351,-1.2270382619838338,0.10344827586206896,0.8978110860687013,1.0,13/40,20.11%,TRDMT1;METTL1;ADAT2;TRMT61A;ALKBH8;THG1L;QTRT2;PUS7;WDR4;ADAT1;CTU1;QTRT1;TRMT9B
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,-0.6268137418049692,-1.2270194011480238,0.23333333333333334,0.8967550326994268,1.0,1/16,4.56%,VAC14
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.743659319781331,1.2268014477618059,0.20634920634920634,1.0,1.0,2/6,18.83%,TRDN;ATP2A2
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6915313539479154,1.2263872483153682,0.1917808219178082,1.0,1.0,5/17,12.92%,CASQ2;CASP7;TGM2;HTR1B;CRHBP
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.534648127359405,1.226236537430234,0.1518987341772152,1.0,1.0,14/77,10.84%,SLC22A3;MGST1;ABCC6;ABCG2;SLCO1A2;CA14;SLC26A6;SLC4A1;CA1;ABCC11;SLC22A25;SLC22A6;SLC22A24;CA13
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.74566541777631,-1.226223951623875,0.23255813953488372,0.898976120816086,1.0,2/5,1.89%,SLC25A29;SLC6A20
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.5818182796322067,-1.2259733835972804,0.1875,0.8987312344595172,1.0,4/28,5.01%,OSR1;TWIST1;PTCH1;WNT7A
prerank,KEGG_2021_Human__Leishmaniasis,0.561702518267083,1.225934315245828,0.22077922077922077,1.0,1.0,18/54,18.84%,ITGB2;TLR2;C3;TGFB1;ITGAM;FCGR3A;IL12A;HLA-DMA;TGFB3;HLA-DPB1;STAT1;EEF1A1;IL4;CYBA;MAPK3;NOS2;NFKBIA;HLA-DPA1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.7094962204834199,-1.2256138190604873,0.3684210526315789,0.8991128197319558,1.0,1/7,1.23%,UBASH3B
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),0.8179650446646184,1.2255501056886882,0.13636363636363635,1.0,1.0,1/7,1.12%,LMOD3
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.5941952362230571,1.2255448880725028,0.21739130434782608,1.0,1.0,2/32,1.48%,RAB34;S100A13
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.7313235475552051,1.2255144130606868,0.15254237288135594,1.0,1.0,2/12,4.24%,CASQ2;CASR
prerank,CellMarker_Augmented_2021__Progenitor cell:Corneal Epithelium,-0.4659057214704315,-1.2254890361932425,0.17647058823529413,0.8985938983952181,1.0,9/71,4.13%,ADGRF4;EMP1;PHLDB2;ANXA8;COL12A1;FRMD6;ARSJ;LAMA3;CAPN2
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4877627034646538,-1.2252993181408656,0.14285714285714285,0.8980609788141825,1.0,8/46,17.20%,SPRY4;FLNA;WASHC2C;CRK;CSPG5;CRKL;LIMS1;ABL1
prerank,KEGG_2021_Human__Ether lipid metabolism,0.5950930245286061,1.2252634966449831,0.16666666666666666,1.0,1.0,5/38,11.23%,ENPP2;PLA2G10;PLD4;UGT8;PLA2G7
prerank,Reactome_2022__CREB3 Factors Activate Genes R-HSA-8874211,-0.7539787791281563,-1.2250826955008778,0.19047619047619047,0.8979856619791909,1.0,2/8,3.88%,CREB3L4;CREB3L1
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,0.505281665812726,1.224722239115392,0.11538461538461539,1.0,1.0,17/130,14.04%,CDC25A;PSMB9;POLE2;TK1;CDKN2A;CCND2;MCM3;CCND1;CKS1B;RPA3;CCNE2;RPS27A;CDKN1B;CDKN1A;CCNA2;CDKN2C;PSMC5
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.5808156384584607,-1.224697718857513,0.11428571428571428,0.898427096579271,1.0,5/32,17.59%,CDH5;CLIP3;MAPRE1;TRIM54;CAMSAP3
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Esophagus,0.5870083491349248,1.2246510265194797,0.1566265060240964,1.0,1.0,10/55,10.55%,MACC1;ADAM28;BLNK;STEAP4;LIPH;TMPRSS11D;CDKN2A;ATP10B;SLC15A1;TGM2
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.5225401735686495,-1.2246032142137053,0.13333333333333333,0.8976838087759259,1.0,8/40,11.92%,GCK;GLA;KHSRP;CRY1;SNAI2;WDTC1;AKR1C3;PGP
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.7372489272216255,1.224541248179542,0.2647058823529412,1.0,1.0,3/12,9.71%,TGFB1;WNT5A;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.4881219295540528,-1.2244415257151515,0.2,0.8972151102319742,1.0,11/80,11.91%,GPR3;PER2;ELOVL6;ADCYAP1;PPARGC1B;GNAS;HDAC3;ALMS1;PEMT;HSF1;DECR1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.47351841514476556,-1.2242786288435914,0.17647058823529413,0.8968383545804607,1.0,20/91,13.08%,AOAH;METRNL;PRKCD;TYRO3;CDH5;SIGIRR;IFI16;GRID2;APOE;CCN3;MEFV;SERPINE1;TRIB1;NR1D1;PTPRS;SHARPIN;MVK;SMPDL3B;MAPK7;CRK
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.5577858336668354,1.224214677626948,0.2077922077922078,1.0,1.0,8/54,16.35%,SMAD6;TMEM100;TGFB1;NODAL;TGFB3;GDF9;MAPK3;ENG
prerank,GO_Biological_Process_2021__response to acetylcholine (GO:1905144),0.7878267906123492,1.2238893710343484,0.21666666666666667,1.0,1.0,2/5,18.31%,CHRNB2;CHRNA3
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.6725454995908674,1.2237321848680114,0.18309859154929578,1.0,1.0,5/20,11.63%,VSIR;NR1H4;AXL;PDCD1LG2;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.6304487842146022,1.223478824516684,0.2191780821917808,1.0,1.0,8/24,11.69%,CD160;SCIMP;WNT5A;HLA-F;HLA-A;TNFSF4;F2RL1;LACC1
prerank,Reactome_2022__Transport Of Organic Anions R-HSA-879518,0.7524850724753769,1.223305247855397,0.18032786885245902,1.0,1.0,2/9,15.20%,SLCO1A2;SLCO2B1
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,0.46915280655142355,1.2232295747474864,0.056818181818181816,1.0,1.0,70/375,19.09%,ITGB2;CLEC5A;OSCAR;C3AR1;ARHGAP9;TCN1;MGST1;TLR2;TNFRSF1B;ITGAX;GMFG;HSPA8;PTX3;C3;PTPRC;CLEC4C;PTAFR;SNAP23;ITGAM;NFAM1;PRDX4;FCAR;CLEC12A;FGL2;ANPEP;MMP9;CHIT1;FLG2;CEACAM8;ENPP4;DDX3X;HLA-A;PLAUR;TMC6;PLAU;CD63;PYGL;LAMP2;EEF1A1;FPR1;PDAP1;RHOG;ITM2C;ORMDL3;ARHGAP45;ELANE;P2RX1;CYBA;CD44;FTH1;ADGRE3;NDUFA2;STOM;EEF2;A1BG;DYNLL1;SERPINB1;HRNR;IMPDH2;PGLYRP1;PADI2;IDH1;ACTR1B;LAMTOR3;HVCN1;APAF1;ATP6AP2;FTL;CYSTM1;DOCK2
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.7261276485649585,-1.2232101826175537,0.24390243902439024,0.9001975577953923,1.0,5/6,25.78%,TENT4A;RBM24;LARP4B;ELAVL4;METTL16
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.807689055746491,1.2229781435994322,0.2459016393442623,1.0,1.0,4/7,15.79%,PLA2G10;IQCF1;GLRA1;POMZP3
prerank,CellMarker_Augmented_2021__Cancer cell:Undefined,0.7467470659217277,1.2229163508875116,0.23529411764705882,1.0,1.0,4/7,18.28%,TNFRSF10A;EPCAM;GLUL;GFAP
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.7610957525177355,-1.2228531316941997,0.19607843137254902,0.9003468183266106,1.0,2/5,16.77%,FSCN1;PODXL
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.504092082588305,1.2227632490111822,0.0975609756097561,1.0,1.0,10/136,10.19%,NEK2;CDC25A;PSMB9;KIF14;FBXL7;DTL;CCND1;CEP72;CEP70;RAB11A
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.5499049014306389,-1.2225293238864063,0.18181818181818182,0.9009634005030146,1.0,4/20,13.61%,ADRA1A;GRIN1;TRPM2;JPH3
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),-0.7835571839628696,-1.2225164966783202,0.3055555555555556,0.8988960948603931,1.0,2/7,9.35%,MAP10;KIF4B
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),-0.7835571839628696,-1.2225164966783202,0.3055555555555556,0.8988960948603931,1.0,2/7,9.35%,MAP10;KIF4B
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.7869832504843342,1.2224221120114425,0.27941176470588236,1.0,1.0,4/5,21.28%,NLRP12;TAF7;HSPH1;CIITA
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,-0.4908175110405604,-1.2223784096164507,0.13333333333333333,0.8983245860885803,1.0,3/57,1.26%,SPRED3;SPRED2;SPRED1
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,0.5184353102965957,1.2221958618425404,0.14285714285714285,1.0,1.0,18/136,14.11%,CAVIN1;ARHGAP9;ARHGEF40;PLEKHG6;ARHGAP24;ARHGAP31;VAPB;PLEKHG3;PREX2;SNAP23;ARHGAP28;TAGAP;ECT2;ATP6AP1;RASGRF2;RTKN;ARHGAP45;ANLN
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),-0.686055336237301,-1.222181027404064,0.23076923076923078,0.8979496173536797,1.0,3/8,20.80%,PLEKHM1;PIP4K2B;CLN3
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.7774824626783867,1.2221434900954566,0.29310344827586204,1.0,1.0,2/7,18.35%,ERBB4;LHX6
prerank,Reactome_2022__Acetylcholine Inhibits Contraction Of Outer Hair Cells R-HSA-9667769,0.7690162709368682,1.2219279250403723,0.2545454545454545,1.0,1.0,1/5,0.20%,CHRNA9
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",0.6496547491724536,1.2218228832562508,0.22950819672131148,1.0,1.0,6/12,20.48%,RP1;PDE6A;CNGA1;PDE6B;PDE6G;GNGT1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),-0.6474078079475407,-1.2217567915412377,0.21739130434782608,0.8984604118569233,1.0,5/17,12.16%,RNF168;PCGF1;KDM2B;PCGF6;RING1
prerank,Reactome_2022__Metallothioneins Bind Metals R-HSA-5661231,-0.7547378962950163,-1.2217061472727317,0.21052631578947367,0.8976217615241064,1.0,1/6,0.33%,MT1G
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.7063503421268211,1.2216565002660293,0.25,1.0,1.0,3/13,7.66%,FGF2;ERBB4;IGF1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),0.7977753743613776,1.2216332719937522,0.21153846153846154,1.0,1.0,2/6,17.08%,PRDM12;MYB
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),0.8086290764296018,1.221627786582454,0.27419354838709675,1.0,1.0,2/5,9.71%,TGFB1;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.8296839313086167,1.2215116995355644,0.140625,1.0,1.0,1/6,2.11%,TNFRSF1B
prerank,Reactome_2022__Activation Of ATR In Response To Replication Stress R-HSA-176187,0.6169389027028507,1.2214828821020418,0.19117647058823528,1.0,1.0,4/31,9.53%,CDC25A;RRAD;MCM3;RPA3
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),-0.7332290163050461,-1.2213070013223795,0.28888888888888886,0.8983412312528231,1.0,4/6,22.22%,CRYM;SLC7A5;SLC16A10;SLC7A8
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),0.7092836723516442,1.2210816363250843,0.2028985507246377,1.0,1.0,4/15,17.02%,STOML2;ATP5PF;ATP5F1E;ATP5MC3
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),-0.7021351799445308,-1.2209774686485935,0.19047619047619047,0.8987601117012252,1.0,3/8,17.47%,FOXO1;AQP1;MTR
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.50050084796837,1.220697203079245,0.14634146341463414,1.0,1.0,40/130,16.64%,GATA4;SLC28A1;CLDN2;CDHR5;ACSL5;ACE2;CYP3A4;COL18A1;NR1I3;CYP4F12;LCT;SOX10;ABCG2;TMEM45B;NPC1L1;ABCC2;MUC17;ANPEP;SLC51A;CLCA1;CA1;NR1H4;ALDOB;TMC4;TREH;SLC15A1;VIL1;MTTP;ASPN;SDSL;DEGS2;SLC5A1;GBA3;PDZK1;ART3;MOGAT2;HNF1A;CYBRD1;ABCG5;NR5A2
prerank,Reactome_2022__Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,0.6472534439888489,1.2206119983871975,0.25,1.0,1.0,6/16,11.87%,GP1BA;SERPIND1;F8;KNG1;VWF;FAM110A
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.7341332348646287,1.2205435165729466,0.1864406779661017,1.0,1.0,3/12,6.20%,CYP3A4;CYP3A5;CYP26B1
prerank,Reactome_2022__RUNX3 Regulates WNT Signaling R-HSA-8951430,0.8282808064525412,1.2204423340015602,0.1746031746031746,1.0,1.0,4/7,13.42%,TCF7;LEF1;CCND1;TCF7L1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.6551048555559289,1.2203611573446191,0.2328767123287671,1.0,1.0,5/19,11.63%,VSIR;TGFB1;IL12A;NR1H4;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.6899956320099228,1.220226266841975,0.22727272727272727,1.0,1.0,4/13,11.07%,TGFB1;NODAL;TGFB3;DAB2
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.5776025117269107,1.2200482316229517,0.18840579710144928,1.0,1.0,6/37,6.90%,ANXA1;STOML2;PTPRC;VSIG4;SFTPD;CD80
prerank,KEGG_2021_Human__Influenza A,0.5075754935713294,1.2199580794769858,0.11688311688311688,1.0,1.0,26/118,21.28%,SLC25A31;PIK3R3;CCL5;TMPRSS11D;TNFRSF10A;CPSF4L;ACTG1;TRIM25;DNAJB1;IL12A;HLA-DMA;RAB11A;HLA-DPB1;STAT1;OAS2;PLG;MAPK3;KPNA5;APAF1;NFKBIA;HLA-DPA1;RAE1;MAP2K1;IFIH1;TMPRSS4;CIITA
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.5970114858265333,-1.219956892324816,0.2647058823529412,0.9016710488892566,1.0,7/21,17.30%,RASSF2;PDGFD;RAD50;TAOK2;NEK10;NBN;TNKS1BP1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.6208157213170916,-1.2199433751994997,0.23076923076923078,0.9006238118986768,1.0,1/10,0.51%,BUD23
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,0.5340480190328976,1.2198453158581246,0.15384615384615385,1.0,1.0,12/76,21.18%,NEK2;PSMB9;RPS27A;CDC14A;CCNA2;PSMC5;BUB1B;FBXO5;PSMA3;PSMB6;PSMD6;CCNB1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.6970631186897541,1.2197080353996759,0.2786885245901639,1.0,1.0,1/12,3.48%,TRIM62
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.543886418178308,1.2196654994078786,0.1891891891891892,1.0,1.0,2/56,2.20%,PSMB9;FBXL7
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),0.8291163339696073,1.2195426300752892,0.21311475409836064,1.0,1.0,2/5,14.71%,JAM2;CD44
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Blood,-0.5700517680111706,-1.219456227195826,0.2962962962962963,0.9012917792873245,1.0,7/30,8.43%,IL7R;JUNB;SELE;CRABP1;F11R;KCNQ4;SELPLG
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.7147793390127204,1.2193524106973925,0.30158730158730157,1.0,1.0,3/10,17.36%,STEAP4;COX17;ATOX1
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,0.5259035119898077,1.2192941681380105,0.14102564102564102,1.0,1.0,9/75,9.00%,MICB;ITGB2;PIK3R3;TNFRSF10A;SH3BP2;FCGR3A;SH2D1B;SYK;HLA-A
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.78589670628199,1.2192866569488483,0.19117647058823528,1.0,1.0,2/8,7.66%,LMOD3;IGF1
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.6020665459667778,-1.2191281898185515,0.1724137931034483,0.9012441298273329,1.0,3/15,12.03%,EMC4;EMC8;BAG6
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.5929396192133143,-1.2189767908170452,0.2571428571428571,0.9008102510512388,1.0,4/18,12.00%,TSKU;APOE;SCARB1;SOAT1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.7850510998570123,1.218801080440682,0.2,1.0,1.0,2/8,11.68%,C3;F2RL1
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,0.5124332598163462,1.218794093027183,0.08641975308641975,1.0,1.0,25/156,22.13%,CDC25A;PSMB9;MAT2B;H2BC4;RPS27A;USP13;CCNA2;USP18;TOMM20;PSMC5;H2BC18;CYLD;PTRH2;TAF10;FKBP8;TAF9B;NFKBIA;PSMA3;USP17L2;PSMB6;PSMD6;IFIH1;H2AC25;OTUB1;POLG2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.709885999142801,1.2187236010019646,0.2463768115942029,1.0,1.0,4/14,17.02%,STOML2;ATP5PF;ATP5F1E;ATP5MC3
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.5487498686612808,1.2185109516444261,0.14705882352941177,1.0,1.0,11/60,21.53%,PSMB9;SNAP23;HLA-F;HLA-A;PSMC5;CYBA;PSMA3;PSMB6;PSMD6;TAP1;B2M
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.8185032063458347,1.218438172929972,0.16071428571428573,1.0,1.0,1/6,11.68%,F2RL1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.5797101821589168,-1.2183243113673936,0.1724137931034483,0.9026482072322515,1.0,4/25,6.21%,NAA40;FOXO1;ESCO2;DSCC1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.5305955325110034,1.218119863291724,0.2125,1.0,1.0,32/90,16.42%,ITGB2;BLNK;CYTIP;ARHGAP9;ITGAX;GMFG;SASH3;PTPRC;CLEC4C;ITGAM;JCHAIN;NFAM1;WAS;CD80;NAPSB;HCK;IKZF1;TAGAP;CD37;CD4;GPR183;ALOX5AP;PSTPIP1;MYO1F;IGLL1;ITM2C;PARVG;CD300LF;PIK3R6;IL3RA;IL17RB;CD244
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.4876142877491501,-1.2180371828924366,0.13333333333333333,0.9028660047093666,1.0,13/86,10.14%,PER2;RFX6;GCK;MIDN;ITPR2;CELA2A;DOC2B;ABCC8;CCN3;ENSA;CAPN10;NLGN2;NR1D1
prerank,GO_Biological_Process_2021__AV node cell to bundle of His cell communication (GO:0086067),0.7986110087382594,1.2178786758166025,0.1896551724137931,1.0,1.0,1/5,2.51%,GJC3
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.7491002591566441,1.217793074290999,0.22033898305084745,1.0,1.0,1/9,2.12%,MYRF
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,0.5395061915487762,1.217703021118501,0.16666666666666666,1.0,1.0,2/66,0.92%,NEK2;PSMB9
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.48263657352554,-1.2175540977646484,0.16666666666666666,0.9035719571707894,1.0,13/90,12.09%,CPSF1;NUP210;NUP42;MAGOHB;POM121C;NUP214;SRRM1;SRSF4;AAAS;NXF5;UPF2;SYMPK;U2AF2
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.7853822673348103,-1.2171322251061247,0.24444444444444444,0.9040692126488531,1.0,3/5,20.07%,GTF2H2;ARRB2;ARRB1
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Germ,0.5290512369396196,1.217035670991622,0.1506849315068493,1.0,1.0,11/78,10.67%,SLC25A31;GALNTL5;ADAM7;TOPAZ1;MOBP;TRIM51FP;HTR5A;SGO1P1;SLC22A24;RFX4;LRRC72
prerank,KEGG_2021_Human__Circadian entrainment,-0.45186286256607244,-1.216950638953623,0.15789473684210525,0.90373799537952,1.0,12/84,12.53%,PER2;FOS;ADCYAP1;GNAS;KCNJ6;GNB5;GRIA4;GNB3;ADCY3;GRIN1;ADCY2;PER3
prerank,Reactome_2022__Chondroitin Sulfate Biosynthesis R-HSA-2022870,-0.5407015709316243,-1.2168728300825418,0.10344827586206896,0.9029353238927231,1.0,8/19,14.57%,CHPF2;CHST11;CHST12;CHSY1;CSGALNACT1;VCAN;CHST3;CSPG5
prerank,Reactome_2022__Glycogen Storage Diseases R-HSA-3229121,-0.6381448599591978,-1.216871627057224,0.25,0.9018986587677028,1.0,2/13,5.09%,G6PC3;GYS1
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,-0.570763579046988,-1.2167252623341027,0.25925925925925924,0.9013796725668021,1.0,7/27,7.41%,NDST3;GPC6;GPC2;SDC3;GPC4;HS6ST2;AGRN
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5858219383870372,1.2166355314068762,0.25757575757575757,1.0,1.0,6/34,17.77%,ESR1;GPER1;KDM3A;WBP2;UBE3A;PADI2
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.6637573196457138,1.2164502058989908,0.2361111111111111,1.0,1.0,7/16,25.72%,PRDM12;MME;OPRM1;CHRNB2;OPRL1;PTGES;SCN9A
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.6209274599744933,1.2163233524614367,0.1643835616438356,1.0,1.0,11/29,27.27%,CENPU;OIP5;CENPX;ITGB3BP;CENPN;CENPL;RBBP7;CENPM;CENPO;CENPK;CENPP
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,0.5817189441707612,1.2161229205600297,0.2318840579710145,1.0,1.0,10/29,24.63%,PIK3R3;HSD11B2;IGF1;ATP1A4;MAPK3;SCNN1A;KRAS;SCNN1G;ATP1A1;PIK3CB
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,0.5260568755362869,1.2159381202262425,0.12162162162162163,1.0,1.0,52/104,24.42%,VSIG2;RPL37A;RPL21;INMT;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;AHCY;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;GNMT;RPL27;RPS14;RPL7A;SEPHS2;RPL23;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),0.7548618967340035,1.2159376947550844,0.203125,1.0,1.0,2/7,12.87%,TMEM79;SFRP4
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.7255378240644533,1.2155643482401106,0.25925925925925924,1.0,1.0,3/10,14.91%,CCL5;CD4;CRTAM
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.6394347764156963,-1.2155622035023435,0.35294117647058826,0.9055678043610045,1.0,7/12,26.56%,CCN3;SLIT2;MIA3;PLCB1;GREM1;ADTRP;AKT1
prerank,CellMarker_Augmented_2021__Myeloid cell:Blood,0.5846646971568769,1.2154795562664322,0.18055555555555555,1.0,1.0,16/46,14.99%,RASGRP4;C19ORF38;TRIM58;SLFN14;GP1BA;ALOX12;NLRP12;HEMGN;SLC4A1;MFSD2B;CD37;ITGA2B;ARHGAP45;TRPC2;P2RX1;ADGRE3
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),-0.7143024070232462,-1.2150067621317073,0.20930232558139536,0.9066322414889424,1.0,1/6,1.19%,DNMT1
prerank,CellMarker_Augmented_2021__Parietal Progenitor cell:Stomach,0.7663920127306089,1.2149450122161354,0.3275862068965517,1.0,1.0,1/5,2.57%,ANXA1
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.7783620730829683,1.2148206954810419,0.2,1.0,1.0,3/6,19.77%,HEY2;ENG;HEY1
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.7783620730829683,1.2148206954810419,0.2,1.0,1.0,3/6,19.77%,HEY2;ENG;HEY1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Germ,-0.7018482267025734,-1.2145308103789536,0.2857142857142857,0.9072394007707415,1.0,2/10,3.46%,CD38;KIT
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.7657763308435526,1.2144930477776308,0.30434782608695654,1.0,1.0,1/6,5.77%,GPER1
prerank,KEGG_2021_Human__Hematopoietic cell lineage,-0.4696569588721041,-1.2144715167682631,0.1875,0.9063796073353863,1.0,9/59,5.83%,IL7R;CD38;IL11;CD14;HLA-DQB1;KIT;HLA-DRA;KITLG;ITGA4
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.7628706541796723,1.2142358185746416,0.15625,1.0,1.0,3/7,22.95%,KCNA5;SCN5A;KCNQ1
prerank,CellMarker_Augmented_2021__Paneth cell:Pyloric Gland,0.5876687785663254,1.2134744563131439,0.16176470588235295,1.0,1.0,11/32,15.80%,LRRC19;ACE2;ADAMDEC1;MUC17;CLCA1;ALDOB;MEP1B;C17ORF78;GBA3;TM4SF20;MOGAT2
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.5156155326789719,-1.2133094361548302,0.1724137931034483,0.909840266076517,1.0,11/51,10.89%,CDH4;KIRREL3;CDH13;DSG2;IGSF21;PVR;AMIGO2;PCDHB6;BSG;SDK2;NECTIN3
prerank,Reactome_2022__IRAK4 Deficiency (TLR2/4) R-HSA-5603041,0.7496945286760733,1.2132794513704745,0.21666666666666667,1.0,1.0,1/10,1.83%,TLR2
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,-0.46790662679439277,-1.2132052661008192,0.125,0.9092134254013339,1.0,12/49,18.09%,MYO10;TRPC3;SLIT3;NTN4;TRPC6;RGMA;ABLIM3;SLIT2;DSCAML1;FYN;PITPNA;MAPK12
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.7963704238872311,1.2130243018788138,0.15789473684210525,1.0,1.0,1/6,4.27%,TGFB1
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.6754294162797403,-1.2129716824054992,0.25,0.9090992085861423,1.0,3/9,10.57%,PAH;GSTZ1;KYAT1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.49039994658012365,-1.2128901769854479,0.13793103448275862,0.90841627846593,1.0,8/47,7.01%,TSKU;WNT3A;PTPN9;PTPRO;PRAG1;APOE;MINAR1;RTN4RL2
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.5595490723995507,-1.2128830436236466,0.18421052631578946,0.9074288764334487,1.0,5/27,9.47%,PRKCD;CDH5;CLIP3;KANK4;MAPRE1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.745137174798781,-1.2128455371172777,0.22448979591836735,0.9065456051746426,1.0,4/6,23.03%,NPHS1;JAG1;PODXL;MAGI2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.5482971367553103,1.2127635784913302,0.14705882352941177,1.0,1.0,15/62,25.56%,PSMB9;SNAP23;HLA-F;HLA-A;PSMC5;CYBA;PSMA3;PSMB6;PSMD6;TAP1;B2M;LNPEP;PSMA7;NCF2;PSMB1
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),0.7861613504550949,1.2126745264705747,0.1935483870967742,1.0,1.0,1/6,6.14%,IL12A
prerank,GO_Biological_Process_2021__negative regulation of macrophage migration (GO:1905522),-0.7447105780361833,-1.2124528445242861,0.23809523809523808,0.9072345985875399,1.0,3/6,21.57%,EMILIN1;CD200R1;C5
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),0.7004755903112895,1.2123836526024567,0.1864406779661017,1.0,1.0,4/16,6.13%,LYVE1;FGF2;TGFB1;STAB2
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,0.5378454842408358,1.2123477093356863,0.16666666666666666,1.0,1.0,2/67,0.92%,NEK2;PSMB9
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.717293347010521,-1.2122969734046203,0.23809523809523808,0.9068763746981481,1.0,4/9,13.40%,PEX7;DHRS7B;PLA2G4C;LPCAT2
prerank,Reactome_2022__Uptake Of Dietary Cobalamins Into Enterocytes R-HSA-9758881,0.750291203909524,1.2120575372124438,0.26865671641791045,1.0,1.0,3/7,13.35%,TCN1;AMN;CBLIF
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.6932711190568097,-1.212009319278,0.2222222222222222,0.9073458379465269,1.0,7/11,23.10%,KIT;CCN3;SERPINB8;CAMSAP3;VCL;KIFC3;DSP
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.470948721209601,-1.2117393163387937,0.23076923076923078,0.9073650436693838,1.0,14/67,12.71%,AOAH;METRNL;PRKCD;TYRO3;CDH5;IFI16;APOE;CCN3;MEFV;NR1D1;SHARPIN;MVK;SMPDL3B;MAPK7
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.7796429837346881,1.2117305629852753,0.24615384615384617,1.0,1.0,2/7,13.02%,ERBB4;FOXB1
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.4603118154660376,1.2116229560897023,0.08791208791208792,1.0,1.0,75/388,19.09%,ITGB2;CLEC5A;OSCAR;C3AR1;ARHGAP9;TCN1;MGST1;TLR2;TNFRSF1B;ITGAX;GMFG;HSPA8;LILRB3;PTX3;C3;PTPRC;CLEC4C;PTAFR;SNAP23;ITGAM;NFAM1;PRDX4;FCAR;CLEC12A;FGL2;ANPEP;SYK;MMP9;CHIT1;FLG2;CEACAM8;ENPP4;DDX3X;PLAUR;PSAP;TMC6;PLAU;CFD;HK3;CD63;PYGL;PGAM1;LAMP2;EEF1A1;FPR1;MME;PDAP1;RHOG;ORMDL3;ARHGAP45;ELANE;P2RX1;CYBA;CD44;FTH1;ADGRE3;PRDX6;STOM;EEF2;A1BG;DYNLL1;SERPINB1;HRNR;IMPDH2;PGLYRP1;PADI2;IDH1;ACTR1B;LAMTOR3;HVCN1;APAF1;ATP6AP2;FTL;CYSTM1;DOCK2
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.7389468988848417,-1.2113202613023364,0.32,0.9078039496227217,1.0,3/7,19.37%,PLIN5;LPL;OSBPL11
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.6700540605583469,-1.2112929910740509,0.21951219512195122,0.9068683935710068,1.0,5/14,15.55%,APOB;SCARB1;LPL;NR1H2;ABCG1
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.6045868392272906,1.2112011632675954,0.19402985074626866,1.0,1.0,2/23,6.12%,GPER1;SLC26A6
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.7678104188408998,1.2110491342289098,0.21875,1.0,1.0,4/8,19.58%,ACE2;MME;ATP6AP2;CTSZ
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.7678104188408998,1.2110491342289098,0.21875,1.0,1.0,4/8,19.58%,ACE2;MME;ATP6AP2;CTSZ
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.701188057402332,1.2109425926297335,0.26153846153846155,1.0,1.0,5/13,16.69%,CD160;HLA-F;IL12A;CRTAM;RASGRP1
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),-0.8096099651907411,-1.2107541146613137,0.2777777777777778,0.90785564217634,1.0,1/5,5.41%,UBE2D4
prerank,Reactome_2022__Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,-0.6015318056857346,-1.2106311629132813,0.25,0.9072683334531071,1.0,3/14,10.63%,MAML1;GATD3;MAMLD1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.6187288757970256,1.2104707572776359,0.22950819672131148,1.0,1.0,4/20,8.02%,CYP4F12;CYP26B1;LDHD;LPIN3
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,0.5818569962111141,1.2101086265192007,0.21333333333333335,1.0,1.0,10/47,13.70%,LRP4;ITGAX;TGFB1;ITGA2;ITGB6;TGFB3;DCN;VTN;ASPN;ITGA2B
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.47607704526052436,-1.210092849694731,0.15,0.9082385082091593,1.0,19/87,15.83%,NGF;MFSD2A;BCL2;LIMK1;CPNE6;ERBB2;ISLR2;DNPH1;SYT3;SYT17;SLC25A33;GOLGA4;SDCBP;KLHL22;DBNL;RPS6KA3;RNF157;MAP3K13;TGFB2
prerank,Reactome_2022__Purine Salvage R-HSA-74217,0.7204996123930774,1.209755240296672,0.2361111111111111,1.0,1.0,2/11,10.57%,ADA;DCK
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.7096058277435939,-1.2095989998914072,0.25,0.9089762231542493,1.0,1/7,2.45%,RNF168
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.796062339979736,1.2094202319019964,0.2,1.0,1.0,2/8,5.05%,GATA4;HEY2
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.611408132269305,-1.2093721874726675,0.2,0.9090509592524689,1.0,2/16,3.81%,WWC1;MAML1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.5523821404775087,-1.209275394759556,0.3125,0.9084505806804666,1.0,1/35,0.18%,NOX4
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.6103445637665939,1.2092241154499916,0.2318840579710145,1.0,1.0,9/27,24.43%,NOX5;ATP1A4;ATP6V0E2;UCP1;SLC46A1;HVCN1;SLC36A3;ATP6V0D1;ATP1A1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.5441265144769192,-1.2090710934690927,0.22727272727272727,0.908124089982051,1.0,10/29,19.69%,NDST3;XYLT1;CHST11;CHST12;CSGALNACT1;B3GAT3;CHST8;EXT1;EXT2;PXYLP1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.48801234903476365,-1.2088059235513322,0.1724137931034483,0.9081708698298734,1.0,8/46,13.78%,PM20D1;SMPD4;ASS1;PNPLA1;PAM;SPTSSB;PCSK1;ASL
prerank,CellMarker_Augmented_2021__Goblet cell:Small Intestine,0.6102286655508707,1.2086958074325203,0.19444444444444445,1.0,1.0,8/31,15.36%,ESR1;ST6GALNAC1;PLEKHG6;CLCA1;ERN2;MYO1F;BCAS1;MT1M
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.6882855274655356,-1.208571213225715,0.275,0.9079742319249886,1.0,2/7,13.78%,ASS1;ASL
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5663303189219562,-1.2083228742686902,0.1935483870967742,0.9078066252016661,1.0,6/33,14.77%,ENTPD2;ADPRM;RNASET2;DNASE1L1;PABPC4;NUDT18
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.6081771054267038,1.2082685892142062,0.23076923076923078,1.0,1.0,16/54,24.14%,COX6A1;NDUFB11;NDUFS2;NDUFB10;NDUFA2;COX4I1;COX7B;NDUFB9;COX6C;COX6B1;NDUFB4;UQCRFS1;NDUFA1;NDUFB2;COX5A;COX7C
prerank,CellMarker_Augmented_2021__Germ cell:Ovary,0.6830399487088564,1.2082257115270347,0.27586206896551724,1.0,1.0,4/10,5.35%,DAZL;SALL4;NLRP5;SYCP3
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.5214441676222688,1.2081587829093408,0.1375,1.0,1.0,30/122,16.69%,GATA4;GPR55;CCL5;ALKAL2;FGF2;PTPRC;TGFB1;SCIMP;GPER1;NODAL;ERBB4;P2RY6;FLT4;IL26;RAMP3;ATP6AP1;F2RL1;CD4;GPR183;PRXL2C;TNFAIP8L3;ALOX15;CSF1R;CALCR;OPRM1;CD44;MAPK3;AGER;HTR2B;RASGRP1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.7795546139664755,1.2079207090942994,0.2,1.0,1.0,2/5,9.22%,REST;PINK1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.44207214996706923,-1.207851795588243,0.16,0.9087818485370507,1.0,15/66,15.05%,ACAD10;MECR;SLC25A17;SLC27A2;GLYATL2;ECHDC2;ACADS;ECHS1;PEX13;CEL;SLC27A4;DECR1;NUDT19;CROT;EHHADH
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.48032612483525133,-1.2076757187702358,0.20689655172413793,0.9083284199742858,1.0,1/26,0.13%,PER2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.5545146180643539,-1.207654380880057,0.16666666666666666,0.9073487843530417,1.0,6/26,12.03%,BCL2;QRICH1;ERN1;CHAC1;DAB2IP;BAG6
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),-0.5144781485525155,-1.207575327774618,0.2,0.9066844516683922,1.0,10/26,14.57%,CHPF2;ARSB;CHST11;CHST12;CHSY1;CSGALNACT1;VCAN;IDUA;CHST3;CSPG5
prerank,CellMarker_Augmented_2021__Stem cell:Endometrium,-0.6321313988463539,-1.2074035276289958,0.19444444444444445,0.9062917220347787,1.0,5/12,11.62%,CDH5;KIT;LGR5;MSI1;ALCAM
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.6435828918840517,1.2070864583075454,0.25806451612903225,1.0,1.0,4/16,14.41%,BLK;AXL;F2RL1;IL4
prerank,CellMarker_Augmented_2021__Neutrophil:Blood,0.6972710975093042,1.2067644332389234,0.28125,1.0,1.0,7/12,9.21%,TLR2;ITGAX;ITGAM;FCGR3A;ANPEP;CEACAM8;CSF3R
prerank,CellMarker_Augmented_2021__Intermediate Progenitor cell:Undefined,-0.45380850041925436,-1.2066482977840987,0.09090909090909091,0.9080301205557696,1.0,22/88,17.06%,XKR7;DMRTC1;SBK1;DTX1;NLGN3;SEZ6L;ELAVL3;TTBK1;C12ORF42;ASCL1;CD8A;C4ORF50;BCL11B;BEX5;DSCAML1;EVL;GLCCI1;RNF157;DLGAP3;OTUD7A;FXYD7;INSM1
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),-0.7773154261349767,-1.2064880098819621,0.3333333333333333,0.9074807255095559,1.0,1/6,3.22%,EGR1
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,0.5461029539947923,1.206355260089346,0.10526315789473684,1.0,1.0,17/70,25.56%,PSMB9;ABCC6;ABCC2;RPS27A;PSMC5;ABCG5;SEL1L;PSMA3;PSMB6;KCNJ11;PSMD6;ABCA12;RNF5;PSMA7;DERL2;ABCB11;PSMB1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.6481335069743499,1.2063521226773783,0.25,1.0,1.0,2/14,7.03%,STAT5A;SOCS2
prerank,Reactome_2022__CD163 Mediating An Anti-Inflammatory Response R-HSA-9662834,-0.6634123601317494,-1.206342945534403,0.23684210526315788,0.9069183728777744,1.0,2/7,27.85%,MYH9;FURIN
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.5106196216235523,1.2062904434296755,0.15384615384615385,1.0,1.0,24/83,18.48%,GATA4;RRAS;ITGAX;FGF2;HIPK1;FLT1;WNT5A;ANGPTL4;NODAL;CYP1B1;AGGF1;RHOB;MYDGF;HMGA2;BTG1;ANGPTL3;THBS1;EPHA1;PIK3R6;VASH2;HYAL1;BRCA1;ITGB8;VEGFC
prerank,KEGG_2021_Human__Primary bile acid biosynthesis,0.6471387748836005,1.2061923875553946,0.27419354838709675,1.0,1.0,3/15,9.76%,ACOX2;HSD3B7;CYP39A1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.5071857979128624,-1.2060946220246653,0.23333333333333334,0.9069800694856796,1.0,7/43,17.65%,METRNL;CARM1;SYAP1;TFE3;LPL;CDS1;CMKLR1
prerank,Reactome_2022__Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,0.6918698984442049,1.2060178521063551,0.24324324324324326,1.0,1.0,1/17,3.68%,SLC18A2
prerank,CellMarker_Augmented_2021__Pit Progenitor cell:Stomach,-0.5123113408647063,-1.205967279896944,0.17857142857142858,0.9063629502358596,1.0,5/49,4.76%,BCL2;HACD1;GBP2;CFAP221;CNN1
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),0.6927382762105051,1.2059399102447355,0.23214285714285715,1.0,1.0,4/11,14.80%,AQP3;SLC26A6;AQP4;UPK3A
prerank,GO_Biological_Process_2021__pharyngeal arch artery morphogenesis (GO:0061626),-0.7954573821987131,-1.2059283916112342,0.3,0.9054364693369018,1.0,2/5,15.83%,HES1;TGFB2
prerank,Reactome_2022__DNA Damage Reversal R-HSA-73942,-0.7103345232557221,-1.2056798690871224,0.23684210526315788,0.905429050560888,1.0,3/8,21.09%,ASCC2;ALKBH3;MGMT
prerank,CellMarker_Augmented_2021__Goblet Progenitor cell:Large Intestine,0.671598232126071,1.205639349149118,0.2318840579710145,1.0,1.0,4/14,13.04%,GPRIN2;FOXA3;GALNT5;SLC39A7
prerank,Reactome_2022__Erythrocytes Take Up Carbon Dioxide And Release Oxygen R-HSA-1237044,0.7766984058157089,1.205564403771362,0.25396825396825395,1.0,1.0,3/7,18.04%,SLC4A1;CA1;CYB5R2
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.7219156955419075,1.205493766731312,0.25396825396825395,1.0,1.0,1/10,1.19%,ADA
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.6487723246691475,1.2052782267834223,0.23529411764705882,1.0,1.0,3/22,5.05%,TBX1;LRP2;HEY2
prerank,Reactome_2022__G1/S-Specific Transcription R-HSA-69205,0.5930783943555673,1.2048354550867704,0.22535211267605634,1.0,1.0,2/26,3.61%,CDC25A;TK1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.6595086864913748,-1.2047769008657607,0.275,0.9076200943597889,1.0,4/11,17.80%,SOX12;PKD2;DLL1;NF1
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,0.4979681222655441,1.2047129395168126,0.12048192771084337,1.0,1.0,61/151,25.85%,PSMB9;RPL37A;RPL21;RPL9;LHX4;RPL18A;COL4A5;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;PSMC5;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RBX1;RPL38;PSMA3;PSMB6;RPS15A;RPSA;RPLP0;RPS6;RPL35;PSMD6;RPL27;RPS14;RPL7A;RPL23;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24;NCBP1;PSMA7;RPS29;PSMB1;RPLP1;RPS28
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),0.7906845072438062,1.2046920706247484,0.2222222222222222,1.0,1.0,1/5,6.14%,IL12A
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,-0.5211090172915958,-1.2046742402206945,0.16129032258064516,0.9070472114476608,1.0,10/39,18.95%,EARS2;LARS2;VARS1;WARS2;DTD1;PARS2;CARS1;MARS1;FARSA;YARS1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.6833966260343123,-1.2045856252534783,0.22580645161290322,0.9063068426805763,1.0,1/12,1.19%,DNMT1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.7104826980178128,-1.20441905893406,0.325,0.9058349745997611,1.0,1/7,13.44%,CTPS2
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Large Intestine,0.6873543104449049,1.2042476344282513,0.23880597014925373,1.0,1.0,2/16,2.25%,NRIP2;ITGAX
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.6484135313115842,-1.2040279799154665,0.3333333333333333,0.9061779357735104,1.0,4/13,9.40%,ADAMTS12;SNAI2;RFLNB;EFEMP1
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.7351242098297328,-1.2037348435128867,0.23684210526315788,0.9062258188497742,1.0,3/5,16.62%,PRKCD;DLL1;PRKCA
prerank,Reactome_2022__Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,0.6424873075508509,1.2037217564665692,0.21428571428571427,1.0,1.0,14/24,32.28%,TUBA4A;TUBA3D;TUBB6;TUBA1C;CCT7;TUBB4B;CCT8;VBP1;PFDN6;CCT3;CCT6A;CCT2;TUBA1A;TUBB
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.7046316734812382,1.2033035926208309,0.18461538461538463,1.0,1.0,1/12,2.83%,SLC37A2
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.45730374024412795,1.2032330446119301,0.0989010989010989,1.0,1.0,74/386,19.09%,ITGB2;CLEC5A;OSCAR;C3AR1;ARHGAP9;TCN1;MGST1;TLR2;TNFRSF1B;ITGAX;GMFG;HSPA8;LILRB3;PTX3;C3;PTPRC;CLEC4C;PTAFR;SNAP23;ITGAM;NFAM1;PRDX4;FCAR;CLEC12A;FGL2;ANPEP;MMP9;CHIT1;FLG2;CEACAM8;ENPP4;DDX3X;PLAUR;PSAP;TMC6;PLAU;CFD;HK3;CD63;PYGL;PGAM1;LAMP2;EEF1A1;FPR1;MME;PDAP1;RHOG;ORMDL3;ARHGAP45;ELANE;P2RX1;CYBA;CD44;FTH1;ADGRE3;PRDX6;STOM;EEF2;A1BG;DYNLL1;SERPINB1;HRNR;IMPDH2;PGLYRP1;PADI2;IDH1;ACTR1B;LAMTOR3;HVCN1;APAF1;ATP6AP2;FTL;CYSTM1;DOCK2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.5991876933747438,1.2028346712684597,0.22535211267605634,1.0,1.0,1/31,0.33%,ENPP2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.6042472178163301,-1.2027227481979232,0.23529411764705882,0.9088776710433131,1.0,1/19,0.64%,RASSF2
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),-0.7634749236525051,-1.202610444557064,0.3023255813953488,0.9082652071213152,1.0,3/5,19.90%,FGFR2;RAB26;IGSF3
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.643967576529649,-1.2025029037088715,0.2894736842105263,0.9076540760914216,1.0,5/7,32.81%,FNTA;MAPT;PRKAA2;EP300;TPPP
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.7914123992898378,-1.2024992932964809,0.29411764705882354,0.906667495573931,1.0,2/6,16.61%,PEX14;ETF1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.4762478386709992,-1.2024793232640467,0.17391304347826086,0.9057388158289716,1.0,13/93,12.09%,CPSF1;NUP210;NUP42;MAGOHB;POM121C;NUP214;SRRM1;SRSF4;AAAS;NXF5;UPF2;SYMPK;U2AF2
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.4746345221931212,-1.2023619107249397,0.16,0.9052159602438525,1.0,7/23,14.35%,ADAMTS12;XYLT1;CHST11;CHST12;CSGALNACT1;SULF2;CHST8
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,-0.6201551991150922,-1.2023364670220926,0.2619047619047619,0.9043743217453936,1.0,9/17,31.84%,CARM1;CPT1A;SMARCD3;RORA;CREBBP;NCOA2;RXRA;NCOA6;EP300
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5839279768816303,1.201756256474429,0.2702702702702703,1.0,1.0,10/38,14.62%,ITGB2;ACE2;TGFB1;ITGAM;SYK;F2RL1;CDKN1A;AGT;THBS1;CYBA
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.7278818941945889,-1.2017027542830796,0.20930232558139536,0.9056881264098952,1.0,3/6,21.38%,PMM2;GMDS;PMM1
prerank,Reactome_2022__Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,0.5975567141685927,1.2015895746512546,0.24615384615384617,1.0,1.0,9/24,17.55%,GP1BA;SERPIND1;F8;KNG1;F7;VWF;FAM110A;PROCR;TFPI
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.5474962039425316,-1.2014186951766714,0.24,0.9057221938094674,1.0,7/41,10.86%,GCK;NUP210;NUP42;POM121C;NUP214;AAAS;ZBTB7A
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.6874778081668319,-1.2014168398166138,0.3684210526315789,0.9037819499853009,1.0,1/5,8.46%,SNF8
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.6874778081668319,-1.2014168398166138,0.3684210526315789,0.9037819499853009,1.0,1/5,8.46%,SNF8
prerank,"Reactome_2022__POU5F1 (OCT4), SOX2, NANOG Activate Genes Related To Proliferation R-HSA-2892247",0.7841135802555393,1.2014076060385739,0.28846153846153844,1.0,1.0,2/6,15.18%,SALL4;EPHA1
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.6981600046827909,1.2013009543963626,0.25,1.0,1.0,2/10,3.71%,LOX;CHCHD4
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.5628594916643775,1.2012931958710795,0.21052631578947367,1.0,1.0,11/52,11.68%,ITGB2;CCL5;SASH3;PTPRC;ITGAM;GPR151;SH2D1B;CD81;IFNK;TNFSF4;F2RL1
prerank,Reactome_2022__Activation Of Phototransduction Cascade R-HSA-2485179,0.7833965611893875,1.2009105556043398,0.1568627450980392,1.0,1.0,6/8,20.48%,PDE6A;SLC24A1;CNGA1;PDE6B;PDE6G;GNGT1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.4924681832375514,1.2007869262944444,0.13793103448275862,1.0,1.0,16/169,9.04%,GPR62;ENPP2;MYRF;GJC3;MOBP;ST18;STMN4;SHISA6;SOX10;HTR5A;PLP1;NFE2L3;FAM181B;LY6H;PPP1R1B;TCEAL5
prerank,CellMarker_Augmented_2021__Myogenic Endothelial cell:Skeletal Muscle,0.5063687023938797,1.2006243873499125,0.1794871794871795,1.0,1.0,15/69,11.38%,C1QB;LYVE1;CYYR1;PTPRC;PREX2;FLT1;FCGR3A;VSIG4;MYH11;GPIHBP1;FGL2;RAMP3;ZNF366;VWF;CLDN5
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.5832879960144682,-1.2005281621120245,0.2682926829268293,0.9053740457117682,1.0,1/24,0.68%,CPSF1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.5832879960144682,-1.2005281621120245,0.2682926829268293,0.9053740457117682,1.0,1/24,0.68%,CPSF1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.5400660458693378,-1.2005182354092252,0.27586206896551724,0.9044143299234938,1.0,3/34,9.26%,PTCD2;IWS1;SAFB2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5501767094399108,1.200300481169781,0.2,1.0,1.0,8/51,20.47%,PSMB9;FBXL7;PSMC5;RBX1;PSMA3;PSMB6;ATF5;PSMD6
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.6438097850168109,-1.2002025334660402,0.28125,0.904421966245575,1.0,4/14,14.90%,MT1G;AQP1;HSF1;MT1E
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.6722571094601544,1.1999061918947127,0.23880597014925373,1.0,1.0,4/14,8.61%,BCO1;RDH13;DHRS13;CYP1B1
prerank,CellMarker_Augmented_2021__Sertoli cell:Undefined,0.7717548736602778,1.1998322336512701,0.25396825396825395,1.0,1.0,1/8,0.23%,GATA4
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.7389746295279022,-1.1997581304111142,0.24444444444444444,0.9052836403461834,1.0,1/6,2.45%,RNF168
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.5406940141178691,-1.1997513097177073,0.1,0.9043271073582629,1.0,8/20,14.57%,CHPF2;CHST11;CHST12;CHSY1;CSGALNACT1;VCAN;CHST3;CSPG5
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.6537918488945038,1.199733197624463,0.18571428571428572,1.0,1.0,7/24,13.80%,LMOD3;LRP2;GPER1;TGM2;ATP6AP1;MME;OPRM1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.6431353917591025,-1.1995764557014394,0.21621621621621623,0.9039774277120001,1.0,3/11,20.18%,SPAST;SIRT7;CTDP1
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.4780965561051525,1.1994951978419388,0.15294117647058825,1.0,1.0,31/230,13.99%,TBX1;ITGB2;ROPN1B;PIK3R3;FGF20;FAM20A;C3;FGF2;FAXDC2;CARD14;TGFB1;GPER1;RSPO1;ERBB4;MMP9;FLT4;CCND2;CCND1;PRR5L;HGF;CDK2AP1;PLAUR;PINK1;MYDGF;ECT2;DAB2;PPP2R5A;CD4;CSF1R;NOP53;SOX9
prerank,CellMarker_Augmented_2021__Mesangial cell:Kidney,0.7957125227309101,1.199453777714874,0.22,1.0,1.0,2/5,20.39%,ACTA2;FN1
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.6671877979417066,-1.199345785146959,0.16129032258064516,0.9037795356037855,1.0,3/9,10.46%,PNP;NT5C1A;AMPD3
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.7760641775302951,1.1993344464565874,0.2698412698412698,1.0,1.0,1/7,7.79%,REST
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.5920360814740432,-1.1991083300139431,0.25,0.9037466607344774,1.0,4/11,22.04%,POLD3;XPC;ERCC1;INO80
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.45541199410930183,-1.1990168364273668,0.1,0.9030150764268449,1.0,21/93,15.32%,PDE10A;PDLIM3;TYRO3;CALD1;COL4A2;SLIT3;PARVA;FSTL1;EML1;RASSF8;RNF150;GPR161;AMOTL1;EDNRA;ANTXR1;DENND2A;SLIT2;CHST3;CDH11;COL4A1;ADGRL2
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.633907592300538,1.1990117498762374,0.2328767123287671,1.0,1.0,4/18,9.58%,ALPK2;HEY2;MYH11;CSRP3
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In3:Brain,0.6775609586101683,1.198921889395458,0.26785714285714285,1.0,1.0,3/12,5.18%,SLC12A7;SYT2;SCTR
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5557914822943989,1.1984110604110292,0.17333333333333334,1.0,1.0,20/73,15.65%,TULP1;TYR;CABP4;COL18A1;CRYBB1;GPR179;DHRS3;COL1A1;CRYBG3;SLC24A1;GNAT2;FSCN2;RDH12;ROM1;PDE6C;PRPH2;TULP2;GUCY2F;RABGGTB;CRYBB3
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.6295956794694,1.1978200789958602,0.2328767123287671,1.0,1.0,11/27,24.39%,PTX3;TRIM62;TRIM25;TRIM68;CD4;TRIM5;TMPRSS4;CIITA;CD74;HLA-DRB1;LY6E
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.602641561647233,-1.1976613356370942,0.2647058823529412,0.9074176596563694,1.0,8/16,25.68%,PTPRJ;LIMS1;ABL1;COL16A1;TSC1;PPM1F;S100A10;TEK
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.44348411290377093,-1.1973666163372387,0.12,0.9073536705967759,1.0,16/75,14.31%,SMYD5;DNMT1;IFI16;POLR1A;CTCF;MACROH2A2;PHF2;MECP2;GPX1;DNMT3A;KDM1B;MPHOSPH8;MYBBP1A;POLR2F;TAF1B;MORC2
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.5651629784737224,1.1971859903102045,0.19117647058823528,1.0,1.0,3/27,6.35%,ITGB2;ITGAM;SYK
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.6569786403512389,-1.1971797453658934,0.2222222222222222,0.9069347140372743,1.0,2/8,18.97%,WASF3;WASF2
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),0.7963039589814345,1.196788043299324,0.2982456140350877,1.0,1.0,3/5,16.21%,SLC26A6;SLC51A;GHRL
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.5986008549290464,1.1966999842837753,0.26153846153846155,1.0,1.0,4/26,5.05%,GATA4;SMAD6;TGFB1;HEY2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.7980928361263369,1.1966044368129294,0.23076923076923078,1.0,1.0,3/7,15.26%,EXOSC8;EXOSC2;EXOSC4
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.7980928361263369,1.1966044368129294,0.23076923076923078,1.0,1.0,3/7,15.26%,EXOSC8;EXOSC2;EXOSC4
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.7736871061082822,1.1965792909521578,0.27419354838709675,1.0,1.0,2/7,10.00%,AXL;PPT1
prerank,CellMarker_Augmented_2021__Endothelial cell:Liver,0.5395410281076634,1.1964059274633378,0.2222222222222222,1.0,1.0,14/64,19.80%,OIT3;PTPRC;STAB2;F8;VWF;KLHL28;DCLRE1C;CD4;CRHBP;ENG;TSPAN7;BTNL9;CCDC85B;IL1R1
prerank,Reactome_2022__Plasma Lipoprotein Remodeling R-HSA-8963899,-0.558896782936853,-1.1963792730829108,0.24242424242424243,0.9090406618318606,1.0,4/24,6.98%,APOB;LIPC;APOE;ALB
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),-0.7304872289128628,-1.1963687063784412,0.30434782608695654,0.9081029081836667,1.0,3/5,10.39%,KIT;OLFM2;MYOCD
prerank,GO_Biological_Process_2021__negative regulation of anion transport (GO:1903792),-0.766816178166555,-1.1957168163789087,0.2702702702702703,0.9092637583003279,1.0,1/5,0.72%,GABRE
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.436358215353075,-1.1956704744601117,0.125,0.9084229548101258,1.0,8/139,2.14%,CYP1A2;GRP;GCK;APOB;LIPC;APOH;BCHE;PAH
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.7303356963817733,1.1955859068465091,0.3220338983050847,1.0,1.0,3/9,15.27%,SP100;IFIT1;ISG15
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.5379505659632284,1.195560729833304,0.12987012987012986,1.0,1.0,11/69,14.67%,CASQ2;ACE2;CAV3;NPR2;ATP1A4;CYP2J2;KCNG2;TRDN;PLN;AGT;NPPA
prerank,CellMarker_Augmented_2021__M1 macrophage:Lung,0.5586339343549815,1.1955497801671413,0.21518987341772153,1.0,1.0,16/57,13.33%,APOL1;PSMB9;C3AR1;TLR2;TAPBPL;SLC7A7;PTAFR;ADAMDEC1;TFEC;FCGR3A;IRF1;HCK;HLA-DMA;HK3;OAS2;CSF1R
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.602201801849302,1.1954772136587113,0.30985915492957744,1.0,1.0,1/20,0.33%,ENPP2
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.5739295064225417,1.19537690368579,0.21052631578947367,1.0,1.0,9/33,11.68%,GP1BA;ANXA1;FGF2;ACTG1;DUOX1;PLAU;VIL1;VTN;F2RL1
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.5948139859378503,1.1952717297356485,0.15492957746478872,1.0,1.0,3/29,8.11%,HSPA1L;HSPA8;HSPA5
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.6083635828655325,1.195198375253275,0.24675324675324675,1.0,1.0,16/53,24.14%,COX6A1;NDUFB11;NDUFS2;NDUFB10;NDUFA2;COX4I1;COX7B;NDUFB9;COX6C;COX6B1;NDUFB4;UQCRFS1;NDUFA1;NDUFB2;COX5A;COX7C
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,0.5281168801735956,1.195011037187763,0.19117647058823528,1.0,1.0,16/55,24.76%,PIK3R3;SYK;IL5;ALOX5AP;IL4;MAPK3;VAV3;PLA2G4A;MAP2K1;ALOX5;KRAS;PLA2G4D;INPP5D;VAV1;PIK3CB;MAP2K4
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.4998686603381749,1.1947740563582347,0.17721518987341772,1.0,1.0,12/97,10.29%,PCLAF;MCM2;DONSON;POLE2;TICRR;RAD1;MCM3;POLD4;CDK2AP1;PIF1;RPA3;GRWD1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.6754592613933115,1.1947236723544485,0.2537313432835821,1.0,1.0,5/12,14.48%,ALOX12;PLA2G7;ALOX12B;ALOX15;ALOX15B
prerank,CellMarker_Augmented_2021__Pericyte:Undefined,0.6862076794841229,1.194686264584973,0.25806451612903225,1.0,1.0,6/15,16.35%,ANPEP;NT5E;ACTA2;MME;CD44;ENG
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex R-HSA-937042,0.6727070441281389,1.1942590846718832,0.25,1.0,1.0,1/10,11.00%,RPS27A
prerank,CellMarker_Augmented_2021__Glomerular Epithelial cell:Renal Glomerulus,0.5208479497858143,1.1941385300955878,0.18309859154929578,1.0,1.0,10/66,11.25%,CLIC1;ELMO3;CASP7;MISP;BAIAP2L1;EIF6;LAMC2;TJP3;CELSR1;AP1M2
prerank,CellMarker_Augmented_2021__Podocyte:Renal Glomerulus,0.5208479497858143,1.1941385300955878,0.18309859154929578,1.0,1.0,10/66,11.25%,CLIC1;ELMO3;CASP7;MISP;BAIAP2L1;EIF6;LAMC2;TJP3;CELSR1;AP1M2
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.709848430206977,-1.1940357512934134,0.26666666666666666,0.9133849687212823,1.0,6/8,27.75%,KIT;FGFR2;CHD8;CLMP;COBL;NIPBL
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.7686784478879607,-1.1940230949559123,0.29411764705882354,0.9125280151612524,1.0,2/5,17.20%,MARK2;ABL1
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,0.5459609566762154,1.1937732014351174,0.22972972972972974,1.0,1.0,14/53,14.71%,ITGB2;ITGAX;COL18A1;ITGAM;ITGA2;ITGB6;JAM2;COL4A4;COL4A3;ITGA5;VTN;THBS1;ITGA2B;CD44
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),0.7488512058586676,1.1937653535466115,0.20689655172413793,1.0,1.0,3/5,21.86%,GPR183;PIK3CG;CXCL16
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.6796658558091995,-1.1935838921883555,0.2894736842105263,0.9134759360839392,1.0,4/8,26.27%,APOE;ABL1;DNM2;OLFM1
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In WNT Signaling R-HSA-8939256,0.7581210580239779,1.1933511680777364,0.3114754098360656,1.0,1.0,1/6,0.46%,ESR1
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,0.6474218683263099,1.1931787454991227,0.23529411764705882,1.0,1.0,4/22,9.73%,COL18A1;NID1;ITGA2;LAMC2
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),0.704978334997564,1.1931015164234025,0.3333333333333333,1.0,1.0,1/7,2.10%,SLC12A7
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.5959235026721543,1.193044334459023,0.1794871794871795,1.0,1.0,12/35,27.27%,CENPU;HAT1;OIP5;CENPX;ITGB3BP;CENPN;CENPL;RBBP7;CENPM;CENPO;CENPK;CENPP
prerank,CellMarker_Augmented_2021__Macrophage:Lung,0.7181120681974902,1.1930095657567383,0.2711864406779661,1.0,1.0,4/11,6.90%,ITGAX;ITGAM;FCGR3A;CD80
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.7097640666277915,1.1929665110958845,0.29508196721311475,1.0,1.0,3/11,14.41%,CD81;TNFSF4;IL4
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.5408304992893256,-1.1929527053714113,0.11538461538461539,0.9146520809756526,1.0,2/13,9.74%,EPHB2;SHISA7
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.41600050443056297,-1.1929454541544817,0.0625,0.9137288596973326,1.0,13/103,6.75%,RFX6;ARX;WWC1;RGS16;DUSP15;CKMT1B;CACNG4;ABCC8;HES1;ASS1;HS6ST2;PTPRF;PRR36
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.7195474760963236,1.1928575932137235,0.31343283582089554,1.0,1.0,2/9,19.65%,ERBB4;FIS1
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),-0.734938921962407,-1.1926422541381434,0.3142857142857143,0.9139292495134728,1.0,2/10,11.92%,PNPLA3;PGP
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.8342147955234935,-1.1925261419031332,0.25,0.9134137255564124,1.0,4/5,16.44%,MYO9B;SLIT3;SLIT2;RHOA
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.7148480271934153,1.1923834950149037,0.21875,1.0,1.0,7/11,23.66%,ART1;ART3;NDUFAF5;PADI2;ART4;PRMT1;PARK7
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.8040269917884886,-1.1922228815329292,0.22448979591836735,0.9133712832584867,1.0,1/5,0.87%,PDE10A
prerank,CellMarker_Augmented_2021__Granulosa cell:Ovarian Follicle,-0.7024403468226557,-1.192059321202822,0.2564102564102564,0.9130056134493298,1.0,2/5,14.35%,MGARP;CHST8
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.6441583487260569,-1.1918641230585223,0.23809523809523808,0.9126810824530326,1.0,2/12,7.60%,CCDC22;PKD2
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.6289168441947044,1.1916454150257598,0.2916666666666667,1.0,1.0,2/23,4.37%,ITGB2;ITGAM
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.7413064403961097,1.1916013343542233,0.23728813559322035,1.0,1.0,1/7,1.99%,RENBP
prerank,CellMarker_Augmented_2021__Immature Endothelial cell:Subcutaneous Adipose Tissue,0.5339320171387018,1.1915538055522579,0.20253164556962025,1.0,1.0,16/61,10.69%,C1QB;C3AR1;TNFRSF1B;GMFG;LYVE1;PTPRC;TFEC;FCGR3A;VSIG4;MYH11;FLI1;FGL2;GGT5;ZNF366;VWF;HLA-DPB1
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Subcutaneous Adipose Tissue,0.5339320171387018,1.1915538055522579,0.20253164556962025,1.0,1.0,16/61,10.69%,C1QB;C3AR1;TNFRSF1B;GMFG;LYVE1;PTPRC;TFEC;FCGR3A;VSIG4;MYH11;FLI1;FGL2;GGT5;ZNF366;VWF;HLA-DPB1
prerank,CellMarker_Augmented_2021__Inflammatory cell:Muscle,0.5339320171387018,1.1915538055522579,0.20253164556962025,1.0,1.0,16/61,10.69%,C1QB;C3AR1;TNFRSF1B;GMFG;LYVE1;PTPRC;TFEC;FCGR3A;VSIG4;MYH11;FLI1;FGL2;GGT5;ZNF366;VWF;HLA-DPB1
prerank,CellMarker_Augmented_2021__Endothelial cell:Lymph Node,0.5339320171387018,1.1915538055522579,0.20253164556962025,1.0,1.0,16/61,10.69%,C1QB;C3AR1;TNFRSF1B;GMFG;LYVE1;PTPRC;TFEC;FCGR3A;VSIG4;MYH11;FLI1;FGL2;GGT5;ZNF366;VWF;HLA-DPB1
prerank,CellMarker_Augmented_2021__Megakaryocyte:Undefined,0.6707501566401314,1.1909932693715373,0.2857142857142857,1.0,1.0,3/11,15.41%,GP1BA;ITGA2B;IL3RA
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.7968116049879135,1.190940601346987,0.23728813559322035,1.0,1.0,2/6,5.60%,ABCG2;ABCC2
prerank,Reactome_2022__Competing Endogenous RNAs (ceRNAs) Regulate PTEN Translation R-HSA-8948700,-0.638168115100611,-1.1908462003342883,0.37142857142857144,0.9156105125197913,1.0,3/10,17.40%,AGO2;TNRC6C;TNRC6A
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,-0.42644765411750746,-1.1906334898973472,0.0,0.915485374412795,1.0,27/280,7.56%,DUSP4;SPRED3;SPRED2;ABHD17A;DUSP6;SPRED1;SHC3;CSK;GFRA2;MMP2;FOXO1;KIT;DUSP2;PPP5C;GPRIN1;FGF18;SPTBN4;ERBB2;KITLG;PTPRA;FGF1;FNTA;TGFA;SPTB;PPP2R5D;MPP2;HSPB1
prerank,Reactome_2022__Activation Of RAC1 R-HSA-428540,-0.6068631088104182,-1.1905113217232983,0.29545454545454547,0.9151190239224285,1.0,6/11,32.01%,SLIT2;PKN2;NCK1;RNASE1;PKN1;PAK4
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.679295555164792,1.1901809969067922,0.2459016393442623,1.0,1.0,3/14,12.25%,PTPRC;HMGA2;EPCAM
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),0.7776202951288038,1.1899897850327508,0.3275862068965517,1.0,1.0,1/6,1.19%,ADA
prerank,Reactome_2022__Acyl Chain Remodelling Of PI R-HSA-1482922,0.6720703267584553,1.1898034840282208,0.2631578947368421,1.0,1.0,1/11,0.98%,PLA2G10
prerank,KEGG_2021_Human__Bile secretion,-0.4734709044453213,-1.189752262586441,0.125,0.916911033643188,1.0,1/58,0.03%,UGT2B15
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,0.4914289820629631,1.1896645139298268,0.13924050632911392,1.0,1.0,19/162,14.04%,ESR1;ACTL6A;PSMB9;BLK;GP1BA;CBX8;LMO2;H2BC4;CCND2;CCND1;H2AZ1;RPS27A;SMARCE1;CLDN5;LIFR;THBS1;TCF7L1;ITGA2B;PSMC5
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.7977189982672683,1.1896643362328037,0.20689655172413793,1.0,1.0,2/5,15.19%,CSF1R;MAPK3
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),0.7646145573983969,1.189602779024992,0.22807017543859648,1.0,1.0,3/6,16.91%,CDKN1A;MME;HYAL1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.5067552861647863,1.1894337040013658,0.16455696202531644,1.0,1.0,25/95,18.48%,GATA4;RRAS;ITGAX;FGF2;HIPK1;FLT1;WNT5A;ANGPTL4;NODAL;ITGA5;CYP1B1;AGGF1;RHOB;MYDGF;HMGA2;BTG1;ANGPTL3;THBS1;EPHA1;PIK3R6;VASH2;HYAL1;BRCA1;ITGB8;VEGFC
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.5979925652885085,1.1893639661649937,0.22857142857142856,1.0,1.0,6/31,9.19%,ELOVL2;TECRL;ACOX2;CYP4F12;HACD4;SLC27A6
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.5508305702243749,1.1893159597869707,0.2714285714285714,1.0,1.0,7/39,15.72%,TBX1;WNT8B;WNT5A;STRA8;WNT6;SOX9;WNT5B
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.5975132044655825,1.1891436270068998,0.22388059701492538,1.0,1.0,13/31,24.51%,CASQ2;MYBPC3;SGCG;CSRP3;TRDN;SGCZ;SCN5A;MYH7;SCN4B;KCNQ1;GAA;TCAP;SCN1B
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.741196585365005,1.1890731659060267,0.25,1.0,1.0,1/7,1.29%,RORC
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),0.7730868342436036,1.1889063185337425,0.2222222222222222,1.0,1.0,2/5,13.21%,TIMP3;THBS1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5348395572660295,1.1886074243252462,0.17857142857142858,1.0,1.0,10/71,12.89%,SLC9A2;SLC12A7;SLC5A2;KCNJ15;SLC12A3;TRPV6;ATP1A4;SLC9C1;SLC24A1;SLC5A1
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreatic Islet,0.5181662418013583,1.1883800619048883,0.20512820512820512,1.0,1.0,16/89,17.19%,CLIC1;RRAS;ITGA5;CD99;MYL6;MYDGF;SSR4;SMIM3;MYL12A;CD63;RHOG;CMTM3;ATRAID;LAPTM4A;ENG;TMEM109
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.5497548016735909,1.188340584990046,0.1891891891891892,1.0,1.0,15/75,15.54%,DENND1C;AQP3;ELMO3;CARD14;DTX2;UPK1B;TRIM25;POLD4;TMEM79;TMC4;TJP3;ALOX15;UPK3A;EPHA1;SLC14A1
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.5948510277263627,1.1883097933848807,0.25,1.0,1.0,3/28,6.49%,GATA4;HEY2;DAND5
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.5442274143161063,-1.18827073207555,0.21951219512195122,0.9211625581731442,1.0,9/25,18.89%,PTPRO;CDH13;KIT;ARFIP2;SRGAP2;ABLIM3;CCDC88A;VCL;PARVB
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),-0.7430670457913413,-1.188159905106669,0.27906976744186046,0.9206175859678761,1.0,2/5,19.16%,ASCL1;CHD5
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.468608948909531,-1.1879359243316607,0.17142857142857143,0.9204077323992638,1.0,7/41,12.03%,SPRY4;PRKCD;APOE;PTPRJ;SPRY1;DUSP19;DAB2IP
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.6691183369426857,1.187571209754414,0.25862068965517243,1.0,1.0,1/16,2.18%,CYP3A4
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.7134108853450375,-1.1873724971361834,0.22580645161290322,0.9214394458062072,1.0,1/6,6.02%,NBDY
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.7441937879221917,1.1870922826949177,0.25396825396825395,1.0,1.0,3/9,15.14%,NPR2;NPPA;GUCY2F
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.7812467433343873,1.1870064328506107,0.36923076923076925,1.0,1.0,2/6,4.58%,DNAH11;CCDC39
prerank,Reactome_2022__Creatine Metabolism R-HSA-71288,0.6827360439014315,1.1868581529118831,0.2537313432835821,1.0,1.0,4/10,16.85%,CKMT2;CKB;SLC6A12;CKM
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.6901436015358234,1.1867838823840131,0.30158730158730157,1.0,1.0,2/11,5.77%,PLA2G10;GPER1
prerank,GO_Biological_Process_2021__regulation of apoptotic cell clearance (GO:2000425),0.7833093382166912,1.186412130449488,0.3114754098360656,1.0,1.0,3/5,15.08%,C3;TGM2;CD300LF
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),0.751449992888467,1.1863830827592312,0.23333333333333334,1.0,1.0,2/8,3.82%,SLC7A7;SLC38A3
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),0.6536759302015108,1.1863716584425208,0.22580645161290322,1.0,1.0,1/18,0.47%,RAB34
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.8236383629955148,1.1861801915107903,0.20967741935483872,1.0,1.0,2/5,8.49%,USP50;DDX3X
prerank,CellMarker_Augmented_2021__Pericyte:Adipose Tissue,0.771093949601353,1.1860668989504861,0.2653061224489796,1.0,1.0,2/6,16.35%,PTPRC;ENG
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Salivary Gland,-0.413639612919886,-1.1858264993427414,0.07142857142857142,0.9260818890597694,1.0,9/85,4.03%,ADGRF4;ADAMTS12;COL4A2;COL12A1;MMP2;RAI14;FRMD6;ARSJ;RND3
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Peripheral Blood,0.5319127498178167,1.1857665323825863,0.2,1.0,1.0,20/64,15.20%,C1QB;LYVE1;CYYR1;PREX2;FLT1;FCGR3A;VSIG4;MYH11;GPIHBP1;FGL2;GGT5;RAMP3;ADGRL4;ZNF366;VWF;HLA-DPB1;CLDN5;CSF1R;EDNRB;SLCO2B1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.548497467173846,1.18571249227947,0.21621621621621623,1.0,1.0,8/43,20.47%,PSMB9;NQO1;OAZ2;PSMC5;AZIN1;PSMA3;PSMB6;PSMD6
prerank,Reactome_2022__Nef Mediated CD8 Down-regulation R-HSA-182218,0.7536867560829812,1.185500943348726,0.3103448275862069,1.0,1.0,1/7,18.03%,CD8B
prerank,Reactome_2022__FLT3 Signaling By CBL Mutants R-HSA-9706377,0.7354726583726972,1.185404764500777,0.23880597014925373,1.0,1.0,1/6,11.00%,RPS27A
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.6859960902735638,1.1854034764384505,0.3220338983050847,1.0,1.0,2/11,11.19%,IL12A;STAT1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.5518175935904297,1.1853461165406602,0.20270270270270271,1.0,1.0,8/52,10.66%,CIDEB;BOK;GPER1;MMP9;PLAUR;PINK1;MOAP1;DCN
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.657411510628997,1.1853214138425798,0.23880597014925373,1.0,1.0,4/16,15.85%,CEP55;KLHDC8B;CHMP3;MITD1
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.5734363544880543,-1.1852863313557822,0.3333333333333333,0.9269457622853081,1.0,5/10,21.53%,ZBTB7A;G6PD;MED1;ABCB10;ALAS1
prerank,CellMarker_Augmented_2021__Cancer cell:Blood,0.6897534193446513,1.1849934037902166,0.2714285714285714,1.0,1.0,6/11,15.77%,PTPRC;PLAUR;FOLH1;EPCAM;CD44;KRT8
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.6070369065813171,1.184980537252116,0.171875,1.0,1.0,4/21,12.93%,CASQ2;CAV3;HTR1B;PLN
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.6917829098025122,1.1849700569965522,0.234375,1.0,1.0,1/14,1.83%,TLR2
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.45464770265400467,1.1849213372556548,0.10112359550561797,1.0,1.0,74/391,19.09%,ITGB2;CLEC5A;OSCAR;C3AR1;ARHGAP9;TCN1;MGST1;TLR2;TNFRSF1B;ITGAX;GMFG;HSPA8;LILRB3;PTX3;C3;PTPRC;CLEC4C;PTAFR;SNAP23;ITGAM;NFAM1;PRDX4;FCAR;CLEC12A;FGL2;ANPEP;MMP9;CHIT1;FLG2;CEACAM8;ENPP4;DDX3X;PLAUR;PSAP;TMC6;PLAU;CFD;HK3;CD63;PYGL;PGAM1;LAMP2;EEF1A1;FPR1;MME;PDAP1;RHOG;ORMDL3;ARHGAP45;ELANE;P2RX1;CYBA;CD44;FTH1;ADGRE3;PRDX6;STOM;EEF2;A1BG;DYNLL1;SERPINB1;HRNR;IMPDH2;PGLYRP1;PADI2;IDH1;ACTR1B;LAMTOR3;HVCN1;APAF1;ATP6AP2;FTL;CYSTM1;DOCK2
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.6835206266296523,1.1849193377450546,0.2463768115942029,1.0,1.0,4/18,15.26%,INTS5;EXOSC8;EXOSC2;EXOSC4
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.6189123336833131,-1.184755682947449,0.22,0.9281537491705165,1.0,4/10,13.83%,DDX11;ZNF618;KDM4D;MED25
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.7987398153290581,-1.184702321687296,0.2857142857142857,0.9273922809407847,1.0,2/6,10.86%,TTBK1;NUPR1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.4866107391574705,-1.1844215318526554,0.16666666666666666,0.9274422533067863,1.0,13/37,17.00%,CFAP46;RP1L1;JHY;GAS2L2;AAAS;SPAST;NCKAP5L;TPPP3;CDK5RAP2;CHP1;MARK4;CCDC40;NAV1
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.48067196129432105,-1.18436987511247,0.16666666666666666,0.9266830933749088,1.0,6/36,11.36%,PIWIL2;TRIM71;KHSRP;DGCR8;AGO2;DTD1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.6258602925521393,1.1842120962899156,0.2028985507246377,1.0,1.0,8/17,23.00%,PWP2;RPS5;RPS19;RPSA;RPS14;ABT1;RPS15;RPS27
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.6429197922574912,-1.1841348762963213,0.34375,0.9264952109583865,1.0,8/15,29.19%,PCM1;CEP83;HOOK3;C2CD3;CSNK1D;PIBF1;BBS4;CEP192
prerank,CellMarker_Augmented_2021__Lymphatic Endothelial cell:Lymph Node,0.7855548494593462,1.1839926338976494,0.3404255319148936,1.0,1.0,1/5,7.20%,FLT4
prerank,Reactome_2022__Chemokine Receptors Bind Chemokines R-HSA-380108,0.6665419155523599,1.1839530381033867,0.328125,1.0,1.0,8/15,21.86%,CCL5;CXCR5;ACKR4;XCR1;CXCL12;ACKR2;CCL25;CXCL16
prerank,"Reactome_2022__TICAM1,TRAF6-dependent Induction Of TAK1 Complex R-HSA-9014325",0.6704405210029785,1.183936779493316,0.2459016393442623,1.0,1.0,1/10,11.00%,RPS27A
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.5260343058364613,1.1837414483607531,0.18072289156626506,1.0,1.0,17/120,12.77%,GATA4;TBX1;PKP2;MYBPC3;SGCG;TGFB1;ALPK2;MESP1;DAND5;ERBB4;MMP21;HEG1;CSRP3;POPDC2;CDKN1B;SGCZ;CDKN1A
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.7310043074573263,-1.1836415888197183,0.34146341463414637,0.9275650813391978,1.0,4/7,21.11%,GALE;TKTL1;PGM2;GALT
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.6493876554730178,1.1835425883433854,0.25396825396825395,1.0,1.0,2/16,4.37%,ITGB2;ITGAM
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.635289137172998,-1.1832470469834133,0.32432432432432434,0.9279981019297306,1.0,3/12,11.11%,CLDN4;KLHL3;AKR1C3
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.612817133086953,1.1830237065332816,0.24615384615384617,1.0,1.0,1/22,0.37%,NEK2
prerank,Reactome_2022__Glutamate And Glutamine Metabolism R-HSA-8964539,-0.6029137831075974,-1.1829695163705332,0.18421052631578946,0.9280604021556065,1.0,7/11,17.70%,GLUD2;KYAT1;PYCR3;ALDH18A1;RIMKLB;GLUD1;GOT2
prerank,KEGG_2021_Human__Renin-angiotensin system,0.6903120863049472,1.1828822742409382,0.2463768115942029,1.0,1.0,5/15,18.78%,ACE2;ANPEP;AGT;MME;ATP6AP2
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.5152926553408288,-1.1827231343495346,0.07692307692307693,0.9281225743234638,1.0,12/51,16.86%,NUP210;PIAS3;NUP42;POM121C;NUP214;AAAS;BCL11A;RNF212;NUP37;PIAS4;NUP98;SUMO2
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.6643320986697224,1.182562497014029,0.2542372881355932,1.0,1.0,1/12,0.98%,PLA2G10
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Undefined,0.5227648005226314,1.1824362360813818,0.189873417721519,1.0,1.0,14/74,5.54%,C1QB;C3AR1;ARHGAP9;TNFRSF1B;GMFG;SASH3;CMAHP;PTPRC;JCHAIN;FCGR3A;VSIG4;MYH11;FLI1;FGL2
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.5964001573837967,-1.1823991235230111,0.25806451612903225,0.9282768863208704,1.0,8/32,15.86%,SMPD3;RAB3D;RAB7A;SNF8;RAB5A;SDCBP;RAB27A;SDC4
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.6185582409546911,-1.1823755707826609,0.32432432432432434,0.9274301478743188,1.0,7/17,18.80%,SMPD3;RAB7A;SNF8;ATP9A;SDCBP;SDC4;TSG101
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,-0.523876075684093,-1.1822784082387274,0.25,0.9268745338688114,1.0,9/44,18.35%,GATAD2A;CHD4;POLR1A;GTF2H2;ERCC2;POLR2F;TAF1B;TAF1D;GATAD2B
prerank,CellMarker_Augmented_2021__Stromal cell:Adipose Tissue,0.7669428443203989,1.1822219340189966,0.2545454545454545,1.0,1.0,3/5,16.35%,NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.6499001961229378,-1.1819993813153162,0.23255813953488372,0.9268062593155315,1.0,3/8,15.97%,EGR1;NAB2;C5AR1
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5527991196824397,1.1819808093008846,0.2054794520547945,1.0,1.0,11/46,17.34%,SMAD6;TGFB1;NODAL;GDF11;TGFB3;DAB2;TTK;BMP3;GDF9;ENG;INHBC
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.653124335579601,-1.1819660549781734,0.25,0.9259242404543533,1.0,4/11,21.32%,RFLNB;ECM1;AHSG;GREM1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),-0.7299975923812767,-1.1818934346836447,0.25,0.92535875350382,1.0,3/6,13.41%,APOB;SCARB1;LPL
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.6928194633025125,1.1818859329552338,0.3188405797101449,1.0,1.0,3/8,24.81%,PIK3CG;PIK3CB;PIK3C2G
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,0.47790029831287545,1.1818823886978183,0.12048192771084337,1.0,1.0,29/224,19.29%,CDC25A;ESR1;ACTL6A;PSMB9;MAT2B;TGFB1;TRIM25;H2BC4;JOSD2;RPS27A;USP13;TFPT;CCNA2;USP18;TOMM20;PSMC5;YOD1;H2BC18;CYLD;PTRH2;TAF10;FKBP8;BRCA1;TAF9B;HCFC1;NFKBIA;PSMA3;USP17L2;PSMB6
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.7309531949346952,1.1818711985331636,0.3076923076923077,1.0,1.0,5/7,26.20%,CAV3;CSRP3;TCAP;CTNNB1;TTN
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.39894716746831504,-1.1818590442351966,0.1111111111111111,0.9245193128379317,1.0,10/82,4.43%,COL22A1;P3H4;COL6A3;COL4A2;COL12A1;LOXL1;COL13A1;LAMA3;COL8A1;CD151
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.8099665653970255,1.181766380318829,0.2711864406779661,1.0,1.0,1/5,6.12%,SLC26A6
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.7491177098409817,1.1816872268008547,0.31666666666666665,1.0,1.0,1/6,1.99%,RENBP
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.6844815553614869,1.1816491528026538,0.296875,1.0,1.0,2/10,11.35%,PIK3R3;PPP2R5A
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,-0.4078587745877846,-1.181632332246347,0.058823529411764705,0.9244537175091618,1.0,25/150,17.05%,SEC24C;MGAT4C;KDELR1;PPP6R1;MAN1A1;SPTBN4;COG4;B4GALT2;SEC22A;TGFA;SPTB;TRAPPC9;STX5;PREB;B4GALT4;CNIH3;CAPZB;ST3GAL4;TRAPPC1;MIA3;CHST8;COG7;ANKRD28;F5;FUCA1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.7717676113130816,1.1815921039380872,0.2857142857142857,1.0,1.0,3/5,20.63%,BBOX1;ALDH9A1;TMLHE
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.7717676113130816,1.1815921039380872,0.2857142857142857,1.0,1.0,3/5,20.63%,BBOX1;ALDH9A1;TMLHE
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.7373163165958109,1.1814141008523875,0.2807017543859649,1.0,1.0,2/6,13.21%,ACSL5;THBS1
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.5416785201726215,1.1809850544269223,0.22727272727272727,1.0,1.0,8/46,8.36%,CLDN2;ACE2;CASR;MUC17;ANPEP;ANGPTL4;NR1H4;ALDOB
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.6233466469484855,1.1809217972521298,0.27941176470588236,1.0,1.0,3/18,4.27%,PKP2;MYBPC3;TGFB1
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,0.6264278861717923,1.180919603635736,0.2459016393442623,1.0,1.0,5/19,21.53%,HLA-A;AP1M2;CD4;CD8B;B2M
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.5298098625981249,-1.180845810979261,0.20588235294117646,0.9263231617505745,1.0,2/17,2.22%,PER2;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7003144700329998,1.1806400038553726,0.3220338983050847,1.0,1.0,2/10,9.64%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7003144700329998,1.1806400038553726,0.3220338983050847,1.0,1.0,2/10,9.64%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.6763933350855226,-1.1806245663709611,0.25,0.9262428044473673,1.0,3/9,12.80%,GBP2;GBP4;BATF2
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),-0.7767211392284445,-1.1804892502273459,0.34146341463414637,0.9258233854435238,1.0,1/5,13.89%,ABHD12
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.7502593291323562,1.180452788667963,0.3235294117647059,1.0,1.0,2/8,10.68%,ITGA5;VTN
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),-0.7316148228181931,-1.1803216320414986,0.3953488372093023,0.9254048180518709,1.0,1/5,8.45%,AQP1
prerank,KEGG_2021_Human__Circadian rhythm,-0.5060863535082292,-1.1803170668815364,0.2222222222222222,0.924479294263397,1.0,1/28,0.13%,PER2
prerank,Reactome_2022__Drug ADME R-HSA-9748784,-0.4764280479406421,-1.180162180409524,0.24,0.9239848920695796,1.0,5/56,3.94%,UGT2B15;GLYATL1;BCHE;CES2;ABCC4
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,-0.508927221428857,-1.1800999718868446,0.19230769230769232,0.9232186105128454,1.0,8/39,14.87%,GOLIM4;STX6;MAN1A1;COG4;STX5;GOLGA8B;CUX1;COG7
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.6404860330175487,1.1800457024743363,0.2898550724637681,1.0,1.0,4/16,16.61%,ATP1A4;ATP6AP1;LACC1;KCNJ2
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.680629902118545,1.1799934018138967,0.30303030303030304,1.0,1.0,1/13,2.83%,SLC37A2
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.5460028270386749,-1.179676115986823,0.2903225806451613,0.9238298810293942,1.0,4/15,11.90%,METTL8;PCIF1;TRMT61B;TRMT61A
prerank,CellMarker_Augmented_2021__Pericyte:Subcutaneous Adipose Tissue,0.5277732739997549,1.179613622770363,0.16,1.0,1.0,17/67,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;ABI3BP;VSIG4;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;ZNF366;VWF;DCN;CLDN5
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.6488319888363738,1.179537484752293,0.2608695652173913,1.0,1.0,8/17,28.25%,SCIN;SOX9;SOX6;BMP1;TRPS1;PTHLH;SCX;SOX5
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.5778303453424501,-1.179482657442104,0.2564102564102564,0.9235840258149015,1.0,3/23,4.76%,NOX4;TST;MTHFR
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),-0.728359101122808,-1.1794401340004306,0.3333333333333333,0.9228334234443849,1.0,1/6,3.81%,MAML1
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.6469646760946857,1.1793123179819947,0.25,1.0,1.0,2/12,2.37%,GAD1;DAO
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.5161148638012704,-1.1791822482784926,0.25,0.9228090806618446,1.0,3/36,4.78%,TSKU;APOB;APOE
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.6295460518028664,-1.179166323777719,0.3235294117647059,0.9219702684339036,1.0,3/14,8.76%,TRIM71;KHSRP;ZC3H12D
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),-0.7211236049494318,-1.1791135822551613,0.23255813953488372,0.9212881342500828,1.0,1/6,3.30%,COL13A1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.5118882032921105,1.1791123798878418,0.1590909090909091,1.0,1.0,33/126,17.29%,GATA4;NRAP;CASQ2;LMOD1;MYBPC3;ASB5;RRAD;LOX;FGF2;HAMP;SGCG;HEY2;GPIHBP1;CAV3;KLHL38;COL21A1;CSRP3;TRDN;CKMT2;MTTP;CTNNA3;SLC5A1;PLN;NEXN;RXRG;CKB;NPPA;ART3;PGAM2;C14ORF180;CKM;SMPX;PRKG1
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.5253098562021532,1.1790457050539758,0.22972972972972974,1.0,1.0,19/78,19.29%,PLEKHS1;CAPN13;CCDC60;EYA2;MAP3K19;VWA3B;FUT2;MUC4;AKAP14;BPIFB1;MROH9;MORN5;DNAI1;DNAH3;AGR2;MUC16;CHST9;DNAH12;SNTN
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In8:Brain,0.5130363465958248,1.1788488637953614,0.20270270270270271,1.0,1.0,18/79,14.79%,NEK2;CDC25A;BUB1;CEP55;CENPU;TICRR;PDCL2;CKS1B;EI24;RAD54L;ECT2;EPCAM;TTK;CCNA2;DEPDC1;PKMYT1;ANLN;NUF2
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.7015273476790672,1.1788204890223057,0.2807017543859649,1.0,1.0,1/9,2.54%,TMEM100
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.4205281161368853,-1.1788077581862126,0.21739130434782608,0.9213815438103484,1.0,14/94,14.05%,DNMT1;DDX56;GATAD2A;CHD4;SAP130;POLR1A;GTF2H2;DNMT3A;ERCC2;BAZ2A;H2AJ;MYBBP1A;POLR2F;TAF1B
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.7228006383701154,-1.1787949028654012,0.22727272727272727,0.9205209115505821,1.0,1/5,6.28%,KDM7A
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,0.5669020227315053,1.178757584842603,0.1875,1.0,1.0,6/37,14.32%,AQP3;GNG12;GNG4;RAB11A;AQP4;ADCY7
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.582939986284409,-1.1786582608249292,0.2608695652173913,0.9201513314913693,1.0,12/37,23.25%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;NUP98;TSC1;SEH1L;XPOT;NUP50;TPR
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.7453063670364581,-1.1786087660824338,0.3409090909090909,0.9195123461667947,1.0,3/5,20.99%,PPP5C;PPP1CA;MAPT
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.6632442064514794,1.1786086959405948,0.23529411764705882,1.0,1.0,6/14,26.20%,CAV3;CSRP3;NPPA;TCAP;CTNNB1;TTN
prerank,KEGG_2021_Human__Maturity onset diabetes of the young,-0.6153517644494844,-1.1785670176076015,0.21951219512195122,0.9186947230984926,1.0,2/15,0.51%,RFX6;GCK
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.7972447450921648,1.1784499402449724,0.23728813559322035,1.0,1.0,2/6,15.19%,CSF1R;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6194694978577157,1.1784294011623424,0.2898550724637681,1.0,1.0,2/20,2.77%,ADA;CCL5
prerank,"KEGG_2021_Human__Neomycin, kanamycin and gentamicin biosynthesis",-0.7593498719939358,-1.1782932462613716,0.32432432432432434,0.9187003904837918,1.0,1/5,0.51%,GCK
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Undefined,-0.480831555901664,-1.1782768798534813,0.2,0.917808258950075,1.0,5/47,3.05%,ADGRF4;EHF;ANXA8;GBP2;JUNB
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.6179268969860559,-1.1779881658012799,0.358974358974359,0.9180198035122644,1.0,2/12,12.78%,MPV17;SLC25A33
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.7371853428899279,1.1779515881211904,0.3787878787878788,1.0,1.0,1/7,7.67%,LEF1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.5215481177919361,-1.1778076392389465,0.3103448275862069,0.9179109271825892,1.0,2/24,3.29%,PER2;IFI16
prerank,Reactome_2022__Beta Oxidation Of hexanoyl-CoA To butanoyl-CoA R-HSA-77350,-0.8100165729773532,-1.1777510829532227,0.23809523809523808,0.9171373326224305,1.0,2/5,8.91%,ACADS;ECHS1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.605731752289089,1.177747319602266,0.2898550724637681,1.0,1.0,3/20,11.21%,FAM20A;TRPV6;TMC8
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.6012617724266922,-1.1777217452758721,0.2972972972972973,0.9163141795932701,1.0,3/17,7.60%,DDAH2;ASS1;PKD2
prerank,Reactome_2022__Formyl Peptide Receptors Bind Formyl Peptides And Many Other Ligands R-HSA-444473,0.7800272024700619,1.1774468325395764,0.2786885245901639,1.0,1.0,3/6,17.71%,ANXA1;FPR1;FPR3
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,-0.5267258110697668,-1.1772776179762552,0.20689655172413793,0.9170113162832331,1.0,8/40,11.47%,TBC1D10A;TBC1D16;RAB35;RAB7B;RAB7A;TBC1D2;RAB5A;GGA2
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.5308765462058411,-1.1772537794397742,0.25,0.9162026723752389,1.0,8/42,12.89%,TSKU;APOB;LIPC;APOE;CEL;SCARB1;SOAT1;OSBPL5
prerank,Reactome_2022__Eicosanoids R-HSA-211979,0.7048370520670302,1.177192994908851,0.26865671641791045,1.0,1.0,1/9,3.42%,CYP4F12
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,0.5666172787328929,1.1771615546893595,0.18309859154929578,1.0,1.0,10/56,20.47%,NOTUM;PSMB9;RPS27A;SCUBE2;PSMC5;SYVN1;SEL1L;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.5828287703055832,1.1771330140004017,0.28,1.0,1.0,5/29,7.44%,CCL5;TRIM62;WNT5A;SH2D1B;IFNK
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6349908643707708,1.1770649907230386,0.3384615384615385,1.0,1.0,3/15,11.68%,PELI3;TRAIP;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.6251526599050762,-1.1768813243055116,0.3333333333333333,0.9165673882376282,1.0,1/15,0.50%,ADRA1A
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.5853877317209405,1.1768497146072352,0.27692307692307694,1.0,1.0,5/40,10.73%,CLIC1;SLC26A6;SLC4A1;SLC13A4;GLRA1
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.7339729320198507,-1.1768382569070153,0.3142857142857143,0.9158498540959155,1.0,2/7,10.06%,ZDHHC5;SLC15A4
prerank,KEGG_2021_Human__Autoimmune thyroid disease,0.6011425859464644,1.1766377947188247,0.2878787878787879,1.0,1.0,8/22,14.41%,TSHR;HLA-F;CD80;HLA-A;IL5;HLA-DMA;HLA-DPB1;IL4
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.5919025775985011,1.1765128006620673,0.2459016393442623,1.0,1.0,6/23,8.20%,SLC10A1;SLCO1A2;ABCC2;SLC51A;NR1H4;ABCC11
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),0.7554427254315602,1.1764984939287122,0.2692307692307692,1.0,1.0,1/6,5.90%,PRDM12
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,-0.4520842722756046,-1.1764653410521957,0.15384615384615385,0.9162141970737051,1.0,19/127,12.06%,ADRA1A;ADRA1B;BCL2;CREB3L4;TPM4;KCNE1;CREB3L1;TPM2;CACNG4;MYL3;TPM3;SLC8A3;PPP2R5D;CACNB1;GNAS;CREM;ADCY3;ADCY2;CACNG2
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.6985860592928955,-1.1763382795079564,0.29545454545454547,0.9157778026323021,1.0,4/8,27.02%,ST3GAL2;ST3GAL4;PARN;PARP1
prerank,CellMarker_Augmented_2021__Paneth cell:Large Intestine,0.47655576336027416,1.1762701037998529,0.12643678160919541,1.0,1.0,49/231,15.20%,EOLA1;C1QB;ITGB2;TLR2;TNFRSF1B;ITGAX;GMFG;LYVE1;SLC37A2;EYA2;PTPRC;PTAFR;LMO2;ITGAM;TFEC;NFAM1;FCGR3A;FLI1;FGL2;WAS;STK26;MMP9;CPVL;LCP1;HCK;PLAUR;SOD2;CSF3R;KIAA0930;HLA-DMA;PLAU;HPGDS;IKZF1;HLA-DPB1;LPAR6;CD37;DAB2;PLA2G7;IGSF6;OGFRL1;FAM110A;CD4;CSF1R;FPR1;ACTRT3;GPR137B;ADCY7;LOC100130357;SLCO2B1
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.6704775166703063,-1.1761610977349701,0.2619047619047619,0.9147048208223322,1.0,4/7,22.78%,ADGRG6;PARD3;NF1;SKI
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.6704775166703063,-1.1761610977349701,0.2619047619047619,0.9147048208223322,1.0,4/7,22.78%,ADGRG6;PARD3;NF1;SKI
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.4814579906251778,-1.176078086923017,0.11764705882352941,0.9141066116329603,1.0,7/45,8.86%,MFSD2A;TEAD2;COL13A1;KIT;KITLG;TEAD4;RARB
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.7018276908199915,1.1760002343281815,0.2542372881355932,1.0,1.0,2/8,18.83%,CAV3;ATP2A2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.5373472754833477,-1.1759439858085585,0.2,0.9136740134114653,1.0,11/23,32.62%,FSCN1;AVIL;AUTS2;ARPC2;WASF2;OCLN;PLCE1;CARMIL2;TWF2;AKIRIN1;CYFIP1
prerank,Reactome_2022__Activation Of AP-1 Family Of Transcription Factors R-HSA-450341,-0.6732341577899834,-1.1759084952494212,0.2564102564102564,0.9129389983530055,1.0,1/10,1.87%,FOS
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.717056704582937,-1.1757729096637688,0.23255813953488372,0.9125083989611297,1.0,3/8,8.96%,GLA;NEU4;NEU3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.5744675774010256,-1.1756058209416864,0.2,0.9122173704804198,1.0,8/15,27.02%,RAD50;SLX4;NBN;RTEL1;ERCC1;ATM;SMG6;PARP1
prerank,Reactome_2022__SEMA3A-Plexin Repulsion Signaling By Inhibiting Integrin Adhesion R-HSA-399955,0.7214000802116269,1.1752406820404577,0.26229508196721313,1.0,1.0,3/14,11.18%,RRAS;SEMA3A;PLXNA3
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,-0.47818418210427455,-1.1751474876209802,0.13793103448275862,0.9128970348146681,1.0,5/33,18.11%,PRKCD;ADCY2;PRKCA;ADCY6;PRKAR2A
prerank,CellMarker_Augmented_2021__Endothelial cell:Undefined,0.56564355439486,1.1749179785092583,0.2714285714285714,1.0,1.0,10/23,17.05%,A4GALT;PTPRC;FLT1;FLT4;NT5E;F8;IL3RA;PROCR;ENG;TSPAN7
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.49155392967705974,1.1747398235187487,0.14473684210526316,1.0,1.0,21/133,13.70%,ESR1;FGF20;LRP2;FGF2;GFRAL;TGFB1;ERBB4;CD80;IL26;RAMP3;AXL;HGF;KLB;F7;PINK1;P2RY12;MYDGF;TNFAIP8L3;THBS1;RHOG;CALCR
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),-0.7067272812629888,-1.1747129856654712,0.3333333333333333,0.9137138194039307,1.0,4/6,14.77%,PNP;NT5C1A;SAMHD1;NUDT18
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.7961502448940737,1.1745948241538746,0.2727272727272727,1.0,1.0,1/8,0.92%,CLEC5A
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.6177339702222927,1.1745180655302654,0.23076923076923078,1.0,1.0,1/24,0.31%,AQP3
prerank,Reactome_2022__Nectin/Necl Trans Heterodimerization R-HSA-420597,-0.6720383501087573,-1.1744346921758466,0.37142857142857144,0.9139757347235451,1.0,4/6,26.15%,PVR;NECTIN3;CADM1;CADM3
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),0.8150692680424136,1.1742487193724138,0.234375,1.0,1.0,2/5,14.28%,SLC47A1;SLC7A3
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.6309521654769735,-1.1742209925586289,0.2702702702702703,0.9139105255239116,1.0,3/13,17.40%,AGO2;TNRC6C;TNRC6A
prerank,Reactome_2022__Acetylcholine Regulates Insulin Secretion R-HSA-399997,-0.6035786683861553,-1.174123146431097,0.15789473684210525,0.9134187533618473,1.0,5/10,26.41%,GNA14;GNA11;PRKCA;PLCB1;PLCB3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.488470077998165,-1.1740910163122702,0.22580645161290322,0.9126270425684598,1.0,2/24,1.53%,NGF;BCL2
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,-0.4448423666490342,-1.1733722923675365,0.17391304347826086,0.9142542463180944,1.0,4/52,1.33%,GCK;FBP2;G6PC3;ENO3
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,0.596766800860732,1.173306258156068,0.29850746268656714,1.0,1.0,8/32,12.51%,ELOVL2;TECRL;ACSL5;OLAH;HACD4;ACSL3;PPT1;SCD
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.5460704272732413,-1.173294248890448,0.2962962962962963,0.9136384468358798,1.0,3/22,11.96%,CDH5;CCN1;UBE2O
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.7462420328597432,1.1732862537784399,0.27586206896551724,1.0,1.0,1/7,8.50%,EIF6
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),-0.7446822207767125,-1.1732801341684402,0.3157894736842105,0.9127613289349847,1.0,2/5,11.16%,CSGALNACT1;IDUA
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5308966111941259,1.1730313748502712,0.15384615384615385,1.0,1.0,11/74,10.68%,ENPP2;ITGB2;PTPRC;TGFB1;CD81;CD80;ITGA5;IGF1;HGF;IL5;VTN
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.6173570753152814,-1.1729854945521268,0.36,0.9128225684582622,1.0,6/15,8.43%,PODXL2;SELE;ITGA4;SELL;CX3CR1;SELPLG
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),0.7724416631243531,1.1729569616069326,0.18181818181818182,1.0,1.0,1/5,10.19%,RAB11A
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,0.5190597942303773,1.1729548721157126,0.21686746987951808,1.0,1.0,26/121,24.63%,COX6A1;PIK3R3;PKLR;MAP3K11;CASP7;TGFB1;NDUFB11;NDUFS2;COX7A2;NDUFB10;NDUFA2;COX4I1;COX7B;NDUFB9;COX6C;COX6B1;NDUFB4;UQCRFS1;DDIT3;NDUFA1;COX7A1;NDUFB2;COX5A;COX7C;PRKAB2;PIK3CB
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.6555850916931325,1.172863416038631,0.3142857142857143,1.0,1.0,4/19,10.68%,TMEM204;CNMD;ITGA5;VTN
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.5282023936137731,-1.1728435361301166,0.2727272727272727,0.9123596741536045,1.0,2/28,2.07%,GATAD2A;CHD4
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.6279340598377887,1.1727360872578108,0.2698412698412698,1.0,1.0,1/21,0.31%,AQP3
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.6975722511943717,-1.1726743306383962,0.2564102564102564,0.9119226075322893,1.0,2/14,4.21%,MLYCD;NR4A3
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.6929228529344243,1.1726173353942408,0.29508196721311475,1.0,1.0,5/11,11.68%,ITGB2;TGFB1;ITGAM;SYK;F2RL1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),0.7580106198007688,1.1725616453144754,0.3448275862068966,1.0,1.0,2/5,18.48%,CAV3;SCN5A
prerank,CellMarker_Augmented_2021__Semilunar Valve cell:Heart,-0.4961871851034646,-1.172336396546415,0.16666666666666666,0.9122459815054041,1.0,5/48,1.61%,ADGRF4;EHF;CLDN4;ANXA8;SLITRK6
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.5644759073637289,-1.1721498647366917,0.2962962962962963,0.9121084386521994,1.0,4/16,12.32%,CDH13;RHBDF1;ERBB2;WDR54
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Fat Pad,0.7660292463597538,1.1719998576338289,0.23214285714285715,1.0,1.0,3/7,16.35%,ANPEP;CD44;ENG
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.5969282822991222,1.1718183446189725,0.32432432432432434,1.0,1.0,3/25,5.52%,AIM2;VSIR;USP50
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.6763167372438336,-1.1717766381037504,0.3023255813953488,0.912667143032526,1.0,6/9,27.32%,NR4A3;GNB3;SGIP1;UCN;EIF2AK4;STAT3
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Embryo,-0.7266913469240351,-1.171542803031774,0.40540540540540543,0.912479794061055,1.0,2/5,16.77%,TERT;PODXL
prerank,Reactome_2022__GRB7 Events In ERBB2 Signaling R-HSA-1306955,-0.7368283464105043,-1.1714801898048643,0.3333333333333333,0.911759425867775,1.0,2/5,17.98%,ERBB2;NRG2
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),-0.7314629823867683,-1.1714366098476818,0.28888888888888886,0.9110652328304987,1.0,4/6,23.18%,WNT7A;LRFN4;SEMA4A;VSTM5
prerank,CellMarker_Augmented_2021__Stem cell:Deciduous Tooth,0.8271114363309198,1.1712932213480005,0.32727272727272727,1.0,1.0,3/5,16.35%,NT5E;CD44;ENG
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Skeletal Muscle,0.8271114363309198,1.1712932213480005,0.32727272727272727,1.0,1.0,3/5,16.35%,NT5E;CD44;ENG
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,0.5002275494795485,1.1712782872139575,0.2692307692307692,1.0,1.0,11/81,8.51%,C1QTNF1;GPHB5;GNAT3;GPR27;GNG12;TSHR;SCTR;ADRB1;RAMP3;GNG4;RXFP2
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),-0.7804010180946973,-1.17123178662704,0.24324324324324326,0.9108304494392109,1.0,1/5,3.46%,KIT
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.5464035521615546,1.1710592300156204,0.2222222222222222,1.0,1.0,14/54,25.56%,PSMB9;NR1H4;NQO1;OAZ2;PDK4;PSMC5;AZIN1;PSMA3;PSMB6;PSMD6;PANK2;PSMA7;FGFR4;PSMB1
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),0.7746076016190612,1.171009421983691,0.2833333333333333,1.0,1.0,3/5,21.73%,PLAU;VIL1;ALOX5
prerank,CellMarker_Augmented_2021__Epithelial cell:Corneal Epithelium,-0.4450248309603705,-1.1710090867790854,0.19047619047619047,0.9108558540842736,1.0,17/84,8.98%,IL7R;APOL3;PLK3;FOS;TMEM106A;GBP2;BCL2A1;JUNB;STK10;STX11;USP4;LRRFIP1;TNFRSF14;ERN1;PTPRE;SELPLG;SERPINB8
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.4766097825868071,1.1708852012175452,0.18181818181818182,1.0,1.0,47/154,24.42%,SLFN14;PWP2;RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;EXOSC8;RPS16;RPL15;EXOSC2;RPL41;ERN2;RPL13;RPL27A;NOB1;NOP53;RPS19;EXOSC4;RPL32;RPL11;RPL23A;RPL35A;RPS7;WDR36;RPLP2;RPL7;RPL38;EMG1;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL24;RPL23;RPS15;WDR18;RPS27;RPL8;SENP3;WDR12;RPS24
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),-0.7111063792573746,-1.1705735078332034,0.2777777777777778,0.9119562219038861,1.0,2/5,13.19%,CX3CR1;CARD9
prerank,GO_Biological_Process_2021__cellular response to magnesium ion (GO:0071286),0.7793349525730549,1.1704783503106222,0.2857142857142857,1.0,1.0,1/5,1.75%,SLFN14
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.7058021653444697,1.170461419921113,0.2903225806451613,1.0,1.0,3/10,11.68%,IFNK;LCP1;F2RL1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5804093716562564,1.1702843170646833,0.22807017543859648,1.0,1.0,7/13,28.71%,ABHD14B;SULT2A1;BPNT2;SULT4A1;SULT6B1;TPST2;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.7491297900536509,1.1701319791435767,0.3508771929824561,1.0,1.0,2/6,14.62%,F2RL1;CYBA
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.6771928190369546,1.169947318861313,0.25,1.0,1.0,4/14,15.97%,ARHGAP24;KBTBD7;KBTBD6;PIK3CG
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.727437935762599,-1.1699318343297334,0.2857142857142857,0.9134124664352709,1.0,4/6,26.01%,ALCAM;SLIT2;ROBO2;PTPRM
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.6019609151953396,-1.1699106962050936,0.3076923076923077,0.912609025233796,1.0,2/9,17.36%,MLYCD;PPCS
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.4871385587761123,-1.169499838039756,0.21739130434782608,0.9132733115119587,1.0,8/80,7.54%,ADGRF4;EHF;CLDN4;LAMA3;ESRP1;ERBB2;TMEM125;PERP
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.747553221756992,-1.1692410646698124,0.3076923076923077,0.9134439610909635,1.0,3/8,14.94%,MID1;MAPRE1;CHAMP1
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.7114146375609551,-1.169023858146673,0.35555555555555557,0.9124083028226218,1.0,3/5,28.73%,KIF17;KIF5C;KIF3B
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.7114146375609551,-1.169023858146673,0.35555555555555557,0.9124083028226218,1.0,3/5,28.73%,KIF17;KIF5C;KIF3B
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),0.7839399811133427,1.1688986674884536,0.3333333333333333,1.0,1.0,2/6,10.87%,HIGD1C;COX7A2
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.7392389691973053,1.1688118529491256,0.34375,1.0,1.0,1/7,5.42%,SFTPD
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.7392389691973053,1.1688118529491256,0.34375,1.0,1.0,1/7,5.42%,SFTPD
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,-0.504051821429428,-1.168811455564426,0.18181818181818182,0.9121988030888508,1.0,11/74,12.09%,CPSF1;NUP210;NUP42;MAGOHB;POM121C;NUP214;SRRM1;SRSF4;AAAS;SYMPK;U2AF2
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.5685255063523204,-1.168701849217575,0.21428571428571427,0.911744462616909,1.0,2/18,8.14%,ANAPC2;CDC26
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.7055586923603426,1.168694245897075,0.2542372881355932,1.0,1.0,5/10,19.77%,TMEM204;HEY2;EDNRB;TBX18;HEY1
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),-0.761765756754566,-1.1685735463946996,0.2631578947368421,0.9112787388609281,1.0,4/5,20.57%,ASCL1;DLL1;POU3F2;MNX1
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,0.5306979770819761,1.1684152350616275,0.2465753424657534,1.0,1.0,11/74,21.50%,ACTL6A;PSMB9;TGFB1;RPS27A;TFPT;PSMC5;HCFC1;PSMA3;PSMB6;PSMD6;H2AC25
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.4570183636559288,-1.1683652889696752,0.2,0.9111565857443921,1.0,9/45,15.00%,TRIM67;GPC6;GPC2;GPC4;RALB;GBF1;SPIDR;GPC1;CSNK1E
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.5914055503704466,-1.168301709835185,0.27586206896551724,0.9104722227477304,1.0,11/17,29.25%,TGFBR3;PKD2;PHF2;NF1;PROX1;PRKCSH;CEBPA;COBL;NIPBL;WNT4;ARID5B
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.4932374604580481,1.1681729503094815,0.17333333333333334,1.0,1.0,14/140,10.06%,NRAP;LMOD3;TMOD4;ELMO3;LMOD1;NLRP5;WAS;SCIN;BAIAP2L1;LCP1;FHOD1;GAS2L3;RHOB;VIL1
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.5504137505115325,1.1681624483045292,0.25,1.0,1.0,10/58,11.23%,ENPP2;PLA2G10;RENBP;CYP3A4;CYP3A5;ERAP2;ANPEP;LVRN;PPT1;PLA2G7
prerank,Reactome_2022__Post-transcriptional Silencing By Small RNAs R-HSA-426496,-0.7035014864694705,-1.1680784826917792,0.3488372093023256,0.9104487924887389,1.0,3/7,17.40%,AGO2;TNRC6C;TNRC6A
prerank,Reactome_2022__Defects Of Contact Activation System (CAS) And Kallikrein/Kinin System (KKS) R-HSA-9651496,0.6590308427582422,1.1680655131739215,0.2714285714285714,1.0,1.0,5/12,14.52%,GP1BA;F8;VWF;FAM110A;GGCX
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.6107719097480955,1.1679710162074655,0.2459016393442623,1.0,1.0,3/19,7.52%,WNT8B;FRAT1;WNT8A
prerank,CellMarker_Augmented_2021__Colonic Stem cell:Colon,-0.4295232149682586,-1.1679485886653873,0.2,0.9100714975383367,1.0,29/89,17.72%,TEAD2;TBC1D16;P3H4;RAI14;LOXL1;RHBDF1;ERBB2;DLG5;PARD3;PTPRF;MID1;FSTL1;ASAP3;GPR161;DCBLD2;ADGRA3;P3H3;ANTXR1;DAB2IP;AADAT;AMOTL2;CHST3;FKBP9;GPC1;SERPINH1;NFATC4;ADCY6;SH3BP4;RBFOX2
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.7518784961791896,1.1678171307452019,0.3157894736842105,1.0,1.0,3/6,17.26%,PIK3R6;AGER;NOS2
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.5333529346967132,1.1677486626818752,0.21621621621621623,1.0,1.0,20/84,15.08%,RASGRP4;C19ORF38;SLFN14;GMFG;LOX;PKLR;NR1I3;CLEC12A;HEMGN;SLC4A1;CA1;CSF3R;MYO1F;THBS1;CCNA2;FPR1;P2RX1;CD44;ADGRE3;CD300LF
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,-0.5362165446767428,-1.1675615556910355,0.3142857142857143,0.9105605637804145,1.0,4/32,4.62%,RFX6;FOXO1;MAML1;GATD3
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.6323070898623596,1.1675201436268399,0.2028985507246377,1.0,1.0,1/18,0.40%,CDC25A
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.5911165180875464,1.1674697236865579,0.2857142857142857,1.0,1.0,3/18,18.99%,CCL5;CXCL12;CCL25
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,-0.5009835957511481,-1.1673983424755627,0.18604651162790697,0.9101960593245338,1.0,4/31,12.07%,CD38;NMRK1;NAMPT;RNLS
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.6013320681503636,1.1673084098403308,0.2857142857142857,1.0,1.0,6/15,18.99%,CCL5;HSD3B7;MSMP;GPR183;PIK3CG;CCL25
prerank,CellMarker_Augmented_2021__Serotonergic neuron:Undefined,-0.5045860934478335,-1.1670897429394431,0.2777777777777778,0.9104528681410323,1.0,9/53,8.33%,RFX6;VWA5B2;PODXL2;CKMT1B;CFC1;ABCC8;VGF;INSRR;FAM163A
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,0.5458785987552927,1.1669741710569859,0.25,1.0,1.0,8/48,20.47%,PSMB9;TGFB1;CDKN2A;RPS27A;PSMC5;PSMA3;PSMB6;PSMD6
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.7111986459806964,1.1668152651306718,0.38596491228070173,1.0,1.0,5/7,27.48%,HLA-F;HLA-A;B2M;LNPEP;HLA-B
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.5662839525078778,-1.1667287262908264,0.24,0.9106970330368398,1.0,9/26,12.15%,TYRO3;CD14;SARM1;RAB7B;TICAM2;NR1D1;PTPRS;DAB2IP;SMPDL3B
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.6458040975035321,-1.1667280661499366,0.27906976744186046,0.9098354464398323,1.0,1/15,0.81%,SKAP1
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.7523479145681821,1.1666456949682367,0.35384615384615387,1.0,1.0,2/7,4.58%,DNAH11;CCDC39
prerank,KEGG_2021_Human__Platelet activation,0.5052655356711007,1.1664264487051221,0.2625,1.0,1.0,21/102,18.10%,GP1BA;PIK3R3;SNAP23;ITGA2;ACTG1;SYK;VASP;P2RY12;VWF;COL1A1;MYL12A;ITGA2B;P2RX1;ADCY7;MAPK3;PIK3R6;FERMT3;PIK3CG;RASGRP1;PRKG1;PLA2G4A
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.5395243987678796,1.16628572741295,0.25,1.0,1.0,21/72,15.65%,TULP1;TYR;CABP4;COL18A1;CRYBB1;GPR179;DHRS3;COL1A1;GRM6;CRYBG3;SLC24A1;GNAT2;FSCN2;RDH12;ROM1;PDE6C;PRPH2;TULP2;GUCY2F;RABGGTB;CRYBB3
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,0.5447132440117979,1.1662542285007236,0.3013698630136986,1.0,1.0,8/43,20.47%,PSMB9;NQO1;OAZ2;PSMC5;AZIN1;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),0.7706182350380022,1.1662099817066185,0.41509433962264153,1.0,1.0,3/5,19.28%,ANXA1;ITK;TNFSF8
prerank,Reactome_2022__Ubiquinol Biosynthesis R-HSA-2142789,-0.6071153475257093,-1.1661710303960726,0.3611111111111111,0.9108442105197209,1.0,3/8,20.02%,COQ2;COQ9;PDSS2
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.5246248564507594,-1.166123433680392,0.18421052631578946,0.9100810969129346,1.0,4/19,13.18%,CNGA4;EXOC7;ASAP1;RAB11FIP3
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,0.5413816013336368,1.1660477910923144,0.2602739726027397,1.0,1.0,7/45,20.47%,PSMB9;CCND1;RPS27A;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.7238975532128674,1.1659592307738227,0.23636363636363636,1.0,1.0,6/8,27.06%,MESP1;SNAI1;TBX19;SCX;MESP2;CRB2
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.6496642860345754,1.1657569320382113,0.23880597014925373,1.0,1.0,1/17,0.35%,TBX1
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.5628964125240451,1.165693015144133,0.28169014084507044,1.0,1.0,6/34,9.58%,LMOD3;TMOD4;LMOD1;SIX4;PGM5;CSRP3
prerank,Reactome_2022__Formation Of Editosome R-HSA-75094,-0.7558720875571999,-1.1652247129755444,0.28205128205128205,0.9122988922032294,1.0,1/5,4.60%,APOBEC3H
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),-0.7209384935827055,-1.1651941740293528,0.35555555555555557,0.9115600465236469,1.0,2/5,20.33%,HIP1;PTPN2
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.8089459060098309,1.1651287992886024,0.30158730158730157,1.0,1.0,1/5,2.57%,ANXA1
prerank,KEGG_2021_Human__Oxytocin signaling pathway,-0.4154525007994493,-1.164978221798241,0.09523809523809523,0.911475390366341,1.0,17/133,12.71%,CD38;CAMK1G;FOS;ITPR2;CACNG4;EEF2K;CACNB1;NFATC3;PLA2G4C;GNAS;KCNJ6;MYLK3;ADCY3;ADCY2;CACNG2;TRPM2;MAPK7
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Adipose Tissue,0.7762795882640058,1.1649587061031146,0.29411764705882354,1.0,1.0,3/6,16.35%,NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.6682961604913893,1.164850854619107,0.27450980392156865,1.0,1.0,1/8,10.19%,RAB11A
prerank,KEGG_2021_Human__Parkinson disease,0.48778929068104215,1.1644476262222168,0.15730337078651685,1.0,1.0,44/199,25.56%,COX6A1;SLC25A31;UBE2L6;SLC18A2;ATP5PF;NDUFB11;HSPA5;NDUFS2;PINK1;COX7A2;RPS27A;ATP5F1E;PSMC5;TUBA4A;TUBA3D;TUBB6;NDUFB10;NDUFA2;ATP5MC3;COX4I1;TUBA1C;APAF1;PSMA3;COX7B;PSMB6;NDUFB9;COX6C;COX6B1;NDUFB4;PSMD6;RYR3;UQCRFS1;TUBB4B;DDIT3;NDUFA1;COX7A1;NDUFB2;COX5A;PARK7;COX7C;PSMA7;VDAC1;KLC2;PSMB1
prerank,KEGG_2021_Human__Hepatocellular carcinoma,0.4930820328810539,1.1643659299336684,0.22666666666666666,1.0,1.0,21/148,13.42%,ACTL6A;MGST1;WNT8B;TCF7;FRAT1;PIK3R3;TGFB1;WNT5A;ACTG1;CDKN2A;WNT8A;LEF1;CCND1;HGF;NQO1;TGFB3;FZD8;SMARCE1;WNT6;CDKN1A;TCF7L1
prerank,CellMarker_Augmented_2021__Myeloid cell:Peripheral Blood,0.7136351867709645,1.1643587475303603,0.3898305084745763,1.0,1.0,5/8,8.06%,ITGAX;PTPRC;ITGAM;FCGR3A;CEACAM8
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.6152665508050034,1.1643322305056225,0.2714285714285714,1.0,1.0,2/17,0.98%,SLC28A1;PLA2G10
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),-0.6167887020750452,-1.164256881394137,0.3235294117647059,0.9134078328631201,1.0,1/6,9.16%,FSCN1
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.6380643946404703,-1.1642389834330023,0.25,0.9126700281575781,1.0,5/10,20.40%,MUS81;DNASE1L1;FBH1;SETMAR;XRN2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),-0.6102785866160271,-1.1641186428351449,0.32,0.9123434722204647,1.0,6/12,29.84%,SNX5;C1QTNF12;GKAP1;SORL1;ZBTB7B;ERFE
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.5826400062907159,1.164107918159492,0.21333333333333335,1.0,1.0,11/48,14.48%,PLA2G10;ELOVL2;ALOX12;CYP4F12;PTGR1;CYP2J2;CYP1B1;SCD;ALOX12B;ALOX15;ALOX15B
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.6442872089322249,-1.164072032425131,0.21621621621621623,0.911668267686721,1.0,3/11,8.62%,APOH;F11;SERPINE1
prerank,CellMarker_Augmented_2021__Adventitial cell:Undefined,0.7759431683362097,1.1639414622193678,0.25925925925925924,1.0,1.0,3/6,16.35%,NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.6554112410622686,-1.1639157060837406,0.2826086956521739,0.9113793593224239,1.0,2/9,5.85%,MTHFR;MTHFD1L
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.7792633169774545,1.1638992950749039,0.2830188679245283,1.0,1.0,1/5,3.28%,SIX4
prerank,CellMarker_Augmented_2021__B cell:Thyroid,0.5467893029046644,1.1634336136613022,0.23529411764705882,1.0,1.0,11/35,12.21%,BLK;CYTIP;ARHGAP9;SASH3;JCHAIN;WAS;NAPSB;TAGAP;CD37;TMC8;PNOC
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.49513513303258583,1.1632458875076825,0.21518987341772153,1.0,1.0,11/100,12.33%,SMAD6;MAPKAPK3;TNFRSF1B;WNT5A;IL12A;CD80;GGT5;AXL;PDCD1LG2;TNFSF4;LIAS
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.5750843293288874,1.1632403321792155,0.27692307692307694,1.0,1.0,5/37,3.76%,SLC12A7;FAM20A;CYP4F12;SLC12A3;TRPV6
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,0.5596722093245113,1.1631724941662969,0.2714285714285714,1.0,1.0,8/48,20.47%,PSMB9;RPS27A;PSMC5;RBX1;PSMA3;TACC3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6746246507313176,1.163077788220375,0.2676056338028169,1.0,1.0,3/17,7.94%,SPDYA;CCND2;CCND1
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.7124397054896601,1.162891566758624,0.23880597014925373,1.0,1.0,1/8,0.70%,MICB
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.7199480315621023,-1.1626389365257386,0.358974358974359,0.9149617342720644,1.0,2/8,13.06%,DDX11;SPIDR
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.7370789808988724,1.1625983668332645,0.31746031746031744,1.0,1.0,1/6,1.87%,BHMT
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.5608199325036513,1.1625491864171735,0.2876712328767123,1.0,1.0,11/32,25.05%,ACAA2;FAXDC2;NPC1L1;PLPP6;FDFT1;MSMO1;INSIG1;SQLE;INSIG2;HMGCR;HMGCS1
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.4228746056978777,-1.1624727990759962,0.17647058823529413,0.9146462661555783,1.0,27/140,15.00%,SPRED3;RASSF2;TRIB2;SPRED2;UBASH3B;SPRED1;PRKCD;TWIST1;MEN1;PARD3;CEP85;HSPB1;EPHB2;PID1;CAMK2N1;TRIB1;EMILIN1;DUSP19;DAB2IP;SLIT2;CHP1;DEPTOR;TRAF3IP1;CRKL;IMPACT;SAMSN1;PRKRIP1
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,0.5601656362976561,1.1621603337531126,0.16176470588235295,1.0,1.0,7/46,20.47%,PSMB9;RPS27A;PSMC5;RBX1;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.49617727095426106,-1.1621292944249328,0.25,0.9149913035345579,1.0,9/33,12.99%,NGF;VWC2;ASCL1;DLX1;PCP4;BEND6;MMD2;NEUROD2;BRINP1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.41580378887689473,-1.1620422368900596,0.1,0.9144126770515029,1.0,22/150,12.23%,GCK;MFSD2A;TYRP1;SLC25A37;PPP1R3E;PIWIL2;DDAH2;EGR1;ASS1;ERBB2;UPF3A;PLIN5;CTC1;PCIF1;PKD2;LDB1;NR1D1;SCARB1;CIRBP;FXR2;BRPF3;STN1
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Heart,0.7329975543473486,1.1618359365042006,0.36507936507936506,1.0,1.0,2/8,4.64%,GATA4;ABCG2
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.6673369664989945,-1.1618061054202766,0.2777777777777778,0.9144339343219906,1.0,1/6,10.50%,PTPRS
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Spinal Cord,-0.440321782075901,-1.1617330104092767,0.14285714285714285,0.9138090461163934,1.0,15/76,9.67%,NPAS4;CNGA3;XKR7;HCRTR2;TRIM67;ADCYAP1;GPR149;SLC17A6;ELAVL3;TTBK1;SRRM4;ASCL1;KCNIP1;ISLR2;KIRREL2
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.4384677198642376,-1.1616991613432035,0.15,0.9130657837490126,1.0,9/89,4.43%,ADGRF4;EHF;CLDN4;EMP1;ANXA8;BCL2;SLC25A37;LAMA3;CD151
prerank,Reactome_2022__Activated NTRK2 Signals Thru FYN R-HSA-9032500,-0.7143330336440638,-1.161650559617427,0.325,0.9124194454985326,1.0,6/6,28.59%,FYN;NTRK2;SRC;DOCK3;GRIN2B;RNASE1
prerank,Reactome_2022__RUNX3 Regulates CDKN1A Transcription R-HSA-8941855,0.7678034856092486,1.161539248988133,0.3090909090909091,1.0,1.0,2/6,12.77%,TGFB1;CDKN1A
prerank,KEGG_2021_Human__FoxO signaling pathway,-0.4566905839220144,-1.1614591234153764,0.2857142857142857,0.9122157764797589,1.0,5/113,3.43%,IL7R;PLK3;G6PC3;BCL6;FOXO1
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.7315395911591183,1.1613039574495798,0.3620689655172414,1.0,1.0,1/7,7.06%,NDC80
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.7315395911591183,1.1613039574495798,0.3620689655172414,1.0,1.0,1/7,7.06%,NDC80
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.47756154018774694,-1.1612835277236566,0.25,0.9120363266469381,1.0,10/42,11.53%,GLA;SMPD3;SMPD4;STS;NEU4;B4GALNT1;NEU3;ESYT3;ST3GAL5;SUMF2
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.5198940379476521,-1.1611889454907323,0.22857142857142856,0.9114880174992284,1.0,6/27,13.32%,CPSF1;LSM10;SNRPB;SYMPK;CSTF2;CPSF7
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,-0.5655391018414253,-1.1609068907366673,0.2413793103448276,0.9115951361200177,1.0,7/27,13.89%,DGKD;PRKCD;ITPR2;TRPC3;TRPC6;DAGLA;ABHD12
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.6271981611828664,1.1608290580500058,0.2727272727272727,1.0,1.0,3/17,13.35%,TCN1;AMN;CBLIF
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.6271981611828664,1.1608290580500058,0.2727272727272727,1.0,1.0,3/17,13.35%,TCN1;AMN;CBLIF
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),0.765072929760867,1.160822828342488,0.3380281690140845,1.0,1.0,2/5,20.04%,HSPA5;DNAJB9
prerank,Reactome_2022__Prostanoid Ligand Receptors R-HSA-391908,0.7732972768308665,1.1606707657489757,0.3469387755102041,1.0,1.0,1/5,5.78%,PTGER3
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.6206667102162398,-1.1605155250055166,0.2682926829268293,0.9120349028111995,1.0,5/15,16.95%,PKD2;GRIN1;CPSF7;TMEM120B;FARSA
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.7575956800230166,1.1602635534207364,0.34545454545454546,1.0,1.0,1/5,21.18%,CCNB1
prerank,GO_Biological_Process_2021__regulation of immunoglobulin mediated immune response (GO:0002889),0.7677674549049351,1.1600713196240588,0.3125,1.0,1.0,2/5,14.41%,TNFSF4;IL4
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.4027395441661505,-1.1599337286657236,0.15384615384615385,0.9133170785795313,1.0,61/250,18.09%,EMP1;IFT88;CFAP221;PTPRO;CDH13;MKS1;DCDC2;CFAP410;KIT;CNGA4;ABCC4;EXOC7;SCLT1;PARVA;ARFIP2;PCM1;CEP83;PPP1R9B;FLNA;CLUAP1;TTC36;TMEM138;SRGAP2;FGD1;GBF1;DZIP1L;FSCN1;FBF1;FGD5;RILPL1;EHD4;CFAP44;ASAP1;EHD3;ABLIM3;CEP250;SDCBP;RAB11FIP3;CILK1;CFAP70;B9D1;AVIL;DNAH5;TEKT3;TRAF3IP1;CCDC57;KIF24;DYNC2I1;AHI1;CEP41;CYS1;TCTN1;KIF27;EMP2;ARMC9;CCDC88A;IFT52;IFT43;IFT81;CEP290;EMP3
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.6342259489944087,1.1599070142600383,0.2537313432835821,1.0,1.0,5/20,14.41%,PLA2G10;WNT5A;THBS1;GPR137B;IL4
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.5493278271658854,-1.1596397060196293,0.21875,0.9135645945519443,1.0,5/27,7.87%,KCNIP3;KCNE1;KCNIP1;SLC30A5;DPP6
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.7300462593034831,1.1594342453370532,0.3333333333333333,1.0,1.0,2/9,12.94%,PHKA1;PYGL
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Deciduous Tooth,0.5202340856101582,1.1593462845518656,0.16,1.0,1.0,18/69,11.38%,C1QB;LYVE1;ANGPT2;PTPRC;FLT1;ABI3BP;VSIG4;MYH11;GPIHBP1;FLI1;GGT5;RAMP3;ADGRL4;ZNF366;VWF;DCN;HLA-DPB1;CLDN5
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Prostate,0.5899982833579565,1.1593405269162327,0.21621621621621623,1.0,1.0,9/25,14.71%,CSF2RA;A4GALT;ABCG2;ITGA2;ITGA5;HGF;EPCAM;BMI1;CD44
prerank,CellMarker_Augmented_2021__Basal cell:Lung,0.514927330853075,1.1593025886097064,0.2676056338028169,1.0,1.0,15/65,20.46%,CLCA2;AQP3;CLCA4;CCND2;PLAT;RAB38;IGFBP6;LY6D;SERPINB5;TUBB6;SERPINB1;DSG3;FAT2;PLP2;C16ORF74
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.6134166173437302,-1.1592483901773167,0.28888888888888886,0.9140724511943675,1.0,1/9,4.78%,APOE
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.7297198223791695,1.1589650518511652,0.32727272727272727,1.0,1.0,1/7,9.64%,TRDN
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.6520305261531598,-1.1588741180587248,0.2857142857142857,0.9145319968001199,1.0,1/10,2.40%,DCPS
prerank,Reactome_2022__GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,0.6834030580844883,1.158866229298117,0.2923076923076923,1.0,1.0,3/11,20.39%,VWF;ITGA2B;FN1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.726975661353128,-1.1588378408223365,0.3409090909090909,0.913795603497585,1.0,1/8,0.81%,SKAP1
prerank,KEGG_2021_Human__Ferroptosis,0.5757222595231204,1.1588095763925732,0.23943661971830985,1.0,1.0,8/35,19.99%,ACSL5;ACSL3;CP;ALOX15;FTH1;TF;FTL;SLC7A11
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,0.5278496148664623,1.158777166876165,0.2236842105263158,1.0,1.0,10/59,20.47%,PSMB9;MCM3;RPS27A;CCNA2;PSMC5;ORC4;RBX1;PSMA3;PSMB6;PSMD6
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,0.5511437378273127,1.1587583777409571,0.23943661971830985,1.0,1.0,9/43,14.01%,CDKN2A;CCND2;CCND1;CKS1B;CCNE2;RPS27A;CDKN1B;CDKN1A;CDKN2C
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,0.4763134621976827,1.158620140158071,0.2,1.0,1.0,14/106,8.80%,C1QTNF1;GPHB5;GNAT3;GPR27;GNG12;TSHR;SCTR;SYK;GGT5;ADRB1;RAMP3;GNG4;RXFP2;HCK
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.7479957184693763,1.1584370005742362,0.35714285714285715,1.0,1.0,2/5,15.27%,UBE2L6;ISG15
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.5914026510107517,1.1582016172897498,0.2711864406779661,1.0,1.0,3/24,9.64%,GPER1;P2RY6;TRDN
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.6146207402915884,1.158069025415025,0.234375,1.0,1.0,4/15,12.18%,TULP1;RP1;GRM6;GNAT2
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),0.7598404139248682,1.1580222567489926,0.3448275862068966,1.0,1.0,1/5,8.89%,TCAF2
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.7122484987912278,1.1580114763312983,0.2727272727272727,1.0,1.0,1/10,3.49%,STOML2
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.7596073580747605,1.1578359789216035,0.3548387096774194,1.0,1.0,1/6,2.00%,NOX5
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.5344435269676718,1.1575008378287415,0.2638888888888889,1.0,1.0,9/46,20.47%,PSMB9;BHMT;NQO1;OAZ2;PSMC5;AZIN1;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.506525014931305,-1.1573354671346225,0.17857142857142858,0.9181793610234182,1.0,7/31,9.67%,GRP;GCK;ADCYAP1;DOC2B;CRH;CAPN10;NLGN2
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),-0.6766875420800701,-1.1572925088446244,0.4146341463414634,0.9175000212953683,1.0,1/6,3.47%,LIN28B
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.6036987563581888,1.157093960998996,0.296875,1.0,1.0,4/22,7.30%,ITGB2;CCL5;SYK;NT5E
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.43747505450200685,-1.15700442450777,0.13043478260869565,0.9177187277422448,1.0,15/97,12.56%,PM20D1;SMPD3;PC;THEM4;PDZD11;MLYCD;MTHFR;MTHFD1L;DHFR;NSMAF;FPGS;CPN1;ACOT9;PLPP2;ABCB9
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,-0.4071227102700254,-1.1569566047699484,0.05263157894736842,0.9169703238608774,1.0,13/159,2.67%,P2RY10;TACR3;ADRA1A;GRK5;ADRA1B;NTSR2;PROKR2;NMU;DGKD;PRKCD;RGS16;ITPR2;GPRC6A
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,0.54714103002425,1.1568981194692614,0.21428571428571427,1.0,1.0,7/45,20.47%,PSMB9;RPS27A;CD4;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.47244996905706904,1.1568139525503676,0.21052631578947367,1.0,1.0,25/182,11.98%,TBX1;PIK3R3;FGF20;FAM20A;C3;FGF2;FAXDC2;CARD14;TGFB1;GPER1;RSPO1;ERBB4;MMP9;FLT4;CCND2;CCND1;HGF;CDK2AP1;DDX3X;PLAUR;PINK1;MYDGF;DAB2;PPP2R5A;CD4
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.7067157069023996,1.1567999760853147,0.2608695652173913,1.0,1.0,5/10,19.70%,ATP1A4;ATP6AP1;LACC1;PDK4;SLC26A4
prerank,CellMarker_Augmented_2021__4-Cell Stage Cell (Blastomere):Embryo,0.5953837634636532,1.1567726279751889,0.2535211267605634,1.0,1.0,4/31,7.39%,CDCA7L;GNG12;TRAF3IP2;NLRP11
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),0.7504231052063175,1.156513411275082,0.2777777777777778,1.0,1.0,4/5,24.97%,NR1H4;PANK2;FGFR4;ABCB11
prerank,Reactome_2022__Mitochondrial Iron-Sulfur Cluster Biogenesis R-HSA-1362409,-0.6226633071659052,-1.1564436286348287,0.3076923076923077,0.9176955824885394,1.0,2/11,5.28%,SLC25A37;HSCB
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.6804472578741011,1.1562301732105837,0.3103448275862069,1.0,1.0,1/11,3.51%,FGF2
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.4942111682482143,1.1562072223398048,0.2345679012345679,1.0,1.0,7/122,6.38%,GPR62;TRIL;TMEM100;STMN4;SOX10;LRRC3B;PLP1
prerank,Reactome_2022__Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,-0.5198541293400649,-1.1561417275738723,0.32142857142857145,0.9178664382195588,1.0,5/25,13.12%,GRIN3A;GPRIN1;MPP2;KIF17;LLGL1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.741683263566767,-1.1559505774969623,0.3684210526315789,0.9160887577169896,1.0,1/5,5.08%,MAN1A1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.741683263566767,-1.1559505774969623,0.3684210526315789,0.9160887577169896,1.0,1/5,5.08%,MAN1A1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.741683263566767,-1.1559505774969623,0.3684210526315789,0.9160887577169896,1.0,1/5,5.08%,MAN1A1
prerank,Reactome_2022__Beta Defensins R-HSA-1461957,0.7923756500043254,1.155920192183903,0.3387096774193548,1.0,1.0,3/5,16.88%,TLR2;DEFB109B;DEFB135
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.5514308718142886,-1.1558155297723633,0.21052631578947367,0.9157797509224979,1.0,3/13,14.57%,PACSIN2;PID1;CSPG5
prerank,Reactome_2022__Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.5684954385395624,-1.1555169158756906,0.29411764705882354,0.9160569997342296,1.0,5/19,12.58%,EARS2;LARS2;WARS2;DTD1;PARS2
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.6337038620247019,1.1553653742853125,0.30158730158730157,1.0,1.0,1/17,0.92%,PSMB9
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.6648650351686202,-1.155169173551833,0.3157894736842105,0.9163220399222235,1.0,1/7,2.40%,DCPS
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.4687027437799579,1.1546687907660034,0.18181818181818182,1.0,1.0,31/173,12.12%,TBX1;OIT3;APOLD1;C1QTNF1;TIMP3;S100A13;LMOD1;LYVE1;TMEM100;LOX;CYYR1;FLT1;ABCG2;GPIHBP1;FLI1;ELK3;INMT;STAB2;FLT4;GGT5;ANGPTL2;RAMP3;F8;CYP1B1;ADGRL4;VWF;ID1;DCN;CLDN5;RBP7;LIFR
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex7:Brain,0.4877796413219091,1.1545092032831474,0.25,1.0,1.0,13/100,9.92%,PRRX1;TRIL;FBXL7;PREX2;SHISA6;TMEM35A;PCDH18;JAM2;PLP1;DAAM2;TMEM200C;GFRA1;NEFM
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.7371794117807992,-1.1544064223113915,0.30952380952380953,0.9180130820763867,1.0,2/6,4.40%,DNMT1;SMARCB1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.7218923859288622,-1.1544015732288906,0.375,0.917212810926044,1.0,5/8,24.40%,NR4A3;CRH;NPAS2;SGIP1;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.6619905898410048,1.1543973568208972,0.2857142857142857,1.0,1.0,2/11,5.77%,C1QTNF1;GPER1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.49402370985392063,-1.1543406620250385,0.17857142857142858,0.9166124058727774,1.0,5/32,12.03%,EMC4;EMC8;STX5;EMD;BAG6
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.7456547725931817,-1.154300610996416,0.34210526315789475,0.9158615031774491,1.0,1/5,1.23%,UBASH3B
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.592645676398543,1.154237868516483,0.24615384615384617,1.0,1.0,6/31,8.61%,CCL5;PTPRC;CRLF3;ERBB4;IL26;CYP1B1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.7501136891990189,-1.1542266996820165,0.35,0.9154964151570207,1.0,2/5,19.44%,BDP1;BRF1
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.7875906461616573,1.1540521375751192,0.2711864406779661,1.0,1.0,1/5,5.59%,TRIM25
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.6977685964585612,1.1539940279520395,0.36065573770491804,1.0,1.0,2/10,7.52%,MESP1;WNT8A
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.6220287766486382,-1.1539592848477518,0.325,0.9156208479035366,1.0,2/10,1.87%,DUSP6;WWC1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.4408704366270777,-1.1538218556814843,0.14285714285714285,0.9153264129691723,1.0,12/107,11.94%,NOX4;ETV5;PRKCD;FOS;FOXO1;GSR;PKD2;MPV17;GPX1;AKR1C3;SLC4A11;G6PD
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.661799479763296,-1.1537920134405932,0.275,0.9146258659789586,1.0,4/8,20.60%,KCNE1;KCNH2;KCNE2;KCND3
prerank,KEGG_2021_Human__Fatty acid biosynthesis,0.6702798109501138,1.1535892484588908,0.3484848484848485,1.0,1.0,3/15,9.64%,ACSL5;OLAH;ACSL3
prerank,KEGG_2021_Human__Collecting duct acid secretion,0.5890693806963483,1.153449793962575,0.30434782608695654,1.0,1.0,4/22,9.47%,SLC12A7;ATP6V1G2;SLC4A1;ATP6V0E2
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.6542324882772147,-1.1533807278020018,0.3157894736842105,0.9148436117018502,1.0,3/8,19.14%,PNKP;AK8;AK7
prerank,CellMarker_Augmented_2021__Stem cell:Submandibular Gland,0.5119734608419574,1.1533591911795966,0.21052631578947367,1.0,1.0,21/69,16.75%,C1QB;TIMP3;LYVE1;CYYR1;PREX2;FLT1;ABCG2;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;CLDN5;PDK4;EDNRB;SLCO2B1;CXCL12;GPR17;A2M
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.6970483296357894,-1.1532045341044723,0.2972972972972973,0.914666651173241,1.0,3/11,11.37%,BTN3A2;CD8A;JAG1
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),-0.6370315525903606,-1.1531257311703293,0.24489795918367346,0.9141192270321093,1.0,4/11,16.95%,PKD2;GRIN1;CPSF7;FARSA
prerank,Reactome_2022__TP53 Regulates Transcription Of Death Receptors And Ligands R-HSA-6803211,0.6757931515218485,1.1528596521527943,0.34615384615384615,1.0,1.0,2/9,8.95%,TNFRSF10A;TP53BP2
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,-0.4717840669246682,-1.152782203795163,0.2727272727272727,0.9144062996959189,1.0,8/27,13.20%,ST3GAL3;GLB1L;B4GALT2;ST3GAL2;CHST6;PRELP;B4GALT4;ST3GAL4
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.6164323892924654,1.1527080589615253,0.2698412698412698,1.0,1.0,7/19,27.66%,ACSL3;PPT1;SCD;FASN;GCDH;DGAT2;ACLY
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,0.4838054706713308,1.1527070939664568,0.19753086419753085,1.0,1.0,21/147,15.97%,MICB;TCF7;PIK3R3;ANGPT2;C3;FGF2;GNG12;HLA-F;SYK;LEF1;CCND1;GNG4;HCK;HLA-A;RPS27A;STAT1;CDKN1A;TCF7L1;MAPK3;PIK3R6;PIK3CG
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In BCR Signaling R-HSA-8939245,0.719819161867272,1.1526566338155233,0.3,1.0,1.0,1/6,1.06%,BLK
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Undefined,0.7827511542865057,1.152556291907117,0.20754716981132076,1.0,1.0,2/5,15.41%,CLEC4C;IL3RA
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.6628845975401847,1.1524391085980659,0.3018867924528302,1.0,1.0,2/12,14.15%,ANXA1;ELANE
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In7:Brain,0.7385232055911345,1.152378937970621,0.37142857142857144,1.0,1.0,1/6,2.82%,AOX1
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6712178768491036,1.1523780182512038,0.22950819672131148,1.0,1.0,3/10,23.28%,TGFB1;MAP2K1;MYCN
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.45966647727742804,-1.152367986720798,0.18518518518518517,0.9152480275491618,1.0,11/80,10.13%,NGF;BAMBI;WNT3A;APOE;HES1;MEN1;RALB;DDX11;ZNF618;RIPK2;KDM4D
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.6350960803752862,-1.1520852425310386,0.32432432432432434,0.9154295662711223,1.0,2/11,10.39%,MTHFR;MYOCD
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),0.6994078480619379,1.1519153071173582,0.375,1.0,1.0,3/9,14.38%,EXOSC8;EXOSC2;RPS21
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.5569974757017416,1.1519116338445174,0.25,1.0,1.0,19/48,16.23%,GNAT3;PTPRC;PTAFR;POU2F3;ITGAM;JCHAIN;NFAM1;FCGR3A;FGL2;ASIC5;HCK;CSF3R;KLF3;HK3;SOX9;P2RX1;ADGRE3;CD300LF;IL17RB
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.7003524776648644,1.1517836081773718,0.3387096774193548,1.0,1.0,3/9,13.21%,FGF2;IL12A;THBS1
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,0.562247003155528,1.1517587382575714,0.2876712328767123,1.0,1.0,4/24,8.04%,C1QTNF1;GNG12;SCTR;GNG4
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.6714872100074822,-1.1516186015986332,0.2777777777777778,0.9163150411820853,1.0,1/8,0.88%,PLK3
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood Vessel,0.5235400646034847,1.1516045309739174,0.24285714285714285,1.0,1.0,12/62,9.20%,ITGB2;TNFRSF1B;LYVE1;CD160;A4GALT;FLT1;TNFRSF10A;CD81;STAB2;ANPEP;FLT4;AGGF1
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.641045674768673,1.1514147917551532,0.25396825396825395,1.0,1.0,3/18,1.28%,MICB;BLK;C3AR1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7435405291540023,1.1514044028029236,0.34545454545454546,1.0,1.0,2/7,14.62%,F2RL1;CYBA
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.5209745853731611,1.1512911669433834,0.2328767123287671,1.0,1.0,25/90,16.42%,RASGRP4;TRIM58;SLFN14;GMFG;SNAP23;LMO2;HEMGN;STAT5A;SLC4A1;VASP;MFSD2B;TMC8;ZC3HAV1;TALDO1;RHOG;ITGA2B;ARHGAP45;P2RX1;ADCY7;CD44;FERMT3;PIK3CG;RGS10;ENG;CD244
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.5935286020655796,1.151191686914692,0.3142857142857143,1.0,1.0,3/23,8.89%,ITGB2;ITGAM;TCAF2
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.6802680632142697,1.1510297844629958,0.31343283582089554,1.0,1.0,4/10,24.39%,PTX3;TRIM5;CIITA;LY6E
prerank,CellMarker_Augmented_2021__Fibroblast:Heart,-0.46334355368062696,-1.1508528785522718,0.25,0.9176603216230065,1.0,16/81,8.32%,TEAD2;CALD1;P3H4;LOXL1;COL13A1;TWIST2;ARSJ;RND3;CD151;PAPSS2;QSOX1;PARVA;FSTL1;PVR;PERP;NTN4
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.6716818022206167,1.1506841055558923,0.2537313432835821,1.0,1.0,3/12,17.37%,PTPRC;GLI3;RAG1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Chorionic Villus,0.5302269069711609,1.1504377281950726,0.18181818181818182,1.0,1.0,22/68,14.71%,ITGB2;C3AR1;CYTIP;TNFRSF1B;ITGAX;GMFG;SP100;SASH3;CMAHP;PTPRC;FCGR3A;FLI1;FGL2;STAT5A;TAGAP;HLA-DPB1;GPR183;ALOX5AP;CSF1R;EVI2A;PARVG;CD44
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.7150735322965904,1.1503838238723685,0.3103448275862069,1.0,1.0,3/8,19.54%,DAB2;MSN;RAB21
prerank,GO_Biological_Process_2021__regulation of blood vessel remodeling (GO:0060312),0.7739748197297882,1.1500801907673908,0.30357142857142855,1.0,1.0,2/5,7.20%,TGFB1;FLT4
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),-0.6198653360709844,-1.150072308444718,0.2222222222222222,0.9192221535260768,1.0,6/11,29.84%,SNX5;C1QTNF12;GKAP1;SORL1;ZBTB7B;ERFE
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.6120955394935894,1.1498883413835752,0.2318840579710145,1.0,1.0,3/16,6.12%,ABCG2;ABCC2;SLC26A6
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.4771510432600547,1.1497121294273345,0.2289156626506024,1.0,1.0,10/128,6.57%,GATA4;C1QTNF1;TIMP3;LMOD1;ACOX2;COL18A1;C3;BOK;ANGPTL4;AARD
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),-0.46755156539453646,-1.1496176038410177,0.28125,0.9198830742651082,1.0,2/55,0.51%,RFX6;GCK
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.7623028567902718,1.1494439352969368,0.4074074074074074,1.0,1.0,3/6,14.67%,ADRB1;SOD2;NPPA
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.7002654193934484,1.149370338628834,0.3582089552238806,1.0,1.0,2/7,9.05%,CCL5;PLAUR
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.6537191877968895,-1.1490671369071006,0.34285714285714286,0.9207153691956909,1.0,1/7,10.50%,PTPRS
prerank,CellMarker_Augmented_2021__Eosinophil:Lung,0.6024845523647784,1.1490560372711551,0.3484848484848485,1.0,1.0,15/36,15.08%,RASGRP4;C19ORF38;OSCAR;NFAM1;NLRP12;CLEC12A;HCK;CSF3R;HK3;MYO1F;FPR1;ELANE;P2RX1;ADGRE3;CD300LF
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,0.528061860913884,1.1489213048821887,0.273972602739726,1.0,1.0,8/52,20.47%,PSMB9;RPS27A;GLI3;PSMC5;RBX1;PSMA3;PSMB6;PSMD6
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,0.521817224068317,1.148843600425361,0.20833333333333334,1.0,1.0,6/63,8.32%,ESR1;PIK3R3;FGF20;ERBB4;CD80;KLB
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),0.7229388294096768,1.1488158294395643,0.35294117647058826,1.0,1.0,3/7,13.47%,DCLRE1A;DCLRE1C;TFIP11
prerank,KEGG_2021_Human__RNA polymerase,-0.5002054786485697,-1.1487225310084446,0.2,0.921178378366566,1.0,8/29,15.56%,POLR1A;POLR3D;POLR3E;POLR3K;POLR2F;POLR3A;POLR3B;POLR2C
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.5819173495646724,1.1487040786397116,0.2535211267605634,1.0,1.0,3/26,13.21%,PLA2G10;LPIN3;ALOX15
prerank,Reactome_2022__G2/M Transition R-HSA-69275,0.4646506648957334,1.1485297090169106,0.14457831325301204,1.0,1.0,28/166,22.60%,NEK2;CDC25A;PSMB9;FBXL7;FKBPL;BORA;FOXM1;CEP72;CEP70;RPS27A;CDKN1A;CCNA2;PKMYT1;PSMC5;TUBA4A;PHLDA1;DYNLL1;CEP76;RBX1;PSMA3;PSMB6;CDC25C;PSMD6;CCNB1;TUBB4B;DCTN3;DCTN1;YWHAG
prerank,Reactome_2022__YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,0.6178722088129278,1.1484411215661223,0.35294117647058826,1.0,1.0,2/13,3.98%,GATA4;HIPK1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.487561402833791,-1.1483890034262614,0.3055555555555556,0.9213534760135075,1.0,4/27,10.30%,PEX7;SLC25A17;PEX13;PEX14
prerank,GO_Biological_Process_2021__regulation of thymocyte apoptotic process (GO:0070243),-0.7788408099918596,-1.1483703643707468,0.35714285714285715,0.9206218883682168,1.0,1/5,6.78%,ADAM8
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6430865887644234,1.1483638961285583,0.36666666666666664,1.0,1.0,2/12,3.51%,ANXA1;FGF2
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),-0.5888473598525774,-1.1482901823942901,0.2222222222222222,0.9200635494859082,1.0,5/26,13.45%,TEAD2;WWC1;TEAD4;AMOTL1;AMOTL2
prerank,Reactome_2022__Endosomal/Vacuolar Pathway R-HSA-1236977,0.6678911867368386,1.148154992529589,0.2903225806451613,1.0,1.0,5/10,27.48%,HLA-F;HLA-A;B2M;LNPEP;HLA-B
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.7722407319363854,1.1481107953833107,0.32142857142857145,1.0,1.0,1/5,12.99%,DOCK5
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5514375578443279,1.147955706110956,0.2602739726027397,1.0,1.0,5/33,11.19%,ESR1;NLRP12;NR1H4;NLRC3;STAT1
prerank,CellMarker_Augmented_2021__Epithelial cell:Breast,-0.7486792056298731,-1.1476958432804665,0.32558139534883723,0.9213729802595105,1.0,3/5,17.99%,KIT;ALCAM;SMN1
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,-0.4173743986422016,-1.1475663860035412,0.21428571428571427,0.920906506338705,1.0,12/69,13.17%,DTX1;HDAC7;HDAC10;MAML1;GATD3;JAG2;HDAC3;MAMLD1;JAG1;NEURL1;ARRB2;TLE2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Embryo,0.5073173389605874,1.1473699075170662,0.3026315789473684,1.0,1.0,19/57,18.12%,C1QB;MYO15B;LYVE1;FLT1;ADAMDEC1;VSIG4;ANPEP;GGT5;HPGDS;COL6A2;ZNF366;VWF;CSF1R;SLCO2B1;CXCL12;ENG;A2M;FPR3;FBP1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.4391774264828426,-1.1472169015953049,0.17391304347826086,0.9214354647380143,1.0,15/50,21.46%,GANC;FBXO27;MAN1A1;NEU4;AGA;ST3GAL2;ST3GAL4;NGLY1;ADAMTS13;FBXO44;ST6GALNAC3;ADAMTS9;PRKCSH;MAN2B1;MAN1A2
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.6980632455311224,1.1468702949012775,0.3620689655172414,1.0,1.0,5/10,11.68%,ITGB2;TGFB1;ITGAM;SYK;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.7799899534500689,-1.146807222534171,0.22580645161290322,0.9219977480226003,1.0,1/6,0.50%,ADRA1A
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Plasma,0.5354077684681243,1.1467520225183463,0.27631578947368424,1.0,1.0,10/49,10.38%,TRIM58;SLFN14;CTCFL;OR52A5;HEMGN;TRAPPC3L;SLC4A1;CA1;CEACAM8;MFSD2B
prerank,CellMarker_Augmented_2021__Erythroblast:Fetal Liver,0.5354077684681243,1.1467520225183463,0.27631578947368424,1.0,1.0,10/49,10.38%,TRIM58;SLFN14;CTCFL;OR52A5;HEMGN;TRAPPC3L;SLC4A1;CA1;CEACAM8;MFSD2B
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),-0.7609605910767498,-1.1467362777322814,0.3684210526315789,0.9213836082706687,1.0,2/5,17.28%,GLYATL2;ABHD1
prerank,Reactome_2022__Interleukin-2 Signaling R-HSA-9020558,0.6369279051913826,1.1466848829500396,0.35185185185185186,1.0,1.0,2/10,6.35%,STAT5A;SYK
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,0.5397102083773639,1.146543919324171,0.2112676056338028,1.0,1.0,7/63,8.28%,GATA4;C1QTNF1;ACE2;GNAT3;ANPEP;IGF1;CPB2
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,0.46125630294869735,1.146526758111365,0.1411764705882353,1.0,1.0,28/168,22.60%,NEK2;CDC25A;PSMB9;FBXL7;FKBPL;BORA;FOXM1;CEP72;CEP70;RPS27A;CDKN1A;CCNA2;PKMYT1;PSMC5;TUBA4A;PHLDA1;DYNLL1;CEP76;RBX1;PSMA3;PSMB6;CDC25C;PSMD6;CCNB1;TUBB4B;DCTN3;DCTN1;YWHAG
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.48796534848823275,1.1465081222955888,0.2235294117647059,1.0,1.0,9/128,6.41%,GPR62;LRP4;LMOD1;TRIL;CTHRC1;SHISA6;SOX10;PLP1;DAAM2
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,0.47092488138757993,1.1464362138165038,0.17105263157894737,1.0,1.0,18/111,17.60%,WNT8B;TCF7;PIK3R3;FGF2;WNT5A;NODAL;WNT8A;IGF1;REST;FZD8;ID1;WNT6;LIFR;BMI1;MAPK3;WNT5B;INHBC;ID3
prerank,Reactome_2022__SHC1 Events In EGFR Signaling R-HSA-180336,-0.6182268871179871,-1.146420547638448,0.35135135135135137,0.9217397075080067,1.0,3/9,19.41%,TGFA;HRAS;BTC
prerank,KEGG_2021_Human__Sphingolipid metabolism,-0.4912569727859529,-1.1463842027977098,0.2,0.9210585368282301,1.0,6/43,5.43%,GLA;SMPD3;ACER2;SMPD4;ACER3;NEU4
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.4964387660351442,-1.1461529664295595,0.25,0.9210500839992874,1.0,9/49,7.92%,PER2;NR4A1;IL11;METRNL;FOXO1;NR4A3;CLIP3;SDF4;PID1
prerank,CellMarker_Augmented_2021__Paneth cell:Intestine,0.7819838982287257,1.1460846372373892,0.3389830508474576,1.0,1.0,4/5,20.73%,OR5V1;IL5;IL4;DPPA5P1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5037483394969531,-1.1460653520398454,0.16666666666666666,0.9204617023946227,1.0,10/40,18.95%,EARS2;LARS2;VARS1;WARS2;PARS2;CARS1;MARS1;FARSA;HARS2;YARS1
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.7007902690661466,1.145889877900084,0.31746031746031744,1.0,1.0,4/11,19.00%,LEF1;TNFSF4;IL4;IRF4
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.7459259877529996,1.1456987464555413,0.2830188679245283,1.0,1.0,1/5,5.05%,HEY2
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),0.6584818343603653,1.1456134072570499,0.3125,1.0,1.0,2/9,15.27%,RPS27A;ISG15
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,0.5187217789455139,1.1455848047654553,0.2625,1.0,1.0,17/73,14.41%,ITGB2;RORC;TNFRSF1B;ITGAX;HSPA8;ANXA1;TGFB1;ITGAM;IL12A;MMP9;CCND1;STAT1;RHOU;CDKN1A;ALOX15;OPRM1;IL4
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.47446755897163706,1.1455646855543806,0.20253164556962025,1.0,1.0,22/153,11.00%,SQOR;SMAD6;BACE2;C1QTNF1;TIMP3;SMOC1;LMOD1;LOX;GNG12;ITGBL1;HEY2;SCARA3;UACA;COL4A4;COL4A3;ITGA5;ANGPTL2;ENPP4;CYP1B1;ADGRL4;DCN;COL1A1
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,-0.5482940277988584,-1.1454510424244602,0.2857142857142857,0.921680822045935,1.0,4/21,16.91%,KIRREL3;KIRREL2;NPHS1;FYN
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,0.4643981183274556,1.145329627223337,0.16853932584269662,1.0,1.0,49/204,19.99%,SLC28A1;SLC22A3;SLC9A2;SLC12A7;SLC5A4;SLC5A2;SLC7A7;SLC18A2;SLC16A8;SLC12A3;SLC38A3;SLC22A8;SLC28A3;SLCO1A2;SLC17A8;SLC26A6;SLC4A1;SLC22A7;SLC13A4;SLC22A6;SLC27A6;SLC15A1;SLC38A4;SLC5A9;CP;SLC24A1;SLC25A18;SLC5A1;SLC39A7;SLC47A1;SLC47A2;SLC35C1;SLC7A3;SLC30A2;SLCO2B1;SLC14A1;SLC22A4;SLC38A2;SLC16A1;SLC6A12;SLC16A3;SLC35D2;SLC44A3;CTNS;SLC7A10;SLC1A6;SLC26A4;SLC25A22;SLC7A11
prerank,CellMarker_Augmented_2021__Activated CD4+ T cell:Blood,-0.7072502148003263,-1.1451130372806895,0.35135135135135137,0.922080489577265,1.0,2/7,1.93%,CD38;CD14
prerank,CellMarker_Augmented_2021__Neural Stem cell:Inferior Colliculus,0.48865239307263875,1.144843831061107,0.2839506172839506,1.0,1.0,17/97,20.04%,LRP4;TRIL;TSPAN11;FBXL7;CACHD1;PLP1;TMEM200C;AIF1L;LIFR;CRISPLD1;FBN3;RBP1;FRZB;EFNB3;FIGN;ID4;SMARCA1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.44408509929496676,1.144835133949367,0.14893617021276595,1.0,1.0,57/441,14.14%,GPR62;TBX1;ESR1;S100A13;LPAR1;TLR2;LRRC19;FGF20;CCL5;LRP2;TRIM62;FGF2;PTPRC;GFRAL;FLT1;TGFB1;NLRP12;BOK;SCTR;WNT5A;TRAF3IP2;TRIM25;GPER1;ERBB4;CD80;FLT4;IL26;IGF1;RAMP3;AXL;GSDME;HGF;KLB;DDX3X;RRAGA;F7;PINK1;TRIM68;C1QTNF4;P2RY12;MYDGF;VWF;ECT2;TGM2;TIFA;DCN;CASP10;F2RL1;CD4;ALOX12B;TNFAIP8L3;AGT;THBS1;RHOG;CALCR;SOX9;WDR24
prerank,Reactome_2022__VEGF Binds To VEGFR Leading To Receptor Dimerization R-HSA-195399,0.7498437077974114,1.1444486591201521,0.24489795918367346,1.0,1.0,2/6,7.20%,FLT1;FLT4
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.418757673193454,-1.1442760013816993,0.11764705882352941,0.9237269950527354,1.0,23/70,20.64%,CBARP;FGF1;FZD7;MID1;MPP2;VGF;DLX1;B4GALNT1;SRRM3;FHOD3;MSI1;AADAT;VAX2;RCOR2;CSPG5;CSNK1E;POU3F2;RBFOX2;ARHGEF25;LINGO1;SEZ6L2;MNX1;APLP1
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.6829051693825154,1.1437214651299128,0.30985915492957744,1.0,1.0,2/9,0.98%,ENPP2;PLA2G10
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.5437138355098471,-1.1437149147579353,0.28,0.924928673385223,1.0,11/35,23.25%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;NUP98;SEH1L;XPOT;NUP50;TPR
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.6453133045210171,-1.1436842334692052,0.28125,0.9241583248641305,1.0,1/9,3.30%,COL13A1
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.5232773767170569,-1.1434278686997184,0.3225806451612903,0.9241811270744978,1.0,7/24,25.50%,DGCR8;AGO2;POLR2F;POLR2C;XPO5;TARBP2;DROSHA
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bone Marrow,0.5029583155263737,1.1433846676052228,0.29577464788732394,1.0,1.0,11/67,13.47%,STEAP4;TLR2;SP100;KCNJ15;AHR;APOL6;SOD2;CSF3R;DOCK5;LAMP2;FPR1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.49936568338146764,1.1432249640981598,0.2702702702702703,1.0,1.0,12/62,15.97%,CCL5;FGF2;FLT1;GPER1;IGF1;HGF;MYDGF;DCN;F2RL1;AGT;SOX9;PIK3CG
prerank,CellMarker_Augmented_2021__Stem cell:Esophagus,0.47156689974178173,1.1430590308275848,0.25,1.0,1.0,13/100,14.14%,LRP4;TRIL;TSPAN11;FBXL7;CACHD1;PCDH18;SCARA3;PLP1;TMEM200C;GFRA1;LIFR;SOX9;PCDHB10
prerank,Reactome_2022__PP2A-mediated Dephosphorylation Of Key Metabolic Factors R-HSA-163767,-0.69241377857867,-1.1429819525164746,0.3611111111111111,0.9248480675460689,1.0,2/6,20.85%,PPP2R5D;PPP2R1B
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.6642362508131252,-1.142809724071016,0.3333333333333333,0.9245314799362059,1.0,3/8,21.02%,EPHB2;NFIB;NCAM1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.5835661687330813,-1.142780944293577,0.3076923076923077,0.9238318772527528,1.0,2/14,5.98%,CDH5;F11R
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Endometrium,0.5266910698543006,1.1423870304568802,0.26582278481012656,1.0,1.0,7/68,3.81%,DENND1C;ADAM28;CYTIP;ARHGAP9;ITM2A;SASH3;PTPRC
prerank,Reactome_2022__RHOT2 GTPase Cycle R-HSA-9013419,-0.6586663297570873,-1.1423735415527094,0.3157894736842105,0.924429738051547,1.0,3/7,28.17%,MYO19;TRAK2;TRAK1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.7293760246668578,1.1422480571525364,0.3559322033898305,1.0,1.0,2/7,6.03%,VSIR;CD81
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Subcutaneous Adipose Tissue,0.5148818196939289,1.1420507765715713,0.2077922077922078,1.0,1.0,16/68,15.71%,STEAP4;PPP1R3B;TLR2;ARHGAP24;LYVE1;ANPEP;ITGA5;CD302;PLAC9;DAB2;FOSL2;FPR1;MME;ADGRE3;TGFBI;SLC22A4
prerank,GO_Biological_Process_2021__multinuclear osteoclast differentiation (GO:0072674),0.7434541348243333,1.141981476169733,0.3387096774193548,1.0,1.0,1/5,6.03%,CD81
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.6618741954859976,1.1417867352507252,0.3,1.0,1.0,1/9,4.88%,NPC1L1
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Eye,0.495578310533342,1.1416343071123538,0.2631578947368421,1.0,1.0,11/95,9.04%,TRIL;TSPAN11;FBXL7;CYYR1;PREX2;SHISA6;TMEM35A;PCDH18;PLP1;TMEM200C;TCEAL5
prerank,Reactome_2022__Regulation Of Cytoskeletal Remodeling And Cell Spreading By IPP Complex Components R-HSA-446388,-0.6763579175191712,-1.1415617076965254,0.3181818181818182,0.9262540776254428,1.0,3/8,18.89%,PARVA;LIMS1;PARVB
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.5968059863454298,1.1413876483430112,0.3088235294117647,1.0,1.0,2/20,2.83%,DISC1;LRP2
prerank,CellMarker_Augmented_2021__Stem cell:Salivary Gland,0.495178147378529,1.1413734061607155,0.3037974683544304,1.0,1.0,23/93,21.93%,MICB;ANXA1;SP100;AHR;TNFRSF10A;ELK3;RBM43;REST;ZC3HAV1;BMI1;CD44;STK17A;PARP14;PARP4;DDX60;UHMK1;STK17B;PLP2;PYROXD1;TMEM243;ANXA2;B2M;MLKL
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.6219491841496267,-1.1410250385086658,0.29545454545454547,0.9271300638786151,1.0,3/10,20.80%,SHANK1;PCDH15;CLN3
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",-0.5404228691486527,-1.1408633387671254,0.25806451612903225,0.9270152201118488,1.0,7/30,23.04%,CACNG4;GRIA4;CACNG2;LLGL1;PRKCA;EPB41L1;CACNG3
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.6929722988334874,1.1405630080125553,0.36486486486486486,1.0,1.0,4/9,14.14%,MUC4;STRAP;SOX9;PBLD
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.7330647782257167,-1.1402985701613446,0.30952380952380953,0.9279339363173168,1.0,2/5,10.20%,EGR1;NAB2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.5532054363904537,1.1402669754286883,0.2608695652173913,1.0,1.0,1/31,0.37%,NEK2
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Testis,-0.6812898967980662,-1.1402212043734836,0.3684210526315789,0.9273921415327729,1.0,2/9,1.86%,ETV5;BCL6
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.5719230311921104,1.1402071767189983,0.3194444444444444,1.0,1.0,6/30,11.67%,LRRC19;CCL5;POU2F3;LEF1;REST;HMGA2
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),0.6259183787374952,1.1401099749958976,0.32432432432432434,1.0,1.0,6/21,21.19%,GPR55;LILRB3;GPR137B;IL4;CEACAM1;ZFPM1
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.6029424330019603,-1.140038396427127,0.38461538461538464,0.9271316067089148,1.0,4/13,5.05%,TPH1;PAH;MOXD1;HDC
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.5741751871276551,1.1399541492163456,0.2631578947368421,1.0,1.0,13/35,27.27%,CENPU;OIP5;CENPX;ITGB3BP;CENPN;CENPL;RBBP7;ANP32E;CENPM;CENPO;CENPK;ACTR6;CENPP
prerank,Reactome_2022__Synthesis Of PIPs At ER Membrane R-HSA-1483248,-0.6927925476327427,-1.139930042235781,0.3488372093023256,0.9267034851751074,1.0,2/5,28.97%,PI4KA;PI4K2B
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.40932578879569526,-1.139908294567786,0.25,0.925929127374475,1.0,23/127,14.15%,POU3F1;SPHKAP;CDH20;SLC17A6;SEZ6L;ELAVL3;TTBK1;IGSF21;SRRM4;SNCB;HPCA;PCP4;SHISA7;NEUROD6;MMD2;TAGLN3;GRIA4;KCNB2;ADGRA1;BRINP1;LRRTM3;CELF4;TCEAL6
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,0.5261321415465802,1.1398655609552182,0.2236842105263158,1.0,1.0,11/54,25.56%,PSMB9;RPS27A;PSMC5;SEL1L;PSMA3;PSMB6;PSMD6;RNF5;PSMA7;DERL2;PSMB1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.4981044423353212,-1.1398591368616395,0.19047619047619047,0.9252008516000343,1.0,11/42,20.40%,FBXO27;NEU4;RNASET2;DNASE1L1;DAB2IP;NGLY1;PABPC4;FBXO44;HTRA2;ADAMTS9;XRN2
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.5976624234155641,-1.1398173754910015,0.23076923076923078,0.9245520580622039,1.0,2/9,12.31%,RGN;GSTO2
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.7085911159614078,1.139803871534067,0.3230769230769231,1.0,1.0,1/7,5.31%,WNT5A
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),-0.677747346594038,-1.1396634349946406,0.34375,0.9226904465986869,1.0,3/8,29.68%,HSPB1;KIF5C;RAB27B
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),-0.677747346594038,-1.1396634349946406,0.34375,0.9226904465986869,1.0,3/8,29.68%,HSPB1;KIF5C;RAB27B
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),-0.677747346594038,-1.1396634349946406,0.34375,0.9226904465986869,1.0,3/8,29.68%,HSPB1;KIF5C;RAB27B
prerank,KEGG_2021_Human__Endometrial cancer,0.5398654295137808,1.139562513122181,0.234375,1.0,1.0,8/57,15.19%,TCF7;PIK3R3;LEF1;CCND1;CTNNA3;CDKN1A;TCF7L1;MAPK3
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,0.6210752682487057,1.139551238264687,0.28125,1.0,1.0,4/21,18.84%,TLR2;NFKB2;NDUFA2;NFKBIA
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.6618915943439618,1.139544440342557,0.3384615384615385,1.0,1.0,6/18,14.48%,ELOVL2;ALOX12;CYP2J2;ALOX12B;ALOX15;ALOX15B
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),-0.7227778537233998,-1.139503851032984,0.3829787234042553,0.9224135277750817,1.0,1/5,2.05%,PACSIN2
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.7195680319150755,-1.1393443502926452,0.36363636363636365,0.9221037135873493,1.0,4/6,26.44%,FYN;NTRK2;SRC;DOCK3
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.6956389341048336,-1.1392758193778338,0.391304347826087,0.9214276255139257,1.0,2/5,9.85%,SEPTIN9;CEP135
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.6244840992184932,-1.1389848422736528,0.3235294117647059,0.921485693244001,1.0,3/11,9.40%,ADAMTS12;SNAI2;EFEMP1
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.70649696791742,1.1385809585588695,0.3225806451612903,1.0,1.0,1/7,4.37%,ITGAM
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),-0.6626015175292497,-1.1384903699366427,0.3076923076923077,0.9223314944315704,1.0,6/8,28.64%,GALNT13;GALNT2;GALNT11;GALNT1;GALNTL6;EOGT
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.7206123860177776,1.1384895100729107,0.33766233766233766,1.0,1.0,1/7,5.32%,HAT1
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.7206123860177776,1.1384895100729107,0.33766233766233766,1.0,1.0,1/7,5.32%,HAT1
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.6279167855720422,1.1384681965760481,0.3898305084745763,1.0,1.0,4/12,21.45%,IFIT1;PLN;ATP5IF1;PAM16
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.5713871210688292,-1.138283898402767,0.28125,0.9223775946599235,1.0,2/20,1.87%,MT1G;FOS
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.5429889884405521,1.1382755423485469,0.32051282051282054,1.0,1.0,14/43,22.89%,TLR2;SP100;CCL5;WNT5A;SLC26A6;RPL13A;STAT1;AQP4;GBP1;HLA-DPA1;CCL25;CIITA;CXCL16;CD74
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.691375423817527,1.138229220077104,0.3283582089552239,1.0,1.0,1/7,3.81%,PTPRC
prerank,Reactome_2022__Loss Of Function Of SMAD2/3 In Cancer R-HSA-3304349,0.7625330190466031,1.1382068974315946,0.3333333333333333,1.0,1.0,1/7,4.27%,TGFB1
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex In Cancer R-HSA-3304351,0.7625330190466031,1.1382068974315946,0.3333333333333333,1.0,1.0,1/7,4.27%,TGFB1
prerank,CellMarker_Augmented_2021__Plasma cell:Undefined,-0.6554125467927135,-1.1381429799955145,0.42424242424242425,0.9220913022403422,1.0,1/9,0.22%,CD38
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.5094734295818918,1.1380174212891456,0.2962962962962963,1.0,1.0,14/64,16.91%,CCL5;ECM2;RNASE10;IL12A;SYK;NODAL;P2RY12;TGM2;ADGRG1;ALOX15;SIRPG;CXCL12;AGR2;HYAL1
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),0.7668058354298508,1.1378119204374348,0.32075471698113206,1.0,1.0,2/5,13.61%,JCHAIN;RPS19
prerank,CellMarker_Augmented_2021__Epithelial cell:Epithelium,0.518961668406646,1.137561767788466,0.2894736842105263,1.0,1.0,15/57,13.33%,C1QB;MYO15B;LYVE1;CYYR1;VSIG4;MYH11;GPIHBP1;GGT5;RAMP3;HPGDS;ZNF366;VWF;CLDN5;EPCAM;CSF1R
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.5867244494983129,-1.1372192011091955,0.37209302325581395,0.924517054153446,1.0,2/12,2.14%,DRD4;PAH
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.6974088198763098,1.1372158468554903,0.37254901960784315,1.0,1.0,3/7,13.47%,HMGA2;NUDT16L1;TFIP11
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,-0.46788008126818775,-1.137092811377038,0.275,0.9241962380796837,1.0,12/41,11.53%,SMPD3;GLB1L;ARSL;ARSJ;SMPD4;STS;NEU4;ARSB;B4GALNT1;NEU3;ESYT3;SUMF2
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,0.5294702951554594,1.1366318275308323,0.26865671641791045,1.0,1.0,7/50,20.47%,PSMB9;CDKN2A;RPS27A;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.6799121174159698,1.1366265745675557,0.38333333333333336,1.0,1.0,1/10,1.49%,PKP2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.5429770303010676,1.1365759848718109,0.26666666666666666,1.0,1.0,1/30,0.37%,NEK2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),0.7554639579514595,1.136230440557819,0.3728813559322034,1.0,1.0,1/5,3.45%,TICRR
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,0.628383493519003,1.136140278465027,0.296875,1.0,1.0,5/21,9.64%,ELOVL2;TECRL;ACSL5;HACD4;ACSL3
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.6432817786876902,1.136089656453542,0.3333333333333333,1.0,1.0,5/14,20.04%,HSPA5;COPS5;AGR2;TMEM33;DNAJB9
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.5495221044549555,1.1360119304498337,0.3333333333333333,1.0,1.0,13/32,24.63%,C3;RSPO1;PPT1;LRPAP1;VTN;LDLRAP1;IL4;TF;RAB21;B2M;HNRNPK;PROM2;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),0.7114201728090963,1.1357669667243961,0.3442622950819672,1.0,1.0,4/6,23.17%,PINK1;ATP5IF1;TOMM7;HK2
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.787092942720506,1.13568575289568,0.3333333333333333,1.0,1.0,2/5,14.11%,KANK2;ANLN
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5658976506357375,1.1353823282758833,0.2692307692307692,1.0,1.0,9/37,16.95%,CCL5;CLCF1;CRLF1;IL12A;ERBB4;IGF1;CSF1R;IL4;PARP14
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.5744420283563392,1.135381432520949,0.3466666666666667,1.0,1.0,2/23,0.98%,ENPP2;PLA2G10
prerank,CellMarker_Augmented_2021__Natural Killer cell:Liver,0.5674434673314034,1.135380963486755,0.3333333333333333,1.0,1.0,18/43,15.08%,C3AR1;ITGAX;LILRB3;ITGAM;NFAM1;FCGR3A;VSIG4;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;CSF1R;FPR1;ADGRE3;CD300LF
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.6848292576307071,1.1353215923156257,0.25862068965517243,1.0,1.0,1/12,1.49%,PKP2
prerank,CellMarker_Augmented_2021__Cancer cell:Kidney,-0.7259284712365532,-1.1352899544711588,0.3684210526315789,0.929168208000341,1.0,1/5,2.80%,PTPRO
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.585970571454074,1.1352651970879828,0.30303030303030304,1.0,1.0,6/24,18.83%,PKP2;CAV3;CTNNA3;PLN;SCN5A;ATP2A2
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6437706938397485,1.1352320930595163,0.31666666666666665,1.0,1.0,2/11,16.58%,HGF;BCAR1
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,-0.4165570958164929,-1.1351174265729855,0.19047619047619047,0.9288660223681383,1.0,34/125,14.81%,ADAMTS1;ADAMTS12;ST3GAL3;GALE;GPC6;GPC2;SDC3;DPM3;PAPSS2;ADAMTS8;GPC4;THSD7A;MUC19;AGRN;PMM2;ADAMTS3;ADAMTS10;CHSY1;VCAN;RFT1;ALG12;CHST6;PRELP;ADAMTS16;B3GAT3;ADAMTS6;DHDDS;SPON2;GALNT12;ALG11;CHST3;ADAMTS13;CSPG5;GPC1
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.5882849692343513,-1.1350267604647841,0.3170731707317073,0.9283547950534169,1.0,4/9,25.50%,AGO2;TERT;TARBP2;DROSHA
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.46427197548141896,-1.134971754341738,0.2857142857142857,0.9277122047371761,1.0,12/62,17.40%,NUP210;TRIM71;NUP42;POM121C;NUP214;AAAS;AGO2;POLR2F;NUP37;POLR2C;NUP98;TNRC6A
prerank,Reactome_2022__Fatty Acids Bound To GPR40 (FFAR1) Regulate Insulin Secretion R-HSA-434316,-0.6101432609259677,-1.1348893972460727,0.4,0.9271367802496937,1.0,4/7,26.41%,GNA14;GNA11;PLCB1;PLCB3
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.5123266616090211,1.1342177479744622,0.31343283582089554,1.0,1.0,7/51,16.50%,CHRNA9;MYO3B;GRXCR2;FSCN2;GRXCR1;TMC1;MSN
prerank,CellMarker_Augmented_2021__Ductal cell:Pancreas,0.4752443986840783,1.1342093766427217,0.27631578947368424,1.0,1.0,17/76,18.55%,CAPN13;TSPAN11;ACE2;CYYR1;FOXA3;MUC4;TMEM200C;CP;EPCAM;DNAI1;FBN3;RBP1;NOS2;SVOPL;FRZB;CHST9;SLC44A3
prerank,CellMarker_Augmented_2021__Dermal Papilla cell:Hair Follicle,0.4752443986840783,1.1342093766427217,0.27631578947368424,1.0,1.0,17/76,18.55%,CAPN13;TSPAN11;ACE2;CYYR1;FOXA3;MUC4;TMEM200C;CP;EPCAM;DNAI1;FBN3;RBP1;NOS2;SVOPL;FRZB;CHST9;SLC44A3
prerank,CellMarker_Augmented_2021__Early Hematopoietic cell:Blood,0.4752443986840783,1.1342093766427217,0.27631578947368424,1.0,1.0,17/76,18.55%,CAPN13;TSPAN11;ACE2;CYYR1;FOXA3;MUC4;TMEM200C;CP;EPCAM;DNAI1;FBN3;RBP1;NOS2;SVOPL;FRZB;CHST9;SLC44A3
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Pancreas,0.4752443986840783,1.1342093766427217,0.27631578947368424,1.0,1.0,17/76,18.55%,CAPN13;TSPAN11;ACE2;CYYR1;FOXA3;MUC4;TMEM200C;CP;EPCAM;DNAI1;FBN3;RBP1;NOS2;SVOPL;FRZB;CHST9;SLC44A3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Larynx,0.4752443986840783,1.1342093766427217,0.27631578947368424,1.0,1.0,17/76,18.55%,CAPN13;TSPAN11;ACE2;CYYR1;FOXA3;MUC4;TMEM200C;CP;EPCAM;DNAI1;FBN3;RBP1;NOS2;SVOPL;FRZB;CHST9;SLC44A3
prerank,CellMarker_Augmented_2021__Neural Stem cell:Bone Marrow,0.4752443986840783,1.1342093766427217,0.27631578947368424,1.0,1.0,17/76,18.55%,CAPN13;TSPAN11;ACE2;CYYR1;FOXA3;MUC4;TMEM200C;CP;EPCAM;DNAI1;FBN3;RBP1;NOS2;SVOPL;FRZB;CHST9;SLC44A3
prerank,CellMarker_Augmented_2021__Progenitor cell:Embryonic Stem Cell,0.4752443986840783,1.1342093766427217,0.27631578947368424,1.0,1.0,17/76,18.55%,CAPN13;TSPAN11;ACE2;CYYR1;FOXA3;MUC4;TMEM200C;CP;EPCAM;DNAI1;FBN3;RBP1;NOS2;SVOPL;FRZB;CHST9;SLC44A3
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5600494149415719,1.1341223095452178,0.2698412698412698,1.0,1.0,5/27,13.59%,ESR1;KANK2;ZNF366;VPS18;WBP2
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.48274376551660897,1.134069939219281,0.1951219512195122,1.0,1.0,10/75,14.62%,TULP1;ANXA1;BOK;SFTPD;SCIN;PON1;ACSL3;DAB2;SIRPG;CYBA
prerank,Reactome_2022__p38MAPK Events R-HSA-171007,0.6558871320427238,1.1337302803161535,0.31666666666666665,1.0,1.0,1/12,0.88%,MAPKAPK3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Germ,0.7481563747223567,1.1337112561879805,0.40384615384615385,1.0,1.0,4/6,16.35%,PTPRC;NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.5113501401404313,1.1336117188251802,0.23376623376623376,1.0,1.0,9/70,9.22%,GATA4;ACAA2;PELI3;MMP9;IGF1;HGF;DDX3X;PLAUR;PINK1
prerank,Reactome_2022__PTK6 Regulates Cell Cycle R-HSA-8849470,0.7628034659352381,1.133568646085695,0.34545454545454546,1.0,1.0,2/5,12.37%,CCND1;CDKN1B
prerank,Reactome_2022__Disinhibition Of SNARE Formation R-HSA-114516,-0.7499154674965192,-1.1335065908649546,0.4222222222222222,0.9306107716078812,1.0,1/5,16.62%,PRKCA
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.6057320638713926,1.1333234819996307,0.3088235294117647,1.0,1.0,1/13,4.41%,SHISA6
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.48252517792308725,1.1331024637195755,0.2597402597402597,1.0,1.0,28/104,22.50%,PANX3;SLC9A2;SLC12A7;SLC12A3;SLC17A8;SLC26A6;SLC4A1;ATP1A4;SLC15A1;PIEZO2;GLRA1;CHRNB1;SLC24A1;SLC25A18;P2RX1;PKD1L3;CHRNB2;CHRNA3;CTNS;SLC1A6;SLC26A4;SLC25A22;PLP2;AQP11;LRRC8A;SLC4A2;MCOLN1;SLC24A5
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.633126875475316,1.1330863371520747,0.22727272727272727,1.0,1.0,3/15,12.25%,PTPRC;HMGA2;EPCAM
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.6574415451226256,1.1329531331943956,0.3559322033898305,1.0,1.0,2/12,5.72%,SMAD6;MESP1
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,-0.525860526485129,-1.1328760138982128,0.3333333333333333,0.9318145140947129,1.0,20/51,24.67%,NUP210;NUP42;POM121C;NUP214;CDK1;AAAS;EMD;LMNB1;NUP37;PRKCA;NUP98;CTDNEP1;LPIN2;NEK9;VRK2;SEH1L;NUP50;TPR;NEK6;LPIN1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6660319050360286,1.132810460469405,0.2833333333333333,1.0,1.0,2/12,6.30%,RENBP;B4GALNT2
prerank,CellMarker_Augmented_2021__Bipolar cell:Eye,-0.4360643855689079,-1.1327476499183367,0.2,0.9312919688007192,1.0,14/94,11.63%,SYNJ2;SHC3;KIRREL3;PDE7B;CLIP3;LIX1L;SHANK1;FGF1;AFAP1;DCLK2;DOK6;BEND6;NECTIN3;MAP3K12
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),0.7233196181709647,1.1325106225231807,0.3181818181818182,1.0,1.0,2/6,13.90%,CD63;RAB38
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),0.7233196181709647,1.1325106225231807,0.3181818181818182,1.0,1.0,2/6,13.90%,CD63;RAB38
prerank,Reactome_2022__Butyrophilin (BTN) Family Interactions R-HSA-8851680,-0.6494862497873986,-1.132385147852029,0.2777777777777778,0.931373829519121,1.0,1/11,0.68%,BTN3A2
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.6468050131743487,1.132332840300427,0.3968253968253968,1.0,1.0,1/11,2.73%,GLRX
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.5089151509236036,-1.132312355884676,0.28,0.9307977350894143,1.0,1/15,2.40%,DCPS
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.7181195094742936,-1.132310005999367,0.2903225806451613,0.9300035390697134,1.0,1/6,4.95%,JADE2
prerank,GO_Biological_Process_2021__regulation of intestinal cholesterol absorption (GO:0030300),0.7454015766728395,1.1321808647398355,0.45,1.0,1.0,1/5,16.24%,ABCG5
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),-0.6817495961594505,-1.1320954684144013,0.3695652173913043,0.929933060291903,1.0,3/7,17.47%,MTHFR;CBS;MTR
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Limbal Epithelium,-0.5344273419577192,-1.1320667594063192,0.2608695652173913,0.9292065672045161,1.0,3/33,1.40%,ADGRF4;EHF;ANXA8
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.6440963958738872,1.131979619300561,0.36764705882352944,1.0,1.0,2/13,5.31%,CCL5;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),-0.7004822294808994,-1.1319174514929762,0.35294117647058826,0.9289511401415464,1.0,2/9,9.06%,RALB;LRSAM1
prerank,Reactome_2022__Response To Metal Ions R-HSA-5660526,-0.6341208259320062,-1.1318781755368577,0.32432432432432434,0.9283031363778343,1.0,2/9,7.90%,MT1G;SNCB
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.5593618877532618,1.1317077175864816,0.273972602739726,1.0,1.0,6/34,6.91%,ACOX2;GPR151;WNT5A;IER5;CD80;CDKN2A
prerank,Reactome_2022__Interleukin-35 Signaling R-HSA-8984722,0.6508719557077007,1.131690655949798,0.36065573770491804,1.0,1.0,2/12,11.19%,IL12A;STAT1
prerank,Reactome_2022__ROBO Receptors Bind AKAP5 R-HSA-9010642,-0.637741336367948,-1.1316867034069844,0.37209302325581395,0.9283434188098536,1.0,3/7,18.74%,PRKCA;PRKAR2A;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.6788107149182082,1.131546492462013,0.3220338983050847,1.0,1.0,1/7,9.64%,TRDN
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.6102968082182889,1.1315422294291981,0.32,1.0,1.0,1/19,1.05%,BACE2
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,0.6047561779262345,1.1314807193803351,0.29411764705882354,1.0,1.0,2/14,15.84%,RPS27A;NDUFA2
prerank,CellMarker_Augmented_2021__PROCR+ Progenitor cell:Small Intestine,0.6075842462670896,1.1313474056453494,0.2676056338028169,1.0,1.0,3/18,11.05%,ITM2A;PLAC9;PI15
prerank,CellMarker_Augmented_2021__Neuron:Embryonic Prefrontal Cortex,-0.617533941441132,-1.1312425792379757,0.3333333333333333,0.9291029299072663,1.0,3/11,12.47%,ARX;NEUROD6;NEUROD2
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.6124848694538108,1.1308325943802195,0.3055555555555556,1.0,1.0,4/16,11.63%,TNFRSF1B;HLA-F;HLA-A;TNFSF4
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.6791264296795854,1.1307130854223413,0.3582089552238806,1.0,1.0,3/9,8.20%,ABCC6;ABCC2;ABCC11
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.6786331778524554,-1.1306855158599902,0.29545454545454547,0.9303076096603935,1.0,2/6,9.85%,SEPTIN9;CEP135
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.6149694806780557,1.130639424475064,0.32432432432432434,1.0,1.0,1/18,2.62%,SP100
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5834543608520251,1.1304502907036071,0.3548387096774194,1.0,1.0,2/18,2.11%,TIMP3;TNFRSF1B
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.7252082831274499,1.1302940745188466,0.41935483870967744,1.0,1.0,3/6,15.97%,CCL5;GPR183;PIK3CG
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),-0.7241773069216686,-1.130234676218567,0.30952380952380953,0.9307812897060453,1.0,2/7,21.00%,GNAS;GNG2
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,0.5290969958671418,1.1301224524701616,0.2857142857142857,1.0,1.0,7/47,20.47%,PSMB9;RPS27A;PSMC5;RBX1;PSMA3;PSMB6;PSMD6
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.4090873280740302,-1.1300566293641736,0.1111111111111111,0.9306127929909245,1.0,26/149,9.32%,SPRY4;KCNIP3;PRDM5;MYO10;TEAD2;DPPA2;COL4A2;PIWIL2;RAI14;KIT;DSG2;RND3;HES1;ERBB2;KITLG;ITGA4;PARD3;PTPRF;FZD7;MID1;FSTL1;FBXO15;TEAD4;NACC1;DCBLD2;ADGRA3
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,0.6070500953477622,1.1298928640035264,0.29850746268656714,1.0,1.0,6/18,18.71%,CASP7;UACA;CDKN2A;GSDME;MAPK3;APAF1
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Peripheral Blood,0.703701603948999,1.129860120972746,0.375,1.0,1.0,4/6,18.03%,PTPRC;FCGR3A;KLRB1;CD8B
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),0.7583138220634212,1.1297276938827832,0.3333333333333333,1.0,1.0,1/5,7.24%,NR1H4
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.701777283835672,-1.1295525927202454,0.358974358974359,0.9314438447987823,1.0,1/5,4.06%,EXOC7
prerank,CellMarker_Augmented_2021__CD4-CD28- T cell:Peripheral Blood,0.6793353761691487,1.1293906904484488,0.36065573770491804,1.0,1.0,2/7,3.81%,ITGB2;PTPRC
prerank,CellMarker_Augmented_2021__CD4-CD28+ T cell:Peripheral Blood,0.6793353761691487,1.1293906904484488,0.36065573770491804,1.0,1.0,2/7,3.81%,ITGB2;PTPRC
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.48010657310884497,1.1293239528175623,0.30864197530864196,1.0,1.0,25/131,12.87%,OLFML1;ESR1;LRP4;C1QTNF1;TIMP3;PRRX1;LMOD1;LOX;TNFRSF10A;ITGA2;WNT5A;PCDH18;GPER1;ITGA5;ANGPTL2;ACTA2;OSMR;ADGRL4;CALB1;COL6A2;DCN;COL1A1;PENK;HMCN1;SFRP4
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),-0.7262883857212663,-1.1291791333635135,0.4166666666666667,0.9311065860561292,1.0,1/5,5.18%,PDZD7
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),-0.7262883857212663,-1.1291791333635135,0.4166666666666667,0.9311065860561292,1.0,1/5,5.18%,PDZD7
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.5353482476105912,-1.1289761405094145,0.22580645161290322,0.9301859187583938,1.0,2/19,8.91%,BCKDK;ECHS1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.5353482476105912,-1.1289761405094145,0.22580645161290322,0.9301859187583938,1.0,2/19,8.91%,BCKDK;ECHS1
prerank,CellMarker_Augmented_2021__Endothelial cell:Intervertebral Disc,0.5154256203284682,1.128943217651481,0.3055555555555556,1.0,1.0,16/62,11.38%,C1QB;LYVE1;CYYR1;FLT1;FCGR3A;VSIG4;MYH11;GPIHBP1;FGL2;GGT5;RAMP3;ADGRL4;ZNF366;VWF;DCN;CLDN5
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.6622954479789069,1.1285903540169873,0.36363636363636365,1.0,1.0,1/12,6.63%,SLC6A4
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,0.6172624642927846,1.128482723581357,0.288135593220339,1.0,1.0,4/16,15.19%,STAT5A;SOCS2;STAT1;MAPK3
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),-0.6986163542811181,-1.1281448486230379,0.43243243243243246,0.9324415160427376,1.0,1/7,0.95%,IL11
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.5754705864311014,1.1279957541964354,0.34782608695652173,1.0,1.0,4/18,6.35%,BLK;C1QTNF1;ALOX12;SYK
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.6775228983467049,1.1279381152026864,0.3492063492063492,1.0,1.0,1/9,3.45%,TICRR
prerank,CellMarker_Augmented_2021__Neural Tube cell:Germ,0.718897551744209,1.1275446241436327,0.3125,1.0,1.0,2/9,6.03%,ABCG2;CD81
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.497353414029168,1.1275257722689318,0.2597402597402597,1.0,1.0,9/69,11.63%,TNFRSF1B;CCL5;TGFB1;WNT5A;CD80;AXL;HCK;PDCD1LG2;TNFSF4
prerank,Reactome_2022__RHOT1 GTPase Cycle R-HSA-9013425,-0.7110617791897089,-1.1274399342515176,0.375,0.9339152334424295,1.0,3/5,28.17%,MYO19;TRAK2;TRAK1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.6263975396808956,1.1274265620021404,0.3548387096774194,1.0,1.0,3/12,8.60%,ACTG1;WAS;FHOD1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.677641723791578,-1.1273952614097262,0.4186046511627907,0.933237746808892,1.0,1/7,2.54%,CCDC22
prerank,CellMarker_Augmented_2021__Amacrine cell:Eye,-0.4449771353961066,-1.1272984976724045,0.2,0.9327340154485758,1.0,11/77,14.35%,TACR3;XKR7;GRID2;CACNG4;CRABP1;PRR36;PCP4;MSI1;BRINP1;RCOR2;CHST8
prerank,CellMarker_Augmented_2021__FOXN4+ cell:Lung,0.4991227417121696,1.127279399645361,0.2465753424657534,1.0,1.0,5/66,11.52%,NEK2;ACTL6A;CDKN2A;CARHSP1;USP13
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),-0.7231485361476199,-1.1271940937594545,0.3181818181818182,0.9322203505031242,1.0,3/6,13.63%,RNF113A;SLIT3;SLIT2
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),-0.6845176969077842,-1.127143346973052,0.4375,0.9315675317119302,1.0,2/5,20.60%,DCP1B;DCP1A
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.47688069373018416,-1.1271048221972704,0.14814814814814814,0.930948091567368,1.0,11/33,22.18%,RHEX;STAT5B;ETS1;LDB1;ZNF16;CDK6;MAFB;MED1;ABCB10;HSPA1A;ANKRD54
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Lymphoid Tissue,0.5243354448011007,1.1269964726814348,0.3466666666666667,1.0,1.0,20/55,16.42%,CYTIP;GMFG;SASH3;PTPRC;PTAFR;LMO2;CLEC12A;WAS;SYK;NAPSB;HCK;IKZF1;TAGAP;CD37;P2RX1;CD300LF;PIK3R6;FERMT3;PIK3CG;CD244
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.7004327271228747,1.1269457698694616,0.4153846153846154,1.0,1.0,2/8,2.83%,TBX1;LRP2
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),-0.6932741621922942,-1.1268637609036531,0.3409090909090909,0.931028594848577,1.0,3/6,21.32%,CCN3;SLIT2;GREM1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),0.7225502443929777,1.1268419348353318,0.39655172413793105,1.0,1.0,1/6,11.63%,TNFSF4
prerank,KEGG_2021_Human__Insulin signaling pathway,-0.404519922076777,-1.1267313940338117,0.21052631578947367,0.9306469972100556,1.0,12/119,6.41%,GCK;FBP2;G6PC3;PPP1R3E;SHC3;FOXO1;SH2B2;SHC4;EXOC7;EIF4EBP1;GYS1;PTPRF
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.5635342001826478,1.1264513922278794,0.32,1.0,1.0,7/32,15.21%,AMBP;PINK1;DNAJA1;MARVELD3;F2RL1;NPPA;CYLD
prerank,KEGG_2021_Human__Calcium signaling pathway,-0.3968365584093407,-1.1261607154737767,0.23529411764705882,0.9315004956385827,1.0,29/199,11.89%,CD38;TACR3;NGF;CAMK1G;ADRA1A;ADRA1B;PDGFD;HRH2;ITPR2;HRH1;FGF18;MCOLN3;TNNC2;ERBB2;MCOLN2;FGF1;SLC8A3;NTRK1;CCKBR;GNAS;GNA14;MYLK3;GNA11;ITPKA;ADCY3;GRIN1;ADCY2;EDNRA;HTR2C
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5308145566898935,1.1261001602664285,0.32432432432432434,1.0,1.0,10/43,20.84%,CASQ2;ACE2;NPR2;ATP1A4;TRDN;AGT;NPPA;ATP2A2;KCNJ11;RYR3
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),-0.7247046280533305,-1.1259991253474702,0.3953488372093023,0.9312263958452187,1.0,3/5,24.64%,NR1H2;ABCB4;ABCA13
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.6328784203003951,1.1259413490885106,0.37142857142857144,1.0,1.0,1/15,0.84%,SGO1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.4618667198425353,1.1258602879001276,0.23529411764705882,1.0,1.0,59/160,25.85%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;EXOSC8;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPL13;RPS12;RPS4X;RPL27A;RPS19;RPS21;EXOSC4;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RPLP2;RPL7;RPL38;PNLDC1;RPS15A;RPSA;RPLP0;RPS6;RPL35;CSDE1;CNOT8;RPL27;RPS14;RPL7A;RPL24;RPL23;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS18;PAN2;RPS24;NCBP1;RPL10;RPS29;RPLP1;RPS28
prerank,Reactome_2022__Gastrulation R-HSA-9758941,0.6858780091553252,1.1256795505005424,0.40625,1.0,1.0,2/11,7.67%,TCF7;LEF1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.7020017151983757,1.1256054924248045,0.3220338983050847,1.0,1.0,3/9,16.48%,C15ORF62;F2RL1;WASHC1
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.7020017151983757,1.1256054924248045,0.3220338983050847,1.0,1.0,3/9,16.48%,C15ORF62;F2RL1;WASHC1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.7096799853600095,1.1255873375332928,0.3392857142857143,1.0,1.0,1/6,3.49%,STOML2
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.46149033778286447,1.125526863634356,0.23529411764705882,1.0,1.0,49/237,17.10%,ENPP2;ITGAX;PIK3R3;CCL5;PTPRC;VSIR;FLT1;TGFB1;SYNE2;SEMA3A;ACTG1;GPER1;SMIM22;MMP9;IGF1;LEF1;HSPA5;HGF;TCAF2;SOD2;F7;LAMC2;PLAU;VIL1;RAB11A;VTN;COL1A1;DAB2;F2RL1;SEMA3F;DOCK5;ANGPTL3;THBS1;CSF1R;SOX9;SNAI1;SEMA3B;IL4;CARMIL1;DDR2;EPHA1;CXCL12;WNT5B;FERMT3;CSF1;WASHC1;BCAR1;HYAL1;FBXO5
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.6630790710304952,-1.1253572000572354,0.35555555555555557,0.9324852126242801,1.0,3/5,26.56%,MIA3;ADTRP;AKT1
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,0.5460806161997794,1.1252834643333383,0.34328358208955223,1.0,1.0,7/39,9.76%,ACOX2;HSD3B7;SLC10A1;SLCO1A2;SLC51A;NR1H4;CYP39A1
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.6413040351724433,1.1251162469483633,0.4107142857142857,1.0,1.0,2/9,6.35%,STAT5A;SYK
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.6413040351724433,1.1251162469483633,0.4107142857142857,1.0,1.0,2/9,6.35%,STAT5A;SYK
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.6053875844705986,1.1250872516496997,0.2898550724637681,1.0,1.0,2/21,6.91%,CDC25A;CDKN2A
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),0.4830430392472203,1.1250408923496653,0.22666666666666666,1.0,1.0,4/78,5.59%,NLRP4;UBE2L6;RNF26;TRIM25
prerank,Reactome_2022__Cytosolic tRNA Aminoacylation R-HSA-379716,-0.5764913477155249,-1.1249144788057102,0.2857142857142857,0.9332279668185568,1.0,12/23,32.45%,VARS1;CARS1;MARS1;FARSA;YARS1;EPRS1;KARS1;RARS1;SARS1;FARSB;IARS1;QARS1
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.6525936804982084,-1.1248786048126158,0.34375,0.9325465645658328,1.0,2/6,24.09%,INO80;DBF4B
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),-0.6888942936485527,-1.1248503401547718,0.32558139534883723,0.9318128484008874,1.0,1/6,1.12%,METRNL
prerank,Reactome_2022__SMAD2/3 Phosphorylation Motif Mutants In Cancer R-HSA-3304356,0.782437103068349,1.1248375727791924,0.37037037037037035,1.0,1.0,1/6,4.27%,TGFB1
prerank,Reactome_2022__Loss Of Function Of TGFBR1 In Cancer R-HSA-3656534,0.782437103068349,1.1248375727791924,0.37037037037037035,1.0,1.0,1/6,4.27%,TGFB1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),0.7074065630246347,1.1246060748800752,0.3958333333333333,1.0,1.0,3/7,16.30%,PINK1;DNAJA1;ATP5IF1
prerank,KEGG_2021_Human__Prion disease,0.47325025055766123,1.1246053646500445,0.21839080459770116,1.0,1.0,57/212,25.56%,COX6A1;SLC25A31;C1QB;HSPA1L;HSPA8;PIK3R3;CCL5;CAV3;ATP5PF;NDUFB11;HSPA5;GRIN2D;NDUFS2;COX7A2;ATP5F1E;PSMC5;CYBA;TUBA4A;TUBA3D;TUBB6;MAPK3;NDUFB10;NDUFA2;ATP5MC3;COX4I1;TUBA1C;HSPA2;C6;APAF1;PSMA3;COX7B;PSMB6;NDUFB9;CREB3;COX6C;GRIN2C;COX6B1;NDUFB4;PSMD6;RYR3;UQCRFS1;GRIN3B;TUBB4B;DDIT3;NDUFA1;ATF2;COX7A1;NDUFB2;COX5A;COX7C;PIK3CB;PSMA7;CAV2;VDAC1;NCF2;KLC2;PSMB1
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.4522112432493414,-1.1243629889607052,0.2,0.932789286521293,1.0,19/115,15.97%,PLK3;STX6;COG4;MYO18A;GOLGA8A;TICAM2;UBXN2A;TMED4;TRAPPC12;GBF1;FAM174B;CDK1;ZNF501;STX5;GOLGA8B;BLZF1;COG7;DNAJC28;TRAPPC11
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.41661204782918404,-1.124324897427668,0.15384615384615385,0.9321526360038324,1.0,5/86,7.60%,NOX4;ETV5;FOXO1;GSR;PKD2
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,0.5710499557580135,1.1242137128465313,0.3150684931506849,1.0,1.0,9/34,17.83%,LOX;TGFB1;ITGB6;ITGA5;TGFB3;VTN;FBN2;FBN3;ITGB8
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.6384757152165883,1.1241593442782514,0.379746835443038,1.0,1.0,3/16,4.27%,TNFRSF1B;CLCF1;TGFB1
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),0.7149416088049609,1.124012122723976,0.3684210526315789,1.0,1.0,2/5,25.18%,CYBA;GRN
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.49032841060053645,-1.1238482085987247,0.24242424242424243,0.9329778866321474,1.0,9/21,17.13%,PNP;PRPSAP1;NT5C1A;NT5C;GPX1;DNPH1;GART;FHIT;ITPA
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.45349429791970386,1.123838282143538,0.25,1.0,1.0,31/229,20.81%,CDC25A;ESR1;ACTL6A;PSMB9;USP50;USP6;JOSD2;RPS27A;USP13;OTUD4;TFPT;CCNA2;USP18;TOMM20;PSMC5;YOD1;CYLD;TAF10;COPS5;BRCA1;SPATA2;TAF9B;HCFC1;NFKBIA;PSMA3;USP17L2;PSMB6;OTUD1;ATXN7L3;PSMD6;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.7178921350494781,1.1238142934725284,0.36666666666666664,1.0,1.0,3/5,27.94%,MAPK3;RPS6KA5;CDK9
prerank,Reactome_2022__Fibronectin Matrix Formation R-HSA-1566977,0.7925842127005838,1.1236538192089522,0.32142857142857145,1.0,1.0,4/5,20.39%,ITGA5;CEACAM8;CEACAM1;FN1
prerank,CellMarker_Augmented_2021__Exhausted T cell:Undefined,0.6518586622107224,1.1236253576204878,0.375,1.0,1.0,4/8,17.06%,CD160;CD4;CD244;TIGIT
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,0.5084694758043669,1.1235492139478158,0.2597402597402597,1.0,1.0,9/53,21.18%,PSMB9;FKBPL;RPS27A;CDKN1A;PSMC5;PSMA3;PSMB6;PSMD6;CCNB1
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.700006642419254,-1.1234940410133576,0.48484848484848486,0.9332370926796012,1.0,1/6,1.86%,BCL6
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.6569245595190127,-1.1232669550148908,0.3142857142857143,0.9333574785561498,1.0,1/7,1.58%,SLC38A5
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.6676004568102345,-1.1231369508667284,0.32432432432432434,0.9330415648146081,1.0,1/7,7.56%,HSPB1
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,0.5131482346901256,1.1230924954163917,0.32051282051282054,1.0,1.0,24/94,18.00%,ITGB2;CLDN2;CLDN6;PIK3R3;CLDN18;CD99L2;ITGAM;ACTG1;JAM2;MMP9;VASP;CD99;CLDN5;MYL12A;CTNNA3;CLDN9;ITK;CYBA;CXCL12;MYL9;MSN;BCAR1;VAV3;CLDN14
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",0.721891238827533,1.1230555698872449,0.4444444444444444,1.0,1.0,2/6,7.33%,ARHGAP24;ITGA5
prerank,CellMarker_Augmented_2021__Common Myeloid progenitor:Undefined,-0.700580944768884,-1.1229730156839663,0.32432432432432434,0.9328111963780465,1.0,1/6,0.22%,CD38
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.768548856468551,1.1227390135609008,0.3508771929824561,1.0,1.0,2/5,11.98%,NPR2;CD4
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.768548856468551,1.1227390135609008,0.3508771929824561,1.0,1.0,2/5,11.98%,NPR2;CD4
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.6372502015324222,1.1222116823946546,0.3387096774193548,1.0,1.0,3/11,14.49%,LCP1;FHOD1;CARMIL1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.6870966924987311,-1.1217260535652263,0.43243243243243246,0.9361385717077764,1.0,4/6,29.16%,ATP9A;EIPR1;PRKN;ARFIP1
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.5880110512742802,1.1216772138432949,0.29850746268656714,1.0,1.0,5/20,17.10%,BUB1;TEX14;TTK;BUB1B;FBXO5
prerank,Reactome_2022__Phase 4 - Resting Membrane Potential R-HSA-5576886,-0.5666473464068377,-1.121611052885004,0.34375,0.9357044304119287,1.0,1/14,0.63%,KCNK6
prerank,Reactome_2022__RHO GTPases Activate Rhotekin And Rhophilins R-HSA-5666185,0.6912212994413746,1.1215544290071051,0.38596491228070173,1.0,1.0,2/7,12.17%,RHOB;RTKN
prerank,CellMarker_Augmented_2021__Amniotic Fluid Stem cell:Amniotic Fluid,0.497695106742994,1.121489232461856,0.24358974358974358,1.0,1.0,27/87,16.38%,PRRX1;LPAR1;ARHGAP31;ANXA1;MMP19;ITGBL1;NT5E;AXL;OSMR;HEG1;PDCD1LG2;ADGRL4;PLAU;COL6A2;PLAC9;DCN;DAB2;THBS1;PLAT;IGFBP6;CD44;TGFBI;MYL9;EHD2;CYBRD1;ENG;CSF1
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone,0.497695106742994,1.121489232461856,0.24358974358974358,1.0,1.0,27/87,16.38%,PRRX1;LPAR1;ARHGAP31;ANXA1;MMP19;ITGBL1;NT5E;AXL;OSMR;HEG1;PDCD1LG2;ADGRL4;PLAU;COL6A2;PLAC9;DCN;DAB2;THBS1;PLAT;IGFBP6;CD44;TGFBI;MYL9;EHD2;CYBRD1;ENG;CSF1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovial Fluid,0.497695106742994,1.121489232461856,0.24358974358974358,1.0,1.0,27/87,16.38%,PRRX1;LPAR1;ARHGAP31;ANXA1;MMP19;ITGBL1;NT5E;AXL;OSMR;HEG1;PDCD1LG2;ADGRL4;PLAU;COL6A2;PLAC9;DCN;DAB2;THBS1;PLAT;IGFBP6;CD44;TGFBI;MYL9;EHD2;CYBRD1;ENG;CSF1
prerank,Reactome_2022__Nucleotide-like (Purinergic) Receptors R-HSA-418038,-0.6330345136093966,-1.1214763160880452,0.2647058823529412,0.9353876221229969,1.0,1/9,0.17%,P2RY10
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.6679158046919864,1.1213670640099989,0.3728813559322034,1.0,1.0,1/13,2.62%,SP100
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.55296850774043,-1.1213540666273434,0.32432432432432434,0.9350713366200201,1.0,1/15,0.59%,MFSD2A
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.410010704662669,-1.1213396792400379,0.23529411764705882,0.9343216296032133,1.0,13/83,12.83%,TBC1D10A;STX6;RAB7B;SNX8;RAB7A;GBF1;SNX32;SNX5;STX5;WASHC2C;EHD3;UBE2O;DENND2A
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,-0.5174002060399691,-1.1212986536970821,0.28125,0.9336789102636716,1.0,8/22,18.42%,KDM7A;KDM3B;KDM2B;PHF2;KDM4D;KDM1B;KDM4B;KDM2A
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.7293204567713601,1.121156936984916,0.4189189189189189,1.0,1.0,1/6,2.20%,FBXL7
prerank,CellMarker_Augmented_2021__Stem cell:Undefined,-0.6456268389941601,-1.1207460313963293,0.3958333333333333,0.9347595971341633,1.0,2/9,4.40%,KIT;LGR5
prerank,KEGG_2021_Human__Systemic lupus erythematosus,0.5343517835309665,1.1207110894159447,0.29577464788732394,1.0,1.0,11/49,14.56%,C1QB;C3;FCGR3A;H2BC4;CD80;H4C8;H2AZ1;HLA-DMA;HLA-DPB1;ELANE;H2BC18
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.4284007282126249,-1.1207004560447003,0.24,0.9341281325921255,1.0,19/82,17.80%,TRIB2;UBASH3B;SPRED1;PTPRO;PTPRB;CEP85;SLC8A3;HSPB1;CAMK2N1;TRIB1;DUSP19;DAB2IP;CHP1;DEPTOR;PRKRIP1;GADD45A;PPIA;ABL1;NF1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.6635539027208064,-1.1206754046292033,0.34,0.9326258820360217,1.0,5/6,31.61%,DPH1;DPH5;DPH6;DPH2;DPH7
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.6635539027208064,-1.1206754046292033,0.34,0.9326258820360217,1.0,5/6,31.61%,DPH1;DPH5;DPH6;DPH2;DPH7
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),-0.6744971050710551,-1.120627547186451,0.46875,0.9319766581695305,1.0,4/6,25.90%,FSTL1;CHRDL1;GREM1;GREM2
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.506776727557834,1.1205966447574032,0.3,1.0,1.0,11/44,16.35%,TGFB1;HEY2;WNT5A;LEF1;HGF;RANBP3L;HMGA2;SOX9;SNAI1;HTR2B;ENG
prerank,Reactome_2022__Defensins R-HSA-1461973,0.701481989103661,1.120421009612127,0.40540540540540543,1.0,1.0,4/8,16.88%,TLR2;CD4;DEFB109B;DEFB135
prerank,Reactome_2022__GRB2 Events In EGFR Signaling R-HSA-179812,-0.6202158293107971,-1.1203831123813313,0.38461538461538464,0.9320125097274768,1.0,3/8,19.41%,TGFA;HRAS;BTC
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.5992179057202265,-1.1203742175726312,0.34210526315789475,0.9305186390796821,1.0,1/15,0.83%,MLPH
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.5992179057202265,-1.1203742175726312,0.34210526315789475,0.9305186390796821,1.0,1/15,0.83%,MLPH
prerank,CellMarker_Augmented_2021__Microglial cell:Embryonic Prefrontal Cortex,0.4519294947392506,1.120360347608282,0.2,1.0,1.0,82/410,16.85%,C1QB;ITGB2;ADAM28;BLNK;C3AR1;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SP100;SASH3;CRYBB1;SLC7A7;C3;PTPRC;PTAFR;ITGAM;TFEC;SYNE2;ABCG2;FCGR3A;VSIG4;FLI1;CPED1;WAS;DNAJB1;PLD4;CD81;SYK;CPVL;IGF1;AXL;CCND1;POLD4;LCP1;HCK;TSC22D3;CSF3R;PSAP;RAPGEF6;P2RY12;RHOB;TMC6;HPGDS;PPT1;DHRS3;IKZF1;TAGAP;B3GNT5;LPAR6;CD37;DAB2;PLA2G7;IGSF6;MYL12A;TM6SF1;CD4;GPR183;ALOX5AP;PDK4;CD63;MYO1F;LAMP2;CSF1R;PNMA1;FPR1;RHOG;ITM2C;EVI2A;BEX1;PARVG;TGOLN2;CYBA;SLCO2B1;STOM;RGS10;MSN;RBP1;IER2;MAF;A2M;GLUL
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.6188307682834533,1.1203276699704103,0.35294117647058826,1.0,1.0,2/14,4.27%,CLCF1;TGFB1
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.6856556279794173,-1.120267334342869,0.35135135135135137,0.9300727128649803,1.0,2/9,13.06%,DDX11;SPIDR
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.5616180892331571,1.1202500859191775,0.29411764705882354,1.0,1.0,5/35,16.07%,NEK2;RPS27A;CDC14A;ANLN;BUB1B
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.666832061994619,1.1202447530750927,0.359375,1.0,1.0,3/11,9.05%,ST18;MMP9;PLAUR
prerank,CellMarker_Augmented_2021__Lymphocyte:Blood,0.5060202995785116,1.1201996745727034,0.29069767441860467,1.0,1.0,14/58,15.08%,OSCAR;C3AR1;TLR2;FCGR3A;CLEC12A;FGL2;NLRC4;HCK;HK3;ALOX5AP;CSF1R;FPR1;ADGRE3;CD300LF
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,-0.5021642716291476,-1.1199797281661985,0.32142857142857145,0.9302253802136585,1.0,6/35,6.46%,TPM4;SH3RF1;VANGL1;DLG5;TPM3;GIT2
prerank,CellMarker_Augmented_2021__Monocyte:Fetal Kidney,0.43585884991000245,1.1194640534480713,0.17525773195876287,1.0,1.0,129/646,19.39%,CLIC1;RASGRP4;C19ORF38;ITGB2;MAPKAPK3;CLEC5A;OSCAR;STEAP4;C3AR1;CYTIP;PRRX1;TLR2;TNFRSF1B;ITGAX;GMFG;CSF2RA;LILRB3;ANXA1;PTX3;GLRX;AHR;SLC7A7;PTPRC;PTAFR;ITGAM;RGL4;NFAM1;NLRP12;FCGR3A;SCIMP;ADGRE1;FCAR;CLEC12A;FGL2;TRIM25;WAS;PLD4;ANPEP;VASP;CPVL;NLRC4;LCP1;DDX3X;GRINA;CYP1B1;HCK;TSC22D3;TP53BP2;HLA-A;PLAUR;SOD2;CSF3R;PSAP;HLA-DMA;CD302;DNAJA1;ACSL3;CFD;PPT1;NOP10;LRPAP1;CHCHD7;HK3;CD37;IGSF6;OGFRL1;CD4;RBP7;ASGR2;TMEM258;COX17;BTG1;ALOX5AP;PSTPIP1;CDKN1A;TALDO1;CD63;PYGL;DOCK5;MYO1F;PGAM1;THBS1;LAMP2;PNRC1;FPR1;CCNI;EVI2A;P2RX1;S100Z;PARVG;OLIG2;CYBA;CD44;UPK3A;ADGRE3;CD300LF;TGFBI;NDUFA2;BASP1;RGS10;MSN;TAF13;IER2;GLUL;ASGR1;SLC16A3;FKBP8;TOMM7;SERPINB1;EIF1B;ATP6V0B;GAS7;ATOX1;PADI2;GABARAPL2;UBL7;RSL24D1;FBP1;HVCN1;ATP6AP2;NFKBIA;RAE1;DOCK2;TACC3;SRSF5;COX7B;RIN3;PTP4A2;DSE
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.6012139618278823,-1.1194210964455205,0.4186046511627907,0.9313734264308128,1.0,2/11,4.78%,PC;APOE
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,0.5154962725976568,1.1193785719759708,0.26666666666666666,1.0,1.0,7/49,20.47%,PSMB9;RPS27A;PSMC5;RBX1;PSMA3;PSMB6;PSMD6
prerank,CellMarker_Augmented_2021__Liver Bud Hepatic cell:Liver,0.46132089295651646,1.1192331157748356,0.25,1.0,1.0,46/162,20.86%,AMBP;LECT2;APOL1;PRG4;ITIH2;RRAD;CASP7;CPM;P2RY6;NR1H4;CYP2J2;HPD;CPB2;OSMR;ABHD14B;SOD2;RHOB;PTRH1;ECT2;TGM2;CARHSP1;KLHL2;SDSL;PON3;FILIP1L;MASP2;TUBA4A;FTH1;RHOQ;IFI6;TGFBI;MT1M;FKBP5;SLC38A2;FKBP4;RBP1;TMEM109;GBP1;CHCHD2;SERPINF1;IL1R1;PLP2;SF3B5;TNFSF14;POLE3;GMNN
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),0.5460963938455344,1.119160167504613,0.28169014084507044,1.0,1.0,10/28,23.81%,ART1;ZC3HAV1;ART3;PARP14;PARP4;ART4;PARP15;PARP9;PARP10;PARP8
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.6695342756226124,-1.1191342638055792,0.38461538461538464,0.9314724250508236,1.0,2/6,10.86%,ERCC8;ZBTB7A
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,0.5332504790217931,1.1190860962118787,0.3013698630136986,1.0,1.0,7/47,20.47%,PSMB9;RPS27A;PSMC5;FBXO5;PSMA3;PSMB6;PSMD6
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.47352128665890664,1.1190179830575457,0.30864197530864196,1.0,1.0,16/112,9.86%,TMEM213;MACC1;IYD;ACE2;CYP3A5;NPHS2;SLC12A3;SLC22A8;ITGB6;SCIN;MUC4;EMX1;ATP10B;SLC22A6;EPB41L4A;CALB1
prerank,CellMarker_Augmented_2021__Eosinophil:Peripheral Blood,0.6681040717241955,1.1189297259604027,0.3972602739726027,1.0,1.0,7/10,15.41%,ITGAX;ITGAM;FCGR3A;CEACAM8;IL5;IL4;IL3RA
prerank,GO_Biological_Process_2021__metanephric nephron tubule morphogenesis (GO:0072282),0.7634699071285296,1.1188917725998928,0.34545454545454546,1.0,1.0,1/5,13.99%,SOX9
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.37641083510104983,-1.1184605579878553,0.2,0.9330151857277665,1.0,41/234,17.97%,CPSF1;DDX41;HNRNPL;RNF113A;TXNL4A;CWF19L1;MAGOHB;PDCD7;LSM7;SRRM1;DHX8;SUGP1;SRSF4;GPATCH1;SNRPB;HNRNPF;DDX46;SMU1;SF3A2;SYMPK;U2AF2;CSTF2;NOVA1;PTBP1;GEMIN5;CPSF7;POLR2F;RBMX2;ZMAT5;GPKOW;SNRPN;POLR2C;IK;SNIP1;RALY;RBM41;HNRNPUL1;RNPC3;RBMX;PCF11;CPSF4
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.45491752575158256,1.1184537706690851,0.21428571428571427,1.0,1.0,15/192,7.33%,ITGB2;LPAR1;RRAS;ITGAX;PIK3R3;FGF20;FGF2;GNG12;ITGAM;ITGA2;MYH11;ITGB6;ACTG1;SCIN;ITGA5
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.6379801086750495,-1.1183681694150833,0.375,0.932631770311212,1.0,2/8,8.48%,NOD1;RIPK2
prerank,CellMarker_Augmented_2021__Unrestricted Somatic Stem cell:Embryo,0.6942645120762427,1.118333886440693,0.32727272727272727,1.0,1.0,2/6,16.35%,PTPRC;ENG
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Adipose Tissue,0.4980488554161323,1.1182544184909118,0.2727272727272727,1.0,1.0,15/68,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;FLT1;VSIG4;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;ZNF366;VWF;DCN;CLDN5
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lymphoid Tissue,-0.48941167105375244,-1.118185490142127,0.3,0.9323429945157989,1.0,4/29,7.39%,P2RY10;SKAP1;CD247;SELL
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.48784670039587785,1.1180792118371174,0.2875,1.0,1.0,17/110,21.35%,PSMB9;MCM2;MCM3;RPA3;GRWD1;NAP1L2;RPS27A;SOX9;PSMC5;H2BC18;ORC4;RBX1;PSMA3;PSMB6;PSMD6;GMNN;DMC1
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.36917710676007903,-1.1179508260375421,0.16666666666666666,0.9324721960018951,1.0,33/381,7.61%,NOX4;SPRED3;NR4A1;SPRED2;DUSP6;SPRED1;WNT3A;CSK;TPM4;AGTRAP;HDAC7;BCL2A1;HDAC10;FOXO1;KIT;TENT4A;MAML1;KIAA1549;ESRP1;FGF18;GATD3;MYO18A;ERBB2;KITLG;HHAT;TPM3;KDM7A;FGF1;STAT5B;TGFA;PPP2R5D;LRRFIP1;JAG2
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.7253395827915144,1.1179286064872553,0.390625,1.0,1.0,1/7,2.57%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),-0.6684481778235596,-1.117765943164881,0.38461538461538464,0.9323195987929291,1.0,4/6,30.60%,CEP250;MARK4;PARD6A;BICD1
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.5661360094914684,-1.117534941084717,0.2894736842105263,0.9323235605398621,1.0,5/13,14.07%,TWIST1;SLC30A10;RBL1;TERT;CDK6
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,0.5797725819717684,1.1175115086844285,0.34782608695652173,1.0,1.0,3/27,6.80%,ESR1;STAT5A;ERBB4
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.5896987985587157,1.1174522254708463,0.2982456140350877,1.0,1.0,10/25,24.51%,CASQ2;MYBPC3;CSRP3;SCN5A;MYH7;SCN4B;KCNQ1;GAA;TCAP;SCN1B
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.5911248149755419,1.1174426109105604,0.3380281690140845,1.0,1.0,3/30,12.77%,KIF14;CDKN1B;CDKN1A
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.7033171990362945,1.117315571725588,0.3333333333333333,1.0,1.0,1/12,0.39%,COX6A1
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),0.7087609333193952,1.117312397755682,0.34615384615384615,1.0,1.0,2/7,13.60%,JCHAIN;NOXO1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.4183948974855998,-1.1170339199607002,0.25,0.9329522537008293,1.0,33/128,23.22%,EFR3B;BCL2;CELF5;SLC17A6;ICAM5;ELAVL3;TTBK1;NTRK1;SRRM4;ASCL1;MMD2;GRIA4;ADGRA1;NOVA1;LRRTM3;CELF4;ERC2;SYN1;POU3F2;PAK3;NF1;PTPN5;ROBO2;PROX1;CUX2;MAPK4;SLITRK3;FEZF2;PAK5;NOTCH1;ELAVL4;TMEM179;ST8SIA3
prerank,CellMarker_Augmented_2021__T Helper cell:Liver,0.6745805298058837,1.1169795528710422,0.39285714285714285,1.0,1.0,6/8,30.11%,CD4;PARP8;ABCB1;DPP4;IFNGR1;DUSP1
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.7008047412146747,1.1169589317490567,0.3709677419354839,1.0,1.0,1/6,6.35%,SYK
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.6884523923233818,1.1169244115292822,0.373134328358209,1.0,1.0,5/9,28.25%,SOX9;SOX6;GDF5;LOXL2;SOX5
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,-0.3973080743026118,-1.1167682908679273,0.23809523809523808,0.9331013503733954,1.0,11/144,4.21%,PER2;ETV5;DUSP6;ETV1;BCL6;ERG;CD14;BCL2A1;FOXO1;MLF1;NR4A3
prerank,KEGG_2021_Human__Allograft rejection,0.5913178362513345,1.116764770928245,0.375,1.0,1.0,8/19,14.41%,HLA-F;IL12A;CD80;HLA-A;IL5;HLA-DMA;HLA-DPB1;IL4
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.5798693388727525,1.1167573947907772,0.34782608695652173,1.0,1.0,4/19,16.32%,NODAL;REST;HMGA2;TAF6L
prerank,KEGG_2021_Human__Chagas disease,0.5202549678866899,1.1166855783725536,0.2835820895522388,1.0,1.0,9/77,9.71%,C1QB;TLR2;PIK3R3;CCL5;C3;TGFB1;IL12A;KNG1;TGFB3
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.5975898794836894,1.1166328548688107,0.3157894736842105,1.0,1.0,6/26,16.59%,GATA4;CCDC39;NPY;GLI3;EDNRB;AGR2
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.5727508011121296,1.1166151173571353,0.3472222222222222,1.0,1.0,5/25,17.10%,FGF2;HGF;DACH1;CDKN1A;PARP4
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.4052402330486663,-1.1163041703642915,0.18181818181818182,0.933426927994251,1.0,16/61,18.26%,SLC38A5;SLC25A29;SLC6A20;LRRC8B;SLC3A2;SLC7A5;ABCC1;SLC13A3;SLC25A42;SLC25A41;SLC16A7;SLC36A4;SLC6A9;SLC39A8;SLC19A1;ABCC5
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.7180040120955308,-1.1160042021156142,0.3,0.9336481085427699,1.0,3/6,19.93%,APOE;FYN;HOMER1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.4477849979268849,-1.1156462913747032,0.37142857142857144,0.9340142322728053,1.0,9/37,15.29%,DRD4;GPRC6A;DHFR;IRF5;GLRA3;RHBDD1;TRPM2;MEAK7;TRPV1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.5742229555231311,1.1156263387099123,0.3188405797101449,1.0,1.0,7/23,19.95%,ABCC2;SLC26A6;SLC22A6;SLC25A18;SLC46A1;SLC1A6;SLC25A22
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.44510559492455914,-1.115451140973682,0.32,0.934058286949064,1.0,8/31,12.86%,CLIP3;HHAT;ZDHHC23;ZDHHC5;ZDHHC11B;ZDHHC16;ZDHHC14;ZDHHC18
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.5555372415272317,-1.1153169599543415,0.30303030303030304,0.9336359861555072,1.0,5/17,10.41%,UPB1;NT5C1A;UPP1;NT5C;UPP2
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Undefined,0.5037956535106614,1.115216460600782,0.2727272727272727,1.0,1.0,20/65,14.40%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;WAS;IKZF1;TAGAP;CD37;TMC8;GPR183;ALOX5AP;PSTPIP1;MYO1F;ITK;EVI2A;PARVG
prerank,CellMarker_Augmented_2021__White Blood cell:Blood,0.5037956535106614,1.115216460600782,0.2727272727272727,1.0,1.0,20/65,14.40%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;WAS;IKZF1;TAGAP;CD37;TMC8;GPR183;ALOX5AP;PSTPIP1;MYO1F;ITK;EVI2A;PARVG
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.6623296888783181,1.1151827187960939,0.4032258064516129,1.0,1.0,2/10,2.47%,BHMT;CHDH
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.505364484490836,-1.1151804351051564,0.2727272727272727,0.9332040129740234,1.0,4/28,6.42%,PTPRO;CDH13;KIT;ARFIP2
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,-0.46130562942472514,-1.1150621002667753,0.3125,0.932814116663474,1.0,13/137,8.48%,DUSP4;APOB;DUSP6;FOS;SIGIRR;NKIRAS2;S100B;SARM1;ECSIT;PPP2R5D;NOD1;ALPK1;RIPK2
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,0.48738161094654864,1.1148654345753441,0.2716049382716049,1.0,1.0,15/103,15.19%,SMAD6;ESR1;PSMB9;ITGBL1;HEY2;ITGA5;CCND1;COL1A1;RPS27A;STAT1;CDKN1A;GLI3;SOX9;PSMC5;MAPK3
prerank,CellMarker_Augmented_2021__Endoderm Progenitor cell:Adipose Tissue,0.498423836169318,1.11472261157708,0.25675675675675674,1.0,1.0,15/60,11.38%,C1QB;LYVE1;CYYR1;FLT1;FCGR3A;VSIG4;MYH11;FGL2;GGT5;RAMP3;HPGDS;ZNF366;VWF;HLA-DPB1;CLDN5
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.6722542768059991,1.1145154508958484,0.37142857142857144,1.0,1.0,2/10,13.35%,CCDC39;ZMYND10
prerank,Reactome_2022__Pyrimidine Catabolism R-HSA-73621,-0.5994401830726199,-1.1143654784502461,0.2702702702702703,0.9342544699308357,1.0,5/12,10.41%,UPB1;NT5C1A;UPP1;NT5C;UPP2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.5051639842726136,-1.1142903070653567,0.3793103448275862,0.933771399100668,1.0,8/21,22.84%,MYO10;KIF1C;CCDC88A;HOOK3;CCDC88B;CCDC88C;KIF5C;MAP6
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,0.5258002554926307,1.1142130205880418,0.24675324675324675,1.0,1.0,5/37,8.04%,GNAT3;GNG12;GPER1;ITGA5;GNG4
prerank,KEGG_2021_Human__B cell receptor signaling pathway,0.521877937431721,1.1141095986586398,0.30434782608695654,1.0,1.0,5/61,6.35%,BLNK;PIK3R3;LILRB3;CD81;SYK
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),0.6833771758716072,1.1139860674131372,0.3880597014925373,1.0,1.0,3/8,20.02%,BTG1;STK17A;STK17B
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),0.708089512494259,1.1137328409628884,0.3492063492063492,1.0,1.0,2/7,15.70%,CCL5;IDO1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.4156061834538849,-1.1136425380994808,0.15,0.9351054648960536,1.0,35/96,17.72%,ADAMTS1;TEAD2;P3H4;COL4A2;COL12A1;RAI14;RND3;RHBDF1;PARVA;PTPRF;B4GALT2;FZD7;MID1;FSTL1;CAP2;TEAD4;SNAI2;NLGN2;GNA11;AMOTL1;ANTXR1;DAB2IP;PACSIN3;AMOTL2;CHST3;FKBP9;GPC1;COL5A2;COL4A1;AMH;SERPINH1;DDAH1;ADCY6;INHA;RBFOX2
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),-0.7181912787030922,-1.11362020139844,0.35294117647058826,0.9344162477962975,1.0,2/5,11.57%,GPD1;GK5
prerank,CellMarker_Augmented_2021__Stem cell:Stomach,0.4984194176589169,1.1135748643338401,0.3253012048192771,1.0,1.0,28/90,16.38%,C1QTNF1;PRRX1;LPAR1;ANXA1;AHR;ITGBL1;ELK3;SERPINB7;NT5E;FLG;AXL;ACTA2;OSMR;HEG1;PDCD1LG2;PLAU;DCN;DAB2;GLIS3;FOSL2;TNS3;PLAT;FILIP1L;NDRG1;CD44;TGFBI;CYBRD1;CSF1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovarian Cortex,0.4984194176589169,1.1135748643338401,0.3253012048192771,1.0,1.0,28/90,16.38%,C1QTNF1;PRRX1;LPAR1;ANXA1;AHR;ITGBL1;ELK3;SERPINB7;NT5E;FLG;AXL;ACTA2;OSMR;HEG1;PDCD1LG2;PLAU;DCN;DAB2;GLIS3;FOSL2;TNS3;PLAT;FILIP1L;NDRG1;CD44;TGFBI;CYBRD1;CSF1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),0.6613058377715877,1.1134997210241047,0.3181818181818182,1.0,1.0,3/11,13.90%,DCK;SLC25A19;ERH
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.709056319837152,1.113406152006153,0.3442622950819672,1.0,1.0,2/7,14.41%,SYK;IL4
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.6774209010178376,1.113392825721953,0.3333333333333333,1.0,1.0,3/9,15.58%,GP1BA;F2RL1;PROCR
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),-0.6900228901144811,-1.1132965982113563,0.425,0.9346348592233984,1.0,1/6,7.68%,CX3CR1
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,0.43915289023200943,1.1131644497011544,0.2125,1.0,1.0,90/318,21.68%,SQOR;PSMB9;IYD;TYR;DBH;BHMT;DAO;CHDH;VSIG2;RPL37A;RPL21;NAT8L;FTCD;INMT;ACMSD;RPL9;LDHD;HPD;DUOX1;RPL18A;NQO1;SERINC2;RPS9;RPL3;RPL36;RPL13A;RPS16;CKMT2;RPL15;FOLH1;RPS5;RPS27A;RPS3A;RPL41;OAZ2;SDSL;LIAS;RPS12;CARNS1;RPS4X;RPL27A;RPS19;FAU;PSMC5;RPS21;CKB;BBOX1;GPT;AHCY;RPL32;IDO1;RPL11;RPL23A;RPL35A;RPS11;FAH;SLC6A12;RPS13;CKM;GLUL;RPS7;GADL1;ALDH9A1;HAAO;RSL24D1;GRHPR;RPLP2;RPL7;RPL38;AZIN1;PSMA3;ATAT1;ASPA;PSMB6;ASMT;RPS15A;RPSA;RPLP0;RPS6;RPL35;PSMD6;IDO2;TMLHE;GNMT;RPL27;RPS14;SERINC1;RPL7A;SEPHS2;RPL23
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.694053596057115,1.1131343943302419,0.35,1.0,1.0,1/9,10.91%,CELSR1
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Corneal Epithelium,0.5117091470290698,1.1131020349596457,0.3150684931506849,1.0,1.0,15/67,9.59%,CLCA2;MACC1;STEAP4;KCNJ15;A2ML1;TMPRSS11D;C3;RHBDL2;APOL6;ITGB6;FUT2;DUOX1;ATP10B;SOD2;TRIM29
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,0.5725841823156899,1.1130643048884,0.35135135135135137,1.0,1.0,5/30,11.00%,POLE2;DTL;POLD4;RPA3;RPS27A
prerank,Reactome_2022__Telomere C-strand Synthesis Initiation R-HSA-174430,-0.625588202382969,-1.1130528223956262,0.29411764705882354,0.9345854396554013,1.0,2/11,12.23%,CTC1;STN1
prerank,KEGG_2021_Human__Thiamine metabolism,-0.6011226742724939,-1.1130357558053865,0.3333333333333333,0.9338777217153461,1.0,5/11,22.98%,AK8;NFS1;NTPCR;AK7;ALPL
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Endometrium,0.5122030869859057,1.1129381167803194,0.25333333333333335,1.0,1.0,25/76,17.83%,ADAM28;TCN1;ANXA1;AHR;CLCA4;RARRES1;SLC28A3;ITGB6;NT5E;PRR5L;HLA-A;LAMC2;PLAU;CP;B3GNT5;FOSL2;CD44;TGFBI;IDO1;PARP14;NSUN7;SERPINB1;DDX60;GBP1;ITGB8
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.5939734959993557,1.1129232159022393,0.391304347826087,1.0,1.0,4/28,11.21%,HSPA1L;ARIH2;PINK1;RHOU
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.583648745576023,-1.1128278687085233,0.3142857142857143,0.9338187085637043,1.0,4/11,26.10%,PPIB;PRKN;EIF2AK4;TBC1D20
prerank,CellMarker_Augmented_2021__M1 macrophage:Peripheral Blood,-0.6174206666762405,-1.1127646166457401,0.30952380952380953,0.9332359846383461,1.0,2/12,3.16%,IL7R;SELE
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.6269408461246818,1.1126277929777815,0.35294117647058826,1.0,1.0,3/17,13.02%,ERBB4;TGFB3;FOXB1
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,0.49358951687015573,1.1126109359781362,0.2564102564102564,1.0,1.0,12/68,20.47%,PSMB9;CDKN2A;NQO1;RPS27A;TALDO1;PSMC5;IDH1;RBX1;PSMA3;PSMB6;SLC7A11;PSMD6
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,0.5342051137341715,1.1125708013082087,0.2753623188405797,1.0,1.0,11/49,25.56%,PSMB9;RPS27A;PSMC5;SYVN1;SEL1L;PSMA3;PSMB6;PSMD6;PSMA7;DERL2;PSMB1
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5495284301941661,1.112553657661963,0.323943661971831,1.0,1.0,6/30,13.36%,DONSON;DTL;TICRR;HMGA2;CDKN1A;NOP53
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.6646838622088432,1.1124980922485743,0.3114754098360656,1.0,1.0,2/8,11.23%,PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.6394192283604928,1.1124777481476882,0.375,1.0,1.0,3/12,22.95%,KCNA5;SCN5A;KCNQ1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.5365439567129419,1.1124008651611288,0.3625,1.0,1.0,5/38,6.68%,ADA;RNASE10;TGFB1;B4GALNT2;NODAL
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),0.7153123536104017,1.1119897225947024,0.37142857142857144,1.0,1.0,4/7,25.75%,DDX60;USP17L2;TKFC;RIOK3
prerank,Reactome_2022__Loss Of MECP2 Binding Ability To NCoR/SMRT Complex R-HSA-9022537,-0.6135306661322177,-1.1115217960650385,0.3157894736842105,0.9364718349266085,1.0,2/7,9.70%,MECP2;HDAC3
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.5217135412210528,1.1113454847070767,0.32894736842105265,1.0,1.0,4/49,7.31%,SMAD6;MAPKAPK3;IL12A;GGT5
prerank,Reactome_2022__P2Y Receptors R-HSA-417957,-0.6340130112726095,-1.1113388234007098,0.28125,0.9361750426903508,1.0,1/7,0.17%,P2RY10
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.4564279762535795,-1.1112156656634906,0.3157894736842105,0.9358479858863537,1.0,4/91,3.55%,GPR3;PER2;ELOVL6;ADCYAP1
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.38070593496543037,-1.1111870206809997,0.2222222222222222,0.9351938369849687,1.0,31/141,11.80%,CLDN4;CDH4;CDH20;CDH5;KIRREL3;CDH19;GPC6;CLDN15;CDH13;SELE;GRID2;DSG2;CLDN16;GPC4;ACVR1;PTPRF;CDH26;IGSF21;SELL;PVR;AMIGO2;CDH9;SLITRK2;PCDHB6;BSG;SDK2;PTPRS;NECTIN3;ALCAM;PCDHB9;LRFN4
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,0.5280551006132297,1.1109028454123324,0.30434782608695654,1.0,1.0,6/34,12.89%,PIK3R3;GNAT3;LCT;ATP1A4;HK3;SLC5A1
prerank,Reactome_2022__Miro GTPase Cycle R-HSA-9715370,-0.658440065492562,-1.1108594234048055,0.3125,0.9353488824616851,1.0,3/8,28.17%,MYO19;TRAK2;TRAK1
prerank,Reactome_2022__Synaptic Adhesion-Like Molecules R-HSA-8849932,-0.5470654215926885,-1.1108036945608895,0.375,0.9347166158265905,1.0,6/21,13.12%,GPRIN1;PTPRF;PTPRS;GRIA4;LRFN4;LLGL1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.5041688788572597,1.1105685384893278,0.2898550724637681,1.0,1.0,18/50,21.37%,SLC16A8;SLC10A1;ABCG2;SLCO1A2;ABCC2;SLC26A6;SLC51A;NR1H4;ABCC11;SLCO2B1;SLC16A1;SLC6A12;SLC16A3;SLC16A12;SLC10A5;CEACAM1;STARD5;SLC16A4
prerank,CellMarker_Augmented_2021__Stem cell:Periodontal Ligament,0.5969856383472971,1.1105006461865043,0.3076923076923077,1.0,1.0,4/16,16.35%,PTPRC;NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.6372173663986063,1.1102155785406742,0.35714285714285715,1.0,1.0,3/16,16.21%,NLRP12;NLRC3;GHRL
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.6113227960537447,-1.1101711055695935,0.36363636363636365,0.9360974136057739,1.0,4/20,5.70%,IL7R;KIT;HES1;OCIAD2
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.570240463575838,1.110137544867272,0.33783783783783783,1.0,1.0,7/33,17.83%,RORC;SOX9;CD44;GHRL;SOX6;HYAL1;ITGB8
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.6671503636385585,-1.110099665804624,0.34146341463414637,0.9355267894013836,1.0,1/6,6.56%,FNTA
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),0.7410500447662128,1.110081868807658,0.375,1.0,1.0,2/6,16.35%,DAND5;ENG
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.6394913979860818,-1.1099890578286893,0.3584905660377358,0.9351304252548898,1.0,4/7,13.83%,DDX11;ZNF618;KDM4D;MED25
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.504189477156549,1.1099212824061917,0.36486486486486486,1.0,1.0,12/59,18.89%,LMOD1;C15ORF62;CAV3;VASP;BAIAP2L1;HCK;PINK1;ALOX15;CARMIL1;CDK5R1;ANKRD53;LMOD2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Meniscus,0.717408494119182,1.1098627949281457,0.34,1.0,1.0,3/6,16.35%,PTPRC;CD44;ENG
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.4685402117449877,-1.1098238507365557,0.2972972972972973,0.9349690413214717,1.0,7/29,19.83%,PDZD11;PARD3;MARK2;SCRIB;RHOA;CAMSAP3;RAP2A
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Ovary,0.5546025601597289,1.1097311510931032,0.38461538461538464,1.0,1.0,11/37,11.86%,SLC25A31;GALNTL5;TOPAZ1;SLCO1A2;DAZL;CCDC172;TRIM51FP;WNT8A;LRRC72;TRIM77;L1TD1
prerank,CellMarker_Augmented_2021__Neutrophil:Sputum,0.5112071985011974,1.1096284429997896,0.2535211267605634,1.0,1.0,22/50,21.86%,ST6GALNAC1;TCN1;LIPH;VSIG2;CYP4F12;TMEM45B;SMIM22;TMC4;TRIM29;TJP3;AP1M2;SERPINB5;AGR2;SPINT1;SERPINB1;PRRG4;SCNN1A;CEACAM1;TMPRSS4;CBLC;B3GNT3;CXCL16
prerank,CellMarker_Augmented_2021__Neutrophil:Bronchoalveolar System,0.5112071985011974,1.1096284429997896,0.2535211267605634,1.0,1.0,22/50,21.86%,ST6GALNAC1;TCN1;LIPH;VSIG2;CYP4F12;TMEM45B;SMIM22;TMC4;TRIM29;TJP3;AP1M2;SERPINB5;AGR2;SPINT1;SERPINB1;PRRG4;SCNN1A;CEACAM1;TMPRSS4;CBLC;B3GNT3;CXCL16
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,0.5329804580816456,1.109529387303791,0.3283582089552239,1.0,1.0,7/48,20.47%,PSMB9;HSPA8;RPS27A;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6570459876118436,1.1094890619984068,0.359375,1.0,1.0,1/10,0.72%,LRP4
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5870342587650137,-1.1092214449416309,0.2631578947368421,0.9360907315019023,1.0,3/16,7.51%,PDGFD;NR4A3;PTPRJ
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.6184447453155819,1.10907038502781,0.33783783783783783,1.0,1.0,8/16,31.72%,SOX9;SOX6;BMP1;GDF5;SCX;LOXL2;SOX5;BMP2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.6138645022077835,1.1089180194052193,0.3559322033898305,1.0,1.0,5/18,12.93%,CASQ2;CAV3;MMP9;TCAF2;PLN
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),-0.6591185767339702,-1.1087211072705512,0.26666666666666666,0.9367935498537724,1.0,2/7,9.83%,GNA14;GNA11
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.5803828248335724,-1.1086919383822256,0.2916666666666667,0.9361433136809268,1.0,10/21,25.68%,PTPRJ;IQSEC1;LIMS1;ABL1;COL16A1;TSC1;DUSP3;PPM1F;S100A10;TEK
prerank,Reactome_2022__Pre-NOTCH Processing In Endoplasmic Reticulum R-HSA-1912399,-0.6642700608806591,-1.1085873592402629,0.42105263157894735,0.9356769311468826,1.0,1/6,3.52%,POFUT1
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.6363996849331516,1.1085126945958403,0.36507936507936506,1.0,1.0,6/12,17.87%,WNT5A;SYK;NOXO1;CYBA;NOS2;NOX1
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,0.6026564502725613,1.1084858900563044,0.417910447761194,1.0,1.0,5/17,13.21%,SDC2;TGFB1;ITGA2;VTN;THBS1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.4770683349219881,-1.108469669646598,0.21875,0.935383817331851,1.0,19/46,20.90%,GLA;SMPD3;SMPD4;STS;NEU4;B4GALNT1;ST3GAL2;NEU3;ESYT3;SUMF2;ST3GAL4;PGAP1;ESYT1;FUCA1;ST6GALNAC3;GLB1;GBA2;PIGW;PGAP3
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.4562557988099796,-1.10836731406327,0.34615384615384615,0.9349491941574175,1.0,17/56,18.88%,ZNF703;CDH20;CDH5;CDH19;GJB6;CDH9;FSCN1;FBF1;CDH12;PATJ;CDH11;PARD6B;RHOA;PRKCA;CD9;CDH22;VCL
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.34257826427133575,-1.108307770189759,0.0,0.934373396689153,1.0,53/384,13.36%,PER2;CD38;PRDM5;ZNF703;GATAD2A;BCL6;TWIST1;IKZF4;IFI16;HDAC10;FOXO1;TWIST2;CREB3L1;CIART;WWP2;KLF10;PRICKLE1;THAP7;CTCF;HES1;HIC2;MAP3K10;MEN1;CRY1;LBH;PHC2;KDM8;PA2G4;ASCL1;MTERF3;NACC1;MECP2;NIBAN2;MLX;HDAC3;LDB1;NR1D1;CBY1;PEX14;NKAP;HEXIM2;ZBTB7A;SFMBT1;PCGF6;DAB2IP;RING1;YWHAQ;MPHOSPH8;KCTD1;SBNO2;MYBBP1A;TLE2;BAHD1
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.5988589094271908,-1.108189006496071,0.2727272727272727,0.9339706305768973,1.0,3/11,10.60%,LIPC;APOE;SCARB1
prerank,Reactome_2022__Organic Cation Transport R-HSA-549127,0.7097288836779396,1.1081689222934223,0.47619047619047616,1.0,1.0,1/7,1.34%,SLC22A3
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5578535505832752,-1.1081304857525969,0.3611111111111111,0.9335280315897465,1.0,2/11,6.35%,DGKD;PARD3
prerank,CellMarker_Augmented_2021__Endothelial cell:Bone Marrow,-0.5977093679495143,-1.1080907724341038,0.4166666666666667,0.9329142775108565,1.0,4/13,7.65%,CDH5;SELE;KIT;S1PR5
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.5520999642911834,-1.1078342177030556,0.3333333333333333,0.9329984577582496,1.0,2/21,1.87%,MT1G;FOS
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.5294644033516591,-1.1076957547826185,0.4,0.9326686904995288,1.0,8/39,17.97%,NUP210;NUP42;POM121C;NUP214;AAAS;NUP37;NUP98;CPSF4
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone Marrow,0.4786187059289431,1.107396123453012,0.2631578947368421,1.0,1.0,13/93,10.33%,ENPP2;TRIL;TSPAN11;FBXL7;CYYR1;PREX2;SHISA6;JAM2;PLP1;ANGPTL2;TCEAL5;ADGRL4;VWF
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.5449340207985283,1.1073640370477391,0.3194444444444444,1.0,1.0,4/39,11.61%,TENT5B;DAZL;MEIOC;BOLL
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.5408448761662082,1.1072281350367994,0.35135135135135137,1.0,1.0,14/28,30.09%,ACAA2;NPC1L1;PLPP6;FDFT1;MSMO1;INSIG1;SQLE;INSIG2;HMGCR;HMGCS1;ACLY;IDI2;IDI1;DHCR24
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),0.736898314715712,1.1071344375058583,0.423728813559322,1.0,1.0,2/6,12.48%,HTR5A;HTR1B
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),-0.6523787590455743,-1.1070775995215607,0.38095238095238093,0.9339530611458976,1.0,4/6,34.39%,SNPH;UNC13A;SNAP25;UNC13C
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,0.489576037982764,1.1070210667737297,0.34782608695652173,1.0,1.0,8/70,16.50%,CHRNA9;SLC17A8;MYO3B;GRXCR2;FSCN2;GRXCR1;TMC1;MSN
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.6460972991909566,-1.1069537357904755,0.3939393939393939,0.9336029078635477,1.0,2/10,3.46%,TYRP1;KIT
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6632946559146,1.1068987196447928,0.38333333333333336,1.0,1.0,2/10,6.80%,FGF2;ERBB4
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.4959735169685445,-1.1067475337687742,0.22580645161290322,0.9334446206174964,1.0,4/25,10.30%,PEX7;SLC25A17;PEX13;PEX14
prerank,Reactome_2022__Regulation Of Gene Expression In Early Pancreatic Precursor Cells R-HSA-210747,0.6834481147116697,1.1067057949856294,0.4067796610169492,1.0,1.0,3/5,26.03%,NR5A2;HNF1B;ONECUT3
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.7086448162328389,1.1066707756143073,0.39344262295081966,1.0,1.0,1/6,5.72%,MESP1
prerank,Reactome_2022__GP1b-IX-V Activation Signaling R-HSA-430116,0.7338119088631132,1.1066353750744493,0.3684210526315789,1.0,1.0,2/6,10.33%,GP1BA;VWF
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.476636128461295,-1.1065137007910866,0.35294117647058826,0.9333871955976667,1.0,9/38,19.20%,MFSD2A;HLA-DRA;DOP1B;RP9;ST3GAL4;C5AR1;NF1;METTL23;CUX2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.5971931989996723,-1.106316754870851,0.41304347826086957,0.933289646380165,1.0,4/12,13.63%,CORO1B;SERPINE1;TRIB1;SLIT2
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,-0.4849676169667308,-1.106196001294175,0.375,0.9330315191474589,1.0,17/54,23.25%,CPSF1;NUP210;NUP42;POM121C;NUP214;AAAS;CSTF2;NUP37;NLRP2B;NUP98;CPSF4;TSEN2;FAM98B;SEH1L;XPOT;NUP50;TPR
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),0.724429856253209,1.1061817656486914,0.42105263157894735,1.0,1.0,2/5,12.01%,SDS;SDSL
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.45874565819236746,-1.105991239825123,0.32,0.9328741736822522,1.0,12/55,22.03%,IWS1;GTF2H2;RTF1;ERCC2;SSRP1;POLR2F;LEO1;POLR2C;ELOA;CCNT1;CTDP1;GTF2F2
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.6906838642432669,1.105969688828363,0.36231884057971014,1.0,1.0,2/10,5.18%,ALPK2;MYH11
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4842404672675248,1.1058983517936223,0.2727272727272727,1.0,1.0,11/57,15.21%,SP100;TNFRSF10A;PELI3;GPER1;IGF1;TMC8;BCL2L14;AGT;THBS1;IL4;CYLD
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.5604567651656139,1.1056146569303127,0.38028169014084506,1.0,1.0,5/20,16.81%,MYRF;SOX10;PRDM8;SOX9;SOX6
prerank,GO_Biological_Process_2021__response to cocaine (GO:0042220),0.740966041929773,1.1056072860862685,0.3548387096774194,1.0,1.0,3/5,18.30%,TGM2;CRHBP;CHRNB2
prerank,Reactome_2022__Defective C1GALT1C1 Causes TNPS R-HSA-5083632,0.6372641552762598,1.1055650866666868,0.3870967741935484,1.0,1.0,5/14,16.75%,MUC17;MUC4;C1GALT1C1;MUCL1;MUC16
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle contraction (GO:0060452),-0.7939376864755134,-1.1054775884685804,0.2857142857142857,0.9335194717328748,1.0,1/5,0.50%,ADRA1A
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),0.6458912995915096,1.1054633944112033,0.4266666666666667,1.0,1.0,4/10,16.49%,COPS4;TOR1A;GPS1;COPS5
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.5596349599750421,-1.105386299380586,0.3235294117647059,0.9330813710647635,1.0,5/14,23.64%,BCL2;YWHAQ;AKT2;YWHAE;BID
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,0.5044769104620513,1.1052336775142582,0.273972602739726,1.0,1.0,19/69,25.56%,PSMB9;LMO2;H2BC4;H2AZ1;RPS27A;TCF7L1;PSMC5;MYB;PSMA3;PSMB6;PSMD6;H2AZ2;YAP1;RUNX1;SPI1;PSMA7;H2AC6;LMO1;PSMB1
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.4675921552693068,1.1052141117475243,0.32051282051282054,1.0,1.0,20/102,9.15%,AMBP;OIT3;SLC28A1;CLDN2;BHMT;CYP3A4;DAO;SLC5A2;LRP2;SLC22A8;ABCC2;SCIN;PON1;SLC22A7;NR1H4;SMLR1;ALDOB;KNG1;SLC22A6;F7
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),0.7704792294380932,1.1052018622887652,0.35185185185185186,1.0,1.0,3/5,17.26%,BPIFB1;IL4;NOS2
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,0.47098360432998004,1.1049571529325501,0.24691358024691357,1.0,1.0,13/91,11.34%,CLCA2;CLCA4;TRPV6;TRPC7;CLCA1;ASIC5;TSC22D3;TTYH2;TRDN;ASIC1;SLC9C1;RPS27A;ANO2
prerank,CellMarker_Augmented_2021__Multilymphoid Progenitor cell:Umbilical Cord Blood,-0.3686433062876738,-1.1046926702153559,0.16666666666666666,0.9344565463989511,1.0,64/472,11.28%,DUSP4;IL7R;TRIB2;DGKD;EFR3B;MIDN;BCL6;KMT2B;TTC21A;TMEM106A;MYO9B;NRDE2;BCL2A1;JUNB;OVGP1;DDAH2;STK10;CABLES2;DUSP2;TRIM71;TPM2;ZNF133;DHX30;GSDMB;NLRP1;CMYA5;USP36;STX6;HES1;FBRSL1;OCIAD2;ABCA9;LSM7;KDM7A;SUSD1;MINAR1;DPP9;BDP1;KATNIP;SLC30A5;KDM2B;SSBP3;AKAP7;CDH9;DHX8;RAPGEF1;EMC8;RNASET2;SRSF4;TP53I11;GRIK1;COTL1;MOB3A;ATP10A;SLC15A4;CROCC;TFE3;CIRBP;ZBTB7A;LTB;ZNF608;MVK;ATP9A;UPF2
prerank,KEGG_2021_Human__Acute myeloid leukemia,-0.4420636452992887,-1.104590691011841,0.3076923076923077,0.9339683656946646,1.0,6/62,4.21%,PER2;DUSP6;CD14;BCL2A1;KIT;EIF4EBP1
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,-0.5802190498884039,-1.1045652425988337,0.2777777777777778,0.9333309645247698,1.0,2/18,7.73%,EFNB1;EPHB2
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),0.7141812493239226,1.104522126567286,0.38095238095238093,1.0,1.0,1/6,2.40%,GMFG
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.5994042930660862,-1.1042621625318136,0.34210526315789475,0.9328577900359523,1.0,1/14,0.83%,MLPH
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.5994042930660862,-1.1042621625318136,0.34210526315789475,0.9328577900359523,1.0,1/14,0.83%,MLPH
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.49461685416433265,1.1041353879367632,0.32894736842105265,1.0,1.0,13/52,23.43%,CCL5;VAPB;IFIT1;DDX3X;ZC3HAV1;OAS2;ISG15;NR5A2;PPID;FKBP6;IFIH1;PARP10;OASL
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.47840414743517135,-1.1039210010251543,0.28125,0.9333399843534168,1.0,8/16,25.68%,ADGRG6;TGFBR3;TGFB2;RBP4;S1PR1;NOTCH1;TGFBR1;TEK
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,-0.3856588727113398,-1.1039147194718344,0.21052631578947367,0.932625309181261,1.0,18/122,16.90%,SEC24C;KDELR1;PPP6R1;SPTBN4;COG4;SEC22A;TGFA;SPTB;TRAPPC9;STX5;PREB;CNIH3;CAPZB;TRAPPC1;MIA3;COG7;ANKRD28;F5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.591448565630117,1.103853626386188,0.3870967741935484,1.0,1.0,3/17,5.42%,PTPRC;VSIG4;SFTPD
prerank,Reactome_2022__SHC-related Events Triggered By IGF1R R-HSA-2428933,0.7057630073570111,1.1037733652071242,0.37735849056603776,1.0,1.0,1/7,7.66%,IGF1
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.6055538215185683,-1.1036145048430535,0.40476190476190477,0.9330471760483918,1.0,3/7,14.26%,FKTN;RAMP1;CHP1
prerank,CellMarker_Augmented_2021__Nucleus Pulposus cell:Intervertebral Disc,-0.43631904634054913,-1.1035798103783439,0.23076923076923078,0.9324532625119328,1.0,11/88,2.56%,ADAMTS1;FIBIN;PDE10A;PDLIM3;MYO10;BOC;PAMR1;CALD1;COL6A3;COL4A2;COL12A1
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Limit Cholesterol Uptake R-HSA-9031525,-0.670507367841397,-1.1034956355695411,0.4222222222222222,0.9321387153428934,1.0,3/5,28.53%,NR1H2;MYLIP;RXRA
prerank,CellMarker_Augmented_2021__B cell:Lymphoid Tissue,0.7443657674293642,1.103491638853482,0.4,1.0,1.0,1/5,6.90%,CD80
prerank,KEGG_2021_Human__Measles,0.4628592327865348,1.1034186028493238,0.34146341463414637,1.0,1.0,12/93,12.45%,HSPA1L;TLR2;HSPA8;PIK3R3;IL12A;STAT5A;CCND2;CCND1;CCNE2;STAT1;CDKN1B;OAS2
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.71950755301288,-1.1030929490104902,0.4,0.9328083995928826,1.0,2/5,21.33%,ETS1;PML
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,-0.3611904058348612,-1.1027622275645566,0.17647058823529413,0.9329309459369052,1.0,28/233,8.52%,P2RY10;TACR3;GALR3;DRD4;GRP;ADRA1A;ADRA1B;NTSR2;GABRE;NMU;HCRTR2;CHRNA10;HRH2;CRHR2;HRH1;ADCYAP1;GRID2;GRIN3A;GRIK4;TAC3;GPR156;PARD3;VIPR1;S1PR5;CRH;GABRA5;PRSS3;CCKBR
prerank,CellMarker_Augmented_2021__Preadipocyte Progenitor cell:Adipose Tissue,0.49576489318980416,1.1026250754942837,0.3333333333333333,1.0,1.0,17/80,11.36%,OLFML1;PRRX1;LMOD1;ADAM33;LYVE1;ECM2;CYYR1;ABI3BP;PCDH18;JAM2;DAAM2;ANGPTL2;ACTA2;ADGRL4;VWF;DCN;ASPN
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.44051494321929907,1.1026078010433331,0.24468085106382978,1.0,1.0,105/355,24.25%,NOTUM;APOL1;ITIH2;SDC2;CSF2RA;LOX;SFTPA1;C3;STOML2;UBE2L6;RPL37A;RPL21;SFTPD;SERPIND1;USP6;RPL9;IGF1;RPL18A;KNG1;MMP15;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;CP;RPS5;RPS27A;RPS3A;RPL41;RPL13;RPS12;RPS4X;RPL27A;PENK;MRPL34;PIGH;EEF1A1;RPS19;SERPINA10;YARS2;PLAT;PLG;IGFBP6;PCMT1;RPS21;TGOLN2;GGCX;RABGGTB;RPL32;RPL11;RPL23A;CSF1;RPL35A;RPS11;COPS5;PAPPA;RPS13;RPS7;PARP4;UBE2M;PAPPA2;TF;RSL24D1;RPLP2;RPL7;LAMB2;RPL38;ASMT;RPS15A;SPCS2;PRSS23;RPSA;RPLP0;RPS6;RPL35;FN1;GNMT;IGF2BP3;AMBN;RPL27;RPS14;RPL7A;RPL24;RPL23;RNF5;PLOD2;RPS15;MRPL28;UBA3;BAP1;MRPL10;RPS27;PCSK5;APLP2;RPL8;IGFBP2;RPS3;FDXR;MGAT4A;RPS23;CPE;RPS20;RPS18
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.42442600910369677,-1.1025935538024947,0.3125,0.9326167588591193,1.0,15/98,14.26%,PER2;PRICKLE1;CRY1;MINAR1;FBXO4;USP4;RIPK2;COMMD1;HDAC3;U2AF2;ARRB2;HSPBP1;MALT1;SIRT7;CHP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.6568200640675365,1.10253479729549,0.30303030303030304,1.0,1.0,2/13,13.21%,WNT5A;THBS1
prerank,Reactome_2022__Bicarbonate Transporters R-HSA-425381,0.6891774742136669,1.102493812560579,0.39655172413793105,1.0,1.0,2/9,21.67%,SLC4A1;SLC4A2
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.5226975974319594,-1.1024815078717436,0.36666666666666664,0.9322435742511835,1.0,6/22,15.48%,NR4A3;PID1;MRAP2;SDHAF4;GFPT2;ACSM1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.5152110265944242,1.1024306763519827,0.323943661971831,1.0,1.0,6/40,13.36%,DONSON;DTL;TICRR;HMGA2;CDKN1A;NOP53
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.34538365279874256,-1.1022024922555527,0.0,0.932455428041085,1.0,80/459,16.84%,PER2;CD38;GMNC;PRDM5;ZNF703;GATAD2A;BCL6;TWIST1;IKZF4;IFI16;HDAC10;FOXO1;TWIST2;TRIM71;CREB3L1;CIART;WWP2;KLF10;PRICKLE1;THAP7;CTCF;HES1;HIC2;MAP3K10;MEN1;CRY1;LBH;PHC2;KDM8;DHFR;NANOS3;PA2G4;PCIF1;ASCL1;MTERF3;NACC1;ATR;CNOT9;MECP2;NIBAN2;MLX;HDAC3;LDB1;NR1D1;CBY1;PEX14;NKAP;HEXIM2;ZBTB7A;SFMBT1;PCGF6;FXR2;DAB2IP;RING1;YWHAQ;MPHOSPH8;KCTD1;SBNO2;MYBBP1A;TLE2;BAHD1;LANCL2;RCOR2;SMARCA4;NR1H2;EIF2AK3;ZBTB4;LIMS1;PUS7;VGLL4;MIDEAS;PIAS4;SAMD4B;BHLHE40;IGF2BP1;CDK5;PER1;ZNF541;RAD17;HDAC5
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,0.5202473182559957,1.1020928557625755,0.36619718309859156,1.0,1.0,6/43,20.47%,PSMB9;RPS27A;PSMC5;PSMA3;PSMB6;PSMD6
prerank,CellMarker_Augmented_2021__Basophil:Blood,0.6807169234569916,1.1020020475980459,0.35294117647058826,1.0,1.0,4/6,29.74%,CD63;IL3RA;SMAD1;ENPP3
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.554697880074301,1.1019989463049256,0.3783783783783784,1.0,1.0,4/22,15.21%,GPER1;AGT;THBS1;CYLD
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.6563767523587591,-1.1018082484318574,0.3333333333333333,0.9331519819548383,1.0,3/8,23.95%,ADIPOR1;VHL;NF2
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,-0.48425151239915076,-1.101721972698099,0.25,0.9326902296020475,1.0,17/34,16.59%,ST3GAL3;GPC6;GPC2;SDC3;PAPSS2;GPC4;AGRN;CHSY1;VCAN;CHST6;PRELP;B3GAT3;CHST3;CSPG5;GPC1;SDC4;EXT1
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,0.6312147586870823,1.1016770347326934,0.3283582089552239,1.0,1.0,5/15,12.77%,CCND2;CCND1;CCNE2;CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.5617396202673025,1.1015983720931941,0.3333333333333333,1.0,1.0,6/35,17.04%,HSPA1L;ARIH2;PINK1;RHOU;ATP5IF1;TOMM7
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.6366223086670185,1.1015461233081365,0.3559322033898305,1.0,1.0,7/17,22.63%,SYK;AXL;IL7;IL4;ZAP70;XRCC6;CD27
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,0.4669182219051406,1.1014290247019698,0.25,1.0,1.0,9/161,5.56%,NLRP4;CLDN2;CLDN6;LPAR1;CLDN18;CASP7;TNFRSF10A;MYH11;ACTG1
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,0.4349896260021727,1.1013679888559738,0.22727272727272727,1.0,1.0,21/176,9.00%,C1QTNF1;C3AR1;GPHB5;GNAT3;C3;GPR27;GNG12;TSHR;SCTR;WNT5A;ACTG1;WAS;SYK;NT5E;GGT5;ADRB1;RAMP3;GNG4;RXFP2;HCK;NCKIPSD
prerank,KEGG_2021_Human__Rheumatoid arthritis,0.4987845794850562,1.1013082881872815,0.28205128205128205,1.0,1.0,12/56,11.20%,ITGB2;TLR2;CCL5;ATP6V1G2;FLT1;TGFB1;CD80;ATP6V0E2;HLA-DMA;TGFB3;HLA-DPB1;ATP6AP1
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),0.7203490564802866,1.1011986866782062,0.3617021276595745,1.0,1.0,2/5,16.30%,PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.5433966964821085,1.1011516284243097,0.35526315789473684,1.0,1.0,5/26,7.20%,PTPRC;FLT1;TGFB1;PLD4;FLT4
prerank,CellMarker_Augmented_2021__Epithelial cell:Kidney,0.6192154919018514,1.100849230354108,0.3582089552238806,1.0,1.0,3/14,13.50%,ANPEP;EPCAM;MME
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,-0.5437287716893566,-1.100795429029858,0.3448275862068966,0.9350063859482408,1.0,1/15,1.32%,ST3GAL3
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",-0.6919391634682144,-1.1007183516462626,0.3888888888888889,0.9345340418555234,1.0,3/7,7.36%,SH3RF1;HLA-DRA;TWSG1
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.6133166207136144,-1.1005922405658255,0.4,0.9342104449783597,1.0,1/6,7.51%,PTPRJ
prerank,Reactome_2022__PI3K Events In ERBB4 Signaling R-HSA-1250342,0.6684490548169504,1.1005431228403537,0.38333333333333336,1.0,1.0,1/8,6.80%,ERBB4
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.5317525027478908,1.1004980435789369,0.28169014084507044,1.0,1.0,1/34,0.37%,NEK2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Tooth,0.4929411548490453,1.1004677342076747,0.2716049382716049,1.0,1.0,23/69,19.09%,CYTIP;ARHGAP9;GMFG;ITM2A;SASH3;PTPRC;FCGR3A;FLI1;FGL2;HCK;IKZF1;TAGAP;HLA-DPB1;CD4;GPR183;MYO1F;PARVG;PIK3CG;CD244;P2RY14;ARHGAP15;HLA-DPA1;DOCK2
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,0.5116297810156475,1.1004396923094575,0.375,1.0,1.0,9/46,17.29%,PIK3R3;TSHR;PTGER3;ADRB1;NPY1R;NPY;ADCY7;NPPA;PRKG1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.6746880484123821,1.1001232165187187,0.42857142857142855,1.0,1.0,4/8,21.73%,CCL5;GPR183;PIK3CG;ALOX5
prerank,KEGG_2021_Human__Insulin secretion,-0.4265053062119061,-1.0999785109764042,0.2916666666666667,0.9353269772377419,1.0,10/73,11.43%,GCK;CREB3L4;ADCYAP1;CREB3L1;ABCC8;KCNMB2;GNAS;GNA11;ADCY3;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5923477593811444,1.0999288096235322,0.3484848484848485,1.0,1.0,4/22,14.62%,TLR2;DDX3X;F2RL1;CYBA
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.7376877483963514,1.099803667613698,0.36507936507936506,1.0,1.0,1/5,18.60%,TMEM33
prerank,Reactome_2022__Cellular Hexose Transport R-HSA-189200,0.6269351367229645,1.0997889480003948,0.375,1.0,1.0,4/16,12.89%,SLC5A4;SLC5A2;SLC5A9;SLC5A1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.5431095028650456,-1.0997842368642239,0.2727272727272727,0.935229885808433,1.0,2/15,1.83%,OSR1;WNT3A
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.4371555877967562,-1.0997737672292172,0.3103448275862069,0.9345717571963863,1.0,3/69,0.96%,DUSP4;EHF;CLDN4
prerank,GO_Biological_Process_2021__positive regulation of activation of Janus kinase activity (GO:0010536),0.7755544809483198,1.0997366683400658,0.36507936507936506,1.0,1.0,2/5,13.08%,CCL5;AGT
prerank,GO_Biological_Process_2021__regulation of activation of Janus kinase activity (GO:0010533),0.7755544809483198,1.0997366683400658,0.36507936507936506,1.0,1.0,2/5,13.08%,CCL5;AGT
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.5678524098371074,1.0997035307877732,0.359375,1.0,1.0,7/20,16.50%,CCL5;THBS1;CSF1R;IL4;MAPK3;CSF1;MSN
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Serum,0.4844951009443802,1.099600038694061,0.352112676056338,1.0,1.0,17/58,16.98%,DENND1C;MACC1;CAPN13;TMEM45B;ITGB6;MISP;SMIM22;TMC4;TJP3;AP1M2;EPCAM;RAB19;CD44;EPHA1;AGR2;SPINT1;NSUN7
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),0.5022326670376659,1.0995275153951922,0.29333333333333333,1.0,1.0,19/74,14.71%,TLR2;SP100;CCL5;TRIM62;PTAFR;WNT5A;HLA-F;TRIM25;SLC26A6;IRF1;HCK;HLA-A;TRIM68;RPL13A;HLA-DPB1;STAT1;OAS2;AQP4;CD44
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.5847475799484164,1.0993236026936628,0.4,1.0,1.0,7/16,33.94%,CAV3;SCN5A;SCN1B;SCN2B;GPD1L;SCN10A;FHL1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.7441874408516254,-1.0992095257437813,0.39473684210526316,0.9357838241049413,1.0,1/5,13.44%,CTPS2
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,0.528158797404789,1.0991908570060775,0.3181818181818182,1.0,1.0,13/35,18.80%,AMBP;APOL1;SCGB3A2;JCHAIN;STAB2;HPR;COL1A1;COLEC12;FTH1;MASP1;MSR1;HSPH1;FTL
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.4129258867312411,-1.0991514049818205,0.15384615384615385,0.9351656003699194,1.0,12/79,4.76%,ADAMTS1;FIBIN;CALD1;COL6A3;COL4A2;COL12A1;MMP2;LOXL1;COL13A1;TWIST2;TPM2;CNN1
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.6374269729398581,1.0990981088194898,0.3448275862068966,1.0,1.0,4/10,17.01%,KANK2;ZNF366;VPS18;BRCA1
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.6755153189508798,-1.0990522357477068,0.2972972972972973,0.9348037147186792,1.0,3/8,13.63%,RNF113A;SLIT3;SLIT2
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.48314461327362057,-1.0989386344714398,0.36666666666666664,0.9344031213616558,1.0,4/28,5.98%,MFSD2A;CDH5;GJB6;F11R
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),-0.7422173078140097,-1.0988374198713193,0.3902439024390244,0.933914870191924,1.0,1/5,9.47%,PLEKHM1
prerank,CellMarker_Augmented_2021__Platelet:Peripheral Blood,0.5261687513291002,1.09851352311586,0.2692307692307692,1.0,1.0,14/44,14.92%,RASGRP4;TRIM58;SLFN14;GP1BA;ALOX12;NLRP12;HEMGN;SLC4A1;CSF3R;MFSD2B;ITGA2B;TRPC2;P2RX1;PTP4A2P2
prerank,CellMarker_Augmented_2021__Platelet:Plasma,0.5261687513291002,1.09851352311586,0.2692307692307692,1.0,1.0,14/44,14.92%,RASGRP4;TRIM58;SLFN14;GP1BA;ALOX12;NLRP12;HEMGN;SLC4A1;CSF3R;MFSD2B;ITGA2B;TRPC2;P2RX1;PTP4A2P2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.5668260415833324,-1.0984235133470452,0.3684210526315789,0.9339002969473867,1.0,1/10,1.53%,BCL2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.5668260415833324,-1.0984235133470452,0.3684210526315789,0.9339002969473867,1.0,1/10,1.53%,BCL2
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.483199518993214,1.0983785126359216,0.3333333333333333,1.0,1.0,32/118,16.83%,C1QB;C3AR1;MGST1;TLR2;LYVE1;PTPRC;LMO2;TFEC;ABCG2;FCGR3A;VSIG4;CLEC12A;FLI1;FGL2;ANPEP;HGF;HCK;CSF3R;VWF;HK3;DAB2;ADGRG1;TAF7;CSF1R;ITGA2B;BMI1;CD44;CD300LF;IL3RA;PROCR;ENG;THSD1
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.45672600529769014,-1.0981985396406473,0.32,0.9336581788899561,1.0,10/62,13.32%,CPSF1;LIN28B;TENT4A;MAGOHB;SRRM1;SRSF4;SYMPK;U2AF2;CSTF2;CPSF7
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.6276366139899762,1.098190502165049,0.36065573770491804,1.0,1.0,2/9,17.96%,IFIT1;MSH6
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5476872814351145,1.0981091103925886,0.30666666666666664,1.0,1.0,9/43,16.95%,CCL5;CLCF1;CRLF1;IL12A;ERBB4;IGF1;CSF1R;IL4;PARP14
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.64578685396567,1.0980818200312146,0.328125,1.0,1.0,1/12,1.04%,ELOVL2
prerank,Reactome_2022__NOTCH4 Activation And Transmission Of Signal To Nucleus R-HSA-9013700,-0.5824447103411343,-1.0980066115289628,0.3548387096774194,0.9334262075185358,1.0,2/9,19.15%,JAG1;NCSTN
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.6130252911945067,-1.097993427158067,0.35294117647058826,0.9327549192711597,1.0,5/10,33.46%,CHD8;ICE1;CEBPA;RPTOR;ICE2
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.43590035458875226,-1.0979882189422803,0.3333333333333333,0.932065125967709,1.0,10/65,15.25%,SMYD5;PLK3;FGF1;PRDM15;FGFR2;RAB11FIP3;MYO19;ESRRB;ENTR1;DLL1
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.6556733119626383,1.0975719161622925,0.4,1.0,1.0,3/7,22.45%,WBP2;UBE3A;YAP1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.5366226009361856,1.0975643047014985,0.3698630136986301,1.0,1.0,14/29,30.09%,ACAA2;NPC1L1;PLPP6;FDFT1;MSMO1;INSIG1;SQLE;INSIG2;HMGCR;HMGCS1;ACLY;IDI2;IDI1;DHCR24
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.6680161135488883,1.0974006578564235,0.375,1.0,1.0,2/10,13.35%,CCDC39;ZMYND10
prerank,CellMarker_Augmented_2021__Dendritic Cell progenitor:Bone Marrow,0.6490816283221044,1.097341729535001,0.4107142857142857,1.0,1.0,6/12,15.41%,CSF2RA;PTPRC;CLEC4C;AXL;CSF1R;IL3RA
prerank,Reactome_2022__mRNA Editing R-HSA-75072,-0.6642274500972835,-1.0972036255574444,0.43243243243243246,0.9336494345459321,1.0,1/7,4.60%,APOBEC3H
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.6351450516182774,1.0971786587815577,0.4067796610169492,1.0,1.0,3/7,22.63%,DDX3X;GPS2;PARP10
prerank,CellMarker_Augmented_2021__Activated B cell:Peripheral Blood,-0.5052825244722734,-1.0971167922902811,0.28,0.9331257287412017,1.0,7/40,8.43%,P2RY10;SKAP1;PCED1B;CD247;ADAM8;SELL;SELPLG
prerank,CellMarker_Augmented_2021__Granulocyte:Peripheral Blood,0.6453414106841131,1.097010673908071,0.44285714285714284,1.0,1.0,8/12,15.41%,ITGAX;PTPRC;ITGAM;FCGR3A;CEACAM8;CD63;CD44;IL3RA
prerank,Reactome_2022__Acyl Chain Remodelling Of PC R-HSA-1482788,0.5828610507471725,1.0968778611031722,0.34328358208955223,1.0,1.0,1/19,0.98%,PLA2G10
prerank,GO_Biological_Process_2021__nodal signaling pathway (GO:0038092),-0.7348479521831196,-1.0968524601540486,0.3404255319148936,0.9332359690530806,1.0,1/5,5.22%,CFC1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.454755411091605,-1.0967956766493123,0.26666666666666666,0.9325965699395576,1.0,25/85,14.81%,ST3GAL3;CHPF2;XYLT1;GPC6;UST;GPC2;SDC3;GPC4;HS6ST2;B4GALT2;AGRN;CHST11;ST3GAL2;CHST12;CHSY1;CSGALNACT1;VCAN;CHST6;PRELP;B3GAT3;B4GALT4;ST3GAL4;CHST3;CSPG5;GPC1
prerank,"Reactome_2022__Synthesis Of IP2, IP, And Ins In Cytosol R-HSA-1855183",0.6380489959983056,1.0966360296725968,0.36764705882352944,1.0,1.0,2/13,19.94%,IMPA1;IMPA2
prerank,GO_Biological_Process_2021__bundle of His cell action potential (GO:0086043),0.7472136680840213,1.0963282574591366,0.3898305084745763,1.0,1.0,2/5,18.48%,KCNA5;SCN5A
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.5719391600185637,1.095972021779722,0.36619718309859156,1.0,1.0,2/32,4.27%,BACE2;TGFB1
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.6139769554330918,-1.0959516032620802,0.3953488372093023,0.9345258121358975,1.0,4/7,25.13%,ACADS;PCCB;PCCA;PCK2
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.5375913082577518,1.095855950924055,0.30985915492957744,1.0,1.0,4/32,9.53%,MCM2;POLE2;MCM3;RPA3
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,0.5041325207014578,1.0958505205119744,0.3333333333333333,1.0,1.0,13/53,20.56%,TCF7;PDE6A;GNG12;WNT5A;LEF1;GNG4;GNAT2;TCF7L1;PRKG1;PDE6B;PDE6G;GNGT1;GNB4
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.530644733297055,-1.095842078635307,0.3125,0.9341585274117841,1.0,4/28,13.51%,MFSD2A;CHKA;PEMT;SLC44A5
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.6660372620672349,1.0957177835522094,0.3728813559322034,1.0,1.0,6/10,18.99%,CCL5;MSMP;CRTAM;ZAP70;MSN;CCL25
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Brain,0.5037068079657081,1.0955078351623995,0.3026315789473684,1.0,1.0,16/58,11.38%,C1QB;TNFRSF1B;LYVE1;FLT1;TFEC;FCGR3A;VSIG4;MYH11;GPIHBP1;FLI1;FGL2;GGT5;RAMP3;ZNF366;VWF;CLDN5
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),-0.549334968416797,-1.0949419494038135,0.42105263157894735,0.9362196278795067,1.0,4/14,16.17%,EGR1;PIAS3;ZMIZ1;PIAS4
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.7030096742111365,-1.094810004916058,0.4,0.9359680658349885,1.0,2/5,24.37%,CYP46A1;RFTN1
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),-0.7294375818750847,-1.0947182187197786,0.3783783783783784,0.9355908273630327,1.0,1/5,1.67%,SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),0.6391277309390302,1.0945724462593205,0.41509433962264153,1.0,1.0,1/11,4.98%,TMEM35A
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,0.5068813603266995,1.094511269073994,0.30952380952380953,1.0,1.0,9/45,21.42%,CRLF1;IL12A;IL27;CA1;STAT1;TALDO1;MSN;RPLP0;ANXA2
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,0.5442261723980611,1.0942659522363276,0.34210526315789475,1.0,1.0,7/34,18.57%,ACTL6A;RPS27A;TFPT;COPS4;GPS1;COPS5;RBX1
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.553187684634799,1.0939581289857998,0.40298507462686567,1.0,1.0,2/19,5.05%,GATA4;HEY2
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,0.46725421774016274,1.0939151649749843,0.2804878048780488,1.0,1.0,12/87,15.19%,CDC25A;BUB1;PIK3R3;SPDYA;IGF1;SPDYE1;CCNA2;SPDYE3;PKMYT1;ADCY7;SPDYE18;MAPK3
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.731394048264269,1.0938970256583047,0.38596491228070173,1.0,1.0,1/5,11.63%,OTUD4
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),-0.711968511683952,-1.0938490471591527,0.3684210526315789,0.9378787241337325,1.0,3/5,14.54%,RRM2B;RRM2;SAMHD1
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,0.5103290676953935,1.0938047293842146,0.323943661971831,1.0,1.0,7/52,20.47%,PSMB9;RPS27A;PSMC5;RBX1;PSMA3;PSMB6;PSMD6
prerank,Reactome_2022__Reversible Hydration Of Carbon Dioxide R-HSA-1475029,0.6066980589334808,1.093695673930886,0.3770491803278688,1.0,1.0,3/11,10.84%,CA14;CA1;CA13
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.4543744845179943,-1.0936933347298814,0.2857142857142857,0.9375974339610312,1.0,12/121,8.48%,DUSP4;DUSP6;FOS;SIGIRR;NKIRAS2;S100B;SARM1;ECSIT;PPP2R5D;NOD1;ALPK1;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.513065941795981,1.0936857391998906,0.28,1.0,1.0,9/54,13.19%,ASB5;DTL;VSIR;WNT5A;C4BPA;C4BPB;OAZ2;CDKN1B;ANGPTL3
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.4481816840762497,1.0936524966901031,0.29069767441860467,1.0,1.0,42/188,16.58%,CAVIN1;ITGAX;PIK3R3;CCL5;VSIR;FLT1;TGFB1;SYNE2;SEMA3A;ACTG1;GPER1;SMIM22;MMP9;IGF1;LEF1;DUOX1;HSPA5;HGF;TCAF2;SOD2;F7;LAMC2;PLAU;VIL1;COL1A1;DAB2;F2RL1;SEMA3F;ANGPTL3;THBS1;CSF1R;SNAI1;SEMA3B;IL4;CARMIL1;EPHA1;CXCL12;WNT5B;FERMT3;CSF1;WASHC1;BCAR1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.505668769889884,-1.093554783678659,0.36666666666666664,0.9374036402795849,1.0,4/25,9.43%,TXNL4A;KHSRP;SRRM1;SRSF4
prerank,KEGG_2021_Human__VEGF signaling pathway,0.5078582108478675,1.0935027856758082,0.3492063492063492,1.0,1.0,2/49,2.55%,MAPKAPK3;PIK3R3
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.6551089315055576,-1.093243896670538,0.3333333333333333,0.9369299863241706,1.0,1/7,1.29%,TYRP1
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.6551089315055576,-1.093243896670538,0.3333333333333333,0.9369299863241706,1.0,1/7,1.29%,TYRP1
prerank,CellMarker_Augmented_2021__Basal cell:Epithelium,-0.4282291248205472,-1.093014578639403,0.30434782608695654,0.9369205367918951,1.0,4/55,4.43%,ADGRF4;ANXA8;LAMA3;CD151
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5622858113758774,1.0928990385369788,0.3492063492063492,1.0,1.0,8/28,17.26%,CD160;ITGAM;HLA-F;IL12A;HLA-A;CRTAM;RASGRP1;NOS2
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.6364616109260958,1.0928958789007945,0.37681159420289856,1.0,1.0,1/11,2.57%,PTX3
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.6422995412852074,-1.092888346684663,0.3333333333333333,0.9365349210364909,1.0,4/8,27.49%,CLEC16A;MLST8;LARP1;RPTOR
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.5874963459075292,1.0927565866993065,0.36486486486486486,1.0,1.0,3/17,5.72%,ALPK2;MYH11;MESP1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.47390655042330077,1.0927037414318228,0.275,1.0,1.0,32/118,15.08%,ITGB2;CYTIP;TNFRSF1B;ITGAX;ANXA1;SASH3;PTPRC;PTAFR;ITGAM;NFAM1;FCGR3A;SCIMP;ADGRE1;VSIG4;CLEC12A;FGL2;AXL;HCK;HLA-A;PDCD1LG2;HLA-DMA;TAGAP;HLA-DPB1;HK3;DAB2;IGSF6;XCR1;ALOX5AP;MYO1F;GPR68;PARVG;CD300LF
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.6814593400715392,1.0926885893905667,0.36507936507936506,1.0,1.0,3/7,8.20%,ABCC6;ABCC2;ABCC11
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.40990474485536166,-1.0925777170762665,0.2777777777777778,0.936757104137212,1.0,10/87,8.71%,GCK;NR4A1;PRKCD;FOXO1;NR4A3;CPEB1;MGARP;SYAP1;CAPN10;SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.4563668001746387,-1.092174410811415,0.3157894736842105,0.9373353075309668,1.0,7/45,9.44%,EYA4;RNF168;HDAC10;BRCC3;DDX11;ERCC8;WRAP53
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.5204113909961617,1.0921640930020153,0.3,1.0,1.0,10/37,15.97%,CLIC1;GP1BA;ACTG1;CD99;MEGF11;P2RY12;MYL12A;MYL9;FERMT3;PIK3CG
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Undefined,0.4987971186548091,1.092112433152513,0.29333333333333333,1.0,1.0,11/66,8.34%,ITGB2;PTPRC;ITGAM;DAZL;ITGA2;ANPEP;NT5E;ITGA5;CD99;STRA8;ACTA2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.59202464345418,-1.0920336242225834,0.27586206896551724,0.936979119934766,1.0,1/13,1.19%,DNMT1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",-0.6736304891981661,-1.0918928343289633,0.38095238095238093,0.9366715497080597,1.0,3/5,29.13%,PARN;TOE1;XRN1
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.6017738931085712,1.0917897460470138,0.38235294117647056,1.0,1.0,1/22,3.68%,SLC18A2
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,-0.5531205451748732,-1.091771744235883,0.3333333333333333,0.9363836590215383,1.0,3/18,9.72%,ANAPC2;CDC26;CDK1
prerank,Reactome_2022__Signaling By Activated Point Mutants Of FGFR1 R-HSA-1839122,0.6746251221312253,1.0917688133322285,0.4807692307692308,1.0,1.0,1/9,2.58%,FGF20
prerank,GO_Biological_Process_2021__chylomicron remodeling (GO:0034371),-0.6652939874714612,-1.0917300435527832,0.3888888888888889,0.935108719855599,1.0,2/5,4.78%,APOB;APOE
prerank,Reactome_2022__Chylomicron Remodeling R-HSA-8963901,-0.6652939874714612,-1.0917300435527832,0.3888888888888889,0.935108719855599,1.0,2/5,4.78%,APOB;APOE
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5528531374128264,-1.091692296953104,0.32558139534883723,0.9344870605434835,1.0,1/13,0.34%,DRD4
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.6262080340107515,-1.0916507938929585,0.41025641025641024,0.9338854908163363,1.0,2/9,14.20%,TST;CBS
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.4537068852451756,-1.0915410709262297,0.29411764705882354,0.9336007511457167,1.0,6/40,6.52%,APOB;LIPC;APOH;PNPLA3;APOE;PNPLA1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),0.6566416273416021,1.0914591180723885,0.40625,1.0,1.0,3/10,12.18%,TULP1;GRM6;GNAT2
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),0.6566416273416021,1.0914591180723885,0.40625,1.0,1.0,3/10,12.18%,TULP1;GRM6;GNAT2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.469624398222786,1.0914011543872357,0.3466666666666667,1.0,1.0,12/77,16.58%,RRAS;FGF2;TGFB1;WNT5A;STAT5A;FLT4;RHOB;AGT;THBS1;ZNF580;PIK3CG;BCAR1
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),-0.6441095038009734,-1.0911918643487766,0.4117647058823529,0.9339669638873715,1.0,1/6,6.75%,LHFPL2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.4419823523925153,1.0911910845311912,0.28735632183908044,1.0,1.0,30/238,19.67%,CDC25A;ESR1;ACTL6A;PSMB9;USP50;USP6;JOSD2;RPS27A;USP13;OTUD4;TFPT;CCNA2;USP18;TOMM20;PSMC5;YOD1;COPS4;CYLD;TOR1A;GPS1;TAF10;COPS5;BRCA1;TAF9B;HCFC1;NFKBIA;PSMA3;USP17L2;PSMB6;OTUD1
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,0.4707738151638368,1.0911577174889933,0.3333333333333333,1.0,1.0,15/95,20.86%,PSMB9;POLE2;H2BC4;MCM3;H2AZ1;RPA3;RPS27A;PSMC5;ORC4;PSMA3;PSMB6;PSMD6;H2AZ2;POLE3;GMNN
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.5826660836829494,1.0910897819327967,0.3230769230769231,1.0,1.0,4/19,16.07%,BUB1;TEX14;TTK;BUB1B
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.5826660836829494,1.0910897819327967,0.3230769230769231,1.0,1.0,4/19,16.07%,BUB1;TEX14;TTK;BUB1B
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.5826660836829494,1.0910897819327967,0.3230769230769231,1.0,1.0,4/19,16.07%,BUB1;TEX14;TTK;BUB1B
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.6547283329745667,1.0908795456823936,0.4,1.0,1.0,2/10,21.78%,MOAP1;BLOC1S2
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),-0.6496483045041506,-1.0907532583625024,0.4,0.9346672125680427,1.0,4/6,15.71%,PNP;SH3RF1;NKAP;PRDM1
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,0.481185606940701,1.0905342463307162,0.3176470588235294,1.0,1.0,37/153,25.35%,COX6A1;SLC25A31;PIK3R3;TGFB1;MMP9;ATP5PF;NDUFB11;NDUFS2;TGFB3;COX7A2;COL1A1;PDK4;PLN;ATP5F1E;AGT;CYBA;NDUFB10;NDUFA2;AGER;ATP5MC3;COX4I1;ATP2A2;COX7B;NDUFB9;COX6C;COX6B1;NDUFB4;UQCRFS1;NDUFA1;COX7A1;NDUFB2;COX5A;COX7C;PLCB4;PIK3CB;VDAC1;NCF2
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.6177718243418368,1.090383527679885,0.42857142857142855,1.0,1.0,4/12,14.41%,TNFRSF1B;MMP9;IGF1;IL4
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),-0.6277491975096487,-1.090241083870357,0.375,0.9355479139215968,1.0,3/6,12.59%,MECP2;KDM1B;MPHOSPH8
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5748657510440593,-1.09017288163862,0.36585365853658536,0.9350146085316795,1.0,2/15,12.71%,TMEM106A;MAPK7
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,0.4795372432284411,1.090144151423315,0.25316455696202533,1.0,1.0,27/110,17.05%,ITGB2;SDC2;ITGAX;ANGPT2;SLC7A7;SLC16A8;TGFB1;CD99L2;ITGAM;JCHAIN;TNFRSF10A;JAM2;ITGA5;CD99;CEACAM8;PSG8;EPCAM;PSG11;SELENOP;IGLL1;SIRPG;CD44;PROCR;CD244;SLC16A1;SLC16A3;TSPAN7
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.6123740534279567,1.0899894532492576,0.375,1.0,1.0,6/10,29.17%,SLC25A18;SLC1A6;SLC25A22;SLC1A3;PRAF2;SLC25A13
prerank,CellMarker_Augmented_2021__Hepatocyte:Liver,0.6615087410568249,1.0898502527535183,0.3770491803278688,1.0,1.0,4/10,15.77%,CYP3A4;ABCC2;MME;KRT8
prerank,KEGG_2021_Human__AMPK signaling pathway,-0.4132241537700974,-1.0897876006718448,0.23076923076923078,0.9355599075893547,1.0,10/107,5.09%,ADRA1A;FBP2;G6PC3;CREB3L4;FOXO1;CREB3L1;MLYCD;EIF4EBP1;EEF2K;GYS1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.5512608544283759,1.0897012403526403,0.4722222222222222,1.0,1.0,5/35,14.56%,HAT1;GRWD1;NAP1L2;SOX9;H2BC18
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Gingiva,0.7267779286571808,1.0893126088050353,0.4482758620689655,1.0,1.0,4/7,16.35%,NT5E;ITGA5;CD44;ENG
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.6678233173946954,-1.0892449529743302,0.3783783783783784,0.9363426739575724,1.0,3/6,21.51%,ATP10A;ASAP1;DNM2
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.5725472711135163,-1.0891738758043172,0.3170731707317073,0.9358290138802419,1.0,4/10,24.76%,PID1;VAT1;PRKN;PLD6
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,0.4465497981814692,1.0891075864565378,0.35365853658536583,1.0,1.0,68/190,26.25%,PSMB9;RPL37A;RPL21;VASP;RPL9;LHX4;RPL18A;COL4A5;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;PSMC5;RPS21;CXCL12;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RBX1;RPL38;PSMA3;PSMB6;RPS15A;RPSA;RPLP0;RPS6;RPL35;PSMD6;TMPRSS4;RPL27;RPS14;RPL7A;RPL23;RPS15;RPS27;RPL8;RPS3;RPS23;RPS20;RPS24;NCBP1;PSMA7;FLRT3;RPS29;NTN1;PSMB1;RPLP1;RPS28;NELL2;RPL34
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.4291605051506516,1.0889871946282619,0.26136363636363635,1.0,1.0,53/306,16.69%,ENPP2;TBX1;PIK3R3;FGF20;SPDYA;FAM20A;C3;FGF2;PTPRC;FAXDC2;CARD14;TGFB1;GPER1;CD81;RSPO1;NODAL;ERBB4;MMP9;CD80;FLT4;ITGA5;CCND2;IGF1;RAMP3;CCND1;HGF;CDK2AP1;DDX3X;GDF11;PLAUR;PINK1;IL5;MYDGF;TGFB3;VTN;DAB2;CD4;CDKN1A;TTK;AGT;CSF1R;CALCR;SOX9;DDR2;BMP3;GDF9;CD44;MAPK3;MTCP1;AGER;ENG;CSF1;RASGRP1
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.6083763130046399,1.0888801958652954,0.35,1.0,1.0,7/14,27.99%,CRTAM;PIK3CG;MSN;RASGRP1;TNFSF14;DOCK8;SLC11A1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.5269139721829048,1.0888629175936597,0.36923076923076925,1.0,1.0,4/43,2.19%,MYH8;LMOD3;CASQ2;MYBPC3
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.5467418191585113,-1.088828003872713,0.3548387096774194,0.9364105643448444,1.0,5/19,14.62%,LRSAM1;PACSIN3;SNX33;RUBCN;NR1H2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.6950048257674105,-1.0888038771348652,0.38095238095238093,0.9357930060756504,1.0,3/6,12.30%,OLFM2;MYOCD;FGFR2
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,0.5037731327515315,1.0884068683550259,0.3918918918918919,1.0,1.0,7/51,20.47%,PSMB9;RPS27A;PSMC5;RBX1;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.4769713748550398,1.0883114465726174,0.35365853658536583,1.0,1.0,30/111,20.81%,SLC22A3;TCN1;LRP2;SLC18A2;ABCG2;SLCO1A2;SLC6A4;RAMP3;ABCC11;SLC22A25;SLC22A6;SLC22A24;PPT1;MFSD2B;AMN;SLC47A1;CHMP3;CBLIF;RAB38;SLCO2B1;CLN8;SLC22A4;ABCG5;DENND10;SLC23A1;TXNIP;MFSD12;ARRDC3;ABCA12;TAP1
prerank,Reactome_2022__Anchoring Fibril Formation R-HSA-2214320,0.6784851294374218,1.087959687332954,0.3793103448275862,1.0,1.0,4/7,22.59%,LAMC2;TLL2;BMP1;COL7A1
prerank,Reactome_2022__S Phase R-HSA-69242,0.4484427125973772,1.0877166100511773,0.2926829268292683,1.0,1.0,22/144,20.86%,CDC25A;PSMB9;POLE2;MCM3;CCND1;POLD4;CKS1B;RPA3;CCNE2;RPS27A;CDKN1B;CDKN1A;CCNA2;PSMC5;GINS1;ORC4;RBX1;PSMA3;PSMB6;PSMD6;POLE3;GMNN
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.6218025151441182,-1.0876219406480072,0.39473684210526316,0.9386924198898714,1.0,1/8,3.72%,GRID2
prerank,CellMarker_Augmented_2021__Epithelial cell:Prostate,0.6825635697169334,1.0873753617803534,0.44642857142857145,1.0,1.0,4/6,29.08%,KRT8;AMACR;CTNNB1;TP63
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,0.5582796105530486,1.0873410637553613,0.36363636363636365,1.0,1.0,13/36,21.16%,TNFRSF1B;CCL5;TNFRSF10A;CXCR5;ACKR4;XCR1;CSF1R;CXCL12;CSF1;CCL25;IL2RA;TNFSF14;IL18R1
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.6654073682630677,-1.0870431109455096,0.47619047619047616,0.9398213201875815,1.0,1/6,2.34%,PSAT1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5635346372435924,1.0870091406427107,0.37142857142857144,1.0,1.0,1/22,0.98%,PLA2G10
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.6102717692263668,1.0868975372322183,0.3793103448275862,1.0,1.0,2/9,11.97%,SLC22A3;OAZ2
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),-0.698591227614386,-1.0868494675472882,0.37209302325581395,0.9398004054984415,1.0,2/5,21.90%,PPP1R9B;DRD2
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.6496198453180577,1.0867886877446993,0.3389830508474576,1.0,1.0,3/11,13.62%,TPGS1;TTLL2;TTLL4
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.44292187254299226,-1.086533887439979,0.3333333333333333,0.9401777574705102,1.0,13/57,22.03%,FOS;GTF2H2;ERCC2;SSRP1;MDC1;POLR2F;POLR2C;ELOA;CCNT1;ATM;CTDP1;JUN;GTF2F2
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.6734196393756936,-1.0865169600380256,0.2972972972972973,0.9395596977977891,1.0,4/7,24.40%,GRIN3A;PTPRS;SRGAP2C;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.6272121120407216,1.0865018628517096,0.36923076923076925,1.0,1.0,3/13,10.80%,SP100;WAS;SPOCK3
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,0.47199992583558936,1.0862977393429794,0.3026315789473684,1.0,1.0,13/97,20.47%,PSMB9;BLK;BLNK;SYK;RPS27A;PSMC5;RASGRP1;NFKBIA;PSMA3;PSMB6;ORAI1;NFATC2;PSMD6
prerank,CellMarker_Augmented_2021__Interstitial cell:Dorsolateral Prefrontal Cortex,0.48407991815733004,1.0862098201899437,0.3157894736842105,1.0,1.0,9/76,11.74%,APOL1;PSMB9;SP100;GLRX;TAPBPL;POLD4;FMO4;PPP2R5A;MYL12A
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4837728525808308,-1.0860488586951866,0.30303030303030304,0.9404195294875607,1.0,8/22,26.65%,EAPP;LEO1;CCNT1;TCERG1;BRD4;ALYREF;THOC1;HMGN1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.4951155829443315,1.0859576497450132,0.34210526315789475,1.0,1.0,1/50,0.14%,DENND1C
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3959735276166392,-1.08592668307371,0.3157894736842105,0.9400292627773505,1.0,20/72,18.94%,MFSD2A;SLITRK6;DCDC2;S100B;WNT7A;SPTBN4;PARD3;SLITRK2;CDHR1;FGFR2;TAOK2;LLGL1;DSCAML1;PARD6B;CDK5;PAK3;UNK;BRSK1;AFG3L2;RAB10
prerank,CellMarker_Augmented_2021__Myofibroblast:Undefined,0.48866748025338497,1.0857699302757504,0.33766233766233766,1.0,1.0,20/83,15.72%,OLFML1;PRRX1;LMOD1;ADAM33;ECM2;ABI3BP;PCDH18;ANGPTL2;ACTA2;ADGRL4;COL6A2;DCN;COL1A1;ASPN;SFRP4;FILIP1L;DDR2;CXCL12;ELN;MYL9
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Blood Vessel,0.48866748025338497,1.0857699302757504,0.33766233766233766,1.0,1.0,20/83,15.72%,OLFML1;PRRX1;LMOD1;ADAM33;ECM2;ABI3BP;PCDH18;ANGPTL2;ACTA2;ADGRL4;COL6A2;DCN;COL1A1;ASPN;SFRP4;FILIP1L;DDR2;CXCL12;ELN;MYL9
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Undefined,0.48866748025338497,1.0857699302757504,0.33766233766233766,1.0,1.0,20/83,15.72%,OLFML1;PRRX1;LMOD1;ADAM33;ECM2;ABI3BP;PCDH18;ANGPTL2;ACTA2;ADGRL4;COL6A2;DCN;COL1A1;ASPN;SFRP4;FILIP1L;DDR2;CXCL12;ELN;MYL9
prerank,CellMarker_Augmented_2021__Fibroblast:Corneal Endothelium,0.48866748025338497,1.0857699302757504,0.33766233766233766,1.0,1.0,20/83,15.72%,OLFML1;PRRX1;LMOD1;ADAM33;ECM2;ABI3BP;PCDH18;ANGPTL2;ACTA2;ADGRL4;COL6A2;DCN;COL1A1;ASPN;SFRP4;FILIP1L;DDR2;CXCL12;ELN;MYL9
prerank,CellMarker_Augmented_2021__Peritubular Myoid cell:Testis,0.48866748025338497,1.0857699302757504,0.33766233766233766,1.0,1.0,20/83,15.72%,OLFML1;PRRX1;LMOD1;ADAM33;ECM2;ABI3BP;PCDH18;ANGPTL2;ACTA2;ADGRL4;COL6A2;DCN;COL1A1;ASPN;SFRP4;FILIP1L;DDR2;CXCL12;ELN;MYL9
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),-0.6596760728724111,-1.085571661967365,0.375,0.9399022897843098,1.0,2/5,25.48%,NRXN2;HTT
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),-0.6596760728724111,-1.085571661967365,0.375,0.9399022897843098,1.0,2/5,25.48%,NRXN2;HTT
prerank,KEGG_2021_Human__Melanoma,0.4875739507879517,1.0855585687463722,0.32432432432432434,1.0,1.0,7/64,8.21%,PIK3R3;FGF20;FGF2;CDKN2A;IGF1;CCND1;HGF
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.6258040321940573,1.085267663199874,0.43333333333333335,1.0,1.0,5/13,22.39%,GPER1;PPP2R5A;CEACAM1;APOD;ADRA2A
prerank,Reactome_2022__Folding Of Actin By CCT/TriC R-HSA-390450,0.631463096785177,1.0851266018085444,0.3870967741935484,1.0,1.0,5/9,30.82%,CCT7;CCT8;CCT3;CCT6A;CCT2
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,0.5781457474071294,1.0851128300529997,0.43283582089552236,1.0,1.0,4/22,12.94%,PHKA1;PHKG1;RPS27A;PYGL
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),-0.6369000308182973,-1.0850933376580916,0.4318181818181818,0.9404100616685219,1.0,4/6,33.87%,CFAP100;PAFAH1B1;CFAP73;MTCL1
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.4514351905093334,-1.0850323078660697,0.2962962962962963,0.9398983194407832,1.0,8/53,12.78%,GCK;NUP210;NUP42;POM121C;NUP214;AAAS;ZBTB7A;SLC25A33
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Corneal Endothelium,0.46932228736310166,1.0848080276474783,0.3157894736842105,1.0,1.0,10/85,9.49%,TIMP3;LMOD1;TRIL;TSPAN11;CYYR1;PREX2;FLT1;ANGPTL2;COL21A1;ADGRL4
prerank,Reactome_2022__SLBP Dependent Processing Of Replication-Dependent Histone Pre-mRNAs R-HSA-77588,-0.5853423860666028,-1.0847868802648242,0.38461538461538464,0.9399151908628146,1.0,2/10,9.65%,LSM10;SNRPB
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.6187726240158953,1.0846343016380224,0.4782608695652174,1.0,1.0,2/14,7.79%,IGF1;REST
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),-0.6788780644274208,-1.084518961604877,0.3404255319148936,0.9401298406209467,1.0,1/5,1.41%,GLA
prerank,CellMarker_Augmented_2021__Corneal Epithelial Stem cell:Eye,-0.5319874145232483,-1.0844086217739424,0.2727272727272727,0.9396570785238512,1.0,2/25,1.40%,ADGRF4;ANXA8
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,-0.469485633656202,-1.084262980241787,0.37037037037037035,0.9394671709342232,1.0,7/28,16.81%,POU3F1;ADGRG6;NAB2;PLPPR3;SMARCA4;POU3F2;LAMA2
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.553210350686147,1.0842597833492533,0.3835616438356164,1.0,1.0,4/26,7.79%,ANXA1;CERS3;WNT5A;FLG
prerank,CellMarker_Augmented_2021__Effector CD4+ Memory T (Tem) cell:Blood,0.4651555269832143,1.0838772743358112,0.3125,1.0,1.0,22/61,20.42%,ITGB2;CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;IKZF1;TAGAP;CD37;GPR183;ALOX5AP;PSTPIP1;MYO1F;PARVG;PIK3CG;CD244;ARHGAP15;DOCK2;TNFSF8;CD5;IL2RA
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),-0.5313658393138774,-1.083786769084071,0.2926829268292683,0.9405181445163193,1.0,7/18,19.83%,MYO18A;PARD3;FBF1;SIPA1L3;RHOA;CAMSAP3;RAP2A
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.4302997553601131,-1.0837201404051935,0.26666666666666666,0.9401494438465674,1.0,9/54,12.08%,HDAC7;HDAC10;MAML1;GATD3;JAG2;HDAC3;MAMLD1;JAG1;NEURL1
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),0.6858075939005035,1.0836854276389627,0.47368421052631576,1.0,1.0,1/8,2.29%,DONSON
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.5270616311717727,1.0835956603391874,0.32894736842105265,1.0,1.0,4/32,5.31%,GATA4;LRP2;SIX4;WNT5A
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.6762309530395274,1.0835598774190707,0.45454545454545453,1.0,1.0,3/10,16.06%,SLC5A2;SLC5A1;HNF1A
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood,0.48077240446776,1.083537537942716,0.33783783783783783,1.0,1.0,15/64,11.38%,C1QB;LYVE1;ITM2A;CYYR1;PTPRC;PREX2;FLT1;VSIG4;MYH11;RAMP3;ADGRL4;HPGDS;VWF;HLA-DPB1;CLDN5
prerank,CellMarker_Augmented_2021__Exhausted CD4+ T cell:Liver,-0.4274406299149506,-1.083258960752713,0.29411764705882354,0.9410576106601504,1.0,2/100,0.22%,DUSP4;CD38
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.5725589845393038,1.0832368735001427,0.3333333333333333,1.0,1.0,7/23,12.65%,SIX4;SGCG;PGM5;MYL6;CSRP3;POPDC2;SGCZ
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,0.5123984689197544,1.0831595229081494,0.391304347826087,1.0,1.0,6/45,20.47%,PSMB9;RPS27A;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.39902777214815327,-1.0829040861563866,0.2222222222222222,0.9413923980338195,1.0,12/95,11.11%,RASSF2;TRIB2;UBASH3B;SPRED1;ADCYAP1;CCN1;CEP85;HSPB1;CAMK2N1;TRIB1;MMD2;DUSP19
prerank,Reactome_2022__Urea Cycle R-HSA-70635,-0.6580932992358052,-1.0828028980858626,0.37209302325581395,0.9410051244613368,1.0,2/6,13.78%,ASS1;ASL
prerank,CellMarker_Augmented_2021__B cell:Synovium,0.4904761423261061,1.0827434118590031,0.36231884057971014,1.0,1.0,10/40,12.21%,BLK;CYTIP;ARHGAP9;SASH3;PTPRC;JCHAIN;NAPSB;TAGAP;CD37;PNOC
prerank,CellMarker_Augmented_2021__B cell:Brain,0.4904761423261061,1.0827434118590031,0.36231884057971014,1.0,1.0,10/40,12.21%,BLK;CYTIP;ARHGAP9;SASH3;PTPRC;JCHAIN;NAPSB;TAGAP;CD37;PNOC
prerank,CellMarker_Augmented_2021__B cell:Salivary Gland,0.4904761423261061,1.0827434118590031,0.36231884057971014,1.0,1.0,10/40,12.21%,BLK;CYTIP;ARHGAP9;SASH3;PTPRC;JCHAIN;NAPSB;TAGAP;CD37;PNOC
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.49027821628376944,-1.0826549867162534,0.38235294117647056,0.9406933296985388,1.0,2/22,6.29%,NGF;ADGRG6
prerank,CellMarker_Augmented_2021__Gonocyte:Gonad,0.5145623853439285,1.0825720013348432,0.3287671232876712,1.0,1.0,15/51,16.54%,CLDN6;SCGB3A2;ZNF738;DAZL;CCDC172;SALL4;CA14;NODAL;PIF1;CALB1;L1TD1;SLC7A3;EPHA1;ZNF850;VASH2
prerank,CellMarker_Augmented_2021__Ovarian Germ Stem cell:Ovary,0.5145623853439285,1.0825720013348432,0.3287671232876712,1.0,1.0,15/51,16.54%,CLDN6;SCGB3A2;ZNF738;DAZL;CCDC172;SALL4;CA14;NODAL;PIF1;CALB1;L1TD1;SLC7A3;EPHA1;ZNF850;VASH2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.6347747387657481,1.0825478285072054,0.375,1.0,1.0,3/13,6.12%,ACSL5;C3;SLC26A6
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.6674709696093023,-1.082486800254732,0.4,0.9404568487042969,1.0,5/6,33.25%,PIH1D1;FBL;PRPF31;NOP58;ZNHIT6
prerank,CellMarker_Augmented_2021__Lymphoid cell:Undefined,-0.4516255695646759,-1.0824553191246709,0.28,0.9398840908766894,1.0,4/34,3.46%,IL7R;CD38;KLRC1;KIT
prerank,CellMarker_Augmented_2021__Macrophage:Bone Marrow,0.702093768237481,1.0824304141377445,0.42424242424242425,1.0,1.0,3/7,5.07%,ITGB2;ITGAM;ADGRE1
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),0.5953695427457296,1.0823738344216898,0.3698630136986301,1.0,1.0,3/17,5.44%,BANF2;HAT1;H1-0
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.4512976917714055,-1.082248106314715,0.3076923076923077,0.9397886998679351,1.0,15/61,22.21%,ADAMTS12;CAPN2;HM13;RHBDD1;NR1D1;BAG6;NGLY1;MALT1;FBXO44;OTUD7A;RSPRY1;CTSO;ZER1;CTSC;CTSV
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),-0.6431163548285435,-1.0822417507071973,0.3829787234042553,0.9391332281501038,1.0,3/6,29.04%,INSM1;NF1;WNT4
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.502394360596242,1.0822232354095382,0.375,1.0,1.0,10/50,8.49%,AIM2;CIDEB;USP50;GPER1;SYK;NODAL;UACA;NLRC4;REST;DDX3X
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.6430895857126668,-1.0821807091831388,0.4318181818181818,0.9386279924390326,1.0,1/5,7.99%,LIG3
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.708905232307714,1.081924032519862,0.3870967741935484,1.0,1.0,2/5,17.08%,ACSL3;CNST
prerank,CellMarker_Augmented_2021__Foxp3+IL-17+ T cell:Undefined,0.7155555258580145,1.0818045361105633,0.44642857142857145,1.0,1.0,3/5,20.42%,SIRPG;CD5;IL2RA
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Umbilical Cord Blood,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Monocyte:Umbilical Cord Blood,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Bone Marrow,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Cardiomyocyte Progenitor cell:Myocardium,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Keratinocyte:Epithelium,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Periodontal Ligament,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Dendritic cell:Umbilical Cord Blood,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Peripheral Blood,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Stromal Vascular Fraction cell:Adipose Tissue,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Endothelial cell:Corpus Luteum,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Adipose Tissue,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Blood,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Progenitor-like Angiogenesis-Promoting cell:Blood,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Endothelial cell:Bladder,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Submandibular Gland Stem cell:Submandibular Gland,0.4943591104332055,1.081742915167392,0.2916666666666667,1.0,1.0,16/64,11.38%,C1QB;LYVE1;ANGPT2;CYYR1;PREX2;FLT1;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;HPGDS;VWF;DCN;ASPN;CLDN5
prerank,CellMarker_Augmented_2021__Platelet:Undefined,0.5941086235571639,1.0816850817596908,0.37681159420289856,1.0,1.0,4/16,13.70%,GP1BA;TGFB1;LAMP2;ITGA2B
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.5606749152301347,1.0812051478936446,0.3698630136986301,1.0,1.0,6/23,14.52%,WNT5A;IGF1;CDKN1A;AGT;BMI1;DDR2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.6574172595807174,1.081143796303418,0.36363636363636365,1.0,1.0,2/15,4.27%,ESR1;TGFB1
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.551996336474193,-1.0810829322434872,0.37037037037037035,0.941190898901015,1.0,3/22,8.71%,MT1G;SLC30A5;SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.42331002286479213,-1.0809810383091412,0.2,0.9407780698857621,1.0,3/64,1.83%,NGF;IL11;WNT3A
prerank,Reactome_2022__Gap Junction Degradation R-HSA-190873,0.6246868640653164,1.0809256698143956,0.390625,1.0,1.0,1/10,11.07%,DAB2
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.46764963153737116,1.0807035346836713,0.35714285714285715,1.0,1.0,16/127,10.55%,ESR1;RORC;CCL5;AHR;SSTR1;CASP7;TGFB1;GPER1;SLC26A6;P2RY6;NR1H4;RAMP3;H2AZ1;CYP1B1;P2RY12;TGM2
prerank,Reactome_2022__Phase 2 - Plateau Phase R-HSA-5576893,-0.591427213675637,-1.0805515470679106,0.3125,0.9415668176910866,1.0,3/14,7.21%,KCNE1;CACNG4;CACNB1
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.5261454567955328,-1.0804899142019824,0.375,0.9411357082512012,1.0,5/20,13.43%,BUD23;NSUN4;TFB1M;GAR1;ZCCHC4
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.5750494592284674,-1.0803483623763401,0.35294117647058826,0.9409004480754932,1.0,6/12,32.70%,FNTA;SAP30BP;NIPBL;ZBTB7B;AKAP8L;ING2
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.6196397565107632,1.08029938884362,0.38461538461538464,1.0,1.0,2/13,7.79%,ANXA1;REST
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.40468579253343373,-1.080276355358325,0.2631578947368421,0.9404239962155009,1.0,17/107,14.15%,SPHKAP;CELF5;SLC17A6;ELAVL3;TTBK1;TNR;SRRM4;HPCA;NEUROD6;FRRS1L;MMD2;GRIA4;ADGRA1;GRIN1;LRRTM3;CELF4;TCEAL6
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,0.5670299102363433,1.0802245193331717,0.2753623188405797,1.0,1.0,2/25,7.24%,ESR1;NR1H4
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.6555387393379513,1.0801270853727567,0.43636363636363634,1.0,1.0,4/9,28.09%,THBS1;ATP6AP2;PTGS2;LGALS9
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.584492924649724,1.080118081500032,0.4126984126984127,1.0,1.0,6/13,22.95%,NPC1L1;SLC26A6;SLC5A1;SLC46A1;ADRA2A;KCNQ1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.6713955466620105,1.0800987808687539,0.41935483870967744,1.0,1.0,2/6,9.00%,HLA-F;HLA-A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.6713955466620105,1.0800987808687539,0.41935483870967744,1.0,1.0,2/6,9.00%,HLA-F;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.4184004439043355,-1.0800687621309821,0.375,0.9404866462611374,1.0,17/152,5.91%,SPRED3;TSKU;TRIB2;SPRED2;ADAMTS12;SPRED1;BAMBI;DTX1;OSR1;TWIST1;PTCH1;HDAC7;FOXO1;TWIST2;HOPX;HES1;MEN1
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.6352161645727944,-1.079784434508152,0.36585365853658536,0.9406141396869944,1.0,3/8,17.47%,DHFR;RTN4RL2;MTR
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.6809384484567149,-1.079732891712468,0.3888888888888889,0.9400647699663777,1.0,3/5,17.51%,CROCC;ENTR1;CCDC88A
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.4283237174104292,-1.0793109090511763,0.2777777777777778,0.9407018426370818,1.0,12/65,9.34%,ADAMTS1;APOH;SPRED1;COL4A2;CREB3L1;VASH1;GTF2I;MINAR1;ANGPT4;SERPINE1;MECP2;NIBAN2
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.6659535124206972,1.079250302041476,0.3728813559322034,1.0,1.0,2/10,12.01%,SDS;SDSL
prerank,Reactome_2022__Orexin And Neuropeptides FF And QRFP Bind To Their Respective Receptors R-HSA-389397,0.7001951223786497,1.0791146715661915,0.39344262295081966,1.0,1.0,1/6,2.11%,NPFFR1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.42148623297679216,-1.0790491600219654,0.2727272727272727,0.9406808057972433,1.0,12/56,12.44%,NPTX2;CACNG4;SHANK1;DLGAP4;CRH;NLGN2;SHISA7;GRIA4;GRIN1;CACNG2;DLGAP1;CNIH3
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,0.566786623321638,1.0789340791467512,0.37142857142857144,1.0,1.0,3/22,2.19%,MYH8;TMOD4;MYBPC3
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.5274531857496512,1.078886265932149,0.3815789473684211,1.0,1.0,7/49,15.08%,MCM2;ANXA1;MCMDC2;PIF1;RPS27A;RECQL4;HMGA1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.5051979860361501,1.0788754726237082,0.3235294117647059,1.0,1.0,4/49,6.80%,TBX1;SOX10;SEMA3A;ERBB4
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.7094186978329252,1.078742861299233,0.47058823529411764,1.0,1.0,1/7,7.79%,REST
prerank,Reactome_2022__WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,0.5964341196330298,1.0787401021656033,0.4090909090909091,1.0,1.0,1/15,5.31%,WNT5A
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,0.5471745696403958,1.0787063659148706,0.42028985507246375,1.0,1.0,4/32,8.38%,ST6GALNAC1;GALNTL5;GALNT5;C1GALT1C1
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Brain,0.4753903597302172,1.0787056241114072,0.379746835443038,1.0,1.0,14/61,11.07%,C1QB;TNFRSF1B;LYVE1;FLT1;LMO2;TFEC;VSIG4;FGL2;GGT5;RAMP3;ADGRL4;ZNF366;VWF;DAB2
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.6269780928617276,-1.078585477996338,0.4186046511627907,0.9414645093185913,1.0,5/7,25.32%,RAD50;NBN;ERCC1;ATM;SMG6
prerank,KEGG_2021_Human__Gastric cancer,0.4607211707619783,1.0784897451105289,0.4,1.0,1.0,23/127,15.72%,WNT8B;TCF7;FRAT1;PIK3R3;FGF20;FGF2;TGFB1;WNT5A;WNT8A;LEF1;CCND1;HGF;TGFB3;FZD8;CCNE2;WNT6;CTNNA3;CDKN1B;CDKN1A;TCF7L1;RXRG;MAPK3;WNT5B
prerank,Reactome_2022__Androgen Biosynthesis R-HSA-193048,-0.6385367132274697,-1.0784788161186987,0.375,0.9411471814803841,1.0,2/6,14.48%,HSD17B12;HSD3B2
prerank,Reactome_2022__Synthesis Of 12-Eicosatetraenoic Acid Derivatives R-HSA-2142712,0.6872907699952522,1.0784717872206249,0.42424242424242425,1.0,1.0,3/7,13.21%,ALOX12;ALOX12B;ALOX15
prerank,Reactome_2022__Hyaluronan Metabolism R-HSA-2142845,0.6019081913074789,1.0784099367308202,0.421875,1.0,1.0,3/15,14.71%,LYVE1;STAB2;CD44
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.5779881279587235,-1.078396113032237,0.39473684210526316,0.9407471841401098,1.0,5/12,17.83%,ACO1;ASS1;IDH2;GLUD1;ACO2
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,0.5072501578928003,1.0781164645124026,0.33766233766233766,1.0,1.0,21/77,24.14%,COX6A1;TMEM186;NDUFB11;NDUFS2;ETFB;CCNI;NDUFB10;NDUFA2;NDUFAF5;COX20;COX4I1;COX7B;NDUFB9;COX6C;COX6B1;NDUFB4;UQCRFS1;NDUFA1;NDUFB2;COX5A;COX7C
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.6430543956690792,1.0779982079519894,0.38095238095238093,1.0,1.0,2/7,22.54%,DDX3X;SPSB4
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),0.6557803940302546,1.0779309542764874,0.3709677419354839,1.0,1.0,3/8,16.34%,PTGER3;EDNRB;HTR2B
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein particle clearance (GO:0010986),0.7320521661480938,1.0775817985325458,0.4626865671641791,1.0,1.0,2/5,10.77%,GPIHBP1;LDLRAP1
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.6908223840876311,-1.0775108473373192,0.475,0.9428766701583103,1.0,2/5,19.02%,IVD;HMGCL
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.6896434842698098,1.0773027314888026,0.36666666666666664,1.0,1.0,3/6,20.18%,RNF26;HOOK2;HOOK1
prerank,CellMarker_Augmented_2021__Keratinocyte:Skin,0.7425192978849311,1.0771106987808567,0.36065573770491804,1.0,1.0,2/5,15.77%,CD44;KRT8
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),0.6586190400629138,1.077014192746155,0.40625,1.0,1.0,2/8,5.18%,LMOD3;MYH11
prerank,KEGG_2021_Human__Amoebiasis,0.4842537119068431,1.076883313892791,0.32894736842105265,1.0,1.0,13/69,11.00%,ITGB2;TLR2;PIK3R3;TGFB1;ITGAM;IL12A;COL4A4;COL4A3;COL4A6;COL4A5;TGFB3;LAMC2;COL1A1
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreatic Islet,-0.43263281480053933,-1.0768629781417498,0.3333333333333333,0.9439424559804264,1.0,6/80,7.47%,EPHX2;ARX;KLHL41;C11ORF24;MCOLN3;VGF
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Blood,0.6596696853034352,1.076819105796941,0.3561643835616438,1.0,1.0,2/8,14.71%,EPCAM;CD44
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,-0.47629045216745153,-1.0766575450347236,0.3103448275862069,0.9438823180330712,1.0,10/33,14.83%,NGF;SHC3;RALB;NTRK1;RAPGEF1;RALGDS;MAPKAPK2;CRK;BCL11B;CRKL
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.5704819498323975,1.076623224275894,0.3333333333333333,1.0,1.0,6/18,27.56%,RPS27A;SYVN1;SEL1L;RNF5;DERL2;AMFR
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,-0.3757901718240684,-1.0765497018872883,0.25,0.9434262480077958,1.0,42/171,18.08%,DYNLT5;IFT88;MKS1;CNGA4;EXOC7;HAUS1;SCLT1;PCM1;CEP83;KIF17;CLUAP1;RPGRIP1L;MAPRE1;FBF1;CNTRL;CDK1;CEP135;ALMS1;BBS12;ASAP1;CDK5RAP2;CEP152;CEP250;NUDT19;RAB11FIP3;HAUS7;B9D1;TRAF3IP1;KIF24;DYNC2I1;SDCCAG8;CSNK1E;MARK4;AHI1;CEP41;CYS1;TCTN1;PRKCA;IFT52;IFT43;IFT81;CEP290
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.4263018927228724,-1.076492073674557,0.30434782608695654,0.9429524255917087,1.0,9/66,10.90%,GCK;NUP210;NUP42;POM121C;NUP214;AAAS;ZBTB7A;NUPR1;PFKFB3
prerank,Reactome_2022__Serotonin Neurotransmitter Release Cycle R-HSA-181429,0.6214858713629463,1.076361584161608,0.3283582089552239,1.0,1.0,1/17,3.68%,SLC18A2
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.4311716048159887,-1.0763161659478664,0.2857142857142857,0.9428379468624987,1.0,4/30,5.90%,PTCH1;GPC2;PTCH2;MAP3K10
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.5938560513893192,1.0761964454797683,0.39436619718309857,1.0,1.0,5/16,23.71%,TGFB1;FLT4;DDR2;CEACAM1;RUNX1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.4786656904150405,1.0760924961284715,0.32926829268292684,1.0,1.0,14/92,17.10%,NEK2;BUB1;IHO1;BORA;GPER1;RAB11A;ECT2;HMGA2;PKMYT1;SOX9;KLHL13;RMI2;RCC1;FBXO5
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,0.5217397427618821,1.0758262320076537,0.3287671232876712,1.0,1.0,13/42,24.77%,MYH11;H2BC4;H2AZ1;MYL6;RHOB;MYL9;PKN3;YWHAH;CDC25C;H2AZ2;YWHAG;KDM1A;H2AC6
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.46045526935811654,1.0757526247459528,0.352112676056338,1.0,1.0,17/96,20.80%,PSMB9;AIM2;TNFRSF1B;CARD14;ST18;STAT1;TNFSF4;TXNDC17;PSMC5;EDAR;NFKBIA;PSMA3;TNFSF8;PSMB6;PSMD6;TNFSF14;TRAF5
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.4385393044615266,1.0756476228135976,0.345679012345679,1.0,1.0,39/220,16.69%,TBX1;PIK3R3;FGF20;CCL5;ROS1;FAM20A;C3;FGF2;FAXDC2;FLT1;CARD14;TGFB1;GPER1;RSPO1;ERBB4;MMP9;PFKFB2;FLT4;CCND2;IGF1;AXL;CCND1;HGF;CDK2AP1;PLAUR;PINK1;MYDGF;DAB2;CD4;PRXL2C;THBS1;CSF1R;SOX9;DDR2;EPHA1;MAPK3;AGER;ENG;RASGRP1
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,-0.45872698710459825,-1.0755736028350245,0.39285714285714285,0.944598382185724,1.0,5/45,8.34%,SPRED2;SPRED1;FGF18;FGF1;ANOS1
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.4822650331352698,-1.0753714494093125,0.29411764705882354,0.9445379901350293,1.0,8/28,11.04%,P2RY10;SKAP1;KLRC1;CD247;SELL;CD8A;KLRC4-KLRK1;LTB
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),0.5944517801016569,1.0752267281768049,0.3382352941176471,1.0,1.0,3/15,9.41%,NODAL;IGF1;WEE2
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.6859041062581123,1.0750911505703744,0.3968253968253968,1.0,1.0,1/5,5.79%,JAM2
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Membrane,0.4905554303335256,1.0750057884891793,0.35365853658536583,1.0,1.0,18/92,11.07%,CLCA2;RAB34;TIMP3;LPAR1;ARHGAP31;ANXA1;ABCG2;ITGBL1;ELK3;NT5E;AXL;OSMR;HEG1;PDCD1LG2;ADGRL4;PLAU;TGM2;DAB2
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.49414556933805365,1.0746785737544933,0.2894736842105263,1.0,1.0,4/57,3.76%,AQP3;ZACN;HAMP;TRPV6
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.5744003633354507,1.0746254230569008,0.35384615384615387,1.0,1.0,1/21,4.27%,TGFB1
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.6789157012734652,1.0746126913728251,0.4426229508196721,1.0,1.0,2/6,13.24%,SIX4;GLI3
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.523720502364567,1.0743361341373607,0.33783783783783783,1.0,1.0,13/50,14.48%,PLA2G10;ALOX12;CYP4F12;PTGR1;PON1;GGT5;CYP2J2;CYP1B1;ALOX5AP;ALOX12B;ALOX15;PON3;ALOX15B
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.6330863744089895,-1.0742300791109298,0.38636363636363635,0.9474785025587743,1.0,5/8,31.61%,DPH1;DPH5;DPH6;DPH2;DPH7
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.6712991948396533,-1.0741286924739963,0.3829787234042553,0.9471043507471958,1.0,3/5,28.42%,CTDP1;RPRD1A;RPAP2
prerank,CellMarker_Augmented_2021__Myeloid cell:Tonsil,0.6897102959444931,1.0740927515290963,0.31666666666666665,1.0,1.0,3/7,4.70%,ITGAX;ITGAM;FCGR3A
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,0.5148444906844736,1.0739107159770083,0.352112676056338,1.0,1.0,6/48,20.47%,PSMB9;RPS27A;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.6142377267282824,1.0738714281445252,0.39344262295081966,1.0,1.0,5/14,24.28%,NLRP5;CFL1;ESPL1;LLGL2;OOEP
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6184114597170554,1.0738661842827548,0.41935483870967744,1.0,1.0,1/11,6.03%,CD81
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.696121525101379,-1.073780792592058,0.4634146341463415,0.9475004849908784,1.0,2/5,8.24%,CELA2A;ERN1
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.7021069849019903,1.0737420359662992,0.4642857142857143,1.0,1.0,1/5,3.45%,C3
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,0.5090240956021895,1.0735803247230917,0.38028169014084506,1.0,1.0,1/40,0.92%,PSMB9
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.5265590385114872,1.0734262842963924,0.30434782608695654,1.0,1.0,8/30,15.97%,CLIC1;GP1BA;ACTG1;P2RY12;MYL12A;MYL9;FERMT3;PIK3CG
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.5721227139040781,1.0733329224025006,0.3888888888888889,1.0,1.0,8/23,24.36%,ERAP2;ANPEP;GGT5;LVRN;CHAC2;ERAP1;LNPEP;DPEP1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.692223256069313,1.0733046310832595,0.4,1.0,1.0,3/7,9.00%,VSIR;IRF1;HLA-A
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.5945663817891473,1.073292763508646,0.38461538461538464,1.0,1.0,4/12,9.05%,BLK;CCL5;SYK;PLAUR
prerank,KEGG_2021_Human__Proteasome,0.5107421599955811,1.0732550488444557,0.4,1.0,1.0,1/39,0.92%,PSMB9
prerank,Reactome_2022__Synthesis Of PI R-HSA-1483226,-0.6756727253040075,-1.0731623115891464,0.4666666666666667,0.9486652570315008,1.0,2/5,13.46%,PITPNM1;PITPNM3
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.45561967196614955,-1.0731574536946873,0.34782608695652173,0.9479982385750398,1.0,4/57,1.33%,P2RY10;CD38;IGLL3P;IL16
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.48087912844433456,1.0731493008608104,0.30985915492957744,1.0,1.0,8/62,12.89%,APOL1;SLC12A7;SLC37A2;SLC12A3;GLRA2;GLRA1;ANO2;SLC5A1
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Germ,0.5022390175989347,1.0731356977045448,0.3472222222222222,1.0,1.0,21/64,15.97%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;FLI1;FGL2;HCK;IKZF1;TAGAP;HLA-DPB1;GPR183;ALOX5AP;MYO1F;PARVG;PIK3R6;IL3RA;PIK3CG
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Germ,0.5022390175989347,1.0731356977045448,0.3472222222222222,1.0,1.0,21/64,15.97%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;FLI1;FGL2;HCK;IKZF1;TAGAP;HLA-DPB1;GPR183;ALOX5AP;MYO1F;PARVG;PIK3R6;IL3RA;PIK3CG
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Undefined,-0.6626856558798293,-1.0730337610564384,0.39473684210526316,0.9469594541279334,1.0,1/6,0.22%,CD38
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Undefined,-0.6626856558798293,-1.0730337610564384,0.39473684210526316,0.9469594541279334,1.0,1/6,0.22%,CD38
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.4666396679341636,-1.0730005339077568,0.3,0.9463955145100612,1.0,12/38,17.75%,PRKCD;SMYD2;CRY1;RADX;RFWD3;CASP9;ANKLE1;FXR2;SIRT7;MCL1;ABL1;KMT5A
prerank,KEGG_2021_Human__Basal cell carcinoma,0.4906041630707905,1.0729913975440235,0.36231884057971014,1.0,1.0,11/55,13.42%,WNT8B;TCF7;HHIP;WNT5A;WNT8A;LEF1;FZD8;WNT6;CDKN1A;GLI3;TCF7L1
prerank,Reactome_2022__PTK6 Regulates RTKs And Their Effectors AKT1 And DOK1 R-HSA-8849469,0.6622675357590979,1.072930333147891,0.36065573770491804,1.0,1.0,1/8,11.00%,RPS27A
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.5092920865925896,-1.0728962180632455,0.43243243243243246,0.9459144982346094,1.0,2/16,11.71%,MGARP;KIF1C
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,0.5059434245315524,1.0728696316372663,0.38571428571428573,1.0,1.0,8/48,20.47%,PSMB9;NQO1;OAZ2;PSMC5;AZIN1;PSMA3;PSMB6;PSMD6
prerank,CellMarker_Augmented_2021__Neutrophil:Vagina,0.5375207388920779,1.0728612104581559,0.36231884057971014,1.0,1.0,18/36,15.60%,TLR2;ITGAX;LILRB3;PTAFR;ITGAM;NFAM1;FCGR3A;CLEC12A;FGL2;HCK;CSF3R;HK3;IGSF6;MYO1F;FPR1;ADGRE3;CD300LF;KCNE3
prerank,CellMarker_Augmented_2021__Natural Killer cell:Undefined,-0.4045181238646626,-1.0725371824724352,0.28,0.9462092084186497,1.0,4/48,3.46%,IL7R;CD38;KLRC1;KIT
prerank,Reactome_2022__Beta Oxidation Of octanoyl-CoA To hexanoyl-CoA R-HSA-77348,-0.7026247629996207,-1.0724202763357902,0.45454545454545453,0.9459750226111123,1.0,1/5,8.91%,ECHS1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.6007961306155329,-1.072397173608865,0.42424242424242425,0.9454133810003239,1.0,4/12,12.23%,SHANK1;NLGN2;NPHS1;NRXN2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.5700601140437342,1.072394712631661,0.39655172413793105,1.0,1.0,2/17,10.49%,PLA2G10;MBOAT1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.6079485329180215,1.0723160558026636,0.4307692307692308,1.0,1.0,4/18,13.99%,TGFB1;HEY2;ASPN;SOX9
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.6747782812271097,1.07222316373775,0.38181818181818183,1.0,1.0,1/5,27.61%,LAGE3
prerank,CellMarker_Augmented_2021__Megakaryocyte:Fetal Kidney,0.7350435166450566,1.0721572124200922,0.37037037037037035,1.0,1.0,2/6,14.21%,ITGA2B;FYB1
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),0.6522114815751779,1.072108076295193,0.42424242424242425,1.0,1.0,5/9,22.10%,F8;F7;A2M;TFPI;F10
prerank,CellMarker_Augmented_2021__Blast cell:Bone Marrow,0.47385849207799313,1.0720067233367683,0.34146341463414637,1.0,1.0,15/63,11.07%,C1QB;C3AR1;LYVE1;TFEC;VSIG4;FLI1;FGL2;ANPEP;GGT5;HGF;ADGRL4;ZNF366;VWF;DCN;DAB2
prerank,CellMarker_Augmented_2021__Endothelial cell:Skin,0.4911505432641146,1.0718595831826947,0.36619718309859156,1.0,1.0,15/58,11.38%,C1QB;LYVE1;CYYR1;FLT1;FCGR3A;VSIG4;MYH11;GPIHBP1;FGL2;GGT5;RAMP3;ADGRL4;ZNF366;VWF;CLDN5
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.5801707102290488,-1.0717202864589788,0.4411764705882353,0.9464903138432676,1.0,3/10,13.97%,FBP2;PFKP;GFPT2
prerank,Reactome_2022__RUNX3 Regulates p14-ARF R-HSA-8951936,0.6548125895921484,1.0716415049933425,0.45161290322580644,1.0,1.0,3/9,7.94%,TGFB1;CDKN2A;CCND1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.4939202421203921,1.0716201642192191,0.345679012345679,1.0,1.0,10/68,10.78%,LRP4;TGFB1;ACTG1;MARVELD2;VASP;FBLIM1;MYOT;TGFB3;MARVELD3;TJP3
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.6872300075512561,1.0714715240096042,0.5384615384615384,1.0,1.0,1/6,12.77%,CDKN1A
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.53497410938958,1.0714338684763436,0.375,1.0,1.0,4/27,8.49%,CCL5;IL12A;GSDME;DDX3X
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.5325404864674566,-1.0712541092192067,0.38461538461538464,0.9472838592168054,1.0,5/11,17.70%,OGDH;AADAT;GPT2;IDH2;GOT2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Breast,0.456192417526798,1.0712449450397066,0.37333333333333335,1.0,1.0,11/81,10.33%,ENPP2;TRIL;TSPAN11;LYVE1;CYYR1;PREX2;FLT1;SHISA6;RAMP3;ADGRL4;VWF
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Corneal Endothelium,0.456192417526798,1.0712449450397066,0.37333333333333335,1.0,1.0,11/81,10.33%,ENPP2;TRIL;TSPAN11;LYVE1;CYYR1;PREX2;FLT1;SHISA6;RAMP3;ADGRL4;VWF
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.5726637150877001,-1.0711943931980101,0.35135135135135137,0.9467315696589846,1.0,3/10,15.83%,SLIT3;ACVR1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.6131757284951911,1.0710172807917788,0.4411764705882353,1.0,1.0,4/15,13.21%,CD160;GPER1;SFRP4;THBS1
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.3721915758647161,-1.0707154220241202,0.2777777777777778,0.9474057889642202,1.0,49/168,17.22%,EFNB1;TRIB2;CALD1;COL4A2;COL12A1;PTPRO;CDH13;RAI14;SYNPO;GOLIM4;LAMA3;RND3;RHBDF1;KITLG;PARVA;PTPRF;CCN2;THSD7A;MID1;FSTL1;CAP2;RASSF8;GPRC5A;NTN4;EFEMP1;EPB41L5;ITGA3;NPHS1;EHD4;EDNRA;ANTXR1;DAB2IP;NFIB;NAV2;AMOTL2;CORO2B;CHST3;ADAMTS13;FKBP9;CTNNAL1;COL4A1;ADGRL2;ETF1;MAFB;DDAH1;PODXL;SH3D19;ADCY6;SH3BP4
prerank,KEGG_2021_Human__Tight junction,0.45923653124321984,1.0706800022769525,0.3409090909090909,1.0,1.0,26/138,18.09%,GATA4;CLDN2;CLDN6;CLDN18;MYH11;ACTG1;WAS;JAM2;MARVELD2;VASP;CCND1;MYL6;RAPGEF6;MARVELD3;TJP3;CLDN5;MYL12A;CLDN9;IGSF5;TUBA4A;TUBA3D;MYL9;MSN;HSPA4;CLDN14;TUBA1C
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),-0.6411741484915439,-1.0705034830643534,0.45,0.9473985767253863,1.0,2/7,16.25%,LETM1;SLC8B1
prerank,Reactome_2022__Molecules Associated With Elastic Fibres R-HSA-2129379,0.586566919103419,1.0704772309376014,0.4225352112676056,1.0,1.0,4/24,10.68%,TGFB1;ITGB6;TGFB3;VTN
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.4988748066606384,1.0702747575070992,0.37681159420289856,1.0,1.0,10/50,17.26%,TLR2;ANXA1;PTPRC;AFAP1L2;SYK;F2RL1;ELANE;ZNF580;CD244;NOS2
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.5208091513435283,-1.0702033000209596,0.2692307692307692,0.9475727074786503,1.0,9/26,26.09%,RNF168;LDB1;EAPP;LEO1;TCERG1;BRD4;WDR43;RECQL5;ZMYND11
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.6893596546375044,1.070053280503079,0.47540983606557374,1.0,1.0,2/8,11.08%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.6893596546375044,1.070053280503079,0.47540983606557374,1.0,1.0,2/8,11.08%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__Schwann cell differentiation (GO:0014037),-0.6202516507837043,-1.0695226126558417,0.42857142857142855,0.9491962311445146,1.0,3/5,17.80%,ADGRG6;GPC1;NF1
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,0.4289088096623054,1.0694283867399192,0.3375,1.0,1.0,48/224,16.72%,CHRNA9;OR52N2;OR2H2;OR51I2;OR52I2;SDC2;LRAT;LRP2;BCO1;GNAT3;OR7C1;PDE6A;OR52A5;EBF1;GPIHBP1;OR2AJ1;SLC17A8;MYO3B;OR5V1;OR56A3;OR10A2;OR8A1;OR2G6;GRK7;APOM;OR52E5;GRXCR2;DHRS3;OR2AG1;OR3A3;ANO2;SLC24A1;FSCN2;RDH12;RDH16;OR2T10;GRXCR1;OR6N1;OR3A2;CNGA1;OR2T12;GUCY2F;OR51M1;TMC1;MSN;RBP1;KCNJ2;RCVRN
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.5306845598913844,1.069401022242551,0.4142857142857143,1.0,1.0,7/35,17.37%,TCF7;ANXA1;PTPRC;CD4;GLI3;ZAP70;RAG1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.5451235634964401,1.0693313706007288,0.42028985507246375,1.0,1.0,5/25,14.84%,METTL18;SUV39H1;ETFBKMT;EEF2KMT;METTL21C
prerank,Reactome_2022__Cross-presentation Of Particulate Exogenous Antigens (Phagosomes) R-HSA-1236973,0.6733300145275533,1.0691708542568161,0.43137254901960786,1.0,1.0,4/5,29.18%,CYBA;NCF2;ITGB5;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.5471024561798234,1.069054536941001,0.41935483870967744,1.0,1.0,5/21,17.12%,CDKN2A;CDKN1B;CDKN1A;CDKN2C;DYNLL1
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,0.48572475689089056,1.0687669130612618,0.3717948717948718,1.0,1.0,11/71,13.70%,PKP2;TCF7;SGCG;ITGA2;ITGB6;ACTG1;ITGA5;LEF1;CTNNA3;TCF7L1;ITGA2B
prerank,CellMarker_Augmented_2021__Endothelial cell:Heart,0.4640606370699657,1.0687389956413769,0.35526315789473684,1.0,1.0,16/67,13.33%,C1QB;LYVE1;CYYR1;FLT1;VSIG4;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;ZNF366;VWF;ANO2;CLDN5;PDK4;CSF1R
prerank,CellMarker_Augmented_2021__Erythroid cell:Umbilical Cord Blood,0.46083054100102927,1.068729845347321,0.3076923076923077,1.0,1.0,13/84,18.26%,KIF14;POLE2;POLQ;FRRS1;HEMGN;CA1;SDE2;KIF18A;YOD1;BRCA1;WDR36;CEP76;ALG10
prerank,Reactome_2022__Formation Of Annular Gap Junctions R-HSA-196025,0.6267639604521622,1.0685772778470808,0.390625,1.0,1.0,1/9,11.07%,DAB2
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),0.7227262200116933,1.0685583679806783,0.47058823529411764,1.0,1.0,2/5,5.75%,SLC18A2;SLC17A8
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.4481070098182748,1.0685326061090323,0.32098765432098764,1.0,1.0,31/133,21.48%,ANXA1;UBE2L6;PTPRC;VSIR;NLRP12;VSIG4;SFTPD;TRIM25;IL12A;NR1H4;LEF1;AXL;PDCD1LG2;NLRC3;TNFSF4;F2RL1;THBS1;ELANE;ADCY7;CYLD;ISG15;AGER;GHRL;TIGIT;GBP1;RPS6KA5;CEACAM1;FN1;IFIH1;ZFPM1;APOD
prerank,Reactome_2022__Interleukin-18 Signaling R-HSA-9012546,0.6975139960315108,1.0684366638367513,0.4074074074074074,1.0,1.0,3/5,21.73%,IL4;IL18R1;ALOX5
prerank,Reactome_2022__Metabolism Of Folate And Pterines R-HSA-196757,-0.5707152376448809,-1.0684209105752653,0.3939393939393939,0.9519673041791952,1.0,4/14,8.58%,MTHFR;MTHFD1L;DHFR;FPGS
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.6957235657598657,1.068250037908054,0.4166666666666667,1.0,1.0,2/7,16.58%,HGF;BCAR1
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.6957235657598657,1.068250037908054,0.4166666666666667,1.0,1.0,2/7,16.58%,HGF;BCAR1
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.5831346781306976,1.0681924432198895,0.3728813559322034,1.0,1.0,2/14,10.49%,PLA2G10;MBOAT1
prerank,CellMarker_Augmented_2021__Effector Regulatory T (Treg) cell:Peripheral Blood,0.4802328565509436,1.068081100584452,0.3698630136986301,1.0,1.0,19/62,14.40%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;GMFG;SASH3;PTPRC;FLI1;WAS;IKZF1;TAGAP;CD37;CD4;GPR183;ALOX5AP;PSTPIP1;MYO1F;EVI2A;PARVG
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.4968881544449478,1.067938101240485,0.375,1.0,1.0,16/52,21.73%,ACE2;FOXM1;EIF6;CYP1B1;PINK1;UCP1;CDKN1A;AGT;THBS1;NOXO1;STK17A;BRCA1;CCN6;ROMO1;BCO2;ALOX5
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.5317503122557816,1.0679329899002739,0.38571428571428573,1.0,1.0,17/39,25.85%,PWP2;RPS16;RPS5;NOB1;RPS19;RPS7;TSR3;EMG1;RPSA;RPS6;RPS14;RIOK2;RPS15;RPS27;RPS24;RIOK3;RPS28
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.40959277546047607,-1.067725421331325,0.2727272727272727,0.9533683032877435,1.0,12/58,15.00%,TRIB2;UBASH3B;SPRED1;CEP85;HSPB1;CAMK2N1;TRIB1;DUSP19;NPRL2;CHP1;DEPTOR;PRKRIP1
prerank,Reactome_2022__tRNA Modification In Mitochondrion R-HSA-6787450,-0.559168348807128,-1.0677187140664928,0.36585365853658536,0.952705958259102,1.0,3/8,29.51%,TRMT61B;MTO1;PUS1
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.5874940554208673,-1.0676271394766566,0.3684210526315789,0.9524420739237673,1.0,1/8,7.92%,PID1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.5557849934857773,1.0676017313035826,0.4126984126984127,1.0,1.0,7/23,12.77%,GPER1;IL12A;OGN;SOD2;TGFB3;CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),-0.6578018856103528,-1.0675009834829277,0.3958333333333333,0.9521514755805711,1.0,3/5,25.43%,CDK5;PLAA;SNCA
prerank,Reactome_2022__Influenza Infection R-HSA-168255,0.44773448612168865,1.0673400570949851,0.36363636363636365,1.0,1.0,51/146,24.42%,TGFB1;RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;ISG15;RPL32;RPL11;RPL23A;RPL35A;RPS11;KPNA5;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL23;RPS15;RPS27;GNL3;RPL8;RPS3;RPS23;RPS20;RPS24
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.6025733102605245,-1.0672896785448915,0.38235294117647056,0.9523845639755696,1.0,1/7,2.40%,TMEM106A
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.42863704569829447,1.0671085242565905,0.3023255813953488,1.0,1.0,31/247,12.92%,TBX1;ESR1;RORC;WNT8B;TLR2;TNFRSF1B;AHR;SSTR1;TSHR;WNT5A;GPER1;SLC26A6;MMP9;CD80;P2RY6;NR1H4;RAMP3;STRA8;AXL;H2AZ1;GLRA2;RRAGA;PDCD1LG2;P2RY12;TGM2;UCP1;GLRA1;WNT6;TNFSF4;PDK4;CRHBP
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Vein,0.4584669277132841,1.0671001591074263,0.31645569620253167,1.0,1.0,22/83,16.91%,PRRX1;ADAM33;LYVE1;ECM2;CYYR1;PTPRC;ABI3BP;GGT5;ANGPTL2;ACTA2;ADGRL4;VWF;DCN;DAB2;ASPN;FILIP1L;CXCL12;ELN;CYBRD1;ENG;A2M;GALNT15
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),-0.5888348333064607,-1.067082585186855,0.43243243243243246,0.9523468538766854,1.0,4/11,8.62%,APOH;SERPINE2;APOE;SERPINE1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.5466092424315693,1.0670249998256716,0.39705882352941174,1.0,1.0,11/29,24.51%,PKP2;CAV3;KCNA5;KCNE3;KCNJ2;SCN5A;KCNE4;SCN4B;KCNQ1;ATP1A1;SCN1B
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.3991001891270512,-1.0670069177880723,0.21739130434782608,0.9518316997086896,1.0,6/63,5.52%,TSKU;APOB;EPHX2;LIPC;APOE;CYP7B1
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.7116997807297175,1.0668252711316353,0.4925373134328358,1.0,1.0,2/5,19.83%,ATP6AP1;NOTCH2
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.6800322639158027,1.06665926081904,0.42857142857142855,1.0,1.0,1/7,5.31%,WNT5A
prerank,PanglaoDB_Augmented_2021__B Cells,0.4467356424721915,1.0666407785171903,0.25301204819277107,1.0,1.0,27/111,15.08%,IL21R;BLNK;CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;JCHAIN;EBF1;FLI1;WAS;CD80;POLD4;NAPSB;IKZF1;TAGAP;CD37;TMC8;TNFSF4;ALOX5AP;PSTPIP1;SCD;MME;IGLL1;LY6D;PARVG;HMGA1
prerank,Reactome_2022__LGI-ADAM Interactions R-HSA-5682910,-0.559090191453045,-1.0663516445894017,0.2727272727272727,0.9533609625268876,1.0,3/14,13.12%,CACNG4;CACNG2;LLGL1
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.5110275337639405,1.066195185847603,0.36486486486486486,1.0,1.0,9/37,21.42%,IL12A;CA1;LCP1;SOD2;TALDO1;CFL1;MSN;RPLP0;ANXA2
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.5140130599074495,-1.0661840928278696,0.3888888888888889,0.9531697027204089,1.0,4/17,10.77%,NMU;CNN1;MYOCD;KCNB2
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.45011295055803463,1.0661527209799129,0.3253012048192771,1.0,1.0,17/91,17.96%,SGO1;CLDN6;BUB1;TICRR;SALL4;ERCC6L;NDC80;MCM3;PIF1;CCNA2;SLC7A3;BUB1B;GINS1;VASH2;PAICS;FBXO5;MSH6
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,0.441615617108886,1.0660221678335593,0.34177215189873417,1.0,1.0,48/127,24.42%,RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPS12;RPS4X;RPL27A;RPS19;FAU;RPS21;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;RPS15A;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;RPL23;RPS15;RPS27;GNL3;RPL8;RPS3;RPS23;RPS20;RPS24
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),0.6866611532873063,1.0660009244057198,0.40625,1.0,1.0,2/7,18.48%,KCNA5;SCN5A
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.648621086674777,1.0659239578951112,0.4262295081967213,1.0,1.0,2/7,21.26%,HERPUD1;BCAP31
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.5781310341824564,-1.0658677719937917,0.3333333333333333,0.9533023669852269,1.0,2/10,11.59%,XYLT1;B3GAT3
prerank,Reactome_2022__Drug-mediated Inhibition Of CDK4/CDK6 Activity R-HSA-9754119,0.6931158930224867,1.065725396198454,0.48484848484848486,1.0,1.0,2/5,7.94%,CCND2;CCND1
prerank,CellMarker_Augmented_2021__Fibroblast:Pancreas,-0.38550784007364364,-1.06561586815431,0.19047619047619047,0.9534168772586084,1.0,12/98,7.20%,FIBIN;ADAMTS12;BOC;CALD1;GPC6;COL4A2;MMP2;CLIP3;KIAA1549L;MEGF10;ZFHX4;FSTL1
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,-0.5259515139629992,-1.0656101851195372,0.3870967741935484,0.9527770857974833,1.0,6/19,11.68%,NGF;SHC3;RALB;NTRK1;RALGDS;MAPKAPK2
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.5529683106719397,1.0655357008382618,0.38028169014084506,1.0,1.0,2/22,9.64%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__progesterone metabolic process (GO:0042448),-0.6867117075709832,-1.0654982527573635,0.43478260869565216,0.9524791094043907,1.0,3/5,16.89%,AKR1C3;CYP46A1;AKR1C1
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",0.6766189090811365,1.0652331644848043,0.45901639344262296,1.0,1.0,2/7,8.62%,C4BPA;C4BPB
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.6766189090811365,1.0652331644848043,0.45901639344262296,1.0,1.0,2/7,8.62%,C4BPA;C4BPB
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.6766189090811365,1.0652331644848043,0.45901639344262296,1.0,1.0,2/7,8.62%,C4BPA;C4BPB
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.5559441967550269,1.0650519251280506,0.4,1.0,1.0,1/25,0.72%,LRP4
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.5859170174205489,-1.064934903824437,0.4318181818181818,0.9535173843958407,1.0,3/9,22.22%,AGO2;ADAR;TARBP2
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.4852769339986274,1.0647701078516512,0.4375,1.0,1.0,28/82,18.84%,C1QB;ADAM28;GPR55;FAM20A;C3;APOL6;FMO5;CPM;MAP3K19;VSIG4;FGL2;ANKUB1;SOD2;CD302;CP;HLA-DPB1;CSF1R;SLCO2B1;KCNE3;OMG;KCNJ2;GAS7;MSR1;FPR3;HSPA2;DNAH12;HVCN1;HLA-DPA1
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.6596759804748963,1.0645846937776164,0.4406779661016949,1.0,1.0,3/8,17.43%,UGT8;GBA3;B3GALT2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.3906699248596094,-1.0645695866237783,0.2727272727272727,0.9540345836149614,1.0,15/157,8.69%,ARC;NGF;TSKU;IFT88;ADCYAP1;GPRIN1;GPRIN3;RAB35;APOE;WNT7A;SHANK1;SAMD14;EPHB2;PPP1R9B;SRGAP2
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.6206036256181251,1.0641906651599113,0.48484848484848486,1.0,1.0,2/10,11.68%,VIL1;F2RL1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.45110909939310556,1.0640878408061767,0.325,1.0,1.0,20/90,14.40%,BLK;ADAM28;CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;CXCR5;NAPSB;IKZF1;TAGAP;CD37;TMC8;STAG3;PNOC;PSTPIP1;MYO1F;MME;PARVG
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5535161877828697,1.0638618150945462,0.3548387096774194,1.0,1.0,1/24,0.72%,LRP4
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.6701206850818034,1.0637566090477582,0.45901639344262296,1.0,1.0,1/6,14.31%,PCMT1
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.6018360019997403,1.0637452954572153,0.43661971830985913,1.0,1.0,7/15,25.81%,ODAD1;ZMYND10;DNAI1;ODAD2;CCDC63;ODAD3;DNAH8
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.5799320272791868,1.0637196324554168,0.40540540540540543,1.0,1.0,5/12,29.89%,PLN;KCNJ2;ATP1A1;RGS2;ATP1A2
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.4896215958486232,1.0636951284106937,0.373134328358209,1.0,1.0,22/46,25.98%,PWP2;DDX3X;EIF6;RPL3;MPV17L2;RPS5;MRPL20;NOP53;RPS19;RPL11;RPL23A;RSL24D1;MRPS2;RPSA;RPLP0;RPS14;RPL24;RPS15;RPS27;RPL10;RPS28;BRIX1
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,0.5269856354327078,1.0636569501469764,0.379746835443038,1.0,1.0,5/31,15.27%,UBE2L6;TRIM25;RPS27A;CYLD;ISG15
prerank,Reactome_2022__Hyaluronan Uptake And Degradation R-HSA-2160916,0.6587148603885047,1.0635446357084455,0.4642857142857143,1.0,1.0,3/11,14.71%,LYVE1;STAB2;CD44
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.5118328813122873,1.0635020051085666,0.3382352941176471,1.0,1.0,6/47,16.50%,TBX1;ANXA1;TGFB3;SOX9;ALOX15B;MSN
prerank,Reactome_2022__Synthesis Of UDP-N-acetyl-glucosamine R-HSA-446210,0.6640715810292466,1.0634893540986396,0.4915254237288136,1.0,1.0,1/8,1.99%,RENBP
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.6014230126813076,-1.063382121909178,0.40625,0.9570489019216712,1.0,4/13,25.54%,PPP5C;PPP1CA;PPM1F;NCK1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.5056969462936097,-1.0632003120279614,0.39285714285714285,0.9569903372917128,1.0,4/22,10.39%,BOC;OLFM2;BNIP2;MYOCD
prerank,GO_Biological_Process_2021__purine ribonucleoside catabolic process (GO:0046130),0.7192902594902769,1.0631727737860124,0.49019607843137253,1.0,1.0,2/5,8.22%,ADA;ENPP4
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.6299781086804296,1.0631166552304228,0.48,1.0,1.0,5/10,26.26%,B3GNT9;B4GAT1;B3GALT2;B3GNT3;B3GNT2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5182940754389036,1.0630417346709093,0.4647887323943662,1.0,1.0,6/33,18.70%,PDE6A;WNT5A;LEF1;GNAT2;PDE6B;PDE6G
prerank,CellMarker_Augmented_2021__Malignant Mesothelioma cell:Pleura,0.49766997506742316,1.0626649585807577,0.4050632911392405,1.0,1.0,16/53,16.75%,MACC1;PLEKHS1;RP1;ITGB6;MISP;MUC4;TMC4;TRIM29;LAMC2;BPIFB1;GPR87;LY6D;SERPINB5;DNAH3;AGR2;MUC16
prerank,CellMarker_Augmented_2021__Malignant Mesothelioma cell:Lung,0.49766997506742316,1.0626649585807577,0.4050632911392405,1.0,1.0,16/53,16.75%,MACC1;PLEKHS1;RP1;ITGB6;MISP;MUC4;TMC4;TRIM29;LAMC2;BPIFB1;GPR87;LY6D;SERPINB5;DNAH3;AGR2;MUC16
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.425469017303661,1.062655915529143,0.3614457831325301,1.0,1.0,51/250,17.26%,GATA4;S100A13;TLR2;NOX5;ANXA1;C3;STOML2;PTPRC;TGFB1;NFAM1;SCIMP;WNT5A;IL12A;AFAP1L2;SYK;IL27;NODAL;CD80;FLT4;NR1H4;IL26;IRF1;CYP1B1;HLA-A;C1QTNF4;HLA-DPB1;TNFSF4;F2RL1;LACC1;CD4;IL7;NFKB2;AGT;CSF1R;ITK;ELANE;POLR1C;IL4;ALOX15B;CYBA;CRTAM;ISG15;ZNF580;PIK3CG;AGER;HTR2B;CD244;RASGRP1;BRCA1;TIGIT;NOS2
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.6825726144691489,1.0626062277459067,0.39622641509433965,1.0,1.0,1/7,3.23%,POLQ
prerank,CellMarker_Augmented_2021__Epithelial cell:Undefined,0.5683808610642194,1.0625809445063745,0.38571428571428573,1.0,1.0,7/22,20.17%,SFTPD;ANPEP;EPCAM;KRT8;NOS2;IL1R1;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.581986764935698,1.0625606991963015,0.36,1.0,1.0,3/16,9.71%,VSIR;TGFB1;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),0.6863149134365482,1.0624820460219375,0.4696969696969697,1.0,1.0,3/7,20.02%,BTG1;STK17A;STK17B
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.632302384164637,1.0622873422390158,0.4461538461538462,1.0,1.0,2/9,10.00%,AXL;PPT1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestinal Crypt,-0.4089661886061139,-1.0622738635692863,0.3333333333333333,0.9589076746586458,1.0,7/71,4.03%,ADGRF4;EHF;MLPH;EMP1;ANXA8;ARSJ;RND3
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,0.6193132006975229,1.062240682010944,0.4576271186440678,1.0,1.0,2/15,15.18%,SALL4;EPHA1
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.46660987481020666,1.0621166363987269,0.3493975903614458,1.0,1.0,19/104,11.94%,MYH8;LMOD3;TMOD4;CASQ2;MYH4;LMOD1;MYBPC3;MYH11;CAV3;UTS2;ACTA2;MYH13;MYL6;MYOT;TRDN;CKMT2;GLRA1;MYL12A;CHRNB1
prerank,Reactome_2022__Defective B4GALT1 Causes B4GALT1-CDG (CDG-2d) R-HSA-3656244,0.7241380775766856,1.0619210286306613,0.4,1.0,1.0,2/5,10.10%,OGN;OMD
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.49276883258124604,1.0618685623114936,0.3870967741935484,1.0,1.0,10/51,13.70%,ITGB2;ACOX2;CIDEB;ITGAM;WNT5A;RAMP3;DDIT4;HPR;CDKN1B;CALCR
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.5667682354243774,1.061623744288739,0.4189189189189189,1.0,1.0,5/24,9.55%,RASGRP4;LPAR1;GPR55;P2RY6;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5905776786480941,1.0616216539857612,0.45161290322580644,1.0,1.0,2/14,8.21%,IGF1;HGF
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Salivary Gland,-0.5181247316078441,-1.0615662721225767,0.37037037037037035,0.9603220315236545,1.0,5/34,7.39%,P2RY10;IL16;BCL6;CD247;SELL
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.661023310122777,1.0614902440895766,0.4032258064516129,1.0,1.0,5/7,22.79%,ERAP2;HLA-A;TAP1;B2M;ERAP1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.46941036382127793,-1.061267077251992,0.38461538461538464,0.9607077093798708,1.0,14/47,17.70%,MTHFR;ASS1;GLUD2;MTHFD1L;DHFR;FPGS;OGDH;AADAT;GPT2;IDH2;ALDH18A1;ME2;SLC19A1;GOT2
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.3984237023684445,-1.0612154278739807,0.26666666666666666,0.9602096004016473,1.0,37/127,18.93%,NPTX2;EDARADD;RGS16;ADCYAP1;HOPX;SLC17A6;SEZ6L;CFC1;ABCC8;ELAVL3;TGFBR3;IGSF21;NTRK1;KCNIP1;DPP6;WSCD2;PCP4;GRIA4;KCNB2;ADGRA1;NOVA1;PCSK1;JPH3;SERTM1;CELF4;SVOP;PCDH17;MAFB;PLPPR1;PAK3;INSM1;SLC30A8;AMER3;RIMBP2;CDH22;ROBO2;PROX1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.5331590613350323,1.0611238919726764,0.36,1.0,1.0,7/28,15.97%,ADA;SYK;CYP1B1;P2RY12;PLAU;FERMT3;PIK3CG
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.5582781921865856,1.0610774420466216,0.42857142857142855,1.0,1.0,6/17,15.21%,ANXA1;FCGR3A;FLG;TGM2;THBS1;TGM6
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),0.6926081315133731,1.0609023565622455,0.45,1.0,1.0,1/5,2.83%,LRP2
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.5841425248060576,-1.060878036002035,0.3877551020408163,0.9606661449081016,1.0,6/12,30.21%,MSTO1;TRAK2;MAPT;MTM1;TRAK1;CLUH
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.5126694818025201,1.060690973556125,0.4264705882352941,1.0,1.0,13/32,17.55%,C1QTNF1;GP1BA;F8;CPB2;KNG1;PLAUR;F7;PLAU;VTN;PLAT;PLG;A2M;TFPI
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.38372603026170077,-1.0604047972209687,0.25,0.9614427920968504,1.0,15/110,12.83%,TBC1D10A;KLHL20;STX6;RAB7A;SNF8;GBF1;SNX32;RAB5A;DOP1B;SNX5;STX5;WASHC2C;EHD3;UBE2O;DENND2A
prerank,CellMarker_Augmented_2021__Mesothelial cell:Lung,-0.37910519922642155,-1.0601561916733586,0.3333333333333333,0.9601566013995098,1.0,20/95,15.32%,CALD1;ETV1;GPC6;COL4A2;KIAA1549L;ZFHX4;FSTL1;CAP2;INA;DCLK2;P3H3;WASF3;NECTIN3;FHOD3;ANTXR1;AADAT;NAV2;SLIT2;COL4A1;ADGRL2
prerank,CellMarker_Augmented_2021__Interstitial cell:Bladder,-0.37910519922642155,-1.0601561916733586,0.3333333333333333,0.9601566013995098,1.0,20/95,15.32%,CALD1;ETV1;GPC6;COL4A2;KIAA1549L;ZFHX4;FSTL1;CAP2;INA;DCLK2;P3H3;WASF3;NECTIN3;FHOD3;ANTXR1;AADAT;NAV2;SLIT2;COL4A1;ADGRL2
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Germ,-0.37910519922642155,-1.0601561916733586,0.3333333333333333,0.9601566013995098,1.0,20/95,15.32%,CALD1;ETV1;GPC6;COL4A2;KIAA1549L;ZFHX4;FSTL1;CAP2;INA;DCLK2;P3H3;WASF3;NECTIN3;FHOD3;ANTXR1;AADAT;NAV2;SLIT2;COL4A1;ADGRL2
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.4559974968646117,-1.0601338695365992,0.39285714285714285,0.9595454412433162,1.0,1/23,0.18%,COL22A1
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.5966847040211799,-1.0596570928725206,0.3157894736842105,0.9603556921099262,1.0,3/13,7.73%,TSKU;SPTBN4;EPHB2
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.6489579565708768,1.059634149836541,0.48333333333333334,1.0,1.0,2/9,22.25%,HSPA5;DDIT3
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),-0.7284523101452229,-1.0595991857658735,0.4090909090909091,0.9598694526905915,1.0,3/5,18.80%,SDCBP;SDC4;TSG101
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.5946418230032646,-1.0595811134873594,0.45,0.9592597570573106,1.0,3/13,10.92%,XKR7;MEGF10;RHOBTB2
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",-0.3981196579933778,-1.0595477269351221,0.2222222222222222,0.9587129240393389,1.0,18/91,17.00%,BCL2;FOS;CREB3L4;ITPR2;EGR1;CREB3L1;PLD2;MMP17;GNAS;GNA11;ADCY3;ADCY2;ARRB2;CREB3L2;RHOA;PRKCA;MAFB;ADCY6
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,0.4994340030419894,1.0595405297549645,0.43478260869565216,1.0,1.0,4/51,11.00%,ESR1;STAT5A;ERBB4;RPS27A
prerank,Reactome_2022__PI-3K cascade:FGFR1 R-HSA-5654689,0.5880111299993022,1.0593385613411885,0.375,1.0,1.0,1/18,2.58%,FGF20
prerank,Reactome_2022__NOSTRIN Mediated eNOS Trafficking R-HSA-203641,-0.688885761444315,-1.0592303442667748,0.38095238095238093,0.9590611036353783,1.0,2/5,21.51%,NANOS3;DNM2
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.7117529291548561,1.0591847040634546,0.42592592592592593,1.0,1.0,1/5,6.23%,STAT5A
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,-0.3998413374028386,-1.0591264886429124,0.38095238095238093,0.9589133186099679,1.0,11/61,16.90%,SEC24C;PPP6R1;SEC22A;TGFA;TRAPPC9;STX5;PREB;CNIH3;TRAPPC1;ANKRD28;F5
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Undefined,0.7124738203916426,1.0590501143589381,0.3709677419354839,1.0,1.0,3/5,14.71%,ANPEP;EPCAM;CD44
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),0.6994808537660258,1.0589782675549018,0.42857142857142855,1.0,1.0,1/5,2.37%,DAO
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.5903365845786903,1.058783163270877,0.43283582089552236,1.0,1.0,2/13,11.61%,DAZL;BOLL
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.5154426527398416,-1.0586712315061524,0.36666666666666664,0.9594023501675111,1.0,9/21,23.53%,TWIST1;FOSL1;MED16;MED1;MED17;SRF;JUN;DHX36;SETX
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.4666129927633888,1.0582695902302965,0.4358974358974359,1.0,1.0,12/85,13.42%,WNT8B;TCF7;FRAT1;WNT5A;WNT8A;LEF1;DDX3X;FZD8;RPS27A;WNT6;SFRP4;TCF7L1
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),-0.6944516296316426,-1.0579550184490922,0.4318181818181818,0.9608803139686521,1.0,2/5,19.07%,CRH;SYT7
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.6249615439207291,1.0579275809628805,0.41935483870967744,1.0,1.0,1/10,3.45%,TICRR
prerank,KEGG_2021_Human__ECM-receptor interaction,0.45974248352652297,1.0573652711795365,0.3375,1.0,1.0,19/76,14.71%,GP1BA;FREM2;ITGA2;COL6A5;COL6A6;ITGB6;COL4A4;COL4A3;ITGA5;COL4A6;COL4A5;LAMC2;COL6A2;VWF;VTN;COL1A1;THBS1;ITGA2B;CD44
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,0.4223423420397584,1.0570703611255095,0.34408602150537637,1.0,1.0,66/301,25.81%,COX6A1;NUP210L;TNFRSF1B;DNAH11;VAPB;ACTG1;ERBB4;ATP5PF;NDUFB11;HSPA5;GRIN2D;NDUFS2;PINK1;NEFM;COX7A2;DNAH10;ATG101;ATP5F1E;PSMC5;DNAI1;TUBA4A;TUBA3D;TUBB6;DNAH3;NDUFB10;NDUFA2;ATP5MC3;NOS2;GABARAPL2;COX4I1;TUBA1C;ACTR1B;DNAH12;APAF1;PSMA3;RAE1;COX7B;PSMB6;ULK1;NDUFB9;COX6C;GRIN2C;COX6B1;NDUFB4;PSMD6;SRSF3;NEFH;UQCRFS1;TUBB4B;DDIT3;DCTN3;DCTN1;NDUFA1;COX7A1;GABARAPL1;NDUFB2;COX5A;COX7C;NCBP1;PSMA7;VDAC1;GPX2;KLC2;PSMB1;ACTR10;DNAH8
prerank,GO_Biological_Process_2021__nephron tubule development (GO:0072080),-0.7084759875886155,-1.056952051250489,0.4418604651162791,0.963627719509266,1.0,1/5,1.74%,OSR1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.4468484544053209,-1.056565498870561,0.37037037037037035,0.9641919151685121,1.0,6/53,8.48%,BAMBI;WNT3A;APOE;MEN1;RALB;RIPK2
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.6305003040321395,-1.0564360936538462,0.4,0.9639529381701811,1.0,1/8,1.33%,IL16
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.5570734185619693,-1.0563089450274274,0.4482758620689655,0.9638376502800376,1.0,1/17,3.27%,PDZD11
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.5526916668023049,-1.05618320260677,0.4166666666666667,0.963493578540613,1.0,4/10,11.37%,TIE1;SCUBE1;FSTL1;JAG1
prerank,Reactome_2022__Acyl Chain Remodelling Of PE R-HSA-1482839,0.5357925988431214,1.0561422169458097,0.4406779661016949,1.0,1.0,2/20,10.49%,PLA2G10;MBOAT1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5626322785129044,-1.0559438219212531,0.3611111111111111,0.9636163480363908,1.0,3/10,5.65%,SH3RF1;CBFB;HLA-DRA
prerank,CellMarker_Augmented_2021__Brown Adipogenic Precursor cell:Adipose Tissue,0.46156361116310285,1.0558732984442045,0.3783783783783784,1.0,1.0,18/91,12.87%,PRRX1;CASQ2;LMOD1;FBXL7;MAB21L1;TMEM100;SGCG;PCDH18;JAM2;ANGPTL2;EBF3;GFRA1;DCN;COL1A1;ASPN;COLEC12;HMCN1;SFRP4
prerank,CellMarker_Augmented_2021__Beige Adipogenic Precursor cell:Adipose Tissue,0.46156361116310285,1.0558732984442045,0.3783783783783784,1.0,1.0,18/91,12.87%,PRRX1;CASQ2;LMOD1;FBXL7;MAB21L1;TMEM100;SGCG;PCDH18;JAM2;ANGPTL2;EBF3;GFRA1;DCN;COL1A1;ASPN;COLEC12;HMCN1;SFRP4
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.6747379672898346,1.055844206755162,0.423728813559322,1.0,1.0,2/7,15.53%,WAS;CXCL12
prerank,GO_Biological_Process_2021__calcitonin family receptor signaling pathway (GO:0097646),0.6485689769766989,1.0557430425979129,0.4,1.0,1.0,2/5,13.70%,RAMP3;CALCR
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.39086252999139315,-1.055741324996762,0.3181818181818182,0.963624635167095,1.0,29/79,25.78%,HNRNPL;CELF5;SRRM4;SRSF4;CIRBP;ZBTB7A;FXR2;SMU1;U2AF2;NOVA1;PTBP1;CELF4;THRAP3;RBM11;NUP98;RBMX;RBFOX2;RBM24;RBM8A;KHDRBS1;CELF2;RBM25;RBM4;SON;PCBP4;DAZAP1;PUF60;SFSWAP;METTL16
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,0.40987954627885675,1.0557114378033765,0.3829787234042553,1.0,1.0,117/599,20.90%,CLCA2;AQP3;SLC28A1;PSMB9;MCUB;SLC22A3;ABCC6;SLC9A2;SLC12A7;SLC5A4;SLC5A2;ATP6V1G2;SLC7A7;STOML2;CLCA4;SLC18A2;SLC16A8;GNG12;SLC12A3;TRPV6;SLC38A3;SLC22A8;TRPC7;SLC28A3;ABCG2;SLCO1A2;GPIHBP1;ABCC2;SLC17A8;SLC26A6;ANGPTL4;SLC4A1;CLCA1;ASIC5;CA1;SLC22A7;ATP1A4;SLC13A4;GNG4;ABCC11;ATP10B;TSC22D3;SLC22A6;SLC27A6;TTYH2;ATP6V0E2;TRDN;SLC15A1;SLC38A4;RAB11A;ASIC1;SLC5A9;CP;SLC9C1;LDLRAP1;ATP8B3;RPS27A;ATP6AP1;ANO2;SLC24A1;SLC25A18;ATP11C;AMN;SLC5A1;PLN;SLC39A7;SLC47A1;ANGPTL3;AQP4;SLC47A2;SLC35C1;PSMC5;SLC7A3;SLC9B1;ADCY7;SLC30A2;CLCN7;FTH1;SLCO2B1;SLC14A1;SLC22A4;SLC38A2;STOM;SLC46A1;CYBRD1;ABCG5;SLC16A1;SLC6A12;SLC16A3;ATP6V0B;SLC35D2;TF;CYB5R2;SEL1L;SLC44A3;FTL;ATP2A2;PSMA3;TRPM8;PSMB6;SCNN1A;CTNS;SLC7A10;SLC1A6;SLC26A4;KCNJ11;SLC25A22;SLC7A11;RHBG;PSMD6;GNGT1;ABCA12;GNB4;AQP11;RYR3;LRRC8A;BMP1
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.642929201154971,-1.055478643950528,0.5,0.963711997376025,1.0,3/7,22.22%,AGO2;ADAR;TARBP2
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.5001376454277109,1.0552539638882301,0.4342105263157895,1.0,1.0,6/59,11.20%,PLA2G10;TGFB1;GPER1;IGF1;TGFB3;ATP6AP1
prerank,Reactome_2022__Regulation Of Localization Of FOXO Transcription Factors R-HSA-9614399,-0.5767320186829193,-1.0552344684190895,0.47368421052631576,0.963825584183746,1.0,3/12,18.84%,FOXO1;YWHAQ;AKT2
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),0.6634237118692372,1.0552066102991275,0.45098039215686275,1.0,1.0,3/6,27.31%,OAS2;OASL;OAS1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6145622564604548,1.0552005095104553,0.39344262295081966,1.0,1.0,1/11,0.72%,LRP4
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.5619364512987269,1.0550777008999541,0.42857142857142855,1.0,1.0,5/20,14.14%,TGFB1;NODAL;TGFB3;DAB2;PBLD
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.3991242803301289,-1.0549547403351913,0.23809523809523808,0.9639828925495444,1.0,6/62,5.52%,TSKU;APOB;EPHX2;LIPC;APOE;CYP7B1
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.43292919726186757,1.0549447697144214,0.3253012048192771,1.0,1.0,67/195,25.85%,RPL37A;RPL21;MRPS34;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPL13;RPS12;RPS4X;RPL27A;MRPL34;EEF1A1;RPS19;YARS2;RPS21;RPL32;RPL11;RPL23A;EEF2;RPL35A;RPS11;COPS5;GFM2;RPS13;RPS7;RSL24D1;RPLP2;RPL7;RPL38;MRPS2;DARS2;ASMT;RPS15A;RPSA;RPLP0;RPS6;RPL35;IGF2BP3;RPL27;RPS14;RPL7A;RPL24;RPL23;RPS15;MRPL28;MRPL10;RPS27;RPL8;RPS3;RPS23;RPS20;RPS18;RPS24;MRPL37;RPL10;RPS29;RPLP1;RPS28
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),-0.5795309929884822,-1.0549331257898946,0.4594594594594595,0.9633770505298385,1.0,4/8,10.46%,PNP;PRTFDC1;NT5C1A;AMPD3
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.6209637244192752,1.0547311052711568,0.5087719298245614,1.0,1.0,3/12,8.08%,ELOVL2;TECRL;HACD4
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.6409816436803782,1.0546949473411398,0.43859649122807015,1.0,1.0,3/8,17.26%,BPIFB1;IL4;NOS2
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.519969424982889,-1.054599728370382,0.3333333333333333,0.9638674590296672,1.0,5/21,15.77%,LIMK1;ISLR2;GOLGA4;DBNL;MAP3K13
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),0.672888395269164,1.0545523830540333,0.4852941176470588,1.0,1.0,3/6,21.53%,MMP9;ANXA2;B2M
prerank,Reactome_2022__Signal Amplification R-HSA-392518,0.5164672583843817,1.0545332947421135,0.4,1.0,1.0,4/28,9.55%,GNAT3;GNG12;GNG4;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),0.7565959497898508,1.0544549564589827,0.5,1.0,1.0,3/5,21.26%,TGM2;FIS1;BCAP31
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.3892969360411476,-1.0544528855572872,0.3076923076923077,0.9637354223979949,1.0,25/96,20.54%,HNRNPL;CHD4;TTF2;ITGA4;URB2;CEP85;ZDHHC5;DDX11;NEU3;NOP14;RFWD3;UBE2O;PTBP1;SSRP1;GART;PABPC4;NUP98;NCAPD2;HDGF;UCP3;XPO5;DCAF1;TBRG4;POLG;ABCB10
prerank,CellMarker_Augmented_2021__Trophectoderm cell:Embryo,0.4792952038268279,1.05430186873371,0.4,1.0,1.0,10/81,11.07%,OLFML1;FRMD4B;LRP2;SLC12A3;SLC28A3;ABCG2;TMEM171;C4BPB;PPT1;DAB2
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.4516046885406076,-1.0542882852208342,0.28,0.9636298200956432,1.0,17/53,22.16%,PLK3;MAP10;CLIP3;PCM1;TUBGCP2;CLIP2;SPAST;SLK;CHP1;RHOA;CCDC88A;CAMSAP3;HOOK3;MAPT;CCDC88B;TRPV4;CCDC88C
prerank,CellMarker_Augmented_2021__Naive T cell:Bone Marrow,0.4747484561091587,1.0542624188758374,0.37662337662337664,1.0,1.0,15/54,13.09%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;GMFG;SASH3;PTPRC;WAS;IKZF1;TAGAP;CD37;GPR183;ALOX5AP;PSTPIP1;MYO1F
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.5345067236028407,1.054251906322731,0.410958904109589,1.0,1.0,1/32,0.47%,RAB34
prerank,CellMarker_Augmented_2021__MKI67+ Progenitor cell:Large Intestine,0.4559247042791373,1.0542422881871778,0.37333333333333335,1.0,1.0,22/81,17.55%,APOLD1;TK1;CYYR1;FLT1;EBF1;JAM2;ASPM;NDC80;DIPK2B;RAMP3;HEG1;TRAIP;VWF;CLDN5;CASP10;HMCN1;CCNA2;ANLN;NUF2;ENG;TSPAN7;TFPI
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.48130984178826,-1.0541129673288163,0.28125,0.9635156161870163,1.0,10/36,18.95%,LARS2;VARS1;QRSL1;WARS2;CARS1;MARS1;FARSA;GATB;HARS2;YARS1
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,0.4682351483460716,1.054061703260864,0.35135135135135137,1.0,1.0,4/71,3.43%,CAVIN1;ARHGEF40;CCDC187;VAPB
prerank,CellMarker_Augmented_2021__Muscle Satellite cell:Muscle,-0.41028886692662636,-1.0540417467642764,0.3333333333333333,0.9630956843792983,1.0,15/84,11.86%,COL22A1;CAMK1G;EMP1;BOC;CAPN2;MEGF10;CXCL14;CDCP1;MS4A8;TAGLN3;CHST6;PTPRZ1;ADGRA1;TPPP3;HYDIN
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.38624757358613154,-1.0539734494079773,0.2777777777777778,0.9626850574873843,1.0,30/109,23.61%,NGF;GPC2;APOE;STYXL1;ARSB;NTRK1;RAPGEF1;P3H1;DAB2IP;ZNF804A;CUX1;SLIT2;PLXNA4;MARK2;AVIL;MAP3K13;RHOA;ARHGAP35;ROBO2;CUX2;CUL7;FZD1;PLXNA2;NTRK2;GRIP1;SS18L2;MAP6;MAGI2;SETX;PLK5
prerank,Reactome_2022__Coenzyme A Biosynthesis R-HSA-196783,-0.5580815403587319,-1.0539292866332324,0.37142857142857144,0.9621353466062914,1.0,4/8,22.67%,PPCDC;PANK1;PPCS;SLC25A16
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.6405992596265234,1.0539006698231224,0.47761194029850745,1.0,1.0,1/10,5.05%,HEY2
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.6847680958414567,1.0538899233936283,0.48148148148148145,1.0,1.0,3/8,13.99%,RP1;RPGRIP1;SOX9
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.5427580804061113,1.0538516124915858,0.45588235294117646,1.0,1.0,2/28,11.25%,TENT5B;MEIOC
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.394091206132001,-1.0538179033713713,0.3157894736842105,0.9618305905995381,1.0,14/101,8.02%,DRD4;RASSF2;TYRO3;TIE1;KIT;ADCYAP1;VAC14;CCN1;ERBB2;EPHA6;NTRK1;RAD50;EPHB2;INSRR
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),0.6708397779700678,1.0537871028650236,0.4827586206896552,1.0,1.0,1/6,11.77%,COLEC12
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.4961980655258299,1.0537728265055146,0.44871794871794873,1.0,1.0,15/67,17.26%,EOLA1;TLR2;NLRP12;SCIMP;WNT5A;AFAP1L2;SYK;C1QTNF4;NLRC3;TNFSF4;F2RL1;CYBA;AGER;GHRL;NOS2
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.5435660791799138,1.0536974933950394,0.3380281690140845,1.0,1.0,4/27,5.31%,GATA4;LRP2;SIX4;WNT5A
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.6377046368591559,1.0536655576903067,0.43548387096774194,1.0,1.0,2/7,20.24%,TRMT10A;TRNT1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.482940453013889,-1.053636819436544,0.37037037037037035,0.9617790063700393,1.0,6/40,11.45%,KIFC1;MAP10;FLNA;KIF4B;AAAS;KIFC2
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.48975481108529506,-1.053532192740532,0.39473684210526316,0.9613790969463706,1.0,5/31,9.76%,PRDM5;KMT2B;SMYD2;MEN1;DYDC1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.62349059533842,1.0534799819814011,0.4915254237288136,1.0,1.0,3/12,12.42%,SEMA3A;PLXNA3;SEMA3F
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.5680665635747896,1.0533032530372584,0.3492063492063492,1.0,1.0,6/13,21.06%,GAD1;ACOT4;GLUL;QPRT;ASPA;PM20D2
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),0.737632917879869,1.053284097849455,0.44,1.0,1.0,3/5,22.64%,ALDOB;GLYCTK;TKFC
prerank,Reactome_2022__Fructose Catabolism R-HSA-70350,0.737632917879869,1.053284097849455,0.44,1.0,1.0,3/5,22.64%,ALDOB;GLYCTK;TKFC
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),0.737632917879869,1.053284097849455,0.44,1.0,1.0,3/5,22.64%,ALDOB;GLYCTK;TKFC
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.5129874736337257,-1.053255605120022,0.4,0.9614236324801906,1.0,4/24,10.96%,RHEX;STAT5B;ETS1;ZNF16
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.6940622893830949,1.053240660941985,0.4716981132075472,1.0,1.0,2/6,11.19%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.6940622893830949,1.053240660941985,0.4716981132075472,1.0,1.0,2/6,11.19%,TGFB1;STAT1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Fetal Liver,0.6804551623347161,1.0532151016763898,0.42857142857142855,1.0,1.0,2/5,14.71%,PTPRC;CD44
prerank,Reactome_2022__Metabolism Of Amine-Derived Hormones R-HSA-209776,0.6095987635065033,1.0531711365336527,0.43548387096774194,1.0,1.0,3/13,8.05%,IYD;DBH;DUOX1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.4413956790332556,1.0529669385653002,0.36046511627906974,1.0,1.0,10/67,14.49%,LMOD1;C15ORF62;VASP;BAIAP2L1;HCK;VIL1;F2RL1;ALOX15;GPSM2;CARMIL1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.39818981144482485,-1.0528997807414449,0.3076923076923077,0.9619378038610502,1.0,8/62,8.12%,P2RY10;MYO9B;PRAG1;APOE;SCAI;F11R;STARD8;BCR
prerank,CellMarker_Augmented_2021__Mast cell:Undefined,0.579349725924087,1.0525759029346988,0.39705882352941174,1.0,1.0,2/12,3.81%,CSF2RA;PTPRC
prerank,Reactome_2022__Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,0.6227606918530639,1.0525395812108032,0.44285714285714284,1.0,1.0,3/13,17.02%,ATP5PF;ATP5F1E;ATP5MC3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),0.7189776284469177,1.0525046365353645,0.5,1.0,1.0,4/5,28.09%,HLA-F;CEACAM1;SPI1;LGALS9
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex3:Brain,-0.4242284152338615,-1.0524989029292913,0.30434782608695654,0.9624078180612431,1.0,19/101,14.08%,SPHKAP;CDH20;VWC2;GRID2;TMEM132C;TRPC3;ZNF385D;SRRM4;DPP6;RNF150;SLITRK2;DOK6;FRRS1L;RGMA;GRIA4;ADCY2;NOVA1;VIPR2;CELF4
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.36122149464704584,-1.0523512248665032,0.26666666666666666,0.9622170368708646,1.0,36/229,17.97%,CPSF1;NUP210;HNRNPL;TXNL4A;NUP42;MAGOHB;PDCD7;LSM7;POM121C;NUP214;SRRM1;SUGP1;SRSF4;SNRPB;AAAS;HNRNPF;DDX46;SF3A2;SYMPK;U2AF2;CSTF2;PTBP1;CPSF7;POLR2F;ZMAT5;GPKOW;NUP37;SNRPN;POLR2C;ISY1-RAB43;HNRNPUL1;NUP98;RNPC3;RBMX;PCF11;CPSF4
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.6518526113193273,1.0522496051121268,0.4838709677419355,1.0,1.0,1/10,0.35%,TBX1
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Brain,0.4661113661029952,1.052221853660542,0.32894736842105265,1.0,1.0,16/52,17.06%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;IKZF1;TAGAP;CD37;TMC8;PSTPIP1;SIRPG;PARVG;CD244;ZAP70;TIGIT
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.4763864970096873,1.0517677579999878,0.35526315789473684,1.0,1.0,11/63,14.49%,LMOD1;KANK3;C15ORF62;VASP;ARHGAP28;BAIAP2L1;HCK;VIL1;RASA1;ALOX15;CARMIL1
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.6651755977559923,1.05166622459365,0.4032258064516129,1.0,1.0,2/7,12.73%,GPR55;IL7
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5826075346144175,-1.0514352863663534,0.2894736842105263,0.9643268288081324,1.0,1/11,4.78%,APOE
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,0.41379765987242323,1.051378871762426,0.4166666666666667,1.0,1.0,41/238,21.18%,CDC25A;SGO1;PSMB9;BUB1;CENPU;RRAD;H2BC4;ERCC6L;CDKN2A;NDC80;MCM3;RPA3;CCNE2;RPS27A;KIF18A;PPP2R5A;SKA2;CDKN1B;CDKN1A;CCNA2;PKMYT1;PSMC5;NUF2;SPC25;ARTN;BUB1B;RMI2;ORC4;BRCA1;DYNLL1;ITGB3BP;YWHAH;PSMA3;PSMB6;RAD9B;CENPN;CENPL;CDC25C;PSMD6;CENPS-CORT;CCNB1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4695477992017153,-1.0512942782568586,0.4166666666666667,0.9640482631079345,1.0,2/23,1.49%,DRD4;CBARP
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6329206712753176,1.0511688130795505,0.5,1.0,1.0,1/11,3.51%,FGF2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),0.7190730535819247,1.0511643533617427,0.43478260869565216,1.0,1.0,1/5,5.31%,WNT5A
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),0.7190730535819247,1.0511643533617427,0.43478260869565216,1.0,1.0,1/5,5.31%,WNT5A
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.4478660817053452,1.051152678257158,0.35,1.0,1.0,14/116,9.92%,AMBP;GPHB5;GPR27;TSHR;FCGR3A;RNF26;SCTR;SYK;GGT5;ADRB1;RAMP3;RXFP2;HCK;NLRC3
prerank,Reactome_2022__Phospholipase C-mediated Cascade: FGFR1 R-HSA-5654219,0.605120727072809,1.0511438824946173,0.44642857142857145,1.0,1.0,1/13,2.58%,FGF20
prerank,CellMarker_Augmented_2021__CD8+ T cell:Liver,-0.5270285403549925,-1.0510566596529436,0.36666666666666664,0.9627213698638846,1.0,2/25,4.55%,P2RY10;CD247
prerank,CellMarker_Augmented_2021__CD8+ Cytotoxic T cell:Peripheral Blood,-0.5270285403549925,-1.0510566596529436,0.36666666666666664,0.9627213698638846,1.0,2/25,4.55%,P2RY10;CD247
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Liver,-0.5270285403549925,-1.0510566596529436,0.36666666666666664,0.9627213698638846,1.0,2/25,4.55%,P2RY10;CD247
prerank,CellMarker_Augmented_2021__B cell:Spleen,0.4607733023513942,1.0510312944797875,0.379746835443038,1.0,1.0,16/60,16.42%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;NAPSB;IKZF1;TAGAP;CD37;TMC8;PSTPIP1;MYO1F;PARVG;PIK3CG;CD244
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.5605215991798299,-1.0508435978029997,0.3870967741935484,0.9627128236804392,1.0,4/15,7.78%,SARM1;DHFR;RTN4RL2;MORN4
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4623698978068232,1.0508392756449076,0.3918918918918919,1.0,1.0,12/86,8.80%,GPHB5;GPR27;TSHR;FCGR3A;SCTR;CD81;SYK;GGT5;ADRB1;RAMP3;RXFP2;HCK
prerank,Reactome_2022__NF-kB Activation Thru FADD/RIP-1 Pathway Mediated By Caspase-8 And -10 R-HSA-933543,0.6137191539309489,1.0508337953966644,0.40625,1.0,1.0,4/12,25.66%,TRIM25;CASP10;IFIH1;CASP8
prerank,CellMarker_Augmented_2021__Lymphoid-primed Multipotent Progenitor cell:Umbilical Cord Blood,0.4701752729455053,1.0508088074492006,0.4,1.0,1.0,12/66,17.26%,CYTIP;LY6G5C;PROX2;EBF1;SSC4D;KCTD9;PRAME;OAS2;ALOX15B;MTUS1;QPRT;GAS7
prerank,CellMarker_Augmented_2021__Sertoli cell:Seminal Plasma,0.48252392549781886,1.0507026775130084,0.40540540540540543,1.0,1.0,19/66,13.41%,AMBP;ITIH2;DAO;SLC38A3;SERPIND1;PON1;SLC22A7;SMLR1;CPB2;RANBP3L;KNG1;F7;HPR;CP;VTN;SLC25A18;AGT;ANGPTL3;AQP4
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.47312826386011547,1.0506642082983906,0.379746835443038,1.0,1.0,13/64,16.47%,BLK;FLT1;SYK;ERBB4;FLT4;HCK;CSF1R;ITK;IL4;DDR2;EPHA1;MAPK3;ZAP70
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),0.6726992555692923,1.050529332828341,0.3939393939393939,1.0,1.0,5/7,29.69%,SFRP4;GCM2;FGFR4;ENPP1;SLC34A2
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.669366861371773,1.0504049264756798,0.46875,1.0,1.0,1/8,4.58%,CCDC39
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Peripheral Blood,0.5581295260696786,1.0503294588768017,0.4307692307692308,1.0,1.0,5/22,7.33%,GP1BA;ITGAX;ITGAM;CD81;ITGA5
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.6163162508019966,1.0502545134934447,0.40298507462686567,1.0,1.0,3/7,22.63%,GPS2;OTUB1;PARP10
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),-0.5697048674106933,-1.0502509904152268,0.4074074074074074,0.9640010933117159,1.0,6/14,22.58%,MLYCD;MVK;TDO2;PPCS;ACACB;NUDT7
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.5308511872977073,1.050248855728298,0.4032258064516129,1.0,1.0,7/33,15.93%,FGF2;TGFB1;F7;P2RY12;F2RL1;THBS1;ZNF580
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.6332329565389125,1.0502126799251696,0.5084745762711864,1.0,1.0,3/11,21.25%,SLCO1A2;SLCO2B1;SLCO6A1
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.6391519730664357,1.050204026963665,0.38235294117647056,1.0,1.0,4/7,31.04%,LEF1;HLA-DRB1;TMEM98;IL18
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.6606022121870307,-1.050163459737293,0.5333333333333333,0.9622301013576819,1.0,1/6,0.26%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.6606022121870307,-1.050163459737293,0.5333333333333333,0.9622301013576819,1.0,1/6,0.26%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.6606022121870307,-1.050163459737293,0.5333333333333333,0.9622301013576819,1.0,1/6,0.26%,TACR3
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.6896398854444817,1.0501399562327935,0.4909090909090909,1.0,1.0,2/5,19.64%,HMGA2;RPS6KA5
prerank,KEGG_2021_Human__Huntington disease,0.4367318591191788,1.0501243869324237,0.4044943820224719,1.0,1.0,60/260,25.81%,COX6A1;SLC25A31;DNAH11;ATP5PF;TBPL1;REST;NDUFB11;NDUFS2;SOD2;TGM2;UCP1;COX7A2;DNAH10;ATG101;ATP5F1E;PSMC5;DNAI1;TUBA4A;TUBA3D;BBC3;TUBB6;DNAH3;NDUFB10;NDUFA2;ATP5MC3;COX4I1;TUBA1C;ACTR1B;DNAH12;APAF1;PSMA3;COX7B;PSMB6;DLG4;ULK1;NDUFB9;CREB3;COX6C;COX6B1;NDUFB4;PSMD6;UQCRFS1;TUBB4B;DCTN3;DCTN1;NDUFA1;COX7A1;NDUFB2;COX5A;COX7C;PLCB4;PSMA7;PPARGC1A;VDAC1;GPX2;KLC2;PSMB1;CASP8;ACTR10;DNAH8
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Premolar,0.6397259281408911,1.0500205923878676,0.5,1.0,1.0,4/8,7.30%,PTPRC;ITGAM;ANPEP;NT5E
prerank,GO_Biological_Process_2021__regulation of ribonuclease activity (GO:0060700),0.6662841969060482,1.0499333006726717,0.46,1.0,1.0,3/5,27.31%,OAS2;OASL;OAS1
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,0.5084692404474056,1.049817912388907,0.463768115942029,1.0,1.0,6/45,20.47%,PSMB9;RPS27A;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.5980428764382814,1.0497944223605966,0.463768115942029,1.0,1.0,1/10,4.45%,SYNE2
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.6035004137985365,1.0495636845205512,0.4461538461538462,1.0,1.0,7/13,35.02%,CD81;RAB29;RPS3;RELA;CARD11;NECTIN2;CD226
prerank,Reactome_2022__Defective GALNT3 Causes HFTC R-HSA-5083625,0.6019650210291627,1.0495465583638972,0.4426229508196721,1.0,1.0,4/13,16.75%,MUC17;MUC4;MUCL1;MUC16
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.6740534067678627,1.0493681352195197,0.5373134328358209,1.0,1.0,2/7,8.67%,SHISA6;GRIN2D
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.4872758078889573,-1.0490957686418017,0.3333333333333333,0.9645585130443047,1.0,4/31,4.55%,P2RY10;S100B;HOPX;CD247
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.42410424664961566,-1.0490710261270495,0.5,0.9639542400913107,1.0,19/123,11.62%,RFX6;CNGA3;VWA5B2;ARX;ADCYAP1;SLC17A6;CFC1;ABCC8;ELAVL3;TTBK1;LHFPL4;INA;KCNIP1;HPCA;TAGLN3;GRIA4;KCNB2;ADGRA1;ALCAM
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),0.6642338413328106,1.0490690465739274,0.4838709677419355,1.0,1.0,2/9,16.34%,ADGRG1;HTR2B
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),-0.7098829278109019,-1.048979962709309,0.5161290322580645,0.9636693688571104,1.0,1/5,1.67%,SLC25A29
prerank,GO_Biological_Process_2021__cell differentiation involved in metanephros development (GO:0072202),-0.6582761478722463,-1.048854032706934,0.574468085106383,0.9634279034912423,1.0,1/7,1.74%,OSR1
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,0.4770942798685091,1.0488504078931808,0.44285714285714284,1.0,1.0,7/61,8.04%,ESR1;PIK3R3;GNAT3;GNG12;MMP9;CCND1;GNG4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.5531315424154191,1.048833853309421,0.45161290322580644,1.0,1.0,5/24,19.02%,PKP2;CAV3;CTNNA3;ATP2A2;TBX18
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.6214030435068213,1.0487444989228552,0.4666666666666667,1.0,1.0,3/12,13.69%,SEMA3A;LAMC2;RHOG
prerank,GO_Biological_Process_2021__determination of left/right asymmetry in lateral mesoderm (GO:0003140),0.7239630390826041,1.0486765642808744,0.4918032786885246,1.0,1.0,3/5,26.03%,DAND5;CITED2;FOXH1
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),-0.4464985278014201,-1.0483923638773873,0.4583333333333333,0.9641240566491148,1.0,5/35,7.73%,ARC;DCDC2;WNT7A;SHANK1;EPHB2
prerank,CellMarker_Augmented_2021__Syncytiotrophoblast:Placenta,-0.47791138177893033,-1.04823813990508,0.3548387096774194,0.9637966773721179,1.0,3/29,3.47%,GPR78;DPPA2;LIN28B
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,0.5354114423928699,1.0481970343389335,0.4090909090909091,1.0,1.0,4/26,11.35%,WNT8B;FRAT1;WNT8A;PPP2R5A
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.5383421609481606,1.048169580499257,0.47540983606557374,1.0,1.0,4/15,15.93%,F7;F2RL1;MTUS1;ZNF580
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.5300948099998383,-1.0481546596676832,0.4375,0.9633495105913891,1.0,3/8,2.45%,SLC25A29;SLC6A20;SLC25A45
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.4552987567117268,1.0481304320096865,0.3684210526315789,1.0,1.0,22/86,13.42%,BLK;ADAM28;CYTIP;ARHGAP9;AIM2;GMFG;SASH3;PTPRC;WAS;CXCR5;CD80;NT5E;NAPSB;IKZF1;TAGAP;CD37;TMC8;ZBTB32;TMEM156;PNOC;IL7;CLCA3P
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.43643271772056785,-1.047699212396431,0.2857142857142857,0.9640357383286801,1.0,9/54,11.37%,DTX1;WWC1;POFUT1;MAML1;HES1;ASCL1;JAG2;SNAI2;JAG1
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,-0.4297192815847782,-1.0476204472481518,0.275,0.9636061613928664,1.0,6/32,16.59%,CFLAR;CLIP3;USP4;SHARPIN;RBCK1;TRAF1
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,-0.4337279577059526,-1.0476035840799567,0.4090909090909091,0.9630143216160353,1.0,6/41,3.97%,COL22A1;COL6A3;COL4A2;COL12A1;COL13A1;COL8A1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.6734338552709731,-1.0475974378436137,0.42105263157894735,0.9623890130127112,1.0,1/5,10.66%,AGO2
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Lung,0.4550042549432845,1.0474821083673276,0.32098765432098764,1.0,1.0,26/89,20.39%,TIMP3;LPAR1;ARHGAP24;AOX1;MMP19;ITGBL1;ANPEP;ITGA5;PDCD1LG2;ADGRL4;PLAU;TGM2;DAB2;FOSL2;THBS1;TNS3;FILIP1L;TGFBI;EHD2;FAM114A1;LAMB2;VEGFC;PDLIM5;IL1R1;PRSS23;FN1
prerank,Reactome_2022__GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,-0.4941664945107902,-1.0472645581528834,0.35294117647058826,0.9628857551560444,1.0,11/25,15.86%,XYLT1;GPC6;GPC2;SDC3;GPC4;AGRN;VCAN;B3GAT3;CSPG5;GPC1;SDC4
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.5671095479856714,-1.0472130968289364,0.4222222222222222,0.9623982166963131,1.0,4/11,16.65%,PACSIN2;PACSIN3;SNX33;SNX9
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.5209547744624135,-1.047203909934252,0.3448275862068966,0.9617745672346202,1.0,2/18,4.09%,CDH13;RGN
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.587592261463786,-1.0471141611689692,0.42857142857142855,0.9613567514400744,1.0,4/7,33.84%,BRPF3;KAT7;ING5;MEAF6
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5228205282855583,1.0470058246106633,0.43548387096774194,1.0,1.0,1/30,0.46%,ESR1
prerank,Reactome_2022__Regulation Of Gene Expression In Beta Cells R-HSA-210745,-0.5738155382644227,-1.046906329072758,0.4444444444444444,0.9613492262287652,1.0,2/15,3.43%,RFX6;FOXO1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5698859635521855,1.0467650283052958,0.4426229508196721,1.0,1.0,5/19,18.41%,RGPD1;RGPD3;KPNA5;RGPD4;RGPD2
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.4647204332845122,1.0465592312276952,0.35526315789473684,1.0,1.0,21/111,13.70%,CHRNA9;ESR1;C1QTNF1;C3AR1;LPAR1;TRPC7;WNT5A;CAV3;GPER1;PTGER3;NMUR2;CXCR5;ACKR4;KNG1;CALB1;F2RL1;TAC4;XCR1;PLN;FPR1;CALCR
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.6096008409316045,1.0461009732401072,0.4444444444444444,1.0,1.0,3/10,26.20%,LCP1;MROH2B;TTN
prerank,CellMarker_Augmented_2021__Colony-forming cell:Prostate,-0.36602876375906107,-1.0459501532225874,0.36363636363636365,0.9636108169685839,1.0,23/88,13.45%,EMP1;PHLDB2;CALD1;COL12A1;FRMD6;ARSJ;LAMA3;CAPN2;KIAA1671;PARVA;ADGRG6;TGFA;FSTL1;PERP;NTN4;ITGB4;ITGA3;PAM;NECTIN3;JAG1;PCDH1;OSBPL10;AMOTL2
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.43715610542685934,-1.0456695026325495,0.375,0.9638490244935141,1.0,21/62,22.56%,TRDMT1;METTL1;METTL6;TRMT61B;ADAT2;TRMT61A;ALKBH8;THG1L;QTRT2;PUS7;PUS10;WDR4;CTU1;QTRT1;TRMT9B;DTWD1;TARBP1;PUSL1;TRMT1;ANKRD16;MTO1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.4749230844827327,-1.0456245925522465,0.3225806451612903,0.9633713070849026,1.0,7/24,14.77%,MLYCD;PNP;PRTFDC1;NT5C1A;AMPD3;NUDT4B;NUDT18
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone Marrow,0.574627007301465,1.0455236013057758,0.4393939393939394,1.0,1.0,7/16,16.35%,PTPRC;ANPEP;NT5E;CD4;MME;CD44;ENG
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.6685486834315791,-1.045464940774239,0.4888888888888889,0.963226249873152,1.0,3/5,20.05%,KCNE1;KCNH2;KCNE2
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,0.5504371374241198,1.0453924425091623,0.43661971830985913,1.0,1.0,3/22,7.24%,ACOX2;HSD3B7;NR1H4
prerank,KEGG_2021_Human__Thyroid cancer,0.5260783245100955,1.045335271940444,0.4507042253521127,1.0,1.0,7/37,15.19%,TCF7;LEF1;CCND1;CDKN1A;TCF7L1;RXRG;MAPK3
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Uterus,0.45473682784628133,1.0453031392046859,0.36486486486486486,1.0,1.0,7/80,7.75%,APOL1;RRAS;CLCF1;HSD3B7;C3;ANPEP;DRAM1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),0.7067749902895952,1.0452433631045048,0.46551724137931033,1.0,1.0,2/5,9.05%,MMP9;PLAUR
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5879860732964566,-1.0452349793684217,0.4883720930232558,0.9626901472558678,1.0,2/9,29.52%,MYLIP;CLTA
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5879860732964566,-1.0452349793684217,0.4883720930232558,0.9626901472558678,1.0,2/9,29.52%,MYLIP;CLTA
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.4408831999441902,1.0451935376438721,0.3855421686746988,1.0,1.0,52/165,25.85%,PWP2;RPL37A;RPL21;RPL9;RPL18A;EIF6;RPS9;RPL3;RPL36;RPL13A;EXOSC8;RPS16;RPL15;EXOSC2;RPL41;RPL13;RPL27A;NOB1;NOP53;RPS19;EXOSC4;RPL32;RPL11;RPL23A;RPL35A;RPS7;WDR36;RPLP2;RPL7;TSR3;RPL38;EMG1;RPLP0;RPS6;RPL35;RPL27;RPS14;RIOK2;RPL7A;RPL24;RPL23;RPS15;WDR18;RPS27;RPL8;SENP3;WDR12;RPS24;RPL10;RIOK3;RPLP1;RPS28
prerank,Reactome_2022__p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,0.6008312389143592,1.0450378561295197,0.4307692307692308,1.0,1.0,4/11,20.39%,VWF;ITGA2B;BCAR1;FN1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.4492688469261746,-1.0449756015034681,0.3448275862068966,0.9629196792476883,1.0,6/38,12.03%,MFSD2A;SARM1;LZTS1;KIAA0319;BCL11A;DAB2IP
prerank,CellMarker_Augmented_2021__Epithelial cell:Cornea,-0.5394747780132064,-1.0449130412743335,0.32432432432432434,0.9624611381998719,1.0,2/20,1.40%,ADGRF4;ANXA8
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.6309913076146134,-1.0448637607418427,0.40540540540540543,0.9619522910756483,1.0,3/5,18.26%,ABCC4;SLC19A1;ABCC5
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.5783055602983964,1.0446845173789203,0.45714285714285713,1.0,1.0,2/16,11.19%,ST18;STAT1
prerank,Reactome_2022__Adenylate Cyclase Inhibitory Pathway R-HSA-170670,0.603156909110902,1.0446695728066506,0.4225352112676056,1.0,1.0,2/12,14.32%,GNAT3;ADCY7
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.6201021704430423,1.0446399473449925,0.4032258064516129,1.0,1.0,1/11,6.03%,CD81
prerank,CellMarker_Augmented_2021__Endothelial cell:Lung,0.6126554973678109,1.0446360905993282,0.5,1.0,1.0,3/8,10.33%,LYVE1;FLT1;VWF
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.4805120591221003,1.0445889475875405,0.39080459770114945,1.0,1.0,11/68,14.49%,HSPA8;DNAJB1;PON1;NR1H4;APOM;HSPA5;DDX3X;TMC8;NOP53;TFIP11;CARMIL1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.4302801050477835,1.0444545181797515,0.32142857142857145,1.0,1.0,49/184,24.42%,PWP2;RPL37A;RPL21;RPL9;RPL18A;EIF6;RPS9;RPL3;RPL36;RPL13A;EXOSC8;RPS16;RPL15;EXOSC2;RPL41;RPL13;RPL27A;NOB1;NOP53;RPS19;EXOSC4;RPL32;RPL11;RPL23A;RPL35A;GLUL;RPS7;WDR36;RPLP2;RPL7;RPL38;EMG1;RPLP0;RPS6;RPL35;ZNF622;RPL27;RPS14;RIOK2;RPL7A;RPL24;RPL23;RPS15;WDR18;RPS27;RPL8;SENP3;WDR12;RPS24
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.4319128192033839,-1.044431282558951,0.3333333333333333,0.9626058438013106,1.0,17/83,12.31%,SPRY4;TRIB2;PRKCD;PDGFD;KIT;FGF18;APOE;ERBB2;FGF1;ADAM8;PTPRJ;SNF8;TRIB1;SPRY1;DUSP19;DAB2IP;EDN3
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.3889147202769572,-1.0443637069076244,0.2916666666666667,0.9622331595751156,1.0,21/92,16.44%,CDH20;SLITRK6;CDH5;KIRREL3;CDH19;NLGN3;FLNA;CDH9;PCDHB6;FSCN1;SDK2;NLGN2;PCDHB9;NRXN2;CDH12;DBNL;CDH11;PARD6B;LIMS1;CDK5;RHOA
prerank,Reactome_2022__Lysosphingolipid And LPA Receptors R-HSA-419408,0.624126266166859,1.0440008389328204,0.4411764705882353,1.0,1.0,1/11,1.71%,LPAR1
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.5686797507761464,1.0439129241406027,0.4647887323943662,1.0,1.0,4/17,23.43%,NOP53;DDX60;USP17L2;OASL
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.4508100330894394,-1.043905074808812,0.4074074074074074,0.9631312535553505,1.0,7/35,11.91%,ACAD10;THEM4;MECR;ACADS;ECHS1;ACOT9;DECR1
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.5342694062042995,-1.0435206865649305,0.41025641025641024,0.9637404216839529,1.0,5/9,21.90%,SHANK1;ADCY3;BRSK1;CLN3;DRD2
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.5269252774394226,-1.043515513927051,0.3235294117647059,0.9631224614096111,1.0,4/17,8.58%,MTHFR;MTHFD1L;DHFR;FPGS
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,0.5476252973305672,1.043451237765378,0.3918918918918919,1.0,1.0,6/20,27.56%,RPS27A;SYVN1;SEL1L;RNF5;DERL2;AMFR
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.41536623365284303,-1.0434210676131002,0.34615384615384615,0.9627166110667801,1.0,8/54,14.05%,DDX56;GATAD2A;CHD4;POLR1A;H2AJ;MYBBP1A;POLR2F;TAF1B
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.41290804994939356,-1.0432198390422727,0.45454545454545453,0.9627082704237302,1.0,17/85,10.09%,ADGRF4;EMP1;COL4A2;COL12A1;FRMD6;LAMA3;RND3;RHBDF1;CNN1;ERBB2;PARVA;CA3;PERP;NTN4;SNAI2;EFEMP1;ITGA3
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.4974836866371252,1.0432116347607603,0.4,1.0,1.0,9/39,21.42%,IL12A;CA1;LCP1;SOD2;TALDO1;CFL1;MSN;RPLP0;ANXA2
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.4593237289383557,-1.0431740927135333,0.3235294117647059,0.9622357001537055,1.0,8/26,16.91%,ITGA4;CACNB1;NTRK1;GRIN1;ABCC1;CACNA1A;CDK5;FYN
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex8:Brain,0.46785366974635917,1.0430658532761383,0.4024390243902439,1.0,1.0,21/58,22.39%,TRPC7;KLHL1;MAMDC2;GNG4;HGF;HPSE2;GAS2L3;GFRA1;SPOCK3;THEMIS;CTNNA3;CDC14A;SYT10;ITGB8;PDLIM5;PTPRU;SWAP70;CRTAC1;RASSF3;MCTP2;ADRA2A
prerank,Reactome_2022__Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) Bind RNA R-HSA-428359,0.6935603720069287,1.0427410517558398,0.4262295081967213,1.0,1.0,3/5,20.75%,IGF2BP2;CD44;IGF2BP3
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5746243437287256,1.042612660178978,0.42857142857142855,1.0,1.0,3/14,8.80%,CCL5;TGFB1;HCK
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.45203011901785284,-1.0425954328369822,0.3333333333333333,0.9634676597056914,1.0,5/34,10.13%,SYNJ2;NLGN3;SNCB;NLGN2;CEL
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6073509265230526,1.042494430295327,0.391304347826087,1.0,1.0,2/16,1.99%,BUB1;IHO1
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.5723723540319551,-1.0424836574431768,0.42857142857142855,0.963146945166696,1.0,7/11,25.84%,PSAT1;CBS;SEPHS1;SRR;SERINC5;PSPH;MTHFD1
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.559206454106485,-1.0423477031321196,0.44,0.962894044492537,1.0,4/13,25.66%,MGARP;SPAST;MAPT;UXT
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.4466771971577648,1.0423205957186152,0.42105263157894735,1.0,1.0,13/81,20.47%,PSMB9;ST18;PELI3;RPS27A;PSMC5;MAPK3;RBX1;NFKBIA;PSMA3;PSMB6;RPS6KA5;IL1R1;PSMD6
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),-0.5481156555720244,-1.0422345507884656,0.3125,0.9625993824992077,1.0,6/18,21.70%,CPEB1;HSF1;CPSF7;ZC3H14;CCNT1;RNF40
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.4868376412248688,1.042128660956437,0.36619718309859156,1.0,1.0,7/49,13.28%,WNT8B;FRAT1;HSPA8;LIX1;WNT8A;CHMP3;LAMP2
prerank,CellMarker_Augmented_2021__Basal cell:Salivary Gland,-0.48097529228549163,-1.0420765976981305,0.3448275862068966,0.9612135864321268,1.0,3/32,3.43%,ADGRF4;ANXA8;TP53AIP1
prerank,CellMarker_Augmented_2021__Buccal Epithelial Stem cell:Oral Mucosa,-0.48097529228549163,-1.0420765976981305,0.3448275862068966,0.9612135864321268,1.0,3/32,3.43%,ADGRF4;ANXA8;TP53AIP1
prerank,CellMarker_Augmented_2021__Basal cell:Submandibular Gland,-0.48097529228549163,-1.0420765976981305,0.3448275862068966,0.9612135864321268,1.0,3/32,3.43%,ADGRF4;ANXA8;TP53AIP1
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Undefined,0.5354414909198564,1.0417586086003858,0.45161290322580644,1.0,1.0,5/23,7.30%,ADA;TGFB1;ITGA2;STAT5A;NT5E
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,0.45786509045920565,1.0414858589415803,0.40963855421686746,1.0,1.0,3/80,2.45%,ENPP2;PSMB9;HSPA8
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.45344863134773095,1.0414386483735987,0.3902439024390244,1.0,1.0,34/135,17.01%,AQP3;PLEKHS1;PRG4;PLEKHG6;LIPH;VSIG2;FMO5;BOK;ITGA2;ITGB6;MISP;ANPEP;CDKN2A;EPN3;ITGA5;BAIAP2L1;TMC4;TRIM29;LAMC2;ECT2;AP1M2;EPCAM;ALOX15;BMI1;ANLN;LY6D;SERPINB5;TM4SF20;KRT8;AGER;AGR2;MUC16;SPINT1;BRCA1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4568344899110172,-1.0413938213425742,0.4666666666666667,0.9625581264115102,1.0,5/21,12.71%,EYA4;BCL2;SNAI2;TERT;MAPK7
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.4852043811793249,1.0413322831611076,0.4166666666666667,1.0,1.0,12/60,14.43%,CDC25A;SPDYA;MAP3K11;CRLF3;CDKN2A;CCND1;CCNE2;CDKN1B;CDKN1A;CCNA2;CDKN2C;LATS2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.4329266513992262,1.0413163682243487,0.4189189189189189,1.0,1.0,25/112,21.85%,ROPN1B;BLK;GPRIN2;CFAP126;STMN4;MANF;PRDM12;PLP1;NPY;RAB11A;CSF1R;CARMIL1;CDK5R1;TOR1A;AGER;UHMK1;PLEKHA1;ULK1;SNAPIN;STMND1;CATIP;L1CAM;BLOC1S2;MICALL1;EHD1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5561282509845039,1.0412773817192327,0.4722222222222222,1.0,1.0,2/25,10.49%,DISC1;MBOAT1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.44156537988416644,-1.0412447179171127,0.3333333333333333,0.962407295393691,1.0,9/53,8.78%,KCNIP3;KCNJ16;KCNE1;WWP2;KCNMB2;KCNIP1;DPP6;FLNA;KCNJ6
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,-0.3890883057117611,-1.0412276806845941,0.4,0.9618038386937932,1.0,15/75,19.25%,SPRED2;SPRED1;ESRP1;FGF18;FGF1;ANOS1;HNRNPF;FGFR2;PTBP1;POLR2F;POLR2C;SPRY2;RBFOX2;FGF17;HRAS
prerank,GO_Biological_Process_2021__regulation of NAD(P)H oxidase activity (GO:0033860),0.759002432940072,1.0412073003474163,0.4918032786885246,1.0,1.0,3/5,23.66%,RFK;AGT;PARK7
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.4096450248960208,1.0411971178468227,0.36046511627906974,1.0,1.0,87/283,25.20%,PCLAF;MCM2;DONSON;POLE2;TICRR;RPL37A;RPL21;RAD1;RPL9;MCM3;RPL18A;PIF1;RPA3;RPS9;RPL3;RPL36;RPL13A;RPS16;GRWD1;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPL13;RECQL4;RPS12;RPS4X;RPL27A;MRPL34;EEF1A1;RPS19;YARS2;RPS21;RPL32;RPL11;RPL23A;EEF2;RPL35A;RPS11;RMI2;COPS5;RPS13;ORC4;BRCA1;RPS7;RSL24D1;RPLP2;RPL7;RPL38;ASMT;RPS15A;RPSA;HELB;RPLP0;RPS6;RAD9B;RPL35;GCNT1;IGF2BP3;POLE3;SET;RPL27;RPS14;XAB2;RPL7A;RPL24;RPL23;RPS15;MRPL28;MRPL10;ALAS2;RPS27;RPL8;ORC5;RPS3;RMI1;RPS23;RPS20;KAT5;RPS18;RPS24;PTMS;MRPL37;RPL10;SCX;RPS29
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),0.6558108513240957,1.0411640553885357,0.4098360655737705,1.0,1.0,3/9,19.00%,TNFSF4;IL4;IRF4
prerank,KEGG_2021_Human__Breast cancer,0.4566633834005898,1.0409694553628632,0.4246575342465753,1.0,1.0,19/128,13.42%,ESR1;WNT8B;TCF7;FRAT1;PIK3R3;FGF20;FGF2;HEY2;WNT5A;FLT4;WNT8A;IGF1;LEF1;CCND1;FZD8;WNT6;CDKN1A;NFKB2;TCF7L1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.5465692668593749,1.0408670280161747,0.45714285714285713,1.0,1.0,4/22,12.87%,HHIP;CYP26B1;FBN2;SFRP4
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.46193473445896854,1.0406863475635075,0.3783783783783784,1.0,1.0,3/63,4.50%,PSMB9;CARD14;TNFRSF10A
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.5288759394576131,-1.0405409739028757,0.42424242424242425,0.9630447988927591,1.0,1/10,4.78%,APOE
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.4514931039695446,-1.0405289986864108,0.41935483870967744,0.962441713627891,1.0,5/26,9.33%,SLC38A5;SLC6A20;SLC6A17;SLC3A2;SLC7A5
prerank,KEGG_2021_Human__Th17 cell differentiation,0.4695941450589996,1.0405192982662075,0.3835616438356164,1.0,1.0,19/83,20.42%,IL21R;RORC;AHR;TGFB1;STAT5A;HLA-DMA;HLA-DPB1;STAT1;CD4;RXRG;IL4;MAPK3;ZAP70;NFKBIA;HLA-DPA1;IRF4;IL1R1;NFATC2;IL2RA
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.5039931393045143,-1.04028623650827,0.4074074074074074,0.9624085206892685,1.0,3/17,9.42%,AUP1;HM13;RHBDD1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.39334059363349466,-1.0401894654632806,0.4166666666666667,0.9620910033577547,1.0,11/64,13.66%,SPRED2;SPRED1;TRIM71;ESRP1;FGF18;FGF1;ANOS1;HNRNPF;FGFR2;PTBP1;POLR2F
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.47041982377866376,-1.040169728673002,0.4,0.9615398668084004,1.0,2/29,0.58%,MT1G;NR4A1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.5044558083558195,-1.039899384772721,0.3870967741935484,0.9617412058013988,1.0,1/13,4.78%,APOE
prerank,CellMarker_Augmented_2021__Circulating Stem Like cell:Peripheral Blood,-0.40308767619192043,-1.0396755339543107,0.23333333333333334,0.9619923676147574,1.0,5/62,2.44%,IL7R;KCNK6;OR7D2;TMEM106A;CFLAR
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.5145882358680751,1.0396589555701514,0.43661971830985913,1.0,1.0,4/30,9.13%,VSIG4;SFTPD;CD80;PDCD1LG2
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.6733739871686757,1.0396214998375406,0.41379310344827586,1.0,1.0,2/7,7.29%,HIPK1;COL4A3
prerank,Reactome_2022__Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,-0.5437988499430185,-1.0394412666007347,0.46875,0.9621264148080639,1.0,8/14,33.63%,STXBP1;PPFIA3;STX1A;PPFIA1;SNAP25;PPFIA2;RIMS1;SH2D3C
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,0.43814045577934096,1.0393193506955516,0.37662337662337664,1.0,1.0,17/160,14.04%,PSMB9;WNT8B;TCF7;FRAT1;WNT5A;H2BC4;RSPO1;WNT8A;LEF1;H2AZ1;FZD8;RPS27A;PPP2R5A;DKK2;TCF7L1;SOX9;PSMC5
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.3956950654774778,-1.0392931988719842,0.3157894736842105,0.96193516054914,1.0,16/92,12.47%,RNF113A;NRDE2;TXNL4A;KHSRP;MAGOHB;PDCD7;SRRM1;PPP1R9B;DHX8;PRPF18;SRSF4;SNRPB;RP9;SMU1;NOVA1;PTBP1
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Control Bile Acid Homeostasis R-HSA-9623433,-0.6062719530094792,-1.0392629819798256,0.5,0.961394244563168,1.0,4/8,34.40%,NR1H2;NCOR2;RXRA;FABP6
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.4241147034075521,-1.0392294435541538,0.3684210526315789,0.9608623559407425,1.0,12/74,13.43%,PRKCD;SMPD3;PIWIL2;ERBB2;UPF3A;PCIF1;GSAP;NSMAF;CIRBP;FXR2;LRRTM3;ZCCHC4
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.4810066048138621,1.0391494368545813,0.375,1.0,1.0,10/57,5.91%,CLDN2;PTPRH;ACE2;ANXA10;LIPH;CLDN18;ITGB6;PTGR1;MISP;SMIM22
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.4193815376933858,1.0390308271076742,0.44086021505376344,1.0,1.0,60/341,13.99%,ITGB2;RORC;AIM2;TLR2;TCF7;TNFRSF1B;ITGAX;HSPA8;CSF2RA;ANXA1;CCL5;CLCF1;FGF2;PTAFR;TGFB1;CRLF1;ITGAM;NLRP12;WNT5A;GPER1;SLC26A6;IL12A;STAT5A;SYK;MMP9;CD80;SOCS2;NPR2;IFNK;IL26;LEF1;AXL;GSDME;CCND1;DUOX1;IFIT1;HGF;IRF1;HCK;OSMR;CSF3R;IL5;RPL13A;LDLRAP1;RPS27A;STAT1;RHOU;CD4;LIFR;CDKN1B;IL7;CDKN1A;CRHBP;ALOX15;CSF1R;AQP4;FPR1;MME;OPRM1;SOX9
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.4474655119768689,-1.038798724005393,0.32142857142857145,0.9615792153220369,1.0,7/34,11.62%,SELE;GRID2;IGSF21;PVR;AMIGO2;NECTIN3;ALCAM
prerank,Reactome_2022__Role Of LAT2/NTAL/LAB On Calcium Mobilization R-HSA-2730905,0.5805811304141186,1.0387531375643293,0.45901639344262296,1.0,1.0,1/12,6.35%,SYK
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5625452132233051,1.0386607477837813,0.4375,1.0,1.0,2/16,8.80%,BAIAP2L1;HCK
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.49180994392613625,-1.0383987109892157,0.28125,0.9620955860883305,1.0,5/23,10.13%,SYNJ2;NLGN3;SNCB;NLGN2;CEL
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.47691533358040594,1.0383906969736931,0.3880597014925373,1.0,1.0,7/64,9.91%,TBX1;TGFB1;ALPK2;HEY2;FOXM1;PINK1;PRAME
prerank,KEGG_2021_Human__Nicotine addiction,-0.43641057269446604,-1.0383368421064176,0.36,0.9616556821345942,1.0,6/38,11.31%,GABRE;GRIN3A;SLC17A6;GABRA5;GRIA4;GRIN1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.5553089360793682,1.0381345697513453,0.47619047619047616,1.0,1.0,2/21,9.55%,ARHGAP24;P2RY12
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.5111812350639635,1.0380816883909891,0.4533333333333333,1.0,1.0,5/28,10.84%,CA14;SLC26A6;SLC4A1;CA1;CA13
prerank,CellMarker_Augmented_2021__Immature neuron:Undefined,-0.39155749315054456,-1.0380317770295746,0.2857142857142857,0.9619388165738431,1.0,14/96,10.42%,EFR3B;CBARP;CELF5;SLC17A6;CASKIN1;ELAVL3;LHFPL4;INA;VGF;SNCB;B4GALNT1;HPCA;SRRM3;TAGLN3
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.45531159989951,-1.0379502707069603,0.36,0.9615825714459558,1.0,8/32,11.94%,GSTT2B;GSTM5;GSTZ1;GSR;GSTK1;CHAC1;GPX1;G6PD
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,0.47968734239822897,1.0376864977501772,0.4444444444444444,1.0,1.0,11/47,22.64%,TRIM25;IL12A;IFNK;DDX3X;CASP10;CYLD;ISG15;NFKBIA;IFIH1;TRADD;TKFC
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.6076258363113796,1.0375439291352788,0.4027777777777778,1.0,1.0,4/11,16.75%,VSIG4;C4BPA;C4BPB;A2M
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),0.6825496455156301,1.0373857747792672,0.5172413793103449,1.0,1.0,2/5,13.70%,RAMP3;CALCR
prerank,Reactome_2022__Protein Repair R-HSA-5676934,0.6657184342337256,1.037383453161411,0.5,1.0,1.0,1/6,14.31%,PCMT1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.6332074789013256,1.0373229548053302,0.4857142857142857,1.0,1.0,3/11,13.21%,CD160;GPER1;THBS1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.4371576125439542,1.0372682625365492,0.36486486486486486,1.0,1.0,13/95,14.56%,AQP3;CASQ2;SYT15;TRPV6;SYT2;CASR;WNT5A;ECT2;ALOX5AP;CRHBP;THBS1;ALOX15;SYT10
prerank,CellMarker_Augmented_2021__Naive B cell:Blood,0.4788178622031339,1.0371072978595568,0.3582089552238806,1.0,1.0,14/38,12.21%,BLK;CYTIP;ARHGAP9;SASH3;PTPRC;JCHAIN;WAS;HSH2D;NAPSB;IKZF1;TAGAP;CD37;TMC8;PNOC
prerank,CellMarker_Augmented_2021__Regulatory B cell:Undefined,0.4788178622031339,1.0371072978595568,0.3582089552238806,1.0,1.0,14/38,12.21%,BLK;CYTIP;ARHGAP9;SASH3;PTPRC;JCHAIN;WAS;HSH2D;NAPSB;IKZF1;TAGAP;CD37;TMC8;PNOC
prerank,CellMarker_Augmented_2021__Transitional B cell:Peripheral Blood,0.4788178622031339,1.0371072978595568,0.3582089552238806,1.0,1.0,14/38,12.21%,BLK;CYTIP;ARHGAP9;SASH3;PTPRC;JCHAIN;WAS;HSH2D;NAPSB;IKZF1;TAGAP;CD37;TMC8;PNOC
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),0.6857369478670204,1.0370605395222978,0.5094339622641509,1.0,1.0,2/5,15.83%,ASIC1;PKD1L3
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.6582615994922687,1.0369649178679896,0.421875,1.0,1.0,3/7,23.66%,CHCHD4;NOS2;PARK7
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),-0.487555101723691,-1.0369431553096045,0.35135135135135137,0.9638226570604863,1.0,2/23,1.82%,GCK;PPP1R3E
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.5314275464280567,1.0369089935285571,0.43478260869565216,1.0,1.0,8/26,17.76%,TLR2;LYG2;STAB2;IL12A;HLA-A;LYG1;PGLYRP2;PGLYRP1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.48151331182828194,1.036685305003342,0.3972602739726027,1.0,1.0,3/44,6.49%,SMAD6;LRP2;DAND5
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6316257096155549,1.0365121870301852,0.4931506849315068,1.0,1.0,5/9,26.26%,B3GNT9;B4GAT1;B3GALT2;B3GNT3;B3GNT2
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Embryonic Stem Cell,0.45856526796016855,1.0365038146409538,0.4605263157894737,1.0,1.0,7/93,3.72%,ENPP2;LPAR1;ARHGEF40;SDC2;ARHGAP24;ARHGAP31;NID1
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Embryonic Stem Cell,0.45856526796016855,1.0365038146409538,0.4605263157894737,1.0,1.0,7/93,3.72%,ENPP2;LPAR1;ARHGEF40;SDC2;ARHGAP24;ARHGAP31;NID1
prerank,KEGG_2021_Human__Pentose phosphate pathway,-0.46033178765496036,-1.0364409001700239,0.46875,0.9647254563273684,1.0,5/26,11.94%,FBP2;RGN;PGLS;PFKP;G6PD
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,-0.44003728021002925,-1.0363294534253904,0.52,0.9644343653908123,1.0,9/65,12.09%,NUP210;NUP42;MAGOHB;POM121C;NUP214;SRRM1;SRSF4;AAAS;U2AF2
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.596065283411584,-1.0361740274406341,0.4878048780487805,0.9642595344532928,1.0,2/9,7.60%,ABCC8;PKD2
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.4822042579744816,-1.036035426921164,0.37037037037037035,0.9639608467004549,1.0,10/43,16.86%,NUP210;NUP42;PHC2;POM121C;NUP214;AAAS;RING1;NUP37;NUP98;SUMO2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.49084953949942184,1.0357513082069,0.4084507042253521,1.0,1.0,12/49,16.20%,ROPN1B;C15ORF62;WAS;RHOB;ARHGDIG;CELSR1;RHOU;ADGRG1;RTKN;RHOG;PLEKHG7;CFL1
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.581056431978159,-1.035513442625936,0.45714285714285713,0.9643890497604031,1.0,1/11,1.05%,SYNJ2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.581056431978159,-1.035513442625936,0.45714285714285713,0.9643890497604031,1.0,1/11,1.05%,SYNJ2
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,-0.4989899071129225,-1.035481999903568,0.35135135135135137,0.9638101447850479,1.0,4/20,5.52%,PRKCD;ITPR2;CD247;PLD2
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,0.45945839751477724,1.0354382219989806,0.4189189189189189,1.0,1.0,12/78,20.86%,PSMB9;MCM3;CCNE2;RPS27A;CCNA2;PSMC5;ORC4;RBX1;PSMA3;PSMB6;PSMD6;GMNN
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.4747361064008269,1.0353626242271003,0.4473684210526316,1.0,1.0,10/58,16.35%,SMAD6;TMEM100;TGFB1;NODAL;TGFB3;SOX9;GDF9;MAPK3;VSTM2A;ENG
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,0.48902932088066375,1.0352929137525437,0.4507042253521127,1.0,1.0,2/62,0.92%,ESR1;PSMB9
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.5845677525711005,1.0352674819637147,0.47058823529411764,1.0,1.0,4/17,14.41%,AHR;TNFSF4;IGLL1;IL4
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.46017313612682376,-1.0351188170640444,0.36,0.9641808346110191,1.0,6/41,10.78%,NGF;IFI16;SH3RF1;IGBP1;AQP1;GPX1
prerank,Reactome_2022__MET Receptor Activation R-HSA-6806942,-0.6257291741250876,-1.0350738616508341,0.5416666666666666,0.9636935083215233,1.0,1/6,3.21%,HGFAC
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5914537536049348,1.0348537800404691,0.49230769230769234,1.0,1.0,2/13,12.35%,SLFN14;RPP40
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,0.4729871739999863,1.0344620010432388,0.4246575342465753,1.0,1.0,7/60,20.47%,PSMB9;RPS27A;PSMC5;NFKBIA;PSMA3;PSMB6;PSMD6
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.562487916665443,-1.034215469244891,0.47058823529411764,0.964837125883784,1.0,3/14,13.30%,NANOS3;AGO2;TNRC6C
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.562487916665443,-1.034215469244891,0.47058823529411764,0.964837125883784,1.0,3/14,13.30%,NANOS3;AGO2;TNRC6C
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.595540095185359,-1.0341909043933797,0.4883720930232558,0.9642927080233136,1.0,4/7,17.07%,ASS1;GLUD2;ALDH18A1;GLUD1
prerank,CellMarker_Augmented_2021__Monocyte Derived Dendritic cell:Peripheral Blood,0.6690509012800411,1.0341071402734976,0.5,1.0,1.0,4/7,8.06%,ITGAX;ITGAM;FCGR3A;CEACAM8
prerank,Reactome_2022__Acyl Chain Remodelling Of PS R-HSA-1482801,0.5756019594375419,1.0340091445140356,0.46296296296296297,1.0,1.0,2/14,10.49%,PLA2G10;MBOAT1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.3462092696264661,-1.034002983515453,0.3333333333333333,0.9642506789875296,1.0,65/370,15.97%,ARC;PTCD2;PACSIN2;CFAP410;MAST2;SMPD4;MSTO1;KLHL20;PNPLA3;FANCG;AUP1;NIPSNAP2;APOE;HPS3;MTFR2;PEX7;COG4;PLD2;MYO18A;PLIN5;TFB1M;GOLGA8A;SH3KBP1;PAK6;TICAM2;UBXN2A;RAB7A;PKD2;AFG1L;TMED4;TRAPPC12;FGD1;GBF1;FAM174B;FGD5;WASF3;DOP1B;PEX14;ZNF501;SYNE3;GOLGA8B;BLZF1;PACSIN3;SPTSSB;TERT;TTC17;SLC25A33;CAPZB;SIPA1L3;ZNF135;MICAL1;TTC29;MIA3;BIN1;MICAL3;CSPG5;EIF2AK3;COG7;CHCHD10;MARK4;CFAP61;DNAJC28;TOR1B;REEP6;TRAPPC11
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.6074213611440172,-1.0338545557660843,0.45714285714285713,0.9641182927617894,1.0,2/7,20.71%,DENND4B;DENND1A
prerank,Reactome_2022__CLEC7A (Dectin-1) Induces NFAT Activation R-HSA-5607763,-0.6199742057133946,-1.0336909418396907,0.4864864864864865,0.9638792949291621,1.0,2/10,7.88%,ITPR2;NFATC3
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.4118053838661203,-1.0335022257746334,0.3888888888888889,0.9638868628728545,1.0,10/58,9.34%,ADAMTS1;APOH;SPRED1;COL4A2;VASH1;GTF2I;MINAR1;ANGPT4;MECP2;NIBAN2
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.65265901009645,1.0334517784667479,0.417910447761194,1.0,1.0,3/10,14.14%,MUC4;STRAP;PBLD
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Undefined,0.7258786718388984,1.0333850198859542,0.47058823529411764,1.0,1.0,2/5,14.53%,SOX10;OLIG2
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,0.514990609575557,1.0333370567973605,0.47540983606557374,1.0,1.0,3/18,11.19%,PIK3R3;STAT5A;STAT1
prerank,CellMarker_Augmented_2021__Neutrophil:Kidney,-0.41805710848947236,-1.0333013495446641,0.36666666666666664,0.964009269117343,1.0,7/45,8.86%,ADGRG3;SLC25A37;FOS;BCL2A1;CLC;SELL;LST1
prerank,Reactome_2022__Membrane Trafficking R-HSA-199991,-0.3409208327816739,-1.0330766637023243,0.5,0.9640823299032178,1.0,59/539,13.14%,IL7R;SYT12;APOB;KIFC1;SYNJ2;TBC1D10A;KIF2B;SEC24C;TBC1D16;PACSIN2;KDELR1;PPP6R1;CCZ1B;GOLIM4;EXOC7;GJB6;RIN1;RAB35;STX6;MAN1A1;RINL;RAB7B;SPTBN4;COG4;SH3KBP1;ARFIP2;SEC22A;ARPC3;TGFA;SPTB;RABEPK;RAB7A;KIF15;TBC1D2;SNF8;TRAPPC12;ASPSCR1;KIAA0319;KIF4B;RAB5A;SNX5;TRAPPC9;STX5;COPS8;KIFC2;GGA2;KIF1C;PREB;GOLGA8B;PACSIN3;CUX1;HIP1;YWHAQ;CNIH3;DENND2A;GOLGA4;ARRB2;CAPZB;SLC2A8
prerank,Reactome_2022__Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.48917733556165816,-1.032899410075679,0.40540540540540543,0.9639013157926744,1.0,4/19,15.56%,FGF1;FGFR2;POLR2F;POLR2C
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),-0.6143744218301317,-1.03278514402016,0.47058823529411764,0.9636222797923487,1.0,1/5,0.18%,COL22A1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.6035279615193878,1.0327040416014304,0.43548387096774194,1.0,1.0,5/11,32.50%,FLT4;VEGFC;VEGFD;VEGFA;VEGFB
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,-0.37402179614828734,-1.0326741033657867,0.3333333333333333,0.9633517819912693,1.0,57/253,18.09%,DYNLT5;IFT88;MKS1;APOO;CNGA4;EXOC7;HAUS1;GLUD2;CARM1;TFB1M;SCLT1;PCM1;CEP83;PPARGC1B;KIF17;CLUAP1;RPGRIP1L;MAPRE1;FBF1;CNTRL;HDAC3;CDK1;CEP135;ALMS1;BBS12;NR1D1;ASAP1;CDK5RAP2;CEP152;CEP250;NUDT19;IDH2;RAB11FIP3;HAUS7;SAMM50;B9D1;TRAF3IP1;KIF24;DYNC2I1;SDCCAG8;CSNK1E;MARK4;AHI1;CEP41;DNAJC11;CYS1;CHCHD3;TCTN1;PRKCA;GLUD1;SMARCD3;IFT52;IFT43;CRTC1;IFT81;CEP290;MAPK12
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.5011951654232538,1.0326626476199428,0.3918918918918919,1.0,1.0,3/44,7.66%,NEK2;BORA;IGF1
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),0.6095268683771216,1.0326410640856316,0.4507042253521127,1.0,1.0,3/8,12.86%,SCIN;ACSL3;ALOX12B
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.5280078354414808,1.032569437843037,0.4444444444444444,1.0,1.0,5/22,14.84%,BHMT;ETFBKMT;EEF2KMT;PCMT1;METTL21C
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.6570068587149832,1.0324277184742685,0.49206349206349204,1.0,1.0,2/7,5.79%,CCL5;JAM2
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.5295463286382038,-1.0320764031196394,0.375,0.9642673374226829,1.0,6/18,25.65%,F11R;DAB2IP;SH3BP4;HRAS;RRP1B;BCAS3
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.49765487491460536,1.0318837740961342,0.37333333333333335,1.0,1.0,4/38,7.73%,SLC12A7;KCNJ15;SLC12A3;ATP1A4
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.5741137657108845,1.0317950990320532,0.3939393939393939,1.0,1.0,6/13,25.66%,MMP9;CD4;CSF1R;CSF1;HLA-DRB1;CASP8
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.3724414149850313,-1.0317890950990867,0.375,0.9644952712305066,1.0,18/106,22.52%,KIFC1;KIF2B;KDELR1;KIF15;KIF4B;KIFC2;KIF1C;CAPZB;KIF26A;KIF27;GALNT2;STX18;KIF6;CAPZA1;KIF21A;RAB6A;TMED3;KIF5C
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.4719317239558374,-1.031751334238628,0.41379310344827586,0.964061396361763,1.0,13/36,22.83%,ERBB2;SH3KBP1;TGFA;PTPRJ;SPRY1;DAB2IP;SPRY2;TSG101;BTC;PTPN2;DUSP3;PTPN3;ZFYVE28
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,-0.4992000275770457,-1.0316789364783663,0.35135135135135137,0.9636362348511598,1.0,2/16,8.48%,NOD1;RIPK2
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.4363660985290809,-1.031656242179409,0.3333333333333333,0.9630811092498035,1.0,6/57,6.28%,CSK;AGTRAP;TENT4A;KIAA1549;ESRP1;KDM7A
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.5215292226701825,1.0316232396875713,0.4444444444444444,1.0,1.0,6/27,25.02%,STRADA;RRAGA;STRADB;LAMTOR3;PRKAB2;CAB39L
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.42783568138382616,-1.03161565141331,0.3103448275862069,0.9625674452765653,1.0,4/33,7.68%,PER2;HES1;ASCL1;CX3CR1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.5068251618457336,1.0315779043578313,0.4383561643835616,1.0,1.0,11/40,19.83%,GATA4;SGCG;HEY2;MESP1;CSRP3;SGCZ;NPPA;SCN5A;TBX18;HEY1;NOTCH2
prerank,CellMarker_Augmented_2021__Stem cell:Ovarian Cortex,0.4848327980252009,1.0315710804333857,0.4788732394366197,1.0,1.0,8/64,5.88%,CLDN6;SCGB3A2;LRAT;TUNAR;SLCO1A2;CCDC172;SALL4;CA14
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.5050323490037403,1.0315432023145943,0.4383561643835616,1.0,1.0,10/51,9.15%,AMBP;DBH;DAO;SLC18A2;FTCD;SHD;SLC22A7;NR1H4;ALDOB;F7
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Germ,0.48853781771072635,1.0314055852467867,0.4507042253521127,1.0,1.0,12/55,5.54%,C1QB;TNFRSF1B;LYVE1;CMAHP;PTPRC;JCHAIN;TFEC;FCGR3A;VSIG4;MYH11;FLI1;FGL2
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.5465008602577425,-1.031207262002028,0.375,0.9632030430145528,1.0,4/10,13.49%,LAMA3;CD151;ITGB4;PLEC
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),0.5516784885360572,1.0311841633921066,0.36923076923076925,1.0,1.0,4/17,17.87%,PRDX4;DUOX1;CYBA;NOX1
prerank,KEGG_2021_Human__Phenylalanine metabolism,-0.5289665776254179,-1.031126459881135,0.4857142857142857,0.9627957862120173,1.0,2/11,5.92%,PAH;AOC3
prerank,Reactome_2022__RNA Polymerase I Promoter Opening R-HSA-73728,0.5738773684026247,1.0310031270730988,0.417910447761194,1.0,1.0,5/14,24.77%,H2BC4;H2AZ1;MAPK3;H2AZ2;H2AC6
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.6212831710916065,1.0309960657093762,0.484375,1.0,1.0,1/9,3.38%,AHR
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.6212831710916065,1.0309960657093762,0.484375,1.0,1.0,1/9,3.38%,AHR
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.57858634020803,-1.0309373180910673,0.45714285714285713,0.9626656642907051,1.0,1/12,1.05%,SYNJ2
prerank,Reactome_2022__Regulation Of IFNA/IFNB Signaling R-HSA-912694,0.6556254988643087,1.0308918134742229,0.4603174603174603,1.0,1.0,2/9,13.53%,STAT1;USP18
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.6167724524685455,1.0308900749948557,0.4411764705882353,1.0,1.0,3/8,19.83%,C17ORF99;GPR183;NOTCH2
prerank,Reactome_2022__RUNX2 Regulates Genes Involved In Cell Migration R-HSA-8941332,0.6274090500270111,1.03087204397093,0.48484848484848486,1.0,1.0,2/7,7.33%,ITGBL1;ITGA5
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),-0.6016409039380575,-1.030758185583957,0.5128205128205128,0.9626414061805767,1.0,2/6,11.12%,EMILIN1;COLGALT1
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.6241355179774122,1.0306619302540847,0.47692307692307695,1.0,1.0,4/11,20.13%,CCL5;PLA2G7;CXCL12;CREB3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.5696508322510242,1.0304492914066554,0.4666666666666667,1.0,1.0,4/11,19.63%,CHMP3;MAPK3;DENND10;MAP2K1
prerank,CellMarker_Augmented_2021__Type I pneumocyte:Undefined,-0.40904036213696976,-1.030366943102645,0.4166666666666667,0.9632428458158285,1.0,11/78,8.09%,EHF;CLDN4;WWC1;LAMA3;ESRP1;ERBB2;KIAA1671;PTPRF;TMEM125;PERP;EPB41L4B
prerank,GO_Biological_Process_2021__negative regulation of adaptive immune response (GO:0002820),0.6443536501762985,1.0302340269191073,0.42857142857142855,1.0,1.0,2/5,13.21%,CD160;ALOX15
prerank,Reactome_2022__Antimicrobial Peptides R-HSA-6803157,0.5493377168087673,1.029947802902285,0.45714285714285713,1.0,1.0,9/22,17.76%,TLR2;BPIFB1;CD4;DEFB109B;ELANE;DEFB135;PGLYRP2;ATOX1;PGLYRP1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.7122948417358562,1.0299044513551923,0.5294117647058824,1.0,1.0,1/6,8.89%,TCAF2
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6272229872724766,1.0298871766213242,0.4745762711864407,1.0,1.0,1/11,1.99%,RENBP
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.5716750105112267,-1.029861596382689,0.45,0.9639166082747866,1.0,2/8,8.32%,LAMB4;NTN4
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.463509696772849,1.0297779863752683,0.4868421052631579,1.0,1.0,7/65,11.63%,TLR2;TNFRSF1B;WNT5A;CD80;AXL;PDCD1LG2;TNFSF4
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.5262771176286721,1.0296104336400862,0.463768115942029,1.0,1.0,6/27,15.26%,SLFN14;EXOSC8;EXOSC2;ERN2;NUDT16L1;EXOSC4
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.620380796970733,-1.0294720630034728,0.4634146341463415,0.9644028676584598,1.0,3/5,29.07%,PRKCA;DCAF1;PKN1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.4859869026406947,-1.0293813469414068,0.3333333333333333,0.9640369472610122,1.0,5/23,14.55%,RNF168;PCGF1;KDM2B;RING1;LEO1
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.661672195129998,-1.029157545145312,0.4878048780487805,0.9640605301756817,1.0,3/5,24.65%,SPATA7;ZDHHC3;ARL13B
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,-0.4168979411364927,-1.0290575770422703,0.36,0.9636628878399448,1.0,7/45,19.41%,CSK;SH3KBP1;TGFA;SPRY1;SPRY2;HRAS;BTC
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Germ,0.6399335033456813,1.028912126319672,0.5070422535211268,1.0,1.0,1/10,4.64%,ABCG2
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.5445104933583359,1.0287563595765694,0.48484848484848486,1.0,1.0,5/20,22.36%,UBE2U;RAG1;ATXN7L3;WAC;PAF1
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,0.4411000931748109,1.028755722276047,0.4177215189873418,1.0,1.0,21/127,20.56%,PSMB9;TCF7;PDE6A;GNG12;WNT5A;LEF1;GNG4;FZD8;RPS27A;GNAT2;TCF7L1;PSMC5;WNT5B;PRKG1;PDE6B;PDE6G;PSMA3;PSMB6;PSMD6;GNGT1;GNB4
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.4256544527862046,-1.0287344541793744,0.3333333333333333,0.9640671327574981,1.0,13/62,22.03%,IWS1;GTF2H2;RTF1;ERCC2;SSRP1;POLR2F;LEO1;POLR2C;ELOF1;ELOA;CCNT1;CTDP1;GTF2F2
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.5337706079286584,1.028726641115601,0.421875,1.0,1.0,2/22,1.77%,ELOVL2;ACSL5
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.4306462847212332,1.02863234865898,0.4430379746835443,1.0,1.0,18/126,17.94%,ARHGAP9;ARHGAP24;ARHGAP31;FOXM1;ARHGAP28;RHOB;TAGAP;ECT2;TGM2;ARHGDIG;RHOU;RASGRF2;RHOG;ARHGAP45;RHOQ;A2M;VAV3;ARHGAP15
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.6111065546251419,1.0286136461409112,0.5,1.0,1.0,4/14,21.54%,INTS5;TRNT1;PTCD1;INTS2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.7017367040115903,1.0285535858643189,0.4918032786885246,1.0,1.0,2/5,11.08%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.7017367040115903,1.0285535858643189,0.4918032786885246,1.0,1.0,2/5,11.08%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.7017367040115903,1.0285535858643189,0.4918032786885246,1.0,1.0,2/5,11.08%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.7017367040115903,1.0285535858643189,0.4918032786885246,1.0,1.0,2/5,11.08%,EXOSC8;EXOSC2
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.48868873755654274,1.0284956918001746,0.42105263157894735,1.0,1.0,17/66,16.94%,SLC22A3;SLC18A2;SLC16A8;SLC22A8;SLC22A7;SLC13A4;SLC22A6;CP;SLC39A7;SLC47A1;SLC47A2;SLC30A2;SLC14A1;SLC22A4;SLC16A1;SLC6A12;SLC16A3
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.4672171525356048,-1.0284188819012934,0.36,0.964446599113183,1.0,10/50,16.86%,NUP210;NUP42;PHC2;POM121C;NUP214;AAAS;RING1;NUP37;NUP98;SUMO2
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.5989210060555955,-1.0282846400693861,0.4883720930232558,0.9641303109866626,1.0,2/6,11.94%,PRPSAP1;G6PD
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.6463077411852229,1.0282671936257788,0.5333333333333333,1.0,1.0,3/5,29.32%,LGALS9;ZFP36;ZFP36L1
prerank,KEGG_2021_Human__Insulin resistance,-0.39600450812718835,-1.0282462399288868,0.3157894736842105,0.963685148583482,1.0,13/93,10.68%,G6PC3;PRKCD;PPP1R3E;CREB3L4;FOXO1;CREB3L1;GYS1;SLC27A2;PTPRF;PPARGC1B;MLX;CPT1A;SLC27A4
prerank,CellMarker_Augmented_2021__Induced Regulatory T (Treg) cell:Peripheral Blood,-0.41920876120548967,-1.0282445461619247,0.3684210526315789,0.9630871317369619,1.0,3/46,1.33%,IL7R;P2RY10;IL16
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.39445158660534185,-1.0282217694452955,0.3103448275862069,0.9625786296751534,1.0,8/28,20.07%,DTX1;JAG2;JAG1;NEURL1;ARRB2;DLL1;NCSTN;ARRB1
prerank,Reactome_2022__Translation R-HSA-72766,0.41751046911530487,1.0282107535153242,0.42045454545454547,1.0,1.0,77/259,26.25%,RPL37A;RPL21;MRPS34;RPL9;RPL18A;RPS9;RPL3;SSR4;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;MRPL20;RPS12;RPS4X;RPL27A;MRPL34;EEF1A1;RPS19;YARS2;MRPL50;FAU;SRP19;RPS21;RPL32;GADD45GIP1;RPL11;RPL23A;EEF2;RPL35A;RPS11;GFM2;MRPL54;RPS13;RPS7;EIF1AX;RSL24D1;RPLP2;RPL7;RPL38;MRPS2;DARS2;RPS15A;SPCS2;RPSA;RPLP0;RPS6;RPL35;EIF3G;RPL27;RPS14;RPL7A;RPL23;EIF4A2;MRPL19;RPS15;EIF2B2;MRPL10;SRP14;RPS27;RPL8;EIF2B5;RPS3;RPS23;RPS20;RPS24;MRPL37;RPS29;RPLP1;RPS28;MRPL44;MRPL40;RPL34
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.5567071710463698,1.0281645365749792,0.43548387096774194,1.0,1.0,7/23,17.10%,NOTUM;TGFB1;HEY2;SOX9;DDR2;ODAPH;FBXO5
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,0.578028994477277,1.0280286177030784,0.45,1.0,1.0,8/18,29.18%,ITGA5;ITGA2B;MAPK3;MAP2K1;L1CAM;ITGA9;CSNK2A2;ITGAV
prerank,Reactome_2022__Neurotransmitter Clearance R-HSA-112311,-0.5602736138412733,-1.0280239726682143,0.5142857142857142,0.962482045639458,1.0,1/9,1.37%,BCHE
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.610015743989837,1.0277469812651319,0.5384615384615384,1.0,1.0,3/8,21.26%,TGM2;FIS1;BCAP31
prerank,Reactome_2022__Formation Of Xylulose-5-Phosphate R-HSA-5661270,-0.6004388920074857,-1.0277333603374945,0.42857142857142855,0.9608339981870911,1.0,3/5,21.37%,XYLB;SORD;CRYL1
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.6004388920074857,-1.0277333603374945,0.42857142857142855,0.9608339981870911,1.0,3/5,21.37%,XYLB;SORD;CRYL1
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.6004388920074857,-1.0277333603374945,0.42857142857142855,0.9608339981870911,1.0,3/5,21.37%,XYLB;SORD;CRYL1
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.6004388920074857,-1.0277333603374945,0.42857142857142855,0.9608339981870911,1.0,3/5,21.37%,XYLB;SORD;CRYL1
prerank,CellMarker_Augmented_2021__Epidermal Transit Amplifying cell:Foreskin,0.46542543788819335,1.0275945508406377,0.38961038961038963,1.0,1.0,23/84,30.73%,PLAU;COX7A2;TXNDC17;SNRPD2;RAB38;SLIRP;HSPE1;DYNLL1;RSL24D1;NUDT15;PSMA3;GGCT;COX5A;COX7C;AK6;VDAC1;BTG3;PSMB1;MTX2;COX16;MPHOSPH6;SSB;EEF1B2
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.587145243137293,1.0275540371008411,0.4264705882352941,1.0,1.0,1/12,1.83%,TLR2
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.6608243651293934,1.0275234004034866,0.4827586206896552,1.0,1.0,1/6,3.29%,HSD3B7
prerank,GO_Biological_Process_2021__regulation of T-helper 1 type immune response (GO:0002825),0.6882390858280087,1.0275121983203925,0.5084745762711864,1.0,1.0,1/5,6.66%,IL27
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.4539716832810651,1.0274349588766598,0.4125,1.0,1.0,17/109,16.91%,CYTIP;KIF14;CCL5;ADAMDEC1;FUT2;IL12A;KNG1;PLAU;TGM2;ARHGDIG;PLXNA3;ADGRG1;RASA1;TGFBI;CXCL12;PIK3CG;HYAL1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.49702803050953254,1.027425552629613,0.4153846153846154,1.0,1.0,5/26,14.91%,VSIG4;SFTPD;CD80;PDCD1LG2;CRTAM
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.7339544139385163,1.027424884069462,0.4444444444444444,1.0,1.0,2/5,22.45%,WBP2;YAP1
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,0.5800184377117913,1.0273879166796576,0.4032258064516129,1.0,1.0,6/17,16.31%,HSPA8;ETFBKMT;EEF2KMT;ETFB;EEF1A1;EEF2
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),0.6994451447957061,1.0272207729172105,0.5517241379310345,1.0,1.0,4/5,26.20%,CSRP3;HTR2B;TCAP;TTN
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.4635968473725585,-1.0270513983520302,0.45454545454545453,0.9620170179132689,1.0,1/18,0.17%,PKD1L1
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,0.5165427604176798,1.027028830309197,0.5,1.0,1.0,3/31,11.25%,HSPA8;DNASE2;AP1M2
prerank,Reactome_2022__Disorders Of Developmental Biology R-HSA-9675151,-0.5306909012705315,-1.0270270881901662,0.45,0.9614551748564291,1.0,5/12,25.86%,MECP2;HDAC3;PRKCA;NCOR2;HDAC1
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.6014037083792861,-1.0270223181866411,0.42424242424242425,0.960861918563596,1.0,1/6,8.24%,AFG1L
prerank,Reactome_2022__Activation Of Pre-Replicative Complex R-HSA-68962,0.5271031889703516,1.0268177355024954,0.43283582089552236,1.0,1.0,7/25,23.47%,POLE2;MCM3;RPA3;ORC4;POLE3;GMNN;ORC5
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,0.46423601528027303,1.026769602447261,0.4307692307692308,1.0,1.0,2/37,2.77%,AIM2;CCL5
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.4923257064767058,-1.0266946679955244,0.3333333333333333,0.9611440172943876,1.0,2/18,5.67%,KMT2B;SMYD2
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.4773956622628245,-1.0266933437453614,0.37142857142857144,0.9605436774959526,1.0,2/16,4.86%,BUD23;USP36
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.5768579631585485,-1.0265084825143111,0.42857142857142855,0.9604008828590315,1.0,1/7,0.50%,ADRA1A
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.3936252039709868,-1.0264038667294288,0.3333333333333333,0.9600660513453008,1.0,5/59,4.30%,SPRED3;SPRED2;SPRED1;BAMBI;BCL9L
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),0.6771281390362746,1.026382092659407,0.532258064516129,1.0,1.0,3/5,24.55%,PLN;INSIG1;CRYAB
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.6048066606600166,-1.0263783904170514,0.4878048780487805,0.9595555500594141,1.0,2/6,15.28%,KCNE1;GDI1
prerank,Reactome_2022__MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,-0.49915047318087635,-1.0263736357143174,0.425,0.9589896920534373,1.0,3/18,9.11%,GPRIN1;TRPC3;MECP2
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,0.5230851647948195,1.0263027441386485,0.4342105263157895,1.0,1.0,4/25,11.00%,POLE2;POLD4;RPA3;RPS27A
prerank,PanglaoDB_Augmented_2021__Pericytes,0.450241602947452,1.0260384385212367,0.4266666666666667,1.0,1.0,21/124,11.36%,C1QTNF1;STEAP4;TIMP3;PRRX1;LMOD1;ADAM33;ECM2;ANGPT2;GPIHBP1;PCDH18;ANPEP;DAAM2;NT5E;ANGPTL2;ACTA2;ADGRL4;COL6A2;DCN;VTN;COL1A1;ASPN
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.675167975773635,1.0257780150404798,0.5636363636363636,1.0,1.0,5/5,32.50%,VEGFC;RIN3;VEGFD;VEGFA;VEGFB
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.36950239325938194,-1.0256793221468303,0.38461538461538464,0.9603830685163817,1.0,55/277,20.59%,CPSF1;DDX41;HNRNPL;RNF113A;TXNL4A;CWF19L1;MAGOHB;PDCD7;LSM7;SRRM4;SRRM1;ERN1;DHX8;KIN;PRPF18;SUGP1;SRSF4;GPATCH1;GTF2H2;SNRPB;HNRNPF;DDX46;SMU1;SF3A2;SYMPK;U2AF2;CSTF2;ERCC2;NOVA1;PTBP1;GEMIN5;CPSF7;POLR2F;RBMX2;ZMAT5;GPKOW;SNRPN;POLR2C;IK;SNIP1;RALY;RBM41;HNRNPUL1;RNPC3;RBMX;PCF11;CPSF4;LSM2;RAVER1;TBRG4;TCERG1;LSM6;RBM8A;CCAR1;EIF4A3
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.46245491674078765,1.0255099452030272,0.42857142857142855,1.0,1.0,6/85,7.94%,CDC25A;PCLAF;DTL;SCARA3;IL12A;CCND1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.562225389826555,1.0251460830520567,0.484375,1.0,1.0,4/19,10.68%,CCL5;IGF1;PLAU;VTN
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),0.6971245345571373,1.02508114594452,0.5686274509803921,1.0,1.0,2/5,21.78%,DCN;MLLT11
prerank,Reactome_2022__Keratinization R-HSA-6805567,0.4820207728467116,1.0248448431336685,0.4153846153846154,1.0,1.0,4/35,8.55%,KRTAP5-1;PKP2;FLG;SPINK6
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.6604509676693462,1.024827708448139,0.4827586206896552,1.0,1.0,2/5,11.63%,STOML2;TNFSF4
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.5579241444158091,-1.0246886945230267,0.45161290322580644,0.9628612181983283,1.0,1/12,0.33%,MT1G
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.5816449927553842,1.0244666713387491,0.43478260869565216,1.0,1.0,3/11,15.71%,ERBB4;FOXB1;SLC22A4
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.44887775347171616,1.0243657616991906,0.45,1.0,1.0,25/85,18.61%,GSDMA;TLR2;HAMP;JCHAIN;LYG2;SFTPD;STAB2;IL12A;SYK;NLRC4;HLA-A;COLEC12;DEFB109B;OAS2;RPS19;IGLL1;ELANE;ISG15;LYG1;PGLYRP2;NOS2;PGLYRP1;WFDC11;TF;LYZL4
prerank,Reactome_2022__HS-GAG Degradation R-HSA-2024096,-0.4990403846733155,-1.0243183486110117,0.375,0.9633402715161437,1.0,10/18,15.86%,GLB1L;GPC6;GPC2;SDC3;GPC4;AGRN;IDUA;GUSB;GPC1;SDC4
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.5832354820055504,-1.02390057387058,0.42857142857142855,0.9639304366860397,1.0,5/12,10.41%,UPB1;NT5C1A;UPP1;NT5C;UPP2
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.647322868091879,1.0237323595708687,0.4745762711864407,1.0,1.0,1/6,14.41%,IL4
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.5779902404540588,1.0237294310058451,0.40298507462686567,1.0,1.0,2/21,5.72%,TBX1;MESP1
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Bone Marrow,-0.5415031727662456,-1.0237272593243245,0.4358974358974359,0.9638739635315335,1.0,2/9,3.46%,CD38;KIT
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.475930327944781,-1.0237076172606707,0.45714285714285713,0.9633473783670508,1.0,6/20,19.16%,RAB7A;SNF8;RAB5A;EMP2;STX8;HOOK3
prerank,CellMarker_Augmented_2021__Thymocyte:Undefined,0.4406084712566505,1.0236610564090456,0.46153846153846156,1.0,1.0,12/53,12.49%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;IKZF1;TAGAP;CD37;GPR183;ALOX5AP;PSTPIP1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.5396005469003393,-1.0235659306940463,0.4166666666666667,0.9632196587740075,1.0,2/14,7.92%,DNAJC30;PID1
prerank,KEGG_2021_Human__MAPK signaling pathway,-0.35299055559202064,-1.0235030858824181,0.3333333333333333,0.9628214810967862,1.0,25/261,8.44%,DUSP4;NGF;NR4A1;DUSP6;FOS;CD14;PDGFD;MAP3K14;KIT;DUSP2;PPP5C;CACNG4;FGF18;ECSIT;ERBB2;KITLG;FGF1;TGFA;CACNB1;ANGPT4;NTRK1;HSPB1;NFATC3;FLNA;PLA2G4C
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,0.43290109339784244,1.0233372446680362,0.43902439024390244,1.0,1.0,18/164,14.62%,ARHGAP9;PLEKHG6;ARHGAP24;ARHGAP31;PIK3R3;PLEKHG3;PREX2;SNAP23;WAS;BAIAP2L1;DOCK6;TAGAP;ECT2;RASGRF2;DOCK5;NOXO1;ARHGAP45;CYBA
prerank,"Reactome_2022__Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",-0.45200510476718886,-1.023304715183454,0.4,0.9627817437374724,1.0,9/19,15.86%,GPC6;GPC2;SDC3;GPC4;AGRN;VCAN;CSPG5;GPC1;SDC4
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.5596064459514445,-1.023185072122452,0.3684210526315789,0.9624797237208025,1.0,1/9,2.22%,TWIST1
prerank,CellMarker_Augmented_2021__Pancreatic Ductal Stem cell:Pancreas,-0.4444415330621119,-1.0230764850388532,0.4444444444444444,0.9622019110852483,1.0,6/42,6.77%,RFX6;EHF;CLDN4;ESRP1;CFC1;TMEM125
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.43608906947935877,-1.0230450809007423,0.3939393939393939,0.9616862535188174,1.0,5/23,9.80%,DRD4;CBARP;PKD2;EPHB2;GNB5
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.379577087509675,-1.0228743180984141,0.32142857142857145,0.9615600341992021,1.0,22/99,19.32%,PHLDB2;PRKCD;RND3;CAPN2;F11R;FSCN1;RHOBTB2;CORO1A;TAOK2;CRK;CORO2B;SORBS3;MARK2;TRAF3IP1;RHOA;PAK3;ABL1;CCDC88A;CAMSAP3;ARHGAP35;RHOBTB1;MLST8
prerank,Reactome_2022__Aryl Hydrocarbon Receptor Signaling R-HSA-8937144,0.6873629748864003,1.0227661860326251,0.5964912280701754,1.0,1.0,1/6,3.38%,AHR
prerank,CellMarker_Augmented_2021__Stromal cell:Amniotic Membrane,0.43912654289941155,1.0227494359696254,0.4507042253521127,1.0,1.0,16/89,16.50%,RAB34;ARHGAP31;ANXA1;PTX3;NID1;FLI1;ITGA5;HEG1;PDCD1LG2;COL6A2;PRDM8;CMTM3;CYBRD1;ENG;CSF1;MSN
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,0.43316843077843004,1.0226639450750215,0.4,1.0,1.0,23/154,14.82%,CLCA2;ATP6V1G2;CLCA4;TRPV6;TRPC7;CLCA1;ASIC5;ATP1A4;ATP10B;TSC22D3;TTYH2;ATP6V0E2;TRDN;ASIC1;SLC9C1;ATP8B3;RPS27A;ATP6AP1;ANO2;ATP11C;PLN;SLC9B1;CLCN7
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.4555150193892184,1.0225762721923946,0.45454545454545453,1.0,1.0,14/54,14.41%,ANXA1;CCL5;SASH3;CLCF1;PTPRC;CD81;IL12A;CD80;PDCD1LG2;HLA-DPB1;TNFSF4;GPR183;IL7;IL4
prerank,Reactome_2022__DSCAM Interactions R-HSA-376172,-0.5092444222431416,-1.022520048928422,0.4,0.962036636372795,1.0,6/11,29.07%,DSCAML1;MAPK12;MAPK8;RNASE1;DSCAM;PKN1
prerank,Reactome_2022__Vitamin D (Calciferol) Metabolism R-HSA-196791,0.6261435325913257,1.022364136386381,0.45454545454545453,1.0,1.0,3/11,14.88%,LRP2;LDLRAP1;CYP24A1
prerank,Reactome_2022__Meiosis R-HSA-1500620,0.4821851234008716,1.0223231346545443,0.4657534246575342,1.0,1.0,14/62,20.57%,SYCP1;SYNE2;SYCP3;H2BC4;H2AZ1;PSMC3IP;RPA3;STAG3;SMC1B;ARTN;BRCA1;HSPA2;FKBP6;H2AZ2
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.4875239242053029,-1.0221588781839235,0.4666666666666667,0.9625601996398152,1.0,3/20,6.89%,BCL2;FOS;TGFA
prerank,Reactome_2022__Alpha-protein Kinase 1 Signaling Pathway R-HSA-9645460,0.5639717601242182,1.0221562345803508,0.47619047619047616,1.0,1.0,2/11,11.00%,TIFA;RPS27A
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.5514922016557923,-1.0220877709233087,0.47058823529411764,0.9622435941444063,1.0,4/18,9.56%,GRID2;SLC17A6;GRIK4;GRIK1
prerank,KEGG_2021_Human__Olfactory transduction,0.4587985365695714,1.022040803715962,0.48,1.0,1.0,21/82,15.17%,OR52N2;OR2H2;OR51I2;OR52I2;OR7C1;OR52A5;OR2AJ1;OR5V1;OR56A3;OR10A2;OR8A1;OR2G6;OR52E5;OR2AG1;OR3A3;ANO2;OR2T10;OR6N1;OR3A2;OR2T12;OR51M1
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.3749388360949443,-1.0218579417084643,0.35294117647058826,0.9622677302047967,1.0,34/118,17.72%,ADAMTS1;EPHX2;TBC1D16;GPC6;PC;RND3;RHBDF1;ASS1;PLIN5;PTPRF;B4GALT2;CAP2;EPB41L4B;CHKA;ECHS1;GNA11;CITED4;ALDH4A1;DAB2IP;PACSIN3;AADAT;GPT2;GALNT18;AMOTL2;CHST3;FKBP9;GPC1;ADGRL2;DDAH1;SH3D19;ADCY6;SH3BP4;TNKS1BP1;RBFOX2
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),0.6614452187035532,1.0217276133592696,0.5555555555555556,1.0,1.0,2/7,17.04%,PINK1;TOMM7
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.4054973646099993,1.021665425379812,0.4117647058823529,1.0,1.0,59/348,16.58%,ENPP2;KIF14;ITGAX;PIK3R3;ANXA1;FGF20;CCL5;FGF2;VSIR;FLT1;TGFB1;SYNE2;SEMA3A;ACTG1;GPER1;SMIM22;STK26;ERBB4;MMP9;IGF1;LEF1;HSPA5;PRR5L;HGF;DUSP22;CYP1B1;TCAF2;SOD2;F7;RHOB;LAMC2;PLAU;VIL1;COL1A1;DAB2;PLXNA3;CLDN5;DACH1;F2RL1;IGSF10;SEMA3F;ANGPTL3;THBS1;CSF1R;NEXN;SNAI1;SEMA3B;TMSB10;IL4;ALOX15B;CARMIL1;EPHA1;CXCL12;WNT5B;FERMT3;ENG;CSF1;WASHC1;BCAR1
prerank,CellMarker_Augmented_2021__Specialist Antigen Presenting cell:Undefined,-0.48480633368306353,-1.021614535164551,0.4411764705882353,0.9624421315871805,1.0,2/29,0.22%,IL7R;CD38
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.39346878154538456,-1.0215923990066065,0.391304347826087,0.9618969271808459,1.0,13/73,10.89%,CDH4;CDH20;CDH5;CSK;CDH19;CDH13;DSG2;PVR;CDH9;FSCN1;SDK2;NLGN2;NECTIN3
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.559208122253342,1.0215760144092623,0.44594594594594594,1.0,1.0,3/19,12.94%,PFKFB2;IGF1;PRXL2C
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.559208122253342,1.0215760144092623,0.44594594594594594,1.0,1.0,3/19,12.94%,PFKFB2;IGF1;PRXL2C
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),0.6430386658719928,1.0215349089572998,0.48333333333333334,1.0,1.0,1/7,2.40%,GMFG
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.5807441958219419,-1.02136188482875,0.4864864864864865,0.9621424468794197,1.0,5/7,34.95%,LIG3;PARP1;DNA2;LONP1;TOP3A
prerank,CellMarker_Augmented_2021__Tumor Endothelial cell:Kidney,-0.4730374339350487,-1.0213415137269266,0.4864864864864865,0.9610070721295371,1.0,1/21,0.04%,ADGRF4
prerank,CellMarker_Augmented_2021__Tumor Endothelial cell:Colon,-0.4730374339350487,-1.0213415137269266,0.4864864864864865,0.9610070721295371,1.0,1/21,0.04%,ADGRF4
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.6136601057500173,1.0212049100938,0.4838709677419355,1.0,1.0,1/15,2.00%,NOX5
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.42614007669288567,1.021204583882021,0.4090909090909091,1.0,1.0,18/194,9.56%,TBX1;GML;ITGB2;GSDMA;MCM2;TLR2;NOX5;AHR;CIDEB;CASP7;TNFRSF10A;BOK;DUX4;DDIT4;RFK;IRF1;TRAIP;RHOB
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.5115915259036695,1.0210462580235165,0.38461538461538464,1.0,1.0,3/26,2.19%,MYH8;MYH4;MYBPC3
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.5115915259036695,1.0210462580235165,0.38461538461538464,1.0,1.0,3/26,2.19%,MYH8;MYH4;MYBPC3
prerank,Reactome_2022__Constitutive Signaling By Overexpressed ERBB2 R-HSA-9634285,-0.574498167773159,-1.0209139712519806,0.4864864864864865,0.9615208090424361,1.0,2/10,19.25%,ERBB2;HRAS
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,0.43641370291954706,1.0208371545564356,0.4430379746835443,1.0,1.0,13/137,11.51%,ARHGAP9;ARHGAP24;ARHGAP31;PLEKHG3;PREX2;MAP3K11;SNAP23;WAS;DOCK6;TAGAP;ECT2;ARHGDIG;RASGRF2
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),-0.6748692810215675,-1.0207878505272723,0.5531914893617021,0.9612930888897796,1.0,3/5,23.83%,IRGM;GPLD1;ATG7
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.6179775369561716,1.0206450432041523,0.5084745762711864,1.0,1.0,1/12,1.99%,RENBP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.6097636875085962,-1.0205346790406986,0.45454545454545453,0.9613885762877904,1.0,5/11,10.41%,UPB1;NT5C1A;UPP1;NT5C;UPP2
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),-0.6247251374586992,-1.0205216891157578,0.47619047619047616,0.9608306148372561,1.0,1/5,13.89%,ABHD12
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.6561809021230982,1.0201439749899541,0.49019607843137253,1.0,1.0,2/6,13.83%,RP1;RPGRIP1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.6219132095647393,-1.020001654775131,0.4857142857142857,0.9615398668084005,1.0,1/6,10.66%,AGO2
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.5653919558122681,1.0196173958352832,0.515625,1.0,1.0,4/15,14.06%,ITGA2;MESP1;HMGA2;SNAI1
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.6576350312679043,1.0195266663377194,0.5740740740740741,1.0,1.0,3/6,16.50%,TGFB1;TGFB3;MSN
prerank,Reactome_2022__Serotonin Receptors R-HSA-390666,0.6065647475518929,1.0193139035730767,0.5151515151515151,1.0,1.0,2/10,12.48%,HTR5A;HTR1B
prerank,"Reactome_2022__Defective EXT1 Causes Exostoses 1, TRPS2 And CHDS R-HSA-3656253",-0.5245855649043859,-1.0191833946933844,0.38235294117647056,0.9631995311326804,1.0,5/12,7.41%,GPC6;GPC2;SDC3;GPC4;AGRN
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.49589842730227285,1.019061581092404,0.4625,1.0,1.0,6/44,11.00%,TBX1;SIX4;TGFB1;WNT5A;TGFB3;COL1A1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.5169497112168656,1.0190525443136809,0.4358974358974359,1.0,1.0,4/44,7.66%,TBX1;SGCG;CAV3;IGF1
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,-0.3796543963895462,-1.0190126433980067,0.3,0.9630736216242648,1.0,20/82,22.45%,APOO;GLUD2;CARM1;TFB1M;PPARGC1B;HDAC3;NR1D1;IDH2;SAMM50;DNAJC11;CHCHD3;GLUD1;SMARCD3;CRTC1;MAPK12;PRKAG2;ALAS1;ATP5F1B;CREBBP;CHCHD6
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,0.49445841038496907,1.0189384107364394,0.43661971830985913,1.0,1.0,6/46,10.17%,ESR1;RORC;NR1I3;NR2E3;NR1H4;HNF4G
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.605888043959941,1.0189278803321087,0.47058823529411764,1.0,1.0,5/11,22.89%,WNT5A;AXL;IL7;IFIH1;CD74
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.6308770151452684,-1.018875225934375,0.5641025641025641,0.9627672653139129,1.0,2/7,17.20%,APOE;ABL1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.3749274019984632,-1.0188649133686067,0.2222222222222222,0.9622101664050821,1.0,19/102,11.08%,EFR3B;CELF5;LGR5;GALNT13;CASKIN1;CRABP1;HES1;ELAVL3;LHFPL4;MEGF10;INA;SNCB;HPCA;WNK2;SRRM3;MMD2;TAGLN3;PTPRZ1;MSI1
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),-0.402161609847432,-1.0187699698452195,0.48,0.962022351088676,1.0,4/70,5.95%,RFX6;GCK;FOXO1;CRY1
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,-0.43210856147223703,-1.0184681144998364,0.42857142857142855,0.9622109808493342,1.0,12/49,9.19%,CLDN4;CDH4;CDH5;CDH19;CLDN15;CDH13;CLDN16;F11R;PARD3;PVR;CDH9;SDK2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.4464500720311055,-1.0184616181479633,0.40625,0.9616395749581712,1.0,13/31,28.61%,PEX14;BICDL2;TMEM201;CLN3;TRAK2;MAPT;RAB6A;BICDL1;HTT;UXT;PAFAH1B1;TRAK1;ARHGAP21
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.5621763591893059,-1.0183322294153743,0.4444444444444444,0.9613350270796595,1.0,1/9,8.67%,METAP2
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.4327328477269981,1.0182691794850673,0.43209876543209874,1.0,1.0,15/109,14.31%,ENPP2;CAVIN1;KIF14;FGF20;FGF2;TGFB1;WAS;ERBB4;DUOX1;RHOB;SPOCK3;PLXNA3;CSF1R;NEXN;TMSB10
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,-0.49454299891944864,-1.0178211272421827,0.4857142857142857,0.9622121987933896,1.0,6/19,19.41%,PRKCD;ERBB2;PRKCA;NRG2;HRAS;BTC
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,-0.38944354844313345,-1.0177741893481227,0.42857142857142855,0.9616965672859331,1.0,20/105,10.93%,CLDN4;CDH4;CDH5;KIRREL3;CDH19;CLDN15;CDH13;CD151;CLDN16;F11R;PARVA;PARD3;PVR;FLNA;CDH9;ITGB4;SDK2;KIRREL2;NECTIN3;NPHS1
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression Linked To Lipogenesis R-HSA-9029558,0.566160874131642,1.0177415804695529,0.4827586206896552,1.0,1.0,2/9,13.19%,SCD;ANGPTL3
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.4843169715999868,1.0176836282559616,0.42857142857142855,1.0,1.0,10/60,13.42%,WNT8B;TCF7;FRAT1;WNT5A;WNT8A;LEF1;FZD8;WNT6;SFRP4;TCF7L1
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.5386930201825523,-1.017672887600451,0.4,0.961470680562305,1.0,2/12,7.05%,CD14;TICAM2
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.5446013556637154,1.0176395663754292,0.4935064935064935,1.0,1.0,6/26,15.43%,SYCP1;IHO1;MEIOB;STAG3;RNF212B;KASH5
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.6659528451366276,1.0175868030250115,0.5535714285714286,1.0,1.0,1/6,4.73%,SCIMP
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.47821285256851076,1.0174421030664313,0.4,1.0,1.0,8/35,20.66%,CCL5;SCIMP;SH2D1B;IFNK;CYBA;DDX60;USP17L2;LY86
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,0.5732534467166893,1.0174140539946848,0.4918032786885246,1.0,1.0,2/16,11.35%,FRAT1;PPP2R5A
prerank,KEGG_2021_Human__Other glycan degradation,-0.5025826844627289,-1.0174086320450928,0.37142857142857144,0.9617058127972105,1.0,8/15,22.33%,NEU4;AGA;NEU3;FUCA1;GLB1;GBA2;MAN2B1;MAN2C1
prerank,CellMarker_Augmented_2021__Intermediate monocyte:Peripheral Blood,0.6745714366680502,1.0172291292328646,0.5079365079365079,1.0,1.0,4/6,8.06%,ITGAX;ITGAM;FCGR3A;CEACAM8
prerank,CellMarker_Augmented_2021__CD16+ Dendritic cell:Peripheral Blood,0.6745714366680502,1.0172291292328646,0.5079365079365079,1.0,1.0,4/6,8.06%,ITGAX;ITGAM;FCGR3A;CEACAM8
prerank,CellMarker_Augmented_2021__Classical monocyte:Peripheral Blood,0.6745714366680502,1.0172291292328646,0.5079365079365079,1.0,1.0,4/6,8.06%,ITGAX;ITGAM;FCGR3A;CEACAM8
prerank,CellMarker_Augmented_2021__Immature Myeloid cell:Peripheral Blood,0.6745714366680502,1.0172291292328646,0.5079365079365079,1.0,1.0,4/6,8.06%,ITGAX;ITGAM;FCGR3A;CEACAM8
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Peripheral Blood,0.6745714366680502,1.0172291292328646,0.5079365079365079,1.0,1.0,4/6,8.06%,ITGAX;ITGAM;FCGR3A;CEACAM8
prerank,CellMarker_Augmented_2021__Suppressive monocyte:Peripheral Blood,0.6745714366680502,1.0172291292328646,0.5079365079365079,1.0,1.0,4/6,8.06%,ITGAX;ITGAM;FCGR3A;CEACAM8
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.4248176456199393,-1.0172104980595331,0.45,0.9616831114571498,1.0,18/74,19.47%,SMPD3;CDH5;LIMK1;SYNPO;RAB7A;SNF8;SLX4;EMILIN1;DAB2IP;SDCBP;SPIDR;PIH1D1;SDC4;PRKCA;ERCC1;TSG101;ICE1;STX18
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Liver,0.6773371905057987,1.0171985670422945,0.44642857142857145,1.0,1.0,3/7,16.35%,NT5E;CD44;ENG
prerank,KEGG_2021_Human__GnRH signaling pathway,-0.37914510867731643,-1.0168464063848721,0.45,0.9622220185685341,1.0,11/79,12.71%,PRKCD;ITPR2;MMP2;EGR1;PLD2;PLA2G4C;GNAS;GNA11;ADCY3;ADCY2;MAPK7
prerank,Reactome_2022__SLBP Independent Processing Of Histone Pre-mRNAs R-HSA-111367,-0.5877252199330801,-1.0168095216616309,0.475,0.9617936914487794,1.0,2/9,9.65%,LSM10;SNRPB
prerank,"Reactome_2022__Gamma-carboxylation, Transport, And Amino-Terminal Cleavage Of Proteins R-HSA-159854",0.6195983459959927,1.016787047083429,0.5,1.0,1.0,4/9,14.52%,PROZ;F7;FAM110A;GGCX
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.5664901765030639,1.0167390885699192,0.5294117647058824,1.0,1.0,4/13,21.26%,RNFT1;USP13;HERPUD1;BCAP31
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.4320120173669679,1.0167334811833184,0.48148148148148145,1.0,1.0,12/139,14.04%,PSMB9;DISC1;TLR2;FRAT1;TGFB1;DAAM2;RSPO1;DDX3X;COL1A1;SFRP4;DKK2;PSMC5
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Ovarian Cortex,0.47944946642705444,1.0166635655408907,0.5,1.0,1.0,12/58,16.54%,CLDN6;SCGB3A2;TUNAR;ZNF738;CCDC172;SALL4;CA14;CALB1;L1TD1;SLC7A3;ZNF850;VASH2
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Fluid,0.601974736005189,1.0164445965274083,0.4444444444444444,1.0,1.0,5/10,16.35%,FLT1;ANPEP;NT5E;CD44;ENG
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",0.44584221308092864,1.0163409856345635,0.4,1.0,1.0,9/87,15.19%,ESR1;PIK3R3;FGF20;ERBB4;CD80;KLB;PPP2R5A;RHOG;MAPK3
prerank,GO_Biological_Process_2021__glucocorticoid metabolic process (GO:0008211),0.5955333682764885,1.0162863292044098,0.475,1.0,1.0,4/7,25.71%,HSD11B2;YWHAH;CYP21A2;CYP17A1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.6514533115434292,1.0162027727177754,0.5161290322580645,1.0,1.0,2/7,5.69%,TNFRSF1B;WAS
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.5363276234436763,-1.016199805004026,0.4827586206896552,0.9629550989334138,1.0,1/12,0.18%,NOX4
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.527009232012091,1.0161341969150888,0.410958904109589,1.0,1.0,4/27,5.31%,GATA4;LRP2;SIX4;WNT5A
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.5664961177872958,-1.015993870594709,0.425,0.9628849817919733,1.0,2/9,6.48%,CFLAR;CD53
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.43057094475460933,1.015742821666808,0.425,1.0,1.0,28/102,16.87%,AMBP;OIT3;SLC28A1;ELOVL2;CLDN2;BHMT;ACOX2;CYP3A4;FAXDC2;PON1;NR1H4;SMLR1;ALDOB;F7;NPY1R;MTTP;VTN;AGT;CALCR;PON3;MASP1;GRAMD2A;KRT8;MOGAT2;HNF1A;GHRL;A2M;ASGR1
prerank,Reactome_2022__DNA Replication R-HSA-69306,0.436703426992564,1.0157367216087076,0.43037974683544306,1.0,1.0,20/121,20.86%,PSMB9;POLE2;H2BC4;MCM3;POLD4;H2AZ1;RPA3;CCNE2;RPS27A;CCNA2;PSMC5;GINS1;ORC4;RBX1;PSMA3;PSMB6;PSMD6;H2AZ2;POLE3;GMNN
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.5128676390090606,-1.0155866393835566,0.39285714285714285,0.9633829499264704,1.0,6/14,14.57%,UST;CHST12;CSGALNACT1;VCAN;B3GAT3;CSPG5
prerank,CellMarker_Augmented_2021__Naive Regulatory T (Treg) cell:Peripheral Blood,-0.3931195322827531,-1.0154351502545693,0.3333333333333333,0.9632037929949977,1.0,4/61,1.33%,IL7R;P2RY10;AOAH;IL16
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.5939265201923839,1.0153495633304424,0.5,1.0,1.0,2/13,7.73%,SLC26A6;SLC13A4
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.3145907556346808,-1.0153296227795665,0.25,0.9629238246832869,1.0,99/567,14.93%,PER2;ETV5;KCNIP3;PLK3;ZNF25;PRDM5;GFI1B;OSR1;GATAD2A;BCL6;WWC1;TWIST1;PTCH1;IFI16;HDAC10;SAP130;ZNF133;NR4A3;ZNF69;CBFB;WWP2;ZNF596;KLF10;THAP7;CTCF;HES1;NFX1;SMYD2;MEN1;CRY1;CRYM;ZNF239;PCGF1;ZNF75A;LRRFIP1;IGBP1;ASCL1;ZNF764;ZNF3;E2F6;NFATC3;KDM2B;DLX1;MACROH2A2;ZNF846;TGIF1;RARB;SNAI2;MECP2;POU6F1;SPDEF;MLX;MLIP;HDAC3;LDB1;BPTF;NR1D1;ZNF79;NKAP;ATF3;CREM;NR2C1;BCL11A;HEXIM2;ZBTB7A;DNMT3A;WWC2;ZNF608;ZNF268;HSF1;KDM1B;RTF1;MIER2;ZNF589;ZNF263;DAB2IP;ZNF692;CUX1;FGFR2;NFIB;PER3;KCTD1;SDCBP;ZNF557;ZNF136;E4F1;FHL2;MED25;SIRT7;HIVEP1;TCF25;KLF8;GTF2IRD1;SMARCA4;NR1H2;SP2;ZBTB4;ZNF254;IMPACT
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.44737774399970454,-1.0152624974066693,0.4722222222222222,0.9625898281793843,1.0,6/29,5.91%,BAMBI;TWIST1;PTCH1;HDAC7;TWIST2;MEN1
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Brain,0.44887136448660303,1.0152314990645122,0.4358974358974359,1.0,1.0,11/97,7.41%,TIMP3;PRRX1;LPAR1;LMOD1;SDC2;FBXL7;NID1;PCDH18;PLP1;DAAM2;ANGPTL2
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.5338650932972395,1.0151116117668044,0.509090909090909,1.0,1.0,4/21,11.19%,CLCF1;STAT5A;SOCS2;STAT1
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.6055985637404796,1.0150973533527894,0.5245901639344263,1.0,1.0,3/8,22.48%,UBE2M;RBX1;UBA3
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),-0.6149783659775092,-1.0150761704130022,0.46511627906976744,0.9626055259383333,1.0,3/5,16.82%,SMARCB1;PIH1D1;AUTS2
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,0.4496201544733118,1.0150694977081618,0.4931506849315068,1.0,1.0,12/82,20.86%,PSMB9;H2BC4;MCM3;H2AZ1;RPS27A;PSMC5;ORC4;PSMA3;PSMB6;PSMD6;H2AZ2;GMNN
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.5047243278510941,1.0149672543880452,0.4375,1.0,1.0,8/23,18.70%,PDE6H;GPER1;AFAP1L2;MMP9;PLAUR;AGT;AGR2;PDE6G
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.4644555452600534,-1.0148764345841041,0.3548387096774194,0.9626289620459824,1.0,6/42,9.44%,EYA4;RNF168;BRCC3;RADX;ERCC8;WRAP53
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.5176748854908452,-1.0147959114672416,0.4634146341463415,0.9622879960309277,1.0,2/12,7.73%,SPTBN4;EPHB2
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.6124635228631197,1.0145530724611225,0.5094339622641509,1.0,1.0,3/11,9.32%,BAIAP2L1;LCP1;GAS2L3
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.5444783949290554,-1.0143918911643965,0.4411764705882353,0.9627222371333709,1.0,2/8,11.68%,CX3CR1;MAPKAPK2
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",0.5010459296162608,1.014362353891,0.4246575342465753,1.0,1.0,2/45,2.82%,ACAA2;AOX1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5056414736700794,1.0142701094268942,0.391304347826087,1.0,1.0,2/24,3.51%,ANXA1;FGF2
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.4730813291368728,1.0142418161988738,0.475,1.0,1.0,14/70,22.77%,LOX;UBE2L6;USP6;MMP15;PIGH;PLAT;GGCX;RABGGTB;PARP4;UBE2M;GNMT;PLOD2;UBA3;BAP1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.4382065641960295,1.0140473509693149,0.4473684210526316,1.0,1.0,22/117,20.86%,PSMB9;MCM2;POLE2;MCMDC2;MCM3;POLD4;CDK2AP1;RPA3;RPS27A;RECQL4;PSMC5;HMGA1;DDX23;GINS1;ORC4;LRWD1;PSMA3;PSMB6;HELB;PSMD6;POLE3;GMNN
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.3920215508637821,-1.0140287944821673,0.3333333333333333,0.9631559544226628,1.0,42/154,22.05%,NGF;DTX1;CELF5;THEM4;YDJC;SLC17A6;ELAVL3;TTBK1;INA;NKAIN3;SNCB;AKAP7;HPCA;SRRM3;MMD2;TAGLN3;ADGRA1;ABLIM3;BRINP1;JPH3;RBPMS;CDK14;ERC2;FBXO44;CPNE4;GALNT9;SYN1;FXYD7;PRKCA;POU6F2;PTPN5;LINGO1;BRSK1;CSDC2;MAPK4;GGT7;TTLL1;APLP1;FBLL1;GPHN;PAK5;GRIP1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.5589836349489944,1.0138912377193805,0.5076923076923077,1.0,1.0,6/14,17.29%,GPER1;SOD2;TGFB3;CDKN1B;CDKN1A;PRKG1
prerank,Reactome_2022__SARS-CoV-2 Modulates Autophagy R-HSA-9754560,-0.5796184939003142,-1.0138532546579984,0.42424242424242425,0.9632409111620287,1.0,1/9,2.61%,VPS16
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",0.686753308885428,1.0138531938269695,0.5714285714285714,1.0,1.0,4/5,30.87%,TALDO1;RPE;RPEL1;TKT
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.6663206783775686,1.013701947410992,0.5535714285714286,1.0,1.0,4/7,25.79%,ALDOB;GLYCTK;TKFC;TPI1
prerank,CellMarker_Augmented_2021__Unrestricted Somatic Stem cell:Undefined,0.6807734478477663,1.0134802033697001,0.49056603773584906,1.0,1.0,3/6,16.35%,NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),-0.605272238473361,-1.013297840773835,0.4897959183673469,0.964238372043132,1.0,1/6,6.41%,PTPRF
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),0.6402286257552555,1.0131942830345395,0.46296296296296297,1.0,1.0,3/8,9.57%,LCP1;HCK;IL5
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5646036032282802,1.0128732128925269,0.4868421052631579,1.0,1.0,3/15,11.52%,BOK;RNFT1;USP13
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.44794520158735235,-1.012707781128807,0.42424242424242425,0.9653273834538183,1.0,2/30,2.79%,ADAMTS1;LSM10
prerank,KEGG_2021_Human__Pyrimidine metabolism,-0.42871899688505044,-1.0126607307499265,0.28,0.9648624304187977,1.0,12/51,14.86%,NME1-NME2;UPB1;PNP;NT5C1A;UPP1;RRM2B;NT5C;RRM2;UPP2;DUT;CTPS2;NME3
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.567625102097727,-1.0126147801293708,0.4375,0.9644443565670422,1.0,4/7,32.32%,SYT7;GREM1;SUCO;LEPR
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6802402531553704,1.0123554689021237,0.48148148148148145,1.0,1.0,1/5,12.93%,PLN
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5835404647544351,1.0122131738678422,0.48484848484848486,1.0,1.0,3/10,24.93%,YOD1;INSIG1;DERL2
prerank,KEGG_2021_Human__mTOR signaling pathway,0.4112739465895691,1.0121903789036013,0.35064935064935066,1.0,1.0,21/138,19.97%,WNT8B;PIK3R3;ATP6V1G2;STRADA;WNT5A;DEPDC5;WNT8A;IGF1;LPIN3;DDIT4;RRAGA;FZD8;WNT6;WDR24;MAPK3;WNT5B;STRADB;LAMTOR3;MAP2K1;ULK1;RPS6
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,0.5291627503076729,1.0120009072877028,0.5,1.0,1.0,6/19,24.77%,H2BC4;H2AZ1;ORC4;H2AZ2;ORC5;H2AC6
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.5207466886101273,-1.0119852303012633,0.5135135135135135,0.9656470112592751,1.0,7/14,25.86%,FZD7;CCN3;HDAC3;HDAC5;HDAC4;NOTCH1;HDAC1
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),-0.580910307300352,-1.0119833757814507,0.5,0.9650670430843447,1.0,1/6,0.67%,EPHX2
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.5493277830966179,-1.011884737815597,0.5227272727272727,0.9648268395501595,1.0,2/7,2.55%,UBASH3B;COL4A2
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.41759390672252833,-1.0117921470531235,0.4482758620689655,0.9644097902252641,1.0,12/34,17.30%,CTC1;RAD50;WRAP53;GAR1;STN1;TERT;ZBTB48;ANKRD28;ZSCAN4;RTEL1;DCLRE1B;TNKS1BP1
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),-0.600324682221767,-1.0117649566969376,0.4888888888888889,0.9639239692187738,1.0,2/7,8.62%,APOH;SERPINE1
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Peripheral Blood,0.4471073826465753,1.0117600693201503,0.4166666666666667,1.0,1.0,5/90,3.45%,CDC25A;CEP55;DTL;POLQ;TICRR
prerank,CellMarker_Augmented_2021__Erythroblast:Blood,0.4471073826465753,1.0117600693201503,0.4166666666666667,1.0,1.0,5/90,3.45%,CDC25A;CEP55;DTL;POLQ;TICRR
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Subcutaneous Adipose Tissue,0.4471073826465753,1.0117600693201503,0.4166666666666667,1.0,1.0,5/90,3.45%,CDC25A;CEP55;DTL;POLQ;TICRR
prerank,CellMarker_Augmented_2021__Mast Cell progenitor:Bone Marrow,0.4471073826465753,1.0117600693201503,0.4166666666666667,1.0,1.0,5/90,3.45%,CDC25A;CEP55;DTL;POLQ;TICRR
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.4597914078934816,-1.0116636488772928,0.38235294117647056,0.9636541133382746,1.0,9/35,17.39%,PRKCD;CDH5;PPP6R1;ENSA;SYMPK;PTBP1;PPP1R7;PPIA;PTPA
prerank,CellMarker_Augmented_2021__Epithelial cell:Airway Epithelium,0.6485658350891591,1.0116355113648732,0.48333333333333334,1.0,1.0,2/7,17.26%,ANPEP;NOS2
prerank,CellMarker_Augmented_2021__Epithelial cell:Skin,0.6485658350891591,1.0116355113648732,0.48333333333333334,1.0,1.0,2/7,17.26%,ANPEP;NOS2
prerank,CellMarker_Augmented_2021__Epithelial cell:Lung,0.6485658350891591,1.0116355113648732,0.48333333333333334,1.0,1.0,2/7,17.26%,ANPEP;NOS2
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.6115136038042532,-1.0110705893147676,0.47058823529411764,0.9646069157618505,1.0,1/8,3.46%,KIT
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.549633902865122,-1.0110676138335652,0.4642857142857143,0.9640373355385441,1.0,2/10,19.83%,RAPGEF1;RAP2A
prerank,Reactome_2022__Small Interfering RNA (siRNA) Biogenesis R-HSA-426486,-0.5909457795308883,-1.0110219488443473,0.46153846153846156,0.9635759348828689,1.0,2/8,22.22%,AGO2;TARBP2
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.6144937100199578,1.0109868363900543,0.5,1.0,1.0,3/7,16.34%,NR1H4;ACSL3;HTR2B
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4916274025964731,-1.010839851506496,0.4444444444444444,0.9634143662315929,1.0,3/11,10.48%,PLK3;FBXO31;RFWD3
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.5499869171048578,-1.0107611322086087,0.4444444444444444,0.9631149437034969,1.0,2/9,21.30%,ZSWIM5;YTHDF1
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),0.547757049552407,1.010717728278774,0.43661971830985913,1.0,1.0,9/19,25.37%,SYK;LEF1;TNFSF4;IRF4;ZFPM1;DDIT3;HLA-DRB1;PRKCQ;CEBPB
prerank,Reactome_2022__SHC-mediated cascade:FGFR1 R-HSA-5654688,0.5689306719353047,1.0105945724401253,0.4807692307692308,1.0,1.0,1/17,2.58%,FGF20
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.3844325659233241,-1.0104636937473035,0.5555555555555556,0.9634060601404977,1.0,8/75,6.71%,MYO10;PRKCD;LIMK1;MYO9B;ITPR2;CD247;PLD2;ARPC3
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),-0.5765279045549783,-1.0102606692133622,0.55,0.963390424347463,1.0,1/5,3.55%,ADCYAP1
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.6492476309925327,1.0100496666889416,0.48484848484848486,1.0,1.0,3/8,23.44%,DNAJB1;HSPA2;DNAJB2
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.49591496307506455,-1.009998953725662,0.4444444444444444,0.9635126071582956,1.0,4/17,8.07%,DTX1;HES1;ASCL1;DLX1
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),0.6519414249448211,1.0099492785174922,0.5806451612903226,1.0,1.0,1/6,3.42%,CYP4F12
prerank,PanglaoDB_Augmented_2021__T Cells,-0.3968935904922099,-1.009842796097543,0.43478260869565216,0.9634051146150635,1.0,15/91,8.55%,IL7R;P2RY10;SKAP1;IL16;BCL2;JUNB;DUSP2;EEF1B2P3;HOPX;CD247;CCL4L2;CD53;SELL;SELPLG;TGIF1
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.6291652017233254,1.0098011361345596,0.509090909090909,1.0,1.0,1/6,4.50%,TNFRSF10A
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.344435659489817,-1.0095174478658822,0.4166666666666667,0.9636494860774607,1.0,45/257,17.99%,CPSF1;DDX41;HNRNPL;DCPS;RNF113A;TXNL4A;CWF19L1;MAGOHB;PDCD7;LSM7;SRRM1;DHX8;SUGP1;SRSF4;GPATCH1;SNRPB;HNRNPF;DDX46;SMU1;SF3A2;SYMPK;U2AF2;CSTF2;NOVA1;PTBP1;GEMIN5;CPSF7;POLR2F;RBMX2;ZMAT5;CELF4;GPKOW;SNRPN;POLR2C;IK;SNIP1;RALY;RBM41;HNRNPUL1;COIL;RNPC3;RBMX;PCF11;CPSF4;SMN1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5511901410178113,1.0094797370608994,0.5230769230769231,1.0,1.0,5/22,8.61%,CCL5;CRLF3;ERBB4;IL26;CYP1B1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.6560272497610385,1.0092044647642557,0.546875,1.0,1.0,1/7,4.58%,CCDC39
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.4664531372681573,1.0091874919769952,0.46153846153846156,1.0,1.0,10/53,16.47%,BLK;FLT1;SYK;ERBB4;FLT4;HCK;CSF1R;DDR2;EPHA1;ZAP70
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.4783459667770209,1.009124298880453,0.45454545454545453,1.0,1.0,9/41,16.35%,TGFB1;HEY2;WNT5A;LEF1;HGF;HMGA2;SOX9;SNAI1;ENG
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4887184248540555,-1.0088186070779077,0.40625,0.9645497729359397,1.0,6/16,15.36%,EYA4;BCL2;SNAI2;TERT;MAPK7;MCL1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4887184248540555,-1.0088186070779077,0.40625,0.9645497729359397,1.0,6/16,15.36%,EYA4;BCL2;SNAI2;TERT;MAPK7;MCL1
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.43415256190824214,1.0087003789363027,0.42857142857142855,1.0,1.0,10/97,7.94%,GATA4;SMAD6;LRP4;GNG12;ABCG2;WNT5A;MESP1;SCARA3;UACA;CCND1
prerank,Reactome_2022__Synthesis Of Dolichyl-phosphate R-HSA-446199,-0.6156008028837419,-1.0086778167792196,0.5208333333333334,0.9643503258463317,1.0,2/5,18.79%,DHDDS;DOLPP1
prerank,Reactome_2022__Activated NTRK2 Signals Thru RAS R-HSA-9026519,-0.6266577706704248,-1.0086699175994023,0.5238095238095238,0.9638002157821626,1.0,2/6,21.74%,HRAS;NTRK2
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.4225521568415387,1.0085809389406928,0.45977011494252873,1.0,1.0,19/139,16.52%,PPP1R1C;STMN4;SHISA6;TMEM35A;PRDM12;PLP1;VAMP1;LY6H;DRGX;TCEAL5;NEFM;PIEZO2;CLGN;AHNAK2;AQP4;ZNF536;VSTM2A;CNTN2;LRRTM1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),0.6050139358919985,1.008511568383429,0.4782608695652174,1.0,1.0,3/10,13.47%,DCLRE1A;DCLRE1C;TFIP11
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,0.5284667554904237,1.0083717235851335,0.4411764705882353,1.0,1.0,2/16,8.04%,GNG12;GNG4
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.588730304016579,1.0083576821720839,0.5074626865671642,1.0,1.0,2/14,7.33%,FGF2;ITGA5
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.5398206276132593,-1.008139244969847,0.4722222222222222,0.9647602577478167,1.0,3/13,6.60%,MFSD2A;PTCH1;STAT5B
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.5028219845789491,1.0080960880013643,0.45454545454545453,1.0,1.0,6/29,14.18%,ANGPT2;SEMA3A;SEMA3F;THBS1;ELANE;SEMA3B
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.6856391984138643,-1.0080727306297423,0.5111111111111111,0.9644315143329707,1.0,1/5,1.41%,GLA
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.42958489074807465,-1.0080437235972164,0.4074074074074074,0.963905179019428,1.0,12/56,17.40%,NUP210;NUP42;POM121C;NUP214;AAAS;AGO2;H2AJ;POLR2F;NUP37;POLR2C;NUP98;TNRC6A
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.6189501120738627,1.0079663005192467,0.4857142857142857,1.0,1.0,2/9,12.87%,CYP26B1;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.6120354302268235,1.0076532973481618,0.5,1.0,1.0,3/9,12.29%,FAXDC2;SCIN;PITHD1
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,-0.34206933635771,-1.0075972369527415,0.4,0.9645438242340252,1.0,41/249,11.92%,G6PC3;NUP210;NDST3;ST3GAL3;ENO3;GALE;CHPF2;XYLT1;GLB1L;GPC6;UST;GPC2;SDC3;PAPSS2;GYS1;NUP42;GPC4;HS6ST2;ARSB;POM121C;B4GALT2;PGLS;PPP2R5D;AGRN;NUP214;CHST11;ST3GAL2;CHST12;CHSY1;CSGALNACT1;SPAM1;AAAS;VCAN;PFKP;CHST6;PRELP;PFKFB3;IDUA;B3GAT3;B4GALT4;PGP
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.6855531904303229,1.007510355814312,0.5555555555555556,1.0,1.0,2/7,11.19%,IFIT1;STAT1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.44353251499001795,1.0074207825842547,0.44594594594594594,1.0,1.0,11/85,8.80%,GPHB5;GPR27;TSHR;FCGR3A;SCTR;SYK;GGT5;ADRB1;RAMP3;RXFP2;HCK
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.5883249073198231,-1.007346210256216,0.5135135135135135,0.9647481898517163,1.0,3/7,5.14%,SLC16A9;PNP;SLC2A9
prerank,Reactome_2022__TFAP2 (AP-2) Family Regulates Transcription Of Growth Factors And Their Receptors R-HSA-8866910,0.651753751061579,1.0073135991970734,0.5384615384615384,1.0,1.0,1/9,0.46%,ESR1
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.6490165546880193,-1.006974809156987,0.5208333333333334,0.9651803483333884,1.0,2/6,6.49%,OSR1;FGF1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.434882795979369,1.006516985630815,0.44871794871794873,1.0,1.0,15/88,15.97%,CCL5;FGF2;FLT1;GPER1;IGF1;HGF;MYDGF;NLRC3;DCN;F2RL1;AGT;NOP53;SOX9;MAPK3;PIK3CG
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.570318899797644,-1.006463194475594,0.43243243243243246,0.9659842319341444,1.0,5/13,29.49%,CLIP3;CAMSAP3;DYNC1I2;ARHGAP21;SPG11
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.5558028511386168,1.00641235380919,0.453125,1.0,1.0,1/16,0.73%,ACTL6A
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.5503074674148903,-1.0061612270288454,0.47058823529411764,0.9662708970694167,1.0,4/10,24.78%,JMJD4;IRGM;SETX;INSR
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,0.5678337666477579,1.006113079886362,0.484375,1.0,1.0,3/18,14.15%,GSDME;IRF1;ELANE
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.667386547291325,1.006033391296703,0.515625,1.0,1.0,2/6,15.53%,WAS;CXCL12
prerank,CellMarker_Augmented_2021__Liver Progenitor cell:Fetal Liver,-0.3817625862061567,-1.0060316039385109,0.4117647058823529,0.9660640238475072,1.0,32/95,18.36%,TEAD2;BOC;TBC1D16;PTGFRN;COL4A2;COL12A1;RND3;RHBDF1;GPC4;ERBB2;DLG5;PTPRF;FZD7;CRABP2;ASAP3;EDNRA;ANTXR1;DAB2IP;AMOTL2;CHST3;GTF2IRD1;FKBP9;GPC1;COL5A2;ADGRL2;NFATC4;ADCY6;SH3BP4;TNKS1BP1;RBFOX2;COL16A1;PTPN21
prerank,CellMarker_Augmented_2021__HES1High Progenitor cell:Stomach,0.459779703725736,1.0057329160699002,0.5365853658536586,1.0,1.0,15/91,11.36%,BACE2;PRRX1;LMOD1;ADAM33;PLEKHH2;ECM2;ABI3BP;MYH11;NFIA;OSMR;OMD;VWF;DCN;AHNAK2;ASPN
prerank,CellMarker_Augmented_2021__Morula Cell (Blastomere):Embryo,0.43814232106525464,1.0057019519601684,0.4430379746835443,1.0,1.0,9/88,11.35%,CHCHD4;CACHD1;RPL21;GUF1;NDC80;PDCL2;KLF3;RPS27A;PPP2R5A
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.5229481608976236,-1.0055923395066775,0.5151515151515151,0.966638464917362,1.0,8/14,24.24%,PPCDC;CROT;PANK1;PPCS;NUDT7;SLC25A16;DCAKD;ACOT7
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.42144539652943336,-1.005528875056014,0.41935483870967744,0.9662497295205983,1.0,6/33,12.55%,GLA;DDAH2;APOE;DHFR;SCARB1;TERT
prerank,CellMarker_Augmented_2021__Conventional Dendritic cell:Undefined,0.6152669589630971,1.0055075264313198,0.4696969696969697,1.0,1.0,3/9,9.13%,TLR2;ITGAX;PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6128013046035593,1.005497856165843,0.5,1.0,1.0,3/10,24.10%,STK26;PARK7;PYCR1
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,0.5473506019299709,1.0054171141099932,0.4153846153846154,1.0,1.0,5/16,24.77%,H2BC4;H2AZ1;H2AZ2;KDM1A;H2AC6
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.6253278741868399,1.0053650192390675,0.5,1.0,1.0,2/6,15.27%,VAPB;GRAMD2A
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.6137400658803068,1.0052646240140126,0.55,1.0,1.0,3/9,16.34%,HTR5A;HTR1B;HTR2B
prerank,KEGG_2021_Human__Alzheimer disease,0.39953129953844047,1.005200354137455,0.45263157894736844,1.0,1.0,72/299,25.70%,COX6A1;SLC25A31;BACE2;WNT8B;FRAT1;PIK3R3;CASP7;WNT5A;ATP5PF;WNT8A;NDUFB11;GRIN2D;NDUFS2;FZD8;COX7A2;WNT6;ATG101;ATP5F1E;DKK2;MME;PSMC5;TUBA4A;TUBA3D;TUBB6;MAPK3;CDK5R1;NDUFB10;WNT5B;NDUFA2;AGER;CSF1;ATP5MC3;NOS2;NOX1;COX4I1;TUBA1C;PPID;APAF1;ATP2A2;PSMA3;COX7B;PSMB6;MAP2K1;ULK1;NDUFB9;COX6C;GRIN2C;COX6B1;NDUFB4;PSMD6;CHRM5;RYR3;UQCRFS1;TUBB4B;DDIT3;FRAT2;KRAS;NDUFA1;COX7A1;NDUFB2;COX5A;COX7C;PLCB4;PIK3CB;PSMA7;VDAC1;FZD6;KLC2;PTGS2;PSMB1;CASP8;CTNNB1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),-0.38176455836352396,-1.0050992231603808,0.3333333333333333,0.9668915515200915,1.0,13/62,17.84%,SBK1;PRKCD;GALNT13;TTBK1;MAP3K10;ACVR1;CDK1;MAP3K12;WNK3;MARK2;CDK5;PRKCA;GALNT2
prerank,Reactome_2022__EPHA-mediated Growth Cone Collapse R-HSA-3928663,0.5815033993130929,1.0050365801479764,0.5324675324675324,1.0,1.0,3/15,15.72%,MYH11;MYL6;MYL9
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),0.6665876325351541,1.0049223121603534,0.5636363636363636,1.0,1.0,4/5,32.34%,SCN5A;SCN1B;SCN2B;SCN10A
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.4193349686592122,-1.0048660818928064,0.47619047619047616,0.9669118939331678,1.0,6/35,12.78%,TEFM;LARS2;QRSL1;MRPS21;NOA1;SLC25A33
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),0.6551737363547323,1.0048516630182838,0.5357142857142857,1.0,1.0,2/6,14.91%,HLA-A;CRTAM
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.60817135485546,-1.0048196242933487,0.5384615384615384,0.9664782926563065,1.0,2/8,5.85%,GLUD2;MTHFD1L
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.54198206508199,1.0047019134995585,0.43478260869565216,1.0,1.0,5/16,19.76%,PKP2;CAV3;KCNE3;SCN5A;KCNE4
prerank,CellMarker_Augmented_2021__Plasma cell:Salivary Gland,-0.3955367071826401,-1.0045526627583377,0.42105263157894735,0.9665442197276498,1.0,17/81,8.09%,CLDN4;WWC1;RAI14;DSG2;RND3;RHBDF1;ASS1;ERBB2;DLG5;ADGRG6;PARD3;PTPRF;B4GALT2;AGRN;PERP;TEAD4;EPB41L4B
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,0.5010380818659528,1.0044622224518698,0.40540540540540543,1.0,1.0,6/27,16.70%,SMAD6;HEY2;COL1A1;GLI3;MAPK3;MAF
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.5958406572060295,1.0043153628816475,0.5588235294117647,1.0,1.0,3/10,5.53%,AHR;PTPRC;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.5143814890893205,-1.0042273091173686,0.47619047619047616,0.9669123261106606,1.0,2/13,2.84%,IL16;CDH13
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.590047625485894,1.004083099392323,0.41935483870967744,1.0,1.0,1/11,2.54%,TMEM100
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5582680204394277,1.0040287058341397,0.5161290322580645,1.0,1.0,8/15,32.36%,NOP10;CCT7;CCT8;CCT3;CCT6A;CCT2;SHQ1;DKC1
prerank,GO_Biological_Process_2021__positive regulation of NK T cell activation (GO:0051135),0.6696309190567724,1.003662314652625,0.4827586206896552,1.0,1.0,2/5,17.66%,IL12A;HSPH1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.5016117062090624,1.003613772573242,0.49230769230769234,1.0,1.0,2/23,10.49%,PLA2G10;MBOAT1
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.6238447262459589,-1.0035295063856673,0.5384615384615384,0.9681711328324928,1.0,1/7,3.00%,KDELR1
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.5850713928388331,1.0034385150873057,0.5217391304347826,1.0,1.0,2/16,6.41%,TNFRSF1B;DAAM2
prerank,Reactome_2022__Packaging Of Telomere Ends R-HSA-171306,0.5666877698142374,1.0034234615934823,0.46153846153846156,1.0,1.0,2/16,8.12%,H2BC4;H2AZ1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.44018953451233167,-1.0033378550269172,0.41379310344827586,0.9680548075086631,1.0,8/35,20.80%,CRLS1;CPNE6;FADS1;DHDDS;AGPAT5;DOLPP1;CPNE7;CLN3
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.4233936616030143,1.003290036488069,0.5,1.0,1.0,42/205,16.69%,GATA4;TBX1;LPAR1;GPR55;CCL5;ALKAL2;FGF2;PTPRC;GFRAL;FLT1;TGFB1;SCIMP;GPER1;NODAL;ERBB4;P2RY6;FLT4;IL26;IGF1;RAMP3;GSDME;MYDGF;ATP6AP1;F2RL1;CD4;GPR183;ALOX12B;PRXL2C;TNFAIP8L3;ALOX15;CSF1R;CALCR;OPRM1;ELANE;CD44;MAPK3;PIK3R6;TPD52L1;PIK3CG;AGER;HTR2B;RASGRP1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.38757523775109615,1.0032551090561403,0.4842105263157895,1.0,1.0,79/436,16.56%,IL21R;ITGB2;PSMB9;RORC;AIM2;TNFRSF1B;ITGAX;HSPA8;CSF2RA;ANXA1;SP100;CCL5;CLCF1;TRIM62;FGF2;PTAFR;CARD14;ST18;TGFB1;CRLF1;ITGAM;PELI3;TRAF3IP2;HLA-F;TRIM25;IL12A;STAT5A;SYK;IL27;MMP9;CD80;CA1;SOCS2;IFNK;IL26;CCND1;LCP1;DUOX1;IFIT1;HGF;IRF1;HCK;OSMR;HLA-A;SOD2;CSF3R;TRIM68;IL5;HLA-DPB1;RPS27A;STAT1;RHOU;TNFSF4;TXNDC17;CD4;LIFR;CDKN1B;OAS2;IL7;CDKN1A;TALDO1;ALOX15;CSF1R;FPR1;OPRM1;PSMC5;IL4;CD44;CD300LF;MAPK3;ISG15;IFI6;IL3RA;CXCL12;CFL1;IL17RB;CSF1;MSN;EDAR
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.40387122953229576,-1.0032025015490003,0.37037037037037035,0.9679009033584905,1.0,5/72,1.53%,IL7R;P2RY10;SKAP1;IL16;BCL2
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.634693625480814,-1.0031985201328621,0.5333333333333333,0.9673325528573993,1.0,1/5,8.45%,AQP1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta activation (GO:1901388),0.6742414583130437,1.0031869742919903,0.53125,1.0,1.0,4/5,29.18%,ITGB6;ITGB8;HSP90AB1;ITGAV
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.62346160741336,-1.002966733076835,0.5434782608695652,0.9674429519669295,1.0,1/6,1.08%,PRDM5
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.4424770509417644,-1.002779241852134,0.4838709677419355,0.9674252144414442,1.0,4/32,4.78%,DRD4;IL11;RHBDF1;APOE
prerank,CellMarker_Augmented_2021__B cell:Bone Marrow,-0.5895764214925885,-1.0026911518100978,0.4827586206896552,0.9670312268246454,1.0,2/7,1.86%,BCL2;BCL6
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.5655947773797976,1.0025009755871201,0.47619047619047616,1.0,1.0,6/13,30.43%,SLC25A18;SLC1A6;SLC25A22;SLC25A11;SLC25A13;SLC25A30
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.6028383711985983,1.002463227779342,0.5084745762711864,1.0,1.0,3/11,14.15%,WAS;SPOCK3;ELANE
prerank,GO_Biological_Process_2021__positive regulation of establishment of endothelial barrier (GO:1903142),-0.6672100341257599,-1.0024201350452595,0.574468085106383,0.96671066517883,1.0,2/5,5.98%,CDH5;F11R
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell development (GO:1901552),-0.6672100341257599,-1.0024201350452595,0.574468085106383,0.96671066517883,1.0,2/5,5.98%,CDH5;F11R
prerank,Reactome_2022__Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,-0.466004592653556,-1.00226057709114,0.48,0.9666408122048797,1.0,10/19,15.86%,GPC6;GPC2;SDC3;GPC4;AGRN;VCAN;B3GAT3;CSPG5;GPC1;SDC4
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.541521455188761,-1.002259405300601,0.43478260869565216,0.9660755251801985,1.0,1/12,0.18%,COL22A1
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.6404067797067668,1.0021217831886269,0.5873015873015873,1.0,1.0,3/11,9.92%,USP50;DDX3X;NLRC3
prerank,KEGG_2021_Human__Epstein-Barr virus infection,0.41414459002159093,1.0018585206280042,0.4230769230769231,1.0,1.0,21/157,15.27%,BLNK;TLR2;PIK3R3;HLA-F;SYK;CCND2;CCND1;HLA-A;HLA-DMA;HLA-DPB1;CCNE2;STAT1;CDKN1B;OAS2;CDKN1A;NFKB2;CCNA2;PSMC5;SAP30L;CD44;ISG15
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.45909413016800676,1.0018249887324109,0.5205479452054794,1.0,1.0,11/72,13.75%,TBX1;LRP2;MYO3B;MARVELD2;COL4A3;GSDME;GRXCR2;PIEZO2;COL1A1;CDC14A;GRXCR1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.5090772401627603,-1.0017865047027579,0.42424242424242425,0.9668765225332362,1.0,8/17,29.97%,SLX4;RTEL1;ATM;SMG5;DHX36;SMG6;PARP1;TERF1
prerank,CellMarker_Augmented_2021__CD14+ Endothelial Progenitor cell:Blood,0.44121142227671123,1.0015519067322889,0.4230769230769231,1.0,1.0,20/67,18.98%,C1QB;LYVE1;C3;CYYR1;FLT1;FCGR3A;VSIG4;RAMP3;ADGRL4;VWF;CLDN5;PDK4;CSF1R;EDNRB;SLCO2B1;MAF;A2M;FPR3;KCTD12;GPR34
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.6428531212422934,1.0015075225820056,0.4918032786885246,1.0,1.0,3/6,28.22%,VPS18;NDP;VPS4A
prerank,KEGG_2021_Human__Renin secretion,0.4898687131272678,1.0014845462531432,0.5285714285714286,1.0,1.0,4/55,7.51%,CLCA2;CLCA4;CLCA1;ADRB1
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.45927832350950026,1.001467990514696,0.35526315789473684,1.0,1.0,11/51,11.00%,COL18A1;LOX;COL6A5;COL6A6;MMP9;COL4A4;COL4A3;COL4A5;LAMC2;COL6A2;COL1A1
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.5585016341050711,1.0012795216062662,0.4444444444444444,1.0,1.0,5/13,29.89%,PLN;KCNJ2;ATP1A1;RGS2;ATP1A2
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.5375843117313104,1.0011721426196154,0.4507042253521127,1.0,1.0,3/21,12.86%,FUT2;CYP1B1;ALOX12B
prerank,Reactome_2022__EGFR Transactivation By Gastrin R-HSA-2179392,-0.6203274336705058,-1.0010724737603063,0.5365853658536586,0.9683889932822283,1.0,2/6,19.25%,PRKCA;HRAS
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),0.638740453273325,1.0009668509453356,0.4716981132075472,1.0,1.0,3/6,28.48%,TBCE;TBCC;VBP1
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.5329708527965421,-1.0009133561186605,0.43243243243243246,0.9676335324562466,1.0,5/12,19.97%,CRYM;OGDH;AADAT;HYKK;PHYKPL
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.5329708527965421,-1.0009133561186605,0.43243243243243246,0.9676335324562466,1.0,5/12,19.97%,CRYM;OGDH;AADAT;HYKK;PHYKPL
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,-0.36470828157249846,-1.0009101421957725,0.43478260869565216,0.9670693146530652,1.0,6/64,3.97%,COL22A1;COL6A3;COL4A2;COL12A1;COL13A1;COL8A1
prerank,Reactome_2022__Gamma-carboxylation Of Protein Precursors R-HSA-159740,0.6336679959491505,1.0008255302676514,0.5522388059701493,1.0,1.0,4/8,14.52%,PROZ;F7;FAM110A;GGCX
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.606314530199874,1.0005880985245343,0.43548387096774194,1.0,1.0,2/12,10.78%,TGFB1;TJP3
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.4996038873844865,-1.000341675082698,0.44,0.9682190324412682,1.0,1/12,0.50%,ADRA1A
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.6035064218843997,-1.0002354635857678,0.5,0.9678869242343225,1.0,3/5,18.70%,MUS81;SLX4;FBH1
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.5888241659435364,1.0001825245539375,0.4714285714285714,1.0,1.0,2/12,10.57%,ADA;DCK
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.3772869433944954,-1.0001795990954285,0.38461538461538464,0.9674954198198571,1.0,22/94,14.29%,KCNIP3;EYA4;BOC;OSR1;GPC6;RAI14;KIAA1549;FZD7;MID1;ZFHX4;CAP2;ADAMTS3;B4GALNT1;GPR161;FHOD3;ANTXR1;DAB2IP;AADAT;AMOTL2;SLIT2;CHST3;GTF2IRD1
prerank,Reactome_2022__Tie2 Signaling R-HSA-210993,0.5738580680497698,1.000154039891257,0.4603174603174603,1.0,1.0,1/15,3.34%,ANGPT2
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Fetal Kidney,-0.21598894038046654,-1.0,1.0,0.965298825876424,1.0,535/4122,16.06%,DUSP4;IL7R;P2RY10;CD38;ADGRG3;NR4A1;BTN3A2;TRIB2;KIFC1;SKAP1;PCED1B;APOL3;ZNF808;SYNJ2;AOAH;ABHD17A;TBC1D10A;METRNL;NUP210;EIF5AL1;DNMT1;UBASH3B;H1-4;SBK1;BAMBI;KLRC1;IL16;PHLDB2;DGKD;MIDN;ZNRF1;ZFPL1;GATAD2A;SLC25A37;DDX41;FOS;HNRNPL;SIGIRR;CSK;PDGFD;CHD4;C5ORF63;COL6A3;PTPN9;TIE1;DCPS;GBP2;CFLAR;RNF168;NOC3L;CREB3L4;TPM4;RGS16;ELOVL6;RNF113A;VPS16;AGTRAP;PPP1R35;IFT88;TCOF1;NXPH4;CHCHD5;THEM4;KDELR1;EBPL;HDAC7;JUNB;RHEBL1;TRMT2A;PDZD11;IFI16;ASCC2;PPP6R1;STK10;HDAC10;PTPRB;CFAP410;KIT;CCZ1B;DPM3;DUSP2;POLM;CCDC174;ACYP2;POFUT2;YDJC;SMPD4;IWS1;EXOC7;PPP5C;PUM3;CAPN2;KLHL20;PRR14;NR4A3;EYS;SLFN5;PNKP;NSUN4;RAB11FIP1;HOPX;CD151;GPRIN3;GJB6;RAB35;CD247;QRICH1;APOBEC3H;AUP1;COMMD6;BOD1L1;HAUS1;NLRP1;USP36;CBFB;HPS3;QSOX1;SMC2;JADE2;ZNF641;RINL;COG4;CWF19L1;SLX4IP;KLF10;SLC27A2;CTCF;CARNMT1;GRIK4;ZNF701;RPF1;PDCD7;SMYD2;OCIAD2;UPF3A;ITGA4;GTF2I;TFB1M;SCLT1;PDIA6;CCL4L2;NCALD;CRY1;LBH;PREX1;SH3KBP1;DLG5;TPM3;HM13;FAM177A1;NMRK1;PTPRA;LSM7;DHFR;KDM7A;DLGAP4;URB2;CD53;LPXN;FNTA;POM121C;POLR3D;STAT5B;KPTN;SEC22A;ARPC3;TBCB;FBXO4;ADAM8;TTC7A;SDF4;PCM1;USP4;DDX11;SLC25A39;PGLS;DPP9;CEP83;GBP4;HSD17B12;TGFBR3;SIMC1;RAD54L2;CTC1;UBXN2A;ZNF75A;PI4KB;RAB7A;LRRFIP1;TMEM175;ZNF275;PA2G4;GTF2IRD2B;SELL;NDUFAF3;SYAP1;EMC4;CLPTM1;ARIH2OS;IGBP1;FHL3;PCIF1;PERP;LUC7L;RAD50;PRPSAP1;ETS1;ARRDC2;PLCL2;BDP1;S1PR5;BNIP2;TAF12;SRRM1;NFATC3;SSBP3;FCF1;LIG3;AKAP7;WDR74;TNFRSF14;EEFSEC;ISG20L2;ECHDC2;CDC26;IAH1;CCDC97;ERN1;TMED4;CHST11;FLNA;ITIH5;ENSA;PTPRE;SELPLG;SNF8;GSTK1;COMMD1;GNAS;FPGS;RPGRIP1L;DCAF13;METAP2;UPP1;ITPRIP;ATR;PRPF18;ECHS1;MRPS21;TRPC4AP;KMT5C;NOP14;DAP3;SH3BGRL3;PEX13;SLC3A2;MECP2;BSG;HEMK1;POLR3E;RIC8A;ZNF195;SAFB2;SLC7A5;EMC8;SRSF4;CHST12;P3H1;MAPRE1;RAB5A;SP140;SLC10A3;NOA1;BNIPL;SNRPB;CNTRL;NT5C;HDAC3;HPGD;STAMBP;CNPY3;COTL1;CTDSP1;RALGDS;CEP135;PTPRR;MOB3A;FAM167A;STARD3NL;TUBGCP2;PITPNM1;ELOVL1;SLC15A4;DPP3;ST3GAL5;TMEM134;BPTF;NR1D1;PAM;XPC;CD8A;KIAA1328;METTL15;INTS9;PEMT;INO80D;NKAP;MAEA;C12ORF43;SHARPIN;HNRNPF;PAAF1;GMEB1;AGO2;CREM;ALG12;TFDP1;DNPH1;CIRBP;ZBTB7A;SFMBT1;DDX27;PFKFB3;SPRY1;MOB2;ZNF16;DNMT3A;NAMPT;LTB;DDX46;ZNF831;AKR1C3;TM2D1;CD72;MVK;RLF;HSF1;UPF2;WARS2;TRIM44;DTD1;JAG1;ATG2A;GTF2E2;VOPP1;STX5;COPS8;FAM120AOS;GGA2;SUMF2;EAPP;NHSL2;RTF1;GK5;B3GAT3;ASAP1;SMU1;EMD;SF3A2;ZNF263;B4GALT4;PSMB2;SLK;DECR1;CORO1A;G6PD;BRAP;EPC2;ANKRD44;PNISR;BAG6;GOLGA8B;BRPF3;U2AF2;LRP10;SMPDL3B;RING1;SPTSSB;WDR54;HIP1;TPGS2;YWHAQ;PLGRKT;PTBP1;BAZ2A;ZNF586;FAM184A;LINGO2;GRM2;MPHOSPH8;OTUD5;TTC17;ATF1;CEP250;GON4L;SLC37A1;SPON2;SSRP1;GOLGA4;ZDHHC18;NPRL2;OSBPL5;H2AJ;SDCBP;ARRB2;IDH2;CAPZB;PCDH1;EXOSC10;ZNF569;ST3GAL4;BAALC;RNF10;TNRC6C;CPSF7;OSBPL10;HAUS7;SCAMP2;HAVCR2;HSPBP1;ZNF331;BCL11B;DBNL;NGLY1;RAB27A;TRIM14;POLR2F;SAMM50;TRAPPC1;KANSL2;MALT1;ASL;SIRT7;EXOSC1;ZMAT5;HIVEP1;RUFY1;LANCL2;DISP2;MIA3;UBE2E3;CHRAC1;TCF25;PIH1D1;BRD3;RABEP2;ANKS3;SLC25A42;GUSB;SP140L;PPP1R7;CD58;SMARCA4;SUGP2;LMNB1;THRAP3;RAB40A;GART;CSNK1G2;ZNF708;TRAF3;BIN1;PMS1;LEO1;FHIT;PBRM1;NR1H2;RRAS2;SYTL2;RBCK1;GMDS;NAALADL1;AGPAT5;NME3;COG7;CCDC57;CLINT1;TKTL1;COA1;SAMSN1;TYSND1;APBA3;PRKRIP1;GPKOW;EVL;GLCCI1;CABIN1;FBXO44;RPS6KA3;USP16;PSME4;DLL1;RNF157;GDI1;LGALS1;SLC66A3;MCL1;POLR3B;NUP37;C19ORF12;PDE3B;OSBPL7;PPIB;STXBP2;SNRPN;POLR2C;EIF5A;MOGS;ESYT1;MRPS35;FBXO22;AHI1;IK;PRDM1;VGLL4;MTDH;MIDEAS;ZDHHC3;RASA2;FAM98C;DNAJC11;TOR1B;SDC4;UTP14A;OSBPL8;ACBD3;OTUD7A;EIF3M;SLC35E2B;RWDD4;FLNB;ME2;MATK;HNRNPAB;AP5Z1
prerank,Reactome_2022__Signal Transduction R-HSA-162582,-0.2582951908565765,-1.0,1.0,0.965298825876424,1.0,171/2043,8.90%,DUSP4;ARC;P2RY10;SPRED3;TACR3;GALR3;DRD4;NGF;ADRA1A;GRK5;ADRA1B;NR4A1;NTSR2;SPRED2;PROKR2;PDE10A;TPH1;ABHD17A;DUSP6;NMU;SPRED1;BAMBI;ST3GAL3;KIF2B;DGKD;BOC;PRKCD;BCL2;DTX1;SMPD3;TAS2R8;GATAD2A;CDH5;WNT3A;FOS;WWC1;SHC3;CSK;PDGFD;CHD4;HRH2;COL6A3;LIMK1;MYO9B;CFLAR;COL4A2;TPM4;RGS16;PTCH1;ITPR2;GPRC6A;CRHR2;IFT88;GFRA2;MMP2;THEM4;PLEKHG4B;HDAC7;MKS1;HGFAC;PRAG1;EGR1;STK10;HDAC10;FOXO1;KIT;S100B;POFUT1;ADCYAP1;SH2B2;DUSP2;ATP6V0D2;SKA1;PMF1-BGLAP;MAML1;PTCH2;DSG2;ESRP1;RND3;PPP5C;EIF4EBP1;GPRIN1;BCL9L;LGR5;FGF18;EEF2K;GATD3;SH3RF1;VANGL1;NIPSNAP2;APOE;TRPC3;CBFB;PDE7B;WWP2;WNT7A;SCAI;CLIP3;SPTBN4;CRABP1;PRICKLE1;PLD2;TTF2;ERBB2;PLEKHG2;TAC3;KITLG;CARM1;HHAT;MEN1;RALB;F11R;ARHGAP11A;PREX1;SH3KBP1;DLG5;TPM3;PHC2;PTPRA;PARD3;GIT2;ATP6V1E2;FGF1;FNTA;STAT5B;NANOS3;ARPC3;OTUD3;STARD8;FZD7;USP4;TGFA;CRABP2;VIPR1;SPTB;GREB1;PPP2R5D;FSTL1;MPP2;NTRK1;RAB7A;VGF;PTPRJ;HSPB1;ASCL1;JAG2;S1PR5;CX3CR1;CRH;SGO2;NSMAF;SRRM1;AMIGO2;SENP1;FLNA;ANOS1;ARHGAP33;RIPK2;CCKBR;GNAS;TGIF1;RPGRIP1L;SERPINE1;GPR161;SRGAP2;FGD1;GNA14;RAPGEF1;RARB;OPN5;FOSL1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.2756168624089718,-1.0,1.0,0.965298825876424,1.0,281/1744,15.25%,PER2;RFX6;POU3F1;ETV5;NPAS4;GALR3;EHF;NR4A1;TBX15;SKAP1;KCNIP3;PLK3;IL11;ZNF808;ZNF25;PRDM5;ZNF70;ZNF99;TEAD2;GFI1B;ARID3B;ZNF408;ZNF860;ETV1;OSR1;GATAD2A;WNT3A;ARX;BCL6;FOS;WWC1;ZNF496;ERG;ZSCAN21;ZNF534;CHD4;FOXD4L5;ZNF777;TWIST1;IKZF4;ZNF485;CREB3L4;ZNF215;PTCH1;ZBTB9;MSC;CDH13;ZNF773;JUNB;EGR1;ZNF607;ZNF514;IFI16;HDAC10;FOXO1;SAP130;KIT;ADCYAP1;TWIST2;MAML1;CREB3L1;RFX1;ZNF133;LHX2;NR4A3;ZNF48;BCL9L;HOPX;SMARCB1;ZNF69;GABPB2;BHLHA9;ZNF287;ZNF835;ZNF470;APOE;PIAS3;CBFB;ZNF641;SP7;WWP2;WNT7A;ZFP3;ZNF596;KLF10;CCN1;THAP7;CTCF;HES1;ZNF701;NFX1;ERBB2;SMYD2;BCLAF3;HIC2;MEN1;ZNF33B;CRY1;ZNF845;ZNF347;SOX12;KDM7A;ACVR1;BACH2;FGF1;CRYM;ZNF623;STAT5B;ZNF239;ZNF212;SMARCAL1;PCGF1;TGFA;TFAP2D;ZFHX4;KDM3B;ZNF75A;ATOH7;LRRFIP1;MAFG;ZSCAN12;ZNF275;AGRN;PPARGC1B;IGBP1;TEAD4;PRDM15;ASCL1;PKD2;ETS1;ZNF764;ZNF3;E2F6;NFATC3;ZNF316;KDM2B;PID1;SSBP3;SENP1;IRF5;DLX1;NACC1;MACROH2A2;ZNF846;SNF8;RIPK2;TGIF1;SERPINE1;PHF2;RARB;FOSL1;SNAI2;MECP2;ZNF14;SAFB2;POU6F1;SPDEF;ZNF765;ZFP62;SP140;ZNF594;MLX;GTF2H2;MLIP;CARF;HDAC3;CDK1;NEUROD6;CTDSP1;CITED4;BARX2;LDB1;BPTF;NR1D1;MYOCD;ZMIZ1;ZNF79;MKX;NKAP;RGMA;MAMLD1;GMEB1;ATF3;AGO2;TFE3;CREM;NR2C1;BCL11A;HEXIM2;TFDP1;ZBTB7A;ZNF549;ZNF16;DNMT3A;NAMPT;WWC2;ZNF608;ZNF268;PCGF6;ZNF415;ZNF575;RLF;HSF1;GRIN1;ZNF501;JAG1;PAX3;KDM1B;RTF1;MIER2;ZNF589;ZNF611;ZNF263;EPC2;DAB2IP;ZNF692;RBL1;CUX1;FGFR2;NFIB;NEUROD2;ZNF2;ZNF586;PER3;KCTD1;ZNF157;ATF1;MAPK7;BATF2;SDCBP;ZNF707;VAX2;SBNO2;CRK;ZNF557;ZNF569;ZNF135;RNF10;TNRC6C;ZNF334;BCL11B;ZNF136;CREB3L2;E4F1;TFCP2;FHL2;ZNF28;ESRRB;MED25;SIRT7;HIVEP1;ZNF561;RCOR2;TCF25;ZNF324;BRD3;KLF8;SP140L;GTF2IRD1;HR;SMARCA4;THRAP3;TCF20;ZNF627;NR1H2;POU2AF1;SRCAP;EBF4;SP2;ZBTB4;PKNOX2;ZNF254;ZNF449;IMPACT;RAI1;ZFP82;RPS6KA3;USP16;ZBTB47;ZNF688;DLL1
prerank,Reactome_2022__Metabolism R-HSA-1430728,-0.2621349367457455,-1.0,1.0,0.965298825876424,1.0,238/1769,13.51%,CYP1A2;UGT2B15;PM20D1;CD38;APOB;MFSD2A;ACAD10;EPHX2;ENTPD2;TPH1;G6PC3;GLYATL1;SYNJ2;NUP210;NDST3;TYRP1;ST3GAL3;ENO3;BCHE;SEC24C;SMPD3;SLC25A37;GALE;RPL3L;CHPF2;PAH;PODXL2;GSTT2B;XYLT1;PSAT1;HACD1;ACER2;GLB1L;GPC6;ELOVL6;ITPR2;CES2;DCT;UST;BPHL;NDOR1;HNMT;THEM4;PUDP;CRLS1;FLVCR1;DDAH2;PDZD11;GPC2;SDC3;AMDHD1;BCKDK;ARSL;MECR;UPB1;CYP4V2;ARSJ;ASPG;SMPD4;MLYCD;STS;PDPR;PNPLA3;AKR7L;PAPSS2;VAC14;ACER3;LTC4S;ACBD4;MTHFR;APOE;GYS1;SLC25A17;HSCB;ABCC8;NUP42;GSTM5;NEU4;GPC4;PLD2;CYP7B1;SLC27A2;CARNMT1;CPNE6;ECSIT;ASS1;GLUD2;CARM1;HS6ST2;FAAH2;MTHFD1L;AOC3;GSTZ1;NMRK1;DHFR;FLAD1;GSR;SARDH;DHRS7B;ARSB;CRYM;PPIP5K1;OSBPL3;POM121C;GPD1;NANOS3;B4GALT2;ADPRM;GLYATL2;PGLS;CA3;ALB;HSD17B12;ACOX3;PPP2R5D;NDUFAF1;PI4KB;PTGS1;NDUFAF3;AGRN;PLA2G5;PPARGC1B;NUP214;NT5C1A;EEFSEC;CHST11;PRSS3;B4GALNT1;PLA2G4C;GSTK1;GNAS;FPGS;ST3GAL2;PPCDC;CHKA;ACADS;UPP1;GNA14;ECHS1;RRM2B;NEU3;SLC3A2;BSG;UBIAD1;SLC7A5;APIP;CHST12;RAB5A;CHSY1;NT5C;HDAC3;CSGALNACT1;HPGD;GNB5;GNA11;PGS1;SPAM1;STARD3NL;RRM2;AAAS;ITPKA;PTGR2;DHTKD1;VCAN;ESYT3;PITPNM1;ELOVL1;NR1D1;PFKP;TAFAZZIN;CHAC1;NQO2;OGDH;PEMT;UPP2;AMPD3;CPT1A;KYAT1;ALDH4A1;GPX1;CHST6;PRELP;DNPH1;NDUFAF6;CMBL;PFKFB3;NAMPT;AKR1C3;IDUA;GNB3;ACOT9;MVK;SECISBP2;AK8;ADCY2;SUMF2;CYP46A1;B3GAT3;PYCR3;COQ2;MAPKAPK2;B4GALT4;PSMB2;DECR1;PGP;SOAT1;RNLS;LRP10;SPTSSB;PLPP2;GSTO2;ERCC2;FAM120B;AADAT;ABCC1;NUDT19;SLC37A1;GPT2;KYAT3;NPRL2;OSBPL5;PSTK;DUT;UROC1;IDH2;LDHC;MED22;MTMR14;ST3GAL4;OSBPL10;LPCAT2;BDH1;LPL;CTPS2;PITPNM3;TMEM86B;ALDH18A1;SLC44A5
prerank,Reactome_2022__Gene Expression (Transcription) R-HSA-74160,-0.231332708735128,-1.0,1.0,0.965298825876424,1.0,173/1265,14.62%,NR4A1;CPSF1;PLK3;ZNF25;ZNF703;NUP210;ZNF70;ZNF99;DNMT1;TEAD2;ZNF860;DDX56;GATAD2A;BCL6;FOS;ZNF496;KMT2B;CHD4;ZNF777;TWIST1;ZNF485;ZNF215;PIWIL2;LSM10;ZNF773;HDAC7;ZNF607;ZNF514;HDAC10;TP53AIP1;FOXO1;SAP130;KIT;TWIST2;ZNF664;EXO1;MAML1;INTS11;ZNF133;IWS1;NR4A3;GPRIN1;SMARCB1;GATD3;ZNF287;ZNF470;APOE;TRPC3;CBFB;ZNF641;SP7;NUP42;ZNF596;POLR1A;MAGOHB;ZNF701;ERBB2;SMYD2;CARM1;ZNF839;ITGA4;MEN1;ZNF33B;PHC2;ZNF347;GSR;POM121C;POLR3D;CCN2;ZNF212;TGFA;TFAP2D;ZNF75A;PPARGC1B;PERP;RAD50;TEAD4;BDP1;CRH;ZNF764;ANAPC2;ZNF3;E2F6;NUP214;TAF12;SRRM1;CDC26;DGCR8;TGIF1;SERPINE1;RARB;CNOT9;RRM2B;ZNF492;MECP2;ZNF14;POLR3E;ZNF195;SRSF4;GTF2H2;SNRPB;HDAC3;CDK1;CITED4;RRM2;AAAS;NR1D1;INTS9;ZNF79;MAMLD1;AGO2;NR2C1;TFDP1;ZNF549;DNMT3A;ZNF268;PCGF6;ZNF415;JAG1;RSPO3;GTF2E2;RTF1;ZNF589;ZNF611;ZNF263;SYMPK;PSMB2;BRPF3;U2AF2;ZNF692;RBL1;RING1;CSTF2;NFIB;ERCC2;YWHAQ;NR2C2AP;BAZ2A;ZNF586;KCTD1;ZNF157;SSRP1;H2AJ;ZNF707;MYBBP1A;PPP1R13B;ZNF557;ZNF569;ZNF135;TNRC6C;ZNF334;CPSF7;POLR3K;ZNF331;ZNF136;MDC1;POLR2F;ZNF28;PLXNA4;ESRRB;MED25;ZNF561;TAF1B;CDK6;ZNF324;TACO1;SMARCA4;POLR3A;ZNF708;ZNF627;LEO1;PBRM1;NR1H2
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Kidney,-0.35912448068774744,-0.9999269988365307,0.45,0.9637995351609953,1.0,24/95,21.58%,MIDN;NOP9;RAB35;CARM1;TTYH3;PHC2;ZDHHC5;AGRN;PVR;NACC1;DAGLA;BAG6;SBNO2;TOR1B;DNAJC5;LSM14B;PITPNA;HDGF;PBX2;GOLM1;UBE2E1;CUEDC1;YTHDF1;IGF2R
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Lymph,-0.35912448068774744,-0.9999269988365307,0.45,0.9637995351609953,1.0,24/95,21.58%,MIDN;NOP9;RAB35;CARM1;TTYH3;PHC2;ZDHHC5;AGRN;PVR;NACC1;DAGLA;BAG6;SBNO2;TOR1B;DNAJC5;LSM14B;PITPNA;HDGF;PBX2;GOLM1;UBE2E1;CUEDC1;YTHDF1;IGF2R
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Liver,-0.35912448068774744,-0.9999269988365307,0.45,0.9637995351609953,1.0,24/95,21.58%,MIDN;NOP9;RAB35;CARM1;TTYH3;PHC2;ZDHHC5;AGRN;PVR;NACC1;DAGLA;BAG6;SBNO2;TOR1B;DNAJC5;LSM14B;PITPNA;HDGF;PBX2;GOLM1;UBE2E1;CUEDC1;YTHDF1;IGF2R
prerank,CellMarker_Augmented_2021__Adipose Multilineage-Differentiating Stress-Enduring cell:Adipose Tissue,0.4380640959197497,0.9998761426743119,0.44,1.0,1.0,18/80,16.35%,TIMP3;PRRX1;LMOD1;FBXL7;ADAM33;PCDH18;ANGPTL2;ACTA2;ADGRL4;COL6A2;DCN;COL1A1;DDR2;CXCL12;ELN;MYL9;EHD2;ENG
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.5952435275614512,0.9998410482759592,0.5138888888888888,1.0,1.0,1/10,0.98%,PLA2G10
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.5331976407129427,-0.9997868689854483,0.4117647058823529,0.9636057194302796,1.0,1/9,2.59%,PTCH1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.476437333734705,0.9996457908480508,0.4625,1.0,1.0,3/59,5.77%,NEK2;DUX4;GPER1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Small Intestine,-0.5328893829393555,-0.999644736806966,0.5121951219512195,0.9633824095913436,1.0,4/9,11.62%,LGR5;EPHB2;MSI1;ALCAM
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.4861155365779334,0.9996396062940661,0.5072463768115942,1.0,1.0,14/44,24.48%,CHCHD4;TIMM22;PINK1;TOMM20;TOMM7;TIMM17A;TIMM10;FIS1;ROMO1;BCAP31;PAM16;FBXO7;HK2;TIMM21
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.4534531852929379,-0.999517349896016,0.5,0.9632039099290282,1.0,7/47,7.68%,PER2;WNT3A;WNT7A;HES1;PCM1;ASCL1;CX3CR1
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.6010993119656537,0.9993663274807357,0.49230769230769234,1.0,1.0,1/9,1.16%,IYD
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.5249750255866414,-0.9989829271586009,0.5625,0.9640348751887866,1.0,3/15,6.15%,ADAMTS1;NR4A3;CCN4
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.4144761861624849,-0.9989421598632179,0.48148148148148145,0.9635892024932698,1.0,8/39,13.20%,ST3GAL3;GLA;NEU4;ST6GAL2;ST3GAL2;NEU3;IDUA;ST3GAL4
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.43307058331089027,-0.9987378768358111,0.37037037037037035,0.9636406785510475,1.0,5/33,11.71%,MGARP;HSPB1;AP3B2;SPAST;KIF1C
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,0.4305757771344794,0.9987129322499305,0.524390243902439,1.0,1.0,17/104,20.86%,PSMB9;POLE2;MCM3;POLD4;RPA3;CCNE2;RPS27A;CCNA2;PSMC5;GINS1;ORC4;RBX1;PSMA3;PSMB6;PSMD6;POLE3;GMNN
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.5760182172756221,0.9986840031973713,0.5142857142857142,1.0,1.0,7/15,14.48%,ALOX12;PON1;ALOX5AP;ALOX12B;ALOX15;PON3;ALOX15B
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.447987547906505,0.9986287274901852,0.5125,1.0,1.0,10/75,12.89%,SLC9A2;SLC5A2;SLC12A3;SLC6A4;ASIC5;ATP1A4;ASIC1;SLC9C1;SLC24A1;SLC5A1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.527511452790249,0.9986053738162624,0.46774193548387094,1.0,1.0,5/25,12.51%,ELOVL2;ACSL5;ACSL3;PPT1;SCD
prerank,Reactome_2022__HuR (ELAVL1) Binds And Stabilizes mRNA R-HSA-450520,0.6233269013160382,0.9984245935697849,0.5223880597014925,1.0,1.0,1/9,0.33%,ENPP2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.43948166524014665,0.9982307452398685,0.42857142857142855,1.0,1.0,9/72,5.79%,C1QB;STEAP4;SFTPA1;C3;CLDN18;CRLF1;VSIG4;SFTPD;INMT
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.46582415641346225,0.9982117961792213,0.5,1.0,1.0,7/47,12.89%,APOL1;SLC12A7;SLC12A3;GLRA2;GLRA1;ANO2;SLC5A1
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,0.4749118957391154,0.9981034645652791,0.43478260869565216,1.0,1.0,4/36,14.55%,ESR1;TRIM25;RPS27A;YOD1
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.6302331863275702,0.9980353785593243,0.5396825396825397,1.0,1.0,3/6,19.95%,SLC25A18;SLC1A6;SLC25A22
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.43983144330486174,0.998007411495151,0.4189189189189189,1.0,1.0,19/87,16.75%,ENPP2;SSTR1;ADGRG4;MUC17;SLC17A8;CLCA1;NR1H4;ANGPTL2;SMLR1;ALDOB;TREH;PIEZO2;MTTP;DCN;AGT;EDNRB;MASP1;MOGAT2;A2M
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,0.4459014292997791,0.997973086464499,0.46835443037974683,1.0,1.0,13/74,20.47%,PSMB9;HEY2;FLT4;ACTA2;RPS27A;PSMC5;RBX1;PSMA3;TACC3;PSMB6;HEY1;NOTCH2;PSMD6
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.6598057290324852,-0.9979436469312906,0.6,0.9653811584890775,1.0,2/5,28.55%,ADIPOR1;APPL2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.5649255462172273,0.9977636790437698,0.47058823529411764,1.0,1.0,2/12,7.24%,TGFB1;NR1H4
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.5273067853253878,-0.9976929651485992,0.5,0.965505580751039,1.0,2/11,8.27%,PKD2;FLNA
prerank,Reactome_2022__SUMOylation Of DNA Methylation Proteins R-HSA-4655427,-0.5122350757594326,-0.997558165849388,0.40540540540540543,0.9652376790572624,1.0,4/14,12.16%,DNMT1;PHC2;DNMT3A;RING1
prerank,CellMarker_Augmented_2021__Lymphoid cell:Blood,-0.4092281748747043,-0.9974477160392982,0.34782608695652173,0.9649478998954777,1.0,20/74,18.57%,RASSF2;AOAH;HRH2;GPRIN3;CD247;BACH2;CX3CR1;CD8A;KLRC4-KLRK1;GLT1D1;RNF175;PNISR;C1ORF162;EVL;TRAC;FYN;SAMD3;RNPC3;RCBTB2;ELMO1
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.4362179844827193,-0.997348325402244,0.42424242424242425,0.9645919343748982,1.0,5/22,15.33%,METTL8;PCIF1;TRMT61B;TRMT61A;PUS7
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.5262980572102233,0.997079958458682,0.46774193548387094,1.0,1.0,4/21,13.61%,CAVIN1;DUOX1;CSF1R;RPS19
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.5509471224588031,0.9970513211265724,0.4827586206896552,1.0,1.0,10/19,29.38%,IGF1;SOX9;MAPK3;HTR2B;MAP2K1;EGF;LGALS9;ITGAV;ZFP36L1;ZFP36L2
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.5999603739953374,-0.9970191802550127,0.5111111111111111,0.9649676776173156,1.0,2/6,17.81%,WWP2;CTTNBP2NL
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.6280190123868732,0.996914856404066,0.5352112676056338,1.0,1.0,1/11,5.32%,HAT1
prerank,Reactome_2022__Acyl Chain Remodelling Of PG R-HSA-1482925,0.5901015817686656,0.9968705351915298,0.5223880597014925,1.0,1.0,1/10,0.98%,PLA2G10
prerank,Reactome_2022__EGFR Interacts With Phospholipase C-gamma R-HSA-212718,-0.6275175489180588,-0.996868630274346,0.5405405405405406,0.9648778841539635,1.0,2/5,19.41%,TGFA;BTC
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.5927349486527759,0.9968623780147207,0.5245901639344263,1.0,1.0,2/9,15.19%,TGM2;MAPK3
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.5927349486527759,0.9968623780147207,0.5245901639344263,1.0,1.0,2/9,15.19%,TGM2;MAPK3
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.5518353326321175,0.9967682712608394,0.5166666666666667,1.0,1.0,1/10,4.92%,PRDX4
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,0.4770873210342156,0.9966307637706036,0.5070422535211268,1.0,1.0,11/50,25.56%,PSMB9;RPS27A;PSMC5;SYVN1;SEL1L;PSMA3;PSMB6;PSMD6;PSMA7;DERL2;PSMB1
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.6323116946208335,0.9966230947881187,0.47540983606557374,1.0,1.0,2/5,24.50%,LARP6;NCBP1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.5076141093397393,-0.9966092052484189,0.3902439024390244,0.9650464368276854,1.0,5/10,16.56%,KDM7A;KDM3B;KDM4D;HR;KDM4B
prerank,GO_Biological_Process_2021__extracellular exosome biogenesis (GO:0097734),0.6186535578403176,0.9963486857415089,0.559322033898305,1.0,1.0,2/5,16.49%,RAB11A;COPS5
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,-0.3980425228980604,-0.9960802386587586,0.32142857142857145,0.9658342229043081,1.0,17/67,23.35%,NUP210;NUP42;POM121C;NUP214;SNF8;AAAS;PCSK1;NUP37;NUP98;MVB12A;TSG101;TARBP1;SEH1L;UBAP1;NUP50;TPR;RNF103-CHMP3
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.4994109744095588,-0.9959234842345602,0.4444444444444444,0.9657514565349395,1.0,6/19,17.97%,CPSF1;SYMPK;CSTF2;CPSF7;PCF11;CPSF4
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.5178843682771346,0.9959098301657285,0.48333333333333334,1.0,1.0,4/25,11.19%,CLCF1;STAT5A;SOCS2;STAT1
prerank,Reactome_2022__FGFR2b Ligand Binding And Activation R-HSA-190377,-0.6059410248520786,-0.9958552745670065,0.5319148936170213,0.9653520613303582,1.0,2/7,12.30%,FGF1;FGFR2
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.5533775066512705,-0.9956490340702936,0.475,0.9653359193634339,1.0,1/7,6.88%,DDX11
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.5780035636844669,0.9956283138299336,0.5245901639344263,1.0,1.0,3/14,4.27%,PKP2;MYBPC3;TGFB1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",-0.6250974974618518,-0.9956202949541973,0.5526315789473685,0.9648857194535596,1.0,1/6,5.82%,HS6ST2
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.6433992539854552,0.9954861175248905,0.5454545454545454,1.0,1.0,1/5,3.64%,RNASE10
prerank,Reactome_2022__Nef Mediated Downregulation Of MHC Class I Complex Cell Surface Expression R-HSA-164940,0.574919252925123,0.9954706512637506,0.47619047619047616,1.0,1.0,3/10,21.53%,HLA-A;AP1M2;B2M
prerank,Reactome_2022__SHC1 Events In ERBB4 Signaling R-HSA-1250347,0.5825418758426184,0.9954162170319698,0.4925373134328358,1.0,1.0,1/11,6.80%,ERBB4
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,0.45063028604196903,0.9953844936398267,0.5,1.0,1.0,8/63,20.47%,PSMB9;CCNE2;RPS27A;CCNA2;PSMC5;PSMA3;PSMB6;PSMD6
prerank,Reactome_2022__GLI Proteins Bind Promoters Of Hh Responsive Genes To Promote Transcription R-HSA-5635851,-0.5891817878383373,-0.9951189440439785,0.5116279069767442,0.965649282562909,1.0,3/6,3.86%,BOC;PTCH1;PTCH2
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),-0.599676948870868,-0.9949717139408317,0.5098039215686274,0.9649924413469416,1.0,1/5,9.44%,WRAP53
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),-0.599676948870868,-0.9949717139408317,0.5098039215686274,0.9649924413469416,1.0,1/5,9.44%,WRAP53
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.6661110236138351,0.9949643794176869,0.5,1.0,1.0,1/5,9.06%,SOD2
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperone Genes R-HSA-381183,0.5850614164318682,0.9949351814820507,0.5373134328358209,1.0,1.0,3/9,22.25%,HSPA5;NFYB;DDIT3
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.6121556139932611,0.9948479773958032,0.5087719298245614,1.0,1.0,1/8,4.26%,ST18
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.5830113631134324,0.9945226790605418,0.5263157894736842,1.0,1.0,2/11,9.64%,VAPB;TRDN
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.6476974563028544,-0.9945027714599473,0.5666666666666667,0.9656959105099476,1.0,3/5,30.29%,PRPF39;SFSWAP;SNRPC
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4657986029993425,0.9941757992681942,0.4788732394366197,1.0,1.0,4/41,6.23%,ANXA1;FGF2;TGFB1;STAT5A
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.4907466257921317,-0.993768708733578,0.5151515151515151,0.9672275671228702,1.0,5/17,18.11%,CRY1;ADCY3;ADCY2;ADCY6;PRKAR2A
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.6014300826100398,-0.9935420026556799,0.5,0.9673057348087114,1.0,2/6,13.99%,GBF1;MIA3
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.6053692007343147,0.9934134492523753,0.4927536231884058,1.0,1.0,1/7,5.32%,HAT1
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.557096753585078,0.9933650985380741,0.5070422535211268,1.0,1.0,5/20,14.52%,TPGS1;AGBL5;TTLL2;TTLL4;GGCX
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.41198356685397125,-0.9932204034247188,0.43333333333333335,0.9675596812430841,1.0,7/46,16.02%,CNGA4;EXOC7;BBS12;ASAP1;NUDT19;RAB11FIP3;CYS1
prerank,KEGG_2021_Human__TGF-beta signaling pathway,0.4417202860085747,0.9932133199052198,0.4533333333333333,1.0,1.0,12/80,18.57%,SMAD6;HAMP;TGFB1;NODAL;TGFB3;ID1;DCN;THBS1;MAPK3;INHBC;ID3;RBX1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.6647433807890506,0.9929420191371889,0.5614035087719298,1.0,1.0,3/6,16.61%,CAV3;C12ORF57;KCNJ2
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.5717932733161454,0.992915790501044,0.5692307692307692,1.0,1.0,3/12,11.19%,AIM2;IRF1;STAT1
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.6438521810846279,0.9928381372306119,0.5178571428571429,1.0,1.0,1/6,1.04%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.6438521810846279,0.9928381372306119,0.5178571428571429,1.0,1.0,1/6,1.04%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.6438521810846279,0.9928381372306119,0.5178571428571429,1.0,1.0,1/6,1.04%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.6438521810846279,0.9928381372306119,0.5178571428571429,1.0,1.0,1/6,1.04%,ELOVL2
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.6713250944379129,0.9927671534362926,0.5166666666666667,1.0,1.0,1/5,5.45%,CAV3
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.6590136427758624,0.9927438258454275,0.5254237288135594,1.0,1.0,1/5,16.50%,MSN
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.6590136427758624,0.9927438258454275,0.5254237288135594,1.0,1.0,1/5,16.50%,MSN
prerank,CellMarker_Augmented_2021__CD1C-CD141- Dendritic cell:Blood,0.40017689027577946,0.9925635819238438,0.46153846153846156,1.0,1.0,45/260,17.32%,RASGRP4;C3AR1;CYTIP;TLR2;TNFRSF1B;CABP4;SLC7A7;PTPRC;APOL6;NFAM1;SH3BP2;FCGR3A;SCIMP;FCAR;CLEC12A;SH2D1B;DNAJB1;VASP;DNASE2;IRF1;HCK;TSC22D3;SOD2;HEG1;KLF3;PSAP;TMC6;CFD;HK3;L1TD1;FAM110A;PYGL;CSF1R;FPR1;P2RX1;CKB;FTH1;CD300LF;ISG15;IFI6;CD244;MSN;GLUL;ARL4A;DDX60
prerank,CellMarker_Augmented_2021__Endothelial cell:Brain,0.6350721097317833,0.9922737006308008,0.5614035087719298,1.0,1.0,3/6,10.33%,APOLD1;FLT1;VWF
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Gland,0.41552737914661614,0.9920257235737057,0.4588235294117647,1.0,1.0,6/97,7.41%,LRP4;TRIL;TSPAN11;PCDH18;SCARA3;ANGPTL2
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Gastrointestinal Tract,0.41552737914661614,0.9920257235737057,0.4588235294117647,1.0,1.0,6/97,7.41%,LRP4;TRIL;TSPAN11;PCDH18;SCARA3;ANGPTL2
prerank,CellMarker_Augmented_2021__Ovarian Somatic cell:Ovary,0.41552737914661614,0.9920257235737057,0.4588235294117647,1.0,1.0,6/97,7.41%,LRP4;TRIL;TSPAN11;PCDH18;SCARA3;ANGPTL2
prerank,CellMarker_Augmented_2021__Corneal Limbal Stem cell:Limbal Epithelium,0.41552737914661614,0.9920257235737057,0.4588235294117647,1.0,1.0,6/97,7.41%,LRP4;TRIL;TSPAN11;PCDH18;SCARA3;ANGPTL2
prerank,CellMarker_Augmented_2021__Somatic Stem cell:Endometrium,0.41552737914661614,0.9920257235737057,0.4588235294117647,1.0,1.0,6/97,7.41%,LRP4;TRIL;TSPAN11;PCDH18;SCARA3;ANGPTL2
prerank,CellMarker_Augmented_2021__Stem cell:Gastric Gland,0.41552737914661614,0.9920257235737057,0.4588235294117647,1.0,1.0,6/97,7.41%,LRP4;TRIL;TSPAN11;PCDH18;SCARA3;ANGPTL2
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.5864017762080396,0.9919502416119811,0.55,1.0,1.0,3/10,12.45%,STEAP4;ASIC1;ALOX5AP
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.5864017762080396,0.9919502416119811,0.55,1.0,1.0,3/10,12.45%,STEAP4;ASIC1;ALOX5AP
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.4877906619486807,0.9919468072511387,0.47435897435897434,1.0,1.0,2/31,2.57%,SHCBP1L;ANXA1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Pancreas,-0.5454033480596402,-0.9919015468556087,0.45454545454545453,0.9708160354241492,1.0,1/7,4.40%,LGR5
prerank,Reactome_2022__Regulation Of FOXO Transcriptional Activity By Acetylation R-HSA-9617629,-0.5366200727702588,-0.9918557464563988,0.37142857142857144,0.9703942991024134,1.0,1/10,3.43%,FOXO1
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Embryonic Stem Cell,0.4271617785349556,0.9917528353371623,0.4878048780487805,1.0,1.0,14/84,11.00%,ENPP2;PRRX1;LMOD1;FBXL7;ADAM33;NID1;PCDH18;DAAM2;ANGPTL2;ACTA2;ADGRL4;COL6A2;DCN;COL1A1
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.6746216493361004,0.9916753963161581,0.5660377358490566,1.0,1.0,1/5,3.81%,PTPRC
prerank,Reactome_2022__G Beta:Gamma Signaling Thru BTK R-HSA-8964315,0.5343197587870874,0.9916609998561874,0.5147058823529411,1.0,1.0,2/14,8.04%,GNG12;GNG4
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.5060453489214461,-0.9915528952090182,0.48484848484848486,0.97062410565562,1.0,2/15,12.55%,ATR;TERT
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.5715613069829372,0.9914334099285359,0.5238095238095238,1.0,1.0,3/11,24.43%,ATP1A4;KCNJ2;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5689998699136238,-0.991293241778,0.4186046511627907,0.9707074276613099,1.0,4/8,15.40%,ACER2;SERPINE1;SNAI2;PDE3B
prerank,Reactome_2022__Eicosanoid Ligand-Binding Receptors R-HSA-391903,0.6168375108648909,0.9912402361392865,0.5384615384615384,1.0,1.0,2/9,16.01%,PTGER3;GPR17
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.46556997728237537,0.9910480150258003,0.4782608695652174,1.0,1.0,2/46,3.25%,RAB34;HHIP
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.42243496910098266,0.9909092149971478,0.47560975609756095,1.0,1.0,16/94,14.62%,TLR2;CCL5;TGFB1;NLRP12;SCIMP;WNT5A;SH2D1B;IFNK;P2RY12;PLA2G7;TNFSF4;F2RL1;AGT;THBS1;PLG;CYBA
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.43961614362796253,0.990907192750092,0.5116279069767442,1.0,1.0,16/81,16.69%,TLR2;PTPRC;VSIR;WNT5A;SYK;NR1H4;IGF1;C1QTNF4;NLRC3;OAS2;THBS1;IL4;CYBA;AGER;GHRL;RASGRP1
prerank,Reactome_2022__Microbial Modulation Of RIPK1-mediated Regulated Necrosis R-HSA-9686347,0.6050927329307885,0.9909018531134016,0.5166666666666667,1.0,1.0,3/5,25.66%,MLKL;GNL3;CASP8
prerank,CellMarker_Augmented_2021__Platelet:Blood,0.5289208515597832,0.9908887854334296,0.52,1.0,1.0,7/27,13.70%,GP1BA;CCL5;ITGA2;CSF3R;CD63;LAMP2;ITGA2B
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5382373175821156,0.9907550540329497,0.5135135135135135,1.0,1.0,4/17,15.14%,NPR2;ADCY7;NPPA;GUCY2F
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.5189359926754189,-0.9907389829051955,0.4827586206896552,0.9717624830671144,1.0,2/24,1.35%,DUSP6;GFI1B
prerank,GO_Biological_Process_2021__glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),0.6632247093631167,0.9905514455847094,0.49122807017543857,1.0,1.0,1/5,3.88%,GFRAL
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.5455926522412338,0.9905411132953575,0.5072463768115942,1.0,1.0,3/17,12.80%,GCHFR;SPR;DEGS2
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.3326081150410759,-0.9902229449792105,0.45,0.9725680422045586,1.0,16/180,7.73%,DUSP4;SPRED3;ADRA1A;SPRED2;DUSP6;SPRED1;PDGFD;ADCYAP1;APOE;CCN1;ERBB2;CCN2;TGFBR3;NTRK1;PLA2G5;EPHB2
prerank,KEGG_2021_Human__Toxoplasmosis,0.42359266981895705,0.9899130456548922,0.4358974358974359,1.0,1.0,18/93,18.84%,HSPA1L;TLR2;HSPA8;TGFB1;IL12A;HLA-DMA;TGFB3;LAMC2;HLA-DPB1;STAT1;MAPK3;PIK3R6;PIK3CG;NOS2;HSPA2;LAMB2;NFKBIA;HLA-DPA1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.5998546733700652,-0.98964859038547,0.5510204081632653,0.9734237761117821,1.0,2/7,17.47%,MTHFR;MTR
prerank,Reactome_2022__MET Receptor Recycling R-HSA-8875656,-0.5342216285221817,-0.9894928440617375,0.4117647058823529,0.9731916534862253,1.0,2/9,14.83%,CRK;CRKL
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.6251874804570258,0.9894872529706552,0.5769230769230769,1.0,1.0,2/6,23.82%,DNAJA1;LMAN1
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.5831472083076141,0.9893935639730452,0.5074626865671642,1.0,1.0,1/10,7.73%,ATP1A4
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.6239528018234016,0.9893373357810963,0.5846153846153846,1.0,1.0,1/9,0.72%,LRP4
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,-0.37724809680433924,-0.9892427586666046,0.375,0.9733534751119743,1.0,14/91,16.74%,SYNJ2;DGKD;ITPR2;PPIP5K1;PI4KB;ITPKA;MTMR8;MTMR14;PLCZ1;CDS1;PI4KA;MTMR1;PRKCA;ITPK1
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.5401297633175735,-0.9892397029698711,0.5405405405405406,0.9728010611079381,1.0,4/13,8.62%,APOH;SERPINE2;APOE;SERPINE1
prerank,KEGG_2021_Human__Pathways in cancer,0.38104778378130055,0.9888771056105241,0.45054945054945056,1.0,1.0,67/448,15.72%,RASGRP4;ESR1;MGST1;WNT8B;LPAR1;TCF7;FRAT1;CSF2RA;PIK3R3;FGF20;HHIP;FGF2;GNG12;CASP7;TGFB1;ITGA2;HEY2;WNT5A;PTGER3;IL12A;STAT5A;MMP9;CDKN2A;COL4A4;FLT4;COL4A3;CCND2;WNT8A;IGF1;LEF1;CCND1;GNG4;HGF;CKS1B;NQO1;COL4A6;COL4A5;KNG1;CSF3R;IL5;TGFB3;LAMC2;FZD8;CCNE2;LPAR6;STAT1;WNT6;CTNNA3;CDKN1B;IL7;CDKN1A;NFKB2;AGT;GLI3;CCNA2;CSF1R;TCF7L1;ITGA2B;RXRG;ADCY7;EDNRB;IL4;BBC3;MAPK3;IL3RA;CXCL12;WNT5B
prerank,CellMarker_Augmented_2021__T cell:Undefined,-0.38834884332142805,-0.988825713419643,0.43478260869565216,0.973210512500047,1.0,6/57,5.83%,IL7R;CD38;KLRC1;SELE;APOE;ITGA4
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5556614355673558,0.9888153924677375,0.4927536231884058,1.0,1.0,2/12,11.80%,PKP2;CTNNA3
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,0.5346761632085224,0.9886786126185326,0.5303030303030303,1.0,1.0,1/13,5.59%,TRIM25
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.460123486429428,0.9885799653147449,0.5189873417721519,1.0,1.0,10/45,23.48%,DNAH11;CCDC39;ODAD1;TEKT5;DNAI1;CABYR;ODAD2;CCDC63;ODAD3;DNHD1
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.4808799554639175,-0.9884215233987427,0.42857142857142855,0.9738014492451217,1.0,2/19,4.86%,BRCC3;USP36
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.4917282340040247,0.9882517471924358,0.4861111111111111,1.0,1.0,5/32,9.64%,CASQ2;ANXA1;SOCS2;GRK7;TRDN
prerank,CellMarker_Augmented_2021__Leydig cell:Testis,0.44108645281352266,0.9881487261039665,0.4868421052631579,1.0,1.0,5/72,6.78%,RHOXF2;CTCFL;C17ORF99;CA14;MEIOB
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.47370241087360615,0.9880306514723605,0.5,1.0,1.0,13/45,23.72%,KIF14;CEP55;NDC80;RAB11A;KIF18A;CHMP3;NUF2;ANKRD53;CCNB1;CHMP1A;BOD1;CDCA5;PSRC1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.5261205575539732,0.9880241768452519,0.5074626865671642,1.0,1.0,5/24,19.15%,TGFB1;PPT1;ELANE;CLN8;SIAH1
prerank,CellMarker_Augmented_2021__Endometrial Stromal Stem cell:Endometrium Stroma,0.43152926425504257,0.9878770020185402,0.5256410256410257,1.0,1.0,15/83,11.07%,PRRX1;LMOD1;GP1BA;ADAM33;LOX;NID1;CYYR1;ABI3BP;PCDH18;ANGPTL2;ADGRL4;COL6A2;DCN;COL1A1;DAB2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.5454510681230611,0.9878727260656799,0.4626865671641791,1.0,1.0,7/15,29.18%,ITGB6;ITGB8;FN1;PTGS2;HIF1A;LGALS9;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.48434071107169696,-0.9878590831260537,0.5,0.9749445297212863,1.0,2/19,3.16%,WNT3A;SELE
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.5786508018233314,-0.9877526548511772,0.5111111111111111,0.9746977951234254,1.0,1/8,8.13%,VPS8
prerank,Reactome_2022__Maturation Of Nucleoprotein R-HSA-9683610,0.579159809398073,0.9877330184417951,0.5238095238095238,1.0,1.0,5/11,23.81%,PARP14;PARP4;PARP9;PARP10;PARP8
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.6213773826858664,0.9877234372464233,0.4576271186440678,1.0,1.0,1/8,8.19%,SUV39H1
prerank,CellMarker_Augmented_2021__Luminal cell:Prostate,-0.39308873730248234,-0.9874830369064793,0.38095238095238093,0.9748146211367852,1.0,15/78,8.09%,TSKU;MLPH;CLDN4;WWC1;DSG2;ESRP1;RHBDF1;ASS1;ERBB2;PARVA;ADGRG6;PTPRF;PERP;TEAD4;EPB41L4B
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.4853084555792352,0.9872957428115458,0.4927536231884058,1.0,1.0,4/29,12.64%,C3;GPER1;EIF6;PDK4
prerank,Reactome_2022__Triglyceride Biosynthesis R-HSA-75109,0.5693385070410126,0.9869444176410949,0.5686274509803921,1.0,1.0,6/12,27.13%,LPIN3;MOGAT1;MOGAT2;GK3;AGMO;DGAT2
prerank,CellMarker_Augmented_2021__Stromal cell:Embryoid Body,0.4404232256288161,0.9867962380087404,0.4810126582278481,1.0,1.0,16/85,11.00%,C1QTNF1;TIMP3;PRRX1;LMOD1;ADAM33;LOX;ABI3BP;ITGBL1;PCDH18;ANGPTL2;ACTA2;HEG1;ADGRL4;COL6A2;DCN;COL1A1
prerank,Reactome_2022__Nucleotide Salvage R-HSA-8956321,0.5397216230342112,0.9866238207856691,0.5147058823529411,1.0,1.0,3/21,10.57%,ADA;TK1;DCK
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Adipose Tissue,0.5560548129713015,0.9865784328786702,0.48333333333333334,1.0,1.0,6/15,16.35%,PTPRC;ANPEP;NT5E;MME;CD44;ENG
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.4904558983608987,-0.9865099392617881,0.3783783783783784,0.9767103867367113,1.0,5/22,8.62%,APOH;PHLDB2;SERPINE2;APOE;SERPINE1
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),0.5705941404217597,0.9863970194949725,0.5285714285714286,1.0,1.0,7/14,30.32%,PINK1;COX7A2;NOP53;COX7A1;ACTN3;CBFA2T3;SHMT2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.445445604317237,0.9863571614298708,0.44871794871794873,1.0,1.0,19/99,14.71%,ENPP2;CCL5;CLCF1;PTPRC;TGFB1;CRLF1;CD81;IL12A;ERBB4;CD80;ITGA5;IGF1;HGF;IL5;VTN;AGT;CSF1R;IL4;CD44
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,0.41421856229933457,0.9861632668227988,0.5581395348837209,1.0,1.0,65/178,24.42%,PWP2;RPL37A;RPL21;RPL9;DIMT1;RPP38;RPL18A;RPS9;RPL3;RPL36;RPL13A;EXOSC8;RPS16;NOP10;RPL15;RPS5;RPS27A;RPS3A;EXOSC2;RPL41;RPP40;RPS12;RPS4X;RPL27A;NOB1;RPS19;FAU;RPS21;EXOSC4;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;WDR36;RSL24D1;RPLP2;NOL12;RPL7;TSR3;RPL38;RPS15A;EMG1;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RIOK2;RPL7A;RPL23;RPS15;WDR18;RPS27;GNL3;RPL8;RPS3;SENP3;RPS23;RPS20;WDR12;RPS24
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.3303057313415975,-0.98609061066817,0.5,0.9775008823259372,1.0,21/203,8.07%,NGF;APOB;ZNF703;BAMBI;BOC;VWC2;TWIST1;BCL9L;SP7;CCN1;KITLG;CARM1;CCN4;ACVR1;CCN2;PA2G4;SYAP1;PLA2G5;ASCL1;BNIP2;DLX1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.4151977843354656,0.9860732864427586,0.4810126582278481,1.0,1.0,24/120,23.12%,SGO1;BUB1;CENPU;ERCC6L;NDC80;KIF18A;SKA2;TTK;GPSM2;NUF2;SPC25;TBCE;BUB1B;RCC1;DYNLL1;ITGB3BP;TACC3;CENPN;CENPL;CCNB1;ESPL1;RPS27;CENPM;DYNLL2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.4236550644755519,-0.9859539787100681,0.5428571428571428,0.9773693140487841,1.0,7/39,8.24%,ADAMTS1;DNMT1;CDH13;MMP2;NR4A3;CCN4;ERN1
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.4200927169055556,0.985941950695574,0.5060240963855421,1.0,1.0,14/134,7.41%,LRP4;TIMP3;PRRX1;TLR2;LMOD1;TRIL;TSPAN11;FBXL7;SFTPA1;SLC38A3;PCDH18;SCARA3;PLP1;ANGPTL2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.5340096590739587,0.9858192851548139,0.5416666666666666,1.0,1.0,2/15,10.00%,CAV3;PPT1
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.5355479380255416,0.9856939149376129,0.5507246376811594,1.0,1.0,5/17,15.71%,SLC22A3;SLC47A1;SLC25A19;PDZK1;SLC22A4
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.44601049534696136,0.9856408365718409,0.5,1.0,1.0,9/52,15.27%,PTX3;CCL5;TRIM62;IFIT1;STAT1;ZC3HAV1;OAS2;CHMP3;ISG15
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,0.4486433832856594,0.9856396941182589,0.49333333333333335,1.0,1.0,8/54,20.47%,PSMB9;WNT5A;FZD8;RPS27A;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.5431904085929468,0.9855505334227731,0.5238095238095238,1.0,1.0,5/17,15.17%,OR51I2;OR52A5;OR8A1;SYT10;OR51M1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5495884779076265,0.9855355215664172,0.53125,1.0,1.0,2/16,1.77%,ELOVL2;ACSL5
prerank,KEGG_2021_Human__Ubiquinone and other terpenoid-quinone biosynthesis,0.6097304590876571,0.9855338827798016,0.5333333333333333,1.0,1.0,3/9,14.52%,HPD;NQO1;GGCX
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,0.4309472709030501,0.9854711641790419,0.4578313253012048,1.0,1.0,11/89,14.04%,PSMB9;RORC;TCF7;TGFB1;CDKN2A;LEF1;CCND1;RPS27A;CDKN1A;TCF7L1;PSMC5
prerank,CellMarker_Augmented_2021__CD141+CLEC9A+ Dendritic cell:Blood,-0.3814173182605687,-0.9853893002447853,0.4117647058823529,0.9783687721435956,1.0,10/89,6.56%,CD38;KCNK6;APOL3;BCL6;PPM1M;HLA-DQB1;DUSP2;VAC14;NCALD;OSBPL3
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.5194250114960183,-0.9853692801962982,0.47058823529411764,0.9778818514276849,1.0,2/14,7.05%,CD14;TICAM2
prerank,GO_Biological_Process_2021__cellular response to macrophage colony-stimulating factor stimulus (GO:0036006),0.6895569308943477,0.9849864546316699,0.6226415094339622,1.0,1.0,2/5,22.42%,CSF1R;DCSTAMP
prerank,GO_Biological_Process_2021__response to macrophage colony-stimulating factor (GO:0036005),0.6895569308943477,0.9849864546316699,0.6226415094339622,1.0,1.0,2/5,22.42%,CSF1R;DCSTAMP
prerank,CellMarker_Augmented_2021__T cell:Liver,0.603950505070393,0.9848950354095055,0.543859649122807,1.0,1.0,5/7,22.63%,PTPRC;CD4;CD244;IL2RA;CD27
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.5402620318347101,0.9848479846569836,0.4262295081967213,1.0,1.0,1/12,0.47%,RAB34
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),0.5993560119331123,0.9846908587536984,0.5555555555555556,1.0,1.0,5/10,22.63%,ZC3HAV1;PARP14;PARP15;PARP9;PARP10
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.41823872425579334,-0.9846587801437833,0.45161290322580644,0.9792419449862657,1.0,16/42,17.70%,NOX4;DDAH2;ASPG;MTHFR;ASS1;KYAT1;PYCR3;AADAT;GPT2;KYAT3;ALDH18A1;CBS;RIMKLB;DDAH1;GLUD1;GOT2
prerank,CellMarker_Augmented_2021__FOXP3+ Natural Regulatory T (Treg) cell:Blood,0.4570433516458664,0.9845364653554368,0.4852941176470588,1.0,1.0,17/57,14.40%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;GMFG;SASH3;PTPRC;IKZF1;TAGAP;CD37;CD4;GPR183;PSTPIP1;MYO1F;SIRPG;ITK;PARVG
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.6562538086627905,0.9844846493829458,0.603448275862069,1.0,1.0,1/5,4.27%,TGFB1
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.6122752212540614,0.9843264107161063,0.46875,1.0,1.0,2/7,18.11%,QPRT;HAAO
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.518670344683973,0.9842068057007988,0.5074626865671642,1.0,1.0,1/16,1.83%,TLR2
prerank,Reactome_2022__Mitophagy R-HSA-5205647,0.5125535826035537,0.9841646875574178,0.5606060606060606,1.0,1.0,7/25,19.84%,PINK1;RPS27A;TOMM20;PGAM5;TOMM7;FUNDC1;ULK1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.4411758479842325,-0.9840282383601163,0.47058823529411764,0.9802893160084135,1.0,5/28,12.70%,MFSD2A;ATP10A;ABCA4;ATP9A;ABCC1
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.577936379971512,-0.9839387086423353,0.5833333333333334,0.9799395609871501,1.0,3/8,22.56%,TRMT61B;RPUSD4;MTO1
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.6685744696363903,0.9838041314673586,0.5454545454545454,1.0,1.0,1/6,13.36%,NOP53
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.5865539271004305,0.9837942007386181,0.5573770491803278,1.0,1.0,7/11,33.50%,CCT7;CCT8;CCT3;CCT6A;CCT2;DKC1;MEPCE
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.5865539271004305,0.9837942007386181,0.5573770491803278,1.0,1.0,7/11,33.50%,CCT7;CCT8;CCT3;CCT6A;CCT2;DKC1;MEPCE
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.5279757003723373,-0.9837607596390394,0.41379310344827586,0.9798504369142207,1.0,3/13,19.14%,PNP;AK8;AK7
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.41700680625850217,-0.9837482234186384,0.5,0.9793351535018228,1.0,4/35,5.01%,OSR1;KIT;SP7;WNT7A
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.6392882392966817,0.9837452008633271,0.5178571428571429,1.0,1.0,1/5,15.98%,CNTN2
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),-0.5682194840059501,-0.9836748793582099,0.47058823529411764,0.9789432012093955,1.0,6/12,15.97%,WNT3A;NLGN3;WNT7A;NLGN2;LRRTM3;C5AR1
prerank,Reactome_2022__Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,-0.4471222263809962,-0.9833464946596558,0.5,0.9794249002835773,1.0,9/19,15.86%,GPC6;GPC2;SDC3;GPC4;AGRN;VCAN;CSPG5;GPC1;SDC4
prerank,CellMarker_Augmented_2021__Primitive Vesicle cell:Fetal Kidney,0.592111306051117,0.9831562767516044,0.5576923076923077,1.0,1.0,1/8,6.67%,RSPO1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.5304617825945767,0.983147910877985,0.5217391304347826,1.0,1.0,4/21,7.66%,LMOD3;TGFB1;MESP1;IGF1
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 27-Hydroxycholesterol R-HSA-193807,0.5681462921774275,0.9831300423647963,0.5,1.0,1.0,2/13,7.24%,HSD3B7;NR1H4
prerank,CellMarker_Augmented_2021__T cell:Lymph Node,0.6678042659163308,0.9831226578331423,0.5384615384615384,1.0,1.0,3/5,19.79%,PTPRC;CD4;CD5
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.557097004858969,0.9830978834503193,0.5441176470588235,1.0,1.0,6/13,29.17%,SLC25A18;ETFB;SLC25A22;UQCRFS1;PPARGC1A;SLC25A13
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,0.4845406765103845,0.9829854083604722,0.47297297297297297,1.0,1.0,9/48,10.50%,GALNTL5;MUC17;GCNT7;B3GNT9;MUC4;GALNT5;C1GALT1C1;MUCL1;B3GNT5
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.6147749138580497,0.9829511709354282,0.5671641791044776,1.0,1.0,5/10,23.49%,CD4;CSF1;DCSTAMP;CD74;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.6472722952709218,0.9829159858381136,0.5806451612903226,1.0,1.0,3/7,23.71%,LEF1;CEACAM1;RUNX1
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,-0.3974319388027275,-0.9828285899146029,0.3902439024390244,0.9802811114127684,1.0,12/39,22.32%,POLR3D;BDP1;POLR3E;NFIB;POLR3K;POLR2F;POLR3A;POLR3B;BRF1;POLR3F;SNAPC3;BRF2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5494383093687377,0.9827419744742883,0.5,1.0,1.0,1/12,0.80%,ITGB2
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.5397355128042925,0.9826626937105933,0.5223880597014925,1.0,1.0,8/30,23.31%,NDUFB11;NDUFS2;NDUFB10;NDUFA2;NDUFB9;NDUFB4;NDUFA1;NDUFB2
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.5440369610815309,-0.9824893931914832,0.5208333333333334,0.9804587607742885,1.0,3/9,22.16%,PARVA;EMP2;CCDC88C
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.41528249940387374,-0.982421303334186,0.53125,0.980074262221768,1.0,4/37,2.81%,GALR3;DRD4;HRH2;HRH1
prerank,CellMarker_Augmented_2021__Plasma cell:Kidney,0.549187835838324,0.9823928735099745,0.5483870967741935,1.0,1.0,3/15,13.61%,JCHAIN;PNOC;IGLL1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.4736526888466316,0.9819531629264165,0.4657534246575342,1.0,1.0,3/41,3.67%,PLA2G10;LIPH;LIPI
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.49169086816542207,0.9818490674518596,0.5072463768115942,1.0,1.0,11/37,19.78%,TGFB1;NODAL;GDF11;TGFB3;DAB2;TTK;BMP3;GDF9;ENG;INHBC;GDF15
prerank,CellMarker_Augmented_2021__Ciliated cell:Lung,0.40483445965902126,0.9817947378169146,0.5444444444444444,1.0,1.0,50/211,23.44%,DNAAF8;ENDOG;CCDC60;RRAD;LRRC46;FAM81B;HIPK1;ERICH2;AHSA1;VWA3B;CCDC81;SMIM22;NQO1;RRAGA;RPA3;JOSD2;AGBL5;AKAP14;EFCAB10;PNMA1;MORN5;CKB;KLHL13;SPC25;BASP1;LXN;DYNLL1;PLEKHB1;ALDH9A1;CWH43;LRWD1;DALRD3;CIBAR2;AZIN1;ZNHIT2;CYSTM1;SNTN;ODAD2;STMND1;CYB561A3;CCDC74B;PLAC8;TUBB4B;CTBS;SPAG6;VWA5A;DYNLT1;TSPAN19;CD59;DNAJB2
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,-0.5093212502305018,-0.9817580846745684,0.5454545454545454,0.9813534937654604,1.0,7/20,25.25%,WWC1;AMOTL1;AMOTL2;CASP3;YWHAE;STK4;NPHP4
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.6042095216562271,0.981635456322807,0.5517241379310345,1.0,1.0,1/9,4.39%,JCHAIN
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.6506358347530723,-0.9815393919958032,0.5652173913043478,0.9813575298796506,1.0,1/6,0.67%,FBP2
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.4048174085560452,-0.9815184133130797,0.4482758620689655,0.9808509039109224,1.0,2/27,7.05%,CD14;TICAM2
prerank,Reactome_2022__SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,0.5433734554336724,0.9814100404919843,0.5,1.0,1.0,5/19,20.57%,H2BC4;H2AZ1;SUV39H1;TAF1A;H2AZ2
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.4763920368283715,0.9811020531502599,0.5147058823529411,1.0,1.0,2/29,6.06%,PLA2G10;PON1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.4138362920999035,0.9810719886984377,0.47560975609756095,1.0,1.0,14/91,15.29%,PLA2G10;TLR2;PTPRC;IFIT1;DDIT4;IRF1;ZDHHC11;AGBL5;STAT1;F2RL1;OAS2;EXOSC4;ISG15;IFI6
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.37859222552169464,-0.9810434947494138,0.5263157894736842,0.9817178168625273,1.0,13/91,10.94%,SPRED3;SPRED2;SPRED1;BAMBI;VWC2;BCL9L;ACVR1;CCN3;DLX1;EMILIN1;VWC2L;ZBTB7A;SPRY1
prerank,KEGG_2021_Human__Thermogenesis,0.42076783476940655,0.9809676857013623,0.5411764705882353,1.0,1.0,44/183,24.77%,COX6A1;ACTL6A;ACSL5;ACTG1;ATP5PF;NDUFB11;KLB;NDUFS2;ACSL3;KDM3A;UCP1;COX7A2;SMARCE1;COX17;ATP5F1E;ADCY7;NPPA;NDUFB10;NDUFA2;NDUFAF5;ATP5MC3;PRKG1;CNR1;COX20;COX4I1;COX7B;RPS6;NDUFB9;CREB3;COX6C;COX6B1;NDUFB4;UQCRFS1;KRAS;NDUFA1;ATF2;COX7A1;NDUFB2;COX5A;KDM1A;COX7C;PRKAB2;ATP5ME;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.4516191588590675,0.9809579811384804,0.4383561643835616,1.0,1.0,6/27,13.08%,PDE6H;GPER1;AFAP1L2;MMP9;PLAUR;AGT
prerank,Reactome_2022__Regulation Of PTEN Localization R-HSA-8948747,0.5789686011933143,0.9808448224505794,0.5862068965517241,1.0,1.0,1/9,11.00%,RPS27A
prerank,Reactome_2022__TP53 Regulates Transcription Of Caspase Activators And Caspases R-HSA-6803207,0.5752138496364252,0.9806096455688853,0.5333333333333333,1.0,1.0,3/10,18.71%,NLRC4;CASP10;APAF1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.463828243098047,0.9803547437670769,0.5142857142857142,1.0,1.0,1/43,0.37%,NEK2
prerank,GO_Biological_Process_2021__lipoprotein metabolic process (GO:0042157),0.6142875614095727,0.9802668403223982,0.546875,1.0,1.0,2/5,10.51%,NPC1L1;MTTP
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5192904213085224,-0.9800489182591886,0.5142857142857142,0.9838338295731647,1.0,4/20,4.21%,ADAMTS1;DNMT1;MMP2;NR4A3
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5083589393945774,0.9800321118678453,0.5633802816901409,1.0,1.0,7/27,28.90%,WNT5A;USP18;ISG15;CACTIN;HSP90AB1;OAS1;PTPN6
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.6534581247823995,0.9798224274454544,0.5483870967741935,1.0,1.0,2/5,21.35%,RAD54L;DMC1
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.5502821568527925,-0.9798209192827788,0.4782608695652174,0.9839010920762169,1.0,2/7,17.28%,SENP1;SENP5
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.5269102677942572,0.9796500268328965,0.5735294117647058,1.0,1.0,3/17,11.19%,AIM2;IRF1;STAT1
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.5065736364879413,0.9796438151930795,0.5068493150684932,1.0,1.0,5/22,16.38%,GPR55;LILRB3;GPR137B;IL4;CSF1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.5044243089336707,0.9795256249339159,0.5492957746478874,1.0,1.0,2/41,2.45%,GAD1;HSPA8
prerank,KEGG_2021_Human__Antigen processing and presentation,0.4681922546304359,0.9793793263353512,0.5211267605633803,1.0,1.0,19/47,23.49%,HSPA1L;HSPA8;HLA-F;HSPA5;HLA-A;HLA-DMA;HLA-DPB1;CD4;HSPA4;CD8B;HSPA2;HLA-DPA1;RFXANK;TAP1;NFYB;CIITA;B2M;CD74;HLA-DRB1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.3513264084550021,-0.979244411174739,0.35714285714285715,0.9848868430588239,1.0,21/125,12.32%,MFSD2A;DNAJC30;SYNJ2;KLHL17;PTCH1;SLC6A17;MDGA1;JHY;CX3CR1;EML1;AMIGO2;MACROH2A2;POU6F1;TUBGCP2;PITPNM1;BPTF;UTP3;GRIN1;CDK5RAP2;BAG6;NFIB
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),0.6099899840086925,0.9790718044186649,0.5396825396825397,1.0,1.0,2/6,11.80%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),0.6099899840086925,0.9790718044186649,0.5396825396825397,1.0,1.0,2/6,11.80%,PKP2;CTNNA3
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,-0.40126151803498505,-0.9789277120313256,0.48,0.9850251648287335,1.0,16/74,9.19%,CLDN4;CDH4;CDH5;CDH19;CLDN15;CDH13;CD151;CLDN16;F11R;PARVA;PARD3;PVR;FLNA;CDH9;ITGB4;SDK2
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.42760877451061835,0.9787225419991398,0.5,1.0,1.0,7/94,8.74%,ESR1;NOTUM;DISC1;TLR2;DAAM2;RSPO1;HIC1
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.5038794970071455,0.9786863820366759,0.4861111111111111,1.0,1.0,8/19,29.07%,SEMA3A;SEMA3F;SEMA3B;SEMA6A;SEMA4C;SEMA7A;SEMA3E;SEMA4G
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,0.46721941796871863,0.9786335246895239,0.4520547945205479,1.0,1.0,5/49,8.12%,CDC25A;H2BC4;CDKN2A;GSDME;H2AZ1
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,0.5109733366469529,0.9782116207527899,0.5060240963855421,1.0,1.0,4/24,9.56%,RRAS;MYH11;MYL6;RHOB
prerank,Reactome_2022__Activation Of Matrix Metalloproteinases R-HSA-1592389,0.5292820202838693,0.9781242846496373,0.5967741935483871,1.0,1.0,7/18,14.15%,COL18A1;MMP9;MMP15;SPOCK3;PLG;MMP11;ELANE
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Liver,0.5592650032405968,0.9781082645780723,0.4838709677419355,1.0,1.0,4/16,14.71%,ANPEP;EPCAM;SOX9;CD44
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.5250518092653859,0.9780974687870447,0.5223880597014925,1.0,1.0,4/26,12.46%,KIF14;CXCR5;ECT2;CDC14A
prerank,Reactome_2022__Receptor Mediated Mitophagy R-HSA-8934903,0.5842612763552992,0.9780195531532141,0.5245901639344263,1.0,1.0,4/9,27.63%,PGAM5;FUNDC1;ULK1;CSNK2A2
prerank,KEGG_2021_Human__Pathways of neurodegeneration,0.38399350415978345,0.9780098542758772,0.5161290322580645,1.0,1.0,92/397,25.81%,COX6A1;SLC25A31;WNT8B;TNFRSF1B;FRAT1;DNAH11;VAPB;UBE2L6;CASP7;WNT5A;ATP5PF;WNT8A;NDUFB11;HSPA5;PDYN;GRIN2D;NDUFS2;PINK1;NEFM;FZD8;COX7A2;RPS27A;DNAH10;WNT6;ATG101;ATP5F1E;DKK2;PSMC5;DNAI1;TUBA4A;TUBA3D;TUBB6;MAPK3;CDK5R1;DNAH3;NDUFB10;WNT5B;NDUFA2;AGER;CSF1;ATP5MC3;NOS2;GABARAPL2;NOX1;COX4I1;TUBA1C;ACTR1B;DNAH12;PPID;APAF1;ATP2A2;PSMA3;COX7B;PSMB6;DLG4;MAP2K1;ULK1;NDUFB9;COX6C;GRIN2C;COX6B1;NDUFB4;PSMD6;CHRM5;RYR3;NEFH;UQCRFS1;TUBB4B;DDIT3;FRAT2;DCTN3;KRAS;DCTN1;NDUFA1;COX7A1;GABARAPL1;NDUFB2;COX5A;PARK7;COX7C;PLCB4;PSMA7;VDAC1;FZD6;GPX2;KLC2;PTGS2;PSMB1;CASP8;ACTR10;CTNNB1;DNAH8
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.6323812141151413,-0.9780006526633889,0.5384615384615384,0.9870987636857183,1.0,1/5,10.06%,SLC15A4
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.4272416669892547,-0.9778752591510258,0.53125,0.9867843480622043,1.0,2/26,2.07%,GATAD2A;CHD4
prerank,CellMarker_Augmented_2021__Bulge Stem cell:Scalp,0.43151719770287345,0.9778084399635083,0.5176470588235295,1.0,1.0,10/93,9.04%,ITM2A;CYYR1;PREX2;SHISA6;JAM2;PLP1;KCNA5;CCND2;ZIK1;TCEAL5
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.5256028090718118,-0.9777872707120103,0.5161290322580645,0.9865490461141116,1.0,5/12,30.23%,ABCG1;NCSTN;CLN3;ADAM19;ABCA7
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.4568225412304101,0.9777532567573053,0.52,1.0,1.0,11/46,18.80%,HAMP;FRRS1;ABCG2;CP;ATP6AP1;FTH1;SLC46A1;NUBP1;CYBRD1;TF;FTL
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.5601276235073595,0.9773582625438397,0.4603174603174603,1.0,1.0,1/12,3.45%,TICRR
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.43627562103432227,0.9773344736029496,0.5277777777777778,1.0,1.0,8/57,18.48%,MAPKAPK3;FLT1;FLT4;AXL;CYBA;BCAR1;VAV3;VEGFC
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.4841462408998149,0.9771068246618331,0.49382716049382713,1.0,1.0,1/33,0.23%,GATA4
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.5682156944690047,0.9770700502655715,0.55,1.0,1.0,3/12,15.27%,PINK1;DNAJA1;ISG15
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.5226496440528071,-0.9769120394449321,0.42857142857142855,0.9885968591485177,1.0,5/15,10.41%,UPB1;NT5C1A;UPP1;NT5C;UPP2
prerank,CellMarker_Augmented_2021__Stem cell:Lacrimal Gland,0.43485061640031164,0.9768268259486559,0.5064935064935064,1.0,1.0,10/80,13.20%,TIMP3;SLC22A3;GNG12;ABCG2;PTGR1;NR1H4;SMLR1;SH2D4A;LIFR;SOWAHA
prerank,CellMarker_Augmented_2021__Corneal Epithelial Progenitor cell:Embryonic Stem Cell,0.43485061640031164,0.9768268259486559,0.5064935064935064,1.0,1.0,10/80,13.20%,TIMP3;SLC22A3;GNG12;ABCG2;PTGR1;NR1H4;SMLR1;SH2D4A;LIFR;SOWAHA
prerank,CellMarker_Augmented_2021__Stem cell:Limbal Epithelium,0.43485061640031164,0.9768268259486559,0.5064935064935064,1.0,1.0,10/80,13.20%,TIMP3;SLC22A3;GNG12;ABCG2;PTGR1;NR1H4;SMLR1;SH2D4A;LIFR;SOWAHA
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.519467774812374,-0.9767936776485582,0.5681818181818182,0.988346505037515,1.0,3/10,14.13%,NT5C1A;UPP2;NME5
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,0.48826433497977495,0.9767225751439982,0.5205479452054794,1.0,1.0,9/25,31.61%,RPS27A;SYVN1;SEL1L;GANAB;RNF5;DERL2;AMFR;CANX;CALR
prerank,CellMarker_Augmented_2021__Multipotent Mesenchymal Stroma cell:Bone Marrow,0.6067815293321983,0.976670013913993,0.5357142857142857,1.0,1.0,3/7,7.30%,PTPRC;ITGAM;NT5E
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.5829211761563818,0.9766526652948317,0.5074626865671642,1.0,1.0,3/9,23.43%,DDX60;USP17L2;OASL
prerank,CellMarker_Augmented_2021__Beta cell:Undefined,0.47555145179589303,0.9762859022680604,0.5294117647058824,1.0,1.0,12/42,18.03%,RASGRP4;ARHGAP9;FRAT1;SH2D1B;CSF3R;MYO1F;S100Z;ADGRE3;CD244;ZAP70;PGLYRP1;CD8B
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,0.4090497832032185,0.976201290982943,0.5641025641025641,1.0,1.0,33/155,25.73%,SGO1;PSMB9;BUB1;CENPU;ERCC6L;NDC80;RPS27A;KIF18A;PPP2R5A;SKA2;PSMC5;NUF2;SPC25;BUB1B;DYNLL1;ITGB3BP;PSMA3;PSMB6;CENPN;CENPL;PSMD6;CENPS-CORT;ESPL1;RPS27;CENPM;DYNLL2;CDCA5;PSMA7;BUB3;CDCA8;PSMB1;CENPO;CENPK
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.4458328624249542,0.9760232890617728,0.5128205128205128,1.0,1.0,15/66,24.53%,ARHGAP9;RAPGEF6;PLXNA3;GPR137B;EPHA1;TDG;ATP5IF1;PRKG1;VAV3;ARHGAP15;PPP1R17;EPHA5;ADAP1;VAV1;PROM2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5569933449109605,0.975924423959904,0.5151515151515151,1.0,1.0,3/20,7.94%,SPDYA;CCND2;CCND1
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.5632283733440949,-0.9758766532122163,0.41025641025641024,0.990305257138518,1.0,3/10,14.55%,CPEB1;HSF1;LEO1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Placenta,0.4926681976812891,0.975793943485961,0.4868421052631579,1.0,1.0,14/40,14.99%,RASGRP4;SLFN14;FCGR3A;CLEC12A;HEMGN;SLC4A1;CA1;CSF3R;HK3;MYO1F;FPR1;ITGA2B;P2RX1;ADGRE3
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),0.6523545977316432,0.9757254791035664,0.578125,1.0,1.0,3/5,25.23%,PLN;SLC30A1;VDAC1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.5657529258976883,-0.9756880826704806,0.5116279069767442,0.990368581527996,1.0,1/7,11.53%,SPAST
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,0.4243788090342484,0.975511187163398,0.4936708860759494,1.0,1.0,15/74,24.15%,COX6A1;DDIT4;RRAGA;COX20;COX4I1;LAMTOR3;YWHAH;COX7B;COX6C;COX6B1;SESN1;YWHAG;COX5A;COX7C;PRKAB2
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.4484827793508936,0.9752595416816768,0.5135135135135135,1.0,1.0,3/57,8.21%,NEK2;FGF2;HGF
prerank,Reactome_2022__Removal Of Aminoterminal Propeptides From Gamma-Carboxylated Proteins R-HSA-159782,0.6115467077340269,0.975241014308976,0.59375,1.0,1.0,3/8,11.87%,PROZ;F7;FAM110A
prerank,CellMarker_Augmented_2021__Primitive Streak cell:Primitive Streak,0.4524435473769862,0.9752195198203828,0.5142857142857142,1.0,1.0,17/71,17.12%,SGO1;CLDN6;SALL4;PHF21B;WNT8A;GNG4;CHRNA5;PIF1;HMGA2;FOXB1;SLC7A3;SPC25;MAP3K15;FBN3;GINS1;VASH2;ZNF114
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,0.5111635446004688,0.9751724213259118,0.547945205479452,1.0,1.0,2/17,8.04%,GNG12;GNG4
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.42588066293424864,-0.9751715874034912,0.42105263157894735,0.9914029240860412,1.0,6/23,19.15%,WWP2;JAG2;JAG1;NEURL1;DLL1;NCSTN
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.6247310297403423,0.9751528896192392,0.582089552238806,1.0,1.0,1/7,5.59%,TRIM25
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.47379468374008726,0.9751318134270311,0.6025641025641025,1.0,1.0,5/40,9.49%,TLR2;LRRC19;NLRP12;DDX3X;C1QTNF4
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,0.42549591425427163,0.9750748621418448,0.5324675324675324,1.0,1.0,13/87,17.41%,SGO1;BUB1;CENPU;ERCC6L;NDC80;KIF18A;PPP2R5A;SKA2;NUF2;SPC25;BUB1B;DYNLL1;ITGB3BP
prerank,CellMarker_Augmented_2021__Stem cell:Cartilage,0.5967703690644985,0.9750197686115089,0.5084745762711864,1.0,1.0,3/8,16.35%,NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.5576647199360145,0.9750088602661496,0.5737704918032787,1.0,1.0,4/12,14.29%,RENBP;PON1;PON3;ACOT4
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.46692018368955884,0.9749567086455263,0.5443037974683544,1.0,1.0,8/45,15.85%,CEP55;KLHDC8B;RHOB;ECT2;RTKN;RASA1;ANLN;MITD1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.49588909086320476,0.9748793916183001,0.5147058823529411,1.0,1.0,5/22,23.16%,PTPRC;DUSP22;CBLC;SH3BP5L;ERRFI1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.43007797228328587,0.9747023590382888,0.5714285714285714,1.0,1.0,19/103,15.53%,LRP4;TIMP3;PRRX1;LMOD1;TSPAN11;FBXL7;TMEM100;PCDH18;SCARA3;ANGPTL2;GFRA1;ALX4;DCN;VTN;LIFR;SLC47A1;DDR2;ZIC1;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.582948614196882,0.9746988366720479,0.5517241379310345,1.0,1.0,3/13,27.21%,HSPA5;DNAJB9;WFS1
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.6037771068859883,-0.9746027268533629,0.5384615384615384,0.9923861620173866,1.0,1/8,6.78%,ADAM8
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.5246938200400727,0.974466848487515,0.5,1.0,1.0,4/15,24.15%,EIF6;PDK4;PANK2;PRKAB2
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.5882723042484385,0.9743270625010437,0.55,1.0,1.0,1/11,4.72%,MANF
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.46764494435066734,0.9742960145931963,0.5277777777777778,1.0,1.0,7/32,18.55%,SP100;TNFRSF10A;DDX3X;TMC8;THBS1;BRCA1;FEM1B
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.41895746166657843,0.9742494841378929,0.4936708860759494,1.0,1.0,25/103,18.48%,BLK;TIMP3;TGFB1;MANF;IGF1;F8;HGF;KNG1;PSAP;TGFB3;CFD;VWF;SELENOP;CD63;THBS1;LAMP2;ITGA2B;PLG;ITIH4;TUBA4A;FERMT3;A1BG;A2M;TF;VEGFC
prerank,CellMarker_Augmented_2021__Megakaryocyte Erythroid cell:Undefined,-0.39227629765378225,-0.9736577595721279,0.4782608695652174,0.9942384631506025,1.0,6/55,5.83%,IL7R;CD38;KLRC1;SELE;APOE;ITGA4
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,0.4017678972192081,0.9735448979334124,0.5,1.0,1.0,20/123,21.18%,CDC25A;PSMB9;RRAD;H2BC4;MCM3;RPA3;RPS27A;PKMYT1;PSMC5;ARTN;RMI2;ORC4;BRCA1;YWHAH;PSMA3;PSMB6;RAD9B;CDC25C;PSMD6;CCNB1
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.5628430180080319,-0.9735371652195302,0.4666666666666667,0.9940570952399497,1.0,4/8,19.19%,GLA;GUSB;FUCA1;GBA2
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.5676997373300625,-0.973461238230637,0.5263157894736842,0.9936906914290689,1.0,2/8,11.63%,PRKCD;MAP3K12
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.4963409872080331,-0.9733364990662959,0.5217391304347826,0.9935454312946923,1.0,3/24,8.71%,MT1G;SLC30A5;SLC30A10
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.6282811394514995,0.9731448971904901,0.5555555555555556,1.0,1.0,1/7,8.11%,HSPA5
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.37126504722522863,-0.9728741984309615,0.3333333333333333,0.9944037740700796,1.0,17/67,17.99%,CPSF1;LSM10;POLR1A;TTF2;GTF2H2;SNRPB;SYMPK;CSTF2;ERCC2;CPSF7;POLR3K;POLR2F;TAF1B;TAF1D;PCF11;CPSF4;SMN1
prerank,GO_Biological_Process_2021__regulation of T cell tolerance induction (GO:0002664),-0.6039102764581076,-0.9727420373776317,0.5,0.9941515898350819,1.0,1/5,3.68%,CLC
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.5898225833167111,-0.9727371378222475,0.4878048780487805,0.9936011183013969,1.0,2/6,18.30%,ATPAF1;ATPAF2
prerank,KEGG_2021_Human__Primary immunodeficiency,-0.45811113926613867,-0.9727259269552013,0.41935483870967744,0.9930583608273045,1.0,1/26,0.07%,IL7R
prerank,Reactome_2022__Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.5058252226258193,0.9727144448087313,0.5147058823529411,1.0,1.0,12/21,29.63%,CYP26B1;CYP1B1;CYP24A1;AHCY;FDXR;CYP21A2;CYP17A1;CYP2R1;CYP19A1;TBXAS1;FDX1;MAOA
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.586733140637458,0.9724452958170344,0.5846153846153846,1.0,1.0,4/9,14.48%,ALOX12;SCD;ALOX15;ALOX15B
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,0.4696665556788163,0.9724295263127002,0.5769230769230769,1.0,1.0,9/61,15.72%,RRAS;PTPRC;MYH11;SEMA3A;MYL6;RHOB;PLXNA3;CDK5R1;MYL9
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,-0.44811838388438685,-0.9723231703590247,0.46875,0.9934464169692119,1.0,5/27,18.09%,NOD1;RIPK2;CASP9;CARD9;MAPK12
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,0.4537931104837091,0.9720587110994366,0.4722222222222222,1.0,1.0,6/36,12.37%,STAT5A;SYK;SOCS2;HCK;RPS27A;CDKN1B
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.5123332521078381,0.9719904506707439,0.547945205479452,1.0,1.0,2/20,10.55%,MCUB;TGM2
prerank,Reactome_2022__Defects In Cobalamin (B12) Metabolism R-HSA-3296469,0.5493106668547323,0.9719136130335184,0.5147058823529411,1.0,1.0,2/13,13.35%,AMN;CBLIF
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.564601842557573,0.9716718016285814,0.49206349206349204,1.0,1.0,1/10,0.47%,RAB34
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),0.6170570442307082,0.9716295753074321,0.5178571428571429,1.0,1.0,3/6,32.17%,AQP11;UBXN1;SVIP
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.4724290274534124,0.9714479714414992,0.5070422535211268,1.0,1.0,3/42,3.67%,PLA2G10;LIPH;LIPI
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.42331841982089335,-0.9713745700393971,0.5,0.9954237584145148,1.0,6/34,11.22%,DNAJC30;WWC1;NUP214;CAPN10;AAAS;ATP9A
prerank,KEGG_2021_Human__Tyrosine metabolism,0.49090262285301123,0.9710813402357532,0.4722222222222222,1.0,1.0,4/25,8.01%,TYR;DBH;AOX1;HPD
prerank,CellMarker_Augmented_2021__Non-switched Memory B cell:Peripheral Blood,0.4382444422487681,0.9708957732868452,0.515625,1.0,1.0,12/45,13.63%,BLK;CYTIP;ARHGAP9;SASH3;WAS;NAPSB;TAGAP;CD37;TMC8;PNOC;PSTPIP1;SIRPG
prerank,CellMarker_Augmented_2021__Double-negative B cell:Peripheral Blood,0.4382444422487681,0.9708957732868452,0.515625,1.0,1.0,12/45,13.63%,BLK;CYTIP;ARHGAP9;SASH3;WAS;NAPSB;TAGAP;CD37;TMC8;PNOC;PSTPIP1;SIRPG
prerank,CellMarker_Augmented_2021__Memory B cell:Blood,0.4382444422487681,0.9708957732868452,0.515625,1.0,1.0,12/45,13.63%,BLK;CYTIP;ARHGAP9;SASH3;WAS;NAPSB;TAGAP;CD37;TMC8;PNOC;PSTPIP1;SIRPG
prerank,CellMarker_Augmented_2021__IgG Memory B cell:Undefined,0.4382444422487681,0.9708957732868452,0.515625,1.0,1.0,12/45,13.63%,BLK;CYTIP;ARHGAP9;SASH3;WAS;NAPSB;TAGAP;CD37;TMC8;PNOC;PSTPIP1;SIRPG
prerank,CellMarker_Augmented_2021__Class-switched Memory B cell:Peripheral Blood,0.4382444422487681,0.9708957732868452,0.515625,1.0,1.0,12/45,13.63%,BLK;CYTIP;ARHGAP9;SASH3;WAS;NAPSB;TAGAP;CD37;TMC8;PNOC;PSTPIP1;SIRPG
prerank,CellMarker_Augmented_2021__Double-negative Memory B cell:Peripheral Blood,0.4382444422487681,0.9708957732868452,0.515625,1.0,1.0,12/45,13.63%,BLK;CYTIP;ARHGAP9;SASH3;WAS;NAPSB;TAGAP;CD37;TMC8;PNOC;PSTPIP1;SIRPG
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Peripheral Blood,0.4382444422487681,0.9708957732868452,0.515625,1.0,1.0,12/45,13.63%,BLK;CYTIP;ARHGAP9;SASH3;WAS;NAPSB;TAGAP;CD37;TMC8;PNOC;PSTPIP1;SIRPG
prerank,KEGG_2021_Human__Cell adhesion molecules,0.4184275894272887,0.9708928604964596,0.5125,1.0,1.0,20/116,11.98%,ITGB2;CLDN2;CLDN6;SDC2;PTPRC;CLDN18;VSIR;CD99L2;ITGAM;HLA-F;JAM2;CD80;CD99;HLA-A;PDCD1LG2;HLA-DMA;HLA-DPB1;CLDN5;CLDN9;CD4
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.39094444398787886,-0.9708287418037025,0.4482758620689655,0.9963349622491072,1.0,14/84,13.32%,ARC;IKZF4;UPB1;MPP2;PKD2;TRMT61B;GLRA3;KCNC3;EHD4;HGSNAT;SPAST;EHD3;CARD9;CPSF7
prerank,Reactome_2022__Diseases Associated With Visual Transduction R-HSA-2474795,0.6206634057250724,0.970653666331417,0.609375,1.0,1.0,3/8,16.57%,LRAT;RDH12;RBP1
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,0.531349298818404,0.9706042225788358,0.5161290322580645,1.0,1.0,3/16,11.19%,STAT5A;IL26;STAT1
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),0.6563765346780582,0.9705461650876135,0.6166666666666667,1.0,1.0,1/5,6.64%,KCNA5
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),0.6563765346780582,0.9705461650876135,0.6166666666666667,1.0,1.0,1/5,6.64%,KCNA5
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.5238151174748306,-0.9704140318024442,0.47368421052631576,0.9969119720192872,1.0,1/10,7.92%,PID1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4763339652856052,0.9703852678493801,0.515625,1.0,1.0,5/26,11.47%,NODAL;KANK2;ZNF366;DAB2;VPS18
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.3767972316092629,-0.9703303045552033,0.42857142857142855,0.9965956110890054,1.0,24/85,15.32%,ADAMTS12;MYO10;CALD1;COL4A2;MMP2;RAI14;LOXL1;RND3;PARVA;CXCL14;FZD7;MID1;FSTL1;GPR161;SNAI2;EDNRA;ANTXR1;AMOTL2;SLIT2;CHST3;GFPT2;CDH11;COL4A1;ADGRL2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5403780560172381,-0.9702701731405577,0.53125,0.9962441927449223,1.0,1/10,1.47%,PRKCD
prerank,Reactome_2022__Cleavage Of Damaged Purine R-HSA-110331,0.5400182987532298,0.9702313753541421,0.5692307692307692,1.0,1.0,2/18,8.12%,H2BC4;H2AZ1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.5647895001344357,0.9702160691296665,0.5441176470588235,1.0,1.0,2/13,10.69%,SCTR;UCP1
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,0.47764001700054526,0.9700964066390905,0.5138888888888888,1.0,1.0,13/36,25.94%,FLI1;H2BC4;LEF1;H2AZ1;CSF3R;CDKN1A;MYB;H2AZ2;RUNX1;SPI1;H2AC6;CEBPB;DEK
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.5441323134190461,0.9700531807757301,0.5735294117647058,1.0,1.0,1/17,1.12%,CAVIN1
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.5185436655789775,-0.9700460584710706,0.5,0.9963248818739937,1.0,2/14,8.96%,DGKD;NEU3
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),-0.6061483305218879,-0.9699437110605049,0.525,0.9961154694903707,1.0,3/7,25.91%,PLIN5;GPLD1;SORL1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),0.6212207376452541,0.9698366738291098,0.6078431372549019,1.0,1.0,2/5,5.72%,HEY2;MESP1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.45246566245810876,0.9697689401514273,0.5616438356164384,1.0,1.0,15/49,24.06%,HAMP;FRRS1;ABCG2;CP;ATP6AP1;FTH1;SLC46A1;NUBP1;CYBRD1;TF;FTL;CYB561A3;B2M;ALAS2;ATP6V0D1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.46817884594428283,0.9697129932127831,0.52,1.0,1.0,5/36,11.68%,AMBP;FOXM1;PINK1;MARVELD3;F2RL1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3851266601156375,-0.9696136843671899,0.5454545454545454,0.9965778981163003,1.0,17/70,18.11%,SPRY4;PRKCD;APOE;MEN1;SLC8A3;PTPRJ;PKIA;MYOCD;HEXIM2;SPRY1;DAB2IP;SPRY2;GADD45A;ABL1;IPO7;NF1;PRKAR2A
prerank,Reactome_2022__Reelin Signaling Pathway R-HSA-8866376,-0.6292366777055831,-0.9695924608235199,0.5882352941176471,0.996093014993259,1.0,2/5,16.91%,SH3KBP1;FYN
prerank,GO_Biological_Process_2021__plasminogen activation (GO:0031639),-0.621452096745865,-0.96948207968844,0.575,0.9957499014073893,1.0,2/6,5.48%,APOH;F11
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.47366022506668437,0.9693910431935606,0.5735294117647058,1.0,1.0,10/47,15.73%,SLFN14;FRAT1;GMFG;HEMGN;MFSD2B;FAM110A;RHOG;ITGA2B;BORCS6;FERMT3
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Myeloid Cells R-HSA-8939246,-0.6159259153139884,-0.9692018575520841,0.5142857142857142,0.9960988415673152,1.0,1/6,4.89%,CBFB
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.6638663578949665,0.9692005491931086,0.578125,1.0,1.0,2/5,16.38%,P2RY12;CSF1
prerank,Reactome_2022__InlA-mediated Entry Of Listeria Monocytogenes Into Host Cells R-HSA-8876493,0.6000659723794411,0.969165845639487,0.5483870967741935,1.0,1.0,3/8,25.70%,RPS27A;CBLL1;CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of response to food (GO:0032096),0.6378960129787657,0.9690586530373738,0.6101694915254238,1.0,1.0,4/5,36.06%,SPX;PPARA;CARTPT;LEP
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.6089747342720583,0.9688730295963606,0.5625,1.0,1.0,4/8,32.29%,AGER;GRN;EFNA1;PICALM
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.484611961095596,0.968797497776867,0.5,1.0,1.0,10/33,15.99%,TLR2;WNT5A;SYK;DDX3X;TNFSF4;F2RL1;IL7;CSF1R;ALOX15B;AGER
prerank,"Reactome_2022__Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",-0.4585682328418731,-0.9686768634682854,0.3939393939393939,0.9969270733632911,1.0,4/21,13.12%,GPRIN1;MPP2;GRIA4;LLGL1
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.543816569653419,-0.9686034704607744,0.5897435897435898,0.9966193178748798,1.0,1/10,1.29%,TYRP1
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.5910762035100657,0.9685881531684316,0.5303030303030303,1.0,1.0,1/8,2.77%,CCL5
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6094143534119512,0.9685735877399574,0.609375,1.0,1.0,1/8,6.81%,VAMP1
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.6477407996500095,0.9684662251359805,0.603448275862069,1.0,1.0,2/5,9.58%,TAPBPL;HLA-DMA
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,0.40940574084431813,0.9684162044360445,0.5714285714285714,1.0,1.0,62/169,24.42%,PWP2;RPL37A;RPL21;RPL9;RPP38;RPL18A;RPS9;RPL3;RPL36;RPL13A;EXOSC8;RPS16;RPL15;RPS5;RPS27A;RPS3A;EXOSC2;RPL41;RPP40;RPS12;RPS4X;RPL27A;NOB1;RPS19;FAU;RPS21;EXOSC4;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;WDR36;RSL24D1;RPLP2;NOL12;RPL7;RPL38;RPS15A;EMG1;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RIOK2;RPL7A;RPL23;RPS15;WDR18;RPS27;GNL3;RPL8;RPS3;SENP3;RPS23;RPS20;WDR12;RPS24
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),-0.5791908442909892,-0.968393084586577,0.6216216216216216,0.9966501227138969,1.0,4/7,22.83%,LIG3;XRCC4;MGMT;LIG1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5978054325486902,0.9683605105234003,0.5441176470588235,1.0,1.0,1/9,3.68%,SLC18A2
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.6108181335440991,-0.9678789935587614,0.5,0.9969790969480702,1.0,1/6,1.41%,GLA
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.6108181335440991,-0.9678789935587614,0.5,0.9969790969480702,1.0,1/6,1.41%,GLA
prerank,CellMarker_Augmented_2021__Purkinje cell:Undefined,0.5048295495615593,0.9678615604460401,0.5441176470588235,1.0,1.0,11/24,30.45%,GAD1;PDE5A;PRKG1;GFAP;CBLN1;MPZ;CLU;ENPP1;ITPR3;CA8;MBP
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4324683714803576,0.967843155937225,0.5569620253164557,1.0,1.0,13/79,20.47%,PSMB9;FBXL7;CDKN2A;KANK2;MYO16;CDKN1A;CDKN2C;PSMC5;FBXO5;RBX1;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),-0.6565097798936674,-0.9678409547834215,0.5531914893617021,0.9965101889435964,1.0,1/5,3.94%,ABCC4
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Keratinocytes R-HSA-8939242,-0.6091821505551867,-0.9676925312364263,0.5945945945945946,0.9963652143982539,1.0,1/6,4.89%,CBFB
prerank,CellMarker_Augmented_2021__T cell:Fetal Liver,0.4526915668946977,0.96755081143529,0.5333333333333333,1.0,1.0,17/56,14.40%,ITGB2;CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;IKZF1;TAGAP;CD37;TMC8;PSTPIP1;MYO1F;KLRB1;SIRPG;ITK;PARVG
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Peripheral Blood,-0.40331241030917964,-0.9675374348508556,0.56,0.9961922904816054,1.0,4/62,1.33%,IL7R;P2RY10;AOAH;IL16
prerank,CellMarker_Augmented_2021__Oogenesis Phase Fetal Germ cell:Fetal Gonad,0.3771267396993867,0.9675135512547987,0.6363636363636364,1.0,1.0,92/770,15.83%,NLRP4;AMBP;C19ORF38;LMOD3;ADA;DISC1;GAD1;ITIH2;SLC12A7;ACE2;GLRX;HIPK4;BCO1;EYA2;MAT2B;DNAH11;ADARB2;GNG12;CLEC4C;NLRP14;ITGBL1;BOK;COL6A6;HEY2;NLRP5;H1-0;ADAMTS17;FTCD;MESP1;MYO3B;IRF2BPL;PON1;SHD;NR2E3;PHF21B;ERBB4;PDGFRL;NLRP11;BAIAP2L1;TDRD9;GNG4;DUSP22;EI24;TTC32;WDR76;AGGF1;MEGF11;WEE2;KIAA0930;SERINC2;SSR4;CFD;MARVELD3;TRIM77;SPOCK3;CELSR1;TEKT5;STAT1;BRDT;DNAH10;EFCAB10;STAG3;RASGRF2;SH2D4A;ASGR2;CDKN1B;PADI6;PSTPIP1;ING3;DEGS2;NFKB2;FAM227B;CSF1R;USP18;CAPN12;FAM184B;CCNI;MAP3K7CL;ACOT4;PCMT1;GDF9;BCAS1;TMC3;TUBA4A;MTUS1;CRISPLD1;CATSPERD;DNAH3;NLRP2;POMZP3;LRRC40;PKD1L3
prerank,"KEGG_2021_Human__Glycine, serine and threonine metabolism",0.4991558756642655,0.9672577611786106,0.5507246376811594,1.0,1.0,9/35,18.12%,BHMT;DAO;CHDH;SDS;SDSL;PGAM1;PGAM2;GLYCTK;GRHPR
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.6035825930701515,-0.966957819407019,0.575,0.9970870782529013,1.0,1/6,4.83%,NLRP1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.41560603518962397,-0.9669175538054733,0.5,0.99671740738749,1.0,6/25,13.29%,USP36;QSOX1;LZTS1;CLEC16A;NUPR1;RUBCN
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.62588898141715,0.966896962533363,0.671875,1.0,1.0,1/6,5.45%,CAV3
prerank,Reactome_2022__Innate Immune System R-HSA-168249,0.36270882119855763,0.9668588549475956,0.6847826086956522,1.0,1.0,127/775,19.09%,NLRP4;RASGRP4;C1QB;ITGB2;MAPKAPK3;CLEC5A;PSMB9;OSCAR;C3AR1;ARHGAP9;TCN1;MGST1;AIM2;TLR2;TNFRSF1B;ITGAX;GMFG;HSPA8;PTX3;ATP6V1G2;C3;UBE2L6;PTPRC;CLEC4C;PTAFR;SNAP23;ITGAM;NFAM1;PRDX4;FCAR;PELI3;CLEC12A;FGL2;ACTG1;TRIM25;MUC17;WAS;PLD4;CD81;ANPEP;SYK;MUC4;MMP9;CHIT1;NLRC4;FLG2;GSDME;CEACAM8;ENPP4;CPB2;C4BPA;DDX3X;C4BPB;HCK;NCKIPSD;HLA-A;PLAUR;ATP6V0E2;TMC6;PLAU;NLRC3;MUCL1;TIFA;VTN;RPS27A;CASP10;BPIFB1;CD4;DEFB109B;PSTPIP1;CD63;PYGL;NFKB2;LAMP2;EEF1A1;FPR1;USP18;PDAP1;RHOG;ITM2C;ORMDL3;ARHGAP45;ITK;PSMC5;ELANE;P2RX1;CYBA;CD44;MASP2;FTH1;MASP1;ADGRE3;MAPK3;CYLD;ISG15;NDUFA2;STOM;AGER;EEF2;A1BG;RASGRP1;MUC16;DEFB135;PGLYRP2;DYNLL1;SERPINB1;UBE2M;ATP6V0B;HRNR;ATOX1;VAV3;IMPDH2;PGLYRP1;PADI2;IDH1;TXNIP;ACTR1B;LAMTOR3;HVCN1;APAF1;ATP6AP2;FTL;NFKBIA;PSMA3;CYSTM1;PLPP4;DOCK2
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.4217001837194026,0.9667956425307448,0.569620253164557,1.0,1.0,22/104,16.24%,TIMP3;PRRX1;TLR2;LMOD1;ADAM33;ABI3BP;PCDH18;MMP9;ANGPTL2;ACTA2;ADGRL4;LAMC2;COL6A2;DCN;COL1A1;DAB2;MME;DDR2;CXCL12;ELN;MYL9;CYBRD1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.4728333918945896,0.9666912504652623,0.5238095238095238,1.0,1.0,3/29,5.45%,PLEKHH2;KANK3;CAV3
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),0.6229377222953585,0.9666689852362226,0.5666666666666667,1.0,1.0,1/6,20.17%,CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.3516910316989616,-0.9666152174286607,0.5161290322580645,0.9970356594063198,1.0,10/90,11.42%,EIF2S3B;EIF5AL1;PIWIL2;JMJD4;ERBB2;UPF3A;PCIF1;AGO2;CIRBP;FXR2
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.4231437926602263,0.966407730472796,0.5921052631578947,1.0,1.0,7/75,9.53%,GML;HSPA1L;HSPA8;DNAJB1;HSPA5;COL4A6;RPA3
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.5653403802347602,-0.9664007762360005,0.525,0.9971572371175017,1.0,1/7,14.10%,PIH1D1
prerank,Reactome_2022__Regulation Of Signaling By NODAL R-HSA-1433617,0.6198875748220376,0.9662965689319041,0.6612903225806451,1.0,1.0,2/8,6.68%,DAND5;NODAL
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.4188554541026554,0.9662651346881517,0.5176470588235295,1.0,1.0,21/76,23.66%,DISC1;SP100;ARHGAP28;LEF1;IFIT1;LRPAP1;DAB2;TMC8;HMGA2;CDKN1A;PLN;TFIP11;MITD1;EFHB;NFKBIA;CTSZ;ZFPM1;BAG2;DNAJB2;KDM1A;PARK7
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.4341139902033039,-0.9662183203340198,0.5428571428571428,0.9970614390663813,1.0,3/25,6.06%,PHLDB2;F11R;SHANK1
prerank,CellMarker_Augmented_2021__Follicular T cell:Undefined,0.4303404833391926,0.9661840470705343,0.5,1.0,1.0,17/40,20.42%,CYTIP;ARHGAP9;SASH3;WAS;IKZF1;TAGAP;CD37;TMC8;PSTPIP1;SIRPG;PARVG;ZAP70;TIGIT;IRF4;TNFSF8;CD5;IL2RA
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.5804945405911731,-0.9658566327872725,0.5,0.9975050548273627,1.0,2/6,27.75%,RAD21L1;NIPBL
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.4893990943725508,0.9657077709967404,0.5428571428571428,1.0,1.0,6/38,14.84%,BHMT;CTCFL;ETFBKMT;EEF2KMT;PCMT1;METTL21C
prerank,Reactome_2022__Defective GALNT12 Causes CRCS1 R-HSA-5083636,0.5612844526766686,0.9655443959098231,0.59375,1.0,1.0,4/13,16.75%,MUC17;MUC4;MUCL1;MUC16
prerank,GO_Biological_Process_2021__negative regulation of serine-type peptidase activity (GO:1902572),-0.6107169355866154,-0.9655023584933857,0.5294117647058824,0.9981021911696114,1.0,1/5,1.40%,ANXA8
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.6210096415498613,-0.9654898479043695,0.6,0.9976072409500728,1.0,1/6,0.67%,FBP2
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.46775314437157245,-0.9654620542015383,0.4230769230769231,0.9971408001809188,1.0,1/19,0.54%,APOB
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.5340686444074033,0.9654466686665786,0.5423728813559322,1.0,1.0,1/11,1.64%,PPP1R3B
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperones R-HSA-381033,0.5516344515451819,0.965257135409347,0.5692307692307692,1.0,1.0,3/11,22.25%,HSPA5;NFYB;DDIT3
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,-0.3861662098925798,-0.965231138639959,0.5652173913043478,0.9972339684977031,1.0,4/51,8.70%,NGF;PLEKHG2;PREX1;FGD1
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),0.6538643822169093,0.9651959235765841,0.5666666666666667,1.0,1.0,2/5,16.38%,ATP6AP1;CSF1
prerank,Reactome_2022__Signal Regulatory Protein Family Interactions R-HSA-391160,0.5590798195371018,0.9651162369829404,0.5223880597014925,1.0,1.0,5/11,31.26%,SIRPG;FYB1;PTPN6;CD47;SIRPA
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.5832213668358632,0.9649854412942996,0.546875,1.0,1.0,5/9,37.12%,HERPUD1;BCAP31;SVIP;UBQLN1;UBQLN2
prerank,CellMarker_Augmented_2021__T cell:Placenta,-0.4783158723361685,-0.9649164885534749,0.4,0.9975994490045935,1.0,2/28,4.55%,P2RY10;CD247
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5257101788084092,0.9648863026439966,0.5272727272727272,1.0,1.0,1/10,6.23%,STAT5A
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),-0.6162650249520856,-0.9647949660930403,0.6097560975609756,0.9974060388261418,1.0,3/5,37.23%,NCK1;ABCA7;PTPN1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.45203780066644955,0.9646060542350532,0.5555555555555556,1.0,1.0,11/41,15.06%,TIMP3;SERPIND1;SERPINB7;SPINK6;SERPINE3;KNG1;VTN;SPOCK3;AGT;SERPINA10;SERPINB5
prerank,Reactome_2022__Interaction With Cumulus Cells And Zona Pellucida R-HSA-2534343,-0.6426429480360285,-0.9645908331351993,0.575,0.9974291373767513,1.0,2/5,9.88%,OVGP1;SPAM1
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.5848707057587867,0.9644762518357813,0.6029411764705882,1.0,1.0,1/8,2.57%,ANXA1
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,0.44318898240290605,0.9644415191170692,0.5211267605633803,1.0,1.0,11/52,25.56%,PSMB9;RPS27A;NFKB2;PSMC5;UBE2M;PSMA3;PSMB6;PSMD6;UBA3;PSMA7;PSMB1
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.537331747856272,-0.9641225333917294,0.5454545454545454,0.9981914104196269,1.0,5/7,37.60%,NCSTN;GALNT11;PSEN1;APH1B;ADAM10
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,-0.40954669616493256,-0.9641011721446406,0.44,0.9977331416579439,1.0,10/59,13.32%,CPSF1;LSM10;MAGOHB;SRRM1;SRSF4;SNRPB;SYMPK;U2AF2;CSTF2;CPSF7
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.4605166136198427,0.963983325360515,0.547945205479452,1.0,1.0,19/58,14.40%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;GMFG;SASH3;PTPRC;CXCR5;IKZF1;TAGAP;CD37;TNFSF4;CD4;GPR183;ALOX5AP;PSTPIP1;MYO1F;SIRPG;PARVG
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.47604345788359537,0.9639668418598099,0.5,1.0,1.0,7/36,17.96%,MYBPC3;AHSA1;DNAJB1;ALDOB;DYNLL1;GABARAPL2;MSH6
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.4091730129167289,0.9637483479470499,0.47368421052631576,1.0,1.0,12/89,17.46%,MCM2;MCMDC2;POLQ;MEIOB;MCM3;RAD54L;RPA3;RECQL4;RNF138;SWSAP1;BRCA1;RAD51AP2
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),0.5647513761016765,0.9637462269697653,0.5862068965517241,1.0,1.0,4/10,33.06%,RHOG;OLFM4;RHOH;RAC1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.5986140779803698,0.9636978591716164,0.6060606060606061,1.0,1.0,5/11,30.47%,HSPA5;SEC62;SEC61G;SGTB;CHMP4B
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,-0.3439527381352505,-0.9636165303504076,0.5714285714285714,0.9983342042338906,1.0,18/128,11.43%,NTSR2;SPHKAP;CDH20;PTCH1;S100B;GRIN3A;HOPX;GJB6;ELAVL3;TNR;KCNIP1;DPP6;SLITRK2;MMD2;GRIA4;PTPRZ1;ADGRA1;ADCY2
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.5388920952806212,-0.9635442344343494,0.4523809523809524,0.998029524258149,1.0,4/8,17.18%,DDAH2;ASS1;DDAH1;SLC39A8
prerank,CellMarker_Augmented_2021__1-Cell Stage Cell (Blastomere):Embryo,-0.4260060649856092,-0.9635363833499855,0.5357142857142857,0.9975233791572411,1.0,7/38,14.99%,ZSWIM3;DCLK2;GUCD1;INTS9;PPIL2;RNF10;SDCCAG8
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.5051117562005673,0.9635288631359383,0.5797101449275363,1.0,1.0,2/40,2.45%,GAD1;HSPA8
prerank,CellMarker_Augmented_2021__Vascular Endothelial cell:Placenta,0.4385398463725219,0.9634696945257951,0.5641025641025641,1.0,1.0,18/56,17.71%,C1QB;LYVE1;CYYR1;FLT1;VSIG4;MYH11;GPIHBP1;GGT5;RAMP3;ADGRL4;ZNF366;VWF;CLDN5;CSF1R;SLCO2B1;ENG;A2M;FPR3
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,0.504250454438771,0.9634341715608182,0.5714285714285714,1.0,1.0,6/21,20.56%,GNG12;GNG4;PIK3R6;PIK3CG;GNGT1;GNB4
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.49835488204192596,0.9633777637026487,0.6363636363636364,1.0,1.0,4/23,14.96%,GLRX;COX17;STAC;PDZK1
prerank,GO_Biological_Process_2021__glucocorticoid biosynthetic process (GO:0006704),0.539687523342684,0.9631946041749385,0.49019607843137253,1.0,1.0,1/7,6.98%,HSD11B2
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.39788416457106085,-0.9631769493178698,0.5,0.9981027144779999,1.0,4/39,10.14%,GCK;FOXO1;ERN1;NR1D1
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),0.6458125512685422,0.9631384296144256,0.5769230769230769,1.0,1.0,2/5,16.34%,PTGER3;HTR2B
prerank,Reactome_2022__Sensory Perception Of Salty Taste R-HSA-9730628,0.6429723562848726,0.9630049373557727,0.5178571428571429,1.0,1.0,3/5,28.50%,SCNN1A;SCNN1G;SCNN1B
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.49288838446696526,-0.9628567156530838,0.4444444444444444,0.9985632567098989,1.0,4/13,16.31%,NT5C;UPP2;DUT;NTHL1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.45228830287403315,-0.9628302887248082,0.4838709677419355,0.998120168950117,1.0,1/23,0.13%,PER2
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.29117785495054277,-0.9627324724777016,1.0,0.9978442022710916,1.0,291/1778,14.89%,PER2;RFX6;CD38;POU3F1;ETV5;NPAS4;EHF;NR4A1;TBX15;SKAP1;ZNF808;ZNF25;PRDM5;ZNF703;ZNF70;ZNF99;TEAD2;BAMBI;GFI1B;ARID3B;ZNF408;ZNF860;ETV1;OSR1;ZFPL1;GATAD2A;WNT3A;ARX;BCL6;FOS;WWC1;ZNF496;ERG;ZSCAN21;KMT2B;ZNF534;CHD4;FOXD4L5;OR7D2;ZNF777;TWIST1;IKZF4;ZNF485;CREB3L4;ZNF215;ZBTB9;MSC;ZNF773;TESMIN;JUNB;EGR1;ZNF607;ZNF514;IFI16;ASCC2;HDAC10;FOXO1;KIT;POFUT1;TWIST2;ZNF664;MLF1;CREB3L1;RFX1;ZNF133;WBP2NL;LHX2;NR4A3;ZNF48;CIART;HOPX;SMARCB1;ZNF69;BHLHA9;QRICH1;ZNF287;ZNF835;ZNF470;APOE;PIAS3;CBFB;ZNF641;SP7;WWP2;WNT7A;ZFP3;ZNF596;KLF10;PRICKLE1;THAP7;CTCF;HES1;ZNF701;NFX1;ERBB2;CARM1;FADS1;HIC2;MAP3K10;MEN1;ZNF33B;CRY1;LBH;PHC2;KDM8;ZNF845;ZNF347;SOX12;DHFR;KDM7A;ACVR1;BACH2;PAK6;ZNF623;STAT5B;ZNF239;ZNF212;SMARCAL1;FZD7;PCGF1;TGFA;CRABP2;ZNF117;TFAP2D;ZFHX4;APBB3;SPIN2B;KDM3B;ZNF75A;ATOH7;LRRFIP1;MAFG;ZSCAN12;ZNF275;PA2G4;PPARGC1B;TEAD4;PRDM15;ASCL1;ETS1;ZNF764;ZNF3;E2F6;NFATC3;ZNF316;KDM2B;IRF5;DLX1;MTERF3;NACC1;ZNF846;SNF8;TGIF1;FANK1;PHF2;FOSL1;ZNF492;SNAI2;MECP2;ZNF14;ZNF195;SAFB2;LBHD1;POU6F1;SPDEF;NIBAN2;ZNF765;EFEMP1;ZFP62;SP140;ZNF594;MLX;GTF2H2;CARF;HDAC3;NEUROD6;CTDSP1;BARX2;LDB1;RRM2;BPTF;NR1D1;SNX5;XPC;NAB2;CBY1;PEX14;MYOCD;ZMIZ1;ZNF79;MKX;NKAP;MAMLD1;GMEB1;ATF3;TFE3;CREM;NR2C1;BCL11A;HEXIM2;HMGN5;TFDP1;ZBTB7A;SFMBT1;ZNF549;ZNF16;ZNF66;WWC2;ZNF608;ZNF268;PCGF6;ZNF415;ZNF575;RLF;HSF1;ZNF501;TRIM44;PAX3;ZFAT;ZNF589;MAP3K12;ZNF611;ZNF263;IL31RA;CDK5RAP2;EPC2;DAB2IP;ZNF692;RING1;CUX1;NFIB;CAND2;YWHAQ;NEUROD2;GDF7;BAZ2A;ZNF2;ZNF586;MPHOSPH8;KCTD1;ZNF157;ATF1;GON4L;BATF2;ZNF707;VAX2;SBNO2;MYBBP1A;CRK;ZNF557;ZNF569;TLE2;ZNF135;RNF10;ZNF334;BAHD1;ZNF331;BCL11B;ZNF136;NAT14;CREB3L2;E4F1;TFCP2;ZNF28;ESRRB;HIVEP1;LANCL2;ZNF561;TCIM;RCOR2;ZNF324;BRD3;KLF8;TRIM45;SP140L;GTF2IRD1;HR;SMARCA4;THRAP3;ZNF708;TCF20;ZNF627;NR1H2;SRCAP;EBF4;CDK14;SP2;ZBTB4;PKNOX2;ZNF254;ZNF449
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.407516046242239,0.9626721813757134,0.4675324675324675,1.0,1.0,10/111,7.85%,LRP4;TRIL;TSPAN11;FBXL7;SHISA6;TMEM35A;LRRC3B;PLP1;TMEM200C;LY6H
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.607502942786659,0.9626670467870475,0.5862068965517241,1.0,1.0,2/6,11.19%,STAT5A;STAT1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.607502942786659,0.9626670467870475,0.5862068965517241,1.0,1.0,2/6,11.19%,STAT5A;STAT1
prerank,Reactome_2022__Interleukin-9 Signaling R-HSA-8985947,0.607502942786659,0.9626670467870475,0.5862068965517241,1.0,1.0,2/6,11.19%,STAT5A;STAT1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.39562854180716067,0.9622772379059091,0.5853658536585366,1.0,1.0,31/197,19.11%,NEK2;CDC25A;FBXL7;SPDYA;BORA;CRLF3;CCNG2;CDKN2A;FOXM1;CCND2;CCND1;CEP72;CEP70;CCNE2;CDKN1B;CDKN1A;CCNA2;FBXL3;CCNI;PKMYT1;CDKN2C;LATS2;TUBA4A;TPD52L1;RCC1;PHLDA1;DYNLL1;CEP76;CCNI2;MASTL;TACC3
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.418906224642599,0.9622556875291114,0.6,1.0,1.0,25/143,20.47%,LRP4;NOTUM;PSMB9;SHISA6;WNT5A;MESP1;MCC;DAB2;SFRP4;GLI3;DKK2;IGFBP6;SOX9;PSMC5;LATS2;CYLD;DKKL1;FRZB;RBX1;PSMA3;TBX18;PSMB6;DRAXIN;PTPRU;PSMD6
prerank,CellMarker_Augmented_2021__Lymphoid cell:Peripheral Blood,0.4531212918086147,0.9622455288311296,0.5405405405405406,1.0,1.0,12/65,14.40%,LINGO3;BLK;ARHGAP9;NFAM1;NAPSB;HCK;IKZF1;TAGAP;CD37;PNOC;P2RX1;PARVG
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3650138063808465,-0.9621317310841498,0.6,0.9988870684734277,1.0,3/72,5.49%,TRIB2;PLK3;PRICKLE1
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.5705414871443784,-0.9619677804681059,0.5588235294117647,0.9987913192238282,1.0,1/8,1.92%,SIGIRR
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5491284264993569,0.9618930338706722,0.5245901639344263,1.0,1.0,7/12,40.14%,RHOQ;RAB23;GNAI3;OPA1;MFN1;RAN;ENTPD7
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.6323874250647202,0.9617856754068203,0.5901639344262295,1.0,1.0,2/5,16.04%,ABCC2;SLC46A1
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),0.6370435296409419,0.9616617005147261,0.5666666666666667,1.0,1.0,3/5,26.00%,SOD2;ALAS2;HIF1A
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,0.4634147692679973,0.9616127394432041,0.5333333333333333,1.0,1.0,6/28,20.56%,GNG12;GNG4;PIK3R6;PIK3CG;GNGT1;GNB4
prerank,Reactome_2022__Reproduction R-HSA-1474165,0.43050232244032727,0.9615151445987692,0.5185185185185185,1.0,1.0,18/79,19.16%,SYCP1;KCNU1;SYNE2;SYCP3;IZUMO1;H2BC4;H2AZ1;PSMC3IP;RPA3;STAG3;SMC1B;ADAM21;CATSPERD;ARTN;BRCA1;HSPA2;HVCN1;FKBP6
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5269638048226772,0.9614854503628025,0.5571428571428572,1.0,1.0,1/15,2.00%,ACOX2
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.6030904262075549,0.9612718567053492,0.5535714285714286,1.0,1.0,6/8,32.98%,CSRP3;HTR2B;TCAP;TTN;INPP5F;RYR2
prerank,CellMarker_Augmented_2021__Astrocyte:Spinal Cord,-0.3911979355795699,-0.9612125909365237,0.6086956521739131,0.9986861925702588,1.0,16/93,11.03%,NTSR2;SPHKAP;CDH20;CPNE6;ELAVL3;TNR;DPP6;SNCB;RPH3A;HEPN1;NEUROD6;FRRS1L;TTYH1;MMD2;GRIA4;ADGRA1
prerank,CellMarker_Augmented_2021__Schwann cell:Intervertebral Disc,-0.3911979355795699,-0.9612125909365237,0.6086956521739131,0.9986861925702588,1.0,16/93,11.03%,NTSR2;SPHKAP;CDH20;CPNE6;ELAVL3;TNR;DPP6;SNCB;RPH3A;HEPN1;NEUROD6;FRRS1L;TTYH1;MMD2;GRIA4;ADGRA1
prerank,CellMarker_Augmented_2021__Glial cell:Brain,-0.3911979355795699,-0.9612125909365237,0.6086956521739131,0.9986861925702588,1.0,16/93,11.03%,NTSR2;SPHKAP;CDH20;CPNE6;ELAVL3;TNR;DPP6;SNCB;RPH3A;HEPN1;NEUROD6;FRRS1L;TTYH1;MMD2;GRIA4;ADGRA1
prerank,CellMarker_Augmented_2021__Glial cell:Sympathetic Ganglion,-0.3911979355795699,-0.9612125909365237,0.6086956521739131,0.9986861925702588,1.0,16/93,11.03%,NTSR2;SPHKAP;CDH20;CPNE6;ELAVL3;TNR;DPP6;SNCB;RPH3A;HEPN1;NEUROD6;FRRS1L;TTYH1;MMD2;GRIA4;ADGRA1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.46458301602671714,0.961131233480442,0.5342465753424658,1.0,1.0,3/50,2.89%,PCLAF;TYR;DTL
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.5011022953675361,0.9610741554915904,0.5652173913043478,1.0,1.0,2/18,10.06%,SCIN;VIL1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.5011022953675361,0.9610741554915904,0.5652173913043478,1.0,1.0,2/18,10.06%,SCIN;VIL1
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Lung,0.4393319224642894,0.9610190536741463,0.5633802816901409,1.0,1.0,15/65,12.89%,PLEKHS1;CAPN13;SFTPA1;C3;CLDN18;SCTR;SFTPD;ITGB6;DUOX1;C16ORF89;TMC4;CP;BPIFB1;ADGRG1;SLC5A1
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),-0.6412795080422266,-0.9609867741046411,0.6078431372549019,0.9986668989299987,1.0,1/5,3.72%,GRID2
prerank,KEGG_2021_Human__Prostate cancer,-0.38097527956333116,-0.9608748927976211,0.42857142857142855,0.9985093561432377,1.0,10/88,8.02%,ETV5;BCL2;ERG;PDGFD;CREB3L4;FOXO1;CREB3L1;ERBB2;TGFA;INSRR
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.5917644315865254,-0.960715833982218,0.5172413793103449,0.9983658024903878,1.0,4/6,39.09%,PDCD2;KAT7;ACE;THPO
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),-0.5943351272939308,-0.9606689229808616,0.5555555555555556,0.9978978185332475,1.0,1/6,1.67%,SLC25A29
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.3532634676094811,-0.9605357104325526,0.6153846153846154,0.997616701112969,1.0,50/223,18.94%,EFNB1;SLITRK6;SHC3;PTPRO;GFRA2;NLGN3;S100B;LAMA3;WNT7A;SPTBN4;SH3KBP1;SLIT3;PTPRA;EPHA6;PARD3;SPTB;TNR;EPHB2;NTN4;ANOS1;SLITRK2;DOK6;BSG;NIBAN2;DOK5;FGFR2;TAOK2;MAPK7;LLGL1;SLIT2;DSCAML1;GPC1;EVL;PARD6B;LRTM2;CDK5;PRKCA;LAMA2;AUTS2;PAK3;FYN;DAB1;ARHGAP35;ROBO4;SEMA4A;SEMA3C;ROBO2;BRSK1;AFG3L2;RAB10
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.6122801149727983,-0.960468592863209,0.5128205128205128,0.9973013926243173,1.0,3/6,23.22%,ST3GAL2;ST3GAL4;ST8SIA3
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.4780692980880633,0.9603853983032381,0.5,1.0,1.0,5/35,8.34%,ITGB2;ITGAM;WNT5A;REST;DDIT4
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.5287485952564779,-0.9603645776389554,0.48484848484848486,0.9971587961025793,1.0,7/14,26.43%,IGBP1;MTMR1;SMG5;PPP1R16B;SRC;SMG6;INPP5K
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4576265540059078,0.960295863819853,0.5142857142857142,1.0,1.0,3/39,9.64%,CASQ2;GPER1;TRDN
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.3953689619065217,-0.9601390966845292,0.53125,0.9972506545040885,1.0,10/57,16.62%,APOB;LIPC;APOE;ALB;SCARB1;SOAT1;LPL;NR1H2;ABCG1;PRKCA
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.3539540113982449,-0.9600782802448696,0.35714285714285715,0.9968671745271903,1.0,19/146,11.03%,NTSR2;ENTPD2;SPHKAP;CDH20;S100B;GJB6;TMEM132C;APOE;SYNDIG1;FGF1;IGSF21;ETS1;KCNIP1;NFATC3;CMTM5;HEPN1;MMD2;PTPRZ1;ADGRA1
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,-0.3955991848964613,-0.9600330955487589,0.5161290322580645,0.9964496865861477,1.0,11/37,16.33%,MYO9B;VANGL1;RAB7A;SENP1;SRGAP2;CAPZB;DIAPH2;LMNB1;ESYT1;STEAP3;MTMR1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.4550601535530798,-0.9600030527531702,0.4827586206896552,0.9959776049017766,1.0,2/25,2.79%,ADAMTS1;LSM10
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.4535606103518222,0.9599873809576608,0.49382716049382713,1.0,1.0,8/40,14.95%,WNT5A;IGF1;NLRC3;CDKN1A;AGT;BMI1;DDR2;FTH1
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,0.4029915595717639,0.9599687366158308,0.5189873417721519,1.0,1.0,14/116,20.47%,RASGRP4;PSMB9;SYK;RPS27A;ITK;PSMC5;MAPK3;RASGRP1;VAV3;NFKBIA;PSMA3;PSMB6;NFATC2;PSMD6
prerank,KEGG_2021_Human__Histidine metabolism,-0.47161328493142923,-0.9599345473531534,0.4888888888888889,0.9956848170531856,1.0,4/18,5.58%,HNMT;AMDHD1;HDC;CARNMT1
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,0.4781583524740638,0.959923530190657,0.5230769230769231,1.0,1.0,4/22,24.63%,SYK;VAV3;B2M;PIK3CB
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.4100835969185037,-0.9597709600165769,0.5769230769230769,0.9955779078803687,1.0,2/26,7.05%,CD14;TICAM2
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.485286956386936,0.9597574605110669,0.5396825396825397,1.0,1.0,2/31,3.91%,ACTL6A;CBX8
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,0.4437992524496462,0.9597264256435615,0.5571428571428572,1.0,1.0,8/60,20.47%,PSMB9;PREX2;RPS27A;USP13;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),0.6423350091357454,0.9596851303372739,0.5846153846153846,1.0,1.0,3/6,15.14%,NPR2;NPPA;GUCY2F
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.4547672195974297,-0.9595911438975855,0.48717948717948717,0.9954985895415872,1.0,4/17,8.44%,PNPLA3;AUP1;PLIN5;PLA2G4C
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.516217447432869,0.9595789871719793,0.55,1.0,1.0,3/13,24.68%,PSAP;ABCA12;ABCB1
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.38605560748019535,-0.9592888990961976,0.5172413793103449,0.9958106858048518,1.0,2/28,2.11%,BOC;KLHL41
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.5697427435800786,0.9592369945124505,0.5833333333333334,1.0,1.0,2/14,5.77%,SLC18A2;GPER1
prerank,Reactome_2022__Adaptive Immune System R-HSA-1280218,0.36329314310555033,0.9591326980386272,0.6170212765957447,1.0,1.0,68/591,17.29%,HERC3;MICB;ITGB2;PSMB9;BLK;BLNK;OSCAR;TLR2;UBE2U;FBXL7;ASB5;PIK3R3;CD160;C3;UBE2L6;ARIH2;PTPRC;SNAP23;ERAP2;ASB14;HLA-F;WAS;SH2D1B;CD81;SYK;VASP;CD80;CD99;LAIR2;HSPA5;SPSB2;HLA-A;PDCD1LG2;ASB15;TRAIP;HLA-DMA;ASB17;RPS27A;AP1M2;KIF18A;PPP2R5A;KLHL2;COLEC12;CD4;FBXL13;RNF138;KLRB1;FBXL3;ITK;PSMC5;FYB1;KBTBD7;CYBA;KLHL13;UBE3A;CRTAM;CD300LF;FBXO40;NDUFA2;KBTBD6;BTN3A3;ZAP70;RASGRP1;DYNLL1;UBE2M;BTNL9;ASB16;PRKG1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.587125447866611,-0.9590114764452838,0.5,0.9960332455066291,1.0,2/6,15.55%,APOE;ABCG1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.45075577956544277,-0.9589965357601634,0.6153846153846154,0.9950108021989336,1.0,2/22,1.33%,GCK;ENO3
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.45075577956544277,-0.9589965357601634,0.6153846153846154,0.9950108021989336,1.0,2/22,1.33%,GCK;ENO3
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),0.5836603344989912,0.9589213475931436,0.576271186440678,1.0,1.0,3/5,38.54%,VDAC1;SLC25A5;VPS13D
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,0.4054281555987128,0.9589000140892967,0.5681818181818182,1.0,1.0,35/199,14.32%,C3AR1;LPAR1;GPR55;RGSL1;ANXA1;CCL5;GNAT3;C3;GNG12;SSTR1;CASR;GPER1;PTGER3;NMUR2;HTR5A;CXCR5;ACKR4;GNG4;PPP1R1B;PDYN;KNG1;NPY1R;NPY;P2RY12;RGS21;GRM6;GPR183;GNAT2;PNOC;HTR1B;PENK;GPSM2;FPR1;OPRM1;ADCY7
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.5720470920243694,-0.9587594905387271,0.5555555555555556,0.9950484613744843,1.0,1/7,21.43%,NMD3
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.5391058628607422,0.9587550217806247,0.5362318840579711,1.0,1.0,1/11,1.24%,DISC1
prerank,Reactome_2022__Apoptosis Induced DNA Fragmentation R-HSA-140342,-0.5218842215392607,-0.9587263457317163,0.4358974358974359,0.9946204757626842,1.0,1/11,1.23%,H1-4
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.4187012163833749,0.9585982729863473,0.5421686746987951,1.0,1.0,12/96,14.41%,KIF14;STRADA;CARD14;TNFRSF10A;BORA;WNT5A;IGF1;PINK1;ECT2;PRRC1;ADCY7;IL4
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.609593687497972,0.9585592992347591,0.55,1.0,1.0,2/7,11.80%,PKP2;CTNNA3
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,-0.3821754642909523,-0.9585367545428345,0.48,0.9947130506679885,1.0,15/86,17.40%,NUP210;PIWIL2;NUP42;POM121C;NUP214;DGCR8;AAAS;AGO2;H2AJ;TNRC6C;POLR2F;NUP37;POLR2C;NUP98;TNRC6A
prerank,KEGG_2021_Human__Butanoate metabolism,0.5139690272595606,0.9584622530172525,0.5254237288135594,1.0,1.0,3/24,12.36%,GAD1;ACSM3;ACSM6
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.4610674087716932,0.9583682383752822,0.52,1.0,1.0,6/33,6.03%,BLK;SASH3;CLCF1;AHR;PTPRC;CD81
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4706620316249902,0.9583341523158476,0.6119402985074627,1.0,1.0,7/44,9.24%,TNFRSF1B;CIDEB;HIPK1;BOK;DDIT4;HIC1;MOAP1
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,0.44158032309172296,0.9583206786386353,0.5211267605633803,1.0,1.0,4/38,13.41%,AQP3;RAB11A;ARHGDIG;AQP4
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.6277553030422236,0.9582585579726127,0.6101694915254238,1.0,1.0,1/6,1.54%,GAD1
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.41804172678286744,0.9582548877590069,0.5316455696202531,1.0,1.0,21/90,19.99%,SLC9A2;SLC12A7;SLC7A7;SLC12A3;SLC38A3;SLC17A8;SLC26A6;SLC4A1;SLC15A1;SLC38A4;SLC24A1;SLC25A18;SLC7A3;SLC38A2;SLC6A12;CTNS;SLC7A10;SLC1A6;SLC26A4;SLC25A22;SLC7A11
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Undefined,0.4326113825237273,0.958228491374228,0.4634146341463415,1.0,1.0,18/74,15.72%,OLFML1;PRRX1;CASQ2;LMOD1;ADAM33;MYH11;ANGPTL2;ACTA2;ADGRL4;COL6A2;DCN;COL1A1;ASPN;SFRP4;PLN;CXCL12;ELN;MYL9
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Ascites,0.45403507519481706,0.9582048415440976,0.5,1.0,1.0,14/46,14.40%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;IKZF1;TAGAP;CD37;CD4;PSTPIP1;MYO1F;SIRPG;PARVG
prerank,CellMarker_Augmented_2021__CD4+ Regulatory T cell:Undefined,0.45403507519481706,0.9582048415440976,0.5,1.0,1.0,14/46,14.40%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;IKZF1;TAGAP;CD37;CD4;PSTPIP1;MYO1F;SIRPG;PARVG
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.572660341557331,0.9581758407999407,0.578125,1.0,1.0,3/8,21.68%,OPRM1;CHRM5;HRH4
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.47010501251640374,0.9580681935917459,0.5256410256410257,1.0,1.0,5/33,15.27%,UBE2L6;TRIM25;NLRC3;CYLD;ISG15
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,0.41550491045541726,0.9579316193022034,0.5405405405405406,1.0,1.0,6/94,8.32%,ESR1;PIK3R3;FGF20;ERBB4;CD80;KLB
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.6023697003402755,0.957798399567589,0.578125,1.0,1.0,1/5,9.46%,TRAIP
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.5164870901194294,0.9577648385842711,0.5797101449275363,1.0,1.0,3/18,17.74%,MISP;LDLRAP1;GBP1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.399739508471393,0.9576946490720519,0.5595238095238095,1.0,1.0,16/119,11.00%,GATA4;C1QTNF1;TIMP3;SLC22A3;LMOD1;MLANA;CYP26B1;HSD11B2;ANGPTL2;IGF1;COL21A1;PLAUR;ADGRL4;CFD;DCN;COL1A1
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.4655283672109826,0.9576249929982947,0.5211267605633803,1.0,1.0,7/43,11.69%,MAPKAPK3;TLR2;SFTPA1;SFTPD;TIFA;RPS27A;LACC1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.5541525726671133,0.9573335245707723,0.5517241379310345,1.0,1.0,2/14,6.80%,FGF2;ERBB4
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),0.5329046677587809,0.9573015364713087,0.5373134328358209,1.0,1.0,6/11,30.58%,STAT1;PARP9;HSP90AB1;IFNGR1;PIAS1;IFNGR2
prerank,Reactome_2022__Signaling By RNF43 Mutants R-HSA-5340588,-0.5762292927508974,-0.9572657532432928,0.5135135135135135,0.9978560915174638,1.0,1/6,1.83%,WNT3A
prerank,Reactome_2022__Metabolism Of Lipids R-HSA-556833,-0.31766191881483075,-0.9571798055126272,0.5,0.9975571821657323,1.0,100/648,14.78%,CYP1A2;MFSD2A;ACAD10;EPHX2;SYNJ2;BCHE;SEC24C;SMPD3;HACD1;ACER2;GLB1L;ELOVL6;THEM4;CRLS1;ARSL;MECR;ARSJ;SMPD4;MLYCD;STS;PNPLA3;VAC14;ACER3;LTC4S;ACBD4;SLC25A17;NEU4;PLD2;CYP7B1;SLC27A2;CPNE6;CARM1;FAAH2;DHRS7B;ARSB;OSBPL3;GPD1;ALB;HSD17B12;ACOX3;PI4KB;PTGS1;PLA2G5;PPARGC1B;B4GALNT1;PLA2G4C;CHKA;ACADS;ECHS1;NEU3;RAB5A;HDAC3;HPGD;PGS1;STARD3NL;PTGR2;ESYT3;PITPNM1;ELOVL1;NR1D1;TAFAZZIN;PEMT;CPT1A;GPX1;AKR1C3;ACOT9;MVK;SUMF2;CYP46A1;MAPKAPK2;DECR1;SOAT1;SPTSSB;PLPP2;FAM120B;ABCC1;NUDT19;OSBPL5;MED22;MTMR14;OSBPL10;LPCAT2;BDH1;PITPNM3;TMEM86B;SLC44A5;FHL2;MED25;RUFY1;MIA3;AGPAT2;MORC2;THRAP3;CSNK1G2;HSD3B2;NR1H2;OSBPL6;CROT;AGPAT5;PLD3
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.5035421209979439,0.9567444624584105,0.5657894736842105,1.0,1.0,6/17,15.41%,TGFB1;TGFB3;THBS1;WBP2;UBE3A;CATSPERD
prerank,KEGG_2021_Human__Lipid and atherosclerosis,0.3871229698653337,0.956741902326601,0.5411764705882353,1.0,1.0,13/159,9.06%,HSPA1L;TLR2;HSPA8;PIK3R3;CCL5;POU2F3;CASP7;TNFRSF10A;IL12A;MMP9;CYP2J2;HSPA5;SOD2
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.6057518193807248,0.9567223662591532,0.55,1.0,1.0,2/8,8.34%,DAO;SDS
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.4359453657455384,-0.956714267359399,0.5,0.9983381339700049,1.0,8/32,8.48%,TBC1D10A;APOH;HGFAC;IFI16;F11;PERP;PRSS3;RIPK2
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.6241869887799735,0.9566789220028455,0.6226415094339622,1.0,1.0,3/7,16.35%,HEY2;SNAI1;ENG
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,0.4066999425969295,0.9566688513428745,0.5512820512820513,1.0,1.0,25/99,25.73%,SGO1;BUB1;CENPU;ERCC6L;NDC80;KIF18A;PPP2R5A;SKA2;NUF2;SPC25;BUB1B;DYNLL1;ITGB3BP;CENPN;CENPL;CENPS-CORT;CCNB1;RPS27;CENPM;DYNLL2;CDCA5;BUB3;CDCA8;CENPO;CENPK
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),-0.3738962291793499,-0.9566211495654777,0.4583333333333333,0.9980187994525291,1.0,12/111,7.92%,ARC;CLDN4;LZTS3;PHLDB2;BCL6;SARM1;VASH1;BCL9L;ERBB2;LZTS1;ETS1;PID1
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",0.46058038021807546,0.9565761003171955,0.547945205479452,1.0,1.0,7/36,17.44%,SLC28A1;SLC28A3;SLCO1A2;SLC27A6;SLC35C1;SLCO2B1;SLC35D2
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Undefined,0.54944637440123,0.956564010529751,0.576271186440678,1.0,1.0,3/14,11.98%,IL27;STAT1;CD4
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.597680837587167,0.9564360938911423,0.6166666666666667,1.0,1.0,2/7,17.43%,UGT8;B3GALT2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.4429828407714378,0.9562706400197746,0.5925925925925926,1.0,1.0,10/67,15.85%,ROPN1B;NOX5;CEP55;RHOB;ECT2;RTKN;RASA1;ANLN;SEPTIN14;MITD1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.33672940573907706,-0.9562411587575189,0.5714285714285714,0.9985666157704324,1.0,52/202,18.08%,IFT88;CFAP221;MKS1;DCDC2;CFAP410;CNGA4;ABCC4;EXOC7;SCLT1;PARVA;PCM1;CEP83;PKD2;FLNA;CLUAP1;TTC36;TMEM138;GBF1;DZIP1L;FBF1;RILPL1;EHD4;CFAP44;ASAP1;EHD3;ABLIM3;TTC17;CEP250;RAB11FIP3;CILK1;CFAP70;TTC29;B9D1;AVIL;DNAH5;TEKT3;TRAF3IP1;CCDC57;KIF24;DYNC2I1;MARK4;CFAP61;AHI1;CEP41;CYS1;TCTN1;KIF27;ARMC9;IFT52;IFT43;IFT81;CEP290
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.547407483358534,0.9561731217545508,0.5714285714285714,1.0,1.0,1/11,5.93%,SCIN
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.44470958355700313,-0.9561354268162505,0.44,0.99824067754659,1.0,7/42,13.50%,TCOF1;TRIM71;PUM3;NANOS3;PCIF1;GEMIN5;ZC3H7B
prerank,Reactome_2022__IkBA Variant Leads To EDA-ID R-HSA-5603029,0.5911558818961187,0.955931458743364,0.5333333333333333,1.0,1.0,2/7,18.84%,NFKB2;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.4887775604301302,0.9558756729071217,0.5909090909090909,1.0,1.0,3/26,4.27%,ANGPT2;FGF2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.5511982287579333,0.9558100031503157,0.5,1.0,1.0,3/13,7.66%,TGFB1;H1-0;IGF1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.5776549550440258,0.9558068291761735,0.4406779661016949,1.0,1.0,2/6,18.35%,WNT5A;LHX6
prerank,GO_Biological_Process_2021__cellular response to vitamin D (GO:0071305),0.6844627288598079,0.9557873636554963,0.6607142857142857,1.0,1.0,2/5,29.92%,CYP24A1;VDR
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.44632680387270407,0.9556158049120588,0.5061728395061729,1.0,1.0,7/67,9.81%,LMOD3;TMOD4;LMOD1;SIX4;PGM5;CSRP3;EPB41L4A
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.5838738057450474,-0.9553855153577232,0.5,0.9992389281597165,1.0,2/8,6.19%,PDPR;GSTZ1
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.5838738057450474,-0.9553855153577232,0.5,0.9992389281597165,1.0,2/8,6.19%,PDPR;GSTZ1
prerank,Reactome_2022__Negative Feedback Regulation Of MAPK Pathway R-HSA-5674499,0.6319264249064322,0.9553757835159052,0.6078431372549019,1.0,1.0,2/5,19.63%,MAPK3;MAP2K1
prerank,CellMarker_Augmented_2021__Neuroepithelial cell:Undefined,-0.6313494694102457,-0.955366819974872,0.5526315789473685,0.9987633143521694,1.0,3/5,23.35%,HES1;NOTCH1;OCLN
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.40795492436027175,-0.9553544516756098,0.4827586206896552,0.9982745905246762,1.0,2/30,1.35%,PLK3;GFI1B
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.6061509369328805,-0.9552651584362725,0.6153846153846154,0.998058528039165,1.0,3/5,22.69%,MAPT;NTRK2;TMEM108
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.4040009324948351,-0.9551421057356623,0.4,0.997835894453206,1.0,7/32,12.03%,SPRY4;SCAI;EPHB2;STAMBP;ITGA3;SPRY1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.5763833188823608,-0.9550055966050407,0.5813953488372093,0.9975931074417952,1.0,2/5,21.80%,CEP295;CEP120
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.5069502888118589,-0.9549699268421132,0.5609756097560976,0.9971807577365261,1.0,3/11,7.48%,DRD4;ABCC4;PLA2G5
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.4609756021478973,0.9549689725995787,0.5733333333333334,1.0,1.0,13/46,16.75%,MMP19;SCUBE3;MMP9;LCP1;MMP15;NOXO1;PLG;MMP11;ELANE;CD44;TLL2;WASHC1;A2M
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.4785213538721677,-0.9549453305687877,0.4444444444444444,0.9967213198033849,1.0,3/13,9.56%,NOP9;NOP14;TBL3
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.4069932781272749,-0.9549279912717958,0.6086956521739131,0.9962216539105005,1.0,10/31,20.99%,PLEKHG2;TTBK1;COTL1;TPPP3;DBNL;PAK3;ABL1;CAMSAP3;GBA2;MAPT
prerank,"Reactome_2022__Synthesis, Secretion, And Deacylation Of Ghrelin R-HSA-422085",-0.48520815122485067,-0.9548697553411348,0.5555555555555556,0.9958513742941625,1.0,2/15,2.69%,BCHE;CRHR2
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,0.43748461329383886,0.9547448277393135,0.5352112676056338,1.0,1.0,11/53,25.56%,PSMB9;RPS27A;NFKB2;PSMC5;UBE2M;PSMA3;PSMB6;PSMD6;UBA3;PSMA7;PSMB1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.3821792701315977,-0.9547134122193811,0.4666666666666667,0.9958339644852678,1.0,5/41,11.69%,PRKCD;NRDE2;FLNA;HDAC3;EMD
prerank,CellMarker_Augmented_2021__T cell:Synovium,-0.4544533501123189,-0.9546668945464871,0.48484848484848486,0.9938637816779838,1.0,2/28,4.55%,P2RY10;CD247
prerank,CellMarker_Augmented_2021__T cell:Optic Nerve,-0.4544533501123189,-0.9546668945464871,0.48484848484848486,0.9938637816779838,1.0,2/28,4.55%,P2RY10;CD247
prerank,CellMarker_Augmented_2021__T cell:Bone Marrow,-0.4544533501123189,-0.9546668945464871,0.48484848484848486,0.9938637816779838,1.0,2/28,4.55%,P2RY10;CD247
prerank,CellMarker_Augmented_2021__T cell:Colorectum,-0.4544533501123189,-0.9546668945464871,0.48484848484848486,0.9938637816779838,1.0,2/28,4.55%,P2RY10;CD247
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.4679600516356077,0.9545444910797107,0.5,1.0,1.0,3/25,9.76%,ACOX2;HSD3B7;CYP39A1
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",0.3683025545364949,0.9545343775917009,0.6739130434782609,1.0,1.0,68/461,20.87%,NEK2;CDC25A;SGO1;PSMB9;BUB1;CENPU;FBXL7;POLE2;TK1;FKBPL;BORA;H2BC4;ERCC6L;CDKN2A;NDC80;FOXM1;CCND2;MCM3;CCND1;POLD4;LPIN3;H2AZ1;CEP72;CKS1B;RPA3;CEP70;CCNE2;RPS27A;KIF18A;PPP2R5A;SKA2;CDKN1B;CDC14A;CDKN1A;CCNA2;PKMYT1;CDKN2C;PSMC5;NUF2;TUBA4A;TUBA3D;TUBB6;MAPK3;SPC25;BUB1B;GINS1;RCC1;PHLDA1;ORC4;FBXO5;DYNLL1;NCAPG;ITGB3BP;CEP76;TUBA1C;RBX1;PSMA3;MASTL;PSMB6;CENPN;CENPL;CDC25C;PSMD6;H2AZ2;POLE3;CENPS-CORT;GMNN;SET
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,-0.3911255159034802,-0.9541095178160337,0.6190476190476191,0.9945911293885681,1.0,11/71,11.19%,APOB;PDE10A;ITPR2;TRPC3;NANOS3;SLC8A3;PPP2R5D;GNAS;TRPC6;GNB5;GNB3
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.39057068842000625,-0.9539701103786675,0.42857142857142855,0.9944663253175117,1.0,17/58,20.06%,RNF168;POLM;BRCC3;SMARCAL1;RAD50;LIG3;ERCC8;ZBTB7A;MDC1;PIAS4;NBN;DCLRE1B;ERCC1;KDM2A;XRCC4;SETMAR;ATM
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,0.47959076175516585,0.953929303295332,0.5540540540540541,1.0,1.0,7/37,14.52%,SDC2;TGFB1;ITGA2;LAMC2;VTN;THBS1;DDR2
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.5446606902541129,0.9538562120242071,0.5555555555555556,1.0,1.0,1/14,3.45%,TICRR
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),-0.5679738201966683,-0.9538523496030608,0.5813953488372093,0.9942065829801796,1.0,3/5,17.80%,CDK6;DLL1;NF1
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.5130758323438149,0.9538110849569266,0.5138888888888888,1.0,1.0,1/18,3.49%,STOML2
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.48604802716600604,-0.953769912264359,0.5263157894736842,0.9939201140572573,1.0,3/15,11.37%,BTN3A2;CD8A;JAG1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.569480763514129,0.9536980549729643,0.5588235294117647,1.0,1.0,3/14,9.36%,TRIM62;TRIM25;TRIM68
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,-0.39272850872882903,-0.9535821113783409,0.5,0.9938565767708012,1.0,8/86,3.43%,NOX4;PRKCD;BCL2;COL4A2;MMP2;SELE;EGR1;FOXO1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.5641981119136293,0.9534526074299812,0.5806451612903226,1.0,1.0,1/11,7.66%,IGF1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.5347468523640749,0.9532538533906901,0.5797101449275363,1.0,1.0,6/13,34.68%,RAET1G;TUBB4B;CEBPG;TUBB;ULBP3;CLEC2A
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.600655688655597,-0.9531646412022902,0.5833333333333334,0.9945752753762055,1.0,5/7,35.58%,IVD;HMGCL;BCAT1;BCAT2;MCCC1
prerank,Reactome_2022__CD28 Dependent Vav1 Pathway R-HSA-389359,0.5399002029128094,0.9530941398891141,0.5892857142857143,1.0,1.0,1/11,6.90%,CD80
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.5801408072652233,-0.9530891045286233,0.5897435897435898,0.9942284103644766,1.0,2/6,14.69%,FOXO1;EIF2AK3
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),0.403637615787885,0.953015314336499,0.55,1.0,1.0,13/84,15.29%,PLA2G10;TLR2;PTPRC;IFIT1;DDIT4;IRF1;AGBL5;STAT1;F2RL1;OAS2;EXOSC4;ISG15;IFI6
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.394857325031339,-0.9529773565253647,0.56,0.9940503033776371,1.0,8/50,10.06%,SLC16A9;SLC38A5;SLC25A29;SLC6A20;SLC6A17;SLC3A2;SLC7A5;SLC15A4
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,0.4837265896094668,0.9527722568601796,0.6153846153846154,1.0,1.0,5/22,21.53%,TLR2;RPS27A;MAPK3;DUSP16;B2M
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.40382091761311334,0.9527648432393656,0.5616438356164384,1.0,1.0,12/92,20.47%,PSMB9;CLEC4C;MUC17;SYK;MUC4;MUCL1;PSMC5;MUC16;PSMA3;PSMB6;RPS6KA5;PSMD6
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.40382091761311334,0.9527648432393656,0.5616438356164384,1.0,1.0,12/92,20.47%,PSMB9;CLEC4C;MUC17;SYK;MUC4;MUCL1;PSMC5;MUC16;PSMA3;PSMB6;RPS6KA5;PSMD6
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.40382091761311334,0.9527648432393656,0.5616438356164384,1.0,1.0,12/92,20.47%,PSMB9;CLEC4C;MUC17;SYK;MUC4;MUCL1;PSMC5;MUC16;PSMA3;PSMB6;RPS6KA5;PSMD6
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.4811045601722642,0.9526754010927502,0.5507246376811594,1.0,1.0,4/31,8.95%,HIPK1;BOK;DDIT4;TP53BP2
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.5135380935914633,-0.9526118825024679,0.5625,0.9946331251740453,1.0,3/10,6.25%,BCL6;HLA-DRA;SOX12
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.5900704644152703,-0.9522276772451377,0.575,0.9949529166844778,1.0,1/5,1.67%,SLC25A29
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.5263080948431162,0.9522077667331187,0.6029411764705882,1.0,1.0,4/15,19.13%,ANXA1;NDUFS2;METTL14;GCM2
prerank,CellMarker_Augmented_2021__Neuron:Spinal Cord,-0.35700456700112715,-0.9521710536009407,0.7142857142857143,0.994572954766335,1.0,25/97,24.94%,SHC3;CAP2;DCLK2;WASF3;TAGLN3;PTPRZ1;ATP9A;BRINP1;LRRTM3;ADGRL2;ARNT2;DDAH1;RBFOX2;MAPK4;EPB41L1;STXBP1;MAP6;MARK1;CRMP1;NLGN1;MPDZ;ATRNL1;SNAP91;NUAK1;PLPPR4
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.509641550031065,0.951966374038068,0.5538461538461539,1.0,1.0,3/16,6.84%,HAMP;CAV3;MMP9
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.44363050751499183,-0.9519246715981995,0.5769230769230769,0.9947781747704344,1.0,2/23,1.33%,GCK;ENO3
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),0.5850413080576595,0.9519232729504832,0.6111111111111112,1.0,1.0,2/5,9.57%,LCP1;IL5
prerank,Reactome_2022__FRS-mediated FGFR1 Signaling R-HSA-5654693,0.5526061390580751,0.9518621916571597,0.5294117647058824,1.0,1.0,1/19,2.58%,FGF20
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.42179426904230805,-0.9517986294080938,0.5714285714285714,0.99452634658095,1.0,12/25,17.05%,GPC6;OVGP1;GPC2;SDC3;GPC4;AGRN;IDUA;HGSNAT;GUSB;GPC1;SDC4;FUCA1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.5778288115913665,0.951639442802489,0.6231884057971014,1.0,1.0,3/11,14.49%,VIL1;F2RL1;CARMIL1
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),0.613569510498988,0.9514820293319524,0.5238095238095238,1.0,1.0,1/5,3.48%,TRIM62
prerank,CellMarker_Augmented_2021__T cell:Kidney,-0.4452199627849773,-0.9509157972212797,0.43333333333333335,0.9963496008731175,1.0,2/29,4.55%,P2RY10;CD247
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreatic Acinar Tissue,0.4330832409145796,0.9508694581281859,0.52,1.0,1.0,18/58,16.47%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;IKZF1;TAGAP;CD37;TMC8;GPR183;ALOX5AP;PSTPIP1;MYO1F;PARVG;PIK3CG;CD244;ZAP70
prerank,CellMarker_Augmented_2021__Definitive Endoderm cell:Germ,0.4330832409145796,0.9508694581281859,0.52,1.0,1.0,18/58,16.47%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;IKZF1;TAGAP;CD37;TMC8;GPR183;ALOX5AP;PSTPIP1;MYO1F;PARVG;PIK3CG;CD244;ZAP70
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreatic Acinar Tissue,0.4330832409145796,0.9508694581281859,0.52,1.0,1.0,18/58,16.47%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;IKZF1;TAGAP;CD37;TMC8;GPR183;ALOX5AP;PSTPIP1;MYO1F;PARVG;PIK3CG;CD244;ZAP70
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,0.40863683383855176,0.950842050758915,0.6103896103896104,1.0,1.0,15/92,19.67%,GML;HSPA1L;HSPA8;DNAJB1;HSPA5;COL4A6;RPA3;EEF1A1;MAPK3;FKBP4;HSPH1;HSPA4;HSPA2;BAG5;BAG1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.5779011155443408,0.9507059617968033,0.6363636363636364,1.0,1.0,2/11,5.31%,LRP4;WNT5A
prerank,Reactome_2022__Transport Of Gamma-Carboxylated Protein Precursors From Endoplasmic Reticulum To Golgi Apparatus R-HSA-159763,0.6269894190218297,0.9505512528295832,0.640625,1.0,1.0,3/7,11.87%,PROZ;F7;FAM110A
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Undefined,-0.602226146639736,-0.9504977176810321,0.6666666666666666,0.9969428149836709,1.0,2/5,11.31%,SLC17A6;GRIN1
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.5664970617518506,-0.9503688795755807,0.575,0.9969048940293417,1.0,2/7,3.12%,PM20D1;TST
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.4329991110945105,-0.9502243870885954,0.44,0.9967195223514317,1.0,4/36,4.30%,ZNF703;BAMBI;TWIST1;BCL9L
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.563471623846794,0.950157066894233,0.5555555555555556,1.0,1.0,4/11,20.67%,RNFT1;USP13;HERPUD1;AQP11
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.37152496001889396,-0.9500404043796863,0.5263157894736842,0.9955755285637243,1.0,10/58,16.90%,SEC24C;PPP6R1;TGFA;TRAPPC9;STX5;PREB;CNIH3;TRAPPC1;ANKRD28;F5
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.37152496001889396,-0.9500404043796863,0.5263157894736842,0.9955755285637243,1.0,10/58,16.90%,SEC24C;PPP6R1;TGFA;TRAPPC9;STX5;PREB;CNIH3;TRAPPC1;ANKRD28;F5
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.37152496001889396,-0.9500404043796863,0.5263157894736842,0.9955755285637243,1.0,10/58,16.90%,SEC24C;PPP6R1;TGFA;TRAPPC9;STX5;PREB;CNIH3;TRAPPC1;ANKRD28;F5
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.48529812745338063,0.9499505812424831,0.5151515151515151,1.0,1.0,4/22,12.92%,AIM2;REST;HTR1B;CRHBP
prerank,Reactome_2022__Ligand-receptor Interactions R-HSA-5632681,-0.5889114293434654,-0.949601154040322,0.5555555555555556,0.9961940518134711,1.0,2/6,2.59%,BOC;PTCH1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.4133412405319993,0.9495604029419257,0.5,1.0,1.0,26/64,20.42%,ITGB2;CYTIP;TNFRSF1B;CCL5;SASH3;PTPRC;HLA-F;NT5E;TAGAP;HLA-DPB1;CD4;GPR183;ALOX5AP;PSTPIP1;KLRB1;SIRPG;ITK;PARVG;ZAP70;MAF;TIGIT;ITGB8;TNFSF8;CD5;IL1R1;IL2RA
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.6288801835101855,0.9495444645487725,0.6140350877192983,1.0,1.0,1/6,5.33%,SEMA3A
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.4810225525959368,0.9495232951655412,0.5797101449275363,1.0,1.0,4/34,7.79%,ANXA1;CERS3;WNT5A;FLG
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),-0.5544417908383887,-0.9494295141229869,0.5909090909090909,0.9960964595181767,1.0,4/5,36.87%,CTU1;URM1;TRMU;CTU2
prerank,CellMarker_Augmented_2021__Decidual cell:Blood,0.4188541950444919,0.9493876194240877,0.5802469135802469,1.0,1.0,7/83,5.53%,APOL1;ANXA1;SP100;SH3TC1;AHR;C3;HLA-F
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.5147938810828425,-0.9493758045688492,0.5897435897435898,0.9956648105095864,1.0,5/14,17.24%,KMT5C;SLC15A4;SHLD2;MAD2L2;SHLD1
prerank,Reactome_2022__Glucocorticoid Biosynthesis R-HSA-194002,0.5681221030788725,0.9491811332119746,0.5227272727272727,1.0,1.0,3/6,25.71%,HSD11B2;CYP21A2;CYP17A1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.5962599125893707,0.9491125564505336,0.5932203389830508,1.0,1.0,1/9,2.57%,ANXA1
prerank,Reactome_2022__Synthesis Of Lipoxins (LX) R-HSA-2142700,0.5906648926132625,0.949038158073201,0.5692307692307692,1.0,1.0,3/6,12.45%,ALOX12;PTGR1;ALOX5AP
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),0.5906648926132625,0.949038158073201,0.5692307692307692,1.0,1.0,3/6,12.45%,ALOX12;PTGR1;ALOX5AP
prerank,KEGG_2021_Human__Human papillomavirus infection,0.3669208705638718,0.948859120078589,0.5795454545454546,1.0,1.0,45/281,15.72%,WNT8B;TCF7;PIK3R3;ATP6V1G2;ITGA2;COL6A5;COL6A6;HEY2;WNT5A;ITGB6;HLA-F;COL4A4;TBPL1;COL4A3;ITGA5;CCND2;WNT8A;CCND1;IRF1;COL4A6;COL4A5;HLA-A;PPP2R3A;ATP6V0E2;LAMC2;COL6A2;FZD8;VWF;VTN;CCNE2;COL1A1;STAT1;ATP6AP1;PPP2R5A;WNT6;CDKN1B;CDKN1A;THBS1;CCNA2;TCF7L1;ITGA2B;UBE3A;MAPK3;ISG15;WNT5B
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.5338471510228892,0.9487267775232323,0.5538461538461539,1.0,1.0,1/13,1.29%,RORC
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.36466418996969047,-0.9486930914498571,0.5652173913043478,0.9968901735857738,1.0,10/58,13.29%,MFSD2A;BCL2;NRDE2;PLIN5;NUPR1;DAB2IP;TIMP1;MTMR8;KLHL22;RUBCN
prerank,Reactome_2022__LTC4-CYSLTR Mediated IL4 Production R-HSA-9664535,0.646174169486953,0.9486836677797686,0.5714285714285714,1.0,1.0,1/5,7.31%,GGT5
prerank,CellMarker_Augmented_2021__Kupffer cell:Liver,0.6111887799910283,0.9486170473716167,0.5217391304347826,1.0,1.0,3/6,5.09%,ITGB2;ITGAM;VSIG4
prerank,Reactome_2022__Suppression Of Apoptosis R-HSA-9635465,0.6022758657867815,0.9485962855321768,0.6,1.0,1.0,4/5,36.07%,MAPK3;RNF213;GSK3A;MAPK1
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,0.4533274972673389,0.948367755060101,0.6086956521739131,1.0,1.0,7/47,15.35%,UBE2L6;H2BC4;H2AZ1;CALB1;RPS27A;NPPA;TGFBI
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,0.40924196474860514,0.9480622690765478,0.5822784810126582,1.0,1.0,13/103,8.51%,C1QTNF1;GPHB5;GNAT3;GPR27;GNG12;TSHR;SCTR;GPER1;ITGA5;ADRB1;RAMP3;GNG4;RXFP2
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),0.6273673791926566,0.947953726518662,0.5806451612903226,1.0,1.0,2/5,25.18%,ALOX5;GRN
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",0.5097678690380246,0.94787855194528,0.5238095238095238,1.0,1.0,1/16,3.20%,GNAT3
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.3948759081024648,-0.9478201223933015,0.5384615384615384,0.9987618551474844,1.0,14/55,15.48%,ACAD10;MECR;CYP4V2;SLC25A17;SLC27A2;ECHDC2;ACADS;ECHS1;PEX13;DECR1;ADH4;CROT;EHHADH;ACSM1
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Umbilical Cord Blood,0.40643468093981777,0.9477620627138481,0.5512820512820513,1.0,1.0,23/88,17.95%,MGST1;ANXA1;ERAP2;CLEC12A;ASPM;MAMDC2;HGF;NQO1;CSF3R;CP;CCNE2;USP13;TTK;PYGL;IGLL1;ELANE;NUF2;KCNE3;DENND10;RMI2;SERPINB1;M1AP;ZFP37
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.3716483591579468,-0.9477261615685056,0.5416666666666666,0.9984562760147324,1.0,7/51,11.11%,PLK3;FOS;APOE;PKD2;MPV17;GPX1;AKR1C3
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.44071317661677645,-0.9474557325689432,0.42857142857142855,0.9986378717543333,1.0,7/22,12.71%,ADCYAP1;PDE7B;ADGRG6;CAP2;ADCY2;PDE3A;MAPK7
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),0.6027404643935932,0.9473463813276923,0.5185185185185185,1.0,1.0,1/6,1.49%,PKP2
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.5814268120010937,0.9472436677597728,0.5522388059701493,1.0,1.0,1/6,8.49%,DDX3X
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.44234310271101085,-0.9472182282399983,0.4642857142857143,0.9987926156549178,1.0,3/27,5.44%,GPC6;GPC2;GPC4
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.5131044555866371,-0.9472035593311057,0.6111111111111112,0.9983209373584266,1.0,3/11,7.48%,LTC4S;FADS1;PLA2G5
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.475627966843819,-0.9471841093102462,0.5454545454545454,0.9978297716494579,1.0,3/18,7.60%,OSR1;PTCH1;PKD2
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.48717699339944565,0.9469589915899337,0.4782608695652174,1.0,1.0,2/22,11.00%,RPA3;RPS27A
prerank,Reactome_2022__Hemostasis R-HSA-109582,0.36570688634863474,0.9468834432856832,0.6630434782608695,1.0,1.0,81/477,17.55%,GATA4;ITGB2;TIMP3;GP1BA;SDC2;ITGAX;PIK3R3;GNAT3;ANGPT2;SLC7A7;SLC16A8;GNG12;TRPC7;TGFB1;CD99L2;ITGAM;JCHAIN;TNFRSF10A;MANF;ITGA2;SERPIND1;JAM2;SYK;IRAG1;ITGA5;CD99;IGF1;F8;GNG4;CEACAM8;HSPA5;IRF1;DOCK6;KNG1;PLAUR;F7;P2RY12;RHOB;TGFB3;PLAU;VWF;PSG8;KIF18A;PPP2R5A;FAM110A;EPCAM;PDE5A;PSG11;SELENOP;CD63;DOCK5;THBS1;LAMP2;IGLL1;SIRPG;RHOG;ITGA2B;PLAT;PLG;P2RX1;CARMIL1;ITIH4;CD44;TUBA4A;MAPK3;PIK3R6;PROCR;FERMT3;PIK3CG;EHD2;CD244;BCAR1;A1BG;RASGRP1;SLC16A1;SLC16A3;TSPAN7;MYB;PRKG1;VAV3;TFPI
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.33622551142618434,-0.9468197022414946,0.4666666666666667,0.9982642227031279,1.0,36/172,16.49%,ADGRG3;PDE10A;SPRED1;DGKD;BCL2;WWC1;TWIST1;CCDC22;THEM4;HDAC7;DLG5;MINAR1;OTUD3;PTPRJ;PRDM15;CCN3;STAMBP;NR1D1;WWC2;PDE3A;DAB2IP;NLRX1;NPRL2;ARRB2;SLIT2;EPM2A;DEPTOR;RNF157;CDC34;MCL1;PDE3B;VGLL4;OTUD7A;TMEM127;USP10;PER1
prerank,PanglaoDB_Augmented_2021__T Cells Naive,0.45420554945495545,0.9467206742294992,0.5972222222222222,1.0,1.0,18/51,16.47%,ITGB2;CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;IKZF1;TAGAP;CD37;CD4;ALOX5AP;PSTPIP1;KLRB1;SIRPG;PARVG;CD244;ZAP70
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.48373169701959456,0.9467117503991137,0.5833333333333334,1.0,1.0,9/26,15.99%,TLR2;WNT5A;TNFSF4;F2RL1;IL7;CSF1R;ELANE;ALOX15B;AGER
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,0.42469760517092564,0.9465808826606723,0.5616438356164384,1.0,1.0,1/51,0.39%,COX6A1
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.5234110162921083,-0.9465220150797458,0.42857142857142855,0.9986117475308269,1.0,2/10,5.56%,H1-4;CTCF
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.6466623890821916,0.9463324924407003,0.6607142857142857,1.0,1.0,1/5,7.67%,LEF1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.5345032399521287,0.946248376376827,0.59375,1.0,1.0,2/12,11.07%,NODAL;DAB2
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,0.41739642674290034,0.9461298394486218,0.5733333333333334,1.0,1.0,13/91,17.41%,SGO1;BUB1;CENPU;ERCC6L;NDC80;KIF18A;PPP2R5A;SKA2;NUF2;SPC25;BUB1B;DYNLL1;ITGB3BP
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.47125683632172943,-0.946030689452849,0.5428571428571428,0.9992514489020147,1.0,7/15,17.13%,PNP;NT5C1A;NT5C;GPX1;DNPH1;SAMHD1;ITPA
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),0.6415812848635845,0.9460230317025902,0.5223880597014925,1.0,1.0,1/5,3.98%,HIPK1
prerank,Reactome_2022__Calcitonin-like Ligand Receptors R-HSA-419812,0.6089746087975781,0.9460170599823394,0.5833333333333334,1.0,1.0,3/6,20.30%,RAMP3;CALCR;CALCB
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.45772352678348277,0.9459575626276925,0.5844155844155844,1.0,1.0,13/46,16.75%,MMP19;SCUBE3;MMP9;LCP1;MMP15;NOXO1;PLG;MMP11;ELANE;CD44;TLL2;WASHC1;A2M
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,0.4343838260899091,0.945842869571088,0.5405405405405406,1.0,1.0,15/81,12.41%,AQP3;ESR1;CAPN13;ANXA1;WNT5A;ITGB6;MISP;ANPEP;EPN3;TMC4;TRIM29;LAMC2;AP1M2;EPCAM;BTG1
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,-0.33379385896058533,-0.9458078090771894,0.5714285714285714,0.9993588788383823,1.0,12/124,10.58%,NGF;SMPD3;CFLAR;CLIP3;PLEKHG2;PREX1;USP4;NSMAF;RIPK2;FGD1;HDAC3;SHARPIN
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,0.45243128108724195,0.9456780475928752,0.5121951219512195,1.0,1.0,9/36,20.56%,KCNJ15;GNAT3;GNG12;GNG4;ADCY7;KCNJ2;KCNJ4;GNGT1;GNB4
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.49142287693057335,0.945606319323135,0.5915492957746479,1.0,1.0,5/29,20.17%,CD160;CD81;GBP1;RAB29;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.4666198686032496,-0.945553871456741,0.5384615384615384,0.9995791061387485,1.0,3/20,5.31%,PPP1R14D;BOD1L1;STYXL1
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),0.5663316249519412,0.9453411336002274,0.6346153846153846,1.0,1.0,3/7,20.67%,SCTR;AQP4;AQP11
prerank,Reactome_2022__Beta-oxidation Of pristanoyl-CoA R-HSA-389887,0.5767180943612358,0.9452071884600195,0.6323529411764706,1.0,1.0,1/9,2.00%,ACOX2
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.6394727399744771,0.9450828175542282,0.55,1.0,1.0,3/5,31.77%,THBS1;NOS1AP;VEGFA
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.42748795745540535,-0.9449796002786123,0.5151515151515151,1.0,1.0,7/23,13.20%,ST3GAL3;B4GALT2;ST3GAL2;CHST6;PRELP;B4GALT4;ST3GAL4
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,-0.42748795745540535,-0.9449796002786123,0.5151515151515151,1.0,1.0,7/23,13.20%,ST3GAL3;B4GALT2;ST3GAL2;CHST6;PRELP;B4GALT4;ST3GAL4
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.48394257733904994,-0.9449694418808513,0.6060606060606061,0.9995951785866357,1.0,7/18,22.73%,CUX1;DBNL;LRP8;CUX2;CUL7;DHX36;SS18L2
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.5828971439582513,-0.9449556278137802,0.5862068965517241,0.999105637167885,1.0,2/7,13.19%,CX3CR1;CARD9
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,-0.3349645187046297,-0.944785719427339,0.6111111111111112,0.9990273225628953,1.0,13/84,9.86%,COL22A1;COL6A3;COL4A2;COL12A1;LOXL1;COL13A1;COL8A1;CD151;ADAMTS3;ITGB4;MMP28;P3H1;P3H3
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.354252615532928,-0.9447386697979692,0.5454545454545454,0.9986908648362767,1.0,24/92,14.57%,ST3GAL3;CHPF2;GSTT2B;UST;PAPSS2;GSTM5;GSTZ1;B4GALT2;CHST11;GSTK1;ST3GAL2;CHST12;CHSY1;CSGALNACT1;VCAN;CHAC1;CHST6;PRELP;B4GALT4;GSTO2;ST3GAL4;CHST3;CBS;CSPG5
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.5959792135994615,-0.9446174034033965,0.6041666666666666,0.9985003436524513,1.0,1/5,12.71%,MAPK7
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.4483304796996616,-0.9446000014609165,0.48148148148148145,0.9980189894378353,1.0,5/30,7.54%,PRKCD;TCOF1;PUM3;NANOS3;PCIF1
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.5091352333108856,0.9445970599285692,0.5211267605633803,1.0,1.0,1/16,1.24%,DISC1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.4826269880464645,0.9445464820067664,0.5774647887323944,1.0,1.0,4/26,11.63%,HLA-F;IL12A;HLA-A;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.5769044881633182,-0.9443915802391332,0.5588235294117647,0.9980868354320815,1.0,3/5,32.81%,MAPT;PRKAA2;TPPP
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.5859314630330287,0.943992775434994,0.6363636363636364,1.0,1.0,4/7,27.40%,MOGAT1;MOGAT2;DGAT2;PNPLA2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.5699352787801675,-0.9439079355897594,0.5609756097560976,0.9987823236067663,1.0,1/7,13.44%,CTPS2
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.5309816082943523,0.943800561378203,0.5483870967741935,1.0,1.0,1/15,2.57%,ANXA1
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.48597113678864956,0.9436226387546466,0.6190476190476191,1.0,1.0,1/17,1.54%,GAD1
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.4832032696592504,0.9433436543414223,0.5694444444444444,1.0,1.0,11/28,27.81%,CCDC39;ODAD1;ZMYND10;DNAI1;ODAD2;CCDC63;ODAD3;DNAH8;DRC1;DNAAF2;DNAAF3
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.4341793241122198,0.9430388672476802,0.5909090909090909,1.0,1.0,9/72,8.34%,ITGB2;KIF14;TNFRSF1B;CCL5;ITGAM;WNT5A;HLA-F;REST;DDIT4
prerank,Reactome_2022__FGFR1c Ligand Binding And Activation R-HSA-190373,0.5802750139688403,0.942941573631505,0.6071428571428571,1.0,1.0,1/10,2.58%,FGF20
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,0.4618434063953954,0.9429258199253061,0.6338028169014085,1.0,1.0,4/32,9.76%,ACOX2;HSD3B7;NR1H4;CYP39A1
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.40747575587562723,-0.9428517868088128,0.5675675675675675,1.0,1.0,3/25,5.98%,P2RY10;PRAG1;F11R
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.5083720098954221,0.9427197574825079,0.5652173913043478,1.0,1.0,3/22,12.94%,PFKFB2;IGF1;PRXL2C
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.5354487764748008,0.9427119006017453,0.5846153846153846,1.0,1.0,5/14,25.07%,TGFB1;DDR2;FGFR4;DDR1;DPP4
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,0.5152940757283415,0.9427060871294489,0.589041095890411,1.0,1.0,4/16,28.30%,RPS27A;MAP2K1;MAP2K4;MAP3K8
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.5054969413798962,0.942611696452156,0.5373134328358209,1.0,1.0,3/18,15.23%,LCP1;FHOD1;RHOQ
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.5495431232133865,0.9424585269913417,0.5671641791044776,1.0,1.0,3/12,18.72%,PHF23;PINK1;FEZ1
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.4807503607657433,0.94244895732274,0.5205479452054794,1.0,1.0,7/20,27.30%,CCDC39;TEKT5;DNAH3;DNAH8;DRC1;DNAAF2;DNAH2
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.4865104823423461,0.9422981826605823,0.5753424657534246,1.0,1.0,5/20,13.21%,ALOX12;PTGR1;GGT5;ALOX5AP;ALOX15
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.5225798245599221,0.9422028936128412,0.5862068965517241,1.0,1.0,2/19,8.50%,RENBP;NANS
prerank,KEGG_2021_Human__Cholesterol metabolism,-0.4075545474763383,-0.9421139130165704,0.5806451612903226,1.0,1.0,4/41,4.78%,APOB;LIPC;APOH;APOE
prerank,Reactome_2022__PD-1 Signaling R-HSA-389948,-0.5381910258932876,-0.9419992808884138,0.5238095238095238,1.0,1.0,3/12,5.65%,CSK;CD247;HLA-DRA
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),0.6708978477471664,0.9419954873174797,0.6785714285714286,1.0,1.0,1/6,5.18%,MYH11
prerank,Reactome_2022__Defective Factor VIII Causes Hemophilia A R-HSA-9662001,0.5843471708488706,0.9419800669394868,0.65,1.0,1.0,3/6,11.87%,F8;VWF;FAM110A
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.4618164375965475,0.9419792522069963,0.5396825396825397,1.0,1.0,5/29,15.27%,TLR2;IRF1;DDX3X;OAS2;ISG15
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.49034353103329076,0.941965182070874,0.5757575757575758,1.0,1.0,3/13,15.72%,DAAM2;SFRP4;WNT5B
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.5255095510104517,0.9418104451163604,0.5733333333333334,1.0,1.0,1/17,0.98%,PLA2G10
prerank,KEGG_2021_Human__Prolactin signaling pathway,0.42121156237796664,0.9417746103255957,0.5522388059701493,1.0,1.0,8/57,11.19%,ESR1;PIK3R3;STAT5A;SOCS2;CCND2;CCND1;IRF1;STAT1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.5469060960043907,0.941721069785459,0.5230769230769231,1.0,1.0,3/9,32.17%,YOD1;DERL2;SVIP
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.49348918071645964,-0.9415977950812048,0.47058823529411764,1.0,1.0,1/14,1.53%,BCL2
prerank,CellMarker_Augmented_2021__Progenitor cell:Breast,0.6292323824270752,0.941588687318363,0.640625,1.0,1.0,2/6,14.71%,EPCAM;CD44
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.4766193080098448,0.9415684787324917,0.5303030303030303,1.0,1.0,3/25,7.59%,CASQ2;CAV3;KCNS2
prerank,CellMarker_Augmented_2021__Gonadal Endothelial cell:Fetal Gonad,0.3726136207725452,0.9414939628035339,0.6444444444444445,1.0,1.0,42/414,12.64%,CLIC1;TIMP3;S100A13;BUB1;SLC12A7;FBXL7;SP100;TMEM204;ITM2A;SH3TC1;NID1;CYYR1;MAP3K11;TSPAN4;LMO2;TRAF3IP2;ELK3;IRF2BPL;IGF2BP2;CYP26B1;ANGPTL4;TP53I3;DIMT1;GGT5;ITGA5;ARHGAP28;CCND1;CDK2AP1;CKS1B;FBLIM1;RAPGEF6;COL6A2;PIEZO2;ID1;NT5DC2;LPAR6;DAB2;STON2;HMGA2;RTKN;TRMT10A;PDK4
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,0.3816096784253464,0.9414345197208699,0.5529411764705883,1.0,1.0,49/161,25.85%,TLR2;NLRP12;DDX20;SFTPD;HLA-F;TRIM25;HLA-A;RPS9;RPS16;GEMIN4;RPS5;RPS27A;RPS3A;STAT1;VPS18;RPS12;RPS4X;SNRPD2;RPS19;FAU;RPS21;MASP2;MASP1;ISG15;RPS11;RPS13;RPS7;YWHAH;RPS15A;G3BP1;RPSA;RPS6;IFIH1;RPS14;B2M;RPS15;YWHAG;TKFC;RPS27;RPS3;RPS23;RPS20;RPS24;IRAK1;SEC23A;RPS29;HSP90AB1;SEC24D;RPS28
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.6015644824644464,0.9414175730826523,0.6507936507936508,1.0,1.0,2/8,10.10%,OGN;OMD
prerank,CellMarker_Augmented_2021__Glial cell:Undefined,0.5287368821881911,0.9414022137285206,0.6417910447761194,1.0,1.0,2/13,4.37%,PTPRC;ITGAM
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5697519494799598,0.9412589781120433,0.6056338028169014,1.0,1.0,4/9,23.44%,DNAJB1;HSPA2;BAG5;DNAJB2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.41168884613289053,0.9411567287338272,0.5662650602409639,1.0,1.0,26/102,21.82%,TRIL;TSPAN11;SLC18A2;SHISA6;SOX10;PLP1;DAAM2;RAMP3;PPP1R1B;TCEAL5;DHRS3;AQP4;RXRG;ZNF536;EDNRB;CNTN2;TSPAN7;NOS2;FRZB;GFAP;ID4;PHYHIP;L1CAM;CRTAC1;APOD;SCN4B
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.48175969606472546,-0.9410938387374824,0.5,1.0,1.0,2/11,10.77%,SHANK1;CHRNA1
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.5502874121100871,-0.9410451842884627,0.5526315789473685,1.0,1.0,3/12,27.57%,SEC14L2;H6PD;MBTPS2
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.49840531111497655,0.9410190990360381,0.6153846153846154,1.0,1.0,2/20,3.51%,SP100;FGF2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.4553459613341082,0.9409935601649906,0.5846153846153846,1.0,1.0,5/41,11.19%,ANXA1;GPER1;STAT5A;EIF6;STAT1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.36141808722585006,-0.9409890313785457,0.5263157894736842,1.0,1.0,16/87,12.87%,DRD4;TYRO3;TIE1;KIT;VAC14;ERBB2;EPHA6;NTRK1;RAD50;EPHB2;INSRR;LDB1;ZNF16;RBL1;FGFR2;NPRL2
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Bone Marrow,-0.37236845279351294,-0.9408950066586489,0.6470588235294118,1.0,1.0,19/91,9.40%,FIBIN;ADAMTS12;PAMR1;CALD1;COL4A2;COL12A1;MMP2;FRMD6;SYNPO;ARSJ;RND3;SERPINE2;PARVA;FGF1;FSTL1;NTN4;SERPINE1;SNAI2;EFEMP1
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.5382765890507045,0.9406724924673714,0.5538461538461539,1.0,1.0,1/11,3.51%,FGF2
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,0.4107578178113439,0.9405378968261059,0.6233766233766234,1.0,1.0,13/94,20.52%,PSMB9;ABCC6;ABCC2;ABCC11;RPS27A;PSMC5;ABCG5;SEL1L;PSMA3;PSMB6;KCNJ11;PSMD6;ABCA12
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.4445182224898105,0.940483790551277,0.5492957746478874,1.0,1.0,12/42,19.88%,SP100;HLA-F;IFIT1;IRF1;HLA-A;STAT1;OAS2;ISG15;IFI6;XAF1;IRF4;IFIT3
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.4445182224898105,0.940483790551277,0.5492957746478874,1.0,1.0,12/42,19.88%,SP100;HLA-F;IFIT1;IRF1;HLA-A;STAT1;OAS2;ISG15;IFI6;XAF1;IRF4;IFIT3
prerank,KEGG_2021_Human__Selenocompound metabolism,-0.4456382240979443,-0.9404164620490657,0.5897435897435898,1.0,1.0,8/15,17.56%,PAPSS2;KYAT1;KYAT3;PSTK;SEPHS1;MARS1;MTR;TXNRD3
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,0.44469448212204415,0.9402424639651111,0.589041095890411,1.0,1.0,7/56,20.47%,PSMB9;RPS27A;PSMC5;RBX1;PSMA3;PSMB6;PSMD6
prerank,Reactome_2022__RNA Polymerase I Transcription Termination R-HSA-73863,0.4700068809236863,0.9401813975636704,0.5138888888888888,1.0,1.0,1/29,1.12%,CAVIN1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.5388367166694366,0.9401152923047377,0.5833333333333334,1.0,1.0,4/9,17.76%,NLRC4;HLA-A;PGLYRP2;PGLYRP1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Kidney,-0.36838040633982916,-0.940063343405757,0.5294117647058824,1.0,1.0,14/95,11.82%,RASSF2;DTX1;PTPRO;GFRA2;KIT;GPRIN3;TMEM132C;SEZ6L;NCALD;KCNIP1;SDK2;DNMT3A;GLT1D1;RNF175
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,0.4169404368319598,0.9398797193183753,0.6103896103896104,1.0,1.0,10/70,21.18%,PSMB9;RPS27A;CCNA2;PSMC5;BUB1B;FBXO5;PSMA3;PSMB6;PSMD6;CCNB1
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,0.43938094535623573,0.9398552980652897,0.5802469135802469,1.0,1.0,10/64,19.93%,HSPA8;SNAP23;DNASE2;AP1M2;TGOLN2;FTH1;TPD52L1;FTL;CTSZ;SNAPIN
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,-0.3337049640721359,-0.9397175712963183,0.6842105263157895,1.0,1.0,7/83,7.73%,EFNB1;LIMK1;MMP2;GPRIN1;EPHA6;ARPC3;EPHB2
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,-0.32964542786178663,-0.939691432576716,0.5384615384615384,1.0,1.0,34/182,20.59%,CPSF1;HNRNPL;TXNL4A;MAGOHB;PDCD7;LSM7;SRRM1;SUGP1;SRSF4;SNRPB;HNRNPF;DDX46;SF3A2;SYMPK;U2AF2;CSTF2;PTBP1;CPSF7;POLR2F;ZMAT5;GPKOW;SNRPN;POLR2C;ISY1-RAB43;HNRNPUL1;RNPC3;RBMX;PCF11;CPSF4;LSM2;LSM6;RBM8A;CCAR1;EIF4A3
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.5897447712973309,-0.9394900716634338,0.525,1.0,1.0,4/6,36.54%,ERC2;BSN;PCLO;ERC1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.5002700562637616,0.93947428339144,0.5230769230769231,1.0,1.0,4/22,13.70%,ACE2;RAMP3;CRHBP;CALCR
prerank,KEGG_2021_Human__Rap1 signaling pathway,0.38848653523430693,0.9393641455113264,0.6708860759493671,1.0,1.0,28/182,17.64%,ITGB2;LPAR1;RRAS;PIK3R3;FGF20;ANGPT2;FGF2;FLT1;ITGAM;ACTG1;VASP;FLT4;IGF1;HGF;RAPGEF6;ID1;PRKD3;THBS1;CSF1R;FPR1;ITGA2B;FYB1;ADCY7;MAPK3;CSF1;BCAR1;VAV3;CNR1
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.5456772991892553,0.9393438852201544,0.5614035087719298,1.0,1.0,2/10,11.45%,NODAL;PLAC1
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,-0.3839233356135654,-0.9392837373070705,0.5172413793103449,1.0,1.0,11/59,13.00%,ADAMTS1;ADAMTS12;ADAMTS8;THSD7A;MUC19;ADAMTS3;ADAMTS10;ADAMTS16;ADAMTS6;SPON2;GALNT12
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.44098342373384347,-0.9391800363866486,0.6190476190476191,1.0,1.0,1/15,1.39%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.44098342373384347,-0.9391800363866486,0.6190476190476191,1.0,1.0,1/15,1.39%,PHLDB2
prerank,CellMarker_Augmented_2021__Naive B cell:Undefined,0.4081484348531199,0.9391617718527616,0.48717948717948717,1.0,1.0,13/55,12.49%,BLK;CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;NLRC3;IKZF1;TAGAP;CD37;TMC8;PSTPIP1
prerank,CellMarker_Augmented_2021__Naive B cell:Peripheral Blood,0.4081484348531199,0.9391617718527616,0.48717948717948717,1.0,1.0,13/55,12.49%,BLK;CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;NLRC3;IKZF1;TAGAP;CD37;TMC8;PSTPIP1
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Undefined,0.4306581411974814,0.9391508808260532,0.5333333333333333,1.0,1.0,19/66,14.40%,CYTIP;ARHGAP9;TNFRSF1B;ITGAX;GMFG;SASH3;PTPRC;FCGR3A;FLI1;FGL2;HCK;IKZF1;TAGAP;HLA-DPB1;IGSF6;MYO1F;MME;EVI2A;PARVG
prerank,"Reactome_2022__Base-Excision Repair, AP Site Formation R-HSA-73929",0.48457189076455637,0.9391478091495409,0.5645161290322581,1.0,1.0,6/25,26.70%,H2BC4;H2AZ1;TDG;H2AZ2;H2AC6;OGG1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.4327504449604668,-0.9390715896512125,0.5135135135135135,1.0,1.0,6/14,31.34%,EMD;YWHAE;TPR;ANP32B;RBM22;TP53
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.5113192656353998,0.9390040133250721,0.6,1.0,1.0,2/16,8.04%,GNG12;GNG4
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.41074232271267336,0.9389321670567872,0.6341463414634146,1.0,1.0,20/130,14.36%,ROPN1B;RRAS;FGF2;C15ORF62;USP50;WAS;CDKN2A;IGF1;RAPGEF6;RHOB;ARHGDIG;RERG;CELSR1;ADGRG1;RTKN;CDKN1A;CCNA2;GPSM2;RHOG;PLEKHG7
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.5250612581615823,-0.938639690884386,0.41304347826086957,1.0,1.0,4/10,15.79%,APOBEC3H;MPHOSPH8;MORC2;SETDB1
prerank,CellMarker_Augmented_2021__Extravillous Trophoblast cell:Placenta,-0.3741317224363994,-0.9385123113613894,0.5416666666666666,1.0,1.0,8/74,4.25%,COL22A1;IL1RL2;PAMR1;COL6A3;MSC;MMP2;IFI16;SERPINE2
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Liver,-0.3010014138908078,-0.9383396400324217,0.8333333333333334,1.0,1.0,38/362,11.21%,DUSP4;P2RY10;SMPD3;EDARADD;HACD1;IKZF4;GBP2;CCDC22;HDAC7;FOXO1;SERPINE2;RAB11FIP1;PLEKHG2;OCIAD2;TTYH3;PDIA6;GOLGA8A;METTL8;SDF4;GBP4;CORO1B;MYO5C;PTPRJ;HSPB1;IRF5;FANK1;ZC3H12D;TMEM154;SLC3A2;HPGD;TRIM69;CREM;GPX1;DNPH1;SERPINB9;NAMPT;ACOT9;ADCY3
prerank,CellMarker_Augmented_2021__Non-switched B cell:Blood,-0.4602894640783064,-0.9382381018421397,0.5365853658536586,1.0,1.0,5/21,11.04%,P2RY10;CD247;SELL;SP140;LTB
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Blood,-0.4602894640783064,-0.9382381018421397,0.5365853658536586,1.0,1.0,5/21,11.04%,P2RY10;CD247;SELL;SP140;LTB
prerank,CellMarker_Augmented_2021__Memory B cell:Peripheral Blood,-0.4602894640783064,-0.9382381018421397,0.5365853658536586,1.0,1.0,5/21,11.04%,P2RY10;CD247;SELL;SP140;LTB
prerank,CellMarker_Augmented_2021__Memory B cell:Liver,-0.4602894640783064,-0.9382381018421397,0.5365853658536586,1.0,1.0,5/21,11.04%,P2RY10;CD247;SELL;SP140;LTB
prerank,CellMarker_Augmented_2021__Plasma cell:Sinonasal Mucosa,-0.4602894640783064,-0.9382381018421397,0.5365853658536586,1.0,1.0,5/21,11.04%,P2RY10;CD247;SELL;SP140;LTB
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.6017021120104324,0.9381981318311534,0.576271186440678,1.0,1.0,1/6,2.57%,ANXA1
prerank,KEGG_2021_Human__Pancreatic secretion,0.42230475504719345,0.938160772012679,0.5555555555555556,1.0,1.0,9/73,10.19%,CLCA2;PLA2G10;CLCA4;SCTR;CLCA1;ATP1A4;CPB2;CELA2B;RAB11A
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.5270507191400182,-0.938051758928408,0.6,0.9997313087209572,1.0,6/11,24.24%,PPCDC;PANK1;PPCS;SLC25A16;DCAKD;ACOT7
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.5270507191400182,-0.938051758928408,0.6,0.9997313087209572,1.0,6/11,24.24%,PPCDC;PANK1;PPCS;SLC25A16;DCAKD;ACOT7
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.5270507191400182,-0.938051758928408,0.6,0.9997313087209572,1.0,6/11,24.24%,PPCDC;PANK1;PPCS;SLC25A16;DCAKD;ACOT7
prerank,CellMarker_Augmented_2021__Endothelial cell:White Adipose Tissue,-0.3698321335112687,-0.9380178227982806,0.4,0.999308979818977,1.0,9/69,3.42%,CDH5;ERG;TIE1;COL4A2;CLEC14A;MMP2;SYNPO;SELE;PTPRB
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,0.45062408770107365,0.9379945504050592,0.56,1.0,1.0,8/42,12.70%,LMOD1;ANXA1;MYH11;CAV3;ACTA2;MYL6;MYL12A;PDE5A
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.4508179962833206,-0.9379339574674772,0.5526315789473685,0.9989911914439459,1.0,4/18,20.62%,CDK1;EMD;LMNB1;VRK2
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Nasal Concha,-0.548664431821905,-0.9378960801754418,0.5405405405405406,0.9985956802854044,1.0,1/5,1.93%,CD14
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.5263702625820585,0.9375980975162095,0.546875,1.0,1.0,2/12,14.41%,PTPRC;IL4
prerank,CellMarker_Augmented_2021__Oviduct-derived Stem cell:Oviduct,0.5331439087956469,0.937146428707236,0.5932203389830508,1.0,1.0,5/17,16.35%,PTPRC;ABCG2;NT5E;CD44;ENG
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR1 R-HSA-5654687,0.47865710509460163,0.9369444199862841,0.546875,1.0,1.0,1/27,2.58%,FGF20
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.6005649057024751,0.936771151911654,0.5689655172413793,1.0,1.0,2/6,17.43%,UGT8;B3GALT2
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.6005649057024751,0.936771151911654,0.5689655172413793,1.0,1.0,2/6,17.43%,UGT8;B3GALT2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Stomach,0.6066136962182971,0.9367544609744612,0.5147058823529411,1.0,1.0,2/6,14.71%,EPCAM;CD44
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,0.4231205428126319,0.9367451457610322,0.56,1.0,1.0,7/87,5.54%,NOTUM;APOL1;ITIH2;SDC2;FAM20A;C3;SERPIND1
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.5816207245676815,-0.9365778750324858,0.5789473684210527,1.0,1.0,4/6,20.07%,SMARCB1;PIH1D1;AUTS2;ARRB1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.46112027044442155,0.9365443235793407,0.5584415584415584,1.0,1.0,5/30,14.41%,PFKFB2;IGF1;PINK1;PRXL2C;IL4
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.5671933034002918,-0.9365094597102533,0.6470588235294118,1.0,1.0,2/9,7.01%,DHFR;RTN4RL2
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Brain,0.4253111432771598,0.9364043420782499,0.5138888888888888,1.0,1.0,12/40,17.06%,CYTIP;ARHGAP9;SASH3;PTPRC;NLRC3;TAGAP;PSTPIP1;KLRB1;SIRPG;CD244;ZAP70;TIGIT
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Brain,0.4253111432771598,0.9364043420782499,0.5138888888888888,1.0,1.0,12/40,17.06%,CYTIP;ARHGAP9;SASH3;PTPRC;NLRC3;TAGAP;PSTPIP1;KLRB1;SIRPG;CD244;ZAP70;TIGIT
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.44698658121829704,-0.936376289202061,0.5277777777777778,1.0,1.0,4/21,12.87%,ENO3;IFT88;RAB5A;NPRL2
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.426492822047461,0.9363475522185917,0.5466666666666666,1.0,1.0,8/53,13.36%,DONSON;DTL;TICRR;CCND1;SDE2;HMGA2;CDKN1A;NOP53
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.37639948857415406,-0.9363069054151184,0.5416666666666666,1.0,1.0,6/34,9.97%,EFR3B;TMEM150A;TTC7A;PI4KB;TTC7B;ITPKA
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.5871764919279031,0.9362730181156124,0.5454545454545454,1.0,1.0,1/8,1.06%,BLK
prerank,Reactome_2022__Prevention Of Phagosomal-Lysosomal Fusion R-HSA-9636383,-0.5176530964275583,-0.9362465631070268,0.5121951219512195,1.0,1.0,3/8,11.92%,RAB7A;RAB5A;CORO1A
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Embryonic Stem Cell,0.44383762044330727,0.9362419392848894,0.5428571428571428,1.0,1.0,20/47,15.08%,ARHGAP9;ITGAX;SASH3;PTPRC;NFAM1;FCGR3A;CLEC12A;FGL2;HCK;CSF3R;IKZF1;TAGAP;HLA-DPB1;HK3;CD4;MYO1F;FPR1;PARVG;ADGRE3;CD300LF
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Pluripotent Stem Cell,0.44383762044330727,0.9362419392848894,0.5428571428571428,1.0,1.0,20/47,15.08%,ARHGAP9;ITGAX;SASH3;PTPRC;NFAM1;FCGR3A;CLEC12A;FGL2;HCK;CSF3R;IKZF1;TAGAP;HLA-DPB1;HK3;CD4;MYO1F;FPR1;PARVG;ADGRE3;CD300LF
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord Blood,0.41439416834472265,0.9359654420510152,0.575,1.0,1.0,11/71,6.23%,ITGB2;APOL1;C3AR1;TNFRSF1B;SP100;TMEM204;TAPBPL;CMAHP;FLI1;FGL2;STAT5A
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.5989273424162469,-0.9359281682948761,0.6428571428571429,1.0,1.0,3/5,28.88%,SLC6A6;SLC6A13;RIPK1
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",0.4688897286594065,0.9359109982395634,0.5945945945945946,1.0,1.0,5/24,22.39%,GNG12;GNG4;GNGT1;GNB4;ADRA2A
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,0.4106799806271606,0.9358663060840041,0.6056338028169014,1.0,1.0,15/66,16.02%,C1QTNF1;WNT8B;GNG12;ADGRE1;SCTR;WNT5A;WNT8A;RAMP3;GNG4;FZD8;WNT6;CRHBP;CALCR;ADGRE3;PTRH2
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Undefined,0.4400872514901673,0.935863162561034,0.5857142857142857,1.0,1.0,14/59,12.25%,PLEKHS1;ELMO3;ITGB6;MISP;CYB561;SMIM22;MUC4;TMEM54;SERINC2;TMC4;TRIM29;LAMC2;TJP3;EPCAM
prerank,CellMarker_Augmented_2021__Epithelial cell:Bladder,0.4400872514901673,0.935863162561034,0.5857142857142857,1.0,1.0,14/59,12.25%,PLEKHS1;ELMO3;ITGB6;MISP;CYB561;SMIM22;MUC4;TMEM54;SERINC2;TMC4;TRIM29;LAMC2;TJP3;EPCAM
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.5258951485082423,-0.935825167068825,0.5,1.0,1.0,2/11,9.06%,RALB;LRSAM1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5742279708796639,0.9357361132807039,0.5774647887323944,1.0,1.0,2/9,2.77%,ADA;CCL5
prerank,CellMarker_Augmented_2021__B cell:Undefined,-0.38386239016996193,-0.9357047964034865,0.48,1.0,1.0,3/53,1.93%,IL7R;CD38;CD14
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),-0.5874574030163929,-0.9356377421081133,0.6222222222222222,1.0,1.0,2/5,22.76%,CAMSAP3;KIFC3
prerank,CellMarker_Augmented_2021__Lymphocyte:Undefined,-0.3722180171163489,-0.9353848665485688,0.4444444444444444,1.0,1.0,9/50,8.43%,P2RY10;APOL3;IL16;BCL2A1;CD247;STX11;CD53;SELL;SELPLG
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),0.6184255449129676,0.9353121996968016,0.5818181818181818,1.0,1.0,2/5,30.43%,SLC25A11;SLC25A30
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Brain,0.3859977320789134,0.9349629002005967,0.5487804878048781,1.0,1.0,28/141,19.32%,LPAR1;MYT1;MOBP;ACTG1;AFAP1L2;SHD;PLP1;DAAM2;ANGPTL2;RPL13A;UGT8;ASIC1;RTKN;SCD;ATP5F1E;FAU;TMSB10;OLIG2;NPPA;GPR17;EEF2;OMG;PHLDA1;ARL4A;PLEKHB1;ASPA;RAB33A;MAG
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),-0.6198042387868805,-0.9348930120368403,0.6944444444444444,1.0,1.0,2/5,7.03%,ADGRG6;TGFBR3
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,-0.37217732000723325,-0.934846487619054,0.45454545454545453,1.0,1.0,19/73,24.00%,NUP210;NUP42;POM121C;NUP214;HDAC3;AAAS;PCSK1;DUT;USH2A;NUP37;NUP98;CBX1;SEH1L;PML;NFKB1;NUP50;TPR;NCOR2;KCNH8
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.6144871745609022,0.9346764821743123,0.5636363636363636,1.0,1.0,3/7,20.39%,CXCL12;FERMT3;FN1
prerank,Reactome_2022__CDC6 Association With ORC:origin Complex R-HSA-68689,0.6045209893291856,0.9346066325983086,0.6071428571428571,1.0,1.0,2/6,23.47%,ORC4;ORC5
prerank,Reactome_2022__Regulation Of Commissural Axon Pathfinding By SLIT And ROBO R-HSA-428542,-0.5164012724751168,-0.9345803326914046,0.5348837209302325,1.0,1.0,4/9,24.62%,SLIT3;SLIT2;ROBO2;SRC
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.34116026776192565,-0.9344841905563807,0.5263157894736842,1.0,1.0,26/165,14.66%,HNRNPL;PIWIL2;NRDE2;LIN28B;TENT4A;KHSRP;MAGOHB;PDCD7;SRRM4;SRRM1;PPP1R9B;DHX8;KIN;PRPF18;SRSF4;SNRPB;HNRNPF;RP9;SMU1;SF3A2;U2AF2;NOVA1;PTBP1;ZMAT5;RBPMS;PABPC4
prerank,CellMarker_Augmented_2021__Lymphoblast:Fetal Liver,-0.45433320495699375,-0.934462132961226,0.40540540540540543,1.0,1.0,2/17,4.55%,P2RY10;CD247
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.44492597862868777,-0.934448144713563,0.5555555555555556,0.9996245899483135,1.0,8/29,21.53%,DHFR;RRM2;TFDP1;ESRRB;CDK14;CDK5;BRD4;KLF11
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Lymphoid Tissue,0.4218215797378785,0.9343328420937029,0.5362318840579711,1.0,1.0,12/46,13.63%,CYTIP;ARHGAP9;GMFG;SASH3;WAS;CXCR5;TAGAP;CD37;TMC8;ALOX5AP;PSTPIP1;SIRPG
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.4773601777752833,0.9341858329735241,0.5616438356164384,1.0,1.0,8/23,29.07%,SEMA3A;SEMA3F;SEMA3B;SEMA6A;SEMA4C;SEMA7A;SEMA3E;SEMA4G
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.36681898433994875,-0.9341430670967614,0.5555555555555556,0.9998898539168877,1.0,11/44,16.91%,ITGA4;DDX11;CACNB1;NTRK1;NOD1;RIPK2;GRIN1;ABCC1;CACNA1A;CDK5;FYN
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5445980747444078,0.9340380036983538,0.5932203389830508,1.0,1.0,1/11,4.20%,SNAP23
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.3849326200832197,0.9340032469725309,0.5679012345679012,1.0,1.0,15/122,17.12%,NEK2;CDC25A;FBXL7;BORA;FOXM1;CEP72;CEP70;CDKN1A;CCNA2;FBXL3;PKMYT1;TUBA4A;TPD52L1;PHLDA1;DYNLL1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.5193802817792199,-0.9338979200153571,0.5454545454545454,1.0,1.0,2/15,1.16%,LIPC;APOH
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.5701520981641487,0.9338748279501853,0.6212121212121212,1.0,1.0,3/10,8.01%,IYD;TYR;HPD
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.4188188788739333,-0.9338697532671802,0.5357142857142857,0.9995692752563405,1.0,3/24,5.56%,NGF;TWIST1;HES1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.4037940675805347,0.9337880035389738,0.6024096385542169,1.0,1.0,11/94,13.08%,PLA2G10;ASB5;DTL;TGFB1;WNT5A;CD80;C4BPA;C4BPB;OAZ2;CDKN1B;AGT
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.5069200966718952,-0.9337516526521922,0.5526315789473685,0.99938347309634,1.0,3/14,10.60%,MFSD2A;PLIN5;SCARB1
prerank,CellMarker_Augmented_2021__Chromaffin cell:Adrenal Gland,-0.35855914149024076,-0.9337496859645013,0.5652173913043478,0.9978821458958949,1.0,16/98,14.08%,SPHKAP;CDH20;TMEM132C;SEZ6L;ELAVL3;SYNDIG1;MEGF10;TMEM132E;KCNIP1;MMD2;GRIA4;ADGRA1;NRXN2;LRRTM3;PLXNA4;CELF4
prerank,CellMarker_Augmented_2021__Definitive Zone cell:Adrenal Gland,-0.35855914149024076,-0.9337496859645013,0.5652173913043478,0.9978821458958949,1.0,16/98,14.08%,SPHKAP;CDH20;TMEM132C;SEZ6L;ELAVL3;SYNDIG1;MEGF10;TMEM132E;KCNIP1;MMD2;GRIA4;ADGRA1;NRXN2;LRRTM3;PLXNA4;CELF4
prerank,CellMarker_Augmented_2021__Natural Killer cell:Breast,-0.35855914149024076,-0.9337496859645013,0.5652173913043478,0.9978821458958949,1.0,16/98,14.08%,SPHKAP;CDH20;TMEM132C;SEZ6L;ELAVL3;SYNDIG1;MEGF10;TMEM132E;KCNIP1;MMD2;GRIA4;ADGRA1;NRXN2;LRRTM3;PLXNA4;CELF4
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.564698609421856,-0.9337434647794408,0.575,0.99742768463084,1.0,3/7,26.43%,IMPACT;YY1;MAP3K4
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.4269210196821664,0.9337256812550293,0.5915492957746479,1.0,1.0,12/57,25.56%,PSMB9;LMO2;PSMC5;MYB;PSMA3;PSMB6;PSMD6;YAP1;RUNX1;PSMA7;LMO1;PSMB1
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.5353632140364131,0.9336341964540877,0.5735294117647058,1.0,1.0,3/9,21.42%,RAMP3;RAB29;ANXA2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.4901670553276897,0.9334496358115458,0.546875,1.0,1.0,3/21,13.70%,GPER1;RAMP3;CALCR
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.5626390938832281,0.9334492189642236,0.625,1.0,1.0,1/12,0.35%,TBX1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Skin,0.4036209182089942,0.9334239493075724,0.5308641975308642,1.0,1.0,15/87,18.37%,TRIL;TSPAN11;FREM2;SHISA6;PLP1;ERBB4;TMEM200C;LY6H;AQP4;DNAI1;CRISPLD1;FBN3;ZDHHC22;CHST9;EFNB3
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.5706434983597066,-0.9333312276144523,0.6052631578947368,0.9973931341424568,1.0,4/8,23.04%,CACNG4;CACNG2;GPHN;CACNG3
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.5706434983597066,-0.9333312276144523,0.6052631578947368,0.9973931341424568,1.0,4/8,23.04%,CACNG4;CACNG2;GPHN;CACNG3
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,0.40919092822597175,0.933251953060821,0.5652173913043478,1.0,1.0,5/68,6.90%,TLR2;PIK3R3;CCL5;IL12A;CD80
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.5546746081850301,0.9330620785267437,0.5882352941176471,1.0,1.0,1/14,5.32%,HAT1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.47778838921893363,-0.932894538995258,0.6,0.9979597383704523,1.0,2/16,1.53%,IL16;BCL2
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),-0.5712324469562111,-0.9328078336833375,0.6041666666666666,0.9976985294186266,1.0,4/6,20.46%,PUS7;PUS10;RPUSD4;PUSL1
prerank,Reactome_2022__CRMPs In Sema3A Signaling R-HSA-399956,0.5270625848908955,0.9327974518163896,0.6142857142857143,1.0,1.0,3/16,15.38%,SEMA3A;PLXNA3;CDK5R1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.3776292540911015,-0.9327895378084681,0.5,0.997232475141874,1.0,11/56,16.62%,SBK1;PRKCD;TTBK1;MAP3K10;ACVR1;CDK1;MAP3K12;WNK3;MARK2;CDK5;PRKCA
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Fetal Liver,0.4087686192283252,0.9327566929943314,0.5375,1.0,1.0,12/86,10.33%,LMOD1;TRIL;FBXL7;LYVE1;CYYR1;PREX2;FLT1;PCDH18;ANGPTL2;COL21A1;ADGRL4;VWF
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.44252158873250536,-0.9326166491925133,0.5333333333333333,0.9972217381577035,1.0,4/16,18.15%,GSAP;LRRTM3;ABCG1;CASP3
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5449901604986132,0.9325543295051307,0.6065573770491803,1.0,1.0,1/11,3.83%,SYT2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.5022803375801013,0.9325368561254822,0.5633802816901409,1.0,1.0,2/14,11.63%,C17ORF99;TNFSF4
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.4103989129368393,-0.932536012671587,0.5625,0.9968908532149978,1.0,6/31,13.49%,LAMA3;CD151;BCR;ITGB4;TAOK2;PLEC
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.5710781063097895,-0.9325008359771043,0.6052631578947368,0.996451498484357,1.0,4/10,32.48%,NR1H2;SLC45A3;ABCD2;MLXIPL
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.4823694232627187,0.9324845681104513,0.5915492957746479,1.0,1.0,3/28,8.89%,ITGB2;ITGAM;TCAF2
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.4235428124941826,0.9323181900568063,0.5526315789473685,1.0,1.0,14/86,17.83%,ITGB2;LYVE1;ECM2;ITGBL1;ITGA2;ITGB6;VTN;CD63;ANGPTL3;PARVG;CD44;FERMT3;THSD1;ITGB8
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.40576563176424313,0.9322686427395032,0.5662650602409639,1.0,1.0,29/119,20.44%,SLC22A3;TCN1;LRP2;SLC7A7;SLC18A2;SLC38A3;ABCG2;ABCC2;SLC6A4;RAMP3;PPT1;SLC38A4;AMN;CHMP3;CBLIF;RAB38;SLC7A3;SLC22A4;SLC38A2;DENND10;SLC6A12;SLC23A1;TXNIP;SLC7A10;ARRDC3;SLC52A1;SLC7A11;SLC7A4;RHBG
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),0.6005334733349121,0.9321239396962713,0.6440677966101694,1.0,1.0,2/6,15.60%,NPPA;KCNE3
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.5950410042479837,0.9321096848257863,0.6666666666666666,1.0,1.0,1/7,3.51%,NPHS2
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.49236014443631515,0.9321092563064057,0.578125,1.0,1.0,3/25,8.61%,ENPP2;LPIN3;CYP1B1
prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.4151744006590541,0.9320933227058147,0.5844155844155844,1.0,1.0,5/66,9.47%,ATP6V1G2;SLC18A2;SLC17A8;SLC6A4;ATP6V0E2
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.4261856759004767,0.9320068908901102,0.6338028169014085,1.0,1.0,11/64,19.59%,TEX101;CPM;GPIHBP1;LY6H;PLAUR;PIGH;LY6D;ART3;PIGC;ART4;RAET1G
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.4592159301859289,0.9319175204986149,0.5454545454545454,1.0,1.0,1/35,1.34%,TIMP3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.4335814568664578,0.9318298340427803,0.5972222222222222,1.0,1.0,6/36,7.41%,S100A13;AIM2;NLRP12;WNT5A;USP50;NLRC4
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.43084111086665705,-0.9318292049516805,0.5,0.9976309700872837,1.0,10/34,17.30%,RASSF2;PDGFD;PPP2R5D;RAD50;TAOK2;CHP1;IMPACT;NEK10;NBN;TNKS1BP1
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.39896687679893483,-0.9316584132396247,0.5185185185185185,0.9975753007897045,1.0,9/45,16.36%,TBC1D10A;SERPINE2;PERP;GSAP;CSTA;CAMK2N1;BAG6;TRAF3;CDK5
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.5946973875155271,0.9315805358876633,0.6031746031746031,1.0,1.0,2/6,22.63%,PADI2;PARP10
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,0.39453129890143374,0.9313747795867741,0.5949367088607594,1.0,1.0,15/112,17.41%,SGO1;BUB1;CENPU;ACTG1;ERCC6L;NDC80;RHOB;KIF18A;PPP2R5A;SKA2;NUF2;SPC25;BUB1B;DYNLL1;ITGB3BP
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,0.5120360266829715,0.9313168630032665,0.671875,1.0,1.0,5/19,18.28%,HSPA8;RPS27A;LAMP2;EEF1A1;GFAP
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.44732054368170154,0.9312286149191227,0.5421686746987951,1.0,1.0,14/42,22.45%,BOK;MMP9;GSDME;DDX3X;PLAUR;PINK1;BBC3;CYLD;HERPUD1;SIAH1;FIS1;BCAP31;DDIT3;BCL2L2
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.403304647501067,-0.9311732333860339,0.5238095238095238,0.9984079559034278,1.0,7/56,7.69%,MFSD2A;FOXO1;KLF10;FADS1;RALB;ALB;CLEC16A
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.42568968503284715,0.9311405359037638,0.5657894736842105,1.0,1.0,1/49,0.37%,NEK2
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.3924774304454275,-0.930687387827128,0.625,0.9991695228086883,1.0,10/34,19.31%,MMS22L;BOD1L1;SMARCAL1;DDX11;ATR;RFWD3;SAMHD1;RTEL1;FBH1;SETMAR
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.4737622636261972,0.930631168364745,0.5833333333333334,1.0,1.0,1/23,1.75%,SLFN14
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.3607145953906315,0.9304212278941223,0.6483516483516484,1.0,1.0,70/486,14.65%,TBX1;TULP1;S100A13;CDCA7L;KIF14;TLR2;ACOX2;TNFRSF1B;MYRF;ITGAX;FGF20;CCL5;CLCF1;SPDYA;FGF2;CIDEB;TSHR;FLT1;TGFB1;CRLF1;WNT5A;SFTPD;GPER1;IER5;CD81;IL12A;ERBB4;FLT4;FOXM1;CCND2;IGF1;LEF1;RAMP3;TBX6;CCND1;DDX3X;RNF187;HCK;OSMR;RPS9;TGFB3;LAMC2;PRAME;HPR;TGM2;EXOSC2;CLDN5;TNFSF4;HMGA2;COLEC12;ADGRG1;LIFR;EPCAM;COX17;CDKN1B;RPS4X;IL7;TTK;THBS1;CSF1R;NOXO1;RPS19;SIRPG;RHOG;CALCR;SOX9;SLC30A2;IL4;CYBA;GDF9
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.6142274603715047,-0.9303430172280773,0.6341463414634146,0.9995792085216437,1.0,3/5,23.22%,ST3GAL2;ST3GAL4;ST8SIA3
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.5094863365686999,0.9303240403672278,0.6190476190476191,1.0,1.0,6/22,15.17%,OR51I2;OR52A5;OR8A1;OR3A2;SYT10;OR51M1
prerank,PanglaoDB_Augmented_2021__NK Cells,0.40946255788400787,0.9302442151514374,0.6351351351351351,1.0,1.0,21/81,14.40%,CYTIP;ARHGAP9;ITGAX;GMFG;CCL5;SASH3;AHR;PTPRC;TGFB1;ITGAM;FCGR3A;ITGA2;LAIR2;TAGAP;THEMIS;PSTPIP1;MYO1F;KLRB1;SIRPG;ITK;PARVG
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.35073919410466814,-0.9302171269409222,0.6666666666666666,0.9993631591909333,1.0,36/168,22.52%,KIFC1;KIF2B;KDELR1;GOLIM4;STX6;MAN1A1;COG4;ARFIP2;RABEPK;KIF15;KIF4B;STX5;KIFC2;KIF1C;GOLGA8B;CUX1;GOLGA4;CAPZB;COG7;KIF26A;KIF27;VPS53;GALNT2;STX18;KIF6;GOLGA1;GCC2;CAPZA1;MAN1A2;IGF2R;KIF21A;COG2;CYTH4;RAB6A;TMED3;KIF5C
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.4827275051548553,0.9296295397985892,0.5909090909090909,1.0,1.0,5/27,16.50%,MARVELD2;RAPGEF6;TJP3;F2RL1;MSN
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.3859702132546291,0.9295628810891537,0.632183908045977,1.0,1.0,28/221,14.15%,BACE2;CAPN13;ADAM33;MMP19;HTRA4;TMPRSS11D;CASP7;CPM;ERAP2;ANPEP;MMP9;GGT5;HGF;CPB2;MMP15;F7;CELA2B;PLAU;LVRN;FOLH1;SDE2;MMP23B;PRSS38;MME;CAPN12;PLAT;PLG;ELANE
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.631510674100468,0.9295498401523107,0.6666666666666666,1.0,1.0,2/5,18.71%,BOK;APAF1
prerank,Reactome_2022__Gain-of-function MRAS Complexes Activate RAF Signaling R-HSA-9726842,-0.5409016840118314,-0.9294035588609072,0.6097560975609756,1.0,1.0,2/7,23.50%,PPP1CB;BRAF
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.5308467614028242,-0.9293212368793402,0.5348837209302325,1.0,1.0,1/8,1.53%,BCL2
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.39241609231659424,-0.929308047622201,0.5428571428571428,1.0,1.0,13/28,28.27%,ERN1;CIRBP;U2AF2;CELF4;THRAP3;NUP98;RBMX;HSPA1A;SETX;DAZAP1;SF3B4;RBM22;TRA2A
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.40738049767311324,-0.9292960942163372,0.4642857142857143,0.9998575393601334,1.0,6/33,12.87%,IFT88;RALB;LRSAM1;RAB5A;NUPR1;NPRL2
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Brain,-0.5473799456602446,-0.9292467074453208,0.6170212765957447,0.9994445701854463,1.0,1/7,1.61%,SLITRK6
prerank,Reactome_2022__Cell Cycle R-HSA-1640170,0.3538700947683432,0.9291948287354886,0.7368421052631579,1.0,1.0,86/582,20.87%,NEK2;CDC25A;SGO1;PSMB9;SYCP1;BUB1;CENPU;FBXL7;RRAD;POLE2;TK1;FKBPL;SYNE2;BORA;SYCP3;H2BC4;ERCC6L;CDKN2A;NDC80;FOXM1;CCND2;MCM3;CCND1;POLD4;LPIN3;H2AZ1;CEP72;CKS1B;OIP5;PSMC3IP;PIF1;RPA3;CEP70;NOP10;CCNE2;RPS27A;KIF18A;PPP2R5A;STAG3;SKA2;CDKN1B;CDC14A;SMC1B;CDKN1A;CCNA2;PKMYT1;CDKN2C;PSMC5;NUF2;TUBA4A;TUBA3D;TUBB6;MAPK3;SPC25;ARTN;BUB1B;GINS1;RMI2;RCC1;CENPX;PHLDA1;ORC4;BRCA1;FBXO5;DYNLL1;NCAPG;ITGB3BP;CEP76;TUBA1C;HSPA2;RBX1;YWHAH;PSMA3;MASTL;FKBP6;PSMB6;RAD9B;CENPN;CENPL;CDC25C;PSMD6;H2AZ2;POLE3;CENPS-CORT;GMNN;SET
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,-0.3580432450158467,-0.929080320669864,0.45454545454545453,0.9993501064959828,1.0,25/97,24.00%,NUP210;NUP42;POM121C;NUP214;SNF8;HDAC3;AAAS;PCSK1;DUT;USH2A;NUP37;NUP98;MVB12A;CBX1;TSG101;TARBP1;SEH1L;PML;NFKB1;UBAP1;NUP50;TPR;RNF103-CHMP3;NCOR2;KCNH8
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.43304996519327693,0.928688611738821,0.5625,1.0,1.0,5/26,6.35%,BLK;BLNK;PTPRC;NFAM1;SYK
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.3860661785684138,0.9286584233676856,0.620253164556962,1.0,1.0,15/121,17.12%,NEK2;CDC25A;FBXL7;BORA;FOXM1;CEP72;CEP70;CDKN1A;CCNA2;FBXL3;PKMYT1;TUBA4A;TPD52L1;PHLDA1;DYNLL1
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Umbilical Cord Blood,-0.42991022495917997,-0.9286554737521157,0.40625,0.9999806364992755,1.0,7/35,11.08%,P2RY10;CD247;SELL;CD8A;KLRC4-KLRK1;LTB;ZNF831
prerank,GO_Biological_Process_2021__adult heart development (GO:0007512),-0.596119219156143,-0.9285611902351156,0.5675675675675675,0.9997334659574685,1.0,1/5,4.59%,SCUBE1
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.3644466312925263,0.9284362121865507,0.6976744186046512,1.0,1.0,31/334,15.92%,HERC3;PSMB9;TLR2;UBE2U;FBXL7;ASB5;UBE2L6;ARIH2;SNAP23;ERAP2;ASB14;HLA-F;HSPA5;SPSB2;HLA-A;ASB15;TRAIP;ASB17;RPS27A;KLHL2;FBXL13;RNF138;FBXL3;PSMC5;KBTBD7;CYBA;KLHL13;UBE3A;FBXO40;NDUFA2;KBTBD6
prerank,KEGG_2021_Human__Dopaminergic synapse,-0.37168750804129236,-0.9282097868399348,0.6666666666666666,0.9999502710772635,1.0,17/116,16.67%,DRD4;FOS;CREB3L4;ITPR2;CREB3L1;PPP2R5D;GNAS;KCNJ6;GNB5;GRIA4;GNB3;ARRB2;CREB3L2;PPP1CA;CACNA1A;PRKCA;COMT
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.4135502713268727,0.9281563622268267,0.56,1.0,1.0,10/75,13.75%,TBX1;LRP2;MYO3B;MARVELD2;COL4A3;GSDME;GRXCR2;COL1A1;CDC14A;GRXCR1
prerank,Reactome_2022__SOS-mediated Signaling R-HSA-112412,-0.5943325814463436,-0.9281174004104208,0.675,0.999677962679887,1.0,2/6,23.98%,HRAS;IRS2
prerank,CellMarker_Augmented_2021__Nephron Epithelial cell:Kidney,-0.4497758902894841,-0.9280436111630948,0.5666666666666667,0.9993741924949237,1.0,4/14,4.81%,SLC16A9;PTPRO;ATP6V0D2;CLDN16
prerank,Reactome_2022__Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,-0.5103473729374797,-0.9279406139929428,0.6571428571428571,0.9991912407042716,1.0,3/11,25.57%,TFDP1;PPP2R1B;PPP2R3B
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.5325503982379525,0.9279144431787563,0.59375,1.0,1.0,2/13,12.35%,RPP38;RPP40
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.4168335015113585,-0.9278569005497393,0.5,0.9989514102173389,1.0,10/33,20.90%,IFI16;KPTN;MYBBP1A;EIF2AK3;IMPACT;SIK2;SZT2;BRSK1;PRKAG2;SESN3
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.42392394934907773,0.9276319104465184,0.5256410256410257,1.0,1.0,9/48,10.66%,SDC2;LYVE1;FGF2;TGFB1;STAB2;OGN;HPSE2;OMD;DCN
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.5323934787678604,0.9275942311814855,0.6142857142857143,1.0,1.0,6/14,14.32%,SASH3;AHR;IRF1;TNFSF4;ALOX15;ADCY7
prerank,KEGG_2021_Human__MicroRNAs in cancer,0.39194981373665483,0.9275861995126111,0.6071428571428571,1.0,1.0,21/152,15.19%,CDC25A;TIMP3;PIK3R3;MMP9;CDKN2A;ITGA5;CCND2;CCND1;DDIT4;CYP1B1;PLAU;CCNE2;HMGA2;CDKN1B;CDKN1A;THBS1;BMI1;CD44;CYP24A1;SERPINB5;MAPK3
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.5136159939334033,0.9275424236899829,0.5373134328358209,1.0,1.0,2/12,11.98%,STAT5A;CD4
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.5136159939334033,0.9275424236899829,0.5373134328358209,1.0,1.0,2/12,11.98%,STAT5A;CD4
prerank,Reactome_2022__HIV Elongation Arrest And Recovery R-HSA-167287,-0.39618611808726545,-0.92742495454521,0.5,0.9996560001108861,1.0,9/31,27.93%,SSRP1;POLR2F;POLR2C;ELOA;CCNT1;CTDP1;GTF2F2;GTF2F1;NELFCD
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.6072776310438236,0.9274150909444496,0.6166666666666667,1.0,1.0,4/6,34.24%,CYLD;DUSP10;DUSP1;EZR
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),0.5537005239320542,0.927277220202547,0.6065573770491803,1.0,1.0,2/11,12.35%,RPP38;RPP40
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",0.4417859975044643,0.9270641062818463,0.6,1.0,1.0,7/31,19.17%,GAD1;NAT8L;FOLH1;GPT;ADSS1;GLUL;ASPA
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.40446557334859873,-0.9269656199182779,0.43333333333333335,1.0,1.0,3/23,4.62%,WWC1;MAML1;GATD3
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD Domain Mutants R-HSA-2691232,-0.4380440710253842,-0.9268566496696642,0.5384615384615384,1.0,1.0,4/15,15.25%,JAG2;JAG1;NEURL1;DLL1
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.5060842724891826,-0.9268561481473142,0.5,0.9998673726186776,1.0,2/9,4.21%,GCK;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.5044455675197574,-0.9267696681932092,0.575,0.9990850451240912,1.0,3/10,13.20%,APOH;SERPINE1;ST3GAL4
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.5044455675197574,-0.9267696681932092,0.575,0.9990850451240912,1.0,3/10,13.20%,APOH;SERPINE1;ST3GAL4
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.416333032110551,0.9267610411972099,0.5487804878048781,1.0,1.0,13/90,11.60%,TMEM213;CCDC60;RP1;NPHS2;SLC22A8;VWA3B;SCIN;SLC4A1;ERBB4;SLC22A6;EPB41L4A;RERG;BPIFB1
prerank,Reactome_2022__FGFR1b Ligand Binding And Activation R-HSA-190370,-0.5971750823706574,-0.9267547990455897,0.6304347826086957,0.9986123236884247,1.0,1/5,6.49%,FGF1
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.4469618528928304,0.9267299938679701,0.5540540540540541,1.0,1.0,5/33,7.89%,TBX1;DNAH11;CCDC39;DAND5;MMP21
prerank,Reactome_2022__Cleavage Of Damaged Pyrimidine R-HSA-110329,0.48492735327533926,0.9267143717990496,0.5901639344262295,1.0,1.0,6/24,26.70%,H2BC4;H2AZ1;TDG;H2AZ2;H2AC6;OGG1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.38909828156054194,-0.9265238406387274,0.5666666666666667,0.9987652507239428,1.0,5/54,5.52%,TSKU;APOB;CYP4V2;APOE;CYP7B1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.3791784283338086,-0.926486640672773,0.5161290322580645,0.9983752057638358,1.0,5/37,8.78%,KCNJ16;KCNE1;KCNMB2;FLNA;KCNJ6
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.46831515489053543,-0.92634553926664,0.5588235294117647,0.9982189689151468,1.0,3/14,12.23%,CTC1;BRPF3;STN1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.5145737738736647,-0.9263069915771268,0.5897435897435898,0.9978989378845642,1.0,1/11,1.80%,CDH5
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),-0.5616559344916756,-0.9261981523695882,0.5483870967741935,0.997629641740086,1.0,2/5,11.59%,CSGALNACT1;B3GAT3
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,0.4624149853629908,0.926190112261493,0.6811594202898551,1.0,1.0,4/32,15.19%,ACTG1;WAS;NCKIPSD;MAPK3
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.5810946121634453,-0.9260567645072356,0.6111111111111112,0.9974677012171835,1.0,2/6,16.42%,SPATA7;TCTN1
prerank,Reactome_2022__rRNA Processing R-HSA-72312,0.38872996684863503,0.9259895881215672,0.6666666666666666,1.0,1.0,65/186,24.42%,PWP2;RPL37A;RPL21;RPL9;DIMT1;RPP38;RPL18A;RPS9;RPL3;RPL36;RPL13A;EXOSC8;RPS16;NOP10;RPL15;RPS5;RPS27A;RPS3A;EXOSC2;RPL41;RPP40;RPS12;RPS4X;RPL27A;NOB1;RPS19;FAU;RPS21;EXOSC4;RPL32;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;WDR36;RSL24D1;RPLP2;NOL12;RPL7;TSR3;RPL38;RPS15A;EMG1;RPSA;RPLP0;RPS6;RPL35;RPL27;RPS14;RIOK2;RPL7A;RPL23;RPS15;WDR18;RPS27;GNL3;RPL8;RPS3;SENP3;RPS23;RPS20;WDR12;RPS24
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.44901234793100037,0.9259838727618139,0.5679012345679012,1.0,1.0,9/41,11.88%,CLDN2;CLDN6;CLDN18;ACTG1;MARVELD2;MARVELD3;ECT2;CLDN5;CLDN9
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.41179437053380297,-0.9259292887922579,0.5757575757575758,0.9972681411284873,1.0,1/17,0.96%,CLDN4
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.35442816477650846,-0.9259259579401329,0.5714285714285714,0.9967792841965615,1.0,16/77,17.39%,PNKP;MEN1;EPHB2;PID1;ENSA;P3H1;G6PD;DAB2IP;SLIT2;CHP1;TRAF3IP1;CRKL;IMPACT;INSM1;PPIA;PTPA
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.5701652959166353,0.925899962838386,0.578125,1.0,1.0,3/8,30.05%,BLOC1S2;ATF2;BNIP3
prerank,Reactome_2022__TRIF-mediated Programmed Cell Death R-HSA-2562578,0.5707378296101531,0.9258569269763534,0.5535714285714286,1.0,1.0,3/7,26.30%,NDUFA2;CASP8;TMED7-TICAM2
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Undefined,0.4062203432073967,0.9258523977276842,0.575,1.0,1.0,11/74,10.33%,LYVE1;CYYR1;PREX2;FLT1;CASR;SCTR;ANGPTL2;RAMP3;ALDOB;ADGRL4;VWF
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.43900800401582174,-0.9258298396482508,0.5769230769230769,0.9965236448690842,1.0,6/23,17.69%,DSCC1;POLD3;CTC1;STN1;RFC3;SLC19A1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.5212420057198952,0.9257866374771636,0.6031746031746031,1.0,1.0,1/16,0.67%,SLC25A31
prerank,Reactome_2022__Suppression Of Phagosomal Maturation R-HSA-9637687,-0.5048473948876284,-0.9257318535687866,0.5,0.996337414585406,1.0,3/11,11.92%,RAB7A;RAB5A;CORO1A
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.37925735301945773,0.9256622389588482,0.6,1.0,1.0,25/138,20.80%,PSMB9;AIM2;TNFRSF1B;CCL5;CARD14;ST18;GPER1;GSDME;STAT1;TNFSF4;TXNDC17;CRHBP;PSMC5;EDAR;HYAL1;BRCA1;GBP1;NFKBIA;PSMA3;CCL25;TNFSF8;PSMB6;PSMD6;TNFSF14;TRAF5
prerank,CellMarker_Augmented_2021__Liver Stem cell:Fetal Liver,-0.34864732485925054,-0.9256124594825653,0.6842105263157895,0.9962204914232896,1.0,29/92,18.36%,ADAMTS12;CALD1;COL4A2;COL12A1;MMP2;RAI14;FRMD6;RND3;RHBDF1;PARVA;FSTL1;SNAI2;EFEMP1;EDNRA;ANTXR1;AMOTL2;CHST3;FKBP9;CDH11;GPC1;COL5A2;COL4A1;ADGRL2;SERPINH1;SH3D19;SH3BP4;RBFOX2;COL16A1;PTPN21
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.4148876635075987,-0.9255599880042074,0.5925925925925926,0.9958587236937931,1.0,1/28,0.50%,ADRA1A
prerank,KEGG_2021_Human__mRNA surveillance pathway,-0.34365663495058746,-0.9253364657639742,0.5652173913043478,0.9960497674291979,1.0,22/86,21.41%,CPSF1;MAGOHB;UPF3A;PPP2R5D;SRRM1;NXF5;MSI1;UPF2;SYMPK;CSTF2;CPSF7;PABPC4;PPP1CA;ETF1;PCF11;CPSF4;PPP1CB;RBM8A;ACIN1;EIF4A3;PPP2R1B;SMG5
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.3715581505364745,-0.9252781647725667,0.5384615384615384,0.9957135362148138,1.0,5/45,6.56%,PER2;PSAT1;CYP7B1;SLC27A2;OSBPL3
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,-0.426624255639395,-0.9252416387541099,0.5862068965517241,0.995327459158464,1.0,8/27,18.67%,SEC24C;TGFA;STX5;PREB;CNIH3;MIA3;F5;CNIH2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.38227893015633607,-0.925116031544894,0.47619047619047616,0.9951862396685988,1.0,12/85,10.94%,SPRED3;SPRED2;ZNF703;SPRED1;BAMBI;BCL9L;MEN1;TGFBR3;ITGA3;EMILIN1;ZBTB7A;SPRY1
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,0.429328216445816,0.9248216259897735,0.6,1.0,1.0,6/56,20.47%,PSMB9;RPS27A;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.4687136204714575,-0.9247214262187566,0.5135135135135135,0.9958910237864573,1.0,2/17,9.75%,SNF8;HPGD
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.4000641674049402,-0.9247004133157984,0.5625,0.9954678494461549,1.0,10/26,25.73%,CELF5;LUC7L;SF3A2;CELF4;CELF2;SF3A3;SETX;PUF60;PRPF39;SFSWAP
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.43326069263106604,-0.9246208252551505,0.5,0.9951827981318135,1.0,4/21,9.89%,DPM3;DPY19L3;RXYLT1;FKTN
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.5931111758112215,0.9242950527530447,0.6065573770491803,1.0,1.0,3/7,32.29%,AGER;EFNA1;PICALM
prerank,Reactome_2022__Proton-coupled Monocarboxylate Transport R-HSA-433692,0.5776386756737054,0.924002780848436,0.6,1.0,1.0,3/6,16.94%,SLC16A8;SLC16A1;SLC16A3
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.3594460779789495,-0.9236055198587441,0.5714285714285714,0.9975007336357711,1.0,5/52,6.71%,MYO10;LIMK1;MYO9B;CD247;ARPC3
prerank,KEGG_2021_Human__Wnt signaling pathway,0.39247672051394217,0.9235892602890206,0.6375,1.0,1.0,16/144,13.42%,NOTUM;WNT8B;TCF7;FRAT1;WNT5A;DAAM2;RSPO1;CCND2;WNT8A;LEF1;CCND1;FZD8;WNT6;SFRP4;DKK2;TCF7L1
prerank,Reactome_2022__Signaling By ERBB2 ECD Mutants R-HSA-9665348,-0.48446510371596413,-0.923239668045338,0.6451612903225806,0.9978715835845501,1.0,1/15,5.66%,ERBB2
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.44003269296027886,0.9230900068491555,0.6282051282051282,1.0,1.0,10/45,18.25%,HSPA1L;HSPA8;DNAJB1;HSPA5;DNAJA1;HSPE1;HSPH1;HSPA4;HSPA2;HERPUD1
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.33161410899665306,-0.9230596046292656,0.47368421052631576,0.9979045497547526,1.0,15/101,7.21%,NGF;STK40;ADAMTS12;ENO3;CALD1;COL4A2;COL12A1;MMP2;TPM2;RND3;RHBDF1;MYL3;PARVA;FSTL1;CAP2
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.4929848513680969,0.9230121681290898,0.5970149253731343,1.0,1.0,2/17,9.22%,HSPA5;PINK1
prerank,Reactome_2022__RNA Polymerase III Transcription Termination R-HSA-73980,-0.43378947797129147,-0.9229222357100066,0.5581395348837209,0.9977500624890238,1.0,7/21,15.37%,POLR3D;POLR3E;NFIB;POLR3K;POLR2F;POLR3A;POLR3B
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,-0.37199500726392803,-0.922480533529179,0.56,0.998345046278026,1.0,10/63,13.11%,GCK;KIT;ERBB2;NTRK1;SLC7A5;PFKP;G6PD;FGFR2;IDH2;LDHC
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.476888794969584,-0.9223682318258047,0.6097560975609756,0.9981842537694149,1.0,4/11,20.99%,MGARP;SPAST;TRAK2;MAPT
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.5775042690054809,0.9223557009623122,0.5645161290322581,1.0,1.0,1/8,4.27%,TGFB1
prerank,CellMarker_Augmented_2021__Hepatic Progenitor-Like cell:Pluripotent Stem Cell,0.41507816731426,0.9223550558206062,0.6216216216216216,1.0,1.0,16/59,16.98%,ACE2;C3;NID1;CYYR1;RARRES1;ANPEP;ALDOB;SLC5A9;CP;DAB2;TGFBI;KCNE3;IDO1;MOGAT2;A2M;NSUN7
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),-0.4902790549767008,-0.9222186641129457,0.6060606060606061,0.9981483829504784,1.0,5/12,14.57%,UST;CHST12;VCAN;IDUA;CSPG5
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.49249005733315815,-0.922162924988571,0.5789473684210527,0.997328880007225,1.0,1/8,0.34%,DRD4
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.49249005733315815,-0.922162924988571,0.5789473684210527,0.997328880007225,1.0,1/8,0.34%,DRD4
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,-0.38440837016944684,-0.9221524642775824,0.45,0.9968698914436437,1.0,8/45,12.08%,WWC1;MAML1;GATD3;WWP2;JAG2;MAMLD1;JAG1;NEURL1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.5490390763613282,-0.9221222173235766,0.5897435897435898,0.9964300265779179,1.0,2/8,18.11%,PKIA;PRKAR2A
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Small Intestine,0.40995651526429117,0.9220072669081544,0.620253164556962,1.0,1.0,14/90,11.00%,TIMP3;PRRX1;LMOD1;FBXL7;LOX;GNG12;CLDN18;PCDH18;SCARA3;UACA;ANGPTL2;KANK2;DCN;COL1A1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.406187024127222,-0.9219809353172557,0.45,0.9963204152014855,1.0,9/57,15.83%,MFSD2A;BCL2;ERBB2;DNPH1;SLC25A33;SDCBP;KLHL22;RPS6KA3;TGFB2
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.364710603174677,-0.9219670907018176,0.53125,0.9958688025066608,1.0,16/64,19.32%,PRKCD;RND3;F11R;FSCN1;RHOBTB2;CORO1A;TAOK2;CRK;CORO2B;RHOA;PAK3;ABL1;CCDC88A;ARHGAP35;RHOBTB1;MLST8
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.6184865430243409,0.9218464868544886,0.6271186440677966,1.0,1.0,1/5,10.78%,TJP3
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.4864281520502577,0.9218270521316653,0.5522388059701493,1.0,1.0,2/29,6.68%,DONSON;RAD1
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",0.46611686534315744,0.9218238247333468,0.6268656716417911,1.0,1.0,4/26,9.00%,ERAP2;HLA-F;HSPA5;HLA-A
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,0.41622214430874815,0.9217906120296416,0.6901408450704225,1.0,1.0,9/71,20.47%,PSMB9;RPS27A;PSMC5;RASGRP1;NFKBIA;PSMA3;PSMB6;NFATC2;PSMD6
prerank,Reactome_2022__Defective CHST6 Causes MCDC1 R-HSA-3656225,0.6095876674084654,0.9217245286497365,0.7142857142857143,1.0,1.0,2/5,10.10%,OGN;OMD
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.6339723370413171,-0.9217240268661548,0.6052631578947368,0.9961574650548234,1.0,2/5,30.21%,MAPT;CLUH
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.41771337608383025,0.9215148799387359,0.55,1.0,1.0,4/58,9.22%,AQP3;ACAA2;SUV39H1;PINK1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.47467131162963827,0.9213729841538553,0.5774647887323944,1.0,1.0,2/24,4.58%,ANXA1;CCDC39
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.6087600113310307,0.9213651925767464,0.640625,1.0,1.0,1/6,3.48%,TRIM62
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.5233624563688112,-0.9212258484983543,0.5957446808510638,0.9970361891341983,1.0,4/9,23.76%,PIAS3;PIAS4;HDAC4;RASD2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.5406262268104215,0.9211735135129444,0.5076923076923077,1.0,1.0,1/8,5.31%,WNT5A
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.5223852306229553,-0.9211624991448101,0.5945945945945946,0.9966656300330687,1.0,1/7,2.01%,CSK
prerank,CellMarker_Augmented_2021__Neural Stem cell:Spinal Cord,-0.32606047245568964,-0.9211417657020392,0.6666666666666666,0.9957518434892634,1.0,24/98,15.32%,SPRY4;TEAD2;ETV1;TBC1D16;COL4A2;RAI14;SDC3;RND3;RHBDF1;FZD7;CAP2;RASSF8;GPR161;ANTXR1;DAB2IP;NAV2;AMOTL2;SLIT2;CHST3;FKBP9;GPC1;COL5A2;COL4A1;ADGRL2
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Eye,-0.32606047245568964,-0.9211417657020392,0.6666666666666666,0.9957518434892634,1.0,24/98,15.32%,SPRY4;TEAD2;ETV1;TBC1D16;COL4A2;RAI14;SDC3;RND3;RHBDF1;FZD7;CAP2;RASSF8;GPR161;ANTXR1;DAB2IP;NAV2;AMOTL2;SLIT2;CHST3;FKBP9;GPC1;COL5A2;COL4A1;ADGRL2
prerank,Reactome_2022__PKA Activation In Glucagon Signaling R-HSA-164378,-0.45043541845899476,-0.9210462003918233,0.5333333333333333,0.9955995156511921,1.0,5/14,18.11%,GNAS;ADCY2;PRKCA;ADCY6;PRKAR2A
prerank,CellMarker_Augmented_2021__Leukocyte:Peripheral Blood,0.42109006574612323,0.9210395960621302,0.5384615384615384,1.0,1.0,18/66,16.42%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;WAS;NLRC3;IKZF1;TAGAP;CD37;TMC8;GPR183;PSTPIP1;MYO1F;ITK;PARVG;PIK3CG;CD244
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.5434439167502693,0.92084158351621,0.5645161290322581,1.0,1.0,5/14,17.26%,NQO1;CYP1B1;GCHFR;SPR;NOS2
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.48053557512700573,0.9208055516740783,0.6,1.0,1.0,5/25,10.44%,LMOD3;SIX4;MYL6;CSRP3;POPDC2
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Tooth,0.4201877891262035,0.9203115035598142,0.6164383561643836,1.0,1.0,15/64,16.54%,CLDN6;SCGB3A2;TUNAR;CCDC172;SALL4;CA14;NODAL;ZBTB8A;CALB1;L1TD1;ADGRG2;SLC7A3;ZNF850;FBN3;VASH2
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.5559848025232514,-0.9201999218235443,0.6190476190476191,0.9974000554519022,1.0,2/8,4.40%,IWS1;SMARCB1
prerank,Reactome_2022__PI-3K cascade:FGFR4 R-HSA-5654720,0.5270769406118697,0.9201576728073465,0.576271186440678,1.0,1.0,2/16,8.32%,FGF20;KLB
prerank,Reactome_2022__G-protein Activation R-HSA-202040,0.4789333109330907,0.9200188172581866,0.5666666666666667,1.0,1.0,6/19,20.56%,GNG12;GNG4;PDYN;OPRM1;GNGT1;GNB4
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,0.38321378788473015,0.9198933475022304,0.691358024691358,1.0,1.0,18/163,12.93%,GATA4;MYH8;TMOD4;LMOD1;MYBPC3;ANXA1;HIPK1;MYH11;CAV3;KCNA5;ATP1A4;ACTA2;MYL6;TRDN;KCNK7;MYL12A;PDE5A;PLN
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.3591778400351994,0.9198659786233461,0.717391304347826,1.0,1.0,58/381,16.49%,GATA4;TBX1;SMAD6;CLEC5A;CAPN13;KIF14;ANXA1;FGF20;LRP2;CLCF1;SIX4;ALOX12;CARD14;CRLF1;WNT5A;ANGPTL4;MMP9;SOCS2;FLT4;NR1H4;ITGA5;CCND2;IGF1;LEF1;AXL;HSPA5;HGF;DDX3X;HCK;PLAUR;SOD2;PINK1;NAA38;MYDGF;DNAJA1;TGFB3;PRAME;PPT1;RPS27A;RPS3A;DAB2;HMGA2;PDK4;IL7;FOXB1;RASA1;THBS1;SOX9;IL4;CD44;MAPK3;THOC6;IFI6;PTRH2;CFL1;GHRL;HTR2B;COPS5
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,0.38060893707537585,0.9197732636478562,0.6666666666666666,1.0,1.0,17/225,11.51%,CHRNA9;GAD1;HSPA8;KCNJ15;GNAT3;SLC18A2;GNG12;SLC6A4;ERBB4;HTR3E;GNG4;CHRNA5;GRIN2D;GLRA2;GLRA1;HTR3C;RASGRF2
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.5395309191877272,0.9196882380650481,0.5818181818181818,1.0,1.0,1/12,3.51%,FGF2
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),0.587729004252576,0.9196826826780098,0.5932203389830508,1.0,1.0,1/6,1.72%,DBH
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.35018380675490796,-0.9196343547612221,0.65,0.9982322624110116,1.0,28/137,14.44%,MFSD2A;PAH;GSTT2B;HACD1;ACER2;ELOVL6;ACER3;APOE;GSTM5;ASS1;GSTZ1;PLA2G4C;GSTK1;ST3GAL2;CHKA;ELOVL1;PAM;PEMT;SPTSSB;PLPP2;GSTO2;PCSK1;ST3GAL4;LPCAT2;SLC44A5;ASL;NFS1;CSNK1G2
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,0.3750505156151799,0.9195777534976615,0.6555555555555556,1.0,1.0,44/243,14.71%,LRP4;ITGB2;CAPN13;SDC2;ITGAX;COL18A1;LOX;MMP19;NID1;TGFB1;ITGAM;SCUBE3;ITGA2;COL6A5;COL6A6;ITGB6;JAM2;MMP9;COL4A4;COL4A3;ITGA5;CEACAM8;COL4A6;COL21A1;COL4A5;MMP15;TGFB3;LAMC2;COL6A2;DCN;VTN;SPOCK3;COL1A1;ASPN;FBN2;THBS1;P4HA3;CAPN12;ITGA2B;PLG;MMP11;ELANE;DDR2;CD44
prerank,"GO_Biological_Process_2021__regulation of blood coagulation, intrinsic pathway (GO:2000266)",0.6536986966026568,0.9195183013839483,0.6229508196721312,1.0,1.0,2/5,16.75%,F8;A2M
prerank,"GO_Biological_Process_2021__negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",0.6536986966026568,0.9195183013839483,0.6229508196721312,1.0,1.0,2/5,16.75%,F8;A2M
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,-0.3579375955214385,-0.9194828976845116,0.5384615384615384,0.9981718554623964,1.0,5/50,11.43%,PRKCD;ITPR2;GNA14;GNA11;ADCY2
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.5681007287441545,0.9194293707855193,0.5714285714285714,1.0,1.0,1/8,5.48%,DYDC2
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.5439186536357066,0.9193954769095954,0.5645161290322581,1.0,1.0,5/13,17.26%,NQO1;CYP1B1;GCHFR;SPR;NOS2
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.5299014803536629,0.9193400223239945,0.6551724137931034,1.0,1.0,2/16,9.22%,A2ML1;PINK1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.5030245823317859,0.9191710810475631,0.5882352941176471,1.0,1.0,2/15,22.89%,IL4;CD74
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.5023749141527505,-0.9190141221390548,0.6410256410256411,0.9990028877764099,1.0,4/11,19.90%,EAPP;LEO1;TCERG1;BRD4
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.4409717283658597,0.9188987969095075,0.6216216216216216,1.0,1.0,8/34,20.89%,SLC12A7;LRP2;SLC47A1;SLC22A4;SLC46A1;GLUL;SLC1A6;LRRC8A
prerank,Reactome_2022__Cytochrome C-Mediated Apoptotic Response R-HSA-111461,0.5369757537150163,0.9187306427372194,0.6206896551724138,1.0,1.0,4/12,18.71%,CASP7;UACA;MAPK3;APAF1
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,0.4011535415420598,0.9187169237504954,0.6125,1.0,1.0,15/96,14.51%,NOTUM;APOL1;ITIH2;SDC2;FAM20A;C3;SERPIND1;IGF1;KNG1;CP;PENK;SERPINA10;PLG;IGFBP6;TGOLN2
prerank,KEGG_2021_Human__Oocyte meiosis,0.39029922355789987,0.918555180770042,0.6097560975609756,1.0,1.0,22/107,21.77%,SGO1;BUB1;SPDYA;IGF1;CCNE2;PPP2R5A;STAG3;SPDYE1;SMC1B;SPDYE3;PKMYT1;ADCY7;SPDYE18;MAPK3;FBXO5;RBX1;YWHAH;SPDYE5;MAP2K1;CDC25C;CCNB1;ESPL1
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,0.5004078457888325,0.9183499624323255,0.5901639344262295,1.0,1.0,4/20,17.04%,PINK1;RPS27A;TOMM20;TOMM7
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Small Intestine,0.46341385076450986,0.9182535000572586,0.6376811594202898,1.0,1.0,4/35,3.48%,FBXL7;LOX;AOX1;TRIM62
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.3159243608364168,-0.9182024343180113,0.6875,1.0,1.0,33/101,24.51%,TEAD2;CD247;HES1;SHANK1;PARD3;LPXN;NDUFAF1;FANCA;MATN1;WASF3;TUBGCP2;PEX14;GEMIN5;LLGL1;CHCHD10;PARD6B;TRAF1;SNX9;NUP98;HFE;AFG3L2;CAPZA1;SEH1L;PML;TAPBP;KMT2A;CREBBP;TFAP4;TPR;OCLN;SLC7A9;LAMC1;PPIH
prerank,Reactome_2022__Insulin Processing R-HSA-264876,-0.4735567269746501,-0.9181641314356387,0.5769230769230769,1.0,1.0,5/24,17.47%,EXOC7;SLC30A5;PCSK1;RAB27A;SLC30A8
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.589313308926339,0.9181037441353259,0.5961538461538461,1.0,1.0,3/7,11.68%,ANGPT2;F7;F2RL1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.513005070508791,-0.9180200686438096,0.5405405405405406,1.0,1.0,6/11,16.35%,SPRY4;CREB3L1;SPRY1;SULF2;GPC1;SPRY2
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.3408103827110047,-0.9178850592545771,0.6111111111111112,0.9998353700554828,1.0,17/58,23.83%,DPM3;HHAT;ZDHHC23;ZDHHC5;ZDHHC16;ZDHHC14;ZDHHC18;ZDHHC3;PIGQ;PORCN;PIGW;GPLD1;PGAP3;ZDHHC20;PIGO;WIPI1;ATG7
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.5670003782047425,0.9178769584930945,0.5862068965517241,1.0,1.0,4/10,27.52%,PTGER3;SPX;CD74;EGF
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.45568630960122136,-0.9178692024296544,0.45714285714285713,0.9994285518646912,1.0,7/16,23.86%,WRAP53;CEP135;CORO2B;CHP1;CEP295;CEP120;PTP4A3
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.4841758825933836,-0.9178573313395487,0.6052631578947368,0.998991263396639,1.0,2/10,10.31%,SERPINE2;CHAC1
prerank,CellMarker_Augmented_2021__T cell:Spleen,0.4375625489314818,0.9178554937637963,0.5714285714285714,1.0,1.0,19/40,19.79%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;IKZF1;TAGAP;THEMIS;CD4;PSTPIP1;KLRB1;SIRPG;ITK;PARVG;ZAP70;TIGIT;CD8B;TNFSF8;CD5
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreatic Islet,-0.36941777089068206,-0.9178343162336745,0.5806451612903226,0.9985790724910103,1.0,12/53,11.11%,TRIB2;SLC38A5;SLC25A37;PSAT1;SERPINI2;CELA2A;ALB;AZGP1;PRSS3;CEL;NUPR1;AKR1C3
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.5142078092627883,0.9178115193073347,0.6119402985074627,1.0,1.0,2/16,14.74%,C3;MTCH1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.34063711000306857,-0.9176169847907094,0.6521739130434783,0.9981318453917297,1.0,6/60,6.71%,MYO10;PRKCD;LIMK1;CD247;PLD2;ARPC3
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.34063711000306857,-0.9176169847907094,0.6521739130434783,0.9981318453917297,1.0,6/60,6.71%,MYO10;PRKCD;LIMK1;CD247;PLD2;ARPC3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.47528391843691536,0.9175254466706712,0.5625,1.0,1.0,3/20,14.86%,P2RY6;TRDN;STAC
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,0.468779537420259,0.9175191607148893,0.5857142857142857,1.0,1.0,4/26,15.19%,FGF20;KLB;RPS27A;MAPK3
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.3940285929984714,0.9173653527314146,0.6785714285714286,1.0,1.0,10/115,9.35%,LRP4;LMOD1;TRIL;TSPAN11;FBXL7;TMEM35A;PCDH18;SLC17A8;TMEM200C;GFRA1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.41598894144904486,0.9173437796899894,0.6,1.0,1.0,10/65,14.62%,TLR2;CCL5;NLRP12;WNT5A;SH2D1B;IFNK;PLA2G7;TNFSF4;AGT;CYBA
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),-0.4721010013321647,-0.9173107656753797,0.5135135135135135,0.9984167902665237,1.0,2/11,12.03%,AUP1;BAG6
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.4639567267365665,-0.9172921254050582,0.5588235294117647,0.9979687207331027,1.0,3/13,13.47%,PEX7;DHRS7B;TMEM86B
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,-0.3323306804239554,-0.9172478301176991,0.6666666666666666,0.9975764716227957,1.0,17/103,12.31%,ADRA1A;ADRA1B;PRKCD;CALD1;ITPR2;PLA2G2C;KCNMB2;PLA2G5;PLA2G4C;GNAS;MYLK3;GNA11;ADCY3;ADCY2;EDNRA;RAMP1;EDN3
prerank,KEGG_2021_Human__Tuberculosis,0.3984450922481712,0.9172380966425905,0.6172839506172839,1.0,1.0,15/122,11.59%,ITGB2;TLR2;ITGAX;C3;TGFB1;ITGAM;FCGR3A;IL12A;SYK;HLA-DMA;TGFB3;HLA-DPB1;STAT1;ATP6AP1;CASP10
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.5253632562793147,0.9170994989522672,0.5081967213114754,1.0,1.0,3/12,11.12%,FTCD;GCHFR;SPR
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.32479334000928967,-0.9169283307940428,0.7222222222222222,0.9977505444381961,1.0,34/112,21.17%,PTGFRN;RHBDF1;ASS1;ERBB2;PTPRF;TMEM125;AGRN;PERP;INSRR;EPB41L4B;HID1;TMEM63B;GNA11;OGDH;DAB2IP;PCDH1;MAL2;FKBP9;GPC1;CDS1;TSPAN1;SDC4;ADCY6;SH3BP4;TNKS1BP1;CAMSAP3;ACO2;PTPN21;SYT7;ST14;CDC42BPB;TMEM117;HDAC11;EPB41L1
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.491247629030812,-0.9167596647189642,0.5813953488372093,0.997770734489685,1.0,5/12,29.32%,TET3;KMT2A;ZNF335;TET2;SETD1A
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.4192370415303834,-0.9166477863699896,0.6129032258064516,0.9975696600920111,1.0,7/24,13.20%,ST3GAL2;RRM2B;RRM2;GK5;G6PD;ALG11;ST3GAL4
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.6082970792076873,0.9166319046854635,0.6949152542372882,1.0,1.0,3/7,16.81%,REST;SOX9;SOX6
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,0.49003036636210384,0.916386797186755,0.6451612903225806,1.0,1.0,4/15,12.77%,CCNG2;CDKN1B;BTG1;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),0.5041495359596451,0.9163715667146565,0.5633802816901409,1.0,1.0,1/15,2.66%,CD160
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.42219357284251985,0.9162434162809381,0.6533333333333333,1.0,1.0,12/103,6.69%,CHRNA9;ESR1;C1QTNF1;C3AR1;LPAR1;GPR55;CAV3;GPER1;PTGER3;NMUR2;CXCR5;ACKR4
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.3708254627560722,-0.9161829270196014,0.6875,0.9982901916949546,1.0,5/55,11.39%,IFT88;AUP1;RAB7A;KLHL3;ATG2A
prerank,KEGG_2021_Human__Dilated cardiomyopathy,0.40208250653182676,0.9161227040677746,0.6049382716049383,1.0,1.0,14/81,14.32%,MYBPC3;SGCG;TGFB1;ITGA2;ITGB6;ACTG1;ITGA5;ADRB1;IGF1;TGFB3;PLN;AGT;ITGA2B;ADCY7
prerank,CellMarker_Augmented_2021__T1 (Transitional) B cell:Bone Marrow,0.4318471544765844,0.9161172949220902,0.6086956521739131,1.0,1.0,17/52,16.47%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;IKZF1;TAGAP;CD37;PSTPIP1;MYO1F;KLRB1;MME;SIRPG;PARVG;PIK3CG;CD244;ZAP70
prerank,CellMarker_Augmented_2021__Transitional B cell:Bone Marrow,0.4318471544765844,0.9161172949220902,0.6086956521739131,1.0,1.0,17/52,16.47%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;IKZF1;TAGAP;CD37;PSTPIP1;MYO1F;KLRB1;MME;SIRPG;PARVG;PIK3CG;CD244;ZAP70
prerank,CellMarker_Augmented_2021__T2 (Transitional) B cell:Bone Marrow,0.4318471544765844,0.9161172949220902,0.6086956521739131,1.0,1.0,17/52,16.47%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;IKZF1;TAGAP;CD37;PSTPIP1;MYO1F;KLRB1;MME;SIRPG;PARVG;PIK3CG;CD244;ZAP70
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.47903494083107523,-0.9160774324400079,0.5263157894736842,0.9980767815566571,1.0,5/12,31.76%,CTPS2;CDA;CRMP1;DPYSL2;DPYSL4
prerank,CellMarker_Augmented_2021__Neutrophil:Peripheral Blood,0.6074142292684355,0.9160408360621636,0.6557377049180327,1.0,1.0,6/8,15.41%,ITGAX;ITGAM;FCGR3A;CEACAM8;FPR1;IL3RA
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,0.45311610418617604,0.9159543887382535,0.6029411764705882,1.0,1.0,6/26,25.28%,SYT2;VAMP1;EEF2;MAP2K1;MAP2K4;HSP90AB1
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,-0.3773354079173813,-0.9159214298321349,0.6153846153846154,0.9980231344433642,1.0,8/36,13.20%,ST3GAL3;GLA;B4GALT2;B4GALNT1;ST3GAL2;ST3GAL5;B4GALT4;ST3GAL4
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.3916238452593398,0.9157265615452516,0.6153846153846154,1.0,1.0,16/99,15.66%,CDC25A;CCNG2;CCND2;CCND1;DDX3X;CCNE2;HMGA2;CDKN1B;CDKN1A;CCNA2;CSF1R;CCNI;PKMYT1;CDKN2C;CDK5R1;MTCP1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tooth,0.565810497850088,0.9156998897463664,0.603448275862069,1.0,1.0,2/9,16.35%,CD81;ENG
prerank,Reactome_2022__Synthesis Of Prostaglandins (PG) And Thromboxanes (TX) R-HSA-2162123,-0.4389072370000934,-0.9156600167037756,0.5,0.9983314417919004,1.0,4/14,11.11%,PTGS1;HPGD;PTGR2;AKR1C3
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.4341454002551173,-0.9156595247812138,0.6363636363636364,0.9978546837012643,1.0,6/29,11.09%,WWC1;PTCH1;NKD1;KIAA0319;PTPRS;WWC2
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.48604666869215646,0.9156334412202493,0.5666666666666667,1.0,1.0,1/15,3.56%,A4GALT
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.3002008136754156,-0.915413055198677,1.0,0.9978625003900532,1.0,129/787,14.93%,PER2;CD38;ETV5;KCNIP3;PLK3;ZNF25;PRDM5;ZNF703;GFI1B;OSR1;GATAD2A;BCL6;WWC1;TWIST1;IKZF4;PTCH1;IFI16;HDAC10;FOXO1;SAP130;TWIST2;CREB3L1;ZNF133;NR4A3;CIART;ZNF69;CBFB;WWP2;ZNF596;KLF10;PRICKLE1;THAP7;CTCF;HES1;NFX1;SMYD2;HIC2;MAP3K10;MEN1;CRY1;LBH;PHC2;KDM8;CRYM;ZNF239;PCGF1;ZNF75A;LRRFIP1;PA2G4;IGBP1;ASCL1;ZNF764;ZNF3;E2F6;KDM2B;DLX1;MTERF3;FLNA;NACC1;MACROH2A2;ZNF846;TGIF1;RARB;SNAI2;MECP2;POU6F1;SPDEF;NIBAN2;MLX;MLIP;HDAC3;LDB1;BPTF;NR1D1;NAB2;CBY1;PEX14;ZNF79;NKAP;ATF3;CREM;NR2C1;BCL11A;HEXIM2;ZBTB7A;SFMBT1;DNMT3A;WWC2;ZNF608;ZNF268;PCGF6;HSF1;KDM1B;RTF1;MIER2;ZNF589;ZNF263;DAB2IP;ZNF692;RING1;CUX1;FGFR2;YWHAQ;PER3;MPHOSPH8;KCTD1;SDCBP;SBNO2;MYBBP1A;ZNF557;TLE2;BAHD1;ZNF136;E4F1;FHL2;MED25;SIRT7;HIVEP1;LANCL2;RCOR2;TCF25;KLF8;GTF2IRD1;SMARCA4;NR1H2;SP2;ZBTB4;ZNF254;IMPACT
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.5023176626638705,-0.9153934520585512,0.5641025641025641,0.9974415475098815,1.0,1/10,3.46%,KIT
prerank,Reactome_2022__RUNX3 Regulates Immune Response And Cell Migration R-HSA-8949275,0.6505515551578612,0.9153782135037526,0.6721311475409836,1.0,1.0,1/5,1.29%,RORC
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.5458703361233408,0.9152380262559434,0.6811594202898551,1.0,1.0,2/12,3.49%,TULP1;RP1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.43124161334301536,0.9151881909332288,0.5797101449275363,1.0,1.0,7/43,21.53%,UBE2L6;CALB1;RPS27A;NPPA;TGFBI;SIAH1;B2M
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),-0.5811383949061784,-0.9150810779307744,0.631578947368421,0.9972433756828205,1.0,4/7,5.58%,HNMT;AMDHD1;HDC;CARNMT1
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),-0.5811383949061784,-0.9150810779307744,0.631578947368421,0.9972433756828205,1.0,4/7,5.58%,HNMT;AMDHD1;HDC;CARNMT1
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.44053703233356195,-0.915023792996648,0.5757575757575758,0.9968477850865048,1.0,8/23,19.05%,PRKCD;CDH5;SYMPK;PTBP1;PPP1R7;PPIA;PTPA;CAMTA1
prerank,CellMarker_Augmented_2021__DCLK1+ Progenitor cell:Large Intestine,0.40499087231823583,0.9148971657508168,0.5384615384615384,1.0,1.0,16/85,11.77%,OLFML1;LPAR1;LOX;CTHRC1;C3;COL6A6;OGN;PDGFRL;TTYH2;PIEZO2;DCN;RERG;COL1A1;ASPN;SCUBE2;COLEC12
prerank,KEGG_2021_Human__Glioma,-0.3619381597315997,-0.9147623852524215,0.6060606060606061,0.9969477652297799,1.0,4/68,6.89%,CAMK1G;SHC3;SHC4;TGFA
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.45109257047361795,-0.9147109993866634,0.4838709677419355,0.996564913099375,1.0,3/17,11.94%,TWIST1;SNAI2;ARMC10
prerank,Reactome_2022__Infectious Disease R-HSA-5663205,0.3502339471339033,0.9146878375705889,0.7894736842105263,1.0,1.0,158/794,23.15%,PSMB9;C1QTNF1;BLNK;C3AR1;TLR2;ACE2;SDC2;GPHB5;GNAT3;C3;GPR27;GNG12;SYT2;TSHR;TGFB1;NLRP12;RPL37A;RPL21;SCTR;DDX20;WNT5A;SFTPD;HLA-F;ACTG1;TRIM25;WAS;SYK;H2BC4;VAMP1;RPL9;NT5E;GGT5;ADRB1;TAF5;RAMP3;ATP1A4;REST;GNG4;RPL18A;ZDHHC11;RXFP2;HCK;NCKIPSD;HLA-A;RPS9;GTF2E1;RPL3;RPL36;RPL13A;RPS16;RPL15;GEMIN4;RPS5;RPS27A;RPS3A;MOGAT1;STAT1;AP1M2;RPL41;VPS18;CD4;TAF7;PSTPIP1;RPS12;RPS4X;RPL27A;NFKB2;SNRPD2;NOXO1;RPS19;CALCR;FAU;PSMC5;SAP30L;ADCY7;RPS21;H2BC18;CYBA;MASP2;MASP1;HMGA1;MAPK3;ISG15;RPL32;TAF7L;MOGAT2;FKBP4;PTRH2;RPL11;RPL23A;EEF2;TAF10;RPL35A;RPS11;RCC1;TAF13;KPNA5;RPS13;PARP14;RPS7;PARP4;DYNLL1;VAV3;GNAZ;TAF9B;IMPDH2;NOX1;CD8B;TXNIP;RSL24D1;RPLP2;RPL7;RBX1;RPL38;YWHAH;PSMA3;DUSP16;DOCK2;PSMB6;RPS15A;SH3GL3;MAP2K1;G3BP1;IL1R1;RPSA;RPLP0;RPS6;RPL35;CALCB;PSMD6;GNGT1;GNB4;GANAB;IFIH1;PARP9;RPL27;TAF6;RPS14;RPL7A;GPS2;H2AC25;B2M;RBBP7;RPL23;MTA2;RPS15;XRCC6;YWHAG;PARP10;TKFC;HNRNPK;CHMP1A;RPS27;CBLL1;LRIG1;PRMT1;DYNLL2;GNL3
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,0.4257541115842217,0.9146543017857901,0.6086956521739131,1.0,1.0,10/41,15.82%,H1-0;H2BC4;H2AZ1;CCNE2;HMGA2;CDKN1B;CDKN1A;CCNA2;HMGA1;ARTN
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3777072487946501,0.9140980662620496,0.6,1.0,1.0,11/120,13.08%,AIM2;TLR2;TRIM62;CARD14;WNT5A;TRIM25;NLRC4;TRIM68;RPS27A;NFKB2;AGT
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.5404373714051821,0.9139481914477484,0.625,1.0,1.0,4/10,16.38%,CD81;P2RY12;MTUS1;CSF1
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.4615080459620099,0.9139020558410085,0.625,1.0,1.0,4/45,3.98%,SMOC1;MAB21L1;FREM2;HIPK1
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,0.4609980654283683,0.9138394121264597,0.6567164179104478,1.0,1.0,6/31,15.19%,DAND5;CDKN2A;ID1;RPS27A;CDKN2C;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.5648029548496811,0.9138311059233266,0.5441176470588235,1.0,1.0,1/7,5.31%,WNT5A
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.47927092399713067,-0.9138158106820635,0.625,0.9984300548544045,1.0,2/15,3.43%,BCL6;FOXO1
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.5413011600677268,0.9136376084214549,0.6557377049180327,1.0,1.0,5/11,30.10%,DDX3X;PARK7;KAT5;RAPGEF3;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.43715360098406436,0.9136129171302589,0.5975609756097561,1.0,1.0,7/55,10.19%,CDC25A;ANXA1;DTL;CCND2;CCND1;DDX3X;RAB11A
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.544896078216025,-0.9134754282407955,0.6176470588235294,0.9987611218113903,1.0,3/7,24.78%,ITGA3;FYN;INSR
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.43760950072691385,0.9133929770267426,0.5540540540540541,1.0,1.0,2/42,3.60%,TLR2;HAMP
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.39850291228565643,-0.9131120787322725,0.5757575757575758,0.999232217383523,1.0,7/32,14.04%,GPRC6A;CAPN2;CPEB1;GLRA3;GRIN1;NEURL1;MEAK7
prerank,CellMarker_Augmented_2021__Endocrine cell:Embryonic Stem Cell,0.41899379536428727,0.9130337185728572,0.573170731707317,1.0,1.0,16/74,18.04%,MACC1;GPRIN2;CYYR1;RARRES1;FUT2;MUC4;DUOX1;FBLIM1;LAMC2;B3GNT5;L1TD1;MYL9;SPINT1;NSUN7;ITGB8;CYB5R2
prerank,CellMarker_Augmented_2021__Endocrine cell:Undefined,0.41899379536428727,0.9130337185728572,0.573170731707317,1.0,1.0,16/74,18.04%,MACC1;GPRIN2;CYYR1;RARRES1;FUT2;MUC4;DUOX1;FBLIM1;LAMC2;B3GNT5;L1TD1;MYL9;SPINT1;NSUN7;ITGB8;CYB5R2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.4477657962459909,0.9130118543231273,0.5932203389830508,1.0,1.0,9/38,17.87%,CCL5;IL12A;OGN;IGF1;STAT1;THBS1;ELANE;ELN;NOX1
prerank,CellMarker_Augmented_2021__Germline Stem cell:Ovarian Cortex,0.4182458588944155,0.912946500320934,0.6375,1.0,1.0,23/77,26.23%,RRAS;C3;AXL;IFIT1;ADGRL4;VWF;WBP2;FTH1;IFI6;MT1M;MYL9;EHD2;GBP1;IL1R1;IFIT3;MYOF;MT2A;SCN1B;CRYAB;IGFBP7;BGN;MROH2B;CLU
prerank,CellMarker_Augmented_2021__Germinal Stem cell:Ovary,0.4182458588944155,0.912946500320934,0.6375,1.0,1.0,23/77,26.23%,RRAS;C3;AXL;IFIT1;ADGRL4;VWF;WBP2;FTH1;IFI6;MT1M;MYL9;EHD2;GBP1;IL1R1;IFIT3;MYOF;MT2A;SCN1B;CRYAB;IGFBP7;BGN;MROH2B;CLU
prerank,"Reactome_2022__SMAC, XIAP-regulated Apoptotic Response R-HSA-111469",0.5763792186175286,0.9128099715987869,0.6619718309859155,1.0,1.0,1/7,4.13%,CASP7
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4265916265127362,0.9127628139432168,0.6282051282051282,1.0,1.0,9/76,8.04%,RASGRP4;PDE6H;CCL5;C3;PDE6A;GPER1;GRK7;RAMP3;GNG4
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.5321837669867797,0.9127047446381577,0.5846153846153846,1.0,1.0,1/12,7.73%,ATP1A4
prerank,CellMarker_Augmented_2021__Muller Glia Precursor cell:Retina,-0.37139877037529034,-0.9125280275291426,0.5454545454545454,0.9972445989698524,1.0,6/80,4.31%,IL7R;EMP1;GBP2;IFI16;STK10;SLFN5
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Myometrium,-0.37139877037529034,-0.9125280275291426,0.5454545454545454,0.9972445989698524,1.0,6/80,4.31%,IL7R;EMP1;GBP2;IFI16;STK10;SLFN5
prerank,CellMarker_Augmented_2021__Prostate Stem cell:Prostate,-0.37139877037529034,-0.9125280275291426,0.5454545454545454,0.9972445989698524,1.0,6/80,4.31%,IL7R;EMP1;GBP2;IFI16;STK10;SLFN5
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Amniotic Fluid,-0.37139877037529034,-0.9125280275291426,0.5454545454545454,0.9972445989698524,1.0,6/80,4.31%,IL7R;EMP1;GBP2;IFI16;STK10;SLFN5
prerank,CellMarker_Augmented_2021__Myometrial Stem cell:Myometrium,-0.37139877037529034,-0.9125280275291426,0.5454545454545454,0.9972445989698524,1.0,6/80,4.31%,IL7R;EMP1;GBP2;IFI16;STK10;SLFN5
prerank,CellMarker_Augmented_2021__Serous Acinar cell:Salivary Gland,-0.37139877037529034,-0.9125280275291426,0.5454545454545454,0.9972445989698524,1.0,6/80,4.31%,IL7R;EMP1;GBP2;IFI16;STK10;SLFN5
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Oral Cavity,-0.37139877037529034,-0.9125280275291426,0.5454545454545454,0.9972445989698524,1.0,6/80,4.31%,IL7R;EMP1;GBP2;IFI16;STK10;SLFN5
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.42058513197287156,-0.9123409898855457,0.5882352941176471,0.997246562835917,1.0,8/28,19.05%,PRKCD;CDH5;SYMPK;PTBP1;PPP1R7;PPIA;PTPA;CAMTA1
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Hair Follicle,0.44185632904720074,0.9122267424727307,0.6388888888888888,1.0,1.0,8/60,5.88%,SCGB3A2;LRAT;TUNAR;CTCFL;ZNF738;CCDC172;SALL4;CA14
prerank,CellMarker_Augmented_2021__Amnion Epithelial cell:Amniotic Membrane,0.44185632904720074,0.9122267424727307,0.6388888888888888,1.0,1.0,8/60,5.88%,SCGB3A2;LRAT;TUNAR;CTCFL;ZNF738;CCDC172;SALL4;CA14
prerank,Reactome_2022__Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,-0.463650288261917,-0.9120068895346936,0.5526315789473685,0.9976130784432333,1.0,2/19,6.66%,PDE10A;NANOS3
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.47689438683299257,0.9118780974479674,0.6101694915254238,1.0,1.0,3/18,11.77%,IFNK;IFIT1;COLEC12
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,-0.391109581535047,-0.911623201263215,0.52,0.9980885616455758,1.0,8/32,17.40%,APOE;HDAC3;AGO2;KDM1B;TNRC6C;NR1H2;ABCG1;TNRC6A
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.45221238659816276,-0.911562637648801,0.5833333333333334,0.9977501954119683,1.0,3/21,11.59%,DGKD;PGS1;DAGLA
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),-0.5459168245364093,-0.9115468185546425,0.6078431372549019,0.9972847361337097,1.0,3/7,18.01%,SNAI2;FGFR2;MED1
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",0.4673321713770313,0.9115192892552278,0.5671641791044776,1.0,1.0,1/16,11.00%,RPS27A
prerank,Reactome_2022__SMAC (DIABLO) Binds To IAPs R-HSA-111463,0.5975891944198429,0.9114199134051442,0.6323529411764706,1.0,1.0,1/6,4.13%,CASP7
prerank,Reactome_2022__Activation Of Caspases Thru Apoptosome-Mediated Cleavage R-HSA-111459,0.5975891944198429,0.9114199134051442,0.6323529411764706,1.0,1.0,1/6,4.13%,CASP7
prerank,GO_Biological_Process_2021__regulation of catecholamine uptake involved in synaptic transmission (GO:0051940),0.5948980329008832,0.9114128455291025,0.6,1.0,1.0,1/5,15.56%,TOR1A
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.42154866653839923,-0.911327545943963,0.45161290322580644,0.997456479969907,1.0,9/28,23.69%,TUBGCP2;TPPP3;CCDC57;MAP7D3;AKAP9;MAPT;TRPV4;CSNK1D;TUBG1
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.4003723087487368,-0.9112759511446821,0.5161290322580645,0.9971370760914585,1.0,7/27,13.20%,ST3GAL3;B4GALT2;ST3GAL2;CHST6;PRELP;B4GALT4;ST3GAL4
prerank,Reactome_2022__CS/DS Degradation R-HSA-2024101,-0.4598130800407922,-0.9111005663859139,0.6,0.9970784973193205,1.0,5/12,14.57%,ARSB;SPAM1;VCAN;IDUA;CSPG5
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.5067732055018441,0.9104668270421546,0.59375,1.0,1.0,2/20,13.28%,HSPA8;LAMP2
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.33972439282276046,-0.9104245681174419,0.5882352941176471,0.9982916984089928,1.0,11/77,7.36%,BAMBI;CDH5;FOS;DUSP15;F11R;ACVR1;PARD3;LPXN;FNTA;TGFBR3;TWSG1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.3242605724248406,-0.9103706116960457,0.5555555555555556,0.997960246566359,1.0,21/118,12.23%,SLITRK6;KIRREL3;GPC6;NLGN3;GPC4;PTPRF;PPFIBP2;SLC8A3;CACNB1;AGRN;CX3CR1;SNCB;SLITRK2;PCDHB6;SDK2;NLGN2;PTPRS;CHRNA1;PCDHB9;LRFN4;NRXN2
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,0.3636831227517534,0.9102538819285454,0.686046511627907,1.0,1.0,39/231,21.25%,SGO1;KIF14;BUB1;CENPU;MYH11;ACTG1;WAS;H2BC4;ERCC6L;NDC80;H2AZ1;MYL6;NCKIPSD;RHOB;KIF18A;PPP2R5A;SKA2;RTKN;CDKN1B;NOXO1;RHOG;CYBA;NUF2;MAPK3;RHOQ;SPC25;MYL9;BUB1B;DYNLL1;ITGB3BP;NOX1;PKN3;YWHAH;CENPN;CENPL;CDC25C;H2AZ2;CENPS-CORT;IQGAP2
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.4007115200166766,0.9102063593875807,0.6125,1.0,1.0,11/94,13.99%,TBX1;PKP2;TGFB1;HEY2;ERBB4;FLT4;HEG1;POPDC2;CDKN1B;CDKN1A;SOX9
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.5081089250047853,0.9100282432624707,0.5806451612903226,1.0,1.0,8/23,23.96%,IL12A;HLA-DPB1;TNFSF4;IGLL1;SIRPG;HLA-DPA1;XRCC6;PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.46949703344171234,-0.9099876300997048,0.6,0.9985547760545594,1.0,3/10,27.35%,DAB2IP;LRP8;COBL
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.4883750557152944,-0.9099763790548291,0.5555555555555556,0.9981025670634127,1.0,4/14,8.48%,TBC1D10A;IFI16;PERP;RIPK2
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.42509632207646825,0.909932433569085,0.6052631578947368,1.0,1.0,9/54,12.86%,ANXA1;ALOX12;CERS3;WNT5A;FLG;FLG2;TMEM79;COL1A1;ALOX12B
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.45439171219059127,0.909813347507984,0.5857142857142857,1.0,1.0,1/31,0.67%,SLC25A31
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4887928667972429,0.9095892928729339,0.625,1.0,1.0,9/28,22.89%,WNT5A;AXL;C1QTNF4;IL7;CD300LF;CSF1;PARP14;PARP9;CD74
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),0.4299360757953761,0.9095551626663776,0.6216216216216216,1.0,1.0,12/51,12.45%,SP100;TRIM62;PTAFR;HLA-F;TRIM25;IRF1;HCK;HLA-A;TRIM68;HLA-DPB1;STAT1;OAS2
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,0.41067716270806204,0.9094471090023151,0.5833333333333334,1.0,1.0,8/63,20.47%,PSMB9;RPS27A;CCNA2;PSMC5;BUB1B;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),-0.570717944082485,-0.9093083098940611,0.5348837209302325,0.9991377128847304,1.0,3/5,38.87%,AXIN1;CSNK1A1;APC
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periosteum,-0.3356502687628404,-0.9092960358832561,0.5,0.9987037799260551,1.0,31/95,16.75%,ADAMTS12;CALD1;COL4A2;COL12A1;MMP2;FRMD6;ARSJ;RND3;KITLG;PARVA;FSTL1;NTN4;SERPINE1;SNAI2;EFEMP1;ITGA3;PAM;NECTIN3;EDNRA;ALCAM;ANTXR1;NAV2;AMOTL2;CHST3;FKBP9;CDH11;COL5A2;COL4A1;TNFRSF11B;EXT1;DDAH1
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.3753643606824074,0.9092242944637008,0.6551724137931034,1.0,1.0,40/183,20.79%,ENPP2;C1QB;LPAR1;GP1BA;LYVE1;A4GALT;CYYR1;VSIG4;SLC6A4;SOCS2;RAMP3;ARMCX3;HGF;ADGRL4;PLAU;HPGDS;CFD;VWF;DCN;DAB2;PDK4;TCF7L1;EDNRB;IL4;SLCO2B1;CXCL12;KCNE3;CYBRD1;A2M;SMPX;GNAZ;FPR3;KCTD12;KDELR3;GPR34;IL1R1;SMARCA1;IL2RA;ENO2;SHROOM4
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.439383211174787,0.9090596396861254,0.5733333333333334,1.0,1.0,3/29,9.76%,ACOX2;HSD3B7;CYP39A1
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),0.5742414886112843,0.9088990070809726,0.6333333333333333,1.0,1.0,1/7,7.68%,HSD17B2
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),-0.6032813583657439,-0.9087897929468286,0.6842105263157895,0.9996229330878142,1.0,1/5,10.06%,SLC15A4
prerank,CellMarker_Augmented_2021__Stem cell:Liver,-0.42546799015738346,-0.9085681982610215,0.5294117647058824,0.9996298008422225,1.0,4/18,13.60%,KIT;LGR5;MSI1;AFP
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.45185366796026094,0.9085346082318396,0.5797101449275363,1.0,1.0,8/35,23.80%,DTL;TRIM25;RAG1;RBX1;ATXN7L3;WAC;PAF1;PEX12
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.5249622334117219,0.9082597940229954,0.6333333333333333,1.0,1.0,1/13,0.35%,TBX1
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.3951405204868941,-0.9082108114016993,0.5882352941176471,1.0,1.0,7/46,13.17%,HDAC7;HDAC10;MAML1;GATD3;HDAC3;MAMLD1;TLE2
prerank,CellMarker_Augmented_2021__Stem cell:Placenta,0.3937772132052086,0.9081910628500044,0.6710526315789473,1.0,1.0,22/89,16.35%,C1QTNF1;TIMP3;PRRX1;LOX;ITGBL1;NT5E;ANGPTL2;AXL;HEG1;PDCD1LG2;ADGRL4;COL6A2;DCN;COL1A1;PLAT;IGFBP6;DDR2;TGFBI;MYL9;EHD2;CYBRD1;ENG
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Breast,0.3937772132052086,0.9081910628500044,0.6710526315789473,1.0,1.0,22/89,16.35%,C1QTNF1;TIMP3;PRRX1;LOX;ITGBL1;NT5E;ANGPTL2;AXL;HEG1;PDCD1LG2;ADGRL4;COL6A2;DCN;COL1A1;PLAT;IGFBP6;DDR2;TGFBI;MYL9;EHD2;CYBRD1;ENG
prerank,Reactome_2022__Erythropoietin Activates RAS R-HSA-9027284,-0.4681620155162371,-0.9081680240932992,0.6,0.9996495472275492,1.0,5/13,23.98%,RAPGEF1;EPOR;CRKL;HRAS;IRS2
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.39567561971922904,-0.9078836548023309,0.5416666666666666,0.9998070778214001,1.0,9/42,22.03%,GTF2H2;ERCC2;SSRP1;POLR2F;POLR2C;ELOA;CCNT1;CTDP1;GTF2F2
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.5659111778469788,0.9076685126442544,0.711864406779661,1.0,1.0,2/9,2.37%,DBH;DAO
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.5311536242054857,0.9075542453439527,0.6212121212121212,1.0,1.0,2/15,13.50%,RENBP;CHST4
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.5135828135736135,-0.9074880869431938,0.5952380952380952,1.0,1.0,1/7,1.08%,ZNF703
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.41808472858492557,0.9074738897126708,0.64,1.0,1.0,4/44,6.23%,ANGPT2;FGF2;TGFB1;STAT5A
prerank,CellMarker_Augmented_2021__Muscle cell:Embryoid Body,0.390506724917257,0.9073564936625939,0.6,1.0,1.0,9/85,9.64%,CASQ2;LMOD1;TRIL;FBXL7;TMEM100;PCDH18;ANGPTL2;COL21A1;TRDN
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.41342417715595037,-0.9072786009065142,0.5757575757575758,1.0,1.0,8/31,25.48%,KDM8;NR1D1;IRGM;CCDC88C;CREBBP;PRKN;SNCA;HTT
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,0.4937788104773835,0.9071566597542197,0.6440677966101694,1.0,1.0,2/17,7.73%,SLC38A3;ATP1A4
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.47838871713891457,0.9071260459198432,0.5774647887323944,1.0,1.0,6/19,16.69%,CD160;HLA-F;IL12A;CRTAM;PIK3R6;RASGRP1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.5048216825456826,0.9070502354116923,0.6575342465753424,1.0,1.0,1/22,2.62%,SP100
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,0.45599720100698904,0.9069274177940284,0.65,1.0,1.0,7/26,21.53%,HCK;HLA-A;AP1M2;CD4;CD8B;DOCK2;B2M
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.3705167180134312,0.9067496184036489,0.6352941176470588,1.0,1.0,47/192,24.42%,PWP2;INTS5;RPL37A;RPL21;RPL9;RPL18A;RPS9;RPL3;RPL36;RPL13A;EXOSC8;RPS16;RPL15;EXOSC2;RPL41;RPL13;RPL27A;NOB1;NOP53;RPS19;EXOSC4;RPL32;RPL11;RPL23A;RPL35A;RPS7;WDR36;RPLP2;RPL7;RPL38;EMG1;RPLP0;RPS6;RPL35;RPL27;RPS14;RPL7A;INTS2;RPL24;RPL23;RPS15;WDR18;RPS27;RPL8;SENP3;WDR12;RPS24
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.47076568152940734,0.9066414132849603,0.6285714285714286,1.0,1.0,4/28,9.00%,TAPBPL;ERAP2;HLA-F;HLA-A
prerank,Reactome_2022__Acyl Chain Remodeling Of DAG And TAG R-HSA-1482883,-0.5396077682257512,-0.9065333476718284,0.6190476190476191,1.0,1.0,2/7,15.64%,PNPLA3;AWAT2
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.5396077682257512,-0.9065333476718284,0.6190476190476191,1.0,1.0,2/7,15.64%,PNPLA3;AWAT2
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.4168635657733518,-0.9065071070454318,0.5833333333333334,1.0,1.0,5/24,10.92%,XKR7;TYRO3;MEGF10;SCARB1;RHOBTB2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.33202168703233204,-0.9064309221256168,0.6,1.0,1.0,21/81,23.61%,GPC2;APOE;STYXL1;ARSB;NTRK1;RAPGEF1;P3H1;DAB2IP;ZNF804A;DBNL;MARK2;AVIL;ARHGAP35;LRP8;CUX2;FZD1;NTRK2;DHX36;MAGI2;SETX;PLK5
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.4013409656700838,0.9064208247591439,0.5625,1.0,1.0,11/57,14.41%,BLNK;CLCF1;NFIL3;PTPRC;NFAM1;IFNK;AXL;IKZF1;CD4;LY6D;IL4
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.4309075551837007,-0.9063987521465741,0.5,1.0,1.0,4/26,15.56%,GTF2H2;ERCC2;POLR2F;POLR2C
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.478676389435516,0.9063603190011101,0.6164383561643836,1.0,1.0,2/23,4.58%,FGF2;CCDC39
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.37557179549711084,-0.9061217296720503,0.5483870967741935,1.0,1.0,22/50,25.80%,PHLDB2;PTPRA;PTPRJ;LDB1;SLK;LIMS1;RHOA;ABL1;CAMSAP3;COL16A1;ARHGAP6;VCL;TSC1;DUSP3;PPM1F;FAM107A;S100A10;SRC;PEAK1;BCAS3;TEK;DAPK3
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.3760510644396479,-0.906115903088964,0.6153846153846154,1.0,1.0,9/55,14.05%,DNMT1;SAP130;POLR1A;GTF2H2;ERCC2;BAZ2A;H2AJ;POLR2F;TAF1B
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.5202989907776099,0.9060878134556652,0.6557377049180327,1.0,1.0,3/18,12.89%,SLC5A2;SLC5A9;SLC5A1
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,0.45768632938184917,0.906085168432888,0.6571428571428571,1.0,1.0,4/35,11.26%,ACTL6A;CCND1;H2AZ1;SMARCE1
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3447029429312187,-0.9060377000770798,0.6190476190476191,0.9997784899181579,1.0,18/80,22.46%,KIF2B;KDELR1;COG4;KIF15;GBF1;KIF4B;ATP9A;KIF1C;COG7;KIF26A;DNAJC28;PITPNB;ERGIC1;STX18;ATP9B;TAPBP;RAB6A;TMED3
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.497662728715275,-0.9059552201326077,0.5897435897435898,0.9995513792291094,1.0,2/13,5.18%,KIT;PDZD7
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.6202489801640139,0.9058824808498496,0.660377358490566,1.0,1.0,1/5,13.45%,GPSM2
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,0.38863102190107546,0.9058061030563282,0.6794871794871795,1.0,1.0,21/109,18.48%,TIMP3;TGFB1;MANF;IGF1;F8;HSPA5;KNG1;TGFB3;VWF;SELENOP;CD63;THBS1;LAMP2;ITGA2B;PLG;ITIH4;TUBA4A;FERMT3;A1BG;TF;VEGFC
prerank,KEGG_2021_Human__Apoptosis,-0.3332298378412342,-0.9057763631669324,0.6842105263157895,0.9994563405283636,1.0,12/121,8.24%,NGF;BCL2;FOS;CFLAR;ITPR2;MAP3K14;BCL2A1;TP53AIP1;CAPN2;TUBA8;NTRK1;ERN1
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.4354632725032326,-0.9055621946788466,0.6,0.999553097292449,1.0,1/20,4.92%,MTFR2
prerank,Reactome_2022__Establishment Of Sister Chromatid Cohesion R-HSA-2468052,-0.49665614182256335,-0.9055601418033964,0.6046511627906976,0.9990868878254283,1.0,1/11,5.09%,ESCO2
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),0.5667239407880406,0.905459900899342,0.5873015873015873,1.0,1.0,3/5,30.87%,KDM3A;TPI1;TKT
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.5407104011655663,0.9054529694555492,0.6226415094339622,1.0,1.0,1/9,1.64%,PPP1R3B
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.4073717699863598,0.9054276964532036,0.5641025641025641,1.0,1.0,4/56,9.64%,ACSL5;TNFRSF1B;NPY;ACSL3
prerank,CellMarker_Augmented_2021__Immune cell:Breast,0.5686026548649782,0.9052133276772841,0.6307692307692307,1.0,1.0,2/5,6.27%,PTPRC;ANPEP
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.4621834655425936,-0.9051577412934332,0.5789473684210527,0.9996146646583122,1.0,6/19,24.64%,NR1H2;OSBPL6;NAXE;NFKB1;ABCB4;ABCA13
prerank,Reactome_2022__cGMP Effects R-HSA-418457,-0.47445164157560243,-0.9050894606803864,0.6153846153846154,0.9992864576105605,1.0,1/14,0.87%,PDE10A
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,0.4274820612295223,0.9047583105885839,0.64,1.0,1.0,8/70,15.19%,MAPKAPK3;CBX8;H2BC4;CDKN2A;H2AZ1;RPS27A;CDKN2C;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.5496418713028899,0.9046081862484372,0.639344262295082,1.0,1.0,3/10,15.08%,GPER1;IL4;CD300LF
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5459765604230854,0.9045500903193991,0.6140350877192983,1.0,1.0,5/8,25.38%,NPPA;LRRC38;LRRC55;ALG10B;NOS1AP
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH3 (MutSbeta) R-HSA-5358606,-0.42077449166503367,-0.9044106146167364,0.625,1.0,1.0,3/14,6.63%,EXO1;POLR1A;POLD3
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,-0.4002673082230735,-0.9043051566029555,0.5714285714285714,1.0,1.0,2/27,1.33%,G6PC3;ENO3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.4680632565278039,-0.9043050814246741,0.5526315789473685,0.9996777144972713,1.0,4/13,13.32%,CPSF1;ERN1;CSTF2;CPSF7
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.6009605974254257,0.9041783462801585,0.6825396825396826,1.0,1.0,2/6,9.22%,PRR5L;PINK1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.41522425186488515,0.9039783212049818,0.6081081081081081,1.0,1.0,9/67,12.60%,ACSL5;LIPH;OLAH;LIPI;ACSM3;MBOAT1;ACSM6;SCD;FDFT1
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Embryo,0.39571299579469404,0.9037311461081267,0.5789473684210527,1.0,1.0,13/93,11.00%,PRRX1;LMOD1;TSPAN11;FBXL7;ADAM33;FGF2;TMEM35A;PCDH18;SCARA3;ANGPTL2;ADGRL4;DCN;COL1A1
prerank,CellMarker_Augmented_2021__Fibroblast:Embryonic Stem Cell,0.39571299579469404,0.9037311461081267,0.5789473684210527,1.0,1.0,13/93,11.00%,PRRX1;LMOD1;TSPAN11;FBXL7;ADAM33;FGF2;TMEM35A;PCDH18;SCARA3;ANGPTL2;ADGRL4;DCN;COL1A1
prerank,CellMarker_Augmented_2021__Retinal Ganglion cell:Embryonic Stem Cell,0.39571299579469404,0.9037311461081267,0.5789473684210527,1.0,1.0,13/93,11.00%,PRRX1;LMOD1;TSPAN11;FBXL7;ADAM33;FGF2;TMEM35A;PCDH18;SCARA3;ANGPTL2;ADGRL4;DCN;COL1A1
prerank,CellMarker_Augmented_2021__Testis Somatic cell:Testis,0.39571299579469404,0.9037311461081267,0.5789473684210527,1.0,1.0,13/93,11.00%,PRRX1;LMOD1;TSPAN11;FBXL7;ADAM33;FGF2;TMEM35A;PCDH18;SCARA3;ANGPTL2;ADGRL4;DCN;COL1A1
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Pancreas,0.39571299579469404,0.9037311461081267,0.5789473684210527,1.0,1.0,13/93,11.00%,PRRX1;LMOD1;TSPAN11;FBXL7;ADAM33;FGF2;TMEM35A;PCDH18;SCARA3;ANGPTL2;ADGRL4;DCN;COL1A1
prerank,CellMarker_Augmented_2021__Fibroblast:Synovium,0.39571299579469404,0.9037311461081267,0.5789473684210527,1.0,1.0,13/93,11.00%,PRRX1;LMOD1;TSPAN11;FBXL7;ADAM33;FGF2;TMEM35A;PCDH18;SCARA3;ANGPTL2;ADGRL4;DCN;COL1A1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Blood Vessel,0.39571299579469404,0.9037311461081267,0.5789473684210527,1.0,1.0,13/93,11.00%,PRRX1;LMOD1;TSPAN11;FBXL7;ADAM33;FGF2;TMEM35A;PCDH18;SCARA3;ANGPTL2;ADGRL4;DCN;COL1A1
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5544774452714377,0.903722673234979,0.6666666666666666,1.0,1.0,3/13,19.66%,RENBP;CHST4;PGM3
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,0.3930931248882461,0.9037201524534397,0.6623376623376623,1.0,1.0,21/104,18.48%,TIMP3;TGFB1;MANF;IGF1;F8;HSPA5;KNG1;TGFB3;VWF;SELENOP;CD63;THBS1;LAMP2;ITGA2B;PLG;ITIH4;TUBA4A;FERMT3;A1BG;TF;VEGFC
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.4531486866636185,0.9036440809439423,0.5507246376811594,1.0,1.0,4/27,11.26%,KIF14;STMN4;VIL1;KIF18A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.3374685681001942,-0.9033378930045008,0.7,1.0,1.0,17/67,17.92%,NR4A1;GMNC;TRIM35;MEN1;HPGD;CAMK2N1;MYOCD;HEXIM2;NUPR1;BRINP1;PPP1R13B;CDK6;SCRIB;NLRP2B;IPO7;INHA;HTRA2
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.3865271748819241,0.9033304437680132,0.6626506024096386,1.0,1.0,18/93,23.72%,SGO1;KIF14;CEP55;NDC80;TEX14;RAB11A;KIF18A;CHMP3;NCAPG;PHF13;ANKRD53;SET;CCNB1;ESPL1;CHMP1A;BOD1;CDCA5;PSRC1
prerank,CellMarker_Augmented_2021__Periosteum-derived Progenitor cell:Periosteum,0.4044868533192097,0.9033244544303697,0.6388888888888888,1.0,1.0,19/89,16.68%,C1QB;PRRX1;LPAR1;C3;PTPRC;RARRES1;ANGPTL2;PDCD1LG2;ADGRL4;VWF;DCN;LACC1;TNS3;TGFBI;MT1M;CXCL12;MYL9;CYBRD1;FAM114A1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.45157366020248835,0.903289726321356,0.6031746031746031,1.0,1.0,4/28,4.27%,SP100;ANGPT2;FGF2;TGFB1
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.4784815848095767,0.9031630294710847,0.5671641791044776,1.0,1.0,2/25,4.58%,FGF2;CCDC39
prerank,CellMarker_Augmented_2021__Monocyte:Peripheral Blood,-0.4075854371373984,-0.903160922847572,0.5294117647058824,1.0,1.0,4/26,3.46%,CD38;KLRC1;CD14;KIT
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.4507387524828511,-0.902897897518165,0.5454545454545454,1.0,1.0,6/16,16.35%,SPRY4;CREB3L1;SPRY1;SULF2;GPC1;SPRY2
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.3710389172409164,-0.902463233453411,0.6551724137931034,1.0,1.0,14/43,23.53%,BUD23;LIN28B;ERN1;U2AF2;SIRT7;RIOK1;HRAS;WDR75;DXO;NMD3;HSPA1A;NFKB1;WDR43;SETX
prerank,Reactome_2022__Conjugation Of Salicylate With Glycine R-HSA-177128,-0.5322105678651812,-0.9022103954754358,0.675,1.0,1.0,2/6,6.85%,GLYATL1;GLYATL2
prerank,CellMarker_Augmented_2021__B cell:Fetal Liver,0.489834892454818,0.9021408658713004,0.6666666666666666,1.0,1.0,4/13,7.99%,BLK;BLNK;JCHAIN;NAPSB
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.5593294294641274,-0.9019615595734051,0.6341463414634146,1.0,1.0,2/7,7.88%,KIT;NFATC3
prerank,Reactome_2022__Glycolysis R-HSA-70171,-0.37087763858028006,-0.9019132600178447,0.6071428571428571,1.0,1.0,10/63,11.92%,NUP210;ENO3;NUP42;POM121C;PPP2R5D;NUP214;AAAS;PFKP;PFKFB3;PGP
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.5480462319226708,0.9018478022691863,0.6615384615384615,1.0,1.0,5/9,38.90%,ATP5MC3;ATP5PB;ATP5F1D;ATP5F1A;ATP5MC1
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.5568454691680225,0.9016823367681783,0.625,1.0,1.0,1/7,8.30%,DUSP22
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.5241023978699648,0.9014809422632617,0.6031746031746031,1.0,1.0,1/9,3.81%,PTPRC
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.462269541536052,-0.9014011584328678,0.5675675675675675,1.0,1.0,4/15,12.22%,PTCH1;TRIM71;PKD2;ALDH1A2
prerank,Reactome_2022__SHC-mediated cascade:FGFR4 R-HSA-5654719,0.5136261357098972,0.901371806991077,0.5666666666666667,1.0,1.0,2/15,8.32%,FGF20;KLB
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.47924788026459747,0.9012415024756769,0.6811594202898551,1.0,1.0,8/17,27.52%,CAV3;GRM6;PLN;CXCL12;PLPP4;SLC30A1;CTNNB1;EGF
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.4639962539540966,0.901111166838857,0.6666666666666666,1.0,1.0,4/30,10.91%,LRP2;TGFB1;VASP;CELSR1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.4639962539540966,0.901111166838857,0.6666666666666666,1.0,1.0,4/30,10.91%,LRP2;TGFB1;VASP;CELSR1
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.5258406276762765,-0.9005501988262374,0.6590909090909091,1.0,1.0,1/10,3.39%,HDAC10
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,0.5049889850702305,0.9004166595772922,0.6805555555555556,1.0,1.0,5/19,12.12%,CLCF1;CRLF1;OSMR;STAT1;LIFR
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.5815825261548551,-0.90040852145575,0.6153846153846154,1.0,1.0,3/5,38.16%,ALKBH3;ALKBH5;FTO
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.5455037021368874,-0.900377496675763,0.6216216216216216,1.0,1.0,2/6,17.47%,MTHFR;MTR
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.406787222291706,-0.9003317598910602,0.5714285714285714,1.0,1.0,11/30,25.35%,TRIM71;AGO2;TNRC6C;ZC3H7B;SNIP1;TNRC6A;XPO5;ADAR;TARBP2;RBM4;CNOT6
prerank,Reactome_2022__Signaling By NODAL R-HSA-1181150,0.4796818156579619,0.9003306032370417,0.6307692307692307,1.0,1.0,3/18,15.19%,DAND5;NODAL;MAPK3
prerank,KEGG_2021_Human__alpha-Linolenic acid metabolism,0.49515534091163377,0.9002434809750897,0.6428571428571429,1.0,1.0,1/16,0.98%,PLA2G10
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.49873383959001594,-0.9000845999830074,0.6666666666666666,1.0,1.0,1/9,2.59%,PTCH1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.4506741014481451,0.8997496784142597,0.6323529411764706,1.0,1.0,2/33,2.81%,RAB34;ATP6V1G2
prerank,CellMarker_Augmented_2021__T cell:Eye,0.39886172056908714,0.8997402321941914,0.6197183098591549,1.0,1.0,12/58,14.40%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;IKZF1;TAGAP;CD37;GPR183;ALOX5AP;ITK;PARVG
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.3841916188892586,0.899655761782521,0.654320987654321,1.0,1.0,34/134,17.87%,ITGB2;BLNK;C3AR1;TLR2;ANXA1;PTX3;CCL5;TGFB1;NFAM1;TRAF3IP2;PTGER3;AFAP1L2;GGT5;NLRC4;HPR;TNFSF4;TAC4;LIAS;XCR1;CRHBP;THBS1;ALOX15;CSF1R;FPR1;GPR68;IL4;CYBA;CD44;PIK3CG;HYAL1;PARP4;NOS2;FPR3;NOX1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.5594064338757141,0.8996196372772264,0.6363636363636364,1.0,1.0,3/7,16.35%,TGFB1;TGFB3;ENG
prerank,Reactome_2022__Voltage Gated Potassium Channels R-HSA-1296072,0.4327889831282532,0.8996035710343937,0.6285714285714286,1.0,1.0,4/39,8.30%,KCNA7;KCNA5;KCNS2;KCNG2
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.4103854456439612,0.8994877241104394,0.6338028169014085,1.0,1.0,17/52,25.71%,ACOX2;HSD3B7;FAXDC2;HSD11B2;CYP39A1;FDFT1;MSMO1;AMACR;INSIG1;FDXR;STAR;CYP21A2;SQLE;INSIG2;ABCB11;HMGCR;CYP17A1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.48987582754445697,0.8994323942956876,0.6111111111111112,1.0,1.0,5/15,19.83%,TGFB1;HEY2;SNAI1;HEY1;NOTCH2
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.504681841793748,-0.899198823797896,0.5625,1.0,1.0,3/8,12.03%,TWIST1;STAMBP;DAB2IP
prerank,Reactome_2022__Signaling By FGFR3 In Disease R-HSA-5655332,0.49646384022476125,0.8991136887873107,0.6190476190476191,1.0,1.0,1/18,2.58%,FGF20
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,-0.40030784702367456,-0.8990154485212896,0.5945945945945946,1.0,1.0,2/22,4.53%,EIF4EBP1;EEF2K
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.4471987431888413,-0.8989050276039128,0.5238095238095238,1.0,1.0,5/17,16.89%,STARD3NL;AKR1C3;CYP46A1;HSD3B2;AKR1C1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.642014862166086,0.8989035324925709,0.6721311475409836,1.0,1.0,3/5,26.00%,PINK1;PARK7;HIF1A
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.4919849538479353,0.8988990328521795,0.6363636363636364,1.0,1.0,2/10,10.00%,NOTUM;PPT1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.43564658850774807,0.898695729339046,0.6103896103896104,1.0,1.0,7/37,23.66%,TGFB1;ORMDL3;LATS2;GLUL;PARP9;YAP1;PARK7
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.46675525975755155,0.8986930189892509,0.6268656716417911,1.0,1.0,6/21,32.28%,CHMP3;GPSM2;CHMP1A;CHMP4B;DRG1;CHMP2B
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.4832477872321942,0.8986436039437212,0.6060606060606061,1.0,1.0,2/16,15.56%,SNAP23;TOR1A
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.4104213289224138,0.8986324887501056,0.7066666666666667,1.0,1.0,10/77,12.89%,SLC5A4;SLC5A2;SLC12A3;SLC6A4;ASIC5;ATP1A4;ASIC1;SLC5A9;SLC24A1;SLC5A1
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR3 R-HSA-5654708,0.48451928520961696,0.8985943005196052,0.5970149253731343,1.0,1.0,1/21,2.58%,FGF20
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.431010328881946,0.8985759978225255,0.5857142857142857,1.0,1.0,8/37,17.26%,TLR2;AFAP1L2;SYK;F2RL1;ELANE;ZNF580;CD244;NOS2
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.5038357140622611,0.8985583371201058,0.582089552238806,1.0,1.0,1/14,2.18%,SHCBP1L
prerank,CellMarker_Augmented_2021__Erythroid precursor:Bone Marrow,0.4105750513063106,0.8983324307532641,0.6438356164383562,1.0,1.0,11/75,15.73%,C19ORF38;MAPKAPK3;WAS;VASP;CD37;TMC8;TALDO1;RHOG;ARHGAP45;THOC6;FERMT3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.5202836977077978,-0.898312691189869,0.5666666666666667,1.0,1.0,2/6,21.86%,IQSEC1;DUSP3
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.5202836977077978,-0.898312691189869,0.5666666666666667,1.0,1.0,2/6,21.86%,IQSEC1;DUSP3
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,0.4432219922767189,0.8980254111136186,0.6231884057971014,1.0,1.0,4/35,15.19%,FGF20;KLB;RPS27A;MAPK3
prerank,KEGG_2021_Human__Viral carcinogenesis,0.36989293318494965,0.898001621869361,0.6075949367088608,1.0,1.0,24/158,15.19%,PIK3R3;SP100;C3;HLA-F;SCIN;STAT5A;SYK;H2BC4;CDKN2A;TBPL1;CCND2;H4C8;CCND1;DDX3X;HLA-A;GTF2E1;CCNE2;CDKN1B;CDKN1A;NFKB2;CCNA2;H2BC18;UBE3A;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.515498957464212,-0.8980008025389971,0.6486486486486487,1.0,1.0,1/7,1.32%,KLRC1
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.5845778569083947,-0.8978623181665051,0.6,1.0,1.0,2/5,16.68%,LDB1;MAFB
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4185273777995681,0.8977284724876812,0.6486486486486487,1.0,1.0,11/64,26.00%,PSMB9;RPS27A;PSMC5;RBX1;PSMA3;PSMB6;PSMD6;CITED2;PSMA7;PSMB1;HIF1A
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,0.3655668345962244,0.8977187866777058,0.6301369863013698,1.0,1.0,17/132,14.88%,ACOX2;LRP2;HSD3B7;SLC10A1;SLCO1A2;DAND5;SLC51A;HSD11B2;NR1H4;HSD17B2;PLPP6;CYP39A1;LDLRAP1;SCD;FDFT1;PKMYT1;CYP24A1
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),0.5952165661175225,0.8976925828701376,0.676923076923077,1.0,1.0,4/6,31.51%,TRNT1;PTCD1;SSB;HSD17B10
prerank,CellMarker_Augmented_2021__Paneth cell:Undefined,0.3889211838418829,0.8975051065983201,0.6395348837209303,1.0,1.0,23/85,29.13%,PRDX4;C1GALT1C1;STEAP1;PLPP6;SPR;B4GAT1;HSDL2;ALDH9A1;IDH1;ADH5;SLC44A3;AMACR;PCYOX1;MRPL19;FAM47E-STBD1;CISD1;MAGEF1;NDFIP2;MTX2;ARL1;PLPP1;COA3;PEBP1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.47267952874647845,0.8974768801903901,0.6491228070175439,1.0,1.0,5/16,25.75%,IFIT1;COLEC12;IFIH1;PQBP1;RIOK3
prerank,CellMarker_Augmented_2021__CD4+ Cytotoxic T cell:Liver,0.4178919671877019,0.8973591128475169,0.6794871794871795,1.0,1.0,14/65,20.22%,CCL5;PZP;PLEKHG3;SYNE2;FCGR3A;ADGRG1;MYO1F;CD244;A2M;GLUL;PLEKHA1;RAB29;PRSS23;LITAF
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3915224551577767,0.8972249943874144,0.6753246753246753,1.0,1.0,16/122,18.69%,ESR1;ACTL6A;SUV39H1;SMARCE1;BRDT;HMGA2;TCF7L1;FAM47E;TNP1;SOX9;SNAI1;TAF6L;MYB;PADI2;HCFC1;LRWD1
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.3356113686933089,-0.8971503984736493,0.8,1.0,1.0,18/82,19.32%,PRKCD;CDH5;ITPR2;THEM4;NANOS3;HSPB1;WASF3;MAPKAPK2;CRK;RHOA;PRKCA;FYN;MAPK12;ELMO1;AKT2;WASF2;HRAS;MLST8
prerank,Reactome_2022__Glutathione Synthesis And Recycling R-HSA-174403,0.5350237623850316,0.897135829750057,0.65625,1.0,1.0,3/9,20.88%,GGT5;CHAC2;GGCT
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,0.39124135053169634,0.8969355639595079,0.6842105263157895,1.0,1.0,13/102,17.41%,SGO1;BUB1;CENPU;ERCC6L;NDC80;KIF18A;PPP2R5A;SKA2;NUF2;SPC25;BUB1B;DYNLL1;ITGB3BP
prerank,Reactome_2022__Heme Degradation R-HSA-189483,0.5515951651221551,0.8968214669150026,0.639344262295082,1.0,1.0,3/9,15.20%,ABCG2;ABCC2;SLCO2B1
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),0.5322714034141772,0.8967503053912664,0.6818181818181818,1.0,1.0,1/9,6.14%,IL12A
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.41767826011661496,-0.8966218704093413,0.5862068965517241,1.0,1.0,1/39,0.51%,GCK
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.36918405542678173,-0.896616122444566,0.5769230769230769,1.0,1.0,10/43,17.09%,KCNJ16;KCNE1;KCNMB2;FLNA;KCNJ6;WNK2;WNK3;GABBR2;KCNH2;KCNN2
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.5093854401342566,0.8965644810124891,0.6612903225806451,1.0,1.0,1/14,1.65%,WNT8B
prerank,Reactome_2022__Scavenging By Class A Receptors R-HSA-3000480,-0.42552141455286563,-0.896509170488368,0.6216216216216216,1.0,1.0,3/16,4.78%,APOB;COL4A2;APOE
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",0.35670491477905775,0.8964078455284236,0.7142857142857143,1.0,1.0,38/219,18.48%,TIMP3;GP1BA;PIK3R3;GNAT3;GNG12;TRPC7;TGFB1;MANF;SYK;IGF1;F8;GNG4;HSPA5;KNG1;P2RY12;RHOB;TGFB3;VWF;SELENOP;CD63;THBS1;LAMP2;RHOG;ITGA2B;PLG;ITIH4;TUBA4A;MAPK3;PIK3R6;FERMT3;PIK3CG;BCAR1;A1BG;RASGRP1;VAV3;TF;PLA2G4A;VEGFC
prerank,Reactome_2022__Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.4300762181523107,-0.8963599790925544,0.5789473684210527,1.0,1.0,3/18,10.30%,SLC25A17;PEX13;PEX14
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,-0.3889744977486489,-0.8963428761547236,0.7083333333333334,1.0,1.0,10/47,19.41%,PRKCD;ERBB2;MATK;RHOA;PRKCA;FYN;NRG2;AKT2;HRAS;BTC
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.37281105595394143,-0.8961545945200218,0.6,1.0,1.0,12/64,20.18%,IWS1;GTF2H2;RTF1;ERCC2;SSRP1;POLR2F;LEO1;POLR2C;ELOF1;ELOA;CCNT1;CTDP1
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.5261008096372726,-0.8961323454561229,0.6046511627906976,1.0,1.0,1/8,1.49%,CBARP
prerank,KEGG_2021_Human__Ras signaling pathway,0.36290954278930376,0.8961135892279855,0.7142857142857143,1.0,1.0,13/189,8.21%,RASGRP4;PLA2G10;RRAS;PIK3R3;FGF20;ANGPT2;FGF2;GNG12;FLT1;FLT4;IGF1;GNG4;HGF
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3609023600039677,0.896066160419566,0.6746987951807228,1.0,1.0,18/182,11.98%,ESR1;S100A13;LPAR1;TRIM62;NLRP12;WNT5A;TRAF3IP2;TRIM25;NR1H4;PINK1;TRIM68;NLRC3;ECT2;TIFA;STAT1;CASP10;F2RL1;CD4
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.5631181871205169,0.8959727668517239,0.6451612903225806,1.0,1.0,2/8,11.67%,ITGA2;HMGA2
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.4544221049458542,-0.8957740217180938,0.5263157894736842,1.0,1.0,3/11,12.46%,SERPINE2;SERPINE1;PLGRKT
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.5097511725032744,0.8956118250590643,0.578125,1.0,1.0,4/9,29.98%,RPL11;HIF1A;COPS9;RPL5
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.555614387336536,0.8956020913670878,0.6617647058823529,1.0,1.0,4/8,32.00%,PAICS;SHMT2;DPYD;PRPS1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.49403346917709917,0.8955609729122457,0.5846153846153846,1.0,1.0,4/18,9.36%,TRIM62;TRIM25;AXL;TRIM68
prerank,Reactome_2022__FCGR Activation R-HSA-2029481,0.5342432143140201,0.895169687058452,0.6071428571428571,1.0,1.0,2/7,8.80%,SYK;HCK
prerank,Reactome_2022__Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.3969558478031819,-0.8950383464041203,0.5517241379310345,1.0,1.0,9/29,27.93%,SSRP1;POLR2F;POLR2C;ELOA;CCNT1;CTDP1;GTF2F2;GTF2F1;NELFCD
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.43676002752351367,-0.8947654097458323,0.5625,1.0,1.0,6/16,24.78%,DOC2B;RAB3D;RAB27A;CACNA1G;NLGN1;KCNB1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.37852223462734613,0.8943638452361804,0.686046511627907,1.0,1.0,30/109,27.36%,CLDN2;TRIL;SDC2;SLC13A4;MMP15;AGT;SOX9;BCAR1;FRZB;EFNB3;LAMB2;SLC44A3;ID4;SMARCA1;PTPRU;SLC4A2;CLDN1;CHMP1A;CPE;ARHGEF17;CDC42EP4;IGFBP5;DDR1;FLRT3;CGNL1;TMEM98;CLIC6;SLC26A11;WFS1;SLC31A1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.46592191767394175,0.8942975808823255,0.6461538461538462,1.0,1.0,3/18,9.00%,HLA-F;IL12A;HLA-A
prerank,Reactome_2022__Transport Of Nucleotide Sugars R-HSA-727802,0.5848730708267669,0.8941494670176627,0.7333333333333333,1.0,1.0,2/8,17.44%,SLC35C1;SLC35D2
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.3842334893678308,0.8940186440903163,0.6582278481012658,1.0,1.0,18/88,21.42%,PLA2G10;ACE2;CCL5;TGFB1;RAMP3;CDKN1A;SFRP4;CD63;AGT;THBS1;IL4;CSF1;CHCHD2;NFKBIA;RAB29;ROMO1;CCNB1;ANXA2
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.5011694792908579,0.8939150936838878,0.6268656716417911,1.0,1.0,2/15,7.86%,IHO1;STRA8
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.5901559600200476,-0.8938564260709527,0.675,1.0,1.0,1/5,5.56%,HES1
prerank,Reactome_2022__Immune System R-HSA-168256,0.33220271258484835,0.8936108380609151,0.85,1.0,1.0,203/1484,17.38%,NLRP4;RASGRP4;HERC3;IL21R;MICB;C1QB;ITGB2;MAPKAPK3;CLEC5A;PSMB9;BLK;BLNK;OSCAR;C3AR1;RORC;ARHGAP9;TCN1;MGST1;AIM2;TLR2;UBE2U;TNFRSF1B;FBXL7;ITGAX;ASB5;GMFG;HSPA8;CSF2RA;PIK3R3;ANXA1;PTX3;SP100;CD160;CCL5;ATP6V1G2;CLCF1;C3;TRIM62;UBE2L6;ARIH2;PTPRC;CLEC4C;PTAFR;SNAP23;TGFB1;CRLF1;ITGAM;NFAM1;PRDX4;FCAR;ERAP2;ASB14;PELI3;CLEC12A;HLA-F;FGL2;ACTG1;TRIM25;MUC17;WAS;SH2D1B;PLD4;CD81;IL12A;STAT5A;ANPEP;SYK;IL27;MUC4;MMP9;VASP;CD80;CA1;SOCS2;CHIT1;NLRC4;CD99;IL26;LAIR2;FLG2;GSDME;CCND1;CEACAM8;IFIT1;HSPA5;ENPP4;CPB2;C4BPA;IRF1;SPSB2;DDX3X;C4BPB;HCK;OSMR;NCKIPSD;HLA-A;PLAUR;PDCD1LG2;CSF3R;TRIM68;ASB15;TRAIP;ATP6V0E2;IL5;HLA-DMA;TRIM29;TMC6;PLAU;NLRC3;MUCL1;ASB17;TIFA;VTN;RPS27A;STAT1;RHOU;AP1M2;KIF18A;PPP2R5A;KLHL2;CASP10;BPIFB1;TNFSF4;COLEC12;CD4;DEFB109B;LIFR;CDKN1B;OAS2;PSTPIP1;FBXL13;IL7;CDKN1A;RNF138;TALDO1;CD63;PYGL;NFKB2;ALOX15;KLRB1;LAMP2;EEF1A1;CSF1R;FPR1;USP18;PDAP1;RHOG;ITM2C;OPRM1;ORMDL3;FBXL3;ARHGAP45;ITK;PSMC5;ELANE;FYB1;P2RX1;IL4;KBTBD7;CYBA;CD44;KLHL13;MASP2;UBE3A;CRTAM;FTH1;MASP1;ADGRE3;CD300LF;MAPK3;CYLD;ISG15;IFI6;IL3RA;FBXO40;NDUFA2;KBTBD6;STOM;AGER;IL17RB;EEF2;CSF1;BTN3A3;ZAP70;MSN;EDAR;A1BG;KPNA5;RASGRP1;MUC16;DEFB135;PGLYRP2;DYNLL1;SERPINB1;UBE2M;ATP6V0B;BTNL9;HRNR;ASB16;PRKG1;ATOX1;RAG1;VAV3
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.5548108134896571,0.8934772768548231,0.6615384615384615,1.0,1.0,2/9,3.37%,C1QTNF1;ALOX12
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.3718773500693715,-0.8932790549734406,0.5714285714285714,1.0,1.0,5/45,3.82%,SLC38A5;SLC25A29;SLC6A20;SLC25A45;SLC6A17
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4944951230539527,0.8932140064458337,0.6567164179104478,1.0,1.0,3/16,17.65%,CCDC39;AQP4;CABYR
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR4 R-HSA-5654716,0.49740289056012066,0.8931991757938276,0.6101694915254238,1.0,1.0,2/22,8.32%,FGF20;KLB
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.3838349947603226,-0.89305125421655,0.5666666666666667,1.0,1.0,16/70,16.86%,NUP210;RNF168;HDAC7;NUP42;POLR1A;PHC2;POM121C;NUP214;AAAS;XPC;RING1;MDC1;NUP37;PIAS4;NUP98;SUMO2
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),0.5637601874850269,0.89304484367299,0.6290322580645161,1.0,1.0,3/6,25.18%,PPT1;ATP6AP2;GRN
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),-0.5459374459281963,-0.8929612240160228,0.5581395348837209,1.0,1.0,1/6,2.80%,PTPRO
prerank,CellMarker_Augmented_2021__Natural Killer cell:Peripheral Blood,0.5478135390957678,0.8928727390132232,0.6557377049180327,1.0,1.0,3/10,4.70%,CD160;PTPRC;FCGR3A
prerank,Reactome_2022__Vesicle-mediated Transport R-HSA-5653656,-0.2932809399966526,-0.8928430138698383,1.0,1.0,1.0,63/571,13.14%,IL7R;SYT12;APOB;KIFC1;SYNJ2;TBC1D10A;KIF2B;SEC24C;TBC1D16;PACSIN2;COL4A2;KDELR1;PPP6R1;CCZ1B;GOLIM4;EXOC7;GJB6;RIN1;RAB35;APOE;STX6;MAN1A1;RINL;RAB7B;SPTBN4;COG4;SH3KBP1;ARFIP2;SEC22A;ARPC3;TGFA;ALB;SPTB;RABEPK;RAB7A;KIF15;TBC1D2;SNF8;TRAPPC12;ASPSCR1;KIAA0319;KIF4B;RAB5A;SNX5;TRAPPC9;SCARB1;STX5;COPS8;KIFC2;GGA2;KIF1C;PREB;GOLGA8B;PACSIN3;CUX1;HIP1;YWHAQ;CNIH3;DENND2A;GOLGA4;ARRB2;CAPZB;SLC2A8
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.4227697012545872,0.8927102558019161,0.6811594202898551,1.0,1.0,6/59,11.23%,ENPP2;PLA2G10;PON1;LPIN3;MBOAT1;PLA2G7
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.5837025962468966,0.8923522589518204,0.6833333333333333,1.0,1.0,1/7,5.45%,CAV3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.3619385462034947,-0.892341606254851,0.6,1.0,1.0,7/82,9.35%,KIF2B;SEC24C;HLA-DQB1;HLA-DRA;RAB7A;KIF15;KIF4B
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Blood,-0.34481969742573726,-0.8923401190321186,0.7083333333333334,1.0,1.0,15/75,9.69%,CDH5;ERG;TIE1;CLEC14A;SELE;KIT;TMEM132C;FREM1;EFCC1;CXCL14;THSD7A;ITIH5;AQP1;GNA14;FGD5
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood Vessel,-0.34481969742573726,-0.8923401190321186,0.7083333333333334,1.0,1.0,15/75,9.69%,CDH5;ERG;TIE1;CLEC14A;SELE;KIT;TMEM132C;FREM1;EFCC1;CXCL14;THSD7A;ITIH5;AQP1;GNA14;FGD5
prerank,CellMarker_Augmented_2021__Lymphoid Stem cell:Peripheral Blood,0.3807863453229757,0.8923079329084836,0.6923076923076923,1.0,1.0,15/96,20.88%,CHCHD4;STRAP;RPA3;RPP40;SNRPD2;ERH;PSMC5;CHAC2;HSPE1;CACYBP;TEX30;TIMM10;POLE3;GMNN;GGCT
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.38162806817661926,-0.892196591681337,0.6,1.0,1.0,6/23,15.77%,CLIP3;ZDHHC23;ZDHHC11B;ZDHHC14;ZDHHC18;ZDHHC3
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.38162806817661926,-0.892196591681337,0.6,1.0,1.0,6/23,15.77%,CLIP3;ZDHHC23;ZDHHC11B;ZDHHC14;ZDHHC18;ZDHHC3
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.44520878258418023,0.8921624148537659,0.6507936507936508,1.0,1.0,5/30,10.19%,ACTG1;USP6;PINK1;DNAJA1;RAB11A
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.47758389743380036,-0.8920770375621708,0.6111111111111112,1.0,1.0,5/9,29.23%,NXF5;SIDT1;ATXN2;YBX1;RBFOX1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.3739806135428566,-0.8920162510189732,0.5294117647058824,1.0,1.0,4/48,7.64%,NGF;PI4KB;NTRK1;PLCL2
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.4570913983328946,0.8918608651364145,0.6666666666666666,1.0,1.0,3/26,9.22%,WNT5A;IGF1;PINK1
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.538936518669862,0.8917982824175386,0.6567164179104478,1.0,1.0,1/10,1.93%,BUB1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.43678272616571484,0.8916696277407619,0.6290322580645161,1.0,1.0,7/29,15.99%,ANXA1;STAT5A;MMP9;RAMP3;STAT1;CALCR;AGER
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.4247180938800587,0.8916212944978269,0.5974025974025974,1.0,1.0,5/37,12.06%,FGF2;TRPV6;PTPRC;GRIN2D;SLC24A1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.43871542241898887,-0.8915963085182805,0.6060606060606061,1.0,1.0,2/15,13.71%,JADE2;KANSL2
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.43871542241898887,-0.8915963085182805,0.6060606060606061,1.0,1.0,2/15,13.71%,JADE2;KANSL2
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.42575087861356226,0.8915804795520891,0.6857142857142857,1.0,1.0,6/39,15.27%,TLR2;IRF1;DDX3X;NLRC3;OAS2;ISG15
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.3873370021868906,-0.8915731181462847,0.6,1.0,1.0,3/23,3.39%,ABHD17A;HDAC7;HDAC10
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.5245130860309681,-0.8915390369019357,0.6333333333333333,1.0,1.0,3/7,15.93%,SELE;ST3GAL4;SELP
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),-0.5516525621534457,-0.8914676723302859,0.6285714285714286,1.0,1.0,1/6,3.68%,CLC
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.5791772359327148,0.8913662760235329,0.609375,1.0,1.0,2/7,8.97%,PTGER3;OSMR
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),0.5693595850821789,0.8913207785720353,0.6833333333333333,1.0,1.0,4/6,22.95%,KCNA5;NPPA;SCN5A;KCNQ1
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,0.43691739067448915,0.8912384406261309,0.6875,1.0,1.0,6/38,16.81%,TCF7;LEF1;RPS27A;TCF7L1;SOX9;SOX6
prerank,CellMarker_Augmented_2021__Cancer cell:Esophagus,0.38935870191089655,0.8911440459336072,0.6588235294117647,1.0,1.0,25/82,20.39%,C3;A4GALT;RARRES1;PTGR1;ANGPTL4;NT5E;AXL;OSMR;PLAU;SYNC;TGM2;DAB2;THBS1;TNS3;PLAT;IGFBP6;TGFBI;MYL9;EHD2;FAM114A1;PDLIM5;AFAP1L1;IL1R1;PRSS23;FN1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.4395011909079815,0.8911250615267344,0.676056338028169,1.0,1.0,3/25,9.63%,HSPA8;LCP1;DNAJA1
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.58096942924128,0.8909766711342917,0.6833333333333333,1.0,1.0,1/7,12.06%,SLC24A1
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,0.3806992048762701,0.8906703239327706,0.7027027027027027,1.0,1.0,9/89,13.69%,ESR1;PIK3R3;FGF20;ERBB4;CD80;KLB;CDKN1B;CDKN1A;RHOG
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.5621341657522173,0.8905961038575555,0.6610169491525424,1.0,1.0,2/6,10.73%,JAM2;GLRA1
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.4134852450412929,-0.8905688086450032,0.55,1.0,1.0,8/16,22.26%,SMARCB1;SMARCA4;TAF11;CCNT1;CTDP1;JUN;RRP1B;TFAP4
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Liver,0.38784311207550015,0.8905169099992991,0.6329113924050633,1.0,1.0,20/90,24.52%,SP100;AHR;PTPRC;CD80;DRAM1;KCTD9;ZC3HAV1;OTUD4;CD44;UHMK1;WDR36;IFIH1;TMOD3;MLKL;ERAP1;UBA6;RUNX1;CD164;BAZ1A;TEC
prerank,CellMarker_Augmented_2021__CD8+ Regulatory T cell:Undefined,0.4206838496417954,0.8904138336588288,0.6521739130434783,1.0,1.0,20/53,20.42%,CYTIP;ARHGAP9;GMFG;CCL5;SASH3;PTPRC;TAGAP;THEMIS;GPR183;PSTPIP1;KLRB1;SIRPG;ITK;CRTAM;ZAP70;TIGIT;CD8B;TNFSF8;CD5;IL2RA
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.4124494820586559,0.89028647717116,0.6376811594202898,1.0,1.0,3/52,4.57%,AMBP;HHIP;NLRP12
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,-0.3797196844978143,-0.8902232570381191,0.6060606060606061,1.0,1.0,4/23,9.63%,ITPR2;TRPC3;SLC8A3;TRPC6
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.38297376115312093,0.8901873896692031,0.6931818181818182,1.0,1.0,24/118,18.59%,LECT2;NOTUM;HHIP;CNMD;WNT5A;IGF1;GDF11;ALX4;TGM2;COL1A1;RPL13;NPR3;SOX9;TRAPPC2;BMP3;CD44;HAPLN2;GHRL;SOX6;HYAL1;ITGB8;HAPLN1;FRZB;COL10A1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.45605701418483907,-0.8898579121309313,0.43243243243243246,1.0,1.0,3/17,13.89%,SMPD4;PLA2G4C;ABHD12
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,0.3683433729978102,0.8898464387205803,0.759493670886076,1.0,1.0,34/247,20.57%,PSMB9;WNT8B;TCF7;FRAT1;PDE6A;GNG12;WNT5A;H2BC4;RSPO1;WNT8A;LEF1;GNG4;H2AZ1;FZD8;RPS27A;PPP2R5A;WNT6;GNAT2;DKK2;TCF7L1;SOX9;PSMC5;WNT5B;SOX6;PRKG1;PDE6B;RBX1;PDE6G;PSMA3;PSMB6;PSMD6;GNGT1;GNB4;H2AZ2
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,0.3695495211448027,0.8898387757985561,0.6835443037974683,1.0,1.0,41/211,25.73%,SGO1;PSMB9;BUB1;CENPU;ERCC6L;NDC80;RPS27A;KIF18A;PPP2R5A;SKA2;PSMC5;NUF2;TUBA4A;TUBA3D;TUBB6;SPC25;BUB1B;RCC1;FBXO5;DYNLL1;ITGB3BP;TUBA1C;PSMA3;PSMB6;CENPN;CENPL;PSMD6;CENPS-CORT;CCNB1;ESPL1;TUBB4B;RPS27;CENPM;DYNLL2;CDCA5;PSMA7;BUB3;CDCA8;PSMB1;CENPO;CENPK
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.3012816771400981,-0.889424847991737,0.6923076923076923,1.0,1.0,65/283,18.08%,IFT88;CFAP221;MKS1;DCDC2;CFAP46;CFAP410;CNGA4;ABCC4;EXOC7;HAUS1;RP1L1;JHY;SCLT1;PARVA;PCM1;CEP83;KIF17;FLNA;CLUAP1;TTC36;RPGRIP1L;TMEM138;GBF1;DZIP1L;MAPRE1;FBF1;CNTRL;CDK1;CEP135;ALMS1;RILPL1;EHD4;CFAP44;ASAP1;EHD3;CDK5RAP2;ABLIM3;CEP152;CEP250;RAB11FIP3;CILK1;HAUS7;CFAP70;B9D1;AVIL;DNAH5;TEKT3;TRAF3IP1;CCDC57;KIF24;DYNC2I1;SDCCAG8;CSNK1E;MARK4;CCDC40;AHI1;CEP41;CYS1;TCTN1;KIF27;ARMC9;IFT52;IFT43;IFT81;CEP290
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.47542896267922063,0.8893248840546736,0.6285714285714286,1.0,1.0,4/21,10.68%,ANXA1;ACTG1;DUOX1;VTN
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Muscle,0.49361578352088403,0.8892741819853184,0.6721311475409836,1.0,1.0,7/21,16.35%,PTPRC;ANPEP;NT5E;ITGA5;MME;CD44;ENG
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tendon,0.49361578352088403,0.8892741819853184,0.6721311475409836,1.0,1.0,7/21,16.35%,PTPRC;ANPEP;NT5E;ITGA5;MME;CD44;ENG
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone,0.49361578352088403,0.8892741819853184,0.6721311475409836,1.0,1.0,7/21,16.35%,PTPRC;ANPEP;NT5E;ITGA5;MME;CD44;ENG
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.44613641518392244,0.8889950902650053,0.6153846153846154,1.0,1.0,7/34,15.99%,CCL5;RNASE10;NODAL;PLAUR;SIRPG;CD44;AGER
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4841034480591245,0.8885785322537288,0.6666666666666666,1.0,1.0,1/17,2.40%,GMFG
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.44946741785370925,0.8885384818372868,0.6619718309859155,1.0,1.0,2/24,11.00%,TLR2;RPS27A
prerank,CellMarker_Augmented_2021__Merkel cell:Skin,0.3980561842105734,0.8882011169670673,0.6282051282051282,1.0,1.0,10/74,10.17%,PKP2;PTPRH;ACE2;BCO1;GPRIN2;MISP;CLCA1;MMP15;TMEM54;HNF4G
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,-0.3438144151918585,-0.8881259072727544,0.7096774193548387,1.0,1.0,12/80,12.74%,G6PC3;NUP210;ENO3;NUP42;POM121C;PPP2R5D;NUP214;AAAS;PFKP;PFKFB3;PGP;SLC37A1
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,0.45241612117966656,0.8880996941145006,0.7,1.0,1.0,5/32,12.77%,CCND2;CCND1;CCNE2;CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.5409539138624195,-0.8878281033976695,0.627906976744186,1.0,1.0,2/6,7.72%,PARVA;CCN3
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.3700590816341908,0.8877315098369672,0.6547619047619048,1.0,1.0,32/157,17.01%,GATA4;RRAS;ITGAX;SP100;CD160;FGF2;HIPK1;FLT1;CNMD;ISM1;WNT5A;ANGPTL4;NODAL;COL4A3;CYP1B1;AGGF1;RHOB;MYDGF;DCN;STAT1;CLDN5;HMGA2;BTG1;ANGPTL3;THBS1;EPHA1;PIK3R6;GHRL;VASH2;GLUL;HYAL1;BRCA1
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.4787048920130523,0.8877284883782737,0.6865671641791045,1.0,1.0,2/19,10.57%,ADA;DCK
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.4921732823874589,0.8875809892266112,0.578125,1.0,1.0,4/18,5.52%,PSMB9;AIM2;NLRP12;USP50
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.544735400742271,0.8875765633816646,0.6666666666666666,1.0,1.0,1/7,10.19%,RAB11A
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.46718870036084686,-0.8875295297698937,0.6818181818181818,1.0,1.0,2/11,12.08%,RAB5A;NEURL1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Cartilage,0.4835790035095017,0.8873423178351445,0.6666666666666666,1.0,1.0,7/23,16.35%,PTPRC;ANPEP;NT5E;ITGA5;MME;CD44;ENG
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.4754234664485255,-0.8872962007758455,0.5526315789473685,1.0,1.0,2/11,3.10%,BCL2;ACO1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.41423610376987535,0.8872785990594868,0.6,1.0,1.0,5/42,12.41%,BUB1;TGFB1;WEE2;CDKN1B;BTG1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.5705375173198886,-0.8871842405940857,0.6842105263157895,1.0,1.0,1/6,12.71%,MAPK7
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.5705375173198886,-0.8871842405940857,0.6842105263157895,1.0,1.0,1/6,12.71%,MAPK7
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.5735879495708148,0.887125914222949,0.7076923076923077,1.0,1.0,1/6,6.07%,STK26
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,0.41890714684007074,0.8871249904534221,0.6451612903225806,1.0,1.0,9/29,27.91%,LPIN3;MOGAT1;MOGAT2;GK3;AGMO;PNPLA4;DGAT2;LIPE;PLIN1
prerank,Reactome_2022__PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,0.47459498469709127,0.8869083388617096,0.6438356164383562,1.0,1.0,3/20,9.53%,POLE2;POLD4;RPA3
prerank,CellMarker_Augmented_2021__Clara cell:Undefined,-0.3092772753549052,-0.8867184326044714,0.8571428571428571,1.0,1.0,20/94,21.44%,PTPRA;ZNF275;PHF2;RAPGEF1;MECP2;ZMIZ1;IQSEC1;ANGEL1;SIK3;SUGP2;EP400;PI4KA;CLCN6;SIK2;ZNF337;SNX30;UBAP1L;PIP4K2B;ADD1;TMEM131
prerank,CellMarker_Augmented_2021__Myeloid cell:Bone Marrow,0.419137062290908,0.8866705073524597,0.6666666666666666,1.0,1.0,16/45,17.26%,TLR2;ITGAX;PTPRC;ITGAM;FCGR3A;CD81;ANPEP;CD80;CEACAM8;CD4;CSF1R;MME;IL3RA;CD244;ZAP70;NOS2
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Large Intestine,0.4370319599917398,0.8866489124049471,0.569620253164557,1.0,1.0,10/42,11.68%,CLDN2;MGST1;PKP2;TMEM171;HSD17B2;PPP1R1B;ATP10B;C16ORF89;SLC38A4;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.46454246082207185,0.8865679215966761,0.6619718309859155,1.0,1.0,3/23,16.42%,CCL5;THBS1;CD244
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5333218080179785,-0.8864233836944553,0.5833333333333334,1.0,1.0,1/9,1.49%,CBARP
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.47503922197227566,-0.8863931227626622,0.5714285714285714,1.0,1.0,2/8,24.09%,INO80;DBF4B
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,0.38779343815268463,0.8862344210140131,0.7638888888888888,1.0,1.0,15/81,22.63%,PSMB9;TNFRSF1B;RPS27A;TNFSF4;NFKB2;PSMC5;EDAR;UBE2M;PSMA3;TNFSF8;PSMB6;PSMD6;TNFSF14;UBA3;CD27
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.522096355589365,-0.8860963463837349,0.5961538461538461,1.0,1.0,2/5,14.26%,RAMP1;CHP1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.4075558521327795,-0.8860165035407577,0.5641025641025641,1.0,1.0,3/20,10.30%,SLC25A17;PEX13;PEX14
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,-0.44387002443628143,-0.8859864912115397,0.6666666666666666,1.0,1.0,2/16,4.48%,PODXL2;PAPSS2
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.520418679028765,0.8859452802096991,0.609375,1.0,1.0,1/11,4.29%,METTL18
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.38944459445537316,0.8858457193191358,0.6625,1.0,1.0,21/97,17.26%,ENPP2;C1QB;LYVE1;SSTR1;SHISA6;FCGR3A;VSIG4;PLP1;RAMP3;P2RY12;VWF;PDK4;CSF1R;AQP4;EDNRB;SLCO2B1;MAF;A2M;GLUL;GALNT15;GAS7
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.493294445168246,0.8858418401958095,0.6612903225806451,1.0,1.0,3/17,11.26%,KIF14;STMN4;KIF18A
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.40806409172546787,-0.8857802065701318,0.6190476190476191,1.0,1.0,18/47,19.69%,XYLT1;GPC6;GPC2;SDC3;GPC4;HS6ST2;AGRN;IDUA;HGSNAT;B3GAT3;GUSB;GPC1;SDC4;EXT1;FUCA1;GLB1;EXT2;PXYLP1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Eye,0.41074290947155573,0.8856092469327811,0.6712328767123288,1.0,1.0,20/66,21.75%,CAPN13;PKP2;GPRIN2;MISP;MARVELD2;HSD11B2;EPN3;BAIAP2L1;MARVELD3;AP1M2;EPCAM;KRT8;AGR2;SPINT1;SLC44A3;SOWAHB;SCNN1A;CBLC;B3GNT3;GRHL2
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.552367710093895,0.8854069565741942,0.6666666666666666,1.0,1.0,1/7,5.55%,MISP
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.33447383998953617,-0.8853417739411753,0.64,1.0,1.0,15/89,12.30%,EHF;MFSD2A;OSR1;PTCH1;TST;TRIM71;PKD2;GSTK1;SNAI2;CDK1;CPT1A;DNPH1;RHCG;ALDH1A2;FGFR2
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.39468489666161427,0.8852858307919711,0.7317073170731707,1.0,1.0,11/75,13.70%,MYBPC3;SGCG;TGFB1;ITGA2;ITGB6;ACTG1;ITGA5;IGF1;TGFB3;AGT;ITGA2B
prerank,CellMarker_Augmented_2021__Microglial cell:Brain,-0.42506799534360995,-0.8851883265517367,0.6666666666666666,1.0,1.0,3/16,5.65%,CD14;BCL2A1;HLA-DRA
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.46218217978232107,-0.8851799578096565,0.65,1.0,1.0,1/12,0.68%,CPSF1
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.540214660406979,-0.8851120788736387,0.7021276595744681,1.0,1.0,5/9,39.12%,SEC14L2;MBTPS2;SREBF2;LPCAT3;KPNB1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.47146583756879007,-0.8850646271037054,0.5555555555555556,1.0,1.0,2/12,5.74%,LIPC;PLIN5
prerank,GO_Biological_Process_2021__positive regulation of triglyceride lipase activity (GO:0061365),-0.5563199244195454,-0.8850585509049593,0.6842105263157895,1.0,1.0,1/5,1.16%,APOH
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein lipase activity (GO:0051006),-0.5563199244195454,-0.8850585509049593,0.6842105263157895,1.0,1.0,1/5,1.16%,APOH
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.4798588902248655,0.8850585392921153,0.6029411764705882,1.0,1.0,6/16,17.66%,IL12A;SYK;HLA-A;TNFSF4;GLI3;HSPH1
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.5729391162721561,0.8850036515733083,0.6984126984126984,1.0,1.0,1/6,1.83%,TLR2
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.5729391162721561,0.8850036515733083,0.6984126984126984,1.0,1.0,1/6,1.83%,TLR2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Undefined,-0.44920558967269336,-0.884785121871998,0.5806451612903226,1.0,1.0,3/16,5.83%,CD38;KIT;ITGA4
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.5052069644792643,-0.8846997738021276,0.5909090909090909,1.0,1.0,2/8,12.55%,POLR1A;TERT
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.5042276884353408,0.8846528648049826,0.5714285714285714,1.0,1.0,1/12,2.77%,CCL5
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,0.35656857504923695,0.8846332980313235,0.7804878048780488,1.0,1.0,38/173,25.73%,NEK2;SGO1;BUB1;CENPU;ERCC6L;NDC80;CEP72;CEP70;KIF18A;PPP2R5A;SKA2;NUF2;TUBA4A;SPC25;BUB1B;DYNLL1;NCAPG;ITGB3BP;CEP76;CENPN;CENPL;CENPS-CORT;CCNB1;TUBB4B;DCTN3;DCTN1;YWHAG;RPS27;CENPM;DYNLL2;CDCA5;HAUS2;BUB3;CETN2;CDCA8;CENPO;HAUS6;CENPK
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.46056833732500124,-0.8845897430428237,0.6333333333333333,1.0,1.0,3/16,7.72%,MIDN;CRH;CCN3
prerank,Reactome_2022__Activated NTRK3 Signals Thru RAS R-HSA-9034864,-0.5319021683633536,-0.884574809293656,0.627906976744186,1.0,1.0,1/6,19.25%,HRAS
prerank,Reactome_2022__WNT Ligand Biogenesis And Trafficking R-HSA-3238698,0.47427090219176193,0.8844937672436597,0.6865671641791045,1.0,1.0,5/22,15.72%,WNT8B;WNT5A;WNT8A;WNT6;WNT5B
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.4328718368309863,-0.8844923111771251,0.53125,1.0,1.0,2/21,3.35%,PPP1R35;PPP6R1
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.4523464817748596,0.8842961908538204,0.6714285714285714,1.0,1.0,2/33,6.68%,DONSON;RAD1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Anterior Cruciate Ligament,0.3936795179806292,0.8841697210081226,0.6794871794871795,1.0,1.0,26/87,16.68%,ANXA1;LOX;MMP19;ITGBL1;NT5E;ITGA5;AXL;OSMR;HEG1;PDCD1LG2;ADGRL4;PLAU;COL6A2;DCN;COL1A1;DAB2;THBS1;PLAT;IGFBP6;CD44;TGFBI;MYL9;EHD2;CYBRD1;ENG;FAM114A1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.4674906838452634,-0.8839936772913776,0.6285714285714286,1.0,1.0,2/13,9.07%,TWIST1;SNAI2
prerank,Reactome_2022__FRS-mediated FGFR4 Signaling R-HSA-5654712,0.5019085689576334,0.8839898611824434,0.5666666666666667,1.0,1.0,2/17,8.32%,FGF20;KLB
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,0.3735113926807289,0.8837512579737848,0.7215189873417721,1.0,1.0,25/146,21.11%,PSMB9;ABCC6;SLC5A2;SLC7A7;SLC12A3;ABCC2;SLC17A8;SLC4A1;CP;RPS27A;SLC24A1;TAC4;SLC5A1;SLC35C1;PSMC5;ABCG5;SLC16A1;SEL1L;PSMA3;PSMB6;SLC26A4;KCNJ11;PSMD6;ABCA12;SLC3A1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.3188782353912426,-0.8836910374362277,0.6666666666666666,1.0,1.0,24/97,18.90%,CASKIN1;CLIP3;ELAVL3;TTBK1;PRR36;INA;MPP2;SNCB;HPCA;NLGN2;SHISA7;SRRM3;MMD2;TAGLN3;ADGRA1;GRIN1;BRINP1;JPH3;CSPG5;SYN1;SLC6A9;CNIH2;LINGO1;BRSK1
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.49597912414425827,-0.8835689227899807,0.5945945945945946,1.0,1.0,3/7,16.12%,CORO1B;SYAP1;MARS1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.5126590153192909,0.8835680909793057,0.6323529411764706,1.0,1.0,3/12,8.90%,JAM2;CD81;ERVW-1
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,0.3661815752980125,0.8834372479575296,0.6962025316455697,1.0,1.0,40/210,25.73%,SGO1;PSMB9;BUB1;CENPU;ERCC6L;NDC80;RPS27A;KIF18A;PPP2R5A;SKA2;PSMC5;NUF2;TUBA4A;TUBA3D;TUBB6;SPC25;BUB1B;RCC1;DYNLL1;ITGB3BP;TUBA1C;PSMA3;PSMB6;CENPN;CENPL;PSMD6;CENPS-CORT;CCNB1;ESPL1;TUBB4B;RPS27;CENPM;DYNLL2;CDCA5;PSMA7;BUB3;CDCA8;PSMB1;CENPO;CENPK
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Undefined,-0.3288443659083362,-0.8831588241035225,0.64,1.0,1.0,12/94,7.68%,CD38;BCL2;CD14;PTCH1;KIT;LIN28B;LGR5;CD151;ERBB2;SOX12;ASCL1;CX3CR1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.43825455797607293,0.8831580754014046,0.6571428571428571,1.0,1.0,7/31,19.56%,PTX3;PINK1;LRPAP1;EDNRB;BRCA1;RIN3;DLG4
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.4638533108933329,-0.883141733341108,0.6842105263157895,1.0,1.0,6/12,24.67%,CDK1;PRKCA;CTDNEP1;NEK9;NEK6;LPIN1
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,-0.33346081250299436,-0.883032442753701,0.8181818181818182,1.0,1.0,7/69,11.19%,ADRA1A;ADRA1B;PLEKHG2;PREX1;FGD1;GNB5;GNB3
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.48912080456491525,-0.8830249803406077,0.6842105263157895,1.0,1.0,2/7,13.70%,RAB5A;RAB22A
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,0.4031576308683196,0.8829538943677332,0.6388888888888888,1.0,1.0,11/51,13.91%,COL6A5;COL6A6;STAT5A;COL4A4;COL4A3;COL4A5;COL6A2;STAT1;THBS1;PLAT;PLG
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,0.47892650832331785,0.8828480075445727,0.6119402985074627,1.0,1.0,2/14,8.04%,GNG12;GNG4
prerank,CellMarker_Augmented_2021__Leydig Precursor cell:Fetal Gonad,0.37350487219575484,0.8828279636697837,0.7333333333333333,1.0,1.0,46/199,17.03%,OLFML1;RAB34;TIMP3;ANGPT2;NID1;EBF1;WNT5A;PCDH18;OGN;RPL9;ARHGAP28;IGF1;ANGPTL1;RPL18A;CYP1B1;KANK2;FBLIM1;TSC22D3;COL4A5;RPL13A;COL6A2;RPL15;PLAC9;DCN;RPS5;COL1A1;RPS27A;RPS3A;PLAC1;RPL13;FBN2;LIFR;RPS12;PDE5A;EEF1A1;RPS19;ITM2C;EDNRB;CXCL12;ELN;EHD2;CYBRD1;ENG;FAM114A1;PHLDA1;RPS7
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.5303805138147492,-0.8827721761522239,0.5348837209302325,1.0,1.0,1/8,2.75%,NRDE2
prerank,KEGG_2021_Human__Nitrogen metabolism,0.4473099482916846,0.8827194108949331,0.6470588235294118,1.0,1.0,5/16,20.64%,CA14;CA1;CA13;GLUL;CA12
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.5053456395113427,0.8824938146250831,0.625,1.0,1.0,4/14,17.22%,SLC5A2;SLC5A9;SLC5A1;SLC23A1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.3739563034901374,0.8822244040045749,0.7325581395348837,1.0,1.0,16/143,18.67%,CASQ2;HIGD1C;CHCHD4;TGFB1;CCDC39;TMEM35A;VAMP1;COX7A2;CHMP3;ANLN;SRP19;CYBA;TBCE;HSPA4;CHRNA3;RPL38
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.4041878648025919,0.8821455553537713,0.6666666666666666,1.0,1.0,13/80,11.25%,CAPN13;ACE2;GPRIN2;CYP4F12;PLEKHG3;TMEM45B;ANPEP;HSD11B2;PPP1R1B;TMC4;SLC5A9;TJP3;AP1M2
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.40494938054455504,0.882081601125333,0.6119402985074627,1.0,1.0,24/62,20.42%,RORC;CYTIP;GMFG;CCL5;SASH3;AHR;PTPRC;IL5;HPGDS;TAGAP;THEMIS;CD4;KLRB1;SIRPG;ITK;IL4;IL17RB;ZAP70;TIGIT;IRF4;TNFSF8;CD5;NFATC2;IL2RA
prerank,Reactome_2022__DCC Mediated Attractive Signaling R-HSA-418885,-0.47330262093156006,-0.8817751288651432,0.5675675675675675,1.0,1.0,6/14,28.59%,ABLIM3;FYN;ABLIM2;SRC;NCK1;RNASE1
prerank,Reactome_2022__Branched-chain Amino Acid Catabolism R-HSA-70895,-0.3896096198045826,-0.8817731731698918,0.6176470588235294,1.0,1.0,3/20,12.00%,BCKDK;ECHS1;SOAT1
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.3839041584998188,0.8815990670159317,0.6626506024096386,1.0,1.0,12/101,13.90%,RRAS;ARHGAP31;RRAD;FGF2;USP50;CDKN2A;IGF1;RAPGEF6;RERG;CDKN1A;CCNA2;RAB38
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3814688905431218,0.8815395148466908,0.7012987012987013,1.0,1.0,10/119,14.04%,PSMB9;FRAT1;TGFB1;DAAM2;RSPO1;DDX3X;COL1A1;SFRP4;DKK2;PSMC5
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.4792000758127146,-0.8812864659019862,0.6363636363636364,1.0,1.0,5/18,18.81%,PPP1R35;ENSA;CHP1;PTPA;ZCCHC9
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.46472947528544073,0.8811657087822423,0.6666666666666666,1.0,1.0,2/18,5.31%,LRP4;WNT5A
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,-0.3467595754399199,-0.8811534886637826,0.6666666666666666,1.0,1.0,16/81,12.27%,SMPD3;ACER2;GLB1L;ARSL;ARSJ;SMPD4;STS;ACER3;NEU4;ARSB;B4GALNT1;NEU3;ESYT3;SUMF2;SPTSSB;PLPP2
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.49529809043751344,0.8811297937621488,0.6617647058823529,1.0,1.0,2/14,3.37%,C1QTNF1;ALOX12
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.4498009889615347,0.8810822025627426,0.6142857142857143,1.0,1.0,5/25,25.99%,TGFB1;MAP2K1;MYCN;DDX6;FXR1
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,-0.384839997730532,-0.8808613947187652,0.5555555555555556,1.0,1.0,10/48,17.99%,NUP210;NUP42;POM121C;NUP214;SNRPB;AAAS;GEMIN5;NUP37;NUP98;SMN1
prerank,CellMarker_Augmented_2021__Naive T cell:Umbilical Cord Blood,0.4227956427533731,0.8808264593274977,0.7222222222222222,1.0,1.0,13/47,13.96%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;NLRC3;IKZF1;TAGAP;THEMIS;PSTPIP1;KLRB1;SIRPG;ITK
prerank,CellMarker_Augmented_2021__T cell:Brain,0.4227956427533731,0.8808264593274977,0.7222222222222222,1.0,1.0,13/47,13.96%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;NLRC3;IKZF1;TAGAP;THEMIS;PSTPIP1;KLRB1;SIRPG;ITK
prerank,CellMarker_Augmented_2021__Memory T cell:Liver,0.4227956427533731,0.8808264593274977,0.7222222222222222,1.0,1.0,13/47,13.96%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;NLRC3;IKZF1;TAGAP;THEMIS;PSTPIP1;KLRB1;SIRPG;ITK
prerank,CellMarker_Augmented_2021__Memory T cell:Peripheral Blood,0.4227956427533731,0.8808264593274977,0.7222222222222222,1.0,1.0,13/47,13.96%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;NLRC3;IKZF1;TAGAP;THEMIS;PSTPIP1;KLRB1;SIRPG;ITK
prerank,CellMarker_Augmented_2021__T cell:Tonsil,0.4227956427533731,0.8808264593274977,0.7222222222222222,1.0,1.0,13/47,13.96%,CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;NLRC3;IKZF1;TAGAP;THEMIS;PSTPIP1;KLRB1;SIRPG;ITK
prerank,KEGG_2021_Human__Non-homologous end-joining,-0.4893842494169369,-0.8808262585516905,0.6052631578947368,1.0,1.0,2/11,7.56%,POLM;RAD50
prerank,KEGG_2021_Human__Hepatitis C,0.3856259913416982,0.8807705017291709,0.7468354430379747,1.0,1.0,23/118,22.60%,CLDN2;CLDN6;PIK3R3;CLDN18;CD81;CCND1;IFIT1;STAT1;CLDN5;CLDN9;OAS2;CDKN1A;MAPK3;CLDN14;APAF1;YWHAH;NFKBIA;MAP2K1;CLDN10;TRADD;KRAS;CLDN1;YWHAG
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.39898852543817953,-0.8806511988955379,0.5185185185185185,1.0,1.0,4/23,9.07%,CBFB;F11R;RAPGEF1;SNAI2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.4333305324175901,-0.8806368689285599,0.5384615384615384,1.0,1.0,1/10,0.98%,ADAMTS12
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In4:Brain,-0.5882109340029132,-0.8805571956531089,0.717948717948718,1.0,1.0,3/6,5.59%,KIT;TRPC3;FREM1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.36712837219321237,-0.8804479012732433,0.5384615384615384,1.0,1.0,13/37,21.09%,PNKP;DDX11;KMT5C;WRAP53;KDM4D;SPIDR;SHLD2;SMCHD1;MAD2L2;SHLD1;SETMAR;RAD51AP1;MGMT
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.37354841255532695,0.880422212762534,0.6829268292682927,1.0,1.0,19/150,21.18%,NEK2;PSMB9;TGFB1;BORA;AFAP1L2;CKS1B;CDKN1B;BTG1;PKMYT1;PSMC5;CYLD;BUB1B;RCC1;FBXO5;PSMA3;PSMB6;CDC25C;PSMD6;CCNB1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.42203896274242936,0.8803508670813541,0.6447368421052632,1.0,1.0,8/31,27.94%,FAM47E;MAPK3;BRCA1;RPS6KA5;PAF1;KDM1A;PPARGC1A;CDK9
prerank,Reactome_2022__STAT5 Activation R-HSA-9645135,0.5694343265892062,0.880328547374551,0.625,1.0,1.0,1/6,6.23%,STAT5A
prerank,Reactome_2022__Class C/3 (Metabotropic Glutamate/Pheromone Receptors) R-HSA-420499,-0.43918958317561807,-0.8802634468194395,0.6206896551724138,1.0,1.0,2/15,2.67%,TAS2R8;GPRC6A
prerank,Reactome_2022__Multifunctional Anion Exchangers R-HSA-427601,0.5657942610701527,0.8801394822590012,0.6721311475409836,1.0,1.0,3/7,26.51%,SLC26A6;SLC26A4;SLC26A11
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.3167394022855802,-0.8799813882784884,0.6153846153846154,1.0,1.0,13/258,4.78%,GPR3;PER2;ADRA1A;TSKU;ADRA1B;ZNF703;BAMBI;TWIST1;ELOVL6;IFI16;ADCYAP1;BCL9L;APOE
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,-0.36563454546232027,-0.8798158445628665,0.76,1.0,1.0,7/53,8.06%,CSK;MAP3K14;THEM4;CD247;HLA-DRA;PPP2R5D;TNFRSF14
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.4019131160383407,0.8797768893117269,0.6578947368421053,1.0,1.0,6/67,11.26%,SGO1;MISP;NDC80;KLHDC8B;RAB11A;KIF18A
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.420489462503642,-0.8796454376974457,0.6176470588235294,1.0,1.0,2/14,8.49%,CCDC22;COMMD1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.4121169605592466,-0.8794319660163433,0.5862068965517241,1.0,1.0,7/34,8.24%,ADAMTS1;DNMT1;MMP2;NR4A3;CNN1;TAFA5;ERN1
prerank,Reactome_2022__PI-3K cascade:FGFR3 R-HSA-5654710,0.5173457317387418,0.8793085786212528,0.6206896551724138,1.0,1.0,1/15,2.58%,FGF20
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.5193503760813123,-0.879122251972861,0.65,1.0,1.0,2/7,5.05%,PSAT1;HDC
prerank,KEGG_2021_Human__Inositol phosphate metabolism,-0.31516236453851526,-0.8791044427358259,0.7727272727272727,1.0,1.0,14/72,23.45%,SYNJ2;PI4KB;ITPKA;MTMR8;MTMR14;PLCZ1;PI4KA;MTMR1;ITPK1;PLCH2;PIP4K2B;PLCB1;ITPKC;PLCE1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),-0.3063221773943555,-0.878895042899529,0.7647058823529411,1.0,1.0,6/106,5.71%,EYA4;PRDM5;PRKCD;HDAC10;USP36;CARM1
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),0.6174998922035532,0.8786582870531131,0.7166666666666667,1.0,1.0,3/5,22.89%,CD81;CD27;CD74
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.45872061758962057,0.8784953963584555,0.578125,1.0,1.0,3/21,1.80%,C3AR1;LPAR1;GPR55
prerank,Reactome_2022__Endogenous Sterols R-HSA-211976,0.4686436148819568,0.878463456873148,0.6231884057971014,1.0,1.0,4/19,9.76%,AHR;NR1H4;CYP1B1;CYP39A1
prerank,Reactome_2022__Fructose Metabolism R-HSA-5652084,0.6083750655627822,0.878307557662982,0.6923076923076923,1.0,1.0,3/7,22.64%,ALDOB;GLYCTK;TKFC
prerank,CellMarker_Augmented_2021__Villous cytotrophoblast:Placenta,0.3829206099111916,0.8782934098398194,0.7108433734939759,1.0,1.0,13/94,18.87%,CDC25A;MCM2;TICRR;MCM3;RAD54L;TRAIP;RECQL4;CCNA2;NUF2;BUB1B;PAICS;MSH6;CCT7
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.41317108792081003,-0.8782364356967723,0.7368421052631579,1.0,1.0,3/19,7.72%,ADGRG3;HDAC7;CCN3
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.29665796366995645,-0.8781743057160256,0.8823529411764706,1.0,1.0,20/148,10.01%,PER2;WNT3A;DCDC2;MDGA1;LHX2;SH3RF1;WNT7A;HES1;ERBB2;FZD7;ATOH7;ASCL1;CX3CR1;EML1;ANOS1;PEX13;KIAA0319;NEUROD6;LDB1;TUBGCP2
prerank,CellMarker_Augmented_2021__CD1C+ B Dendritic cell:Blood,0.4365894405650297,0.8781201923168998,0.7058823529411765,1.0,1.0,6/35,9.21%,MGST1;ANXA1;PTAFR;NLRP12;ITGA5;CSF3R
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.3580657471618021,-0.878030911674872,0.6923076923076923,1.0,1.0,12/36,22.81%,MAML1;JAG2;CCN3;ZMIZ1;JAG1;DLL1;TGFB2;ROBO2;AAK1;TSPAN14;CREBBP;NOTCH1
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.527579807738136,0.8780308918514939,0.7288135593220338,1.0,1.0,2/9,16.24%,NPC1L1;ABCG5
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.4330996119707049,0.8779228573584573,0.6619718309859155,1.0,1.0,8/29,16.30%,FLT1;CNMD;IL12A;COL4A3;STAT1;THBS1;GHRL;ATP5IF1
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.5261808920313142,0.8779209691468247,0.711864406779661,1.0,1.0,2/10,16.24%,NPC1L1;ABCG5
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),0.5852165159545095,0.8779096541978045,0.6666666666666666,1.0,1.0,1/5,21.73%,ALOX5
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,-0.3118029771643141,-0.8778842359927573,0.8461538461538461,1.0,1.0,31/174,20.59%,CPSF1;HNRNPL;TXNL4A;MAGOHB;LSM7;SRRM1;SUGP1;SRSF4;SNRPB;HNRNPF;DDX46;SF3A2;SYMPK;U2AF2;CSTF2;PTBP1;CPSF7;POLR2F;GPKOW;SNRPN;POLR2C;ISY1-RAB43;HNRNPUL1;RBMX;PCF11;CPSF4;LSM2;LSM6;RBM8A;CCAR1;EIF4A3
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,0.4520529704686951,0.877877441657083,0.6714285714285714,1.0,1.0,5/34,12.77%,CCND2;CCND1;CCNE2;CDKN1B;CDKN1A
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.3307634097926643,-0.8778760057180309,0.7272727272727273,1.0,1.0,19/87,11.07%,DRD4;ADRA1B;PDE10A;TPH1;MGAT4C;CATSPERG;RP1L1;RNFT2;PDZD7;TVP23A;TNR;SRRM4;SLC2A11;KCNJ6;FRRS1L;AP3B2;CATSPER2;CREM;OPRD1
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.5571608096262304,0.8777058356681562,0.6290322580645161,1.0,1.0,2/6,15.26%,EXOSC2;EXOSC4
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.4996304643478588,0.8776175128330174,0.6415094339622641,1.0,1.0,2/10,14.91%,PDCD1LG2;CRTAM
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.5377735191591705,-0.8773088152293517,0.6176470588235294,1.0,1.0,1/7,4.74%,NIPSNAP2
prerank,Reactome_2022__mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,-0.47040277916004924,-0.8772752775835306,0.7142857142857143,1.0,1.0,8/15,29.13%,LSM7;LSM2;DCP1B;LSM6;DCP1A;LSM1;PATL1;XRN1
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.37115972107765177,0.8771327084847905,0.7283950617283951,1.0,1.0,11/129,10.19%,BLK;VSX1;GPRIN2;RP1;STMN4;MANF;PRDM12;PLP1;NPY;PPT1;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.4548100797283907,-0.8770430151593759,0.6829268292682927,1.0,1.0,2/12,8.50%,SIGIRR;MEFV
prerank,CellMarker_Augmented_2021__Germ cell:Undefined,0.4771145074530419,0.8766678378656286,0.6923076923076923,1.0,1.0,2/20,4.99%,TEX101;DAZL
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.4591612100182533,0.8766412368637323,0.6944444444444444,1.0,1.0,5/21,20.17%,NLRP12;IGF1;GHRL;SERPINB1;CEACAM1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.3479256291827416,-0.8766079957835459,0.6842105263157895,1.0,1.0,6/66,7.64%,NGF;TYRO3;ERBB2;PI4KB;NTRK1;PLCL2
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR4 R-HSA-5654228,0.5389468967411167,0.876562373012032,0.6610169491525424,1.0,1.0,2/11,8.32%,FGF20;KLB
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.3720322288575104,0.8764668829786654,0.6867469879518072,1.0,1.0,8/109,6.38%,LRP4;LMOD1;TRIL;TSPAN11;FBXL7;PCDH18;SCARA3;PLP1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Uterus,-0.3219189459079886,-0.8763735692375596,0.85,1.0,1.0,13/82,9.75%,EMP1;CDH5;ERG;COL12A1;CLEC14A;SELE;PTPRB;LAMA3;PARVA;FSTL1;NTN4;EFEMP1;PALMD
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.43138991397039084,-0.8763604606639864,0.5517241379310345,1.0,1.0,5/25,10.09%,ZNF703;TGFBR3;FSTL1;TWSG1;ITGA3
prerank,KEGG_2021_Human__Protein export,0.46467725194904413,0.8763211296712152,0.6575342465753424,1.0,1.0,9/23,32.77%,HSPA5;SRP19;SPCS2;SRP14;SEC62;SEC61G;SRP9;SPCS1;SRPRB
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),-0.5441214750284257,-0.8762611979836479,0.6666666666666666,1.0,1.0,2/5,29.05%,IGF2BP1;YBX1
prerank,Reactome_2022__Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.44986713276210255,-0.876225589775665,0.6521739130434783,1.0,1.0,3/18,12.03%,STX5;EMD;BAG6
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.5911916658024916,0.8762073793438877,0.7547169811320755,1.0,1.0,1/6,21.68%,RPL23
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.3392501680539759,-0.8761744551378136,0.7333333333333333,1.0,1.0,8/57,10.82%,BUD23;UTP25;FCF1;DCAF13;NOP14;TBL3;GAR1;UTP3
prerank,CellMarker_Augmented_2021__CD4+ T cell:Colon,0.40528253136533887,0.8761357275482663,0.6351351351351351,1.0,1.0,10/45,13.96%,CYTIP;ARHGAP9;SASH3;PTPRC;NLRC3;TAGAP;THEMIS;KLRB1;SIRPG;ITK
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.5129914985388684,0.8761063503758592,0.6491228070175439,1.0,1.0,2/11,10.78%,RAPGEF6;TJP3
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.40207205086417336,0.8760470085428016,0.6753246753246753,1.0,1.0,5/59,8.49%,CCL5;VAPB;AXL;IFIT1;DDX3X
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.46727161756657676,-0.8759709838324445,0.6585365853658537,1.0,1.0,2/11,6.85%,TRIM35;TRIM8
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.4300680152388346,0.8756224444535685,0.625,1.0,1.0,3/27,8.82%,STRADA;TGFB1;RANBP3L
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,0.405068754572921,0.8756131469453642,0.6376811594202898,1.0,1.0,6/58,20.47%,PSMB9;RPS27A;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.48890803086212486,0.8755486858983245,0.7083333333333334,1.0,1.0,5/15,28.10%,LEF1;CDKN1A;SPI1;DEK;CBFA2T3
prerank,Reactome_2022__Cellular Responses To Stress R-HSA-2262752,0.33218645976939387,0.8755360130915056,0.8787878787878788,1.0,1.0,157/627,25.85%,COX6A1;GML;MAPKAPK3;PSMB9;HSPA1L;NOX5;HSPA8;ATP6V1G2;CBX8;RPL37A;RPL21;H1-0;DEPDC5;DNAJB1;DAND5;H2BC4;CDKN2A;RPL9;HSPA5;H2AZ1;RPL18A;NQO1;COL4A6;RRAGA;ATP6V0E2;RPA3;MYDGF;DNAJA1;RPS9;RPL3;RPL36;RPL13A;EXOSC8;RPS16;RPL15;ID1;RPS5;CCNE2;RPS27A;RPS3A;EXOSC2;RPL41;HMGA2;CDKN1B;RPS12;RPS4X;RPL27A;CDKN1A;TALDO1;CCNA2;EEF1A1;RPS19;FAU;CDKN2C;PSMC5;WDR24;RPS21;CYBA;HMGA1;MAPK3;EXOSC4;RPL32;FKBP5;ARTN;FKBP4;SLC46A1;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;DYNLL1;ATP6V0B;ATOX1;HSPH1;COX20;HSPA4;COX4I1;IDH1;SYVN1;TXNIP;RSL24D1;RPLP2;HSPA2;HERPUD1;LAMTOR3;RPL7;RBX1;RPL38;BAG5;KDELR3;PSMA3;COX7B;PSMB6;RPS15A;BAG1;RPSA;RPLP0;RPS6;SLC7A11;ATF5;RPL35;DNAJB9;COX6C;COX6B1;PSMD6;H2AZ2;SESN1;NFYB;RPL27;RPS14;RPL7A;EPX;RBBP7;RPL23;ATP6V1D;DNAJC2;RPS15;DDIT3;DCTN3;BAG2;DCTN1;DCSTAMP;CDKN2D;RPS27;DYNLL2;RPL8;COX5A;STAP2;RPS3;HSPA13;RPS23;PHGDH;CITED2;ATP6V0D1;RPS20;COX7C;KAT5;RPS24;CRYAB;PSMA7;MAP2K4;PPARGC1A;H2AC6;RPS29;HSP90AB1;GPX2;TATDN2;NCF2;CEBPB;IGFBP7;RPS6KA1;PSMB1;ACTR10;RPLP1;RPS28
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.5288654308595012,0.8755254792026179,0.6666666666666666,1.0,1.0,1/6,4.73%,SCIMP
prerank,KEGG_2021_Human__Arginine and proline metabolism,0.415550045191932,0.8755185547667099,0.6666666666666666,1.0,1.0,9/44,19.38%,DAO;CKMT2;CARNS1;P4HA3;CKB;CKM;NOS2;ALDH9A1;ALDH3A2
prerank,GO_Biological_Process_2021__positive regulation of defense response to bacterium (GO:1900426),0.5717340706242281,0.8752494032757244,0.6764705882352942,1.0,1.0,2/5,25.18%,CYBA;GRN
prerank,CellMarker_Augmented_2021__Leydig cell:Fetal Gonad,-0.3058766471944275,-0.8752338266283802,1.0,1.0,1.0,72/346,18.38%,EFNB1;BTN3A2;DNAJC30;PRKCD;GATAD2A;GALE;SLC29A3;PSAT1;IKZF4;VPS16;SLC39A11;PTCH2;PAPSS2;APOE;ZNF385D;EARS2;PRICKLE1;KCNMB2;MGARP;UPF3A;EMID1;DPP9;TGFBR3;RABEPK;PI4KB;ZNF275;PMM2;CMSS1;SUSD4;P3H1;MPV17;CEP135;NOL8;NDUFAF6;JAG1;ALCAM;PSMB2;ANGEL1;SULF2;SPIDR;BAHD1;SLIT2;ABHD12;CDK6;BRD3;TACO1;CHP1;DEPTOR;RBPMS;HSD3B2;CTNNAL1;SLC16A7;CDH11;NETO2;POLR3B;LRP3;RRP12;EIF5A;HNRNPAB;TIMM23;GADD45A;MAFB;SLC39A8;CD9;CCDC86;IPO7;CDK4;RIOK1;ADPGK;MATN2;TMEM69;PTS
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.37683903577391076,0.8751622055127538,0.6867469879518072,1.0,1.0,2/95,0.73%,ESR1;ACTL6A
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),0.5088099520780577,0.8751112468614352,0.6338028169014085,1.0,1.0,5/15,29.72%,SYK;CD27;ZFP36L1;ZFP36L2;PPP2R3C
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4756823380573595,-0.8750848631706379,0.5483870967741935,1.0,1.0,2/13,4.21%,KIT;NR4A3
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.5687328126074676,-0.8749609064887148,0.6046511627906976,1.0,1.0,2/5,14.55%,RTF1;LEO1
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),-0.5580887874766362,-0.8748594226082965,0.6341463414634146,1.0,1.0,2/6,23.47%,AMPD3;ATIC
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Skin,0.39539725188218916,0.8748200367207906,0.6575342465753424,1.0,1.0,18/87,16.68%,ARHGEF40;ACOX2;COL18A1;AOX1;NID1;ANPEP;UACA;FBLIM1;ADGRL4;PLAU;TGM2;DAB2;SEMA3F;TNS3;TGFBI;MYL9;EHD2;FAM114A1
prerank,Reactome_2022__TRAF3-dependent IRF Activation Pathway R-HSA-918233,0.4873725939989591,0.8748044557264819,0.6521739130434783,1.0,1.0,1/12,5.59%,TRIM25
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,0.4488949606945284,0.8747956490776707,0.684931506849315,1.0,1.0,8/24,21.25%,SLC7A7;SLC16A8;SLC16A1;SLC16A3;MAG;SLC7A10;SLC7A11;L1CAM
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,0.39657899031307714,0.874752339417957,0.7160493827160493,1.0,1.0,9/76,16.49%,ACTL6A;POLE2;POLD4;RPA3;RPS27A;TFPT;COPS4;GPS1;COPS5
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.5597532296972918,0.8747370778320603,0.6891891891891891,1.0,1.0,2/8,11.20%,NDUFS2;ATP6AP1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.3745490432391365,-0.874698583582124,0.7083333333333334,1.0,1.0,11/55,10.71%,TSKU;WNT3A;PTPN9;PTPRO;PRAG1;APOE;MINAR1;RTN4RL2;KIAA0319;PTPRS;BCL11A
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.5083961610837179,-0.874665740930389,0.6046511627906976,1.0,1.0,4/7,34.19%,VCL;TNFRSF1A;ZDHHC21;ROCK1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.3620442104628384,0.8746650747902285,0.7294117647058823,1.0,1.0,12/138,15.26%,PSMB9;TENT5B;HSPA8;IGF2BP2;EXOSC8;CARHSP1;RPS27A;EXOSC2;MEIOC;PSMC5;METTL14;EXOSC4
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),0.5913279131230559,0.874576945582599,0.7321428571428571,1.0,1.0,3/5,28.28%,BRCA1;CTNNB1;CTNNA1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),0.5913279131230559,0.874576945582599,0.7321428571428571,1.0,1.0,3/5,28.28%,BRCA1;CTNNB1;CTNNA1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.31621663679447776,-0.8745343120226562,0.6363636363636364,1.0,1.0,8/84,12.03%,UBXN8;AUP1;FBXO27;MAN1A1;SEL1L2;RHBDD1;RNF175;BAG6
prerank,Reactome_2022__Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,-0.4613176398105884,-0.8743245716980699,0.6923076923076923,1.0,1.0,5/14,19.25%,CCKBR;MAPK7;RPS6KA3;PRKCA;HRAS
prerank,KEGG_2021_Human__Fatty acid degradation,0.4340830923080223,0.8742111762016808,0.581081081081081,1.0,1.0,3/37,9.64%,ACSL5;ACAA2;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.503288884250424,-0.8739988626982792,0.5526315789473685,1.0,1.0,2/7,22.19%,MAPT;RNF122
prerank,KEGG_2021_Human__Focal adhesion,0.35287493747359117,0.8738854720687541,0.6931818181818182,1.0,1.0,37/187,18.65%,PIK3R3;FLT1;ITGA2;COL6A5;COL6A6;CAV3;ITGB6;ACTG1;VASP;COL4A4;FLT4;COL4A3;ITGA5;CCND2;IGF1;CCND1;HGF;COL4A6;COL4A5;LAMC2;COL6A2;VWF;VTN;COL1A1;MYL12A;THBS1;ITGA2B;PARVG;MAPK3;MYL9;BCAR1;VAV3;ITGB8;LAMB2;VEGFC;PPP1R12C;THBS2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.42013631832270554,-0.8738695020638028,0.7419354838709677,1.0,1.0,6/16,26.56%,ASS1;MIA3;DUSP3;ADTRP;LAPTM5;AKT1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),0.5679802291913416,0.8738460907172295,0.6451612903225806,1.0,1.0,2/5,14.91%,IL12A;CRTAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),0.5679802291913416,0.8738460907172295,0.6451612903225806,1.0,1.0,2/5,14.91%,IL12A;CRTAM
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.43840638280906874,0.873767797774282,0.6285714285714286,1.0,1.0,5/22,15.23%,SCIN;RHOU;RHOG;PARVG;RHOQ
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.5148127526592503,-0.8736699737021261,0.6428571428571429,1.0,1.0,3/6,17.20%,TWSG1;TNFRSF14;HFE
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,0.4122686433599182,0.8736542734802203,0.6756756756756757,1.0,1.0,12/63,26.00%,PSMB9;RPS27A;PSMC5;RBX1;PSMA3;PSMB6;PSMD6;EPX;CITED2;PSMA7;PSMB1;HIF1A
prerank,KEGG_2021_Human__Small cell lung cancer,0.37199348928273634,0.8732951972267583,0.7228915662650602,1.0,1.0,20/87,20.80%,PIK3R3;ITGA2;COL4A4;COL4A3;CCND1;CKS1B;COL4A6;COL4A5;LAMC2;CCNE2;CDKN1B;CDKN1A;ITGA2B;RXRG;NOS2;LAMB2;APAF1;NFKBIA;FN1;TRAF5
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",-0.31492434631264604,-0.8732201444355718,0.6428571428571429,1.0,1.0,14/103,13.59%,FOS;SHC3;CREB3L4;ITPR2;JUNB;SHC4;CREB3L1;STAT5B;GNAS;GNA11;ADCY3;ADCY2;CRK;CREB3L2
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.2917350753860038,-0.8732116454133697,0.6923076923076923,1.0,1.0,33/161,20.10%,CAMK1G;SBK1;PRKCD;MAST2;GALNT13;TTBK1;MAP3K10;ATR;CDK1;MAP3K12;MAPKAPK2;PARP2;POGLUT3;MARK2;CSNK1G2;EIF2AK3;CSNK1E;RPS6KA3;MAP3K13;CDK5;PRKCA;MARK3;GALNT2;MAPK12;SGK2;AKT2;MAST1;BRSK1;CLSPN;MORC3;SGK1;ATM;CSNK1G1
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.483297340904282,-0.8731684137765873,0.6333333333333333,1.0,1.0,5/12,10.83%,PNP;NT5C1A;NT5C;GPX1;DNPH1
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreas,-0.3428084736912504,-0.8731022560471867,0.76,1.0,1.0,32/97,20.17%,KCNIP3;TBC1D16;SHC3;RND3;LRRC73;DLG5;PTPRF;MID1;CAP2;EPB41L4B;NCS1;NLGN2;SRRM3;GNA11;FHOD3;ANTXR1;DAB2IP;PCDH1;NAV2;AMOTL2;CHST3;GPC1;ARNT2;DDAH1;SH3BP4;RBFOX2;PCDH7;PTPN21;SYT7;CDC42BPB;IGSF3;SEZ6L2
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.4790750330809799,0.8730756202820421,0.6081081081081081,1.0,1.0,1/13,5.19%,DDX20
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.447331001918305,0.8729012237664047,0.6428571428571429,1.0,1.0,1/43,0.47%,RAB34
prerank,CellMarker_Augmented_2021__Migration Phase Fetal Germ cell:Fetal Gonad,0.37600823703172354,0.8728300249383865,0.6790123456790124,1.0,1.0,33/131,21.12%,MGST1;S100A13;TP53I3;TCEAL8;NDUFB11;ARMCX3;H2AZ1;NQO1;MYL6;RPA3;NOP10;COX7A2;CARHSP1;ZC3HAV1;SKA2;MRPL34;ETFB;SNRPD2;TMSB10;SLIRP;TMEM144;MYL9;TPD52L1;TOMM7;RPL7;TIMM10;CYSTM1;ASPA;COX7B;PSMB6;NLRP9;GGCT;RPS14
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.38562585617209755,0.8727477024569382,0.6621621621621622,1.0,1.0,8/63,9.24%,TNFRSF1B;HIPK1;TGFB1;TNFRSF10A;BOK;IL12A;DDX3X;MOAP1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.3946299779305722,-0.8726250599601441,0.6956521739130435,1.0,1.0,3/20,9.33%,SLC6A20;SLC3A2;SLC7A5
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Peripheral Blood,0.3809217047004822,0.8724955297827788,0.6623376623376623,1.0,1.0,14/70,16.75%,C1QB;LYVE1;CYYR1;GPIHBP1;ANGPTL2;RAMP3;ADGRL4;VWF;DCN;CLDN5;EDNRB;SLCO2B1;ELN;A2M
prerank,Reactome_2022__FGFR1 Ligand Binding And Activation R-HSA-190242,0.5282910875945953,0.8722790641253027,0.6862745098039216,1.0,1.0,1/13,2.58%,FGF20
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.5073501522526087,0.8722184201942218,0.6857142857142857,1.0,1.0,5/13,11.88%,CLDN2;CLDN6;CLDN18;CLDN5;CLDN9
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.36719919625189734,0.8721561639766043,0.7012987012987013,1.0,1.0,2/79,1.79%,NEK2;KIF14
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.4998474871590318,0.8721067056219794,0.6129032258064516,1.0,1.0,5/13,18.01%,JCHAIN;SFTPD;HLA-A;WFDC11;TF
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,-0.421793812010528,-0.8720942176172075,0.5666666666666667,1.0,1.0,2/30,7.21%,CACNG4;CACNB1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.34859277275512335,0.8720805824579078,0.6941176470588235,1.0,1.0,18/148,17.41%,SGO1;BUB1;CENPU;MISP;ERCC6L;NDC80;RAB11A;KIF18A;SKA2;TTK;GPSM2;NUF2;SPC25;TBCE;BUB1B;RCC1;DYNLL1;ITGB3BP
prerank,Reactome_2022__Neurofascin Interactions R-HSA-447043,-0.5016483199622512,-0.8720654528652105,0.5789473684210527,1.0,1.0,1/7,12.90%,SDCBP
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),-0.4875017831470926,-0.8720074072942489,0.6511627906976745,1.0,1.0,2/7,10.39%,NMU;MYOCD
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.5733336549952878,0.871930632476409,0.7288135593220338,1.0,1.0,2/6,24.68%,PDZK1;ABCB1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.4260132770170852,0.871881025025262,0.6119402985074627,1.0,1.0,4/33,10.91%,LRP2;TGFB1;VASP;CELSR1
prerank,Reactome_2022__SHC-mediated cascade:FGFR3 R-HSA-5654704,0.5023524592303849,0.8718315335773819,0.6557377049180327,1.0,1.0,1/14,2.58%,FGF20
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.357924163873803,0.87173320033913,0.6904761904761905,1.0,1.0,34/190,11.36%,C1QTNF1;TIMP3;PRRX1;PRG4;LMOD1;TNFRSF1B;ADAM33;PTX3;LOX;CTHRC1;HHIP;FGF2;ABI3BP;ITGBL1;FLI1;PCDH18;INMT;COL4A4;COL4A3;NT5E;ANGPTL2;IGF1;HGF;ACTA2;CYP1B1;HCK;ADGRL4;COL6A2;PLAC9;DCN;VTN;COL1A1;DAB2;ASPN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.43511470266190605,-0.871681310779698,0.5,1.0,1.0,3/10,10.39%,WNT3A;FZD7;MYOCD
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.48235284602511813,0.8714831348034239,0.6417910447761194,1.0,1.0,1/19,1.49%,PKP2
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.5221550286411947,0.8712800738767511,0.6825396825396826,1.0,1.0,1/8,9.56%,RHOB
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,0.3716718229243341,0.871237226907868,0.75,1.0,1.0,18/132,15.82%,MAPKAPK3;CBX8;H1-0;DAND5;H2BC4;CDKN2A;H2AZ1;ID1;CCNE2;RPS27A;HMGA2;CDKN1B;CDKN1A;CCNA2;CDKN2C;HMGA1;MAPK3;ARTN
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),0.5697658993873826,0.8712282496253095,0.6739130434782609,1.0,1.0,3/5,20.67%,SCTR;AQP4;AQP11
prerank,CellMarker_Augmented_2021__Beta cell:Pancreas,-0.4352887289672981,-0.8709750735500323,0.5686274509803921,1.0,1.0,2/13,7.03%,NPTX2;TGFBR3
prerank,CellMarker_Augmented_2021__SLC16A7+ cell:Lung,-0.27644496925309786,-0.870835481543854,1.0,1.0,1.0,96/874,10.92%,UGT2B15;NOX4;NIPAL1;DYNLT5;BTN3A2;MLPH;NAA40;SLC25A29;SLC6A20;SLC29A3;IBA57;IKZF4;CFLAR;GOLGA6L10;GLB1L;PIWIL2;ZNF773;THEM4;PLEKHG4B;BCL2L15;FLVCR1;OVGP1;ZNF514;CFAP410;TMPRSS7;POFUT2;MDGA1;PDPR;NEK8;ACER3;ABCF3;MTHFR;GSDMB;CLDN16;RINL;HSCB;CCBE1;PDCD7;FAAH2;ZNF33B;KANK4;ABCA9;GOLGA8A;ST6GAL2;NMRK1;LRRC8B;METTL8;ARFIP2;DPP9;MID1;GBP4;BEST4;GREB1;NKD1;ARIH2OS;ZNF3;CLASRP;ZNF316;TTC12;METTL6;RASSF8;ISG20L2;ECHDC2;SLC2A11;CLUAP1;ITIH5;ALPK1;GUCA1B;MEFV;FANK1;ATR;ZC3H12D;QRSL1;NCR3LG1;DZIP1L;KIAA0319;MYLK3;UBIAD1;TIGD1;CHST12;GTF2H2;CNTRL;CARF;GNB5;RALGDS;XPC;NPIPA2;CROCC;GMEB1;NR2C1;PRELP;CMBL;NYAP2;MANEAL;ZNF549;ANKLE1
prerank,Reactome_2022__Interleukin-15 Signaling R-HSA-8983432,0.4972176350250875,0.8706665984313657,0.676923076923077,1.0,1.0,1/13,6.23%,STAT5A
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.556770850109383,0.8706565680728289,0.6938775510204082,1.0,1.0,1/5,15.65%,TDG
prerank,CellMarker_Augmented_2021__Myofibroblast:Lung,-0.3353184374550176,-0.8706386922784822,0.75,1.0,1.0,12/84,7.20%,FIBIN;ADAMTS12;PAMR1;CALD1;COL6A3;COL4A2;COL12A1;MMP2;TPM2;CNN1;SLIT3;FSTL1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.5253175206328339,0.8706236564941671,0.7076923076923077,1.0,1.0,1/9,7.14%,KLF15
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3086352165453779,-0.8705459942569371,0.6666666666666666,1.0,1.0,18/99,12.91%,BAMBI;CDH5;FOS;DUSP15;WNT7A;F11R;ACVR1;PARD3;LPXN;FNTA;TGFBR3;TWSG1;DLX1;HPGD;ZMIZ1;PDE3A;MAPK7;ARRB2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.5533262651374357,0.8705419250381318,0.7377049180327869,1.0,1.0,3/6,29.38%,ATF5;ZFP36L1;ZFP36L2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.46464955684976894,0.8702340632664526,0.6615384615384615,1.0,1.0,5/23,16.38%,F7;F2RL1;IL4;ZNF580;CSF1
prerank,KEGG_2021_Human__Glycerolipid metabolism,-0.36733732032630373,-0.870131807175648,0.6923076923076923,1.0,1.0,4/54,4.35%,LIPC;GLA;DGKD;PNPLA3
prerank,Reactome_2022__Apoptotic Cleavage Of Cell Adhesion Proteins R-HSA-351906,-0.4949140415199548,-0.870071057688608,0.6,1.0,1.0,1/9,3.89%,DSG2
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.29916260368531733,-0.8700679464816875,0.8333333333333334,1.0,1.0,33/177,14.75%,KCNIP3;ABHD17A;EFR3B;PTCH1;PDZD11;TMEM150A;SPTBN4;RAB3D;ITGA4;ZDHHC23;F11R;TTC7A;AGRN;DPP6;FLNA;TTC7B;BSG;NLGN2;PRAM1;KCNB2;EHD4;CYP46A1;SYNE3;EHD3;RAMP1;NRXN2;MRAP2;PPIL2;WNK3;RAB40A;RAB40C;FRMPD1;SCRIB
prerank,KEGG_2021_Human__p53 signaling pathway,0.3818931864092197,0.8699894833767118,0.6891891891891891,1.0,1.0,13/68,15.15%,TNFRSF10A;CCNG2;CDKN2A;TP53I3;CCND2;IGF1;CCND1;EI24;CCNE2;CDKN1A;THBS1;SERPINB5;BBC3
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.2635033723711748,-0.8699587561004194,1.0,1.0,1.0,109/966,12.38%,RFX6;CD38;POU3F1;ETV5;NPAS4;GALR3;EHF;NR4A1;SKAP1;IL11;TEAD2;H1-4;BAMBI;ETV1;OSR1;WNT3A;FOS;ZNF496;ERG;ZSCAN21;KMT2B;TWIST1;CREB3L4;CDH13;JUNB;EGR1;IFI16;FOXO1;ADCYAP1;MAML1;WBP2NL;LHX2;NR4A3;BCL9L;SMARCB1;GABPB2;QRICH1;APOE;SP7;WNT7A;KLF10;CCN1;CTCF;HES1;ERBB2;BCLAF3;MEN1;LBH;KDM8;SOX12;ACVR1;FGF1;STAT5B;FZD7;AGRN;PPARGC1B;PRDM15;ASCL1;PKD2;ETS1;NFATC3;PID1;SSBP3;SENP1;IRF5;DLX1;RIPK2;FANK1;SERPINE1;RARB;FOSL1;LBHD1;NIBAN2;MLX;MLIP;HDAC3;CITED4;BARX2;LDB1;BPTF;NR1D1;SNX5;XPC;MYOCD;ZMIZ1;RGMA;ATF3;AGO2;TFE3;HMGN5;TFDP1;NAMPT;ZNF268;RLF;HSF1;GRIN1;TRIM44;JAG1;PAX3;KDM1B;MAP3K12;ZNF263;IL31RA;CDK5RAP2;DAB2IP;RBL1;FGFR2;NFIB;CAND2
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.5701313400629714,-0.8699301686042445,0.7,1.0,1.0,3/6,12.03%,RAB7B;NR1D1;DAB2IP
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.43955636535711157,0.869865063382676,0.7123287671232876,1.0,1.0,1/29,1.12%,CAVIN1
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.4727274219989497,-0.8698526762708858,0.6363636363636364,1.0,1.0,3/8,29.74%,BRF1;GTF3C5;GTF3C2
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.5105282775609122,0.8696366926078097,0.7464788732394366,1.0,1.0,5/13,23.49%,CD4;CSF1;DCSTAMP;CD74;HLA-DRB1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.3761273274819148,0.8696231110716222,0.7294117647058823,1.0,1.0,29/117,20.05%,AQP3;A4GALT;GNG12;CLDN18;CRLF1;ITGB6;SCARA3;COL4A4;COL4A3;FBLIM1;OSMR;TMEM54;TRIM29;LAMC2;COL1A1;SEMA3F;IGFBP6;MMP11;SEMA3B;GRAMD2A;AGER;SERTAD4;FAM114A1;PPIC;LAMB2;SLC44A3;SCNN1A;SMARCA1;PTPRU
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.3730604029334358,-0.869559842394264,0.6956521739130435,1.0,1.0,8/50,8.91%,ACAD10;MECR;SLC25A17;SLC27A2;ACOX3;ECHDC2;ACADS;ECHS1
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5208612923656472,0.8694624123968402,0.7162162162162162,1.0,1.0,3/12,18.60%,BOK;AGR2;TMEM33
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.40290700309980093,-0.8693515323195159,0.6451612903225806,1.0,1.0,2/19,9.33%,SLC6A20;SLC7A5
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,-0.3841043404833347,-0.8692156775362716,0.6666666666666666,1.0,1.0,3/38,3.39%,GATAD2A;CHD4;HDAC10
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,0.34929147242075415,0.869045885945608,0.7530864197530864,1.0,1.0,22/186,15.19%,SLC25A31;ITGB2;PIK3R3;TGFB1;HLA-F;STAT5A;CDKN2A;TBPL1;CCND2;CCND1;HLA-A;HLA-DMA;TGFB3;HLA-DPB1;CCNE2;CD4;CDKN1A;NFKB2;CCNA2;CDKN2C;ADCY7;MAPK3
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.3987111858358698,-0.8689872514156443,0.6551724137931034,1.0,1.0,9/35,17.20%,LIMK1;APOE;ISLR2;KIAA0319;PTPRS;GOLGA4;DBNL;MAP3K13;ABL1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.36198048198685995,-0.8689041700212055,0.76,1.0,1.0,6/36,14.72%,PHLDB2;SKA1;MAPRE1;GAS2L2;MARK2;TRAF3IP1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.4547197482704542,-0.8688951810872166,0.5,1.0,1.0,6/15,14.07%,TWIST1;SLC30A10;MARCHF5;RBL1;TERT;CDK6
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Peripheral Blood,-0.3328176233078936,-0.8688433915383296,0.7272727272727273,1.0,1.0,8/74,3.99%,EMP1;CDH5;ERG;COL6A3;TIE1;CLEC14A;MMP2;TPM2
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Undefined,-0.33384151921224825,-0.8688061680322955,0.5384615384615384,1.0,1.0,9/91,7.63%,XKR7;TRIM67;DUSP15;CRABP1;ELAVL3;TTBK1;INA;ASCL1;KCNIP1
prerank,Reactome_2022__Presynaptic Nicotinic Acetylcholine Receptors R-HSA-622323,0.5026188618818966,0.8687347647564395,0.6818181818181818,1.0,1.0,4/11,22.69%,CHRNA5;CHRNB2;CHRNA3;CHRNA6
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.5225007588420576,0.8687124114726519,0.6551724137931034,1.0,1.0,2/9,13.33%,F2RL1;CSF1R
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.35511843207143784,-0.868659456729786,0.631578947368421,1.0,1.0,7/84,9.35%,KIF2B;SEC24C;HLA-DQB1;HLA-DRA;RAB7A;KIF15;KIF4B
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.38240422749052155,-0.8686120840464812,0.72,1.0,1.0,7/24,26.65%,LDB1;CCNT1;WDR43;ALYREF;ZMYND11;THOC1;HMGN1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5128488827440735,0.8685255761533295,0.6461538461538462,1.0,1.0,2/10,13.91%,EPCAM;PLG
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5392697229182853,0.8685151181787042,0.6206896551724138,1.0,1.0,2/8,10.66%,IL12A;DCN
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),0.5053711456449024,0.868500995474054,0.7142857142857143,1.0,1.0,2/12,13.21%,WNT5A;THBS1
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,-0.34932819293376755,-0.8683078670449385,0.5,1.0,1.0,9/56,13.30%,ST3GAL3;POFUT1;MAML1;MAMLD1;AGO2;TFDP1;H2AJ;ST3GAL4;TNRC6C
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.4455521203454241,0.868186963673765,0.6461538461538462,1.0,1.0,3/26,12.58%,ANXA1;PIF1;RECQL4
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,-0.33620440137369734,-0.8681667177789548,0.7368421052631579,1.0,1.0,14/56,16.13%,EPHX2;MLYCD;PEX7;SLC27A2;ACOX3;GSTK1;PEX13;MPV17;PEX14;NUDT19;CROT;TYSND1;EHHADH;DHRS4
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.43468214454889853,-0.8681596067785089,0.6764705882352942,1.0,1.0,4/15,12.55%,APOE;DHFR;SCARB1;TERT
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.5117671564455826,0.8679899263990081,0.7101449275362319,1.0,1.0,1/13,3.00%,OLAH
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.49392256649342714,0.8678973449920672,0.6071428571428571,1.0,1.0,2/10,19.63%,MAPK3;MAP2K1
prerank,Reactome_2022__Gap Junction Trafficking R-HSA-190828,0.4542325824505622,0.867812144323513,0.6551724137931034,1.0,1.0,2/16,11.07%,GJB7;DAB2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),0.5575584368740143,0.8677082031207605,0.696969696969697,1.0,1.0,2/7,24.92%,SIGLEC1;CAV2
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.3864072103849077,0.867658038342311,0.7361111111111112,1.0,1.0,13/74,16.85%,RRAS;SP100;FGF2;WNT5A;FLT4;RHOB;DCN;AGT;THBS1;ZNF580;PIK3CG;BCAR1;GLUL
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),0.5505028930963332,0.8674057450012446,0.7413793103448276,1.0,1.0,1/6,6.68%,NODAL
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Undefined,0.48345405619199405,0.8673789649883349,0.65625,1.0,1.0,2/14,13.25%,EPCAM;CCNA2
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.4967913014513307,0.867348249346417,0.6666666666666666,1.0,1.0,4/10,19.83%,HEY2;SNAI1;HEY1;NOTCH2
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.33995254472857583,-0.8673071329908871,0.8,1.0,1.0,11/87,4.54%,ADAMTS1;TEAD2;BOC;CALD1;TWIST1;COL4A2;COL12A1;MMP2;TWIST2;RND3;RHBDF1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.3711969955034921,0.86727296865214,0.7790697674418605,1.0,1.0,16/131,15.15%,ITGB2;HSPA1L;ARIH2;TGFB1;ITGAM;CD81;PRR5L;TCAF2;TP53BP2;PINK1;ECT2;RHOU;OAZ2;ZIC1;PDZK1;BBC3
prerank,KEGG_2021_Human__Non-small cell lung cancer,0.38443356720263483,0.8670954216736058,0.6447368421052632,1.0,1.0,8/70,15.19%,PIK3R3;STAT5A;CDKN2A;CCND1;HGF;CDKN1A;RXRG;MAPK3
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.3218498384214933,-0.8670419782419374,0.88,1.0,1.0,4/66,8.70%,NGF;PLEKHG2;PREX1;FGD1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.34729521278895353,0.8670218153150966,0.7555555555555555,1.0,1.0,46/299,19.39%,NOTUM;APOL1;PSMB9;ITIH2;SDC2;FBXL7;ASB5;DTL;C3;ASB14;SERPIND1;SOCS2;SPSB2;ANKRD9;KNG1;ASB15;ASB17;RAB11A;CP;KLHL2;FBXL13;PENK;SERPINA10;FBXL3;RAB38;PSMC5;KBTBD7;TGOLN2;COPS4;KLHL13;RABGGTB;FBXO40;KBTBD6;GPS1;CSF1;COPS5;UBE2M;ASB16;TF;LAMB2;FEM1B;RBX1;PSMA3;NEURL2;PSMB6;PTP4A2
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.42865206961530516,0.8670155602202174,0.5714285714285714,1.0,1.0,1/36,0.72%,LRP4
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.36754215259898315,-0.8668585653266105,0.7391304347826086,1.0,1.0,6/56,6.56%,PER2;LIPC;MLYCD;CYP7B1;SLC27A2;OSBPL3
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,0.3912265647949553,0.8666003756929539,0.7,1.0,1.0,5/73,7.33%,ELMO3;PIK3R3;CAV3;ACTG1;ITGA5
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.4110594098088728,-0.86654509334054,0.5652173913043478,1.0,1.0,9/46,9.67%,NLGN3;GRID2;WNT7A;DLG5;SYNDIG1;PTPRJ;EPHB2;SLITRK2;NLGN2
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.4426331822100782,-0.8662800845219012,0.6,1.0,1.0,4/11,20.60%,KCNE1;KCNH2;YWHAE;KCND3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.41800729998167885,0.866231236443398,0.6818181818181818,1.0,1.0,8/32,15.99%,AIM2;NLRP12;WNT5A;USP50;NLRC4;F2RL1;NLRP2;AGER
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.3408001500983446,-0.8661207071325046,0.6521739130434783,1.0,1.0,7/71,12.03%,UBXN8;AUP1;FBXO27;MAN1A1;SEL1L2;RNF175;BAG6
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,0.3777633969051165,0.8660768667394286,0.7215189873417721,1.0,1.0,13/87,20.60%,PSMB9;CDKN2A;NQO1;RPS27A;TALDO1;PSMC5;IDH1;RBX1;PSMA3;PSMB6;SLC7A11;PSMD6;SESN1
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,0.38685752641298665,0.8659881117385424,0.64,1.0,1.0,12/51,18.80%,ATP6V1G2;ABCG2;ATP6V0E2;CP;RPS27A;ATP6AP1;FTH1;SLC46A1;CYBRD1;ATP6V0B;TF;FTL
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),0.5742096634316567,0.8659732839358365,0.7115384615384616,1.0,1.0,1/6,11.98%,CD4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),0.5742096634316567,0.8659732839358365,0.7115384615384616,1.0,1.0,1/6,11.98%,CD4
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.42216639671971573,-0.8659188629129743,0.6333333333333333,1.0,1.0,4/24,19.48%,PEX7;PEX14;PEX3;ACOT8
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Fetal Liver,-0.5174959568952318,-0.865858492559939,0.6666666666666666,1.0,1.0,2/8,3.46%,CD14;KIT
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.41872015829064835,-0.8655466203015527,0.575,1.0,1.0,4/16,16.68%,LDB1;CDK6;LEO1;MAFB
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.57432876392554,0.8655390241683537,0.6935483870967742,1.0,1.0,1/5,8.49%,DDX3X
prerank,"Reactome_2022__PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",-0.43975456680579605,-0.8655385022657527,0.5172413793103449,1.0,1.0,5/13,19.25%,CRK;RHOA;ARHGAP35;ELMO1;HRAS
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.38074050312293034,-0.8655040604210101,0.6590909090909091,1.0,1.0,3/29,5.27%,SYT12;CBARP;DOC2B
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.3889147264889898,0.8654723207456895,0.6951219512195121,1.0,1.0,12/75,15.11%,SMAD6;SMOC1;HEMGN;IGF1;REST;HGF;RANBP3L;ATP6AP1;FBN2;SOX9;DDR2;ATRAID
prerank,CellMarker_Augmented_2021__Pericyte:Brain,0.38254031495010377,0.8654671223091178,0.6842105263157895,1.0,1.0,13/85,11.00%,C1QTNF1;TIMP3;PRRX1;LMOD1;ADAM33;PCDH18;ANGPTL2;ACTA2;ADGRL4;SYNC;COL6A2;DCN;COL1A1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.44281577245056736,0.8653561649925644,0.6615384615384615,1.0,1.0,3/22,13.21%,TLR2;DUSP22;THBS1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.38714230624606427,-0.8652651591122955,0.6296296296296297,1.0,1.0,10/32,12.71%,ADCYAP1;APOE;PDE7B;ADGRG6;CAP2;AQP1;ADCY2;PDE3A;HTR2C;MAPK7
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.4969194288215778,-0.8651530545177603,0.7105263157894737,1.0,1.0,1/10,4.78%,APOE
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.40540895985093456,-0.8650061091933241,0.5925925925925926,1.0,1.0,3/30,5.31%,PPP6R1;BOD1L1;STYXL1
prerank,Reactome_2022__Trafficking And Processing Of Endosomal TLR R-HSA-1679131,-0.4638133581392212,-0.8649025445817418,0.6086956521739131,1.0,1.0,2/9,22.21%,CNPY3;CTSV
prerank,CellMarker_Augmented_2021__Naive T cell:Peripheral Blood,0.5252730215803221,0.8648853072439338,0.6727272727272727,1.0,1.0,4/6,22.63%,PTPRC;CD4;CD8B;CD27
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,0.4343839833880853,0.8648635496448448,0.7605633802816901,1.0,1.0,4/40,8.12%,TCF7;H2BC4;LEF1;H2AZ1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.5275422283665293,0.8648623847628979,0.6896551724137931,1.0,1.0,5/9,22.36%,RPL11;RPS7;FBXO5;RPL23;BAG2
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.36184348614806666,0.8648395909930193,0.8045977011494253,1.0,1.0,13/167,11.51%,CHRNA9;KCNJ15;GNAT3;GNG12;ERBB4;HTR3E;GNG4;CHRNA5;GRIN2D;GLRA2;GLRA1;HTR3C;RASGRF2
prerank,CellMarker_Augmented_2021__Hematopoietic Precursor cell:Fetal Liver,-0.517532709609556,-0.864828071700702,0.6486486486486487,1.0,1.0,2/7,3.46%,CD14;KIT
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.36069626663297194,0.8647622812588602,0.7625,1.0,1.0,38/180,15.58%,ITGB2;SMOC1;ITGAX;COL18A1;LOX;MMP19;ECM2;FGF2;NID1;ITGAM;ITGA2;ITGB6;ADAMTS17;JAM2;MMP9;COL4A4;COL4A3;ITGA5;MMP21;COL4A6;COL4A5;MMP15;LAMC2;TEX14;COL6A2;VWF;DCN;VTN;COL1A1;FBN2;MMP23B;THBS1;ITGA2B;MMP11;DDR2;CD44;TGFBI;ELN
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),-0.4390697884371879,-0.8647475691098833,0.6285714285714286,1.0,1.0,6/18,25.78%,LIN28B;RBM24;DXO;YTHDF1;RIDA;METTL16
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,-0.36822666125138714,-0.8647441627776941,0.5,1.0,1.0,12/37,24.25%,RND3;VANGL1;DLG5;SCRIB;RBMX;CCDC88A;ARHGAP35;MUC13;ANKRD26;UBXN11;KTN1;KCTD13
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.5396384797056526,-0.8646756897038819,0.6590909090909091,1.0,1.0,1/6,1.41%,GLA
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.35081074230413817,-0.8646155996642838,0.65,1.0,1.0,17/72,21.29%,GCK;FOXO1;CPEB1;CELA2A;SYAP1;CAPN10;SLC25A33;MEAK7;PDE3B;MARS1;HDAC5;AKT2;RAB10;LPIN2;GPLD1;TSC1;RAB31
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.43375094406383297,0.8644133633170245,0.6944444444444444,1.0,1.0,2/26,4.60%,MYRF;SOX10
prerank,KEGG_2021_Human__Gastric acid secretion,-0.32325921722366935,-0.8644032936848302,0.8571428571428571,1.0,1.0,10/62,14.18%,HRH2;KCNJ16;ITPR2;CCKBR;GNAS;MYLK3;ADCY3;ADCY2;KCNJ1;SLC26A7
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.3748589653886741,0.8643331155893135,0.7101449275362319,1.0,1.0,18/64,18.56%,AQP3;TCN1;PLEKHG6;TMEM45B;ANGPTL4;TRIM29;TJP3;AP1M2;F2RL1;RDH12;LY6D;CYP24A1;SERPINB5;AGR2;SPINT1;CNR2;FBP1;PRRG4
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5413995084798326,0.8641637941651839,0.734375,1.0,1.0,2/7,16.69%,CD80;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.5413995084798326,0.8641637941651839,0.734375,1.0,1.0,2/7,16.69%,CD80;RASGRP1
prerank,Reactome_2022__Metabolism Of Proteins R-HSA-392499,0.3254846683645017,0.863774618089438,0.93,1.0,1.0,242/1610,20.02%,GATA4;CDC25A;ESR1;RAB34;TEX101;ACTL6A;NOTUM;ARSH;APOL1;PSMB9;ST6GALNAC1;C1QTNF1;GALNTL5;RENBP;ITIH2;ACE2;SDC2;FBXL7;ASB5;HSPA8;CSF2RA;SP100;DTL;MAT2B;SFTPA1;GNAT3;FAM20A;C3;UBE2L6;GNG12;CBX8;CPM;TGFB1;RPL37A;RPL21;GPIHBP1;ASB14;TPGS1;SFTPD;ADAMTS17;SERPIND1;TRIM25;MUC17;ANPEP;GCNT7;B4GALNT2;B3GNT9;MRPS34;H2BC4;MUC4;CDKN2A;SOCS2;RPL9;NR1H4;MPDU1;IGF1;LY6H;F8;PROZ;GNG4;H2AZ1;CPB2;GALNT5;RPL18A;C1GALT1C1;SPSB2;NANS;HIC1;ANKRD9;HLA-A;KNG1;PLAUR;RRAGA;F7;ASB15;RPS9;RPL3;SSR4;RPL36;RPL13A;CALB1;JOSD2;RPS16;MUCL1;ASB17;RAB11A;RPL15;CP;B3GNT5;AGBL5;RPS5;CCNE2;RAB6B;RPS27A;RPS3A;MOGAT1;PLA2G7;TTLL2;RPL41;USP13;KLHL2;ENGASE;UHRF2;FAM110A;ETFBKMT;ASGR2;B4GAT1;MRPL20;ING3;RAB19;RPS12;EEF2KMT;FBXL13;RPS4X;TFPT;RPL27A;PENK;MRPL34;NFKB2;ARSF;ETFB;THBS1;PIGH;B3GLCT;CCNA2;EEF1A1;CHST4;SLC35C1;USP18;RPS19;TTLL4;TOMM20;SERPINA10;YARS2;MRPL50;FBXL3;RAB38;PLG;IGFBP6;FAU;PSMC5;TRAPPC2;PCMT1;SRP19;RPS21;LY6D;KBTBD7;TGOLN2;GGCX;YOD1;H2BC18;NPPA;COPS4;KLHL13;TUBA4A;TUBA3D;ART3;RABGGTB;TUBB6;CYLD;TGFBI;RPL32;TDG;MOGAT2;FBXO40;TBCE;KBTBD6;PTRH2;GPS1;GADD45GIP1;RPL11;RPL23A;RAB39A;GHRL;EEF2;TAF10;CSF1;RPL35A;RPS11;COPS5;VASH2;NR5A2;GFM2;MRPL54;MUC16;PAPPA;RPS13;THSD1;ASGR1;FKBP8;BRCA1;RPS7;DYNLL1;UBE2M;ASB16;INHBC;EIF1AX;TAF9B;ERO1B;PAPPA2;TF;SYVN1;TUBA1C;RSL24D1;RPLP2;HCFC1;RPL7;TRAPPC5;SEL1L;FEM1B;RBX1;PIGC;THBS2;RPL38;MRPS2;POMGNT1;ATP6AP2;NFKBIA;CCT7;KDELR3;PSMA3;SIAH1;USP17L2;ART4;NEURL2;DARS2;PSMB6;RAB33A;PTP4A2;RPS15A;SPCS2;RAB29;RAB21;CTSZ;RAET1G;PGM3;PRSS23;RPSA;RPLP0;RPS6;GALNT6;RPL35
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gall Bladder,-0.3313831786777286,-0.8637547921088414,0.7037037037037037,1.0,1.0,7/69,5.32%,TACR3;DPPA2;PLEKHG4B;LIN28B;GRID2;TRIM71;CRABP1
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),-0.523479052221385,-0.863726169032577,0.5581395348837209,1.0,1.0,4/7,2.72%,TPH1;TYRP1;MOXD1;DCT
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5046294185362368,0.8635438097430693,0.7419354838709677,1.0,1.0,3/11,20.75%,IGF2BP2;RASA1;IGF2BP3
prerank,CellMarker_Augmented_2021__Astroglial Progenitor cell:Embryo,-0.32091836874305546,-0.8635034214897596,0.8235294117647058,1.0,1.0,12/73,12.10%,APOL3;GBP2;PPM1M;NLRP1;TNFRSF14;SELPLG;GSTK1;CTDSP1;WDTC1;MOB2;CTDSP2;LRP10
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In1:Brain,-0.3174208801765054,-0.8631299973862829,0.75,1.0,1.0,14/95,12.23%,XKR7;NLGN3;TMEM132C;SLC17A6;SEZ6L;ELAVL3;TMEM132E;KCNIP1;WSCD2;SDK2;RGMA;PTPRZ1;ADGRA1;NRXN2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.4122156359142264,-0.8630863230215943,0.6774193548387096,1.0,1.0,6/26,12.71%,IL11;CDH5;ITGA4;SERPINE1;AKR1C3;MAPK7
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.46902073009864476,-0.8630290253664351,0.7,1.0,1.0,3/8,23.62%,AK8;AK7;AK9
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.47787835162292025,0.8629468601620186,0.7,1.0,1.0,1/15,0.33%,ENPP2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.4214532677650319,0.8629315577077395,0.647887323943662,1.0,1.0,2/33,3.18%,CASQ2;KCNJ15
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.4538499398319146,0.8629276254982221,0.7049180327868853,1.0,1.0,2/20,3.81%,FGF2;PTPRC
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.46375540123821235,-0.8628549966408934,0.7,1.0,1.0,3/8,20.02%,MVK;DHDDS;PDSS2
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,0.3500060561033057,0.8628500505810288,0.7912087912087912,1.0,1.0,53/264,13.89%,C1QTNF1;C3AR1;WNT8B;LPAR1;GPR55;NPFFR1;GNRHR;GPHB5;ANXA1;CCL5;C3;GNG12;SSTR1;PTAFR;TSHR;CASR;ADGRE1;SCTR;WNT5A;GPER1;PTGER3;NMUR2;HTR5A;UTS2;CXCR5;ACKR4;P2RY6;ADRB1;WNT8A;RAMP3;GNG4;PDYN;RXFP2;KNG1;NPY1R;NPY;P2RY12;FZD8;GNRH1;LPAR6;GRM6;WNT6;F2RL1;GPR183;PNOC;XCR1;HTR1B;PENK;CRHBP;FPR1;CALCR;OPRM1;GPR68
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3570469632931801,0.8627478874098087,0.7471264367816092,1.0,1.0,12/96,8.49%,ST18;TNFRSF10A;NLRP12;BOK;GPER1;SYK;NODAL;UACA;COL4A3;NLRC4;REST;DDX3X
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.36291097972345787,0.8626437957594421,0.7125,1.0,1.0,17/112,20.92%,PSMB9;HSPA8;IGF2BP2;PRR5L;EXOSC8;CARHSP1;RPS27A;EXOSC2;ZC3HAV1;PSMC5;EXOSC4;PSMA3;PSMB6;PSMD6;IGF2BP3;SET;CNOT8
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.49316847105001776,-0.8626056543712344,0.6764705882352942,1.0,1.0,2/9,11.31%,GRIN3A;GRIN1
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337),-0.5837908469674734,-0.8622182671449629,0.6153846153846154,1.0,1.0,2/5,33.85%,PAX2;BMP4
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.5794280319627482,-0.8621666356848703,0.7352941176470589,1.0,1.0,2/5,32.71%,XRCC4;SLF2
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Foreskin,0.3850575264796011,0.8619654938011173,0.6626506024096386,1.0,1.0,15/89,25.10%,SNAP23;DDX3X;KLF3;CMTR2;PPP2R5A;TGOLN2;UHMK1;SEL1L;CEACAM1;CPD;CTBS;ERAP1;CD164;RBL2;TMEM87B
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.37334111187514823,0.861777532638043,0.7073170731707317,1.0,1.0,18/100,15.21%,GP1BA;LRRC19;ACE2;ANXA1;PDE6A;WNT5A;GRK7;IRF1;HCK;P2RY12;TNFSF4;F2RL1;LACC1;ALOX15;USP18;CNGA1;GUCY2F;CYLD
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.36300977343199,0.861545414158266,0.7317073170731707,1.0,1.0,14/143,7.91%,TBX1;LPAR1;RRAS;ROS1;FGF2;PTPRC;GFRAL;FLT1;CAV3;GPER1;SYK;FLT4;IGF1;GSDME
prerank,Reactome_2022__ALK Mutants Bind TKIs R-HSA-9700645,-0.49894437598279034,-0.8615255851819341,0.6538461538461539,1.0,1.0,3/11,14.69%,BCL11A;HIP1;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.4364795757195795,0.8615037462575612,0.6621621621621622,1.0,1.0,3/22,17.38%,CAV3;MSN;VAV3
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.5185237377509765,0.8614913603524209,0.7575757575757576,1.0,1.0,4/10,26.99%,NDC80;NUF2;BOD1;KIF2C
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.47091569388211607,-0.8614492371995238,0.6071428571428571,1.0,1.0,3/10,10.47%,PNP;CBFB;NKAP
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,0.4338925331027309,0.8612882407408042,0.6956521739130435,1.0,1.0,6/29,16.69%,GP1BA;SYK;VWF;ITGA2B;BCAR1;RASGRP1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.4348964454214114,-0.8611351306144075,0.6486486486486487,1.0,1.0,3/12,11.88%,SNX8;STX5;EHD3
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.39014869772060917,0.8609870891558673,0.7368421052631579,1.0,1.0,14/96,11.00%,C1QTNF1;TIMP3;PRRX1;LMOD1;FBXL7;LOX;TGFB1;PCDH18;ANGPTL2;ACTA2;ADGRL4;COL6A2;DCN;COL1A1
prerank,Reactome_2022__Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,0.44552569759722227,0.8607074464810713,0.6133333333333333,1.0,1.0,3/24,9.53%,POLE2;POLD4;RPA3
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,-0.34384346728056053,-0.8606831440534273,0.7307692307692307,1.0,1.0,8/58,14.05%,GATAD2A;CHD4;POLR1A;GTF2H2;ERCC2;H2AJ;POLR2F;TAF1B
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,0.36463138285408186,0.860631557308291,0.6805555555555556,1.0,1.0,22/98,25.66%,PSMB9;PELI3;TIFA;RPS27A;NFKB2;USP18;PSMC5;AGER;RBX1;NFKBIA;PSMA3;PSMB6;IKBIP;MAP2K1;IL1R1;PSMD6;NKIRAS1;IRAK1;PSMA7;MAP2K4;PSMB1;CASP8
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.5535082667504301,0.8606176168922174,0.7413793103448276,1.0,1.0,1/8,7.66%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.5535082667504301,0.8606176168922174,0.7413793103448276,1.0,1.0,1/8,7.66%,IGF1
prerank,Reactome_2022__Killing Mechanisms R-HSA-9664420,0.5147190013883133,0.8605787572352587,0.6984126984126984,1.0,1.0,4/11,17.87%,WNT5A;NOXO1;CYBA;NOX1
prerank,Reactome_2022__Signaling By Retinoic Acid R-HSA-5362517,0.4398738180536598,0.8604960887157075,0.6708860759493671,1.0,1.0,7/34,13.95%,RDH13;CYP26B1;LDHD;DHRS3;PDK4;RDH16;RXRG
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.3828010489264959,-0.8604378371875759,0.6551724137931034,1.0,1.0,11/26,26.26%,UBE2D4;ANAPC2;CDC26;UBE2L5;UBE2E3;ANAPC13;UBE2L3;UBE2B;PRKN;UBE2A;ANAPC7
prerank,CellMarker_Augmented_2021__pro-Natural Killer Cell (pro-NK cell):Peripheral Blood,0.40285888449931895,0.860349408253458,0.6666666666666666,1.0,1.0,19/56,21.25%,CYTIP;SASH3;FCGR3A;FGL2;TAGAP;HK3;CD4;GPR183;ASGR2;BTG1;KLRB1;PNRC1;CD244;MAF;CD8B;NFKBIA;TNFSF8;LY86;IQGAP2
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.3624750472920833,0.8600042661260243,0.759493670886076,1.0,1.0,16/154,13.92%,EOLA1;TRIM58;AHR;PTPRC;ALPK2;PRDM12;IGF2BP2;RSPO1;IGF1;REST;RNF187;TRIM68;TRIM77;AFF2;RASA1;BMI1
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,0.4269553104373728,0.8598005447939207,0.7,1.0,1.0,12/34,31.61%,RPS27A;ENGASE;SYVN1;SEL1L;GANAB;RNF5;DERL2;AMFR;RAD23B;UBXN1;CANX;CALR
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.4397132156189097,0.8597276512309189,0.734375,1.0,1.0,10/29,19.00%,VSIR;SYK;PDCD1LG2;TNFSF4;F2RL1;IL4;ISG15;AGER;TIGIT;IRF4
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,-0.3016026275319897,-0.8596388824747706,0.7,1.0,1.0,38/207,13.03%,ADAMTS1;ADAMTS12;G6PC3;ST3GAL3;GALE;PAH;GPC6;GPC2;SDC3;DPM3;PAPSS2;ADAMTS8;GYS1;GPC4;CYP7B1;ARSB;THSD7A;MUC19;AGRN;PMM2;ADAMTS3;ADAMTS10;CHSY1;SPAM1;VCAN;RFT1;ALG12;CHST6;PRELP;ADAMTS16;IDUA;HGSNAT;B3GAT3;ADAMTS6;DHDDS;SPON2;GALNT12;ALG11
prerank,GO_Biological_Process_2021__cannabinoid signaling pathway (GO:0038171),0.5922952639547256,0.859557062915414,0.7169811320754716,1.0,1.0,3/5,17.89%,ALOX15B;CNR1;CNR2
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),-0.42800363125316754,-0.8595308831842543,0.6470588235294118,1.0,1.0,5/14,20.02%,UBIAD1;COQ2;COQ9;AIFM2;PDSS2
prerank,Reactome_2022__MET Activates PTK2 Signaling R-HSA-8874081,0.49049208781334985,0.8594908147467485,0.7,1.0,1.0,2/17,9.73%,ITGA2;LAMC2
prerank,Reactome_2022__FGFR4 Ligand Binding And Activation R-HSA-190322,0.5396310388201675,0.859406602046875,0.6607142857142857,1.0,1.0,2/10,8.32%,FGF20;KLB
prerank,Reactome_2022__Signaling By Rho GTPases R-HSA-194315,0.33619135469399775,0.8593180174301877,0.8494623655913979,1.0,1.0,62/580,16.07%,SGO1;CAVIN1;ARHGAP9;KIF14;ARHGEF40;BUB1;PLEKHG6;CENPU;ARHGAP24;ARHGAP31;CCDC187;PIK3R3;VAPB;PLEKHG3;PREX2;MAP3K11;SNAP23;MYH11;ACTG1;WAS;H2BC4;ERCC6L;UACA;NDC80;ARHGAP28;BAIAP2L1;ARMCX3;H2AZ1;DOCK6;MYL6;NCKIPSD;RHOB;TAGAP;ECT2;ARHGDIG;ATP6AP1;RHOU;KIF18A;PPP2R5A;RASGRF2;SKA2;RTKN;CDKN1B;PDE5A;DOCK5;WDR6;NOXO1;RHOG;ARHGAP45;ANLN;CKB;CYBA;NUF2;COPS4;MAPK3;RHOQ;SPC25;MYL9;STOM;GPS1;BASP1;BUB1B
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.35760034012100517,0.859269652864127,0.7848101265822784,1.0,1.0,25/162,20.47%,LRP4;NOTUM;PSMB9;SHISA6;ALPK2;WNT5A;HIC1;MCC;DAB2;SFRP4;GLI3;DKK2;IGFBP6;SOX9;PSMC5;LATS2;CYLD;DKKL1;FRZB;RBX1;PSMA3;PSMB6;DRAXIN;PTPRU;PSMD6
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),-0.49963551518869065,-0.8592176038896727,0.6551724137931034,1.0,1.0,1/5,3.49%,AGBL1
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,0.39029581596856694,0.8591954737559847,0.6891891891891891,1.0,1.0,6/63,20.47%,PSMB9;RPS27A;PSMC5;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.4961786924241608,0.859178054337651,0.6716417910447762,1.0,1.0,7/12,23.49%,ERAP2;HLA-F;HLA-A;TAP1;B2M;ERAP1;HLA-DRB1
prerank,Reactome_2022__Amino Acid Conjugation R-HSA-156587,-0.5044975046042371,-0.8591284512735308,0.6585365853658537,1.0,1.0,2/7,6.85%,GLYATL1;GLYATL2
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.5147560476394624,0.8590356842063505,0.639344262295082,1.0,1.0,5/8,36.06%,SPX;PPARA;BBS2;CARTPT;LEP
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.35434620771911063,0.858957610119877,0.7682926829268293,1.0,1.0,37/180,15.58%,ITGB2;SMOC1;ITGAX;COL18A1;LOX;MMP19;ECM2;FGF2;NID1;ITGAM;ITGA2;ITGB6;ADAMTS17;JAM2;MMP9;COL4A4;COL4A3;ITGA5;MMP21;COL4A6;COL4A5;MMP15;LAMC2;COL6A2;VWF;DCN;VTN;COL1A1;FBN2;MMP23B;THBS1;ITGA2B;MMP11;DDR2;CD44;TGFBI;ELN
prerank,Reactome_2022__Canonical Retinoid Cycle In Rods (Twilight Vision) R-HSA-2453902,0.4855134899442214,0.8588144208023374,0.6557377049180327,1.0,1.0,4/15,16.57%,LRAT;RDH12;RDH16;RBP1
prerank,CellMarker_Augmented_2021__Mesothelial cell:Undefined,0.41331560430082337,0.8587247851001883,0.7222222222222222,1.0,1.0,10/57,11.25%,ELMO3;PLEKHG6;DTX2;ITGB6;MISP;EPN3;BAIAP2L1;LAMC2;CELSR1;AP1M2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.3685155063455392,0.8587144412344485,0.7926829268292683,1.0,1.0,22/125,22.36%,TULP1;ROPN1B;SIX4;DDX3X;CSRP3;DNAJA1;RAB11A;COL1A1;LAMP2;TULP2;ISG15;TOR1A;RPL11;GBP1;GABARAPL2;FSIP2;ALDH3A2;OBSCN;ATP6V1D;MICALL1;EHD1;PAF1
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.527337681613006,-0.8586738294036673,0.717948717948718,1.0,1.0,4/9,22.17%,NFATC3;NFATC4;NFAT5;NFATC1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.527337681613006,-0.8586738294036673,0.717948717948718,1.0,1.0,4/9,22.17%,NFATC3;NFATC4;NFAT5;NFATC1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.35917560100626783,0.858608505210926,0.7948717948717948,1.0,1.0,12/114,12.87%,ESR1;PLA2G10;AIM2;SP100;NLRP12;CDKN2A;TBX6;CYP1B1;NLRC3;ID1;TNFSF4;SFRP4
prerank,Reactome_2022__Type I Hemidesmosome Assembly R-HSA-446107,-0.45811968361710287,-0.8585237860926299,0.6666666666666666,1.0,1.0,3/9,13.49%,CD151;ITGB4;PLEC
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.42896151947512634,0.8585141007414671,0.6575342465753424,1.0,1.0,3/46,7.67%,ACTL6A;HAT1;LEF1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.48421557620081146,0.8584676235807075,0.6865671641791045,1.0,1.0,1/16,3.51%,FGF2
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Adipose Tissue,0.4469773053682263,0.8583625580653006,0.6615384615384615,1.0,1.0,6/25,16.35%,ITGAX;PTPRC;NT5E;MME;CD44;ENG
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),0.5888965083256683,0.8583389605238511,0.7407407407407407,1.0,1.0,1/5,2.72%,LOX
prerank,CellMarker_Augmented_2021__Eosinophil:Sinonasal Mucosa,0.4011820337905397,0.8583352291159263,0.7307692307692307,1.0,1.0,14/50,16.42%,GMFG;WAS;STAT5A;IKZF1;TMC8;IGLL1;TRPC2;ELANE;P2RX1;PARVG;PIK3R6;FERMT3;PIK3CG;CD244
prerank,Reactome_2022__Highly Calcium Permeable Nicotinic Acetylcholine Receptors R-HSA-629597,0.5169851938528948,0.8582613960412201,0.6666666666666666,1.0,1.0,4/9,22.69%,CHRNA5;CHRNB2;CHRNA3;CHRNA6
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.3704498516429963,-0.8582445977695693,0.696969696969697,1.0,1.0,6/46,12.14%,PLK3;CARM1;CNOT9;CDK1;TFDP1;RBL1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.3627676377544801,-0.8581693935060098,0.6296296296296297,1.0,1.0,14/58,14.49%,RASSF2;DUSP15;SH3RF1;WNT7A;MAP3K10;CCN2;FZD7;SH3RF3;DUSP19;DAB2IP;TAOK2;SDCBP;CARD9;TRAF3
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.4314966957579674,-0.8581387022622947,0.6875,1.0,1.0,6/15,24.62%,FAM171A1;PHACTR1;RHOA;ARRB1;KCTD13;SRC
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.4314966957579674,-0.8581387022622947,0.6875,1.0,1.0,6/15,24.62%,FAM171A1;PHACTR1;RHOA;ARRB1;KCTD13;SRC
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.4628174701571044,-0.8580408224134377,0.5483870967741935,1.0,1.0,2/15,7.72%,MIDN;CCN3
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.39662360446727374,0.8580287159816288,0.6811594202898551,1.0,1.0,2/57,3.56%,CDC25A;PDE6A
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,0.4053897775177231,0.8579861818971073,0.7142857142857143,1.0,1.0,10/51,21.19%,KCNJ15;GNAT3;GNG12;GNG4;ADCY7;KCNJ2;KCNJ4;GNGT1;GNB4;GABRR1
prerank,Reactome_2022__Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,0.4721255551646337,0.8578908822558735,0.6714285714285714,1.0,1.0,5/22,20.68%,DAO;LDHD;LIAS;GRHPR;GNMT
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.5247438798609183,0.8578194182421608,0.7014925373134329,1.0,1.0,2/8,11.94%,WNT5A;CHRNB1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.40302039459916766,0.8578016254000752,0.7307692307692307,1.0,1.0,19/60,22.25%,VSIR;IL12A;IL27;NR1H4;AXL;HLA-A;PDCD1LG2;HLA-DPB1;TNFSF4;F2RL1;CRTAM;ISG15;CD244;RASGRP1;HLA-DPA1;IL1R1;IL18R1;ZFPM1;DDIT3
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.40489299335491735,-0.8577609353635499,0.6206896551724138,1.0,1.0,6/27,9.49%,WNT3A;SLC17A6;WNT7A;PLD2;SYNDIG1;RAB5A
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.3273237916382765,-0.8577492805210023,0.8666666666666667,1.0,1.0,10/79,15.76%,PLK3;DHRSX;FOXO1;TRIM8;MEFV;NPRL2;TRIM14;EPM2A;IRGM;MTDH
prerank,Reactome_2022__Histidine Catabolism R-HSA-70921,-0.5210076658544641,-0.8576762898660438,0.7045454545454546,1.0,1.0,3/7,5.58%,HNMT;AMDHD1;CARNMT1
prerank,CellMarker_Augmented_2021__Macrophage:Spleen,0.5914694073928992,0.8576233921362817,0.6779661016949152,1.0,1.0,2/5,5.07%,ITGAM;ADGRE1
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.5140688292075959,0.8576181909149039,0.7101449275362319,1.0,1.0,4/10,26.12%,UCP1;CCN6;ALOX5;THRSP
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.37722855326520116,0.8576034373453267,0.6707317073170732,1.0,1.0,12/79,17.10%,CDC25A;SPDYA;CRLF3;CDKN2A;CCND1;CCNE2;CDKN1B;CDKN1A;CDKN2C;LATS2;RCC1;FBXO5
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.39797037071690183,-0.8575357337859413,0.6153846153846154,1.0,1.0,2/20,4.78%,PTCH1;APOE
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.30804939612907284,-0.8573940020305967,0.7727272727272727,1.0,1.0,6/82,4.81%,DRD4;CDH5;TESMIN;RGN;LETM2;CLDN16
prerank,Reactome_2022__Estrogen Biosynthesis R-HSA-193144,0.5838636583507268,0.8573434796696948,0.7272727272727273,1.0,1.0,3/5,28.86%,HSD17B2;AKR1B15;CYP19A1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.46828723672133427,-0.857256703525059,0.6333333333333333,1.0,1.0,1/11,1.19%,DNMT1
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.3724989639695908,0.8572178030523891,0.704225352112676,1.0,1.0,4/64,9.09%,ROS1;DEPDC5;DDIT4;RRAGA
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.432977612172738,-0.8571513875777494,0.6875,1.0,1.0,4/18,21.95%,CDH13;DBNL;ELMO1;FARP2
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.4225513308337747,0.8571023738136623,0.6805555555555556,1.0,1.0,5/31,12.51%,ALOX12;GGT5;PPT1;ALOX5AP;SCD
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.364908848563425,0.8570711861679573,0.7625,1.0,1.0,32/153,18.48%,BLK;TIMP3;SYT15;SYT2;TGFB1;MANF;SCIN;IGF1;F8;HGF;TMEM79;KNG1;PSAP;TGFB3;CFD;VWF;SELENOP;CRHBP;CD63;THBS1;LAMP2;ITGA2B;PLG;SYT10;ITIH4;TUBA4A;FERMT3;A1BG;A2M;TF;SYT4;VEGFC
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,0.3909834335624709,0.8570526262808472,0.704225352112676,1.0,1.0,13/54,25.23%,HSPA8;PINK1;RPS27A;TOMM20;PGAM5;TOMM7;DYNLL1;FUNDC1;ULK1;DYNLL2;PARK7;PRKAB2;VDAC1
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,0.466977506752666,0.8569168371382772,0.6764705882352942,1.0,1.0,2/15,15.19%,RPS27A;MAPK3
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.5233230123339709,0.856783865771379,0.6885245901639344,1.0,1.0,2/9,12.42%,SEMA3A;SEMA3F
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.5220666300824268,0.8566149922989381,0.7611940298507462,1.0,1.0,3/9,16.34%,ACTA2;EDNRB;HTR2B
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),0.5622918728099058,0.8565941034495519,0.6666666666666666,1.0,1.0,1/5,5.45%,CAV3
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.5306049153937534,0.8564593522971403,0.782608695652174,1.0,1.0,1/7,13.17%,CHMP3
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.42384821489146746,-0.8563213777242484,0.5757575757575758,1.0,1.0,1/23,1.25%,NMU
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.4742401658879496,0.856022876258807,0.6764705882352942,1.0,1.0,3/13,12.45%,SCIN;ACSL3;OAS2
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.4425503122653833,-0.8559732085348644,0.65,1.0,1.0,3/19,12.90%,CFLAR;NUPR1;SDCBP
prerank,CellMarker_Augmented_2021__Epiblast cell:Embryo,0.3866879601192793,0.8559507855702382,0.7435897435897436,1.0,1.0,10/70,12.12%,LRP4;TENT5B;RRAD;HEY2;NODAL;MUC4;ARGFX;DOCK6;LDLRAP1;RASD1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.4459542798533224,0.8558523594506017,0.7272727272727273,1.0,1.0,6/19,20.65%,LY6H;CDK5R1;RGS10;CHRNB2;CHRNA3;CHRM5
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.4037729734064659,0.855722700425701,0.6710526315789473,1.0,1.0,3/47,6.95%,FGF2;PLD4;IMPA1
prerank,Reactome_2022__Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,0.4406857347785719,0.8556465254862824,0.684931506849315,1.0,1.0,14/27,32.28%,TUBA4A;TUBA3D;TUBB6;TUBA1C;CCT7;TUBB4B;CCT8;VBP1;PFDN6;CCT3;CCT6A;CCT2;TUBA1A;TUBB
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),-0.40986025202413007,-0.8556139485967827,0.6176470588235294,1.0,1.0,3/16,9.07%,CBFB;F11R;SNAI2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.3752951193542581,0.8555637230495482,0.7222222222222222,1.0,1.0,16/85,19.58%,ACOX2;TNFRSF1B;CCL5;FGF2;CIDEB;RAMP3;LRPAP1;HPR;CDKN1B;CALCR;HTR2B;AGR2;TMEM109;CCN6;RAB29;CTSZ
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5252766514691124,0.8554319659500045,0.6379310344827587,1.0,1.0,4/10,20.87%,KLF15;TAF7;BRCA1;SET
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.5814543929627601,-0.8552450386964235,0.7,1.0,1.0,3/5,30.04%,SF3A2;SF3A3;SF1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.3309839044111119,0.8552204411129984,0.8645833333333334,1.0,1.0,54/378,17.03%,RHOXF2;C1QTNF1;S100A13;TLR2;NOX5;ITGAX;PIK3R3;FGF20;FGF2;CTCFL;VSIR;TGFB1;NFAM1;HEY2;WNT5A;ACTG1;GPER1;IL26;IGF1;LEF1;RAMP3;ACTA2;DDX3X;EIF6;CLDN5;WNT6;TNFSF4;HMGA2;RPS4X;ALOX12B;SFRP4;AGT;THBS1;WBP2;CALCR;ITK;SOX9;POLR1C;METTL14;IL4;CRTAM;MAPK3;VSTM2A;SLC38A2;ZNF580;PIK3CG;RPL11;EEF2;HTR2B;CSF1;MSN;AGR2;BRCA1;RPS7
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.5891475719209783,0.8551666596256564,0.7169811320754716,1.0,1.0,1/5,11.16%,AIF1L
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),0.5555317752067802,0.8549684855049318,0.7058823529411765,1.0,1.0,4/7,14.48%,ALOX12;ALOX5AP;ALOX15;ALOX15B
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.46754838233747464,-0.8548382527727783,0.6122448979591837,1.0,1.0,1/9,5.38%,TNNC2
prerank,CellMarker_Augmented_2021__Endometrial Progenitor cell:Endometrium,-0.3269110646392043,-0.8548327995982423,0.6111111111111112,1.0,1.0,20/99,15.45%,SMYD5;PC;MAST2;B4GALT2;PPP2R5D;CLPTM1;NACC1;PEX14;OGDH;ALDH4A1;CENPB;FXR2;ACAP3;BAG6;RING1;TAOK2;HSPBP1;ANKRD52;SCRIB;ABCB8
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.38771490852893775,0.8547767810461544,0.7702702702702703,1.0,1.0,11/76,10.63%,TBX1;SIX4;FGF2;TGFB1;FUT2;NODAL;IL26;IGF1;NLRC3;MARVELD3;MCC
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.42450094324405896,0.8547516108880214,0.7285714285714285,1.0,1.0,9/35,21.17%,PWP2;RPS16;NOB1;RPS19;TSR2;TSR3;HELB;RPS14;RIOK2
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.39533606098089064,0.8544663039695193,0.6944444444444444,1.0,1.0,14/61,25.56%,PSMB9;LMO2;PSMC5;METTL14;MYB;PSMA3;PSMB6;PSMD6;YAP1;RUNX1;SPI1;PSMA7;LMO1;PSMB1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.39530720344211884,0.8544190187588421,0.7246376811594203,1.0,1.0,11/50,17.14%,AIM2;NLRP12;WNT5A;USP50;NLRC4;IGF1;F2RL1;NLRP2;AGER;GHRL;SERPINB1
prerank,CellMarker_Augmented_2021__Epithelial cell:Embryoid Body,-0.3199134188698857,-0.8540349886591018,0.8888888888888888,1.0,1.0,22/98,13.74%,FIBIN;MYO10;BOC;PAMR1;COL4A2;COL12A1;RND3;PARVA;MID1;FSTL1;CAP2;EML1;RASSF8;ASAP3;EFEMP1;PTPRZ1;EDNRA;ANTXR1;NAV2;AMOTL2;SLIT2;CHST3
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,0.42382633052945073,0.8539383179314434,0.6933333333333334,1.0,1.0,4/35,13.33%,CDKN2A;LEF1;CCND1;CSF1R
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),0.4608494335448747,0.8538186638497016,0.6785714285714286,1.0,1.0,4/13,25.62%,IFIT1;COLEC12;IFIH1;PQBP1
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),-0.5131173628445765,-0.853803628037636,0.62,1.0,1.0,1/5,8.48%,RIPK2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.44217265984031795,-0.8535753711604938,0.6206896551724138,1.0,1.0,4/17,12.03%,RAB7B;TICAM2;NR1D1;DAB2IP
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.5495851616419618,-0.8534378358857525,0.6136363636363636,1.0,1.0,2/6,14.55%,RTF1;LEO1
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.49179652839599336,0.853345962469519,0.5689655172413793,1.0,1.0,2/9,3.45%,PLA2G10;C3
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4513347071851399,0.8532980873028059,0.6818181818181818,1.0,1.0,3/25,19.72%,PINK1;BMI1;ARRDC3
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.37100404216135047,0.8532312220938929,0.7439024390243902,1.0,1.0,26/103,23.72%,TP53TG5;TGFB1;CRLF3;CDKN2A;GNG4;DDX3X;EI24;PPT1;RERG;CDKN1B;BTG1;CDKN1A;CDKN2C;HYAL1;TCHP;NAIF1;FBP1;FRZB;CCDC85B;MAG;ULK1;RBBP7;DCSTAMP;CDKN2D;DNAJB2;PSRC1
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.45802207222982816,0.8532060857497152,0.6612903225806451,1.0,1.0,2/16,3.45%,PLA2G10;C3
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.5904784932165539,-0.8531227486298535,0.6666666666666666,1.0,1.0,2/5,14.10%,SMARCB1;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.3877473313084494,-0.8530751589387656,0.6666666666666666,1.0,1.0,2/24,1.53%,CD38;BCL2
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,0.3969388591760107,0.8530607711605018,0.65,1.0,1.0,9/38,15.15%,TNFRSF10A;TP53I3;NLRC4;TP53BP2;BCL2L14;CASP10;NDRG1;BBC3;RABGGTB
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.39674308352455406,0.8530216040605126,0.7121212121212122,1.0,1.0,5/44,15.65%,POLQ;POLD4;RPA3;HMGA2;TDG
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.3967370025946525,0.852844854963371,0.631578947368421,1.0,1.0,14/44,23.01%,C3;AXL;PPT1;VTN;LDLRAP1;DAB2;F2RL1;IL4;TOR1A;TF;RAB21;B2M;HNRNPK;CBLL1
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.3255844864415668,-0.8527555560771687,0.84,1.0,1.0,7/57,9.70%,GATAD2A;CHD4;HDAC7;EGR1;PHC2;SNAI2;HDAC3
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,0.42153103051432317,0.8527284091231151,0.6521739130434783,1.0,1.0,3/29,15.19%,FGF20;RPS27A;MAPK3
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.4167431685158629,-0.8527219803801855,0.64,1.0,1.0,12/42,24.01%,USP36;MGARP;PID1;MARCHF5;MYO19;SIRT7;HTRA2;MAPT;CYRIB;MIEF2;STOX1;PRKN
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,-0.28375294397774514,-0.8525461013339771,0.8888888888888888,1.0,1.0,60/260,21.50%,ST3GAL3;SEC24C;MGAT4C;KDELR1;PPP6R1;DPM3;MAN1A1;SPTBN4;COG4;NEU4;ST6GAL2;B4GALT2;SEC22A;TGFA;SPTB;PMM2;ST3GAL2;NEU3;ST3GAL5;TRAPPC9;RFT1;ALG12;STX5;PREB;B4GALT4;AMDHD2;RPN1;CNIH3;DHDDS;CAPZB;ALG11;ST3GAL4;NGLY1;TRAPPC1;GFPT2;MIA3;CHST8;GMDS;COG7;MOGS;NAGK;ANKRD28;F5;FUCA1;ST6GALNAC3;CNIH2;DOLPP1;GLB1;ALG1;B4GALT3;ST6GALNAC5;GOLGB1;PRKCSH;CAPZA1;ALG3;DAD1;PMM1;ALG8;MAN1A2;CTSC
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,-0.3959462761641768,-0.8524688213697841,0.7419354838709677,1.0,1.0,6/19,20.02%,DHFR;NANOS3;COQ2;COQ9;PTS;PDSS2
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.5324323310098484,0.852451588835706,0.6774193548387096,1.0,1.0,1/9,6.30%,B4GALNT2
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.3775996938219379,0.8522728693239345,0.7285714285714285,1.0,1.0,4/69,5.45%,HSPA8;PLEKHH2;KANK3;CAV3
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.4555127865602628,-0.8522709954982645,0.6756756756756757,1.0,1.0,1/8,0.95%,IL11
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.551906104232598,0.8521337087431496,0.7272727272727273,1.0,1.0,2/9,13.32%,OGFOD1;P4HA3
prerank,"Reactome_2022__Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",0.3327116597509464,0.8519891258568796,0.8494623655913979,1.0,1.0,62/595,16.07%,SGO1;CAVIN1;ARHGAP9;KIF14;ARHGEF40;BUB1;PLEKHG6;CENPU;ARHGAP24;ARHGAP31;CCDC187;PIK3R3;VAPB;PLEKHG3;PREX2;MAP3K11;SNAP23;MYH11;ACTG1;WAS;H2BC4;ERCC6L;UACA;NDC80;ARHGAP28;BAIAP2L1;ARMCX3;H2AZ1;DOCK6;MYL6;NCKIPSD;RHOB;TAGAP;ECT2;ARHGDIG;ATP6AP1;RHOU;KIF18A;PPP2R5A;RASGRF2;SKA2;RTKN;CDKN1B;PDE5A;DOCK5;WDR6;NOXO1;RHOG;ARHGAP45;ANLN;CKB;CYBA;NUF2;COPS4;MAPK3;RHOQ;SPC25;MYL9;STOM;GPS1;BASP1;BUB1B
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.2979245327646158,-0.8519841242215938,0.8571428571428571,1.0,1.0,33/150,20.06%,RNF168;TENT4A;POLM;BRCC3;PPP5C;MMS22L;FAN1;SMARCAL1;RAD50;LIG3;KDM4D;SLX4;RFWD3;SPIDR;MDC1;PARP2;SAMHD1;AP5Z1;PIAS4;NBN;KDM4B;TRIP13;DCLRE1B;MAD2L2;TNKS1BP1;ERCC1;KDM2A;FBH1;MCM9;XRCC4;SETMAR;RAD51AP1;ATM
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,0.504097013265044,0.8518634614367123,0.6896551724137931,1.0,1.0,4/12,23.09%,CD4;HMGA1;XRCC6;LRIG1
prerank,Reactome_2022__AKT Phosphorylates Targets In Cytosol R-HSA-198323,0.48464716429893606,0.8518460351277735,0.7301587301587301,1.0,1.0,2/13,12.77%,CDKN1B;CDKN1A
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.47896888505559077,0.8517512641902295,0.7285714285714285,1.0,1.0,1/14,7.38%,SRSF9
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.4184499575439866,0.8516204659694375,0.6984126984126984,1.0,1.0,9/57,13.61%,TLR2;NLRP12;WNT5A;CD81;OSMR;PLA2G7;TNFSF4;AGT;RPS19
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.49238502261500744,-0.8516159986881778,0.6976744186046512,1.0,1.0,2/6,19.41%,TGFA;BTC
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 cell differentiation (GO:2000320),0.5300959535098004,0.8515858422051147,0.7301587301587301,1.0,1.0,1/6,14.41%,IL4
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),-0.5593688180007516,-0.8514267086987133,0.7142857142857143,1.0,1.0,1/5,2.76%,UST
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.39124844269216763,0.8513295649886387,0.6933333333333334,1.0,1.0,11/67,12.25%,AMBP;CLDN2;PKP2;FOXA3;NR1H4;FOXM1;SMLR1;BAIAP2L1;HNF4G;AP1M2;EPCAM
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.4494987008914394,-0.8513230973573137,0.6410256410256411,1.0,1.0,3/13,23.25%,NUP98;SEH1L;TPR
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.5471603931149367,0.8512560495967154,0.660377358490566,1.0,1.0,1/6,10.19%,RAB11A
prerank,CellMarker_Augmented_2021__Dental Pulp cell:Dental Pulp,0.37431554656942784,0.8511861557553984,0.72,1.0,1.0,22/89,16.68%,TIMP3;PRRX1;LPAR1;LOX;AOX1;ITGBL1;NT5E;ANGPTL2;AXL;OSMR;HEG1;PDCD1LG2;ADGRL4;COL1A1;THBS1;PLAT;IGFBP6;DDR2;TGFBI;EHD2;ENG;FAM114A1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Amniotic Membrane,0.37431554656942784,0.8511861557553984,0.72,1.0,1.0,22/89,16.68%,TIMP3;PRRX1;LPAR1;LOX;AOX1;ITGBL1;NT5E;ANGPTL2;AXL;OSMR;HEG1;PDCD1LG2;ADGRL4;COL1A1;THBS1;PLAT;IGFBP6;DDR2;TGFBI;EHD2;ENG;FAM114A1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.39084146357463606,-0.8511667997493593,0.7307692307692307,1.0,1.0,6/16,26.78%,LST1;SAMSN1;DUSP3;LAPTM5;LGALS3;PIBF1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.4470416880611493,-0.8511423625508682,0.78125,1.0,1.0,1/14,1.47%,BOC
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.3754375009750661,-0.8509844488767083,0.75,1.0,1.0,3/23,11.77%,AUP1;TECPR2;PREB
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5063800406676654,0.8509249106532036,0.7,1.0,1.0,4/13,17.73%,RFK;ADSS1;PAICS;IMPDH2
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,0.36346725968109345,0.8508829678671271,0.7368421052631579,1.0,1.0,11/151,8.12%,ESR1;PIK3R3;GNAT3;GNG12;DAND5;H2BC4;ERBB4;MMP9;CCND1;GNG4;H2AZ1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.5146872726207121,0.8508359427205381,0.671875,1.0,1.0,2/9,16.38%,TGFB1;CSF1
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,-0.318468545544788,-0.8508349441427085,0.8,1.0,1.0,13/82,14.69%,CREB3L4;EXTL1;CREB3L1;KHSRP;PDIA6;DDX11;ERN1;ATF3;CTDSP2;PREB;CREB3L2;EXOSC1;EIF2AK3
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.497989929269725,0.8506334376626149,0.6521739130434783,1.0,1.0,1/13,5.33%,SEMA3A
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.4786849358767218,-0.850567368403129,0.6666666666666666,1.0,1.0,1/11,1.23%,H1-4
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.3796658066458142,0.8505507334753674,0.8072289156626506,1.0,1.0,4/82,4.14%,MCUB;STOML2;TRPV6;TRPC7
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.3913589490834441,0.8504697535146615,0.6956521739130435,1.0,1.0,8/47,15.72%,GP1BA;FAXDC2;SCIN;EIF6;PITHD1;THBS1;ITGA2B;MYL9
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.5236596643617674,0.8503513444089807,0.711864406779661,1.0,1.0,2/8,12.42%,SEMA3A;SEMA3F
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,0.37831801937459103,0.8503273159866036,0.6794871794871795,1.0,1.0,9/78,20.47%,PSMB9;WNT5A;FZD8;RPS27A;PSMC5;WNT5B;PSMA3;PSMB6;PSMD6
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,0.37525036437686976,0.8503184839064127,0.7654320987654321,1.0,1.0,11/82,21.59%,ACTL6A;HAT1;H2BC4;ING3;H2BC18;TAF6L;TAF10;HCFC1;ATXN7L3;H2AC25;RBBP7
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.4006773660059078,0.8502798662961077,0.7375,1.0,1.0,15/67,17.83%,ITGB2;ITGBL1;ITGA2;ITGB6;SYK;ITGA5;HCK;DAB2;ANGPTL3;ITGA2B;FYB1;ISG15;FERMT3;BCAR1;ITGB8
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.33986148454034415,-0.8502701113278655,0.7916666666666666,1.0,1.0,12/81,6.17%,FIBIN;PAMR1;CALD1;COL6A3;COL4A2;COL12A1;CLEC14A;MMP2;CREB3L1;CNN1;SLIT3;PARVA
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.4039621581554646,0.8500836615155575,0.7051282051282052,1.0,1.0,9/51,14.32%,LPAR1;GNAT3;HTR5A;NPY1R;PSAP;P2RY12;HTR1B;OPRM1;ADCY7
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR3 R-HSA-5654227,0.5307009307590066,0.8500197206896308,0.6949152542372882,1.0,1.0,1/10,2.58%,FGF20
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,0.3447208224073679,0.8499876327853123,0.8850574712643678,1.0,1.0,45/410,16.70%,CAVIN1;ARHGAP9;KIF14;ARHGEF40;PLEKHG6;ARHGAP24;ARHGAP31;CCDC187;PIK3R3;VAPB;PLEKHG3;PREX2;MAP3K11;SNAP23;ACTG1;WAS;UACA;ARHGAP28;BAIAP2L1;ARMCX3;DOCK6;RHOB;TAGAP;ECT2;ARHGDIG;ATP6AP1;RHOU;RASGRF2;RTKN;PDE5A;DOCK5;WDR6;NOXO1;RHOG;ARHGAP45;ANLN;CKB;CYBA;COPS4;RHOQ;STOM;GPS1;BASP1;ZAP70;HSPE1
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,0.3572881409966708,0.849614545191926,0.6901408450704225,1.0,1.0,17/106,12.77%,IL21R;CSF2RA;PIK3R3;AOX1;IL12A;STAT5A;SOCS2;CCND2;IFNK;CCND1;OSMR;CSF3R;IL5;STAT1;LIFR;IL7;CDKN1A
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.3653599534531551,-0.849523221172023,0.6538461538461539,1.0,1.0,7/30,17.69%,POLR1A;DSCC1;POLD3;CTC1;STN1;RFC3;SLC19A1
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,-0.3368671132676277,-0.8494488003494353,0.6774193548387096,1.0,1.0,2/21,7.51%,SH3KBP1;PTPRJ
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Liver,-0.4231603327758809,-0.8494469256804975,0.6333333333333333,1.0,1.0,2/30,4.55%,P2RY10;CD247
prerank,CellMarker_Augmented_2021__Cytokine Induced Killer cell:Blood,-0.4231603327758809,-0.8494469256804975,0.6333333333333333,1.0,1.0,2/30,4.55%,P2RY10;CD247
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.5045613646245254,0.8492709827196769,0.7068965517241379,1.0,1.0,3/11,19.54%,DAB2;MSN;RAB21
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.3832825103967724,0.8492619851126473,0.75,1.0,1.0,7/62,16.50%,SLC17A8;MYO3B;GRXCR2;FSCN2;GRXCR1;TMC1;MSN
prerank,Reactome_2022__Synthesis Of Leukotrienes (LT) And Eoxins (EX) R-HSA-2142691,0.4693202167530654,0.8492234631107306,0.6818181818181818,1.0,1.0,4/16,13.21%,PTGR1;GGT5;ALOX5AP;ALOX15
prerank,CellMarker_Augmented_2021__Osteoclast:Bone,-0.5323494086326729,-0.8490492487184199,0.6428571428571429,1.0,1.0,1/6,3.82%,THNSL2
prerank,KEGG_2021_Human__Hedgehog signaling pathway,-0.34974280177771505,-0.8490287824200164,0.7407407407407407,1.0,1.0,6/50,8.69%,BOC;BCL2;PTCH1;PTCH2;HHAT;GPR161
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,-0.3017124955469642,-0.8489222837664037,0.92,1.0,1.0,20/126,14.67%,PRKCD;BCL2;GBP2;ITPR2;GPRC6A;IFI16;BRCC3;NLRP1;GBP4;NOD1;RIPK2;MEFV;SHARPIN;NAMPT;ANTXR1;TRPM2;NLRX1;CARD9;TRAF3;RBCK1
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.5442297537916763,0.8489037304996819,0.7213114754098361,1.0,1.0,1/6,14.62%,CYBA
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.4319758170867082,0.848719497268559,0.7123287671232876,1.0,1.0,5/49,13.17%,CASQ2;WAS;VIL1;PSTPIP1;CHMP3
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.5357148154313329,0.8486297391997804,0.6909090909090909,1.0,1.0,4/6,38.22%,CARD8;CARD18;BCL2L12;CARD16
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.3899397125782191,-0.8486194841009534,0.6756756756756757,1.0,1.0,6/25,30.85%,TRIM54;CAMSAP3;TRPV4;ATXN7;KATNB1;APC2
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.37951249599722836,0.8485885046233035,0.7272727272727273,1.0,1.0,8/88,13.31%,ASB5;DTL;WNT5A;C4BPA;C4BPB;OAZ2;CDKN1B;EEF1A1
prerank,KEGG_2021_Human__Taste transduction,-0.3322273159240692,-0.8485300276097887,0.8095238095238095,1.0,1.0,10/52,17.74%,ENTPD2;TAS2R8;HTR3B;GABRA5;GNB3;TAS2R5;GABBR2;CACNA1A;ADCY6;PKD2L1
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.494483003774534,-0.8482702232448899,0.65,1.0,1.0,1/6,5.69%,TAC3
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.45765378748780633,-0.8481820350130651,0.7096774193548387,1.0,1.0,1/10,10.50%,PTPRS
prerank,Reactome_2022__Pexophagy R-HSA-9664873,0.5131958361399004,0.8481760921666245,0.7142857142857143,1.0,1.0,1/11,11.00%,RPS27A
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),-0.5783739735310944,-0.848125293478361,0.7,1.0,1.0,1/5,6.63%,GPD1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.43656825908281754,0.8481054954226974,0.6935483870967742,1.0,1.0,2/19,8.34%,HIPK1;DDIT4
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),-0.5290661098189263,-0.8480877977129286,0.6829268292682927,1.0,1.0,1/5,6.85%,GLYATL2
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.5236850362429304,0.8480698497084693,0.6909090909090909,1.0,1.0,3/9,23.16%,NLRP12;ENG;ERRFI1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.5402908495519421,0.8479496441353928,0.7833333333333333,1.0,1.0,3/7,11.63%,SYK;IRF1;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.36935887454905064,0.847916690246412,0.7692307692307693,1.0,1.0,11/79,15.38%,LMOD1;C15ORF62;CAV3;VASP;BAIAP2L1;HCK;VIL1;F2RL1;ALOX15;CARMIL1;CDK5R1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.44819279186149663,-0.8478641527149638,0.6842105263157895,1.0,1.0,4/14,21.24%,RAD50;MSH3;ERCC1;RAD52
prerank,Reactome_2022__Activated NTRK2 Signals Thru FRS2 And FRS3 R-HSA-9028731,-0.4868057796721677,-0.8478610757203275,0.6666666666666666,1.0,1.0,3/8,29.21%,HRAS;NTRK2;FRS3
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.5292273271311604,0.8478357956320893,0.5901639344262295,1.0,1.0,1/7,9.55%,P2RY12
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.4141452012330699,-0.8478125522771957,0.6551724137931034,1.0,1.0,6/19,17.47%,SLC39A11;SLC30A5;SLC30A10;TRPM2;SLC39A8;SLC30A8
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.5143580794390107,-0.8477936880151551,0.6451612903225806,1.0,1.0,1/7,4.60%,APOBEC3H
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Blood,-0.34812886382668184,-0.847287775860357,0.7142857142857143,1.0,1.0,4/29,8.19%,CD38;KIT;STAT5B;CDCP1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.3399286124967036,-0.8472857817929559,0.6190476190476191,1.0,1.0,5/40,9.40%,DGKD;SHC3;TGFA;SLC30A10;EFEMP1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.3556315283453387,0.8472620420482593,0.7532467532467533,1.0,1.0,8/74,12.37%,TNFRSF1B;ASB5;DTL;WNT5A;C4BPA;C4BPB;OAZ2;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.4864833697162322,0.8472412383368106,0.6666666666666666,1.0,1.0,2/10,15.99%,CD99;AGER
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.43899261963598224,0.8471273805268758,0.684931506849315,1.0,1.0,3/24,11.00%,POLD4;RPA3;RPS27A
prerank,Reactome_2022__Caspase-mediated Cleavage Of Cytoskeletal Proteins R-HSA-264870,0.4942666619899646,0.8471135748458818,0.625,1.0,1.0,1/12,4.13%,CASP7
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.483930173251357,0.8470719202500876,0.7272727272727273,1.0,1.0,1/14,5.69%,WAS
prerank,Reactome_2022__Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,0.5083513649839465,0.8469841583172932,0.7,1.0,1.0,3/9,17.73%,ADSS1;PAICS;IMPDH2
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.5415988997881936,0.8469175982800987,0.765625,1.0,1.0,1/8,4.93%,BOK
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.2705521401586182,-0.8466998513389032,0.9411764705882353,1.0,1.0,10/216,7.20%,IL7R;APOB;SYNJ2;PACSIN2;STX11;SH3KBP1;MOSPD3;ARPC3;TGFA;UBXN2A
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.43021079105326604,0.8466733320289467,0.6901408450704225,1.0,1.0,2/29,5.45%,TMEM35A;CAV3
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.30269481153168715,-0.8463693776581127,0.7857142857142857,1.0,1.0,27/127,16.19%,KCNIP3;EFR3B;PTCH1;PDZD11;TMEM150A;SPTBN4;RAB3D;ZDHHC23;F11R;TTC7A;DPP6;FLNA;TTC7B;BSG;PRAM1;KCNB2;EHD4;EHD3;RAMP1;MRAP2;PPIL2;WNK3;RAB40A;RAB40C;TMEM88;ZDHHC3;NKD2
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.40628719860149076,-0.846342130084618,0.7142857142857143,1.0,1.0,4/18,18.01%,EPB41L4B;SNAI2;FGFR2;MED1
prerank,Reactome_2022__Gap Junction Trafficking And Regulation R-HSA-157858,0.43820211729748015,0.8462990999032903,0.7333333333333333,1.0,1.0,2/18,11.07%,GJB7;DAB2
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.45914549636030394,0.8462904354367394,0.6818181818181818,1.0,1.0,4/18,20.13%,CCL5;PLA2G7;CXCL12;CREB3
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.4137877970078348,0.8461952138433939,0.6166666666666667,1.0,1.0,3/28,3.83%,FGF20;SYT15;SYT2
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.4223121482435443,0.8461428645495794,0.6842105263157895,1.0,1.0,3/24,3.83%,FGF20;SYT15;SYT2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),0.5489997348615321,0.8459239732071416,0.7288135593220338,1.0,1.0,3/6,18.83%,TRDN;PLN;ATP2A2
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.4545245554289551,-0.8459063901786826,0.5588235294117647,1.0,1.0,2/16,2.27%,OSR1;XYLT1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.5334934267441072,0.8457832317964111,0.7666666666666667,1.0,1.0,2/9,16.49%,HSPA5;COPS5
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.33909699068958393,-0.8455094551249531,0.7083333333333334,1.0,1.0,10/52,18.88%,TPM4;BCL2A1;TPM3;MECP2;BCL11A;HIP1;EIF2AK3;CARS1;MYH9;VCL
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Skeletal Muscle,0.49627850905116083,0.8454892275499184,0.6666666666666666,1.0,1.0,4/11,16.35%,PTPRC;NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.4558805000980818,0.8454231631169741,0.7,1.0,1.0,7/18,22.13%,PTPRC;IFNK;PIK3CG;MSN;RASGRP1;TNFSF14;ELF4
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.41178836034079036,0.8452212141940857,0.6623376623376623,1.0,1.0,3/32,11.26%,SGO1;NDC80;KIF18A
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.5097742975612773,-0.8452096402444084,0.6842105263157895,1.0,1.0,2/5,8.33%,FLNA;MACROH2A2
prerank,CellMarker_Augmented_2021__Neuron:Brain,0.4187240606949725,0.8449779999379435,0.7313432835820896,1.0,1.0,12/30,30.67%,GLRA2;DCN;PNOC;GFAP;ENO2;DCLK3;NES;CDO1;SLC10A4;RELN;ARMH4;NXPH1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Lymph,0.5276534947321317,0.8448682868187939,0.7413793103448276,1.0,1.0,4/8,16.35%,PTPRC;NT5E;CD44;ENG
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Tonsil,0.5276534947321317,0.8448682868187939,0.7413793103448276,1.0,1.0,4/8,16.35%,PTPRC;NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.443483378126849,-0.8448649615236524,0.5666666666666667,1.0,1.0,1/15,3.46%,KIT
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,-0.35296059289848847,-0.8448121289943278,0.8,1.0,1.0,7/89,9.35%,KIF2B;SEC24C;PRICKLE1;HLA-DRA;RAB7A;KIF15;KIF4B
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,0.43197283921308277,0.8447925753587053,0.7012987012987013,1.0,1.0,6/28,16.94%,SLC16A8;LDHD;PLPP6;PDK4;SLC16A1;SLC16A3
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.41237571326317046,0.8447792383816264,0.6714285714285714,1.0,1.0,3/29,14.43%,CAV3;DNAJA1;LATS2
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.43406592696700447,0.8447520146289379,0.6764705882352942,1.0,1.0,5/31,16.34%,KIF14;CXCR5;ECT2;CDC14A;HTR2B
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,-0.38128350042808623,-0.8447198549513992,0.5555555555555556,1.0,1.0,8/31,20.06%,EXO1;MUS81;RAD50;SLX4;SPIDR;RTEL1;RAD51AP1;ATM
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,0.37756900451583164,0.844690007419277,0.7162162162162162,1.0,1.0,6/69,9.75%,DENND1C;DTX2;HLA-F;VASP;IRF1;TMC6
prerank,CellMarker_Augmented_2021__Chondrocyte:Cartilage,0.36789039418990455,0.8446610447722392,0.7411764705882353,1.0,1.0,8/93,7.41%,LRP4;PRRX1;LMOD1;TSPAN11;FBXL7;PCDH18;SCARA3;ANGPTL2
prerank,CellMarker_Augmented_2021__Astrocyte:Embryonic Prefrontal Cortex,-0.2820579057537928,-0.844497393615055,1.0,1.0,1.0,48/320,12.34%,ETV5;TRIB2;PDLIM3;G6PC3;TBC1D10A;MYO10;BCHE;ETV1;P3H4;PSAT1;ITPR2;HNMT;NLGN3;SDC3;S100B;SERPINE2;PNPLA3;HOPX;APOE;SEZ6L;HES1;OCIAD2;OLFM2;PREX1;IGFBP4;CXCL14;TECPR2;HSD17B12;HSPB1;ANOS1;SLITRK2;SLC3A2;DOK5;NEUROD6;SNX5;TTYH1;MMD2;TAGLN3;RGMA;BCL11A;TSPAN3;SPRY1;PTPRZ1;ALCAM;DTNA;SOAT1;RAMP1;TIMP1
prerank,CellMarker_Augmented_2021__Luteinizing Granulosa cell:Ovarian Follicle,0.390019068946515,0.8442748418886061,0.7142857142857143,1.0,1.0,12/75,9.64%,TECRL;LRP2;TOPAZ1;LIX1;STON1-GTF2A1L;SHISA6;COL6A6;ERBB4;ARHGAP28;WNT8A;C1ORF105;TRDN
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.42501148858370785,0.844061529337117,0.68,1.0,1.0,8/38,11.88%,CLDN2;CLDN6;CLDN18;MARVELD2;MARVELD3;ECT2;CLDN5;CLDN9
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.43592791200227177,-0.8440265518109415,0.5862068965517241,1.0,1.0,1/21,0.50%,TSKU
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),0.5504408032958984,0.8438878127835309,0.6666666666666666,1.0,1.0,1/6,10.91%,CELSR1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.3431801658937279,0.8438381876748043,0.7738095238095238,1.0,1.0,23/170,22.60%,NEK2;PSMB9;KIF14;CEP72;CEP70;RPS27A;CDC14A;PSMC5;ANLN;TUBA4A;BUB1B;FBXO5;DYNLL1;CEP76;PSMA3;PSMB6;PSMD6;RIOK2;CCNB1;TUBB4B;DCTN3;DCTN1;YWHAG
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,0.4065409846004364,0.8438223119498744,0.7066666666666667,1.0,1.0,7/35,24.24%,IL12A;CA1;TALDO1;MSN;RPLP0;ANXA2;VAMP7
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4392852826146829,0.8437590536545407,0.7076923076923077,1.0,1.0,3/18,5.77%,PDE6H;C3;GPER1
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,0.4155696020094818,0.843686300654653,0.6710526315789473,1.0,1.0,2/34,2.15%,ACE2;SDC2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.31188103646411813,-0.8436760035064275,0.8947368421052632,1.0,1.0,15/108,12.23%,GCK;SLC25A37;PPP1R3E;TMEM106A;PIWIL2;ERBB2;UPF3A;CTC1;PCIF1;LDB1;CIRBP;NAMPT;FXR2;BRPF3;STN1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.4387091319658184,0.8434146003762192,0.7692307692307693,1.0,1.0,5/29,13.69%,ITGB2;ITGAM;THBS1;IGLL1;RHOG
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.49979671243133394,-0.8432854227825615,0.7027027027027027,1.0,1.0,5/7,24.31%,ACVR1;JAG1;TGFB2;NOTCH1;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.5076235439756731,0.8431502229399204,0.6833333333333333,1.0,1.0,2/11,14.67%,DNAJA1;NPPA
prerank,KEGG_2021_Human__Thyroid hormone synthesis,0.37769817349886314,0.8429584409671871,0.7702702702702703,1.0,1.0,6/62,8.11%,IYD;LRP2;TSHR;ATP1A4;DUOX1;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.37720916776617625,0.8429428134281693,0.8271604938271605,1.0,1.0,8/96,9.57%,ESR1;TGFB1;USP50;SYK;LCP1;DDX3X;RPA3;IL5
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.5437572082840859,0.842939270382851,0.6842105263157895,1.0,1.0,1/6,6.35%,SYK
prerank,Reactome_2022__Axon Guidance R-HSA-422475,0.3284454616404069,0.8429355300436409,0.8723404255319149,1.0,1.0,88/481,21.28%,PSMB9;RRAS;SDC2;HSPA8;PIK3R3;PTPRC;TRPC7;RPL37A;RPL21;ITGA2;COL6A5;COL6A6;MYH11;SEMA3A;ACTG1;MMP9;VASP;COL4A4;RPL9;COL4A3;ITGA5;LHX4;RPL18A;MYL6;COL4A5;GFRA1;RHOB;RPS9;RPL3;RPL36;RPL13A;COL6A2;RPS16;RPL15;RPS5;RPS27A;RPS3A;PLXNA3;RPL41;MYL12A;RPS12;RPS4X;RPL27A;RPS19;ITGA2B;FAU;PSMC5;RPS21;EPHA1;MAPK3;CDK5R1;CXCL12;RPL32;MYL9;ARTN;CNTN2;RPL11;RPL23A;RPL35A;RPS11;MSN;RPS13;RPS7;VAV3;RSL24D1;RPLP2;RPL7;EFNB3;SCN5A;RBX1;RPL38;PSMA3;SIAH1;PSMB6;RPS15A;MAP2K1;RPS6KA5;RPSA;RPLP0;RPS6;RPL35;PSMD6;TMPRSS4;RPL27;SPTBN5;RPS14;L1CAM;RPL7A
prerank,CellMarker_Augmented_2021__Effector Memory T cell:Peripheral Blood,0.5474846576301609,0.8425802372559594,0.7884615384615384,1.0,1.0,2/5,11.98%,PTPRC;CD4
prerank,CellMarker_Augmented_2021__Effector T cell:Peripheral Blood,0.5474846576301609,0.8425802372559594,0.7884615384615384,1.0,1.0,2/5,11.98%,PTPRC;CD4
prerank,CellMarker_Augmented_2021__Central Memory T cell:Peripheral Blood,0.5474846576301609,0.8425802372559594,0.7884615384615384,1.0,1.0,2/5,11.98%,PTPRC;CD4
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,0.40186915866213535,0.8425213847194646,0.7638888888888888,1.0,1.0,7/36,9.98%,COL6A5;COL6A6;COL4A4;COL4A3;COL4A5;GFRA1;COL6A2
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.45084099368959935,-0.8424328067693356,0.6341463414634146,1.0,1.0,2/16,2.18%,DRD4;MOXD1
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.3747673491348868,-0.8423901982079921,0.7222222222222222,1.0,1.0,4/23,16.59%,USP4;SHARPIN;RBCK1;TRAF1
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,0.4390837024007338,0.8421808933971857,0.75,1.0,1.0,6/29,14.15%,COL18A1;MMP19;MMP9;MMP15;MMP11;ELANE
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.4068217249893442,0.8421631545222407,0.68,1.0,1.0,5/39,15.18%,LPAR1;FHOD1;TGFB3;CARMIL1;EPHA1
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.5333741105834814,0.8420010664231792,0.6896551724137931,1.0,1.0,1/7,12.59%,TRMT10A
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.38257673704380735,-0.8418683451810782,0.4827586206896552,1.0,1.0,5/30,13.06%,EXO1;MUS81;RAD50;SLX4;SPIDR
prerank,Reactome_2022__Phenylalanine And Tyrosine Metabolism R-HSA-8963691,-0.45657610223051304,-0.8417217120729379,0.6190476190476191,1.0,1.0,3/11,10.57%,PAH;GSTZ1;KYAT1
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.45202565826028185,0.841651324540309,0.6935483870967742,1.0,1.0,3/19,13.17%,TRIM62;TRIM25;CHMP3
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.3694732263169127,0.8416432183596859,0.7763157894736842,1.0,1.0,9/111,14.60%,AQP3;PSMB9;ACAA2;SUV39H1;PINK1;RPS27A;NOP53;PSMC5;NDRG1
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.29643804193429346,-0.8415014233953614,0.9375,1.0,1.0,27/123,16.19%,KCNIP3;EFR3B;PTCH1;TMEM150A;SPTBN4;RAB3D;ZDHHC23;F11R;TTC7A;DPP6;FLNA;TTC7B;BSG;PRAM1;KCNB2;NECTIN3;EHD4;EHD3;RAMP1;MRAP2;PPIL2;WNK3;RAB40A;RAB40C;TMEM88;ZDHHC3;NKD2
prerank,CellMarker_Augmented_2021__Enterocyte Progenitor cell:Small Intestine,0.36649717967477874,0.8414654852627543,0.7586206896551724,1.0,1.0,28/95,21.05%,MGST1;GLRX;UGT3A1;SLC7A7;RARRES1;ABCC2;CYP2J2;ENPP4;ALDOB;TREH;GCHFR;SLC5A9;TGM2;VTN;C17ORF78;AGT;PIGH;TMEM144;TM4SF20;FAH;NR5A2;CAMKV;FBP1;CCL25;STARD5;GCNT1;TSPAN13;DOK7
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.39989721198041456,-0.8413194840475413,0.5897435897435898,1.0,1.0,1/18,1.47%,PRKCD
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,-0.3971807848460169,-0.8412878978771535,0.6666666666666666,1.0,1.0,4/34,7.29%,CSK;VANGL1;NIPSNAP2;RAB7A
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,-0.3697369070101093,-0.8411180353272226,0.6428571428571429,1.0,1.0,8/51,13.32%,CPSF1;MAGOHB;SRRM1;SRSF4;SYMPK;U2AF2;CSTF2;CPSF7
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,0.39284814909701943,0.8411079908559601,0.7051282051282052,1.0,1.0,5/52,9.53%,POLE2;H2BC4;POLD4;H2AZ1;RPA3
prerank,Reactome_2022__Synthesis Of diphthamide-EEF2 R-HSA-5358493,-0.4905060105596169,-0.8410494345582393,0.6136363636363636,1.0,1.0,4/8,23.26%,DNAJC24;DPH1;DPH5;DPH6
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.41704536482449706,-0.8409007118532156,0.65625,1.0,1.0,3/14,5.21%,SLC17A9;ABCC4;SLC25A17
prerank,Reactome_2022__FRS-mediated FGFR3 Signaling R-HSA-5654706,0.4894382835971324,0.840609360450191,0.6557377049180327,1.0,1.0,1/16,2.58%,FGF20
prerank,KEGG_2021_Human__Alcoholism,-0.2968374757491991,-0.8403491740999729,0.8947368421052632,1.0,1.0,17/111,11.31%,SHC3;SLC29A3;CREB3L4;HDAC7;HDAC10;SHC4;CREB3L1;GRIN3A;H4C5;CRH;MACROH2A2;GNAS;HDAC3;PKIA;GNB5;GNB3;GRIN1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.3619030184184244,0.8402296032152926,0.725,1.0,1.0,26/85,20.30%,SLC7A7;SLC16A8;SLC38A3;SLC10A1;ABCG2;SLCO1A2;ABCC2;SLC26A6;SLC51A;NR1H4;ABCC11;SLC22A6;SLC38A4;SLC7A3;SLCO2B1;SLC38A2;SLC46A1;SLC16A1;SLC6A12;SLC23A1;SLC10A5;SLC7A10;SLC7A11;CEACAM1;SLC7A4;STARD5
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.571404866551954,0.8401001967623188,0.8703703703703703,1.0,1.0,2/6,13.13%,ABCC11;SLC25A19
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.4462112065587674,0.8400385558343162,0.7333333333333333,1.0,1.0,8/21,33.80%,CHMP3;DENND10;CHMP1A;SORT1;CHMP4B;CHMP2B;RILP;LEPROTL1
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.4897950075160985,0.84003395749085,0.6461538461538462,1.0,1.0,3/12,19.91%,MAPK3;NOS2;ORAI1
prerank,GO_Biological_Process_2021__positive regulation of plasminogen activation (GO:0010756),-0.5167929047607237,-0.8398085867517187,0.717948717948718,1.0,1.0,1/5,12.46%,PLGRKT
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.3666279575164212,0.8397629959255222,0.7402597402597403,1.0,1.0,15/111,20.47%,PSMB9;PDE6A;WNT5A;LEF1;FZD8;CELSR1;GNAT2;SFRP4;PSMC5;FRZB;PDE6B;PDE6G;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.36824516317857653,0.8396300947258366,0.7662337662337663,1.0,1.0,14/79,17.34%,SLC22A3;LRP2;SLC38A3;SLC22A8;ABCG2;ABCC2;ATP1A4;SLC5A1;SLC7A3;SLCO2B1;SLC38A2;AGER;SLC16A1;SLC16A12
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.3760173285163729,-0.8395993985051676,0.7777777777777778,1.0,1.0,5/46,7.56%,EYA4;RNF168;BRCC3;PPP5C;RAD50
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Whartons Jelly,0.370303849066579,0.8393575077935039,0.8,1.0,1.0,16/72,16.38%,RRAS;ARHGAP31;TMEM204;MMP19;ANPEP;ITGA5;HIC1;PDCD1LG2;ADGRL4;VWF;PLAC9;DAB2;CSF1R;TGFBI;ENG;CSF1
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone,0.370303849066579,0.8393575077935039,0.8,1.0,1.0,16/72,16.38%,RRAS;ARHGAP31;TMEM204;MMP19;ANPEP;ITGA5;HIC1;PDCD1LG2;ADGRL4;VWF;PLAC9;DAB2;CSF1R;TGFBI;ENG;CSF1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.38241875770444944,0.8392332289115738,0.782051282051282,1.0,1.0,13/74,26.82%,PSMB9;DNAJB1;RPS27A;PSMC5;RBX1;PSMA3;PSMB6;PSMD6;DDIT3;PSMA7;PSMB1;HIF1A;CHEK1
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Fetal Liver,0.3643921694641864,0.839125014989718,0.7468354430379747,1.0,1.0,18/88,15.58%,PRRX1;LMOD1;FBXL7;ADAM33;ABI3BP;PCDH18;ANGPTL2;ACTA2;ADGRL4;COL6A2;DCN;COL1A1;ASPN;HMCN1;DDR2;MASP1;CXCL12;ELN
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.36885257741964966,0.8389936985896311,0.7215189873417721,1.0,1.0,14/77,17.34%,SLC22A3;LRP2;SLC38A3;SLC22A8;ABCG2;ABCC2;ATP1A4;SLC5A1;SLC7A3;SLCO2B1;SLC38A2;AGER;SLC16A1;SLC16A12
prerank,CellMarker_Augmented_2021__Myofibroblast:Liver,-0.3191140968699065,-0.8389001684547913,0.7916666666666666,1.0,1.0,16/92,11.56%,FIBIN;ADAMTS12;BOC;PAMR1;CALD1;COL6A3;COL4A2;MMP2;CNN1;SLIT3;FSTL1;DOK5;MYOCD;EMILIN1;OLFML2B;EDNRA
prerank,Reactome_2022__Autophagy R-HSA-9612973,0.3526948130235519,0.8388696633833007,0.7317073170731707,1.0,1.0,22/118,25.28%,HSPA8;RRAGA;PINK1;RPS27A;ATG101;LAMP2;EEF1A1;TOMM20;PGAM5;TOMM7;DYNLL1;GABARAPL2;LAMTOR3;GFAP;FUNDC1;ULK1;DYNLL2;GABARAPL1;PARK7;PRKAB2;VDAC1;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.4785614447760526,0.838824714316417,0.7301587301587301,1.0,1.0,1/13,3.81%,PTPRC
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,0.36175016201445365,0.8386188944074074,0.7682926829268293,1.0,1.0,28/100,17.71%,C3AR1;NPFFR1;ANXA1;CCL5;C3;SSTR1;GPER1;NMUR2;UTS2;CXCR5;ACKR4;PDYN;RXFP2;KNG1;NPY1R;NPY;F2RL1;PNOC;XCR1;PENK;FPR1;OPRM1;EDNRB;CXCL12;GHRL;NPFFR2;KISS1R;FPR3
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.37977415389122005,0.8385517621066503,0.7012987012987013,1.0,1.0,12/74,16.34%,CCL5;FAM20A;VAPB;STOML2;TRPV6;CASR;CSRP3;TRDN;SLC24A1;ELANE;CXCL12;HTR2B
prerank,CellMarker_Augmented_2021__Stem cell:Gastrointestinal Tract,-0.3065786335068436,-0.8385434159021636,0.8823529411764706,1.0,1.0,16/97,16.97%,ZNF664;RND3;SH3RF1;KITLG;HSD17B12;ADGRA3;TSPAN3;ALCAM;AADAT;NME5;DNAH5;ADGRL2;CDS1;TGFB2;DDAH1;SH3D19
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.5110972997963751,0.8385122288438588,0.6923076923076923,1.0,1.0,3/8,14.91%,IRF1;HLA-A;CRTAM
prerank,CellMarker_Augmented_2021__B cell:Peripheral Blood,-0.43621270725587197,-0.8385061575690652,0.7317073170731707,1.0,1.0,1/9,0.22%,CD38
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.4795830019495026,0.838449259472388,0.7272727272727273,1.0,1.0,1/14,5.08%,RNF26
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.3882537961594752,-0.8384131710409329,0.7142857142857143,1.0,1.0,8/24,19.38%,PPP1R35;BOD1L1;STYXL1;CHP1;TGFB2;PTPA;ZCCHC9;PPP1R11
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.49770997996519656,-0.8383848929887742,0.6744186046511628,1.0,1.0,4/8,27.32%,STAT4;IL23A;TYK2;STAT3
prerank,Reactome_2022__Interleukin-23 Signaling R-HSA-9020933,-0.49770997996519656,-0.8383848929887742,0.6744186046511628,1.0,1.0,4/8,27.32%,STAT4;IL23A;TYK2;STAT3
prerank,Reactome_2022__Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,-0.4825546825256316,-0.8382201168387674,0.6666666666666666,1.0,1.0,4/12,7.51%,CSK;CD247;HLA-DRA;PTPRJ
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.47816386785071735,-0.8381553592824654,0.6428571428571429,1.0,1.0,2/9,0.92%,APOB;LIPC
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.44620228703147524,-0.838044269624274,0.6896551724137931,1.0,1.0,4/11,22.83%,LIG3;XRCC4;DCAF1;LIG1
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.46312254058517993,0.8379607991778955,0.65625,1.0,1.0,4/12,30.10%,DDX3X;KAT5;RAPGEF3;TERF2IP
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.4672040621996917,0.8379595978201556,0.6896551724137931,1.0,1.0,6/15,20.54%,ACMSD;HPD;IDO1;FAH;HAAO;IDO2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.4201049101090069,0.8377918408430292,0.7702702702702703,1.0,1.0,5/21,14.43%,CDKN2A;INCA1;CDKN1B;CDKN1A;LATS2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.40068238760830643,0.8377259752887917,0.7162162162162162,1.0,1.0,7/52,12.80%,ELOVL2;VAPB;CERS3;HACD4;B3GNT5;PRKD3;DEGS2
prerank,KEGG_2021_Human__Cardiac muscle contraction,0.39752161656637425,0.8376600811610619,0.7721518987341772,1.0,1.0,17/65,24.43%,COX6A1;CASQ2;ATP1A4;TRDN;COX7A2;COX4I1;ATP2A2;COX7B;COX6C;COX6B1;MYH7;UQCRFS1;CACNA2D4;COX7A1;COX5A;COX7C;ATP1A1
prerank,KEGG_2021_Human__Protein digestion and absorption,0.3685338859178641,0.8376041704731193,0.7558139534883721,1.0,1.0,17/80,11.00%,ACE2;COL18A1;SLC7A7;COL6A5;COL6A6;COL4A4;COL4A3;ATP1A4;CPB2;COL4A6;COL21A1;COL4A5;CELA2B;SLC15A1;COL6A2;MEP1B;COL1A1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.31177125779961073,-0.8375400746398552,0.7692307692307693,1.0,1.0,37/215,12.15%,TSKU;SPRY4;ADAMTS12;UBASH3B;PRKCD;BCL2;TYRO3;SIGIRR;PTCH1;PTCH2;CREB3L1;WWP2;ERBB2;PLIN5;CRY1;ACVR1;NKD1;PTPRJ;CX3CR1;PID1;PTPRE;RPGRIP1L;SNAI2;NIBAN2;BEND6;TRIB1;CBY1;CHAC1;SLC27A4;EMILIN1;ZBTB7A;SPRY1;DLK2;BRAP;DAB2IP;NEURL1;SMPDL3B
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.4239491697390152,-0.8374545181179652,0.6486486486486487,1.0,1.0,1/22,1.29%,TYRP1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.3820355450101585,0.8372566279873995,0.7466666666666667,1.0,1.0,8/68,12.86%,ELOVL2;VAPB;A4GALT;CERS3;HACD4;PRKD3;DEGS2;ALOX12B
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.4180541039594575,-0.8371146697894554,0.7307692307692307,1.0,1.0,3/15,21.90%,HIP1;NSG2;SGIP1
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Undefined,0.4488402008214682,0.8370908959470441,0.7424242424242424,1.0,1.0,3/16,12.25%,ABCG2;L1TD1;EPCAM
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.4657276480620038,0.8369502438144492,0.6825396825396826,1.0,1.0,2/14,17.73%,RHOQ;IMPDH2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4470473986358474,0.8369452783286209,0.72,1.0,1.0,5/23,18.57%,RPS27A;COPS4;GPS1;COPS5;RBX1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.5465333878290236,-0.8369047881594135,0.7317073170731707,1.0,1.0,1/5,12.93%,DUT
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.35355524316133186,0.836883773542714,0.8571428571428571,1.0,1.0,22/171,14.74%,RASGRP4;ESR1;GPHB5;SP100;TMEM204;HHIP;TGFB1;NLRP12;CAV3;CD80;SOCS2;GRK7;GNG4;DHRS3;LIFR;CD63;ALOX15;TCF7L1;IGFBP6;LRIT3;ZIC1;MTCH1
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 type immune response (GO:2000317),0.5453734333875867,0.8367417435490565,0.7704918032786885,1.0,1.0,1/5,14.41%,IL4
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.40742219236560817,-0.8367413584576322,0.7567567567567568,1.0,1.0,4/12,17.18%,FLNA;TIMP1;LIMS1;EMP2
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.4753482932883063,-0.8366733599176212,0.6818181818181818,1.0,1.0,1/11,2.80%,PC
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.5104356306580935,0.836580802379416,0.7288135593220338,1.0,1.0,1/10,4.39%,JCHAIN
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.4802206105970078,0.8364379438690961,0.7428571428571429,1.0,1.0,2/12,13.08%,RFK;AGT
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.3557067094007126,0.8362078179549627,0.75,1.0,1.0,5/104,7.24%,ARHGAP9;AHR;ANGPTL4;DAND5;NR1H4
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.4161553083237721,-0.8361696415268521,0.6774193548387096,1.0,1.0,1/13,8.46%,SNF8
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),-0.45191375009006096,-0.8360882448008892,0.6571428571428571,1.0,1.0,3/13,9.07%,TCOF1;WNT7A;SNAI2
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.40201435754774095,0.8358303561324167,0.7333333333333333,1.0,1.0,11/36,24.51%,PKP2;KCNA5;CTNNA3;KCNE3;KCNJ2;SCN5A;KCNE4;SCN4B;KCNQ1;DSC2;SCN1B
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Liver,0.3883978653601308,0.8357638403368336,0.726027397260274,1.0,1.0,15/62,17.14%,MACC1;PLEKHG6;LIPH;TNFRSF10A;ITGA2;TMC4;LAMC2;AP1M2;F2RL1;DOCK5;SERPINB5;EPHA1;KRT8;SPINT1;SERPINB1
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Lung,0.3883978653601308,0.8357638403368336,0.726027397260274,1.0,1.0,15/62,17.14%,MACC1;PLEKHG6;LIPH;TNFRSF10A;ITGA2;TMC4;LAMC2;AP1M2;F2RL1;DOCK5;SERPINB5;EPHA1;KRT8;SPINT1;SERPINB1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-0.49040876626391056,-0.8356196707176233,0.6285714285714286,1.0,1.0,1/7,1.19%,DNMT1
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.45603050350149843,-0.8355468375223748,0.7428571428571429,1.0,1.0,3/10,18.80%,WWP2;CCDC40;TSG101
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.3471618733456147,-0.8355415715052353,0.6538461538461539,1.0,1.0,8/60,9.82%,TRIM71;SH3RF1;WWP2;NFX1;LRSAM1;ERCC8;SH3RF3;MARCHF5
prerank,CellMarker_Augmented_2021__Endothelial cell:Peripheral Blood,-0.5005013315391108,-0.8355084992439298,0.7142857142857143,1.0,1.0,2/7,3.16%,CDH5;SELE
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.3459550512650831,-0.8354912591273977,0.6086956521739131,1.0,1.0,9/53,15.36%,BCL2;USP36;QSOX1;LZTS1;NUPR1;MTMR8;KLHL22;RUBCN;MCL1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.4340910958714923,-0.8354605806750955,0.6829268292682927,1.0,1.0,3/11,14.10%,MACROH2A2;TERT;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.37947154960074464,0.8354559729128281,0.7567567567567568,1.0,1.0,17/91,16.69%,SPDYA;FGF2;FLT1;TGFB1;WNT5A;CCND2;CCND1;DDX3X;HMGA2;CSF1R;ELANE;PIK3R6;MTCP1;TPD52L1;PIK3CG;HTR2B;RASGRP1
prerank,KEGG_2021_Human__Cholinergic synapse,-0.30133673380913206,-0.8354468226174615,0.8095238095238095,1.0,1.0,12/102,11.43%,BCL2;FOS;CREB3L4;ITPR2;CREB3L1;KCNQ4;KCNJ6;GNB5;GNA11;GNB3;ADCY3;ADCY2
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.3903132057447392,0.8354258076861762,0.6493506493506493,1.0,1.0,2/62,0.98%,ENPP2;PLA2G10
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.3743489952855328,0.8353172369657145,0.7375,1.0,1.0,7/77,13.45%,KIF14;CXCR5;NDC80;IGF1;ECT2;CDC14A;GPSM2
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.29048518450223093,-0.8352895538918608,0.9,1.0,1.0,56/278,18.73%,CDH4;PRKCD;ETV1;ARX;CELF5;PTPRO;NXPH4;SLC17A6;ELAVL3;TTBK1;NCALD;CCN2;CXCL14;CALN1;IGSF21;CACNB1;VGF;CRH;SNCB;DLX1;GABRA5;HPCA;CDHR1;SLC22A15;FRRS1L;MMD2;TAGLN3;RGMA;GRIA4;ADGRA1;CACNG2;DLGAP1;BRINP1;LRRTM3;NAT14;DISP2;CELF4;TCEAL6;SV2B;DEPTOR;ERC2;GABBR2;ADGRL2;DZANK1;RAB26;SYN1;PCF11;FAM81A;NRSN2;ABCC5;PTPN5;ELMO1;RGS7BP;POU2F2;LINGO1;CDH22
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.4119242411617191,-0.8352664752811981,0.7333333333333333,1.0,1.0,3/15,5.21%,SLC17A9;ABCC4;SLC25A17
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,0.35125746991981505,0.8350519440219648,0.8148148148148148,1.0,1.0,29/210,17.08%,ESR1;PIK3R3;GNAT3;GNG12;RDH13;CYP26B1;DAND5;H2BC4;ERBB4;MMP9;LDHD;CCND1;GNG4;H2AZ1;DHRS3;KDM3A;CDKN1B;SCD;PDK4;RDH16;ANGPTL3;RXRG;MAPK3;CXCL12;FKBP5;FKBP4;ABCG5;NR5A2;MYB
prerank,Reactome_2022__Synthesis Of Pyrophosphates In Cytosol R-HSA-1855167,-0.42264080243391283,-0.834976443717203,0.6451612903225806,1.0,1.0,2/10,16.74%,PPIP5K1;ITPK1
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.47076324852380697,0.8349703328993663,0.7972972972972973,1.0,1.0,5/17,12.86%,ALOX12;FLG;FLG2;TMEM79;ALOX12B
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.47076324852380697,0.8349703328993663,0.7972972972972973,1.0,1.0,5/17,12.86%,ALOX12;FLG;FLG2;TMEM79;ALOX12B
prerank,KEGG_2021_Human__Base excision repair,0.41358320171693486,0.8349482027713919,0.8125,1.0,1.0,5/30,20.79%,POLE2;POLD4;TDG;PARP4;POLE3
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.35346772797874737,0.8348455446030068,0.8888888888888888,1.0,1.0,11/149,9.22%,NEK2;MAPKAPK3;MAP3K11;FLT1;MAK;STK26;ERBB4;GRK7;FLT4;HCK;PINK1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.4529933110246377,0.8345966575570491,0.6268656716417911,1.0,1.0,2/14,13.21%,LPIN3;ALOX15
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.5055852019071995,0.8344651688532383,0.7368421052631579,1.0,1.0,1/7,8.49%,DDX3X
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),0.5040294278280567,0.8344435948892434,0.703125,1.0,1.0,3/9,25.18%,PPT1;ATP6AP2;GRN
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.45865451981993266,0.8342853974459286,0.640625,1.0,1.0,3/17,20.05%,EPCAM;PLG;PTPRU
prerank,Reactome_2022__Cellular Responses To Stimuli R-HSA-8953897,0.3181514779734807,0.8341769578905076,0.979381443298969,1.0,1.0,158/636,25.56%,COX6A1;GML;MAPKAPK3;PSMB9;HSPA1L;NOX5;HSPA8;ATP6V1G2;CBX8;RPL37A;RPL21;H1-0;DEPDC5;DNAJB1;DAND5;H2BC4;CDKN2A;RPL9;HSPA5;H2AZ1;RPL18A;NQO1;COL4A6;RRAGA;ATP6V0E2;RPA3;MYDGF;DNAJA1;RPS9;RPL3;RPL36;RPL13A;EXOSC8;RPS16;RPL15;ID1;RPS5;CCNE2;RPS27A;RPS3A;EXOSC2;RPL41;HMGA2;CDKN1B;RPS12;RPS4X;RPL27A;CDKN1A;TALDO1;CCNA2;EEF1A1;RPS19;PKMYT1;FAU;CDKN2C;PSMC5;WDR24;RPS21;CYBA;HMGA1;MAPK3;EXOSC4;MT1M;RPL32;FKBP5;MT4;ARTN;FKBP4;SLC46A1;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;DYNLL1;ATP6V0B;ATOX1;HSPH1;COX20;HSPA4;COX4I1;IDH1;SYVN1;TXNIP;RSL24D1;RPLP2;HSPA2;HERPUD1;LAMTOR3;RPL7;RBX1;RPL38;BAG5;KDELR3;PSMA3;COX7B;PSMB6;RPS15A;BAG1;RPSA;RPLP0;RPS6;SLC7A11;ATF5;RPL35;DNAJB9;COX6C;COX6B1;PSMD6;H2AZ2;SESN1;NFYB;RPL27;RPS14;RPL7A;EPX;RBBP7;RPL23;ATP6V1D;DNAJC2;RPS15;DDIT3;DCTN3;BAG2;DCTN1;DCSTAMP;CDKN2D;RPS27;DYNLL2;RPL8;COX5A;STAP2;RPS3;HSPA13;RPS23;PHGDH;CITED2;ATP6V0D1;RPS20;COX7C;KAT5;MT2A;RPS24;CRYAB;PSMA7;MAP2K4;PPARGC1A;H2AC6;RPS29;HSP90AB1;GPX2;TATDN2;NCF2;CEBPB;IGFBP7;RPS6KA1;PSMB1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.4594031205012956,-0.8341644971765148,0.7586206896551724,1.0,1.0,2/11,6.35%,ADGRG6;PARD3
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.4821540031634594,-0.8341512390128226,0.6666666666666666,1.0,1.0,4/12,15.79%,APOBEC3H;MPHOSPH8;MORC2;SETDB1
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,0.3469556310284336,0.8341022822432133,0.8076923076923077,1.0,1.0,5/81,11.00%,NEK2;BORA;CEP72;CEP70;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.33174490910003185,0.8340968959552257,0.8241758241758241,1.0,1.0,55/366,14.65%,TBX1;S100A13;CDCA7L;KIF14;ITGAX;FGF20;CCL5;CLCF1;SPDYA;FGF2;PTPRC;TSHR;FLT1;TGFB1;CRLF1;WNT5A;GPER1;CD81;NODAL;ERBB4;FLT4;FOXM1;CCND2;IGF1;LEF1;TBX6;RNF187;HCK;OSMR;RPS9;TGFB3;LAMC2;PRAME;STAT1;CLDN5;TNFSF4;HMGA2;LIFR;EPCAM;COX17;RPS4X;IL7;CDKN1A;TTK;AGT;THBS1;CSF1R;SIRPG;RHOG;BMI1;SOX9;ELANE;IL4;DDR2;GDF9
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.5152315868674535,0.8340829971125268,0.6875,1.0,1.0,1/9,5.45%,CAV3
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3934403184399148,-0.8340379848107665,0.7096774193548387,1.0,1.0,4/21,13.08%,BCL2;TFDP1;YWHAQ;PPP1R13B
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3934403184399148,-0.8340379848107665,0.7096774193548387,1.0,1.0,4/21,13.08%,BCL2;TFDP1;YWHAQ;PPP1R13B
prerank,CellMarker_Augmented_2021__B cell:Lymph Node,0.5532864178758987,0.8339549109964486,0.7777777777777778,1.0,1.0,1/6,6.90%,CD80
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,0.3567380704886738,0.8338813799685869,0.75,1.0,1.0,5/102,7.24%,ARHGAP9;AHR;ANGPTL4;DAND5;NR1H4
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.5312784373558952,-0.8338389295910963,0.7142857142857143,1.0,1.0,2/5,21.55%,TRAPPC11;RAB11B
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.4911090988795802,-0.8336138211767721,0.625,1.0,1.0,1/7,4.77%,MRRF
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.3644615845860141,-0.8334942143992807,0.7352941176470589,1.0,1.0,4/28,11.37%,PHLDB2;ACER2;SERPINE1;JAG1
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),-0.4534277011752902,-0.8334353980540417,0.7142857142857143,1.0,1.0,2/8,19.14%,AK8;AK7
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.39614731289943766,-0.8333398119554276,0.6363636363636364,1.0,1.0,9/40,22.03%,GTF2H2;ERCC2;SSRP1;POLR2F;POLR2C;ELOA;CCNT1;CTDP1;GTF2F2
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.35538390241663764,0.8332811898973992,0.7560975609756098,1.0,1.0,30/147,16.07%,TIMP3;PRRX1;SMOC1;LMOD1;FBXL7;ADAM33;RRAD;LOX;HHIP;ADAMDEC1;MYH11;PCDH18;DAAM2;OGN;IRAG1;ANGPTL2;ACTA2;ADGRL4;DCN;COL1A1;PLN;PRXL2C;NEXN;MAP3K7CL;DDR2;CXCL12;ELN;MYL9;KCNAB1;EHD2
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,-0.4124008655786574,-0.8332161065773731,0.5945945945945946,1.0,1.0,2/14,7.51%,CSK;PTPRJ
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.5037529702059549,-0.8331664477558887,0.7105263157894737,1.0,1.0,4/5,37.60%,NCSTN;PSEN1;APH1B;ADAM10
prerank,CellMarker_Augmented_2021__Progenitor cell:Skin,0.37576288690205273,0.8330184570250475,0.7083333333333334,1.0,1.0,8/80,9.95%,CAPN13;PKP2;CLDN6;GPRIN2;FOXA3;HSD11B2;MMP15;MARVELD3
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.36244654948560284,-0.8329794997433075,0.8148148148148148,1.0,1.0,7/35,18.94%,RAB3D;OLFM2;TVP23A;PREB;MIA3;STEAP3;RAB10
prerank,Reactome_2022__Cohesin Loading Onto Chromatin R-HSA-2470946,-0.46679809366665187,-0.8328338724793436,0.6578947368421053,1.0,1.0,1/10,7.05%,MAU2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.5044222165926415,-0.8327020744041348,0.7027027027027027,1.0,1.0,2/8,7.88%,DNMT1;NFATC3
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,0.32863845839602024,0.8326769884804651,0.9032258064516129,1.0,1.0,49/346,14.04%,IL21R;ITGB2;MAPKAPK3;PSMB9;BLNK;RORC;TNFRSF1B;ITGAX;HSPA8;CSF2RA;PIK3R3;ANXA1;CCL5;CLCF1;PTAFR;TGFB1;CRLF1;ITGAM;PELI3;IL12A;STAT5A;SYK;IL27;MMP9;CD80;CA1;SOCS2;IL26;CCND1;HCK;OSMR;CSF3R;IL5;TIFA;RPS27A;STAT1;RHOU;CD4;LIFR;IL7;CDKN1A;TALDO1;NFKB2;ALOX15;CSF1R;FPR1;USP18;OPRM1;PSMC5
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.3802661287252793,0.8326312446932682,0.7228915662650602,1.0,1.0,7/67,16.33%,ACTL6A;HAT1;TAF5;LEF1;ING3;TAF6L;TAF10
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.4594729314757403,0.8325691566738171,0.703125,1.0,1.0,3/21,11.63%,TLR2;IRF1;OTUD4
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.48702138475129964,-0.8325227365839495,0.6170212765957447,1.0,1.0,1/6,5.01%,WNT7A
prerank,CellMarker_Augmented_2021__Fibroblast:Peripheral Blood,0.36913263770022064,0.8324760153887993,0.7631578947368421,1.0,1.0,13/86,11.00%,TIMP3;PRRX1;LMOD1;FBXL7;ADAM33;LOX;ITGBL1;WNT5A;PCDH18;ANGPTL2;ADGRL4;DCN;COL1A1
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.45091488149907977,-0.83240418781244,0.7096774193548387,1.0,1.0,5/12,10.83%,PNP;NT5C1A;NT5C;GPX1;DNPH1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.3094783134650818,-0.8322672057916259,0.7857142857142857,1.0,1.0,14/76,13.00%,NGF;SPRY4;MYO9B;STARD8;NTRK1;EPHB2;BCR;RAPGEF1;STAMBP;MMD2;SPRY1;DAB2IP;RALGPS1;EPOR
prerank,Reactome_2022__Transport Of Fatty Acids R-HSA-804914,-0.525122813333499,-0.832137513877475,0.7567567567567568,1.0,1.0,2/6,10.68%,LCN12;SLC27A4
prerank,Reactome_2022__FGFR3 Ligand Binding And Activation R-HSA-190239,0.5255351008430352,0.8321363744257162,0.6792452830188679,1.0,1.0,1/10,2.58%,FGF20
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.5364166810593212,0.8321342145596913,0.7288135593220338,1.0,1.0,2/5,31.51%,TRNT1;HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.4863105686678748,-0.8319583394857036,0.631578947368421,1.0,1.0,2/7,7.49%,FOXO1;IGBP1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Corneal Endothelium,0.35685845250000253,0.8318009561934699,0.6785714285714286,1.0,1.0,20/87,16.77%,RAB34;ANXA1;PTX3;LOX;NID1;ELK3;ITGA5;AXL;HEG1;PLAU;COL6A2;DAB2;THBS1;PLAT;TUBB6;TGFBI;EHD2;CYBRD1;MSN;PAPPA
prerank,KEGG_2021_Human__Bladder cancer,0.4177032005783192,0.8317895607268302,0.7323943661971831,1.0,1.0,9/37,19.64%,MMP9;CDKN2A;CCND1;CDKN1A;THBS1;UPK3A;MAPK3;MAP2K1;RPS6KA5
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.4004501251843579,0.8317262490300976,0.7625,1.0,1.0,8/45,11.88%,CLDN2;CLDN6;CLDN18;MARVELD2;MARVELD3;ECT2;CLDN5;CLDN9
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,0.37248400433144446,0.8316653410975291,0.7,1.0,1.0,11/66,12.45%,SP100;TRIM62;PTAFR;HLA-F;TRIM25;IRF1;HLA-A;TRIM68;TRIM29;STAT1;OAS2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),-0.5025738461695096,-0.8313036627441517,0.625,1.0,1.0,4/7,33.30%,DFFA;RNF34;BCL2L1;PAK2
prerank,CellMarker_Augmented_2021__Meiotic Prophase Fetal Germ cell:Fetal Gonad,0.31668719717752414,0.8312658647461368,0.9292929292929293,1.0,1.0,121/930,20.04%,C19ORF38;TEX101;SLC25A31;ARHGAP9;DNAAF8;NUP210L;SYCP1;BUB1;IHO1;SHCBP1L;CENPU;ADAD2;PIK3R3;REC114;MCMDC2;TBC1D28;TOPAZ1;CCDC73;SPDYA;ARIH2;SPATA22;CTCFL;HIPK1;SYPL1;CNTD1;DAZL;CCDC172;DCAF4L1;SYCP3;DYDC2;USP6;FTCD;RANBP6;CCDC83;SHOC1;MEIOB;TDRD9;C1ORF105;RNF32;MYDGF;PRAME;TEX14;JOSD2;LRPAP1;NT5DC2;DCK;CLGN;CCNE2;VEZF1;INCA1;ATP6AP1;KIF18A;TMEM17;RNFT1;BOLL;CRYBG3;LACC1;RNF212B;SMC1B;RNF138;EFCAB13;TNFAIP8L3;RASA1;PIGH;PXT1;PNRC1;DEPDC1;PON3;FBXL3;CDKN2C;SLC9B1;METTL14;PATE2;LRRC36;NUF2;HINT3;UBE3A;TUBA3D;ART3;KASH5;SLC38A2;LRRC40;C11ORF65;ADSS1;ORC4;NSUN7;TMEM263;LRRIQ3;ARL4A;EIF1B;FAM107B;ITGB3BP;RAD51AP2;TEX30;TRIM23;STRADB;PHTF1;M1AP;HSPA2;FSIP2;LAMTOR3;FAM217B;DNAH12;FEZ1;FAM117A;C22ORF23;RIBC2;RAE1;CYSTM1;FKBP6;PBX3;RAVER2;ALDH3A2;HSF2;TCEAL3;NOTCH2;MTMR6;RAD9B;RCN2;STK17B;DNAJB9
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,0.4447747802935026,0.8311684822423672,0.7,1.0,1.0,1/18,11.00%,RPS27A
prerank,Reactome_2022__Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,0.444542284866076,0.8311281345623905,0.7101449275362319,1.0,1.0,2/27,5.35%,GLRX;NUDT13
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3620137263538873,0.8311210389341911,0.7901234567901234,1.0,1.0,9/73,21.18%,PSMB9;RPS27A;PSMC5;BUB1B;FBXO5;PSMA3;PSMB6;PSMD6;CCNB1
prerank,CellMarker_Augmented_2021__CD1C+ A Dendritic cell:Blood,0.44065538868525356,0.8310326856034683,0.7205882352941176,1.0,1.0,2/18,7.33%,PTAFR;ITGA5
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.45118079138570777,0.8309215121957654,0.6363636363636364,1.0,1.0,3/18,13.70%,ANXA1;REST;CALCR
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.4459911594003134,0.8309110315393331,0.7571428571428571,1.0,1.0,2/25,5.35%,GLRX;NUDT13
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.5203205805147448,-0.8308067263255403,0.6857142857142857,1.0,1.0,2/8,7.72%,MEGF10;CCN3
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.5306305549394406,0.8307449909326033,0.7358490566037735,1.0,1.0,1/7,2.12%,ACE2
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.400620742922775,0.8306983838329367,0.7777777777777778,1.0,1.0,7/48,15.27%,NOTUM;TGFB1;TGFB3;FBN2;DDR2;ATRAID;ISG15
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.28539204173405,-0.8306331315044844,1.0,1.0,1.0,14/113,9.80%,RGS16;ADCYAP1;ERBB2;PLIN5;F11R;ARHGAP11A;FNTA;NTRK1;AGRN;TBC1D2;ASAP3;SRGAP2;RAPGEF1;GNB5
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),-0.4564498623508509,-0.8305959519561071,0.7931034482758621,1.0,1.0,4/11,14.57%,UST;CHST12;VCAN;CSPG5
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3249949783457131,-0.8303928148375604,0.7142857142857143,1.0,1.0,4/60,3.01%,ADGRG3;RASSF2;CD14;HDAC7
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.35060132651254916,0.8303927476037997,0.7317073170731707,1.0,1.0,25/137,16.68%,TIMP3;PRRX1;LMOD1;FBXL7;ADAM33;ANGPT2;ABI3BP;PCDH18;ANGPTL2;LEF1;ACTA2;ADGRL4;PLAU;DCN;COL1A1;DAB2;RASD1;HMCN1;LATS2;FILIP1L;DDR2;CXCL12;MYL9;EHD2;FAM114A1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Peripheral Blood,0.38643155517655076,0.8301573962557746,0.7702702702702703,1.0,1.0,23/67,21.58%,TCN1;ANXA1;SP100;AHR;SLC28A3;ITGB6;LAMC2;EPCAM;FOSL2;DOCK5;CD44;SERPINB5;TGFBI;PARP14;SERPINB1;DDX60;PRRG4;SCNN1A;IL1R1;IFIH1;PARP9;ANXA2;B3GNT3
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.41247716237841336,-0.830037992386378,0.7,1.0,1.0,2/18,8.14%,ANAPC2;CDC26
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.29879255414649636,-0.8299513247584629,0.8235294117647058,1.0,1.0,28/164,16.33%,MFSD2A;SYNJ2;DGKD;CRLS1;PNPLA3;VAC14;PLD2;CPNE6;GPD1;PI4KB;PLA2G5;PLA2G4C;CHKA;RAB5A;PGS1;PITPNM1;PEMT;MTMR8;MTMR14;LPCAT2;PITPNM3;SLC44A5;RUFY1;AGPAT2;AGPAT5;CDS1;PI4KA;MTMR1
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,0.3959016916696692,0.8299459401603861,0.7702702702702703,1.0,1.0,12/47,19.88%,HLA-F;IFIT1;IRF1;HLA-A;STAT1;OAS2;USP18;ISG15;IFI6;XAF1;IRF4;IFIT3
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.3331627910098059,-0.8298524194130672,0.6818181818181818,1.0,1.0,7/57,7.73%,ADGRG3;IL11;BCL2;KIT;ITGA4;PTPRJ;EPHB2
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,-0.3355985290025713,-0.8297298984625877,0.68,1.0,1.0,25/112,15.88%,MFSD2A;BCHE;CRLS1;PNPLA3;PLD2;CPNE6;GPD1;PLA2G5;PLA2G4C;CHKA;PGS1;PITPNM1;TAFAZZIN;PEMT;OSBPL5;OSBPL10;LPCAT2;PITPNM3;TMEM86B;SLC44A5;AGPAT2;AGPAT5;PLD3;AWAT2;OSBPL8
prerank,CellMarker_Augmented_2021__Neural Crest Stem cell:Hair Follicle,-0.31994819440091155,-0.829688388672845,0.8888888888888888,1.0,1.0,13/91,13.54%,TRIB2;MMP2;VASH1;ZNF287;CLIP3;ITGA4;TBKBP1;LZTS1;P3H3;NRXN2;ZNF569;SV2A;CORO2B
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,-0.35096279554134513,-0.8296436899059212,0.8260869565217391,1.0,1.0,7/72,14.87%,KDELR1;SPTBN4;COG4;SPTB;STX5;CAPZB;COG7
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.38877356763491194,0.8294005903800524,0.7432432432432432,1.0,1.0,7/34,23.30%,PINK1;GABARAPL2;FUNDC1;FIS1;ULK1;FBXO7;GABARAPL1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.47919580251863714,0.8293750761044247,0.7121212121212122,1.0,1.0,6/14,28.09%,SYK;TNFSF4;IRF4;PRKCQ;CEBPB;LGALS9
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),0.5692390704262159,0.8291988369814209,0.7931034482758621,1.0,1.0,3/5,31.36%,RPS23;SLC11A1;COL5A1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.34232974328281374,0.8291021598506588,0.7951807228915663,1.0,1.0,26/120,23.04%,SLC9A2;SLC12A7;KCNA7;KCNJ15;SLC12A3;KCNA5;KCNS2;ATP1A4;KCNG2;KCNK7;SLC9C1;SLC24A1;KCNE3;KCNAB1;KCNJ2;LRRC38;KCNJ4;LRRC55;KCNE4;KCNJ11;KCNJ13;KCND1;KCNK13;KCNS3;KCNQ1;KCNF1
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.28904777686731137,-0.8290288236152203,0.9047619047619048,1.0,1.0,6/86,9.70%,NGF;PLEKHG2;PREX1;RIPK2;FGD1;HDAC3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord,0.5229473446444663,0.8290144922749305,0.7142857142857143,1.0,1.0,4/10,16.35%,PTPRC;NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),-0.45550313841315165,-0.8290002675481851,0.6666666666666666,1.0,1.0,2/6,11.79%,AQP1;RHCG
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,0.328875721787878,0.8287902430472505,0.8192771084337349,1.0,1.0,23/278,15.92%,HERC3;PSMB9;UBE2U;FBXL7;ASB5;UBE2L6;ARIH2;ASB14;SPSB2;ASB15;TRAIP;ASB17;RPS27A;KLHL2;FBXL13;RNF138;FBXL3;PSMC5;KBTBD7;KLHL13;UBE3A;FBXO40;KBTBD6
prerank,Reactome_2022__Activated NTRK3 Signals Thru PI3K R-HSA-9603381,-0.5024014684500522,-0.8287778386850686,0.6904761904761905,1.0,1.0,1/5,24.62%,SRC
prerank,Reactome_2022__RA Biosynthesis Pathway R-HSA-5365859,0.48712409643042104,0.8286703382295252,0.7910447761194029,1.0,1.0,4/16,12.73%,RDH13;CYP26B1;DHRS3;RDH16
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.41403765305623175,-0.828467309388643,0.6923076923076923,1.0,1.0,4/19,17.40%,NRDE2;AGO2;TNRC6C;TNRC6A
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.2731791084806871,-0.8284484510172161,0.9230769230769231,1.0,1.0,26/161,15.35%,TBC1D10A;TBC1D16;RGS16;ADCYAP1;ERBB2;F11R;ARHGAP11A;NTRK1;AGRN;BCR;TBC1D2;ASAP3;SRGAP2;RAPGEF1;TBC1D22B;GNB5;SLC27A4;TBC1D8;SIPA1L3;ARHGAP42;RGS6;GARNL3;RGS7;SCRIB;LIMS1;TBC1D9
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4908792312515674,0.8283616094158891,0.7352941176470589,1.0,1.0,1/10,5.92%,DNAJB1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.4349825246808553,0.8281296880820072,0.6764705882352942,1.0,1.0,6/23,22.77%,USP50;OTUD4;YOD1;USP17L2;OTUB1;BAP1
prerank,CellMarker_Augmented_2021__Decidual cell:Placenta,0.38428903914921575,0.8280891386876932,0.7567567567567568,1.0,1.0,11/71,8.97%,AMBP;RPSAP52;LOX;AOX1;GNG12;ANGPTL4;NT5E;AXL;CCND1;NQO1;OSMR
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4478305159461383,0.8280697271310108,0.6756756756756757,1.0,1.0,6/21,23.66%,SLC18A2;UCP1;CYBA;CCN6;ALOX5;PARK7
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.3264592256683966,-0.82777344423399,0.8888888888888888,1.0,1.0,7/75,4.78%,NR4A1;APOH;TIE1;CDH13;VASH1;FGF18;APOE
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.4364518678566581,0.8277715215268125,0.7246376811594203,1.0,1.0,2/26,4.58%,FGF2;CCDC39
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.5031477280330596,0.8277600978663958,0.7142857142857143,1.0,1.0,1/13,2.57%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.35363549099119296,0.827727824484634,0.813953488372093,1.0,1.0,12/90,16.59%,ITGB2;ITGAM;GPER1;CD81;RAMP3;TCAF2;TP53BP2;RHOG;STAC;PDZK1;BBC3;AGR2
prerank,CellMarker_Augmented_2021__Astrocyte:Undefined,-0.4936143894462687,-0.8276430682165156,0.7317073170731707,1.0,1.0,1/6,3.51%,S100B
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.42882258263648565,0.8276239342836882,0.7818181818181819,1.0,1.0,6/16,28.83%,COX17;BCS1L;COX20;TIMM21;COX16;COA3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.4535167580600697,0.8276227062165918,0.8115942028985508,1.0,1.0,4/22,11.63%,TLR2;SCIMP;SYK;TNFSF4
prerank,Reactome_2022__Prolactin Receptor Signaling R-HSA-1170546,0.4746874413555531,0.8276057178647844,0.7272727272727273,1.0,1.0,2/10,18.57%,STAT5A;RBX1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.5264128965169894,-0.8275285373442957,0.8095238095238095,1.0,1.0,4/5,37.23%,MACROH2A1;SLF2;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.5264128965169894,-0.8275285373442957,0.8095238095238095,1.0,1.0,4/5,37.23%,MACROH2A1;SLF2;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.5264128965169894,-0.8275285373442957,0.8095238095238095,1.0,1.0,4/5,37.23%,MACROH2A1;SLF2;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.4153565036915127,0.8273130816136778,0.6956521739130435,1.0,1.0,2/34,4.20%,SYT2;SNAP23
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.4638313443606553,-0.8272874927944895,0.6444444444444445,1.0,1.0,4/9,22.68%,DBNL;LRP8;CUX2;DHX36
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.410832823859581,0.8272692209055977,0.7671232876712328,1.0,1.0,5/31,20.31%,CAVIN1;POLR1C;MAPK3;TAF1A;POLR1E
prerank,"Reactome_2022__Tetrahydrobiopterin (BH4) Synthesis, Recycling, Salvage And Regulation R-HSA-1474151",-0.46383533524340564,-0.8271803029323301,0.6944444444444444,1.0,1.0,2/10,6.66%,DHFR;NANOS3
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.37419975968894936,0.8270155815116503,0.7804878048780488,1.0,1.0,9/82,13.50%,MYRF;STOML2;VSIR;CPM;F7;HPR;SDE2;CD5L;MME
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),-0.3740663122954596,-0.8269891926264771,0.7,1.0,1.0,5/21,10.31%,SERPINE2;CCBE1;ADAM8;RHBDD1;CHAC1
prerank,KEGG_2021_Human__Lysine degradation,-0.3535696143670142,-0.826830528238412,0.6666666666666666,1.0,1.0,16/62,22.24%,KMT2B;SMYD2;ECHS1;KMT5C;DHTKD1;COLGALT1;AADAT;HYKK;PLOD3;EHHADH;SETDB1;KMT5A;SETMAR;PHYKPL;KMT2A;SUV39H2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.36090662209763047,-0.8267678459040185,0.6578947368421053,1.0,1.0,2/23,9.07%,BCL2;SNAI2
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.34160065979922505,-0.8267462322122018,0.7241379310344828,1.0,1.0,7/43,7.72%,NR4A1;PRKCD;KIT;PARVA;CORO1B;CX3CR1;CCN3
prerank,CellMarker_Augmented_2021__Osteoblast:Bone Marrow,-0.32059922532398805,-0.8266600016099364,0.7391304347826086,1.0,1.0,14/68,13.62%,NLRP9P1;ADGRG3;WDR86;CLC;AOC3;TECPR2;TP53I11;VCAN;GLT1D1;NHSL2;TPPP3;RNF175;SULF2;SERPING1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryoid Body,-0.32059922532398805,-0.8266600016099364,0.7391304347826086,1.0,1.0,14/68,13.62%,NLRP9P1;ADGRG3;WDR86;CLC;AOC3;TECPR2;TP53I11;VCAN;GLT1D1;NHSL2;TPPP3;RNF175;SULF2;SERPING1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.41203753819452305,-0.8266538689614648,0.7222222222222222,1.0,1.0,5/14,11.11%,CES2;PTGS1;HPGD;PTGR2;AKR1C3
prerank,KEGG_2021_Human__ABC transporters,0.38786727419709005,0.8264328668664814,0.7236842105263158,1.0,1.0,4/42,8.20%,ABCC6;ABCG2;ABCC2;ABCC11
prerank,KEGG_2021_Human__Type II diabetes mellitus,-0.3618161724733587,-0.8263336365492235,0.6923076923076923,1.0,1.0,3/37,5.34%,GCK;PRKCD;ABCC8
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.4202776245587334,-0.8263156757074617,0.6829268292682927,1.0,1.0,3/16,6.31%,IL11;UBASH3B;ACVR1
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.38308373067934043,0.8262518750103616,0.72,1.0,1.0,19/60,14.40%,ITGB2;CYTIP;ARHGAP9;GMFG;SASH3;PTPRC;TSHR;WAS;CD99;IKZF1;TAGAP;CD37;TMC8;CD4;ALOX5AP;PSTPIP1;MYO1F;SIRPG;PARVG
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.4916301701176115,0.8261433331986595,0.7142857142857143,1.0,1.0,4/10,20.54%,ACMSD;IDO1;HAAO;IDO2
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.4916301701176115,0.8261433331986595,0.7142857142857143,1.0,1.0,4/10,20.54%,ACMSD;IDO1;HAAO;IDO2
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),0.5452347662354261,0.826124941984151,0.7413793103448276,1.0,1.0,3/6,20.17%,IL12A;CRTAM;CEACAM1
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),0.4967619317229495,0.8258265922948198,0.7192982456140351,1.0,1.0,1/7,11.17%,TEKT5
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,0.45147002078483733,0.8258138530636661,0.6567164179104478,1.0,1.0,4/19,15.72%,MYH11;MYL6;RHOB;MYL9
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,0.4622658971073848,0.8257664264795478,0.6619718309859155,1.0,1.0,1/16,3.81%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.3973918301610065,0.8257661196369565,0.7611940298507462,1.0,1.0,7/55,11.68%,BLK;TLR2;TGFB1;GPER1;IGF1;TGFB3;F2RL1
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.4376518778290794,-0.8256659030856127,0.6666666666666666,1.0,1.0,2/9,2.55%,UBASH3B;COL4A2
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.4865871077768837,0.8255740653455542,0.7536231884057971,1.0,1.0,2/11,11.77%,DAND5;FBN2
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.3843908055289588,-0.8255181099630492,0.7333333333333333,1.0,1.0,4/21,12.55%,APOE;DHFR;SCARB1;TERT
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.5246802485110567,0.8254237410777624,0.7058823529411765,1.0,1.0,1/7,10.78%,TJP3
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.3587541298947759,0.8251766573074849,0.7875,1.0,1.0,13/101,13.82%,ENPP2;ELOVL2;VAPB;CERS3;HACD4;PSAP;PPT1;UGT8;PRKD3;DEGS2;ALOX12B;GBA3;ORMDL3
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,-0.43867171763454826,-0.825106708568382,0.7419354838709677,1.0,1.0,5/18,16.68%,CARM1;CDK1;TFDP1;RBL1;GADD45A
prerank,Reactome_2022__Phosphate Bond Hydrolysis By NUDT Proteins R-HSA-2393930,-0.5132654080370003,-0.8247963198707485,0.7073170731707317,1.0,1.0,3/7,21.06%,ADPRM;NUDT18;NUDT5
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.3842859394207804,-0.8247871099218046,0.7096774193548387,1.0,1.0,7/22,26.07%,SNF8;MVB12A;TSG101;UBAP1L;UBAP1;PLAA;MVB12B
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,-0.3742358509338426,-0.8247661825627497,0.7692307692307693,1.0,1.0,5/47,7.56%,EYA4;RNF168;BRCC3;PPP5C;RAD50
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.46659619763862165,0.824593473761752,0.746268656716418,1.0,1.0,1/12,1.46%,MGST1
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),-0.4892003162324924,-0.8244969374818045,0.7368421052631579,1.0,1.0,2/8,5.01%,GRID2;WNT7A
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.5190660318327912,0.8244523080174889,0.7272727272727273,1.0,1.0,2/9,15.26%,EXOSC8;EXOSC4
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.4377710968714331,-0.824261361587534,0.6388888888888888,1.0,1.0,2/12,6.82%,PCM1;CCDC68
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.33343809229922305,0.8241252371548791,0.7931034482758621,1.0,1.0,21/225,15.21%,LRP4;NOTUM;PSMB9;FRAT1;TGFB1;SHISA6;WNT5A;DAAM2;RSPO1;DDX3X;MCC;COL1A1;DAB2;SFRP4;GLI3;DKK2;IGFBP6;SOX9;PSMC5;LATS2;CYLD
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.3469178934213367,0.8240737283653118,0.8414634146341463,1.0,1.0,34/151,16.56%,IL21R;TNFRSF1B;CSF2RA;CCL5;CLCF1;TGFB1;TNFRSF10A;IL12A;CXCR5;IL27;NODAL;ACKR4;IFNK;IL26;GDF11;OSMR;CSF3R;IL5;TGFB3;IL17B;TNFSF4;CD4;LIFR;XCR1;IL7;CSF1R;IL4;BMP3;GDF9;IL3RA;CXCL12;IL17RB;CSF1;EDAR
prerank,Reactome_2022__STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,-0.4648746320824597,-0.8240689646066778,0.6976744186046512,1.0,1.0,4/9,27.32%,HDAC3;PRDM1;HDAC1;STAT3
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),0.37661137042211945,0.8240642882029539,0.7866666666666666,1.0,1.0,6/38,15.27%,CCL5;IFIT1;ZC3HAV1;HMGA2;OAS2;ISG15
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.37556351672477123,-0.8240611842767588,0.6764705882352942,1.0,1.0,3/20,8.34%,BOD1L1;STYXL1;ENSA
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.3598169844124335,0.8239658689078179,0.7432432432432432,1.0,1.0,15/95,13.41%,AQP3;CAPN13;ACE2;TMEM45B;ITGB6;SMIM22;HSD11B2;EPN3;TMC4;TRIM29;AP1M2;ADGRG1;EPCAM;SLC5A1;AQP4
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.29924630804416164,-0.8239595283732035,0.8695652173913043,1.0,1.0,11/65,16.90%,SEC24C;PPP6R1;TGFA;TRAPPC9;STX5;PREB;CNIH3;TRAPPC1;MIA3;ANKRD28;F5
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.4937366817755667,0.8237608708955022,0.7833333333333333,1.0,1.0,2/12,8.08%,ELOVL2;HACD4
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.4263204816551284,0.823665428587621,0.7142857142857143,1.0,1.0,9/41,14.48%,CYP3A4;ALOX12;CYP3A5;PLPP6;MBOAT1;PLA2G7;ALOX12B;ALOX15;ALOX15B
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,0.341644789371256,0.8236102067275916,0.8764044943820225,1.0,1.0,39/184,14.33%,C3AR1;LPAR1;GPR55;NPFFR1;GNRHR;GPHB5;ANXA1;CCL5;C3;SSTR1;PTAFR;TSHR;GPER1;PTGER3;NMUR2;HTR5A;UTS2;CXCR5;ACKR4;P2RY6;ADRB1;PDYN;RXFP2;KNG1;NPY1R;NPY;P2RY12;GNRH1;LPAR6;F2RL1;GPR183;PNOC;XCR1;HTR1B;PENK;FPR1;OPRM1;GPR68;EDNRB
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In5:Brain,-0.48735584200434323,-0.823591295015756,0.8157894736842105,1.0,1.0,2/7,2.02%,HCRTR2;PDGFD
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,0.3531520653028234,0.8232553242824182,0.7590361445783133,1.0,1.0,7/104,11.19%,SMAD6;TGFB1;ITGB6;DAND5;TGFB3;RPS27A;STAT1
prerank,KEGG_2021_Human__Endocytosis,-0.2620337263714943,-0.8232496972436554,1.0,1.0,1.0,51/229,21.58%,GRK5;RAB11FIP1;RAB35;AGAP9;PLD2;SH3KBP1;PARD3;GIT2;ARPC3;RAB7A;ASAP3;SNF8;GBF1;SNX32;RAB5A;STAMBP;SNX5;EHD4;WASHC2C;ASAP1;ACAP3;EHD3;FGFR2;IQSEC1;WASHC3;ARRB2;CAPZB;RAB11FIP3;IQSEC3;RAB22A;RUFY1;BIN1;PARD6B;GRK4;RHOA;MVB12A;ACTR3C;PSD;ARPC2;TSG101;RAB10;HRAS;ARRB1;ACTR3B;CAPZA1;RABEP1;RAB31;PML;DNM2;RAB11B;IGF2R
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.34288708968918774,-0.8231867284869979,0.7142857142857143,1.0,1.0,8/39,17.38%,PIAS3;POLR1A;GTF2H2;XPC;ERCC2;PARP2;SUMO2;ERCC1
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.4222725104914288,0.8230282666319025,0.6962025316455697,1.0,1.0,3/27,12.18%,SEMA3A;ADGRG1;IGSF10
prerank,CellMarker_Augmented_2021__Fibroblast:Vocal Fold,0.5264348991502384,0.8229500698682849,0.7719298245614035,1.0,1.0,4/9,16.35%,PTPRC;NT5E;CD44;ENG
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH6 (MutSalpha) R-HSA-5358565,-0.4068924368332429,-0.822780965313127,0.7096774193548387,1.0,1.0,3/14,6.63%,EXO1;POLR1A;POLD3
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.3880474990937884,-0.8227203376819962,0.6857142857142857,1.0,1.0,2/16,6.76%,IL11;FZD7
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.3589918507097245,0.8226716777184113,0.8026315789473685,1.0,1.0,20/86,17.29%,PRRX1;LMOD1;ADAM33;CPED1;PCDH18;DAAM2;ANGPTL2;ACTA2;ADGRL4;COL6A2;DCN;COL1A1;DAB2;DDR2;CXCL12;ELN;MYL9;CYBRD1;GALNT15;PRKG1
prerank,Reactome_2022__Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,-0.38514569659026876,-0.8225663475153907,0.7575757575757576,1.0,1.0,3/21,13.12%,GPRIN1;MPP2;LLGL1
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.4373628375952186,0.8224870575359713,0.7297297297297297,1.0,1.0,4/19,10.44%,SIX4;MYL6;CSRP3;POPDC2
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,-0.3517647521546915,-0.8222704904832439,0.6842105263157895,1.0,1.0,6/51,7.29%,VANGL1;NIPSNAP2;WWP2;PREX1;GIT2;RAB7A
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.3965379971915821,0.8222645931370652,0.75,1.0,1.0,2/33,5.45%,GLRX;CAV3
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.47769935598611396,0.8222416109519157,0.6825396825396826,1.0,1.0,1/16,2.37%,DAO
prerank,KEGG_2021_Human__Hepatitis B,0.34313260811533614,0.8222144253130236,0.7662337662337663,1.0,1.0,14/134,13.25%,TLR2;PIK3R3;SLC10A1;TGFB1;STAT5A;MMP9;DDX3X;TGFB3;CCNE2;STAT1;ATP6AP1;CASP10;CDKN1A;CCNA2
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,0.3908396717640687,0.8220937326001484,0.7662337662337663,1.0,1.0,20/66,17.06%,ITGB2;CYTIP;ARHGAP9;TCF7;GMFG;SASH3;PTPRC;IKZF1;TAGAP;THEMIS;PSTPIP1;MYO1F;KLRB1;SIRPG;ITK;PARVG;CD44;CD244;ZAP70;TIGIT
prerank,CellMarker_Augmented_2021__Neuron:Embryo,-0.32326683123921507,-0.8220511092346734,0.8636363636363636,1.0,1.0,30/96,23.27%,CELF5;SEZ6L;ELAVL3;LHFPL4;SNCB;GABRA5;POU6F1;FRRS1L;TTYH1;MMD2;ADGRA1;SV2A;CELF4;TCEAL6;OTUD7A;GALNT9;FXYD7;AMER3;JPH4;PSD;PTPN5;CDH22;TMEM130;PAK5;KIF5C;APBA2;TMEM179;B3GAT1;ST8SIA3;ZFR2
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.45750341161969005,-0.8217772535946135,0.7272727272727273,1.0,1.0,1/9,14.10%,PIH1D1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.4137757759807034,0.8216599468996848,0.7439024390243902,1.0,1.0,4/36,13.48%,DDX20;STRAP;GEMIN4;SNRPD2
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.38678155972557104,-0.821608822757419,0.7777777777777778,1.0,1.0,2/22,5.98%,PHLDB2;F11R
prerank,CellMarker_Augmented_2021__Basal cell:Airway Epithelium,0.3591282120646265,0.8214899853599795,0.7951807228915663,1.0,1.0,16/80,16.98%,S100A13;RRAS;GNG12;TSPAN4;BOK;CCND1;FBLIM1;TMEM54;SERINC2;SPR;CD63;IGFBP6;EHD2;BCAR1;FAM114A1;PPIC
prerank,KEGG_2021_Human__Terpenoid backbone biosynthesis,-0.3903573169866914,-0.821450638419382,0.7142857142857143,1.0,1.0,3/20,12.50%,FNTA;MVK;DHDDS
prerank,Reactome_2022__IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,0.4916504148524656,0.8214018110334342,0.7887323943661971,1.0,1.0,4/14,12.12%,CLCF1;CRLF1;OSMR;LIFR
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.53473885892771,0.8213568435107617,0.7384615384615385,1.0,1.0,4/7,34.15%,CDCA5;SPI1;VCPIP1;WAPL
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.40896186004684315,0.821347312304725,0.7272727272727273,1.0,1.0,3/28,11.07%,NODAL;TRIM68;DAB2
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.4161665334573,0.8212964430763239,0.726027397260274,1.0,1.0,1/29,0.46%,ESR1
prerank,Reactome_2022__MET Activates PI3K/AKT Signaling R-HSA-8851907,0.5067557346557803,0.821188067126173,0.7096774193548387,1.0,1.0,3/6,39.47%,RNMT;GRB2;PIK3R1
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.4535198536831365,0.8211489228917189,0.7115384615384616,1.0,1.0,2/14,13.44%,CTCFL;FAM47E
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.5025564098069143,0.8210876831659925,0.7941176470588235,1.0,1.0,2/11,8.49%,IFIT1;ZDHHC11
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,-0.31918895750034215,-0.8210305878991833,0.6875,1.0,1.0,20/83,20.62%,DSG2;VANGL1;PREX1;GIT2;RAB7A;AMIGO2;SRGAP2;RAPGEF1;JAG1;EMD;ARHGAP42;ESYT1;NOXA1;ARHGAP35;ARHGAP6;WASF2;NCOA3;ARHGDIB;SLITRK3;VRK2
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),-0.5222521112858023,-0.8209573045194497,0.6666666666666666,1.0,1.0,4/5,35.43%,IMMP1L;PMPCA;MIPEP;IMMP2L
prerank,Reactome_2022__Organic Anion Transporters R-HSA-428643,0.4697096174308763,0.8208902007317013,0.7833333333333333,1.0,1.0,3/9,19.95%,SLC17A8;SLC25A18;SLC25A22
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,0.3395357083555224,0.8206325073220151,0.8378378378378378,1.0,1.0,17/112,20.47%,PSMB9;CLEC4C;MUC17;SYK;MUC4;MUCL1;RPS27A;NFKB2;PSMC5;MUC16;UBE2M;NFKBIA;PSMA3;PSMB6;RPS6KA5;NFATC2;PSMD6
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,0.42209394697972397,0.8206113272577861,0.7213114754098361,1.0,1.0,2/19,11.35%,CD80;PPP2R5A
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.40929329066407444,0.8205967609920062,0.8,1.0,1.0,4/35,14.62%,CCL5;TGFB1;TGFB3;CYBA
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.4217452047271748,-0.820433638970543,0.6923076923076923,1.0,1.0,6/18,17.47%,SLC39A11;SLC30A5;SLC30A10;TRPM2;SLC39A8;SLC30A8
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,-0.3478387145100123,-0.8204274877308878,0.5652173913043478,1.0,1.0,7/46,17.24%,TXNL4A;PDCD7;SNRPB;POLR2F;ZMAT5;POLR2C;RNPC3
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.39821153032111345,-0.8203347967018221,0.7352941176470589,1.0,1.0,3/21,9.72%,ANAPC2;CDC26;CDK1
prerank,CellMarker_Augmented_2021__Basophil:Peripheral Blood,0.5340450110873103,0.8203150762300172,0.7910447761194029,1.0,1.0,3/5,15.41%,ITGAM;CD63;IL3RA
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,0.36667480259936497,0.8202959298402581,0.8266666666666667,1.0,1.0,9/48,21.76%,ATP6V1G2;DEPDC5;RRAGA;ATP6V0E2;WDR24;ATP6V0B;LAMTOR3;SESN1;ATP6V1D
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3370900560374132,0.8202091393425249,0.8765432098765432,1.0,1.0,16/198,14.52%,ESR1;AIM2;TLR2;TRIM62;CARD14;NFAM1;WNT5A;TRIM25;NODAL;NLRC4;TRIM68;RPS27A;NFKB2;AGT;BEX1;DDR2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.4005233392952511,0.8201980426940323,0.7205882352941176,1.0,1.0,1/30,1.49%,PKP2
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.3778294986122104,-0.8200700437636899,0.8571428571428571,1.0,1.0,6/35,11.43%,DCPS;NDOR1;AQP1;AKR1C3;ADCY3;ADCY2
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.3911877631177967,-0.8199008470483912,0.7948717948717948,1.0,1.0,1/20,2.44%,CFLAR
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.48172233629807537,0.8198365710478843,0.7758620689655172,1.0,1.0,1/9,10.19%,RAB11A
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.36314796942985483,-0.8198302580942207,0.6551724137931034,1.0,1.0,8/25,27.93%,POLR2F;POLR2C;CCNT1;CTDP1;RSF1;GTF2F2;GTF2F1;NELFCD
prerank,CellMarker_Augmented_2021__Endothelial Stem cell:Blood Vessel,0.4659699753920529,0.8196567620759264,0.7627118644067796,1.0,1.0,4/17,9.21%,TNFRSF1B;PTPRC;ITGA5;CSF3R
prerank,GO_Biological_Process_2021__epithelial tube branching involved in lung morphogenesis (GO:0060441),0.5500258785481099,0.8196361212278599,0.7454545454545455,1.0,1.0,1/5,10.91%,CELSR1
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.34671312492301437,-0.8194903719522504,0.7894736842105263,1.0,1.0,7/27,16.48%,ACER2;IFI16;MYBBP1A;PPP1R13B;FHIT;USP10;NBN
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.5028205314326191,-0.8194754952592643,0.6363636363636364,1.0,1.0,3/5,37.62%,SETMAR;PLSCR1;UHRF1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.5028205314326191,-0.8194754952592643,0.6363636363636364,1.0,1.0,3/5,37.62%,SETMAR;PLSCR1;UHRF1
prerank,Reactome_2022__Interleukin-6 Signaling R-HSA-1059683,0.4820806918530789,0.8193951735368472,0.6666666666666666,1.0,1.0,1/9,11.19%,STAT1
prerank,CellMarker_Augmented_2021__Interneuron:Embryonic Prefrontal Cortex,0.4051602238003163,0.8191868670275376,0.782608695652174,1.0,1.0,7/26,18.98%,GAD1;ERBB4;FDFT1;MAF;PHLDA1;LHX6;PPP1R17
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,-0.3498091617223468,-0.8191705552467481,0.65,1.0,1.0,17/85,15.38%,DGKD;CRLS1;PLA2G2C;PLD2;GPD1;ADPRM;PLA2G5;PLA2G4C;CHKA;PGS1;PEMT;PLPP2;LPCAT2;AGPAT2;AGPAT5;PLD3;CDS1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.4779524982427604,0.8191482104753246,0.7586206896551724,1.0,1.0,2/11,9.64%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.5171113030441985,-0.8191227840510821,0.6410256410256411,1.0,1.0,2/5,11.09%,WWC1;WWC2
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.36116955822057406,0.8189216912662727,0.9,1.0,1.0,21/120,20.04%,WNT8B;VSX1;MANF;WNT5A;WNT8A;LHX4;DDIT4;EMX1;ACSL3;PPT1;FZD8;WNT6;ITM2C;OLIG2;CDK5R1;WNT5B;IER2;LHX6;PBX3;MAP2K1;SMARCA1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),0.5189153554487088,0.8187540720702452,0.746031746031746,1.0,1.0,1/6,11.63%,TNFSF4
prerank,CellMarker_Augmented_2021__Mast cell:Kidney,0.361950230467754,0.8186803117306152,0.7906976744186046,1.0,1.0,5/82,4.21%,RAB34;BACE2;TIMP3;SLC18A2;CPM
prerank,Reactome_2022__FGFR3 Mutant Receptor Activation R-HSA-2033514,0.531472492205927,0.81849417013328,0.7037037037037037,1.0,1.0,1/9,2.58%,FGF20
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,-0.37369066054299604,-0.8184700508156354,0.6571428571428571,1.0,1.0,4/39,7.56%,RNF168;POLM;BRCC3;RAD50
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryoid Body,0.3592726393051403,0.8184595225729984,0.7804878048780488,1.0,1.0,13/73,11.38%,FBXL7;LYVE1;TMEM100;NID1;CYYR1;FLT1;PCDH18;ANGPTL2;RAMP3;ADGRL4;VWF;DAB2;CLDN5
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.4594006283932674,0.8183661061694034,0.7068965517241379,1.0,1.0,4/17,7.66%,PIK3R3;CCL5;TGFB1;IGF1
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3607491709299467,0.8182198333848281,0.8157894736842105,1.0,1.0,7/62,9.00%,BLK;FCGR3A;ACTG1;WAS;SYK;HCK;NCKIPSD
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.5945361245338098,0.8181803655927202,0.7454545454545455,1.0,1.0,1/5,1.83%,TLR2
prerank,KEGG_2021_Human__Longevity regulating pathway,0.3521360147887266,0.8179895235388372,0.7012987012987013,1.0,1.0,18/91,24.77%,HSPA1L;HSPA8;PIK3R3;IGF1;SOD2;ATG101;ADCY7;HSPA2;ULK1;CREB3;SESN1;KRAS;ATF2;EIF4E1B;PRKAB2;CRYAB;PIK3CB;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.3752772599277557,-0.817619898888319,0.7586206896551724,1.0,1.0,9/39,9.67%,NLGN3;GRID2;WNT7A;DLG5;SYNDIG1;CX3CR1;EPHB2;SLITRK2;NLGN2
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),0.43154146471741495,0.817590368288943,0.6986301369863014,1.0,1.0,3/24,11.26%,KIF14;STMN4;KIF18A
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.37302610915397966,0.8174735252065685,0.7088607594936709,1.0,1.0,8/59,16.06%,HEY2;CDKN2A;LEF1;CCND1;CDKN1A;CSF1R;SOX9;HNF1A
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Breast,0.5840509752703128,0.8174392905564991,0.8153846153846154,1.0,1.0,2/6,14.71%,MME;CD44
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.4005521636547041,0.8173642963237521,0.7605633802816901,1.0,1.0,8/36,18.85%,HSPA8;METTL18;PINK1;AGT;MSN;GFAP;HCFC1;BAG5
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.5133914907410707,0.8169328217183432,0.746031746031746,1.0,1.0,2/6,13.19%,ANGPTL4;ANGPTL3
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.5006146225224891,0.8165803503953636,0.6825396825396826,1.0,1.0,1/9,7.79%,REST
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.3754309335135858,-0.816449326986749,0.6363636363636364,1.0,1.0,1/28,0.77%,SMYD5
prerank,Reactome_2022__Common Pathway Of Fibrin Clot Formation R-HSA-140875,0.46490700684343955,0.816395282298587,0.7758620689655172,1.0,1.0,4/12,15.58%,SERPIND1;F8;FAM110A;PROCR
prerank,KEGG_2021_Human__Colorectal cancer,0.37387518441272416,0.8162416256969701,0.8493150684931506,1.0,1.0,10/81,15.19%,TCF7;PIK3R3;TGFB1;LEF1;CCND1;TGFB3;CDKN1A;TCF7L1;BBC3;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.41615301566133756,0.8162276581950344,0.7837837837837838,1.0,1.0,4/19,14.43%,CDKN2A;INCA1;CDKN1B;LATS2
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.3900244017960132,-0.8160837212076564,0.7333333333333333,1.0,1.0,6/27,14.07%,TWIST1;VASH1;SLC30A10;RBL1;TERT;CDK6
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.5514657267318372,0.8160379348121476,0.75,1.0,1.0,2/6,17.96%,RMI2;MSH6
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.35637531280833634,-0.8159408459928303,0.7241379310344828,1.0,1.0,3/28,6.60%,MFSD2A;APOE;STAT5B
prerank,Reactome_2022__Activation Of G Protein Gated Potassium Channels R-HSA-1296041,0.4216310152261472,0.8158091209141822,0.8026315789473685,1.0,1.0,7/24,20.56%,KCNJ15;GNG12;GNG4;KCNJ2;KCNJ4;GNGT1;GNB4
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreas,0.36461990587457094,0.8155283663550418,0.7875,1.0,1.0,22/87,28.17%,RFK;AGGF1;CMTR2;ANKRD18EP;FBXL3;BMI1;TMEM263;UHMK1;LYSMD3;TM9SF3;CSDE1;ATF2;CD164;RNF6;FAM91A1;SUZ12;PPP4R3B;ZBTB33;FAM199X;LMBRD2;THAP12;ZFAND1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.3114241970749367,-0.8153782231172084,0.8076923076923077,1.0,1.0,18/83,19.69%,PRKCD;RND3;F11R;FSCN1;RHOBTB2;CORO1A;TRPM2;TAOK2;CRK;CORO2B;RHOA;PAK3;ABL1;CCDC88A;ARHGAP35;RHOBTB1;MLST8;ARHGDIB
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.37446654680663743,-0.8151899417201984,0.6538461538461539,1.0,1.0,5/19,19.15%,JAG2;JAG1;NEURL1;DLL1;NCSTN
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.45409306256641585,0.8151795679069412,0.7777777777777778,1.0,1.0,2/15,9.71%,TGFB1;TGFB3
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Brain,-0.3067467839402542,-0.8149907192928045,0.88,1.0,1.0,13/98,11.03%,CELF5;SLC17A6;ELAVL3;TNR;SRRM4;SNCB;HPCA;SHISA7;NEUROD6;MMD2;GRIA4;VWC2L;ADGRA1
prerank,CellMarker_Augmented_2021__Hair Follicle cell:Hair Follicle,0.36734507560329055,0.814944599060339,0.8125,1.0,1.0,19/75,13.33%,APOL1;C3AR1;SP100;TAPBPL;CMAHP;APOL6;MYH11;ERAP2;FLI1;FGL2;ELK3;STAT5A;GGT5;IRF1;HPGDS;VWF;FOSL2;OAS2;CSF1R
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),0.5483361655156025,0.8148326290923197,0.7037037037037037,1.0,1.0,1/5,21.31%,GPS2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.30880286406264285,-0.8147753542880372,0.8888888888888888,1.0,1.0,10/64,12.71%,EYA4;BCL2;CFLAR;SH3RF1;ACVR1;SERPINE1;SNAI2;GPX1;TERT;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.5372312507615612,0.8147289156708367,0.7894736842105263,1.0,1.0,1/6,3.86%,VSIR
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.2712785135231542,-0.8146151697698393,1.0,1.0,1.0,58/362,17.63%,GRK5;LMTK3;TRIB2;DGKD;PRKCD;ERG;CSK;LIMK1;PRAG1;STK10;BCKDK;MAML1;MAST2;PNKP;ERBB2;TTBK1;ACVR1;PAK6;NTRK1;EPHB2;BCR;ERN1;MYLK3;WNK2;CDK1;TRIB1;COPS8;GK5;MAP3K12;MAPKAPK2;TAOK2;CILK1;WNK3;CDK6;MARK2;SIK3;CSNK1G2;EIF2AK3;CDK14;XYLB;CSNK1E;MARK4;MAP3K13;TGFB2;NEK10;FRK;MATK;GRK4;PI4KA;CDK5;CDK11B;PRKCA;PAK3;FYN;SIK2;ABL1;MARK3;CDK4
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.40442406073358195,-0.8145780344274959,0.71875,1.0,1.0,2/20,1.80%,NR4A1;CDH5
prerank,CellMarker_Augmented_2021__Pit cell:Stomach,0.4851234988857679,0.8142171986723088,0.8,1.0,1.0,1/10,5.15%,SALL4
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.37770475973347944,0.8141743266761744,0.7567567567567568,1.0,1.0,10/50,16.69%,TLR2;PTPRC;WNT5A;SYK;C1QTNF4;OAS2;THBS1;CYBA;AGER;RASGRP1
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.46183231507214983,0.8141122174683271,0.75,1.0,1.0,3/13,24.93%,YOD1;BCAP31;DERL2
prerank,Reactome_2022__Nucleotide Biosynthesis R-HSA-8956320,0.49404256824995085,0.8141018057550748,0.7352941176470589,1.0,1.0,3/11,17.73%,ADSS1;PAICS;IMPDH2
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,0.3404807585282753,0.8139489979600297,0.8470588235294118,1.0,1.0,3/128,3.55%,HERC3;UBE2U;UBE2L6
prerank,CellMarker_Augmented_2021__Limbal Mesenchymal cell:Sclerocorneal Tissue,0.3583713864086442,0.8135571705981657,0.8048780487804879,1.0,1.0,13/86,11.07%,PRRX1;FBXL7;ARHGAP31;PTX3;NID1;PCDH18;ANGPTL2;ACTA2;HEG1;ADGRL4;COL6A2;DCN;DAB2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.46894208724985953,0.8133730195579422,0.6935483870967742,1.0,1.0,3/10,17.26%,PINK1;IL4;NOS2
prerank,CellMarker_Augmented_2021__Villous Stromal cell:Placenta,0.3592238204485754,0.8133049725115753,0.7714285714285715,1.0,1.0,10/78,11.00%,C1QTNF1;TIMP3;PRRX1;LMOD1;AOX1;ITGBL1;ANGPTL2;ADGRL4;DCN;COL1A1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.3592977789872036,0.8130632470788995,0.7671232876712328,1.0,1.0,9/47,17.77%,PTPRC;PELI3;TRAIP;OTUD4;F2RL1;USP18;ISG15;PARP14;PADI2
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,-0.3372723129520727,-0.8128862970519428,0.7931034482758621,1.0,1.0,5/37,8.69%,VANGL1;WWP2;DLG5;GIT2;SRGAP2
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.49392179006812337,0.8127938527281716,0.6666666666666666,1.0,1.0,1/8,15.08%,CD300LF
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.379369621493193,0.8126583648793928,0.8076923076923077,1.0,1.0,7/47,17.36%,HIPK1;PELI3;SYK;TRAIP;F2RL1;CYLD;SPATA2
prerank,Reactome_2022__Methionine Salvage Pathway R-HSA-1237112,-0.48084417883199243,-0.8126308947469723,0.6190476190476191,1.0,1.0,3/5,26.88%,APIP;GOLT1A;MRI1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.3202898231336873,0.8123180286432814,0.9347826086956522,1.0,1.0,21/317,9.46%,PCLAF;BLK;UBE2U;TNFRSF1B;POLE2;FANCF;DTL;SPDYA;POLQ;TICRR;CIDEB;BOK;RAD1;FAAP20;CCND1;SUV39H1;RAD54L;HIC1;WDR76;MOAP1;TRAIP
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.5328016570586853,0.8123005472600244,0.7741935483870968,1.0,1.0,1/6,2.52%,ACAA2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.43600781066114297,-0.8122496472457054,0.717948717948718,1.0,1.0,1/11,0.70%,TRIB2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.37003234335932456,0.812006087652665,0.759493670886076,1.0,1.0,17/76,24.48%,CHCHD4;NDUFB11;TMEM126A;NDUFS2;COX17;BCS1L;NDUFB10;NDUFA2;NDUFAF5;COX20;SDHAF1;NDUFB9;NDUFB4;UQCRFS1;NDUFA1;NDUFB2;TIMM21
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.5262094209853154,0.8119481550853281,0.7719298245614035,1.0,1.0,1/7,1.48%,S100A13
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.5262094209853154,0.8119481550853281,0.7719298245614035,1.0,1.0,1/7,1.48%,S100A13
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.5492571212264599,0.8119336298848787,0.7424242424242424,1.0,1.0,5/5,45.09%,NAA30;NAA20;NAA16;NAA15;NAA25
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.405305678146212,-0.8119275460209908,0.7741935483870968,1.0,1.0,2/17,8.14%,ANAPC2;CDC26
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,-0.3724310716935179,-0.8118359295448431,0.84,1.0,1.0,15/42,17.84%,ST3GAL3;POFUT1;POFUT2;GALNT13;ST6GAL2;B4GALT2;XXYLT1;GALNT17;COLGALT1;GALNT12;GALNT18;PLOD3;GALNT9;GALNT7;GALNT2
prerank,Reactome_2022__mRNA Capping R-HSA-72086,-0.3755882941473184,-0.8118191293465205,0.625,1.0,1.0,4/28,15.56%,GTF2H2;ERCC2;POLR2F;POLR2C
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.39677775017846983,0.8117643328888422,0.7230769230769231,1.0,1.0,9/25,29.89%,KCNJ2;SCN5A;YWHAH;SCN4B;SCN7A;SCN1B;SCN9A;SCN2B;ATP1A2
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),0.5449531737504735,0.8116867620017155,0.7536231884057971,1.0,1.0,1/5,9.55%,P2RY12
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.3297531138526128,-0.8116865095191256,0.9473684210526315,1.0,1.0,7/86,8.71%,MT1G;DRD4;CDH5;RGN;SLC8A3;SLC30A5;SLC30A10
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,0.3893008177188815,0.8116847453598915,0.7868852459016393,1.0,1.0,3/34,13.25%,CDKN2A;RPS27A;CCNA2
prerank,Reactome_2022__Neddylation R-HSA-8951664,0.33660252635160753,0.8115888793419171,0.8705882352941177,1.0,1.0,29/210,19.29%,PSMB9;FBXL7;ASB5;DTL;ASB14;SOCS2;SPSB2;ANKRD9;ASB15;ASB17;RPS27A;KLHL2;FBXL13;FBXL3;PSMC5;KBTBD7;COPS4;KLHL13;FBXO40;KBTBD6;GPS1;COPS5;UBE2M;ASB16;FEM1B;RBX1;PSMA3;NEURL2;PSMB6
prerank,Reactome_2022__Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,0.4280930238204213,0.8115728920151064,0.7285714285714285,1.0,1.0,12/22,32.28%,TUBA4A;TUBA3D;TUBB6;TUBA1C;CCT7;TUBB4B;CCT8;CCT3;CCT6A;CCT2;TUBA1A;TUBB
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,0.40736215674964343,0.8115350139759949,0.7230769230769231,1.0,1.0,5/20,20.56%,GNG12;GNG4;PLA2G4A;GNGT1;GNB4
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,-0.320130236291296,-0.8114048061702527,0.75,1.0,1.0,8/78,7.05%,BCL2;CD14;EDARADD;CFLAR;MAP3K14;BCL2A1;CCL4L2;TICAM2
prerank,Reactome_2022__Conjugation Of Benzoate With Glycine R-HSA-177135,-0.5090447945934564,-0.8113675508240875,0.6888888888888889,1.0,1.0,2/5,6.85%,GLYATL1;GLYATL2
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.3499610057719088,-0.8112835654157391,0.7777777777777778,1.0,1.0,4/28,9.33%,SLC38A5;SLC6A20;SLC3A2;SLC7A5
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.4422253070306842,0.8112535675251414,0.7222222222222222,1.0,1.0,5/16,32.28%,CHMP3;CHMP1A;CHMP4B;DRG1;CHMP2B
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.44722252180183986,-0.8111593197756226,0.65,1.0,1.0,2/10,17.38%,RAD50;ERCC1
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),0.4660038879453275,0.8111503741174775,0.7592592592592593,1.0,1.0,1/15,1.10%,MYH8
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3923533369363096,-0.8111435341818138,0.7333333333333333,1.0,1.0,2/20,3.05%,BCL2;BCL2A1
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.48689138452456615,-0.8110379952291948,0.76,1.0,1.0,2/16,5.54%,TWIST1;THAP7
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.3750682571933786,-0.8108208394859058,0.65625,1.0,1.0,2/27,4.78%,PTCH1;APOE
prerank,KEGG_2021_Human__Mitophagy,0.3684790655856304,0.8106838069828689,0.7764705882352941,1.0,1.0,12/64,23.90%,RRAS;PINK1;RPS27A;PGAM5;TOMM7;GABARAPL2;FUNDC1;FIS1;ULK1;KRAS;GABARAPL1;CITED2
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,0.424220498674983,0.8106067297064943,0.7647058823529411,1.0,1.0,2/31,8.12%,H2BC4;H2AZ1
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,0.3607452444196927,0.8105473307370709,0.7816091954022989,1.0,1.0,8/72,13.76%,PWP2;SNORD3A;RPP38;EIF6;NOP10;RPP40;NOB1;REXO5
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.32209053441192104,-0.810418945514616,0.782608695652174,1.0,1.0,7/59,9.44%,EYA4;RNF168;BRCC3;RAD50;MECP2;ERCC8;WRAP53
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immune response to tumor cell (GO:0002842),0.5225513317838899,0.8103874340475633,0.7142857142857143,1.0,1.0,2/5,31.79%,HLA-DRB1;HSPD1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.507381144231422,0.810317931232466,0.7323943661971831,1.0,1.0,2/7,14.33%,ACTA2;EDNRB
prerank,CellMarker_Augmented_2021__Medullary Thymus Epithelial cell:Thymus,0.37300005304206546,0.8102684088034587,0.7341772151898734,1.0,1.0,12/62,13.63%,DENND1C;ACSL5;PTPRC;JCHAIN;HSH2D;LCP1;TJP3;TMC8;EPCAM;RAB19;KLRB1;SIRPG
prerank,CellMarker_Augmented_2021__Cortical Thymus Epithelial cell:Thymus,0.37300005304206546,0.8102684088034587,0.7341772151898734,1.0,1.0,12/62,13.63%,DENND1C;ACSL5;PTPRC;JCHAIN;HSH2D;LCP1;TJP3;TMC8;EPCAM;RAB19;KLRB1;SIRPG
prerank,Reactome_2022__SUMOylation Of Transcription Factors R-HSA-3232118,0.4642822330513934,0.8101236460736044,0.7536231884057971,1.0,1.0,2/15,8.74%,CDKN2A;HIC1
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.46448736710696786,-0.8099398150653445,0.7446808510638298,1.0,1.0,3/7,23.62%,APOE;ABL1;FAM107A
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.40995161524854523,-0.8098342346451025,0.7,1.0,1.0,7/19,17.79%,SEPTIN9;CEP135;CROCC;ENTR1;MARK4;CCDC88A;ARHGAP35
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,-0.3752668095853622,-0.8097832811556968,0.8181818181818182,1.0,1.0,6/33,16.15%,E2F6;RRM2;TFDP1;PCGF6;RING1;MGA
prerank,CellMarker_Augmented_2021__Proximal Tubular cell:Kidney,-0.34855446914206917,-0.8096961924660051,0.75,1.0,1.0,6/45,7.39%,P2RY10;AOAH;IL16;CD247;GBP4;SELL
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.4825298853391393,0.809643414867926,0.7121212121212122,1.0,1.0,2/11,13.99%,TGFB1;SOX9
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.3875233691757101,0.8096218937388028,0.782051282051282,1.0,1.0,7/38,11.67%,SP100;TGFB1;MMP9;IGF1;LEF1;PLAUR;HMGA2
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,0.38711292171712997,0.8095841761332857,0.8028169014084507,1.0,1.0,4/41,8.04%,RGSL1;GNAT3;GNG12;GNG4
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.527194900511478,-0.8095001348361706,0.6666666666666666,1.0,1.0,2/5,8.62%,SERPINE2;SERPINE1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Oral Cavity,0.3645405129126878,0.809343191700691,0.7948717948717948,1.0,1.0,18/65,23.07%,BACE2;CYP4F12;C3;ITGB6;TRIM29;LAMC2;CP;PDK4;CD44;TGFBI;NSUN7;SLC44A3;IL1R1;CBLC;ANXA2;B3GNT3;CLDN1;MYOF
prerank,KEGG_2021_Human__ErbB signaling pathway,-0.29611540137786346,-0.8092746246875271,0.8461538461538461,1.0,1.0,7/80,6.89%,SHC3;SHC4;EIF4EBP1;ERBB2;PAK6;STAT5B;TGFA
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.3258786896128546,0.8091321730878897,0.8588235294117647,1.0,1.0,44/251,14.71%,ITGB2;SMOC1;ITGAX;COL18A1;LOX;MMP19;ECM2;FGF2;NID1;TGFB1;ITGAM;SCUBE3;ITGA2;ITGB6;ADAMTS17;JAM2;MMP9;COL4A4;COL4A3;ITGA5;MMP21;LCP1;CYP1B1;COL4A6;COL21A1;COL4A5;MMP15;LAMC2;COL6A2;VWF;DCN;VTN;COL1A1;FBN2;MMP23B;THBS1;P4HA3;NOXO1;ITGA2B;PLG;MMP11;ELANE;DDR2;CD44
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,-0.3258680770751614,-0.809075438889927,0.7692307692307693,1.0,1.0,21/90,21.13%,NUP210;NUP42;POM121C;NUP214;ENSA;CDK1;AAAS;EMD;BLZF1;H2AJ;LMNB1;NUP37;PRKCA;NUP98;CTDNEP1;KMT5A;LPIN2;NEK9;VRK2;PPP2R1B;SEH1L
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.5189541395837532,0.808976962118841,0.7049180327868853,1.0,1.0,1/7,7.66%,IGF1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4377944364219677,-0.8089191386344214,0.6756756756756757,1.0,1.0,3/12,25.48%,PKIA;PRKAR2A;HTT
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.2831197446519731,-0.8086749750793073,1.0,1.0,1.0,30/151,20.10%,CAMK1G;SBK1;PRKCD;MAST2;TTBK1;MAP3K10;ERN1;ATR;CDK1;MAP3K12;MAPKAPK2;MARK2;CSNK1G2;EIF2AK3;CSNK1E;RPS6KA3;MAP3K13;CDK5;PRKCA;MARK3;MAPK12;SGK2;AKT2;MAST1;BRSK1;CLSPN;MORC3;SGK1;ATM;CSNK1G1
prerank,Reactome_2022__Regulation Of IFNG Signaling R-HSA-877312,0.47818300201433256,0.8086406945972695,0.6923076923076923,1.0,1.0,7/11,36.31%,STAT1;IFNGR1;PIAS1;PTPN6;IFNGR2;JAK2;PTPN11
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.49803149120011414,0.808634678202411,0.676923076923077,1.0,1.0,2/10,15.26%,EXOSC8;EXOSC4
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Lung,0.37047440306073526,0.808553725641354,0.8076923076923077,1.0,1.0,8/66,17.26%,ADA;ANXA1;POU2F3;ATP11C;TOMM20;AHCY;SLC16A1;NOS2
prerank,CellMarker_Augmented_2021__Brush Cell (Tuft cell):Lung,0.37047440306073526,0.808553725641354,0.8076923076923077,1.0,1.0,8/66,17.26%,ADA;ANXA1;POU2F3;ATP11C;TOMM20;AHCY;SLC16A1;NOS2
prerank,Reactome_2022__Synthesis Of Ketone Bodies R-HSA-77111,-0.4828328657740653,-0.8084859944716811,0.6382978723404256,1.0,1.0,3/7,19.02%,SOAT1;BDH1;HMGCL
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.48813778276833497,0.8084656665433873,0.8070175438596491,1.0,1.0,1/10,4.28%,CNMD
prerank,KEGG_2021_Human__Serotonergic synapse,0.35642003248072623,0.8084385046574545,0.8055555555555556,1.0,1.0,22/97,22.30%,ALOX12;SLC18A2;GNG12;HTR5A;SLC6A4;HTR3E;CYP2J2;GNG4;HTR3C;HTR1B;ALOX12B;ALOX15;ALOX15B;MAPK3;HTR2B;PLA2G4A;MAP2K1;GNGT1;GNB4;HTR3A;ALOX5;KRAS
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.37885114475335846,0.8083351750551139,0.7435897435897436,1.0,1.0,5/36,7.44%,BLNK;CLCF1;PTPRC;NFAM1;IFNK
prerank,Reactome_2022__Signal Attenuation R-HSA-74749,0.4817634972196867,0.8083292881595239,0.6716417910447762,1.0,1.0,1/9,15.19%,MAPK3
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.38946027278552076,0.8082278143932591,0.746268656716418,1.0,1.0,5/40,10.36%,ANXA1;STK26;CYP1B1;RHOB;ECT2
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.4098211962443479,0.8081343494214439,0.7702702702702703,1.0,1.0,8/22,29.42%,IFIT1;PLN;ATP5IF1;PARP9;TMBIM1;NES;PHPT1;CAND1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Blood,0.5391150439686407,0.8080178854339086,0.7627118644067796,1.0,1.0,2/5,4.70%,ITGAM;FCGR3A
prerank,CellMarker_Augmented_2021__Stem cell:Fetal Liver,0.34807327114965664,0.8079896105189082,0.8452380952380952,1.0,1.0,6/93,7.41%,TRIL;TSPAN11;FBXL7;TMEM35A;PCDH18;ANGPTL2
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.45674414433516636,-0.8078825133199407,0.7647058823529411,1.0,1.0,1/9,2.40%,TMEM106A
prerank,CellMarker_Augmented_2021__Neural cell:Embryoid Body,0.3560337640661152,0.8073766919453458,0.8488372093023255,1.0,1.0,13/92,18.37%,SHISA6;TMEM35A;LRRC3B;PLP1;PHF21B;TMEM200C;TCEAL5;CCDC177;FBN3;ZDHHC22;CAMKV;SYT4;EFNB3
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.30014775785015546,-0.8072970859704717,0.9230769230769231,1.0,1.0,18/115,16.33%,SYNJ2;EFR3B;DPM3;VAC14;TMEM150A;TTC7A;PI4KB;TTC7B;RAB5A;ITPKA;PITPNM1;MTMR8;MTMR14;PITPNM3;RUFY1;CDS1;PI4KA;MTMR1
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.41984675121354825,-0.8072587913307426,0.7,1.0,1.0,5/16,12.26%,MYO18A;STAT5B;LRRFIP1;CNTRL;CUX1
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,0.3794083791989871,0.807230317217982,0.7972972972972973,1.0,1.0,10/48,18.78%,CASP7;UACA;CDKN2A;GSDME;TP53BP2;BBC3;MAPK3;DYNLL1;APAF1;YWHAH
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,0.37884675215735564,0.8071231536412327,0.6764705882352942,1.0,1.0,11/46,26.42%,TNFRSF10A;GSDME;IRF1;RPS27A;ELANE;MLKL;TRADD;GNL3;FASN;CASP8;STUB1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.41967659977724286,0.8070716762495441,0.7627118644067796,1.0,1.0,4/23,14.31%,KANK3;SCIN;VIL1;TMSB10
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.3292772934366639,0.8070559024741013,0.85,1.0,1.0,22/146,14.41%,TNFRSF1B;GPHB5;GPR27;TSHR;NLRP12;FCGR3A;SCTR;GPER1;SYK;NR1H4;GGT5;ADRB1;IGF1;RAMP3;RXFP2;HCK;NLRC3;RPS19;CALCR;ELANE;ADCY7;IL4
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.38618348019396387,-0.8069921509702775,0.8,1.0,1.0,4/16,23.83%,ATG2A;ATG9B;WIPI1;ATG7
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.33641048901129833,-0.8068588079825965,0.8235294117647058,1.0,1.0,10/50,20.19%,RHBDF1;APOE;COMMD1;GPX1;NUPR1;DAB2IP;OSBPL7;FOXF2;KCNE2;GNA12
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.30190591069724854,-0.8067027863210604,0.8823529411764706,1.0,1.0,26/141,13.41%,ADAMTS12;AOAH;IL1RL2;METRNL;IL16;PRKCD;TYRO3;CDH5;BCL6;SELE;APOE;NLRP1;CCN4;ETS1;CCN3;MEFV;SERPINE1;NR1D1;SHARPIN;MVK;DAGLA;SMPDL3B;ABCC1;MAPK7;SBNO2;LPL
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),-0.4463700360246131,-0.8066107133060284,0.7435897435897436,1.0,1.0,1/12,1.08%,ZNF703
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),0.445198042093657,0.8065766237858724,0.7164179104477612,1.0,1.0,5/12,22.58%,F2RL1;CSF1R;CBLN1;DCTN1;CLDN1
prerank,Reactome_2022__Condensation Of Prophase Chromosomes R-HSA-2299718,0.42174819691647225,0.806478546697431,0.7142857142857143,1.0,1.0,6/24,24.77%,H2BC4;H2AZ1;H2AZ2;SET;CCNB1;H2AC6
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.37167030736236684,-0.8063900009944494,0.7333333333333333,1.0,1.0,4/18,8.18%,BCL6;CBFB;SOX12;FANCA
prerank,GO_Biological_Process_2021__glomerulus vasculature development (GO:0072012),0.46864366701093646,0.806334831852684,0.6909090909090909,1.0,1.0,1/6,3.34%,ANGPT2
prerank,KEGG_2021_Human__Intestinal immune network for IgA production,0.4111209140004371,0.8062973226006047,0.734375,1.0,1.0,9/26,18.99%,TGFB1;CD80;IL5;HLA-DMA;HLA-DPB1;IL4;CXCL12;HLA-DPA1;CCL25
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.4585372642280896,0.8061789359911121,0.75,1.0,1.0,1/11,6.84%,MMP9
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.44652090349718176,0.8061470149755549,0.8095238095238095,1.0,1.0,2/17,12.94%,PHKA1;PYGL
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.3753037653394357,-0.8061162570281641,0.7428571428571429,1.0,1.0,3/24,6.81%,SYT12;DOC2B;SDF4
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4177304682090281,-0.8055810928162508,0.7037037037037037,1.0,1.0,4/21,10.09%,ZNF703;TGFBR3;DLX1;ITGA3
prerank,KEGG_2021_Human__Chronic myeloid leukemia,0.3632358463779573,0.8055371941009296,0.8125,1.0,1.0,9/74,15.19%,PIK3R3;TGFB1;STAT5A;CDKN2A;CCND1;TGFB3;CDKN1B;CDKN1A;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),0.5262267374582607,0.8055354429047998,0.7777777777777778,1.0,1.0,1/5,8.49%,DDX3X
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),0.5262267374582607,0.8055354429047998,0.7777777777777778,1.0,1.0,1/5,8.49%,DDX3X
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,0.40094834157098125,0.8055330871374796,0.6973684210526315,1.0,1.0,2/30,5.56%,SDC2;ACTG1
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.480807801477358,0.8052511519127296,0.7619047619047619,1.0,1.0,3/11,15.74%,CRHBP;OPRM1;SLC38A2
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.47928102974074904,-0.805202849125602,0.8285714285714286,1.0,1.0,2/9,10.18%,FOXO1;ATP6V0A2
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.38397423230470984,-0.8050391860454419,0.8,1.0,1.0,5/31,9.17%,CALD1;FSCN3;CORO1B;FSCN1;RFLNB
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,0.4343397206515125,0.8047810059115291,0.7538461538461538,1.0,1.0,5/18,28.34%,RPS27A;USP18;IKBIP;CASP8;LRRC14
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.48724324064201685,-0.8045439470669492,0.6976744186046512,1.0,1.0,1/6,14.60%,FHIT
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.37522959335859285,-0.8044634859603158,0.76,1.0,1.0,9/34,19.47%,PLK3;PCM1;CAPN10;B3GAT3;PGAP1;EIPR1;CEP290;ICE1;STX18
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),-0.5046624171548544,-0.8044367082907727,0.6363636363636364,1.0,1.0,3/5,27.75%,FGFR2;ID2;NIPBL
prerank,CellMarker_Augmented_2021__Abnormal Plasma cell:Peripheral Blood,0.3557195030462739,0.8044236032988946,0.8023255813953488,1.0,1.0,14/95,17.26%,ENPP2;C1QB;TSPAN11;SHISA6;TMEM200C;LY6H;CP;AQP4;ZNF536;EDNRB;RBP1;MAF;A2M;GAS7
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.3518443694937149,0.8043247132366701,0.7901234567901234,1.0,1.0,12/82,10.00%,KIF14;TNFRSF1B;FGF20;CLCF1;SIX4;CRLF1;HLA-F;REST;SOD2;PINK1;TGFB3;PPT1
prerank,Reactome_2022__LRR FLII-interacting Protein 1 (LRRFIP1) Activates Type I IFN Production R-HSA-3134973,-0.49806289669501985,-0.8043220828056415,0.6176470588235294,1.0,1.0,1/5,7.33%,LRRFIP1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.40360915133226827,0.804270304122393,0.7674418604651163,1.0,1.0,7/38,17.10%,IGF1;HGF;ATP6AP1;FBN2;DDR2;ATRAID;FBXO5
prerank,Reactome_2022__Noncanonical Activation Of NOTCH3 R-HSA-9017802,-0.4938347437152931,-0.8042478018399725,0.8048780487804879,1.0,1.0,4/6,37.21%,NCSTN;YBX1;PSEN1;APH1B
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.30368064764262276,-0.8041827569459041,0.9523809523809523,1.0,1.0,14/75,19.25%,EFNB1;MMP2;EPHA6;ARPC3;EPHB2;GRIN1;SDCBP;CRK;RHOA;PAK3;FYN;ARPC2;NCSTN;HRAS
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,0.34470571424481455,0.8040657048596896,0.775,1.0,1.0,17/104,24.15%,HSPA8;RRAGA;PINK1;RPS27A;ATG101;TOMM20;PGAM5;TOMM7;DYNLL1;GABARAPL2;LAMTOR3;FUNDC1;ULK1;DYNLL2;GABARAPL1;PARK7;PRKAB2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.450972405951076,0.8040147654213059,0.7222222222222222,1.0,1.0,3/18,17.01%,SLC18A2;PINK1;BRCA1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.42685804852496806,0.8039517439362448,0.78125,1.0,1.0,10/19,25.38%,CAV3;KCNA5;NPPA;KCNE3;SCN5A;KCNE4;SCN4B;KCNQ1;SCN1B;NOS1AP
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.33598882241806377,-0.8035256952177896,0.76,1.0,1.0,9/58,14.05%,DNMT1;SAP130;POLR1A;GTF2H2;ERCC2;BAZ2A;H2AJ;POLR2F;TAF1B
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.5099713984959918,-0.8034663100114706,0.75,1.0,1.0,2/6,28.56%,DDAH1;ENO1
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.5165180496452489,0.803425848098587,0.803030303030303,1.0,1.0,1/6,10.11%,NOP10
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lymph Node,0.3877894027525352,0.803387208573379,0.7804878048780488,1.0,1.0,6/64,5.72%,RASGRP4;ARHGAP9;NFAM1;NLRP12;FCGR3A;SH2D1B
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.4119421281934161,0.8033569236747179,0.7887323943661971,1.0,1.0,3/28,14.67%,MAP3K11;DNAJA1;NPPA
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.31702539719311723,0.803226077498234,0.8764044943820225,1.0,1.0,21/151,15.15%,CIDEB;ALPK2;TNFRSF10A;STK26;TP53I3;NLRC4;KANK2;TP53BP2;PINK1;MOAP1;TGM2;STAT1;BCL2L14;CASP10;RTKN;AGT;NOP53;SOX9;PSMC5;NDRG1;RABGGTB
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,0.373919974045562,0.8030983699217673,0.8125,1.0,1.0,4/48,11.00%,H2BC4;HLA-A;RRAGA;RPS27A
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.38357889696430103,-0.8030075290187744,0.7272727272727273,1.0,1.0,8/23,18.93%,HES1;SLIT3;ACVR1;TGFBR3;SLIT2;TGFB2;ROBO2;PROX1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.4683948754480031,-0.8028784288745735,0.7027027027027027,1.0,1.0,2/9,14.26%,FHL2;CHP1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.4683948754480031,-0.8028784288745735,0.7027027027027027,1.0,1.0,2/9,14.26%,FHL2;CHP1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.4195653961595268,-0.8027497739503744,0.6764705882352942,1.0,1.0,4/12,29.32%,SSRP1;METTL4;TLK2;SETD1A
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.412779578595353,-0.8026393424209889,0.7741935483870968,1.0,1.0,5/11,26.15%,APOE;PORCN;WIPI1;ATG7;ATG10
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),-0.4904357641080139,-0.8025084005248491,0.6904761904761905,1.0,1.0,4/5,33.03%,HRAS;NFKB1;RC3H1;RC3H2
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.42889454464844046,0.8024162716510467,0.7096774193548387,1.0,1.0,2/21,3.81%,FGF2;PTPRC
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.5169803538419872,-0.8024072235662868,0.7435897435897436,1.0,1.0,2/5,26.10%,PPIB;TBC1D20
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 24-Hydroxycholesterol R-HSA-193775,0.45407035724349953,0.8024020820005756,0.7910447761194029,1.0,1.0,2/13,9.76%,HSD3B7;CYP39A1
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.3374725426545605,-0.8022540059886801,0.8,1.0,1.0,14/81,13.61%,KCNE1;KCNG1;CACNG4;SHANK1;CACNB1;CRH;HPCA;NLGN2;SHISA7;GRIA4;GRIN1;CACNG2;CNIH3;JPH3
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood,0.3557011265700054,0.8022247692707029,0.8571428571428571,1.0,1.0,10/80,5.54%,C3AR1;CYTIP;TNFRSF1B;ARHGAP31;GMFG;SASH3;CMAHP;PTPRC;FLI1;FGL2
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),0.5117559411577226,0.802056358516673,0.7301587301587301,1.0,1.0,1/7,7.86%,STRA8
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.4351562878291574,0.8019385842014287,0.7931034482758621,1.0,1.0,2/17,3.45%,PLA2G10;C3
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,0.42379780149156515,0.801880829927785,0.7424242424242424,1.0,1.0,3/25,15.19%,FGF20;RPS27A;MAPK3
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.46423436477958646,-0.801669929891622,0.7435897435897436,1.0,1.0,2/6,17.80%,CDK1;NF1
prerank,KEGG_2021_Human__Notch signaling pathway,-0.33117699313571636,-0.8014278251133568,0.8636363636363636,1.0,1.0,15/49,24.06%,DTX1;MAML1;HES1;JAG2;JAG1;TLE2;DLL1;ATXN1L;NCSTN;ATXN1;TLE3;CREBBP;NOTCH1;NCOR2;NUMB
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.32009021822462613,-0.8014024527491371,0.8076923076923077,1.0,1.0,3/52,5.71%,SEC24C;ELOVL6;CARM1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.41932980341301157,0.8013374804792559,0.7571428571428571,1.0,1.0,4/24,15.53%,WAS;ARHGAP28;RASA1;CXCL12
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.31545587870920383,-0.8013334687257269,0.8636363636363636,1.0,1.0,7/59,9.86%,DGKD;SHC3;ERBB2;TGFA;SLC30A10;EFEMP1;PTPRR
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.5429912641906844,0.8012796218370474,0.8225806451612904,1.0,1.0,2/6,16.81%,HEY2;SOX6
prerank,Reactome_2022__Ketone Body Metabolism R-HSA-74182,-0.4671185602313294,-0.8011811521621783,0.7209302325581395,1.0,1.0,3/8,19.02%,SOAT1;BDH1;HMGCL
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Oral Mucosa,-0.33532178301851356,-0.8009601825151101,0.8421052631578947,1.0,1.0,8/77,2.96%,FIBIN;PAMR1;CDH5;ERG;COL6A3;TIE1;CLEC14A;MMP2
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.2826334843404655,-0.8009082633298574,0.9333333333333333,1.0,1.0,15/98,17.42%,PNKP;FAN1;POLD3;LIG3;COMMD1;ERCC8;GTF2H2;XPC;SLX4;COPS8;ERCC2;POLR2F;POLR2C;ERCC1;RFC3
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.32392558699091145,-0.8007878580169104,0.8095238095238095,1.0,1.0,13/44,25.11%,EXTL1;PDIA6;DDX11;CTDSP2;PREB;YIF1A;HDGF;CUL7;ADD1;WIPI1;SSR1;CXXC1;SRPRA
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),-0.4664504410293473,-0.8005812004840409,0.7619047619047619,1.0,1.0,2/11,4.78%,DDAH2;APOE
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.524386142157701,0.8004935765360557,0.8548387096774194,1.0,1.0,5/8,37.43%,TXNIP;VPS4A;ZFYVE19;BLM;RFPL1
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,-0.30696873539947317,-0.8004486716433173,1.0,1.0,1.0,10/82,11.89%,NGF;PRKCD;ITPR2;HRH1;NTRK1;PLA2G4C;GNAS;ADCY3;ADCY2;HTR2C
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.4053117598857079,0.8004220753511687,0.7714285714285715,1.0,1.0,6/26,21.53%,CP;TMC8;CYBRD1;TF;FTL;B2M
prerank,CellMarker_Augmented_2021__Dendritic cell:Liver,0.5495091607524896,0.8004119780616805,0.7936507936507936,1.0,1.0,2/5,6.90%,ITGAX;CD80
prerank,KEGG_2021_Human__Adherens junction,0.361845015940222,0.800236607832115,0.7916666666666666,1.0,1.0,8/68,15.19%,TCF7;ACTG1;WAS;LEF1;CTNNA3;TCF7L1;SNAI1;MAPK3
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.5078272865089857,0.8001904703977226,0.746031746031746,1.0,1.0,1/7,7.44%,IFNK
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",0.3660402581340739,0.7998936980624639,0.775,1.0,1.0,26/95,24.43%,COX6A1;TMEM186;ATP5PF;NDUFB11;NDUFS2;UCP1;ATP5F1E;ETFB;CCNI;NDUFB10;NDUFA2;NDUFAF5;ATP5MC3;COX20;COX4I1;COX7B;NDUFB9;COX6C;COX6B1;NDUFB4;UQCRFS1;NDUFA1;NDUFB2;COX5A;COX7C;ATP5ME
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),-0.5080211039016143,-0.7998899653742803,0.7272727272727273,1.0,1.0,1/5,0.81%,SKAP1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.35543595190235683,0.7998596347947717,0.7777777777777778,1.0,1.0,4/54,7.66%,GATA4;FGF2;WNT5A;IGF1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.40457245991880403,0.7997815820306425,0.6956521739130435,1.0,1.0,4/40,13.50%,LRP4;STAT1;AGT;MME
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,0.352019444539944,0.7996848038436088,0.7777777777777778,1.0,1.0,12/60,22.64%,UBE2L6;TRIM25;RPS27A;CASP10;NFKB2;CYLD;ISG15;AGER;NFKBIA;IFIH1;NKIRAS1;TKFC
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Saturated Fatty Acids R-HSA-77286,-0.43369414303837794,-0.7996789661422725,0.7142857142857143,1.0,1.0,3/11,8.91%,MECR;ACADS;ECHS1
prerank,Reactome_2022__MASTL Facilitates Mitotic Progression R-HSA-2465910,-0.4527279237587688,-0.7996400177268985,0.6923076923076923,1.0,1.0,2/9,9.72%,ENSA;CDK1
prerank,CellMarker_Augmented_2021__Cardiovascular Progenitor cell:Heart,0.3666314354201675,0.7995980580599953,0.7901234567901234,1.0,1.0,8/73,9.19%,GATA4;NID1;PREX2;CACHD1;FLT1;HEY2;FLT4;SLC27A6
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3903187333590575,0.7995246403053683,0.8918918918918919,1.0,1.0,8/48,18.78%,HSPA1L;ARIH2;TP53BP2;PINK1;RHOU;BBC3;TOMM7;YWHAH
prerank,Reactome_2022__Regulation Of BACH1 Activity R-HSA-9708530,0.4979556804188763,0.7995149823869825,0.8,1.0,1.0,2/11,18.57%,RPS27A;RBX1
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.35875231337727986,-0.7995092185672953,0.7777777777777778,1.0,1.0,6/22,21.06%,PNP;AK8;CTPS2;FHIT;AK7;NUDT5
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.3457385528830747,0.7995068257321873,0.8395061728395061,1.0,1.0,23/121,14.52%,TIMP3;PRRX1;TYR;LOX;AHR;GNG12;MLANA;UACA;ANGPTL2;FLG;CCND1;OSMR;SYNC;COL1A1;AHNAK2;HMCN1;GLI3;PLAT;RAB38;BMI1;SOX9;FILIP1L;DDR2
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.5052771788839555,0.7993114760985386,0.7272727272727273,1.0,1.0,2/6,27.94%,LARP6;CDK9
prerank,CellMarker_Augmented_2021__Plasmablast:Blood,0.36094372016833504,0.7992655038281182,0.7894736842105263,1.0,1.0,23/60,20.42%,CYTIP;ARHGAP9;GMFG;CCL5;SASH3;PTPRC;NLRC3;IKZF1;TAGAP;THEMIS;PSTPIP1;KLRB1;SIRPG;ITK;PARVG;PIK3CG;CD244;TIGIT;ARHGAP15;GPR18;TNFSF8;CD5;IL2RA
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.36160014101974614,0.7991338374863525,0.8051948051948052,1.0,1.0,13/69,21.80%,PTPRC;NMUR2;CXCR5;ACKR4;P2RY12;XCR1;EDNRB;HTR2B;ACKR2;ATP2A2;FIS1;BCAP31;MCTP2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.5118060165791505,0.7990634226031832,0.75,1.0,1.0,1/6,3.51%,FGF2
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.4613504240228765,-0.7990391656513729,0.7027027027027027,1.0,1.0,1/9,1.95%,GALE
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.41986399176265643,0.7989376250017063,0.8055555555555556,1.0,1.0,5/20,20.89%,TIMM22;MOAP1;HSPA4;TIMM10;ROMO1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.4364355975723144,0.7986967039859436,0.7796610169491526,1.0,1.0,2/12,19.09%,SYK;DOCK2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.4571599283211523,0.7986352612641184,0.8153846153846154,1.0,1.0,1/13,3.51%,FGF2
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.3474105281118671,0.7986244634169323,0.825,1.0,1.0,12/89,11.00%,TIMP3;PRRX1;LMOD1;FBXL7;ADAM33;PCDH18;DAAM2;ANGPTL2;ACTA2;ADGRL4;DCN;COL1A1
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.44986821108627983,-0.7986129799890729,0.6111111111111112,1.0,1.0,2/6,22.12%,MECP2;HSPA1A
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.4906010530675794,0.7985650746257702,0.7580645161290323,1.0,1.0,1/11,2.07%,LRRC19
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,0.3528992678979094,0.7983419422498903,0.7831325301204819,1.0,1.0,18/96,23.09%,CENPU;H2BC4;POLD4;H2AZ1;OIP5;PIF1;RPA3;NOP10;CCNA2;CENPX;ITGB3BP;CENPN;CENPL;H2AZ2;CENPS-CORT;RBBP7;CENPM;LRIG1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.5123291264298192,0.7983392862799261,0.7777777777777778,1.0,1.0,3/7,7.66%,IL12A;CDKN2A;IGF1
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.33304462723653216,-0.79816952888169,0.8148148148148148,1.0,1.0,9/62,12.89%,TSKU;APOB;APOE;CEL;MVK;CYP46A1;G6PD;SOAT1;OSBPL5
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.3938377445927318,-0.7981148754515419,0.5925925925925926,1.0,1.0,4/18,15.36%,BCL2;SNAI2;MYBBP1A;MCL1
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.46513516625988105,-0.7981022314667935,0.7317073170731707,1.0,1.0,1/10,4.74%,NIPSNAP2
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.3956768302009118,0.7980723755666143,0.8,1.0,1.0,3/26,14.32%,GNG12;GNG4;ADCY7
prerank,Reactome_2022__Crosslinking Of Collagen Fibrils R-HSA-2243919,0.48186451610073494,0.7978901045861228,0.6885245901639344,1.0,1.0,1/10,2.72%,LOX
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.3904521237995422,0.7977238977053972,0.7575757575757576,1.0,1.0,6/34,15.68%,TIMP3;KNG1;PLAT;ACP4;TM4SF20;CLN8
prerank,KEGG_2021_Human__Pantothenate and CoA biosynthesis,-0.40772661421752054,-0.7977074671509601,0.6538461538461539,1.0,1.0,4/18,17.36%,UPB1;PPCDC;PANK1;PPCS
prerank,Reactome_2022__Signaling By PDGFRA Extracellular Domain Mutants R-HSA-9673770,0.44415968399763917,0.7976223506466271,0.7540983606557377,1.0,1.0,2/10,24.63%,STAT1;PIK3CB
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),-0.4541103900044751,-0.7976088011510992,0.7391304347826086,1.0,1.0,2/6,14.87%,CDK5RAP2;USP44
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),-0.4541103900044751,-0.7976088011510992,0.7391304347826086,1.0,1.0,2/6,14.87%,CDK5RAP2;USP44
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.36121003159335885,0.7974884869562406,0.8860759493670886,1.0,1.0,6/71,10.50%,ST6GALNAC1;GALNTL5;FUT2;B3GNT9;IGF1;B3GNT5
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.35550342659380796,-0.7974851185921257,0.7560975609756098,1.0,1.0,3/24,9.72%,TENT4A;SMC2;CDK1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.297109173560265,-0.7974538622948673,0.9629629629629629,1.0,1.0,19/108,13.74%,KCNIP3;TYRO3;TBC1D16;SHC3;SDC3;KIAA1549L;PTPRF;CAP2;NCS1;NLGN2;SRRM3;GNA11;CAMK2N1;ALCAM;ANTXR1;DAB2IP;NAV2;AMOTL2;CHST3
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.342805717554795,0.7974261487713992,0.8352941176470589,1.0,1.0,11/137,8.30%,TBX1;TMEM100;ANXA1;CCL5;LRP2;FLT1;TGFB1;WNT5A;FLT4;HGF;DUSP22
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide metabolic process (GO:0010310),0.5033811259558783,0.7973597868905502,0.7115384615384616,1.0,1.0,1/5,13.60%,NOXO1
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.3165291501040162,-0.7972171537421157,0.7619047619047619,1.0,1.0,11/95,9.36%,GCK;XKR7;HGFAC;CACNG4;CRABP1;ABCC8;TTBK1;SARDH;PRR36;HID1;WNK2
prerank,CellMarker_Augmented_2021__Beta cell:Pancreatic Islet,0.34848660525777625,0.797181393650326,0.8,1.0,1.0,9/86,8.22%,CAPN13;SFTPA1;CYYR1;CASR;GCC1;SOCS2;FAM222A;PFKFB2;ENPP4
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.3705416589025592,0.7971513263292703,0.7662337662337663,1.0,1.0,11/59,13.20%,KIF14;FGF20;CLCF1;SIX4;CRLF1;SOD2;PINK1;TGFB3;PPT1;FOXB1;RASA1
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.5161494538443995,-0.7971466995678727,0.8048780487804879,1.0,1.0,2/6,11.11%,PDCD7;AKR1C3
prerank,Reactome_2022__FGFR3b Ligand Binding And Activation R-HSA-190371,0.5406252516988359,0.7971014567295215,0.7222222222222222,1.0,1.0,1/6,2.58%,FGF20
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,0.4157674805938957,0.7970636296874284,0.7377049180327869,1.0,1.0,2/20,6.90%,PIK3R3;CD80
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.3631568345210882,-0.7970069874238048,0.8,1.0,1.0,2/23,3.29%,MT1G;IFI16
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.4946413589323886,0.7969406102581845,0.7878787878787878,1.0,1.0,5/9,28.09%,CD4;TMPRSS4;CD74;HLA-DRB1;LGALS9
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.4946413589323886,0.7969406102581845,0.7878787878787878,1.0,1.0,5/9,28.09%,CD4;TMPRSS4;CD74;HLA-DRB1;LGALS9
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.4920794648214597,0.7967029650117887,0.7540983606557377,1.0,1.0,1/8,1.48%,S100A13
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.45901296449155776,-0.7966834579739802,0.775,1.0,1.0,3/8,11.37%,SCUBE1;FSTL1;JAG1
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.3509992795520896,-0.7965578137616907,0.6285714285714286,1.0,1.0,5/35,8.39%,CDH13;KIT;LPXN;FSTL1;PRSS3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.34543547858539914,0.7965423754237012,0.8292682926829268,1.0,1.0,11/98,13.47%,HSPA8;TGFB1;SYK;HSPA5;DDX3X;FBLIM1;HCK;PINK1;TMC8;NOP53;TFIP11
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.42784146260068234,-0.7962497560994583,0.6666666666666666,1.0,1.0,6/12,19.83%,FSCN1;PATJ;SCRIB;RHOA;CAMSAP3;RAP2A
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,0.3413265553669593,0.7962423834220599,0.8045977011494253,1.0,1.0,9/102,16.49%,ACTL6A;POLE2;POLD4;RPA3;RPS27A;TFPT;COPS4;GPS1;COPS5
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.3326310505002639,-0.7961701813963371,0.8518518518518519,1.0,1.0,7/45,8.69%,TYRO3;ITGA4;PARVA;LAMB4;LPXN;NTN4;SRGAP2
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.4613833362579197,0.7961293475189343,0.7424242424242424,1.0,1.0,2/14,12.06%,TRPV6;SLC24A1
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.4613833362579197,0.7961293475189343,0.7424242424242424,1.0,1.0,2/14,12.06%,TRPV6;SLC24A1
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.4760521215112266,-0.7960933946369646,0.6744186046511628,1.0,1.0,3/6,18.26%,TTBK1;SELP;SOX15
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,0.4534944620765485,0.7960599561225833,0.7796610169491526,1.0,1.0,1/15,11.00%,RPS27A
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.30369644988830297,-0.7960128488818494,0.8,1.0,1.0,18/78,14.03%,ADRA1A;SRL;CMYA5;MYL3;DNAJC5G;CTAGE3P;SPTB;GREB1;NT5C1A;MYLK3;HFM1;PTGR2;RGMA;ADCY2;DTNA;GARNL3;ESRRB;XPNPEP3
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.3829119052102117,0.7958710453414141,0.7714285714285715,1.0,1.0,3/44,4.29%,PLA2G10;TGFB1;METTL18
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.3114557927158065,0.7958051179494096,0.9032258064516129,1.0,1.0,38/290,17.03%,RHOXF2;C1QTNF1;TLR2;ITGAX;PIK3R3;FGF20;FGF2;CTCFL;VSIR;TGFB1;HEY2;WNT5A;ACTG1;GPER1;IGF1;LEF1;RAMP3;ACTA2;DDX3X;CLDN5;WNT6;HMGA2;ALOX12B;SFRP4;CD63;CALCR;SOX9;IL4;MAPK3;VSTM2A;SLC38A2;ZNF580;RPL11;CSF1;MSN;AGR2;BRCA1;RPS7
prerank,Reactome_2022__Mismatch Repair R-HSA-5358508,-0.38885201755780713,-0.7955880133717625,0.7666666666666667,1.0,1.0,3/15,6.63%,EXO1;POLR1A;POLD3
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.37078636456042885,-0.7955849027559838,0.8888888888888888,1.0,1.0,7/42,7.41%,XYLT1;GPC6;GPC2;SDC3;GPC4;HS6ST2;AGRN
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,0.4299377731400595,0.7955098485742418,0.7464788732394366,1.0,1.0,3/21,3.85%,CLDN2;CLDN6;CLDN18
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.32694928503791476,-0.7954906106311374,0.6666666666666666,1.0,1.0,12/60,17.80%,SKAP1;ACER2;CDH13;PTPRA;LDB1;JAG1;SLK;CDK6;RHOA;EMP2;CAMSAP3;NF1
prerank,Reactome_2022__Attachment Of GPI Anchor To uPAR R-HSA-162791,0.5373073779788511,0.7953135878066786,0.8103448275862069,1.0,1.0,1/6,9.05%,PLAUR
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),-0.49040770920377896,-0.7952874555840125,0.65625,1.0,1.0,2/8,14.65%,SPAST;LETM1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.3465569984973787,-0.7951667248786876,0.875,1.0,1.0,3/25,9.70%,PRKCD;FLNA;HDAC3
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.4059784200713741,0.7950874736005715,0.7121212121212122,1.0,1.0,5/24,18.64%,OGFOD1;FKBP5;FKBP4;PPIC;PPID
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR2 R-HSA-5654696,0.41948600100916517,0.7947525822426106,0.7241379310344828,1.0,1.0,1/25,2.58%,FGF20
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.46289266326290024,0.7945511628885036,0.7230769230769231,1.0,1.0,3/11,12.64%,NR1H4;UCP1;PDK4
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",0.4492137405500132,0.7945471154995504,0.7638888888888888,1.0,1.0,3/16,15.26%,EXOSC8;EXOSC2;EXOSC4
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.43091485948748837,0.7945158485192504,0.7571428571428571,1.0,1.0,1/22,2.45%,HSPA8
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.4125245973822927,0.7944906835307237,0.7313432835820896,1.0,1.0,6/23,24.15%,EIF6;PDK4;BRCA1;CEACAM1;ACADL;PRKAB2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3797329637209766,-0.7942910489339265,0.65625,1.0,1.0,4/23,12.71%,CREB3L1;ATF3;HSF1;MAPK7
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.39886437241335565,0.7942908623341502,0.7714285714285715,1.0,1.0,6/30,21.73%,PLD4;NLRC3;ADCY7;NOS2;APOD;ALOX5
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.3354831878882052,0.7942704008333934,0.8488372093023255,1.0,1.0,20/152,13.06%,PANX3;SLC22A3;SLC5A4;SLC5A2;LRP2;KCNJ15;SLC18A2;SLC12A3;KCNA5;KCNS2;ATP1A4;KCNG2;KCNK7;ASIC1;PIEZO2;SLC5A9;CHRNB1;TAF7;SLC5A1;SLC47A1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),-0.47274763205192355,-0.7942501139372036,0.6744186046511628,1.0,1.0,2/6,14.10%,MACROH2A2;PIH1D1
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,0.31560577423866476,0.7942277027366431,0.9111111111111111,1.0,1.0,78/470,16.21%,C1QTNF1;C3AR1;WNT8B;LPAR1;GPR55;ARHGEF40;RGSL1;NPFFR1;GNRHR;GPHB5;PIK3R3;ANXA1;CCL5;GNAT3;C3;GPR27;GNG12;SSTR1;PTAFR;TSHR;TRPC7;CASR;ADGRE1;SCTR;WNT5A;GPER1;PTGER3;NMUR2;HTR5A;UTS2;CXCR5;ACKR4;P2RY6;ITGA5;ADRB1;WNT8A;RAMP3;GNG4;PPP1R1B;PDYN;RXFP2;KNG1;NPY1R;NPY;P2RY12;RHOB;FZD8;GNRH1;ECT2;RGS21;LPAR6;GRM6;WNT6;RASGRF2;F2RL1;GPR183;GNAT2;PNOC;XCR1;HTR1B;PENK;CRHBP;GPSM2;FPR1;CALCR;OPRM1;GPR68;ADCY7;EDNRB;ADGRE3;MAPK3;PIK3R6;CXCL12;PIK3CG;GPR17;PTRH2;RGS10;GHRL
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.43587526511237706,0.794216805234904,0.7857142857142857,1.0,1.0,2/23,10.57%,ADA;DCK
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.3484150172473274,-0.7940585245173986,0.8,1.0,1.0,3/23,7.41%,RHEBL1;EIF4EBP1;SYAP1
prerank,GO_Biological_Process_2021__glutathione catabolic process (GO:0006751),0.5034762371287981,0.7940561427311784,0.6825396825396826,1.0,1.0,3/5,24.36%,GGT5;CHAC2;DPEP1
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),-0.3762829896489562,-0.7940408150755546,0.7435897435897436,1.0,1.0,4/17,15.04%,DPM3;RXYLT1;FKTN;TMTC4
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.420909030892346,0.7939421670019373,0.7846153846153846,1.0,1.0,6/17,29.89%,KCNJ2;SCN5A;SCN4B;SCN1B;SCN2B;ATP1A2
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.4223535549493361,0.7938664782461112,0.8059701492537313,1.0,1.0,7/19,29.98%,RPL11;RPS7;FBXO5;RPL23;BAG2;RAB1A;RPL5
prerank,KEGG_2021_Human__Salmonella infection,0.3148189693859968,0.7938258566621396,0.9032258064516129,1.0,1.0,48/220,25.70%,TLR2;RRAS;TCF7;PTPRC;CASP7;TNFRSF10A;ACTG1;NLRC4;LEF1;FHOD1;RHOB;AHNAK2;VPS18;MYL12A;TCF7L1;RHOG;TUBA4A;TUBA3D;TUBB6;MAPK3;MYL9;PIK3CG;DYNLL1;TUBA1C;ACTR1B;NFKBIA;MAP2K1;ANXA2;MLKL;TRADD;TUBB4B;DCTN3;DCTN1;DYNLL2;DYNLT1;RAB9A;RPS3;IRAK1;PIK3CB;ABI1;MAP2K4;PIK3C2G;FYCO1;HSP90AB1;KLC2;CASP8;ACTR10;CTNNB1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.4124637616780312,-0.7936015599017022,0.7647058823529411,1.0,1.0,1/13,3.33%,NOP9
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,0.4034610134660892,0.7935169231973773,0.7777777777777778,1.0,1.0,2/20,8.04%,GNG12;GNG4
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.4265298229755933,-0.7933741730713852,0.7317073170731707,1.0,1.0,3/14,6.31%,IL11;UBASH3B;ACVR1
prerank,KEGG_2021_Human__Axon guidance,-0.28594751285849096,-0.7933322852022392,0.8823529411764706,1.0,1.0,27/172,17.20%,EFNB1;BOC;LIMK1;PTCH1;TRPC3;SLIT3;EPHA6;PAK6;PARD3;EPHB2;NFATC3;NTN4;SRGAP2;TRPC6;RGMA;ABLIM3;GDF7;SLIT2;PLXNA4;PARD6B;CDK5;RHOA;PRKCA;NFATC4;PAK3;FYN;ABL1
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.2864962074032787,-0.7930348022874056,0.9090909090909091,1.0,1.0,21/106,15.29%,ARC;CLYBL;IKZF4;UPB1;MPP2;PKD2;TRMT61B;GLRA3;APIP;CBY1;EHD4;SPAST;EHD3;ALDH1A2;TRPM2;CARD9;THG1L;SAMHD1;LETM1;USP16;TRPV1
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.46731235196914145,0.7930251094623775,0.765625,1.0,1.0,4/11,20.54%,ACMSD;IDO1;HAAO;IDO2
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.46042357822394725,0.7929728769848127,0.7704918032786885,1.0,1.0,2/13,13.21%,FGF2;THBS1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.3060107980836088,0.7928956926390056,0.96875,1.0,1.0,89/602,17.55%,SMAD6;CLEC5A;CAPN13;KIF14;ANXA1;LRP2;SIX4;CIDEB;MAP3K11;CARD14;ALPK2;TNFRSF10A;BOK;DDX20;WNT5A;GPER1;SCIN;STK26;ANGPTL4;MMP9;SOCS2;TP53I3;FLT4;NR1H4;NLRC4;CCND2;IGF1;LEF1;REST;AXL;HSPA5;HGF;DDX3X;CYP1B1;HCK;TP53BP2;KNG1;PLAUR;PINK1;MOAP1;NAA38;RHOB;MYDGF;DNAJA1;TGFB3;PRAME;PPT1;ECT2;TGM2;RPS27A;RPS3A;DAB2;STAT1;BCL2L14;RASGRF2;CASP10;HMGA2;RTKN;ING3;TFPT;IL7;SFRP4;AGT;RASA1;THBS1;PXT1;NOP53;PNMA1;SOX9;IL4;LATS2;NDRG1;CD44;MTCH1;RABGGTB;THOC6;IFI6;STK17A;CFL1;GHRL;HTR2B;COPS5;BCAR1;PHLDA1;VAV3;ITGB3BP;PNMA2;DKKL1;TAF9B
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.30379274016218555,-0.7928414301619778,0.875,1.0,1.0,17/112,13.19%,NTSR2;SPHKAP;SLC17A6;SPTBN4;ABCC8;ELAVL3;IGSF21;KCNIP1;SNCB;DLX1;HPCA;NEUROD6;MMD2;ADGRA1;CBLN4;BRINP1;LRRTM3
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.3605717506921717,0.7924486462261886,0.8333333333333334,1.0,1.0,11/45,23.10%,SYCP1;TK1;SOD2;AQP4;KCNJ2;ALDH9A1;GNMT;RYR3;B2M;MCOLN1;ALDH1A3
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,0.4006910797477641,0.7922595182850403,0.7894736842105263,1.0,1.0,4/38,11.00%,POLE2;POLD4;RPA3;RPS27A
prerank,CellMarker_Augmented_2021__Stem cell:Molar,0.34733880126818306,0.7922104897787644,0.8513513513513513,1.0,1.0,20/86,16.68%,TIMP3;PRRX1;LOX;AOX1;ITGBL1;PCDH18;ANGPTL2;AXL;ADGRL4;COL6A2;DCN;COL1A1;DAB2;THBS1;IGFBP6;DDR2;MYL9;EHD2;ENG;FAM114A1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.3472005185169882,0.792125703495806,0.7974683544303798,1.0,1.0,23/125,16.58%,RASGRP4;BLK;BLNK;ROS1;FLT1;SYK;ERBB4;FLT4;NPR2;ANGPTL1;AXL;CLNK;HCK;CD4;LIFR;CSF1R;DDR2;NPPA;GUCY2F;EPHA1;CSF1;ZAP70;BCAR1
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),-0.5095125315020635,-0.7920899411769997,0.7073170731707317,1.0,1.0,2/6,8.58%,DHFR;FPGS
prerank,CellMarker_Augmented_2021__Goblet cell:Large Intestine,-0.34143363953964767,-0.791927164916082,0.7894736842105263,1.0,1.0,7/32,15.46%,MLPH;ANO7;SPDEF;SLC37A1;SYTL2;TSPAN1;OSBPL7
prerank,CellMarker_Augmented_2021__Progenitor cell:Undefined,0.34083583150100405,0.7917237693707326,0.8552631578947368,1.0,1.0,22/92,23.15%,CEP55;TK1;MANF;PRDX4;HSPA5;EIF6;STEAP1;MYDGF;SPR;SLC39A7;AHCY;PROCR;RCC1;IMPDH2;TUBA1C;CCT7;PPP1R14B;GANAB;SURF4;XRCC6;OSTC;GNL3
prerank,Reactome_2022__Formation Of Cornified Envelope R-HSA-6809371,0.378888433059472,0.7916722703834042,0.7424242424242424,1.0,1.0,3/27,8.55%,PKP2;FLG;SPINK6
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,0.42157699446755,0.7914515080608331,0.8260869565217391,1.0,1.0,6/17,24.22%,SLC28A3;VAV3;IMPDH2;NUDT15;SLC28A2;VAV1
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition (GO:0060231),-0.4772370037968895,-0.7913467283535977,0.6904761904761905,1.0,1.0,1/6,6.76%,FZD7
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.4383511634415677,0.7913191469303585,0.7692307692307693,1.0,1.0,6/20,24.32%,DDX3X;OGFOD1;G3BP1;CSDE1;RPS23;DDX6
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.445058440331243,-0.7912513533498606,0.625,1.0,1.0,4/11,21.81%,SMARCB1;PIH1D1;HDAC5;KMT2A
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.39212763629121067,0.7912172685788393,0.8405797101449275,1.0,1.0,1/31,1.49%,PKP2
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.4294893979194011,0.7910811803470279,0.8181818181818182,1.0,1.0,3/20,7.24%,RORC;FMO5;NR1H4
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.3468939028195577,-0.7910445949458971,0.84375,1.0,1.0,3/24,9.70%,PRKCD;FLNA;HDAC3
prerank,Reactome_2022__Post-translational Protein Modification R-HSA-597592,0.29895628044995826,0.7910211399389584,0.9797979797979798,1.0,1.0,159/1190,19.66%,CDC25A;ESR1;RAB34;TEX101;ACTL6A;NOTUM;ARSH;APOL1;PSMB9;ST6GALNAC1;GALNTL5;RENBP;ITIH2;SDC2;FBXL7;ASB5;HSPA8;SP100;DTL;MAT2B;FAM20A;C3;CBX8;CPM;TGFB1;GPIHBP1;ASB14;TPGS1;ADAMTS17;SERPIND1;TRIM25;MUC17;GCNT7;B4GALNT2;B3GNT9;H2BC4;MUC4;CDKN2A;SOCS2;NR1H4;MPDU1;LY6H;F8;PROZ;GALNT5;C1GALT1C1;SPSB2;NANS;HIC1;ANKRD9;HLA-A;KNG1;PLAUR;RRAGA;F7;ASB15;JOSD2;MUCL1;ASB17;RAB11A;CP;B3GNT5;AGBL5;RAB6B;RPS27A;MOGAT1;TTLL2;USP13;KLHL2;ENGASE;UHRF2;FAM110A;ETFBKMT;ASGR2;B4GAT1;ING3;RAB19;EEF2KMT;FBXL13;TFPT;PENK;NFKB2;ARSF;ETFB;THBS1;PIGH;B3GLCT;CCNA2;EEF1A1;CHST4;SLC35C1;USP18;TTLL4;TOMM20;SERPINA10;FBXL3;RAB38;PSMC5;TRAPPC2;LY6D;KBTBD7;TGOLN2;GGCX;YOD1;H2BC18;COPS4;KLHL13;TUBA3D;ART3;RABGGTB;TUBB6;CYLD;TDG;MOGAT2;FBXO40;KBTBD6;PTRH2;GPS1;RAB39A;EEF2;TAF10;CSF1;COPS5;VASH2;NR5A2;MUC16;THSD1;ASGR1;FKBP8;BRCA1;DYNLL1;UBE2M;ASB16;TAF9B;TF;SYVN1;TUBA1C;HCFC1;TRAPPC5;SEL1L;FEM1B;RBX1;PIGC;THBS2;POMGNT1;NFKBIA;KDELR3;PSMA3;USP17L2;ART4;NEURL2;PSMB6;RAB33A;PTP4A2;RAB29;RAB21;CTSZ;RAET1G;PGM3
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.4765540458285296,0.790977256591311,0.7727272727272727,1.0,1.0,1/9,6.37%,C12ORF57
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.3363363120013494,-0.7909399733573171,0.8148148148148148,1.0,1.0,5/46,10.78%,NGF;SH3RF1;IGBP1;AQP1;GPX1
prerank,Reactome_2022__PTK6 Promotes HIF1A Stabilization R-HSA-8857538,0.51811891412251,0.79093892087978,0.7941176470588235,1.0,1.0,2/5,36.72%,HIF1A;EGFR
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),0.5109666054532718,0.7908696693336897,0.7333333333333333,1.0,1.0,4/6,27.13%,MOGAT2;PLA2G4A;DGAT2L6;DGAT2
prerank,Reactome_2022__Synthesis Of 15-Eicosatetraenoic Acid Derivatives R-HSA-2142770,0.5087287086673251,0.7907071956232979,0.7868852459016393,1.0,1.0,5/6,28.73%,ALOX15;ALOX15B;GPX2;PTGS2;GPX4
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.4850205837613569,-0.7906745432127511,0.75,1.0,1.0,1/9,1.23%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.4850205837613569,-0.7906745432127511,0.75,1.0,1.0,1/9,1.23%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.4850205837613569,-0.7906745432127511,0.75,1.0,1.0,1/9,1.23%,H1-4
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.4000197370188569,-0.790673877913879,0.7037037037037037,1.0,1.0,2/16,4.21%,MLYCD;NR4A3
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.3132067877749309,0.790646026173278,0.8888888888888888,1.0,1.0,42/359,18.31%,GATA4;ESR1;CRX;ZNF284;VSX1;ZNF676;TCF7;MYT1;AHR;NFIL3;SNAI3;ATF7;ZNF98;ZNF723;IFNK;TAF5;REST;NFIA;HIC1;BRDT;USP13;HMGA2;BTG1;PRDM8;NFKB2;TCF7L1;NAB1;SAP30L;ZNF536;TRAPPC2;HMGA1;TAF6L;ENG;NR5A2;SOX6;MYB;ZNF114;SPIN2A;PLAG1;ZFP37;HINT1;HCFC1
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.44731393152754295,-0.7906452409553337,0.7027027027027027,1.0,1.0,2/7,13.90%,ERCC2;USH2A
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.40543916907791067,0.7906043939717616,0.76,1.0,1.0,8/30,19.67%,USP50;USP13;OTUD4;YOD1;CYLD;SPATA2;USP17L2;OTUD1
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.3131077835094088,0.7903264124497752,0.9333333333333333,1.0,1.0,46/304,16.49%,SMAD6;CLEC5A;CAPN13;KIF14;ANXA1;LRP2;SIX4;CARD14;WNT5A;ANGPTL4;MMP9;SOCS2;FLT4;NR1H4;CCND2;IGF1;LEF1;AXL;HSPA5;HGF;DDX3X;KANK2;HCK;PLAUR;NAA38;MYDGF;DNAJA1;PRAME;PPT1;RPS27A;RPS3A;DAB2;HMGA2;IL7;RASA1;THBS1;SOX9;PSMC5;IL4;CD44;THOC6;IFI6;CFL1;GHRL;HTR2B;COPS5
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.34969031113709337,-0.7901229762928913,0.9259259259259259,1.0,1.0,7/33,10.47%,BCL6;PNP;HLA-DRA;SOX12;ADAM8;ZMIZ1;NKAP
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.36109757195791437,-0.7899992441596134,0.7666666666666667,1.0,1.0,10/24,19.91%,EXO1;MSH4;POLD3;XPC;PMS1;MSH3;ABL1;ERCC1;MCM9;MLH3
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.4719496575987049,0.789676104100893,0.6666666666666666,1.0,1.0,2/8,14.41%,PINK1;IL4
prerank,KEGG_2021_Human__beta-Alanine metabolism,-0.3527011166013504,-0.7892600940241266,0.7666666666666667,1.0,1.0,6/28,8.91%,UPB1;MLYCD;AOC3;ACOX3;ACADS;ECHS1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.39949995191282434,-0.7890973963309699,0.6666666666666666,1.0,1.0,11/27,27.00%,KMT2B;MEN1;DYDC1;DPY30;SETMAR;TET3;KMT2A;ZNF335;CXXC1;SETD4;TET2
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,0.3543946641699728,0.7890463710084482,0.8428571428571429,1.0,1.0,15/77,25.56%,PSMB9;RPS27A;CD4;PSMC5;NFKBIA;HLA-DPA1;PSMA3;PSMB6;PSMD6;HLA-DRB1;PRKCQ;INPP5D;PIK3CB;PSMA7;PSMB1
prerank,Reactome_2022__Signaling By Leptin R-HSA-2586552,0.5020988956871484,0.7889496698430942,0.7735849056603774,1.0,1.0,1/8,6.23%,STAT5A
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.36213927803605406,-0.7888847052421155,0.6764705882352942,1.0,1.0,2/19,13.71%,JADE2;KANSL2
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,0.39239929457376843,0.7885784167863437,0.8135593220338984,1.0,1.0,3/27,11.19%,FGF20;STAT5A;STAT1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.3765591048895824,-0.7885159073740046,0.7567567567567568,1.0,1.0,5/21,30.85%,TRIM54;CAMSAP3;ATXN7;KATNB1;APC2
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.44759571035091394,0.7884214732479619,0.7746478873239436,1.0,1.0,3/16,8.34%,ROS1;TMEM79;ACTA2
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.3353765572117987,0.7883575635456682,0.8604651162790697,1.0,1.0,22/150,19.61%,GAD1;SYT2;STMN4;SHISA6;HTR5A;LRRC3B;PLP1;LY6H;GNG4;TCEAL5;CALB1;PDE5A;PENK;VSTM2A;CNTN2;LRRTM1;TSHZ1;ZDHHC22;PRKG1;SYT4;DLG4;SLC1A6
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.4056025506898188,-0.7882693456497034,0.8,1.0,1.0,5/15,17.49%,CIRBP;CELF4;THRAP3;NUP98;RBMX
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.4167894648738034,0.7881745130477305,0.7746478873239436,1.0,1.0,1/17,4.07%,MAP3K11
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.33288996189653586,-0.7880460901389045,0.918918918918919,1.0,1.0,3/26,13.04%,LSM10;SNRPB;EXOSC10
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.43888301122855844,0.7879418249643448,0.7619047619047619,1.0,1.0,2/12,12.97%,USP50;AFF2
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.3127609529957266,-0.7878926734181709,0.8666666666666667,1.0,1.0,22/125,17.22%,PRKCD;TWIST1;DHRSX;FOXO1;LIN28B;KHSRP;APOE;PLIN5;ADAM8;TRIM8;MEFV;PFKFB3;PACSIN3;SNX33;NPRL2;TRIM14;IRGM;VGLL4;MTDH;SNX9;SH3D19;SH3BP4
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.3362928810332466,0.7878335986949809,0.8125,1.0,1.0,15/115,11.00%,C1QTNF1;TIMP3;PRRX1;LMOD1;FBXL7;ADAM33;PCDH18;NR1H4;ANGPTL2;HGF;ACTA2;ADGRL4;COL6A2;DCN;COL1A1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.5082670486489237,0.7877076964145846,0.7575757575757576,1.0,1.0,1/8,3.69%,CTCFL
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Peripheral Blood,0.37427726132830097,0.7875419849305454,0.8125,1.0,1.0,5/42,11.98%,GLRX;ELK3;TLDC2;FAM110A;CD4
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.40883313287690115,-0.7874275903746768,0.6764705882352942,1.0,1.0,4/18,8.58%,MTHFR;MTHFD1L;DHFR;FPGS
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.4093897464006294,0.787289209983837,0.75,1.0,1.0,8/24,25.66%,LEF1;CD4;CSF1;DCSTAMP;CD74;HLA-DRB1;RUNX1;CASP8
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.27845458161739883,-0.7872144862222412,0.8823529411764706,1.0,1.0,34/198,18.82%,DTX1;TEFM;MLF1;IWS1;PPP5C;CBFB;NFX1;TTF2;TBPL2;TAF12;GTF2H2;TFDP1;HSF1;GTF2E2;RTF1;ERCC2;BAZ2A;SSRP1;SLC25A33;ARRB2;POLR3K;NAT14;POLR2F;TAF1B;POLR3A;LEO1;POLR2C;ELOA;TRIP13;MED16;RBMX;SMN1;TAF11;CCNT1
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,0.3485991275925839,0.7871692799477804,0.8493150684931506,1.0,1.0,26/95,29.59%,HSPA8;ITGA2;ITGA5;ITGA2B;MAPK3;CNTN2;MSN;SCN5A;MAP2K1;RPS6KA5;SPTBN5;L1CAM;SCN4B;ITGA10;SCN7A;SCN1B;NRP2;RPS6KA1;SCN9A;RANBP9;LAMA1;ITGA9;CSNK2A2;DCX;ITGAV;SCN2B
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.34407818033384613,0.7869112473641863,0.8108108108108109,1.0,1.0,13/68,24.06%,ATP6V1G2;DEPDC5;RRAGA;ATP6V0E2;CDKN1A;WDR24;MAPK3;ATP6V0B;LAMTOR3;SESN1;ATP6V1D;ATF2;ATP6V0D1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.434054246015107,0.7869111713515616,0.803030303030303,1.0,1.0,1/18,2.57%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.5101076710273837,0.7869064673741818,0.8064516129032258,1.0,1.0,1/6,21.92%,CBLN1
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.40484975960600134,-0.7866496033283141,0.8043478260869565,1.0,1.0,1/8,7.49%,IGBP1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.3342736651029084,0.7865774087987641,0.8953488372093024,1.0,1.0,33/151,25.28%,ESR1;FGF2;TGFB1;HEY2;ABCC2;GPER1;IGF1;REST;PINK1;LRPAP1;CLDN5;PTRH2;ENG;PARP14;NOS2;MSR1;ITGB8;RIN3;DLG4;MAP2K1;NOTCH2;PARP15;PARP9;YAP1;PARP10;MYCN;PARK7;RUNX1;CITED2;RBL2;SPI1;SFMBT2;HSP90AB1
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.35462903512881183,-0.7864604659255426,0.8076923076923077,1.0,1.0,3/29,1.89%,SLC38A5;SLC25A29;SLC6A20
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.35461910485103754,-0.786437868468244,0.7777777777777778,1.0,1.0,2/28,3.98%,GRID2;MDGA1
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,-0.3448948669881313,-0.7863721936462962,0.72,1.0,1.0,4/47,6.56%,H1-4;PRKCD;DSG2;FNTA
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.3160184203032109,-0.786280020534106,0.8666666666666667,1.0,1.0,8/53,12.03%,CD14;MAP3K14;NKIRAS2;TBKBP1;TICAM2;RIPK2;SHARPIN;DAB2IP
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3461843854530078,0.7862472361144022,0.8513513513513513,1.0,1.0,8/61,13.20%,TNFRSF1B;METTL18;IGF2BP2;AHNAK2;BRDT;OAS2;AFF2;RASA1
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.3854344368450855,-0.7862223944510655,0.75,1.0,1.0,4/15,17.27%,POP1;DTD1;THG1L;ADAT1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.40423577147174866,0.7860733537957372,0.7804878048780488,1.0,1.0,6/34,15.27%,TGFB1;WNT5A;TGFB3;FBN2;ATRAID;ISG15
prerank,Reactome_2022__PI-3K cascade:FGFR2 R-HSA-5654695,0.4442782790690915,0.786073206635017,0.7777777777777778,1.0,1.0,1/19,2.58%,FGF20
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.3055257386581659,0.7860698982376049,0.978494623655914,1.0,1.0,89/604,15.18%,TBX1;SMAD6;GML;S100A13;CDCA7L;KIF14;ACE2;ITGAX;FGF20;COL18A1;CLCF1;SPDYA;SIX4;FGF2;SSTR1;TSHR;FLT1;ST18;TGFB1;CRLF1;BOK;DUX4;GPER1;SMIM22;SCIN;IER5;CD81;STAT5A;ERBB4;CDKN2A;FLT4;FOXM1;COL4A3;CCND2;IFNK;IGF1;LEF1;REST;TBX6;GSDME;DUSP22;IRF1;RNF187;CYP1B1;KANK2;HCK;OSMR;SOD2;MYO16;RPS9;TGFB3;LAMC2;PRAME;GNRH1;TFAP2E;RERG;INCA1;STAT1;CLDN5;TNFSF4;NPR3;ADGRG1;LIFR;EPCAM;COX17;CDKN1B;BTG1;RPS4X;IL7;CDKN1A;TTK;SFRP4;AGT;WDR6;THBS1;CSF1R;SIRPG;RHOG;OPRM1;PLG;IGFBP6;SOX9;CDKN2C;IL4;ALOX15B;GDF9;FTH1;HMGA1;EPHA1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.47638036890034685,-0.7860576983479238,0.7894736842105263,1.0,1.0,1/8,5.41%,UBE2D4
prerank,"Reactome_2022__SUMO Is Transferred From E1 To E2 (UBE2I, UBC9) R-HSA-3065678",-0.4882521087277253,-0.7859139404038974,0.7631578947368421,1.0,1.0,2/5,29.83%,SUMO2;SUMO1
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.3407631187161514,0.7858337189709824,0.8450704225352113,1.0,1.0,25/102,21.01%,CCDC60;FAM81B;CFAP126;MAP3K19;VWA3B;ANGPTL2;MYO16;AKAP14;BPIFB1;ZMYND10;AQP4;DRC3;USP18;MORN5;DNAI1;MYB;HSPA2;GFAP;CFAP77;EFNB3;DNAH12;SNTN;ARMC3;CATIP;MEIG1
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),-0.498930001343898,-0.7856674733006309,0.7333333333333333,1.0,1.0,1/6,1.53%,BCL2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.42465737994217817,0.7856599062328814,0.7457627118644068,1.0,1.0,6/18,30.05%,PINK1;DCN;FIS1;MIEF1;AURKA;BNIP3
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.4586233272603857,0.7856589349931662,0.7922077922077922,1.0,1.0,1/10,6.84%,MMP9
prerank,CellMarker_Augmented_2021__Activated T cell:Undefined,0.46016023608596945,0.785622275496674,0.8070175438596491,1.0,1.0,3/8,22.63%,CD4;IL2RA;CD27
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),0.5084230178387195,0.7855779494091838,0.7619047619047619,1.0,1.0,3/5,28.62%,ZNF473;LSM11;CPSF2
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,0.37887123291214575,0.7855483394875057,0.7903225806451613,1.0,1.0,3/33,11.19%,FGF20;STAT5A;STAT1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.4250860863663782,0.7850896550724465,0.7536231884057971,1.0,1.0,6/17,24.54%,WNT5A;LIFR;IFIH1;PARP9;RUNX1;IRAK1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.35165354792816633,0.7850152274194169,0.821917808219178,1.0,1.0,6/67,9.71%,LPAR1;ACTG1;WAS;ARHGAP28;FHOD1;TGFB3
prerank,Reactome_2022__TCR Signaling R-HSA-202403,0.3400423403081156,0.7849960428353512,0.7857142857142857,1.0,1.0,14/98,19.29%,PSMB9;PTPRC;WAS;VASP;RPS27A;CD4;ITK;PSMC5;FYB1;ZAP70;NFKBIA;HLA-DPA1;PSMA3;PSMB6
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.3978144443232029,-0.7849170250403239,0.6666666666666666,1.0,1.0,3/22,9.40%,ADAMTS12;SNAI2;EFEMP1
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.4344629367586369,-0.7848945438825629,0.7419354838709677,1.0,1.0,2/8,6.65%,AGBL1;AGBL3
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.4118400305689508,0.7847688910233186,0.7142857142857143,1.0,1.0,9/18,32.36%,NOP10;CCT7;DCP2;CCT8;CCT3;CCT6A;CCT2;SHQ1;DKC1
prerank,Reactome_2022__PI5P Regulates TP53 Acetylation R-HSA-6811555,0.4779040489527523,0.7847658915165977,0.7796610169491526,1.0,1.0,1/9,12.49%,ING3
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.3955393969028986,-0.7846190774957338,0.71875,1.0,1.0,4/13,20.02%,UBIAD1;COQ2;COQ9;PDSS2
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.3955393969028986,-0.7846190774957338,0.71875,1.0,1.0,4/13,20.02%,UBIAD1;COQ2;COQ9;PDSS2
prerank,KEGG_2021_Human__Pancreatic cancer,0.3727846290251423,0.7845698341319958,0.7922077922077922,1.0,1.0,8/74,15.19%,PIK3R3;TGFB1;CDKN2A;CCND1;TGFB3;STAT1;CDKN1A;MAPK3
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,0.3125171922639411,0.7845570244921908,0.9444444444444444,1.0,1.0,70/423,16.21%,C1QTNF1;C3AR1;LPAR1;GPR55;ARHGEF40;RGSL1;NPFFR1;GNRHR;GPHB5;PIK3R3;ANXA1;CCL5;GNAT3;C3;GPR27;GNG12;SSTR1;PTAFR;TSHR;TRPC7;CASR;SCTR;GPER1;PTGER3;NMUR2;HTR5A;UTS2;CXCR5;ACKR4;P2RY6;ITGA5;ADRB1;RAMP3;GNG4;PPP1R1B;PDYN;RXFP2;KNG1;NPY1R;NPY;P2RY12;RHOB;GNRH1;ECT2;RGS21;LPAR6;GRM6;RASGRF2;F2RL1;GPR183;GNAT2;PNOC;XCR1;HTR1B;PENK;GPSM2;FPR1;CALCR;OPRM1;GPR68;ADCY7;EDNRB;MAPK3;PIK3R6;CXCL12;PIK3CG;GPR17;PTRH2;RGS10;GHRL
prerank,KEGG_2021_Human__Hippo signaling pathway,0.3329055452753112,0.7845133951626524,0.8333333333333334,1.0,1.0,21/149,15.72%,ITGB2;WNT8B;TCF7;TGFB1;WNT5A;ACTG1;CCND2;WNT8A;LEF1;CCND1;TP53BP2;TGFB3;FZD8;ID1;WNT6;CTNNA3;TCF7L1;LATS2;BBC3;DCHS2;WNT5B
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.4093241636932521,-0.7844858513670333,0.7647058823529411,1.0,1.0,3/14,13.14%,SLC2A9;SLC2A11;SLC2A8
prerank,KEGG_2021_Human__Arachidonic acid metabolism,0.3715711581884198,0.784444552764831,0.7671232876712328,1.0,1.0,8/43,14.48%,PLA2G10;ALOX12;GGT5;CYP2J2;HPGDS;ALOX12B;ALOX15;ALOX15B
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,0.35133350156878335,0.7840052456891398,0.8588235294117647,1.0,1.0,1/84,0.14%,DENND1C
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colon,0.46429629010733786,0.7838730071785714,0.7258064516129032,1.0,1.0,3/12,14.71%,ABCG2;BMI1;CD44
prerank,CellMarker_Augmented_2021__Basophil:Undefined,0.4078561741776306,0.7838722500040765,0.75,1.0,1.0,7/20,15.41%,TLR2;PTPRC;FCGR3A;ANPEP;CD63;CD44;IL3RA
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.3339850675346554,0.7837331676262378,0.8255813953488372,1.0,1.0,22/111,14.48%,ACSL5;ACOX2;LIPH;ALOX12;CYP4F12;LIPI;PON1;ACOT6;GGT5;CYP2J2;LPIN3;SLC27A6;ACSL3;ACSM3;ACSM6;ALOX5AP;ALOX12B;ANGPTL3;ALOX15;PON3;ACOT4;ALOX15B
prerank,KEGG_2021_Human__Melanogenesis,0.34041926220542634,0.7834580603414631,0.8533333333333334,1.0,1.0,14/85,15.72%,TYR;WNT8B;TCF7;WNT5A;WNT8A;LEF1;FZD8;WNT6;TCF7L1;ASIP;ADCY7;EDNRB;MAPK3;WNT5B
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.3479244885733682,0.783443378296432,0.8048780487804879,1.0,1.0,6/98,7.68%,CCL5;TRPV6;TRPC7;CASR;NMUR2;RAMP3
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,-0.3100518053226287,-0.7833599308817015,0.9375,1.0,1.0,33/190,16.33%,MFSD2A;SYNJ2;BCHE;CRLS1;PNPLA3;VAC14;PLD2;CPNE6;GPD1;PI4KB;PLA2G5;PLA2G4C;CHKA;RAB5A;PGS1;PITPNM1;TAFAZZIN;PEMT;OSBPL5;MTMR14;OSBPL10;LPCAT2;PITPNM3;TMEM86B;SLC44A5;RUFY1;AGPAT2;AGPAT5;PLD3;AWAT2;OSBPL8;PI4KA;MTMR1
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,0.34108475814627304,0.7832518296559885,0.8620689655172413,1.0,1.0,26/141,20.42%,COX6A1;SLC16A8;TMEM186;ATP5PF;LDHD;NDUFB11;NDUFS2;PLPP6;UCP1;PDK4;ATP5F1E;ETFB;CCNI;NDUFB10;NDUFA2;NDUFAF5;SLC16A1;SLC16A3;ATP5MC3;COX20;COX4I1;COX7B;NDUFB9;COX6C;COX6B1;NDUFB4
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,0.4013800550468315,0.7832085095800647,0.8055555555555556,1.0,1.0,6/34,7.73%,SDC2;LRAT;LRP2;BCO1;GPIHBP1;APOM
prerank,CellMarker_Augmented_2021__Bile Duct cell:Liver,0.3651380404201992,0.7831690656627448,0.7710843373493976,1.0,1.0,15/66,12.42%,GNG12;ITGA2;ITGB6;MISP;EPN3;BAIAP2L1;CCND1;TMEM54;SERINC2;TRIM29;LAMC2;AP1M2;SH2D4A;EPCAM;SEMA3F
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.41781198908579587,-0.7830386304786544,0.8484848484848485,1.0,1.0,1/12,3.49%,AGBL1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3068963422353713,0.7829999720906952,0.9213483146067416,1.0,1.0,28/354,8.80%,RASGRP4;MAPKAPK3;BLK;BLNK;SDC2;PIK3R3;FGF20;ATP6V1G2;ROS1;ANGPT2;FGF2;GFRAL;FLT1;ACTG1;SYK;ERBB4;MMP9;SOCS2;FLT4;IGF1;ANGPTL1;AXL;CLNK;HGF;KLB;DDIT4;COL4A6;HCK
prerank,CellMarker_Augmented_2021__Trophoblast cell:Placenta,0.3507855114775718,0.7829652314921678,0.8674698795180723,1.0,1.0,14/85,11.03%,RAB34;ANXA1;LOX;AOX1;FGF2;GNG12;ITGBL1;AXL;OSMR;PLAU;SYNC;LVRN;COL1A1;AHNAK2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.4449450317530049,0.782954121892821,0.803030303030303,1.0,1.0,2/16,7.63%,SCIMP;IL26
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.47122413769695803,-0.7828953656718547,0.6666666666666666,1.0,1.0,1/6,12.45%,FAM120B
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,-0.2892424111634545,-0.7827505854443566,0.96,1.0,1.0,28/127,23.35%,NUP210;NUP42;POM121C;NUP214;TAF12;GTF2H2;AAAS;GTF2E2;ERCC2;SSRP1;POLR2F;NUP37;POLR2C;NUP98;ELOA;PPIA;MVB12A;TAF11;TSG101;CCNT1;CTDP1;SEH1L;SGIP1;GTF2F2;UBAP1;NUP50;TPR;RNF103-CHMP3
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,0.333076259650635,0.7826925051843187,0.8375,1.0,1.0,19/140,15.97%,GATA4;SLC25A31;KCNU1;VASP;IRAG1;NPR2;ADRB1;ATP1A4;KNG1;PDE5A;PLN;ADCY7;EDNRB;CNGA1;NPPA;MAPK3;PIK3R6;MYL9;PIK3CG
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.32598854480142686,-0.7825708770533416,0.8,1.0,1.0,8/65,10.68%,NGF;CFLAR;ACER2;NLRP1;NOD1;SENP1;EGLN3;CASP9
prerank,KEGG_2021_Human__Long-term depression,-0.32353111590379546,-0.782565279076599,0.8214285714285714,1.0,1.0,6/55,9.83%,ITPR2;GRID2;CRH;PLA2G4C;GNAS;GNA11
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,0.40383260006429733,0.7825611127605067,0.7534246575342466,1.0,1.0,2/20,13.35%,AMN;CBLIF
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.33138989156508303,0.7825563074775481,0.868421052631579,1.0,1.0,12/90,16.95%,WAS;STK26;DUSP22;CYP1B1;RHOB;SPOCK3;CLDN5;DACH1;ALOX15B;EPHA1;ENG;SINHCAF
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),-0.43040235636901536,-0.7825494238776408,0.6666666666666666,1.0,1.0,2/6,14.60%,NUDT4B;FHIT
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),0.49782635431251093,0.7825320733893106,0.7857142857142857,1.0,1.0,6/7,35.40%,IL1R1;IL18R1;SLC11A1;IL18;IL23R;IL12RB1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Muscle,0.3493358137755195,0.7824735118310844,0.8333333333333334,1.0,1.0,13/89,11.00%,C1QTNF1;TIMP3;PRRX1;FBXL7;LOX;ITGBL1;NT5E;ANGPTL2;AXL;HEG1;ADGRL4;DCN;COL1A1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.37504279669438045,-0.7823297683536923,0.7368421052631579,1.0,1.0,7/12,23.86%,CEP135;SPIDR;CORO2B;CEP290;CEP295;CEP120;PTP4A3
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.3730093905816122,0.7823125227453387,0.8072289156626506,1.0,1.0,10/42,17.83%,FGF2;TGFB1;HMGA2;SOX9;CD44;WNT5B;GHRL;SOX6;HYAL1;ITGB8
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.3626478989664728,0.7821914320175937,0.8133333333333334,1.0,1.0,7/38,23.30%,PINK1;GABARAPL2;FUNDC1;FIS1;ULK1;FBXO7;GABARAPL1
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,0.31587297551574883,0.7821651499603359,0.9431818181818182,1.0,1.0,23/155,20.60%,COX6A1;PSMB9;NOX5;CDKN2A;NQO1;RPS27A;TALDO1;PSMC5;CYBA;ATOX1;COX20;COX4I1;IDH1;TXNIP;RBX1;PSMA3;COX7B;PSMB6;SLC7A11;COX6C;COX6B1;PSMD6;SESN1
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Adipose Tissue,-0.3229900650149634,-0.7821422478495994,0.9411764705882353,1.0,1.0,19/84,11.09%,PHLDB2;COL12A1;RAI14;FRMD6;ARSJ;RND3;CAPN2;CD151;PAPSS2;PARVA;ACVR1;FSTL1;TWSG1;NTN4;SERPINE1;SNAI2;DCBLD2;ITGA3;WWC2
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,0.3568821291537649,0.7819911896406788,0.7777777777777778,1.0,1.0,11/55,19.54%,RAB34;RAB11A;RAB6B;RAB19;RAB38;RABGGTB;RAB39A;RAB33A;PTP4A2;RAB29;RAB21
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.38743895976263126,-0.7819855144300877,0.78125,1.0,1.0,7/22,14.48%,GRIN3A;SLIT3;SDF4;TGFBR3;GRIN1;SLIT2;HSD3B2
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.43760032484771505,0.7818578050135503,0.7142857142857143,1.0,1.0,2/16,3.51%,PIK3R3;FGF2
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.4144648790315228,-0.7818578014094827,0.7647058823529411,1.0,1.0,3/15,13.20%,APOH;SERPINE1;ST3GAL4
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,0.4398304912335137,0.7818177650088695,0.7605633802816901,1.0,1.0,3/16,15.26%,EXOSC8;EXOSC2;EXOSC4
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.3563797670221207,0.7817771925735936,0.8767123287671232,1.0,1.0,7/78,10.18%,GATA4;TNFRSF1B;FGF2;HLA-F;KANK2;PINK1;LRPAP1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.30511399616675317,0.7817695689671762,0.9662921348314607,1.0,1.0,58/464,14.01%,TBX1;SMAD6;GML;TLR2;TNFRSF1B;SP100;COL18A1;FGF2;TP53TG5;SSTR1;ST18;TGFB1;ADAMDEC1;DUX4;GPER1;JAM2;SCIN;CRLF3;ERBB4;CDKN2A;FOXM1;COL4A3;IFNK;TDRD9;REST;GSDME;GNG4;IRF1;DDX3X;EI24;CYP1B1;KANK2;TP53BP2;KNG1;SOD2;RHOB;MYO16;TGFB3;PRAME;PPT1;LRPAP1;GNRH1;ARHGDIG;RERG;INCA1;PLXNA3;ADGRG1;CDKN1B;BTG1;CDKN1A;SFRP4;WDR6;RASA1;SIRPG;OPRM1;PLG;IGFBP6;CDKN2C
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.32118153465406923,0.781758575915781,0.963855421686747,1.0,1.0,28/266,12.92%,CHRNA9;ZACN;GAD1;DBH;SLC12A7;HSPA8;SLC18A2;SYPL1;SHISA6;SLC17A8;HTR5A;UTS2;PLP1;HTR3E;PDYN;NQO1;CHRNA5;GRIN2D;GLRA2;PCDHB5;NPY;GLRA1;HTR3C;CHRNB1;PNOC;HTR1B;PENK;CRHBP
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.44390799746156623,-0.7817303315300671,0.7058823529411765,1.0,1.0,2/8,8.96%,NOP9;NOP14
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.28701475168247187,-0.7817182415202483,0.8947368421052632,1.0,1.0,3/72,5.49%,TRIB2;CCDC22;PRICKLE1
prerank,Reactome_2022__Inflammasomes R-HSA-622312,0.4231960543381785,0.7816800177915102,0.8153846153846154,1.0,1.0,4/18,12.98%,AIM2;NLRC4;PSTPIP1;NFKB2
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.43574664390306966,0.7815395697721089,0.75,1.0,1.0,4/18,21.86%,GPER1;BRCA1;CEACAM1;ACADL
prerank,Reactome_2022__MET Activates PTPN11 R-HSA-8865999,0.5274924647100045,0.7815117047627648,0.8125,1.0,1.0,3/5,39.31%,RNMT;PTPN11;GRB2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.43478331233147927,-0.7815087077693634,0.75,1.0,1.0,2/6,13.45%,TRPC6;WNK3
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.4485514726337287,-0.7814831896320983,0.717948717948718,1.0,1.0,2/10,6.82%,PCM1;CCDC68
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.2927743231738926,-0.7814266615132712,0.9375,1.0,1.0,10/130,7.41%,NOX4;RASSF2;PRKCD;EGR1;ADCYAP1;CCN1;TTBK1;RALB;PAK6;SYAP1
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.37840390462584295,-0.7813348787157888,0.8,1.0,1.0,4/15,18.11%,ADCY3;ADCY2;ADCY6;PRKAR2A
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,0.39220787864802487,0.7813340844941216,0.8484848484848485,1.0,1.0,3/35,15.19%,FGF20;RPS27A;MAPK3
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,0.3377304586875038,0.7811664983805612,0.821917808219178,1.0,1.0,16/110,17.22%,ENPP2;TCN1;AOX1;LRP2;NT5E;RFK;LDLRAP1;AMN;SLC25A19;CBLIF;SLC46A1;MTHFD2;QPRT;PARP14;PARP4;SLC23A1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.37279087565666796,0.7810528213107503,0.8421052631578947,1.0,1.0,6/45,15.18%,LPAR1;FHOD1;TGFB3;VIL1;CARMIL1;EPHA1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.48301060024808384,-0.7809878160282959,0.6511627906976745,1.0,1.0,2/8,8.96%,NEU4;NEU3
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.45276487280069844,-0.7809478511175083,0.7380952380952381,1.0,1.0,2/8,11.30%,EARS2;WARS2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.42908210038696115,-0.7808709921100572,0.78125,1.0,1.0,5/10,26.04%,MACROH2A2;MED1;NCOA3;NUMA1;MACROH2A1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.4736218652438737,0.7808538561537722,0.7586206896551724,1.0,1.0,1/13,2.29%,DONSON
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.3688411668656764,0.7806392557302966,0.7428571428571429,1.0,1.0,9/32,27.09%,SEMA3A;PLXNA3;SEMA3F;SEMA3B;SEMA6A;SEMA4C;NRP2;SEMA7A;SEMA3E
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Pancreas,0.3500161483059398,0.7805753194322571,0.8837209302325582,1.0,1.0,15/94,22.67%,ATP6V1G2;TMEM35A;PHF21B;GDF11;TCEAL5;NEFM;PCDH10;BEX1;ZDHHC22;PNMA2;CAMKV;SULT4A1;ENO2;MLLT11;PIANP
prerank,Reactome_2022__Reduction Of Cytosolic Ca++ Levels R-HSA-418359,-0.44484036305354685,-0.7805408476267939,0.7105263157894737,1.0,1.0,1/10,7.12%,SLC8A3
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.3422323940253778,-0.7803453691798717,0.85,1.0,1.0,4/30,7.87%,KCNIP3;KCNE1;KCNIP1;DPP6
prerank,CellMarker_Augmented_2021__Bipolar cell:Retina,-0.3064764920898632,-0.7803102870964539,0.8888888888888888,1.0,1.0,15/79,10.90%,CBARP;P3H4;ZNF664;KIAA1549;CACNG4;GPRIN1;HS6ST2;LRRC73;PTPRF;MPP2;VGF;TEAD4;GNAS;KDM4D;MANEAL
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Association With Co-factors R-HSA-6804759,0.4445815096112838,0.7802769633409878,0.7833333333333333,1.0,1.0,1/11,8.95%,TP53BP2
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.4871017734325777,0.7800499329210203,0.7777777777777778,1.0,1.0,1/6,6.23%,STAT5A
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.48267732703765936,-0.7799246444224589,0.7045454545454546,1.0,1.0,2/6,28.57%,SRM;SAT2
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),0.4874478252863518,0.7798039242978011,0.7169811320754716,1.0,1.0,3/6,26.36%,HYAL1;HAS1;HAS2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.4678441196469411,0.7795005648246116,0.7241379310344828,1.0,1.0,4/7,37.97%,MSN;EGF;EZR;RDX
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.4678441196469411,0.7795005648246116,0.7241379310344828,1.0,1.0,4/7,37.97%,MSN;EGF;EZR;RDX
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.4678441196469411,0.7795005648246116,0.7241379310344828,1.0,1.0,4/7,37.97%,MSN;EGF;EZR;RDX
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.3321222579941384,0.7792908743219048,0.8518518518518519,1.0,1.0,18/111,20.47%,PSMB9;CCL5;ST18;PELI3;RPS27A;SOX9;PSMC5;MAPK3;HYAL1;GBP1;RBX1;NFKBIA;PSMA3;CCL25;PSMB6;RPS6KA5;IL1R1;PSMD6
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),-0.42390596839855565,-0.7790472782755764,0.717948717948718,1.0,1.0,1/9,1.83%,WNT3A
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.4348288364916678,-0.778869844054844,0.7096774193548387,1.0,1.0,3/8,26.36%,KDM1B;KDM5D;KDM5A
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.43755289100495354,-0.7788037745366191,0.7666666666666667,1.0,1.0,4/13,25.86%,PARP2;SIRT7;AURKC;HDAC1
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.3945309026304471,-0.7787937800440726,0.8205128205128205,1.0,1.0,3/13,19.14%,AK8;ITPA;AK7
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.361729868670658,-0.7787833661278952,0.9655172413793104,1.0,1.0,6/29,11.33%,G6PC3;GYS1;ARSB;SPAM1;IDUA;HGSNAT
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.37002874648059825,-0.7787366089696611,0.7441860465116279,1.0,1.0,1/18,4.78%,APOE
prerank,GO_Biological_Process_2021__cellular ion homeostasis (GO:0006873),0.5198084582873546,0.7787348924339372,0.8253968253968254,1.0,1.0,1/5,6.73%,SLC4A1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.29526245753554053,0.7787318429107816,1.0,1.0,1.0,100/857,17.37%,GATA4;RHOXF2;ESR1;EOLA1;CRX;C1QTNF1;TRIM58;ZNF284;TLR2;VSX1;ZNF676;TCF7;LRRC19;ACE2;ITGAX;MYT1;PIK3R3;FGF20;AHR;FGF2;NFIL3;CTCFL;PTPRC;VSIR;SNAI3;ATF7;TGFB1;METTL18;ALPK2;HEY2;WNT5A;ZNF98;SFTPD;ACTG1;ABCC2;GPER1;PRDM12;IGF2BP2;ZNF723;IFNK;TAF5;IGF1;LEF1;RAMP3;REST;NFIA;ACTA2;DDX3X;RNF187;HIC1;PINK1;TRIM68;TRIM77;AHNAK2;BRDT;CLDN5;WNT6;USP13;HMGA2;BTG1;PRDM8;ALOX12B;SFRP4;AFF2;NFKB2;TCF7L1;NAB1;CALCR;BMI1;SOX9;SAP30L;ZNF536;TRAPPC2;IL4;HMGA1;ATRAID;MAPK3;TDG;VSTM2A;SLC38A2;ZNF580;PTRH2;RPL11;TAF6L;ENG;CSF1;BTN3A3;MSN;AGR2;NR5A2;SOX6;PARP14;BRCA1;RPS7;MYB;ZNF114;BTNL9;NOS2;MSR1;RAG1
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),-0.4604954187530579,-0.778728592380209,0.813953488372093,1.0,1.0,1/5,11.20%,MVK
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.4583034280303684,0.7787170337288314,0.863013698630137,1.0,1.0,4/13,21.86%,SOX9;BRCA1;CEACAM1;ACADL
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,0.3419985451454067,0.7786163884580243,0.8421052631578947,1.0,1.0,15/81,17.55%,RRAD;HIPK1;TAF5;RPA3;RPS27A;TAF7;CCNA2;CDK5R1;TAF7L;ARTN;TAF10;RMI2;TAF13;BRCA1;TAF9B
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),0.5280035969708695,0.7785563666928492,0.7794117647058824,1.0,1.0,1/5,22.23%,UBA5
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),0.5280035969708695,0.7785563666928492,0.7794117647058824,1.0,1.0,1/5,22.23%,UBA5
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),0.5280035969708695,0.7785563666928492,0.7794117647058824,1.0,1.0,1/5,22.23%,UBA5
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.4679959499262199,-0.7783704980129782,0.72,1.0,1.0,1/6,1.95%,GALE
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.43847380643791944,-0.7781117955289186,0.8095238095238095,1.0,1.0,3/9,21.70%,ZC3H14;CCNT1;RNF40
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovary,0.4689066742224191,0.7780948643102819,0.7846153846153846,1.0,1.0,4/12,14.71%,ABCG2;EPCAM;BMI1;CD44
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.3948595148220918,0.7778821481194301,0.78125,1.0,1.0,4/24,13.99%,SOX10;ACTG1;FLG2;SOX9
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),0.4541723136009341,0.7778410657875915,0.7166666666666667,1.0,1.0,4/15,24.08%,PINK1;COX7A2;COX7A1;ACTN3
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,0.35842912549160805,0.7777755307878342,0.8831168831168831,1.0,1.0,5/82,7.79%,BLNK;ACE2;SYK;ATP1A4;REST
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,0.40516336263462643,0.7776597977621008,0.75,1.0,1.0,3/20,8.34%,HEY2;FLT4;ACTA2
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.384736474488921,-0.7775921226167013,0.7333333333333333,1.0,1.0,2/14,9.07%,BCL2;SNAI2
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.3322520252998276,0.7774748440245418,0.8409090909090909,1.0,1.0,18/117,22.24%,LRP4;SLC18A2;SHISA6;TMEM35A;TCEAL5;NPY;LIFR;PLAT;VSTM2A;CNTN2;LRRTM1;SYT4;SLC26A4;SNAPIN;PHYHIP;SULT4A1;LSAMP;RGS4
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.3961524820649254,-0.7774091743872618,0.7878787878787878,1.0,1.0,2/20,4.78%,EPHX2;APOE
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.26531495391589754,-0.7773885281511366,1.0,1.0,1.0,26/290,11.47%,ABHD17A;TBC1D10A;SEPTIN10;TBC1D16;RAB20;GRID2;SEPTIN8;STX6;STX11;SYNDIG1;ARFIP2;SNX8;USP4;SEPTIN9;TICAM2;CORO1B;TMED4;FLNA;TBC1D2;SCFD2;RAB5A;TBC1D22B;CROCC;RABL2A;STX5;GGA2
prerank,Reactome_2022__DNA Repair R-HSA-73894,0.31382616676311914,0.7771682443057834,0.967032967032967,1.0,1.0,28/274,17.01%,ACTL6A;PCLAF;RRAD;POLE2;FANCF;DTL;EYA2;UBE2L6;TRIM25;H2BC4;FAAP20;POLD4;H2AZ1;RPA3;DCLRE1A;RPS27A;DCLRE1C;TFPT;CCNA2;COPS4;ISG15;TDG;ARTN;GPS1;RMI2;COPS5;CENPX;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.43857715809235176,-0.7771217185463154,0.7435897435897436,1.0,1.0,1/9,1.39%,PHLDB2
prerank,CellMarker_Augmented_2021__Stem cell:Pancreas,-0.27036193455704477,-0.7771031432378745,0.9666666666666667,1.0,1.0,11/85,13.45%,TYRO3;MGAT4C;GRID2;TRIM71;LGR5;KIAA1328;RGMA;CHST6;ADCY2;DENND2A;WNK3
prerank,GO_Biological_Process_2021__regulation of T-helper cell differentiation (GO:0045622),0.48415624600940604,0.7769813693431645,0.803030303030303,1.0,1.0,4/6,23.49%,IL27;MYB;IRF4;HLA-DRB1
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.40662930803242925,0.7769702732130457,0.75,1.0,1.0,6/22,17.83%,TGFB1;HEY2;AGGF1;RASA1;ENG;ITGB8
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.34731878831887825,0.7768839291246329,0.863013698630137,1.0,1.0,8/64,17.18%,PIK3R3;ATP6V1G2;ATP6V0E2;ATP6AP1;PDK4;RHOQ;BCAR1;ATP6V0B
prerank,KEGG_2021_Human__Glycosaminoglycan degradation,-0.39301916853473123,-0.7768153982937317,0.7317073170731707,1.0,1.0,9/15,24.71%,ARSB;SPAM1;IDUA;HGSNAT;GUSB;GLB1;SGSH;GALNS;HPSE
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.41367337668405524,0.776805777053377,0.8245614035087719,1.0,1.0,7/29,11.67%,ITGB2;NODAL;MMP9;ITGA5;MMP15;VTN;HMGA2
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.4106156518152989,0.7767559384464828,0.8028169014084507,1.0,1.0,5/22,15.56%,ARHGAP24;ITGA5;LCP1;CD44;TOR1A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Brain,-0.3682354657385777,-0.776359964011836,0.7931034482758621,1.0,1.0,4/22,12.32%,BOC;ASCL1;MSI1;NFIB
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.3561606959604139,-0.77631119667344,0.7647058823529411,1.0,1.0,4/30,12.03%,PHLDB2;NIBAN2;CDK1;BAG6
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,0.3026413212654298,0.7762250972022636,0.9787234042553191,1.0,1.0,92/506,21.28%,PSMB9;RRAS;SDC2;HSPA8;PIK3R3;PTPRC;TRPC7;RPL37A;SOX10;RPL21;ITGA2;COL6A5;COL6A6;MYH11;SEMA3A;ACTG1;MMP9;VASP;COL4A4;RPL9;COL4A3;ITGA5;LHX4;RPL18A;MYL6;COL4A5;GFRA1;RHOB;RPS9;RPL3;RPL36;RPL13A;COL6A2;RPS16;RPL15;RPS5;RPS27A;RPS3A;PLXNA3;RPL41;MYL12A;RPS12;RPS4X;RPL27A;NAB1;RPS19;ITGA2B;FAU;PSMC5;RPS21;EPHA1;MAPK3;CDK5R1;CXCL12;RPL32;MYL9;ARTN;CNTN2;RPL11;RPL23A;RPL35A;RPS11;MSN;RPS13;RPS7;VAV3;RSL24D1;RPLP2;RPL7;EFNB3;SCN5A;RBX1;RPL38;PSMA3;SIAH1;PSMB6;MAG;RPS15A;MAP2K1;RPS6KA5;RPSA;RPLP0;RPS6;RPL35;PSMD6;TMPRSS4;RPL27;SPTBN5;RPS14;PRX;L1CAM;RPL7A
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,0.36539638922813755,0.7761901443426916,0.8611111111111112,1.0,1.0,4/38,11.19%,PIK3R3;STAT5A;MMP9;STAT1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.29886486298045717,-0.7759514451515772,1.0,1.0,1.0,29/106,18.93%,SEZ6;MCOLN3;SEZ6L;CPNE6;TNR;SRRM4;DPP6;RPH3A;KCNJ6;WSCD2;FRRS1L;AP3B2;CATSPER2;GRIA4;C4ORF50;ADCY2;CYP46A1;CACNG2;CELF4;TCEAL6;SV2B;SVOP;OTUD7A;CACNA1A;KCNH2;PKD2L1;AMER3;CDH22;PROX1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),-0.4811116916220872,-0.7759412157289745,0.675,1.0,1.0,2/6,20.56%,MALT1;IL23A
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.38338260402872937,0.7758196693007343,0.7777777777777778,1.0,1.0,3/39,5.49%,ARIH2;PELI3;TRAF3IP2
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.4125976828954962,0.7757981378095449,0.7910447761194029,1.0,1.0,2/21,5.18%,TGFB1;MYH11
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.40374353317489425,0.7756631414927233,0.7164179104477612,1.0,1.0,9/19,31.64%,STAT1;PARP14;PARP9;HSP90AB1;IFNGR1;ARG1;PIAS1;IFNGR2;TXK
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),0.4956374070398041,0.7755988874900669,0.8181818181818182,1.0,1.0,2/7,18.30%,HTR1B;CHRNB2
prerank,Reactome_2022__Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,0.4588348363051269,0.7755520110924233,0.7419354838709677,1.0,1.0,2/8,15.15%,TP53BP2;BBC3
prerank,Reactome_2022__Mitotic Telophase/Cytokinesis R-HSA-68884,-0.44005099935143743,-0.7753369604235686,0.7837837837837838,1.0,1.0,1/12,7.05%,MAU2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Lung,0.4149889674340561,0.7752882425121334,0.8208955223880597,1.0,1.0,5/21,16.24%,ABCG2;EPCAM;BMI1;CD44;ABCG5
prerank,Reactome_2022__DNA Methylation R-HSA-5334118,-0.3747593648244022,-0.7751742863069996,0.75,1.0,1.0,3/15,12.89%,DNMT1;DNMT3A;H2AJ
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.31301701661795966,-0.7749608500774191,0.9,1.0,1.0,16/65,19.42%,TYRO3;ITGA4;PARVA;LAMB4;LPXN;NTN4;SRGAP2;RILPL1;ANTXR1;SIPA1L3;USH2A;RHOA;UNK;PARVB;PROX1;SRCIN1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.42826136546678245,0.7749112741862108,0.7966101694915254,1.0,1.0,4/19,9.00%,PTPRC;HLA-F;IL12A;HLA-A
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.47012567572209873,0.7748140138719545,0.7619047619047619,1.0,1.0,2/10,11.12%,GCHFR;SPR
prerank,Reactome_2022__SHC-mediated cascade:FGFR2 R-HSA-5654699,0.4330058581095352,0.7747899247361711,0.7454545454545455,1.0,1.0,1/18,2.58%,FGF20
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,0.3717160610579776,0.7747806933747275,0.8767123287671232,1.0,1.0,2/31,6.90%,PIK3R3;CD80
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.30132787814185447,0.7746106493507721,0.9662921348314607,1.0,1.0,46/421,14.66%,GATA4;TBX1;ESR1;RORC;MYRF;SP100;SIX4;AHR;FGF2;NFIL3;CTCFL;TGFB1;SOX10;HEY2;WNT5A;FLI1;MESP1;CRLF3;AFAP1L2;ERBB4;CD80;NR1H4;FOXM1;IGF1;LEF1;REST;EBF3;ACTA2;IRF1;RNF187;TGFB3;KDM3A;COL1A1;STAT1;HMGA2;CD4;PITHD1;AGT;GLI3;WBP2;RHOG;SOX9;PSMC5;SNAI1;IL4;ZIC1
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,0.3598811925162619,0.7746063091783528,0.8648648648648649,1.0,1.0,3/57,6.63%,GAD1;MOBP;SLC6A4
prerank,Reactome_2022__Heme Biosynthesis R-HSA-189451,-0.39292842138100864,-0.7745951010843505,0.7647058823529411,1.0,1.0,2/13,6.98%,FLVCR1;ALB
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Brown Adipose Tissue,0.32090189472349,0.7745918356699654,0.925,1.0,1.0,14/100,20.04%,LRP4;ERBB4;CYP39A1;UCP1;CTNNA3;LIFR;AGT;AQP4;PRKG1;FRZB;ACSS3;FIGN;ID4;SMARCA1
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.3938603625844722,-0.7745827444777277,0.7727272727272727,1.0,1.0,6/13,24.40%,SYNDIG1;RAB27A;CDK5;DNM2;KIF5C;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.454807636480356,0.7745074745634344,0.7857142857142857,1.0,1.0,3/14,9.55%,CCL5;SYK;P2RY12
prerank,KEGG_2021_Human__IL-17 signaling pathway,0.35284908381686314,0.7744774551824805,0.8289473684210527,1.0,1.0,16/57,26.31%,TRAF3IP2;MMP9;IL5;IL17B;IL4;MAPK3;IL17RB;NFKBIA;TRAF5;TRADD;HSP90AB1;MUC5B;CEBPB;PTGS2;CASP8;MAPK15
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.3231187092090555,0.7744570217101309,0.9534883720930233,1.0,1.0,30/178,18.13%,KIF14;ROS1;TP53TG5;TGFB1;CRLF3;CDKN2A;SOCS2;GNG4;DDX3X;EI24;PPT1;RERG;EXOSC2;TMC8;CDKN1B;BTG1;CDKN1A;AGT;CDKN2C;EXOSC4;NUBP1;IL17RB;BCAR1;HYAL1;TCHP;TAF9B;NAIF1;PAPPA2;FBP1;FRZB
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,0.3348303888902844,0.774444240336685,0.8518518518518519,1.0,1.0,8/82,8.80%,PIK3R3;PTPRC;FCGR3A;WAS;SCIN;SYK;VASP;HCK
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.41728471207635853,0.7743851265401517,0.7121212121212122,1.0,1.0,3/22,13.08%,CAV3;IGF1;AGT
prerank,Reactome_2022__Activated NTRK2 Signals Thru PI3K R-HSA-9028335,-0.48384181543324645,-0.774287528310389,0.7608695652173914,1.0,1.0,1/5,21.74%,NTRK2
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.39689052033802497,0.7742868499609934,0.8311688311688312,1.0,1.0,7/32,18.72%,CAV3;PHF23;PINK1;MDM1;BRCA1;TCHP;FEZ1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.43708025926136657,0.774109619063778,0.7464788732394366,1.0,1.0,3/11,19.56%,LRPAP1;RIN3;DLG4
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,-0.30055568218744827,-0.7740399020718949,1.0,1.0,1.0,12/46,17.69%,POLR1A;DSCC1;POLD3;CTC1;WRAP53;GAR1;STN1;TERT;ANKRD28;RTEL1;RFC3;SLC19A1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.344825756018257,0.7738128029376262,0.8666666666666667,1.0,1.0,5/66,6.49%,SMAD6;LRP2;FGF2;CNMD;DAND5
prerank,CellMarker_Augmented_2021__Oligodendrocyte Precursor cell:Brain,0.33060382305315783,0.773274536398908,0.8051948051948052,1.0,1.0,13/102,18.89%,STMN4;JAM2;PLP1;FAM181B;MEGF11;RFX4;RFTN2;AQP4;ZNF536;VSTM2A;CNTN2;GFAP;CDR1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.3336533077371101,-0.7732443698373198,0.6764705882352942,1.0,1.0,3/37,7.51%,SKAP1;CDH13;PTPRJ
prerank,Reactome_2022__Melanin Biosynthesis R-HSA-5662702,-0.4713047792221876,-0.7731823001093743,0.775,1.0,1.0,2/5,2.72%,TYRP1;DCT
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),0.48187868402004014,0.7730168771308858,0.7758620689655172,1.0,1.0,3/6,31.04%,IL18R1;ALOX5;IL18
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),0.48187868402004014,0.7730168771308858,0.7758620689655172,1.0,1.0,3/6,31.04%,IL18R1;ALOX5;IL18
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.37122334182613204,0.7729334318778948,0.7638888888888888,1.0,1.0,9/29,27.09%,SEMA3A;SEMA3F;SEMA3B;MAG;SEMA6A;SEMA4C;RNF6;SEMA7A;SEMA3E
prerank,Reactome_2022__Developmental Biology R-HSA-1266738,0.2943144340060985,0.7729030058322747,1.0,1.0,1.0,93/775,17.08%,GATA4;KRTAP5-1;PSMB9;PKP2;RRAS;TCF7;SDC2;HSPA8;PIK3R3;PKLR;PTPRC;TRPC7;TGFB1;RPL37A;SOX10;RPL21;FOXA3;ITGA2;COL6A5;COL6A6;EBF1;SALL4;MYH11;SEMA3A;FLI1;ACTG1;ANGPTL4;DAND5;H2BC4;NODAL;MMP9;VASP;COL4A4;RPL9;COL4A3;ITGA5;LEF1;FLG;LHX4;H2AZ1;RPL18A;SPINK6;MYL6;COL4A5;CSF3R;GFRA1;RHOB;RPS9;RPL3;RPL36;RPL13A;COL6A2;RPS16;HNF4G;RPL15;RPS5;RPS27A;RPS3A;PLXNA3;RPL41;MYL12A;RPS12;RPS4X;RPL27A;CDKN1A;TCF7L1;NAB1;RPS19;ITGA2B;SOX9;FAU;PSMC5;RPS21;EPHA1;MAPK3;CDK5R1;SPINK9;CXCL12;RPL32;MYL9;KRT8;ARTN;CNTN2;HNF1A;RPL11;RPL23A;RPL35A;RPS11;MSN;NR5A2;RPS13;RPS7;MYB
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Placenta,0.3456825381531489,0.7728708905287291,0.8888888888888888,1.0,1.0,13/81,13.24%,CLCA2;TIMP3;GNG12;WNT5A;ITGB6;SCARA3;MAMDC2;COL4A5;TRIM29;LAMC2;COL1A1;SEMA3F;GLI3
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.41852146909640964,0.7728603672989042,0.7910447761194029,1.0,1.0,7/22,19.16%,PTPRC;CD81;TNFSF4;RPS19;MYB;DDX60;USP17L2
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),-0.49949173987979245,-0.7723485868939033,0.675,1.0,1.0,2/5,28.16%,NOTCH1;FSHR
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.47645189542266325,0.7722427675109511,0.8461538461538461,1.0,1.0,2/7,6.03%,SASH3;CD81
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.4077087221941068,-0.7721686858951121,0.75,1.0,1.0,3/10,6.81%,WNT3A;WNT7A;PCM1
prerank,CellMarker_Augmented_2021__Natural Memory B cell:Undefined,0.3619659534601488,0.772106807907849,0.8225806451612904,1.0,1.0,9/40,13.63%,CYTIP;ARHGAP9;SASH3;NLRC3;TAGAP;CD37;PSTPIP1;KLRB1;SIRPG
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3644468067839451,-0.7720959549996305,0.8125,1.0,1.0,5/21,22.83%,TGFA;GPRC5A;TSG101;BTC;ZFYVE28
prerank,CellMarker_Augmented_2021__AXL+SIGLEC6+ Dendritic cell:Blood,0.34557410339000183,0.7718595156334619,0.8142857142857143,1.0,1.0,14/66,23.07%,ADAM33;MYH11;RAD1;AXL;DAB2;CDKN1A;NDRG1;UPK3A;IRF4;CD5;ATF5;SIGLEC1;PLAC8;ACP3
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.44448917966272844,0.7716465332066497,0.7272727272727273,1.0,1.0,4/12,9.71%,WNT5A;WNT8A;LEF1;TGFB3
prerank,KEGG_2021_Human__Cushing syndrome,0.3233953975150724,0.771553553025366,0.8780487804878049,1.0,1.0,21/135,15.72%,WNT8B;TCF7;AHR;WNT5A;CDKN2A;WNT8A;LEF1;CCND1;AIPL1;FZD8;CCNE2;WNT6;RASD1;CDKN1B;CDKN1A;AGT;TCF7L1;CDKN2C;ADCY7;MAPK3;WNT5B
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.3577105472876054,0.7713011105912585,0.8333333333333334,1.0,1.0,8/63,14.14%,BOK;DEPDC5;DRAM1;RRAGA;PSAP;USP13;GPR137B;WDR24
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.4052315580683187,0.771214012365848,0.8035714285714286,1.0,1.0,6/18,28.83%,COX17;BCS1L;COX20;TIMM21;COX16;COA3
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),-0.4127171573588428,-0.7712107966599714,0.7105263157894737,1.0,1.0,4/9,16.83%,KYAT1;AADAT;KYAT3;TDO2
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.3826770419089021,0.7711989018530581,0.7972972972972973,1.0,1.0,2/33,11.25%,TENT5B;MEIOC
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.434895103043061,0.7707705184140642,0.6610169491525424,1.0,1.0,4/11,29.18%,CD4;CBLL1;CTNNB1;ITGAV
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.2940939710784549,-0.7705872441122347,0.8461538461538461,1.0,1.0,6/68,7.92%,ADAMTS12;GBP2;SELE;SMPD4;IGBP1;PID1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.4251994963090284,0.7705559649992236,0.78125,1.0,1.0,1/19,0.72%,LRP4
prerank,CellMarker_Augmented_2021__Radial Glial cell:Undefined,-0.42115908486072967,-0.7704579709389123,0.7857142857142857,1.0,1.0,1/10,5.56%,HES1
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.3871031203990754,0.7703210025859835,0.8441558441558441,1.0,1.0,1/28,0.97%,MCUB
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.4644821883676319,-0.7702654125248579,0.7435897435897436,1.0,1.0,2/6,15.25%,CDK6;DLL1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.2937815262725685,-0.770205347077264,0.9,1.0,1.0,18/122,11.08%,ARX;S100B;RND3;CACNG4;HOPX;APOE;SLC17A6;ELAVL3;MEGF10;INA;ASCL1;KCNIP1;DLX1;SRRM3;TAGLN3;PTPRZ1;ADGRA1;MSI1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.43598911822444303,0.7701093584668427,0.7971014492753623,1.0,1.0,1/14,1.05%,APOLD1
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,0.3826670856161599,0.7700693230566356,0.8450704225352113,1.0,1.0,2/30,6.81%,SNAP23;VAMP1
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,-0.356115110816646,-0.7700049446128046,0.7142857142857143,1.0,1.0,6/31,22.03%,GTF2H2;ERCC2;POLR2F;POLR2C;CTDP1;GTF2F2
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.36655754945614605,0.7698572485201137,0.8028169014084507,1.0,1.0,1/38,3.48%,TRIM62
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.3328301506052674,0.7697817593913746,0.8780487804878049,1.0,1.0,11/114,9.86%,MCUB;CCL5;VAPB;STOML2;TRPC7;CASR;CAV3;GPER1;CSRP3;TRDN;CALB1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.34057768709345826,-0.7697082773218261,0.9,1.0,1.0,6/26,15.93%,GALP;TNFRSF14;AQP1;SERPINE1;IRGM;SELP
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,-0.30149927233953194,-0.7696453805271101,0.9583333333333334,1.0,1.0,16/91,13.20%,ADAMTS1;ADAMTS12;ST3GAL3;POFUT2;ADAMTS8;THSD7A;MUC19;ADAMTS3;ST3GAL2;ADAMTS10;ADAMTS16;ADAMTS6;SPON2;GALNT12;GALNT18;ST3GAL4
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),-0.48362584357986677,-0.7696429012156304,0.7619047619047619,1.0,1.0,1/5,1.32%,KLRC1
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),0.46444112518533187,0.7696215345404465,0.7457627118644068,1.0,1.0,4/6,26.34%,UPK3A;SLC14A1;AQP11;SLC14A2
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),-0.47976480773771646,-0.7694528504801983,0.7619047619047619,1.0,1.0,3/5,20.64%,MRAP2;PRKCA;APLP1
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,0.3828555788551439,0.769451132978748,0.8108108108108109,1.0,1.0,6/37,7.73%,SDC2;LRAT;LRP2;BCO1;GPIHBP1;APOM
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.3119621455408906,-0.7693470903368066,0.9117647058823529,1.0,1.0,7/29,18.11%,ITPR2;CD247;ADCY2;PRKCA;FYN;ADCY6;PRKAR2A
prerank,Reactome_2022__Purine Catabolism R-HSA-74259,-0.41724574705441614,-0.7693403045267636,0.8928571428571429,1.0,1.0,8/15,22.47%,ADPRM;NT5C1A;NT5C;DNPH1;NUDT18;ITPA;NUDT5;XDH
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.31030801018672544,-0.7693159120146835,0.8571428571428571,1.0,1.0,6/42,12.57%,NLGN3;CACNG4;GRIK1;NLGN2;CACNG2;GRM2
prerank,CellMarker_Augmented_2021__Pancreatic Polypeptide cell:Pancreas,0.43053424439062854,0.7693015642561495,0.7536231884057971,1.0,1.0,1/16,0.31%,AQP3
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.33904547092295023,0.769232628005638,0.8472222222222222,1.0,1.0,13/69,24.06%,ATP6V1G2;DEPDC5;RRAGA;ATP6V0E2;CDKN1A;WDR24;MAPK3;ATP6V0B;LAMTOR3;SESN1;ATP6V1D;ATF2;ATP6V0D1
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.3842062725625004,0.7692115273035819,0.8513513513513513,1.0,1.0,1/40,0.73%,ACTL6A
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.36487358780944235,0.7690431707250076,0.8450704225352113,1.0,1.0,2/40,2.77%,PKP2;CCL5
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.3372518062442402,0.768978071250789,0.8607594936708861,1.0,1.0,15/105,12.12%,C1QTNF1;TIMP3;PRRX1;LMOD1;ADAM33;MYH11;UACA;ANGPTL2;ACTA2;CYP1B1;ADGRL4;DCN;COL1A1;ASPN;RASD1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.3455045536344651,0.7688226029397033,0.8961038961038961,1.0,1.0,4/78,3.51%,TBX1;FGF20;CCL5;FGF2
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.38090990827407795,0.768758383035215,0.8450704225352113,1.0,1.0,10/39,15.06%,CLCA2;MYH11;ITGB6;SERPINB7;TRIM29;LAMC2;MUCL1;THBS1;LY6D;SERPINB5
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.4598425620645219,0.7686531630243375,0.8,1.0,1.0,2/10,11.63%,CD81;TNFSF4
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.34497324850489675,0.768648539247711,0.8481012658227848,1.0,1.0,14/64,13.80%,ESR1;C3AR1;LPAR1;GPR55;PTGER3;NMUR2;P2RY6;P2RY12;TGM2;LPAR6;F2RL1;AGT;FPR1;OPRM1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.4551309887710081,0.7686124098211192,0.7413793103448276,1.0,1.0,2/19,13.09%,SYNE2;MYO1F
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,0.30828509906004253,0.7685812518063171,0.9382716049382716,1.0,1.0,20/236,14.06%,ESR1;PSMB9;PIK3R3;FGF20;CBX8;PREX2;SALL4;ERBB4;CD80;REST;KLB;RRAGA;RPS27A;PPP2R5A;USP13;CDKN1B;CDKN1A;RHOG;PSMC5;SNAI1
prerank,CellMarker_Augmented_2021__Macrophage:Brain,-0.32513615849478683,-0.7680744018049569,0.8148148148148148,1.0,1.0,8/37,16.29%,METRNL;ITGA4;CYRIA;CREM;VOPP1;SAMHD1;SLC66A3;BHLHE40
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.30945227798023867,-0.7680181095428833,0.8695652173913043,1.0,1.0,1/49,0.34%,NGF
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.495509987597327,0.7679087340775318,0.7878787878787878,1.0,1.0,2/7,3.64%,TEX101;RNASE10
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.3163078743660756,0.7678226392841165,0.9210526315789473,1.0,1.0,16/118,16.95%,FGF2;STK26;NODAL;DUSP22;CYP1B1;RHOB;MARVELD3;MCC;CLDN5;DACH1;ADGRG1;IL4;ALOX15B;EPHA1;ENG;SINHCAF
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.508500900607082,0.7677744122059388,0.7868852459016393,1.0,1.0,1/5,10.57%,DCK
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.4329549008040249,0.7674982753618809,0.7213114754098361,1.0,1.0,1/8,16.58%,BCAR1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.4781555844168401,-0.7674781162740013,0.7555555555555555,1.0,1.0,2/7,10.97%,RAB7A;SERPINB9
prerank,Reactome_2022__RAF Activation R-HSA-5673000,0.4000804580864364,0.767118064450746,0.9206349206349206,1.0,1.0,2/30,11.35%,MAP3K11;PPP2R5A
prerank,CellMarker_Augmented_2021__FGFR1HighNME5- Epithelial cell:Esophagus,0.32127340053724046,0.7670672300690213,0.9090909090909091,1.0,1.0,21/174,12.84%,HSPA1L;ADAM33;AOX1;CERS3;FRRS1;TSPAN4;ABI3BP;TPGS1;PCDH18;JAM2;AFAP1L2;SOCS2;PDGFRL;CYP1B1;HIC1;GFRA1;PI15;COLEC12;HMCN2;SNX21;TTK
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.31724222715701667,-0.7670503055899968,0.8787878787878788,1.0,1.0,9/32,16.91%,MMP2;ITGA4;CACNB1;NTRK1;GRIN1;ABCC1;CACNA1A;CDK5;FYN
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovium,0.4669836105200803,0.7668930331110378,0.7580645161290323,1.0,1.0,3/8,16.35%,PTPRC;CD44;ENG
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.44368691107366004,-0.7668925826976442,0.7272727272727273,1.0,1.0,1/6,25.66%,UXT
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),-0.4545960688252769,-0.7667661812905316,0.7380952380952381,1.0,1.0,1/5,2.05%,PACSIN2
prerank,CellMarker_Augmented_2021__Neural Stem cell:Undefined,0.35721077758642344,0.7667046529538155,0.8987341772151899,1.0,1.0,14/44,25.70%,ABCG2;CALCR;BMI1;SOX9;LRTM1;ZIC1;GFAP;NOTCH2;ROR2;GNL3;RUNX1;PROM2;FGFR4;CTNNB1
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3846229097803936,0.7663756765972526,0.8,1.0,1.0,9/30,22.16%,PWP2;RPS16;RPP40;RPS19;RPS21;TSR2;HELB;RPS14;ABT1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.3561586394799343,-0.766066619636649,0.7317073170731707,1.0,1.0,3/22,5.86%,RPL3L;DHX30;RPF2
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.30785532997302345,0.7659595895156728,0.8674698795180723,1.0,1.0,28/252,18.69%,MCM2;ENDOG;UBE2U;SP100;POLE2;POLQ;TICRR;RAD1;NT5E;MCM3;DNASE2;POLD4;RAD54L;RPA3;RPS27A;UHRF2;RECQL4;NOP53;DDX23;TDG;RMI2;ORC4;BRCA1;PARP4;RAG1;MSH6;NUDT15;LRWD1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.4196450383667778,0.765705001128,0.7428571428571429,1.0,1.0,1/9,8.16%,CEP72
prerank,CellMarker_Augmented_2021__Leukocyte:Undefined,-0.5348726903931511,-0.7656666937846289,0.7857142857142857,1.0,1.0,2/5,7.68%,CD14;CX3CR1
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.3479447552846028,-0.7656193579311628,0.7931034482758621,1.0,1.0,4/18,13.45%,PKD2;AQP1;SLC4A11;WNK3
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.40836740187506226,0.7653851174061856,0.8095238095238095,1.0,1.0,4/14,21.39%,HMGA2;SNAI1;POLE3;MECOM
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.32524705634166295,-0.765335772172669,0.9047619047619048,1.0,1.0,7/29,14.69%,OSR1;WNT7A;CCN3;NFIB;SULF2;CREB3L2;EIF2AK3
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.4180211748256628,-0.7649444138975364,0.717948717948718,1.0,1.0,1/8,3.16%,KCNE1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.41935524346825215,0.7648940311950087,0.8,1.0,1.0,6/19,20.83%,TGFB1;DAB2;PPP2R5A;RHOQ;GBP1;MRAP
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.43529798293971367,0.7648827040418577,0.7538461538461538,1.0,1.0,2/11,15.71%,SLC22A6;SLC22A4
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.33903309168997453,0.7646074776380516,0.8875,1.0,1.0,15/123,15.27%,MAPKAPK3;TIMP3;ANXA1;SP100;NLRP12;GGT5;LEF1;OSMR;LDLRAP1;STAT1;LIFR;CSF1R;MME;ITIH4;ISG15
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.29903158611293595,-0.7644969452865121,1.0,1.0,1.0,29/86,26.08%,TRIM71;EIF4EBP1;CPEB1;DHFR;NANOS3;PCIF1;CNOT9;AGO2;FXR2;EIF2AK3;PUS7;SAMD4B;IGF2BP1;UNK;RBM24;EIF4A3;TSC1;YTHDF1;MALSU1;LARP1;DHX36;TPR;RBM4;RIDA;ILF3;EIF2AK4;METTL16;DAPK3;CNOT10
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.44005944525697205,-0.7642661446330161,0.7619047619047619,1.0,1.0,3/8,21.70%,ZC3H14;CCNT1;RNF40
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.3683399295624564,-0.7642268620404712,0.7931034482758621,1.0,1.0,3/23,13.55%,AUP1;BAG6;NGLY1
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.4209900351072676,0.7641184623700789,0.8412698412698413,1.0,1.0,6/16,21.68%,GRWD1;SMARCE1;TNP1;HMGA1;SET;RPL23
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.3606655951686819,0.7639023851770644,0.7948717948717948,1.0,1.0,6/46,15.62%,DISC1;SEMA3A;DDIT4;CELSR1;CDK5R1;CCK
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.34470130431296053,0.7638853123628282,0.8589743589743589,1.0,1.0,11/65,15.35%,PTPRC;TGFB1;ADAMDEC1;B4GALNT2;CYP1B1;KNG1;ARHGDIG;PLXNA3;RASA1;PLG;TGFBI
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.38565788761532066,0.763850176276699,0.7714285714285715,1.0,1.0,7/27,20.42%,TCF7;IL7;IL4;CRTAM;ZAP70;NFATC2;IL2RA
prerank,CellMarker_Augmented_2021__Granulosa cell:Undefined,0.3362852936373598,0.7638156763202387,0.8192771084337349,1.0,1.0,13/92,14.52%,TIMP3;PRRX1;LMOD1;FBXL7;PCDH18;ANGPTL2;AXL;MAMDC2;ADGRL4;COL1A1;HMCN1;PLAT;DDR2
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.34363984089444943,0.7637310014981418,0.8734177215189873,1.0,1.0,3/61,6.49%,SMAD6;LRP2;DAND5
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.3195730532085974,-0.7636173296944415,0.8,1.0,1.0,13/50,18.70%,H1-4;PARPBP;RADX;POLR2F;SHLD2;POLR2C;SMCHD1;ZSCAN4;RTEL1;MSH3;MAD2L2;SHLD1;FBH1
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Lung,0.3493215522721025,0.763360267252411,0.8356164383561644,1.0,1.0,10/86,8.97%,S100A13;AOX1;GNG12;ITGA2;PTGR1;SCARA3;UACA;AXL;CCND1;OSMR
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.33624915304167946,-0.7633474674010193,0.8148148148148148,1.0,1.0,7/39,6.49%,EIF5AL1;ARSL;ARSJ;STS;DNAJC24;TTF2;ARSB
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.35589402338697934,0.7632778684741802,0.835820895522388,1.0,1.0,16/43,28.50%,RSPO1;FOXM1;EIF6;CYP1B1;PINK1;PDK4;STK17A;PM20D2;BCO2;PANK2;ABCB11;FASN;STUB1;ACLY;PDK3;LAMTOR1
prerank,Reactome_2022__FGFR2c Ligand Binding And Activation R-HSA-190375,0.48662103108109234,0.7632060697612904,0.7346938775510204,1.0,1.0,1/10,2.58%,FGF20
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.32244533492216826,0.7631962413218482,0.9382716049382716,1.0,1.0,23/114,25.56%,PSMB9;ZFP69;NQO1;PSAP;OAZ2;SCD;FDFT1;TNFAIP8L3;PSMC5;AZIN1;PSMA3;PSMB6;PSMD6;NFYB;GPS2;PRKAB2;SQLE;PSMA7;FGFR4;HMGCR;HMGCS1;FASN;PSMB1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.3325995897801635,-0.7631877058833171,0.8125,1.0,1.0,7/25,15.83%,FOS;EGR1;ETS1;FOSL1;TERT;SMARCA4;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.3860778640147961,0.7631484724689461,0.8253968253968254,1.0,1.0,5/25,22.46%,CCL5;GRM6;CXCL12;ORAI1;MYLK
prerank,Reactome_2022__Tyrosine Catabolism R-HSA-8963684,0.4974359543770096,0.7629010014174351,0.7169811320754716,1.0,1.0,3/5,19.05%,HPD;FAH;ATAT1
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.45269916708525987,0.7627062064035663,0.7647058823529411,1.0,1.0,2/9,25.75%,TKFC;RIOK3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.37936150771242133,0.7627047682796845,0.8,1.0,1.0,10/46,17.26%,TLR2;SCIMP;WNT5A;SYK;C1QTNF4;TNFSF4;F2RL1;CYBA;AGER;NOS2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.35979130969721146,0.7627006912125321,0.8985507246376812,1.0,1.0,10/53,16.69%,TLR2;PTPRC;WNT5A;SYK;C1QTNF4;OAS2;THBS1;CYBA;AGER;RASGRP1
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.45260496465962535,0.7626723424596774,0.7681159420289855,1.0,1.0,1/8,3.86%,VSIR
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,0.43467593555272604,0.7626496538310606,0.8461538461538461,1.0,1.0,3/13,18.10%,PSTPIP1;NFKB2;TXNIP
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Endometrium,0.4164934354152096,0.7626369105111458,0.803030303030303,1.0,1.0,5/21,16.35%,PTPRC;ABCG2;NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.44690844729734425,-0.7625623030235095,0.717391304347826,1.0,1.0,2/7,24.01%,VAT1;PRKN
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.30754705375785296,0.7625490697555624,0.9666666666666667,1.0,1.0,31/182,26.70%,FBXL7;DTL;UBE2L6;ARIH2;TRIM25;SPSB2;PINK1;RPS27A;ISG15;BUB1B;SYVN1;UBL7;HERPUD1;RBX1;SIAH1;PCYOX1;CBLC;RNF5;SPSB4;FBXO7;KLHL15;RNF144B;UBA6;FBXO10;KLHL8;BUB3;RNF6;KCTD10;STUB1;RNF213;RNF20
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),0.4567269615890853,0.7625335351926329,0.765625,1.0,1.0,2/7,21.82%,SCN5A;SCN4B
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Parotid Gland,0.33529718421604426,0.7624738067793796,0.9176470588235294,1.0,1.0,10/95,7.56%,TIMP3;TSPAN11;SDC2;FBXL7;CYYR1;PREX2;WNT5A;PCDH18;ANGPTL2;TMEM200C
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.3574878200003902,0.7624718000700541,0.8108108108108109,1.0,1.0,7/47,17.26%,WAS;SCIN;VIL1;PSTPIP1;CFL1;GHRL;GAS7
prerank,CellMarker_Augmented_2021__Tumor-propagating cell:Undefined,-0.28562582340271925,-0.7622516667155946,1.0,1.0,1.0,22/94,15.32%,SPRY4;CALD1;COL4A2;COL12A1;RAI14;PARVA;MID1;FSTL1;CAP2;RASSF8;SNAI2;EFEMP1;AMOTL1;ANTXR1;DAB2IP;NAV2;AMOTL2;CHST3;FKBP9;COL5A2;COL4A1;ADGRL2
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone,-0.28562582340271925,-0.7622516667155946,1.0,1.0,1.0,22/94,15.32%,SPRY4;CALD1;COL4A2;COL12A1;RAI14;PARVA;MID1;FSTL1;CAP2;RASSF8;SNAI2;EFEMP1;AMOTL1;ANTXR1;DAB2IP;NAV2;AMOTL2;CHST3;FKBP9;COL5A2;COL4A1;ADGRL2
prerank,CellMarker_Augmented_2021__Progenitor cell:Fetal Liver,-0.28562582340271925,-0.7622516667155946,1.0,1.0,1.0,22/94,15.32%,SPRY4;CALD1;COL4A2;COL12A1;RAI14;PARVA;MID1;FSTL1;CAP2;RASSF8;SNAI2;EFEMP1;AMOTL1;ANTXR1;DAB2IP;NAV2;AMOTL2;CHST3;FKBP9;COL5A2;COL4A1;ADGRL2
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone Marrow,-0.28562582340271925,-0.7622516667155946,1.0,1.0,1.0,22/94,15.32%,SPRY4;CALD1;COL4A2;COL12A1;RAI14;PARVA;MID1;FSTL1;CAP2;RASSF8;SNAI2;EFEMP1;AMOTL1;ANTXR1;DAB2IP;NAV2;AMOTL2;CHST3;FKBP9;COL5A2;COL4A1;ADGRL2
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Adipose Tissue,-0.28562582340271925,-0.7622516667155946,1.0,1.0,1.0,22/94,15.32%,SPRY4;CALD1;COL4A2;COL12A1;RAI14;PARVA;MID1;FSTL1;CAP2;RASSF8;SNAI2;EFEMP1;AMOTL1;ANTXR1;DAB2IP;NAV2;AMOTL2;CHST3;FKBP9;COL5A2;COL4A1;ADGRL2
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Molar,-0.28562582340271925,-0.7622516667155946,1.0,1.0,1.0,22/94,15.32%,SPRY4;CALD1;COL4A2;COL12A1;RAI14;PARVA;MID1;FSTL1;CAP2;RASSF8;SNAI2;EFEMP1;AMOTL1;ANTXR1;DAB2IP;NAV2;AMOTL2;CHST3;FKBP9;COL5A2;COL4A1;ADGRL2
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.323651106305902,-0.7621572298667907,0.84375,1.0,1.0,1/31,0.67%,FBP2
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.4215960035097177,-0.762087352622348,0.6744186046511628,1.0,1.0,2/7,15.55%,APOE;ABCG1
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,0.3743450872867464,0.7620616964664826,0.7878787878787878,1.0,1.0,8/28,24.06%,ATP6V1G2;ATP6V0E2;ATP6AP1;ATP6V0B;TF;ATP6V1D;MCOLN1;ATP6V0D1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.3058834633636172,0.7620537519783473,0.945054945054945,1.0,1.0,30/287,19.29%,PSMB9;UBE2U;FBXL7;DTL;TRIM62;UBE2L6;ARIH2;ZNF738;RNF26;PELI3;TRAF3IP2;RNF187;TRIM68;PRAME;MKRN3;RPS27A;FBXL13;FBXL3;PSMC5;KBTBD7;UBE3A;FBXO40;KBTBD6;BRCA1;SYVN1;RMND5A;RBX1;PSMA3;SIAH1;PSMB6
prerank,KEGG_2021_Human__RNA transport,0.3285627549946188,0.76192759249501,0.9090909090909091,1.0,1.0,24/154,23.33%,SMN2;NUP210L;DDX20;SNORD3A;STRAP;PABPC1L2A;RPP38;GEMIN4;RNU5A-1;RPP40;EEF1A1;THOC6;EIF1B;EIF1AX;RAE1;TACC3;PABPC5;TRNT1;EIF3G;PHAX;EIF4A2;EIF2B2;EIF4E1B;EIF2B5
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,0.36380038409216753,0.761654345557995,0.9016393442622951,1.0,1.0,3/35,13.25%,CDKN2A;RPS27A;CCNA2
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),0.4977722160908266,0.761628640021747,0.8305084745762712,1.0,1.0,2/6,4.37%,ITGB2;ITGAM
prerank,CellMarker_Augmented_2021__Stem cell:Muscle,-0.3868554920423505,-0.761600697003963,0.7666666666666667,1.0,1.0,4/15,21.02%,KIT;CD9;CASP3;NCAM1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.4240859360607202,-0.7614298753004348,0.7073170731707317,1.0,1.0,2/7,10.39%,WNT3A;MYOCD
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.40888312577767827,0.7614038721098272,0.8059701492537313,1.0,1.0,6/16,29.17%,SLC25A18;SLC1A6;SLC25A22;SLC1A3;PRAF2;SLC25A13
prerank,CellMarker_Augmented_2021__Basal cell:Undefined,0.3499471728863468,0.7611924422885527,0.821917808219178,1.0,1.0,22/80,22.06%,ANXA1;AHR;DRAM1;POLD4;HLA-A;PLAUR;FOSL2;CD63;CD44;FTH1;TGFBI;SERPINB1;GBP1;IL1R1;IFIT3;TMEM9B;PLP2;TAP1;ANXA2;B2M;CXCL16;TRADD
prerank,Reactome_2022__M Phase R-HSA-68886,0.29882412599392777,0.761096182029163,0.9318181818181818,1.0,1.0,49/331,23.12%,NEK2;SGO1;PSMB9;BUB1;CENPU;H2BC4;ERCC6L;NDC80;LPIN3;H2AZ1;CEP72;CEP70;RPS27A;KIF18A;PPP2R5A;SKA2;PSMC5;NUF2;TUBA4A;TUBA3D;TUBB6;MAPK3;SPC25;BUB1B;RCC1;FBXO5;DYNLL1;NCAPG;ITGB3BP;CEP76;TUBA1C;PSMA3;MASTL;PSMB6;CENPN;CENPL;PSMD6;H2AZ2;CENPS-CORT;SET;CCNB1;ESPL1;TUBB4B;DCTN3;DCTN1;YWHAG;RPS27;CENPM;DYNLL2
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.3114975335000399,0.7610767288560036,0.9876543209876543,1.0,1.0,22/211,12.78%,CHRNA9;ZACN;GAD1;DBH;SLC12A7;SLC18A2;SYPL1;HTR5A;UTS2;PLP1;HTR3E;PDYN;CHRNA5;GLRA2;PCDHB5;NPY;GLRA1;HTR3C;CHRNB1;PNOC;HTR1B;PENK
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.40934339972748296,0.7608708984100945,0.7916666666666666,1.0,1.0,1/18,2.66%,CD160
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.40179937461035115,-0.7608412612677571,0.6666666666666666,1.0,1.0,2/15,5.98%,CDH5;F11R
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.36156390876907996,0.760621840598398,0.8243243243243243,1.0,1.0,1/42,0.31%,RASGRP4
prerank,Reactome_2022__FRS-mediated FGFR2 Signaling R-HSA-5654700,0.4232281396407713,0.7605439000817091,0.7368421052631579,1.0,1.0,1/20,2.58%,FGF20
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,0.3519275586754228,0.760539526966538,0.9054054054054054,1.0,1.0,9/55,15.19%,H2BC4;CDKN2A;H2AZ1;RPS27A;CDKN1B;CDKN1A;CCNA2;CDKN2C;MAPK3
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.29979807666150665,-0.7603662063250972,0.9230769230769231,1.0,1.0,21/81,23.16%,NAA40;PTCH1;ADAMTS3;METAP2;CPN1;CIAO2A;PCSK1;NNAT;XPNPEP3;ADAMTS13;TYSND1;GALNT2;AFG3L2;NCSTN;TSPAN14;LIPT2;CLN3;PCSK7;TESC;AEBP1;CIAO2B
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.45343128687801615,-0.7603549806738114,0.7317073170731707,1.0,1.0,1/6,2.05%,PACSIN2
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.37856253239752846,-0.760307612053074,0.8235294117647058,1.0,1.0,10/20,28.27%,CIRBP;CELF4;THRAP3;LEO1;NUP98;RBMX;DHX36;DAZAP1;SF3B4;TRA2A
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.463855060837159,-0.7602766635280271,0.8108108108108109,1.0,1.0,1/6,3.55%,ADCYAP1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.3244322093077101,-0.7598870856962568,0.8571428571428571,1.0,1.0,11/38,21.53%,FLVCR1;KIT;TGFBR3;INHA;MED1;CASP3;ACIN1;PTPN2;ABCB10;CDIN1;ALAS1
prerank,KEGG_2021_Human__One carbon pool by folate,-0.4016389193931986,-0.7596515036639911,0.8157894736842105,1.0,1.0,6/18,17.47%,MTHFR;MTHFD1L;DHFR;MTFMT;GART;MTR
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.3503717720628595,0.7596179601930675,0.84,1.0,1.0,13/63,25.37%,CCL5;DAZL;C8ORF88;DDX3X;BOLL;EIF1B;UHMK1;CSDE1;EIF4A2;EIF2B2;EIF2B5;NCBP1;CEBPB
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,0.3995143969936854,0.7594055032623549,0.8285714285714286,1.0,1.0,2/29,11.00%,HSPA8;RPS27A
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,0.37721280237606203,0.7592147096492002,0.8472222222222222,1.0,1.0,8/48,21.91%,HSPA8;AP1M2;TGOLN2;FTH1;TPD52L1;FTL;SNAPIN;SNX2
prerank,KEGG_2021_Human__Vitamin digestion and absorption,-0.3523669796579561,-0.7590912988020326,0.9090909090909091,1.0,1.0,1/21,0.54%,APOB
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.4675097959744004,-0.7589293900810332,0.8333333333333334,1.0,1.0,2/8,7.41%,SPTBN4;AGRN
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Tonsil,-0.31115184412100955,-0.7589176097505448,0.8823529411764706,1.0,1.0,11/74,8.67%,EHF;CLDN4;EMP1;LAMA3;CD151;RHBDF1;KITLG;ADGRG6;TMEM125;PERP;ITGB4
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.385281810811983,0.7587904631517507,0.8648648648648649,1.0,1.0,3/29,13.42%,TCF7;LEF1;TCF7L1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.447050169267151,-0.7587855080082155,0.7619047619047619,1.0,1.0,2/8,27.79%,PRKN;AMBRA1
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Undefined,0.48652372944007294,0.7587292226673124,0.8064516129032258,1.0,1.0,2/6,6.03%,PTPRC;CD81
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),-0.4755242336111165,-0.7587092934441096,0.7272727272727273,1.0,1.0,1/5,2.22%,TWIST1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),-0.47205783551765557,-0.7586337773666703,0.8444444444444444,1.0,1.0,1/7,3.98%,MDGA1
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,-0.31448585059151946,-0.7585506300973454,0.7037037037037037,1.0,1.0,8/55,7.41%,COL6A3;COL4A2;GFRA2;SPTBN4;PTPRA;SPTB;CACNB1;AGRN
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.3833293125667429,-0.7585277555696482,0.75,1.0,1.0,3/11,24.99%,EHD3;CLN3;LAPTM5
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.3652437638810402,-0.7583095572318703,0.8387096774193549,1.0,1.0,4/16,20.80%,APOE;ABCG1;NCSTN;CLN3
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,0.3710228895493434,0.7581160789722182,0.8260869565217391,1.0,1.0,14/34,31.87%,ACTG1;PDE5A;COPS4;GPS1;CCT7;TMOD3;HSP90AB1;TXNL1;RNF20;DBN1;HNRNPC;CCT6A;CCT2;RBM15
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.29654442410372894,0.7579699609512549,0.9883720930232558,1.0,1.0,67/283,20.56%,LPAR1;TLR2;PIK3R3;FGF20;ANGPT2;FGF2;GNG12;FLT1;ITGA2;COL6A5;COL6A6;ITGB6;SYK;ERBB4;COL4A4;FLT4;COL4A3;ITGA5;CCND2;IGF1;CCND1;GNG4;HGF;DDIT4;COL4A6;COL4A5;OSMR;PPP2R3A;CSF3R;LAMC2;COL6A2;VWF;VTN;CCNE2;LPAR6;COL1A1;PPP2R5A;CDKN1B;IL7;CDKN1A;THBS1;CSF1R;ITGA2B;IL4;MAPK3;PIK3R6;IL3RA;MTCP1;PIK3CG;CSF1;BRCA1;MYB;ITGB8;LAMB2;VEGFC;THBS2;PKN3;YWHAH;MAP2K1;RPS6;CREB3;CHAD;FN1;IL2RA;FGF22;GNGT1;GNB4
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.39100359194749396,-0.7576363036177944,0.8125,1.0,1.0,7/19,22.75%,CAP2;GRM2;GABBR2;NF1;CAP1;DRD2;PALM
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.45222894755117793,-0.7575983433885747,0.7659574468085106,1.0,1.0,3/5,22.81%,CCBE1;PROX1;NOTCH1
prerank,Reactome_2022__Role Of Second Messengers In Netrin-1 Signaling R-HSA-418890,0.4488447790320038,0.757439362769989,0.819672131147541,1.0,1.0,1/10,4.14%,TRPC7
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,0.3849582221034825,0.7573607062074083,0.8260869565217391,1.0,1.0,6/23,20.39%,SYK;VWF;ITGA2B;BCAR1;RASGRP1;FN1
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.4320727907622903,-0.7573325040911829,0.7837837837837838,1.0,1.0,2/6,21.96%,SLC4A11;TRPV4
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.47749620387705,0.7572935292586752,0.8484848484848485,1.0,1.0,3/8,11.68%,CCL5;SYK;F2RL1
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),0.5273877824590377,0.7571435242855115,0.8095238095238095,1.0,1.0,2/5,16.38%,P2RY12;CSF1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.35932267609893165,0.7571270089095998,0.8518518518518519,1.0,1.0,12/46,23.58%,BOK;GPER1;GSDME;AGT;BBC3;CYLD;TPD52L1;SIAH1;FIS1;BCAP31;DDIT3;RPS3
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.39604080976767736,0.7569843835979526,0.8076923076923077,1.0,1.0,8/34,17.10%,TGFB1;TGFB3;WNT6;FBN2;ATRAID;ISG15;ODAPH;FBXO5
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.40948923952234884,0.7569615987486169,0.7611940298507462,1.0,1.0,7/20,32.28%,CHMP3;ATF5;CHMP1A;AURKA;FBXW5;CHMP4B;CHMP2B
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,0.40093157362343995,0.7568921983796104,0.803030303030303,1.0,1.0,3/22,11.20%,ATP6V1G2;ATP6V0E2;ATP6AP1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.4569146117897548,0.7565944350281728,0.8148148148148148,1.0,1.0,2/9,7.44%,PTPRC;IFNK
prerank,KEGG_2021_Human__Glutamatergic synapse,-0.2730816449501678,-0.7563781904503422,1.0,1.0,1.0,17/100,12.57%,ITPR2;GRIN3A;SLC17A6;PLD2;GRIK4;SHANK1;PLA2G4C;GNAS;GRIK1;GNB5;GRIA4;GNB3;ADCY3;GRIN1;ADCY2;DLGAP1;GRM2
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.32728944403129206,0.7563527687903855,0.9375,1.0,1.0,12/94,13.99%,AHR;TSHR;SLC26A6;P2RY6;NR1H4;GLRA2;RRAGA;P2RY12;GLRA1;HTR1B;CRHBP;SOX9
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,0.36511035516118073,0.7560963252246464,0.8918918918918919,1.0,1.0,6/41,17.83%,TGFB1;ITGB6;TGFB3;RPS27A;UBE2M;ITGB8
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.35903501435124907,-0.755845811353753,0.6785714285714286,1.0,1.0,6/32,13.76%,TRDMT1;METTL1;METTL6;TRMT61B;TRMT61A;ALKBH8
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.34808812138616296,0.7558418936594696,0.868421052631579,1.0,1.0,10/45,24.06%,ATP6V1G2;ATP6V0E2;CP;ATP6AP1;FTH1;ATP6V0B;TF;ATP6V1D;MCOLN1;ATP6V0D1
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,-0.23697448195194845,-0.7554930945094468,1.0,1.0,1.0,85/399,18.84%,ZNF808;ZNF25;ZNF99;ZNF860;BCL2;ZNF534;ZNF777;ZNF773;HLA-DQB1;ZNF607;ZNF514;ZNF133;EIF4EBP1;ZNF470;ZNF641;ZNF596;ZNF701;HLA-DRA;ZNF33B;ZNF845;ZNF347;ZNF623;ZNF212;ZNF275;ZNF764;ZNF3;ZNF316;TNFRSF14;ZNF846;ZNF492;ZNF14;ZNF195;ZNF765;SRSF4;ZNF79;CASP9;ZNF549;NXF5;ZNF268;ZNF415;ZNF589;ZNF611;ZNF2;ZNF157;ZNF707;ZNF557;ZNF569;CARD9;ZNF135;ZNF334;ZNF331;ZNF136;ZNF561;ZNF324;ZNF708;TRAF3;ZNF627;EIF2AK3;ZNF254;ZFP82;ZNF688;ZNF717;ZNF785;PPP1CA;ZNF320;ZNF780B;ZNF665;ZNF155;EIF2B3;IRAK4;ZNF768;ZNF578;ZNF337;ZNF761;ZNF154;ZNF671;CASP3;ZNF786;ZNF441;ZNF559-ZNF177;ZNF251;POU2F2;ZNF273;ZNF621;AKT2
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Undefined,0.42997580913321803,0.7552844555994528,0.7323943661971831,1.0,1.0,9/16,19.80%,IL21R;AHR;IL26;CD4;KLRB1;LRRC36;MAF;IRF4;IL1R1
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.3566893292543491,-0.7552690033121218,0.8387096774193549,1.0,1.0,4/30,9.16%,CALD1;FSCN3;CORO1B;FSCN1
prerank,CellMarker_Augmented_2021__T Helper cell:Bone Marrow,0.34964302095897254,0.755221796748034,0.8243243243243243,1.0,1.0,14/44,20.42%,CYTIP;CCL5;PTPRC;NLRC3;TAGAP;THEMIS;KLRB1;SIRPG;ITK;TIGIT;GPR18;TNFSF8;CD5;IL2RA
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,0.36424370461470446,0.7551306889879403,0.8714285714285714,1.0,1.0,7/33,25.69%,RAB6B;DYNLL1;PLA2G4A;DCTN3;DCTN1;DYNLL2;ACTR10
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.38709801060325993,-0.7550653926170776,0.7878787878787878,1.0,1.0,6/24,13.89%,LIPC;PNPLA3;PNPLA1;DAGLA;LPL;ABHD12
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Undefined,0.44572008577644606,0.7547798678138943,0.7887323943661971,1.0,1.0,5/9,19.00%,CXCR5;TNFSF4;CD4;MAF;IRF4
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.3542299996172814,-0.7547650618589673,0.7272727272727273,1.0,1.0,2/19,12.03%,AUP1;BAG6
prerank,KEGG_2021_Human__Ovarian steroidogenesis,0.3639012998193802,0.7541507546688635,0.9,1.0,1.0,12/38,25.71%,IGF1;HSD17B2;CYP2J2;CYP1B1;ACOT4;ADCY7;PLA2G4A;ALOX5;PLA2G4D;STAR;PTGS2;CYP17A1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.40048493532770896,0.754107783407799,0.75,1.0,1.0,3/17,16.50%,CD81;ATP5IF1;MSN
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.37551465643657017,0.7538397771830627,0.8,1.0,1.0,7/34,17.06%,TLR2;SCIMP;SYK;TNFSF4;THBS1;AGER;TIGIT
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,0.3470873077407685,0.7538079182848356,0.8970588235294118,1.0,1.0,8/65,15.95%,CAVIN1;SNAP23;RHOB;ECT2;ARHGDIG;RTKN;ANLN;STOM
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.3223728987874893,-0.7537737195358046,0.90625,1.0,1.0,9/29,19.91%,RAD50;WRAP53;GAR1;TERT;ANKRD28;RTEL1;PPIA;TNKS1BP1;NHP2
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.3926529276124679,0.7537028344106395,0.8472222222222222,1.0,1.0,5/35,12.92%,AHR;SLC26A6;DUOX1;STAT1;CRHBP
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.2391868993757821,-0.7536041759715084,1.0,1.0,1.0,45/317,15.55%,APOB;TBC1D10A;TBC1D16;RAB20;ATP6V0D2;APOE;STX6;RAB3D;OLFM2;STX11;TVP23A;SYNDIG1;ARFIP2;SNX8;ATP6V1E2;TICAM2;RAB7A;ARRDC2;TMED4;TBC1D2;SCFD2;LRSAM1;RAB5A;TBC1D22B;ATP6V0A2;RABL2A;STX5;GGA2;PREB;BLZF1;RAMP1;ARRDC5;TBC1D8;SNX33;GOLGA4;SCAMP2;RAB28;RAB22A;RUFY1;MIA3;COG7;SCAMP4;TBC1D9;STXBP2;ABCG1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3374280312672847,0.7534519614114787,0.863013698630137,1.0,1.0,21/63,29.35%,AIM2;NLRP12;CDKN2A;CYP1B1;NLRC3;CYLD;NLRP2;NFKBIA;DDIT3;PARP10;IRAK1;SPI1;ERBIN;CACTIN;CARD8;TCEAL7;TMIGD3;LRRC14;TAX1BP1;TRIM37;G3BP2
prerank,KEGG_2021_Human__Spinocerebellar ataxia,0.31389825738828053,0.7534204723480887,0.9425287356321839,1.0,1.0,21/132,25.56%,SLC25A31;PIK3R3;TBPL1;PDYN;GRIN2D;ATG101;PSMC5;ATP2A2;PSMA3;PSMB6;SLC1A6;ULK1;GRIN2C;PSMD6;GRIN3B;PLCB4;KAT5;PIK3CB;PSMA7;VDAC1;PSMB1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.44734905654990975,0.7530002725507581,0.8769230769230769,1.0,1.0,1/15,1.29%,RORC
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4210114733027952,0.7529937700162133,0.7936507936507936,1.0,1.0,4/16,27.31%,USP18;ISG15;CACTIN;OAS1
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,0.33744694125946145,0.7528107443211711,0.8961038961038961,1.0,1.0,5/46,16.58%,ERBB4;CCND1;RPS27A;CDKN1B;BCAR1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.33279626217830294,0.7527899433565591,0.881578947368421,1.0,1.0,11/76,19.67%,HSPA1L;HSPA8;DNAJB1;IER5;RPA3;MAPK3;FKBP4;HSPH1;BAG5;RAE1;BAG1
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,0.3475556580104652,0.7527653528442092,0.8059701492537313,1.0,1.0,13/36,19.79%,CYTIP;SASH3;PTPRC;TAGAP;THEMIS;KLRB1;SIRPG;ITK;ZAP70;TIGIT;CD8B;TNFSF8;CD5
prerank,Reactome_2022__Cytokine Signaling In Immune System R-HSA-1280215,0.2875128864468693,0.7524418997635564,0.9895833333333334,1.0,1.0,68/534,15.41%,IL21R;ITGB2;MAPKAPK3;PSMB9;BLNK;RORC;TNFRSF1B;ITGAX;HSPA8;CSF2RA;PIK3R3;ANXA1;SP100;CCL5;CLCF1;TRIM62;UBE2L6;PTAFR;TGFB1;CRLF1;ITGAM;PELI3;HLA-F;TRIM25;IL12A;STAT5A;SYK;IL27;MMP9;CD80;CA1;SOCS2;IL26;CCND1;IFIT1;IRF1;HCK;OSMR;HLA-A;CSF3R;TRIM68;IL5;TRIM29;TIFA;RPS27A;STAT1;RHOU;TNFSF4;CD4;LIFR;CDKN1B;OAS2;IL7;CDKN1A;TALDO1;NFKB2;ALOX15;CSF1R;FPR1;USP18;OPRM1;PSMC5;IL4;CD44;MAPK3;ISG15;IFI6;IL3RA
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.3244523938560924,0.7523887632572147,0.8823529411764706,1.0,1.0,11/77,13.20%,KIF14;FGF20;CLCF1;SIX4;CRLF1;SOD2;PINK1;TGFB3;PPT1;FOXB1;RASA1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Brain,0.4136088223589434,0.7522579188616115,0.8356164383561644,1.0,1.0,5/19,13.99%,ABCG2;CD81;ADGRG1;BMI1;SOX9
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.32946556276250827,0.7522288993034806,0.8461538461538461,1.0,1.0,11/72,17.74%,TGFB1;GPER1;RAMP3;LDLRAP1;DAB2;PPP2R5A;RHOG;STAC;RHOQ;AGR2;GBP1
prerank,CellMarker_Augmented_2021__Astrocyte:Brain,0.3266335546387692,0.7521893933577607,0.9012345679012346,1.0,1.0,38/151,21.25%,TIMP3;TRIL;LIX1;DAND5;CD80;CPVL;NHSL1;DNASE2;NFIA;HGF;PSAP;C16ORF89;RHOB;RFX4;ID1;GLIS3;AGT;GLI3;AQP4;SOX9;ANLN;EDNRB;BBOX1;FTH1;SLC14A1;CYBRD1;IER2;MTHFD2;GLUL;GFAP;CHST9;NFKBIA;HEPACAM;HEY1;ID4;CA12;LRRC8A;L1CAM
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),-0.53343110059962,-0.751940180208008,0.8297872340425532,1.0,1.0,1/5,1.49%,CBARP
prerank,KEGG_2021_Human__Mineral absorption,0.3559688812794014,0.7518859318082586,0.8450704225352113,1.0,1.0,12/42,18.80%,TRPV6;SLC26A6;ATP1A4;STEAP1;SLC5A1;FTH1;MT1M;SLC46A1;CYBRD1;ATOX1;TF;FTL
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.46648769485131325,-0.7517985479942996,0.75,1.0,1.0,2/6,8.09%,DHX30;MTERF3
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.36081681088875645,0.7515865973702222,0.8823529411764706,1.0,1.0,10/40,15.06%,TIMP3;SERPIND1;SERPINB7;SERPINE3;KNG1;VTN;SPOCK3;AGT;SERPINA10;SERPINB5
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,-0.3010678734039771,-0.7515266021361977,0.9545454545454546,1.0,1.0,7/56,8.69%,VANGL1;WWP2;PREX1;GIT2;RAB7A;ARHGAP33;SRGAP2
prerank,Reactome_2022__Disease R-HSA-1643685,0.2846407144757214,0.7513431450055132,1.0,1.0,1.0,233/1448,20.59%,CDC25A;ESR1;PSMB9;C1QTNF1;ADA;BLNK;C3AR1;ABCC6;TLR2;GP1BA;ACE2;SDC2;GPHB5;LRAT;RRAD;CSF2RA;PIK3R3;SLC5A2;FGF20;SFTPA1;GNAT3;SLC7A7;C3;GPR27;GNG12;SLC12A3;SYT2;TSHR;MAP3K11;TGFB1;LCT;NLRP12;RPL37A;RPL21;HEY2;SCTR;DDX20;WNT5A;SFTPD;ADAMTS17;HLA-F;ACTG1;TRIM25;ABCC2;MUC17;WAS;SLC17A8;CYP26B1;STAT5A;SYK;H2BC4;SLC4A1;MUC4;ERBB4;VAMP1;OGN;CD80;CDKN2A;RPL9;NT5E;GGT5;CCND2;ADRB1;MPDU1;TAF5;RAMP3;ATP1A4;REST;F8;GSDME;CCND1;GNG4;H2AZ1;RPL18A;KLB;ALDOB;C1GALT1C1;ZDHHC11;RXFP2;CYP1B1;HCK;NCKIPSD;HLA-A;AGGF1;RPA3;RPS9;GTF2E1;RPL3;RPL36;RPL13A;FZD8;RPS16;OMD;MUCL1;VWF;RPL15;GEMIN4;CP;DCN;RPS5;CCNE2;RPS27A;RPS3A;MOGAT1;STAT1;AP1M2;PPP2R5A;RPL41;VPS18;ZC3HAV1;FAM110A;CD4;SLC24A1;B4GAT1;TAC4;CDKN1B;TAF7;PSTPIP1;RDH12;RPS12;RPS4X;RPL27A;AMN;CDKN1A;SLC5A1;TALDO1;NFKB2;THBS1;B3GLCT;CBLIF;DKK2;SNRPD2;SLC35C1;NOXO1;RPS19;RHOG;ITGA2B;CALCR;FAU;PSMC5;SAP30L;ADCY7;RPS21;GGCX;H2BC18;CYBA;CYP24A1;MASP2;MASP1;HMGA1;MAPK3;AHCY;ISG15;CDK5R1;RPL32;TAF7L;MOGAT2;ARTN;NDUFA2;FKBP4;PTRH2;RPL11;RPL23A;ABCG5;EEF2;TAF10;RPL35A;RPS11;RMI2;MSN;RCC1;TAF13;RBP1;KPNA5;MUC16;SLC16A1;RPS13;THSD1;PARP14;BRCA1;RPS7;PARP4;DYNLL1;VAV3;GNAZ;TAF9B;IMPDH2;NOX1;MSH6;IDH1;CD8B;SYVN1;TXNIP;RSL24D1;RPLP2;RPL7;SEL1L;RBX1;THBS2;RPL38;POMGNT1;YWHAH;NFKBIA;PSMA3;DUSP16;DOCK2;PSMB6;RPS15A;SH3GL3;MAP2K1;SLC26A4;FIP1L1;HEY1;G3BP1;IL1R1;NOTCH2;RPSA;KCNJ11;RPLP0;RPS6;RAD9B;RPL35;CDC25C;CALCB;FN1;BCAN;FGF22;PSMD6;GNGT1;ABCA12;GNB4;H2AZ2;GANAB
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.3097322081519259,0.7512036251867384,0.9431818181818182,1.0,1.0,18/215,10.68%,RAB34;DISC1;PDE6H;TLR2;C3;PTPRC;SCIMP;MESP1;GPER1;RSPO1;CD80;P2RY6;ITGA5;IGF1;AXL;F7;VWF;VTN
prerank,CellMarker_Augmented_2021__Induced Pluripotent Stem cell:Undefined,0.39678706637785954,0.7511486756222999,0.8615384615384616,1.0,1.0,4/22,16.70%,VSIR;ABCG2;L1TD1;MAF
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4361014247245579,0.750846917826855,0.8269230769230769,1.0,1.0,1/12,2.11%,TNFRSF1B
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.30652500888672385,-0.7507920762191143,0.9444444444444444,1.0,1.0,7/86,9.35%,KIF2B;SEC24C;HLA-DQB1;HLA-DRA;RAB7A;KIF15;KIF4B
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.3870674940918029,0.7507019068158153,0.7878787878787878,1.0,1.0,3/27,13.83%,DISC1;TMEM17;RPGRIP1
prerank,CellMarker_Augmented_2021__Fat Cell (adipocyte):Adipose Tissue,0.39138792604113426,0.7506431787272333,0.8032786885245902,1.0,1.0,4/19,15.69%,SLC27A6;UCP1;ZIC1;VSTM2A
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,0.35658481244243206,0.7506252158966535,0.881578947368421,1.0,1.0,12/58,18.94%,CHCHD4;TIMM22;LDHD;CHCHD7;COX17;TOMM20;CCNI;BCS1L;TOMM7;TIMM17A;CHCHD2;TIMM10
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.42865953661194905,0.7505807499271965,0.8405797101449275,1.0,1.0,2/14,11.50%,SYCP1;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.42865953661194905,0.7505807499271965,0.8405797101449275,1.0,1.0,2/14,11.50%,SYCP1;STAG3
prerank,CellMarker_Augmented_2021__Epithelial cell:Mammary Epithelium,0.3588206145357299,0.7505150130493528,0.8695652173913043,1.0,1.0,16/64,19.36%,ELMO3;MISP;EPN3;BAIAP2L1;TMEM54;SERINC2;LAMC2;TJP3;AP1M2;EPCAM;KRT8;AGR2;SPINT1;PRRG2;SOWAHB;SCNN1A
prerank,CellMarker_Augmented_2021__PDX1+ Pancreatic Progenitor cell:Embryonic Stem Cell,0.3458632680458204,0.7504309444066926,0.868421052631579,1.0,1.0,20/67,21.75%,PKP2;GPRIN2;FOXA3;MISP;HSD11B2;BAIAP2L1;MARVELD3;HNF4G;TJP3;AP1M2;EPCAM;KRT8;AGR2;SLC44A3;SOWAHB;SCNN1A;HOOK1;CBLC;B3GNT3;GRHL2
prerank,CellMarker_Augmented_2021__Bone Marrow Stem cell:Bone Marrow,0.48422863445534237,0.7501241020213818,0.8181818181818182,1.0,1.0,4/9,16.35%,PTPRC;NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2953119715252227,0.7500653240365084,0.9886363636363636,1.0,1.0,45/396,18.31%,GATA4;ESR1;CRX;ZNF284;VSX1;ZNF676;TCF7;MYT1;AHR;NFIL3;SNAI3;ATF7;METTL18;ZNF98;ZNF723;IFNK;TAF5;REST;NFIA;HIC1;BRDT;USP13;HMGA2;BTG1;PRDM8;NFKB2;CCNA2;TCF7L1;NAB1;SAP30L;ZNF536;TRAPPC2;HMGA1;TAF6L;ENG;NR5A2;SOX6;MYB;FBXO5;ZNF114;SPIN2A;PLAG1;ZFP37;HINT1;HCFC1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.29892443590653767,0.750039724547581,1.0,1.0,1.0,48/303,15.11%,SMAD6;GML;COL18A1;SSTR1;ST18;TGFB1;DUX4;WNT5A;GPER1;SCIN;IL12A;NODAL;ERBB4;OGN;CDKN2A;COL4A3;IFNK;IL26;REST;GSDME;IRF1;CYP1B1;KANK2;SOD2;MYO16;TGFB3;NLRC3;MARVELD3;GNRH1;MCC;RERG;INCA1;ADGRG1;CDKN1B;BTG1;CDKN1A;SFRP4;WDR6;SIRPG;OPRM1;PLG;IGFBP6;SOX9;CDKN2C;ALOX15B;FTH1;HMGA1;ATRAID
prerank,GO_Biological_Process_2021__regulation of epinephrine secretion (GO:0014060),-0.4654587644309056,-0.7499638235292015,0.76,1.0,1.0,1/5,7.70%,CRH
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.495030861310528,0.7499571860540758,0.7735849056603774,1.0,1.0,2/5,24.61%,TAF7;SPI1
prerank,Reactome_2022__RHO GTPases Activate IQGAPs R-HSA-5626467,-0.39875134975302207,-0.7498250695211186,0.8611111111111112,1.0,1.0,1/11,5.91%,MEN1
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.435805267092308,0.74977635770184,0.8142857142857143,1.0,1.0,2/11,3.37%,C1QTNF1;ALOX12
prerank,Reactome_2022__Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430,-0.44203679117753797,-0.7496987528071951,0.7142857142857143,1.0,1.0,2/9,5.65%,CD247;HLA-DRA
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.4601600441758978,-0.7495614400220322,0.78125,1.0,1.0,1/6,8.88%,GBF1
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.4601600441758978,-0.7495614400220322,0.78125,1.0,1.0,1/6,8.88%,GBF1
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.4601600441758978,-0.7495614400220322,0.78125,1.0,1.0,1/6,8.88%,GBF1
prerank,GO_Biological_Process_2021__regulation of sequestering of zinc ion (GO:0061088),0.5101737120531737,0.7491996826842381,0.8333333333333334,1.0,1.0,2/5,23.23%,SLC30A2;SLC30A4
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.3413525547374353,0.7491695587834061,0.8974358974358975,1.0,1.0,11/47,16.94%,PKLR;ENO4;SLC16A8;PFKFB2;SDS;ALDOB;HK3;PGAM1;PGAM2;SLC16A1;SLC16A3
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,0.3799314755709332,0.7490903497499529,0.8333333333333334,1.0,1.0,5/40,13.82%,VAPB;CERS3;PRKD3;DEGS2;ORMDL3
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),-0.4378914392728301,-0.7490232233320192,0.7317073170731707,1.0,1.0,1/7,7.58%,ASCL1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.29814088272791006,0.7490188796542364,0.989010989010989,1.0,1.0,34/264,20.47%,RASGRP4;PSMB9;CSF2RA;FGF20;CCL5;FGF2;TGFB1;ERBB4;IGF1;HGF;KLB;GFRA1;IL5;RPS27A;RASGRF2;RASA1;SOX9;PSMC5;KBTBD7;MAPK3;IL3RA;ARTN;HTR2B;RASGRP1;LAMTOR3;RBX1;PSMA3;USP17L2;PSMB6;DLG4;MAP2K1;IL2RA;FGF22;PSMD6
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.3051627833578569,-0.7489322585420253,0.8260869565217391,1.0,1.0,20/80,16.68%,RASSF2;DUSP15;SH3RF1;WNT7A;MAP3K10;CCN2;FZD7;MID1;SH3RF3;DUSP19;DAB2IP;TAOK2;SDCBP;CARD9;RELL2;TRAF3;TGFB2;KLHDC10;TRAF1;GADD45A
prerank,Reactome_2022__Carnitine Metabolism R-HSA-200425,-0.3946630068709648,-0.7489162873063462,0.725,1.0,1.0,6/11,28.53%,CPT1A;PRKAG2;SLC22A5;SLC25A20;PRKAA2;RXRA
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),0.4220088392345406,0.7487278469154292,0.86,1.0,1.0,5/12,27.21%,MANF;AQP11;ALOX5;CLU;WFS1
prerank,CellMarker_Augmented_2021__Placenta cell:Placenta,-0.3349987922474768,-0.7486866289154746,0.9285714285714286,1.0,1.0,2/42,4.09%,RFX6;PPP1R14D
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.3995533458103388,0.7486244439931381,0.7868852459016393,1.0,1.0,4/16,23.58%,IGF1;AGER;IGFBP2;RPS3
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR2 R-HSA-5654221,0.45425071067511347,0.7485473889717076,0.86,1.0,1.0,1/14,2.58%,FGF20
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.34695918878118737,0.7484819110161004,0.9041095890410958,1.0,1.0,1/40,1.75%,SLFN14
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.3538259786765629,-0.7483596803029479,0.7083333333333334,1.0,1.0,4/27,4.78%,EPHX2;BCKDK;MLYCD;APOE
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.32486248186383027,0.7481335058279179,0.8701298701298701,1.0,1.0,9/95,9.62%,TBX1;FGF2;WNT5A;STAT5A;NODAL;FLT4;IGF1;AGGF1;MYDGF
prerank,CellMarker_Augmented_2021__Mitotic Fetal Germ cell:Fetal Gonad,0.29927331564262555,0.7480710951140349,0.9896907216494846,1.0,1.0,98/579,20.02%,CLIC1;AQP3;ST6GALNAC1;CAPN13;S100A13;PPP1R3B;CLDN6;SDC2;SNAP23;SALL4;ELK3;CD81;NFE2L3;RPL9;ARHGAP28;LCP1;RPL18A;DDIT4;C1GALT1C1;CKS1B;EIF6;FBLIM1;DOCK6;MYL6;ZAN;ABHD14B;PSAP;RPL3;RPL13A;PLAU;RPS16;NOP10;GRWD1;RPL15;LDLRAP1;TJP3;CARHSP1;RPS3A;RPL41;ZC3HAV1;STON2;F2RL1;RPL13;L1TD1;RASD1;RPS4X;RPL27A;CD63;MRPL34;SLC47A1;ETFB;PGAM1;EEF1A1;ITM2C;IGFBP6;PCMTD2;KLRG2;PLLP;SLC7A3;TMSB10;POLR1C;TUBB6;THOC6;GIP;RPL32;TMEM160;MYL9;LAPTM4A;STOM;RGS10;RPL11;RPL23A;EEF2;RPL35A;RPS13;PAICS;QPRT;RPS7;TOMM7;EIF1AX;CAMKV;TUBA1C;RPL7;TRAPPC5;RPL38;MRPS2;PDLIM5;CCDC85B;PSMB6;RPS15A;RAB29;SMAGP;EMG1;RPSA;ORAI1;RPLP0;RPS6;RPL35
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.39227053538625545,-0.747989923498047,0.775,1.0,1.0,1/14,1.92%,TBC1D16
prerank,KEGG_2021_Human__Nucleotide excision repair,0.3529749406397487,0.7479350102022904,0.8227848101265823,1.0,1.0,3/43,9.53%,POLE2;POLD4;RPA3
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.41718099066941305,0.7478927793997739,0.7761194029850746,1.0,1.0,2/11,14.96%,PON1;PDZK1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.4655519680443532,-0.747621895184698,0.7619047619047619,1.0,1.0,1/5,10.50%,PTPRS
prerank,Reactome_2022__Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.3751999375193241,-0.7474561685274527,0.7837837837837838,1.0,1.0,2/19,4.40%,WNT3A;LGR5
prerank,Reactome_2022__TNFs Bind Their Physiological Receptors R-HSA-5669034,0.3745384464036354,0.7473683788418359,0.8028169014084507,1.0,1.0,6/21,22.63%,TNFRSF1B;TNFSF4;EDAR;TNFSF8;TNFSF14;CD27
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.41517263887583594,-0.747319989404775,0.8484848484848485,1.0,1.0,1/11,2.54%,CCDC22
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.4122931826315329,-0.7472674835866302,0.8478260869565217,1.0,1.0,6/14,23.84%,NAMPT;RNLS;NAXE;PTGIS;PARP16;SLC5A8
prerank,KEGG_2021_Human__HIF-1 signaling pathway,0.3326689945833685,0.7472272629112697,0.8717948717948718,1.0,1.0,17/93,20.77%,PIK3R3;ENO4;ANGPT2;FLT1;IGF1;ALDOB;HK3;CDKN1B;CDKN1A;NPPA;MAPK3;NOS2;TF;RBX1;MAP2K1;RPS6;ENO2
prerank,"Reactome_2022__Metabolism Of Ingested SeMet, Sec, MeSec Into H2Se R-HSA-2408508",0.48398844699771215,0.7472138960973197,0.8,1.0,1.0,3/5,20.68%,VSIG2;AHCY;GNMT
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.5215194714749365,-0.7471322620008827,0.7878787878787878,1.0,1.0,3/5,34.25%,BCAT1;BCAT2;HIBADH
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.3159358171682742,-0.7471172350313114,0.9696969696969697,1.0,1.0,10/45,15.53%,NR4A1;CDH13;CCBE1;PARVA;RSPO3;RECK;SLIT2;MIA3;DLL1;NAXE
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.3449574587267962,0.746930946464169,0.8658536585365854,1.0,1.0,13/42,19.99%,SLC7A7;SLC38A3;SLC38A4;SLC25A18;SLC47A1;SLC22A4;SLC38A2;SLC38A10;MFSD12;SLC7A10;SLC1A6;SLC25A22;SLC7A11
prerank,Reactome_2022__ABC Transporters In Lipid Homeostasis R-HSA-1369062,-0.366809885656012,-0.7468927172528621,0.8387096774193549,1.0,1.0,9/17,30.34%,ABCA9;ABCG1;PEX3;ABCA3;ABCA6;ABCG4;ABCD3;ABCA7;ABCD2
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.2949772536165328,-0.7468552878706282,0.875,1.0,1.0,9/66,13.73%,PIAS3;PRICKLE1;CRY1;FBXO4;RIPK2;COMMD1;HDAC3;HSPBP1;MALT1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In6:Brain,0.33281246607547826,0.7466086846083815,0.8783783783783784,1.0,1.0,12/91,13.59%,ROGDI;PPP1R1A;RAMP3;LDHD;ANKRD9;PINK1;RHOB;VWF;CLDN5;PDK4;SNX21;WBP2
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,-0.2631861642190463,-0.746311399475323,0.9259259259259259,1.0,1.0,13/71,20.99%,GRIN3A;GPRIN1;MPP2;KIF17;GRIA4;LLGL1;RPS6KA3;PRKCA;PRKAR2A;RASGRF1;HRAS;PRKAG2;MAPT
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.3291376155560609,-0.7462413014650676,0.8529411764705882,1.0,1.0,5/24,11.11%,CES2;PTGS1;HPGD;PTGR2;AKR1C3
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.32861990028390275,-0.7461428565470635,0.8333333333333334,1.0,1.0,5/40,8.48%,NKIRAS2;S100B;NOD1;ALPK1;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.5018767041607088,0.7461241046275368,0.803921568627451,1.0,1.0,1/5,7.62%,CD99
prerank,Reactome_2022__Beta Oxidation Of lauroyl-CoA To decanoyl-CoA-CoA R-HSA-77310,-0.4875932965173272,-0.7459801067282033,0.7209302325581395,1.0,1.0,1/5,8.91%,ECHS1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Breast,-0.34820602602919337,-0.7459512460990941,0.9428571428571428,1.0,1.0,2/18,4.40%,KIT;LGR5
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.49014195471615496,0.7456810345175021,0.8431372549019608,1.0,1.0,1/7,20.05%,PTPRU
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.4963785945133918,0.7456391266761935,0.8571428571428571,1.0,1.0,1/7,3.49%,RP1
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),-0.47231656347566386,-0.7456367159331347,0.7555555555555555,1.0,1.0,1/5,25.91%,SORL1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex4:Brain,0.45701505128446424,0.7454796806997448,0.875,1.0,1.0,1/11,2.57%,ANXA1
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.43807454062668183,0.7454295412776042,0.803030303030303,1.0,1.0,2/11,6.63%,DBH;SLC6A4
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.3578571302257851,-0.7453081391277692,0.7058823529411765,1.0,1.0,2/16,4.78%,CHRNA10;APOE
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.348119998026974,0.745296081191757,0.8533333333333334,1.0,1.0,4/66,5.77%,RORC;TGFB1;WNT5A;GPER1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.4222656801830067,0.7452535777829714,0.8181818181818182,1.0,1.0,1/14,3.72%,NID1
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,-0.3305514654276853,-0.7452311595684802,0.8333333333333334,1.0,1.0,2/44,1.95%,GCK;GALE
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3450401647678125,0.7452077677035002,0.810126582278481,1.0,1.0,10/62,14.01%,KIF14;ANXA1;CDKN2A;CCND2;CCND1;DDX3X;KANK2;MYO16;CDKN1A;CDKN2C
prerank,Reactome_2022__Negative Regulation Of TCF-dependent Signaling By WNT Ligand Antagonists R-HSA-3772470,-0.39750746275710336,-0.7451299980698658,0.7428571428571429,1.0,1.0,1/12,1.83%,WNT3A
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.43428739034401737,0.7449204493945166,0.7636363636363637,1.0,1.0,2/8,24.75%,INSIG1;INSIG2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.39027303995468743,0.7448373137116974,0.7936507936507936,1.0,1.0,4/19,24.77%,MAPK3;BRCA1;RPS6KA5;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),0.5170109510329595,0.7447807765640123,0.8214285714285714,1.0,1.0,2/5,12.07%,P2RY12;GPR183
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Visceral Adipose Tissue,-0.2764849899821573,-0.7447353623215441,1.0,1.0,1.0,9/93,10.99%,CAMK1G;FIBIN;PAMR1;TMEM132C;FGF1;KCNIP1;DOK5;TAGLN3;PTPRZ1
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Visceral Adipose Tissue,-0.2764849899821573,-0.7447353623215441,1.0,1.0,1.0,9/93,10.99%,CAMK1G;FIBIN;PAMR1;TMEM132C;FGF1;KCNIP1;DOK5;TAGLN3;PTPRZ1
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.3344910630505643,0.7446419003630181,0.8717948717948718,1.0,1.0,11/61,15.21%,LRRC19;ACE2;ANXA1;WNT5A;IRF1;HCK;TNFSF4;LACC1;ALOX15;USP18;CYLD
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.4374058734724347,-0.7445688569424893,0.7441860465116279,1.0,1.0,1/7,2.22%,TWIST1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.41866927784692876,0.744542326172537,0.8382352941176471,1.0,1.0,2/11,10.06%,SCIN;VIL1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.3825845047695179,-0.744511220125702,0.8,1.0,1.0,3/11,24.78%,ITGA3;FYN;INSR
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.4061840339293142,0.7441255493769819,0.7971014492753623,1.0,1.0,6/15,32.10%,NLRC3;ADCY7;APOD;NLRP7;SIRPA;PPARA
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.39889835113204464,0.7439954316926706,0.8064516129032258,1.0,1.0,2/18,7.69%,MCMDC2;MCM3
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),-0.4289481791576088,-0.7438477811398179,0.6756756756756757,1.0,1.0,2/8,11.21%,PCGF1;PCGF6
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.43577768500199116,0.7438463140348804,0.85,1.0,1.0,2/11,16.20%,VIL1;CFL1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.3220140342925997,-0.7438318154276908,0.8636363636363636,1.0,1.0,9/62,7.54%,MLPH;CLDN4;WWC1;ESRP1;RND3;RHBDF1;PTPRF;CRABP2;PERP
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.29001341702806743,0.7436360004963543,0.9878048780487805,1.0,1.0,25/153,19.42%,PSMB9;BLK;BLNK;STOML2;PTPRC;NFAM1;WAS;SYK;HLA-A;HLA-DPB1;THEMIS;CD4;IGLL1;ITK;PSMC5;FYB1;BTN3A3;ZAP70;BCAR1;BTNL9;VAV3;HLA-DPA1;PSMA3;PSMB6;PLEKHA1
prerank,CellMarker_Augmented_2021__Myoblast:Muscle,0.493137725260641,0.7435699875354764,0.8392857142857143,1.0,1.0,4/5,26.92%,ID1;ID3;TTN;PCNA
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.2911835807368291,0.7434765686249988,1.0,1.0,1.0,34/461,12.84%,PSMB9;TRIM58;UBE2U;FBXL7;ASB5;DTL;TRIM62;UBE2L6;ARIH2;ZNF738;DTX2;RNF26;PELI3;TRIM25;SPSB2;RNF187;ANKRD9;HLA-A;RRAGA;PINK1;TRIM68;TRAIP;PRAME;MKRN3;TRIM77;SDE2;RPS27A;TRIM74;VPS18;RNFT1;KLHL2;UHRF2;FBXL13;RNF138
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.45055781866053535,-0.7433925953181235,0.7352941176470589,1.0,1.0,3/8,20.56%,CARD9;MALT1;IL23A
prerank,Reactome_2022__Activation Of Arylsulfatases R-HSA-1663150,0.4352300718200586,0.743368278116166,0.8571428571428571,1.0,1.0,1/13,0.85%,ARSH
prerank,CellMarker_Augmented_2021__Tuft Progenitor cell:Small Intestine,-0.43019813142707874,-0.7432397626605252,0.7837837837837838,1.0,1.0,2/7,6.78%,TPM2;TUBA8
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.36293025435447573,0.7429998631060101,0.8840579710144928,1.0,1.0,5/42,18.38%,CEP55;CHMP3;RPS19;TOR1A;WDR73
prerank,KEGG_2021_Human__Fat digestion and absorption,-0.3258713275203049,-0.742852751568475,0.7714285714285715,1.0,1.0,7/28,12.27%,APOB;PLA2G2C;PLA2G5;CEL;SCARB1;SLC27A4;PLPP2
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.40926582158909713,0.742694717887149,0.8225806451612904,1.0,1.0,5/14,20.87%,GRWD1;SMARCE1;TNP1;HMGA1;SET
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.40926582158909713,0.742694717887149,0.8225806451612904,1.0,1.0,5/14,20.87%,GRWD1;SMARCE1;TNP1;HMGA1;SET
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.3400887129219511,0.742607986016808,0.8311688311688312,1.0,1.0,3/45,9.22%,BLK;NR1H4;PINK1
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.47939619568476166,0.7424466334218445,0.859375,1.0,1.0,2/7,7.66%,ALOX12;IGF1
prerank,Reactome_2022__TRAIL Signaling R-HSA-75158,0.4442343231482734,0.7424113746844682,0.7407407407407407,1.0,1.0,2/6,11.59%,TNFRSF10A;CASP10
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.4316046864978692,-0.7423980114681886,0.7837837837837838,1.0,1.0,2/8,17.42%,DSCC1;RFC3
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.4316046864978692,-0.7423980114681886,0.7837837837837838,1.0,1.0,2/8,17.42%,DSCC1;RFC3
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.2882244835619005,-0.7422423641397684,1.0,1.0,1.0,17/87,16.36%,TRIM71;SERPINE2;APOE;DHFR;NANOS3;PCIF1;CNOT9;CSTA;CAMK2N1;FXR2;DAB2IP;BAG6;EIF2AK3;PUS7;SAMD4B;IGF2BP1;CDK5
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.43633465664068133,-0.7422330180427419,0.6666666666666666,1.0,1.0,1/5,6.56%,FNTA
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,0.38234890237780095,0.7421582231507721,0.7428571428571429,1.0,1.0,3/22,13.25%,PIF1;NOP10;CCNA2
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.4298694944013331,0.742058149187139,0.7543859649122807,1.0,1.0,1/11,6.30%,B4GALNT2
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),-0.4714573028990843,-0.7420225418707669,0.8095238095238095,1.0,1.0,1/5,6.76%,FZD7
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.29157388803074336,0.7419910363182175,1.0,1.0,1.0,33/381,10.91%,ACTL6A;WNT8B;LPAR1;FGF2;GFRAL;MOBP;ROGDI;TGFB1;SOX10;JRKL;MESP1;NMUR2;IRF2BPL;PRDM12;SCIN;SCRG1;IGF2BP2;ERBB4;TBX6;LY6H;AXL;EMX1;SPINK6;GDF11;NDUFS2;PCDHB5;GFRA1;PPT1;UGT8;SDCBP2;ECT2;B3GNT5;CELSR1
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),0.37462385903090467,0.741898699519432,0.8243243243243243,1.0,1.0,2/26,4.58%,RP1;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.3912388605018947,-0.7418626084780393,0.8823529411764706,1.0,1.0,2/16,4.83%,NR4A3;TRPC3
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,0.33734714496854923,0.741758499849238,0.918918918918919,1.0,1.0,6/94,8.12%,ESR1;DAND5;H2BC4;ERBB4;CCND1;H2AZ1
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.3989250710947476,-0.7416314969090874,0.7560975609756098,1.0,1.0,3/7,23.83%,ATG2A;ATG9B;ATG7
prerank,CellMarker_Augmented_2021__Oocyte:Embryo,0.3111624348420946,0.7415644144750863,0.922077922077922,1.0,1.0,13/84,22.14%,UBE2U;ABI3BP;C5ORF34;RAPGEF6;TIFA;DCLRE1A;TSPAN7;ITGB3BP;HOOK2;HOOK1;GGCT;MCTP2;EIF4A2
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,0.352830886024461,0.7413154452180504,0.868421052631579,1.0,1.0,5/35,11.00%,FANCF;FAAP20;RPA3;DCLRE1A;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.3644584064793911,-0.741294644066923,0.71875,1.0,1.0,6/17,17.34%,CCBE1;ADAM8;RHBDD1;PLGRKT;NKD2;MYH9
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,-0.35539058358995346,-0.7412589479237832,0.7419354838709677,1.0,1.0,8/18,23.64%,TP53AIP1;PPP1R13B;STEAP3;AIFM2;PRELID3A;ATM;CREBBP;BID
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.30471161727024065,-0.7412430028045145,0.9230769230769231,1.0,1.0,6/49,6.93%,EMP1;DCT;LAMA3;STS;CCN2;CRABP2
prerank,CellMarker_Augmented_2021__Stem cell:Hair Follicle,-0.46088079352647776,-0.7410743223735132,0.8157894736842105,1.0,1.0,1/5,4.40%,LGR5
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.4870273052148815,0.7409293687116154,0.8115942028985508,1.0,1.0,3/6,16.42%,GPER1;P2RY6;CD244
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.4368760118561582,0.7408995518412537,0.8253968253968254,1.0,1.0,5/10,29.30%,MDM1;BRCA1;KAT2B;TRIM37;CCNF
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.3766931711592129,0.7403434462488387,0.8524590163934426,1.0,1.0,6/24,13.21%,GP1BA;ENPP4;KNG1;VTN;F2RL1;THBS1
prerank,CellMarker_Augmented_2021__Epithelial cell:Thymus,-0.3058010287091284,-0.7402778718585008,0.9,1.0,1.0,10/78,8.09%,TSKU;CLDN4;DSG2;LAMA3;ESRP1;ERBB2;PTPRF;TMEM125;PERP;EPB41L4B
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.43767785310001783,-0.7401853393313452,0.75,1.0,1.0,5/9,29.04%,FGF1;ABCG1;PTH1R;SNCA;WNT4
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.35719581850298165,0.7399016608130322,0.8714285714285714,1.0,1.0,12/50,22.81%,CHCHD4;TIMM22;TOMM20;TOMM7;TIMM17A;HSPA4;TIMM10;FIS1;ROMO1;BCAP31;PAM16;FBXO7
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.35981591187789663,0.7398514345277506,0.9090909090909091,1.0,1.0,10/35,25.18%,ATP10B;VPS18;ACP4;HOOK2;SNAPIN;HOOK1;ACP3;GAA;ACP2;GRN
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.41718530915929425,0.7398185871555965,0.8472222222222222,1.0,1.0,3/15,17.84%,MESP1;POPDC2;MTLN
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.4284236384397793,-0.7395509122293047,0.7222222222222222,1.0,1.0,3/12,20.27%,PARP11;PARP2;PARP16
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.2839642881200044,-0.7393310374543964,1.0,1.0,1.0,37/115,18.36%,BOC;COL4A2;COL12A1;FRMD6;RND3;RHBDF1;ERBB2;KITLG;PARVA;FZD7;FSTL1;CAP2;CDCP1;NTN4;SNAI2;EFEMP1;GNA11;BARX2;SPRY1;PAX3;EDNRA;ANTXR1;DAB2IP;AMOTL2;CHST3;FKBP9;SCRIB;GPC1;COL5A2;COL4A1;DDAH1;SH3D19;ADCY6;SH3BP4;RBFOX2;COL16A1;PTPN21
prerank,CellMarker_Augmented_2021__Epithelial cell:Uterus,0.33177907959185615,0.7393171406992511,0.8513513513513513,1.0,1.0,17/70,20.05%,S100A13;GNG12;ITGB6;MISP;SCARA3;TRIM29;AP1M2;EPCAM;SEMA3F;SEMA3B;KRT8;MUC16;PPIC;LAMB2;SLC44A3;SCNN1A;PTPRU
prerank,CellMarker_Augmented_2021__Dopaminergic neuron:Midbrain,0.33177907959185615,0.7393171406992511,0.8513513513513513,1.0,1.0,17/70,20.05%,S100A13;GNG12;ITGB6;MISP;SCARA3;TRIM29;AP1M2;EPCAM;SEMA3F;SEMA3B;KRT8;MUC16;PPIC;LAMB2;SLC44A3;SCNN1A;PTPRU
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.42154209377721086,-0.7392987521168795,0.725,1.0,1.0,1/9,19.25%,XRCC4
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.420770646380223,0.7392821373673575,0.8615384615384616,1.0,1.0,5/20,20.07%,SIX4;CSRP3;MYPN;LMOD2;OBSCN
prerank,Reactome_2022__RET Signaling R-HSA-8853659,-0.34309504659615814,-0.7392193221266994,0.84,1.0,1.0,5/35,12.71%,SHC3;GFRA2;DOK6;DOK5;MAPK7
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),0.37233357778686704,0.7391165064863193,0.8714285714285714,1.0,1.0,2/18,9.41%,BUB1;WEE2
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.3756850992522669,0.7390990634141823,0.8035714285714286,1.0,1.0,4/30,10.36%,ANXA1;CYP1B1;RHOB;ECT2
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.3716677412453744,-0.7390292829044,0.8,1.0,1.0,2/15,6.76%,GALP;CXCL14
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),0.4946982246340863,0.7390131271484088,0.7636363636363637,1.0,1.0,4/5,22.68%,NR1H4;LDLRAP1;ANXA2;HNRNPK
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.41742948306422073,0.738816647574776,0.8095238095238095,1.0,1.0,1/16,3.81%,PTPRC
prerank,CellMarker_Augmented_2021__Pluripotent Very Small Embryonic-Like cell:Ovary,0.3430269014704562,0.7385656959863482,0.88,1.0,1.0,17/61,24.00%,CLDN6;FOXA3;CCDC172;SALL4;MARVELD3;L1TD1;EPCAM;CHST4;SLC7A3;FBN3;CHST9;SCNN1A;C1ORF94;CBLC;SEMA6A;MYCN;PRDM14
prerank,KEGG_2021_Human__Estrogen signaling pathway,0.3257818495694276,0.73849391388375,0.9113924050632911,1.0,1.0,6/95,6.84%,ESR1;HSPA1L;HSPA8;PIK3R3;GPER1;MMP9
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.340083646389842,0.7384191966264713,0.9,1.0,1.0,6/59,14.96%,TGFB1;TMEM35A;NDC80;ORMDL3;GPR137B;PDZK1
prerank,CellMarker_Augmented_2021__Naive CD8+ T cell:Peripheral Blood,0.3257849878731778,0.7384174610991017,0.9090909090909091,1.0,1.0,12/83,17.48%,TCF7;TMEM204;NT5E;LEF1;EXOSC8;LDLRAP1;GPR183;ARHGAP45;FKBP5;EEF2;TOMM7;PLEKHB1
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.3628420307692315,0.7383709249240782,0.78125,1.0,1.0,3/29,15.19%,RPS27A;STAT1;MAPK3
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.40939609542910005,-0.7383676127895334,0.896551724137931,1.0,1.0,3/9,17.00%,ADCY3;ADCY2;ADCY6
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.40785274329949583,-0.7382937428228697,0.7727272727272727,1.0,1.0,1/13,3.14%,NKIRAS2
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),0.4951248249102992,0.7382818486005625,0.8545454545454545,1.0,1.0,2/6,23.07%,SLC25A19;ACP3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.3925246892574091,0.738258346545006,0.803030303030303,1.0,1.0,7/24,20.83%,TGFB1;DAB2;PPP2R5A;RHOQ;GBP1;USP17L2;MRAP
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.46538094976316596,-0.7381884393865937,0.813953488372093,1.0,1.0,1/5,17.40%,ATPAF1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.4436383117420728,0.7380965495634416,0.8,1.0,1.0,3/14,11.19%,P2RY6;DUOX1;STAT1
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,0.3141780506657188,0.738061752225889,0.918918918918919,1.0,1.0,3/64,10.04%,NEK2;CEP72;CEP70
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.3712100809193061,0.7380068631896275,0.9090909090909091,1.0,1.0,2/29,15.99%,GPER1;AGER
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.31360680715420286,0.7377073156598509,0.8846153846153846,1.0,1.0,12/117,11.00%,C1QTNF1;TIMP3;LOX;AOX1;GNG12;SCARA3;RSPO1;UACA;OSMR;ADGRL4;DCN;COL1A1
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,0.3221960492206008,0.7376829285513843,0.8441558441558441,1.0,1.0,10/73,20.41%,TLR2;PIK3R3;STAT1;CD4;MAPK3;ZAP70;RASGRP1;NFKBIA;MAP2K1;NFATC2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.33541778427871194,0.7376317050182921,0.8656716417910447,1.0,1.0,19/59,23.28%,TGFB1;CNMD;IL26;NLRC3;MARVELD3;MCC;STAT1;THBS1;SOX9;GHRL;ATP5IF1;CEACAM1;AQP11;B2M;ALOX5;GDF5;BRCA2;MTSS1;KLF9
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.3510563741101257,0.7376178580472893,0.84,1.0,1.0,9/41,25.03%,CHCHD4;HSPA5;TOMM20;TIMM17A;ROMO1;PAM16;PEX12;TIMM21;SEC62
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.34488116154378506,0.7375258499331633,0.8591549295774648,1.0,1.0,5/39,15.23%,LCP1;FHOD1;RHOB;RHOG;RHOQ
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.3978853690059636,0.7374968602217152,0.8732394366197183,1.0,1.0,3/17,19.93%,RAB11A;TOR1A;SNAPIN
prerank,Reactome_2022__Role Of ABL In ROBO-SLIT Signaling R-HSA-428890,-0.45739573870901606,-0.7374201767704415,0.803921568627451,1.0,1.0,3/8,21.37%,SLIT2;ABL1;CAP1
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,-0.3479781230671622,-0.7372601127929377,0.7941176470588235,1.0,1.0,9/21,29.21%,CDK5;FYN;HRAS;NTRK2;SRC;DOCK3;GRIN2B;RNASE1;FRS3
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.4044812944128379,-0.7371720932966198,0.8421052631578947,1.0,1.0,7/13,27.24%,MUS81;MDC1;RAD17;RAD9A;EME2;NEK11;HUS1
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.3848292789668569,0.7371621741699093,0.7894736842105263,1.0,1.0,9/20,17.87%,NOX5;ALOX12;TAFA4;DUOX1;SOD2;NOXO1;CYBA;NOS2;NOX1
prerank,CellMarker_Augmented_2021__Ureteric Bud cell:Fetal Kidney,0.32515192368567,0.7371183774535436,0.8837209302325582,1.0,1.0,11/77,14.28%,CDC25A;CLDN6;SIX4;SALL4;PHF21B;COL4A6;COL4A5;AIF1L;HMGA2;DEPDC1;SLC7A3
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,0.35756979359871516,0.7370837410741468,0.8450704225352113,1.0,1.0,3/43,8.32%,FGF20;IGF1;KLB
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,0.35756979359871516,0.7370837410741468,0.8450704225352113,1.0,1.0,3/43,8.32%,FGF20;IGF1;KLB
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.23544588671212593,-0.7370560319927992,1.0,1.0,1.0,36/298,15.51%,TBC1D10A;TBC1D16;RASSF9;RAB20;STX6;CLIP3;NUP42;PRICKLE1;STX11;SYNDIG1;ARFIP2;SNX8;POM121C;TECPR2;TICAM2;RAB7A;NUP214;TMED4;TBC1D2;SNF8;SCFD2;RAB5A;TBC1D22B;ANKLE1;RABL2A;STX5;GGA2;PREB;TBC1D8;RAB28;RAB22A;CHP1;AP4S1;COG7;TBC1D9;STXBP2
prerank,Reactome_2022__2-LTR Circle Formation R-HSA-164843,0.4595420804296829,0.736945040436478,0.7636363636363637,1.0,1.0,2/8,22.43%,HMGA1;XRCC6
prerank,CellMarker_Augmented_2021__B1 cell:Salivary Gland,-0.3600212436318682,-0.7369065650065385,0.8888888888888888,1.0,1.0,5/31,11.08%,P2RY10;CD247;SELL;LTB;ZNF831
prerank,CellMarker_Augmented_2021__T cell:Salivary Gland,-0.3600212436318682,-0.7369065650065385,0.8888888888888888,1.0,1.0,5/31,11.08%,P2RY10;CD247;SELL;LTB;ZNF831
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.4167594567125027,-0.7368411939489103,0.8205128205128205,1.0,1.0,1/9,1.83%,WNT3A
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3866178855135674,0.7368399797868002,0.810126582278481,1.0,1.0,3/27,10.55%,RASGRP4;IGF1;TGM2
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.42047794993777465,0.7367567027829155,0.803030303030303,1.0,1.0,3/13,25.28%,NPY;LHX6;HSP90AB1
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.4713058509029838,-0.7367197273773661,0.8048780487804879,1.0,1.0,1/5,5.48%,CCBE1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.520648598636655,-0.7364270909990066,0.8125,1.0,1.0,2/7,16.39%,CLIP3;TLCD2
prerank,Reactome_2022__Dermatan Sulfate Biosynthesis R-HSA-2022923,-0.40638947185885144,-0.7363349348619558,0.7666666666666667,1.0,1.0,3/10,14.57%,UST;VCAN;CSPG5
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.40236907149361334,-0.7363314637781205,0.7894736842105263,1.0,1.0,2/10,9.82%,VASH1;MARCHF5
prerank,GO_Biological_Process_2021__regulation of phospholipase A2 activity (GO:0032429),0.48884581690695145,0.7361895317749056,0.8793103448275862,1.0,1.0,1/5,2.57%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.3932205095005605,0.736164535507401,0.851063829787234,1.0,1.0,1/17,3.83%,SYT2
prerank,KEGG_2021_Human__Graft-versus-host disease,0.4009780833617793,0.7359103793455314,0.828125,1.0,1.0,5/17,10.69%,HLA-F;CD80;HLA-A;HLA-DMA;HLA-DPB1
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.43088509192351887,-0.7358790281172136,0.84375,1.0,1.0,3/8,5.77%,SERPINE2;HES1;TTBK1
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.28354666154036084,-0.7358689523963257,0.9565217391304348,1.0,1.0,19/115,15.95%,ENTPD2;SLITRK6;ETV1;ARX;ADCYAP1;CFC1;ABCC8;THSD7A;PCP4;ADGRA1;ATP9A;FAM149A;NFIB;NOVA1;SERTM1;NME5;ADGRL2;ESRRG;PCDH17
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.3374855785133027,-0.7354473652117823,0.8387096774193549,1.0,1.0,3/16,8.27%,CD151;CCN1;FLNA
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3964850213802682,0.7352568313738952,0.8870967741935484,1.0,1.0,8/15,25.38%,CAV3;KCNE3;SCN5A;KCNE4;SCN4B;KCNQ1;SCN1B;NOS1AP
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Adipose Tissue,0.38434486710467597,0.7352258329836421,0.7846153846153846,1.0,1.0,7/25,16.35%,PTPRC;ANPEP;NT5E;ITGA5;MME;CD44;ENG
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.4592186444476763,0.7350212680470289,0.7704918032786885,1.0,1.0,2/8,13.45%,MISP;GPSM2
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),-0.3823198016203468,-0.7349087582569384,0.7575757575757576,1.0,1.0,2/15,9.07%,TCOF1;SNAI2
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,0.31152028879848764,0.7348463662160059,0.8933333333333333,1.0,1.0,3/67,10.04%,NEK2;CEP72;CEP70
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.3309831606485322,0.7346158161151943,0.8533333333333334,1.0,1.0,5/67,13.28%,RANBP6;SYK;PINK1;RAB11A;LAMP2
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.32282463388702776,0.7346025556075284,0.9506172839506173,1.0,1.0,19/93,15.58%,PRRX1;LMOD1;ADAM33;ECM2;ABI3BP;MYH11;PCDH18;DAAM2;ANGPTL2;ACTA2;ADGRL4;DCN;COL1A1;ASPN;HMCN1;SFRP4;DDR2;CXCL12;ELN
prerank,Reactome_2022__Formation Of Apoptosome R-HSA-111458,0.4311294504128097,0.7344530113437199,0.8596491228070176,1.0,1.0,3/10,18.71%,UACA;MAPK3;APAF1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),0.4902481732754215,0.7344083701395343,0.9074074074074074,1.0,1.0,1/5,3.51%,FGF2
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),-0.4211985678730927,-0.7343982139196928,0.6888888888888889,1.0,1.0,2/6,24.53%,NOTCH1;LRP6
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.3951898282746593,0.7342714279821237,0.8840579710144928,1.0,1.0,2/25,8.19%,CTCFL;SUV39H1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.3126815407071234,0.7340739142740047,0.9411764705882353,1.0,1.0,19/139,18.70%,CRX;STMN4;GPR179;HTR5A;NR2E3;TCEAL5;NEFM;GRM6;ROM1;LRTM1;ZNF536;VSTM2A;CNTN2;ZDHHC22;RCVRN;B3GALT2;PDC;SYT4;PDE6G
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.2982315399655353,-0.7339808916748451,0.92,1.0,1.0,6/29,19.41%,ERBB2;PTPRR;MATK;PRKCA;NRG2;BTC
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.394734972929362,-0.7339374666951716,0.8648648648648649,1.0,1.0,3/14,10.31%,SERPINE2;SERPINE1;CHAC1
prerank,Reactome_2022__Metabolism Of Porphyrins R-HSA-189445,0.38496798988898884,0.7338168618638503,0.8153846153846154,1.0,1.0,2/20,5.60%,ABCG2;ABCC2
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.30477494061208343,0.7338153764031757,0.9540229885057471,1.0,1.0,23/168,15.99%,SMAD6;LRP4;TGFB1;ALPK2;NLRP12;HEY2;PON1;SLC6A4;NODAL;NR1H4;APOM;MARVELD3;LRPAP1;ID1;MCC;NPR3;CRHBP;RPS19;SOX9;IL4;PROCR;PGAM5;AGER
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.2728733266316612,-0.7338032695871324,0.9047619047619048,1.0,1.0,12/85,12.47%,LSM10;SRRM4;ERN1;KIN;PRPF18;ZC3H12D;SRSF4;SNRPB;HSF1;SF3A2;U2AF2;PTBP1
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.4420024647680062,0.7336113626879851,0.8333333333333334,1.0,1.0,2/11,14.41%,OSMR;IL4
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),-0.40532399526114027,-0.7335307012518211,0.7352941176470589,1.0,1.0,2/10,15.90%,DGCR8;PUS10
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.4703061218329879,0.7334378070207906,0.8225806451612904,1.0,1.0,1/7,15.22%,THOC6
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.4703061218329879,0.7334378070207906,0.8225806451612904,1.0,1.0,1/7,15.22%,THOC6
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),0.4003628142963415,0.733397879332349,0.8307692307692308,1.0,1.0,3/13,28.83%,MPV17L2;TRUB2;COA3
prerank,KEGG_2021_Human__Arginine biosynthesis,-0.3772901508533586,-0.7333927143131436,0.8611111111111112,1.0,1.0,6/16,17.70%,ASS1;GLUD2;GPT2;ASL;GLUD1;GOT2
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.3852620635830468,0.7333713083976655,0.8888888888888888,1.0,1.0,5/27,12.25%,PLA2G10;RNASE10;IQCF1;GLRA1;TAC4
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.37307196385929453,-0.7331471631845552,0.8125,1.0,1.0,1/19,1.53%,BCL2
prerank,CellMarker_Augmented_2021__Luminal Progenitor cell:Breast,0.3404277276440828,0.7331187897401352,0.88,1.0,1.0,10/60,12.25%,CAPN13;ACE2;ITGB6;MISP;EPN3;TRIM29;LAMC2;TJP3;AP1M2;EPCAM
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.3997467963495286,0.7331108164027165,0.859375,1.0,1.0,3/14,12.94%,PHKA1;PHKG1;PYGL
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.35791283385644856,0.7331059408697636,0.8507462686567164,1.0,1.0,11/31,29.18%,SEMA3A;SEMA3F;LRTM1;SEMA3B;SEMA6A;SEMA4C;NTN1;SEMA7A;SEMA3E;SEMA4G;ITGAV
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.35112862568072123,-0.7329866541603475,0.8333333333333334,1.0,1.0,6/25,25.91%,GBF1;COG7;GCC2;RAB6A;CSNK1D;SORL1
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,-0.2709378937995779,-0.7329442104608386,1.0,1.0,1.0,22/169,13.30%,ST3GAL3;DTX1;WWC1;HDAC7;HDAC10;POFUT1;MAML1;GATD3;WWP2;JAG2;HDAC3;MAMLD1;AGO2;TFDP1;JAG1;PSMB2;NEURL1;H2AJ;ARRB2;TLE2;ST3GAL4;TNRC6C
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.42883860816976993,-0.7328888305693742,0.8181818181818182,1.0,1.0,2/6,18.79%,DHDDS;DOLPP1
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.42883860816976993,-0.7328888305693742,0.8181818181818182,1.0,1.0,2/6,18.79%,DHDDS;DOLPP1
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,0.36113759841489107,0.7328436225254671,0.8831168831168831,1.0,1.0,5/44,12.93%,ATP1A4;ATP10B;ATP8B3;ATP11C;PLN
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.36795922622872435,0.7328202345924072,0.8289473684210527,1.0,1.0,4/25,17.94%,IHO1;STRA8;GDF9;M1AP
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.30057097228502905,-0.7327242725968908,0.9142857142857143,1.0,1.0,9/71,14.55%,CPSF1;MAGOHB;SRRM1;SRSF4;SYMPK;U2AF2;CSTF2;CPSF7;LEO1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),-0.39914156571796144,-0.732551572535332,0.7058823529411765,1.0,1.0,5/10,27.05%,CPT1A;ACACB;PRKAG2;SLC25A20;PRKAA2
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.42054766045372916,0.7324906843722471,0.8142857142857143,1.0,1.0,1/17,4.27%,TGFB1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.3118968408488898,0.7324071130501731,0.9156626506024096,1.0,1.0,20/123,18.37%,STMN4;SHISA6;HTR5A;LRRC3B;PLP1;LY6H;PPP1R1B;TCEAL5;NPY;ARHGDIG;PENK;AQP4;ZNF536;GPR88;CCK;VSTM2A;CNTN2;LRRTM1;GFAP;SYT4
prerank,GO_Biological_Process_2021__skeletal muscle cell differentiation (GO:0035914),-0.4360634446354405,-0.7323396718945702,0.7872340425531915,1.0,1.0,2/5,6.35%,KLHL41;MEGF10
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.2877086988542496,-0.7323295880140391,1.0,1.0,1.0,19/65,24.37%,ZDHHC23;PARD3;ZDHHC11B;ZDHHC14;NECTIN3;SYNE3;TAOK2;ZDHHC18;SDCBP;FRMPD1;ZDHHC3;RTP1;RAB10;ZDHHC20;RAB11B;SEC63;BRAF;BID;RFTN1
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.2895257626172997,-0.7318380572652475,0.8947368421052632,1.0,1.0,4/91,3.06%,EHF;CD14;JUNB;RAB20
prerank,KEGG_2021_Human__Basal transcription factors,0.3587933290426376,0.7317941155793884,0.8611111111111112,1.0,1.0,9/40,17.55%,TBPL1;TAF5;GTF2E1;TAF7;TAF7L;TAF6L;TAF10;TAF13;TAF9B
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.33795113316711334,0.7317198282968275,0.9324324324324325,1.0,1.0,12/68,15.64%,NLRP12;GPER1;SYK;NODAL;UACA;REST;HGF;DDX3X;THBS1;CD44;IFI6;NLRP2
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.4547443971607925,0.7316926097261067,0.7719298245614035,1.0,1.0,2/7,23.37%,ATP2A2;STX17
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.30912930138685396,0.7316001228647168,0.9438202247191011,1.0,1.0,20/156,17.97%,ESR1;CAVIN1;RORC;NR1I3;NR2E3;TBPL1;NR1H4;TAF5;GTF2E1;HNF4G;TAF7;RXRG;POLR1C;NPPA;MAPK3;TAF10;TAF13;NR5A2;TAF9B;TAF1A
prerank,GO_Biological_Process_2021__purine ribonucleoside metabolic process (GO:0046128),0.4849376050066691,0.7314179230239611,0.7627118644067796,1.0,1.0,3/5,23.07%,ENPP4;GNMT;ACP3
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,0.36739395322502455,0.7311271767732782,0.8615384615384616,1.0,1.0,3/29,15.19%,FGF20;RPS27A;MAPK3
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3234974231317807,0.7310036513550724,0.9402985074626866,1.0,1.0,6/68,14.60%,GML;SP100;FOXM1;CDKN1B;CDKN1A;NDRG1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.3271564881871295,-0.7309844040453812,0.8,1.0,1.0,3/23,10.78%,RHBDF1;APOE;GPX1
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of Adenylate Cyclase R-HSA-442720,-0.3508499705150552,-0.7309630092179288,0.9069767441860465,1.0,1.0,2/11,18.11%,PRKCA;PRKAR2A
prerank,Reactome_2022__Aspartate And Asparagine Metabolism R-HSA-8963693,0.4407030216141165,0.7308936935627239,0.8709677419354839,1.0,1.0,4/10,19.17%,NAT8L;FOLH1;GADL1;ASPA
prerank,Reactome_2022__Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,-0.33496303271007744,-0.7308920074604597,0.868421052631579,1.0,1.0,5/19,19.25%,GPRIN1;MPP2;LLGL1;RASGRF1;HRAS
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,0.31760826655974594,0.7308235596592639,0.9615384615384616,1.0,1.0,10/94,15.27%,TLR2;NLRP12;SFTPD;HLA-F;TRIM25;HLA-A;STAT1;MASP2;MASP1;ISG15
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,-0.2660197191702382,-0.7306429628128484,1.0,1.0,1.0,22/127,17.00%,DGKD;SHC3;PDGFD;KIT;SHC4;PLD2;KITLG;RALB;PLA2G4C;GNAS;RALGDS;ADCY3;ADCY2;PLPP2;GRM2;AGPAT2;RRAS2;AGPAT5;RHOA;PRKCA;FYN;ADCY6
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.41415848659977006,0.7306297124696801,0.8421052631578947,1.0,1.0,4/14,27.91%,CRHBP;WBP2;LOC400499;SRA1
prerank,Reactome_2022__Rap1 Signaling R-HSA-392517,0.4204537983694817,0.730591333940194,0.8059701492537313,1.0,1.0,2/14,17.29%,RASGRP1;PRKG1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.37312709125583576,0.7305139366595566,0.803030303030303,1.0,1.0,3/23,13.45%,MISP;NDC80;GPSM2
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,0.3577040000961951,0.7304929052170751,0.8285714285714286,1.0,1.0,3/42,8.32%,FGF20;IGF1;KLB
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Gonad,0.2947346832517728,0.7300763986415675,0.9651162790697675,1.0,1.0,23/191,17.85%,TIMP3;CENPU;ITM2A;CASP7;TSPAN4;ELK3;MRPS34;ITGA5;H2AZ1;CKS1B;WDR76;COL6A2;DAB2;SKA2;LIFR;TTK;TUBB6;PROCR;BUB1B;A2M;ARL4A;ITGB3BP;HAPLN1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.38548442709845515,-0.730057897117925,0.8717948717948718,1.0,1.0,3/11,11.37%,PTPRO;NPHS1;JAG1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Bone Marrow,0.4306158280719186,0.7300394039273361,0.8870967741935484,1.0,1.0,5/13,16.35%,PTPRC;NT5E;LIFR;CD44;ENG
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.4299615584948876,0.7300386921682169,0.7692307692307693,1.0,1.0,3/8,34.26%,CASP8;ARHGEF2;BIRC3
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.3566329232212064,-0.7299014095947466,0.8387096774193549,1.0,1.0,5/15,17.92%,HSPB1;MAPK7;NME5;PPIA;HTRA2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Embryo,0.33550278057162164,0.7296976803977722,0.9,1.0,1.0,17/71,21.75%,CAPN13;GPRIN2;ITGB6;MISP;MUC4;LAMC2;EPCAM;SOX9;CD44;AGR2;NSUN7;SLC44A3;SOWAHB;SCNN1A;CBLC;B3GNT3;GRHL2
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.43988662417835656,0.7296717563233506,0.8405797101449275,1.0,1.0,2/9,15.15%,AIPL1;RABGGTB
prerank,Reactome_2022__Response Of EIF2AK1 (HRI) To Heme Deficiency R-HSA-9648895,-0.37874347758953486,-0.7295161297576709,0.8333333333333334,1.0,1.0,2/14,10.65%,CHAC1;ATF3
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.4233867406841778,0.7294982604094772,0.8166666666666667,1.0,1.0,1/9,3.81%,PTPRC
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.36657295962853165,-0.7294513345855279,0.7297297297297297,1.0,1.0,6/14,24.67%,CDK1;PRKCA;CTDNEP1;NEK9;NEK6;LPIN1
prerank,CellMarker_Augmented_2021__Mucosal-associated Invariant T cell:Liver,0.3414847998372227,0.7293475030518093,0.9367088607594937,1.0,1.0,10/57,21.16%,RORC;CD160;FLT4;MBOAT1;KLRB1;B3GALT2;P2RY14;NFKBIA;SESN1;IL18R1
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.32408580610164106,-0.7292479007275343,0.8214285714285714,1.0,1.0,4/30,7.89%,PACSIN2;QRICH2;PARVA;KIF17
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),0.4157413141552695,0.7292246221817171,0.7903225806451613,1.0,1.0,2/15,3.67%,LIPH;LIPI
prerank,Reactome_2022__Defective ST3GAL3 Causes MCT12 And EIEE15 R-HSA-3656243,-0.4588538647560513,-0.7287436166814208,0.7857142857142857,1.0,1.0,1/5,1.32%,ST3GAL3
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.3117713998592785,0.72873531322048,0.9146341463414634,1.0,1.0,6/78,13.07%,RORC;ZFP69;PSAP;SCD;FDFT1;TNFAIP8L3
prerank,KEGG_2021_Human__Fructose and mannose metabolism,-0.32769932993543277,-0.7286433445438862,0.8214285714285714,1.0,1.0,4/28,10.90%,FBP2;PMM2;PFKP;PFKFB3
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.37544555840819377,0.7285939340087796,0.7611940298507462,1.0,1.0,5/23,24.51%,CAV3;SCN5A;YWHAH;SCN4B;SCN1B
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.3816193030837365,0.728583938753921,0.8405797101449275,1.0,1.0,1/17,7.62%,CD99
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,-0.330352321736937,-0.7285275691140785,0.8148148148148148,1.0,1.0,5/27,19.41%,SH3KBP1;TGFA;SPRY1;SPRY2;BTC
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,-0.32179118983947874,-0.7284481839910288,0.8333333333333334,1.0,1.0,6/29,17.40%,MECP2;HDAC3;AGO2;TNRC6C;PRKCA;TNRC6A
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),0.4287217576429811,0.7284289747942243,0.8208955223880597,1.0,1.0,1/11,1.62%,ABCC6
prerank,KEGG_2021_Human__Choline metabolism in cancer,-0.3024072863567884,-0.7284235255112061,0.92,1.0,1.0,9/93,9.87%,DGKD;FOS;PDGFD;EIF4EBP1;PLD2;PLA2G4C;CHKA;RALGDS;WASF3
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.3206290640580754,0.7283083305556943,0.9027777777777778,1.0,1.0,10/60,21.67%,ACOX2;SLC4A1;DDX3X;ANGPTL3;AQP4;CLN8;RBP1;AQP11;EIF5A2;SLC4A2
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),-0.3858465202258684,-0.728286073533836,0.84375,1.0,1.0,2/12,9.07%,TCOF1;SNAI2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.2665525998847071,-0.7280336199129022,1.0,1.0,1.0,11/134,7.69%,MFSD2A;IFI16;FOXO1;ATP6V0D2;KLF10;FADS1;RALB;ATP6V1E2;KPTN;ALB;CLEC16A
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.4245192021001477,-0.7279315770671733,0.8387096774193549,1.0,1.0,2/9,22.12%,MECP2;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.3715316386495152,-0.727816959911004,0.8235294117647058,1.0,1.0,2/11,9.66%,FOXO1;MLIP
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.46979157303772073,0.7278007378008122,0.7931034482758621,1.0,1.0,2/6,29.41%,RBX1;SASH1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.43629874746137687,-0.7277232558982398,0.7692307692307693,1.0,1.0,1/8,3.80%,JMJD4
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.2830127069806365,0.7276237358471002,1.0,1.0,1.0,13/322,9.91%,PSMB9;KIF14;UBE2U;FBXL7;DTL;UBE2L6;ARIH2;TRIM25;SPSB2;RNF187;ANKRD9;PINK1;PRAME
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.32918631987167823,-0.7275459600518407,0.90625,1.0,1.0,5/38,14.49%,APOE;GSAP;SNF8;MAPK7;TRAF3
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.2994060509335199,-0.7274562559902001,0.9130434782608695,1.0,1.0,12/48,19.41%,PRAG1;ERBB2;TGFBR3;IGBP1;ETS1;ZSWIM5;CDK6;RHOA;ABL1;CD9;NRG2;BTC
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.34010355341591575,0.7274207112517384,0.8961038961038961,1.0,1.0,9/52,21.26%,SLC25A31;TIMM22;TOMM20;BCS1L;TOMM7;TIMM17A;TIMM10;FIS1;BCAP31
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.32934746375360546,0.7272248228073902,0.918918918918919,1.0,1.0,23/73,21.75%,CAPN13;ACE2;SCTR;ITGB6;MISP;SMIM22;TMC4;TJP3;AP1M2;EPCAM;AQP4;SOX9;KRT8;AGR2;ONECUT2;SLC44A3;SOWAHB;SCNN1A;CBLC;B3GNT3;SLC4A2;LGALS4;GRHL2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),-0.4505453291769129,-0.7272094392348996,0.7435897435897436,1.0,1.0,2/8,15.55%,NR1H2;ABCG1
prerank,Reactome_2022__Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,0.4164768411609003,0.7271231097319756,0.8615384615384616,1.0,1.0,3/15,12.64%,LDHD;PLPP6;PDK4
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.2884554946712836,-0.7270966475406208,0.967741935483871,1.0,1.0,10/63,12.47%,SYT12;CPNE6;PKD2;HPCA;CARF;AKR1C3;SYT3;SYT17;TRPM2;NEUROD2
prerank,CellMarker_Augmented_2021__Ciliated Epithelial cell:Esophagus,0.29400647375949496,0.7269123067884078,0.9764705882352941,1.0,1.0,34/356,11.60%,PLEKHS1;ENDOG;CCDC60;SLC12A7;RRAD;LRRC46;ECT2L;FAM81B;CFAP126;POLQ;DNAH11;PZP;C11ORF16;CCDC39;ITGBL1;TMEM45B;ERICH2;VWA3B;DYDC2;CCDC81;SDF2L1;ERBB4;ANKUB1;ENPP4;COL4A5;PTRH1;ODAD1;ASIC1;CP;AGBL5;AKAP14;DNAH10;EFCAB10;BPIFB1
prerank,CellMarker_Augmented_2021__Stromal cell:Undefined,0.39114737931650245,0.7267640886660902,0.84375,1.0,1.0,2/23,6.84%,TLR2;MMP9
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Blood,0.2933642934709067,0.7266910968823556,0.9891304347826086,1.0,1.0,33/288,15.74%,ADA;BLNK;CDCA7L;ITGAX;SLC12A3;PTPRC;CLEC4C;ITGAM;ADGRE1;PLD4;VAMP1;CD80;P2RY6;PFKFB2;CD99;PDCD1LG2;SSR4;DCK;AHNAK2;DAB2;TRIM74;CD4;GPR183;RASD1;ALOX5AP;ITM2C;LRRC36;TUBB6;AHCY;TGFBI;IL3RA;CLN8;SLC38A2
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.4099615586949196,0.7266413580669672,0.84375,1.0,1.0,1/13,6.68%,NODAL
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.44830775949312346,-0.7263701331847455,0.8260869565217391,1.0,1.0,2/6,23.38%,ADAR;PPM1F
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),-0.42925255706867044,-0.7263579146405083,0.7837837837837838,1.0,1.0,1/7,1.58%,SLC38A5
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.41881881931254594,0.7262559024980876,0.8548387096774194,1.0,1.0,2/12,11.52%,PRR5L;ZC3HAV1
prerank,CellMarker_Augmented_2021__Pancreatic Endoderm cell:Embryonic Stem Cell,-0.29281403882515733,-0.7261598298030022,0.8823529411764706,1.0,1.0,18/89,11.87%,MYO10;EMP1;COL12A1;HRH1;ARSJ;LAMA3;RND3;RHBDF1;SH3RF1;KITLG;PARVA;GPRC5A;NTN4;SNAI2;EFEMP1;ITGA3;JAG1;ANTXR1
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),0.47874165928667606,0.725835986138734,0.8305084745762712,1.0,1.0,1/6,9.32%,PSAP
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.30752744672264315,0.7257087168839693,0.9090909090909091,1.0,1.0,17/98,25.56%,PSMB9;SYK;ITK;PSMC5;MAPK3;VAV3;PSMA3;PSMB6;NFATC2;PSMD6;PRKCQ;VAV1;TEC;PIK3CB;PSMA7;MAP2K4;PSMB1
prerank,KEGG_2021_Human__Fatty acid elongation,0.39745578080952576,0.7254739946847076,0.8387096774193549,1.0,1.0,4/25,10.00%,ELOVL2;ACAA2;HACD4;PPT1
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.45152595143854213,0.7251536729735721,0.7868852459016393,1.0,1.0,2/6,29.32%,BAP1;USP1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.37061002985173686,0.7251292771070261,0.8787878787878788,1.0,1.0,4/24,10.06%,ACTG1;WAS;FHOD1;VIL1
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,-0.2975736521207284,-0.7250745392047231,0.8571428571428571,1.0,1.0,6/46,11.77%,EXTL1;PDIA6;DDX11;ERN1;CTDSP2;PREB
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.3194624273212365,0.7250614094458557,0.9078947368421053,1.0,1.0,19/72,21.77%,FGF20;SYT15;KCNJ15;SYT2;KCNA5;SYT10;PDZK1;TOR1A;KCNJ2;TF;CHRNB2;CHRNA3;SYT4;YWHAH;KCNJ4;KCNJ11;KCNJ13;B2M;CLDN10
prerank,Reactome_2022__PKA-mediated Phosphorylation Of CREB R-HSA-111931,-0.32390677430103837,-0.7249654504048615,0.8048780487804879,1.0,1.0,4/17,18.11%,ADCY2;PRKCA;ADCY6;PRKAR2A
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.39341817728313544,0.7248519628084747,0.7894736842105263,1.0,1.0,4/14,30.02%,LDLRAP1;STAR;VPS4A;STARD4
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.3621323804238726,0.7246750973701955,0.8636363636363636,1.0,1.0,6/31,19.42%,CD160;IGF1;MYO16;PIK3CG;HTR2B;PLEKHA1
prerank,Reactome_2022__Opsins R-HSA-419771,-0.4397751146444765,-0.7245232472874534,0.7027027027027027,1.0,1.0,2/6,17.02%,OPN5;OPN3
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,0.38925468961094,0.7244957974337548,0.8923076923076924,1.0,1.0,7/18,22.18%,TUBA4A;TUBA3D;TUBB6;TBCE;TUBA1C;TBCC;TUBB4B
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.4369347852090667,0.7243376535333779,0.868421052631579,1.0,1.0,1/10,3.22%,CLCF1
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,0.2907712001460052,0.7242891593093411,1.0,1.0,1.0,77/319,25.85%,BLNK;TLR2;ACE2;SDC2;NLRP12;DDX20;SFTPD;HLA-F;TRIM25;SYK;ATP1A4;REST;ZDHHC11;HLA-A;RPS9;RPS16;GEMIN4;RPS5;RPS27A;RPS3A;MOGAT1;STAT1;VPS18;RPS12;RPS4X;SNRPD2;RPS19;FAU;SAP30L;RPS21;MASP2;MASP1;ISG15;MOGAT2;FKBP4;RPS11;RPS13;PARP14;RPS7;PARP4;IMPDH2;RBX1;YWHAH;RPS15A;G3BP1;IL1R1;RPSA;RPS6;GANAB;IFIH1;PARP9;RPS14;B2M;RBBP7;MTA2;RPS15;YWHAG;PARP10;TKFC;RPS27;PRMT1;KDM1A;RPS3;MGAT4A;RPS23;PARP8;RPS20;VAV1;RPS24;IRAK1;SEC23A;RPS29;HSP90AB1;SAP18;ST6GALNAC2;SEC24D;RPS28
prerank,Reactome_2022__Gap Junction Assembly R-HSA-190861,0.43617562061314136,0.7240593828403221,0.7872340425531915,1.0,1.0,1/7,6.17%,GJB7
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.47985435853050995,0.7240139112503561,0.8852459016393442,1.0,1.0,3/5,27.94%,KDM1A;RNF20;CDK9
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.2934425917215199,-0.7237002338070373,1.0,1.0,1.0,13/57,21.22%,ST3GAL3;MGAT4C;ZDHHC5;ST3GAL2;RPN1;ST3GAL4;MOGS;ZDHHC3;ST6GALNAC3;PRKCSH;PARP16;ZDHHC20;DAD1
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.33838687182042565,0.7236867161967799,0.8611111111111112,1.0,1.0,13/39,24.68%,SLC7A7;SLC38A3;SLC38A4;SLC38A2;SLC16A1;SLC23A1;SLC38A10;SLC7A10;SLC7A11;SLC38A11;SLC36A3;SLC25A11;ABCB1
prerank,Reactome_2022__RUNX1 And FOXP3 Control Development Of Regulatory T Lymphocytes (Tregs) R-HSA-8877330,-0.4283631508491138,-0.7236168018589967,0.7948717948717948,1.0,1.0,1/7,4.89%,CBFB
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,0.29541620125773554,0.7232363243455251,1.0,1.0,1.0,63/246,25.85%,TLR2;ACE2;SDC2;NLRP12;DDX20;SFTPD;HLA-F;TRIM25;ZDHHC11;HLA-A;RPS9;RPS16;GEMIN4;RPS5;RPS27A;RPS3A;MOGAT1;STAT1;VPS18;RPS12;RPS4X;SNRPD2;RPS19;FAU;RPS21;MASP2;MASP1;ISG15;MOGAT2;RPS11;RPS13;PARP14;RPS7;PARP4;YWHAH;RPS15A;G3BP1;RPSA;RPS6;GANAB;IFIH1;PARP9;RPS14;B2M;RPS15;YWHAG;PARP10;TKFC;RPS27;PRMT1;RPS3;MGAT4A;RPS23;PARP8;RPS20;RPS24;IRAK1;SEC23A;RPS29;HSP90AB1;ST6GALNAC2;SEC24D;RPS28
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.3516992773123981,0.7231231104080675,0.8285714285714286,1.0,1.0,11/39,20.56%,PLP1;RAD1;ATP5PF;HSPA5;CKB;BASP1;DYNLL1;PADI2;YWHAH;COX6B1;GNB4
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.3519847380643422,0.723069171981341,0.855072463768116,1.0,1.0,8/33,24.06%,ATP6V1G2;ATP6V0E2;ATP6AP1;ATP6V0B;TF;ATP6V1D;MCOLN1;ATP6V0D1
prerank,CellMarker_Augmented_2021__Epithelial cell:Blood,-0.30031777571021356,-0.7225828336126243,0.92,1.0,1.0,11/65,9.32%,CLDN4;DSG2;ESRP1;RHBDF1;ERBB2;PTPRF;TMEM125;PERP;EPB41L4B;ITGB4;SPDEF
prerank,CellMarker_Augmented_2021__Cancer cell:Lung,-0.30031777571021356,-0.7225828336126243,0.92,1.0,1.0,11/65,9.32%,CLDN4;DSG2;ESRP1;RHBDF1;ERBB2;PTPRF;TMEM125;PERP;EPB41L4B;ITGB4;SPDEF
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.431627052649885,0.7225503385925006,0.8253968253968254,1.0,1.0,1/9,5.72%,MESP1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.30576048835886677,-0.7221024853940804,0.9375,1.0,1.0,16/65,22.03%,HNRNPL;RAD50;WDR74;DNASE1L1;HNRNPF;ANKLE1;PTBP1;POLR2F;POLR2C;RBMX;RBFOX2;SETMAR;POLG;XRN2;DXO;GTF2F2
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.4283821511380306,-0.7220556893665544,0.8,1.0,1.0,6/6,57.18%,SMURF1;FNBP1L;SNX3;CHMP2A;FCHO2;HGS
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,0.2950707538268891,0.7219181516655876,0.9634146341463414,1.0,1.0,39/179,26.42%,PSMB9;CASP7;TNFRSF10A;H1-0;STK26;UACA;CDKN2A;GSDME;IRF1;TP53BP2;RPS27A;PSMC5;ELANE;BBC3;MAPK3;NDUFA2;DYNLL1;DSG3;APAF1;YWHAH;PSMA3;PSMB6;PSMD6;BCAP31;MLKL;TRADD;YWHAG;DYNLL2;GNL3;BMX;PRKCQ;PSMA7;FASN;PSMB1;CASP8;CTNNB1;CARD8;TMED7-TICAM2;STUB1
prerank,KEGG_2021_Human__Homologous recombination,0.3567998451812708,0.7218902242519314,0.8205128205128205,1.0,1.0,4/37,9.53%,SYCP3;POLD4;RAD54L;RPA3
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.26585213830619836,-0.7217618961115716,1.0,1.0,1.0,24/90,16.42%,MKS1;HAUS1;SCLT1;PCM1;CEP83;RPGRIP1L;MAPRE1;FBF1;CNTRL;CDK1;CEP135;ALMS1;CDK5RAP2;CEP152;CEP250;HAUS7;B9D1;KIF24;SDCCAG8;CSNK1E;MARK4;AHI1;CEP41;TCTN1
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),-0.4085933488273905,-0.7215698438444789,0.8717948717948718,1.0,1.0,1/10,2.76%,UST
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.26757548265398534,-0.721349329267495,1.0,1.0,1.0,25/92,16.62%,MKS1;HAUS1;SCLT1;PCM1;CEP83;RPGRIP1L;MAPRE1;FBF1;CNTRL;CDK1;CEP135;ALMS1;CDK5RAP2;CEP152;CEP250;HAUS7;B9D1;KIF24;SDCCAG8;CSNK1E;MARK4;AHI1;CEP41;TCTN1;PRKCA
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.4310784359385012,-0.721307274718296,0.8235294117647058,1.0,1.0,4/11,17.40%,TRIM71;AGO2;TNRC6C;TNRC6A
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.4310784359385012,-0.721307274718296,0.8235294117647058,1.0,1.0,4/11,17.40%,TRIM71;AGO2;TNRC6C;TNRC6A
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.3652696957566747,-0.7212845181094819,0.7428571428571429,1.0,1.0,3/11,12.91%,KLRC1;SERPINB9;ARRB2
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.40405799939219234,0.7212141022517747,0.8676470588235294,1.0,1.0,6/17,25.12%,TGFB1;TGFB3;LARP6;CIITA;RUNX1;SCX
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.36044193117956674,0.7211267201679084,0.8507462686567164,1.0,1.0,1/31,2.15%,SDC2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.44753871985464494,0.7210684888217809,0.875,1.0,1.0,3/7,16.35%,GPER1;SOD2;ENG
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.4333815438930183,0.7210612430740727,0.85,1.0,1.0,3/8,33.44%,CDK7;CDK9;CDK12
prerank,CellMarker_Augmented_2021__Neuronal Progenitor cell:Undefined,-0.2851593740200307,-0.7210367491793904,0.8636363636363636,1.0,1.0,15/97,16.43%,SLC17A6;GALNT13;ELAVL3;MEGF10;INA;KCNIP1;SNCB;TAGLN3;GRIA4;PTPRZ1;ADGRA1;LRRTM3;CSPG5;ERC2;POU3F2
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.38542914446813464,0.7210054501475035,0.8727272727272727,1.0,1.0,4/20,15.08%,CDKN2A;SUV39H1;HMGA2;HMGA1
prerank,CellMarker_Augmented_2021__Eosinophil:Sputum,0.3306247549696599,0.720903722877847,0.8846153846153846,1.0,1.0,22/67,23.16%,S100A13;GNG12;BOK;CCND1;TMEM54;SERINC2;SPR;AP1M2;RTKN;SEMA3F;CD63;KRT8;PPIC;IDH1;LAMB2;SLC44A3;SCNN1A;CBLC;YAP1;CLDN1;C1ORF226;ERRFI1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.39739920295029296,0.7207343932147493,0.8243243243243243,1.0,1.0,1/15,3.51%,FGF2
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.2799287418285267,-0.7205321496883267,1.0,1.0,1.0,7/71,12.47%,HNRNPL;ESRP1;SRRM4;ERN1;HNRNPF;U2AF2;PTBP1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.2746875854849992,-0.7204003212588042,1.0,1.0,1.0,38/186,18.74%,EFNB1;SHC3;PTPRO;GFRA2;LAMA3;SPTBN4;SH3KBP1;SLIT3;PTPRA;EPHA6;SPTB;TNR;EPHB2;NTN4;ANOS1;DOK6;BSG;NIBAN2;DOK5;ALCAM;NFIB;MAPK7;SLIT2;PLXNA4;DSCAML1;GPC1;EVL;LRTM2;PRKCA;LAMA2;NTN5;FYN;DAB1;ARHGAP35;ROBO4;SEMA4A;SEMA3C;ROBO2
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.3338827130308507,-0.7203944300250171,0.9615384615384616,1.0,1.0,1/26,1.28%,BAMBI
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.327839689073969,0.7203852479092397,0.9315068493150684,1.0,1.0,6/57,16.57%,ACOX2;DDX3X;ANGPTL3;ORMDL3;CLN8;RBP1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bladder,0.478363974533482,0.7201066541022695,0.8461538461538461,1.0,1.0,1/6,14.71%,CD44
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.4690760044962951,-0.7200692308386009,0.8529411764705882,1.0,1.0,1/5,18.06%,RABL3
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.43886807180347653,0.7200660571956786,0.8615384615384616,1.0,1.0,2/7,18.30%,TMEM126A;CHRNB2
prerank,Reactome_2022__Calcineurin Activates NFAT R-HSA-2025928,-0.45149231507297416,-0.7198574954194301,0.7857142857142857,1.0,1.0,3/7,22.17%,NFATC3;PPIA;NFATC1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.40892206752873705,0.7197088309404667,0.8648648648648649,1.0,1.0,6/16,20.88%,BOK;SOD2;BBC3;IFI6;FIS1;GGCT
prerank,Reactome_2022__FGFR2 Ligand Binding And Activation R-HSA-190241,0.4487672114438601,0.7194656070513635,0.8541666666666666,1.0,1.0,1/14,2.58%,FGF20
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.42465114485044353,-0.7194357071749428,0.8,1.0,1.0,1/6,1.58%,SLC38A5
prerank,Reactome_2022__Elevation Of Cytosolic Ca2+ Levels R-HSA-139853,-0.3714153302355134,-0.7194128297230445,0.78125,1.0,1.0,3/13,9.63%,ITPR2;TRPC3;TRPC6
prerank,Reactome_2022__Cell-extracellular Matrix Interactions R-HSA-446353,0.40657559352108386,0.7193901691933263,0.8115942028985508,1.0,1.0,2/16,8.71%,VASP;FBLIM1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.3540572025836825,0.7193551460300246,0.92,1.0,1.0,1/33,1.12%,CAVIN1
prerank,Reactome_2022__Regulation Of TLR By Endogenous Ligand R-HSA-5686938,-0.4303725220832573,-0.719262495556066,0.8947368421052632,1.0,1.0,1/10,0.54%,APOB
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.3771412966773673,-0.7192533930363856,0.8611111111111112,1.0,1.0,2/12,11.11%,EGR1;AKR1C3
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.36358527424290266,0.719202790903949,0.8615384615384616,1.0,1.0,6/27,23.23%,MISP;NDC80;GPSM2;ESPL1;DCTN1;DYNLT1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.3423913917305774,0.7191483177785984,0.835820895522388,1.0,1.0,3/38,5.77%,BANF2;H1-0;GPER1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.2528183975359592,-0.7191072758013197,1.0,1.0,1.0,53/290,18.01%,NR4A1;CPSF1;TEAD2;DTX1;LSM10;HDAC7;HDAC10;MAML1;INTS11;IWS1;NR4A3;CBFB;NFX1;TTF2;GTF2I;CCN2;TEAD4;TAF12;RARB;GTF2H2;SNRPB;HDAC3;NR1D1;INTS9;NR2C1;TFDP1;GTF2E2;RTF1;SYMPK;CSTF2;ERCC2;NR2C2AP;SSRP1;ARRB2;CPSF7;POLR2F;TFCP2;ESRRB;LEO1;NR1H2;POLR2C;ELOF1;ESRRG;C5AR1;E2F3;ELOA;TRIP13;HDAC5;MED16;RBMX;PCF11;CPSF4;MED1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.3597685539417757,0.7191041669665141,0.8831168831168831,1.0,1.0,6/33,13.21%,ANXA1;ACTG1;DUOX1;ENPP4;VTN;THBS1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.3492983397807652,0.7189975935578967,0.88,1.0,1.0,4/51,13.50%,LRP4;KANK2;AGT;MME
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,0.36311345606269874,0.7189507712078523,0.8656716417910447,1.0,1.0,9/22,30.82%,ACTG1;CCT7;TMOD3;HSP90AB1;TXNL1;DBN1;HNRNPC;CCT6A;CCT2
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.37788861118917627,0.7189210602190717,0.8627450980392157,1.0,1.0,1/18,3.83%,SYT2
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,0.3607995498143657,0.7189022667957821,0.8666666666666667,1.0,1.0,10/43,23.31%,TMEM186;NDUFB11;NDUFS2;NDUFB10;NDUFA2;NDUFAF5;NDUFB9;NDUFB4;NDUFA1;NDUFB2
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,0.29959411284379744,0.7188859735858096,0.9625,1.0,1.0,20/104,21.82%,GATA4;HIPK1;KCNA5;ATP1A4;TRDN;KCNK7;PLN;NPPA;KCNE3;KCNJ2;SCN5A;ATP2A2;KCNJ4;KCNE4;ORAI1;KCNJ11;RYR3;KCND1;KCNK13;SCN4B
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.37299415663595703,0.7187022266935258,0.8235294117647058,1.0,1.0,3/23,13.24%,HHIP;RFX4;GLI3
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,0.4217692738779846,0.7186125692643571,0.8787878787878788,1.0,1.0,2/15,11.00%,TGFB1;RPS27A
prerank,Reactome_2022__Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,-0.3511046162762816,-0.718485682478504,0.8181818181818182,1.0,1.0,3/13,18.84%,ERBB2;NRG2;AKT2
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,0.32431946989837623,0.7184314417460871,0.8857142857142857,1.0,1.0,2/56,1.99%,ST6GALNAC1;RENBP
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.4250941248288918,0.7183308295741766,0.8333333333333334,1.0,1.0,2/10,5.53%,PTPRC;HLA-F
prerank,Reactome_2022__Synthesis Of PE R-HSA-1483213,0.3913547121686318,0.7182116281471722,0.7878787878787878,1.0,1.0,1/12,8.02%,LPIN3
prerank,Reactome_2022__Activated Point Mutants Of FGFR2 R-HSA-2033519,0.45482505778622045,0.7180094007469968,0.875,1.0,1.0,1/13,2.58%,FGF20
prerank,Reactome_2022__TICAM1-dependent Activation Of IRF3/IRF7 R-HSA-9013973,0.42987263244236135,0.7174493081928262,0.873015873015873,1.0,1.0,1/10,11.00%,RPS27A
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.35091073708809833,0.717396090527469,0.8783783783783784,1.0,1.0,12/50,24.48%,NDUFB11;TMEM126A;NDUFS2;BCS1L;NDUFB10;NDUFA2;NDUFAF5;NDUFB9;NDUFB4;NDUFA1;NDUFB2;TIMM21
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.35091073708809833,0.717396090527469,0.8783783783783784,1.0,1.0,12/50,24.48%,NDUFB11;TMEM126A;NDUFS2;BCS1L;NDUFB10;NDUFA2;NDUFAF5;NDUFB9;NDUFB4;NDUFA1;NDUFB2;TIMM21
prerank,Reactome_2022__Advanced Glycosylation Endproduct Receptor Signaling R-HSA-879415,-0.38946901160596087,-0.7172518114794509,0.8936170212765957,1.0,1.0,1/11,3.51%,S100B
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.33393720585643005,-0.717169071846898,0.8285714285714286,1.0,1.0,8/20,30.34%,CPT1A;ACACB;PRKAG2;SLC25A20;PRKAA2;ABCD3;CERT1;ABCD2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.30457306681883023,-0.7170798447847125,1.0,1.0,1.0,16/47,21.82%,TBC1D10A;APOE;CCBE1;ADAM8;PERP;RHBDD1;PACSIN3;SNX33;NKD2;SNX9;SH3D19;MAPK12;GPLD1;ASTL;CTSC;CLN6
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),0.3750027718201556,0.7168749525079982,0.8591549295774648,1.0,1.0,5/20,30.32%,MPV17L2;TRUB2;MTG1;COA3;SHMT2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.3725593019570014,0.7167415696249536,0.8805970149253731,1.0,1.0,3/19,9.64%,CASQ2;CAV3;TRDN
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.3627383962160126,0.7166851294744115,0.8309859154929577,1.0,1.0,7/25,20.54%,DAO;ACMSD;HPD;IDO1;FAH;HAAO;IDO2
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Skin,-0.39865286813375744,-0.7165040581352576,0.8529411764705882,1.0,1.0,1/10,6.76%,FZD7
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.32497716626836004,-0.7164651862332209,0.8125,1.0,1.0,5/25,10.18%,RAB20;ATP6V0D2;ATP6V1E2;RAB7A;ATP6V0A2
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.39232864178892046,0.7163605131032807,0.8615384615384616,1.0,1.0,6/22,23.82%,SP100;USP17L2;APOD;INSIG1;PARK7;LMAN1
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.46667358885459864,-0.7163571887024361,0.8292682926829268,1.0,1.0,2/5,27.18%,INHA;ID2
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.481707232394216,0.7162864618994305,0.890625,1.0,1.0,2/7,18.60%,AGR2;TMEM33
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.41002344163681737,0.716146017613008,0.835820895522388,1.0,1.0,2/12,10.57%,TK1;DCK
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,0.30079139221364476,0.7160340049371487,1.0,1.0,1.0,3/123,3.25%,NOTUM;PSMB9;HHIP
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.424177331366182,0.7156925342757842,0.8214285714285714,1.0,1.0,2/12,15.83%,GPR151;PKD1L3
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.33891447569867755,0.7156897176180376,0.8676470588235294,1.0,1.0,6/36,20.39%,MAP3K11;VWF;ITGA2B;MAPK3;MAP2K1;FN1
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.4306051147477539,0.7155131492874234,0.8,1.0,1.0,1/9,3.82%,SLC38A3
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.30429879201087995,0.7155118943153738,0.9310344827586207,1.0,1.0,9/113,11.38%,SMAD6;TMEM100;TGFB1;NODAL;DUSP22;TGFB3;ID1;RPS27A;CLDN5
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.3727062209153422,0.7153458874352627,0.8783783783783784,1.0,1.0,6/25,13.17%,PKLR;ENO4;PFKFB2;ALDOB;HK3;PGAM1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.3860783684622426,0.7152241178168064,0.9104477611940298,1.0,1.0,5/14,13.99%,NR1H4;UCP1;SCD;PDK4;SOX9
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.3304135265722652,-0.7152178895333731,0.9473684210526315,1.0,1.0,7/46,12.27%,ACER2;SMPD4;ACER3;PNPLA1;NSMAF;SPTSSB;PLPP2
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.36606299168932777,-0.7150919773199272,0.7777777777777778,1.0,1.0,2/18,4.78%,LIPC;APOE
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Mammary Gland,-0.29031764995226167,-0.7150602215636157,0.9130434782608695,1.0,1.0,17/81,12.55%,DUSP6;PACSIN2;HDAC7;CAPN2;RALB;PHC2;ETS1;FLNA;CTDSP1;DNASE1L1;TFE3;GPX1;C1RL;CTDSP2;ABLIM3;LRP10;NLRX1
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.43817123147873005,0.714852678586827,0.8939393939393939,1.0,1.0,1/10,1.28%,C3AR1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.3417967284482914,0.7148334378837953,0.9102564102564102,1.0,1.0,7/46,10.01%,SDC2;LRAT;LRP2;BCO1;GPIHBP1;APOM;DHRS3
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.46606764383275756,0.7146792828547881,0.8771929824561403,1.0,1.0,1/6,11.55%,DACH1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.29172313105267883,-0.7145672139367716,1.0,1.0,1.0,11/61,17.20%,SKAP1;CDH13;FLNA;CRK;CDK6;RELL2;CSPG5;CRKL;LIMS1;EMP2;ABL1
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),-0.3891351858503723,-0.714453303626993,0.7674418604651163,1.0,1.0,2/8,15.95%,OTUD3;OTUD7A
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Blood,0.35559241286681725,0.7144462457229949,0.9,1.0,1.0,13/40,17.94%,ARHGAP9;SASH3;PTPRC;NLRC3;TAGAP;THEMIS;PSTPIP1;KLRB1;SIRPG;ITK;ZAP70;TIGIT;ARHGAP15
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.28434636664329604,0.7144371153212724,0.9887640449438202,1.0,1.0,42/302,23.44%,FBXO48;PSMB9;KIF14;UBE2U;FBXL7;TRIM25;HSPA5;SPSB2;RNF187;ANKRD9;PRAME;RPS27A;FBXL13;FBXL3;PSMC5;KBTBD7;YOD1;KBTBD6;BUB1B;FBXO5;SYVN1;HERPUD1;SEL1L;RMND5A;FEM1B;RBX1;PSMA3;SIAH1;PSMB6;KCTD17;ZFAND2A;DNAJB9;PSMD6;TNFAIP1;CCNB1;RNF5;DDIT3;SPSB4;LTN1;KLHL15;SPSB3;DNAJB2
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.31440471121396507,0.7140121880460605,0.9487179487179487,1.0,1.0,4/103,6.95%,PLA2G10;PIK3R3;FGF2;IMPA1
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.4493003592553939,0.7139498569838275,0.7692307692307693,1.0,1.0,2/8,12.42%,SEMA3A;SEMA3F
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.4493003592553939,0.7139498569838275,0.7692307692307693,1.0,1.0,2/8,12.42%,SEMA3A;SEMA3F
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.3205616168177953,-0.7137631636076193,0.96,1.0,1.0,2/38,4.92%,NR4A3;MTFR2
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.34364137129590766,-0.7134272919783815,0.9142857142857143,1.0,1.0,9/23,28.73%,KIF1C;BICDL2;CLN3;TRAK2;BICDL1;HTT;PAFAH1B1;TRAK1;KIF3B
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.3395285312589171,0.7132697648781321,0.875,1.0,1.0,5/28,15.99%,IGF1;PDCD1LG2;CRTAM;IDO1;AGER
prerank,Reactome_2022__DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,0.4855846011610169,0.7132638430966699,0.8214285714285714,1.0,1.0,1/5,12.98%,NFKB2
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.45554272509707466,-0.7132104708483684,0.8541666666666666,1.0,1.0,3/8,25.43%,PTPRJ;PTPN2;SNCA
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.3195302555541115,0.7128826675957131,0.9294117647058824,1.0,1.0,16/86,18.71%,TNFRSF1B;CIDEB;BOK;DDX3X;CYP1B1;HIC1;TP53BP2;MOAP1;ERN2;CDKN1A;BBC3;IFI6;BRCA1;MSH6;HINT1;APAF1
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.4157466424765054,0.7126898512849652,0.873015873015873,1.0,1.0,2/10,11.20%,SYK;ATP6AP1
prerank,Reactome_2022__Inwardly Rectifying K+ Channels R-HSA-1296065,0.36616329533235276,0.7123927314969669,0.8947368421052632,1.0,1.0,8/30,20.56%,KCNJ15;GNG12;GNG4;KCNJ2;KCNJ4;KCNJ11;GNGT1;GNB4
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.3243108370512708,-0.7122607061655061,0.8536585365853658,1.0,1.0,1/19,2.74%,PIWIL2
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,-0.3398431356966098,-0.7122578218719153,0.9444444444444444,1.0,1.0,2/22,11.25%,IFT88;HSF1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.3347145200343066,-0.712179224584171,0.8695652173913043,1.0,1.0,4/23,13.04%,CTC1;SLX4;STN1;EXOSC10
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.35122432003591303,-0.7120788087099535,0.8064516129032258,1.0,1.0,5/22,20.06%,MEN1;ATR;HSF1;HRAS;ATM
prerank,KEGG_2021_Human__TNF signaling pathway,0.30357351276260397,0.7120215452423726,0.9210526315789473,1.0,1.0,19/89,22.06%,TNFRSF1B;PIK3R3;CCL5;CASP7;MMP9;IRF1;CASP10;MAPK3;PGAM5;CSF1;VEGFC;NFKBIA;MAP2K1;RPS6KA5;CREB3;TRAF5;IL18R1;MLKL;TRADD
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.3739282233625749,0.7119247744391687,0.8571428571428571,1.0,1.0,6/30,19.32%,LRP4;REST;OMG;EFNB3;YWHAH;MAG
prerank,Reactome_2022__Uptake And Function Of Diphtheria Toxin R-HSA-5336415,0.48370888140200735,0.7117815509231611,0.8507462686567164,1.0,1.0,2/5,25.28%,EEF2;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.2580504354662723,-0.7117409110498089,1.0,1.0,1.0,23/170,16.61%,PIWIL2;TCOF1;TRIM71;PUM3;KLHL25;ERBB2;UPF3A;DHFR;NANOS3;PCIF1;HSPB1;CNOT9;CIRBP;FXR2;GEMIN5;ZCCHC4;EIF2AK3;IMPACT;RPS6KA3;PUS7;SAMD4B;IGF2BP1;ETF1
prerank,Reactome_2022__Serine Biosynthesis R-HSA-977347,-0.4313868847341502,-0.7114854436631443,0.7954545454545454,1.0,1.0,1/8,2.34%,PSAT1
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),0.5077227988484972,0.711473111745029,0.8852459016393442,1.0,1.0,1/5,13.90%,RAB38
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,0.38738044049801185,0.7114348997775158,0.8974358974358975,1.0,1.0,4/20,15.72%,MYH11;MYL6;RHOB;MYL9
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.29194697430017263,-0.71142044411809,1.0,1.0,1.0,4/76,3.10%,MT1G;CCDC22;FLVCR1;ACO1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.30710881567808906,0.7111679668578292,0.9594594594594594,1.0,1.0,4/98,4.41%,CAPN13;TRIL;TSPAN11;SHISA6
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.34798231384961215,0.7111542388265415,0.9358974358974359,1.0,1.0,10/40,29.18%,PTX3;EDNRB;AZIN1;CRYAB;HMGCR;HSP90AB1;CLU;VBP1;PFDN6;ITGAV
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.30265758293488093,0.7110219482819388,0.948051948051948,1.0,1.0,17/98,25.56%,PSMB9;SYK;ITK;PSMC5;MAPK3;VAV3;PSMA3;PSMB6;NFATC2;PSMD6;PRKCQ;VAV1;TEC;PIK3CB;PSMA7;MAP2K4;PSMB1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.3539926420455968,0.7110027762976079,0.9324324324324325,1.0,1.0,14/31,33.04%,VPS18;ACP4;HOOK2;SNAPIN;HOOK1;ACP3;GAA;ACP2;GRN;LAMTOR1;HPS4;AKTIP;TFEB;CLVS2
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,0.31339217884150755,0.7109239949702123,0.8977272727272727,1.0,1.0,10/75,21.22%,POLE2;POLD4;RPA3;RPS27A;COPS4;GPS1;COPS5;RBX1;POLE3;XAB2
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.2810445738894546,0.7107883032509813,1.0,1.0,1.0,42/393,17.94%,GATA4;ARHGAP9;RRAS;ARHGAP24;ARHGAP31;ROS1;HIPK1;NLRP12;WNT5A;RAD1;ARHGAP28;TAF5;DDIT4;TP53BP2;RPA3;RHOB;TAGAP;VWF;ECT2;ARHGDIG;RHOU;RASGRF2;F2RL1;TAF7;NOP53;RHOG;ARHGAP45;MAPK3;CYLD;RHOQ;CDK5R1;AGER;RPL11;TAF10;RMI2;TAF13;A2M;BRCA1;VAV3;TAF9B;GBP1;ARHGAP15
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.2818422666417595,0.7107605457184963,1.0,1.0,1.0,30/256,14.48%,CDC25A;PCLAF;DTL;SPATA22;PTPRC;TGFB1;GPER1;SMIM22;IL12A;CRLF3;AFAP1L2;CDKN2A;FOXM1;CCND1;IRF1;CKS1B;TP53BP2;RHOB;HMGA2;UHRF2;CDKN1B;CDC14A;CDKN1A;WDR6;THBS1;NOP53;FBXL3;SOX9;CDKN2C;ALOX15B
prerank,GO_Biological_Process_2021__tryptophan catabolic process to kynurenine (GO:0019441),0.47840312672092,0.710470986265607,0.8387096774193549,1.0,1.0,2/5,20.54%,IDO1;IDO2
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,-0.3345693386830718,-0.7103764454717787,0.9642857142857143,1.0,1.0,4/26,13.08%,BCL2;TFDP1;YWHAQ;PPP1R13B
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.29343506369040445,-0.7102245549450911,0.9444444444444444,1.0,1.0,12/112,10.86%,GCK;NUP210;CDH5;NUP42;POM121C;FZD7;HSPB1;NUP214;LDB1;AAAS;KDM4D;ZBTB7A
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.27474053641273416,-0.710200694470147,0.9411764705882353,1.0,1.0,18/94,20.28%,TRIB2;PRICKLE1;COMMD1;TRIB1;BAG6;SDCBP;HSPBP1;FHIT;CSNK1E;FBXO22;NKD2;FOXF2;SUMO2;HFE;GIPC1;N4BP1;GNA12;ZER1
prerank,GO_Biological_Process_2021__negative regulation of meiotic nuclear division (GO:0045835),0.48180799242839434,0.710155128792044,0.8852459016393442,1.0,1.0,2/6,17.10%,RAD1;FBXO5
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.4684809521683,0.7101019307037427,0.7924528301886793,1.0,1.0,2/6,16.35%,HEY2;ENG
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.2503296445151856,-0.7097612256639435,1.0,1.0,1.0,20/160,14.87%,SEC24C;KDELR1;SPTBN4;COG4;TGFA;TICAM2;SPTB;TMED4;TRAPPC12;GBF1;STX5;SPAST;PREB;CNIH3;CAPZB;STEEP1;PGAP1;TRAPPC1;MIA3;COG7
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.39859839715881595,0.7097260139135796,0.835820895522388,1.0,1.0,3/14,14.44%,TMEM204;SFRP4;LRIT3
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.35664323317341023,-0.7096692925183089,0.868421052631579,1.0,1.0,3/18,5.64%,ASPG;MTHFR;ASS1
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.4103562634390917,0.7096350433199179,0.859375,1.0,1.0,3/12,16.35%,PGM5;CSRP3;ENG
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.36043324383779707,-0.709401334841411,0.8421052631578947,1.0,1.0,2/14,3.57%,KCNE1;KCNG1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.3043086152165007,-0.7093320215763489,0.90625,1.0,1.0,3/32,9.70%,PRKCD;FLNA;HDAC3
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.308583495548592,0.7092235005125296,0.9176470588235294,1.0,1.0,26/124,18.65%,TIMP3;PRRX1;PRG4;LMOD1;FBXL7;NID1;PCDH18;SCRG1;DAAM2;ANGPTL2;ADGRL4;COL6A2;DCN;COL1A1;STAT1;HMCN1;GLI3;DDR2;CXCL12;ELN;AGER;SOX6;HAPLN1;FRZB;COL10A1;THBS2
prerank,CellMarker_Augmented_2021__Gonadal Mitotic Phase Fetal Germ cell:Fetal Gonad,0.2965905253503477,0.7090270873621616,0.9759036144578314,1.0,1.0,45/255,18.78%,AQP3;ST6GALNAC1;PPP1R3B;CLDN6;SCGB3A2;A4GALT;SYT2;SNAP23;CD81;SHD;NFE2L3;MEIOB;CCND2;HSPA5;DDIT4;FHOD1;FBLIM1;ABHD14B;RPL13A;PLAU;ALX4;TJP3;RPL41;RASD1;RPS4X;RPL27A;CD63;SLC47A1;EEF1A1;ITM2C;KLRG2;GIP;TMEM160;STOM;RPL11;RPS13;QPRT;CABYR;MSH6;TUBA1C;HINT1;RPL7;TRAPPC5;TMEM33;ATP6AP2
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.39830944389076584,0.7088064959977578,0.875,1.0,1.0,6/12,23.81%,PARP14;PARP4;PARP15;PARP9;PARP10;PARP8
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.31697685692680416,0.7087758696731562,0.935064935064935,1.0,1.0,17/63,23.66%,DISC1;IFIT1;LRPAP1;DAB2;TMC8;CDKN1A;TFIP11;MITD1;EFHB;ATP2A2;CTSZ;ZFPM1;B2M;BAG2;DNAJB2;KDM1A;PARK7
prerank,CellMarker_Augmented_2021__B cell:Kidney,0.27456163910144715,0.708717523025508,1.0,1.0,1.0,112/582,24.21%,BLK;ADAM28;BLNK;CDHR5;CDCA7L;AIM2;ARHGAP24;SP100;DNAJC5B;TSHR;SYPL1;JCHAIN;SCIMP;EBF1;CCDC81;IL12A;SYK;CXCR5;SLC22A7;COL4A4;NT5E;HSH2D;IGF1;APOM;LDHD;DUSP22;DDX3X;ASB15;HLA-DMA;ACSM3;CALB1;UGT8;TAGAP;NT5DC2;TIFA;HLA-DPB1;CD37;STAG3;ZBTB32;ERN2;TMEM156;GPR183;ATG101;PNOC;TAF7;CTXN3;IL7;NFKB2;IGLL1;ITM2C;CCNI;PLEKHG7;BASP1;EEF2;CHAC2;RPS11;RPS13;QPRT;ORC4;PARP14;BTNL9;ERO1B;ID3;CNR1;STRADB;CNR2;SYVN1;SPATC1L;REPS2;KLHL14;LRWD1;HVCN1;MRPS2;HLA-DPA1;GPR18;PGM3;SWAP70;PLP2;IL2RA;C16ORF74;TSPAN13;LY86;PARP15;TRAF5;LARP6;TMEM243;CYB561A3;CCNB1;CIITA;SNN;RBBP7;CLDN10;SNX2;PLAC8;TEX9;CD27;TKFC;HMGB3;CD74;MTSS1;PKHD1L1;CENPM;PRMT1;TIMD4;HLA-DRB1;ZNF90;HSPA13;PHGDH;INPP5D;DPAGT1;PYCR1;ZNF296
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.4106429274686987,0.708674264543279,0.8636363636363636,1.0,1.0,2/14,10.57%,TK1;DCK
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,0.33799823094509845,0.7085603767247419,0.8918918918918919,1.0,1.0,7/43,17.55%,TAF5;GTF2E1;TAF7;TAF7L;TAF10;TAF13;TAF9B
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.4247626774697161,0.7084357689604917,0.8666666666666667,1.0,1.0,5/11,22.88%,BBOX1;ALDH9A1;TMLHE;ACADL;CRAT
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.2921277916338331,0.7083716793662693,0.9620253164556962,1.0,1.0,13/97,16.24%,SLC10A1;SLCO1A2;NPC1L1;ABCC2;SLC51A;NR1H4;ABCC11;MFSD2B;MTTP;TNFAIP8L3;SLCO2B1;CLN8;ABCG5
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.4243007832049295,0.7083667378875679,0.8245614035087719,1.0,1.0,2/6,20.79%,HMGA2;POLE3
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.33183456101765746,-0.7082040845780835,0.8947368421052632,1.0,1.0,2/22,3.51%,NKIRAS2;S100B
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.3857836443883609,0.7081920181044319,0.875,1.0,1.0,3/18,7.54%,FUT2;B4GALNT2;MPDU1
prerank,KEGG_2021_Human__Relaxin signaling pathway,0.30282934968115766,0.7079881465243175,0.9655172413793104,1.0,1.0,22/112,20.56%,PIK3R3;GNG12;TGFB1;MMP9;COL4A4;COL4A3;GNG4;ACTA2;RXFP2;COL4A6;COL4A5;COL1A1;ADCY7;EDNRB;MAPK3;NOS2;VEGFC;NFKBIA;MAP2K1;CREB3;GNGT1;GNB4
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.4002387873584127,0.7078669035384546,0.835820895522388,1.0,1.0,1/15,3.45%,C3
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),0.4249025927617829,0.7076804178678575,0.8076923076923077,1.0,1.0,4/6,34.24%,PIK3CG;PIK3CB;RAC1;EZR
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.3344746906879151,0.7075098184475912,0.9305555555555556,1.0,1.0,12/45,24.77%,GP1BA;H2BC4;H2AZ1;THBS1;ITGA2B;MYL9;H2AZ2;ZFPM1;PRMT1;RUNX1;PRKCQ;H2AC6
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,0.29736156367809774,0.7073994590111787,0.9620253164556962,1.0,1.0,23/164,17.22%,ENPP2;TCN1;SDC2;LRAT;AOX1;LRP2;BCO1;GPIHBP1;NT5E;APOM;RFK;GCHFR;LDLRAP1;AMN;SLC25A19;CBLIF;SLC46A1;RBP1;MTHFD2;QPRT;PARP14;PARP4;SLC23A1
prerank,Reactome_2022__Removal Of Flap Intermediate R-HSA-69166,0.4105471218727833,0.7072322824355104,0.8235294117647058,1.0,1.0,2/12,9.53%,POLD4;RPA3
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.310633545250404,-0.7072113341293134,0.8928571428571429,1.0,1.0,4/29,11.31%,CRH;EPHB2;GRIA4;GRIN1
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.3237670751295698,0.7068795578184833,0.8846153846153846,1.0,1.0,9/75,9.73%,AMBP;CLDN2;ACE2;C3;ITGB6;MISP;SERINC2;TRIM29;LAMC2
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.4233056578046387,-0.706576468168945,0.8181818181818182,1.0,1.0,3/8,22.75%,DRD2;DTNBP1;PALM
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.46245690759369973,0.7064075154927074,0.8448275862068966,1.0,1.0,3/7,33.49%,STK25;RIPOR1;PDCD10
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.42585404481757594,0.706398121268748,0.8382352941176471,1.0,1.0,4/8,29.47%,GRAMD2A;EFHB;CASQ1;SARAF
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.32728422506532495,-0.7063594293545543,0.9,1.0,1.0,9/39,20.99%,CDH5;CLIP3;MAPRE1;CDK5RAP2;ABL1;CAMSAP3;AKAP9;GBA2;MAPT
prerank,CellMarker_Augmented_2021__Mucous Acinar cell:Salivary Gland,0.31433863010250473,0.7057747096932421,0.9506172839506173,1.0,1.0,9/93,12.29%,LPAR1;LOX;GNG12;ITGA2;CCND1;STEAP1;AHNAK2;LACC1;GLIS3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Intestine,0.31433863010250473,0.7057747096932421,0.9506172839506173,1.0,1.0,9/93,12.29%,LPAR1;LOX;GNG12;ITGA2;CCND1;STEAP1;AHNAK2;LACC1;GLIS3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gastrointestinal Tract,0.31433863010250473,0.7057747096932421,0.9506172839506173,1.0,1.0,9/93,12.29%,LPAR1;LOX;GNG12;ITGA2;CCND1;STEAP1;AHNAK2;LACC1;GLIS3
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,-0.36016446580459893,-0.7057689370559617,0.8461538461538461,1.0,1.0,7/15,26.86%,CDK1;TFDP1;RBL1;LIN52;E2F5;HDAC1;MYBL2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.31982299456851787,0.7055136445927044,0.9545454545454546,1.0,1.0,9/59,16.54%,FGF2;WNT5A;STAT5A;FLT4;AGGF1;MYDGF;ZNF580;HTR2B;VASH2
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.32242862319724463,0.7054979397894453,0.85,1.0,1.0,9/61,15.21%,PTPRC;HIPK1;SYK;AXL;STAT1;LIFR;IL7;USP18;CYLD
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.4274010848555003,0.7054422587750034,0.8412698412698413,1.0,1.0,2/11,22.45%,TCHP;YAP1
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,0.3211399989145876,0.7054157978830918,0.8875,1.0,1.0,15/87,14.71%,CAPN13;COL18A1;MMP19;NID1;SCUBE3;MMP9;MMP15;LAMC2;DCN;SPOCK3;CAPN12;PLG;MMP11;ELANE;CD44
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.3143427704717583,0.7054124081722416,0.9436619718309859,1.0,1.0,16/121,11.55%,C1QTNF1;TIMP3;LMOD1;C3;CYYR1;SLC12A3;HEY2;ANGPTL2;IGF1;DRAM1;PPP1R1B;ADGRL4;VWF;DCN;PLA2G7;DACH1
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),-0.47596563030280453,-0.7053834664216349,0.775,1.0,1.0,1/5,6.19%,GSTZ1
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),-0.47596563030280453,-0.7053834664216349,0.775,1.0,1.0,1/5,6.19%,GSTZ1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.3187700944645286,0.7053205495982603,0.9,1.0,1.0,5/75,7.68%,CCL5;LRP2;TRPV6;NMUR2;RAMP3
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.45100113433451033,0.7048652197344721,0.7903225806451613,1.0,1.0,1/7,2.57%,ANXA1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.3026380629449049,-0.7048398087976983,0.9354838709677419,1.0,1.0,8/28,19.91%,RAD50;WRAP53;GAR1;TERT;ANKRD28;RTEL1;TNKS1BP1;NHP2
prerank,Reactome_2022__Myoclonic Epilepsy Of Lafora R-HSA-3785653,-0.39304853811185003,-0.7047599005862746,0.7857142857142857,1.0,1.0,1/8,5.09%,GYS1
prerank,CellMarker_Augmented_2021__Acinar cell:Salivary Gland,-0.29350136727011206,-0.7046778751679914,0.875,1.0,1.0,10/62,12.09%,GRK5;CALD1;ERG;PAPSS2;LHFPL2;PTGS1;SH3RF3;DNASE1L1;PDE3A;ABLIM3
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.31625066391024315,-0.7045730298728471,0.875,1.0,1.0,15/41,21.80%,RALB;LRSAM1;FSCN1;CROCC;ASAP1;SDCBP;ENTR1;MARK4;SDC4;CCDC88A;ARHGAP35;STX18;PIP4K2B;PLK4;CEP120
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.28981677181964405,0.7044009378198616,0.9886363636363636,1.0,1.0,55/234,24.51%,SLC9A2;NOX5;KCNA7;SLC12A3;TRPV6;TRPC7;SLC6A4;KCNA5;ASIC5;KCNS2;ATP1A4;KCNG2;ATP6V0E2;KCNK7;ASIC1;SLC9C1;UCP1;SLC24A1;SLC39A7;SLC30A2;KCNAB1;SLC46A1;KCNJ2;SLC6A12;SCN5A;HVCN1;LRRC38;ATP2A2;TRPM8;KCNJ4;LRRC55;SCNN1A;ORAI1;KCNJ11;RHD;RHBG;RYR3;KCND1;KCNK13;SCN4B;KCNS3;MCOLN1;SLC24A5;KCNQ1;KCNF1;CACNA2D4;SCN7A;SLC30A4;SCNN1G;SLC36A3;ATP6V0D1;ASIC4;SLC30A1;ATP1A1;SCN1B
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.39972715750465326,-0.70440079305041,0.8095238095238095,1.0,1.0,2/6,27.45%,SRC;ACTN2
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.33820783411931404,0.7043710726968253,0.9066666666666666,1.0,1.0,18/66,24.36%,BACE2;CPM;ERAP2;ANPEP;HPGDS;LVRN;MME;DNPEP;SPCS2;CTNS;RHD;CPD;GSTT2;ERAP1;PCSK5;LNPEP;CPE;DPEP1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.3012541733746973,-0.7043261415846555,0.9722222222222222,1.0,1.0,10/35,16.79%,FOS;EGR1;ETS1;NFATC3;FOSL1;NFIB;TERT;SMARCA4;TGFB2;NFATC4
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Endometrium,0.4638986538754659,0.7041383131264113,0.8235294117647058,1.0,1.0,2/7,7.30%,PTPRC;NT5E
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,0.35741177022176895,0.7040354003959576,0.8840579710144928,1.0,1.0,5/27,21.42%,CA1;TALDO1;MSN;RPLP0;ANXA2
prerank,Reactome_2022__CREB Phosphorylation R-HSA-199920,-0.4137374201204991,-0.7038727268249266,0.7878787878787878,1.0,1.0,2/7,15.15%,MAPKAPK2;RPS6KA3
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.34284121108926946,0.703537246059224,0.9066666666666666,1.0,1.0,7/35,13.17%,PKLR;ENO4;PFKFB2;ALDOB;ENOSF1;HK3;PGAM1
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),-0.4168222076733551,-0.7033369340951059,0.8461538461538461,1.0,1.0,1/7,4.21%,NR4A3
prerank,Reactome_2022__Other Interleukin Signaling R-HSA-449836,-0.32444637479069854,-0.7032995981763711,0.9411764705882353,1.0,1.0,6/19,20.00%,IL16;PTPRZ1;STXBP2;IL10RB;CASP3;IFNLR1
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.4631641944757266,0.7032625454819557,0.9354838709677419,1.0,1.0,3/9,32.28%,CHMP1A;VPS4A;CHMP2B
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.4631641944757266,0.7032625454819557,0.9354838709677419,1.0,1.0,3/9,32.28%,CHMP1A;VPS4A;CHMP2B
prerank,CellMarker_Augmented_2021__Esophageal Mucosal cell:Esophagus,0.2984860327055395,0.7031332221048904,0.9733333333333334,1.0,1.0,9/99,16.69%,TRIL;FBXL7;TMEM35A;PLP1;GFRA1;LIFR;PCDHB10;CNTN2;ZDHHC22
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestine,0.2984860327055395,0.7031332221048904,0.9733333333333334,1.0,1.0,9/99,16.69%,TRIL;FBXL7;TMEM35A;PLP1;GFRA1;LIFR;PCDHB10;CNTN2;ZDHHC22
prerank,CellMarker_Augmented_2021__Small Intestinal Stem cell:Small Intestinal Crypt,0.2984860327055395,0.7031332221048904,0.9733333333333334,1.0,1.0,9/99,16.69%,TRIL;FBXL7;TMEM35A;PLP1;GFRA1;LIFR;PCDHB10;CNTN2;ZDHHC22
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Colon,0.2984860327055395,0.7031332221048904,0.9733333333333334,1.0,1.0,9/99,16.69%,TRIL;FBXL7;TMEM35A;PLP1;GFRA1;LIFR;PCDHB10;CNTN2;ZDHHC22
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Esophagus,0.2984860327055395,0.7031332221048904,0.9733333333333334,1.0,1.0,9/99,16.69%,TRIL;FBXL7;TMEM35A;PLP1;GFRA1;LIFR;PCDHB10;CNTN2;ZDHHC22
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,-0.3009959892682623,-0.7031225991288418,0.9655172413793104,1.0,1.0,10/43,23.34%,KMT2B;SMYD2;KMT5C;SETDB1;KMT5A;DPY30;KMT2A;SUV39H2;NFKB1;NSD2
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.4105015103760683,-0.7031224674417396,0.8333333333333334,1.0,1.0,4/8,22.04%,TCIM;RPS6KA3;RGS14;INO80
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,0.2928814434718105,0.7031160222577246,1.0,1.0,1.0,26/151,20.15%,SP100;TRIM62;UBE2L6;PTAFR;HLA-F;TRIM25;IFIT1;IRF1;HLA-A;TRIM68;TRIM29;RPS27A;STAT1;OAS2;USP18;CD44;MAPK3;ISG15;IFI6;KPNA5;GBP1;HLA-DPA1;XAF1;IRF4;IFIT3;TRIM5
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Ligament,0.3922591572782308,0.7026598272784167,0.890625,1.0,1.0,3/20,7.30%,ITGAX;PTPRC;NT5E
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.3619820388746958,-0.7026322404885373,0.8888888888888888,1.0,1.0,3/11,13.82%,HES1;JAG1;ESRRB
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.259427374881139,-0.702516892294838,1.0,1.0,1.0,16/91,15.04%,ST3GAL3;POFUT1;DPM3;POFUT2;GALNT13;RXYLT1;MUC19;XXYLT1;ST3GAL2;FKTN;GALNT12;GALNT18;ST3GAL4;POGLUT3;PLOD3;TMTC4
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.34198575694949784,0.70243013626975,0.9466666666666667,1.0,1.0,14/40,21.19%,IL12A;IL27;HLA-A;HLA-DPB1;TNFSF4;F2RL1;CRTAM;ISG15;CD244;RASGRP1;HLA-DPA1;IL1R1;IL18R1;ZFPM1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.2932856892256571,-0.7022649227899044,1.0,1.0,1.0,11/66,15.92%,SMPD4;MOSPD3;DOP1B;STX5;EMD;SPTSSB;STEEP1;MIA3;EIF2AK3;TOR1B;REEP6
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.3588523883261925,-0.7021948387505836,0.8787878787878788,1.0,1.0,2/14,16.28%,SNCAIP;SYN1
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,0.32204115069407085,0.7020744978658817,0.9102564102564102,1.0,1.0,8/62,17.01%,RRAD;POLE2;POLD4;RPA3;RPS27A;ARTN;RMI2;BRCA1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.41648810870739067,0.7020010638813635,0.8870967741935484,1.0,1.0,3/15,21.26%,HSPA5;GABARAPL2;BCAP31
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,-0.2655464130893962,-0.7016064470426533,1.0,1.0,1.0,21/105,17.44%,KIFC1;KIF2B;CABLES2;SH2B2;MAFG;KIF15;CABLES1;KIF4B;RAB5A;KIFC2;KIF1C;EHD3;CAPZB;MICAL1;KIF26A;CDK5;PRKCA;ITPK1;KIF27;ABL1;MAFK
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),0.47058910610224014,0.7015571425127702,0.873015873015873,1.0,1.0,1/5,18.48%,SCN5A
prerank,Reactome_2022__Sperm Motility And Taxes R-HSA-1300642,0.4475986196693774,0.7015482417332732,0.8695652173913043,1.0,1.0,3/7,18.70%,KCNU1;CATSPERD;HVCN1
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,0.3646755725004831,0.7014718635777669,0.875,1.0,1.0,3/27,9.84%,MGST1;GGT5;HPGDS
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.4195126581130176,0.7014242414216192,0.8615384615384616,1.0,1.0,2/14,8.71%,KIF14;FBLIM1
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),0.445062910396084,0.7014117105221488,0.8333333333333334,1.0,1.0,1/6,7.62%,CD99
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.3302706941950649,0.7012419388840361,0.8714285714285714,1.0,1.0,6/43,17.01%,AHR;GLRA2;GLRA1;TNFSF4;ADCY7;BRCA1
prerank,KEGG_2021_Human__Asthma,0.4166660618846296,0.7012375262835869,0.803030303030303,1.0,1.0,7/11,23.49%,IL5;HLA-DMA;HLA-DPB1;IL4;HLA-DPA1;EPX;HLA-DRB1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.31110467104633704,0.7010764322823528,0.9390243902439024,1.0,1.0,28/100,23.72%,TP53TG5;TGFB1;CRLF3;CDKN2A;GNG4;DDX3X;EI24;PPT1;RERG;CDKN1B;BTG1;CDKN1A;CDKN2C;ALOX15B;MT1M;HYAL1;TCHP;NAIF1;FBP1;FRZB;CCDC85B;NOTCH2;TMPRSS4;RBBP7;DCSTAMP;CDKN2D;DNAJB2;PSRC1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Thyroid,0.49503142226028185,0.7008065075852138,0.8412698412698413,1.0,1.0,2/5,27.22%,CD44;NES
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.406521674963807,0.700756044276322,0.7878787878787878,1.0,1.0,5/12,27.27%,IL4;EHD2;EHD1;DCSTAMP;RAPGEF3
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,0.35971478639363297,0.7005792010095587,0.896551724137931,1.0,1.0,7/23,18.84%,WAS;VASP;CD4;ITK;FYB1;ZAP70;HLA-DPA1
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.23071268918574334,-0.7003275153722077,1.0,1.0,1.0,69/372,18.08%,KLHL41;IFT88;CFAP221;SYNPO;MKS1;DCDC2;CFAP410;CNGA4;ABCC4;EXOC7;AUP1;HAUS1;SCLT1;GOLGA8A;PARVA;PCM1;CEP83;UBXN2A;RAB7A;FLNA;CLUAP1;PLA2G4C;SNF8;TTC36;TMEM138;GBF1;DZIP1L;MAPRE1;FBF1;HDAC3;TUBGCP2;RILPL1;CIRBP;EHD4;ATG2A;CFAP44;ASAP1;EHD3;CORO1A;GOLGA8B;ABLIM3;CEP250;RAB11FIP3;CILK1;HAUS7;DBNL;CFAP70;B9D1;AVIL;DNAH5;TEKT3;TRAF3IP1;CCDC57;KIF24;DYNC2I1;CDS1;IRGM;AHI1;CEP41;CYS1;TCTN1;KIF27;PRRC2C;MVB12A;ARMC9;IFT52;IFT43;IFT81;CEP290
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,-0.2844444569455283,-0.7001615002737225,0.9642857142857143,1.0,1.0,8/70,7.88%,FOS;HLA-DQB1;MAML1;CD247;HLA-DRA;STAT5B;JAG2;NFATC3
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.3160815010386983,0.7001604769009987,0.9615384615384616,1.0,1.0,5/67,13.48%,DDX20;RANBP6;SYK;GEMIN4;SNRPD2
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.4044632268530666,0.700111861250855,0.8333333333333334,1.0,1.0,3/9,21.53%,MMP9;ATP2A2;B2M
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.42052684269070006,-0.7000119801031012,0.8048780487804879,1.0,1.0,1/7,3.16%,KCNE1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3408401631591465,0.6998446860176853,0.9027777777777778,1.0,1.0,5/27,14.01%,CDKN2A;KANK2;MYO16;CDKN1A;CDKN2C
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.4294274495332062,-0.6998033655135825,0.8055555555555556,1.0,1.0,1/7,10.66%,AGO2
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.4294274495332062,-0.6998033655135825,0.8055555555555556,1.0,1.0,1/7,10.66%,AGO2
prerank,Reactome_2022__Maturation Of Spike Protein R-HSA-9683686,0.4592013265960062,0.6997844324362812,0.8412698412698413,1.0,1.0,2/5,20.59%,MOGAT1;GANAB
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Abdominal Adipose Tissue,0.4468926773162118,0.6996952586686886,0.9259259259259259,1.0,1.0,4/10,16.35%,PTPRC;NT5E;CD44;ENG
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),-0.3721815531712559,-0.6995972988463005,0.7741935483870968,1.0,1.0,2/7,20.02%,MVK;PDSS2
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,0.3161347023754817,0.6995654851343359,0.9583333333333334,1.0,1.0,5/65,11.20%,FGF20;ATP6V1G2;KLB;ATP6V0E2;ATP6AP1
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.4398362325295395,0.699518514371211,0.8571428571428571,1.0,1.0,2/6,13.08%,LDLRAP1;AGT
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.3995761052064767,0.6995161484232258,0.7962962962962963,1.0,1.0,1/9,2.57%,PTX3
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.36384669357750066,-0.6993495692412302,0.9310344827586207,1.0,1.0,1/21,3.20%,DDAH2
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,0.3285982391138868,0.699336721297811,0.9154929577464789,1.0,1.0,9/71,19.09%,VAPB;PLEKHG3;MAP3K11;ARHGDIG;DOCK5;RHOG;HSPE1;VAV3;DOCK2
prerank,"Reactome_2022__Activation Of NIMA Kinases NEK9, NEK6, NEK7 R-HSA-2980767",-0.40361840016880135,-0.6991708928238977,0.9302325581395349,1.0,1.0,3/7,23.91%,CDK1;NEK9;NEK6
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.3456185763838008,-0.6991543266580291,0.8181818181818182,1.0,1.0,9/16,33.19%,PRKCA;FYN;HRAS;CREBBP;NFKB1;PKN2;PKN1;EP300;RELB
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,-0.32437020877120226,-0.69900273041544,0.84375,1.0,1.0,2/29,7.17%,WNT3A;PPP2R5D
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,0.3029497625954254,0.6989100852644463,0.9879518072289156,1.0,1.0,8/89,10.24%,KCNA7;KCNJ15;GNG12;KCNA5;KCNS2;GNG4;KCNG2;KCNK7
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.31027781690118195,0.6988721991891315,0.9493670886075949,1.0,1.0,10/84,21.18%,PSMB9;CDKN1B;CDKN1A;PSMC5;BUB1B;FBXO5;PSMA3;PSMB6;PSMD6;CCNB1
prerank,KEGG_2021_Human__Glyoxylate and dicarboxylate metabolism,-0.33889676016496734,-0.6988664249120724,0.78125,1.0,1.0,8/25,23.41%,ACO1;PGP;ACO2;CS;PCCB;PCCA;AFMID;ACSS2
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.34228945855134624,0.6988113963427955,0.8933333333333333,1.0,1.0,10/42,14.41%,SASH3;CLCF1;PTPRC;CD81;SYK;TNFSF4;GPR183;IL7;IGLL1;IL4
prerank,CellMarker_Augmented_2021__8-Cell Stage Cell (Blastomere):Embryo,0.3901108109799005,0.6987307284760903,0.8985507246376812,1.0,1.0,2/15,17.52%,EIF1AD;FAM32A
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.34041929830220863,0.6987143852523455,0.890625,1.0,1.0,6/29,23.82%,B4GALNT2;ASGR2;ASGR1;OSTC;MCFD2;LMAN1
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,0.3181274186960106,0.69860387914738,0.9375,1.0,1.0,4/63,11.00%,POLE2;POLD4;RPA3;RPS27A
prerank,CellMarker_Augmented_2021__Urine-derived Stem cell:Urine,0.3918165076928277,0.6985698753812867,0.855072463768116,1.0,1.0,4/14,16.35%,PTPRC;NT5E;CD44;ENG
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Large Intestine,0.2886216151854908,0.6984657068506133,0.9736842105263158,1.0,1.0,10/88,18.71%,CYP3A5;ARHGAP28;PGM5P2;ZBTB8A;EPB41L4A;SPINK9;KPNA5;ORC4;FSIP2;CSPG4P12
prerank,Reactome_2022__Acrosome Reaction And Sperm:Oocyte Membrane Binding R-HSA-1300645,0.46741857165309875,0.6984021292761537,0.8,1.0,1.0,1/5,6.52%,IZUMO1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.2982290643781956,-0.698275435014813,1.0,1.0,1.0,9/53,16.15%,H1-4;POLR1A;PHF2;ZMIZ1;MYBBP1A;POLR2F;TAF1B;ELOF1;TAF1D
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,-0.3123740694001102,-0.6981480143301285,0.9642857142857143,1.0,1.0,11/35,20.99%,PRKCD;DSG2;FNTA;PLEC;DBNL;LMNB1;CASP3;CLSPN;ACIN1;ADD1;MAPT
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.2958709498535992,0.6979128425838834,0.9879518072289156,1.0,1.0,8/129,7.79%,TBX1;RORC;SMOC1;TGFB1;HEY2;HEMGN;SCIN;REST
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,0.31324188200514586,0.6978268068821711,0.9166666666666666,1.0,1.0,14/54,24.77%,CCNG2;PINK1;NPY;CDKN1B;BTG1;CDKN1A;BBC3;TXNIP;NFYB;DDIT3;YWHAG;CITED2;RBL2;PPARGC1A
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.3207935768087051,0.6976330989752194,0.922077922077922,1.0,1.0,16/58,25.85%,RPS16;RPS19;RPL11;RPL35A;GLUL;RPS7;RPL7;RPL38;EMG1;RPS6;ZNF622;RIOK2;RPS15;WDR12;RPS24;RPS28
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.30974394670507643,0.6975836818032914,0.975609756097561,1.0,1.0,13/99,13.50%,CCL5;LRP2;TGFB1;NLRP12;SOCS2;NR1H4;LEF1;RAMP3;CYP1B1;UCP1;LDLRAP1;CSF1R;MME
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.4600189850632987,0.6975704236407668,0.8620689655172413,1.0,1.0,3/8,17.96%,C17ORF99;GPR183;MSH6
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.33998367220889564,0.6974083621401984,0.8985507246376812,1.0,1.0,3/47,13.17%,ANXA1;ATP6AP1;CHMP3
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,0.31729569803525104,0.6973286366495746,1.0,1.0,1.0,10/76,13.52%,SLC5A2;SLC7A7;SLC12A3;SLC17A8;SLC4A1;CP;SLC24A1;TAC4;SLC5A1;SLC35C1
prerank,Reactome_2022__Synthesis Of 5-Eicosatetraenoic Acids R-HSA-2142688,0.42449842158499407,0.6972496973706264,0.8484848484848485,1.0,1.0,3/9,13.72%,PON1;ALOX5AP;PON3
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.4305010707980148,0.6971884996828313,0.9344262295081968,1.0,1.0,4/9,30.40%,FBXO7;PARK7;VDAC1;SLC25A5
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.38586285739133463,0.6970329717294519,0.8939393939393939,1.0,1.0,3/17,7.54%,FUT2;B4GALNT2;MPDU1
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),0.4654008427926042,0.69694744499157,0.8727272727272727,1.0,1.0,2/5,21.53%,TF;B2M
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.38894352741694305,0.6968904668585514,0.835820895522388,1.0,1.0,2/15,7.79%,TLR2;REST
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,0.3139545924818866,0.696843788307302,0.9594594594594594,1.0,1.0,4/65,11.00%,H2BC4;HLA-A;RRAGA;RPS27A
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.36447020827847554,-0.6966726809990899,0.9333333333333333,1.0,1.0,1/14,2.39%,TIE1
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,-0.28707260592150535,-0.6966359254140334,0.8928571428571429,1.0,1.0,7/29,20.27%,ST3GAL3;ST3GAL2;ST3GAL4;MOGS;ST6GALNAC3;PRKCSH;PARP16
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.2951166078795712,-0.6964730130171362,0.9714285714285714,1.0,1.0,9/64,13.63%,GCK;NR4A3;MGARP;SLIT3;STAT5B;SERPINB9;AKR1C3;RAMP1;SLIT2
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,0.30774325507462263,0.6964425213153371,0.975,1.0,1.0,7/110,8.47%,MGST1;SDC2;PIK3R3;CAV3;ACTG1;MMP9;NQO1
prerank,Reactome_2022__Unwinding Of DNA R-HSA-176974,0.3987973775540124,0.69639794674822,0.8181818181818182,1.0,1.0,2/9,16.17%,MCM3;GINS1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3626086335597408,0.6963445382741219,0.8813559322033898,1.0,1.0,1/22,2.21%,ARHGAP24
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.30324508294053604,-0.6962659133765937,0.9047619047619048,1.0,1.0,7/51,12.03%,ADAMTS12;GBP2;SELE;IGBP1;MYLK3;NR1D1;DAB2IP
prerank,Reactome_2022__Apoptosis R-HSA-109581,0.28805257161322206,0.6959899970261979,1.0,1.0,1.0,34/156,26.30%,PSMB9;CASP7;TNFRSF10A;H1-0;STK26;UACA;CDKN2A;GSDME;TP53BP2;RPS27A;PSMC5;BBC3;MAPK3;NDUFA2;DYNLL1;DSG3;APAF1;YWHAH;PSMA3;PSMB6;PSMD6;BCAP31;TRADD;YWHAG;DYNLL2;BMX;PRKCQ;PSMA7;FASN;PSMB1;CASP8;CTNNB1;CARD8;TMED7-TICAM2
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),0.4206873691108489,0.6959459358268708,0.85,1.0,1.0,1/6,11.89%,NPR3
prerank,Reactome_2022__Metabolism Of RNA R-HSA-8953854,0.2708533117876139,0.6959006706925097,1.0,1.0,1.0,87/620,21.68%,NLRP4;ENPP2;PSMB9;PWP2;HSPA8;RPL37A;RPL21;DDX20;IGF2BP2;RPL9;DIMT1;SRSF9;RPP38;RPL18A;RPS9;RPL3;RPL36;RPL13A;EXOSC8;RPS16;NOP10;RPL15;GEMIN4;RPS5;RPS27A;RPS3A;EXOSC2;RPL41;COLEC12;RPP40;TRMT10A;RPS12;RPS4X;RPL27A;NOB1;TFIP11;SNRPD2;RPS19;FAU;PSMC5;METTL14;RPS21;CD44;THOC6;EXOSC4;RPL32;DDX23;RPL11;RPL23A;RPL35A;RPS11;RPS13;RPS7;WDR36;RSL24D1;RPLP2;NOL12;RPL7;TSR3;RPL38;PSMA3;DHX38;SRSF5;PSMB6;RPS15A;FIP1L1;EMG1;RPSA;CSTF2T;RPLP0;RPS6;RPL35;TRNT1;SF3B5;PSMD6;IGF2BP3;SET;CNOT8;SRSF3;RPL27;RPS14;RIOK2;XAB2;RPL7A;ZNF473;PHAX;RPL23
prerank,CellMarker_Augmented_2021__Epithelial cell:Amniotic Membrane,0.3090651954976992,0.6958895723035345,0.9178082191780822,1.0,1.0,19/64,21.75%,CAPN13;PLEKHG6;MARVELD2;EPN3;TMC4;MARVELD3;TJP3;AP1M2;EPCAM;EPHA1;KRT8;AGR2;SPINT1;SOWAHB;SCNN1A;HOOK1;CBLC;B3GNT3;GRHL2
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.3931379423749619,0.6957718079449986,0.8412698412698413,1.0,1.0,1/13,4.45%,SYNE2
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,0.3122289540621809,0.6957089356121618,0.963855421686747,1.0,1.0,4/63,11.00%,POLE2;POLD4;RPA3;RPS27A
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.4069275298759374,-0.6956756472074352,0.7692307692307693,1.0,1.0,1/7,7.48%,PLA2G5
prerank,KEGG_2021_Human__Human cytomegalovirus infection,0.28814452723135925,0.6955233401669827,1.0,1.0,1.0,28/177,23.34%,PIK3R3;CCL5;GNG12;HLA-F;PTGER3;CDKN2A;CCND1;GNG4;HLA-A;CDKN1A;ADCY7;MAPK3;CXCL12;BCAR1;NFKBIA;MAP2K1;IL1R1;CREB3;NFATC2;GNGT1;GNB4;TRAF5;TAP1;B2M;TRADD;KRAS;ATF2;AKAP13
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,0.3465424837332801,0.6954689064674392,0.8823529411764706,1.0,1.0,9/24,30.09%,PLPP6;FDFT1;MSMO1;SQLE;HMGCR;HMGCS1;IDI2;IDI1;DHCR24
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3148862611805257,0.6954523340935643,0.9696969696969697,1.0,1.0,1/51,0.67%,GML
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Abdominal Adipose Tissue,-0.2655208941051051,-0.695346345093729,1.0,1.0,1.0,15/72,17.10%,LIN28B;TRIM71;CRABP1;FREM1;TAC3;HFM1;MSI1;PLPPR3;AFP;RCOR2;IGDCC3;IGF2BP1;PLPPR1;KCNH2;PRTG
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Abdominal Adipose Tissue,-0.2655208941051051,-0.695346345093729,1.0,1.0,1.0,15/72,17.10%,LIN28B;TRIM71;CRABP1;FREM1;TAC3;HFM1;MSI1;PLPPR3;AFP;RCOR2;IGDCC3;IGF2BP1;PLPPR1;KCNH2;PRTG
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.381660090968598,0.6953413045249602,0.9,1.0,1.0,1/21,4.27%,TGFB1
prerank,Reactome_2022__Defective RIPK1-mediated Regulated Necrosis R-HSA-9693928,0.4479406073042314,0.695339689831264,0.8,1.0,1.0,2/5,25.66%,TRADD;CASP8
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.27363708977126583,-0.6953220544171534,1.0,1.0,1.0,3/32,11.53%,MGARP;AP3B2;SPAST
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,0.3326597667865188,0.6952910029671905,0.9178082191780822,1.0,1.0,2/27,11.00%,ERBB4;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.30177728672202025,-0.6951331691915675,0.9354838709677419,1.0,1.0,9/45,19.48%,FLNA;CUX1;CRK;CSPG5;CRKL;LIMS1;ABL1;CUX2;CUL7
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.28060526813169684,-0.6951263614827032,0.96,1.0,1.0,5/48,10.09%,PTPN9;CLIP3;ZDHHC5;EPHB2;ITGA3
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,-0.3044596393252459,-0.6949480793171421,0.9375,1.0,1.0,9/44,14.20%,DNMT1;PSAT1;TST;APIP;KYAT1;DNMT3A;KYAT3;LDHC;CBS
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.41485390974005876,0.6946199275950643,0.9076923076923077,1.0,1.0,2/11,10.57%,TK1;DCK
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.41485390974005876,0.6946199275950643,0.9076923076923077,1.0,1.0,2/11,10.57%,TK1;DCK
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Eye,0.31399584626674476,0.6946092899290116,0.9634146341463414,1.0,1.0,10/92,14.14%,LRP4;GAD1;FAM181A;SEMA3A;TMEM200C;STK32A;RFX4;SOX9;MORN5;PCDHB10
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.30769955198476423,-0.6945126041443415,0.9285714285714286,1.0,1.0,9/42,21.64%,CELF5;TXNL4A;LUC7L;SF3A2;CELF4;SMN1;CELF2;SF3A3;PRPF6
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.2631882261360583,0.6943480013241768,1.0,1.0,1.0,62/735,12.40%,GATA4;TBX1;ESR1;CRX;MACC1;TLR2;NR1I3;AHR;FGF2;CTCFL;POU2F3;ST18;TGFB1;LMO2;TFEC;FOXA3;DUX4;HEY2;WNT5A;ELK3;WAS;MESP1;GPER1;IRF2BPL;IER5;CD81;CRLF3;NR2E3;KLF15;NR1H4;FOXM1;WNT8A;IL26;IGF1;LEF1;REST;NFIA;LHX4;LPIN3;H2AZ1;HGF;IRF1;DDX3X;FHOD1;ZNF175;ABHD14B;CSRP3;MYDGF;TGFB3;RFX4;HNF4G;DCN;VEZF1;RPS27A;DAB2;STAT1;HMGA2;F2RL1;EPCAM;GLIS3;FOSL2;TAF7
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.26437209689383734,-0.6942945600159037,0.95,1.0,1.0,21/122,15.32%,FIBIN;BOC;CALD1;GPC6;COL4A2;GFRA2;SDC3;ABCC8;SYNDIG1;CAP2;SRRM3;EDNRA;ANTXR1;DAB2IP;AMOTL2;SLIT2;CHST3;CBS;GPC1;COL4A1;ADGRL2
prerank,Reactome_2022__Removal Of Flap Intermediate From C-strand R-HSA-174437,0.39455347054804435,0.694257568822281,0.8695652173913043,1.0,1.0,2/16,9.53%,POLD4;RPA3
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.3345603184155682,0.6941418515885257,0.9078947368421053,1.0,1.0,3/54,1.80%,RASGRP4;LPAR1;GPR55
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,0.31059604989639467,0.6940468337756178,0.9594594594594594,1.0,1.0,10/76,16.68%,UBE2L6;TRIM25;IFIT1;RPS27A;STAT1;OAS2;USP18;MAPK3;ISG15;KPNA5
prerank,GO_Biological_Process_2021__epithelial cell differentiation involved in kidney development (GO:0035850),0.438556026386227,0.693997185446047,0.8,1.0,1.0,1/6,22.95%,MTSS1
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,0.3385951628938309,0.6939135687186289,0.8831168831168831,1.0,1.0,1/38,1.79%,KIF14
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.39806554670505373,-0.6937858803823705,0.75,1.0,1.0,2/8,9.40%,KDM2B;EFEMP1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.39020139965639095,0.6936976521211745,0.8620689655172413,1.0,1.0,5/16,26.23%,SNAI1;CXCL12;CDKN2D;RPS3;CLU
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.28300209706445745,-0.6934194478954221,0.972972972972973,1.0,1.0,5/54,10.28%,TRIM67;ADCYAP1;STX6;DZIP1L;MMD2
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.3134433520177473,0.6933680659712758,0.9324324324324325,1.0,1.0,9/64,17.22%,TCN1;AOX1;RFK;AMN;SLC25A19;CBLIF;SLC46A1;MTHFD2;SLC23A1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.38527460043500905,0.6933070247029931,0.8695652173913043,1.0,1.0,1/14,4.14%,TRPC7
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.44821808966179066,-0.6932427838861932,0.8421052631578947,1.0,1.0,1/5,24.11%,PBXIP1
prerank,KEGG_2021_Human__Renal cell carcinoma,0.3143173486928216,0.6932008068866117,0.9102564102564102,1.0,1.0,6/64,15.19%,PIK3R3;TGFB1;HGF;TGFB3;CDKN1A;MAPK3
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.3624015011528382,0.6929295199391908,0.9242424242424242,1.0,1.0,6/21,15.41%,TGFB1;TGFB3;THBS1;WBP2;UBE3A;CATSPERD
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.2681302694850125,0.6929210448210195,1.0,1.0,1.0,26/302,11.26%,LMOD3;TMOD4;ELMO3;KIF14;LMOD1;COL18A1;LOX;UBE2L6;STMN4;MYH11;NLRP5;COL4A4;COL4A3;PGM5;CYP1B1;COL4A6;COL21A1;COL4A5;RHOB;TRDN;LAMC2;CALB1;COL6A2;COL1A1;RPS27A;KIF18A
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),-0.436434364287076,-0.6928465696296974,0.7894736842105263,1.0,1.0,1/5,4.89%,CBFB
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.3332365602821702,-0.6928313683979442,0.8787878787878788,1.0,1.0,2/18,10.31%,FPGS;CHAC1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.33036508178614266,0.6923311408442415,0.921875,1.0,1.0,3/34,3.83%,SYT15;TRPV6;SYT2
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.39371455249981424,-0.6921205782019165,0.813953488372093,1.0,1.0,2/9,6.31%,HES1;ACVR1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.3929132567523387,-0.6920852123008222,0.8125,1.0,1.0,2/13,5.37%,NDOR1;ENOX2
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.35683016999418193,0.692070467259905,0.9230769230769231,1.0,1.0,2/31,3.18%,ACE2;KCNJ15
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.2700664813752203,-0.6917942018658525,1.0,1.0,1.0,10/78,12.90%,SLC25A17;ZDHHC23;PARD3;ZDHHC11B;PEX13;PEX14;ZDHHC14;TAOK2;ZDHHC18;SDCBP
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.3523376486501417,0.6915066300703455,0.8767123287671232,1.0,1.0,1/31,1.29%,RORC
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.3043996129925583,0.691432586151558,0.975609756097561,1.0,1.0,8/75,11.46%,TBX1;ANXA1;UPK1B;MESP1;ERBB4;VIL1;DAB2;DEUP1
prerank,Reactome_2022__TRP Channels R-HSA-3295583,0.36415067278506785,0.6913252764717044,0.8636363636363636,1.0,1.0,2/24,4.14%,TRPV6;TRPC7
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,-0.2813657028780716,-0.6911443660779336,0.896551724137931,1.0,1.0,12/62,19.25%,ESRP1;FGF18;FGF1;HNRNPF;FGFR2;PTBP1;POLR2F;POLR2C;SPRY2;RBFOX2;FGF17;HRAS
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreas,0.28878725159609664,0.6909096903264146,1.0,1.0,1.0,13/92,18.36%,TRIL;CYYR1;PREX2;SHISA6;PLP1;TMEM200C;L1TD1;SLC7A3;FBN3;LRRTM1;HUNK;FRZB;CHST9
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,0.31572868433327456,0.6909096753301637,0.9487179487179487,1.0,1.0,16/75,16.72%,SDC2;LRAT;LRP2;BCO1;PDE6A;GPIHBP1;GRK7;APOM;DHRS3;SLC24A1;RDH12;RDH16;CNGA1;GUCY2F;RBP1;RCVRN
prerank,KEGG_2021_Human__Necroptosis,0.2997635566059464,0.6908470658807716,0.9864864864864865,1.0,1.0,26/103,25.66%,SLC25A31;TNFRSF10A;STAT5A;H2AZ1;STAT1;PYGL;CHMP3;ALOX15;FTH1;CYLD;PGAM5;GLUL;SPATA2;PLA2G4A;PPID;FTL;H2AZ2;TRAF5;MLKL;TRADD;CHMP1A;PLA2G4D;H2AC6;VDAC1;HSP90AB1;CASP8
prerank,KEGG_2021_Human__Peroxisome,0.3075009511237947,0.6907815332432522,0.948051948051948,1.0,1.0,6/74,10.62%,ACSL5;ACOX2;DAO;SOD2;ACSL3;MPV17L2
prerank,Reactome_2022__Peroxisomal Lipid Metabolism R-HSA-390918,-0.29113829478539793,-0.6906741981090827,0.9545454545454546,1.0,1.0,5/28,7.13%,MLYCD;ACBD4;SLC25A17;SLC27A2;ACOX3
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.4008453843773058,-0.6906506815845723,0.8604651162790697,1.0,1.0,1/10,2.34%,PSAT1
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.3988058680159241,0.6906016567821569,0.8450704225352113,1.0,1.0,5/10,38.73%,PSMG1;OTUD6B;POMP;PSMD11;PSMD13
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.45380181169365663,0.6904585079794244,0.90625,1.0,1.0,1/7,8.32%,TMEM79
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.292390128531305,-0.6904575537343409,0.9666666666666667,1.0,1.0,7/27,16.77%,HES1;ACVR1;PKD2;SLIT2;SCRIB;COL4A1;PODXL
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,-0.3194345889314486,-0.6903738910239394,0.9375,1.0,1.0,6/21,20.85%,PPP2R5D;PPP1CA;CDK5;PRKCA;PRKAR2A;PPP2R1B
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.40979191917716096,0.6902410264419856,0.8070175438596491,1.0,1.0,6/12,32.95%,ENG;CTNNB1;SEMA3E;TGFBR2;VEGFA;NRARP
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),0.46753389394939027,0.69018768553093,0.8,1.0,1.0,2/5,16.51%,HPD;FAH
prerank,Reactome_2022__Ethanol Oxidation R-HSA-71384,0.4392175724599491,0.6900111354242345,0.8688524590163934,1.0,1.0,2/7,27.07%,ADH5;ADH7
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.3529366089963342,-0.68994599653426,0.8823529411764706,1.0,1.0,1/15,4.05%,SARM1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.3841704042347253,0.6899132033865288,0.8805970149253731,1.0,1.0,2/16,14.52%,TGFB1;DDR2
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.3073151041485344,0.689640739967142,0.96,1.0,1.0,13/65,21.51%,ACOT6;ABHD14B;ACSM3;ACSM6;ACOT4;RHOQ;ADSS1;HINT1;SULT2A1;BPNT2;SULT4A1;GMPR2;SULT6B1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.327787675423516,0.689442234878383,0.958904109589041,1.0,1.0,6/52,13.53%,CCL5;SH2D1B;IFNK;IRF1;NLRC3;USP18
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,0.2757493916127965,0.6891391996168704,1.0,1.0,1.0,21/272,14.32%,ESR1;PSMB9;PIK3R3;FGF20;CBX8;PREX2;SALL4;ERBB4;CD80;REST;KLB;RRAGA;RPS27A;PPP2R5A;USP13;CDKN1B;CDKN1A;RHOG;PSMC5;SNAI1;ADCY7
prerank,Reactome_2022__Neuronal System R-HSA-112316,0.2734938522922313,0.6889620853037194,1.0,1.0,1.0,23/355,11.51%,CHRNA9;GAD1;KCNA7;HSPA8;KCNJ15;GNAT3;SLC18A2;GNG12;SYT2;SLC6A4;KCNA5;ERBB4;HTR3E;KCNS2;GNG4;KCNG2;CHRNA5;GRIN2D;GLRA2;KCNK7;GLRA1;HTR3C;RASGRF2
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.29983912627403303,0.6888772532369067,0.9651162790697675,1.0,1.0,16/79,27.72%,MRPS34;MRPL20;MRPL34;MRPL50;GADD45GIP1;GFM2;MRPL54;MRPS2;MRPL19;MRPL28;MRPL10;MRPL37;MRPL44;MRPL40;MRPS12;MRPL49
prerank,Reactome_2022__Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,-0.3563022397886384,-0.6888627565812281,0.8648648648648649,1.0,1.0,2/16,16.62%,GRIA4;PRKCA
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.2960816057002364,0.6887873692307495,0.9647058823529412,1.0,1.0,18/123,20.17%,KIF14;HSPA8;ROS1;WNT5A;SOCS2;PINK1;TMC8;STON2;AGT;NUBP1;IL17RB;BCAR1;PAPPA2;GFAP;HCFC1;BAG5;ATF5;CEACAM1
prerank,CellMarker_Augmented_2021__Retinoid Acid Signaling-Responsive Fetal Germ cell:Fetal Gonad,0.294618812459919,0.6887577843108889,0.9782608695652174,1.0,1.0,34/188,18.64%,ELOVL2;ADA;LY6G5C;MAP3K11;CASP7;DAZL;SDF2L1;LEF1;STRA8;CCND1;PDCL2;CDK2AP1;NPY;NT5DC2;AGBL5;SPOCK3;FBN2;SMC1B;TRMT10A;FDFT1;MYO1F;NEXN;RPGRIP1;NUDT8;TUBA3D;TLL2;RBP1;A1BG;FAM114A1;ATOX1;NOL12;SEL1L;PDE6B;PPID
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.31038404322605906,-0.688736556941148,0.9615384615384616,1.0,1.0,7/40,16.15%,DDX56;POLR1A;H2AJ;MYBBP1A;POLR2F;TAF1B;TAF1D
prerank,Reactome_2022__Interaction Between L1 And Ankyrins R-HSA-445095,-0.33113056025205934,-0.6887305899048582,0.8611111111111112,1.0,1.0,2/27,7.11%,SPTBN4;SPTB
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.2663126220706109,-0.6885270390871946,0.9047619047619048,1.0,1.0,12/78,16.86%,TRIB2;PRICKLE1;TRIB1;NUPR1;DAB2IP;BAG6;HSPBP1;CSNK1E;OSBPL7;FBXO22;NKD2;SUMO2
prerank,CellMarker_Augmented_2021__Endothelial cell:Cornea,0.4024123046711174,0.6884500660266365,0.8305084745762712,1.0,1.0,3/12,16.35%,NT5E;CD44;ENG
prerank,Reactome_2022__N-glycan Trimming And Elongation In cis-Golgi R-HSA-964739,-0.42808750427259545,-0.6882356122437451,0.8518518518518519,1.0,1.0,1/5,5.08%,MAN1A1
prerank,Reactome_2022__Pyrimidine Salvage R-HSA-73614,0.4109440914756636,0.6881873167499403,0.9375,1.0,1.0,2/11,10.57%,TK1;DCK
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.2586165172053519,-0.6881561088846189,1.0,1.0,1.0,11/75,15.33%,SMYD5;CBFB;SP7;HES1;LDB1;SLC4A11;JAG1;PSMB2;ESRRB;PSME4;PUS7
prerank,Reactome_2022__Resolution Of Abasic Sites (AP Sites) R-HSA-73933,0.3356453024065554,0.6881184308005815,0.8904109589041096,1.0,1.0,3/36,9.53%,POLE2;POLD4;RPA3
prerank,KEGG_2021_Human__Shigellosis,-0.23320081896361688,-0.6880769148725173,1.0,1.0,1.0,13/206,8.83%,PRKCD;BCL2;CD14;ITPR2;FOXO1;CAPN2;SEPTIN8;UBE2D4;ARPC3;SEPTIN9;NOD1;RIPK2;MYL7
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,0.31858889396384116,0.6880441697405889,0.9859154929577465,1.0,1.0,9/68,16.68%,UBE2L6;TRIM25;IFIT1;RPS27A;STAT1;USP18;MAPK3;ISG15;KPNA5
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3268399785473575,-0.6879866279296085,0.9354838709677419,1.0,1.0,11/27,19.31%,PNKP;KMT5C;WRAP53;KDM4D;HSF1;SIRT7;SHLD2;SMCHD1;MAD2L2;SHLD1;SETMAR
prerank,GO_Biological_Process_2021__glyoxylate metabolic process (GO:0046487),-0.40070349893026624,-0.6879360535407514,0.8918918918918919,1.0,1.0,2/6,17.70%,ALDH4A1;GOT2
prerank,CellMarker_Augmented_2021__Mitotic Arrest Phase Fetal Germ cell:Fetal Gonad,0.26845049525369447,0.6878333204369852,1.0,1.0,1.0,70/836,13.98%,NRAP;C19ORF38;TEX101;SLC25A31;NOTUM;ADA;LY6G5C;TCF7;ADAD2;PIK3R3;REC114;TOPAZ1;EYA2;MAT2B;CCDC73;CTHRC1;UBE2L6;CTCFL;GNG12;CLEC4C;SYPL1;SGCG;MAP3K11;CASP7;ABCG2;BOK;HEY2;CCDC172;DCAF4L1;FTCD;DNAJB1;ANGPTL4;C12ORF57;TBPL1;BAIAP2L1;LEF1;LY6H;NFIA;GNG4;DUSP22;HLA-A;AGGF1;RHOB;TRIM29;PRAME;VWF;ID1;NT5DC2;CLGN;AGBL5;INCA1;SPR;STAT1;STAG3;DACH1;CRYBG3;LACC1;SH2D4A;SMC1B;TRMT10A;PENK;PIGH;PNRC1;TCF7L1;LCA5;NAB1;PON3;RAB38;CCNI;MMP11
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.30327196480132423,-0.687813192875726,0.8928571428571429,1.0,1.0,5/32,10.18%,RAB20;ATP6V0D2;ATP6V1E2;RAB7A;ATP6V0A2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.39341316187010283,0.6877043399060008,0.819672131147541,1.0,1.0,1/13,7.06%,NDC80
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,0.29653770356353176,0.6873546566536777,1.0,1.0,1.0,1/75,0.37%,NEK2
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.3676271559537342,0.6873453164642851,0.896551724137931,1.0,1.0,4/19,18.64%,FKBP5;FKBP4;PPIC;PPID
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,0.33517884834074846,0.6873257707585261,0.9605263157894737,1.0,1.0,3/35,8.30%,GNG12;GNG4;KCNG2
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,0.3517519190486895,0.687266311701594,0.88,1.0,1.0,7/27,22.25%,HSPA5;EXOSC8;EXOSC2;EXOSC4;HERPUD1;NFYB;DDIT3
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,0.3623133889386735,0.6872171461975188,0.9210526315789473,1.0,1.0,3/27,13.54%,ITGA2;LAMC2;TNS3
prerank,CellMarker_Augmented_2021__Granulosa cell:Fetal Gonad,0.28629603636321527,0.6870707351832783,0.9885057471264368,1.0,1.0,40/152,26.40%,SYNE2;SYCP3;IGF2BP2;DHRS13;GGT5;TSC22D3;OSMR;COL1A1;RPS27A;PLAC1;HMGA2;PNMA1;RHOG;IFI6;GTSF1;RPS11;QPRT;TSPAN7;RAD51AP2;PLAG1;HINT1;NFKBIA;ZNF436;ENO2;POLE3;RPS14;MLLT11;HMGB3;RPS27;RPL8;HLA-DRB1;ADI1;RPS23;MT2A;ATP1A1;SCN9A;KRT17;RPS28;RPL34;AK1
prerank,GO_Biological_Process_2021__negative regulation of cellular respiration (GO:1901856),0.44694123494403415,0.6869878683916455,0.8545454545454545,1.0,1.0,1/5,24.08%,ACTN3
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.318032643610523,-0.6866044338728172,0.8918918918918919,1.0,1.0,4/17,17.42%,POLD3;TERT;PPIA;RFC3
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.2921750504973437,0.6864592211304925,0.9493670886075949,1.0,1.0,16/112,19.67%,HSPA1L;HSPA8;MANF;DNAJB1;PINK1;RPA3;CRHBP;OPRM1;MAPK3;SLC38A2;FKBP4;HSPH1;CHCHD2;BAG5;RAE1;BAG1
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,0.34248859797253817,0.6864543317391782,0.8970588235294118,1.0,1.0,9/27,20.48%,PDE6A;GRK7;SLC24A1;CNGA1;GUCY2F;RCVRN;PDE6B;PDE6G;GNGT1
prerank,Reactome_2022__SUMOylation Of Immune Response Proteins R-HSA-4755510,-0.3628312190633726,-0.6862949500739676,0.8108108108108109,1.0,1.0,3/10,16.86%,PIAS3;PIAS4;SUMO2
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.2824106286753328,0.6862126160672012,0.9879518072289156,1.0,1.0,32/191,25.70%,PSMB9;KIF14;UBE2U;SPSB2;RNF187;ANKRD9;PRAME;PSMC5;KBTBD7;KBTBD6;SYVN1;SEL1L;RMND5A;FEM1B;RBX1;PSMA3;SIAH1;PSMB6;KCTD17;ZFAND2A;PSMD6;TNFAIP1;RNF5;DDIT3;SPSB4;SPSB3;SOCS6;KAT5;PSMA7;KCTD10;PSMB1;CTNNB1
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",-0.4037084921402089,-0.6862092992360705,0.8292682926829268,1.0,1.0,2/7,11.39%,NKD1;RSPO3
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.4080264829358333,0.6861690193747743,0.8955223880597015,1.0,1.0,2/11,15.26%,EXOSC2;EXOSC4
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.29325402792202404,0.6859894388712012,1.0,1.0,1.0,15/128,16.64%,ESR1;RORC;NR1I3;NR2E3;NR1H4;TAF5;GTF2E1;HNF4G;TAF7;RXRG;NPPA;TAF7L;TAF10;TAF13;NR5A2
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.3677002996652844,0.6858734995604214,0.9565217391304348,1.0,1.0,4/25,13.96%,CLEC5A;VEZF1;CD5L;ITK
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.45288687411420964,0.6858522869259154,0.8235294117647058,1.0,1.0,3/5,29.32%,SFRP4;ZFP36;ZFP36L1
prerank,Reactome_2022__PKA Activation R-HSA-163615,-0.3332008870443448,-0.6858242952023808,0.8181818181818182,1.0,1.0,4/15,18.11%,ADCY2;PRKCA;ADCY6;PRKAR2A
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.37308797701393026,-0.6856138796163384,0.8285714285714286,1.0,1.0,1/11,1.49%,CBARP
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.31081599064544424,0.6853456435335722,0.9736842105263158,1.0,1.0,15/58,23.66%,MMP9;DDX3X;PLAUR;SOD2;PINK1;DNAJA1;SNAI1;CXCL12;SYVN1;HERPUD1;BAG5;CREB3;BCL2L2;CDKN2D;PARK7
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),-0.34977462455686853,-0.6851924370764506,0.8648648648648649,1.0,1.0,3/10,9.42%,CCBE1;ADAM8;RHBDD1
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.3243340309647827,0.6848857102697823,0.9571428571428572,1.0,1.0,10/58,16.69%,FGF2;MAP3K11;FLT1;TGFB1;ELANE;PIK3R6;TPD52L1;PIK3CG;HTR2B;RASGRP1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.3025440468041284,-0.6846689434800319,1.0,1.0,1.0,6/32,18.15%,APOE;GSAP;LRRTM3;BIN1;ABCG1;CASP3
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.4431389950065692,0.684549711616663,0.8507462686567164,1.0,1.0,1/7,7.67%,PHF23
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,0.3103115633785594,0.6844034223667734,0.9701492537313433,1.0,1.0,9/75,20.47%,PSMB9;HHIP;RPS27A;GLI3;PSMC5;RBX1;PSMA3;PSMB6;PSMD6
prerank,Reactome_2022__Glycogen Synthesis R-HSA-3322077,-0.3601369460348449,-0.684365437266656,0.8888888888888888,1.0,1.0,1/12,5.09%,GYS1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.30902124860662317,0.6843470645081272,0.935064935064935,1.0,1.0,9/81,16.69%,ARHGAP24;TBC1D28;USP6;ECT2;TBC1D3L;RHOG;ARHGAP45;EPHA1;RASGRP1
prerank,Reactome_2022__Cobalamin (Cbl) Metabolism R-HSA-9759218,-0.3967467602418723,-0.684206640022908,0.7692307692307693,1.0,1.0,5/6,37.91%,MTR;MMAB;MMACHC;MTRR;MMADHC
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.2671180359457918,-0.6840800768648678,1.0,1.0,1.0,11/111,10.97%,GCK;FOXO1;SH2B2;ATP6V0D2;CPEB1;ATP6V1E2;SYAP1;CAPN10;ATP6V0A2;SLC27A4;NAMPT
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,0.3004609633504123,0.6837430393906596,0.9736842105263158,1.0,1.0,9/81,20.47%,PSMB9;DNAJB1;RPS27A;CDC14A;PSMC5;RAG1;PSMA3;PSMB6;PSMD6
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.3765284434620845,0.6836971950725445,0.9,1.0,1.0,6/19,20.83%,TGFB1;DAB2;PPP2R5A;RHOQ;GBP1;MRAP
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.3401143491031706,-0.6836472443196763,0.8536585365853658,1.0,1.0,2/13,10.66%,EIF4EBP1;AGO2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.43844413280640154,0.6836468688283341,0.8461538461538461,1.0,1.0,1/5,5.31%,WNT5A
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.3996808058401159,0.6835566387730369,0.896551724137931,1.0,1.0,6/13,24.95%,ITK;MAPK3;AATK;BMX;TEC;DDR1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),0.38049110962200317,0.6835013219146756,0.90625,1.0,1.0,2/17,9.84%,MGST1;HPGDS
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),0.38049110962200317,0.6835013219146756,0.90625,1.0,1.0,2/17,9.84%,MGST1;HPGDS
prerank,Reactome_2022__Regulated Proteolysis Of p75NTR R-HSA-193692,-0.38480664812867693,-0.6834789440559327,0.8648648648648649,1.0,1.0,5/8,37.21%,NCSTN;NFKB1;TRAF6;PSEN1;APH1B
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.43029665486037705,0.6834044328142082,0.8615384615384616,1.0,1.0,1/7,3.69%,CTCFL
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,0.2944814892214794,0.6833154432709101,0.9866666666666667,1.0,1.0,1/76,0.37%,NEK2
prerank,KEGG_2021_Human__Vibrio cholerae infection,0.3182650503217645,0.683138465520247,0.96,1.0,1.0,4/45,11.20%,ATP6V1G2;ACTG1;ATP6V0E2;ATP6AP1
prerank,Reactome_2022__Miscellaneous Substrates R-HSA-211958,-0.4083239455225949,-0.6827255150698759,0.7352941176470589,1.0,1.0,4/8,28.21%,CYP2S1;CYP4F2;CYP2U1;CYP4A22
prerank,GO_Biological_Process_2021__kidney mesenchyme development (GO:0072074),-0.41041023656550735,-0.6827152901919745,0.7857142857142857,1.0,1.0,2/5,7.60%,OSR1;PKD2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.4323905306204815,0.6826807688775912,0.8870967741935484,1.0,1.0,2/10,9.22%,REST;PINK1
prerank,KEGG_2021_Human__Apelin signaling pathway,0.2960394013744613,0.6825678396602125,0.9625,1.0,1.0,24/112,24.77%,RRAS;GNG12;CCND1;GNG4;ACTA2;UCP1;PLAT;ADCY7;MAPK3;PIK3R6;PIK3CG;NOS2;GABARAPL2;MAP2K1;RPS6;GNGT1;GNB4;RYR3;KRAS;MYLK;GABARAPL1;PRKAB2;PLCB4;PPARGC1A
prerank,KEGG_2021_Human__Chemokine signaling pathway,0.2840551956993892,0.6824723478091544,0.9876543209876543,1.0,1.0,24/132,20.56%,PIK3R3;CCL5;GNG12;WAS;CXCR5;GRK7;GNG4;HCK;STAT1;XCR1;ITK;ADCY7;MAPK3;PIK3R6;CXCL12;PIK3CG;BCAR1;VAV3;NFKBIA;CCL25;DOCK2;MAP2K1;GNGT1;GNB4
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.3841118084430494,0.6824637969858516,0.9365079365079365,1.0,1.0,3/16,11.19%,DDX3X;NLRC3;STAT1
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.26219174443750415,-0.6821253200877812,1.0,1.0,1.0,15/117,14.73%,CNGA3;ADCYAP1;SLC17A6;ZNF385D;CFC1;AGA;RNF150;HFM1;GRIA4;GNB3;NOVA1;PCSK1;RAB27A;CELF4;CDH11
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.3491641812076817,-0.681883248241561,0.9090909090909091,1.0,1.0,6/15,26.90%,AAAS;NUP98;RGS14;NUTF2;ANP32A;NXT1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colorectum,-0.32908550073078024,-0.6818249405920004,0.9411764705882353,1.0,1.0,4/16,14.33%,LGR5;MSI1;ALCAM;CD58
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.42834167670043777,-0.6818168669102485,0.8536585365853658,1.0,1.0,1/9,0.18%,NOX4
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4029880429268454,-0.6817336246303962,0.8529411764705882,1.0,1.0,2/8,13.56%,GRIN1;RAB27A
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,0.3323243655502501,0.6815808703391681,0.9365079365079365,1.0,1.0,1/38,2.58%,FGF20
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.3593251398918062,-0.6814974885733541,0.8636363636363636,1.0,1.0,4/8,27.92%,ARMC10;EIF5A;PRKN;MSX1
prerank,CellMarker_Augmented_2021__Mesoderm cell:Germ,0.38489311964594025,0.6812266687912063,0.8870967741935484,1.0,1.0,6/15,19.79%,ANPEP;NT5E;MME;CD44;ENG;CD5
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.25427625207115034,-0.6809656495984637,1.0,1.0,1.0,29/124,21.15%,PROKR2;GRID2;CASKIN1;ELAVL3;PRR36;INA;MPP2;ASCL1;CCKBR;TAGLN3;MSI1;MAPK7;JPH3;RCOR2;MARK2;CSPG5;ERC2;IGDCC3;POU3F2;POU6F2;DAB1;LRP8;LINGO1;BRSK1;CUX2;MAPK4;APLP1;NCAM1;FBLL1
prerank,CellMarker_Augmented_2021__Flk1+ Mesodermal cell:Pluripotent Stem Cell,-0.26217269538522237,-0.6807823412887091,0.9444444444444444,1.0,1.0,14/96,13.21%,WWC1;CKMT1B;DSG2;ESRP1;KIAA1671;PTPRF;MID1;EPB41L4B;ADGRA3;WNK2;DAB2IP;FGFR2;AADAT;MAL2
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2748724572979781,-0.6807264756906863,0.9545454545454546,1.0,1.0,12/61,12.33%,DGKD;CDH13;RHBDF1;SH3KBP1;TGFA;PTPRJ;CNOT9;NEU3;SPRY1;DAB2IP;WDR54;HIP1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.33609211266448424,-0.6806554768011817,0.96875,1.0,1.0,10/21,27.28%,PTPRA;LDB1;SLK;RHOA;CAMSAP3;VCL;DUSP3;PEAK1;DAPK3;MACF1
prerank,GO_Biological_Process_2021__regulation of glomerular mesangial cell proliferation (GO:0072124),-0.4378442073025376,-0.6806334301124007,0.8421052631578947,1.0,1.0,3/5,33.85%,IL6R;PDGFB;BMP4
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.4122299867083197,0.6805996137919266,0.8545454545454545,1.0,1.0,3/10,14.48%,ANXA1;SOX9;ALOX15B
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.309844839275781,0.6805762832253005,1.0,1.0,1.0,5/59,12.77%,GML;CCND1;SDE2;CDKN1B;CDKN1A
prerank,CellMarker_Augmented_2021__Cancer cell:Brain,0.3003497590416802,0.6803909871223611,0.9879518072289156,1.0,1.0,5/93,9.28%,ACTL6A;CEP55;DTL;MCM3;C5ORF34
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.40291866913712954,-0.6802428011088949,0.8780487804878049,1.0,1.0,1/8,1.85%,ARX
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),0.4307096407800687,0.6802274320706494,0.8947368421052632,1.0,1.0,2/6,14.41%,LRPAP1;IL4
prerank,CellMarker_Augmented_2021__Osteocyte:Bone,0.42425650338448556,0.6799649862761872,0.9137931034482759,1.0,1.0,3/9,25.51%,CD44;FN1;BGN
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),0.44706051657095913,0.6796488113085234,0.8113207547169812,1.0,1.0,3/5,23.16%,COL1A1;ABCA12;ERRFI1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.3346678997497601,-0.6794546221206725,0.8787878787878788,1.0,1.0,4/15,16.44%,CCN1;FGFR2;MN1;RHOA
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.2787238753310155,-0.679230434467895,0.9642857142857143,1.0,1.0,8/67,9.22%,DDX41;CD14;IFI16;POLR3D;LRRFIP1;IRF5;RIPK2;POLR3E
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,0.3413674422450449,0.679027260646654,0.9180327868852459,1.0,1.0,9/28,28.24%,TNFRSF10A;RPS27A;MLKL;TRADD;GNL3;FASN;CASP8;STUB1;TNFRSF10B
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.31330268177508364,0.6789770646171324,0.9577464788732394,1.0,1.0,5/65,13.50%,CDC25A;MMP9;SDE2;CDKN1A;MME
prerank,"GO_Biological_Process_2021__positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",-0.42460592887062726,-0.6788701592949179,0.8604651162790697,1.0,1.0,2/5,11.39%,NKD1;RSPO3
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.3633075756013958,0.6786887882698981,0.8870967741935484,1.0,1.0,6/25,23.72%,CAV3;CDK5R1;ANKRD53;DCTN1;RPS3;PSRC1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.2881366394352922,0.6786325395848842,0.9882352941176471,1.0,1.0,22/118,23.99%,ST6GALNAC1;GALNTL5;FUT2;B3GNT9;C1GALT1C1;B3GNT5;B4GAT1;TMEM258;B3GALT2;ALG10;POMGNT1;FUT1;PGM3;GALNT6;AQP11;B3GNT3;ALG10B;PLOD2;ALG6;ALG2;MGAT4A;DPAGT1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.38586508550175236,0.6785065310415912,0.8852459016393442,1.0,1.0,1/12,10.77%,LDLRAP1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.3093756009758245,0.6784454494837117,0.9466666666666667,1.0,1.0,2/68,5.55%,NEK2;MISP
prerank,CellMarker_Augmented_2021__CD4+ T cell:Peripheral Blood,0.4577664154443737,0.6784212599544902,0.8793103448275862,1.0,1.0,2/5,20.42%,CD4;IL2RA
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.3150959254481834,0.6783088872764454,0.9701492537313433,1.0,1.0,1/42,1.75%,SLFN14
prerank,KEGG_2021_Human__Yersinia infection,0.2817331929626755,0.6780868932903498,0.9875,1.0,1.0,17/117,20.41%,PIK3R3;ACTG1;WAS;ITGA5;NLRC4;CD4;RHOG;FYB1;MAPK3;ZAP70;BCAR1;VAV3;CD8B;NFKBIA;MAP2K1;FN1;NFATC2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.3284091488149643,0.6780221752178798,0.9571428571428572,1.0,1.0,6/31,24.19%,GPER1;VPS18;CHRNA3;SNAPIN;MCTP2;SLC30A1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.43609247096608417,-0.6778136257429669,0.8571428571428571,1.0,1.0,2/7,17.15%,GTF2H2;MSH3
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,0.3555177604261992,0.6777191570379257,0.9066666666666666,1.0,1.0,8/34,18.09%,TPGS1;AGBL5;TTLL2;TTLL4;TUBA3D;TUBB6;VASH2;TUBA1C
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.38455056789992487,0.6776920052597267,0.890625,1.0,1.0,5/18,25.70%,ITGAM;CDK5R1;DDIT3;GRN;CTNNB1
prerank,Reactome_2022__Beta Oxidation Of butanoyl-CoA To acetyl-CoA R-HSA-77352,0.47133748142524623,0.6776582996127084,0.82,1.0,1.0,2/5,12.36%,ACSM3;ACSM6
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.39414359088011,-0.6772496928063553,0.8421052631578947,1.0,1.0,4/7,37.21%,NCSTN;ABCA7;PSEN1;APH1B
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,-0.2482841422689005,-0.6771343205176558,1.0,1.0,1.0,11/123,11.59%,GABRE;ITPR2;SLC17A6;GABRA5;KCNJ6;GNB5;GRIA4;GNB3;ADCY3;ADCY2;DAGLA
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.3938340540804687,0.6771273255421015,0.8412698412698413,1.0,1.0,1/13,4.27%,TGFB1
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.4330378563840225,0.6770445194428275,0.9423076923076923,1.0,1.0,2/8,21.74%,BCS1L;UQCRFS1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.4330378563840225,0.6770445194428275,0.9423076923076923,1.0,1.0,2/8,21.74%,BCS1L;UQCRFS1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.43428079209313686,-0.6769915522368973,0.9047619047619048,1.0,1.0,2/5,15.83%,ACVR1;TGFB2
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.23034586388770834,-0.6769719856691364,1.0,1.0,1.0,16/94,20.69%,MRRF;EARS2;LARS2;QRSL1;MRPS21;DAP3;NOA1;MRPS18C;MRPL4;MRPS35;GFM1;GATB;MRPL9;MRPL41;MRPL43;MRPS7
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.3756790541280876,-0.6767973519809702,0.7894736842105263,1.0,1.0,2/7,24.48%,ME2;FH
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.4102193689150107,0.676686451796761,0.85,1.0,1.0,4/10,30.45%,F2RL1;CD74;OAS1;MBP
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.3352426707843164,-0.6765688326139151,0.875,1.0,1.0,1/12,4.21%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.39122865148176844,-0.6763560935443091,0.8,1.0,1.0,2/6,17.20%,PTPRF;HFE
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.35991458846096935,-0.6763282175854056,0.8823529411764706,1.0,1.0,7/11,28.88%,HSF1;PRKCA;INHA;PTPN2;ID2;FADD;RIPK1
prerank,GO_Biological_Process_2021__negative regulation of vitamin metabolic process (GO:0046137),-0.4539376082240203,-0.6762199088315393,0.7894736842105263,1.0,1.0,2/5,11.11%,SNAI2;AKR1C3
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Death Genes With Uncertain Roles In P53-Dependent Apoptosis R-HSA-6803205,0.4003625878064868,0.6761411334761467,0.8688524590163934,1.0,1.0,5/12,15.15%,TP53I3;TP53BP2;BCL2L14;NDRG1;RABGGTB
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.33394840267499415,-0.6758324260681509,1.0,1.0,1.0,1/26,2.72%,IFT88
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.3016672012834828,0.6758218228068577,0.975,1.0,1.0,12/71,24.50%,INTS5;DAND5;TAF5;GTF2E1;TAF13;TAF6;INTS2;PHAX;SNAPC5;ELL2;GTF2A1;NCBP1
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.39546703713413844,-0.6757581071276282,0.8333333333333334,1.0,1.0,8/10,28.69%,AKT2;PTH1R;GPLD1;IRS2;SNCA;AKT1;PRKCE;SLC45A3
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,-0.25178296445954046,-0.6756521981502851,1.0,1.0,1.0,29/137,23.35%,NUP210;NUP42;POM121C;NUP214;TAF12;GTF2H2;AAAS;GTF2E2;ERCC2;SSRP1;POLR2F;NUP37;POLR2C;NUP98;ELOA;PPIA;MVB12A;TAF11;TSG101;CCNT1;XRCC4;CTDP1;SEH1L;SGIP1;GTF2F2;UBAP1;NUP50;TPR;RNF103-CHMP3
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.3076883190860809,-0.6755075715812261,0.9411764705882353,1.0,1.0,11/31,20.90%,KPTN;MINAR1;NPRL2;EPM2A;DEPTOR;TMEM127;SH3BP4;SZT2;ATM;TSC1;SESN3
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.33820905646692306,-0.6754106825773242,0.9459459459459459,1.0,1.0,7/18,30.34%,CPT1A;ACACB;PRKAG2;SLC25A20;PRKAA2;ABCD3;ABCD2
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,0.28450506154392113,0.6752666591266923,0.9868421052631579,1.0,1.0,16/121,21.53%,PSMB9;HCK;HLA-A;RPS27A;AP1M2;CD4;PSMC5;HMGA1;RCC1;CD8B;RBX1;PSMA3;DOCK2;PSMB6;PSMD6;B2M
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.41881588748171816,0.6751379912439863,0.7741935483870968,1.0,1.0,4/8,41.00%,OGG1;TERF2IP;ACD;POT1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.32681766092789055,-0.6751134209967422,0.8809523809523809,1.0,1.0,4/10,23.38%,WWP2;CORO2B;MAPT;PPM1F
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),-0.4281444437176972,-0.6748711547000104,0.8378378378378378,1.0,1.0,2/6,16.93%,HES1;GPR157
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.4300398658163824,0.674822357413651,0.8333333333333334,1.0,1.0,1/7,6.41%,DAAM2
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.3583848223639996,0.6745890621606285,0.8793103448275862,1.0,1.0,7/22,20.81%,ABCG2;UPK3A;SLC14A1;SLC46A1;ABCA12;AQP11;TAP1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.3762079424724996,0.6745014278157416,0.9230769230769231,1.0,1.0,2/18,7.69%,MCMDC2;MCM3
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.3985047790290527,-0.6744396601144694,0.75,1.0,1.0,5/5,60.16%,SEC61B;ZFAND2B;SEC61A1;SEC61A2;SRP54
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.30380247288513446,-0.67398860810909,0.9285714285714286,1.0,1.0,3/35,7.51%,THEM4;OTUD3;PTPRJ
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.31128991515915244,0.6738569433502485,0.9315068493150684,1.0,1.0,7/64,13.80%,DISC1;LRP2;GPER1;TGM2;PLXNA3;MME;OPRM1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.2727503382336741,0.6738148013128922,1.0,1.0,1.0,47/264,20.78%,MAP3K11;TNFRSF10A;BOK;DDX20;GPER1;SCIN;NLRC4;REST;DDX3X;CYP1B1;TP53BP2;KNG1;MOAP1;RHOB;DNAJA1;TGFB3;ECT2;TGM2;RPS27A;RASGRF2;HMGA2;BTG1;ING3;TFPT;SFRP4;PXT1;PNMA1;LATS2;MTCH1;CDK5R1;TPD52L1;STK17A;PTRH2;PHLDA1;VAV3;ITGB3BP;PNMA2;DKKL1;FRZB;PPID;APAF1;SIAH1;RPS6;STK17B;OBSCN;PRR7;ZNF622
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),0.4312568087895967,0.6737128240975158,0.8620689655172413,1.0,1.0,1/5,18.48%,SCN5A
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),-0.42163851538004193,-0.6737126846020648,0.9047619047619048,1.0,1.0,1/5,14.62%,NR1H2
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.26347986961395886,0.6736358013044628,1.0,1.0,1.0,23/446,9.22%,NEK2;MAPKAPK3;BLK;TLR2;GMFG;HIPK4;STRADA;ROS1;FAM20A;HIPK1;MAP3K11;FLT1;TGFB1;MAK;PRDX4;STK26;SYK;ERBB4;GRK7;FLT4;STK32A;HCK;PINK1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.379363475233156,-0.673479213123597,0.8461538461538461,1.0,1.0,4/15,15.70%,CTCF;CDK1;CHAMP1;IK
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.30386581243693184,0.6734085224964785,0.96,1.0,1.0,20/81,23.28%,CLDN6;SALL4;PHF21B;TMEM200C;LEF1;L1TD1;EPCAM;SLC7A3;CXCL12;FBN3;VASH2;ZDHHC22;CAMKV;EFNB3;IGLON5;CBLN1;SPSB4;SEMA6A;ADAMTS20;MYCN
prerank,Reactome_2022__Generic Transcription Pathway R-HSA-212436,0.2589746581338462,0.6733153609941109,1.0,1.0,1.0,143/1022,21.43%,GATA4;COX6A1;SMAD6;ESR1;ACTL6A;PSMB9;BLK;RORC;GAD1;ZNF676;GP1BA;TCF7;RRAD;NR1I3;CBX8;HIPK1;MOBP;TGFB1;ZNF738;LMO2;TNFRSF10A;ITGBL1;HEY2;CCNG2;NR2E3;DAND5;H2BC4;SLC6A4;ZFP69;CDKN2A;ZNF582;TP53I3;NR1H4;ITGA5;NLRC4;CCND2;ZIK1;TAF5;LEF1;CCND1;H2AZ1;ZNF616;DDIT4;ZNF175;TP53BP2;ZNF225;RRAGA;PINK1;NPY;RPA3;HNF4G;ZNF585B;CCNE2;TFAP2E;COL1A1;RPS27A;STAT1;SMARCE1;CLDN5;BCL2L14;CASP10;ZNF556;LIFR;CDKN1B;TAF7;BTG1;ING3;CDKN1A;ZNF213;THBS1;GLI3;CCNA2;CSF1R;TCF7L1;ITGA2B;OPRM1;RXRG;SOX9;PSMC5;NDRG1;NPPA;ZNF214;ZNF792;BBC3;RABGGTB;MAPK3;CDK5R1;FKBP5;MYL9;TAF7L;ARTN;HNF1A;TAF10;ZNF550;RMI2;TAF13;NR5A2;MAF;BRCA1;MYB;ZNF114;ZNF740;TAF9B;COX20;COX4I1;ZNF343;ZFP37;ZNF233;TXNIP;LAMTOR3;ZNF543;ZNF394;RBX1;APAF1;YWHAH;PSMA3;COX7B;PSMB6;ZNF436;ZNF750;HEY1;NOTCH2;RAD9B;ZNF732;COX6C;CDC25C;COX6B1;ZNF317;NFATC2;IL2RA;PSMD6;H2AZ2;SESN1;ZNF552;CNOT8;ZNF684;NFYB;TAF6;CCNB1;ZFPM1;GPS2;ZNF473;ZNF749
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.3483296116618983,-0.6733066409497745,0.8518518518518519,1.0,1.0,1/24,1.19%,DNMT1
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.3921560323686378,0.6732812560184989,0.8309859154929577,1.0,1.0,2/9,15.76%,TAF7;TAF7L
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.25853606167848553,0.6732809439194785,1.0,1.0,1.0,122/908,20.05%,NEK2;NOTUM;APOL1;PSMB9;ST6GALNAC1;GALNTL5;GAD1;PTPRH;ITIH2;SDC2;FBXL7;ASB5;GMFG;ANXA1;LOX;GLRX;ART1;DTL;STRADA;ROS1;FAM20A;C3;UBE2L6;PTPRC;HIPK1;MAP3K11;TGFB1;MAK;FCGR3A;ASB14;SERPIND1;USP6;FUT2;STK26;SYK;B3GNT9;SOCS2;GRK7;FLG;SPSB2;DUSP29;ANKRD9;HCK;KNG1;PPP2R3A;MMP15;PINK1;ASB15;ASB17;RAB11A;CP;B3GNT5;TGM2;OGFOD1;PPP2R5A;ZC3HAV1;KLHL2;ERN2;ENGASE;PP2D1;PDK4;FBXL13;PENK;ALOX12B;THBS1;PIGH;CHST4;SERPINA10;FBXL3;PLAT;RAB38;PSMC5;LATS2;KBTBD7;TGOLN2;GGCX;COPS4;KLHL13;ART3;RABGGTB;MAPK3;TGM6;ISG15;FBXO40;KBTBD6;STK17A;GPS1;GLYCTK;CSF1;ZAP70;COPS5;PARP14;PARP4;UBE2M;ASB16;PRKG1;B3GALT2;STRADB;HUNK;TF;LAMB2;CLK3;FEM1B;RBX1;CDK20;PKN3;PSMA3;DUSP16;ART4;NEURL2;DUSP11;PSMB6;PTP4A2;FUT1;MAP2K1;RPS6KA5;TSSK3;ULK1;PRSS23;MTMR6;STK17B;PTPRU
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.3929162283659984,0.6732421600460025,0.8888888888888888,1.0,1.0,1/12,5.83%,DEPDC5
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.35315810534342584,-0.6732257386217942,0.9310344827586207,1.0,1.0,4/20,9.17%,WNT3A;WNT7A;PCM1;RFLNB
prerank,KEGG_2021_Human__Synthesis and degradation of ketone bodies,-0.3863523133867621,-0.6731566122823136,0.8444444444444444,1.0,1.0,2/8,19.02%,BDH1;HMGCL
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.2811949821780818,-0.673110811158737,0.9166666666666666,1.0,1.0,7/33,11.16%,TST;MLYCD;ARSB;VCAN;CHAC1;PRELP;IDUA
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.39457430239209057,0.6730298262182663,0.8166666666666667,1.0,1.0,1/10,6.35%,SYK
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.35181662660702606,0.6729285011459242,0.9014084507042254,1.0,1.0,6/23,24.43%,KCNA5;ATP1A4;KCNE3;KCNE4;KCNQ1;ATP1A1
prerank,Reactome_2022__Signaling By Activin R-HSA-1502540,0.3604077291300301,0.6727694947166641,0.8939393939393939,1.0,1.0,9/13,37.58%,MAPK3;FOXH1;DRAP1;ACVR2B;SMAD3;SMAD4;ACVR2A;MAPK1;INHBA
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.3362986449720478,0.6727694935751426,0.9411764705882353,1.0,1.0,4/42,12.58%,SP100;POLD4;RPA3;RECQL4
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.2789071915516644,0.672702743214745,0.975609756097561,1.0,1.0,9/106,15.07%,CAPN13;CHDH;HAMP;PPP1R1B;CP;SOWAHA;AQP4;BMI1;MTUS1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.3350077122089518,0.6725969153170627,0.9295774647887324,1.0,1.0,9/29,24.63%,FGF2;ITGA5;THBS1;GLUL;FUT1;CEACAM1;ALOX5;SEMA6A;PIK3CB
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.3304866144994055,0.672383467523651,0.921875,1.0,1.0,6/30,23.82%,B4GALNT2;ASGR2;ASGR1;OSTC;MCFD2;LMAN1
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,0.29042346540377345,0.6721160610605257,0.987012987012987,1.0,1.0,4/70,8.50%,ST6GALNAC1;RENBP;MPDU1;NANS
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),0.3763633155921307,0.6720646248729009,0.8888888888888888,1.0,1.0,6/14,29.99%,CRTAM;XRCC6;SPINK5;ZFP36L1;ZFP36L2;PRELID1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.302717188469858,-0.6720592175934819,0.9615384615384616,1.0,1.0,5/31,12.91%,WNT3A;SELE;WDR54;SDCBP;ARRB2
prerank,Reactome_2022__Erythropoietin Activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276,0.37697989969870394,0.6715907603898433,0.890625,1.0,1.0,3/12,24.63%,PIK3CG;EPX;PIK3CB
prerank,CellMarker_Augmented_2021__Sertoli cell:Fetal Gonad,0.2598548265586704,0.671571474529476,1.0,1.0,1.0,43/392,17.48%,ST6GALNAC1;ELOVL2;SMOC1;LIPH;A2ML1;C21ORF91;SYNE2;C1ORF141;PRDX4;JAM2;DNAJB1;DAND5;ERBB4;CPVL;F8;AXL;NANS;MMP15;TCEAL5;SLC27A6;KLHDC8B;PRAME;WNT6;USP13;TXNDC17;TMEM41A;ADGRG1;EPCAM;SOX9;PLLP;BEX1;CKB;PRDX6;IFI6;TRPC5OS;KRT8;ZMYM3;MRPL54;TSPAN7;DYNLL1;SERPINB1;GAS7;PLEKHB1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.34679448064151996,-0.6715184348699675,0.8928571428571429,1.0,1.0,1/15,4.68%,AUP1
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,0.2903574414378878,0.6714941908674892,0.9736842105263158,1.0,1.0,9/77,15.21%,RRAS;PIK3R3;IL12A;SYK;IRF1;STAT1;NFKB2;MAPK3;CYLD
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.3431450864067691,0.6710537776473947,0.9166666666666666,1.0,1.0,5/27,20.72%,WAS;VIL1;PSTPIP1;GAS7;CATIP
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,0.2767092823804249,0.6709606960457082,0.9878048780487805,1.0,1.0,11/128,15.19%,PSMB9;CBX8;PREX2;SALL4;REST;RRAGA;RPS27A;USP13;PSMC5;SNAI1;MAPK3
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,-0.25588579644718035,-0.6709029756501158,1.0,1.0,1.0,8/124,8.48%,IL1RL2;SIGIRR;PTPN9;NKIRAS2;S100B;NOD1;ALPK1;RIPK2
prerank,Reactome_2022__Termination Of O-glycan Biosynthesis R-HSA-977068,-0.3120403517139012,-0.6707787076637192,0.918918918918919,1.0,1.0,3/20,8.59%,ST3GAL3;MUC19;ST3GAL2
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),-0.3217862190296032,-0.670655972214642,0.8823529411764706,1.0,1.0,6/24,16.82%,NLGN3;SLIT3;ALCAM;SLIT2;CDK5;AUTS2
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.3241984927784465,0.670345721591901,0.9117647058823529,1.0,1.0,3/36,12.58%,ENDOG;RAD54L;RECQL4
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,0.3231368915211154,0.6693211659668991,0.9444444444444444,1.0,1.0,9/33,24.21%,RRAD;RPA3;ARTN;RMI2;BRCA1;RAD9B;BRCA2;RMI1;KAT5
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),0.44515940136936993,0.6692679254258331,0.8955223880597015,1.0,1.0,3/7,24.28%,WEE2;FBXO5;OOEP
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.3511671445727265,0.6692573645547802,0.8428571428571429,1.0,1.0,5/27,14.32%,TSHR;ADRB1;RXFP2;CALCR;ADCY7
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.2686180153758575,0.6692394356886026,1.0,1.0,1.0,29/134,24.66%,PSMB9;STOML2;PTPRC;WAS;HLA-A;HLA-DPB1;THEMIS;CD4;ITK;PSMC5;FYB1;BTN3A3;ZAP70;BCAR1;BTNL9;HLA-DPA1;PSMA3;PSMB6;PSMD6;EIF2B2;BTN1A1;BTNL8;EIF2B5;HLA-DRB1;PRKCQ;INPP5D;TEC;PIK3CB;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.3312962762516446,0.6689560051137665,0.9375,1.0,1.0,6/27,14.41%,SP100;MARVELD3;MCC;DCN;THBS1;IL4
prerank,Reactome_2022__SUMOylation R-HSA-2990846,-0.2432802134455005,-0.6687657794422343,1.0,1.0,1.0,15/153,10.96%,NUP210;DNMT1;RNF168;HDAC7;PIAS3;NUP42;POLR1A;PHC2;POM121C;NUP214;SENP1;AAAS;XPC;NR2C1;DNMT3A
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.3684780451493667,0.6687189639946871,0.9310344827586207,1.0,1.0,3/16,15.80%,LPIN3;MOGAT1;MOGAT2
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.36334661804359736,0.6685278566252449,0.921875,1.0,1.0,2/14,17.74%,CD81;GBP1
prerank,"Reactome_2022__Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",0.3361465067254307,0.6684086081771178,0.9130434782608695,1.0,1.0,1/19,3.20%,GNAT3
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.4498575843325413,0.6683600168767851,0.8833333333333333,1.0,1.0,2/5,23.90%,GPS2;CITED2
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.30411735198609713,0.6682264424996756,0.975,1.0,1.0,6/69,12.77%,ANXA1;TICRR;RAD1;RHOB;ECT2;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.28247062739879086,0.6682068269773643,0.9764705882352941,1.0,1.0,14/133,15.19%,NEK2;ROS1;FLT1;TGFB1;ERBB4;FLT4;AXL;PINK1;CD4;CSF1R;BMI1;DDR2;EPHA1;MAPK3
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.3198113742108956,0.6681087061587115,0.9178082191780822,1.0,1.0,11/46,21.74%,SCIMP;FOXM1;IL26;F2RL1;MAPK3;AGER;COPS5;RASGRP1;MAP2K1;STK25;MAPK8IP2
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),-0.3869324723366221,-0.6680989170649382,0.8775510204081632,1.0,1.0,4/6,24.88%,CCDC78;CEP152;PLK4;CCNO
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.3924056927358414,-0.6680686081603625,0.78125,1.0,1.0,4/7,29.76%,DLEC1;PLK5;LAPTM5;RBMS3
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.4337192379984921,0.6676657155181367,0.875,1.0,1.0,1/7,7.24%,NR1H4
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.36499316899203255,0.6673483550149181,0.8450704225352113,1.0,1.0,2/16,13.70%,RAMP3;CALCR
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.2888610380520169,0.6673092835581451,0.9866666666666667,1.0,1.0,11/86,19.63%,PTPRC;USP6;SYK;HCK;RAB11A;STON2;CHMP3;MAPK3;DENND10;RAB21;MAP2K1
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,-0.3008253780463144,-0.6672146269552651,1.0,1.0,1.0,3/24,15.71%,HDAC3;PTPRZ1;PRDM1
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.4593751305527389,0.6671859935165659,0.9104477611940298,1.0,1.0,1/6,25.38%,NOS1AP
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.4174789438818965,-0.6671730383306085,0.8636363636363636,1.0,1.0,5/5,58.27%,AK3;ENTPD4;AK5;DHODH;CMPK1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.3021067410078663,0.667104439462143,0.9746835443037974,1.0,1.0,14/90,16.69%,AMBP;MAP3K11;SEMA3A;FLT4;DUSP22;PINK1;MARVELD3;F2RL1;CYLD;TPD52L1;AGER;COPS5;EDAR;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.27523941257593876,0.6670157931269083,1.0,1.0,1.0,12/139,11.98%,S100A13;LPAR1;TRIM62;TRAF3IP2;TRIM25;PINK1;TRIM68;ECT2;TIFA;CASP10;F2RL1;CD4
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex6:Brain,-0.2890561362952714,-0.6668527163793132,0.9666666666666667,1.0,1.0,5/34,14.56%,HCRTR2;ZNF385D;SDK2;BCL11B;ANKRD18A
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.37661862278090674,-0.6667941795313177,0.925,1.0,1.0,2/9,23.25%,NUP98;TPR
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,-0.3049755956842378,-0.6667466245583854,0.9354838709677419,1.0,1.0,1/27,1.87%,FOS
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.3843361306403358,-0.666733202165898,0.8372093023255814,1.0,1.0,3/8,20.20%,ALDH18A1;ASL;AZIN2
prerank,Reactome_2022__RUNX1 Regulates Expression Of Components Of Tight Junctions R-HSA-8935964,-0.4102489299677866,-0.6665297648915051,0.7857142857142857,1.0,1.0,1/5,4.89%,CBFB
prerank,Reactome_2022__Processive Synthesis On Lagging Strand R-HSA-69183,0.38263698472586183,0.6663959436123426,0.8529411764705882,1.0,1.0,2/13,9.53%,POLD4;RPA3
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),-0.42559023946009134,-0.6663031008678022,0.8372093023255814,1.0,1.0,3/5,20.80%,LETM1;MICU1;CLN3
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,-0.24574086163646516,-0.6660102466328109,1.0,1.0,1.0,11/161,9.08%,UBXN8;SEC24C;BCL2;CAPN2;MAN1A1;UBE2D4;DNAJC5G;PDIA6;UBXN2A;ERN1;SEL1L2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.2736526353834499,0.6658365897929521,1.0,1.0,1.0,44/246,20.78%,MAP3K11;TNFRSF10A;BOK;DDX20;GPER1;SCIN;SYK;NLRC4;REST;DDX3X;CYP1B1;KNG1;MOAP1;RHOB;DNAJA1;TGFB3;ECT2;TGM2;RPS27A;RASGRF2;HMGA2;ING3;TFPT;SFRP4;PXT1;PNMA1;LATS2;MTCH1;STK17A;PHLDA1;NOS2;VAV3;ITGB3BP;PNMA2;DKKL1;FRZB;PPID;APAF1;SIAH1;RPS6;STK17B;OBSCN;PRR7;ZNF622
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.24931296586209462,-0.6656985841530796,1.0,1.0,1.0,18/105,17.41%,BAMBI;PRKCD;WNT3A;TTBK1;MEN1;RALB;DDX11;RIPK2;PEX14;SYMPK;TERT;CRK;MARK2;CSNK1E;PPP1CA;HDAC5;HFE;MARK3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.3726162842890997,-0.6655445176602538,0.9230769230769231,1.0,1.0,2/11,10.65%,CREB3L1;ATF3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.42868434490205143,-0.6654330721017842,0.8333333333333334,1.0,1.0,3/8,27.32%,CARD9;IL17RA;STAT3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.43600579914988774,0.665429421529578,0.8088235294117647,1.0,1.0,2/7,13.82%,CCL5;ORMDL3
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.35947907759643544,0.6653836730059511,0.9565217391304348,1.0,1.0,3/22,10.78%,HEG1;MARVELD3;TJP3
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.23135507306413297,-0.6653803684137104,1.0,1.0,1.0,41/201,20.17%,TTC21A;DCDC2;CNGA4;MLF1;CASKIN1;TRIM66;SPTBN4;LRRC73;PTPRF;PRR36;CAP2;MPP2;MORN4;EPB41L4B;NCS1;HPCA;SRRM3;OSCP1;ATP9A;WDR54;KCTD1;NAT14;B9D1;NME5;CSPG5;TRAF3IP1;GPC1;RIC8B;TTC5;RTP1;FAM81A;IFT43;NRSN2;IMPDH1;LINGO1;SYT7;SRCIN1;KIFBP;CNPPD1;KLHDC9;SEZ6L2
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.327770699314271,0.6653452439801656,0.9452054794520548,1.0,1.0,3/44,6.38%,MYRF;SOX10;PLP1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.35469649666527303,0.6652086166352819,0.8888888888888888,1.0,1.0,8/22,18.70%,ZACN;GLRA2;GLRA1;SLC30A2;MT1M;MT4;HAAO;HVCN1
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.4011035170832971,-0.66500992402736,0.84375,1.0,1.0,2/6,21.96%,SLC4A11;TRPV4
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3268662229515033,-0.6646194615336795,0.9166666666666666,1.0,1.0,2/16,10.10%,SIGIRR;TRIB1
prerank,Reactome_2022__KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,0.38436452313060987,0.6646088537260415,0.8873239436619719,1.0,1.0,3/16,15.26%,EXOSC8;EXOSC2;EXOSC4
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.2826873006725687,-0.6645061150406608,1.0,1.0,1.0,8/35,18.60%,ZNF703;ASS1;JAG1;MAPK7;MIA3;PODXL;MAD2L2;AKNA
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.3447112406966482,-0.6643995140880643,0.9,1.0,1.0,1/18,1.19%,DNMT1
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.34486728635041247,0.6641809841581654,0.8985507246376812,1.0,1.0,10/22,30.60%,HSD17B2;AKR1B15;FDXR;STAR;HSD17B6;CYP21A2;CYP17A1;CYP19A1;FDX1;AKR1B1
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.3818762271858928,-0.6641231972138334,0.825,1.0,1.0,1/10,2.59%,PTCH1
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.44245445672881134,-0.6640176116628509,0.8387096774193549,1.0,1.0,1/5,8.62%,SERPINE1
prerank,Reactome_2022__Axonal Growth Inhibition (RHOA Activation) R-HSA-193634,0.4193977775545563,0.6638895811160593,0.8596491228070176,1.0,1.0,2/7,19.32%,OMG;MAG
prerank,KEGG_2021_Human__T cell receptor signaling pathway,0.2837277665568678,0.6635991831488504,0.9864864864864865,1.0,1.0,19/85,24.63%,PIK3R3;PTPRC;IL5;CD4;ITK;IL4;MAPK3;ZAP70;RASGRP1;VAV3;CD8B;NFKBIA;MAP2K1;NFATC2;KRAS;PRKCQ;VAV1;TEC;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.42039390316300573,0.6635840410584783,0.8666666666666667,1.0,1.0,3/8,21.85%,IL4;EHD2;EHD1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.384278651659696,-0.6634424444114014,0.9090909090909091,1.0,1.0,1/9,6.16%,HM13
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.3466942100754354,0.6633273778717437,0.9259259259259259,1.0,1.0,5/30,15.27%,TGFB1;TGFB3;FBN2;ATRAID;ISG15
prerank,Reactome_2022__Protein Localization R-HSA-9609507,-0.23750547965887692,-0.6632935729170233,1.0,1.0,1.0,27/145,16.42%,EPHX2;CHCHD5;MLYCD;PEX7;SLC25A17;HSCB;SLC27A2;ACOX3;GSTK1;PEX13;MPV17;TAFAZZIN;PEX14;STX5;COQ2;EMD;BAG6;NUDT19;SAMM50;CROT;TYSND1;CHCHD10;EHHADH;TIMM23;CHCHD3;DHRS4;TIMM44
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.30911843129590144,0.663256510112076,0.9594594594594594,1.0,1.0,10/57,16.38%,OSCAR;MMP9;LEF1;F2RL1;CD4;GPR183;CDKN1A;CSF1R;IL4;CSF1
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,0.2577137297886122,0.6630925570970994,1.0,1.0,1.0,58/323,24.26%,COX6A1;RRAD;HIPK1;TNFRSF10A;CDKN2A;TP53I3;NLRC4;TAF5;DDIT4;TP53BP2;RRAGA;RPA3;CCNE2;RPS27A;BCL2L14;CASP10;CDKN1B;TAF7;ING3;CDKN1A;CCNA2;NDRG1;BBC3;RABGGTB;CDK5R1;TAF7L;ARTN;TAF10;RMI2;TAF13;BRCA1;TAF9B;COX20;COX4I1;LAMTOR3;APAF1;YWHAH;COX7B;RAD9B;COX6C;CDC25C;COX6B1;SESN1;CNOT8;TAF6;CCNB1;RBBP7;MTA2;FANCI;YWHAG;SETD9;PRMT1;COX5A;RMI1;COX7C;PRKAB2;KAT5;RBL2
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,-0.2861690446909441,-0.6630355891997026,1.0,1.0,1.0,10/56,15.56%,FGF18;MYO18A;FGF1;STAT5B;LRRFIP1;CNTRL;CUX1;FGFR2;POLR2F;POLR2C
prerank,Reactome_2022__Glycerophospholipid Catabolism R-HSA-6814848,-0.40724966874881696,-0.6629789745791576,0.8292682926829268,1.0,1.0,7/7,59.29%,GDPD5;GDPD1;ENPP6;PNPLA6;GDE1;GDPD3;PNPLA7
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.37308818057771637,-0.6629109975655748,0.9111111111111111,1.0,1.0,4/10,21.57%,CCN3;SLIT2;GREM1;C5
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.3781455916763195,-0.6628262373917351,0.8571428571428571,1.0,1.0,1/6,4.89%,CBFB
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.3030718159557013,0.6628121244702855,0.948051948051948,1.0,1.0,3/74,6.32%,TGFB1;EBF1;ANGPTL4
prerank,CellMarker_Augmented_2021__Spermatogonium:Testis,0.47078004654207234,0.6622798537327619,0.9333333333333333,1.0,1.0,1/5,5.35%,SYCP3
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.253999842790803,-0.6620806565763745,1.0,1.0,1.0,15/111,11.08%,CELF5;SLC17A6;CASKIN1;ABCC8;ELAVL3;TTBK1;LHFPL4;PRR36;SNCB;HPCA;KCNJ6;NEUROD6;KCNB2;ADGRA1;MSI1
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.427799957216386,0.6618072019959789,0.8769230769230769,1.0,1.0,1/8,6.41%,DAAM2
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.32061181131579075,-0.6616453877176632,0.9,1.0,1.0,2/20,15.56%,POLR2F;POLR2C
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.32061181131579075,-0.6616453877176632,0.9,1.0,1.0,2/20,15.56%,POLR2F;POLR2C
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,0.27239365227702006,0.6614924004120647,1.0,1.0,1.0,26/166,22.30%,TLR2;TNFRSF1B;PIK3R3;GNG12;HLA-F;GNG4;HLA-A;WEE2;AP1M2;CD4;MAPK3;CFL1;RBX1;NFKBIA;MAP2K1;TRIM5;CDC25C;NFATC2;GNGT1;GNB4;TRAF5;TAP1;CCNB1;B2M;TRADD;KRAS
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.39941039183545646,-0.6613833217528043,0.8333333333333334,1.0,1.0,2/7,14.93%,G6PD;XYLB
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.3464143410547991,-0.661304649487898,0.9117647058823529,1.0,1.0,4/11,14.57%,ARSB;VCAN;IDUA;CSPG5
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),-0.4175310099815458,-0.6612787011840181,0.8823529411764706,1.0,1.0,2/6,12.07%,SPTBN4;RNLS
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.3892446743367654,0.6611574110699303,0.8703703703703703,1.0,1.0,3/8,32.51%,TDG;OGG1;UNG
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.2935761702687717,-0.661027935545763,1.0,1.0,1.0,11/42,19.25%,PPP1R35;PLIN5;F11R;CSTA;ECM1;DAB2IP;MAPK7;CHP1;SH3BP4;ZCCHC9;HRAS
prerank,GO_Biological_Process_2021__fatty acid omega-oxidation (GO:0010430),-0.4504332750102734,-0.660878848616756,0.8461538461538461,1.0,1.0,2/5,13.42%,CYP4V2;ADH4
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.3610896892416812,0.6608386109909903,0.890625,1.0,1.0,1/15,4.27%,TGFB1
prerank,Reactome_2022__PI3K Events In ERBB2 Signaling R-HSA-1963642,0.3759498576912164,0.6608131059082181,0.9375,1.0,1.0,1/14,6.80%,ERBB4
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.42706876712735325,0.6608103704562874,0.86,1.0,1.0,1/6,5.92%,SCARA3
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.3682978200702915,0.6605879325126386,0.9117647058823529,1.0,1.0,2/13,11.19%,DDX3X;STAT1
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.3122112353936409,0.6605546406890954,0.9358974358974359,1.0,1.0,5/37,15.19%,TNFRSF10A;IRF1;PIEZO2;SOX9;MAPK3
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3946373695766235,0.6604835577672616,0.9583333333333334,1.0,1.0,1/11,21.74%,UQCRFS1
prerank,KEGG_2021_Human__Fanconi anemia pathway,-0.2851719157789444,-0.6604031471814721,1.0,1.0,1.0,7/49,10.38%,FANCG;HES1;MUS81;FAN1;FANCA;ATR;SLX4
prerank,Reactome_2022__HDL Clearance R-HSA-8964011,0.39583235144642004,0.6603817956284578,0.8181818181818182,1.0,1.0,1/5,12.76%,AMN
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.3020670519562316,-0.6601996587001931,0.9444444444444444,1.0,1.0,8/26,22.24%,CARM1;SERPINE1;NAMPT;BMAL2;BHLHE40;SMARCD3;NPAS2;CREBBP
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.4068464075524276,0.660087338674185,0.8153846153846154,1.0,1.0,1/7,19.83%,NOTCH2
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.3478868443783598,0.6600415851907768,0.9428571428571428,1.0,1.0,8/30,20.88%,BOK;ERBB4;SOD2;BBC3;IFI6;NAIF1;FIS1;GGCT
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.34079075426881367,-0.659944984419502,0.9210526315789473,1.0,1.0,1/11,3.00%,KDELR1
prerank,Reactome_2022__FGFR2 Mutant Receptor Activation R-HSA-1839126,0.34845440696321167,0.6599222065809588,0.9827586206896551,1.0,1.0,1/29,2.58%,FGF20
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.28102636401607745,-0.6598778416862514,0.9166666666666666,1.0,1.0,12/53,17.96%,APOE;FBXO27;CELA2A;NEU4;LRSAM1;NR1D1;DAB2IP;BAG6;NGLY1;FBXO44;HTRA2;ADAMTS9
prerank,Reactome_2022__Assembly Of Active LPL And LIPC Lipase Complexes R-HSA-8963889,-0.3843036747432192,-0.6598040107934462,0.875,1.0,1.0,1/13,0.92%,LIPC
prerank,KEGG_2021_Human__RNA degradation,-0.2585844114225817,-0.6596778258347271,1.0,1.0,1.0,9/72,14.66%,ENO3;DCPS;TENT4A;LSM7;CNOT9;PFKP;EXOSC10;EXOSC1;PABPC4
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.33484260448548375,-0.6596140255275965,0.8846153846153846,1.0,1.0,1/25,1.47%,PRKCD
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.29737297111209926,0.6594757485975701,0.9583333333333334,1.0,1.0,12/67,23.35%,PLA2G10;PON1;PLA2G7;PIGH;CSF1R;PRDX6;PLA2G4A;PIGC;PLCD1;SERINC1;ACP6;PLA2G4D
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.321517036762036,0.6594615952300524,0.9583333333333334,1.0,1.0,12/43,22.46%,CCL5;CASR;CAV3;CD4;PLN;GRAMD2A;EFHB;PLPP4;ORAI1;GRIN3B;ADRA2A;MYLK
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,-0.32131278048931655,-0.6593521572873259,0.9,1.0,1.0,1/24,1.19%,DNMT1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.35431304766018235,-0.6592342068886656,0.8611111111111112,1.0,1.0,4/11,16.75%,PTPRJ;PDE3A;SLIT2;DDAH1
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,0.3308058499443094,0.659225730601861,0.921875,1.0,1.0,2/31,8.50%,ST6GALNAC1;NANS
prerank,GO_Biological_Process_2021__sinoatrial node development (GO:0003163),0.4238135930408175,0.6590071920706009,0.8983050847457628,1.0,1.0,1/6,5.72%,MESP1
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,-0.24522386185252104,-0.6589880859641218,1.0,1.0,1.0,36/206,18.69%,GATAD2A;KMT2B;CHD4;HDAC10;SAP130;SMARCB1;JADE2;SMYD2;CARM1;KDM7A;KDM3B;TAF12;KDM2B;PHF2;KMT5C;HDAC3;KDM4D;DNMT3A;PAX3;KDM1B;BRPF3;H2AJ;KANSL2;SMARCA4;PBRM1;EP400;SETDB1;SUPT7L;KDM4B;SMARCD3;CDK4;KMT5A;GATAD2B;DPY30;KDM2A;SMARCD1
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.33131880425509636,-0.6586045412347648,0.96875,1.0,1.0,6/18,21.24%,RAD50;SLX4;NBN;SETMAR;ATM;RAD52
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.2867435640064894,-0.658454262070039,1.0,1.0,1.0,21/51,28.87%,DCPS;LSM7;CNOT9;EXOSC1;SAMD4B;TNKS1BP1;LSM2;DCP1B;LSM6;DCP1A;TUT7;PARN;CNOT6;CNOT10;DIS3;LSM1;CNOT3;RC3H1;PATL1;NT5C3B;SAMD4A
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,0.2956757081767795,0.6583138483696148,0.9880952380952381,1.0,1.0,5/88,7.30%,ADA;GLRX;TK1;NUDT13;NT5E
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.39837355143048647,-0.6583122900925874,0.9487179487179487,1.0,1.0,2/7,24.01%,NR1H2;PRKN
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.3852258727522153,-0.6582406767365968,0.8378378378378378,1.0,1.0,1/9,10.86%,NUPR1
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.41510917420785903,-0.6580927282123239,0.8372093023255814,1.0,1.0,1/7,2.14%,PAH
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.33782584900619383,-0.658058451471065,0.9393939393939394,1.0,1.0,7/19,29.70%,TUBGCP2;CCDC57;AKAP9;CSNK1D;TUBG1;GOLGA2;TUBG2
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.2932078688229141,-0.6575879055700797,0.9090909090909091,1.0,1.0,6/32,17.20%,FLNA;CRK;CSPG5;CRKL;LIMS1;ABL1
prerank,CellMarker_Augmented_2021__Cartilage Progenitor cell:Cartilage,0.28537647794761767,0.6575724042359266,0.9767441860465116,1.0,1.0,9/96,13.24%,LRP4;TSPAN11;FBXL7;PCDH18;COL4A6;COL4A5;AIF1L;LIFR;GLI3
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.2985143874552054,-0.6575477430913768,0.9354838709677419,1.0,1.0,4/20,18.15%,GSAP;LRRTM3;ABCG1;CASP3
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,0.33088197419599086,0.6573985905960444,0.9180327868852459,1.0,1.0,8/26,28.24%,TNFRSF10A;RPS27A;MLKL;TRADD;FASN;CASP8;STUB1;TNFRSF10B
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.37491127620309467,-0.6571411095565871,0.85,1.0,1.0,6/6,62.52%,UFD1;GPATCH3;NPLOC4;DHX58;C1QBP;SEC14L1
prerank,Reactome_2022__Dissolution Of Fibrin Clot R-HSA-75205,0.3882179734098422,0.6571232724983903,0.9166666666666666,1.0,1.0,4/11,13.91%,PLAUR;PLAU;PLAT;PLG
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",0.298415583254599,0.6567053048414483,0.9859154929577465,1.0,1.0,5/45,15.21%,AIM2;NLRC4;PSTPIP1;NFKB2;CYLD
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,0.3460953185157658,0.6566874080906593,0.859375,1.0,1.0,5/18,20.39%,STAT5A;MAPK3;RBX1;RPS6;FN1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.32537317385870373,-0.6566434980298363,0.8461538461538461,1.0,1.0,1/21,1.22%,NDST3
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.367435290374502,-0.6553686511307005,0.8837209302325582,1.0,1.0,3/7,17.18%,FLNA;LIMS1;EMP2
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),-0.36160301365536823,-0.6553014078236573,0.8787878787878788,1.0,1.0,2/10,17.79%,EPHB2;ARHGAP35
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.3044401016455186,-0.6551079395700783,0.9655172413793104,1.0,1.0,5/25,13.04%,MEN1;CTC1;NIBAN2;STN1;EXOSC10
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.3166776120011283,0.6550871394410677,0.9466666666666667,1.0,1.0,7/39,14.02%,PRDM12;PDYN;PNOC;PENK;MME;OPRM1;OR3A2
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.35650970340571,0.654719750115794,0.8787878787878788,1.0,1.0,4/14,19.42%,AIF1L;CSF1R;CARMIL1;PLEKHA1
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.36901823775801934,-0.6546236221725946,0.9210526315789473,1.0,1.0,1/13,4.15%,KLHL20
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lung,-0.2597699328638576,-0.6544413450905266,0.9583333333333334,1.0,1.0,8/73,13.88%,GLA;COMMD6;HAUS1;HSCB;CDC26;MRPS18C;POLR3K;EXOSC1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.3362383782978027,0.6544149301644203,0.9552238805970149,1.0,1.0,7/29,24.48%,CHCHD4;TOMM20;TIMM17A;ROMO1;PAM16;PEX12;TIMM21
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,-0.2743308522610946,-0.6543856139528905,0.9583333333333334,1.0,1.0,9/47,17.79%,VANGL1;RAB7A;EMD;CAPZB;DIAPH2;LMNB1;ESYT1;STEAP3;ARHGAP35
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.32625272285868645,-0.6542165162624538,0.9354838709677419,1.0,1.0,4/12,18.47%,BDP1;TAF12;TAF1B;TAF11
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.4504184217954643,0.6541698826098724,0.9482758620689655,1.0,1.0,4/6,29.28%,MDM1;BRCA1;KAT2B;TRIM37
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,0.29633926018244644,0.6540030889630696,1.0,1.0,1.0,7/71,13.25%,H2BC4;POLD4;H2AZ1;PIF1;RPA3;NOP10;CCNA2
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.32051339093274867,0.6539998194418647,0.9436619718309859,1.0,1.0,2/38,3.18%,ACE2;KCNJ15
prerank,Reactome_2022__TYSND1 Cleaves Peroxisomal Proteins R-HSA-9033500,-0.3800929519849111,-0.653801454141506,0.868421052631579,1.0,1.0,2/7,22.43%,TYSND1;ACAA1
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.28013567789200133,-0.653797171008417,0.96875,1.0,1.0,1/26,1.23%,H1-4
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.3996575672114204,0.6536114896774329,0.9032258064516129,1.0,1.0,1/7,6.95%,IMPA1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.32250663144982966,-0.6535972171099157,0.9117647058823529,1.0,1.0,5/14,20.76%,TRPC3;CIB2;TRPV1;P2RY11;SSH1
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.3440160858789749,0.6532270396786433,0.9253731343283582,1.0,1.0,2/24,11.19%,ST18;STAT1
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),-0.40427291140929533,-0.6531339635434515,0.8571428571428571,1.0,1.0,1/5,2.80%,PTPRO
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),-0.40427291140929533,-0.6531339635434515,0.8571428571428571,1.0,1.0,1/5,2.80%,PTPRO
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.3190995230490188,-0.653057638290405,0.9534883720930233,1.0,1.0,1/21,3.43%,FOXO1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.29676269635495894,0.6529471519443236,0.972972972972973,1.0,1.0,7/69,18.41%,RANBP6;SYK;RGPD1;RGPD3;KPNA5;RGPD4;RGPD2
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.278846182469584,0.6526085434310916,0.9863013698630136,1.0,1.0,22/111,18.70%,SLFN14;SYT15;SYT2;WNT5A;MMP9;GLRA2;ECT2;GLRA1;CDKN1B;ALOX5AP;CRHBP;ALOX15;ADCY7;SYT10;MAPK3;MT1M;MT4;TF;FBP1;SYT4;SCN5A;HVCN1
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Corneal Epithelium,0.2781987106918714,0.6525219450406109,1.0,1.0,1.0,3/93,2.09%,LRP4;TRIL;TSPAN11
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Liver,0.2781987106918714,0.6525219450406109,1.0,1.0,1.0,3/93,2.09%,LRP4;TRIL;TSPAN11
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Corneal Epithelium,0.2781987106918714,0.6525219450406109,1.0,1.0,1.0,3/93,2.09%,LRP4;TRIL;TSPAN11
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Laryngeal Squamous Epithelium,0.2781987106918714,0.6525219450406109,1.0,1.0,1.0,3/93,2.09%,LRP4;TRIL;TSPAN11
prerank,Reactome_2022__FBXW7 Mutants And NOTCH1 In Cancer R-HSA-2644605,0.4560477272378369,0.6524541928941419,0.9411764705882353,1.0,1.0,1/5,18.57%,RBX1
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.3001779614785666,0.6522598689839513,0.9855072463768116,1.0,1.0,16/53,25.98%,EIF6;RPL3;MRPL20;NOP53;RPL11;RPL23A;RPL35A;RSL24D1;RPL7;RPLP0;ZNF622;RPL7A;RPL24;WDR12;RPL10;BRIX1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.25944865833036396,0.6521938066442363,1.0,1.0,1.0,22/238,14.40%,PKP2;SYCP1;RP1;TSPAN4;TGFB1;JCHAIN;WNT5A;ACTG1;WAS;SCIN;VASP;BAIAP2L1;LCP1;FBLIM1;VIL1;AIF1L;RHOU;STAG3;FSCN2;RHOG;SOX9;PARVG
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.36869145397113606,-0.6516622292913427,0.8780487804878049,1.0,1.0,2/14,12.82%,ZNF16;KLHL18
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.32002386913875613,0.6514101655999498,0.9305555555555556,1.0,1.0,6/33,18.01%,TRPC7;CP;COX17;FTH1;ATOX1;TF
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.4214137131233257,-0.6511885075365195,0.8333333333333334,1.0,1.0,4/8,20.06%,CRY1;ABL1;MAPK12;ATM
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.4327008179144328,0.6511318701838521,0.9272727272727272,1.0,1.0,4/8,37.47%,CLU;STUB1;HDAC6;DNAJB12
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.4563397049188366,0.6510877413207439,0.8787878787878788,1.0,1.0,1/5,7.67%,PHF23
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.2719163618073296,-0.6510431720390959,1.0,1.0,1.0,5/41,10.77%,KCNE1;KCNMB2;GNA14;GNA11;CHRNA1
prerank,Reactome_2022__Lewis Blood Group Biosynthesis R-HSA-9037629,0.3937455326874527,0.6508273399453565,0.8857142857142857,1.0,1.0,2/10,6.30%,FUT2;B4GALNT2
prerank,Reactome_2022__PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.27637863596390344,-0.6508097512008373,1.0,1.0,1.0,1/29,2.74%,PIWIL2
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.28839771518541313,-0.6506806220494905,0.967741935483871,1.0,1.0,9/30,23.45%,FSCN1;CAPZB;SLIT2;AVIL;AUTS2;ARPC2;WASF2;OCLN;PLCE1
prerank,Reactome_2022__ERBB2 Activates PTK6 Signaling R-HSA-8847993,0.384299261119432,0.6506050728679945,0.8970588235294118,1.0,1.0,1/11,6.80%,ERBB4
prerank,Reactome_2022__APOBEC3G Mediated Resistance To HIV-1 R-HSA-180689,0.40636753296255307,0.6504085075164368,0.8545454545454545,1.0,1.0,1/6,15.08%,HMGA1
prerank,KEGG_2021_Human__cAMP signaling pathway,0.26871230353519643,0.6499508450802323,1.0,1.0,1.0,23/177,16.21%,RRAS;PIK3R3;HHIP;SSTR1;TSHR;PTGER3;ADRB1;ATP1A4;PPP1R1B;GRIN2D;NPY1R;NPY;HTR1B;PLN;GLI3;SOX9;ADCY7;CNGA1;NPPA;MAPK3;GIP;MYL9;GHRL
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.42755263614804534,0.649812426494911,0.8524590163934426,1.0,1.0,1/6,19.11%,TACC3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.42755263614804534,0.649812426494911,0.8524590163934426,1.0,1.0,1/6,19.11%,TACC3
prerank,Reactome_2022__Mitochondrial Translation Elongation R-HSA-5389840,0.28850446712863453,0.6497961796411852,0.9761904761904762,1.0,1.0,12/73,26.15%,MRPS34;MRPL20;MRPL34;MRPL50;GADD45GIP1;MRPL54;MRPS2;MRPL19;MRPL10;MRPL37;MRPL44;MRPL40
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.30601439869642166,-0.6497845235719055,0.9655172413793104,1.0,1.0,7/27,19.75%,KMT5C;WRAP53;ERCC2;SHLD2;MAD2L2;SHLD1;RAD51AP1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.32067723185646724,0.6494560759253991,0.9857142857142858,1.0,1.0,9/34,28.68%,BAIAP2L1;HCK;CSF1R;NOTCH2;IQGAP2;BAIAP2L2;SEMA3E;RAPGEF3;PHPT1
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.45390722472109424,0.6493150766583775,0.9464285714285714,1.0,1.0,1/5,19.91%,ORAI1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.3383424833557076,0.6492744754774942,0.9,1.0,1.0,2/25,7.66%,C3;IGF1
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),0.3973806048581414,0.6492486196214932,0.9,1.0,1.0,3/8,16.04%,SIX4;STAT1;BASP1
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.3578785715462113,0.6492371135697957,0.8955223880597015,1.0,1.0,5/17,24.48%,TOMM20;TIMM17A;ROMO1;PAM16;TIMM21
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.2671663533042148,-0.6491565731880232,1.0,1.0,1.0,5/55,7.10%,PLK3;MYO18A;ADAM8;PCM1;APBB3
prerank,Reactome_2022__Processive Synthesis On C-strand Of Telomere R-HSA-174414,0.36364256152296326,0.6491358009622764,0.9428571428571428,1.0,1.0,2/18,9.53%,POLD4;RPA3
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,0.33336072494575736,0.6490518404659582,0.9545454545454546,1.0,1.0,4/26,14.29%,ELOVL2;HACD4;SCD;ACOT4
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.2783313391384571,-0.6483525880743926,0.9655172413793104,1.0,1.0,3/38,3.16%,DGKD;WNT3A;SELE
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.31246960020264425,0.6481613952406367,0.927536231884058,1.0,1.0,4/49,12.58%,SP100;POLD4;RPA3;RECQL4
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-0.41021746785481794,-0.6474829107848724,0.8780487804878049,1.0,1.0,2/6,18.45%,RPUSD1;RPUSD4
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.29252522861941566,0.647422108429131,0.9733333333333334,1.0,1.0,2/75,5.31%,PSMB9;WNT5A
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.24268993068656133,-0.6474085994080032,1.0,1.0,1.0,34/179,19.65%,ANXA8;SMPD4;COG4;MYO18A;GOLGA8A;TICAM2;UBXN2A;TMED4;TRAPPC12;GBF1;FAM174B;DOP1B;ZNF501;GOLGA8B;BLZF1;SPTSSB;SNX33;RAB22A;MIA3;EIF2AK3;COG7;DNAJC28;TOR1B;REEP6;TRAPPC11;TLCD2;ALS2CL;CTDNEP1;ATP8B2;HOOK3;FER1L5;CUL7;SUN3;GOLGB1
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.337257493267922,0.6471257631425708,0.9736842105263158,1.0,1.0,3/27,5.77%,TGFB1;WNT5A;GPER1
prerank,Reactome_2022__Metabolism Of Steroid Hormones R-HSA-196071,0.32970090722008205,0.6470736886778525,0.967741935483871,1.0,1.0,2/24,7.68%,HSD11B2;HSD17B2
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.3775247033835739,0.6470357356138281,0.8703703703703703,1.0,1.0,3/11,30.11%,CXCL12;DOCK8;DUSP1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.339772046379869,0.6469512547191899,0.9824561403508771,1.0,1.0,5/18,21.51%,ABHD14B;SULT2A1;BPNT2;SULT4A1;SULT6B1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.3421311973944247,0.6466317611004043,0.9538461538461539,1.0,1.0,8/21,27.40%,LPIN3;MOGAT1;MOGAT2;PLA2G4A;AGMO;DGAT2L6;DGAT2;PNPLA2
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.3550167892090236,-0.6465951134757983,0.9210526315789473,1.0,1.0,4/12,11.89%,APOE;AQP1;PDE3A;HTR2C
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.2886923205606031,0.6465544686212656,0.9868421052631579,1.0,1.0,12/61,23.49%,SYCP1;TK1;SOD2;AQP4;KCNJ2;ALDH9A1;GNMT;RYR3;B2M;MCOLN1;ALDH1A3;HLA-DRB1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.2825515740165162,-0.6465362523487158,1.0,1.0,1.0,6/27,17.47%,WNK2;KLHL3;SLC4A11;RHCG;WNK3;SLC30A8
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.2984947040010931,0.6460438255591953,0.9571428571428572,1.0,1.0,9/50,17.96%,FANCF;FAAP20;RPA3;DCLRE1A;RPS27A;DCLRE1C;CENPX;RAD51AP2;MSH6
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2965484411714784,-0.6460431117403526,0.9411764705882353,1.0,1.0,3/20,12.33%,GTF2H2;XPC;ERCC2
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.33411647960315793,0.6458813458886119,0.922077922077922,1.0,1.0,3/30,12.92%,AHR;SLC26A6;CRHBP
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,-0.24767586753159032,-0.6458269804857723,1.0,1.0,1.0,10/128,7.56%,EYA4;RNF168;POLM;EXO1;BRCC3;PPP5C;POLR1A;MUS81;POLD3;RAD50
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression Linked To Triglyceride Lipolysis In Adipose R-HSA-9031528,-0.410247650086485,-0.6457923661896193,0.8888888888888888,1.0,1.0,2/5,28.53%,NR1H2;RXRA
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.3891994399016237,0.6457277435327415,0.85,1.0,1.0,2/12,12.42%,SEMA3A;SEMA3F
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.3306512362677978,0.645594906611572,0.9242424242424242,1.0,1.0,3/28,13.45%,MISP;NDC80;GPSM2
prerank,CellMarker_Augmented_2021__Luminal progenitor:Breast,-0.41950069335622,-0.6455896371301977,0.8636363636363636,1.0,1.0,1/5,3.46%,KIT
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.27286111427536025,-0.6455126878078833,1.0,1.0,1.0,11/38,19.31%,MMS22L;BOD1L1;SMARCAL1;DDX11;ATR;RFWD3;RTEL1;MSH3;FBH1;MCM9;SETMAR
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.36483982621866823,0.6450420185449476,0.9166666666666666,1.0,1.0,3/15,24.65%,PIGH;PIGC;PIGB
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.39558586726122424,0.6447315409423965,0.873015873015873,1.0,1.0,4/11,30.20%,NOS2;ORAI1;PARK7;ISCU
prerank,PanglaoDB_Augmented_2021__Neurons,0.2611161126485897,0.6444078588526175,1.0,1.0,1.0,18/267,10.98%,GAD1;AIM2;STMN4;SCRG1;HTR5A;CXCR5;FAM181B;IGF1;LY6H;PPP1R1B;TCEAL5;NPY;CALB1;NEFM;PNMA8A;ARHGDIG;SPOCK3;OGFOD1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.3875379166855399,0.6444070837142684,0.9104477611940298,1.0,1.0,1/15,4.30%,INTS5
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.33221090303666234,-0.6443074557762214,0.9285714285714286,1.0,1.0,1/17,4.92%,MTFR2
prerank,CellMarker_Augmented_2021__Schwann cell:Undefined,0.4323865718801365,0.6441144451504041,0.8928571428571429,1.0,1.0,3/6,30.45%,GFAP;MPZ;MBP
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.24831600182344774,-0.6438957065604552,1.0,1.0,1.0,21/82,21.51%,CCDC22;KLHL20;COMMD1;GBF1;DOP1B;OSBPL5;LLGL1;SCAMP2;AP4S1;CLINT1;AP1B1;ACBD3;SH3D19;RAB10;GOLGB1;ARRB1;SORCS1;STXBP6;RABEP1;CLVS1;DNM2
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,-0.2638905808470522,-0.6438935606685011,1.0,1.0,1.0,10/79,18.07%,SYNJ2;VAC14;PI4KB;RAB5A;MTMR14;RUFY1;PI4KA;MTMR1;TPTE2;PITPNB
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.3701872096395124,-0.6436017337271753,0.8461538461538461,1.0,1.0,2/7,23.83%,ATG2A;ATG7
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.3701872096395124,-0.6436017337271753,0.8461538461538461,1.0,1.0,2/7,23.83%,ATG2A;ATG7
prerank,Reactome_2022__Activation Of TFAP2 (AP-2) Family Of Transcription Factors R-HSA-8866907,-0.36046777317405143,-0.6434807582998417,0.8235294117647058,1.0,1.0,2/8,9.87%,TFAP2D;CITED4
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.37058547157106225,0.6429324194283141,0.8548387096774194,1.0,1.0,4/12,24.61%,TAF7;BRCA1;SET;SPI1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.2935488759782727,-0.6427465990454744,0.96875,1.0,1.0,8/24,27.36%,AGRN;FSCN1;NEURL1;MIEN1;PALM;NLGN1;BCAS3;DOCK11
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,0.2875215436814678,0.64272922752347,0.9875,1.0,1.0,4/80,8.09%,PIK3R3;VAPB;BAIAP2L1;ARMCX3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.28619750052178033,0.6426386657649954,0.9714285714285714,1.0,1.0,11/94,16.50%,PLA2G10;TGFB1;DDX3X;EIF6;RPS4X;AGT;THBS1;METTL14;EEF2;CSF1;MSN
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,0.3044409324581859,0.6426225248539945,1.0,1.0,1.0,6/60,13.87%,CCL5;ATP6V1G2;JAM2;ATP6V0E2;ATP6AP1;IGSF5
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.38873811617474036,0.6421262200454144,0.803030303030303,1.0,1.0,1/8,6.49%,DAND5
prerank,Reactome_2022__Defective CHSY1 Causes TPBS R-HSA-3595177,-0.3219810039224417,-0.6420983116819198,0.84375,1.0,1.0,3/8,14.57%,CHSY1;VCAN;CSPG5
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.27768220597572846,-0.6420014540934066,1.0,1.0,1.0,5/32,12.14%,MEN1;TGIF1;SERPINE1;TFDP1;RBL1
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,0.28695495795226733,0.6419004376145186,0.975,1.0,1.0,5/79,8.43%,GNAT3;GNG12;GNG4;PPP1R1B;PDYN
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,0.3559095074443339,0.6418517120122116,0.9577464788732394,1.0,1.0,2/17,11.00%,RPA3;RPS27A
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.3977388648712747,0.6418352621997399,0.8928571428571429,1.0,1.0,1/7,12.58%,RECQL4
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.3386230116568174,0.6408015829628732,0.9722222222222222,1.0,1.0,8/30,21.09%,TBPL1;TAF5;TAF7;TAF10;TAF13;TCEA2;HELB;TAF6
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.3082460942678349,0.6406357849845078,0.958904109589041,1.0,1.0,2/57,3.51%,ANXA1;NPHS2
prerank,Reactome_2022__Zinc Influx Into Cells By SLC39 Gene Family R-HSA-442380,0.40850478622265346,0.6404536577615934,0.918918918918919,1.0,1.0,1/7,13.04%,SLC39A7
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.2724302504760059,0.6399888806868644,1.0,1.0,1.0,21/154,20.75%,LIX1;STMN4;SHISA6;TMEM35A;CYB561;LY6H;TCEAL5;NEFM;SNX21;ZNF536;CCK;VSTM2A;CNTN2;LRRTM1;TSHZ1;CHRNA3;SYT4;ATF5;RGS3;SULT4A1;IGF2BP3
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.3822832014820841,0.6399126797165156,0.8679245283018868,1.0,1.0,1/8,9.22%,PINK1
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.40228413954990766,-0.6399095981449406,0.8444444444444444,1.0,1.0,1/5,5.01%,WNT7A
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.3773477259097063,-0.6398439492875284,0.8260869565217391,1.0,1.0,1/6,10.60%,SCARB1
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.3773477259097063,-0.6398439492875284,0.8260869565217391,1.0,1.0,1/6,10.60%,SCARB1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.3964682242243437,0.6393720416482747,0.8923076923076924,1.0,1.0,3/6,36.88%,SPI1;KLF7;TRPM4
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),-0.38002810756153993,-0.6391878126658371,0.8157894736842105,1.0,1.0,2/6,20.56%,CARD9;IL23A
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.33936874594776867,0.6387306765256034,0.9193548387096774,1.0,1.0,8/29,24.24%,LIX1;CHMP3;LAMP2;GABARAPL2;ATP2A2;GABARAPL1;STX17;VAMP7
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.34661630916773134,0.6384878287375937,0.9264705882352942,1.0,1.0,2/17,7.94%,CCND2;CCND1
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.39426866692795687,0.6382248449515998,0.9074074074074074,1.0,1.0,2/10,14.41%,PINK1;IL4
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.4205710086293015,0.6381684713134433,0.9016393442622951,1.0,1.0,2/5,29.81%,DNAJB2;SGTB
prerank,GO_Biological_Process_2021__negative regulation of histone deacetylation (GO:0031064),0.44498625489073684,0.638139851703826,0.9180327868852459,1.0,1.0,1/5,19.16%,USP17L2
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),-0.41245406946988394,-0.6380613904152681,0.8611111111111112,1.0,1.0,2/6,6.06%,PRKCD;PREX1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.24569307113449085,-0.6379887358393902,1.0,1.0,1.0,11/102,14.69%,BCL2;CREB3L1;QRICH1;ERN1;RHBDD1;CHAC1;ATF3;DAB2IP;BAG6;CREB3L2;EIF2AK3
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,0.34438817558388246,0.6379802045807526,0.8939393939393939,1.0,1.0,3/23,8.12%,H2BC4;GSDME;H2AZ1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.24838291201399937,-0.6378818718604488,1.0,1.0,1.0,11/104,10.18%,ATP6V0D2;EXOC7;USP36;QSOX1;ATP6V1E2;LZTS1;CLEC16A;ERN1;SNX32;SNX5;ATP6V0A2
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.34791125696401404,-0.6377663141300974,0.925,1.0,1.0,5/11,17.11%,TAS2R8;AZGP1;TAS2R5;CA6;RTP1
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.3070309969558921,-0.637453496408776,0.9487179487179487,1.0,1.0,6/14,25.32%,IGBP1;GNB3;RAD17;SMG5;CD24;SMG6
prerank,Reactome_2022__Blood Group Systems Biosynthesis R-HSA-9033658,0.3531573280431257,0.6373969737210885,0.9605263157894737,1.0,1.0,5/14,20.35%,FUT2;B4GALNT2;B3GALT2;FUT1;RHD
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.41046204419583443,0.6373681033104189,0.8596491228070176,1.0,1.0,4/5,28.71%,RFK;SLC52A1;SLC52A2;ENPP1
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.41046204419583443,0.6373681033104189,0.8596491228070176,1.0,1.0,4/5,28.71%,RFK;SLC52A1;SLC52A2;ENPP1
prerank,Reactome_2022__Vitamin B2 (Riboflavin) Metabolism R-HSA-196843,0.41046204419583443,0.6373681033104189,0.8596491228070176,1.0,1.0,4/5,28.71%,RFK;SLC52A1;SLC52A2;ENPP1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.2714915054273496,-0.6372890114102027,1.0,1.0,1.0,3/41,8.49%,CCDC22;QRICH2;COMMD1
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.42241286210213913,-0.6372021552498683,0.8780487804878049,1.0,1.0,1/5,9.86%,PTPRR
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.28898832379555645,-0.6371882645823753,0.9736842105263158,1.0,1.0,5/26,14.48%,HDC;DHRS11;PYCR3;NFS1;HSD3B2
prerank,Reactome_2022__Long-term Potentiation R-HSA-9620244,0.3505669904804655,0.6371558552991794,0.9436619718309859,1.0,1.0,2/23,8.67%,ERBB4;GRIN2D
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,0.3094585695498917,0.6369000161878889,0.9428571428571428,1.0,1.0,9/37,24.21%,RRAD;RPA3;ARTN;RMI2;BRCA1;RAD9B;BRCA2;RMI1;KAT5
prerank,Reactome_2022__Biosynthesis Of EPA-derived SPMs R-HSA-9018679,0.41587950962692954,0.6367720603175954,0.9122807017543859,1.0,1.0,4/6,28.73%,ALOX15;ALOX5;PTGS2;GPX4
prerank,Reactome_2022__Mitochondrial Translation Initiation R-HSA-5368286,0.2807924069429126,0.636770318580247,0.9879518072289156,1.0,1.0,12/73,26.15%,MRPS34;MRPL20;MRPL34;MRPL50;GADD45GIP1;MRPL54;MRPS2;MRPL19;MRPL10;MRPL37;MRPL44;MRPL40
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.2592300240640424,0.6366444133268311,1.0,1.0,1.0,14/272,9.83%,ESR1;SLFN14;FGF2;TGFB1;NLRP12;HEY2;ABCC2;GPER1;IGF2BP2;IGF1;REST;DDX3X;PINK1;RPL13A
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.297503336096706,0.636546046952371,0.9558823529411765,1.0,1.0,6/34,24.51%,CAV3;TCAF2;PDZK1;YWHAH;SCN4B;SCN1B
prerank,GO_Biological_Process_2021__spinal cord dorsal/ventral patterning (GO:0021513),0.4226088771354046,0.636166987449628,0.8771929824561403,1.0,1.0,1/5,9.79%,RFX4
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.28953694399240826,-0.6360252507360085,0.9333333333333333,1.0,1.0,3/19,9.98%,HOPX;NDUFAF1;BBS12
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.26137129446997664,-0.6359600202336176,1.0,1.0,1.0,16/72,24.01%,CAPN2;F11R;CLEC16A;STX5;PREB;EHD3;SIRT7;MARK2;CAMSAP3;AKAP9;STX18;CLN3;MAPT;MIEF2;STOX1;PRKN
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),-0.4183542980095185,-0.6358103688711372,0.8636363636363636,1.0,1.0,1/5,13.67%,PGAP1
prerank,Reactome_2022__CASP8 Activity Is Inhibited R-HSA-5218900,0.36598481446668873,0.6357527797443568,0.8214285714285714,1.0,1.0,1/9,4.50%,TNFRSF10A
prerank,Reactome_2022__Dimerization Of Procaspase-8 R-HSA-69416,0.36598481446668873,0.6357527797443568,0.8214285714285714,1.0,1.0,1/9,4.50%,TNFRSF10A
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,0.3108339092523049,0.6357173013655606,0.9733333333333334,1.0,1.0,6/47,16.94%,SLC16A8;LDHD;PLPP6;PDK4;SLC16A1;SLC16A3
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Corpus,0.28195315709907076,0.6356513477496989,0.9863013698630136,1.0,1.0,7/74,13.99%,PLEKHS1;ITGA2;SCARA3;GALNT5;CELSR1;BPIFB1;SOX9
prerank,KEGG_2021_Human__Purine metabolism,0.2888494453374513,0.6354403515185224,1.0,1.0,1.0,17/118,18.70%,ADA;PDE6H;PKLR;PDE6A;NPR2;NT5E;ENPP4;DCK;PDE5A;PDE6C;ADCY7;GUCY2F;ADSS1;PAICS;IMPDH2;PDE6B;PDE6G
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.3467086802726545,0.6354124481757065,0.90625,1.0,1.0,4/15,32.51%,TDG;OGG1;TERF2IP;UNG
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.27939282037034624,-0.6352610326388463,1.0,1.0,1.0,7/26,18.01%,ERBB2;STAT5B;SYAP1;SNAI2;DAB2IP;MARS1;MED1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.295837380922115,0.6352394871677077,0.9342105263157895,1.0,1.0,5/36,18.58%,A4GALT;B3GNT5;PIGH;CWH43;PIGC
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.37770995458819506,0.635167630783675,0.9253731343283582,1.0,1.0,2/9,20.88%,CHAC2;GGCT
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,0.30771589424109796,0.6351610509766233,0.971830985915493,1.0,1.0,5/37,19.97%,STRADA;RRAGA;STRADB;LAMTOR3;RPS6
prerank,CellMarker_Augmented_2021__Ionocyte cell:Lung,0.250558416501738,0.6349183244458777,1.0,1.0,1.0,31/253,17.60%,SMOC1;SDC2;PLEKHG3;PTAFR;H1-0;IRF2BPL;IGF1;PHF23;LEF1;RFK;DOCK6;ANKRD9;PPP2R3A;TGFB3;CLGN;RERG;NUDT16L1;EPCAM;CDKN1B;MRPL34;THBS1;FAM43A;SLC14A1;TMEM160;KRT8;FAM114A1;MAF;ARL4A;ATP6V0B;TFPI;ID3
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.3030725198055575,-0.6347615575575817,0.9333333333333333,1.0,1.0,2/19,6.98%,FLVCR1;ALB
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.3164665539090692,-0.6346696375442668,0.9428571428571428,1.0,1.0,9/21,28.87%,CNOT9;SAMD4B;TNKS1BP1;TUT7;PARN;CNOT6;CNOT10;CNOT3;SAMD4A
prerank,Reactome_2022__E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,0.4004549041454354,0.6346479072886431,0.8518518518518519,1.0,1.0,3/7,23.47%,ORC4;CCNB1;ORC5
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Ovary,0.36514883883815247,0.634416623053116,0.9230769230769231,1.0,1.0,4/13,14.71%,WNT5A;ITGA5;ACTA2;CD44
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.34141324895901104,0.6340023593731805,0.9206349206349206,1.0,1.0,4/23,14.71%,ITGB2;HLA-DPB1;SIRPG;CD44
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,0.2861507119695144,0.63384562219968,0.9736842105263158,1.0,1.0,3/59,8.12%,CAVIN1;H2BC4;H2AZ1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.3694695499929021,-0.6337808762398416,0.8444444444444444,1.0,1.0,6/6,63.07%,NUAK1;ROCK1;IKBKB;NCKAP1L;ROCK2;PPP1R12A
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,0.3541837300602898,0.6337494761767005,0.9206349206349206,1.0,1.0,2/19,11.00%,RPA3;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.32956967020125894,-0.6337380100387718,0.9302325581395349,1.0,1.0,1/12,5.27%,DOC2B
prerank,Reactome_2022__RNA Polymerase II Transcription R-HSA-73857,0.2429027317956602,0.6335628666984799,1.0,1.0,1.0,156/1135,21.63%,GATA4;COX6A1;SMAD6;ESR1;ACTL6A;PSMB9;BLK;RORC;GAD1;ZNF676;GP1BA;TCF7;RRAD;NR1I3;CBX8;HIPK1;MOBP;TGFB1;ZNF738;INTS5;LMO2;TNFRSF10A;ITGBL1;HEY2;CCNG2;NR2E3;DAND5;H2BC4;SLC6A4;ZFP69;CDKN2A;ZNF582;TP53I3;NR1H4;ITGA5;SRSF9;NLRC4;CCND2;ZIK1;TAF5;LEF1;CCND1;H2AZ1;ZNF616;DDIT4;ZNF175;TP53BP2;ZNF225;RRAGA;PINK1;NPY;RPA3;GTF2E1;HNF4G;ZNF585B;CCNE2;TFAP2E;COL1A1;RPS27A;STAT1;SMARCE1;CLDN5;BCL2L14;CASP10;COLEC12;ZNF556;LIFR;CDKN1B;TAF7;BTG1;ING3;CDKN1A;ZNF213;THBS1;GLI3;CCNA2;CSF1R;TCF7L1;ITGA2B;OPRM1;RXRG;SOX9;PSMC5;NDRG1;NPPA;ZNF214;ZNF792;BBC3;RABGGTB;MAPK3;THOC6;CDK5R1;FKBP5;MYL9;TAF7L;ARTN;HNF1A;TAF10;ZNF550;RMI2;TAF13;NR5A2;MAF;BRCA1;MYB;ZNF114;ZNF740;TAF9B;COX20;COX4I1;ZNF343;ZFP37;ZNF233;TXNIP;LAMTOR3;ZNF543;ZNF394;RBX1;APAF1;YWHAH;PSMA3;DHX38;SRSF5;COX7B;PSMB6;ZNF436;ZNF750;FIP1L1;HEY1;NOTCH2;CSTF2T;RAD9B;ZNF732;COX6C;CDC25C;COX6B1;ZNF317;NFATC2;IL2RA;PSMD6;H2AZ2;SESN1;ZNF552;CNOT8;ZNF684;NFYB;SRSF3;TAF6;CCNB1;ZFPM1;GPS2;ZNF473;ZNF749;INTS2;RBBP7;PHAX
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Fetal Pancreas,-0.23825697443733132,-0.6333788644704497,1.0,1.0,1.0,19/95,21.34%,CLIP3;PRR36;CACNB1;INA;MPP2;SNCB;HPCA;NLGN2;TAGLN3;CELSR3;SV2A;GDI1;SYN1;PSD;CNIH2;BRSK1;APLP1;SNPH;STXBP1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.3218412996880442,0.6333786507027714,0.9305555555555556,1.0,1.0,5/25,25.66%,IRF1;TRIM5;TKFC;ERAP1;CASP8
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3585569634265397,0.6329952392381558,0.9594594594594594,1.0,1.0,6/19,23.66%,BOK;SYVN1;HERPUD1;CREB3;DDIT3;PARK7
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.36544834056021674,-0.6329113923324586,0.8947368421052632,1.0,1.0,3/9,11.92%,GK5;COQ2;PGP
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.2898745882425298,0.6328969713961219,0.9882352941176471,1.0,1.0,3/43,11.47%,RNF26;USP50;VPS18
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.26461637829680895,0.6328093504411912,1.0,1.0,1.0,42/225,20.40%,MYRF;C3;ROGDI;ITGAM;SOX10;SCTR;JRKL;PCDH18;NMUR2;SCIN;TBX6;DDIT4;EMX1;SPINK6;GRIN2D;PPT1;UGT8;B3GNT5;CELSR1;NPAS1;ADGRG1;AFF2;SOX9;NHLH1;ZIC1;UBE3A;HAPLN2;THOC6;CDK5R1;SOX6;SLC23A1;HAPLN1;ATP6AP2;PPP1R17;COX7B;PBX3;ALDH3A2;CTNS;SH3GL3;SMARCA1;GRIN2C;BCAN
prerank,KEGG_2021_Human__GnRH secretion,0.2860259613282111,0.6327437050748145,0.9420289855072463,1.0,1.0,10/61,24.63%,PIK3R3;GPER1;GNRH1;MAPK3;KISS1R;MAP2K1;KCNJ11;KRAS;PLCB4;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),0.40604223209977097,0.632000495051585,0.9193548387096774,1.0,1.0,2/7,13.19%,ANXA1;ANGPTL3
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.36741337428565496,0.6319232465373956,0.9354838709677419,1.0,1.0,6/15,22.44%,ASIC1;GPR68;PKD1L3;HYAL1;HVCN1;MCOLN1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.3777443968811793,0.6318490031747821,0.9516129032258065,1.0,1.0,1/15,4.30%,INTS5
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),0.4257961929598073,0.6317697267362156,0.9285714285714286,1.0,1.0,1/5,18.48%,SCN5A
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.3724846035329392,0.6311260464026786,0.9016393442622951,1.0,1.0,1/11,10.25%,KDM3A
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.3895095360634514,0.6309938728074993,0.9166666666666666,1.0,1.0,3/8,26.82%,FBXO5;TOM1L1;CHEK1
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.252015166042073,0.6308379298161666,1.0,1.0,1.0,85/327,25.97%,ADAD2;ANGPT2;ADARB2;RPL37A;RPL21;DDX20;RPL9;SRSF9;RPL18A;RPS9;RPL3;RPL36;RPL13A;RPS16;RPL15;RPS5;RPS27A;RPS3A;RPL41;RPL13;RPS12;RPS4X;RPL27A;MRPL34;EEF1A1;TFIP11;RPS19;YARS2;RPS21;THOC6;RPL32;RPL11;RPL23A;RPL35A;RPS11;COPS5;RPS13;RPS7;M1AP;RSL24D1;RPLP2;RPL7;RPL38;DHX38;RAE1;SRSF5;DUSP11;ASMT;RPS15A;FIP1L1;RPSA;RPLP0;RPS6;RPL35;IGF2BP3;SRSF3;RPL27;RPS14;XAB2;RPL7A;RPL24;RPL23;RPS15;MRPL28;HNRNPK;MRPL10;RPS27;RPL8;RPS3;RPS23;RPS20;RPS18;RPS24;NCBP1;RBM5;CDC40;MRPL37;RPL10;SCX;RPS29;RBM15B;TSPAN33;RPLP1;RPS28;MRPL44
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.3728761908945876,0.6308124134357734,0.8709677419354839,1.0,1.0,1/12,6.68%,NODAL
prerank,Reactome_2022__Erythropoietin Activates STAT5 R-HSA-9027283,0.4122598336878363,0.6304951244296372,0.8771929824561403,1.0,1.0,1/7,6.23%,STAT5A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3228584101317543,0.6304192562308898,0.9459459459459459,1.0,1.0,3/34,11.00%,POLD4;RPA3;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.36855592501612233,0.6303982706597455,0.9384615384615385,1.0,1.0,1/11,7.79%,REST
prerank,Reactome_2022__Meiotic Recombination R-HSA-912446,0.3272154763989635,0.6301204543396776,0.9857142857142858,1.0,1.0,6/32,17.01%,H2BC4;H2AZ1;PSMC3IP;RPA3;ARTN;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.3677250992040738,0.6300553959857348,0.9066666666666666,1.0,1.0,3/10,21.86%,BRCA1;CEACAM1;ACADL
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.40946870776828653,0.629917525840118,0.8524590163934426,1.0,1.0,4/5,42.45%,NAAA;NAPEPLD;GDPD3;GDE1
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.40946870776828653,0.629917525840118,0.8524590163934426,1.0,1.0,4/5,42.45%,NAAA;NAPEPLD;GDPD3;GDE1
prerank,CellMarker_Augmented_2021__Effector CD8+ Memory T (Tem) cell:Peripheral Blood,0.28771363133529543,0.6299162933053009,0.963855421686747,1.0,1.0,6/65,13.09%,PLEKHG3;ITGAM;FCGR3A;VEZF1;ADGRG1;MYO1F
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.26872071432934164,-0.629527421357487,0.9166666666666666,1.0,1.0,7/37,14.71%,FADS1;PPIP5K1;ITPKA;GK5;G6PD;NFS1;AGPAT5
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.371207504118997,0.6292484274346385,0.9402985074626866,1.0,1.0,5/13,17.35%,PLA2G10;AGT;ALOX15B;CSF1;MSR1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.32371044888738243,0.6291435217428455,0.9206349206349206,1.0,1.0,4/24,23.63%,PINK1;DCN;FIS1;MIEF1
prerank,CellMarker_Augmented_2021__Germ cell:Gonad,0.29420633994401374,0.6290000170973377,0.987012987012987,1.0,1.0,3/58,5.35%,YWHAQP5;CTCFL;SYCP3
prerank,KEGG_2021_Human__Glutathione metabolism,0.3018074528832373,0.6288814347108823,0.9436619718309859,1.0,1.0,4/43,9.84%,MGST1;ANPEP;GGT5;HPGDS
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.30957005403241106,0.6288394711073155,0.9852941176470589,1.0,1.0,9/46,22.36%,H1-0;GRWD1;NAP1L2;HMGA2;SOX9;H2BC18;M1AP;POLE3;PAF1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.2767799473193817,-0.6287963129187885,1.0,1.0,1.0,8/25,22.45%,APOO;SAMM50;LETM1;DNAJC11;CHCHD3;AFG3L2;ATP5F1B;CHCHD6
prerank,Reactome_2022__CaMK IV-mediated Phosphorylation Of CREB R-HSA-111932,0.3553410005206116,0.6287956487715188,0.9253731343283582,1.0,1.0,10/10,64.48%,CALM1;KPNA2;CAMK2G;CAMK2D;CAMK4;CAMK2A;CREB1;CAMKK2;CAMKK1;CAMK2B
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.2759957381518006,0.628498350523327,1.0,1.0,1.0,5/93,11.07%,LRP4;TGFB1;SYK;TGFB3;DAB2
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Liver,-0.2502247333743433,-0.6284881420727075,1.0,1.0,1.0,9/47,17.55%,RAB35;FOSL1;COTL1;EDNRA;ALCAM;SF3A2;SORBS3;FSTL3;CCDC86
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.3337679300347853,0.6283998006641767,0.9285714285714286,1.0,1.0,6/22,18.84%,PLA2G10;AGT;ALOX15B;CSF1;MSR1;NFKBIA
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.3604646947853788,0.6283913028719347,0.9411764705882353,1.0,1.0,2/15,5.33%,SOX10;SEMA3A
prerank,Reactome_2022__Keratan Sulfate Degradation R-HSA-2022857,0.37378514240133454,0.6283628968295978,0.8873239436619719,1.0,1.0,2/8,10.10%,OGN;OMD
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.30479746973630856,0.6283546894462999,0.9358974358974359,1.0,1.0,3/38,11.47%,RNF26;USP50;VPS18
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2869561780575835,0.6283217759378118,1.0,1.0,1.0,11/71,17.34%,TGFB1;NODAL;GDF11;TGFB3;DAB2;TTK;THBS1;BMP3;GDF9;ENG;INHBC
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.2825204521303012,-0.6282907853591182,0.9,1.0,1.0,2/34,3.29%,TYRO3;IFI16
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.3743355678188053,0.6278873539643234,0.9215686274509803,1.0,1.0,3/8,22.42%,IL4;DOCK2;DCSTAMP
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.39663392669273895,0.6277640130567299,0.9354838709677419,1.0,1.0,1/8,13.52%,TNP1
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",0.3138415649554207,0.6275902218015323,0.9714285714285714,1.0,1.0,8/26,20.48%,PDE6A;GRK7;CNGA1;GUCY2F;RCVRN;PDE6B;PDE6G;GNGT1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.2688667671454377,0.6274851703995629,1.0,1.0,1.0,10/109,12.06%,SLC9A2;KCNA7;KCNJ15;KCNA5;KCNS2;ATP1A4;KCNG2;KCNK7;SLC9C1;SLC24A1
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,0.2866273381960524,0.6273814190446022,0.9733333333333334,1.0,1.0,5/51,9.00%,ACTG1;WAS;SYK;HCK;NCKIPSD
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.32208536680689104,0.6273329888946991,0.9682539682539683,1.0,1.0,3/24,15.21%,RPS27A;LACC1;CYLD
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.2900794232258615,0.6273284469062234,0.9868421052631579,1.0,1.0,6/67,14.84%,KIF14;CXCR5;RAB11A;ECT2;CDC14A;KLHL13
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,0.3559189291645817,0.627182406699198,0.927536231884058,1.0,1.0,2/16,11.00%,RPA3;RPS27A
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.3453397701006384,0.62697367573003,0.9166666666666666,1.0,1.0,5/15,25.58%,NEXN;CNTN2;MYPN;PALLD;EMB
prerank,Reactome_2022__Negative Regulation Of Activity Of TFAP2 (AP-2) Family Transcription Factors R-HSA-8866904,-0.37001507379540616,-0.6269115958307688,0.9090909090909091,1.0,1.0,2/7,12.62%,TFAP2D;KCTD1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.3643133028645178,0.6266444997749447,0.967741935483871,1.0,1.0,2/12,10.91%,ACTG1;CELSR1
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.3745736821300997,0.6266018991262086,0.8524590163934426,1.0,1.0,2/8,25.70%,CBLL1;CTNNB1
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.294819867901029,0.6260463934643892,0.9473684210526315,1.0,1.0,6/51,13.07%,PLA2G10;ATP10B;MTTP;ATP8B3;ATP11C;TNFAIP8L3
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,0.30802669447192577,0.6259978447529917,0.9420289855072463,1.0,1.0,9/38,24.21%,RRAD;RPA3;ARTN;RMI2;BRCA1;RAD9B;BRCA2;RMI1;KAT5
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.27512632330726294,-0.6259778428936118,1.0,1.0,1.0,2/29,9.07%,TWIST1;SNAI2
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.356652221353638,-0.6259704263922455,0.972972972972973,1.0,1.0,2/8,22.19%,MAPT;RNF122
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.3109999577442756,0.6253154769444895,0.9852941176470589,1.0,1.0,4/32,12.29%,FAXDC2;SCIN;STAT1;PITHD1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.3440874961961012,0.6250081306439079,0.9375,1.0,1.0,3/12,23.56%,UBA5;UBA3;UBA6
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.35618515613752527,-0.6250061269215325,0.8723404255319149,1.0,1.0,2/7,20.60%,DCP1B;DCP1A
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.4052702291335122,-0.6249751926369862,0.9230769230769231,1.0,1.0,2/5,24.95%,ABCB4;ABCA3
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.28603459817918997,0.6248196057063604,0.9753086419753086,1.0,1.0,4/63,11.00%,IHO1;POLD4;RPA3;RPS27A
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,0.29039055649487316,0.6247568064611532,0.987012987012987,1.0,1.0,7/42,20.84%,ATP1A4;TRDN;PLN;ATP2A2;ORAI1;KCNJ11;RYR3
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.269892568931704,0.6246009959199105,1.0,1.0,1.0,13/78,19.17%,GAD1;DAO;FTCD;ACMSD;SDS;SDSL;CARNS1;IDO1;FAH;GLUL;NOS2;HAAO;ASPA
prerank,Reactome_2022__Impaired BRCA2 Binding To PALB2 R-HSA-9709603,-0.29601427334120295,-0.6242777910445528,0.9411764705882353,1.0,1.0,2/23,7.56%,EXO1;RAD50
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.3712502855023785,0.6242510911156085,0.9365079365079365,1.0,1.0,3/10,20.89%,TIMM22;TIMM10;ROMO1
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.26003427400160845,-0.6241734456092441,0.9655172413793104,1.0,1.0,8/40,17.40%,APOE;HDAC3;AGO2;KDM1B;TNRC6C;NR1H2;ABCG1;TNRC6A
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,0.2995431430927053,0.6241206954619596,0.9393939393939394,1.0,1.0,5/26,20.56%,GNG12;GNG4;MAPK3;GNGT1;GNB4
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.28279837048985546,-0.6240825976182174,1.0,1.0,1.0,2/21,6.98%,FLVCR1;ALB
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.23865420070704263,-0.6235418528273983,1.0,1.0,1.0,15/89,16.43%,LIN28B;CACNG4;CASKIN1;CRABP1;INA;MPP2;VGF;KLHL23;KCNB2;MSI1;JPH3;RCOR2;CSPG5;IGDCC3;POU3F2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.3195377364351111,0.6232435018287016,0.9726027397260274,1.0,1.0,6/24,19.72%,PINK1;BMI1;FBXO5;FEM1B;BAG5;ARRDC3
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.2666096548522487,-0.6232139615766866,1.0,1.0,1.0,3/33,7.99%,PNKP;POLD3;LIG3
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,0.28816477312726657,0.623010584664294,0.9466666666666667,1.0,1.0,5/44,14.51%,GCC1;NAA38;RGPD1;RAB6B;TGOLN2
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.3853547343903475,0.6227890467873958,0.9375,1.0,1.0,2/8,16.48%,PPP2R5A;WASHC1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.2906631713557408,0.6226649529147316,0.9722222222222222,1.0,1.0,7/48,17.08%,GPER1;RAMP3;ACSL3;RHOG;STAC;AGR2;CNST
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.3733679668607187,-0.62265095630341,0.9142857142857143,1.0,1.0,1/8,5.92%,AOC3
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.4013065038683912,-0.6225550056882873,0.8809523809523809,1.0,1.0,2/5,28.91%,ROBO2;GAP43
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.3192518807355044,-0.6220827500066068,0.9302325581395349,1.0,1.0,2/16,14.26%,POLR1A;CHP1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.31958871942339556,0.6215673411225783,0.9848484848484849,1.0,1.0,5/23,19.63%,CDKN2A;HMGA2;CDKN1A;HMGA1;MAP2K1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.3645296792926279,-0.6211702999446791,0.9047619047619048,1.0,1.0,1/9,3.88%,CREB3L1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.3147050813139357,0.6211283767954724,0.9242424242424242,1.0,1.0,11/34,30.33%,NOP53;RPL11;GABARAPL2;BAG5;AQP11;WAC;PARK7;HSP90AB1;UBXN1;UCHL5;CAMLG
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,0.30409047417848833,0.6210241289135413,0.9393939393939394,1.0,1.0,10/29,28.12%,ATP6V1G2;ATP6V0E2;CYBA;ATP6V0B;HVCN1;ATP6V1D;ATP6V0D1;NCF2;SLC11A1;ATP6V1B2
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.35749441517549063,-0.6209467739115772,0.9512195121951219,1.0,1.0,2/6,29.74%,GTF3C5;GTF3C2
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.32457862594836695,-0.6209163217004013,0.9166666666666666,1.0,1.0,5/12,20.60%,KCNE1;KCNH2;KCNE2;YWHAE;KCND3
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.4044297285838284,0.6207955285362051,0.9814814814814815,1.0,1.0,2/6,25.66%,TRADD;CASP8
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.273587446656032,0.6207557974750082,0.9879518072289156,1.0,1.0,14/89,19.01%,NDC80;SUV39H1;RPS27A;HMGA2;TCF7L1;NUF2;COPS4;GPS1;COPS5;PADI2;MSH6;RBX1;LRWD1;RAE1
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.35536445240349857,0.620621676556358,0.9565217391304348,1.0,1.0,2/10,20.88%,CHAC2;GGCT
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.2939720492640698,-0.6205469756317784,0.9459459459459459,1.0,1.0,2/18,10.44%,EGR1;ZMIZ1
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.353880899792489,0.6204860576022287,0.9538461538461539,1.0,1.0,4/12,24.83%,IGF1;IGFBP6;IGFBP2;IGFBP5
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.36249142253439337,0.6203298284545623,0.9107142857142857,1.0,1.0,2/13,13.99%,REST;SOX9
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.28999549241307543,-0.6199720577478557,0.9565217391304348,1.0,1.0,9/33,20.53%,THEM4;MLYCD;OGDH;ACOT9;ACSM1;SUCLA2;ACOT1;ACOT8;ACACB
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.3333913432327741,-0.6198911429244462,0.9615384615384616,1.0,1.0,3/12,15.83%,RARB;FGFR2;TGFB2
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.33456380962000565,-0.6198806531028811,0.8571428571428571,1.0,1.0,6/11,20.29%,SARDH;CHAC1;ALDH4A1;ABHD12;GOT2;GGT7
prerank,Reactome_2022__Pentose Phosphate Pathway R-HSA-71336,0.3459940781891346,0.6198605860134258,0.9365079365079365,1.0,1.0,7/12,30.87%,TALDO1;RPE;PRPS2;PHGDH;DERA;RPEL1;TKT
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.39596923347492724,0.6195915788806939,0.8769230769230769,1.0,1.0,2/8,24.10%,PARK7;PYCR1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.27939746463156645,-0.6194581393610556,0.96,1.0,1.0,5/29,15.05%,BCL2;TFDP1;YWHAQ;PPP1R13B;CHCHD10
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.2798035679538057,-0.6193973914205199,0.9666666666666667,1.0,1.0,6/28,16.76%,THEM4;MLYCD;ACOT9;CROT;ACSM1;ACOT1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.2798035679538057,-0.6193973914205199,0.9666666666666667,1.0,1.0,6/28,16.76%,THEM4;MLYCD;ACOT9;CROT;ACSM1;ACOT1
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.38052430225416306,0.6191899407144371,0.9230769230769231,1.0,1.0,1/11,4.27%,TGFB1
prerank,KEGG_2021_Human__Autophagy,-0.23648551444546487,-0.619068844055749,1.0,1.0,1.0,13/128,14.69%,PRKCD;BCL2;CFLAR;RAB7B;RAB7A;IGBP1;ERN1;ATG2A;MTMR14;RUBCN;DEPTOR;RRAS2;EIF2AK3
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.2580852530957862,-0.6187138990819663,0.9565217391304348,1.0,1.0,10/50,19.28%,ADCYAP1;RAB3D;OLFM2;TVP23A;PREB;MIA3;STEAP3;SLC30A8;RAB10;PORCN
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.29896056816852845,0.6185890143163909,0.9459459459459459,1.0,1.0,2/31,8.04%,GNG12;GNG4
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.2895649418904848,0.6185793265143483,0.9733333333333334,1.0,1.0,12/57,26.82%,SPDYA;CCND2;CCND1;CDKN1B;HCFC1;RPS15A;CCNB1;PSRC1;CITED2;LGMN;SMOC2;CHEK1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.291815093706463,0.6185144885714614,0.9852941176470589,1.0,1.0,8/56,15.93%,ANXA1;MMP9;CYP1B1;RHOB;ECT2;UCP1;MAPK3;ZNF580
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3467704906323772,0.6184962738192689,0.9558823529411765,1.0,1.0,6/21,18.70%,PDE6A;GRK7;CNGA1;GUCY2F;PDE6B;PDE6G
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.2448880387798199,0.6183165860317116,1.0,1.0,1.0,24/353,11.85%,TRIM58;FBXL7;ASB5;TRIM62;ARIH2;DTX2;RNF26;SPSB2;RNF187;ANKRD9;HLA-A;RRAGA;PINK1;TRIM68;TRAIP;MKRN3;TRIM77;SDE2;RPS27A;TRIM74;VPS18;KLHL2;RNF212B;UHRF2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.41889905924829457,0.6177842965760687,0.9333333333333333,1.0,1.0,2/6,19.56%,CRHBP;DLG4
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.41889905924829457,0.6177842965760687,0.9333333333333333,1.0,1.0,2/6,19.56%,CRHBP;DLG4
prerank,Reactome_2022__GRB2 Events In ERBB2 Signaling R-HSA-1963640,0.36125450988837293,0.6176569389350376,0.9428571428571428,1.0,1.0,1/13,6.80%,ERBB4
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.36957806427885004,0.6176400128956996,0.9846153846153847,1.0,1.0,4/11,27.13%,MOGAT2;PLA2G4A;DGAT2L6;DGAT2
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,0.31526334374132103,0.6176301500138153,0.9859154929577465,1.0,1.0,1/22,6.80%,ERBB4
prerank,KEGG_2021_Human__GABAergic synapse,0.2677293939776904,0.6175248563951327,1.0,1.0,1.0,12/79,21.19%,GAD1;GNG12;SLC38A3;GNG4;ADCY7;SLC38A2;SLC6A12;GLUL;GABARAPL2;GNGT1;GNB4;GABRR1
prerank,Reactome_2022__Defective HLCS Causes Multiple Carboxylase Deficiency R-HSA-3371599,-0.4039351898185485,-0.6173274023308785,0.972972972972973,1.0,1.0,4/7,35.58%,PCCB;PCCA;HLCS;MCCC1
prerank,Reactome_2022__Defects In Biotin (Btn) Metabolism R-HSA-3323169,-0.4039351898185485,-0.6173274023308785,0.972972972972973,1.0,1.0,4/7,35.58%,PCCB;PCCA;HLCS;MCCC1
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,0.3581379335522926,0.6170355066433922,0.8867924528301887,1.0,1.0,7/13,28.24%,TNFRSF10A;NDUFA2;TRADD;FASN;CASP8;TMED7-TICAM2;TNFRSF10B
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.3298926751921755,-0.6169253434415746,0.9302325581395349,1.0,1.0,3/13,12.31%,ATF3;HSF1;GSTO2
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.3498494333827362,-0.6166285687777397,0.8717948717948718,1.0,1.0,5/10,17.11%,TAS2R8;AZGP1;TAS2R5;CA6;RTP1
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,0.2686879868468491,0.616586198147714,1.0,1.0,1.0,1/113,0.14%,DENND1C
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.3339962247708221,-0.6163400474965998,0.8666666666666667,1.0,1.0,3/13,14.02%,HDC;PYCR3;NFS1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.3257808029537992,0.6161071102120437,0.9428571428571428,1.0,1.0,2/27,15.19%,RPS27A;MAPK3
prerank,Reactome_2022__Mitochondrial Translation Termination R-HSA-5419276,0.27348922076323123,0.6161020182537733,1.0,1.0,1.0,13/73,26.15%,MRPS34;MRPL20;MRPL34;MRPL50;GADD45GIP1;GFM2;MRPL54;MRPS2;MRPL19;MRPL10;MRPL37;MRPL44;MRPL40
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.34336827466035263,-0.6160965349293457,0.9375,1.0,1.0,2/12,17.79%,EPHB2;ARHGAP35
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),-0.3272717979001248,-0.616079451978214,0.9393939393939394,1.0,1.0,4/10,32.64%,IRAK4;EPG5;PIK3R4;TRAF6
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.3406468997645731,-0.6160618811532034,0.9473684210526315,1.0,1.0,6/8,26.56%,OAZ3;CTTNBP2NL;AKT2;IRS2;INPP5K;AKT1
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,0.29115070851938557,0.6160483602208534,0.948051948051948,1.0,1.0,9/47,26.81%,PLD4;IMPA1;PLCD1;IMPA2;INPP5D;PLCB4;NUDT10;NUDT4;INPPL1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.38612774617025825,-0.6157494007278826,0.8235294117647058,1.0,1.0,2/5,15.55%,FGF1;ABCG1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.39362597123156284,0.6157091775077418,0.9122807017543859,1.0,1.0,2/7,13.08%,TGFB1;AGT
prerank,Reactome_2022__Protein Folding R-HSA-391251,0.2662724819009801,0.6157061882068688,1.0,1.0,1.0,15/82,22.18%,GNG12;GNG4;CCNE2;FBXL3;TUBA4A;TUBA3D;TUBB6;TBCE;TUBA1C;CCT7;GNGT1;GNB4;TBCC;GAPDHS;TUBB4B
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Venous Blood,0.2710487775715178,0.6156857456026134,1.0,1.0,1.0,14/84,17.48%,VSIG2;ROGDI;FOXA3;DHRS13;TJP3;CLDN9;ITM2C;ORMDL3;TTC9;SPINT1;FKBP8;NSUN7;NOS2;PLEKHB1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),0.40603412598077726,0.6152871155080851,0.9107142857142857,1.0,1.0,3/5,37.43%,RPS3;RFFL;RFPL1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.25979047940256295,0.6149170707431075,1.0,1.0,1.0,17/150,19.16%,ARHGAP9;CCL5;ADRB1;RAPGEF6;ECT2;TGM2;PLXNA3;F2RL1;GPR137B;EPHA1;RGS10;RASGRP1;PRKG1;VAV3;ARHGAP15;CCL25;USP17L2
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.26858083559845397,-0.6149004959028398,1.0,1.0,1.0,7/38,15.77%,MAP3K10;NOD1;RIPK2;TRIB1;MAP3K12;CRKL;MAP3K13
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,0.3377462599023995,0.61483571991308,0.9047619047619048,1.0,1.0,4/15,15.08%,H1-0;HMGA2;CDKN1A;HMGA1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.25587031643014063,-0.6148113081369988,0.9583333333333334,1.0,1.0,5/38,12.78%,BCL2;PID1;OPRD1;SLC4A11;SLC25A33
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.373833035854899,0.6148042054867031,0.9558823529411765,1.0,1.0,3/9,26.16%,ATRAID;ANXA2;EFNA1
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.2749741887022932,-0.6147666920664058,0.9655172413793104,1.0,1.0,3/26,17.11%,STX5;EMD;RTP1
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,0.3146068896386119,0.6146530305066441,0.9305555555555556,1.0,1.0,10/23,31.87%,PDE5A;COPS4;GPS1;CCT7;TXNL1;RNF20;DBN1;HNRNPC;CCT2;RBM15
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.316271844588597,0.6146488381674099,0.9701492537313433,1.0,1.0,2/25,8.04%,GNG12;GNG4
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.3159790396413022,0.6146475498940088,0.9855072463768116,1.0,1.0,4/23,13.19%,GPIHBP1;ANGPTL4;NR1H4;ANGPTL3
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),-0.34125928080854184,-0.6145702743576453,0.9354838709677419,1.0,1.0,3/11,17.00%,ADCY3;ADCY2;ADCY6
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.344911798641424,0.6145456285438768,0.9692307692307692,1.0,1.0,7/14,34.68%,RAET1G;TUBB4B;VAMP7;CEBPG;TUBB;ULBP3;CLEC2A
prerank,Reactome_2022__Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.2951801767986554,-0.61418419605217,1.0,1.0,1.0,2/24,7.56%,EXO1;RAD50
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.320364617941129,0.6141655338753016,0.9558823529411765,1.0,1.0,6/25,28.05%,TAF6L;ATAT1;TAF6;KAT5;MORF4L2;KAT2B
prerank,Reactome_2022__Free Fatty Acids Regulate Insulin Secretion R-HSA-400451,-0.3266869792605874,-0.6141453306114939,0.9318181818181818,1.0,1.0,2/10,9.83%,GNA14;GNA11
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),0.42426405964372116,0.6140813239781413,0.9482758620689655,1.0,1.0,2/5,20.14%,OPRM1;OPRL1
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.2940283129017095,-0.6138507045516125,0.9375,1.0,1.0,1/31,1.25%,NMU
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.34635513056993267,-0.6137729551165786,0.9411764705882353,1.0,1.0,7/12,36.51%,SAP30BP;NIPBL;ZBTB7B;AKAP8L;ING2;PRKD2;C6ORF89
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,0.30852984104181447,0.6136810657871773,1.0,1.0,1.0,2/36,8.32%,FGF20;KLB
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.2891091401051349,-0.6136429981934123,0.9166666666666666,1.0,1.0,6/15,20.60%,KCNE1;KCNH2;KCNN2;KCNE2;YWHAE;KCND3
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.28925556635224164,0.6131613553282615,0.9871794871794872,1.0,1.0,7/52,18.57%,ARIH2;RNF187;KBTBD7;UBE3A;KBTBD6;SYVN1;RBX1
prerank,CellMarker_Augmented_2021__Neural Crest cell:Undefined,-0.2984991127826524,-0.6130005727976694,0.96875,1.0,1.0,4/16,11.38%,ITGA4;ASCL1;SNAI2;PAX3
prerank,Reactome_2022__Lysine Catabolism R-HSA-71064,-0.3390436519231607,-0.6128516839126099,0.96875,1.0,1.0,4/12,13.90%,CRYM;OGDH;AADAT;HYKK
prerank,CellMarker_Augmented_2021__Idiopathic Pulmonary Fibrosis cell:Lung,-0.34909665567936854,-0.612786312777532,0.9375,1.0,1.0,2/10,9.32%,PLA2G4C;SPDEF
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.2923651234363657,0.6127112682345388,0.948051948051948,1.0,1.0,9/45,26.81%,PLD4;IMPA1;PLCD1;IMPA2;INPP5D;PLCB4;NUDT10;NUDT4;INPPL1
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.3109768338080367,0.6126593942267933,0.92,1.0,1.0,7/28,17.55%,TGFB1;TGFB3;THBS1;WBP2;UBE3A;CATSPERD;TFPI
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.3843699152302463,0.6123249265943651,0.9206349206349206,1.0,1.0,2/10,19.23%,LRRC38;LRRC55
prerank,Reactome_2022__DNA Strand Elongation R-HSA-69190,0.31522579109870347,0.6123161218901131,0.9066666666666666,1.0,1.0,3/27,9.53%,MCM3;POLD4;RPA3
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.37473439607875036,-0.6117145636225421,0.9574468085106383,1.0,1.0,2/7,12.18%,OVGP1;AMDHD2
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.2990548119855001,-0.6116819834848229,0.9655172413793104,1.0,1.0,4/18,20.81%,OPRD1;CRTC1;LRP8;TSSK4
prerank,Reactome_2022__Depolymerisation Of Nuclear Lamina R-HSA-4419969,-0.3154836237438087,-0.6116321586443842,0.85,1.0,1.0,6/15,19.12%,CDK1;EMD;LMNB1;PRKCA;CTDNEP1;LPIN2
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.22490772752107568,-0.6111177423462058,1.0,1.0,1.0,28/142,21.33%,PLK3;CHD4;EXO1;SMYD2;RPF2;RAD50;TAF12;ATR;CDK1;SSRP1;PPP1R13B;PRDM1;CDK5;NBN;RAD17;TTC5;RFC3;KMT5A;ATRIP;TAF11;CHD5;MLST8;SGK1;ATM;PIP4K2B;PRKAG2;RAD9A;PML
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,0.25842777460500577,0.6108126356239196,1.0,1.0,1.0,4/90,7.90%,MAPKAPK3;FLT1;FLT4;AXL
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.2845291335224911,-0.6106893552381906,1.0,1.0,1.0,1/24,4.92%,MTFR2
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.3691703276032502,0.6106326507849262,0.9166666666666666,1.0,1.0,3/6,19.23%,WDR76;FEM1B;ETAA1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.3509649389125028,-0.6106288782363408,0.9090909090909091,1.0,1.0,4/8,35.22%,NOTCH1;LRP6;PHACTR4;DLL4
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.35930221496981324,0.6106201722846941,0.9354838709677419,1.0,1.0,2/14,13.08%,IGF1;AGT
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,0.32885441420662975,0.6105103319236934,0.953125,1.0,1.0,3/17,24.63%,STAT1;FIP1L1;PIK3CB
prerank,Reactome_2022__Peptide Hormone Biosynthesis R-HSA-209952,-0.36158299616745027,-0.6101159515135166,0.8529411764705882,1.0,1.0,2/5,17.56%,PCSK1;INHA
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.29870669269097866,-0.6101047063844678,0.925,1.0,1.0,2/16,10.09%,SCAI;ITGA3
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.2734884574578772,-0.6100044969251363,0.9722222222222222,1.0,1.0,6/27,19.25%,GPRIN1;MPP2;LLGL1;RPS6KA3;RASGRF1;HRAS
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.3457842918065989,-0.6099815933366621,0.9767441860465116,1.0,1.0,5/9,21.55%,CHP1;IMPACT;TRPV1;PKD2L1;RAB11B
prerank,Reactome_2022__Signaling By NTRK3 (TRKC) R-HSA-9034015,-0.31158907259859303,-0.6099686240384059,0.9736842105263158,1.0,1.0,3/15,24.62%,PTPRS;HRAS;SRC
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,-0.23441132278144744,-0.6099575324455343,1.0,1.0,1.0,8/89,11.85%,PTCH1;IFT88;MKS1;GNAS;RPGRIP1L;GPR161;ADCY2;PSMB2
prerank,KEGG_2021_Human__Pyruvate metabolism,0.29954207694099466,0.609838200012226,1.0,1.0,1.0,6/40,19.38%,PKLR;LDHD;ALDH9A1;GRHPR;ADH5;ALDH3A2
prerank,Reactome_2022__Beta-oxidation Of Very Long Chain Fatty Acids R-HSA-390247,0.35825221206058155,0.6097891520219237,0.9014084507042254,1.0,1.0,2/11,14.29%,ACOT6;ACOT4
prerank,Reactome_2022__RSK Activation R-HSA-444257,0.3685687971107125,0.6091626750034903,0.92,1.0,1.0,3/7,30.01%,MAPK3;RPS6KA1;PDPK1
prerank,Reactome_2022__mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.3429138552721384,0.609051206270533,0.9384615384615385,1.0,1.0,3/14,15.26%,EXOSC8;EXOSC2;EXOSC4
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.3824618454968224,-0.6089423801670559,0.9534883720930233,1.0,1.0,1/5,7.21%,CAP2
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.27530232679957495,-0.6089236139133541,1.0,1.0,1.0,2/27,5.91%,LIMK1;MEN1
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),-0.38054199066352046,-0.6088696070140505,0.9117647058823529,1.0,1.0,2/9,6.85%,TST;GLYATL2
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.289700288176251,0.6088414325074926,0.972972972972973,1.0,1.0,9/32,25.70%,SEMA3A;SEMA3F;FLRT1;ULK1;LLPH;FLRT3;HSP90AB1;NRP2;CTNNB1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.2698419344698696,0.6088222229403067,0.9864864864864865,1.0,1.0,2/77,5.31%,PSMB9;WNT5A
prerank,CellMarker_Augmented_2021__Hepatocyte:Fetal Liver,0.2716609662687663,0.6086521990823601,1.0,1.0,1.0,18/84,18.88%,GNG12;ITGA2;BAIAP2L1;CCND1;TMEM54;LAMC2;ID1;SH2D4A;EPCAM;SEMA3F;SOX9;KRT8;BCAR1;FAM114A1;PPIC;LAMB2;SLC44A3;KDELR3
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.3425290907719977,-0.6086138298459194,0.8947368421052632,1.0,1.0,3/8,15.38%,AUP1;PLA2G4C;CDS1
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,0.2992047947723266,0.608590201685244,0.9855072463768116,1.0,1.0,2/39,8.32%,FGF20;KLB
prerank,GO_Biological_Process_2021__establishment of protein localization to telomere (GO:0070200),-0.37269373769803993,-0.607918950858001,0.8863636363636364,1.0,1.0,1/5,12.55%,TERT
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3298263856522832,-0.6076845391838134,0.875,1.0,1.0,1/14,3.88%,CREB3L1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.3480932432271779,-0.6074100178782119,0.972972972972973,1.0,1.0,2/10,10.68%,SLC27A2;SLC27A4
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.2806039765809279,-0.6072641700324631,0.967741935483871,1.0,1.0,7/28,20.60%,DCPS;LSM7;EXOSC1;LSM2;DCP1B;LSM6;DCP1A
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,0.3535546100143544,0.6071449118234068,0.9701492537313433,1.0,1.0,2/17,11.00%,RPA3;RPS27A
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.25999153585463197,0.6070987476258176,1.0,1.0,1.0,19/93,27.72%,MRPS34;MRPL20;MRPL34;EEF1A1;MRPL50;GADD45GIP1;EEF2;GFM2;MRPL54;MRPS2;MRPL19;MRPL28;LTN1;MRPL10;MRPL37;MRPL44;MRPL40;MRPS12;MRPL49
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.2833256520089974,0.606845922723388,0.9876543209876543,1.0,1.0,2/43,5.69%,POLQ;WAS
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,0.29540429299290016,0.6067354477227153,0.9855072463768116,1.0,1.0,9/50,23.81%,ACE2;RPS27A;MOGAT1;PARP14;PARP4;GANAB;PARP9;PARP10;PARP8
prerank,Reactome_2022__MAPK1 (ERK2) Activation R-HSA-112411,-0.3186787184704936,-0.6065942617516171,0.9473684210526315,1.0,1.0,8/8,68.15%,TYK2;IL6R;MAP2K2;JAK1;PTPN11;MAPK1;JAK2;IL6ST
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.296150072861205,0.6061196982507221,1.0,1.0,1.0,8/37,22.90%,RAD1;RHOB;ECT2;CDKN1A;GPR88;RAD9B;FIGNL1;OPN1SW
prerank,"Reactome_2022__Regulation Of Glycolysis By Fructose 2,6-Bisphosphate Metabolism R-HSA-9634600",0.3646728929375001,0.6055956888767121,0.9180327868852459,1.0,1.0,1/10,7.15%,PFKFB2
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.41259535667326985,0.6054513269913104,0.9661016949152542,1.0,1.0,2/5,28.17%,KLC1;ZFAND1
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.33828689067060735,0.6052645427016804,0.92,1.0,1.0,3/16,13.47%,DCLRE1A;DCLRE1C;TFIP11
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.20998053343344186,-0.6049962755464382,1.0,1.0,1.0,17/161,15.60%,RASSF2;PRKCD;USP36;PARVA;OTUD3;FLNA;P3H1;TRIM44;BAG6;HIP1;PER3;CHP1;COG7;TMEM88;TSPAN1;PPIB;IRGM
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.36373546481227137,-0.6044975450493958,0.9696969696969697,1.0,1.0,2/10,14.49%,CACNB1;BIN1
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,0.2488361901308076,0.6042266218460254,1.0,1.0,1.0,9/148,12.98%,ESR1;SP100;CBX8;CDKN2A;NR1H4;HIC1;UHRF2;ING3;NFKB2
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.39784684679233523,0.6039360814344803,0.984375,1.0,1.0,1/7,9.92%,NLRC3
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.3570464515342171,0.6037804266077306,0.9322033898305084,1.0,1.0,2/9,17.03%,MSN;SYNE4
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.3048266023403719,0.6037650392640815,0.9868421052631579,1.0,1.0,1/33,2.83%,LRP2
prerank,Reactome_2022__Tryptophan Catabolism R-HSA-71240,-0.32250578001138236,-0.6037647838473166,0.9642857142857143,1.0,1.0,7/14,16.83%,SLC3A2;SLC7A5;KYAT1;AADAT;KYAT3;SLC36A4;TDO2
prerank,Reactome_2022__Recycling Of eIF2:GDP R-HSA-72731,0.3743408797646556,0.6036110904256249,0.9245283018867925,1.0,1.0,2/8,23.33%,EIF2B2;EIF2B5
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,-0.284223684094597,-0.6034164561505695,0.967741935483871,1.0,1.0,2/21,9.76%,BRCC3;STAMBP
prerank,KEGG_2021_Human__Lysosome,-0.22662050543652504,-0.6032963903940363,1.0,1.0,1.0,24/113,22.21%,GLA;ATP6V0D2;ARSB;AGA;SPAM1;AP3B2;ATP6V0A2;IDUA;HGSNAT;GGA2;ABCB9;GUSB;AP4S1;AP1B1;FUCA1;GLB1;CTSO;TCIRG1;MAN2B1;CLN3;CTSC;IGF2R;SGSH;CTSV
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.3377231852453685,0.6032234238808672,0.9841269841269841,1.0,1.0,4/16,19.77%,HEY2;SNAI1;ENG;HEY1
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.3642143090043892,0.6030379688423512,0.8923076923076924,1.0,1.0,1/9,8.73%,PIF1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.2524972428994833,0.6030371301979729,1.0,1.0,1.0,15/153,17.10%,ENPP2;NLRP5;WNT5A;REST;TMEM79;PINK1;VIL1;DCN;SOX9;BASP1;CFL1;ODAPH;AGR2;SOX6;FBXO5
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,0.26474277236411436,0.6027919242131525,1.0,1.0,1.0,13/77,22.18%,GNG12;GNG4;CCNE2;FBXL3;TUBA4A;TUBA3D;TUBB6;TUBA1C;CCT7;GNGT1;GNB4;GAPDHS;TUBB4B
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.27699480456655856,0.6027695124217776,0.9864864864864865,1.0,1.0,4/46,15.19%,DAND5;RPS27A;STAT1;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),-0.31652289689204216,-0.6023324569754727,0.90625,1.0,1.0,6/13,28.69%,AKT2;PTPN2;GPLD1;IRS2;AKT1;SLC45A3
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.26447408025236746,0.602158597975435,0.9882352941176471,1.0,1.0,16/79,27.72%,MRPS34;MRPL20;MRPL34;MRPL50;GADD45GIP1;GFM2;MRPL54;MRPS2;MRPL19;MRPL28;MRPL10;MRPL37;MRPL44;MRPL40;MRPS12;MRPL49
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.39359656707259905,-0.60213137635801,0.8571428571428571,1.0,1.0,2/5,11.61%,GK5;COQ2
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.367142685048041,0.601785667318047,0.9811320754716981,1.0,1.0,2/6,34.22%,TTPA;PLEKHA3
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,-0.27343888544476874,-0.6016489337996066,1.0,1.0,1.0,2/26,7.56%,EXO1;RAD50
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.3297133735950098,-0.6014647920034684,0.9705882352941176,1.0,1.0,2/10,13.86%,ZNF692;SIRT7
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.30822215219770355,-0.6011940270715646,0.9629629629629629,1.0,1.0,1/20,4.05%,SARM1
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,-0.28634540243728823,-0.6011008655693055,0.9444444444444444,1.0,1.0,3/19,11.92%,RAB7A;RAB5A;CORO1A
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.34489676548241277,0.6010199323077536,0.9215686274509803,1.0,1.0,2/10,21.48%,F7;APOD
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),-0.3666388422255716,-0.6009402191816368,0.9210526315789473,1.0,1.0,2/6,20.43%,PEX13;EFHC1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),-0.3662777879772761,-0.6009161693831702,0.8717948717948718,1.0,1.0,1/5,15.88%,OSBPL8
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),0.37061046964572825,0.6008104115072742,0.875,1.0,1.0,3/5,28.98%,DHDH;RPE;RPEL1
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,0.29711664472844995,0.6007536051674611,0.9850746268656716,1.0,1.0,9/40,24.21%,RRAD;RPA3;ARTN;RMI2;BRCA1;RAD9B;BRCA2;RMI1;KAT5
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.367492690532345,-0.6006493622150774,0.9142857142857143,1.0,1.0,3/7,21.00%,TGFBR3;ADCY6;GNG2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.3798280159857906,0.6005584799897703,0.9104477611940298,1.0,1.0,3/7,36.03%,HIF1A;ARNT;MT3
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.3282675709382045,0.600378783097111,0.95,1.0,1.0,5/18,21.68%,OPRM1;CDK5R1;RGS10;CHRM5;HRH4
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.24024000789234998,-0.6001703790478825,1.0,1.0,1.0,12/82,16.33%,TRIM71;APOE;DHFR;NANOS3;PCIF1;CNOT9;FXR2;BIN1;EIF2AK3;PUS7;SAMD4B;IGF2BP1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3338342229263757,0.6001019272452797,0.9863013698630136,1.0,1.0,4/21,14.38%,EXOSC8;EXOSC2;RPP40;RPS21
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.3110179527782761,0.5999066280254246,0.9583333333333334,1.0,1.0,6/23,27.56%,RPS27A;SYVN1;SEL1L;RNF5;DERL2;AMFR
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.2921635584657387,0.5996001198456389,0.9722222222222222,1.0,1.0,2/47,6.68%,DONSON;RAD1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.31783964684374755,0.5995132462130509,1.0,1.0,1.0,6/23,25.66%,TIFA;RPS27A;CYLD;IFIH1;IRAK1;CASP8
prerank,Reactome_2022__ERBB2 Regulates Cell Motility R-HSA-6785631,0.34286330746404114,0.5993322580769824,0.9420289855072463,1.0,1.0,1/13,6.80%,ERBB4
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.3324755129772531,-0.5992760062580642,0.8947368421052632,1.0,1.0,7/12,33.53%,GPRC5A;TSG101;ZFYVE28;SNX6;CBL;CHMP6;SOCS4
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.250822845599289,-0.5990811111548849,0.9615384615384616,1.0,1.0,9/40,17.80%,PTPRO;FZD7;WASHC2C;CORO2B;RELL2;LIMS1;RHOA;EMP2;NF1
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.38744847561170553,-0.5988641603649724,0.8913043478260869,1.0,1.0,2/5,24.01%,MAPT;PRKN
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.35082996753593615,0.5988360804225366,0.9411764705882353,1.0,1.0,4/10,29.83%,ANGPTL3;ADRA2A;ABCB11;ALK
prerank,KEGG_2021_Human__Phosphonate and phosphinate metabolism,0.37969368187241165,0.5987492879420758,0.9629629629629629,1.0,1.0,2/6,31.48%,SELENOI;PCYT1B
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.2867125349106562,-0.5984915396256387,0.9696969696969697,1.0,1.0,7/17,26.61%,LDB1;SPTSSB;EMP2;ATM;FEM1A;SMG6;LDB2
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.26166408351667164,0.5984599568427802,1.0,1.0,1.0,11/86,20.47%,PSMB9;SYK;RPS27A;NFKB2;PSMC5;UBE2M;NFKBIA;PSMA3;PSMB6;NFATC2;PSMD6
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.3234296408923594,-0.5984389582555362,0.9285714285714286,1.0,1.0,3/17,13.06%,DDX11;HSF1;SPIDR
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.26769729391722336,0.5981309175220001,1.0,1.0,1.0,14/74,24.85%,STRADA;TGFB1;SRSF9;RANBP3L;THOC6;STRADB;DHX38;RAE1;SRSF5;SRSF3;PHAX;EGR2;NCBP1;CDC40
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,0.31975487045853174,0.5979833550345035,0.9428571428571428,1.0,1.0,1/19,6.80%,ERBB4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.3639732583434515,0.5978682103395049,0.8840579710144928,1.0,1.0,2/8,17.06%,THBS1;TIGIT
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.3340646889038781,0.5978329378541444,0.9558823529411765,1.0,1.0,3/10,27.07%,ADH5;SULT2A1;ADH7
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,0.2852961606526718,0.5976791265499615,1.0,1.0,1.0,10/46,24.21%,RRAD;RPA3;ARTN;RMI2;BRCA1;MSH6;RAD9B;BRCA2;RMI1;KAT5
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.2653734717626088,0.5976450950856496,1.0,1.0,1.0,8/71,17.46%,POLQ;MEIOB;RPA3;RECQL4;RNF138;SWSAP1;BRCA1;RAD51AP2
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,0.2937661295882828,0.5975657681566917,0.9852941176470589,1.0,1.0,3/40,12.49%,CBX8;UHRF2;ING3
prerank,GO_Biological_Process_2021__negative regulation of neuron migration (GO:2001223),0.39563030183217507,0.5969206678339014,0.9272727272727272,1.0,1.0,1/5,12.04%,ADGRG1
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.346630702252508,-0.5967753988751378,0.9459459459459459,1.0,1.0,7/7,65.35%,GTF3C5;GTF3C2;GTF3C4;GTF3C1;GTF3C3;POLR2L;GTF3C6
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,0.31203726966074036,0.5967484779693988,0.9552238805970149,1.0,1.0,1/23,6.80%,ERBB4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.27587025140149696,-0.5965611114422203,1.0,1.0,1.0,7/30,20.60%,DCPS;LSM7;EXOSC1;LSM2;DCP1B;LSM6;DCP1A
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),-0.36079841439145444,-0.5956844620587898,0.8823529411764706,1.0,1.0,1/5,15.60%,IRGM
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.40221142441857094,0.5953423468124246,0.9142857142857143,1.0,1.0,1/6,13.32%,P4HA3
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,0.28140819297452113,0.5953077835705928,0.975,1.0,1.0,3/43,8.12%,H2BC4;CCND1;H2AZ1
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.3505927228527779,0.5952341364855633,0.9253731343283582,1.0,1.0,7/16,30.32%,NOP53;IL4;NOS2;ACTN3;CBFA2T3;PRELID1;SHMT2
prerank,Reactome_2022__Signaling By MST1 R-HSA-8852405,0.38909646062262093,0.595110226306271,0.8431372549019608,1.0,1.0,2/5,29.07%,SPINT1;MST1R
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.28456754813538265,-0.5948236353495421,0.9230769230769231,1.0,1.0,2/21,8.48%,NOD1;RIPK2
prerank,Reactome_2022__Na+/Cl- Dependent Neurotransmitter Transporters R-HSA-442660,0.35094628145256046,0.5945433446070307,0.9571428571428572,1.0,1.0,1/12,3.68%,SLC18A2
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Unsaturated Fatty Acids R-HSA-77288,-0.36659784443424925,-0.594501004935132,0.8809523809523809,1.0,1.0,1/6,11.91%,DECR1
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,0.31055638361823373,0.5944534725983276,0.972972972972973,1.0,1.0,7/21,22.45%,HEY2;COL1A1;GLI3;MAPK3;MAF;HEY1;YAP1
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),-0.36961100487339715,-0.5943816552654971,0.8974358974358975,1.0,1.0,1/5,9.07%,SNAI2
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.3685597412853819,0.5941246565185326,0.9420289855072463,1.0,1.0,3/11,17.73%,ADSS1;PAICS;IMPDH2
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.2976865761140424,-0.5940628302220811,0.9714285714285714,1.0,1.0,4/15,14.19%,CLEC16A;KLHL22;PIH1D1;SIK3
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,0.26352192994340423,0.5935499253338443,1.0,1.0,1.0,7/92,14.32%,PKLR;GNG12;GNG4;KCNG2;ACSL3;TALDO1;ADCY7
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.2920635572686364,-0.593546610386405,1.0,1.0,1.0,2/17,13.77%,MYO5C;MYO19
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.280469969153152,0.5935358390591675,1.0,1.0,1.0,11/45,24.55%,RAD1;RHOB;ECT2;CDKN1A;TMEM109;RAD9B;FIGNL1;XRCC6;YAP1;KDM1A;CRYAB
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,0.2993668225160169,0.5934589496095742,0.9848484848484849,1.0,1.0,3/27,16.58%,STAT5A;STAT1;BCAR1
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.2443020208589796,0.59344603994995,1.0,1.0,1.0,4/118,8.49%,ADAD2;ADARB2;DDX20;DDX3X
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,0.2818967052938832,0.5932725983945795,1.0,1.0,1.0,9/35,25.04%,RRAD;RPA3;ARTN;RMI2;BRCA1;RAD9B;RMI1;KAT5;ERCC4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.38243897136941496,0.5932396549220967,0.9180327868852459,1.0,1.0,3/8,28.09%,AGER;XRCC6;LGALS9
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.30983689621475,0.5931014766179082,0.9836065573770492,1.0,1.0,3/28,10.73%,GLRA2;RRAGA;GLRA1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.3110877530331023,0.5930899932322776,0.9420289855072463,1.0,1.0,6/26,23.72%,CAV3;CDK5R1;ANKRD53;DCTN1;RPS3;PSRC1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.2522552662658326,0.5922807855091468,1.0,1.0,1.0,26/125,22.22%,PWP2;DDX20;STRAP;SRSF9;EIF6;RPL3;GEMIN4;RPS5;MRPL20;NOP53;SNRPD2;RPS19;DDX23;RPL11;RPL23A;RSL24D1;RPL38;SRSF5;RPSA;RPLP0;DENR;RPS14;XAB2;RPL24;ABT1;RPS15
prerank,Reactome_2022__HDR Thru MMEJ (alt-NHEJ) R-HSA-5685939,-0.3221406695490364,-0.5921340302544851,0.9523809523809523,1.0,1.0,3/11,21.24%,RAD50;PARP2;RAD52
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.36527281271032525,-0.5921002965320734,1.0,1.0,1.0,1/6,13.26%,SLC13A3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.32236356795925836,0.5920952827649659,0.9552238805970149,1.0,1.0,3/18,17.14%,IGF1;GHRL;SERPINB1
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.29891198574132194,-0.591979789887602,1.0,1.0,1.0,1/17,5.08%,MAN1A1
prerank,GO_Biological_Process_2021__equilibrioception (GO:0050957),-0.3769831051479532,-0.5918186287774722,0.8666666666666667,1.0,1.0,1/5,19.53%,PCDH15
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.2959350349249006,0.591228146253354,0.9733333333333334,1.0,1.0,9/33,23.58%,BOK;GSDME;BBC3;RPS7;SIAH1;FIS1;BCAP31;DDIT3;RPS3
prerank,GO_Biological_Process_2021__androgen biosynthetic process (GO:0006702),-0.3633095385601049,-0.5904627915886357,0.9183673469387755,1.0,1.0,2/6,18.01%,HSD3B2;MED1
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.4077712359822999,0.5903955595624371,0.9206349206349206,1.0,1.0,2/5,24.06%,ATP6AP1;ATP6V0D1
prerank,Reactome_2022__Diseases Of Mismatch Repair (MMR) R-HSA-5423599,0.3925023084655582,0.5899319065788093,0.9333333333333333,1.0,1.0,2/5,27.50%,MSH6;MLH1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.3050980272220246,0.5898447277512037,0.9722222222222222,1.0,1.0,8/26,31.08%,RPA3;RPS27A;RBX1;CETN2;CDK7;RAD23B;DDB1;RPA2
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.2796054188140932,0.5896245560693767,0.9722222222222222,1.0,1.0,13/50,21.58%,MUC17;MUC4;GALNT5;C1GALT1C1;MUCL1;B3GNT5;CHST4;MUC16;GALNT15;POMGNT1;GALNT6;GCNT1;B3GNT3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.31869185361736946,0.5895588833562756,0.9206349206349206,1.0,1.0,1/17,3.23%,POLQ
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.34522758379276836,0.5894386439041392,0.9552238805970149,1.0,1.0,6/14,38.21%,DCTN1;LGMN;PICK1;PLS1;APP;PRNP
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.3699291844799021,-0.5892364395990722,0.95,1.0,1.0,1/6,21.55%,RAB11B
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,0.33654182190187587,0.589171999494734,0.9682539682539683,1.0,1.0,2/16,11.18%,SEMA3A;PLXNA3
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.30559737914213764,0.5890715492508992,1.0,1.0,1.0,13/31,31.77%,CYLD;AGER;RASGRP1;PRMT1;SPI1;GADD45B;LGALS9;DUSP10;PJA2;SASH1;DUSP1;BMP2;VEGFA
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),0.4301867565037541,0.5887707355975875,0.9137931034482759,1.0,1.0,2/5,13.99%,GPIHBP1;SOX9
prerank,Reactome_2022__HIV Infection R-HSA-162906,0.24546237597688006,0.5886382689325044,1.0,1.0,1.0,24/210,21.53%,PSMB9;TAF5;HCK;HLA-A;GTF2E1;RPS27A;AP1M2;CD4;TAF7;PSMC5;HMGA1;TAF7L;TAF10;RCC1;TAF13;TAF9B;CD8B;RBX1;PSMA3;DOCK2;PSMB6;PSMD6;TAF6;B2M
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.26642702100974597,0.5884838238041608,0.9871794871794872,1.0,1.0,15/68,28.71%,INTS5;TAF5;GTF2E1;TAF13;TAF6;INTS2;PHAX;SNAPC5;ELL2;GTF2A1;NCBP1;SNAPC1;CDK7;CDK9;POLR2H
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,0.3165319408079302,0.5884606681347053,0.96,1.0,1.0,8/22,27.05%,EXOSC8;EXOSC2;EXOSC4;HERPUD1;NFYB;DDIT3;CEBPB;DCP2
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),-0.3246550476829621,-0.5883844121804535,0.875,1.0,1.0,2/7,24.71%,SRF;HPSE
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of CaMKII/CaMKK/CaMKIV Cascasde R-HSA-442729,0.35530736832142346,0.5878556200938673,0.9523809523809523,1.0,1.0,8/8,64.48%,CALM1;KPNA2;CAMK2G;CAMK4;CREB1;CAMKK2;CAMKK1;CAMK2B
prerank,Reactome_2022__Acyl Chain Remodeling Of CL R-HSA-1482798,-0.32690766067330856,-0.5876940369777713,0.868421052631579,1.0,1.0,5/6,33.29%,TAFAZZIN;LCLAT1;HADHA;HADHB;PLA2G6
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.3437145435604634,0.5872229358241601,0.975,1.0,1.0,2/19,11.77%,C12ORF57;FBN2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.30329926858687445,-0.5871641707103993,0.967741935483871,1.0,1.0,4/14,17.23%,LIMK1;USP44;ABL1;MAD2L2
prerank,"Reactome_2022__Defective CHST14 Causes EDS, Musculocontractural Type R-HSA-3595174",0.36974455986392224,0.5864502348077859,0.9130434782608695,1.0,1.0,4/7,28.26%,DCN;BCAN;BGN;CSPG4
prerank,KEGG_2021_Human__Riboflavin metabolism,0.36132920848137545,0.5864231816322849,0.9607843137254902,1.0,1.0,1/7,8.39%,RFK
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.2325668586000783,-0.5861374631395191,1.0,1.0,1.0,6/58,14.69%,PRKCD;FLNA;HDAC3;CDK1;TERT;EIF2AK3
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.3521443764673089,0.5861017352191077,0.9253731343283582,1.0,1.0,4/11,18.64%,MMP9;CCND1;MME;PPID
prerank,Reactome_2022__Lagging Strand Synthesis R-HSA-69186,0.3245786138328993,0.5855292743365746,0.927536231884058,1.0,1.0,2/18,9.53%,POLD4;RPA3
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),-0.2951810824093367,-0.585446574276322,0.9428571428571428,1.0,1.0,5/17,19.47%,STX5;EHD3;CAMSAP3;AKAP9;STX18
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.3024479619382866,-0.5854008957164224,0.9705882352941176,1.0,1.0,1/14,3.16%,KCNE1
prerank,Reactome_2022__Leading Strand Synthesis R-HSA-69109,0.33069550638554324,0.5851860071290806,0.9264705882352942,1.0,1.0,1/13,7.96%,POLD4
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.32919818495649655,0.5850630046746432,0.9344262295081968,1.0,1.0,4/12,21.73%,GGT5;ALOX5AP;PLA2G4A;ALOX5
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.2874440417416221,0.5850545935841777,1.0,1.0,1.0,3/32,13.99%,DEPDC5;RRAGA;GPR137B
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.27881297505721614,0.5844106437311193,1.0,1.0,1.0,9/64,15.08%,H1-0;GRWD1;NAP1L2;SMARCE1;BRDT;TNP1;SOX9;H2BC18;HMGA1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),0.39178616826621937,0.5843894451541262,0.9285714285714286,1.0,1.0,3/5,27.19%,LRPAP1;HMGCR;IFNGR1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3025713899239199,-0.584337591670454,0.9230769230769231,1.0,1.0,3/18,13.04%,CTC1;STN1;EXOSC10
prerank,GO_Biological_Process_2021__choline transport (GO:0015871),-0.374893536481499,-0.5843257555272635,0.8809523809523809,1.0,1.0,5/5,62.52%,SLC44A2;SLC22A2;SLC44A4;SLC44A1;SEC14L1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.2636045571602926,0.5843089187245188,0.9873417721518988,1.0,1.0,15/69,28.71%,INTS5;TAF5;GTF2E1;TAF13;TAF6;INTS2;PHAX;SNAPC5;ELL2;GTF2A1;NCBP1;SNAPC1;CDK7;CDK9;POLR2H
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,0.25653969720311787,0.5841434939358328,1.0,1.0,1.0,10/96,17.01%,RRAD;POLE2;H2BC4;POLD4;RPA3;RPS27A;CCNA2;ARTN;RMI2;BRCA1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.23890186114762374,0.5839335432210998,1.0,1.0,1.0,10/243,7.90%,AIM2;TCF7;FBXL7;STOML2;TSPAN4;JCHAIN;BOK;WAS;LEF1;F8
prerank,Reactome_2022__Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.27696696715220703,-0.5835417981256118,0.9666666666666667,1.0,1.0,6/22,27.93%,POLR2F;POLR2C;CTDP1;GTF2F2;GTF2F1;NELFCD
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.36652296968950415,0.5830989555255777,0.8939393939393939,1.0,1.0,1/5,13.08%,AGT
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.2497695968187466,0.5830616043054477,1.0,1.0,1.0,10/100,17.44%,SHISA6;TMEM35A;PLP1;TMEM200C;TCEAL5;NEFM;CNTN2;LRRTM1;ZDHHC22;PNMA2
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.3530725560299208,-0.5830395099343402,0.918918918918919,1.0,1.0,2/7,24.01%,PNKD;PRKN
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.30089460897128467,-0.5830369992199229,0.9722222222222222,1.0,1.0,2/15,10.86%,PID1;NUPR1
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,0.3103764740159847,0.5830038685340436,0.958904109589041,1.0,1.0,3/21,15.72%,MYH11;MYL6;MYL9
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.35034809141633894,0.582664228413784,0.9508196721311475,1.0,1.0,3/9,19.23%,WDR76;FEM1B;ETAA1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.25209971051257024,-0.582447031619748,0.9655172413793104,1.0,1.0,8/51,21.13%,UBXN2A;CDK1;SPAST;EMD;NUP37;NUP98;UBXN2B;SEH1L
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),-0.3585473898338407,-0.582441874814899,0.9230769230769231,1.0,1.0,2/8,10.68%,SLC27A2;SLC27A4
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.253024616762981,0.5823363189047143,1.0,1.0,1.0,19/108,24.24%,LIX1;EI24;PINK1;ATG101;CHMP3;LAMP2;TOMM20;YOD1;PGAM5;TOMM7;DYNLL1;GABARAPL2;FUNDC1;ULK1;DYNLL2;GABARAPL1;STX17;PRKAB2;VAMP7
prerank,Reactome_2022__Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,0.32711323243001295,0.5822889745832357,0.9661016949152542,1.0,1.0,3/16,24.65%,PIGH;PIGC;PIGB
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.30202436488494094,0.5822753593606406,0.9861111111111112,1.0,1.0,3/23,12.44%,ATP10B;ATP8B3;ATP11C
prerank,GO_Biological_Process_2021__epithelial tube formation (GO:0072175),-0.3772086174846999,-0.5822678790701858,0.8809523809523809,1.0,1.0,3/5,18.08%,FGFR2;PODXL;CEP290
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),-0.3506567235595889,-0.582106466011502,0.8888888888888888,1.0,1.0,1/6,7.70%,CRH
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3069936248507979,0.581615305178065,1.0,1.0,1.0,9/25,28.24%,TNFRSF10A;DDX3X;BRCA1;TRADD;PARK7;CASP8;TMBIM1;FAIM;TNFRSF10B
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),-0.3301668769565541,-0.5814718677974599,1.0,1.0,1.0,2/8,28.14%,AKT1;DAPK2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),-0.34977054202722413,-0.5811073087293257,0.868421052631579,1.0,1.0,1/8,7.88%,NFATC3
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.33309319063854914,0.5810515101053403,0.9420289855072463,1.0,1.0,2/13,6.78%,SHOC1;MEIOB
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,0.2378821985341435,0.5803228620015527,1.0,1.0,1.0,18/142,17.55%,RRAD;HIPK1;CDKN2A;TAF5;TP53BP2;RPA3;RPS27A;TAF7;ING3;CCNA2;CDK5R1;TAF7L;ARTN;TAF10;RMI2;TAF13;BRCA1;TAF9B
prerank,Reactome_2022__Erythropoietin Activates Phospholipase C Gamma (PLCG) R-HSA-9027277,-0.32763821097806883,-0.5799877867968503,0.8333333333333334,1.0,1.0,2/7,23.98%,EPOR;IRS2
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,0.30608051733312575,0.5795671705038317,0.9861111111111112,1.0,1.0,11/25,32.28%,TUBA4A;TUBA3D;TUBB6;TUBA1C;TUBB4B;CC2D1B;VPS4A;CHMP4B;TUBA1A;TUBB;CHMP2B
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.3587431521140722,-0.5795346142145933,0.8809523809523809,1.0,1.0,3/7,32.93%,ATM;NBR1;PJVK
prerank,Reactome_2022__Hydrolysis Of LPC R-HSA-1483115,-0.3466622170000199,-0.5782909727482352,0.925,1.0,1.0,1/7,8.44%,PLA2G4C
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),-0.2759270866556768,-0.5782072655405781,1.0,1.0,1.0,9/20,31.93%,BCR;TAOK2;SRC;PEAK1;WHAMM;ACTN2;TRIP6;PIP5K1A;ACTN1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.26883491702639556,0.5779229833144301,0.9866666666666667,1.0,1.0,12/55,24.61%,GP1BA;EIF6;THBS1;ITGA2B;MYL9;ZFPM1;PAF1;PURB;PRMT1;RUNX1;PRKCQ;SPI1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.28588140104919385,-0.5778045763211397,1.0,1.0,1.0,6/19,22.12%,EMD;TOR1B;CTDNEP1;SUN3;TMEM43;NEMP1
prerank,GO_Biological_Process_2021__regulation of cellular response to hypoxia (GO:1900037),0.3770374771140437,0.5777684069616421,0.8709677419354839,1.0,1.0,1/5,18.82%,CHCHD2
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),0.3887343694847064,0.5776579506619886,0.9824561403508771,1.0,1.0,1/6,24.61%,SPI1
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,0.2548003666049964,0.5773805741808168,1.0,1.0,1.0,9/83,17.83%,TGFB1;ITGB6;DAND5;TGFB3;RPS27A;STAT1;MAPK3;UBE2M;ITGB8
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.22782272163063297,-0.5773721216119605,1.0,1.0,1.0,8/59,15.77%,MAP3K10;NOD1;RIPK2;TRIB1;MAP3K12;TAOK2;CRKL;MAP3K13
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.3811629399924711,0.5770296494690211,0.9464285714285714,1.0,1.0,1/5,24.91%,FYCO1
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),-0.33191084222036504,-0.5769286460052336,0.96875,1.0,1.0,3/8,12.34%,MMP2;OPN5;TIMP1
prerank,Reactome_2022__OAS Antiviral Response R-HSA-8983711,0.34011574566210295,0.5768533863466072,0.9344262295081968,1.0,1.0,3/8,27.31%,OAS2;OASL;OAS1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.31809386971727793,0.5762226191524151,0.9420289855072463,1.0,1.0,2/17,9.22%,SOD2;PINK1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.3680798712974354,-0.5760732800809573,0.9285714285714286,1.0,1.0,5/5,63.21%,DLAT;PDHA1;DLD;PDHB;PDHX
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.2524126711863192,0.5759034685703223,1.0,1.0,1.0,7/76,16.48%,C15ORF62;P2RY12;TGFB3;F2RL1;ANLN;RHOQ;WASHC1
prerank,KEGG_2021_Human__Cocaine addiction,0.28273408099389796,0.5755817903172451,0.9876543209876543,1.0,1.0,4/44,8.67%,SLC18A2;PPP1R1B;PDYN;GRIN2D
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.25634560504967757,0.5755782422185617,1.0,1.0,1.0,3/56,11.03%,A4GALT;CAV3;AHNAK2
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.3692362394884633,-0.5755616447018967,1.0,1.0,1.0,1/5,13.26%,SLC13A3
prerank,Reactome_2022__NrCAM Interactions R-HSA-447038,0.36862454733809014,0.5752735955998718,0.9482758620689655,1.0,1.0,2/7,25.33%,CNTN2;NRP2
prerank,Reactome_2022__Fertilization R-HSA-1187000,0.3313848265099164,0.5751619996603248,0.9558823529411765,1.0,1.0,5/17,18.70%,KCNU1;IZUMO1;ADAM21;CATSPERD;HVCN1
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.27158371693187866,-0.574928777277507,0.9375,1.0,1.0,6/30,19.80%,CACNG4;CACNG2;CACNA1A;KCNH2;ABL1;CACNA1G
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Small Intestine,-0.2459194318580032,-0.5748374053306788,1.0,1.0,1.0,9/35,23.77%,ADAMTS16;FADS6;SV2B;POU2AF1;AMER3;TMEM201;CHD5;HCN1;GNAO1
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.26995874054821695,0.5747899410769408,0.9857142857142858,1.0,1.0,4/38,15.68%,CERS3;DEGS2;ALOX12B;CLN8
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.34388431810589215,0.5743032673542853,1.0,1.0,1.0,2/12,16.79%,NT5E;ADSS1
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,0.24985473948920897,0.5737399210657628,1.0,1.0,1.0,10/100,17.01%,RRAD;POLE2;H2BC4;POLD4;RPA3;RPS27A;CCNA2;ARTN;RMI2;BRCA1
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.32406447371019065,0.5737395639053946,0.9333333333333333,1.0,1.0,3/12,15.83%,GNAT3;GNAT2;PKD1L3
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.3300499096294701,-0.5735468684440075,0.9714285714285714,1.0,1.0,1/8,7.05%,TICAM2
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.28924469230418504,-0.5729383686188535,0.9736842105263158,1.0,1.0,3/11,25.04%,ATG9B;WIPI1;PACS2
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,0.28569529197935256,0.5725130786334222,0.9863013698630136,1.0,1.0,1/39,1.79%,KIF14
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.3646408848417425,-0.5723725313597884,0.925,1.0,1.0,3/6,24.37%,EMP2;S100A10;RFTN1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.30355805866212304,0.5722878594864539,1.0,1.0,1.0,4/29,11.97%,TGFB1;LCP1;PRR5L;OAZ2
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.3092441919238882,0.5721681094202843,0.9714285714285714,1.0,1.0,2/20,15.23%,IGF1;RHOQ
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.35865751002381113,0.5719279623732463,0.9444444444444444,1.0,1.0,2/8,30.32%,MTG1;SHMT2
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.3272256658012745,0.5713201237006098,0.95,1.0,1.0,3/10,19.77%,SOX9;ENG;HEY1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.35606485738688265,0.5712696104572361,0.967741935483871,1.0,1.0,1/9,7.73%,APOM
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.2283597578451101,0.5712105340109905,1.0,1.0,1.0,25/269,17.96%,UBE2U;POLE2;FANCF;POLQ;TICRR;RAD1;FAAP20;POLD4;RAD54L;TRAIP;RPA3;DCLRE1A;RPS27A;DCLRE1C;HMGA2;RECQL4;NOP53;TNP1;TDG;RMI2;CENPX;BRCA1;PARP4;RAD51AP2;MSH6
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,0.25402970845917267,0.5711527021510441,0.9873417721518988,1.0,1.0,14/64,28.71%,TAF5;GTF2E1;TAF7;TAF7L;TAF10;TAF13;TAF9B;TAF6;GTF2A1;NCBP1;NELFB;CDK7;CDK9;POLR2H
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.295860929396063,0.5709878821327807,0.96875,1.0,1.0,2/17,16.50%,ATRAID;MSN
prerank,GO_Biological_Process_2021__regulation of inositol phosphate biosynthetic process (GO:0010919),0.38539223447022253,0.5705774337867097,0.9642857142857143,1.0,1.0,1/5,16.42%,CD244
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.3502986976862513,-0.5703810632861869,0.9523809523809523,1.0,1.0,1/7,11.71%,KIF1C
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,0.2610904197073997,0.5702753215113073,1.0,1.0,1.0,8/65,17.01%,RRAD;H2BC4;RPA3;RPS27A;CCNA2;ARTN;RMI2;BRCA1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),-0.3119320428442769,-0.5702391703506275,1.0,1.0,1.0,3/11,18.69%,ZMIZ1;ELOF1;SMARCD1
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,-0.2679751233897535,-0.5700009782554403,1.0,1.0,1.0,1/33,2.01%,CSK
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.30816085737606225,-0.5699932745888531,0.9666666666666667,1.0,1.0,4/11,22.75%,GRM2;GABBR2;DRD2;PALM
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.30816085737606225,-0.5699932745888531,0.9666666666666667,1.0,1.0,4/11,22.75%,GRM2;GABBR2;DRD2;PALM
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.35288586197313027,0.56989905579597,0.9830508474576272,1.0,1.0,3/6,28.09%,AGER;HLA-B;LGALS9
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.25693866541247645,0.5698814778748977,0.9871794871794872,1.0,1.0,9/82,18.12%,TGFB1;CDKN2A;PRR5L;CDKN1B;CDKN1A;CDKN2C;FKBP8;DYNLL1;FBP1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.3426179056777855,-0.569847289781996,0.9375,1.0,1.0,2/6,27.61%,ACAA1;GSTM3
prerank,Reactome_2022__Activation Of RAC1 Downstream Of NMDARs R-HSA-9619229,-0.3314877910278251,-0.569844308758126,0.9534883720930233,1.0,1.0,7/7,66.87%,RNASE1;GIT1;CAMKK1;CAMKK2;ARHGEF7;CAMK1;CALM1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.24075529623573286,-0.5697108682164826,1.0,1.0,1.0,13/36,28.75%,MYO5C;MYO19;BICDL2;CLN3;TRAK2;BICDL1;HTT;MYO1C;PAFAH1B1;TRAK1;MYO5A;MYO1H;MYO1B
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,0.2733124230451381,0.5694175744657548,0.9722222222222222,1.0,1.0,2/44,8.32%,FGF20;KLB
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.2714201507191751,-0.5692910497811121,0.9722222222222222,1.0,1.0,6/28,20.07%,CSK;ARRB2;MARK3;VCL;HRAS;ARRB1
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.3167938233041529,-0.5692074265435431,0.8974358974358975,1.0,1.0,3/9,15.00%,NKD1;RSPO3;CSNK1E
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.35247995787319697,-0.5690619846488172,0.9565217391304348,1.0,1.0,1/6,9.94%,LDB1
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.3231252220308285,-0.5684947061033155,0.8947368421052632,1.0,1.0,3/7,23.22%,CHCHD10;ERC2;CBLN2
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.28456116547197785,-0.5683229477209848,0.92,1.0,1.0,1/12,6.71%,ARPC3
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Colorectum,0.3344439355217811,0.5682363241059945,0.9285714285714286,1.0,1.0,3/7,19.79%,SIRPG;ZAP70;CD5
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.29930970374787513,0.5678428275328979,0.9705882352941176,1.0,1.0,2/21,15.65%,EXOSC4;TDG
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),-0.3601509157601285,-0.5677434133016769,0.9375,1.0,1.0,1/6,7.81%,EML1
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),-0.29541376526964896,-0.5674690716606184,0.9555555555555556,1.0,1.0,6/13,20.46%,GAR1;PUS7;PUS10;PUS7L;NHP2;PUSL1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),0.36835510061005894,0.5672304983124471,0.9696969696969697,1.0,1.0,3/8,32.27%,DDIT3;ZNF593;LAMTOR5
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),-0.3276085006103989,-0.567157904284431,0.9428571428571428,1.0,1.0,2/6,14.69%,SULF2;EIF2AK3
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.309870713134062,0.5668997478738351,0.9850746268656716,1.0,1.0,7/16,30.88%,HPGDS;PLA2G4A;CD74;PTGES;PTGS2;TBXAS1;PNPLA8
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.3326887606860812,0.5666387769926606,0.9253731343283582,1.0,1.0,1/8,15.11%,ATRAID
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.27769101629198134,0.5664193470159098,0.9850746268656716,1.0,1.0,1/32,4.20%,SNAP23
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.28484788365336955,0.5663545709148016,0.9696969696969697,1.0,1.0,1/33,3.51%,FGF2
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.29827892432337944,-0.5660105727990324,0.9512195121951219,1.0,1.0,4/14,20.33%,NR1H2;ABCG1;OSBPL8;PTPN2
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.2905446657238991,0.565634928240479,1.0,1.0,1.0,2/27,13.17%,RAB11A;CHMP3
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.30247447747511863,0.5656243400578843,1.0,1.0,1.0,4/27,19.97%,STMN4;SKA2;FKBP4;STMND1
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.33698034514333614,-0.5655993347722212,0.9318181818181818,1.0,1.0,2/6,21.77%,NFS1;GPHN
prerank,Reactome_2022__Molybdenum Cofactor Biosynthesis R-HSA-947581,-0.33698034514333614,-0.5655993347722212,0.9318181818181818,1.0,1.0,2/6,21.77%,NFS1;GPHN
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.3073379257876997,0.5655647388634073,0.9538461538461539,1.0,1.0,4/16,14.59%,HPR;TNFSF4;ELANE;ITIH4
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.3706702047309295,0.5645835745253789,0.9193548387096774,1.0,1.0,3/5,36.44%,TAP1;CALR;SEC22B
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.29114770297092096,0.5644420977084759,0.9863013698630136,1.0,1.0,3/24,13.13%,MTTP;TNFAIP8L3;SLC25A19
prerank,Reactome_2022__Synthesis Of PG R-HSA-1483148,0.3591775468576888,0.5640378143241627,0.9850746268656716,1.0,1.0,1/7,5.97%,PLD4
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.32173789578304696,-0.5639782320717064,0.9487179487179487,1.0,1.0,10/10,67.85%,STAT3;BBS4;LEPR;EBI3;UGCG;SIRT1;MKKS;LEP;MT3;BBS2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.2673742255389555,-0.5638011063950744,1.0,1.0,1.0,10/40,21.33%,TWIST1;DDX11;WRAP53;SPIDR;SIRT7;SHLD2;RTEL1;RAD51AP1;MGMT;PML
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.2935110909615126,-0.5637773715829739,0.9714285714285714,1.0,1.0,1/15,4.05%,SARM1
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),-0.35261304808330557,-0.5629892808879138,0.8421052631578947,1.0,1.0,3/5,32.06%,SETMAR;ASH1L;SETD2
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,-0.23447941558090973,-0.5629390514780515,1.0,1.0,1.0,12/62,17.78%,RNF168;EXO1;BRCC3;POLR1A;RAD50;CDK1;YWHAQ;MDC1;PIAS4;RAD17;RFC3;ATRIP
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.2797003299118994,0.5628421215262007,1.0,1.0,1.0,8/31,23.01%,POLQ;HMGA2;NUDT16L1;TFIP11;RMI2;HELB;OTUB1;KLHL15
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.2881805069284461,0.5627139959496258,0.9863013698630136,1.0,1.0,2/24,12.93%,CAV3;PLN
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.2727859385265676,0.5625288203175849,0.9859154929577465,1.0,1.0,1/25,5.29%,GPIHBP1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.3082691852252425,0.5621439404969699,0.9420289855072463,1.0,1.0,3/17,12.93%,IL12A;DCN;CD63
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.3702340693922022,0.5612595740964123,0.9622641509433962,1.0,1.0,1/8,11.18%,PLXNA3
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.3639352759474019,0.5609573381559709,0.9482758620689655,1.0,1.0,3/6,34.70%,ENPP1;PASK;GSK3A
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.3639352759474019,0.5609573381559709,0.9482758620689655,1.0,1.0,3/6,34.70%,ENPP1;PASK;GSK3A
prerank,Reactome_2022__Sensory Perception Of Taste R-HSA-9717189,0.28408333099827293,0.5608746372445453,0.9696969696969697,1.0,1.0,10/24,30.11%,GNAT3;KCNJ2;SCNN1A;SCN4B;SCNN1G;SCN1B;SCN9A;SCNN1B;SCN2B;ITPR3
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.3426579695596317,0.5607510226240218,0.984375,1.0,1.0,1/9,7.24%,NR1H4
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.31222283420807045,0.5606504202415874,0.967741935483871,1.0,1.0,5/13,26.82%,FAM47E;PADI2;SPI1;SERTAD1;CHEK1
prerank,Reactome_2022__Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.2674395773135636,-0.560429992546781,0.96875,1.0,1.0,6/18,20.42%,OGDH;IDH2;SUCLA2;ACO2;SDHB;CS
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.25808043205180653,0.5603798618519678,1.0,1.0,1.0,12/49,30.40%,PINK1;DCN;IL4;SESN1;WAC;SCOC;FYCO1;VDAC1;OPTN;BNIP3;PIP4K2C;SLC25A5
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.3321766123986801,0.5602870809267916,0.9180327868852459,1.0,1.0,1/11,9.55%,P2RY12
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.2700240952633562,-0.5602112495865511,1.0,1.0,1.0,2/25,5.86%,RPF1;RPF2
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.2899045745548923,-0.5599959340752926,1.0,1.0,1.0,5/12,19.83%,SCRIB;RHOA;CAMSAP3;RAB10;RAP2A
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.24228509655366684,0.5599312593085247,1.0,1.0,1.0,35/162,27.80%,HIGD1C;STOML2;CHCHD4;TIMM22;PINK1;COX7A2;TOMM20;RAB38;BCS1L;SLIRP;TOMM7;TIMM17A;HCFC1;CHCHD2;TIMM10;RAB29;FIS1;MTFR1;BCAP31;POLG2;FBXO7;HK2;COX7A1;MIEF1;PARK7;PPARGC1A;CAV2;HAP1;MX1;MTX3;TIMM13;MTX2;AIP;TMEM11;SPATA18
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.3122058711406526,-0.5597744513678379,0.9772727272727273,1.0,1.0,5/13,23.93%,CDK1;CHAMP1;IK;MTBP;SPDL1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.2252015529089322,0.5596089492139381,1.0,1.0,1.0,24/210,18.28%,ATP6V1G2;BOK;DEPDC5;DRAM1;HGF;RRAGA;PINK1;PSAP;TRIM68;ATP6V0E2;DCN;USP13;ATG101;WDR6;EEF1A1;ORMDL3;GPR137B;WDR24;CDK5R1;HTR2B;WASHC1;ATP6V0B;LAMTOR3;GFAP
prerank,CellMarker_Augmented_2021__M1 macrophage:Brain,0.24560704244452944,0.5595754933564774,0.9875,1.0,1.0,6/84,13.69%,RRAS;VASP;POLD4;JOSD2;TALDO1;RHOG
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3461903524895813,0.5589919309529185,0.9655172413793104,1.0,1.0,1/9,7.66%,IGF1
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.3498091559151464,0.5588730182451702,0.9375,1.0,1.0,4/9,41.00%,TERF2IP;H3-3A;ACD;POT1
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.3498091559151464,0.5588730182451702,0.9375,1.0,1.0,4/9,41.00%,TERF2IP;H3-3A;ACD;POT1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.32498971230742246,-0.5585103889438267,0.967741935483871,1.0,1.0,3/8,20.52%,AGA;NGLY1;MAN2B1
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.29086599263380064,-0.5584761326107543,0.9696969696969697,1.0,1.0,4/15,26.56%,PTPA;GPLD1;MAGI2;PLEK
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.24458057679157025,0.5584331319418099,1.0,1.0,1.0,7/95,16.16%,SIX4;RANBP6;SYK;COL1A1;NOP53;TOR1A;RPL11
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.24862065156437765,0.5584044182153016,1.0,1.0,1.0,16/85,27.72%,MRPS34;MRPL20;MRPL34;MRPL50;GADD45GIP1;GFM2;MRPL54;MRPS2;MRPL19;MRPL28;MRPL10;MRPL37;MRPL44;MRPL40;MRPS12;MRPL49
prerank,KEGG_2021_Human__Gap junction,0.24258207462936457,0.5575289995559287,1.0,1.0,1.0,15/82,24.30%,LPAR1;ADRB1;ADCY7;TUBA4A;TUBA3D;TUBB6;MAPK3;HTR2B;PRKG1;TUBA1C;MAP2K1;TUBB4B;KRAS;PLCB4;GJD2
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.32300632059501094,0.5574528775208684,0.9848484848484849,1.0,1.0,5/12,33.10%,RPS19;GRN;ENPP3;CD47;CR1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.3273088013779859,-0.5572193730547261,0.9473684210526315,1.0,1.0,4/10,30.58%,KLHL22;SESN3;RPTOR;SESN2
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.3273088013779859,-0.5572193730547261,0.9473684210526315,1.0,1.0,4/10,30.58%,KLHL22;SESN3;RPTOR;SESN2
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.287696674631987,0.5570678916585884,0.9696969696969697,1.0,1.0,1/20,5.77%,GPER1
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),-0.3179698225701903,-0.556361959597187,0.90625,1.0,1.0,3/9,25.91%,EHD3;RAB11B;SORL1
prerank,Reactome_2022__Phase 3 - Rapid Repolarisation R-HSA-5576890,0.3221701323187913,0.5559531391412091,0.9384615384615385,1.0,1.0,4/8,22.95%,KCNA5;KCNE3;KCNE4;KCNQ1
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.3482596594452061,0.5553289688110148,0.9104477611940298,1.0,1.0,3/7,23.49%,TNFSF4;MYB;HLA-DRB1
prerank,Reactome_2022__Biosynthesis Of E-series 18(S)-resolvins R-HSA-9018896,0.3813099142466815,0.5549831145713306,0.9473684210526315,1.0,1.0,3/5,28.73%,ALOX15;ALOX5;GPX4
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.3422729676692551,0.5549522944618872,0.9122807017543859,1.0,1.0,1/6,21.78%,BLOC1S2
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.3248642652171529,-0.5548936789859902,0.9411764705882353,1.0,1.0,3/5,32.23%,TPR;NUMA1;PLSCR1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.29729185959115795,0.5540122647919755,0.9827586206896551,1.0,1.0,3/19,24.08%,IGF1;EFHB;ACTN3
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.32665614133795284,-0.5536638319759053,0.9761904761904762,1.0,1.0,3/7,24.76%,METAP2;FKBP7;METAP1
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),-0.3262674837182179,-0.5534935740874672,0.918918918918919,1.0,1.0,1/5,13.47%,TMEM86B
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.32779173046432547,0.5534337457302149,0.96,1.0,1.0,1/12,7.67%,PHF23
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.2766071683372436,-0.5531705454965223,0.9722222222222222,1.0,1.0,4/18,20.06%,SMYD2;TTC5;KMT5A;ATM
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),-0.32246934338572475,-0.553066830769335,0.9285714285714286,1.0,1.0,3/7,31.76%,CRMP1;DPYSL2;DPYSL4
prerank,Reactome_2022__Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,0.3044995104532645,0.5526915105449196,0.96875,1.0,1.0,1/15,11.00%,RPS27A
prerank,Reactome_2022__Phosphorylation Of Emi1 R-HSA-176417,0.3509652285566768,0.5525133035610907,0.96875,1.0,1.0,2/5,21.18%,FBXO5;CCNB1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.3330177263093068,-0.5524230441086577,0.9024390243902439,1.0,1.0,3/6,27.41%,MACROH2A1;PHF19;PHF1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.23010539057060853,0.5521117648768838,1.0,1.0,1.0,18/163,18.37%,STMN4;TMEM35A;PHF21B;TMEM200C;EBF3;NEFM;DACH1;CCDC177;PNOC;RNF138;ZNF536;CNTN2;ZDHHC22;PNMA2;CNR1;CAMKV;SYT4;EFNB3
prerank,Reactome_2022__Activated NTRK2 Signals Thru CDK5 R-HSA-9032845,0.3588506840268346,0.5520996337541587,0.9344262295081968,1.0,1.0,1/5,15.38%,CDK5R1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.25758554016421065,0.5518027489412594,1.0,1.0,1.0,4/50,11.61%,VAPB;HSPA5;MYDGF;ERN2
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.3353304478596405,-0.5517589478320927,0.9523809523809523,1.0,1.0,1/7,5.65%,HLA-DRA
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.3353304478596405,-0.5517589478320927,0.9523809523809523,1.0,1.0,1/7,5.65%,HLA-DRA
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.3023396220055292,-0.5517026871705893,0.9375,1.0,1.0,3/11,14.93%,QRICH1;EIF2AK3;IMPACT
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),0.3677768339926479,0.551583373562462,0.9696969696969697,1.0,1.0,1/5,24.92%,CAV2
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.26911095232589205,-0.5514875979584931,1.0,1.0,1.0,1/14,5.86%,RPF2
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.3381370856756003,0.5514174326615857,0.9672131147540983,1.0,1.0,3/8,22.25%,HSPA5;HERPUD1;DDIT3
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.2509415325120159,0.5513774217007786,1.0,1.0,1.0,16/84,19.37%,TK1;PRDX4;HSD11B2;BAIAP2L1;MMP15;TMEM54;AP1M2;RECQL4;AHCY;KRT8;FKBP4;RCC1;DKKL1;TUBA1C;MRPS2;PPP1R14B
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.25832818825604004,0.551001840119001,1.0,1.0,1.0,1/51,2.57%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),0.33787607372108935,0.5509078837364764,0.967741935483871,1.0,1.0,2/10,17.26%,NPPA;NOS2
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.2609915707834232,-0.5505266429954446,1.0,1.0,1.0,11/28,28.53%,KPTN;RAB7A;SH3BP4;SZT2;GCC2;LAPTM5;RNF128;SORL1;M6PR;LAMTOR4;NCOA4
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.28322449447014564,-0.5501414772941349,1.0,1.0,1.0,1/16,2.59%,PTCH1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.2808679287854705,0.5500323461555335,0.96,1.0,1.0,8/27,32.28%,CHMP3;CEP76;CHMP1A;C10ORF90;CCNF;FBXW5;CHMP4B;CHMP2B
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.28930175958809995,0.5499296378270522,0.9861111111111112,1.0,1.0,1/17,5.77%,GPER1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.24589738363196867,-0.5497058021312333,1.0,1.0,1.0,3/31,10.39%,IWS1;THAP7;MYOCD
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.31442677823765874,0.5495356577883829,0.9672131147540983,1.0,1.0,4/10,22.95%,KCNA5;KCNE3;KCNE4;KCNQ1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.30669613117434386,0.5493121766674098,0.984375,1.0,1.0,2/14,12.51%,PPT1;SCD
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),0.3131439639009967,0.5492191668563755,1.0,1.0,1.0,3/11,27.30%,ANGPTL3;ABCB11;TLCD1
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.32219588720889114,0.548584009936881,0.9701492537313433,1.0,1.0,4/13,18.30%,GLRA2;GLRA1;ADCY7;CHRNB2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),-0.31503478302020727,-0.5478509952277668,0.9523809523809523,1.0,1.0,8/8,68.51%,CRMP1;DPYSL2;DPYSL4;DPYS;DPYSL5;ALDH6A1;DPYSL3;DPYD
prerank,Reactome_2022__Mitochondrial Translation R-HSA-5368287,0.24023378089253317,0.5464377619818251,1.0,1.0,1.0,13/79,26.15%,MRPS34;MRPL20;MRPL34;MRPL50;GADD45GIP1;GFM2;MRPL54;MRPS2;MRPL19;MRPL10;MRPL37;MRPL44;MRPL40
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.26010546358569575,-0.5460690716046667,0.967741935483871,1.0,1.0,8/31,25.65%,B3GAT3;MSH3;ABL1;NCSTN;XRCC4;AZIN2;MAPK8;BCAS3
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate metabolic process (GO:1901908),-0.32005565355657944,-0.5459115403061235,0.8823529411764706,1.0,1.0,1/5,11.73%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate metabolic process (GO:1901906),-0.32005565355657944,-0.5459115403061235,0.8823529411764706,1.0,1.0,1/5,11.73%,NUDT4B
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911),-0.32005565355657944,-0.5459115403061235,0.8823529411764706,1.0,1.0,1/5,11.73%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate catabolic process (GO:1901909),-0.32005565355657944,-0.5459115403061235,0.8823529411764706,1.0,1.0,1/5,11.73%,NUDT4B
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910),-0.32005565355657944,-0.5459115403061235,0.8823529411764706,1.0,1.0,1/5,11.73%,NUDT4B
prerank,GO_Biological_Process_2021__diphosphoinositol polyphosphate metabolic process (GO:0071543),-0.32005565355657944,-0.5459115403061235,0.8823529411764706,1.0,1.0,1/5,11.73%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate catabolic process (GO:1901907),-0.32005565355657944,-0.5459115403061235,0.8823529411764706,1.0,1.0,1/5,11.73%,NUDT4B
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,0.24479434749820958,0.5457722318297871,1.0,1.0,1.0,4/67,9.64%,GNG12;GNG4;KCNG2;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.2921603608825041,-0.5456511432841532,0.9459459459459459,1.0,1.0,5/12,26.78%,ADIPOR1;PTPN2;VHL;NF2;PIBF1
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),-0.3176398220876313,-0.5455004720005855,0.9333333333333333,1.0,1.0,5/5,68.25%,HMGB1;PARP3;XRCC1;APLF;RAD51
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.3644647331498903,0.5448867985204372,0.9482758620689655,1.0,1.0,2/5,22.87%,IDH1;IDH3G
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.30571214577581357,-0.5446312251302324,0.9230769230769231,1.0,1.0,4/10,26.04%,MACROH2A2;SMCHD1;LRIF1;MACROH2A1
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.36521095654990454,0.5440348680846451,0.9242424242424242,1.0,1.0,1/5,15.60%,DDX23
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.2640250949384303,-0.5436963895264878,1.0,1.0,1.0,7/25,23.11%,DPM3;PGAP1;PIGQ;PIGW;GPLD1;PGAP3;PIGO
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.292434966155967,-0.5435242717724783,0.9722222222222222,1.0,1.0,7/14,30.48%,DAGLA;GRM2;HOMER1;GRM4;GRM7;GRM8;TRPM1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.3125250512523501,-0.5434237484053565,0.9772727272727273,1.0,1.0,5/11,23.93%,CDK1;CHAMP1;IK;MTBP;SPDL1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.30113125384578976,-0.5434219508022904,1.0,1.0,1.0,12/12,69.91%,TERF1;SIN3A;ATRX;TERF2;TINF2;UBE2N;DAXX;POT1;MIER1;ACD;H3-3A;TERF2IP
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.2512923767671469,-0.5433071214216042,1.0,1.0,1.0,14/30,30.45%,PID1;CAPN10;OSBPL8;AKT2;PRKAG2;OCLN;C1QTNF12;IRS2;INSR;PRKCI;AKT1;APPL2;ERFE;RTN2
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Osteoarthritic Cartilage,-0.33481276702384455,-0.5430766108960532,0.9777777777777777,1.0,1.0,2/5,17.46%,ALCAM;CD9
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.2487956077994738,0.5429839225789465,1.0,1.0,1.0,15/63,23.99%,B4GALNT2;MPDU1;ASGR2;TMEM258;ASGR1;ALG10;PGM3;ALG10B;OSTC;ALG6;ALG2;MCFD2;MGAT4A;LMAN1;DPAGT1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.30816245071047654,0.5429445726517409,0.9464285714285714,1.0,1.0,7/12,32.36%,CCT7;GNL3;CCT8;CCT3;CCT6A;CCT2;DKC1
prerank,KEGG_2021_Human__Spliceosome,0.23146480769425032,0.5429050461530944,1.0,1.0,1.0,12/122,21.22%,HSPA1L;HSPA8;SRSF9;RNU5A-1;SNRPD2;DDX23;HSPA2;DHX38;SRSF5;SF3B5;SRSF3;XAB2
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.3120215103397346,0.5420468422082796,0.9365079365079365,1.0,1.0,2/11,19.65%,SLIRP;FIS1
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.37366329137882087,0.541666533196368,0.9491525423728814,1.0,1.0,5/5,62.64%,P2RX7;ANO6;CLCN3;SHANK3;KCNMA1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.30040112656771134,-0.5416237873497622,0.9210526315789473,1.0,1.0,3/7,25.55%,IRGM;ATG7;EIF2AK4
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.36166185586523447,-0.5416074431557205,0.9166666666666666,1.0,1.0,6/6,63.85%,DHX36;PKM;CNBP;YBX3;DHX9;LIN28A
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.3411368278369394,-0.5416063257491732,0.9069767441860465,1.0,1.0,3/5,24.58%,TRIM44;PPIA;PLAA
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.21785140288364102,-0.5399531733338541,1.0,1.0,1.0,7/36,24.46%,FLNA;NUPR1;PDE3B;MAD2L2;AZIN2;HDAC4;AGAP2
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.21911599935266118,-0.5398468948138594,1.0,1.0,1.0,8/69,13.73%,PRICKLE1;CRY1;FBXO4;RIPK2;COMMD1;HDAC3;HSPBP1;MALT1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.2856811527564016,-0.5395570891501574,1.0,1.0,1.0,1/21,1.60%,TYRO3
prerank,Reactome_2022__InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,0.28548933722738123,0.539549236990159,0.9558823529411765,1.0,1.0,2/15,19.55%,RPS27A;SH3GL3
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,-0.20671350175068903,-0.5393381856097947,1.0,1.0,1.0,15/62,24.62%,HGFAC;SH3KBP1;PTPRJ;RAPGEF1;ITGA3;CRK;CRKL;LAMA2;HRAS;PTPN2;LAMB3;LAMB1;SPINT2;LAMC1;SRC
prerank,GO_Biological_Process_2021__negative regulation of NLRP3 inflammasome complex assembly (GO:1900226),0.3829004266990809,0.5392965691461423,0.9821428571428571,1.0,1.0,1/5,9.92%,NLRC3
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.26315894292247105,-0.539100583685041,1.0,1.0,1.0,7/23,25.43%,NR4A3;ADCY6;ABL1;APLP1;GNG2;PRKN;SNCA
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.3055310270098351,0.5388840033176006,0.971830985915493,1.0,1.0,2/13,17.01%,NR5A2;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),0.3333429344075956,0.5387957179555248,0.9666666666666667,1.0,1.0,1/7,18.30%,CHRNB2
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.2896473188897627,-0.5386132381834292,0.972972972972973,1.0,1.0,4/10,30.58%,IMPACT;SESN3;EIF2AK4;SESN2
prerank,GO_Biological_Process_2021__regulation of natural killer cell proliferation (GO:0032817),-0.3104149907727251,-0.5375458339973181,1.0,1.0,1.0,6/6,68.97%,IL23A;PTPN22;HLA-E;LEP;IL23R;IL18
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.3187521846852198,0.5370279986116432,0.9538461538461539,1.0,1.0,1/9,11.63%,TNFSF4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.2720259852833782,0.5367434577852411,0.9864864864864865,1.0,1.0,3/36,11.00%,POLD4;RPA3;RPS27A
prerank,Reactome_2022__Chk1/Chk2(Cds1) Mediated Inactivation Of Cyclin B:Cdk1 Complex R-HSA-75035,0.316628918119984,0.536591721774283,0.9833333333333333,1.0,1.0,6/12,27.48%,YWHAH;CDC25C;CCNB1;YWHAG;CHEK1;CHEK2
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.33989664815502607,0.5365651401820675,0.9827586206896551,1.0,1.0,1/6,13.02%,FOXB1
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.238010105306748,-0.5357909898194905,1.0,1.0,1.0,1/50,1.05%,SYNJ2
prerank,Reactome_2022__Integration Of Provirus R-HSA-162592,0.33146834809912507,0.5355019912052938,0.9811320754716981,1.0,1.0,2/10,22.43%,HMGA1;XRCC6
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.22416517589637674,-0.5347128511921447,1.0,1.0,1.0,12/80,17.56%,APOE;SLC25A17;PRICKLE1;POM121C;NUP214;PEX13;PEX14;SNX33;SAMM50;RANBP17;E2F3;IPO7
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),-0.30701625635191643,-0.5344751981025713,0.9696969696969697,1.0,1.0,1/9,5.74%,PLIN5
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.3530862587391044,0.53412900571094,0.9622641509433962,1.0,1.0,3/6,36.06%,IL15;JAK2;LEP
prerank,Reactome_2022__Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,-0.30480878455130633,-0.5340873483096048,1.0,1.0,1.0,11/11,69.54%,RNF103-CHMP3;PIK3R4;CHMP6;CHMP7;PIK3C3;UVRAG;BECN1;CHMP2A;MAP1LC3B;CHMP2B;CHMP4B
prerank,Reactome_2022__Triglyceride Catabolism R-HSA-163560,-0.28308569482510526,-0.5329281398318777,0.9428571428571428,1.0,1.0,3/17,19.71%,PPP1CA;PRKCA;PPP1CB
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,0.23068021704134214,0.5327796960721148,1.0,1.0,1.0,6/105,12.80%,PIK3R3;CERS3;KNG1;PPP2R3A;PPP2R5A;DEGS2
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,0.28389235720896994,0.5327352847128703,0.9855072463768116,1.0,1.0,7/19,33.34%,RPS27A;SH3GL3;CBLL1;CTNNB1;RNMT;SH3GL2;STAM
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.3273853069973095,0.5324904755703097,1.0,1.0,1.0,2/8,21.85%,EHD2;EHD1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.27772388751458,0.5323021407549131,0.9857142857142858,1.0,1.0,3/21,23.63%,VPS18;FIS1;MIEF1
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,0.2637625854744537,0.53104016783303,1.0,1.0,1.0,7/23,28.24%,TNFRSF10A;NDUFA2;TRADD;FASN;CASP8;TMED7-TICAM2;TNFRSF10B
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.29220029343524123,0.5306350484643049,0.9545454545454546,1.0,1.0,8/19,31.77%,AGER;PRMT1;SPI1;GADD45B;PJA2;SASH1;BMP2;VEGFA
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.24904138029667472,-0.530304219517963,1.0,1.0,1.0,4/30,15.56%,GTF2H2;ERCC2;POLR2F;POLR2C
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.24904138029667472,-0.530304219517963,1.0,1.0,1.0,4/30,15.56%,GTF2H2;ERCC2;POLR2F;POLR2C
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.2737220691140453,-0.5301014430763108,0.9714285714285714,1.0,1.0,2/18,10.80%,CDK1;TFDP1
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.31306199716043526,0.5297625176052573,0.9672131147540983,1.0,1.0,9/9,68.71%,DLGAP5;CENPA;MIS12;CENPT;POGZ;CENPC;CENPW;CENPF;CENPE
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.31511771423750146,-0.5293153914746279,0.9459459459459459,1.0,1.0,2/7,20.56%,CARD9;IL23A
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),-0.33184735793390385,-0.5282794792319325,0.9795918367346939,1.0,1.0,2/5,15.60%,RIPK2;IRGM
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.2922744275746235,0.5281355132143425,1.0,1.0,1.0,2/20,19.61%,SLC38A2;SLC1A6
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,0.28807393577325147,0.5279641437080418,0.9864864864864865,1.0,1.0,3/22,14.35%,CP;SLC39A7;SLC30A2
prerank,GO_Biological_Process_2021__regulation of glycogen (starch) synthase activity (GO:2000465),-0.3470710703132393,-0.5279562860084727,1.0,1.0,1.0,5/5,65.31%,INPP5K;GSK3B;EPM2AIP1;PPP1R3F;GSK3A
prerank,KEGG_2021_Human__Mismatch repair,-0.25899497982137293,-0.5277298192706693,1.0,1.0,1.0,2/22,6.63%,EXO1;POLD3
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.30097829428242484,0.5260348908943933,0.9666666666666667,1.0,1.0,3/11,19.77%,SOX9;ENG;HEY1
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.22802904090212334,-0.5259611428411909,1.0,1.0,1.0,7/51,15.78%,ERCC8;GTF2H2;COPS8;ERCC2;POLR2F;POLR2C;ISY1-RAB43
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),-0.297605527162597,-0.5257716347360537,0.967741935483871,1.0,1.0,7/7,70.25%,SLC39A8;SLC39A4;SLC39A10;SLC39A14;SLC39A5;SLC39A12;SLC39A6
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.32656846164112247,0.5257176227195482,0.9726027397260274,1.0,1.0,2/8,32.05%,FIS1;PEX11A
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.26894780429477394,0.524687919517108,0.9859154929577465,1.0,1.0,10/30,34.24%,MSN;VAV3;RIN3;VAV1;NEB;PEX11A;LAMTOR5;PICALM;RAC1;EZR
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,0.26978217932650794,0.5243746573745119,1.0,1.0,1.0,5/24,24.63%,STAT5A;PIK3CG;EPX;VAV1;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.25988681019853266,0.5240692754660655,0.9863013698630136,1.0,1.0,9/28,30.33%,NOP53;RPL11;BAG5;WAC;PARK7;HSP90AB1;UBXN1;UCHL5;CAMLG
prerank,CellMarker_Augmented_2021__Large Granular lymphocyte:Peripheral Blood,0.24361859917699122,0.5234248781486049,1.0,1.0,1.0,15/85,22.67%,ATP6V1G2;NAT8L;PHF21B;FAM171A2;B4GAT1;ZCCHC18;CRISPLD1;ZMYM3;CAMKV;EFNB3;CCDC106;DLG4;FADS2;DCTN1;PIANP
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.3461331103256639,0.5223165042623301,0.9672131147540983,1.0,1.0,3/6,32.00%,PAICS;SHMT2;PRPS1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.23631618919384084,-0.5219941537540048,0.9696969696969697,1.0,1.0,4/24,17.38%,GTF2H2;XPC;ERCC2;ERCC1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.2582044902518348,0.5219597124799907,1.0,1.0,1.0,3/33,10.73%,GLRA2;RRAGA;GLRA1
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.3147102816020735,-0.5219404345867809,0.9393939393939394,1.0,1.0,2/5,16.70%,OGDH;SUCLA2
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.3147751095008601,0.5217842714522257,1.0,1.0,1.0,2/14,11.19%,DUOX1;STAT1
prerank,Reactome_2022__Nef And Signal Transduction R-HSA-164944,-0.2932901838261135,-0.5215060955612818,1.0,1.0,1.0,3/8,18.57%,CD247;FYN;ELMO1
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.3074221221724251,0.5214379323608586,0.9841269841269841,1.0,1.0,1/14,7.38%,SRSF9
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.31980627045953347,-0.5213252718501025,0.9459459459459459,1.0,1.0,2/9,15.55%,NR1H2;ABCG1
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.32173130317922555,0.5207977129970085,0.9701492537313433,1.0,1.0,2/8,17.53%,SNAI1;DKKL1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3025682729688791,0.5203170401300873,0.9701492537313433,1.0,1.0,4/12,23.99%,MPDU1;ALG6;ALG2;DPAGT1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.24920385222710698,0.5193107777396813,1.0,1.0,1.0,16/46,32.75%,ID1;NPR3;PGAM5;FIS1;ARRDC3;IL18R1;DDIT3;LNPEP;ACTN3;ADAMTS5;ZDHHC7;PLCL1;IL15;ACVR2B;STK11;ZNF423
prerank,Reactome_2022__MAPK3 (ERK1) Activation R-HSA-110056,0.29752881460770303,0.518947641996907,0.9696969696969697,1.0,1.0,2/9,19.63%,MAPK3;MAP2K1
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.3552569319579823,0.5188874321055956,0.9433962264150944,1.0,1.0,5/5,64.48%,CAMK1;CTNNA2;FRMPD4;SHANK3;CAMK2B
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.34812531813914704,0.5188284468856078,0.9538461538461539,1.0,1.0,1/5,13.99%,SOX9
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.26630003520016626,-0.5184468084195168,1.0,1.0,1.0,2/26,7.88%,ITPR2;NFATC3
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),-0.30301029941073954,-0.5178624149613599,0.9722222222222222,1.0,1.0,5/9,34.17%,BAG6;CREBBP;KAT7;EP300;KAT2A
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3076936846112855,0.5177532118806152,1.0,1.0,1.0,1/13,7.38%,SRSF9
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.24264084814670434,0.51760044800026,1.0,1.0,1.0,7/46,24.15%,SNAP23;RAB11A;RHOQ;YWHAH;YWHAG;LNPEP;PRKAB2
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.23350504957718338,0.5171536452032147,1.0,1.0,1.0,7/70,18.57%,POLD4;RPA3;RPS27A;COPS4;GPS1;COPS5;RBX1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.29116187895012857,0.5166867632536449,0.9848484848484849,1.0,1.0,6/14,29.28%,MDM1;BRCA1;CEP76;C10ORF90;KAT2B;TRIM37
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.2157438544972292,-0.5150578991522344,1.0,1.0,1.0,26/26,78.46%,DLL1;SGIP1;SNAP91;CLTA;ITSN1;DNAJC6;GPR107;ITSN2;FCHSD2;AP2A2;CLTB;FNBP1L;AP2A1;GAK;CLTC;PIP5K1C;LMBRD1;AP2B1;FCHO2;AP2M1;AP2S1;PICALM;INPP5F;FCHO1;CANX;SIGLEC1
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.21696803422318978,-0.5148184728755651,1.0,1.0,1.0,13/75,18.82%,IWS1;TAF12;GTF2H2;GTF2E2;RTF1;ERCC2;SSRP1;POLR2F;LEO1;POLR2C;ELOA;TAF11;CCNT1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.193264997381355,-0.5147389777949904,1.0,1.0,1.0,15/114,17.11%,RASSF9;MAN1A1;MGARP;ZDHHC23;PARD3;ZDHHC11B;ZDHHC14;TAOK2;ZDHHC18;SDCBP;AP4S1;ZDHHC3;TIMM23;TIMM44;RTP1
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.22271827828405816,-0.5145075068388327,1.0,1.0,1.0,7/37,22.76%,FBXO4;WRAP53;HDAC3;FKBP9;XRN2;FBXW4;KIFC3
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.3208612103903383,-0.5144753029740933,0.95,1.0,1.0,1/7,9.16%,FSCN1
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),0.3186262844057539,0.5144391319398058,0.9298245614035088,1.0,1.0,1/5,18.34%,NUDT15
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.31250287230972695,0.5140066653718128,0.9827586206896551,1.0,1.0,2/8,16.50%,JAM2;MSN
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.24406796283807417,0.5138088718296038,1.0,1.0,1.0,6/57,13.99%,CDKN2A;LEF1;CCND1;CDKN1A;CSF1R;SOX9
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.3209810105832872,0.5133647381660655,0.9558823529411765,1.0,1.0,5/8,43.40%,PPP2R3C;CAMLG;TNFRSF13B;MEF2C;LYN
prerank,Reactome_2022__Displacement Of DNA Glycosylase By APEX1 R-HSA-110357,0.30378423374371744,0.5133507882628183,0.9591836734693877,1.0,1.0,3/8,32.51%,TDG;OGG1;UNG
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,0.26543900733620496,0.5132848000301766,1.0,1.0,1.0,1/26,5.97%,PLD4
prerank,Reactome_2022__Constitutive Signaling By EGFRvIII R-HSA-5637810,-0.27531360946745564,-0.5132011515893571,0.9696969696969697,1.0,1.0,14/14,72.49%,HRAS;CBL;PIGU;PIK3CA;SOS1;HSP90AA1;SHC1;PLCG1;PIK3R1;CDC37;GRB2;NRAS;EGFR;EGF
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.2992833758927779,0.512794304276545,0.9710144927536232,1.0,1.0,3/15,18.31%,CHRNB1;CHRNB2;CHRNA3
prerank,Reactome_2022__Pregnenolone Biosynthesis R-HSA-196108,-0.32285066982676924,-0.5126034294777033,0.9,1.0,1.0,3/10,22.34%,STARD3NL;CD163L1;STARD3
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,-0.2675233485359562,-0.5124299165083964,0.9310344827586207,1.0,1.0,3/20,19.41%,TGFA;HRAS;BTC
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),-0.29891638669379644,-0.5115376754535962,0.9148936170212766,1.0,1.0,6/6,70.12%,DRD2;SLC8A1;DRD3;ATP2B1;SMAD3;ATP1A2
prerank,Reactome_2022__Synthesis Of Wybutosine At G37 Of tRNA(Phe) R-HSA-6782861,0.35582473738998766,0.511347718175024,0.9666666666666667,1.0,1.0,5/5,64.43%,TRMT5;TYW3;TYW1;TYW5;LCMT2
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.23877688960260635,0.5113362881728175,1.0,1.0,1.0,9/53,23.97%,ATG101;RAB19;TMEM41B;GABARAPL2;ATP2A2;ULK1;GABARAPL1;STX17;EMC6
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.32391744936721234,0.5105991541693953,0.9833333333333333,1.0,1.0,2/5,27.94%,RNF20;CDK9
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.29780846171588193,-0.5100307926440834,0.9767441860465116,1.0,1.0,3/8,26.15%,EIF2AK3;TMCO1;ATG10
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,-0.24518207472501402,-0.5100116779487883,1.0,1.0,1.0,1/32,2.01%,CSK
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.26939549665347534,0.50935502810542,1.0,1.0,1.0,5/18,25.18%,ATP6V0E2;PPT1;ATP6AP2;ATP6V0D1;GRN
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.2267730620218273,-0.509278403196226,1.0,1.0,1.0,6/38,12.16%,E2F6;RRM2;TFDP1;PCGF6;DAB2IP;RING1
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.2963825274857702,-0.5084188139371147,0.9411764705882353,1.0,1.0,4/10,19.91%,RPUSD1;GAR1;RPUSD4;NHP2
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.2827422957310976,-0.5084050256889635,0.972972972972973,1.0,1.0,2/10,11.11%,PTGS1;AKR1C3
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,0.2277865719366441,0.5080129653076692,1.0,1.0,1.0,4/58,15.19%,ERBB4;GRIN2D;RASGRF2;MAPK3
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.2644956690490841,-0.5077609501901181,1.0,1.0,1.0,12/12,73.57%,ATM;NBR1;PIK3R4;PJVK;PIK3C3;TRAPPC8;SQSTM1;USP30;RB1CC1;MAP1LC3B;PEX5;ACBD5
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.2815147928994083,0.5075374538121263,0.9852941176470589,1.0,1.0,14/14,71.87%,CD74;RAC1;C1QBP;MOSPD2;MDK;TIRAP;NCKAP1L;DNM1L;RIPOR2;RAC2;CAMK1D;MCU;THBS4;DAPK2
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.21742783730330043,-0.5073371810022554,1.0,1.0,1.0,8/42,22.68%,KHSRP;NANOS3;AGO2;TNRC6C;TNRC6A;RBM24;YTHDF1;DHX36
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.2999952310002135,-0.5071744615215782,0.9166666666666666,1.0,1.0,2/10,12.07%,SPTBN4;RNLS
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.2836386009749633,-0.5071502295955502,1.0,1.0,1.0,10/10,71.65%,CDC14B;GOLGA2;PLK1;GORASP1;FZR1;BTRC;PTEN;SKP1;UBE2S;RAB1A
prerank,Reactome_2022__Condensation Of Prometaphase Chromosomes R-HSA-2514853,0.30626746027704205,0.5070553019930845,0.9672131147540983,1.0,1.0,5/9,30.47%,NCAPG;CCNB1;NCAPH;CSNK2A2;RAB33B
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.24561484674942918,-0.5069707320839376,1.0,1.0,1.0,3/18,16.27%,PTPRR;FGFR2;ARNT2
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.317717206132879,-0.506887751369315,0.9444444444444444,1.0,1.0,7/7,68.24%,KDM5A;PRKD2;C6ORF89;SPHK2;PRKD1;CAMK2D;VEGFA
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.26685911693720127,-0.5068687426865749,1.0,1.0,1.0,8/8,73.33%,DNM2;SNAP91;DNM1;AP3D1;DNM3;MX2;PICALM;MX1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.2738670148793155,0.5068495189428434,0.9714285714285714,1.0,1.0,1/17,7.66%,IGF1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.22632750698687887,-0.5063676681951143,1.0,1.0,1.0,28/28,77.40%,POLR3K;ICE1;BRF1;SNAPC3;ZNF345;GTF3C5;GTF3C2;ICE2;SNAPC2;GTF3C4;POLR3G;SNAPC4;GTF3C1;GTF3C3;ZC3H8;CRCP;RO60;ELL;TBP;GTF3A;POLR2L;POLR3H;GTF3C6;POLR2K;IVNS1ABP;SNAPC1;POLR3GL;SNAPC5
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.28193655271811413,-0.5063478119503045,0.9777777777777777,1.0,1.0,2/8,22.70%,DNM2;MIEF2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.28193655271811413,-0.5063478119503045,0.9777777777777777,1.0,1.0,2/8,22.70%,DNM2;MIEF2
prerank,Reactome_2022__AMPK Inhibits chREBP Transcriptional Activity R-HSA-163680,-0.30219831052552565,-0.5062537265936567,0.9361702127659575,1.0,1.0,4/7,32.48%,ADIPOR1;PRKAG2;PRKAA2;MLXIPL
prerank,Reactome_2022__BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.24732455724973956,-0.5060726305204064,1.0,1.0,1.0,21/21,75.30%,BBS12;BBS10;BBS9;BBS4;BBIP1;ARL6;CCT5;MKKS;TCP1;TTC8;MCHR1;SSTR3;CCT4;SMOX;BBS2;BBS7;CCT2;LZTFL1;CCT3;CCT8;RAB3IP
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.25977937211926266,-0.5060084609295319,0.9714285714285714,1.0,1.0,2/11,19.16%,TBCCD1;HOOK3
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,0.2375943687096631,0.5059801989081418,1.0,1.0,1.0,9/39,25.48%,DAND5;SCD;FDFT1;PKMYT1;NFYB;SQLE;HMGCR;HMGCS1;FASN
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.3024140670102873,0.5056131935592207,1.0,1.0,1.0,1/11,12.80%,DEGS2
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.27283560502841836,-0.5054793152898032,0.9761904761904762,1.0,1.0,2/10,12.30%,PLA2G5;FGFR2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.31063412897762693,0.5051521376919105,0.984375,1.0,1.0,1/8,14.41%,IL4
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.26470654147727185,-0.5048188617637077,0.9285714285714286,1.0,1.0,6/15,23.47%,AMPD3;GART;LHPP;IMPDH1;NUDT2;ATIC
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),-0.3143766509758513,-0.504713078165724,0.9512195121951219,1.0,1.0,1/5,13.41%,LPL
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.3107384033092451,0.5041558381045459,0.9814814814814815,1.0,1.0,2/6,26.65%,MAPK3;RNF213
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.2434965822366239,0.5040711221119814,1.0,1.0,1.0,6/42,17.73%,NPR2;ADCY7;NPPA;GUCY2F;ADSS1;IMPDH2
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.24774361774303574,0.5032748739450398,1.0,1.0,1.0,7/38,24.61%,TAF5;LEF1;TAF6L;TAF10;POLE3;BRCA2;SPI1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.2857442244032843,0.5026831916387248,0.9682539682539683,1.0,1.0,1/13,11.03%,AHNAK2
prerank,Reactome_2022__Zinc Efflux And Compartmentalization By SLC30 Family R-HSA-435368,-0.2861489451325618,-0.5023445666730556,0.95,1.0,1.0,2/7,17.47%,SLC30A5;SLC30A8
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.26513483013080946,0.5021014432153906,0.9857142857142858,1.0,1.0,2/17,14.95%,NLRC3;FTH1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.31282266617378024,-0.5018248478175759,0.9333333333333333,1.0,1.0,2/5,15.27%,PKD2;COL4A1
prerank,Reactome_2022__MET Activates RAS Signaling R-HSA-8851805,-0.26535731187884526,-0.5008725275915772,0.9761904761904762,1.0,1.0,9/9,73.48%,HRAS;RANBP10;SOS1;SHC1;GRB2;MUC20;NRAS;RNMT;RANBP9
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.2932524048394137,0.49999036991147416,0.967741935483871,1.0,1.0,2/9,22.88%,ACOT4;CRAT
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.27555088866501143,0.4996505216321635,1.0,1.0,1.0,6/12,30.88%,PLA2G4A;CD74;PTGES;PTGS2;TBXAS1;PNPLA8
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.2551567836586754,0.4996259695227311,1.0,1.0,1.0,2/28,13.17%,RAB11A;CHMP3
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.20801113472829963,-0.49909350493195215,1.0,1.0,1.0,13/59,24.24%,CTCF;RARB;CNOT9;HDAC3;H2AJ;POLR2F;POLR2C;MAFB;NCOA3;JUN;CREBBP;ZNF335;YY1
prerank,KEGG_2021_Human__Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,0.2513642885476356,0.4985426345262226,1.0,1.0,1.0,5/23,26.33%,PIGH;PIGC;PIGB;GPAA1;MPPE1
prerank,KEGG_2021_Human__Long-term potentiation,0.23124021144094872,0.49844698204178073,1.0,1.0,1.0,8/59,25.49%,PPP1R1A;GRIN2D;MAPK3;MAP2K1;GRIN2C;KRAS;PLCB4;RPS6KA1
prerank,Reactome_2022__Adenylate Cyclase Activating Pathway R-HSA-170660,-0.294159293458818,-0.49833264061683374,0.9666666666666667,1.0,1.0,2/8,17.00%,ADCY2;ADCY6
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.29888868325470946,0.49758262542038484,1.0,1.0,1.0,1/9,12.58%,RECQL4
prerank,Reactome_2022__RHO GTPases Activate KTN1 R-HSA-5625970,0.3073144942677186,0.49755283758815494,0.967741935483871,1.0,1.0,1/10,13.69%,RHOG
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2838917551985186,0.4974637077365484,0.9866666666666667,1.0,1.0,4/19,20.68%,ADSS1;PAICS;IMPDH2;GMPR2
prerank,Reactome_2022__Muscarinic Acetylcholine Receptors R-HSA-390648,0.3316182251133614,0.4968455997812744,1.0,1.0,1.0,1/5,20.65%,CHRM5
prerank,Reactome_2022__Reactions Specific To Complex N-glycan Synthesis Pathway R-HSA-975578,-0.2652677818511181,-0.4967980250042764,0.9795918367346939,1.0,1.0,2/8,17.05%,CHST8;FUCA1
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.3094556854330076,0.49557867306504494,1.0,1.0,1.0,5/11,27.48%,CDKN2A;MME;ROMO1;CHEK1;CHEK2
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.29872243406654614,0.49523184526447284,0.9636363636363636,1.0,1.0,3/6,33.36%,ATP2A2;CALM1;AHCYL1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.2491534786538379,0.4952199585622845,1.0,1.0,1.0,3/36,13.48%,DDX20;GEMIN4;SNRPD2
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.31546083478426834,0.4950565777721765,0.9833333333333333,1.0,1.0,1/9,9.22%,PINK1
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.217199262257095,-0.4949469841027467,1.0,1.0,1.0,11/31,23.25%,FGF1;HSF1;TCIM;TRPV1;HTRA2;YWHAE;MAPT;TRPV4;HSPA1A;DHX36;TPR
prerank,Reactome_2022__Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658,-0.26495246305383524,-0.4946572336369351,1.0,1.0,1.0,2/14,12.14%,CDK1;BLZF1
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.345355369265588,0.4941810032757655,0.9682539682539683,1.0,1.0,1/5,26.95%,FAM91A1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.22903546569439842,-0.49311039595199,1.0,1.0,1.0,20/20,77.12%,SLIT2;DAPK2;BST1;THBS4;MCU;CAMK1D;RAC2;RIPOR2;DNM1L;JAM3;NCKAP1L;TIRAP;MDK;MOSPD2;C1QBP;MPP1;C5AR2;RAC1;DPP4;CD74
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.30037466444036487,0.4929758254412679,0.9701492537313433,1.0,1.0,2/11,20.38%,NPPA;SPX
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.2740453757029763,0.4926735782752875,1.0,1.0,1.0,3/22,24.19%,SLC24A1;CBLN1;SLC30A1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),0.33850667171382604,0.49252723698182865,0.9661016949152542,1.0,1.0,5/5,66.16%,NRARP;SEMA5A;ITGB1BP1;BMPER;BMP4
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3037760746260961,0.4925245044317655,0.9696969696969697,1.0,1.0,1/7,16.95%,PARP14
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),0.32303863908068026,0.4921894450499517,1.0,1.0,1.0,3/6,29.85%,NOS2;ARG1;OAT
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.2593731577831183,0.4911199612014462,1.0,1.0,1.0,2/18,13.21%,DAB2;THBS1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.2593731577831183,0.4911199612014462,1.0,1.0,1.0,2/18,13.21%,DAB2;THBS1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.2765514094493201,-0.49107295984425653,0.972972972972973,1.0,1.0,2/12,10.39%,APOE;MYOCD
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.2863361815714223,0.490586067626984,0.9661016949152542,1.0,1.0,6/10,32.36%,CCT7;CCT8;CCT3;CCT6A;CCT2;DKC1
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.27557230999604854,0.4899858315644415,1.0,1.0,1.0,1/18,7.66%,IGF1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.2652894835318475,-0.48998432322579455,0.9642857142857143,1.0,1.0,4/13,22.75%,GRM2;GABBR2;DRD2;PALM
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.23402756129413155,-0.48973892771105504,1.0,1.0,1.0,8/25,25.32%,RAD50;NBN;RTEL1;ERCC1;PML;SMG5;DHX36;SMG6
prerank,Reactome_2022__RHOBTB3 ATPase Cycle R-HSA-9706019,-0.2968906274974238,-0.4894163585240149,0.972972972972973,1.0,1.0,2/9,23.01%,VHL;LRRC41
prerank,Reactome_2022__Vitamin C (Ascorbate) Metabolism R-HSA-196836,0.28781050212583476,0.4893920472204103,0.9841269841269841,1.0,1.0,1/7,17.22%,SLC23A1
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,0.23452590616853802,0.4881121984971021,0.9861111111111112,1.0,1.0,5/40,20.57%,H2BC4;H2AZ1;TAF1A;POLR1E;H2AZ2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.26535777906640545,0.4879503568386356,1.0,1.0,1.0,1/19,7.66%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.3130312774179361,0.48761949702983753,0.9629629629629629,1.0,1.0,3/6,31.04%,TMBIM1;IL15;IL18
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.3082808660542975,0.4869238663296947,0.9696969696969697,1.0,1.0,1/5,16.78%,SLC6A12
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),-0.31768713920696506,-0.4869195134339975,0.9,1.0,1.0,5/5,68.24%,ADD1;PTPN23;BMP6;RDX;VEGFA
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.3064566400053876,0.4867802154642049,0.9850746268656716,1.0,1.0,2/10,20.84%,P2RY12;RYR3
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),-0.30172318511535456,-0.4867550503295687,0.9411764705882353,1.0,1.0,1/5,17.13%,ITPA
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.27606811844416057,0.4865665688193104,1.0,1.0,1.0,2/17,15.26%,EIF6;EXOSC4
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.26983333480615995,-0.48632073372132734,1.0,1.0,1.0,3/12,18.32%,PGLS;G6PD;PGM2
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.23398789942157086,0.4861885548846256,1.0,1.0,1.0,4/38,18.26%,RRAGA;GPR137B;WDR24;LAMTOR3
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.23521611711038884,-0.4857772816026605,1.0,1.0,1.0,9/27,24.99%,CCDC22;NUPR1;DAB2IP;OSBPL7;KCNE2;CTSC;AXIN1;PRKN;LAPTM5
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.20727185436495124,-0.4853362824153885,1.0,1.0,1.0,7/27,25.92%,UBE2E3;CDC34;UBE2D2;UBE2E1;UBE2L3;UBE2B;UBE2A
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.26684648873745975,-0.4852268250011651,1.0,1.0,1.0,7/7,73.33%,DNM2;SNAP91;DNM1;DNM3;MX2;PICALM;MX1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),-0.271627187394232,-0.4851014964360332,1.0,1.0,1.0,5/10,27.45%,ATP9A;EIPR1;RAB11B;SORL1;ACTN2
prerank,KEGG_2021_Human__Steroid biosynthesis,0.2630383259053539,0.4847820157427392,0.9833333333333333,1.0,1.0,6/17,30.09%,FDFT1;CYP24A1;MSMO1;SQLE;CYP2R1;DHCR24
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.23858036239311206,-0.4844523738064116,1.0,1.0,1.0,3/24,14.85%,CREB3L1;NR1H2;TXNDC12
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.28428761277989534,-0.4844335196323614,0.9512195121951219,1.0,1.0,3/6,34.60%,NUTF2;PLK1;INTS13
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.22090567823568916,-0.48412936957045044,1.0,1.0,1.0,6/28,23.11%,DPM3;PGAP1;PIGQ;PIGW;PGAP3;PIGO
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.3133334661189996,0.4832707579490456,0.9322033898305084,1.0,1.0,1/5,16.34%,HTR2B
prerank,Reactome_2022__Sensing Of DNA Double Strand Breaks R-HSA-5693548,-0.29996404769106944,-0.4816430759359773,0.975609756097561,1.0,1.0,1/6,7.56%,RAD50
prerank,Reactome_2022__Activation Of AMPK Downstream Of NMDARs R-HSA-9619483,-0.2810868944193281,-0.4815164605680832,0.9767441860465116,1.0,1.0,3/8,27.05%,PRKAG2;MAPT;PRKAA2
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.3148714424997075,0.4810526144029595,0.9692307692307692,1.0,1.0,1/7,16.88%,PAICS
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),-0.2776718839724703,-0.48072581612500515,0.9615384615384616,1.0,1.0,2/6,24.53%,NOTCH1;LRP6
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.25576284909620267,0.479746824773857,0.9852941176470589,1.0,1.0,3/18,19.56%,LRPAP1;RIN3;DLG4
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.24717549776502373,-0.4786426694629687,0.967741935483871,1.0,1.0,4/16,20.06%,ATR;HSF1;HRAS;ATM
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.23727354876388537,0.47803990559183546,1.0,1.0,1.0,9/37,28.09%,DUX4;BMI1;BRCA1;APAF1;RBBP7;CHEK1;EED;SUZ12;FOXO4
prerank,GO_Biological_Process_2021__myeloid dendritic cell differentiation (GO:0043011),0.3080989269029131,0.4778753073293413,0.9642857142857143,1.0,1.0,2/6,22.42%,IL4;DCSTAMP
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,0.2533639631388208,0.4777402293840981,1.0,1.0,1.0,6/19,25.48%,PARP14;PARP4;PARP9;PARP10;PARP8;PTGS2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.2973310334472907,0.4771654823684888,0.9833333333333333,1.0,1.0,2/9,23.30%,GABARAPL2;GABARAPL1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.2973310334472907,0.4771654823684888,0.9833333333333333,1.0,1.0,2/9,23.30%,GABARAPL2;GABARAPL1
prerank,Reactome_2022__WNT Mediated Activation Of DVL R-HSA-201688,-0.2925346459469946,-0.47709216521974457,0.9743589743589743,1.0,1.0,1/5,15.00%,CSNK1E
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.23889215817912324,0.476450491526101,1.0,1.0,1.0,11/44,27.60%,TIMM22;ATP5PF;ATP5F1E;ATP5MC3;TIMM10;ROMO1;ATP5ME;MTX3;TIMM13;MTX2;TMEM11
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.2759047732734659,-0.4761248739696577,1.0,1.0,1.0,3/7,28.88%,SLC6A6;SLC6A13;RIPK1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.26577325535980273,0.4758874463831192,1.0,1.0,1.0,2/15,14.32%,PRRC1;ADCY7
prerank,Reactome_2022__APC Truncation Mutants Have Impaired AXIN Binding R-HSA-5467337,0.27594673649022,0.47587417679690136,1.0,1.0,1.0,1/13,11.35%,PPP2R5A
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Undefined,0.26673377324238784,0.4751843012915205,0.9846153846153847,1.0,1.0,1/11,12.25%,EPCAM
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.29099833084715493,0.47451683127378247,1.0,1.0,1.0,2/7,26.65%,MAPK3;RNF213
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.28805295613745197,0.4741798457112548,0.9682539682539683,1.0,1.0,3/7,28.17%,TFIP11;KLC1;ZFAND1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.2862165603757252,-0.4734485004638324,0.9714285714285714,1.0,1.0,2/7,19.25%,MSH3;XRCC4
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.31768713920696506,-0.4733264261108193,0.9166666666666666,1.0,1.0,5/5,68.24%,DSCAM;MEGF8;NRP1;SEMA5A;VEGFA
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.32805061370905675,0.47328106671973397,1.0,1.0,1.0,1/5,14.49%,CARMIL1
prerank,Reactome_2022__SARS-CoV-2 Targets Host Intracellular Signaling And Regulatory Pathways R-HSA-9755779,-0.25787387285292673,-0.4732292383518518,1.0,1.0,1.0,3/12,20.46%,YWHAQ;AKT2;YWHAE
prerank,GO_Biological_Process_2021__delamination (GO:0060232),0.30704738564480905,0.4729507789456021,0.9821428571428571,1.0,1.0,2/6,24.61%,ABCA12;SPI1
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),-0.2965001558439777,-0.4723709120843704,0.9714285714285714,1.0,1.0,2/5,23.83%,IRGM;ATG7
prerank,Reactome_2022__Defective CHST3 Causes SEDCJD R-HSA-3595172,0.2872887015417971,0.47214341388639064,1.0,1.0,1.0,4/8,28.26%,DCN;BCAN;BGN;CSPG4
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.20993622852438748,-0.4721214100308866,1.0,1.0,1.0,8/35,21.33%,QRICH2;BAG6;SDCBP;FHIT;HFE;GIPC1;N4BP1;PML
prerank,Reactome_2022__TNFR1-induced Proapoptotic Signaling R-HSA-5357786,-0.262619102745783,-0.47164175446519174,1.0,1.0,1.0,1/11,6.87%,USP4
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.3267887794440574,0.47134246078700964,0.9791666666666666,1.0,1.0,1/5,22.69%,LTN1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),-0.30941303258716724,-0.47118456437544703,1.0,1.0,1.0,2/5,29.80%,ATP8A2;ATP11B
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.27546259123432076,-0.47046131069071423,1.0,1.0,1.0,2/8,19.02%,BDH1;HMGCL
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.2871406789750026,0.4703749527002478,1.0,1.0,1.0,1/8,16.35%,ENG
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.31130093644181356,0.47027908932828744,1.0,1.0,1.0,1/7,23.80%,PEX12
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.2625279120410644,-0.4700208765211896,1.0,1.0,1.0,2/9,19.02%,BDH1;HMGCL
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.22181560269471565,0.4698492504627945,1.0,1.0,1.0,8/51,23.97%,ATG101;RAB19;TMEM41B;GABARAPL2;ATP2A2;ULK1;GABARAPL1;EMC6
prerank,Reactome_2022__Zinc Transporters R-HSA-435354,0.2625303080648983,0.46966795671442646,0.9873417721518988,1.0,1.0,2/14,14.35%,SLC39A7;SLC30A2
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),-0.266821235923157,-0.46883563902674036,0.9803921568627451,1.0,1.0,5/5,73.33%,DNM2;DNM1;DNM3;MX2;MX1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),-0.266821235923157,-0.46883563902674036,0.9803921568627451,1.0,1.0,5/5,73.33%,DNM2;DNM1;DNM3;MX2;MX1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.25997444270907283,-0.46876433121700556,1.0,1.0,1.0,10/10,74.02%,XPO5;STAT3;WTIP;LIMD1;PUM2;FMR1;DHX9;PUM1;ZFP36;FXR1
prerank,CellMarker_Augmented_2021__Lung Epithelial cell:Lung,-0.2969289736431174,-0.46850106546889386,1.0,1.0,1.0,6/6,70.32%,ABCA3;LPCAT1;NAPSA;SFTPC;SFTPB;SLC34A2
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.22882205886823298,0.46809656085798745,1.0,1.0,1.0,8/41,24.08%,ID1;NPR3;PGAM5;ARRDC3;IL18R1;DDIT3;LNPEP;ACTN3
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.23433619787190804,-0.46731135419505093,1.0,1.0,1.0,8/21,27.37%,NAMPT;RNLS;NAXE;PTGIS;PARP16;SLC5A8;NMNAT3;NMNAT1
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.2564439481596751,0.46656118701573923,0.9836065573770492,1.0,1.0,4/20,19.64%,WBP2;MAPK3;BRCA1;RPS6KA5
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.30900108157503436,0.46626230278240877,1.0,1.0,1.0,1/8,23.80%,PEX12
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.25178354122747026,0.4658917034084037,1.0,1.0,1.0,4/16,23.99%,MPDU1;ALG6;ALG2;DPAGT1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.2669451133309564,0.46555490340512445,1.0,1.0,1.0,2/13,22.23%,ULK1;UBA5
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.29563294722890165,-0.4645277944313119,1.0,1.0,1.0,2/5,22.69%,AUTS2;TMEM108
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.28385539459193565,0.46424651218836516,0.9833333333333333,1.0,1.0,3/9,26.90%,ETFB;ACADL;GCDH
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.2381808541471389,0.46414452518707977,1.0,1.0,1.0,1/27,7.66%,IGF1
prerank,Reactome_2022__Netrin Mediated Repulsion Signals R-HSA-418886,-0.252614641995173,-0.4638458235257737,0.9714285714285714,1.0,1.0,8/8,74.75%,SRC;UNC5D;DCC;UNC5A;UNC5C;UNC5B;PTPN11;NTN1
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),-0.25944726328898415,-0.4630428793198915,1.0,1.0,1.0,5/9,34.95%,TOP1MT;HMGB1;TOP3B;ERCC3;TOP3A
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.2626496899701803,0.46245673855632907,1.0,1.0,1.0,12/12,73.75%,ESPL1;DLGAP5;CDC27;ANAPC5;CUL3;NSMCE2;CDC23;ANAPC11;RB1;CDC16;ANAPC4;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.2626496899701803,0.46245673855632907,1.0,1.0,1.0,12/12,73.75%,ESPL1;DLGAP5;CDC27;ANAPC5;CUL3;NSMCE2;CDC23;ANAPC11;RB1;CDC16;ANAPC4;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.2626496899701803,0.46245673855632907,1.0,1.0,1.0,12/12,73.75%,ESPL1;DLGAP5;CDC27;ANAPC5;CUL3;NSMCE2;CDC23;ANAPC11;RB1;CDC16;ANAPC4;ANAPC7
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,0.2466779174175637,0.46186700188068014,1.0,1.0,1.0,1/17,11.00%,RPS27A
prerank,Reactome_2022__PECAM1 Interactions R-HSA-210990,-0.239871260886028,-0.4617160142210947,1.0,1.0,1.0,11/11,76.03%,FYN;SRC;LCK;PECAM1;PLCG1;LYN;PTPN11;YES1;ITGAV;PTPN6;INPP5D
prerank,Reactome_2022__Estrogen-stimulated Signaling Thru PRKCZ R-HSA-9634635,-0.30013248793413455,-0.4588165448422181,0.9795918367346939,1.0,1.0,5/5,70.00%,HRAS;NRAS;PRKCZ;MAPK1;PDPK1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.23744385561398712,0.4584707150826317,1.0,1.0,1.0,8/25,29.98%,RPL11;RPS7;GABARAPL2;RPL23;HSP90AB1;EFNA1;CSNK2A2;RPL5
prerank,Reactome_2022__Ca2+ Activated K+ Channels R-HSA-1296052,0.2847842914651879,0.4583961392666569,1.0,1.0,1.0,4/8,35.69%,KCNMB1;KCNMB4;KCNMB3;KCNN1
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.2824609951427941,0.4579186152746251,0.9850746268656716,1.0,1.0,3/11,24.70%,M1AP;MTA2;CHAF1A
prerank,Reactome_2022__Uptake And Function Of Anthrax Toxins R-HSA-5210891,-0.23784617610308667,-0.4573459373228998,1.0,1.0,1.0,2/11,18.89%,ANTXR1;MAP2K7
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.2995937010852643,0.45700390731014384,0.9655172413793104,1.0,1.0,1/7,19.91%,ORAI1
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,0.23463729679958162,0.4556035080892254,1.0,1.0,1.0,3/26,17.02%,ATP5PF;ATP5F1E;ATP5MC3
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.2538380833217262,0.4554657448327415,0.9850746268656716,1.0,1.0,2/18,16.83%,SRSF9;RPS13
prerank,GO_Biological_Process_2021__regulation of growth rate (GO:0040009),-0.30101769975946135,-0.4531959442511288,0.96,1.0,1.0,3/5,24.37%,BNIPL;NOTCH1;RFTN1
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.28915152390310805,0.4521422799311763,0.9830508474576272,1.0,1.0,3/9,32.29%,AGER;EFNA1;PICALM
prerank,Reactome_2022__Activation Of PPARGC1A (PGC-1alpha) By Phosphorylation R-HSA-2151209,-0.24154086413326392,-0.45137614946921595,1.0,1.0,1.0,8/8,75.86%,MAPK12;PRKAG2;PRKAA2;MAPK11;MAPK14;PRKAB1;PPARGC1A;PRKAB2
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.2513957328980165,0.45020209556893825,0.9855072463768116,1.0,1.0,2/13,26.28%,TMEM33;REEP4
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.27675486344488104,0.44951120271804795,1.0,1.0,1.0,12/12,72.34%,DDX6;LSM3;LSM4;PATL2;EDC3;LIMD1;EIF4ENIF1;DYNC1H1;LSM14A;PATL1;RC3H1;ATXN2
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.24082927060159987,-0.44796134205205473,0.9772727272727273,1.0,1.0,12/12,75.94%,ABCG1;ABCA1;ARV1;OSBPL2;SERAC1;OSBP;RELCH;NPC1;NPC2;STARD4;VPS4A;STAR
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.18252912648707215,-0.4477400485482563,1.0,1.0,1.0,10/67,21.13%,TUBA8;CDK1;SPAST;EMD;LMNB1;NUP37;NUP98;TUBA4B;VRK2;SEH1L
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.27811784931038797,0.4450488865267371,0.9622641509433962,1.0,1.0,3/12,26.84%,THBS1;TBXA2R;MMRN2
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.2999871681147291,0.4445674472706782,0.9795918367346939,1.0,1.0,1/5,21.48%,APOD
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.2709487839547611,-0.4443573357864845,0.9444444444444444,1.0,1.0,2/6,26.69%,TGFB2;CDH3
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.3075835646818495,0.44384475669945805,1.0,1.0,1.0,1/5,21.74%,MAPK8IP2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),-0.2774202706539226,-0.4435549857604196,0.9782608695652174,1.0,1.0,5/5,72.27%,STXBP1;NAPA;UNC13B;STX1B;NAPB
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.27826886559164,0.4425770040909462,1.0,1.0,1.0,1/8,21.18%,CCNB1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.2509965671233662,0.44245639043929785,1.0,1.0,1.0,6/17,26.90%,SDS;SDSL;ASPA;PIPOX;DLST;GCDH
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.24925764384553423,0.44125533248467935,0.9852941176470589,1.0,1.0,5/18,31.08%,RPA3;RBX1;ERCC4;DDB1;RPA2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.24925764384553423,0.44125533248467935,0.9852941176470589,1.0,1.0,5/18,31.08%,RPA3;RBX1;ERCC4;DDB1;RPA2
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.23792416974063557,0.440834534668201,1.0,1.0,1.0,2/19,15.56%,GPER1;TOR1A
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.22429455191504422,-0.4398845502493074,1.0,1.0,1.0,4/15,24.78%,CLEC16A;ETF1;CLN3;INSR
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.22487376905460393,0.43910726585512566,1.0,1.0,1.0,4/25,21.77%,FBXO5;RIOK2;CCNB1;ESPL1
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.24839758299045125,-0.43901495758002657,0.9777777777777777,1.0,1.0,2/10,18.09%,FBXO43;TOM1L2
prerank,Reactome_2022__Sodium/Calcium Exchangers R-HSA-425561,-0.25502189196933195,-0.43835427997643195,0.9393939393939394,1.0,1.0,3/10,21.51%,SLC8A3;SLC8B1;SLC24A4
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.2607468657172957,0.43680880311279385,1.0,1.0,1.0,6/11,32.36%,CCT7;CCT8;CCT3;CCT6A;CCT2;DKC1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.23905571360469982,0.4366173288443521,0.9841269841269841,1.0,1.0,5/11,34.18%,PAF1;NCBP1;ZFP36L1;AHCYL1;NCBP2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),0.2926090659600645,0.43646224089497804,1.0,1.0,1.0,5/5,70.75%,SMOC2;NPTN;DSTYK;PRKD2;FGFBP3
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.2741707702668216,-0.43584206253531893,1.0,1.0,1.0,1/7,14.26%,CHP1
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.2741707702668216,-0.43584206253531893,1.0,1.0,1.0,1/7,14.26%,CHP1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),0.30341812815528557,0.4342010657730553,1.0,1.0,1.0,2/5,28.09%,AGER;LGALS9
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),0.29430206668978043,0.43415918112313445,1.0,1.0,1.0,2/5,30.65%,ADRA2A;ADRA2C
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.28441075215636197,-0.4337085697108582,1.0,1.0,1.0,2/5,20.33%,NR1H2;PTPN2
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.259747169009607,0.43362230577268335,1.0,1.0,1.0,4/8,34.15%,ESPL1;ERCC4;TERF2IP;WAPL
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.2735427772154494,0.43152460423750305,1.0,1.0,1.0,2/6,30.76%,PPARGC1A;DDB1
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.250351624493625,0.4306530821506883,1.0,1.0,1.0,2/11,19.93%,TOR1A;SNAPIN
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.2341208264214416,-0.430114874499462,1.0,1.0,1.0,3/9,21.70%,LEO1;UBE2E1;RNF40
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.2726827137880861,0.42947112052253494,0.9830508474576272,1.0,1.0,2/6,27.38%,PARP14;ARG1
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.2726827137880861,0.42947112052253494,0.9830508474576272,1.0,1.0,2/6,27.38%,PARP14;ARG1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.25142047223662284,-0.42598454903744615,1.0,1.0,1.0,3/8,31.97%,ITPK1;HK1;IPPK
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.24546096148010102,0.42526812491333865,1.0,1.0,1.0,2/14,21.17%,TACC3;RIOK2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.1885024419360956,-0.4250620447436973,1.0,1.0,1.0,5/48,16.66%,CDK1;SPAST;EMD;NUP37;NUP98
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.1885024419360956,-0.4250620447436973,1.0,1.0,1.0,5/48,16.66%,CDK1;SPAST;EMD;NUP37;NUP98
prerank,Reactome_2022__PTK6 Expression R-HSA-8849473,0.2948802876880855,0.4234348449251808,1.0,1.0,1.0,5/5,70.52%,HIF1A;PTK6;EPAS1;PELP1;NR3C1
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,0.2440243525223588,0.4232834107207631,1.0,1.0,1.0,1/14,11.35%,PPP2R5A
prerank,Reactome_2022__POLB-Dependent Long Patch Base Excision Repair R-HSA-110362,-0.2474389739473028,-0.421361828594612,1.0,1.0,1.0,3/7,27.02%,PARP2;APEX1;PARP1
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.27206828940847116,0.4207999505416034,1.0,1.0,1.0,3/6,30.11%,CD27;CD74;CD70
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.23790902201303607,0.4206428207750963,1.0,1.0,1.0,5/19,27.63%,PINK1;FBXO7;PARK7;VDAC1;CSNK2A2
prerank,Reactome_2022__Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.22923736628538385,0.42027082216682876,1.0,1.0,1.0,5/20,23.99%,MPDU1;MOGAT2;ALG6;ALG2;DPAGT1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.23456418510563015,-0.42011439690199803,0.9629629629629629,1.0,1.0,2/10,17.46%,GPC1;CD9
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.2528159015617605,0.4194215474069443,1.0,1.0,1.0,9/9,74.73%,TNFSF14;PPP2R3C;ZC3H8;NCKAP1L;FAS;JAK3;FADD;AKT1;FOXP3
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.24277212035156814,-0.4191152802029446,1.0,1.0,1.0,1/9,9.93%,STARD3NL
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.222521721931916,-0.41791977563469995,1.0,1.0,1.0,6/13,32.20%,CIAO2A;CIAO2B;ISCA1;LTO1;CIAO1;MMS19
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.29700792453727937,0.4172318845422881,1.0,1.0,1.0,2/5,31.77%,HIF1A;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.21791212340794336,-0.41597091181828233,1.0,1.0,1.0,5/14,26.04%,MACROH2A2;MED1;NCOA3;NUMA1;MACROH2A1
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.2542709762907578,0.41583152999528805,1.0,1.0,1.0,8/8,74.58%,KCNQ1;RYR2;ATP2B4;SIRT2;PRKACA;SLC9A1;PDE4B;SNCA
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.2542709762907578,0.41583152999528805,1.0,1.0,1.0,8/8,74.58%,KCNQ1;RYR2;ATP2B4;SIRT2;PRKACA;SLC9A1;PDE4B;SNCA
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),-0.26885587205450934,-0.41299913463535276,1.0,1.0,1.0,5/5,73.13%,PHF19;PHF1;ZNF304;OGT;MTF2
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.25874639490408397,0.412972183296327,1.0,1.0,1.0,3/7,32.36%,TRUB2;PUS3;DKC1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.23516560032855646,0.4111299456721163,1.0,1.0,1.0,3/11,26.16%,SNAPIN;BLOC1S2;AP3M2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.23516560032855646,0.4111299456721163,1.0,1.0,1.0,3/11,26.16%,SNAPIN;BLOC1S2;AP3M2
prerank,Reactome_2022__Regulation Of Gene Expression By Hypoxia-inducible Factor R-HSA-1234158,0.26243952744361154,0.41009788920564016,1.0,1.0,1.0,4/9,31.77%,EPX;CITED2;HIF1A;VEGFA
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.2368558042686101,-0.40865742206312644,1.0,1.0,1.0,8/8,76.33%,PLAAT1;ABHD4;PLAAT3;PLA2G4E;NAPEPLD;NAAA;PLAAT5;PLAAT4
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.28002271221728026,0.4066186534180772,1.0,1.0,1.0,5/5,72.00%,SLC43A1;ARL6IP5;SLC43A2;HRH3;GRM7
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.25286376976237823,0.40565452044920053,1.0,1.0,1.0,13/13,74.73%,USP17L2;AKAP8;CAMK2D;SPHK2;CTBP1;PRMT6;SDR16C5;ING2;AKAP8L;ZBTB7B;NIPBL;SAP30BP;FOXP3
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.27174613314186136,0.4030029917148708,1.0,1.0,1.0,1/5,19.83%,NOTCH2
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),0.25683496909565773,0.40220308280702,1.0,1.0,1.0,2/6,32.66%,KCNQ1;OPRK1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.2568861167049019,0.4007810202466089,1.0,1.0,1.0,1/8,22.38%,DCTN1
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.24913642171012162,-0.39950710984323257,1.0,1.0,1.0,6/6,75.10%,MAPT;KIF3B;KIF13A;KIFAP3;KIF3A;FYCO1
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),0.2601657216531046,0.39716331561661866,0.9846153846153847,1.0,1.0,1/5,17.22%,SLC23A1
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.27530049795341754,0.3965521731392074,1.0,1.0,1.0,2/5,27.99%,SLC30A1;SLC11A1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.27530049795341754,0.3965521731392074,1.0,1.0,1.0,2/5,27.99%,SLC30A1;SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.22969863222067027,0.39625493609014956,1.0,1.0,1.0,2/10,21.48%,PADI2;APOD
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),0.26738904135516245,0.3949358102171307,1.0,1.0,1.0,5/5,73.27%,VAMP7;VAMP3;SNX4;SNX6;VAMP8
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.2014773426772101,-0.39330872159067826,1.0,1.0,1.0,20/20,79.88%,CARF;NOTCH1;SESN2;EP300;ATF4;SMAD5;NFE2L2;CHD6;XBP1;RUNX2;SMAD9;RBPJ;MT3;SMAD4;VEGFA;BMP2;RELA;SMAD1;HIF1A;CREB3
prerank,CellMarker_Augmented_2021__Effector T cell:Undefined,-0.24031764758340807,-0.39103468073264286,0.9743589743589743,1.0,1.0,1/8,13.38%,HAVCR2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.24440434696616198,-0.3908531650097409,1.0,1.0,1.0,2/6,24.01%,MCL1;PRKN
prerank,Reactome_2022__Signaling By FGFR4 In Disease R-HSA-5655291,-0.24904160159023142,-0.38969938745106847,1.0,1.0,1.0,10/10,75.11%,HRAS;FRS2;PIGU;PIK3CA;SOS1;PLCG1;PIK3R1;GRB2;NRAS;FGFR4
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.2344343508623502,-0.38886390818039956,1.0,1.0,1.0,2/8,20.25%,ICE1;SNAPC3
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.21652909439969667,0.38858961340754256,1.0,1.0,1.0,4/12,31.87%,BRCA1;RBM15B;RLIM;RBM15
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.20732736756159448,-0.3885786372462606,1.0,1.0,1.0,5/11,29.48%,CCDC40;SPEF2;HTT;DYNC1I2;SPA17
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.21509204938669976,0.38556037005276483,1.0,1.0,1.0,9/19,36.50%,THBS1;EIF2B2;EIF2B5;GCKR;PFKL;SELENOT;TCF7L2;HNF4A;ZBED3
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.23782096941559905,0.3832325737614964,1.0,1.0,1.0,4/9,32.10%,FBP1;ACTN3;CBFA2T3;PPARA
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.23782096941559905,0.3832325737614964,1.0,1.0,1.0,4/9,32.10%,FBP1;ACTN3;CBFA2T3;PPARA
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.20421303654140593,0.3807037896504494,1.0,1.0,1.0,2/19,19.93%,VPS18;SNAPIN
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.18540590444068167,-0.37705646950018445,1.0,1.0,1.0,7/29,28.05%,SNF8;MVB12A;TSG101;UBAP1;RNF103-CHMP3;MVB12B;VTA1
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,-0.17381867778602522,-0.37478860772467876,1.0,0.9999562496737532,1.0,8/28,29.52%,KIF4B;RPS6KA3;DNM2;NUMB;SRC;DPYSL2;RPS6KA6;CLTA
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.23906871095968196,0.37084253267894646,1.0,1.0,1.0,7/7,76.10%,RIOK2;CDC6;HECW2;CDC23;CENPE;PLK1;NEK6
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.19934476335807821,0.36955243868588344,0.9838709677419355,1.0,1.0,4/14,30.61%,EXOSC4;DCP2;UPF1;SSB
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.2234755325248377,0.3680782969101447,1.0,1.0,1.0,2/8,27.07%,ADH5;ADH7
prerank,Reactome_2022__HDL Assembly R-HSA-8963896,0.2249865668575489,0.36686202414870495,1.0,1.0,1.0,1/6,20.90%,BMP1
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,0.18237591284257373,0.35491431252874384,1.0,1.0,1.0,1/27,11.00%,RPS27A
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.2242831456420933,-0.3447741670772625,1.0,1.0,1.0,5/5,77.58%,ATM;NIPBL;XRCC5;NUCKS1;XRCC6
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.22579395150246748,0.33799346604796865,1.0,1.0,1.0,2/7,29.58%,RAB29;ARL13A
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.21876737816945235,0.3331306641449803,1.0,0.9999612731371958,1.0,4/8,33.14%,AGR2;BBS7;PDGFRA;RBPMS2
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.1653009993842656,-0.3112759889268541,1.0,1.0,1.0,26/26,83.49%,NUP37;NUP98;SEH1L;NUP43;SUMO1;KPNB1;NUP107;NUP160;NUP54;UBE2I;NUP205;NUP35;NUP133;NUP85;POM121;RAN;AHCTF1;RANGAP1;TNPO1;NUP188;SEC13;NDC1;NUP58;NUP93;NUP155;RCC1
